{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [],
   "source": [
    "%%capture\n",
    "!pip install multiversity\n",
    "\n",
    "from multiversity.multicare_dataset import MedicalDatasetCreator"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [],
   "source": [
    "import os\n",
    "import pandas as pd"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Current directory: /home/onyxia/work/projet_NLP\n",
      "Working directory set to: /home/onyxia/work/projet_NLP\n"
     ]
    }
   ],
   "source": [
    "current_directory = os.getcwd()\n",
    "print(f\"Current directory: {current_directory}\")\n",
    "\n",
    "os.chdir(f'{current_directory}')\n",
    "print(f\"Working directory set to: {os.getcwd()}\")"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# 1. Downloading the Whole MultiCaRe Dataset"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "The MultiCaRe Dataset is already downloaded.\n",
      "Importing and pre-processing the main files.\n",
      "Done!\n"
     ]
    }
   ],
   "source": [
    "mdc = MedicalDatasetCreator(directory = 'medical_datasets')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['PMC1',\n",
       " 'PMC2',\n",
       " 'PMC3',\n",
       " 'PMC4',\n",
       " 'PMC5',\n",
       " 'PMC6',\n",
       " 'PMC7',\n",
       " 'PMC8',\n",
       " 'PMC9',\n",
       " 'abstracts.parquet',\n",
       " 'captions_and_labels.csv',\n",
       " 'case_images.parquet',\n",
       " 'cases.parquet',\n",
       " 'data_dictionary.csv',\n",
       " 'metadata.parquet']"
      ]
     },
     "execution_count": 5,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "sorted(os.listdir('medical_datasets/whole_multicare_dataset'))"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# 2. Reading of dataset"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>file</th>\n",
       "      <th>field</th>\n",
       "      <th>explanation</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>captions_and_labels.csv</td>\n",
       "      <td>file_id</td>\n",
       "      <td>Primary key for each row. Each row contains on...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>captions_and_labels.csv</td>\n",
       "      <td>file</td>\n",
       "      <td>Name of the image file. The file path can be d...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>captions_and_labels.csv</td>\n",
       "      <td>main_image</td>\n",
       "      <td>Id from the original image (it corresponds to ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>captions_and_labels.csv</td>\n",
       "      <td>image_component</td>\n",
       "      <td>It is 'undivided' if the source image was not ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>captions_and_labels.csv</td>\n",
       "      <td>patient_id</td>\n",
       "      <td>Id of the patient, created combining the PMC o...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                      file            field  \\\n",
       "0  captions_and_labels.csv          file_id   \n",
       "1  captions_and_labels.csv             file   \n",
       "2  captions_and_labels.csv       main_image   \n",
       "3  captions_and_labels.csv  image_component   \n",
       "4  captions_and_labels.csv       patient_id   \n",
       "\n",
       "                                         explanation  \n",
       "0  Primary key for each row. Each row contains on...  \n",
       "1  Name of the image file. The file path can be d...  \n",
       "2  Id from the original image (it corresponds to ...  \n",
       "3  It is 'undivided' if the source image was not ...  \n",
       "4  Id of the patient, created combining the PMC o...  "
      ]
     },
     "execution_count": 6,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "data_dictionary = pd.read_csv('medical_datasets/whole_multicare_dataset/data_dictionary.csv')\n",
    "\n",
    "data_dictionary.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{'cases': [[{'age': 53,\n",
       "    'case_id': 'PMC3738355_01',\n",
       "    'case_text': 'A 53-year-old woman presented with a 10-year history of intermittent abdominal pain, swelling and continuous vomiting. The patient denied presence of fever, nausea, and weight loss. There were no significant findings at physical examination. An abdominal ultrasound exam revealed a 10.4 x 10.0 cm mass of heterogeneous echogenicity in the left upper abdomen. Axial unenhanced CT scan (Fig. 1a) confirmed an ill-defined heterogeneous mass 9.1 cm in diameter that filled the left abdominal quadrant, located between the left lobe of the liver and the spleen. The CT attenuation of the mass was around 26-53 HU on non-enhanced scan. After intravenous contrast medium injection the mass enhanced gradually and heterogeneously (Fig. 1b-e), but was still hypodense relative to the spleen. There was no accompanying lymphadenopathy or evidence of malignant process elsewhere in the abdomen. Because the origin of the mass was unknown and a primary malignancy could not be excluded, the patient underwent an explorative laparotomy. During the operation, a well-encapsulated mass was found under the left hepatic lobe and the pedicle arising from the spleen. Resection of the mass and the spleen was performed.  \\nGross examination of the spleen showed splenomegaly (580 g, 15 x 10 x 9 cm) with an ill-defined brownish nodule (5 x 8 x 8 cm). Histologic examination (Fig. 2) revealed that the lesion was composed of variably sized vascular channels lined with flat and tall endothelial cells, with papillary fronds extending into the vascular channels. No atypical cells or mitosis were present. The endothelial lining cells of the vascular channels were positive for CD31 and CD68, factor VIII and negative for CD34, CD21, and CD8. These findings were considered diagnostic of benign splenic littoral cell angioma.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 69,\n",
       "    'case_id': 'PMC5015624_01',\n",
       "    'case_text': \"A 69-year-old Caucasian female with coronary artery disease, hyperlipidemia, bilateral cataract extraction three years prior, and a fifty pack-year smoking history presented to the clinic with chronic, progressive vision loss greater in the right eye, bilateral photophobia and flashes, and right eye and temple pain. Best corrected visual acuity was 20/50 in both eyes. Pupils were equal and without afferent pupillary defect (APD). Intraocular pressure was 12 mmHg and 10 mmHg in the right and left eyes, respectively. Confrontation visual fields revealed an inferonasal depression in the right eye. Slit lamp biomicroscopy showed iris neovascularization of both eyes (Figure 1 (Fig. 1)). Dilated fundus examination showed unremarkable optic nerves, attenuated arteries, and dilated, non-tortuous veins in both eyes with few drusen in the right macula and very few hemorrhages. Optical coherence tomography showed no evidence of macular edema (Figure 2 (Fig. 2)). \\nFluorescein angiography exhibited delayed arterial filling and poor peripheral perfusion (Figure 3 (Fig. 3)). Right temporal artery biopsy was negative for giant cell arteritis. We ruled out hyperviscosity syndromes, blood dyscrasia, diabetes, Takayasu, collagen vascular disease, thyroid orbitopathy and various infectious causes of retinal ischemia and aortitis. CBC, SPEP, HbA1c, ESR, CRP, FTA-ABS, and hypercoagulation panel were unremarkable. Carotid duplex ultrasound indicated only mild carotid stenosis (1-39%) bilaterally. At the time of initial presentation, the patient was taking Lipitor, Aspirin 81 mg, Relafen, Klonopin, Zoloft, and Nexium. \\nThe patient received pan-retinal photocoagulation (PRP) in the right eye. Due to low tolerance, a retrobulbar block without epinephrine was administered to the right eye prior to the second PRP ten days later at which time 3,625 spots with a duration of 20 milliseconds of 500 mW were delivered using the indirect laser ophthalmoscope. Eighteen days after this laser session visual acuity had dropped significantly in the right eye to count fingers at 3' with APD and attenuated posterior vasculature consistent with central retinal artery occlusion. MRA Extracranial showed proximal occlusion of aortic arch branches (Figure 4 (Fig. 4)). Due to concern for diminished blood supply from the aortic arch, the patient received a left subclavian artery to right common carotid artery bypass graft. One month after surgery, neovascular glaucoma developed in the right eye with intraocular pressure of 34 mmHg and 22 mmHg in the left eye. Pressures remained stable on Combigan twice daily. We treated the left eye with short sessions of laser for a total of 2,200 burns (0.05-0.07 sec, 300 micron) using the Laser indirect system for one session and the Varia multicolor slit-lamp system for the remaining 5 sessions. Six months after the bypass surgery, she maintained a visual acuity of 20/50 in the left eye and intraocular pressure was 18 mmHg.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 60,\n",
       "    'case_id': 'PMC6381877_01',\n",
       "    'case_text': 'A 60-year-old male smoker presented with persistent cough and severe right-back pain. His performance status (PS) was 2 by the pain despite opioid use in palliative care. In the imaging test of full body, chest X-ray and chest CT revealed a large lung mass, extending to posterior chest wall and vertebral body, surrounded by lymphangitic carcinomatosis in the right lower lung as well as multiple lymphadenopathy and right pleural effusion (Fig. 1a, b). Bronchoscopic biopsy of the tumor lead to a diagnosis of primary lung adenocarcinoma (cT4N2M1a, stage IV) harboring the EGFR exon 19 deletion mutation. No other molecular analysis was performed. The patient was started on gefitinib at 250 mg/day for the treatment of lung adenocarcinoma. However, by 28 days after the start of gefitinib therapy, his symptoms further deteriorated along with the increased tumor size, resulting in PS 3 (Fig. 2a, b).\\nThen, repeat biopsy was performed from the lung tumor. First, in addition to the preserved EGFR exon 19 deletion mutation, EGFR T790M mutation was analyzed, resulting in negative status. Second, as a possible molecular alteration next to EGFR T790M mutation, fluorescence in situ hybridization (FISH) analysis for MET amplification was analyzed, resulting in positive status (mean MET per cell = 6.7, MET/CEP7 [centromeric enumeration probe for chromosome 7] ratio = 2.5). At this point, cytotoxic chemotherapy was not a candidate for treatment due to his poor PS. Furthermore, although crizotinib was known as potential MET inhibitor as well as anaplastic lymphoma kinase (ALK) inhibitor, combination therapy with crizotinib and EGFR-TKI was considered to lack the evidences about safety. Therefore, combination therapy with bevacizumab and erlotinib was selected on the basis of the potential efficacy for activated MET signaling pathway as well as the confirmed safety by the JO25567 phase II clinical trial.\\nThe patient was started on erlotinib at 150 mg/day plus bevacizumab at 15 mg/kg every 3 weeks. By 21 days after the start of this combination therapy, his symptoms gradually improved along with the decreased tumor size, resulting in better PS with no severe toxicities (Fig. 3a, b). However, after 2 cycles of bevacizumab administration, he unfortunately fractured his face from falling down during the rehabilitation to improve the deteriorated activity of daily life (ADL). Then, he underwent open reduction and fixation of his face fracture under general anesthesia. Eventually, he was forced to quit this promising combination therapy.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 41,\n",
       "    'case_id': 'PMC5912312_01',\n",
       "    'case_text': \"A 41-year-old female with a past medical history of hypothyroidism and Prinzmetal's angina presented with worsening typical chest pain for 1 day. She was 10 weeks postpartum. Her pain was unresponsive to nitroglycerin and aspirin. Electrocardiogram showed T-wave inversions in anterolateral leads. She was taken to the cardiac catheterization laboratory and was found to have SCAD of the left main (LM), left anterior descending (LAD), and left circumflex arteries (LCx; Figure 1). She was managed with emergent coronary artery bypass graft (CABG) of 2 vessels, including, left internal mammary artery to the LAD and saphenous vein graft (SVG) to the ramus intermedius artery. Her subsequent recovery was uneventful and she was asymptomatic with normal echocardiogram at the 6-month follow-up.\",\n",
       "    'gender': 'Female'},\n",
       "   {'age': 51,\n",
       "    'case_id': 'PMC5912312_02',\n",
       "    'case_text': 'A 51-year-old male with a history of SCAD presented to our medical Center with refractory angina and decreased exercise tolerance for 2 days. Electrocardiogram showed nonspecific ST-T wave changes with initial troponin level of 0.8 ng/mL (normal <0.01 ng/mL). He was taken to the cardiac catheterization laboratory where coronary angiography showed dissection of both the LAD and the right coronary artery (RCA; Figure 2). He was managed with the deployment of 2 overlapping drug-eluting stents with good angiographic results in the RCA. In his LAD, he had a residual dissection with an angiographically determined good flow. At the 3-month follow-up, he showed recovery of his exercise tolerance and no further episodes of angina.',\n",
       "    'gender': 'Male'},\n",
       "   {'age': 34,\n",
       "    'case_id': 'PMC5912312_03',\n",
       "    'case_text': 'A 34-year-old African American female with a recent Cesarean section presented with sudden-onset chest pain for 15 minutes. On admission, electrocardiogram showed ST-segment elevations in V4, V5, and V6. Cardiac catheterization was performed. It revealed a long dissection of the LAD, originating just distal to the ostium and extending up to the mid portion. Thrombolysis in myocardial infarction (TIMI) grade 3 flow (normal flow) was noted. She was initially managed with medical therapy. Two days later, she had recurrent chest pain. Electrocardiogram changes were consistent with ischemia. Repeat catheterization showed stable LAD dissection with new RCA dissection with TIMI grade 1 flow (incomplete filling of distal coronary artery; Figure 3). She underwent an emergent 2-vessel CABG (SVG to LAD and SVG to RCA). Her postoperative period was uneventful. She developed peripartum cardiomyopathy after 3 months but had recovered left ventricular systolic function at the 6-month follow-up.',\n",
       "    'gender': 'Female'},\n",
       "   {'age': 45,\n",
       "    'case_id': 'PMC5912312_04',\n",
       "    'case_text': \"A 45-year-old female, professional marathon runner, with a history of Raynaud's phenomenon, migraines, gastroesophageal reflux disease, and serum-positive HLA-B27, developed a sudden-onset chest pain while riding her bicycle. The pain lasted 2 hours, throughout the duration of exercise, and was noted to radiate to her back and jaw. In the emergency room, the electrocardiogram showed anterior wall myocardial infarction (MI) with positive serum troponin of 0.15 ng/mL (normal <0.01 ng/mL). Cardiac catheterization ruled out coronary atherosclerotic disease. However, the LM had a long SCAD that was extending to the mid LAD. The blood supply distal to the lesion was compromised. It was successfully stented with 2 bare metal stents. At the 3-month follow-up, she had an uneventful recovery with partial recommencement of her strenuous physical activity.\",\n",
       "    'gender': 'Female'},\n",
       "   {'age': 49,\n",
       "    'case_id': 'PMC5912312_05',\n",
       "    'case_text': 'A 49-year-old female with stage IV sarcoidosis presented to our hospital with chest pain and shortness of breath. Electrocardiogram showed STEMI in the anterolateral leads. Emergent catheterization revealed SCAD in the mid LAD with an unsuccessful wiring (Figure 4). The patient was managed conservatively. Later, her hospital course was complicated by a left ventricular thrombus and an embolic stroke requiring anticoagulation. She was discharged to rehabilitation center where she stayed for a period of 6 weeks. At the follow-up in the outpatient clinic, the patient had no residual deficits of recent stroke and had no angina. Over the next year, she had worsening pulmonary hypertension secondary to her sarcoidosis and was deemed a suitable candidate for a heart and lung transplantation.',\n",
       "    'gender': 'Female'},\n",
       "   {'age': 56,\n",
       "    'case_id': 'PMC5912312_06',\n",
       "    'case_text': \"A 56-year-old female developed sudden-onset, sharp chest pain that led to syncope. On admission, electrocardiogram showed NSTEMI with a troponin level of 4.5 ng/mL (normal <0.01 ng/mL). Left heart catheterization showed a SCAD involving the LCx with TIMI grade 3 distal flow (Figure 5). While receiving cardiac catheterization, she developed an acute stroke with left-sided visual field deficit and received intravenous tissue plasminogen activator with complete resolution. She was managed conservatively with medical therapy for NSTEMI. She remained compliant with her medications. Follow-up catheterization due to persistent chest pains showed healed LCx dissection with no atherosclerotic disease in the rest of her coronary arteries. She was started on nifedipine for possible diagnosis of Prinzmetal's angina (variant angina). Her symptoms improved drastically on subsequent follow-up visits.\",\n",
       "    'gender': 'Female'},\n",
       "   {'age': 60,\n",
       "    'case_id': 'PMC5912312_07',\n",
       "    'case_text': 'A 60-year-old female presented to our medical institution with chest pain lasting 15 minutes. Electrocardiogram showed a new-onset right bundle branch block and she was found to have a troponin of 0.24 ng/mL (normal <0.01 ng/mL). Coronary angiogram showed an abnormality in the diagonal branch of the LAD (mid D1 radiolucency) concerning for thrombus versus dissection (Figure 6). Optical coherence tomography was performed to distinguish the lesion. Therein, a SCAD was noted, which was managed with drug-eluting stent placement. Final angiography displayed no evidence of thrombosis, distal embolization, or further dissection. She remained compliant with her dual antiplatelet therapy for 8 months. Subsequently, she experienced a major gastrointestinal bleeding after which clopidogrel (Plavix) was discontinued. She remained symptom-free on follow-up visits.',\n",
       "    'gender': 'Female'},\n",
       "   {'age': 34,\n",
       "    'case_id': 'PMC5912312_08',\n",
       "    'case_text': 'A 34-year-old female who was 38 weeks pregnant presented with atypical chest pain for 1 day. Electrocardiogram showed ST-segment elevations in the anterolateral leads with a negative first troponin level. Coronary angiogram showed SCAD of the mid portion of the LAD with large intramural hematoma compromising the blood flow to the first and second diagonal branches of the LAD with TIMI grade 3 flow into distal vessel (Figure 7). No intervention was done and she was admitted to the cardiac care unit where a conservative approach was adopted. After undergoing Cesarean section, repeat coronary catheterization was performed. It showed no evidence of intramural hematoma and a healed LAD dissection.',\n",
       "    'gender': 'Female'},\n",
       "   {'age': 36,\n",
       "    'case_id': 'PMC5912312_09',\n",
       "    'case_text': 'A 36-year-old female who was 6-days postpartum presented with typical chest pain radiating to her left arm for 1 hour. Electrocardiogram showed ST-segment elevations in leads V2 and V3 and ST depressions in the inferior leads. Emergent catheterization showed a dissection of the proximal LAD after the first 2 septal perforators with evidence of luminal compromise by a hematoma (Figure 8). Conservative management was planned and she was started on dual antiplatelet therapy. Follow-up catheterization after 6 weeks showed no progression of the LAD dissection with resolution of the hematoma. She remained asymptomatic on follow-up visits.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 30,\n",
       "    'case_id': 'PMC5287946_01',\n",
       "    'case_text': \"A 30-year-old man came to Peking Union Medical College Hospital (PUMCH) with headaches, fatigue, diplopia, and impaired visual field and acuity for 6 months which had worsened since the previous 2 weeks. He denied polydipsia, polyuria, sexual hypoactivity, or any symptoms of unconsciousness, epilepsy, convulsion, and cognitive disorders. Physical examinations revealed that his right visual acuity was 0.5 and the left was 0.4. Goldmann perimetry revealed a bitemporal hemianopia. He was found to have ptosis of the right eyelid. The right pupillary reaction to light was absent. Other neurological examination results were normal. His past history was negative for head trauma. His social and family history and his system review were negative.\\nThe magnetic resonance imaging (MRI) demonstrated an abnormal mixed signal mass with suprasellar, parasellar, and suprasellar invasiveness in the sellar area (Fig. 1A-C). The lesion was about 2.8 x 1.9 x 1.9 cm, inside which was some spotty necrosis. A dynamic contrast-enhanced scan showed heterogeneous enhancement. Relatively normal pituitary tissue with normal enhancement could be seen near the inferior lesion margin, but was squashed. The optic chiasma was mildly compressed but the basic shape was generally normal. The bilateral internal carotid arteries were also partly wrapped. Laboratory tests used to explore pituitary disorders showed normal levels of pituitary hormones, including prolactin (N < 20 mug/L), luteinizing hormone (LH) (N > 10 IU/L), follicle-stimulating hormone (FSH) (N > 20 IU/L), thyrotropin, and corticotropin. The diagnosis of nonfunctioning pituitary macroadenoma was suspected.\\nVia a trans-nasal-sphenoidal approach, a surgical exploration was performed. After drilling the sellar floor and opening the dura, a firm, tough, wheaten mass was found. As its consistency was too elastic and hypervascular to be easily cut by a surgical blade, and it adhered so tightly to the cavernous sinus and internal carotid artery, only subtotal resection was ultimately achieved. Repair of the sellar defect was done with autologous fat and fascia lata. The immediate postoperative sellar MRI was not performed. In a surprise twist, postsurgical hematoxylin and eosin (H & E) stained sections showed that the lesion contains epithelioid and spindled cells with eosinophilic cytoplasm arranged in sheets and nests. Mild-to-moderate nuclear atypia could also be observed. On immunohistochemical evaluation, the tumor cells were positive for Vimentin, CD68, CD34, Nestin, GFAP, Desmin, SMA, AE1/AE3, and S-100 protein, but were negative for NSE, Synuclein, NeuN, EMA, pituitary hormones (LH, FSH, ACTH, TSH, growth hormone, and prolactin), synaptophysin and chromogranin. Ki-67 proliferation index was 6% (Fig. 2A-K). The pathological test supported the diagnosis of adenohypophysis spindle-cell oncocytoma. The postsurgical course was uneventful and his clinical symptoms of headache and diplopia were markedly improved.\\nHowever, 1 month after the surgery, the patient's vision declined sharply and meanwhile he complained of severe ophthalmodynia of the right eye. The sellar MRI revealed that the tumor recurred (Fig. 1D and E) and the patient underwent a gamma-knife treatment. But the symptoms were not relieved significantly. Three months later, the sellar MRI showed the lesion was approximately 2.8 x 2.2 x 3.1 cm with equal T1 signal and inhomogeneous long T2 signal, which were enhanced with mass or nodosity after contrast administration. The suprasellar region, bilateral cavernous sinuses, and optic chiasma were further invaded. Necrosis, cyst degeneration, and hemorrhage within the tumor could be detected (Fig. 1F-H). A secondary surgery was performed through the left pterional approach. The tumor's texture was firm to elastic and the bleeding was heavy; therefore, we just performed a partial resection, decompressed the optic nerves and chiasm. The sellar MRI after 1 week of the secondary surgery was shown as Fig. 1I to K. Postsurgically, transient central diabetes-insipidus persisted for 2 weeks. Visual field and acuity remained unimproved. Histological evaluation revealed similar morphology and immunohistochemical profiles to the previous specimen. The Ki-67 index for this time increased to 19%. From the perspectives of pathologists, the pathological grade was considered WHO III.\\nOne month after the secondary surgery, the patient came to PUMCH again complaining almost blindness and severe headache. A sellar MRI was arranged, demonstrating that the tumor recurred again to approximately 4.9 x 3.6 x 3.1 cm with necrosis, cyst degeneration, and hemorrhage. The enhancement was inhomogeneous and the surrounding structures and tissues were further invaded (Fig. 1L-P). The third surgery via a transsphenoidal approach was conducted for decompressing. Partial resection was achieved and the visual disturbance and headache were alleviated a lot. Pathological evaluation results were similar to previous, confirming the diagnosis of ASCO. And the Ki-67 proliferation index increased to 45% (WHO III-IV grade, Fig. 2L), highly suggesting its malignancy. The patient has already been followed up for nearly half a year and reported no recurrence of headache and visual deterioration. His right visual acuity was 0.4 and the left was 0.3, evaluated recently.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 40,\n",
       "    'case_id': 'PMC9106225_01',\n",
       "    'case_text': 'A 40-year-old female patient was referred for evaluation of an asymptomatic swelling on the lower lip of 6 months duration with a history of local trauma. Clinical examination revealed a well-defined, nontender, smooth-surfaced, roughly oval, fluctuant swelling [Figure 1]. No relevant medical history was elicited. Oral hygiene was fair. A provisional diagnosis of mucocele was made; the lesion was excised under local anesthesia. Histopathological examination of the excised tissue revealed cystic lumen devoid of lining epithelium and surrounded by compressed granulation tissue and peripherally located mixed salivary glands. The lumen was filled with numerous mucinous globular structures which were oval or round in shape and of varying sizes [Figure 2]. Most of the globules present in the cystic lumen were attached to the surrounding cystic capsule and seemed dissociated from one another because of their globular organization. Some of the globules were suspended freely within the lumen [Figure 3]. Individual globules exhibited a mildly cellular core with peripheral laminations of dystrophic calcifications [Figure 4]. The granulation tissue forming the cystic wall was highly cellular, consisting of chronic inflammatory cells. The mucinous globules showed positive results for PAS and Alcian blue [Figures 3 and 4].',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 29,\n",
       "    'case_id': 'PMC7276389_01',\n",
       "    'case_text': \"A 29 years old female, physician by profession presented to the emergency department with a history of aggressive vomiting five weeks back followed by left upper abdominal, a single episode of loose motion, subcostal pain radiating to left shoulder associated with shortness of breath (SOB) and was unable to take full inspiration. The patient has a history of heartburn, early satiety, indigestion, and food regurgitation six years ago and diagnosed and managed as gastroesophageal reflux disease in her native country.\\nThe primary evaluation shows a toxic looking afebrile patient with vitals as; respiratory rate-27/min, pulse 87/min. Along with first-level management, abdominal ultrasonography (US) and initial laboratory workup were done in ED with no abnormal findings and the patient discharged home after the primary management independently and not asking surgeon on-call help. Upon no improvement, the patient revisited the ED where chest x-ray (CXR) as primary imaging modality was requested by surgeon on-call that showed raised right hemidiaphragm with no well discernible outlines, air-filled bowel loops above the hepatic shadow, a chilaiditi's sign, with no mediastinal shift (Fig. 1a), thus a provisional diagnosis of the right-sided diagrammatic hernia was made.\\nFollowing CXR, a non-contrast CT requested showing stomach and parts of the colon in the right thoracic cavity (Fig. 2a) along with spleen located posterior to the heart - the retrocardiac spleen (Fig. 2b), thus a final diagnosis of Bochdalek hernia was made.\\nSevere vomiting, a few weeks earlier was the triggering event in the patient that led to the initiation of the clinical picture. After initial stabilization, the patient was transferred to a regional tertiary care facility for cardiothoracic surgeon evaluation and management where via open thoracotomy, contents reduced and fortunately there was no vascular compromise. Repair done. Post-operative chest x-ray shows normal findings (Fig. 1b). The patient had uneventful recovery and discharged home on 10th post-operative day. The patient did well in her follow-up period. To the best of our knowledge, it is the first reported case of Bochdalek hernia associated with the retrocardiac spleen in an adult female in the published literature.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 63,\n",
       "    'case_id': 'PMC3134036_01',\n",
       "    'case_text': \"A 63-year-old multiparous woman, gravida 4, para 3, complained of abnormal vaginal bleeding of 2 months' duration. She went into menopause at age 54. The patient had no remarkable medical or family histories. On vaginal examination, the uterus was enlarged, non-tender, smooth and movable. Vaginal ultrasonogram and magnetic resonance imaging showed a polypoid mass of 14 x 10 cm in size in the uterus, possibly representing a carcinosarcoma or leiomyosarcoma. No free pelvic fluid was identified. Computed tomography (CT) showed the liver and bile ducts to be normal. The endometrial Pap smear was evaluated as positive. Biopsies of the endometrium were carried out and the histological diagnosis revealed carcinosarcoma. The serum AFP level was 10,131 ng/ml (normal <20). Other tumor markers and liver function test results were within normal limits. The patient underwent a total abdominal hysterectomy, bilateral salpingo-oophorectomy and pelvic lymphadenectomy.\\nThe resected enlarged uterus, weighing 560 g and measuring 14 x 12 x 7 cm, had a smooth glistening surface. The polypoid tumor originated from the uterine cavity when the anterior wall of the uterus was opened. The uterine adnexae were normal in shape and size. There was no evidence of a tumorous lesion. Microscopic examination showed that the polypoid tumor was a mixture of carcinomatous and sarcomatous components (fig. 1a). The tumor had invaded the uterine cervix, but no metastases were found in the dissected lymph nodes. The carcinomatous component showed adenocarcinoma arranged in sheets and cords with a hepatoid appearance. Reactivity for AFP was cytoplasmic in the hepatoid carcinoma lesion (fig. 1b). The sarcomatous component showed no reactivity for AFP. The large pleomorphic cells were positive for desmin, actin, CD10, MyoD1, and myoglobin and could be regarded as being rhabdomyosarcoma. There was no staining with S-100. In summary, the tumor was histopathologically diagnosed as heterologous uterine corpus carcinosarcoma associated with AFP-producing hepatoid adenocarcinoma.\\nPostoperatively, the patient received six courses of chemotherapy with paclitaxel (175 mg/m2) and carboplatin (AUC 5). This regimen was repeated every 3 weeks. After the third course of chemotherapy, the patient's serum AFP level decreased to 4.5 ng/ml. The patient is alive with no evidence of recurrence or increase in the serum AFP level in the 2 years since treatment.\",\n",
       "    'gender': 'Female'},\n",
       "   {'age': 82,\n",
       "    'case_id': 'PMC3134036_02',\n",
       "    'case_text': \"An 82-year-old woman, gravida 0, para 0, was referred to our hospital with vaginal bleeding of 2 months' duration. She had undergone surgery due to breast cancer at the age of 68. On pelvic examination, enlarged uterus without a palpable adnexal mass was detected. The vaginal wall showed no abnormalities. Portio vaginalis could not be detected, so the endometrial Pap smear could not be done. Magnetic resonance imaging revealed an enhanced mass, 8 cm in size, in the uterine corpus cavity, possibly representing malignant tumor. CT scan demonstrated ascites and no lymph nodes were detected. CT and ultrasonography revealed no abnormalities in the liver or bile duct. The serum AFP level was elevated (401 ng/ml), but no elevation of other markers, such as carcinoembryonic antigen or carbohydrate antigen 125, was observed. The blood count and serum biochemical data were unremarkable. From these results, malignant uterine tumor was highly suspected. A total abdominal hysterectomy with bilateral salpingo-oophorectomy and pelvic washings was carried out. The resected uterus was enlarged and filled with a spongy material. There was no apparent extrauterine extension of the tumor. A partially necrotic polyp, 8 cm in size, was present within the endometrial cavity, which infiltrated into the myometrium for about two-thirds of its thickness but did not invade the cervix. Cytology of the pelvic washings was negative. Histologically, the tumor was composed of carcinomatous and sarcomatous components (fig. 2a). The carcinomatous component was an endometrioid adenocarcinoma with trabecular hepatoid cells, mostly showing hepatocellular carcinoma-like proliferation. Immunohistochemistry also revealed AFP-positivity in many tumor cells (fig. 2b).\\nThe sarcomatous component showed rhabdoid features including spindle-shaped tumor cells. Occasional cells with eosinophilic cytoplasm and cytoplasmic cross-striations were identified. Immunohistochemistry showed focal positivity of tumor cells with desmin, MyoD1, and CD10. On pathologic examination, the tumor was interpreted as being a heterologous uterine corpus carcinosarcoma associated with AFP-producing hepatoid adenocarcinoma.\\nWe did not carry out any adjuvant chemotherapy or irradiation because of the patient's advanced age, in addition, she and her family refused these therapies. Two months after the surgery, the patient's serum AFP level decreased to a normal level. However, multiple lung metastases with a high-serum AFP level reappeared and the patient died 1 year after the operation.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': None,\n",
       "    'case_id': 'PMC9184873_01',\n",
       "    'case_text': \"The characteristics of patients are outlined in Table 1. Twenty of the 34 MM patients were females and 14 were males, the median age was 73,2 years (range 64.6-80.3) and the median time from diagnosis of MM to the first treatment with daratumumab was 37 months (range 235-3). Cytogenetic characteristics were obtained from only 7 patients, of these only one was unfavorable. Each patient received one line of therapy and 6 (14,7%) patients received two lines or more. All 34 RRMM patients received a previous bortezomib-based therapy in which bortezomib was given with dexamethasone alone (3 cases) or combined with melphalan (16 cases) or with thalidomide (15 cases). In addition, 4 patients received lenalidomide, 3 patients received pomalidomide and 1 patient received Carfilzomib. Before DRd, seven patients (20,6%) underwent to a prior autologous stem cell transplantation (ASCT), that it is consisted in a single ASCT in 5 patients and in a double ASCT in the other 2 cases.\\nSixteen patients (47%) presented one or more comorbidities: cardiovascular diseases (11), solid tumors (4), metabolic disorders (3), other hematological disorders (2), rheumatological diseases (1), pulmonary diseases (1), neurological diseases (1) and gastrointestinal diseases (1).\\nTwelve patients (36%) were refractory to the previous therapy. Eight patients (23,5%) presented with anemia (Hb < 10 g/dl), 3 (8,8%) with chronic kidney disease (creatinine > 2 mg/dl), 19 (55,9%) with bone lesions, while none of the patients presented with hypercalcemia (Ca2+ > 11 mg/dl). Among the 34 patients, 18 (53%) had a monoclonal component (CM) > 2 g/dl and 18 patients (53%) had a Bence-Jones proteinuria.\\nAll RRMM patients received daratumumab IV at the standard dose of 16 mg/kg whereas in 30 (88,3%) patients it was combined with lenalidomide and dexamethasone (DRd) and in the remaining 4 cases (11,7%) with bortezomib and dexamethasone (DVd). A median number of 8 cycles (range 1-32) was administered within a median follow-up of 16 months (range 1-35). Among DRd treated patients, the lenalidomide starting dose was reduced in 12 patients (35%) according to the renal function or due to neutropenia or thrombocytopenia. At the time of analysis, 25 (73,5%) patients were currently receiving treatment. Nine patients (26,5%) discontinued treatment for progressive disease (8 patients) and intolerance (1 case).\\nPatients who received at least two doses of daratumumab-based triplets were included in the statistical analysis. Progression-free survival (PFS) and overall survival (OS) were calculated using the Kaplan-Meier product-limit estimator.\\nThe overall response rate (ORR) was 88%. A Complete Response (CR) occurred in 12% of cases, a Very Good Partial Response (VGPR) in 44%, and a Partial Response (PR) in 32%. The Median time to achieve at least a PR was 40 days (range 30-110 days). Progressive disease was observed in 8 patients (23,5%), in which 5 cases (14,7%) led to death. Twenty-six patients (76,4%) were responding to treatment at the time of analysis.\\nMoreover, 4 transplant-eligible patients, however refractory to the VTD scheme after a median of 6 cycles of daratumumab, deepened their response, allowed themselves to receive an ASCT, and then continued DRD therapy. One of these four patients progressed and died within 100 days after the transplant.\\nAdverse events are summarized in Table 2. The most common hematological toxicities of any grade were neutropenia (15 patients; 44%), managed with lenalidomide dose reduction, and thrombocytopenia (10 patients; 29%). Other common non-hematological toxicities of grade 1 involved 10 patients (29%), including asthenia, light-headedness and breathlessness, edema of lower extremities, intestinal intolerance with diarrheal episodes, and epigastralgia. Two patients (5,4%) presented pulmonary AEs, one case with pneumonia and the other case with a chronic obstructive pulmonary diseases (COPD) exacerbation. The only grade 4 AE case was observed at the beginning of the third cycle and consisted of intolerance with persistent gastrointestinal disorders that required patient hospitalization leading to a discontinuation of the therapy.\\nAfter an extensive oral premedication of our patients consisting of cetirizine dihydrochloride 10 mg, montelukast 10 mg, paracetamol 1000 mg and dexamethasone 20 mg that was administered once/daily from the day before to the day after the infusion, we observed a DARA infusion-related reactions (IRRs) in only 3 patients (8,8%). All IRRs were a grade 1 - 2 and occurred during the first infusion, with urticaria, tachycardia, and respiratory symptoms, such as bronchospasm and dyspnea.\\nAt a median follow-up of 16 months (range 35 - 1), the median PFS and OS have not been reached (NR); the 12-month PFS and OS rates were 78% and 86,5%, respectively (Fig. 1. A and B). In the univariate analysis, the achievement of at least a VGPR, receiving just one line of previous therapy and the male gender resulted in a statistically significant better PFS (Fig. 1. C, D, and E), whereas the absence of anemia at the start of the daratumumab-based triplets and the achievement of at least a VGPR predicted a better OS (Fig. 1. F and G).\\nIn the multivariate analysis, only the achievement of at least a VGPR resulted as an independent predictor of prolonged PFS, showing an HR of 0.037 (95% CI of 0.0001-0.988; p= .049). Interestingly, other potential predictors of unfavorable prognoses, such as the condition of early or late relapse, did not impact patients' clinical outcomes after DRd.\\nIn the present series, 4 patients received DVd because they were previously exposed to lenalidomide. Compared to the DRd treated patients, they showed a worse PFS and a similar OS. Once again, the small number of cases did not allow conclusions to be drawn concerning this issue. Apart from the daratumumab triplet used, many other factors may have contributed to the worse outcome of these four patients, as for example, the fact that they all had received more than one line of previous therapies.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 71,\n",
       "    'case_id': 'PMC6186336_01',\n",
       "    'case_text': 'A 71-year-old female with a history significant for hypertension, hepatitis B, and hypothyroidism, underwent bone marrow biopsy which showed a hypercellular bone marrow with >90% cellularity and 81% myeloblasts expressing CD 34 and CD 117 markers, confirming a diagnosis of acute myeloid leukemia (AML). Molecular testing showed no evidence for FMS-like tyrosine kinase 3 internal tandem duplication, absence of nucleophosmin1 and KIT exon 8, and 17 mutations, suggesting a lower risk of relapse after chemotherapy. Based on cytogenetic studies, secondary AML was diagnosed. Given her advanced age, decitabine therapy was commenced. A baseline 2-D transthoracic echocardiogram (TTE) showed normal function with an ejection fraction (EF) of 55-60%. After completing 10 cycles of decitabine, she was noted to have a tachycardia and dyspnea by self-report. She was therefore referred to cardiology with these symptoms in preparation for allogeneic stem cell transplant.\\nThe heart rate was 110/min, and a 2/6 ejection systolic murmur and a loud P2 with an S3 and S4 gallop were heard. Lungs were clear. No jugular venous distension or pedal edema was noted.\\nLaboratory data is significant for a serum creatinine level of 0.8 mg/dl, estimated glomerular filtration rate of 80 ml/min per 1.73 m2, and N-terminal pro-b-type natriuretic peptide level of 517 pg/ml. Her complete blood count showed a white blood cell count of 12.6 x 109/l with greater than 50% blasts, low hemoglobin at 7.8 g/dl, hematocrit value of 25%, large platelet count of 212 x 109/l, and lactate dehydrogenase level of 588 U/l. Serum troponin or creatinine phosphokinase levels were not performed due to a lack of discernibility in patients undergoing chemotherapy for cancer. Echocardiogram showed severe left ventricular systolic dysfunction (EF 28%), mildly abnormal end systolic dimension (Figure 1), and a mild reduction in right ventricular systolic function. Global averaged left ventricular longitudinal peak systolic strain was abnormal at -12% (normal more negative than -18%) (Figure 2). Nuclear stress test showed no evidence of coronary disease. Patient was euthyroid at the time of diagnosis.\\nThe patient was diagnosed with New York Heart Association class II and American Heart Association stage B heart failure with reduced ejection fraction. In the absence of any viral illness, toxins, or coronary disease, or concomitant cardiotoxic medication use and known recent normal ejection fraction, the etiology was attributed to decitabine use. The patient was subsequently started on metoprolol succinate 50 mg twice a day and furosemide 20 mg daily. Follow-up echocardiogram 4 weeks later showed no change in the ejection fraction of 28%, but there was mild improvement in the global left ventricular longitudinal peak systolic strain at -15% (improved from -12%).',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 24,\n",
       "    'case_id': 'PMC9937515_01',\n",
       "    'case_text': 'A 24-year-old female was brought to the emergency department with complaints of altered mental status and recurrent seizures associated with low-grade fever, headache, and altered sensorium for the last three days. The seizure was acute in onset, generalized tonic-clonic in nature, and associated with tongue biting, blood-tinged frothing, and urinary incontinence. It was her second episode of abnormal body movement and altered sensorium after being admitted to the hospital. Each episode lasted for 20-30 minutes. She returned from a hill station a few days ago, and her family and social history were insignificant.\\nOn admission, the patient was afebrile, with a blood pressure of 110/70 mmHg, a Spo2 of 97%, and a heart rate of 86/min. Her physical examination revealed a Glasgow coma scale (GCS) score of 11 (eye: 4, verbal: 2, motor: 5). Her rest systemic examination was unremarkable. Her initial laboratory investigations were within normal range except for mild elevation of transaminases (Table 1). Further evaluation with a non-contrast computed tomography (CT) head shows a ring-enhancing lesion in the left temporal region with perifocal edema, an eccentric, and an inflammatory granuloma (Figure 1). In addition, magnetic resonance imaging (MRI) brain showed a well-defined rounded discrete hyperintense lesion in the left parietal region with mild to moderate vasogenic edema, leading to partial effacement of the adjoining sub-arachnoid space and moderate peripheral rim enhancement (Figure 2). On follow-up after two weeks, an MR venogram revealed that the left transverse sinus was hypoplastic, as shown in Figure 3.\\nFollowing confirmation of diagnosis, the patient was started on albendazole 400mg twice daily and carbamazepine. However, on follow-up after two weeks, the patient developed skin rashes, remarkably elevated liver enzymes, and total bilirubin (Figure 4).\\nAfter proper evaluation, immediately anti-epileptic drugs were discontinued, and for skin rashes, the patient was given oral fexofenadine and methylprednisolone, levetiracetam beside topical steroids. On subsequent follow-up, her rashes and deranged aminases resolved, and the patient was doing well.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 0,\n",
       "    'case_id': 'PMC10196249_01',\n",
       "    'case_text': \"A 27-day-old boy presented to the emergency room with a 7-hour history of fever. After giving superficial skin cooling at home, the baby remained febrile. The peak temperature was 38.5 C. The baby had a poor appetite and symptoms of sneezing and a stuffy nose without vomiting and coughing. He was a term baby without extraordinary perinatal history. His parents had a history of sore throat and cough for several days during the Omicron epidemic, but they didn't test for SARS-CoV-2. After admission to our NICU, he was febrile at 38.3 C with a respiratory rate of 52 breaths/min and oxygen saturation of 95%-99% while breathing ambient air. His examination was remarkable for congested nares, clear rhinorrhea, and mild subcostal retractions. There were coarse breath sounds in all lung fields. No murmur of the heart could be heard. The liver was palpated at 1 cm-2 cm under the costal margin (consistent with age), and the spleen was not palpated. Laboratory data revealed that the total WBC count and the proportions of the major leukocyte subsets in peripheral blood were normal. Blood gas, C reactive protein (CRP), and transaminase levels were in the normal range. RNA test for SARS-CoV-2 from a throat swab was positive. Then, the baby was given physical cooling and nasal secretion removal to keep the airway clear (see Table 1).\\nThe baby presented febrile once daily in the following four days, and the peak temperature decreased from 38.4 to 38 C. Meanwhile, he developed a cough and sputum, along with a dropping of SpO2 to 80% when feeding. His lung demonstrated scattered crackles (see Figure 1). Because of continuous fever and pneumonia, more investigations were performed. The total WBC count and the proportions of the major leukocyte subsets were still in the normal range. CRP was 4.3 mg/L (0-10 mg/L). Anemia was noticed: RBC was 2.73 x 1,012/L, hemoglobin was 91.0 g/L, and hematocrit was 27.4%. Alanine transaminase (ALT) was 88 U/L(<=41 U/L), aspartate transaminase (AST) was 180 IU/L(<=40 U/L), and glutamyltranspeptidase (gamma-GT) was 109 U/L(6-42 U/L). Further, pathogens tests identified that parainfluenza virus RNA was positive, but there was no evidence of infection for other pathogens such as RSV, EBV, TORCH, ECHO virus, Coxsackie virus (CA16/CVB), influenza A/B/H1N1/H3N2, adenovirus, mycoplasma, chlamydia, HIV, Human metapneumovirus, rhinovirus, and hepatitis B/C virus. Ultrasonography for the heart and abdomen was normal. Therefore, the baby was given the nebulization treatment of budesonide and ipratropium bromide solution and given Glutathione for hepatoprotection. In addition, he inhaled oxygen intermittently to avoid hypoxia when feeding.\\nOn the 7th day after admission, the patient was no longer febrile but was still coughing and had nasal congestion. On the 10th day, respiratory symptoms improved greatly, and we re-tested the liver function after 5 days of hepatoprotective treatment. The transaminase level elevated markedly. ALT was up to 645 U/L(<=41 U/L), AST increased to 480 IU/L(<=40 U/L), and gamma-GT was 491 U/L(6-42 U/L). However, bilirubin, blood ammonia, blood glucose, lipids, lactate, coagulation function, and albumin levels were within the normal range. The patient's perinatal medical history and family history were tracked carefully, and the possibility of inherited metabolic liver disease was ruled out. Furthermore, the patient's history of drug exposure before/after admission was also reviewed, and there was no evidence of drug-induced liver injury. So, virus infection may contribute to liver injury and the elevation of transaminase levels. When the immune system clears the virus, the injury should be alleviated. Thus, we only administered glycyrrhizin and bicyclol to promote recovery.\\nOn the 14th day, the baby looked well with the normal physical examination. Laboratory tests demonstrated that ALT decreased to 125 U/L(<=41 U/L), AST was 44 IU/L(<=40 U/L), and gamma-GT was 283 U/L(6-42 U/L). He continued to take glycyrrhizin and bicyclol after being discharged home. The liver transaminase level returned to normal on 8 and 15 days after discharge (see Table 2 and Figure 2).\",\n",
       "    'gender': 'Male'},\n",
       "   {'age': 0,\n",
       "    'case_id': 'PMC10196249_02',\n",
       "    'case_text': \"A 7-day-old girl was admitted to our NICU because of a 30-hour intermittent fever with a peak temperature of 38.5 C. Her parents noted that she had a stuffy nose with clear rhinorrhea and choked when feeding over the past two days. She coughed occasionally but had sputum in her throat. Her appetite was unchanged without increasing work of breathing, vomiting, and diarrhea. Her caregivers had confirmed infection of SARS-CoV-2 several days ago. Her mother was healthy during pregnancy but detected fetal hydronephrosis with the right duplex kidney in the third trimester. The baby was born through an uneventful C-section delivery at a gestational age of 40w+6. The baby looked well after birth, and there was no evidence of early-onset sepsis. On physical examination, she had a temperature of 38.6 C and mild tachypnea of a respiratory rate of 50 breaths/min without retraction. Her lungs demonstrated coarse breath sounds without crackles and wheezes. The lab investigations showed that CRP was increased to 19.8 mg/L(0-10 mg/L) (see Table 1).\\nWBC, blood gas analysis, transaminase level, and bilirubin levels were all in the normal range. The blood culture for bacteria was negative. Chest x-rays suggested increased and blurred bilateral lung markings in both lung fields (see Figure 1). Cardiac ultrasound demonstrated a left-to-right shunt of 2.6 mm through a patent foramen ovale (PFO). Abdominal ultrasound showed mild bilateral hydronephrosis and calculus in the right kidney (3.1 mm x 2.7 mm), and there were no abnormalities in the liver, gallbladder, and spleen structures. PCR and quick antigen tests for SARS-CoV-2 from the throat swab were positive. There was no evidence of infection from other viruses [RSV, EBV, TORCH, ECHO virus, Coxsackie virus (CA16/CVB), influenza A/B, adenovirus, mycoplasma, chlamydia, HIV, Human metapneumovirus, rhinovirus, and hepatitis B/C virus]. Normal saline helped to clean the airway, and nasal drops were used to relieve nasal congestion. Moreover, superficial skin cooling was given when the baby was febrile, and piperacillin/tazobactam was administered for pneumonia.\\nThe baby's body temperature declined to normal on the 2nd day after admission. The respiratory symptom alleviated over the following days. On the 6th day, the laboratory tests showed that the transaminase level increased significantly without abnormality of bilirubin and albumin (see Table 2 and Figure 2). Then, the hepatoprotective treatment of glycyrrhizin and bicyclol was administered.\\nALT decreased by half on the 11th day. Given that the baby had recovered from fever and respiratory symptoms, she was discharged home with oral drugs of glycyrrhizin and bicyclol and was continued to be followed up in the outpatient department. Two weeks later, lab tests suggested that ALT and AST decreased to the normal range.\",\n",
       "    'gender': 'Female'},\n",
       "   {'age': 0,\n",
       "    'case_id': 'PMC10196249_03',\n",
       "    'case_text': 'A 15-day-old girl was brought to the emergency center with a 2-day recurrent fever after contracting confirmed cases of COVID-19. The peak temperature was 38.1 C. Besides fever, she had a stuffy nose and a mild cough. She did not develop diarrhea and vomiting during the course. She had no complicated perinatal history. Her examination was febrile at 38.1 C with a respiratory rate of 48 breaths/min and oxygen saturation of 98%-100%. She had normal respiratory effort, and coarse breath sounds could be heard in all lung fields. Lab data of the WBC, CRP, blood gas, transaminase levels, and bilirubin levels were all in the normal range. The PCR test was positive for SARS-CoV-2 without other positive findings of other pathogens [RSV, EBV, TORCH, ECHO virus, Coxsackie virus (CA16/CVB), influenza A/B, adenovirus, mycoplasma, chlamydia, HIV, Human metapneumovirus, rhinovirus, and hepatitis B/C virus]. After admission, the baby was given the nebulization treatment of budesonide and ipratropium bromide, using normal saline and nasal drops to relieve nasal congestion and keep the nasal cavity clean (see Table 1).\\nThe baby returned to normal temperature and developed frequent coughs over the days. Her lung examination demonstrated scattered crackles on the back side, and then, phlegm and wheezing sounds could be heard in the following days. Chest x-rays showed that bilateral lung markings increased and blurred, with patchy shadows on the right upper lung field (see Figure 1). The piperacillin/tazobactam for pneumonia was administered on the fourth day after admission. Since then, her symptoms and signs of respiratory improved gradually.\\nThe baby got better on the 6th day after admission with wild nasal congestion. Laboratory tests showed that ALT and AST increased significantly (see Table 2 and Figure 2). She was also administered hepatoprotective treatment of glycyrrhizin and bicyclol. After a 2-week treatment, the liver function recovered totally.',\n",
       "    'gender': 'Female'},\n",
       "   {'age': 0,\n",
       "    'case_id': 'PMC10196249_04',\n",
       "    'case_text': 'A 24-day-old boy was admitted to the NICU for an 8-hour history of fever with a peak temperature of 38 C. The parents complained that the baby had a mild cough with sputum, and they noticed he seemed to have facial and lip cyanosis when feeding. The baby was lethargic and had a poor appetite, accompanied by watery diarrhea without emesis. He was born at a gestational age of 36w+4 via cesarean delivery. He had no remarkable perinatal history. His mother confirmed COVID-19 with fever and cough before he had symptoms. On physical examination, his temperature was 38 C with a respiratory rate of 46 breaths/min; blood pressure was in the normal range, and his SpO2 was 97% while feeding and breathing ambient air. Coarse breath without crackling sounds in all lung fields could be heard. No heart murmur was detected. Prominent reticulated mottling of the skin could be seen on the lower extremities, especially when he was febrile. Capillary refill time in the lower extremity was 2 s. The liver was palpated at 1 cm under the costal margin, and the spleen was not palpated. Laboratory data revealed that WBC, subsets proportion, CRP, procalcitonin (PCT), blood gas, electrolytes, transaminase, and bilirubin levels were all in the normal range. Blood culture was negative. No other apparent abnormalities were reported on the routine stool test. PCR test for the SARS-CoV-2 virus was positive. The common respiratory pathogens such as influenza A/B, RSV, parainfluenza, adenovirus, mycoplasma, and chlamydia were negative. Chest x-rays showed that bilateral lung markings increased and blurred (see Figure 1). The cardiac ultrasound was normal. The CRP tests were repeated, and sepsis was ruled out in the next few days. So, the baby was administered piperacillin/tazobactam for 36 h and nebulization treatment was given (see Table 1).\\nThe fever lasted for 2 days, and the peak temperature was 38.6 C. The baby recovered with occasional cough and mild nasal congestion on the 5th day after admission. On the 6th day, the ALT and AST were significantly increased (see Table 2 and Figure 2). There was no evidence of infection for other pathogens related to liver injuries such as EBV, TORCH, ECHO virus, Coxsackie virus (CA16/CVB), and hepatitis B/C virus. He was also administered hepatoprotective treatment of glycyrrhizin and bicyclol.\\nThe baby received hepatoprotective treatment for 5 days. On the 11th day after admission, repeated lab tests demonstrated that ALT and AST decreased to 97 U/L and 40 IU/L, respectively. Then he was discharged with hepatoprotective drugs. 4 days after discharge, the liver function went back to the normal range.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 5,\n",
       "    'case_id': 'PMC4122203_01',\n",
       "    'case_text': 'Gloria lived in an intact family with her parents and three younger siblings until her parents divorced at age 5, but she provided no details about her childhood before this time and would not speak at all about her biological father. Gloria and her siblings lived predominantly with their mother after the divorce. Her mother remarried 5 years later when Gloria was 10 years old and she viewed her stepfather as her \"actual\" father. She described him as being humorous, loved, and trusted, but she also described him impulsive, irascible, and argumentative. Gloria seemed insecure about her stepfather\\'s acceptance, wondering how far she could push him before he would break. Would he accept her even if she acted like a wild child? Gloria stated that \"once a week I pushed him until he burst,\" and she told how she tested him with \"mischievousness\" so as to push her stepfather into beating her. Gloria\\'s deliberate misbehavior and her stepfather\\'s beatings were central to their relationship.\\nGloria\\'s first major traumatic experience as a sadistic rape in late adolescence. The only details that she provided about her rape was that it occurred during daytime and that she did not know the rapist. After the rape, she began around 3 weeks later to have sudden headache and fainting attacks, fainting as much as three times a day. She also developed chronic dissociation experiences. Gloria\\'s symptoms appeared to be associated with feeling of being exposed and to school or performance-related pressure. Although these problems persisted, she did not seek psychological treatment. Her symptoms, especially fainting, diminished when she studied abroad. Her symptoms reoccurred after returning home 2 years later, however, and she decided to go back abroad.',\n",
       "    'gender': 'Female'},\n",
       "   {'age': 30,\n",
       "    'case_id': 'PMC4122203_02',\n",
       "    'case_text': 'Gloria\\'s second major traumatic experience was at 30 years old when her boyfriend of 2 years died in an accident. Gloria had separated from him shortly before his death, the reason being that she was no longer able to tolerate physical closeness. She felt severely guilty about his death and her guilt had masochistic qualities. As a result, she did not have another intimate relationship for many years.\\nGloria had recently experienced a third trauma prior to her decision to seek treatment. She had been in a serious accident in which she had been thrown out of her car and into the air rendering her unconscious. She was thought at first to be dead. Her physical injuries included three spinal discs and a strain on the cervical spine and her fainting episodes increased to many episodes a day. Although Gloria reported in her initial interview, almost proudly, saying \"I survived this,\" and she had since was unable to work.\\nGloria felt that her symptoms had become debilitating, and she noticed that her fainting spells seemed related to stress. Her headaches had become so severe that she risked becoming unconscious. She was not able to recall what preceded the headaches and she could not remember any indicators associated with their onset, such as less debilitating headaches or other physical warning signs. Gloria described herself as being on autopilot. This \"defensive mechanism\" had saved her life more than 20 years ago, but now this automatic mechanism was out of her control.\\nGloria had not allowed herself to think about this until she entered treatment and her treatment goal was \"to get rid of it.\" She had a stiff commitment to being strong and carrying on. \"I want to function. I will get through this. I want to be able to work. I have worked for many years to wipe out the traumatic event, to get rid of it, to repress it.\" This perspective had dominated her life and kept her moving forward. She was frightened of not being able to be in control of her symptoms and the prospect of becoming dependent on the pain medication prescribed to combat her severe headaches.\\n was a prominent psychoanalyst to use ethological concepts to describe the infant\\'s biologically predisposed attachment to a primary caregiver. He viewed relatedness in early childhood as a primary and independent developmental goal that is not subservient to a physiological needs (e.g., hunger) or psychoanalytically defined primary processes. The infant is perceived from an interactional perspective, with a focus on the relationships with primary attachment figures. Attachment theory maintained some foundations of psychoanalytic theory (e.g., the developmental point of view) and there is a strong literature that discusses the divergences and convergences of psychoanalysis and attachment theory (e.g.,) and also developed some aspects further, particularly the delineation of the internal world.) overview of the intersection of these two approaches demonstrated that the relationship between attachment theory and psychoanalysis is more complex than adherents of either community have generally recognized. This paper addresses some of these complexities by integrating attachment assessment using the Adult Attachment Projective Picture System (AAP) in psychodynamic psychotherapy in an adult traumatized patient.\\n proposed that one major difference between psychoanalysis and attachment theory falls in the description of forms of defensive processes. Traditional psychoanalytic models provide a complex constellation of defenses to interpret a broad range of intrapsychic phenomenon, including phantasy, dream, wish, and impulse (e.g.,). Attachment theory delineates two basic processes that manifest in three forms. According to), Bowlby defined defense as forms exclusion directed to modulating difficult and anxious experiences with attachment figures, and the child\\'s experiences with incomplete or failed bids for parental protection, care, and comfort. He defined defenses in terms of two qualitatively distinct processes: deactivation (retaining elements of intellectualization and denial) and cognitive disconnection (retaining elements of splitting).) pointed out that under normal circumstances these two exclusion processes are associated with goals to maintain physical and psychological proximity in the attachment-caregiving relationship under conditions when the child\\'s experiences with the attachment figure are less than satisfying. George and Solomon refined model suggesting that deactivation and cognitive disconnection organized and supported at least minimal forms of representational, behavioral, and emotional regulation. proposed that these forms defensive exclusion functioned to segregate (akin to repression) memory, affect, and experience when the attachment figure was not available, conceiving of an extreme process he termed \"segregated systems.\" Segregated systems were thought as associated with the painful and chronic distress experiences, such as those that accompany loss. Bowlby posited that segregated systems were the intrapsychic root of symptoms related pathological mourning and severe psychopathology. Attachment theorists have since demonstrated that segregated systems are associated with experiences of failed protection, attachment trauma, and disorganized/dysregulated attachment behavior and representation.\\nConsistent with a psychoanalytic approach, some attachment theorists have suggested that utilization of defensive process models is needed to provide a complete picture of the emotional and behavioral regulation processes individuals develop from their childhood relationships with attachment figures. Further, concluded, \"In order to understand the relationship between adult attachment and mental health risk we need to examine the attachment concepts of defense and segregated systems, the mental processes that define disorganization\" (p. 295). These theorists operationally defined basic defense scheme as a central element for evaluating representational patterns of attachment using the Adult Attachment Projective Picture System. Suggesting that these representational structures have developed under conditions of attachment trauma (abuse, loss, failed protection), the concept of segregated systems is fruitful to explain some forms of relationship-based psychopathology in adults.\\nThe discussion that follows provides some ideas about using attachment concepts in clinical work by showing how the perspectives of a psychoanalyst and attachment assessment may improve the understanding of an individual case of a traumatized patient with the diagnosis of a PTSD with dissociative states (e.g., fainting in response to stressful situations).\\nThe lifetime prevalence of PTSD in Germany has been found to be 1.3% with a female-to-male ratio of 3.25-1. Traumatized patients are frequently misdiagnosed and mistreated in the mental health system. The number and complexity of the symptoms lead to fragmented and incomplete treatment. PTSD patients are vulnerable to become re-victimized by caregivers because of their difficulties with close relationships. Severely traumatized PTSD patients (complex trauma) develop difficulties in modulating arousal and show signs of severe affect dysregulation (e.g., aggression against self and other, and problems with social attachment and dissociative states).\\nDissociation, defined as a deficit of the integrative functions of memory, consciousness and identity, is often related to traumatic experiences and traumatic memories. During clinical interviews, dissociation is suggested either by such a degree of unwitting absorption in mental states that ordinary attention to the outside environment is seriously hampered. Dissociation can be accompanied by a sudden lack of continuity in discourse, thought or behavior of which the person is unaware (supposedly due to intrusion of dissociated mental contents in the flow of consciousness). Thus, for instance, a dissociative patient may suddenly interrupt her speech during a therapeutic session, stare into the void for minutes, and become unresponsive to the therapist\\'s queries as to what is happening to her. Or a patient suffering from PTSD may suddenly utter fragmented and incoherent comments on intrusive mental images (usually related to traumatic memories) that surface in consciousness and hamper the continuity of the preceding dialog with the therapist. In the most extreme variety of dissociation (Dissociative Identity Disorder), an alternate ego state may appear during the clinical dialog, reporting (sometimes with an unusual tone of voice, e.g., like a child) memories of childhood abuse of which the patient has previously been totally unaware, or expressing attitudes and beliefs quite extraneous to the patients\\' personality.\\nFurthermore, shattered meaning propositions predominate. Trust, hope and sense of agency is accompanied by social avoidance, with loss of meaningful attachment and therefore lack of participation in preparing for future.\\nThe founding premise of attachment theory is that stress, especially traumatic stress, produces a strong desire for proximity to and comfort by attachment figures; this desire is built into human biology as a survival safety mechanism and the mechanism is functions unchanged throughout the life span. Attachment experience shapes the ways in which individuals manage stress and are especially important when individuals experience a traumatic event. When attachment is secure, individuals know how and when to seek attachment figures and develop internal representations of self as deserving of care. Attachment security fosters confidence and trust that figures are available, empathic, and sensitive to their needs; security is a buffer or resilience factor that supports recovery from trauma. When attachment is insecure, emotional and behavioral reactions when distressed may be made even more painful by unconscious evaluations that wishes for comfort are illegitimate. Insecurity may result in additional painful interactions with the attachment figures rather than the functional comfort and protection for which attachment was intended. Insecurity fosters anxiety, anger, and fear, and increases the risk of developing trauma-related emotional disorders. Extreme forms of insecurity are associated with the breakdown of attachment and caregiving regulatory mechanisms risk emotional and homeostatic dysregulation, often termed disorganized attachment. The risk of dysregulation is heightened when attachment relationships are threatened or threatening, such as parental loss or psychiatric debilitation or maltreatment. defined events such as these as attachment traumas, events that involve terrifying threats to the integrity of self or attachment relationships. Attachment disorganization, conceived in terms of mechanisms of dysregulation and attachment trauma, has been shown to predict vulnerability to severe psychiatric symptomology, including dissociative symptoms.\\n found the metaphor of a \"drama triangle\" useful in thinking about the intersection between dissociation and disorganized attachment. The dissociation triangle addresses how disorganized attachment fosters dissociative mechanisms that create incompatible and separate representations of self as victim, rescuer, and persecutor. The child\\'s representation of the attachment figure is represented in a conflicting manifold way. On the one side, the attachment figure is represented as source of the child\\'s fear, the self as a victim of attachment figure as persecutor. On the other side, the attachment figure by virtue of being the child\\'s biological protector is viewed as the child\\'s source of safety and protection (rescuer). In the child\\'s mind, representation of self and attachment figure shift among these three incompatible models that are too complex to be synthesized into an integrated model of self. Liotti\\'s model provides us with an integrated psychodynamic and attachment approach to our first questions concerning Gloria\\'s illness, questions regarding the childhood origins of her episodes of near unconsciousness and her inability to ask for help following traumatic assault.\\n examined cognitive perspectives on unresolved attachment in patients diagnosed with PTSD. They proposed that unresolved loss, as defined in attachment assessment during interview, involves intrusion avoidance phenomena similar to those of PTSD. Specifically, they develop a model based on unresolved loss that involves the failure to integrate representations of self and the world following a loss. The features of unresolved loss can be understood as emerging as a result of the activation of unintegrated representations of the loss experience and cognitive and behavioral avoidance processes. In this model, the sudden intrusion of memories, cognitions, and emotions associated with the loss automatically captures attention and initiates behavioral dispositions that are incompatible. With regard to attachment, the authors suggested that this was the mechanism that interfered with caregiving behavior. Lack of attentional resources and incompatible response tendencies can also result from safety behaviors directed at avoiding the perceived negative consequences of activating trauma memory. The authors proposed that these processes offer a novel way of understanding the disturbances in behavior and speech that are evident in mothers who are designated as unresolved with respect to loss.\\nThis suggests that representational attachment measures, like the AAP, can provide a good understanding of the movement that the client might be making toward empowerment, integration, or understanding. Thus, even if a patient\\'s overall attachment is unresolved (i.e., dysregulated), there may be indications in their responses to the AAP stimuli that suggest they are moving toward mental organization. Given the negative outcomes that are associated with abuse, focusing on resources and defensive strategies is arguably important for therapeutic recommendations.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 20,\n",
       "    'case_id': 'PMC7174775_01',\n",
       "    'case_text': \"The DMD participants had different levels of hand function. Participant one (DP1, 20 years old) was able to use his hands functionally, and no contractures relevant to hand/wrist movement were observed. Participant two (DP2, 22 years old) was able to functionally use his hand but experienced a decrease in strength and minimal contractures relevant to hand/wrist movement. Participant three (DP3, 25 years old) was not able to use his hands at all and was affected by immediate onset of fatigue during its use. Extensive contractures relevant to finger movement were observed, and only minimal movement of the fingers was possible (see Supplementary Video). All participants were able to perform the experimental protocol.\\nThe Medical Ethics Committee of Twente approved the study design, the experimental protocol, and the procedures (Protocol number: NL59061.044.16). The study was conducted according to the ethical standards given in the Declaration of Helsinki in 1975, as revised in 2008.\\nThe experimental setup (Figure 1) included several components, and it was designed to record HD-sEMG signals from the forearm in a repeatable and systematic way. Muscular activity was measured with a 128-channel amplification system (REFA 128 model, TMS International, Oldenzaal, The Netherlands). We used 64 monopolar electrodes around the forearm to acquire the raw sEMG signals. The signals were recorded with a decimal gain of 26.55 before the analog-to-digital converter (ADC); however, this gain factor is compensated by the acquisition software (Polybench, TMS International, Oldenzaal, The Netherlands), after the ADC. Additionally, REFA includes a first-order analog low-pass filter placed before the ADC with a -3 db point at 6.8 kHz. The 6.8-kHz low pass helps to make the REFA immune to high-frequency electromagnetic interference such as mobile phone networks. The analog signals were sampled with a frequency of 2,048 Hz and digitally converted with a 24-bit conversion (a resolution of 0.018 muV per bit, 300 mV dynamic range). The ADC of the device has an anti-aliasing digital low-pass filter with a cutoff frequency of 0.2 * sample frequency. This filter inside the ADC is used to convert the 1-bit signal with a high frequency into a 24-bit signal with a lower frequency. The acquisition software was executed in a host laptop (Lenovo Thinkpad T490, Lenovo, Beijing, China) with a Windows 10 operating system (Microsoft Corporation, Washington, USA). A computer screen was used to provide visual feedback of the task to the participants.\\nElectrode placement and configuration were based on previous work that normalized the electrode locations to each participant's arm circumference in order to account for different forearm thicknesses (Table 1). The inter-electrode distance in the longitudinal direction of the forearm was kept constant at 2 cm for covering the entire forearm.\\nFirst, we cleaned the skin of the dominant forearm of the participant with alcohol. Then, we measured the forearm length from the lateral epicondyle until the styloid process of the ulna and the forearm circumference at 20% of the forearm length from the elbow (Figure 1). The participant had to wear a perforated sleeve (Figure 1) with equally placed holes and elastic only along the circumferal direction to ensure that the electrode placement was standardized for all participants. We used a non-permanent marker to mark the skin of the participant (Figure 1) and then visually inspect the markings before applying the electrodes.\\nConductive gel was applied to each of the 64 electrodes with a syringe, and they were subsequently attached to the forearm. The first row of electrodes was placed above the imaginary line between the lateral epicondyle and the styloid process of the ulna and the last row below in such a way that the line lay in the middle between the two rows of electrodes (Figure 1). The first electrode was attached proximally starting at the 20% of the forearm length from the elbow. Electrodes were placed from proximal to distal and in counterclockwise direction (from the perspective of a right-handed participant). This way, electrodes 1-32 were placed over the dorsal side (mostly extensor muscles) and 33-64 over the ventral side (mostly flexor muscles) of the forearm. The reference electrode was placed at the distal end of the forearm, over the head of the ulna.\\nParticipants performed seven different gestures involving hand and wrist motions (Figure 2). The chosen gestures included: hand open/close, thumb flexion/extension, wrist flexion/extension, and index extension. These were chosen as they are involved in the most frequent ADL. First, each participant was instructed to perform all gestures without constraints (dynamic) with maximal voluntary effort in a single recording. This way, we recorded the maximum voluntary contraction (MVC) for every electrode across all gestures. For every gesture, 10 repetitions of 3 s contractions were performed, together with 10 repetitions of 3-s resting periods between the contractions (Figure 2). The participants were instructed to perform all movements in a comfortable fashion in order to avoid forceful contractions that may elicit co-contractions of agonist-antagonist muscle groups.\\nThe timing of the gestures was dictated with the use of visual feedback. The visual feedback illustrated via photographs of human hands which gesture had to be performed. The sequence of images served to instruct the participant as a metronome when to perform the gesture (image of gesture appearing for 3 s) and when to relax (image of relaxed hand appearing for 3 s). Additionally, the measurements were performed in the morning in order to avoid effects of the end-of-the-day fatigue, especially for the participants with DMD. Furthermore, the participants had short breaks between gestures in order to rest.\\nAll signal processing and data analyses were performed in Matlab 2018b software (The MathWorks Inc., USA). The raw sEMG signals were processed offline in order to compute the envelopes for each of the 64 electrodes per gesture and per participant. First, the raw data were filtered with a band-pass filter (fourth-order Butterworth, 20-450 Hz). Additionally, a second-order digital infinite impulse response notch filter (cutoff frequency of 50 Hz, Q factor of 50) was used to remove the power line noise (50 Hz for the EU). Despite its main limitation (signal distortion around the attenuated frequency), notch filtering is the mainstream technique for powerline signal removal, and a narrow bandwidth with a high Q factor can already address this. For highly powerline-contaminated signals, spectral interpolation may be more appropriate. The signals were subsequently rectified and filtered with a low-pass filter (third-order Butterworth, 2 Hz). Our choice for the cutoff frequency was motivated by the low-frequency dynamic tasks involved in this study and our previous study on real-time sEMG control of a hand exoskeleton. The resulting envelopes were visually inspected segmented, according to the acquisition protocol, to 10 contractions and periods (each lasting approximately 3 s) and normalized. A threshold was selected to define the onset of the activity, and the next 3 s after the onset were chosen as a contraction period. The threshold was defined as the time that the signal exceeded 10 standard deviations of the baseline (non-contraction) activity similar to Di Fabio, and the final segmentation was additionally assessed visually. The maximum value of the envelope of each electrode across the complete dataset was used as a normalization value for each electrode. This value was acquired using a moving average window of 1 s in order to account for signal artifacts. Signal quality was visually assessed both in the time and frequency domains, and faulty channels were replaced by linear interpolation of their surrounding neighboring channels (8-neighborhood). Different local conditions were applied to faulty electrodes placed in the longitudinal extremes (<8 neighboring channels).\\nEvery 3-s contraction was further segmented in 1-s segments by keeping only the middle second of the contraction (steady-state phase) and discarding the transient phase. For every electrode, the average of this 1-s contraction was calculated and used to construct 10 heatmaps per gesture (Figure 2). For the visual inspection of the forearm activity per gesture, we constructed activity heatmaps by averaging the 10 repetition heatmaps (Figure 3).\\nWe analyzed the data to assess HD-sEMG pattern repeatability, peaks, and dimensionality, as well as individuals' potential to generate activation patterns suitable for myocontrol applications for both healthy and DMD participants. The raw data used for this analysis are available online. All signal processing and data analyses were performed in Matlab 2018b software (The Mathworks Inc., USA). In the remainder of this section, we describe a set of analyses aimed at investigating differences between DMD and healthy participants at the level of motor control properties (Motor Control Properties section) and myocontrol performance (Myocontrol Performance section).\\nThe degree of repeatability across repetitions per participant was calculated using squared Pearson correlation. Each heatmap (8 x 8) was reshaped into a vector (1 x 64) before the calculation of the squared Pearson correlation. The coefficient was extracted among the 10 repetitions per gesture and per participant. For every gesture, this resulted in 45 unique comparisons between the 10 repetitions and thus 45 coefficients per gesture (Figure 4).\\nThe temporal distribution of activations between healthy and DMD was calculated via normalized and absolute activations per repetition of each gesture (Figure 5A). A normalization factor was calculated across all gestures and repetitions. For each gesture, the maximum absolute and normalized value of the 64-electrode heatmap were calculated for every participant and each repetition and plotted.\\nFigure 5B shows the average spatial distribution of the healthy and DMD participants. The spatial distribution of the sEMG potentials over the 8 x 8 normalized heatmap was calculated using the center of gravity (COG) by calculating the dorsal-ventral and the proximal-distal position of it as proposed by Elswijk et al.. The COG was calculated over electrodes presenting activations equal or larger than 80% of the maximal value of the heatmap (Figure 3). This way, only clusters of electrodes with a high peak amplitude were considered for the calculation of the COG in order to focus on the most relevant area of activation for each gesture.\\nThe 10 heatmaps, one per gesture repetition, were used to construct one single average heatmap per gesture per participant (Figure 3) that was used for the motor control analysis. We quantified differences in dimensionality of orthogonal and uncorrelated sEMG patterns between the healthy and DMD participants via a PCA to the gesture-specific heatmaps per participant. For every participant, we performed a PCA to the concatenation (64 x 70) of the sEMG heatmaps of all gestures and repetitions per participant [64 electrodes x (7 gestures x 10 repetitions)]. The number of PCs needed to reconstruct the original seven gesture heatmaps was identified per participant by means of the variance explained (VE), and it was taken as the number of PCs that summed together explained more than 90% of the total variance. This number was used to explore the repertoire of orthogonal and uncorrelated sEMG patterns produced by the two groups of participants (Figure 6A).\\nAdditionally, we calculated the squared Pearson correlation between all the gestures per participant (the same way as we did for the repeatability, Activation Pattern Repeatability Tests section). The coefficient was extracted from the average normalized heatmap of the 10 repetitions per gesture and per participant. For every participant, this resulted in 21 unique comparisons between the seven gestures and thus 21 coefficients per participant. We averaged the correlation values of the healthy participants and the participants with DMD separately to identify which gestures are mostly correlated per population, and we presented this in the form of a similarity matrix (Figure 6B).\\nWe explored participants' gesture recognition performance via an offline pattern recognition algorithm applied to the band-pass filtered data (fourth-order Butterworth, 20-450 Hz) of each participant. We used a linear discriminant analysis (LDA) to recognize each of the gestures performed. LDA is a commonly used pattern recognition algorithm for prosthetic control and already commercialized by COAPT LLC (Chicago, USA). We chose it for the ease of implementation, classification speed, and high accuracy compared to other similar approaches. The 10 steady-state segments for every gesture were concatenated and created a 10-s vector. We trained the classifier by extracting four time-domain features from the raw segmented data including mean absolute value, zero crossing, slope sign change, and waveform length. We chose for a feature extraction window of 200 ms (with an overlap of 100 ms), which would be within acceptable range for real-time myoelectric applications. The classifier was validated with a three-split Monte Carlo cross-validation approach. Each time, a different part of the segmented data was used for training (always 70%) and testing (always 30%). The average off-line classification accuracy of these three trainings was used as performance metric per participant. Additionally, we tested how the offline classification accuracy per participant was affected by the number of gestures that had to be classified.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 58,\n",
       "    'case_id': 'PMC7969344_01',\n",
       "    'case_text': \"A 58-year-old female presented with complaints of progressive loss of vision and flashes of light in both eyes (OU). Her past ocular history was significant for progressive nyctalopia which was gradually worsening since her childhood. Her past medical history was significant for asthma, depression, musculoskeletal pain, well-controlled hypertension, and hyperlipidemia. Her systemic medications included hydrochlorothiazide, lisinopril, aspirin, albuterol, buspirone, duloxetine, lorazepam, gabapentin, hydrocodone-acetaminophen, tizanidine, and trazodone.\\nThe patient's family history of adRP was further explored. Her paternal grandmother and the grandmother's two daughters were affected by RP. She has one son who is also affected with nyctalopia.\\nHer best-corrected visual acuity (BCVA) was 20/40 OD and 20/30 OS. Her intraocular pressure (IOP) was 20 OD and 19 OS. Anterior segment examination was unremarkable.\\nFundoscopy of the right eye revealed normal optic nerve with a cup-to-disc ratio of 0.1 bilaterally. Examination of the posterior pole revealed perimacular pigmentary changes in a bull's-eye pattern. Large area of retinal atrophy in a doughnut shape was noted around vascular arcades. Attenuated vasculature was noted in the area of the dystrophic retina. Peripheral retinal examination revealed bone spicule pigmentation along the inferonasal quadrant.\\nFundoscopy of OS showed similar findings. Bone spicules were noted in the inferotemporal quadrant.\",\n",
       "    'gender': 'Female'},\n",
       "   {'age': 38,\n",
       "    'case_id': 'PMC7969344_02',\n",
       "    'case_text': \"The patient's 38- year-old son had similar symptoms of nyctalopia since he was a child. His past medical history was unremarkable. He denied distortions, floaters, and flashing lights OU. His past ophthalmic history was unremarkable.\\nHis BCVA was 20/40-2 OD and 20/60-2 OS. Her intraocular pressure (IOP) was 20 OD and 19 OS. Anterior segment examination was unremarkable.\\nFundoscopy of OD revealed normal optic nerve with a cup-to-disc ratio of 0.1 bilaterally. The fovea was normal. Large area of retinal atrophy was noted along the inferior arcade. An attenuated vasculature was noted in the area of the dystrophic retina. Peripheral retinal examination revealed bone spicule pigmentation along the inferonasal quadrant.\\nFundoscopy of OS showed similar findings. Bone spicules were noted in the inferotemporal quadrant.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 8,\n",
       "    'case_id': 'PMC5769854_01',\n",
       "    'case_text': 'An 8-year-old boy presented at our hospital complaining of recurrent headache and vomiting for 3 months. The patient saw a doctor in a clinic before admission to our hospital and took some medicine for cold. The symptoms got relief temporarily but became severe 1 week ago.\\nNeurological examination showed impaired vision and mild paresis (IV-grade of muscle strength) of the left extremities. CT (Fig. 1A, B) revealed an iso- to hyperdense lesion in the right basal ganglion extending to superasellar cistern, 4.0x4.4 cm in size with peripheral calcification. No hyperostosis of sellaturcica was noticed (Fig. 1C). Magnetic resonance imaging (MRI) demonstrated most of the mass lesion was iso-intense on T1-weighted, T2-weighted and fluid-attenuated inversion recovery images with inhomogeneous enhancement (Fig. 2A-E). No duraltail sign was noted. Diffusion tensor image revealed the right pyramidal tract was partially disrupted.\\nUnder the guide of navigation, a transcortical (through the right middle frontal gyrus) approach was adopted to explore the lesion. There was no dural attachment, but the tumor was tightly adhered with the anterior cerebral artery (ACA). Small vessels supplied the anterior aspect of the tumor, subtotal resection (STR) was achieved.\\nHistopathological examination revealed features of atypical meningioma with Ki-67 labeling index been approximately 10% (Fig. 3A-C). Immunohistochemistry showed the tumor positive for epithelial membrane antigen and negative for glial fibrillary acidic protein and S-100 protein (Fig. 3D-F).\\nThe patient suffered transient exacerbation of impaired vision and weakness of contralateral limbs after operation, which resolved significantly after 3 months follow-up. Postoperative MRI revealed that most of the tumor had been resected and the residual part has been detached from dorsumsellae (Fig. 2F).',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 58,\n",
       "    'case_id': 'PMC7265352_01',\n",
       "    'case_text': 'A 58-year-old female presented with the left lower radiculopathy. Seven years ago, she had a prior L5-S1 ALIF. On examination she had decreased the left lower-extremity 1/5 motor function in the tibialis anterior and extensor hallucis longus distributions, plus a 3/5 in the gastrocnemius. The MRI showed what appeared to be an L4-L5 left-sided disk herniation above the level of her prior fusion (i.e., adjacent L4-L5 segment disk disease) [Figure 1].\\nShe subsequently underwent an L4-L5 left-sided minimally invasive microdiscectomy. After the laminotomy was completed and nerve root identified, there was a large venous plexus in the nerve root axilla extending ventrally and laterally. This was successfully coagulated with bipolar cautery. Due to the fragility of the plexus and recurrent venous bleeding, multiple hemostatic agents were repeatedly employed to control the bleeding [Figure 2]. After successful cauterization, a thorough examination of the nerve root and disk showed no free fragments or accompanying disk herniations.\\nPostoperatively, she reported immediate improvement of her foot strength and resolution of her left lower extremity and buttock pain. She was discharged on postoperative day 1 after a follow-up MRI confirmed an EVP as the ultimate etiology of her radiculopathy [Figure 3]. Six months later, an examination showed improvement to 4-/5 motor strength in the left tibialis anterior and extensor hallucis longus distributions, plus 4+/5 in the gastrocnemius.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 80,\n",
       "    'case_id': 'PMC6159178_01',\n",
       "    'case_text': \"An 80-year-old male was being investigated at a tertiary hospital for iron deficiency anaemia. His medical history, symptomology and physical examination did not indicate a cause. After gastroscopy and colonoscopy were also unremarkable he was referred for capsule endoscopy. The delivery of the capsule in the morning was routine; however, review of the images 8 hlater showed a static picture and no evidence the capsule had entered the stomach. The patient was clinically stable and contacted to present to the emergency department with a suspicion of capsule impaction.\\nA chest radiograph demonstrated a metallic object at the level of the second thoracic vertebra to the left of the trachea (Figure 1). The patient had no known oesophageal or tracheal diverticulum and expressed no symptoms of dysphagia. To pinpoint the exact anatomical location of the foreign body a non-contrast CT scan of the neck (Figure 2) was performed. The effective dose of CT was 0.81 mSv. This confirmed the object was the capsule endoscope lying to the left of the hypopharynx. The adjacent soft tissue was obscured by aliasing metal artefacts arising from the capsule. A single photon metal artefact reduction (MAR) software technique (O-MAR; Philips Healthcare, Cleveland, OH) was applied which successfully removed most of the metallic artefacts. It revealed the capsule was impacted in an oesophageal diverticulum.\\nThe capsule was successfully endoscopically removed under a general anaesthetic and the patient's recovery was uncomplicated. A follow-up barium swallow study confirmed the presence of a Zenker's diverticulum which the patient opted not to surgically repair as he was asymptomatic. He was also offered endoscopic insertion of the capsule endoscope to bypass the diverticulum; however, the patient refused. His anaemia resolved with iron transfusions but no definitive cause was found. He was discharged from the clinic.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 15,\n",
       "    'case_id': 'PMC3678730_01',\n",
       "    'case_text': 'For each death, the DSS has systematically recorded the age at death and the date of death (including day and month of death). A detailed VA questionnaire has been collected for deaths of children aged < 15 years old since 1985, and for all deaths since 2003. VA questionnaires are usually completed by close relatives of the deceased. For adults, they include an assessment of whether the deceased was pregnant at the time of death. After review of VA data by physicians, a likely cause of death is assigned to each recorded death using ICD-9 codes. According to this database, maternal mortality is high ( 915 per 100,000 live births for 2003-06,).\\nIn August 2010, we conducted a pilot study aimed at determining the feasibility of linking retrospective survey data collected during SSH to DSS data, at the individual level. Prior studies comparing SSH and DSS data had been conducted at the aggregate level, and thus did not permit examining misclassification biases. In total, we interviewed 268 women aged 15-59 years who had at least one female sibling known to have died at reproductive ages according to the DSS datasets since the 1980s. Respondents were asked to complete the standard SSH questionnaire used during the 2005 DHS in Senegal. Interviewers were recruited among those who had participated in that DHS. Some survey respondents were members of the same sibship, and some deaths were thus potentially reported multiple times during the SSH survey.\\nWe focus here on the subset of deaths having occurred in 2003-2009 because detailed VA questionnaires for adult deaths were systematically introduced in the Bandafassi DSS in 2003, and because this period matches the \"reference period\" usually used in producing estimates of adult and maternal mortality using SSH data (Timaeus and Jasseh 2004). We identify PR deaths in the DSS data as follows: 1) we use demographic surveillance data on dates of births and deaths to identify deaths having occurred at the time of delivery or within 2 months of a delivery regardless of the actual cause; 2) we use data from the VA questionnaires (i.e., a yes/no question asking VA respondent whether the deceased was pregnant at the time of the survey) to identify deaths having occurred during pregnancy. It is important to note that, in order to classify a death as PR or non-PR according to the DSS data, we do not use the ICD-9 codes assigned by physicians to each death. In SSH data, we define PR deaths as deaths reported to have occurred either during pregnancy, delivery or within 2 months of delivery according to the respondent.\\nWe could not compare PR classifications obtained from SSH and DSS data for all deaths observed between 2003 and 2009 because, for some of the deceased, there were no eligible sisters in the DSS population or eligible sisters could not be located. In other cases, we could not ascertain whether the recorded death was PR because of missing data in the DSS dataset and/or the VA questionnaire. We thus begin by comparing the age at death, date of death, and PR classification obtained from the DSS of included vs. excluded deaths. We do so using chi2 tests of association. Among included deaths, we then examine the cross-classification of deaths as PR or non-PR, according to the SSH and DSS data. We calculate the proportion of deaths identified as PR (non-PR) in the DSS dataset, which were also classified as PR (non-PR) deaths in the SSH data. We do so for all reports collected during the SSH survey, and for a restricted sample in which we select at random one report of death per sibship (to avoid double-counting). In the case of discrepant classifications of PR deaths between SSH and DSS data, we report a) the cause of death as ascertained by physicians (using VA data), b) the time since the last recorded birth of the deceased, and c) the relationship between the deceased and the person who completed the VA questionnaire (e.g., sister-in-law). Finally, we use SSH data to investigate agreement between sisters about the reported timing of death in sibships where multiple sisters were interviewed.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': None,\n",
       "    'case_id': 'PMC7201103_01',\n",
       "    'case_text': \"The demographic and clinical characteristics are shown in Table 1. The median age was 62 years (IQR, 51 to 70). Fever (95.3%) and cough (65.1%) were the most common symptoms, while diarrhea (16.3) was not common. 37.2% of patients had at least one underlying disorder (i.e., hypertension, diabetes, cardiovascular diseases, and chronic lung diseases). There is no significant difference in median age between male and female groups, but the maximum of the range of IQR is lower in male (66 years in men vs. 73 years in women). Symptoms and comorbidities were comparable between men and women. As expected, men had a higher level of hemoglobin. However, male patients also had elevated serum creatinine, white blood cells, and neutrophils. Among the 43-case series, 13 (30.2%) were diagnosed with Mild or Moderate pneumonia, while 14 (32.6%) and 16 (37.2%) were diagnosed with Severe and Critical pneumonia, respectively. Chi-square (chi2) test for trend indicated that men's cases of COVID-19 tended to be more serious than women's (P = 0.035), according to the clinical classification of severity (Figure 1).\\nBetween March 25 and May 22, 2003, a total of 524 SARS patients, including 139 deaths, in the Beijing area were reported from 29 hospitals enrolled in our analysis. Fever (98.4%) and cough (76.9%) were the most common symptoms, while diarrhea (6.7%) was not common. 57.0% of the patients had at least one of the concomitant diseases including hypertension, diabetes, cardiovascular diseases, and chronic lung diseases. The mean duration from self-reported symptoms to death was 15 (IQR: 10-19) days. Table 2 summarizes the clinical and biochemical characteristics of all SARS patients. The median age of the deceased patients was much higher than that of the patients who survived (57 vs. 32, P < 0.001). The rate of the concomitant diseases in the deceased patients was also higher than that of the patients who survived (57.0% vs. 17.9%, P < 0.001). While the deceased patients were significantly older than the patients who survived (Figure 3A), ages were comparable between men and women in both patients who deceased and survived with SARS (Figure 3B). The proportion of men was higher in the deceased group (53.2%) than in the group who survived (42.3%) (chi2 test, P = 0.027) (Figure 3C). Survival analysis showed that men had a significantly higher mortality rate than women (31.2 vs. 22.6%) in this hospital-based cohort (hazard ratio [95% CI] 1.47 [1.05-2.06], P = 0.026) (Figure 3D).\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 54,\n",
       "    'case_id': 'PMC7373792_01',\n",
       "    'case_text': \"The proband (II-2), a 54-year-old lady, came to the hospital due to recurrent chest pain in last 2 years. Coronary angiography indicated approximately 60-80% stenosis of the anterior descending coronary artery (Figure 1B), ECG testing also suggested the patient suffered from CHD (Figure 1C). However, the lipid testing described the level of LDL-c (3.94 mmol/L; control: <3.12 mmol/L) and a distinctly reduced levels of HDL-c (0.41 mmol/L; control: 0.9-2.19 mmol/L) of the proband (Table 1). This discovery attracted our interest because most patients with ASCVD commonly presented high levels of LDL-c, TC, and TG. We then investigated the family history of the proband (II-2), which indicated that her young sister (II-4) has been diagnosed as the occlusion of left iliac artery and her father (I-1) was died from myocardial infarction at 60-year-old. Lipid testing further described that both her son (III-1) and her young sister (II-4) showed an overt reduced levels of HDL-c and normal levels of LDL-c, TC, and TG (Table 1). And his young sister (II-4) also suffered from arterial plaque in the left lower limb. The blood pressure of the proband was 80-120 mmHg and the fasting blood-glucose was 5.2 mmol/L. The proband (II-2) accepted the treatment of percutaneous coronary intervention, the proband did not complain any uncomfortable after treatment. And breathing sound of the lungs was clearly, the heart rate was normal (Figure 1D), and the insertion site recovered well. The II-4 is accepting recovery treatment by exercise and diet control.\\nWe supposed that the low levels of HDL-c may be the leading cause of AS and ASCVD in this family. However, what's the genetic lesion underling the reduced levels of HDL-c in this family? We then isolated the genomic DNA of the proband and other family members (I-2, II-1, II-2, II-4, III-1, and III-2). Whole exome sequencing of the proband (II-2) was performed to detect the candidate gene of reduced levels of HDL-c.\\nIn short, Exome capture and next-generation sequencing were conducted by Novogene Bioinformatics Institute (Beijing, China). One microgram of qualified genomic DNA from each person was captured by the Agilent's SureSelect Human All Exon kit V5 (Agilent Technologies, Inc., Santa Clara, CA, United States) and sequenced by Illumina Hiseq4000 (Illumina Inc., San Diego, CA, United States). Shortly, genomic DNA were randomly carved by Covaris S220 sonicator (Covaris, Inc., Woburn, MA, United States). Then the fragmented DNAs underwent three enzymatic steps: end repair, A-tailing and adapters ligation. The adapter-ligated DNA fragments were amplified with Herculase II fusion DNA polymerase (Agilent). Later, the exomes in the pre-capture libraries were captured by SureSelect capture library kit (Agilent). After DNA quality estimation, the captured DNA library was used for next-generation sequencing on Illumina Hiseq4000 platform. Downstream processing was carried out by Genome Analysis Toolkit (GATK), Varscan2 and Picard, and variant calls were performed by the GATK Haplotype Caller. Variant annotation referred to Ensemble release 82, and filtering was conducted by ANNOVAR Documentation.\\nThe filtered non-synonymous SNPs or INDELs with an alternative allele frequency more than 1% in public databases were kicked before further analysis. The public databases contains the NHLBI Exome Sequencing Project Exome Variant Server (ESP6500), dbSNP1441, the 1000 Genomes project2, the ExAC database3 and in-house exome databases of Novogene (2500 exomes). Then the filtered SNVs and INDELs, predicted by SIFT4, Polyphen25, and MutationTaster6 to be damaging, were remained.\\nAfter data filtering, a novel nonsense mutation (NM_007168: c.3460C>T; p.R1154X) of ABCA8 was identified and validated by Sanger sequencing in the proband (Figure 1E). Previous studies have revealed that deleterious heterozygous ABCA8 mutations may disrupt cholesterol efflux and reduce HDL-c levels in humans and mice. No other meaningful mutations related to lipid metabolism has been identified. Sanger sequencing further confirmed that only the affected individuals (II-2, II-4, and III-1) carried the novel nonsense mutation (NM_007168: c.3460C>T; p.R1154X) of ABCA8 (Figure 1F). The novel mutation, resulting a truncated protein, was absent in the healthy members (I-2, II-1, and III-2) and 200 local people who were used as an internal control to exclude the SNP in local people. Bioinformatics predicted that the newly identified mutation was deleterious and may disrupt the structure and function of ABCA8. On the basis of ACMG guidelines, the novel variant meetings the following criteria from the ACMG guidelines: PVS1, PS3, and PM2.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 68,\n",
       "    'case_id': 'PMC8138243_01',\n",
       "    'case_text': \"A Caucasian 68-year-old male, without systemic diseases, was admitted in March 2020 to a tertiary care center (Hospital Vera Cruz, Campinas, Sao Paulo, Brazil) with history of right upper eyelid swelling and redness for 10 days, which became progressively worse. He denied fever, worsening of visual acuity, or pain due to eye movements.\\nAt presentation, the patient's right eye was closed by erythematous and swelling of the right upper lid (Fig. 1). Vital signs at the time of hospital admission were as follows: systemic blood pressure = 130 x 70 mm Hg, cardiac frequency = 71 bpm, and body temperature = 37.1 C. The full blood count presented a white blood count of leukocytes = 6,478 mm3 (neutrophils = 4,060 mm3, eosinophils 30 mm3, basophils = 20 mm3, lymphocytes = 1,790 mm3, and monocytes = 580 mm3). All of them were within the normal range.\\nOphthalmologic exam at the time of admission showed visual acuity of 0.4 logMAR in both eyes (OU) with spectacles, clear conjunctiva, clear cornea, and nuclear cataract 2+ in OU. Ocular motility and pupillary reflex were normal in OU. The intraocular pressure was 12 mm Hg in OU (with Icare tonometer, which is a rebound tonometer). Fundoscopy showed pink optic disc with sharp margins and a cup to disc ratio of 0.5 in OU.\\nComputerized tomography revealed preseptal and soft tissue edema with an abscess in the anterior right upper eyelid but no signs of orbital involvement or orbital fractures. Figure 2 presents the aspect of both eyelids in the tomography. A presumptive diagnosis of hordeolum with preseptal cellulitis and abscess was made, and intravenous amoxicillin and clavulanate potassium 500/125 mg were administrated twice a day.\\nThe development of purulent discharge from the upper eyelid with an abscess and necrosis was evident. Therefore, the patient underwent abscess drainage and wound debridement. During the procedure, necrosis was observed involving almost the full thickness of the right upper eyelid, measuring 30 x 30 mm in the central area. The tissue surrounding the abscess was friable and necrotic and did not bleed. The necrotic tissue was debrided until healthy viable tissue appeared throughout the wound and no evidence of infection was present in the reminiscent tissue. The wound was left open to heal by secondary intension. Figure 3 presents the eyelid aspect immediately after the surgery.\\nGiven the clinical improvement in his local and systemic condition, the patient was continued on intravenous amoxicillin and clavulanate twice a day for 48 h and was discharged with the same oral antibiotics. He also started using topical medication with retinol acetate (10,000 IU/g), amino acids (25 mg/g), methionine (5 mg/g), and chloramphenicol (5 mg/g) in the affected eyelid for 7 days, 3 times a day.\\nSeven days after debridement, he presented satisfactory cicatrization without any symptoms (Fig. 4). After 2 months, the eyelid was completely healed with no retraction (Fig. 5a, b).\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 35,\n",
       "    'case_id': 'PMC3546213_01',\n",
       "    'case_text': \"A 35-year-old woman developed MVD due to a left HFS 6 years ago, which was refractory to medical treatment. Results of preoperative brain magnetic resonance image and electromyography were normal. Surgery was successfully performed, and the postoperative findings revealed that the branch of the left anterior inferior cerebellar artery had been compressing the VII-VIII cranial nerve complex. The pateint did not show any specific symptoms for about 3 and a half years after MVD. But, the symptoms began to recur 1 year ago and she was medicated with 0.5 mg clonazepam for 3 months, and received two local botulinum toxin injections. No treatment effect occurred, so she visited our pain clinic. The patient was experiencing a twitch on the infraorbital area and chin when the HFS was severe, and spasm frequency was 3-4 Hz. Discomfort on the visual analogue scale (VAS) was 10/10. We initially attempted a left stellate ganglion block twice, but no effect was observed, Then, we performed a fluoroscope-guided left facial nerve block twice using 4 ml of 2% lidocaine, and 20 mg triamcinolone. No complications occurred, and the HFS symptoms were relieved for 4 days. Thus, we decided to perform PRF on the facial nerve. In the right lateral decubitus position, the patient's chin was slightly lifted, which exposed the mastoid process. Both sides of the mastoid process and mandible were superimposed on a lateral fluoroscope imaging view (Fig. 1). The skin was prepared with betadine and aseptic draping. We used a 10 cm, 22-G Sluijter-Mehta cannula needle with a 0.5 mm active tip and verified accurate needle position by fluoroscopy. A 5 mm skinwheal appeared from the mastoid process to the nose beginning at the needle entry point of the local anesthetic. We explored facial nerves with 50 Hz, 0.5 V sensory stimulation to the tongue and 2 Hz, 1.0 V motor stimulation to the left hemi face when the tip of the needle was positioned around the stylomastoid for amen. We administered three PRF pulses at 42C for 120 seconds after confirming that the needle tip was near the facial nerve. After the procedure, we injected 3 ml of 4% lidocaine mixed with 20 mg triamcinolone. The patient was symptom free for only 4 days, so we applied additional PRF treatments twice using the same method to obtain a longer effect. When the patient returned as an outpatient 1 week after the second PRF treatment, HFS frequency was improved to < 0.25 Hz, and subjective complaints improved on the VAS (2-3/10). The modified MacNab criteria at 1 week after the procedure were good. The patient was followed up at 3, 6, 9, and 12 months via telephone, and symptom relief was maintained continuously.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 20,\n",
       "    'case_id': 'PMC9852490_01',\n",
       "    'case_text': \"A 20-year-old male presented with pain and limited motion in the right knee for 15 years. The patient presented to our clinic with HA, restricted flexion and extension of the right knee and a sagittal deformity of the right femur 8 months prior to the surgery. He was diagnosed with severe haemophilia A (coagulation factor VIII was 1.52%) and haemophilic arthritis of right knee. At the age of 13, the patient was fixed with plaster for a fracture of the femoral shaft, which resulted in a malunion.\\nBecause he was positive for inhibitors, the patient was re-examined regularly by the Haematology Clinic after discharge. The patient did not take any interventions during the first 4 months while being positive for inhibitors. During this period, the patient suffered from knee joint bleeding and recovered after ice compression and lying in bed. In the 5th month after the discovery of the inhibitors, the patient received irregular injections of factor VIII intravenously (1,000 IU, BIW or TIW, Kovaltry, Bayer), which did not follow the haematologist's recommendation. After 66 days of injections, he was still positive for inhibitors. Since then, the patient started to receive regular injections of factor VIII (1,500 IU, BID) intravenously. Forty-nine days after the first injection, he became negative for inhibitors (Table 1). The patient came to the hospital again 3 days prior to the surgery.\\nPreoperative examinations showed the patient had pain in his right knee. His right foot could not touch the ground. The range of joint motion (ROM) was 20 -90 , the visual analogue scale (VAS) was 7 and the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) was 106 (Figure 1, Table 2). Other systemic examinations were normal. X-ray and CT showed that the patient's right knee joint space was narrow, with a right femoral flexion deformity (30 , sagittal, anterior) (Figure 2).\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 42,\n",
       "    'case_id': 'PMC4108191_01',\n",
       "    'case_text': 'A 42-year-old, non-smoking, virgin woman presented to our institution with complaints of dyspnea and pleuritic chest pain since 2 days ago along with 2-month transient spotting. She had a history of leiomyoma since 5 months ago, and was hospitalized due to vaginal bleeding, and had been undergone therapy by a gonadotropin-releasing hormone (GnRH) agonist and medroxyprogesterone acetate, intramuscularly. To control her anemia, she was given oral ferrous sulfate. There was no relevant familial history of the same condition. On physical examination, she was anxious and tachypneic on admission, with body mass index of 24.7 kg/m2, body temperature 37 C, blood pressure 100/70 mmHg, heart rate 120 beats per min, respiratory rate of 24 breaths per min, and 96% oxygen saturation while breathing room air. Other findings included regular heart beat with a 2/6 systolic murmur in the left sternal border, clear lung sound, and a non-tender abdomen with a 20-week size uterus. There was no swelling in her lower limbs.\\nAn electrocardiogram revealed a sinus tachycardia and inverted T waves in v1 to v3 and inferior leads. Hematologic testing revealed hemoglobin of 11.3 g/dL and other results were within normal limits. Coagulation factors were also unremarkable. A chest radiograph showed Westermark sign without pleural effusion. An ultrasound investigation revealed an acute DVT in the popliteal and superficial femoral veins of her left leg and an enlarged leiomyoma of the uterus. Thereafter, transesophageal echocardiography (TEE) demonstrated normal left ventricle systolic function, severe right ventricle enlargement, McConnell sign, moderate tricuspid regurgitation, severe pulmonary hypertension of 110 mmHg, and dilatation of the main pulmonary artery. In addition, a 2.6 1.6 cm echogenic mass was detected in the left pulmonary artery, consistent with thrombosis (Figure 1). Given her leiomyoma history, she underwent magnetic resonance imaging (MRI), which revealed a huge uterine-derived mass compressing both common iliac veins (Figure 2).\\nDue to massive PE, the patient was administered loading dose of 250 000 units of streptokinase and the infusion of 100 000 units per hour during 24 h. After undergoing thrombolysis, her general condition significantly improved, and then she underwent anticoagulation therapy. One unit of packed red blood cells was also transfused. Examination by TEE on the fourth day revealed the disappearance of the pulmonary artery thrombosis. After achieving a therapeutic range of international normalized ratio (range 2.0-3.0), she was discharged on warfarin 5 mg daily.\\nThe patient was followed for 3 months and then evaluated again and examined using TEE and ultrasonography, which demonstrated normal findings. After withholding warfarin preoperatively, she underwent myomectomy instead of hysterectomy due to her uterus preservation. Warfarin therapy commenced again following surgery, and she was discharged in stable condition on warfarin therapy. Nine months after myomectomy, she was well, without evidence of thromboembolism.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 67,\n",
       "    'case_id': 'PMC8200619_01',\n",
       "    'case_text': 'A totally bimaxillary edentulous male patient, aged 67 years, diagnosed with prostate cancer who underwent intravenous bisphosphonates treatment (zoledronic acid) for about one year presented himself in March 2018 to Maxillofacial Surgery Department of County Clinical Hospital of Craiova.',\n",
       "    'gender': 'Male'},\n",
       "   {'age': None,\n",
       "    'case_id': 'PMC8200619_02',\n",
       "    'case_text': 'The patient had pain in the anterior mandibular arch, with exposed necrotic bone. Diagnostic was stage 2 MRONJ.\\nBisphosphonate treatment was discontinued about 6 months in advance.\\nFollowing clinical examination corroborated with the imaging investigations, it was decided to adopt a conservative treatment which consisted in removing the necrotic bone tissue by marginal resection of the mandible down to the clinically healthy bone, associated with lavages with antiseptic solutions and antibiotic therapy.\\nPatient gave the written informed consent for the treatment, and also for publication of his case.\\nAlthough initially the evolution was favorable, after about 2 weeks there were numerous infectious episodes that required repeated antibiotic treatment.',\n",
       "    'gender': 'Male'},\n",
       "   {'age': None,\n",
       "    'case_id': 'PMC8200619_03',\n",
       "    'case_text': 'The patient developed a dehiscence in the operated area (Figures 1 a, b).\\nDue to the progressive nature of MRONJ, it was decided to perform a radical surgery, with the written informed consent of the patient.\\nUnder general anesthesia, a submandibular incision was made from the left mandibular angle to the right mandibular angle with the exposure of the entire mandibular body (Figure 2a).\\nIt was revealed a large area of bone necrosis in the anterior mandibular arch level (Figure 2b).\\nThe contour of the mandibular arch was recorded with a guide plate.\\nSegmental anterior mandibular resection was performed with large bone bur drills under saline irrigation down to healthy bone with normal bone specific bleeding (Figures 2 c, d).\\nThe surgical specimen was sent for histopathological examination to exclude malignancy.\\nAs the resulting defect was large, it was decided to restore the contour of the mandibular arch with titanium primary reconstruction plate covered with a pectoralis major flap to close the resulting defect (Figures 2 e, f).\\nThe thoraco-acromial artery was included in the pectoralis major flap (Figure 2f).\\nIt was rotated in the oral cavity with the tegument part closing the endo-oral mucosa defect (Figure 2g).\\nThe donor site was closed primarily after flap harvest.\\nSurgical treatment was associated with postoperative antibiotic therapy for a period of 7 days.\\nBoth the endo-oral wound and the donor site wound healed without complications.',\n",
       "    'gender': 'Unknown'},\n",
       "   {'age': None,\n",
       "    'case_id': 'PMC8200619_04',\n",
       "    'case_text': 'There were no more inflammatory areas and the patient did not complain of local pain.',\n",
       "    'gender': 'Unknown'},\n",
       "   {'age': None,\n",
       "    'case_id': 'PMC8200619_05',\n",
       "    'case_text': 'The patient was monitored weekly for the first month after discharge and then monthly for up to one year after surgery (April 2019).\\nAt 6 months and 1 year after the intervention, there were no recurrences of MRONJ (Figures 3 a,b).',\n",
       "    'gender': 'Unknown'}],\n",
       "  [{'age': 32,\n",
       "    'case_id': 'PMC5420015_01',\n",
       "    'case_text': \"A 32-year-old woman in the 28th week of her fifth pregnancy was referred to our institution with a 3-week history of fetal bradycardia (fetal heart rate 60 beats per minute [bpm]). She had no personal or family histories of cardiac arrest, seizures, or syncope. Of her 4 pregnancies, only 1 had ended in a miscarriage. The initial fetal echocardiogram at our institution revealed a structurally normal heart with normal size, normal function, and second-degree AVB (V rate 60 bpm, atrial rate 120 bpm). Her antibody screen was negative for anti-SSA and anti-SSB antibodies. One week later, a follow-up fetal echocardiogram showed a ventricular rate of 220 bpm (atrial rate was 130 bpm) (Figure 1A). An fMCG was then performed which revealed nonsustained VT alternating with sinus rhythm (rate 130 bpm) (Figure 1B). The VT was present about 75% of the time. The QTc was 591 ms (Figure 1C).\\nOver the ensuing days, the TdP continued and the fetus developed severe hydrops. We therefore decided to administer an intravenous loading dose of magnesium (4 g) followed by a continuous infusion (1-1.4 g/h) to maintain a maternal serum level of 1.2-1.4 (normal = 0.65-1.05 mmol/L). The mother's baseline magnesium level was 0.72 mmol/L. Within 3 days of magnesium infusion the frequency of TdP decreased (by fMCG the fetus was in sinus rhythm 80% of the time). Because of the concern for an SCN5A R1623Q mutation, we began treatment with mexiletine (600 mg orally per day). The fetus remained in sinus rhythm (rate 100 bpm) with continuous magnesium infusion and oral mexiletine given to the mother. At 35 weeks the fetus became bradycardic and was found to be in second-degree AVB.\\nThe mother underwent an elective cesarean section at 35 weeks' gestation and a 2334-g male infant was delivered. The heart rate at birth was 56 bpm owing to functional second-degree AVB with 2:1 conduction (Figure 2A). Immediately after delivery, temporary transvenous pacing wires were placed. On the second day of life, a permanent pacemaker was implanted. We also administered oral mexiletine (4 mg/kg/d) and intravenous propranolol (0.02 mg/kg/h); no VT was observed. On the 14th day of life, the infant's electrocardiography showed sinus rhythm with a left bundle branch block pattern (Figure 2B). On the 40th day of life, the mexiletine blood levels declined, and TdP occurred despite ventricular pacing (VVI 80 bpm). The TdP spontaneously terminated.\\nThe VVI pacing rate was increased to 110 bpm. When the infant was at the age of 5 months, weighing 6.6 kg, we placed an implantable cardioverter-defibrillator (ICD). The shock lead was implanted subcutaneously through the left thoracodorsal region, and the generator was placed under the right abdominal rectus muscle (Figure 2C). Following implantation of the ICD, the child did not experience any appropriate or inappropriate shocks during 4 years of follow-up. He received oral mexiletine (12 mg/kg/d) and propranolol (2 mg/kg/d).\\nGenetic testing of this case revealed a KCNH2 missense mutation (S624R). To date, there has been no functional analysis of this mutation. His mother's QTc was 440 ms, and his father's was 390 ms. Neither of the parents had any mutation in this locus. However, we did not exclude parental germinal mosaicism.\",\n",
       "    'gender': 'Female'},\n",
       "   {'age': 35,\n",
       "    'case_id': 'PMC5420015_02',\n",
       "    'case_text': \"A 35-year-old woman was referred to our institution at 24 weeks' gestation because of a fetal pericardial effusion and fetal tachycardia. The family history was positive for a paternal KCNH2 missense mutation (T613M) diagnosed after a syncopal episode. The fetal echocardiogram revealed a peristent tachycardia with atrioventricular dissociation (Figure 3A). The fMCG confirmed the clinical diagnosis of VT with a rate of 220 bpm (Figure 3B) with a prolonged (511 ms) QTc during brief (<20% of the recording time) episodes of sinus rhythm (rate 110-120 bpm) (Figure 3C). The mother was admitted to the hospital for continuous intravenous magnesium treatment to terminate the fetal VT. However, despite maternal serum magnesium levels of 1.28 mmol/L (normal range 0.65-1.05 mmol/L), the VT persisted and the fetus became hydropic (Figure 3D). Ten days after the mother was on magnesium, we initiated propranolol (initial dose 60-120 mg orally per day), following which the VT resolved. We continued magnesium by a continuous infusion (1.4 g/h) after we started propranolol. fMCG revealed a decreased fetal sinus rate from 120 to 110 bpm. The hydrops then improved gradually. The mother's daily total heart beats decreased from 129,108 to 103,206 (average heart rate decreased from 90 to 71 bpm) after propranolol administration, indicating beta-adrenergic blocking effect. Subsequently, the fetal sinus rhythm (rate 110 bpm) was maintained. A 2010-g female infant was delivered by elective cesarean delivery at 37 weeks' gestation. After birth, the infant's electrocardiography showed an intermittent left bundle branch block pattern. On the fifth day of life, she developed second-degree AVB with a ventricular rate of 60-80 bpm and metabolic acidemia owing to poor cardiac output. She urgently underwent temporary epicardial ventricular pacing lead implantation. At the age of 3 months, sustained VT occurred immediately after permanent pacemaker implantation and was successfully terminated by cardioversion. Hypokalemia (serum potassium level was 2.9 mmol/L) during intensive care likely contributed to the VT. VT did not recur after the potassium was corrected. Her genetic testing identified the KCNH2 missense mutation (T613M), identical to that of her father. She received oral mexiletine (7 mg/kg/d) and propranolol (3 mg/kg/d) with pacing (VVI 110 bpm) for 23 months.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 53,\n",
       "    'case_id': 'PMC6288572_01',\n",
       "    'case_text': \"A 53-year-old male, smoker (20 pack-years), occasional alcoholic, presented with complaints of blood expectoration of 400 ml in one episode followed by 100-150 ml for 2-3 days. He had 3 episodes of similar history which required hospitalizations and emergency care since 9 months. He denied history of fever, chest pain, and loss of appetite. He underwent cholecystectomy 3 years ago. There was no history of systemic immune suppression like diabetes. He had undergone bronchial artery embolization for massive haemoptysis; however, his haemoptysis persisted and diagnosis remained elusive after evaluation with sputum studies and CT-guided aspiration cytology, biopsy, and bronchoscopic lavage. He was treated for LRTI with multiple courses of antibiotics for more than 9 months.\\nOn examination, vitals were normal with no respiratory distress. Oral hygiene was poor with dental caries. Respiratory examination revealed scattered crackles in the left lower lobe area. Chest X-ray showed an inhomogeneous opacity in the left lower zone with raised left diaphragm (Figure 1), and CECT (contrast-enhanced computer tomogram) chest showed a hypodense lesion with irregular margins in the anterior segment of the left lower lobe adjacent to the descending aorta and associated subcarinal lymphadenopathy (Figures 2 and 3). Image-guided transthoracic biopsy showed type 2 alveolar cell hyperplasia with negative immunohistochemistry. Bronchoscopy confirmed left lower lobe bleed with any endoluminal lesion. Bronchial wash was negative for microbiological and cytological studies including AFB stain, geneXpert for MTB complex, and pyogenic culture. Patient's symptoms of haemoptysis persisted; hence, CT angiogram was performed, which showed dilated vascular channels within the lesion without any obvious extravasations of contrast and no aortic abnormality.\\nProbable diagnosis of the left intrapulmonary vascular lesion was made and hence the patient underwent left lower lobe lobectomy. Intraoperatively, the left lower lobe was adherent posterolaterally to the aorta and diaphragm. Multiple prominent blood vessels in areas of adhesion were seen. Histopathology was suggestive of chronic inflammatory cells with focal aggregates of lymphocytes with positive GMS staining for actinomycosis (Figure 4). Postoperatively, the patient received parenteral benzylpenicillin 20 lakh units 6th hourly for 3 months. The patient was in regular follow-up, and no further episodes of haemoptysis and no recent respiratory complaints are reported.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 33,\n",
       "    'case_id': 'PMC6921157_01',\n",
       "    'case_text': 'A 33-year-old woman with intractable epilepsy was referred to our epilepsy center for clinical evaluation. At age 31, she experienced status epilepticus subsequent to a febrile episode and following prolonged coma that continued several weeks. She had no prior history of epilepsy or seizure-related disorders. Initial diagnosis was limbic encephalitis, based on inflammatory findings of cerebrospinal fluid. She was treated with intravenous steroid administration and plasma exchange at another hospital. Although she gradually recovered from comatose state and discharged home in two months without any disability for daily living, symptomatic epilepsy with frequent seizures with impaired awareness persisted. She described that her seizure started with strange odor or deja vu sensation, and then she felt dizziness or lightheadedness. It sometimes accompanied jerky movements of the right side of her face and arm, and eventually led to impaired awareness. Although she was taking levetiracetam 1000 mg and lamotrigine 400 mg, she usually had 1-2 seizures a day. She had previously taken carbamazepine, lacosamide, perampanel and topiramate which did not lead to improvement.\\nHer latest brain magnetic resonance imaging (MRI) revealed a cluster of variably sized multiple nodular high intensity lesions on T2-weighted image (T2WI) and fluid-attenuated inversion recovery (FLAIR) in white matter of the left temporal lobe along with the border of inner cortex (Fig. 1A). The lesions did not show any mass effect or enhancement with gadolinium. Similar findings were also observed in the past MRI when the patient had encephalitis two years before, and the size of the lesions were not different from the latest one. The characteristics of MRI findings were consistent with those of MVNT. 18 fluoro-2-deoxyglucose positron emission tomography (FDG-PET) of brain demonstrated moderate decrease of uptake in the lesion area (Fig. 1B). Laboratory findings of her blood and cerebrospinal fluid did not reveal any other causes of epilepsy.\\nLong-term video electroencephalogram (vEEG) was performed for 72 h and three habitual seizures were recorded: Two of them started with deja vu and strange odor sensation followed by nodding movement of the head and subsequent fluttering of right hand and foot. Her consciousness was partially impaired during the seizure. vEEG showed rhythmic wave that started from the left middle temporal area and spread to the ipsilateral frontal region, and then to the contralateral hemisphere (Fig. 2A); The other started with lightheadedness and vEEG showed similar rhythmic waves that started from the right anterior temporal area (Fig. 2B). Interictal EEG showed frequent multifocal spikes and sharp waves in the bilateral anterior to middle temporal area.\\nBased on the EEG findings that demonstrated the multiple independent seizure onsets in both hemispheres, the patient was considered to have bilateral multifocal epileptic foci, whereas the lesions with MVNT appearance on MRI were localized in the left temporal lobe. Although MVNT had been described as an epilepsy-related brain tumor, we refrained from resection surgery because it was not certain that the lesions were epileptogenic in this patient. She has been followed up with multiple antiepileptic drugs.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 4,\n",
       "    'case_id': 'PMC4550780_01',\n",
       "    'case_text': 'Considerable variations in recursive abilities have also been observed developmentally. Dickinson showed that recursive language production abilities emerge gradually, in a piecemeal fashion. On the comprehension side, training improves comprehension of singly embedded relative clause constructions both in 3-4-year old children (Roth,) and adults (Wells et al.,), independent of other cognitive factors. Level of education further correlates with the ability to comprehend complex recursive sentences (Dabrowska,). More generally, these developmental differences are likely to reflect individual variations in experience with language (see Christiansen and Chater, Forthcoming), differences that may further be amplified by variations in the structural and distributional characteristics of the language being spoken.\\nTogether, these individual, developmental and cross-linguistic differences in dealing with recursive linguistic structure cannot easily be explained in terms of a fundamental recursive competence, constrained by fixed biological constraints on performance. That is, the variation in recursive abilities across individuals, development, and languages are hard to explain in terms of performance factors, such as language-independent constraints on memory, processing or attention, imposing limitations on an otherwise infinite recursive grammar. Invoking such limitations would require different biological constraints on working memory, processing, or attention for speakers of different languages, which seems highly unlikely. To resolve these issues, we need to separate claims about recursive mechanisms from claims about recursive structure: the ability to deal with a limited amount of recursive structure in language does not necessitate the postulation of recursive mechanisms to process them. Thus, instead of treating recursion as an a priori property of the language faculty, we need to provide a mechanistic account able to accommodate the actual degree of recursive structure found across both natural languages and natural language users: no more and no less.\\nWe favor an account of the processing of recursive structure that builds on construction grammar and usage-based approaches to language. The essential idea is that the ability to process recursive structure does not depend on a built-in property of a competence grammar but, rather, is an acquired skill, learned through experience with specific instances of recursive constructions and limited generalizations over these (Christiansen and MacDonald,). Performance limitations emerge naturally through interactions between linguistic experience and cognitive constraints on learning and processing, ensuring that recursive abilities degrade in line with human performance across languages and individuals. We show how our usage-based account of recursion can accommodate human data on the most complex recursive structures that have been found in naturally occurring language: center-embeddings and cross-dependencies. Moreover, we suggest that the human ability to process recursive structures may have evolved on top of our broader abilities for complex sequence learning. Hence, we argue that language processing, implemented by domain-general mechanisms:not recursive grammars:is what endows language with its hallmark productivity, allowing it to \"...make infinite employment of finite means,\" as the celebrated German linguist, Wilhelm von Humboldt (: p. 91), noted more than a century and a half ago.\\nLanguage processing involves extracting regularities from highly complex sequentially organized input, suggesting a connection between general sequence learning (e.g., planning, motor control, etc., Lashley,) and language: both involve the extraction and further processing of discrete elements occurring in temporal sequences (see also e.g., Greenfield,; Conway and Christiansen,; Bybee,; de Vries et al.,, for similar perspectives). Indeed, there is comparative, genetic, and neural evidence suggesting that humans may have evolved specific abilities for dealing with complex sequences. Experiments with non-human primates have shown that they can learn both fixed sequences, akin to a phone number (e.g., Heimbauer et al.,), and probabilistic sequences, similar to \"statistical learning\" in human studies (e.g., Heimbauer et al.,, under review; Wilson et al.,). However, regarding complex recursive non-linguistic sequences, non-human primates appear to have significant limitations relative to human children (e.g., in recursively sequencing actions to nest cups within one another; Greenfield et al.,; Johnson-Pynn et al.,). Although more carefully controlled comparisons between the sequence learning abilities of human and non-primates are needed (see Conway and Christiansen,, for a review), the currently available data suggest that humans may have evolved a superior ability to deal with sequences involving complex recursive structures.\\nThe current knowledge regarding the FOXP2 gene is consistent with the suggestion of a human adaptation for sequence learning (for a review, see Fisher and Scharff,). FOXP2 is highly conserved across species but two amino acid changes have occurred after the split between humans and chimps, and these became fixed in the human population about 200,000 years ago (Enard et al.,). In humans, mutations to FOXP2 result in severe speech and orofacial motor impairments (Lai et al.,; MacDermot et al.,). Studies of FOXP2 expression in mice and imaging studies of an extended family pedigree with FOXP2 mutations have provided evidence that this gene is important to neural development and function, including of the cortico-striatal system (Lai et al.,). When a humanized version of Foxp2 was inserted into mice, it was found to specifically affect cortico-basal ganglia circuits (including the striatum), increasing dendrite length and synaptic plasticity (Reimers-Kipping et al.,). Indeed, synaptic plasticity in these circuits appears to be key to learning action sequences (Jin and Costa,); and, importantly, the cortico-basal ganglia system has been shown to be important for sequence (and other types of procedural) learning (Packard and Knowlton,). Crucially, preliminary findings from a mother and daughter pair with a translocation involving FOXP2 indicate that they have problems with both language and sequence learning (Tomblin et al.,). Finally, we note that sequencing deficits also appear to be associated with specific language impairment (SLI) more generally (e.g., Tomblin et al.,; Lum et al.,; Hsu et al.,; see Lum et al.,, for a review).\\nHence, both comparative and genetic evidence suggests that humans have evolved complex sequence learning abilities, which, in turn, appear to have been pressed into service to support the emergence of our linguistic skills. This evolutionary scenario would predict that language and sequence learning should have considerable overlap in terms of their neural bases. This prediction is substantiated by a growing bulk of research in the cognitive neurosciences, highlighting the close relationship between sequence learning and language (see Ullman,; Conway and Pisoni,, for reviews). For example, violations of learned sequences elicit the same characteristic event-related potential (ERP) brainwave response as ungrammatical sentences, and with the same topographical scalp distribution (Christiansen et al.,). Similar ERP results have been observed for musical sequences (Patel et al.,). Additional evidence for a common domain-general neural substrate for sequence learning and language comes from functional imaging (fMRI) studies showing that sequence violations activate Broca\\'s area (Lieberman et al.,; Petersson et al.,; Forkstam et al.,), a region in the left inferior frontal gyrus forming a key part of the cortico-basal ganglia network involved in language. Results from a magnetoencephalography (MEG) experiment further suggest that Broca\\'s area plays a crucial role in the processing of musical sequences (Maess et al.,).\\nIf language is subserved by the same neural mechanisms as used for sequence processing, then we would expect a breakdown of syntactic processing to be associated with impaired sequencing abilities. Christiansen et al. tested this prediction in a population of agrammatic aphasics, who have severe problems with natural language syntax in both comprehension and production due to lesions involving Broca\\'s area (e.g., Goodglass and Kaplan,; Goodglass, :see Novick et al.,; Martin,, for reviews). They confirmed that agrammatism was associated with a deficit in sequence learning in the absence of other cognitive impairments. Similar impairments to the processing of musical sequences by the same population were observed in a study by Patel et al.. Moreover, success in sequence learning is predicted by white matter density in Broca\\'s area, as revealed by diffusion tensor magnetic resonance imaging (Floel et al.,). Importantly, applying transcranial direct current stimulation (de Vries et al.,) or repetitive transcranial magnetic stimulation (Udden et al.,) to Broca\\'s area during sequence learning or testing improves performance. Together, these cognitive neuroscience studies point to considerable overlap in the neural mechanisms involved in language and sequence learning2, as predicted by our evolutionary account (see also Wilkins and Wakefield,; Christiansen et al.,; Hoen et al.,; Ullman,; Conway and Pisoni,, for similar perspectives).\\nComparative and genetic evidence is consistent with the hypothesis that humans have evolved more complex sequence learning mechanisms, whose neural substrates subsequently were recruited for language. But how might recursive structure recruit such complex sequence learning abilities? Reali and Christiansen explored this question using simple recurrent networks (SRNs; Elman,). The SRN is a type of connectionist model that implements a domain-general learner with sensitivity to complex sequential structure in the input. This model is trained to predict the next element in a sequence and learns in a self-supervised manner to correct any violations of its own expectations regarding what should come next. The SRN model has been successfully applied to the modeling of both sequence learning (e.g., Servan-Schreiber et al.,; Botvinick and Plaut,) and language processing (e.g., Elman,), including multiple-cue integration in speech segmentation (Christiansen et al.,) and syntax acquisition (Christiansen et al.,). To model the difference in sequence learning skills between humans and non-human primates, Reali and Christiansen first \"evolved\" a group of networks to improve their performance on a sequence-learning task in which they had to predict the next digit in a five-digit sequence generated by randomizing the order of the digits, 1-5 (based on a human task developed by Lee,). At each generation, the best performing network was selected, and its initial weights (prior to any training):i.e., their \"genome\":was slightly altered to produce a new generation of networks. After 500 generations of this simulated \"biological\" evolution, the resulting networks performed significantly better than the first generation SRNs.\\nReali and Christiansen then introduced language into the simulations. Each miniature language was generated by a context-free grammar derived from the grammar skeleton in Table 1. This grammar skeleton incorporated substantial flexibility in word order insofar as the material on the right-hand side of each rule could be ordered as it is (right-branching), in the reverse order (left-branching), or have a flexible order (i.e., the constituent order is as is half of time, and the reverse the other half of the time). Using this grammar skeleton, it is possible to instantiate 36 (= 729) distinct grammars, with differing degrees of consistency in the ordering of sentence constituents. Reali and Christiansen implemented both biological and cultural evolution in their simulations: As with the evolution of better sequence learners, the initial weights of the network that best acquired a language in a given generation were slightly altered to produce the next generation of language learners:with the additional constraint that performance on the sequence learning task had to be maintained at the level reached at the end of the first part of the simulation (to capture the fact that humans are still superior sequence learners today). Cultural evolution of language was simulated by having the networks learn several different languages at each generation and then selecting the best learnt language as the basis for the next generation. The best learnt language was then varied slightly by changing the directions of a rule to produce a set of related \"offspring\" languages for each generation.\\nAlthough the simulations started with language being completely flexible, and thus without any reliable word order constraints, after <100 generations of cultural evolution, the resulting language had adopted consistent word order constraints in all but one of the six rules. When comparing the networks from the first generation at which language was introduced and the final generation, Reali and Christiansen found no difference in linguistic performance. In contrast, when comparing network performance on the initial (all-flexible) language vs. the final language, a very large difference in learnability was observed. Together, these two analyses suggest that it was the cultural evolution of language, rather than biological evolution of better learners, that allowed language to become more easily learned and more structurally consistent across these simulations. More generally, the simulation results provide an existence proof that recursive structure can emerge in natural language by way of cultural evolution in the absence of language-specific constraints.\\nNP   {N (PP)}\\nPP   {adp NP}\\nAn important remaining question is whether human learners are sensitive to the kind of sequence learning constraints revealed by Reali and Christiansen\\'s simulated process of cultural evolution. A key result of these simulations was that the sequence learning constraints embedded in the SRNs tend to favor what we will refer to as recursive consistency (Christiansen and Devlin,). Consider rewrite rules (2) and (3) from Table 1: \\n(3) [NP buildings [PP from [NP cities [PP with [NP smog]]]]]\\n(4) [NP [PP [NP [PP [NP smog] with] cities] from] buildings]\\n(5) [NP buildings [PP [NP cities [PP [NP smog] with]] from]]\\n(6) [NP [PP from [NP [PP with [NP smog]] cities]] buildings]\\nTogether, these two skeleton rules form a recursive rule set because each calls the other. Ignoring the flexible version of these two rules, we get the four possible recursive rule sets shown in Table 2. Using these rules sets we can generate the complex noun phrases seen in (3)-(6): \\nThe first two rules sets from Table 2 generate recursively consistent structures that are either right-branching (as in 3) or left-branching (as in 4). The prepositions and postpositions, respectively, are always in close proximity to their noun complements, making it easier for a sequence learner to discover their relationship. In contrast, the final two rule sets generate recursively inconsistent structures, involving center-embeddings: all nouns are either stacked up before all the postpositions (5) or after all the prepositions (6). In both cases, the learner has to work out that from and cities together form a prepositional phrase, despite being separated from each other by another prepositional phrase involving with and smog. This process is further complicated by an increase in memory load caused by the intervening prepositional phrase. From a sequence learning perspective, it should therefore be easier to acquire the recursively consistent structure found in (3) and (4) compared with the recursively inconsistent structure in (5) and (6). Indeed, all the simulation runs in Reali and Christiansen resulted in languages in which both recursive rule sets were consistent.\\nChristiansen and Devlin had previously shown that SRNs perform better on recursively consistent structure (such as those in 3 and 4). However, if human language has adapted by way of cultural evolution to avoid recursive inconsistencies (such as 5 and 6), then we should expect people to be better at learning recursively consistent artificial languages than recursively inconsistent ones. Reeder, following initial work by Christiansen, tested this prediction by exposing participants to one of two artificial languages, generated by the artificial grammars shown in Table 3. Notice that the consistent grammar instantiates a left-branching grammar from the grammar skeleton used by Reali and Christiansen, involving two recursively consistent rule sets (rules 2-3 and 5-6). The inconsistent grammar differs only in the direction of two rules (3 and 5), which are right-branching, whereas the other three rules are left-branching. The languages were instantiated using 10 spoken non-words to generate the sentences to which the participants were exposed. Participants in the two language conditions would see sequences of the exact same lexical items, only differing in their order of occurrence as dictated by the respective grammar (e.g., consistent: jux vot hep vot meep nib vs. inconsistent: jux meep hep vot vot nib). After training, the participants were presented with a new set of sequences, one by one, for which they were asked to judge whether or not these new items were generated by the same rules as the ones they saw previously. Half of the new items incorporated subtle violations of the sequence ordering (e.g., grammatical: cav hep vot lum meep nib vs. ungrammatical: cav hep vot rud meep nib, where rud is ungrammatical in this position).\\nThe results of this artificial language learning experiment showed that the consistent language was learned significantly better (61.0% correct classification) than the inconsistent one (52.7%). It is important to note that because the consistent grammar was left-branching (and thus more like languages such as Japanese and Hindi), knowledge of English cannot explain the results. Indeed, if anything, the two right-branching rules in the inconsistent grammar bring that language closer to English3. To further demonstrate that the preferences for consistently recursive sequences is a domain-general bias, Reeder conducted a second experiment, in which the sequences were instantiated using black abstract shapes that cannot easily be verbalized. The results of the second study closely replicated those of the first, suggesting that there may be general sequence learning biases that favor recursively consistent structures, as predicted by Reali and Christiansen\\'s evolutionary simulations.\\nThe question remains, though, whether such sequence learning biases can drive cultural evolution of language in humans. That is, can sequence-learning constraints promote the emergence of language-like structure when amplified by processes of cultural evolution? To answer this question, Cornish et al. (under review) conducted an iterated sequence learning experiment, modeled on previous human iterated learning studies involving miniature language input (Kirby et al.,). Participants were asked to participate in a memory experiment, in which they were presented with 15 consonant strings. Each string was presented briefly on a computer screen after which the participants typed it in. After multiple repetitions of the 15 strings, the participants were asked to recall all of them. They were requested to continue recalling items until they had provided 15 unique strings. The recalled 15 strings were then recoded in terms of their specific letters to avoid trivial biases such as the location of letters on the computer keyboard and the presence of potential acronyms (e.g., X might be replaced throughout by T, T by M, etc.). The resulting set of 15 strings (which kept the same underlying structure as before recoding) was then provided as training strings for the next participant. A total of 10 participants were run within each \"evolutionary\" chain.\\nThe initial set of strings used for the first participant in each chain was created so as to have minimal distributional structure (all consonant pairs, or bigrams, had a frequency of 1 or 2). Because recalling 15 arbitrary strings is close to impossible given normal memory constraints, it was expected that many of the recalled items would be strongly affected by sequence learning biases. The results showed that as these sequence biases became amplified across generations of learners, the sequences gained more and more distributional structure (as measured by the relative frequency of repeated two- and three-letter units). Importantly, the emerging system of sequences became more learnable. Initially, participants could only recall about 4 of the 15 strings correctly but by the final generation this had doubled, allowing participants to recall more than half the strings. Importantly, this increase in learnability did not evolve at the cost of string length: there was no decrease across generations. Instead, the sequences became easy to learn and recall because they formed a system, allowing subsequences to be reused productively. Using network analyses (see Baronchelli et al.,, for a review), Cornish et al. demonstrated that the way in which this productivity was implemented strongly mirrored that observed for child-directed speech.\\nThe results from Cornish et al. (under review) suggest that sequence learning constraints, as those explored in the simulations by Reali and Christiansen and demonstrated by Reeder, can give rise to language-like distributional regularities that facilitate learning. This supports our hypothesis that sequential learning constraints, amplified by cultural transmission, could have shaped language into what we see today, including its limited use of embedded recursive structure. Next, we shall extend this approach to show how the same sequence learning constraints that we hypothesized to have shaped important aspects of the cultural evolution of recursive structures also can help explain specific patterns in the processing of complex recursive constructions.\\nSo far, we have discussed converging evidence supporting the theory that language in important ways relies on evolutionarily prior neural mechanisms for sequence learning. But can a domain-general sequence learning device capture the ability of humans to process the kind of complex recursive structures that has been argued to require powerful grammar formalisms (e.g., Chomsky,; Shieber,; Stabler,; Jager and Rogers,)? From our usage-based perspective, the answer does not necessarily require the postulation of recursive mechanisms as long as the proposed mechanisms can deal with the level of complex recursive structure that humans can actually process. In other words, what needs to be accounted for is the empirical evidence regarding human processing of complex recursive structures, and not theoretical presuppositions about recursion as a stipulated property of our language system.\\nChristiansen and MacDonald conducted a set of computational simulations to determine whether a sequence-learning device such as the SRN would be able to capture human processing performance on complex recursive structures. Building on prior work by Christiansen and Chater, they focused on the processing of sentences with center-embedded and cross-dependency structures. These two types of recursive constructions produce multiple overlapping non-adjacent dependencies, as illustrated in Figure 1, resulting in rapidly increasing processing difficulty as the number of embeddings grows. We have already discussed earlier how performance on center-embedded constructions breaks down at two levels of embedding (e.g., Wang,; Hamilton and Deese,; Blaubergs and Braine,; Hakes et al.,). The processing of cross-dependencies, which exist in Swiss-German and Dutch, has received less attention, but the available data also point to a decline in performance with increased levels of embedding (Bach et al.,; Dickey and Vonk,). Christiansen and MacDonald trained networks on sentences derived from one of the two grammars shown in Table 4. Both grammars contained a common set of recursive structures: right-branching recursive structure in the form of prepositional modifications of noun phrases, noun phrase conjunctions, subject relative clauses, and sentential complements; left-branching recursive structure in the form of prenominal possessives. The grammars furthermore had three additional verb argument structures (transitive, optionally transitive, and intransitive) and incorporated agreement between subject nouns and verbs. As illustrated by Table 4, the only difference between the two grammars was in the type of complex recursive structure they contained: center-embedding vs. cross-dependency.\\nThe grammars could generate a variety of sentences, with varying degree of syntactic complexity, from simple transitive sentences (such as 7) to more complex sentences involving different kinds of recursive structure (such as 8 and 9).\\n(7) John kisses Mary.\\n(8) Mary knows that John\\'s boys\\' cats see mice.\\n(9) Mary who loves John thinks that men say that girls chase boys.\\nThe generation of sentences was further restricted by probabilistic constraints on the complexity and depth of recursion. Following training on either grammar, the networks performed well on a variety of recursive sentence structures, demonstrating that the SRNs were able to acquire complex grammatical regularities (see also Christiansen,)4. The networks acquired sophisticated abilities for generalizing across constituents in line with usage-based approaches to constituent structure (e.g., Beckner and Bybee,; see also Christiansen and Chater,). Differences between networks were observed, though, on their processing of the complex recursive structure permitted by the two grammars.\\nTo model human data on the processing of center-embedding and cross-dependency structures, Christiansen and MacDonald relied on a study conducted by Bach et al. in which sentences with two center-embeddings in German were found to be significantly harder to process than comparable sentences with two cross-dependencies in Dutch. Bach et al. asked native Dutch speakers to rate the comprehensibility of Dutch sentences involving varying depths of recursive structure in the form of cross-dependency constructions and corresponding right-branching paraphrase sentences with similar meaning. Native speakers of German were tested using similar materials in German, where center-embedded constructions replaced the cross-dependency constructions. To remove potential effects of processing difficulty due to length, the ratings from the right-branching paraphrase sentences were subtracted from the complex recursive sentences. Figure 2 shows the results of the Bach et al. study on the left-hand side.\\nSRN performance was scored in terms of Grammatical Prediction Error (GPE; Christiansen and Chater,), which measures the network\\'s ability to make grammatically correct predictions for each upcoming word in a sentence, given prior context. The right-hand side of Figure 2 shows the mean sentence GPE scores, averaged across 10 novel sentences. Both humans and SRNs show similar qualitative patterns of processing difficulty (see also Christiansen and Chater,). At a single level of embedding, there is no difference in processing difficulty. However, at two levels of embedding, cross-dependency structures (in Dutch) are processed more easily than comparable center-embedded structures (in German).\\nChristiansen and MacDonald demonstrated that a sequence learner such as the SRN is able to mirror the differential human performance on center-embedded and cross-dependency recursive structures. Notably, the networks were able to capture human performance without the complex external memory devices (such as a stack of stacks; Joshi,) or external memory constraints (Gibson,) required by previous accounts. The SRNs ability to mimic human performance likely derives from a combination of intrinsic architectural constraints (Christiansen and Chater,) and the distributional properties of the input to which it has been exposed (MacDonald and Christiansen,; see also Christiansen and Chater, Forthcoming). Christiansen and Chater analyzed the hidden unit representations of the SRN:its internal state:before and after training on recursive constructions and found that these networks have an architectural bias toward local dependencies, corresponding to those found in right-branching recursion. To process multiple instances of such recursive constructions, however, the SRN needs exposure to the relevant types of recursive structures. This exposure is particularly important when the network has to process center-embedded constructions because the network must overcome its architectural bias toward local dependencies. Thus, recursion is not a built-in property of the SRN; instead, the networks develop their human-like abilities for processing recursive constructions through repeated exposure to the relevant structures in the input.\\nAs noted earlier, this usage-based approach to recursion differs from many previous processing accounts, in which unbounded recursion is implemented as part of the representation of linguistic knowledge (typically in the form of a rule-based grammar). Of course, this means that systems of the latter kind can process complex recursive constructions, such as center-embeddings, beyond human capabilities. Since Miller and Chomsky, the solution to this mismatch has been to impose extrinsic memory limitations exclusively aimed at capturing human performance limitations on doubly center-embedded constructions (e.g., Kimball,; Marcus,; Church,; Just and Carpenter,; Stabler,; Gibson and Thomas,; Gibson,; see Lewis et al.,, for a review).\\nTo further investigate the nature of the SRN\\'s intrinsic constraints on the processing of multiple center-embedded constructions, Christiansen and MacDonald explored a previous result from Christiansen and Chater showing that SRNs found ungrammatical versions of doubly center-embedded sentences with a missing verb more acceptable than their grammatical counterparts5 (for similar SRN results, see Engelmann and Vasishth,). A previous offline rating study by Gibson and Thomas found that when the middle verb phrase (was cleaning every week) was removed from (10), the resulting ungrammatical sentence in (11) was rated no worse than the grammatical version in (10).\\n(10) The apartment that the maid who the service had sent over was cleaning every week was well decorated.\\n(11) *The apartment that the maid who the service had sent over was well decorated.\\nHowever, when Christiansen and MacDonald tested the SRN on similar doubly center-embedded constructions, they obtained predictions for (11) to be rated better than (10). To test these predictions, they elicited on-line human ratings for the stimuli from the Gibson and Thomas study using a variation of the \"stop making sense\" sentence-judgment paradigm (Boland et al.,; Boland,). Participants read a sentence, word-by-word, while at each step they decided whether the sentence was grammatical or not. Following the presentation of each sentence, participants rated it on a 7-point scale according to how good it seemed to them as a grammatical sentence of English (with 1 indicating that the sentence was \"perfectly good English\" and 7 indicating that it was \"really bad English\"). As predicted by the SRN, participants rated ungrammatical sentences such as (11) as better than their grammatical counterpart exemplified in (10).\\nThe original stimuli from the Gibson and Thomas study had certain shortcomings that could have affected the outcome of the online rating experiment. Firstly, there were substantial length differences between the ungrammatical and grammatical versions of a given sentence. Secondly, the sentences incorporated semantic biases making it easier to line up a subject noun with its respective verb (e.g., apartment-decorated, service-sent over in 10). To control for these potential confounds, Christiansen and MacDonald replicated the experiment using semantically-neutral stimuli controlled for length (adapted from Stolz,), as illustrated by (12) and (13).\\n(12) The chef who the waiter who the busboy offended appreciated admired the musicians.\\n(13) *The chef who the waiter who the busboy offended frequently admired the musicians.\\nThe second online rating experiment yielded the same results as the first, thus replicating the \"missing verb\" effect. These results have subsequently been confirmed by online ratings in French (Gimenes et al.,) and a combination of self-paced reading and eye-tracking experiments in English (Vasishth et al.,). However, evidence from German (Vasishth et al.,) and Dutch (Frank et al.,) indicates that speakers of these languages do not show the missing verb effect but instead find the grammatical versions easier to process. Because verb-final constructions are common in German and Dutch, requiring the listener to track dependency relations over a relatively long distance, substantial prior experience with these constructions likely has resulted in language-specific processing improvements (see also Engelmann and Vasishth,; Frank et al.,, for similar perspectives). Nonetheless, in some cases the missing verb effect may appear even in German, under conditions of high processing load (Trotzke et al.,). Together, the results from the SRN simulations and human experimentation support our hypothesis that the processing of center-embedded structures are best explained from a usage-based perspective that emphasizes processing experience with the specific statistical properties of individual languages. Importantly, as we shall see next, such linguistic experience interacts with sequence learning constraints.\\nPrevious studies have suggested that the processing of singly embedded relative clauses are determined by linguistic experience, mediated by sequence learning skills (e.g., Wells et al.,; Misyak et al.,; see Christiansen and Chater, Forthcoming, for discussion). Can our limited ability to process multiple complex recursive embeddings similarly be shown to reflect constraints on sequence learning? The embedding of multiple complex recursive structures:whether in the form of center-embeddings or cross-dependencies:results in several pairs of overlapping non-adjacent dependencies (as illustrated by Figure 1). Importantly, the SRN simulation results reported above suggest that a sequence learner might also be able to deal with the increased difficulty associated with multiple, overlapping non-adjacent dependencies.\\nDealing appropriately with multiple non-adjacent dependencies may be one of the key defining characteristics of human language. Indeed, when a group of generativists and cognitive linguists recently met to determine what is special about human language (Tallerman et al.,), one of the few things they could agree about was that long-distance dependencies constitute one of the hallmarks of human language, and not recursion (contra Hauser et al.,). de Vries et al. used a variation of the AGL-SRT task (Misyak et al.,) to determine whether the limitations on processing of multiple non-adjacent dependencies might depend on general constraints on human sequence learning, instead of being unique to language. This task incorporates the structured, probabilistic input of artificial grammar learning (AGL; e.g., Reber,) within a modified two-choice serial reaction-time (SRT; Nissen and Bullemer,) layout. In the de Vries et al. study, participants used the computer mouse to select one of two written words (a target and a foil) presented on the screen as quickly as possible, given auditory input. Stimuli consisted of sequences with two or three non-adjacent dependencies, ordered either using center-embeddings or cross-dependencies. The dependencies were instantiated using a set of dependency pairs that were matched for vowel sounds: ba-la, yo-no, mi-di, and wu-tu. Examples of each of the four types of stimuli are presented in (14-17), where the subscript numbering indicates dependency relationships.\\n(14) ba1 wu2 tu2 la1\\n(15) ba1 wu2 la1 tu2\\n(16) ba1 wu2 yo3 no3 tu2 la1\\n(17) ba1 wu2 yo3 la1 tu2 no3\\nThus, (14) and (16) implement center-embedded recursive structure and (15) and (17) involve cross-dependencies. Participants would only be exposed to one of the four types of stimuli. To determine the potential effect of linguistic experience on the processing of complex recursive sequence structure, study participants were either native speakers of German (which has center-embedding but not cross-dependencies) or Dutch (which has cross-dependencies). Participants were only exposed to one kind of stimulus, e.g., doubly center-embedded sequences as in (16) in a fully crossed design (length x embedding x native language).\\nde Vries et al. first evaluated learning by administering a block of ungrammatical sequences in which the learned dependencies were violated. As expected, the ungrammatical block produced a similar pattern of response slow-down for both for both center-embedded and cross-dependency items involving two non-adjacent dependencies (similar to what Bach et al.,, Bach et al., found in the natural language case). However, an analog of the missing verb effect was observed for the center-embedded sequences with three non-adjacencies but not for the comparable cross-dependency items. Indeed, an incorrect middle element in the center-embedded sequences (e.g., where tu is replaced by la in 16) did not elicit any slow-down at all, indicating that participants were not sensitive to violations at this position.\\nSequence learning was further assessed using a prediction task at the end of the experiment (after a recovery block of grammatical sequences). In this task, participants would hear a beep replacing one of the elements in the second half of the sequence and were asked to simply click on the written word that they thought had been replaced. Participants exposed to the sequences incorporating two dependencies, performed reasonably well on this task, with no difference between center-embedded and cross-dependency stimuli. However, as for the response times, a missing verb effect was observed for the center-embedded sequences with three non-adjacencies. When the middle dependent element was replaced by a beep in center-embedded sequences (e.g., ba1 wu2 yo3 no3<beep> la1), participants were more likely to click on the foil (e.g., la) than the target (tu). This was not observed for the corresponding cross-dependency stimuli, once more mirroring the Bach et al. psycholinguistic results that multiple cross-dependencies are easier to process than multiple center-embeddings.\\nContrary to psycholinguistic studies of German (Vasishth et al.,) and Dutch (Frank et al.,), de Vries et al. found an analog of the missing verb effect in speakers of both languages. Because the sequence-learning task involved non-sense syllables, rather than real words, it may not have tapped into the statistical regularities that play a key role in real-life language processing6. Instead, the results reveal fundamental limitations on the learning and processing of complex recursively structured sequences. However, these limitations may be mitigated to some degree, given sufficient exposure to the \"right\" patterns of linguistic structure:including statistical regularities involving morphological and semantic cues:and thus lessening sequence processing constraints that would otherwise result in the missing verb effect for doubly center-embedded constructions. Whereas the statistics of German and Dutch appear to support such amelioration of language processing, the statistical make-up of linguistic patterning in English and French apparently does not. This is consistent with the findings of Frank et al., demonstrating that native Dutch and German speakers show a missing verb effect when processing English (as a second language), even though they do not show this effect in their native language (except under extreme processing load, Trotzke et al.,). Together, this pattern of results suggests that the constraints on human processing of multiple long-distance dependencies in recursive constructions stem from limitations on sequence learning interacting with linguistic experience.\\nIn this extended case study, we argued that our ability to process of recursive structure does not rely on recursion as a property of the grammar, but instead emerges gradually by piggybacking on top of domain-general sequence learning abilities. Evidence from genetics, comparative work on non-human primates, and cognitive neuroscience suggests that humans have evolved complex sequence learning skills, which were subsequently pressed into service to accommodate language. Constraints on sequence learning therefore have played an important role in shaping the cultural evolution of linguistic structure, including our limited abilities for processing recursive structure. We have shown how this perspective can account for the degree to which humans are able to process complex recursive structure in the form of center-embeddings and cross-dependencies. Processing limitations on recursive structure derive from constraints on sequence learning, modulated by our individual native language experience.\\nWe have taken the first steps toward an evolutionarily-informed usage-based account of recursion, where our recursive abilities are acquired piecemeal, construction by construction, in line with developmental evidence. This perspective highlights the key role of language experience in explaining cross-linguistic similarities and dissimilarities in the ability to process different types of recursive structure. And although, we have focused on the important role of sequence learning in explaining the limitations of human recursive abilities, we want to stress that language processing, of course, includes other domain-general factors. Whereas distributional information clearly provides important input to language acquisition and processing, it is not sufficient, but must be complemented by numerous other sources of information, from phonological and prosodic cues to semantic and discourse information (e.g., Christiansen and Chater,, Forthcoming). Thus, our account is far from complete but it does offer the promise of a usage-based perspective of recursion based on evolutionary considerations.\\nIn this paper, we have argued that there are theoretical reasons to suppose that special-purpose biological machinery for language can be ruled out on evolutionary grounds. A possible counter-move adopted by the minimalist approach to language is to suggest that the faculty of language is very minimal and only consists of recursion (e.g., Hauser et al.,; Chomsky,). However, we have shown that capturing human performance on recursive constructions does not require an innate mechanism for recursion. Instead, we have suggested that the variation in processing of recursive structures as can be observed across individuals, development and languages is best explained by domain-general abilities for sequence learning and processing interacting with linguistic experience. But, if this is right, it becomes crucial to provide explanations for the puzzling aspects of language that were previously used to support the case for a rich innate language faculty: (1) the poverty of the stimulus, (2) the eccentricity of language, (3) language universals, (4) the source of linguistic regularities, and (5) the uniqueness of human language. In the remainder of the paper, we therefore address each of these five challenges, in turn, suggesting how they may be accounted for without recourse to anything more than domain-general constraints.\\nOne traditional motivation for postulating an innate language faculty is the assertion that there is insufficient information in the child\\'s linguistic environment for reliable language acquisition to be possible (Chomsky,). If the language faculty has been pared back to consist only of a putative mechanism for recursion, then this motivation no longer applies:the complex patterns in language which have been thought to pose challenges of learnability concern highly specific properties of language (e.g., concerning binding constraints), which are not resolved merely by supplying the learner with a mechanism for recursion.\\nBut recent work provides a positive account of how the child can acquire language, in the absence of an innate language faculty, whether minimal or not. One line of research has shown, using computational results from language corpora and mathematical analysis, that learning methods are much more powerful than had previously been assumed (e.g., Manning and Schutze,; Klein and Manning,; Chater and Vitanyi,; Hsu et al.,; Chater et al.,). But more importantly, viewing language as a culturally evolving system, shaped by the selectional pressures from language learners, explains why language and languages learners fit together so closely. In short, the remarkable phenomenon of language acquisition from a noisy and partial linguistic input arises from a close fit between the structure of language and the structure of the language learner. However, the origin of this fit is not that the learner has somehow acquired a special-purpose language faculty embodying universal properties of human languages, but, instead, because language has been subject to powerful pressures of cultural evolution to match, as well as possible, the learning and processing mechanism of its speakers (e.g., as suggested by Reali and Christiansen\\'s,, simulations). In short, the brain is not shaped for language; language is shaped by the brain (Christiansen and Chater,).\\nLanguage acquisition can overcome the challenges of the poverty of the stimulus without recourse to an innate language faculty, in light both of new results on learnability, and the insight that language has been shaped through processes of cultural evolution to be as learnable as possible.\\nFodor argue that the generalizations found in language are so different from those evident in other cognitive domains, that they can only be subserved by highly specialized cognitive mechanisms. But the cultural evolutionary perspective that we have outlined here suggests, instead, that the generalizations observed in language are not so eccentric after all: they arise, instead, from a wide variety of cognitive, cultural, and communicative constraints (e.g., as exemplified by our extended case study of recursion). The interplay of these constraints, and the contingencies of many thousands of years of cultural evolution, is likely to have resulted in the apparently baffling complexity of natural languages.\\nAnother popular motivation for proposing an innate language faculty is to explain putatively universal properties across all human languages. Such universals can be explained as consequences of the innate language faculty:and variation between languages has often been viewed as relatively superficial, and perhaps as being determined by the flipping of a rather small number of discrete \"switches,\" which differentiate English, Hopi and Japanese (e.g., Lightfoot,; Baker,; Yang,).\\nBy contrast, we see \"universals\" as products of the interaction between constraints deriving from the way our thought processes work, from perceptuo-motor factors, from cognitive limitations on learning and processing, and from pragmatic sources. This view implies that most universals are unlikely to be found across all languages; rather, \"universals\" are more akin to statistical trends tied to patterns of language use. Consequently, specific universals fall on a continuum, ranging from being attested to only in some languages to being found across most languages. An example of the former is the class of implicational universals, such as that verb-final languages tend to have postpositions (Dryer,), whereas the presence of nouns and verbs (minimally as typological prototypes; Croft,) in most, though perhaps not all (Evans and Levinson,), languages is an example of the latter.\\nIndividual languages, on our account, are seen as evolving under the pressures from multiple constraints deriving from the brain, as well as cultural-historical factors (including language contact and sociolinguistic influences), resulting over time in the breathtaking linguistic diversity that characterize the about 6-8000 currently existing languages (see also Dediu et al.,). Languages variously employ tones, clicks, or manual signs to signal differences in meaning; some languages appear to lack the noun-verb distinction (e.g., Straits Salish), whereas others have a proliferation of fine-grained syntactic categories (e.g., Tzeltal); and some languages do without morphology (e.g., Mandarin), while others pack a whole sentence into a single word (e.g., Cayuga). Cross-linguistically recurring patterns do emerge due to similarity in constraints and culture/history, but such patterns should be expected to be probabilistic tendencies, not the rigid properties of a universal grammar (Christiansen and Chater,). From this perspective it seems unlikely that the world\\'s languages will fit within a single parameterized framework (e.g., Baker,), and more likely that languages will provide a diverse, and somewhat unruly, set of solutions to a hugely complex problem of multiple constraint satisfaction, as appears consistent with research on language typology (Comrie,; Evans and Levinson,; Evans,). Thus, we construe recurring patterns of language along the lines of Wittgenstein\\'s notion of \"family resemblance\": although there may be similarities between pairs of individual languages, there is no single set of features common to all.\\nEven if the traditional conception of language universals is too strict, the challenge remains: in the absence of a language faculty, how can we explain why language is orderly at all? How is it that the processing of myriads of different constructions have not created a chaotic mass of conflicting conventions, but a highly, if partially, structured system linking form and meaning?\\nThe spontaneous creation of tracks in a forest provides an interesting analogy (Christiansen and Chater,). Each time an animal navigates through the forest, it is concerned only with reaching its immediate destination as easily as possible. But the cumulative effect of such navigating episodes, in breaking down vegetation and gradually creating a network of paths, is by no means chaotic. Indeed, over time, we may expect the pattern of tracks to become increasingly ordered: kinks will be become straightened; paths between ecological salient locations (e.g., sources of food, shelter or water) will become more strongly established; and so on. We might similarly suspect that language will become increasingly ordered over long periods of cultural evolution.\\nWe should anticipate that such order should emerge because the cognitive system does not merely learn lists of lexical items and constructions by rote; it generalizes from past cases to new cases. To the extent that the language is a disordered morass of competing and inconsistent regularities, it will be difficult to process and difficult to learn. Thus, the cultural evolution of language, both within individuals and across generations of learners, will impose a strong selection pressure on individual lexical items and constructions to align with each other. Just as stable and orderly forest tracks emerge from the initially arbitrary wanderings of the forest fauna, so an orderly language may emerge from what may, perhaps, have been the rather limited, arbitrary and inconsistent communicative system of early \"proto-language.\" In particular, for example, the need to convey an unlimited number of messages will lead to a drive to recombine linguistic elements is systematic ways, yielding increasingly \"compositional\" semantics, in which the meaning of a message is associated with the meaning of its parts, and the way in which they are composed together (e.g., Kirby,).\\nThere appears to be a qualitative difference between communicative systems employed by non-human animals, and human natural language: one possible explanation is that humans, alone, possess an innate faculty for language. But human \"exceptionalism\" is evident in many domains, not just in language; and, we suggest, there is good reason to suppose that what makes humans special concerns aspect of our cognitive and social behavior, which evolved prior to the emergence of language, but made possible the collective construction of natural languages through long processes of cultural evolution.\\nA wide range of possible cognitive precursors for language have been proposed. For example, human sequence processing abilities for complex patterns, described above, appear significantly to outstrip processing abilities of non-human animals (e.g., Conway and Christiansen,). Human articulatory machinery may be better suited to spoken language than that of other apes (e.g., Lieberman,). And the human abilities to understand the minds of others (e.g., Call and Tomasello,) and to share attention (e.g., Knoblich et al.,) and to engage in joint actions (e.g., Bratman,), may all be important precursors for language.\\nNote, though, that from the present perspective, language is continuous with other aspects of culture:and almost all aspects of human culture, from music and art to religious ritual and belief, moral norms, ideologies, financial institutions, organizations, and political structures are uniquely human. It seems likely that such complex cultural forms arise through long periods of cultural innovation and diffusion, and that the nature of such propagation depends will depend on a multitude of historical, sociological, and, most likely, a host of cognitive factors (e.g., Tomasello,; Richerson and Christiansen,). Moreover, we should expect that different aspects of cultural evolution, including the evolution of language, will be highly interdependent. In the light of these considerations, once the presupposition that language is sui generis and rooted in a genetically-specified language faculty is abandoned, there seems little reason to suppose that there will be a clear-cut answer concerning the key cognitive precursors for human language, any more than we should expect to be able to enumerate the precursors of cookery, dancing, or agriculture.\\nPrior to the seismic upheavals created by the inception of generative grammar, language was generally viewed as a paradigmatic, and indeed especially central, element of human culture. But the meta-theory of the generative approach was taken to suggest a very different viewpoint: that language is primarily a biological, rather than a cultural, phenomenon: the knowledge of the language was seen not as embedded in a culture of speakers and hearers, but primarily in a genetically-specified language faculty.\\nWe suggest that, in light of the lack of a plausible evolutionary origin for the language faculty, and a re-evaluation of the evidence for even the most minimal element of such a faculty, the mechanism of recursion, it is time to return to viewing language as a cultural, and not a biological, phenomenon. Nonetheless, we stress that, like other aspects of culture, language will have been shaped by human processing and learning biases. Thus, understanding the structure, acquisition, processing, and cultural evolution of natural language requires unpicking how language has been shaped by the biological and cognitive properties of the human brain.\\nThe authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 72,\n",
       "    'case_id': 'PMC5987309_01',\n",
       "    'case_text': \"A 72-year-old male with a past medical history of quadriplegia, hypertension, hyperlipidemia, neurogenic bladder, type 2 diabetes mellitus, chronic obstructive pulmonary disease, and chronic hepatitis presented to the emergency department with an acute change in mental status. He was a full-time resident at an assisted living nursing home, and his baseline mental status was awake, alert, and oriented to person, place, and time (AAOx3). Upon arrival in the emergency department, he was oriented only to self. Prior to this admission, the patient was being treated for a urinary tract infection and was on day seven of nitrofurantoin and cefepime. On examination, he was hypotensive at a blood pressure of 81/59 mmHg, pulse rate of 115 beats per minute, respiratory rate of 21 breaths per minute, and oxygen saturation of 78% while breathing ambient air. He was in visible respiratory distress and was lethargic, but arousable. He received a nebulizer treatment and was placed on a non-rebreather mask at 6 liters, after which his oxygen saturation rose to 99%. A chest X-ray was taken and revealed left lower lobe pneumonia. His urinalysis was positive for an infection despite current antibiotic compliance. He began vancomycin and piperacillin/tazobactam for health care-associated pneumonia and was admitted to the ICU. Respiratory status worsened, and he required intubation.\\nDespite these interventions, on his second day of admission, he continued to have copious clear secretions. Pulmonology diagnosed him with aspiration pneumonia and sputum cultures were obtained, which demonstrated moderate white blood cells, rare epithelial cells, few Gram-positive cocci in clusters, and rare yeast. His antibiotics were adjusted for sensitivities to vancomycin and meropenem. To further evaluate his ongoing pulmonary issues, a chest CT scan was obtained, revealing increasing bilateral pleural effusions and patchy sclerotic foci concerning for possible bone metastases, enlarged mediastinal lymph nodes, and nodular infiltrate in the right mid- and upper lung fields. Gastroenterology was consulted for colonoscopy to identify a primary tumor, but the patient was deemed too unstable for a nonemergent procedure. Thoracocentesis revealed exudative pleural effusions negative for malignancy. Abdominal and pelvic CT demonstrated hydronephrosis and a right-sided staghorn renal calculus but no masses.\\nWith these interventions, our patient began to improve, yet daily sedation interruptions and spontaneous breathing trials failed. Initial blood culture results showed Gram-positive bacilli, and further speciation of the organism was requested. On day 13, blood cultures were finalized and grew Clostridium subterminale. Sputum and stool testing showed Pseudomonas aeruginosa and Clostridium difficile, so metronidazole was started. Gastroenterology again stated that the patient was too unstable for colonoscopy and suggested a bone biopsy, which he underwent the following day. The preliminary pathology report stated that the bone biopsy was likely malignant adenocarcinoma, which was confirmed on hospital day 21. Biopsy indicated that the tumor was positive for markers CK7 and CA19-9; primary sites with this immunophenotypic profile include the upper GI tract and pancreaticobiliary system. Carcinoembryonic antigen (CEA) was elevated at 73.8 (normal CEA nonsmokers < 5.1; smokers < 6.6) and CA19-9 was 3,146 (normal < 45). Per oncology, he was not a candidate for any interventions due to his comorbidities.\\nOn day 23, he had increasing secretions and was agitated despite completion of his antibiotic course. The patient's three daughters decided on terminal extubation, and comfort measures were initiated. At 21 : 12 on hospital day 23, the patient was pronounced dead.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 61,\n",
       "    'case_id': 'PMC5337835_01',\n",
       "    'case_text': \"The patient is a 61-year-old male with end stage renal disease from hypertension with cadaveric renal transplant recipient who developed acute decompensated liver cirrhosis from viral hepatitis C after transplant.\\nTwo months after transplant, he had several episodes of gastrointestinal bleeding, urinary tract infections, and cardiac arrest with acute allograft dysfunction requiring renal replacement therapies. His mycophenolate mofetil was held. The transplant kidney biopsy showed evidence of acute cellular rejection with acute tubular necrosis that was treated with high-dose steroids. However, his allograft function never recovered and he required supportive hemodialysis. He also developed Kluyvera bacteremia followed by VRE bacteremia.\\nFour months after transplant, the patient presented with altered mental status and severe volume overload. On admission, the patient was lethargic, afebrile, and normotensive but tachycardic. Physical examination revealed severe anasarca and asterixis with no focal deficit. Diagnosis of metabolic encephalopathy was entertained. Urgent hemodialysis for uremia was started. His lactulose was increased for presumed hepatic encephalopathy without any improvement.\\nOn the 5th hospital day, the patient suddenly became unresponsive, hypotensive with shock, hypoxic, and febrile. He was intubated and started on vasopressors. Chest X-ray showed left lower lobe consolidation, but did not reveal cardiomegaly. His ECG showed diffuse ST segment elevations. PR segment depressions, electrical alternans, and low QRS voltage were absent. Transthoracic echocardiogram showed moderate size pericardial effusion localized circumferentially. This was accompanied by right ventricular compression with tamponade physiology. The patient had emergent pericardiocentesis with pericardial drain placement. A total of 320 ml of purulent fluid was drained. His blood pressure improved and he was taken off vasopressors. He was also started on daptomycin and cefepime.\\nOn the 6th hospital day, the patient continued to be lethargic. A CT scan of the head showed evidence of multifocal infarctions. Subsequent MRI of the brain revealed multiple septic emboli (Figure 1). These results raised suspicion of infective endocarditis for which a transesophageal echocardiogram (TEE) was performed. TEE showed possible small mitral valve vegetations (Figure 2) and resolution of the pericardial effusion. Blood cultures grew vancomycin-resistant Enterococcus faecium. The hemodialysis catheter was changed over the wire and culture of the catheter tip was subsequently found to be negative. Cefepime was switched to ceftaroline for better daptomycin binding to bacterial membrane.\\nOn the 7th hospital day, mold grew in pericardial fluid culture. Amphotericin B was initiated to cover both Aspergillus and Mucor. The patient continued to clinically deteriorate and went into septic shock. The family gave him a do-not-resuscitate status and he expired on the 7th hospital day. The mold was eventually identified as Aspergillus fumigatus 10 days after the patient died.\\nCardiac aspergillosis remains a diagnostic challenge especially without prior established pulmonary aspergillosis. A high degree clinical suspicion on an immunocompromised patient is needed to direct the clinical investigation. There are currently thirty-two cases of pericardial aspergillosis found in literature. Eight had clinical signs of cardiac tamponade. Only three, including our case, did not have established pulmonary or other forms of aspergillosis. Most diagnoses were postmortem. Only six out of the thirty-two were cured.\\nAmong patients predisposed to aspergillosis, cancer is the most common underlying medical condition (44%), followed by bone marrow transplant (25%), solid-organ transplant (13%), HIV/AIDS (3.8), autoimmune (2%), and systemic steroid use (3.5%). Our patient is a renal transplant patient with concurrent immunosuppressant use. His clinical course was complicated by acute decompensated liver cirrhosis, acute renal allograft dysfunction, and severe infections within two months of renal transplant. These extensive comorbidities made him susceptible to opportunistic infections. Four months after his renal transplant, he had aspergillosis pericarditis with tamponade that eventually led to his demise.\\nWeiland et al. studied the clinical pattern of aspergillosis in renal transplant patients. The median time between aspergillosis infection and transplantation was found to be three and a half months. For patients with history of acute rejection, aspergillosis occurred within two months of treatment of acute rejection. These data are consistent with the clinical course of our patient. Weiland et al. also found that aspergillosis took place alongside other illnesses. The most common associated infection was CMV followed by bacterial infections. One-fourth of patients affected were also multiple transplant recipients. Weiland et al. concluded that for renal transplant patients, patients with CMV, recent acute rejection and recipients of multiple transplants appear to be more susceptible to aspergillosis.\\nThe clinical features of cardiac aspergillosis are nonspecific and often depend on which part of the heart is involved. Myocardial aspergillosis is the most common form of the infection and can account to up to 83% of cases. It may occur alone but often with endocarditis or pericarditis. It is often asymptomatic, although it can manifest as a conduction abnormality and is usually diagnosed during autopsy.\\nAspergillosis endocarditis occurs in 17% of patients and presents as fever, embolic episodes, or heart murmur. Unlike Aspergillus endocarditis where large vegetations are easily seen in echocardiography, myocardial or pericardial aspergillosis are harder to detect. Our patient had septic emboli to the brain, a frequent sequelae of endocarditis. Transesophageal echocardiogram did reveal possible small valvular vegetations. This shows that the patient may have accompanying infective endocarditis. Embolic events in the setting of aspergillosis without significant valvular vegetations may also signify mural endocarditis. Aspergillus mural endocarditis is not always apparent in echocardiograms and may start off as a subendocardial focus before developing into an abscess.\\n Aspergillus is difficult to grow in blood cultures. Our hospital uses Bactec Fx culture system and requires 5-7 ml of blood sample per culture bottle. In this patient, a bottle of blood culture on admission did not grow any organism. On day 5, when the patient was clinically deteriorating, repeat blood cultures consisting of two bottles only grew Enterococcus faecium. On day 6, repeat blood cultures again showed no growth in one bottle and E. faecium in the second bottle. It was only in the pericardial fluid fungal culture collected on day 5 that Aspergillus fumigatus was demonstrated and grown.\\n Aspergillus pericarditis occurs in multisite infections and is seen in 17% of cardiac aspergillosis. It presents as chest pain, hypotension, tamponade, or pericardial friction rub. In our patient, diffuse ST segment elevations and hypotension pointed towards cardiac tamponade. Before this, his lethargy was attributed to metabolic encephalopathy. The patient, however, quickly deteriorated and eventually expired.\\nThe initial therapy for invasive aspergillosis is voriconazole, a broad-spectrum triazole antifungal. It has been shown to be more effective than amphotericin B and is associated with lower mortality rate. Our patient, on the other hand, was started on amphotericin B when pericardial fluid revealed mold. This is to cover for both Aspergillus and Mucor. Mucor is another mold infection that occurs in transplant patients and voriconazole does not have anti-Mucor activity. Furthermore, for patients who have liver disease like ours or for patients who cannot tolerate voriconazole, a lipid formulation of amphotericin B is the next alternative to voriconazole.\\nOther treatment strategies involve combination therapy of voriconazole and echinocandins. The combination therapy may be used as primary treatment or as salvage therapy. The dual therapy was shown to have superior outcomes than voriconazole alone in one study. Echinocandins, however, are not used as initial monotherapy of aspergillosis. They can be used as salvage therapy for those who cannot tolerate or are refractory to triazoles.\\nInvasive aspergillosis portends a poor prognosis and has a case fatality rate (CFR) of 58%. The CFR for liver transplant patients is 67.6, while kidney transplant patients' CFR is 62.5%. For pericardial aspergillosis, only six out of thirty-two patients of the cases published in literature have been cured. Factors that contributed to the survival of the six patients were early detection, recovery from immunosuppression, pericardiectomy, and combination antifungal therapy.\\nIn conclusion, pericardial aspergillosis is a rare and fatal disease in immunosuppressed patients. It is often insidious and has nonspecific clinical manifestations. A high degree of clinical suspicion is required for early detection and diagnosis. Once diagnosed, aggressive treatment is warranted.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 34,\n",
       "    'case_id': 'PMC8668347_01',\n",
       "    'case_text': \"The first patient is a 34-year-old Caucasian female with a past medical history consisting of autoimmune hepatitis, type 1 diabetes mellitus requiring insulin pump, end-stage renal disease, history of deep vein thrombosis, peripheral vascular disease with femoral popliteal bypass, and extensive history of solid organ transplantations (previously underwent 6 organ transplants consisting of 3 kidneys and 3 livers) with the most recent being a simultaneous liver-kidney transplant 20 months prior to presentation. The patient was being maintained on tacrolimus, mycophenolate mofetil, and prednisone for immunosuppression (Table 1). Due to loss of previous graft from rejection, she was maintained on a high-dose triple drug immunosuppressive regimen to prevent recurrence of rejection. One month prior to diagnosis, she presented with acute left leg pain and swelling felt to be secondary to chronic pain from hardware repair of extremity several years ago. She continued to experience extremity pain and was subsequently admitted. On this admission, the patient was taken to the operating room (OR) for fasciotomy (Figure 1). No necrotic tissue was found, and she was sent home with a wound vacuum. Upon follow-up with her outpatient wound clinic, fat necrosis was noted on the affected leg and a debridement was completed. A rapid genetic sequencing swab (MicroGen Diagnostics ) was run at the clinic showing 94% Enterococcus faecalis, 93% Rhizopus oryzae, and 5% Aspergillus flavus. The patient presented to our hospital for further work up of polymicrobial infection and potential invasive fungal disease.\\nOn hospital day 2, she was started on intravenous (IV) isavuconazole 372 mg daily and returned to the OR for debridement. Preliminary tissue, fungal, and anaerobic culture reports from the OR grew diphtheroids, Klebsiella oxytoca, Enterococcus faecalis, and an unidentified mould. On hospital day 5, the cultures identified the mould as Rhizopus spp. Intravenous liposomal amphotericin B 3 mg/kg daily was added. The same day she went back to the OR for debridement, and a biopsy sample was sent to pathology. The pathology report confirmed organisms consistent with mucormycosis. On hospital day 15, she went back to the OR for another serial debridement and biopsy. That same day, fungal susceptibilities returned, displaying isavuconazole resistance (Table 2). She was switched to oral posaconazole 300 mg daily and IV micafungin 150 mg daily in addition to amphotericin B. Three days later, her wound vacuum was replaced, and the pathology report showed multifocal fungal elements seen on a Grocott-Gomori's methenamine silver stain consistent with clinical history of 'Mucor/Rhizopus.' There was necrotic tissue with no definite involvement of vessels or margins. Dermal and subcutaneous tissue displayed necrosis, hemorrhage, fibrosis, granulation tissue, and foreign body giant cell reaction. The wound vacuum was left in place, and on hospital day 20, another wound culture grew mould. At this point, given the aggressive nature of the disease, it was decided to utilize amphotericin B deoxycholate irrigation in the wound vacuum and continue systemic antimicrobials. Amphotericin B 50 mg in 1000 mL sterile water for irrigation was added to the Veraflo  wound vacuum, and pulse lavages were administered to the affected area twice daily. Nine days later, the patient went back to the OR for another debridement and repeat pathology report from that sample showed no evidence of fungus. The patient received amphotericin wound vacuum irrigation with pulse lavages for a total of 20 days. She was discharged on oral posaconazole 300 mg every 8 hours and ascorbic acid 1000 mg tablet daily to help with absorption and therapeutic drug monitoring (Table 3) with plans to follow-up for the skin graft of the area. The patient remained Rhizopus spp. free at 1-year postdiagnosis.\",\n",
       "    'gender': 'Female'},\n",
       "   {'age': 58,\n",
       "    'case_id': 'PMC8668347_02',\n",
       "    'case_text': \"Patient 2 is a 58-year-old Caucasian female with past medical history significant for obesity and upper gastrointestinal bleed who underwent an OLT secondary to chronic hepatitis C virus (HCV) infection and alcoholic cirrhosis. MELD-Na at time of transplant was 42. There were no immediate complications that occurred throughout the procedure. Immunosuppression consisting of a corticosteroid taper, tacrolimus, and mycophenolate mofetil (Table 1) was started on day of transplant per institution protocol. Infection prophylaxis consisted of sulfamethoxazole/trimethoprim (POD3), valganciclovir (POD1), and voriconazole (started 5 days prior to transplantation per protocol for high MELD-Na pretransplant patients in intensive care units).\\nOn POD10, department of infectious diseases was consulted for persistent leukocytosis and abdominal cramping. Notable findings included an endoscopy exhibiting ulcerations and old blood on POD18 and an indium scan exhibiting increased uptake in the abdomen; however, leukocytosis resolved and the patient was discharged to inpatient rehabilitation. Patient was then readmitted on POD30 for increased abdominal pain, and a computed tomography (CT) scan exhibited free air in her abdomen suspicious for gastric perforation (Figure 2). The patient was emergently taken to the OR for exploratory laparotomy with findings of a large necrotic ulcer in the antrum causing spillage of gastric contents. An OR biopsy sample resulted in Rhizopus spp., and on POD33, the patient was initiated on IV liposomal amphotericin B 3 mg/kg daily, micafungin 150 mg daily, and isavuconazole 372 mg every 8 hours. After 48 hours of therapy, the patient was transitioned from isavuconazole 372 mg every 8 hours to daily. In conjunction with the antifungal regimen, weekly OR debridement and washouts were performed which resulted in persistently positive margins. After two weeks of treatment (POD46), fungal susceptibilities resulted exhibiting azole resistance with amphotericin B minimal inhibitory concentration (MIC) of 4 mcg/mL (Table 4). Due to these results, amphotericin B was increased to 5 mg/kg and oral terbinafine 500 mg every 12 hours was added. Additionally, liposomal amphotericin B 250 mg/500 mL OR irrigation dwells for 30 minutes were performed by a four-quadrant wash with abdomen oscillation with each dwell taking place 5 days a week. After a total of 8 OR amphotericin B irrigation dwell completions and continued systemic combination antifungal therapy, the patient's abdominal wall was closed on POD49. On POD53, isavuconazole was switched to IV posaconazole 300 mg every 12 hours with dose adjustments per therapeutic drug monitoring (Table 3) and nystatin 100,000 unit/mL suspension to be swallowed was added. The closure of the abdomen was complicated by dehiscence and necrotic appearing tissue at the incision site. After debridement, advancement of fasciocutaneous flap, and incisional wound vacuum placement, the amphotericin dose was transitioned to 7.5 mg/kg three times a week in preparation for discharge. Amphotericin B was continued outpatient until POD213 and posaconazole for a year from discharge. The patient remained Rhizopus spp. free at 1-year postdiagnosis.\",\n",
       "    'gender': 'Female'},\n",
       "   {'age': 62,\n",
       "    'case_id': 'PMC8668347_03',\n",
       "    'case_text': \"The last patient is a 62-year-old Caucasian female with a past medical history of hypertension and coronary artery disease who underwent an OLT secondary to chronic HCV infection and alcoholic cirrhosis. MELD-Na at time of transplant was 51. Overall, the patient tolerated the procedure well. Due to intra-abdominal hemorrhage from ongoing coagulopathy, the patient's abdomen was packed with a planned second operation for completion of the biliary anastomosis on POD2. Immunosuppression with a corticosteroid taper, tacrolimus, and mycophenolate mofetil was started on the day of transplant per institution protocol (Table 1). Infection prophylaxis consisted of sulfamethoxazole/trimethoprim (POD3), valganciclovir (POD1), and voriconazole (started 24 days prior to transplant). Hepatitis B total core antibody resulted positive, and tenofovir disoproxil was initiated POD6.\\nOn POD6, empiric antimicrobials were broadened in response to increased leukocytosis. A minibronchoalveolar lavage was performed on POD8, and cultures resulted mould on POD 10. Prophylactic voriconazole was increased to treatment dosing, and inhaled amphotericin B was started. POD12 observation of a lesion on the patient's nose raised suspicion for mucormycosis, and that same day, the cultures resulted in Rhizopus spp. Triple antifungal therapy was initiated (IV liposomal amphotericin B 7.5 mg/kg, posaconazole 300 mg every 12 hours, and micafungin 150 mg daily). MRI findings showed persistent marked pansinusitis with focal left nasal bridge ulceration and extension of inflammation into the postseptal inferomedial extraconal fat of the left orbit with no acute intracranial abnormality identified (Figure 3). In POD13, the patient underwent extensive surgical intervention including a partial rhinectomy, bilateral endoscopic sinus surgery with left medial maxillectomy, resection of intranasal contents, septectomy, inferior and middle turbinate resection, bilateral ethmoidectomy, right maxillary antrostomy, and resection of left lamina papyracea (Figure 4). Multiple returns for debridement occurred until the patient was found to have extensive necrotic tissue involving the skull base. Given involvement of the skull base, further debridement was stopped as this was unresectable. Susceptibilities resulted showing azole resistance and amphotericin B MIC of 0.25 mcg/mL (Table 5). Due to limitations of further surgical debridement and continued positive biopsy samples for 5 months postdiagnosis despite triple antifungal therapy, nasal packing was impregnated with amphotericin B deoxycholate 50 mg (1 mg/mL) and exchanged every 24 hours to accomplish a higher, localized concentration to combat the lack of tissue perfusion. The amphotericin B nasal packing was in addition to the triple antifungal therapy previously described. Three weeks after initiation of amphotericin B nasal packing, an obtained biopsy sample resulted negative for invasive fungal disease. Nasal packing was discontinued 4 days after negative results, and triple antifungal therapy was continued. The patient was discharged to a long-term acute care hospital with continuation of dual antifungal therapy (amphotericin 7.5 mg/kg daily and oral posaconazole 300 mg every 12 hours) with plan for follow-up reconstruction surgery. The patient remained Rhizopus spp. free at 1-year postdiagnosis.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 80,\n",
       "    'case_id': 'PMC6545747_01',\n",
       "    'case_text': \"We report on an 80-year-old Caucasian woman on warfarin for atrial fibrillation who sustained a spontaneous, atraumatic, spinal subdural hematoma in the thoracic region. The patient awoke in the morning to use the bathroom. Approximately 1 hr after returning to her bed, she was unable to move bilateral lower extremities and was incontinent. She reported no back pain, headache, nausea, vomiting, or any constitutional symptoms. She was transferred to an outside hospital and underwent an MRI, which as read by an attending senior radiologist who suggested an epidural hematoma concentrated around the T4-T9 levels (Figures 1(a) and 1(b)). She was reversed for an INR of 3.6 and then transferred to Albany Medical Center for further management. On examination, the patient was comfortable without any pain. She had a loss of bowel and bladder function and had no sensory or motor function below T5. The patient was seen by a fellowship-trained orthopaedic spine surgeon, and her spinal cord injury was classified as a T5 ASIA impairment scale A.\\nShe was taken emergently to the OR approximately 30 hours after the initial onset of symptoms. After a T3-T11 laminectomy, the spinal cord was fully visible, but no epidural hematoma was noted. However, discoloration and bulging of the thecal sac were noted, and the dura was incised longitudinally from T2 to T10 revealing an expansive jelly-like blood clot. The hematoma was evacuated, and the dura closed with a 4'0-NUROLON.\\nPostoperatively, the patient had regained 1/2 sensory function in the bilateral lower extremities. At the 2-week mark, the patient was still incontinent, showed 2/2 sensory and 2/5 motor functions in select muscle groups in her bilateral lower extremities. The patient's spinal cord injury was classified as an L2 ASIA impairment scale C. An MRI demonstrated a multilevel decompressive thoracolumbar laminectomy (Figures 2(a) and 2(b)), and the patient was discharged to a rehabilitation facility. At the two-month follow-up period, the patient had transitioned to a long-term nursing care facility and her neurological status remained unchanged.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 37,\n",
       "    'case_id': 'PMC4508704_01',\n",
       "    'case_text': \"The patient was a 37-year-old woman with a history of intestinal perforation, but no history of cranial or orbital trauma recently.\\nWhile undergoing genetic diagnosis of vEDS in the outpatient clinic of another hospital, the patient experienced a sudden onset of a vascular murmur in the vicinity of the left ear, tinnitus, and a headache. The tinnitus disappeared when the left carotid artery was compressed, and a bruit was heard over the left eyeball. No clear abnormal findings were detected by computed tomography (CT) of the head, but magnetic resonance imaging (MRI) and magnetic resonance angiography (MRA) of the head revealed a CCF, and the patient was referred to our hospital and examined.\\nThe patient's consciousness level was clear on arrival at our hospital. Ophthalmological examination indicated corrected visual acuity of 1.0/1.0. Bilateral Amsler grid testing indicated no abnormalities at any point in either visual field. The left eye was markedly red with dilated irregular conjunctival and subconjunctival vessels. Hess chart testing indicated abducens nerve paralysis. Based on the patient's family history, past medical history, and the imaging findings, there was a strong possibility of a CCF complicating EDS, and because of the possibility that angiography would cause vascular injury, the preoperative evaluation was performed by 3D CTA.\\nElder brother: Dissection of the thoracic aorta\\nFather's family: Rupture of the abdominal aorta, sudden death\\nAlthough the symptoms temporarily improved in response to intermittent manual compression of the carotid artery, they became more severe again (Fig. 1). Because of the development of higher function disorders, including aphasia and agnosia, associated with marked cortical reflux within the cranium, endovascular treatment (TVE) was performed under general anesthesia. A direct CCF from the vicinity of the left internal carotid artery (ICA) at the C3-4 level was confirmed by digital subtraction angiography (DSA). Marked retrograde flow into the intracranial veins was observed, and treatment was performed as described below (Fig. 2).\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 31,\n",
       "    'case_id': 'PMC3722985_01',\n",
       "    'case_text': \"A 31-year-old male presented to the emergency room complaining of progressive dyspnea and productive cough over the course of 4 months. He also noted decreased appetite with a 50-pound weight loss over the past 5 months. He had no significant past medical or surgical history and was not taking any medications. His family history was unremarkable. He quit smoking tobacco two months ago due to worsening respiratory status; he rarely used alcohol and never used recreational drugs. He was unmarried and in a long-term heterosexual relationship and denied multiple sexual partners. He was currently working in an automobile parts factory as a janitor. After high school he had enlisted in the army and served for four years; at that time he was stationed in Hawaii. While in Hawaii he visited a single prostitute on several occasions.\\nInitial vital signs revealed temperature was 99.9 F, blood pressure 128/83 mmHg, pulse 134 beats per minute, and respiratory rate 22 breaths/minute; oxygen saturation was 92% on room air. He was in moderate respiratory distress, yet was awake, alert, and cooperative. Extraocular muscles were intact; there was no nystagmus or scleral icterus. Pupils were equal, round, and reactive to light. He had thrush under his tongue and on the palate. There was no palpable lymphadenopathy. Heart rate was regular with no murmurs, rubs, or gallops by auscultation. There were no palpable thrills. He had equal chest rise bilaterally. Breath sounds were diminished throughout, with rales and dullness to percussion in the lower lung fields bilaterally. Sensory and motor examination was grossly intact.\\nLaboratory data revealed white blood count 13,900/mcL, hemoglobin 7.2 g/dL, platelets 370,000/mcL, sodium 131 mmol/L potassium 5.8 mmol/L, chloride 99 mmol/L, carbon dioxide 17 mmol/L, blood urea nitrogen 155 mg/dL, and serum creatinine 8.9 mg/dL. Arterial blood gases showed a pH of 7.39, pCO2 32.2 mmHg, bicarbonate 19.1 mmol/L, and pO2 74.5 mmHg on 3 L nasal cannula. Chest X-ray showed diffuse bilateral reticulonodular opacities (Figure 1). He was found to be HIV positive with CD4 count of <5 cells/cc and viral load of 1,180,000 copies. Bronchoalveolar lavage was preformed; Grocott's methenamine silver stain of the washings demonstrated Pneumocystis jiroveci (Figure 2). He received antibiotics and steroids with gradual improvement.\\nOn hospital day 14, he became confused and acutely developed nystagmus with both a horizontal and prominent vertical component. He was also found to have ataxia with finger to nose testing and difficulty sitting up without support. Considering his immunosuppressed state, infectious and neoplastic etiologies were the primary diagnostic considerations. Lumbar puncture revealed clear CSF, normal opening pressure, and normal cell counts. Polymerase chain reactions for Epstein-Barr virus, Herpes simplex virus, cytomegalovirus, and John Cunningham (JC) virus were negative. Nontreponemal serological screening for syphilis (VDRL), toxoplasmosis antibody, and Cryptococcus antigen titers were negative. CT of the head did not show any intracranial mass, hemorrhage, or other acute findings. MRI of the brain revealed a slight increase in T2 signal within the medial aspect of thalamus bilaterally (Figure 3). After excluding infection and neoplasm, the clinical diagnosis of Wernicke's encephalopathy was made. Intravenous thiamine was administered resulting in resolution of symptoms, which confirmed the diagnosis.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 48,\n",
       "    'case_id': 'PMC8574116_01',\n",
       "    'case_text': 'In June 2017, a nonsmoker 48-year-old woman with a history of persistent bronchial asthma and chronic pansinusitis was diagnosed with respiratory failure in the course of hypereosinophilic syndrome. Computed tomography (CT) of the chest showed massive interstitial infiltrates and laboratory tests revealed eosinophilia (8286 cells/microl). Therapy with systemic and inhaled glucocorticoids and inhaled bronchodilators was started, with moderate improvement. Further workup displayed elevated level of eosinophils (8%) in bronchoalveolar lavage (BAL) fluid and negative antinuclear and antineutrophil cytoplasmic antibodies. Previous attempts to taper oral GS led to flare of the disease; therefore the patient had add-on therapy with the humanized anti-IL-5 monoclonal antibody mepolizumab for several months (last dose was given in May 2019). However, instead of the applied treatment and normal level of peripheral eosinophils (< 500 cells/microl) she presented with fluctuating lower respiratory tract symptoms (wheezing, rhonchi, cough, dyspnea), recurrent exacerbations of pansinusitis with persisting hearing impairment (Fig. 1). In July 2019 functional endoscopic sinus surgery was performed, revealing eosinophilic (approx. 10% of the cells) chronic infiltrates of the mucosal stroma.\\nIn December 2019 the patient was admitted to the Department of Rheumatology and Immunology due to exertional dyspnea and cough. Physical examination revealed diffuse expiratory wheezing and prolonged expiration. Initial workup revealed blood eosinophilia (2840 cells/microl) and an elevated level of immunoglobulin E (134 IU/ml, reference range < 100); with normal levels of vitamin B12, tryptase and immunoglobulin G. There were no parasitic eggs or larvae in a stool sample. The patient was negative for FIP1L1-PDGFRA, JAK2 and ETV6-PDGFRB mutations. A bone marrow aspirate revealed an elevated level of eosinophils (< 10% of the cells); no other pathologies were identified. Cytogenetic analysis showed a normal female karyotype. Ground glass opacities on high-resolution CT were described (Fig. 2). Bacterial and fungal cultures of BAL fluid did not yield any organisms. Increased eosinophils in BAL fluid (10%) confirmed HES flare. Therapy with intravenous methylprednisolone (40 mg daily for 5 days, subsequently tapered), combined with inhaled GC and bronchodilators was started. Reduction of methylprednisolone dose less than 32 mg daily led to HES flare.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 36,\n",
       "    'case_id': 'PMC9869191_01',\n",
       "    'case_text': \"The patient was a 36-year-old female. The left side chest pain occurred more than 1 month ago and continued to deteriorate for 10 days. She had repeated pulmonary infection, accompanied by cough and expectoration. Her maximum temperature was 38.5 C, without chest tightness and dyspnea. Physical examination: the chest was barrel shaped, and no definite abnormality was found in chest auscultation and palpation. Cardiac examination was normal. The laboratory test of human immunodeficiency virus (HIV) was negative, and there was no contact history of tuberculosis. The patient's abdominal CT plain scan showed no obvious abnormality.\\nThe lung window in axial and sagittal position of multi-detector spiral CT showed that the bilateral basal lung isthmus was connected, extending behind the pericardium and crossing the midline for fusion. The left lower lung basal segment had sparse lung markings, with increased transparency, and patchy shadows could be seen near the spine at the bottom of both lungs. There was an obvious pleural interface between the isthmus and the left lung (arrow) (Figures 1 and 2). Transparent imaging (Figure 3) showed the isthmus lung tissue among the lungs (arrow). The three-dimensional volume-rendered imaging of the bronchus (Figure 4) showed that the bronchial branches of the lower lobe of the left lung were thinner than those of the right side. Cystic changes could be seen at the beginning of the lower lobe of the left lung. The outer and posterior basal segments of the lower lobe of the left lung fused at the beginning, and the distal branches were sparse. Thoracic CT angiography scanning (Figures 5 and 6): consolidation shadow could be seen in the basal segment of the lower lobe of both lungs, with the left lung as the focus, and multiple calcified nodules could be seen in it. The blood supply arteries of bilateral lesions directly originated from the adjacent trunk of thoracic aorta (arrows).\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 55,\n",
       "    'case_id': 'PMC2750244_01',\n",
       "    'case_text': \"The case reports of patients with brain metastases secondary to NSCLC treated with gefitinib as part of the compassionate-use programme have recently been reported as published case studies, at the World Conference on Lung Cancer 2003, at the American Society of Clinical Oncology 2003 conference and at the 'Iressa' Clinical Experience (ICE) meeting (Awada, ICE abs; Cappuzzo [a & b], ICE abs; Dieriks, ICE abs; Stein, ICE abs; de la Cruz [a & b], ICE abs; Maione, ICE abs; Martinez, ICE abs; Diaz-Canton, ICE abs; van der Kamp, ICE abs; van Zandwijk [b], ICE abs; Petruzelka [a], ICE abs; Azemar, ICE abs; Roggero, ICE abs; Kowalski, ICE abs; Martin-Algarra, ICE abs; Pavlakis, ICE abs). (See appendix for ICE abstracts). Together, these case reports suggest that gefitinib has activity in NSCLC brain metastases. The results of published case series are shown in Table 1 .\\nMost notable are the cases with a complete remission of brain metastases. In the largest case series that included 27 patients who had asymptomatic or symptomatic brain metastases, two of 20 evaluable patients had a response in the brain, with complete remission in one patient. In another case series described in two separate publications by Cappuzzo et al, eight patients with NSCLC and brain metastases were treated with gefitinib (; [a & b] ICE abs). One patient had a complete response and seven had partial responses in the brain, all within 3 months of treatment. The complete response in the brain was observed 6 weeks after treatment with gefitinib started in a patient who had completed whole-brain radiotherapy 3 months prior to the beginning of gefitinib (Figure 1). All eight patients experienced improvements in neurological and systemic symptoms.\\n described the case report of a patient who had achieved a complete response in the brain following treatment with gefitinib. This particular patient was diagnosed in July 1999 with stage IV adenocarcinoma of the left lung. In March 2001, after treatment with three different chemotherapy regimens, asymptomatic brain metastases were detected and subsequently treated with whole-brain radiotherapy. However, by October 2001 the patient's condition had deteriorated, with progressive brain metastases, and the patient was readmitted to hospital. Treatment with gefitinib started in November 2001 after which computed tomography scans showed that brain metastases had disappeared and that there was a marked regression of the lung tumour. The patient was then discharged in December 2001 and was able to resume full-time work for nearly 8 months. Two other published case reports also describe patients whose brain metastases responded to treatment. In all three of these cases, patients had worsening neurological symptoms and deteriorating performance status before treatment with gefitinib. Following treatment, a significant clinical improvement was seen in all three patients: brain metastases disappeared in the patient already described and the sizes of the other two patients' lesions decreased. Quality of life was improved in all three patients.\\nOne patient described at the ICE meeting showed good tolerance of concurrent gefitinib and radiotherapy (van Zandwijk [b], ICE abs, personal communication). In this case study, a 55-year-old male exsmoker with stage IV NSCLC and multiple pulmonary (lymphangitic) metastases developed multiple brain metastases (approximately 20 small lesions) after receiving treatment with gefitinib for >1 year (Figure 2). Radiotherapy to the brain (10 x 3 Gy) and continued treatment with gefitinib resulted in disease stabilisation and symptom improvement and the patient was able to return to work. Delayed imaging 9 months later showed almost complete resolution of the brain metastases (Figure 3). Thus, although gefitinib did not prevent the development of brain metastases, concurrent treatment with radiotherapy and gefitinib resulted in a durable clinical response.\\nIn total, 25 case reports of gefitinib use in patients with brain metastases and NSCLC were described at the ICE meeting (including the eight patients described by Cappuzzo et al) (Awada, ICE abs; Cappuzzo [a & b], ICE abs; Dieriks, ICE abs; Stein, ICE abs; de la Cruz [a & b], ICE abs; Maione, ICE abs; Martinez, ICE abs; Diaz-Canton, ICE abs; van der Kamp, ICE abs; van Zandwijk [b], ICE abs; Petruzelka [a], ICE abs; Azemar, ICE abs; Roggero, ICE abs; Kowalski, ICE abs; Martin-Algarra, ICE abs; Pavlakis, ICE abs). Of these, three patients had a complete response, 10 a partial response, eight had stable disease and four patients had progression of their brain metastases. In all of these case reports, treatment with gefitinib appears to have been well tolerated. Any reported adverse events are consistent with the adverse-event profile of gefitinib established in Phase II trials in patients with advanced NSCLC. There was also no unexpected or cumulative toxicity described for the patient who received concurrent gefitinib and radiotherapy (van Zandwijk [b], ICE abs).\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 41,\n",
       "    'case_id': 'PMC3108731_01',\n",
       "    'case_text': \"A 41-year-old male was admitted to the hospital with symptoms of diarrhea, fever, dyspnea and right pleural effusion. The illness began in the latter part of August 2008, initially presenting with diarrhea and fever. He was an MSM and the serology for HIV antibody was positive. He had no history of traveling abroad, alcoholism, any medication or intravenous drug use. His vital signs on admission were; conscious, blood pressure 95/60 mmHg, pulse late 146 beats/min, respiration, 45 breaths/min, saturation O2 (room air), 88% and body temperature 39 C. The notable findings of a physical examination included emaciation (BMI 16.1), oral candidasis and decreased breath sounds on the right side of his chest. A chest radiograph and computed tomography (CT) of the chest showed a large amount of right pleural effusion (Figure 1). A CT scan of the abdomen detected large liver abscess (Figure 2). The laboratory data included a leukocyte count of 10,320/muL with 89% neutrophils, 8% lymphocytes, 3% monocytes, hemoglobin 8.8 g/dL, C-reactive protein 23.6 mg/dL, aspirate aminotransferase 95 U/L, alanine aminotransferase 74 U/L, alkaline phosphatase 478 U/L, gamma-glutamyl transpeptidase 134 U/L, albumin 2.1 g/dL, total cholesterol 57 mg/dL, blood urea nitrogen 18.4 mg/dL, creatine 0.57 mg/dL and hyponatremia (123 mEq/L). The findings of human immunodeficiency virus type 1 antibody tests were positive for enzyme immunoassays (EIA) and also based on the Western blot method. Thoracentesis revealed milk chocolate or cafe au lait colored pleural fluid (Figure 3). In an examination of the pleural fluid, cytology, bacterial culture, smear and polymerase chain reaction to detect Mycobacterium tuberculosis DNA were negative, the adenosine deaminase activity was 240 IU/L. The pleural fluid showed a cell count of 40125/mL (74.3% neutrocytes, 25.7% monocytes). Other examinations of the laboratory findings detected cysts of Entamoeba histolytica in the patient's stool. The CD4 lymphocyte count in the peripheral blood was 179/muL (repeated counts for CD4 lymphocytes ranged from 286 to 359/muL) and the amount of HIV-RNA was 3700 copies/muL (repeated counts for HIV-RNA ranged from 43,000 to 90,000 copies/mL). Although E. histolytica was not identified from the pleural fluid, antibodies (fluorescence antibody technique) against E. histolytica were demonstrated in the serum (200x). The patient was thus diagnosed to have amoebic colitis, amoebic liver abscess and amoebic empyema complicated with an HIV infection. The right side pleural effusion was drained using a chest tube and he was administered metronidazole (2250 mg/day) orally for 28 days in total. A large volume of pus was drained from the right thoracic space. A small volume remained. The right lung was re-expanded. His fever, dyspnea and general condition significantly improved thereafter. The patient was therefore administered trimethoprim-sulfamethoxazole to prevent pneumocystis pneumonia and itraconazole to prevent fungal infections. However, he developed agranulocytosis 22 days after administration. The absolute neutrophil count was 0/muL. Agranulocytosis in this case was therefore considered to have been caused by the administration of trimethoprim-sulfamethoxazole. After the discontinuation of trimethoprim-sulfamethoxazole, the recombinant human granulocyte colony-stimulating factor (G-CSF) drug filgrastim was administered daily at a dose of 200 mug/m2 intravenously. Following 4 days of treatment with G-CSF, the patient's absolute neutrophil count was above 9/muL, while after 7 days of treatment it was 2990/muL (white blood cell count 4600/muL, neutrophils 65%). The patient did not demonstrate any further infection during the clinical course. He was discharged 45 days after admission.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 74,\n",
       "    'case_id': 'PMC6398058_01',\n",
       "    'case_text': \"A 74-year-old Japanese woman was referred to our hospital with dyspnea, a palpable mass in the right breast, and an enlarged lymph node in the right axilla that had worsened during the two months before admission. History taking revealed that she had moved from her birthplace in Kumamoto prefecture of southwestern Japan to Nagano prefecture after marriage. She had no other remarkable history of disease, transfusion, medication, or drug abuse.\\nOn presentation, patient's body temperature was 37.2 C with a heart rate of 127 bpm and peripheral artery oxygen saturation of 92% in ambient air. Her vesicular sounds decreased without crackling on chest auscultation. Physical examination revealed a distended abdomen without hepatosplenomegaly. Systemic lymphadenopathy and pretibial edema pitting were noted.\\nBlood examination (Table 1) disclosed a lymphocyte count of 680/muL and less than 1% morphological flower cells. Peripheral laboratory tests were as follows: aspartate aminotransferase, 37 U/L; alanine aminotransferase, 6 U/L; lactate dehydrogenase (LDH), 622 U/L; total bilirubin, 1.5 mg/dL; soluble IL-2 receptor, 27,500 U/mL (normal range: 135-421 U/mL); and calcium, 12.9 mg/dL. HTLV-1 antibody was positive. A contrast-enhanced computed tomography (CT) scan of the chest and the abdomen revealed bilateral pleural effusion and ascites with lymphadenopathy (Figure 1). Bilateral pleural effusion samples appeared chylous (Figure 2) with high triglyceride concentrations (Table 2) and class III cytology. A biopsy obtained from the right inguinal lymph node showed diffuse infiltration of moderate- to large-sized lymphoid cells with a pleomorphic nucleus and prominent nucleoli (Figure 3) that were CD3+, CD4+, CD5+, CD8-, CD20-, and CD21- on immunohistochemistry (Figure 4). Two monoclonal bands for HTLV-1 provirus DNA were observed in lymph node specimens by Southern blot hybridization analysis (Figure 5). Tumor cell infiltration into the bone marrow was negative in an aspiration biopsy. Based on these findings, the patient was diagnosed as having lymphomatous ATL.\\nThe clinical course of the patient is summarized in Figure 6. High-dose methylprednisolone therapy was deemed ineffective for her chylothorax since continuous pleural effusion drainage of 500 to 1,000 mL/day was necessary. The patient was soon shifted to a reduced-dose LSG15 chemotherapy regimen with prophylactic hydration, rasburicase, and bisphosphonate. After the first course of modified LSG15 (consisting of vincristine, cyclophosphamide, doxorubicin, prednisolone, vindesine, etoposide, ranimustine, and carboplatin), she required pleural effusion drainage of less than 200 mL/day. Her systemic lymphadenopathy and pleural effusion disappeared over the two subsequent LSG15 treatment courses as confirmed by CT and normalization of LDH and calcium levels.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 21,\n",
       "    'case_id': 'PMC6537081_01',\n",
       "    'case_text': 'A 21-year-old woman was admitted for gradually progressive colicky pain over the hypogastrium for 6 days, associated with vomiting and constipation. She was able to pass flatus, but with cessation of bowel movements. She was diagnosed to have ulcerative colitis (UC) in the past for which total colectomy was performed, followed by a manual side-to-end ileorectal anastomosis. She had previous episodes of partial SBO that resolved with antispasmodics and had an untreated menometrorrhagia for the past year.\\nShe was hemodynamically stable and her abdomen was not distended. Multiple scars from previous abdominal surgery were visible. There was tenderness in all four quadrants, but no signs of peritonism. No anterior wall defects were palpated. Bowel sounds were hyperactive. Parents rejected vaginal and rectal examination.\\nPlain abdominal X-ray showed multiple radiopaque shadows within the small bowel, no air-fluid levels or dilated loops. We further proceeded with plain computed tomography scan to reach to a final diagnosis of multiple enterolithiasis in the small bowel (Figure 1).\\nLaparotomy was done after 48 h of poor response to conservative management. Abdominal exploration revealed multiple dense and cohesive adhesions predominantly in the distal small bowel. An anastomotic ileorectal stricture was found, along with multiple stones. The size of the enteroliths averaging 1 cm did not allow manual \"milking\" of the stones into the rectum (Figure 2). In the pelvic cavity, a cystic mass in the left ovary was found. No communicating fistula was identified between gallbladder and duodenum. Next, left salpingo-oophorectomy was performed, stricture was excised, stones were removed, and intestinal continuity restored with manual end-to-end ileorectal anastomosis at a distance of 12 cm from the anal verge. This was followed by dilation and curettage (D&C).\\nIn the post-operative period, marked malnutrition was detected with a decrease in serum albumin; for this reason, total parenteral nutrition (TPN) was initiated; 5 days after ex-lap, she presented abundant discharge of succus through the wound. Urgent relaparotomy was performed. Anastomotic leak was found and was managed by dismantling of the anastomosis with closure of the rectal stump and end-ileostomy. Analysis of the biochemical composition of the intestinal stones showed the presence of calcium dihydrate oxalate (85%), calcium monohydrate oxalate (10%), and carbonate apatite (5%). The patient made good recovery and continued well upon discharge.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 80,\n",
       "    'case_id': 'PMC9834804_01',\n",
       "    'case_text': 'Patient information: an 80-year-old woman was admitted for chronic right flank pain in the last six months, with one episode of hematuria. The patient mentioned a history of weight loss, decreased appetite, and generalized weakness. There was no significant medical or family history or any relevant past interventions.\\nClinical findings: the physical examination was unremarkable. The temperature was 37.3 C, blood pressure 124/84 mmHg, and pulse rate regular at 86 beats/min. In palpation, we revealed mild tenderness in the right flank but without any palpable mass.\\nDiagnostic assessment: abdominal computer tomography (CT) scan revealed a heterogeneous right renal mass measuring 86 x76x 68 mm and arising from the upper and middle pole (Figure 1), with a lymph node of 8 mm diameter detected in the renal hilum as well as a multi lithiasis gallbladder (Figure 2). Laboratory tests did not detect any alterations, and gave the following results: white blood cell count was 79.000/mm3, red blood cell count 5,3.106/mm3, hemoglobin 13.0 g/dL, hematocrit 39.1%, platelets 19.6 x 104/microL, total bilirubin 0.6 mg/dL, direct bilirubin 0.2 mg/dL, aspartate transaminase 25 IU/L, alanine transaminase 19 IU/L, albumin 4.25 g/ dL, lactate dehydrogenase 240 IU/L, beta-glutamyltransferase 27 IU/L, alkaline phosphatase 201 IU/L, amylase 129 IU/L, blood urea nitrogen 11.6 mg/dL, creatinine 8 mg/L, C-reactive protein 3 mg/L, urinalysis pH 7.0, no uric protein, no urinary sugar, no ketone body, no uric blood, no bilirubin, and no white blood cell, and no bacteriuria. A chest CT was done and did not show any metastasis. The presumptive diagnosis was a renal tumor classified T2a-N2-M0, associated with a multi lithiasis gallbladder.\\nTherapeutic interventions: a right open radical nephrectomy via subcostal incision with lymph node dissection and cholecystectomy was performed. The surgical exploration showed a right renal large superior polar exophytic mass with two palpable hilar lymphadenopathies. The wall of the gallbladder appeared normal except for its lithiasis content. The surgical intervention was performed successfully without adhesion or local invasion.\\nFollow-up and outcome of interventions: the postoperative course was without complications, and the patient was uneventfully discharged on the fifth postoperative day. Pathological assessment of the specimen showed the tumor was well-circumscribed, measuring 9 x 7 x 5 cm and subtotally effacing the kidney. At sectioning, it was tan-yellow with large necrotic areas. The gallbladder was thin-walled with a 0.4 x 0.3 submucosal nodule. Microscopically the renal tumor consisted of a tubulopapillar lined by pseudostratified layers of cells with abundant eosinophilic cytoplasm and high nucleolar grade. It was a clear cell RCC with the pathologic stage of pT2a, Fuhrman 3. The polypoid lesion of the gallbladder was identical to those of the renal tumor population, made up of large, plant-like cells with clear cytoplasm, adopting an acinar or solid architecture within a stroma rich in small vessels (Figure 3A, Figure 3B). Immunohistochemistry was positive for cytokeratin CK7, AMACR (a-Methylacyl Coenzyme A Racemase), cytokeratin (AE1/AE3), and vimentin (Figure 3C, Figure 3D). The morphologic and phenotypic profiles were consistent with synchronous metastasis from renal carcinoma. Additionally, the histopathological study found several lymph nodes to be invaded. So, the final stage of the tumor was pT2a-N2-M1. The follow-up was carried out by CT scan at six months, and then after one year, the patient did not present a recurrence, and the renal function remained normal.\\nPatient perspective: the patient was informed about the all procedure, complication and outcome, and she was agreeing about it. The patient was pleased with the care she received throughout therapy.\\nInformed consent: written informed consent was obtained from the patient for participation in our study.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 61,\n",
       "    'case_id': 'PMC9941022_01',\n",
       "    'case_text': \"The patient is a 61-year-old Hispanic woman with a history of left breast cancer, diabetes mellitus type 2, and hypertension. The patient's medication history before her diagnosis of breast cancer included metformin 500mg twice a day (BID) orally (PO), and Lisinopril 10mg PO daily. She initially presented with left breast pain in 2018 and went to the emergency department. A mammogram was performed revealing a 1.2 cm hypoechoic cystic lesion in the left breast in the periareolar region. A biopsy was performed and determined to be a malignant invasive ductal carcinoma grade 3 out of 3 estrogen receptor (ER)/progesterone receptor (PR) negative HER-2 positive. The patient underwent a left modified radical mastectomy with sentinel lymph node dissection. Pathology showed a 1.8 cm grade 3 invasive carcinoma, pT1c, N0, M0, ER negative, PR negative, and HER2 positive. The patient underwent six cycles of docetaxel, carboplatin, and trastuzumab. She also received a year-long course of trastuzumab. Afterward, the patient started on neratinib 200mg daily.\\nThe patient presented to the ophthalmology consultation for blurry vision six months after the initiation of neratinib. Ophthalmological examination revealed a best corrected visual acuity (BCVA) of 20/300 (PH: 20/200) right eye and 20/25 in the left eye. Intraocular pressure of 15 mmHg in both eyes. The anterior segment exam was unremarkable with posterior chamber intra-ocular lenses. The posterior segment presented with an optic nerve that was pink and sharp with normal cup-to-disc ratios in both eyes. The macula revealed pigmentary changes; with some areas of hyperpigmentation in the macula in the right eye. The hyperpigmentation in the left eye presented a more diffuse appearance with a lacy pattern (Figure 1 A). Of note, the scarring and pigmentary clumping extended beyond the arcades in a reticular and lacy fashion in the left eye (Figure 1 B).\\nThe left eye presented with more profound changes in comparison to the fellow eye. Optical coherence tomography revealed full-thickness scarring mostly of the outer retina in the right eye while presenting internal limiting membrane (ILM) draping and cavitations (Figure 2).\\nFundus autofluorescence revealed hypoautofluorescense in areas of pigmentary clumping that extended beyond the arcades. The right eye presented similar features from the nasal to the optic disc as well (Figure 3).\\nFluorescein angiography revealed early staining and late leakage beyond the area of foveal scarring in the right eye (Figure 4). There was leakage also present from a smaller lesion inferiorly on the macula in the left eye (Figure 4 D).\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 42,\n",
       "    'case_id': 'PMC3981348_01',\n",
       "    'case_text': \"In March 2009, a 42-year-old man patient presented with progressively increasing, occasionally painful lump in the left upper and central abdomen for past 2 months. On physical examination there was a hard, partially mobile, mildly tender 10x10 cm lump with irregular surface occupying the left lumber, left central abdomen and part of left hypochondrium. Contrast-enhanced computed tomography (CECT) abdomen revealed well-defined capsulated heterogeneous soft tissue density lesion with evidence of calcification and patchy contrast enhancement, superior to left kidney (size 164x111x174 mm); no metastasis or lymphadenopathy was there. Computed tomography (CT) - guided true cut biopsy revealed adrenocortical carcinoma. Biochemical examination was consistent with nonfunctioning tumor. In April 2009 the tumor was resected encapsulated along with left kidney (i.e. no rupture of capsule or spillage of tumor occurred). Histological analysis of specimen showed adrenocortical carcinoma with focal areas of capsular invasion and left kidney was unremarkable. No adjuvant chemotherapy was given. The patient was discharged from hospital after eight days. Patient was followed up in out patient's department for 6 months but then patient stopped coming to outpatient department for follow up.\\nIn October 2010, patient presented with swelling in anterior abdominal wall rapidly increasing for last 2 months (Figure 1). Patient was not having any symptoms apart from mild pain locally. On physical examination, there was a single hard, well defined, immobile, mildly tender 80x70 mm lump with irregular and bleeding surface occupying umbilical region. CECT thorax and abdomen was done which revealed a soft tissue mass lesion in the anterior abdominal wall at umbilical level involving the anterior abdominal wall muscle (B/L rectus abdominis), subcutaneous tissues and overlying skin with small calcific foci within, measuring 64.7x66x54 mm (Figure 2). There was no extension beyond the muscle. Cytological features were consistent with metastatic adrenocortical carcinoma (Figure 3). There was no evidence of metastasis elsewhere.\\nPatient was diagnosed as metastatic adrenocortical carcinoma so resection and abdominal wall reconstruction was planned but patient refused for any kind of treatment and opted for some indigenous medicines for his disease. After 2 months, he was brought to casualty department in state of shock with profuse bleeding from tumor site. Despite extensive resuscitation, patient couldn't be salvaged.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 60,\n",
       "    'case_id': 'PMC5259936_01',\n",
       "    'case_text': 'A 60-year-old woman had a frontal mass which she incidentally noticed 1 year back. The mass had been painless and was slowly, but gradually, increasing in size, and hence the delay in presentation. On presentation, her general physical, systemic, and neurological examination were within normal limits. Local examination revealed a 4 x 3.5 x 3 cm mass in the right frontal region. It was pulsatile in nature, firm in consistency, and was fixed to the skull. The skin over the swelling was stretched but was otherwise normal. Routine blood tests and thyroid function tests were normal. Skull X-ray showed a large frontal lesion with some focal calcification in the soft component of the lesion. Fine needle aspiration cytology (FNAC) from the skull swelling was obtained and stained with Leishman stain. Smears showed cells arranged in a repeated microfollicular pattern having monotonous enlarged, hyperchromatic nuclei, reminiscent of follicular neoplasm of thyroid and were suspected to be metastasis from FTC [Figure 1b]. Immunocytochemistry was done and the cells showed positive staining for thyroglobulin [Figure 1c] and cytokeratin.\\nThe patient had no history related to thyroid disease and was clinically euthyroid. Her subsequent workup included thyroid ultrasonography which revealed an occult primary in form of 1 x 1 cm well-defined hyperechoic lesion in the left lobe, with flow on color Doppler, which was suggestive of malignancy. Contrast enhanced computed tomography (CT) demonstrated a 3 x 3 cm soft tissue lesion in scalp in frontal region with destruction of underlying bone [Figure 1a]. Hence, the patient diagnosis was skull metastasis with occult FTC. She was advised further investigation and treatment which she refused, and has since been lost to follow-up.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': None,\n",
       "    'case_id': 'PMC3273437_01',\n",
       "    'case_text': \"We will carry out an economic evaluation designed for at least five Dutch employability interventions. Those undertaking the evaluation are not connected with the organisations or individuals who have developed, or are in the process of developing the employability interventions so no competing interests arise. Within the CASE-study each existing or innovative intervention will be compared with usual care for work-disabled employees or those at risk of work disability due to medical restrictions. At the start of the CASE-study, nine programmes were interested in participating in the project. Unfortunately four programmes could not collaborate because they were unable to provide the minimum required number of participants eligible for the study, or could not provide a comparable control group. The remaining five employability interventions have the ability to comply to the minimal requirements and focus on primary care, secondary or specialist care, and/or on the interaction between the employer and employee. Two existing employability interventions (called 'Best Practices') and three newly developed employability interventions are included in the study. The employability intervention focussing on primary care aims to acknowledge the importance of employability in general practice. This intervention is under development at the University of Nijmegen (UMC St Radboud). The employability intervention in specialist care is being developed jointly by the VU University Medical Centre Amsterdam (VUMC) and the Institute for Health and Care Research (EMGO+) and focuses on employability among patients who suffer from rheumatoid arthritis. The third newly developed intervention aims at improving the interaction between the employee and his/her employer by appointing an independent mediator. The intervention is being developed by a separate team at Maastricht University. One of the 'Best Practice' interventions, developed by Health & Motion Nederland, offers patients with physical health complaints the ability to implement a range of exercises learned at the physiotherapeutic setting in their working environment by means of a workplace-intervention. The fifth and final intervention is developed by Second Care/Care for Companies (Best Practice) and aims at achieving sustainable employability among patients with physical and/or psychological health complaints using a multidisciplinary approach. An overview of these interventions is provided in Figure 1.\\nIt is beyond the scope of this design article to describe the precise content of each employability intervention in detail. This will be done when the results of the economic evaluation per employability intervention are published. What is of importance in this paper is that the employability interventions use an innovative, systematic approach in order to support work participation in employees with health complaints. These are innovative because both the healthcare system and the private/work life of the employees are considered in the intervention. The features of the interventions differ according to the patient population, but the aim remains the same: to reduce sickness absence and increase the potential of achieving sustainable employability.\\nThe protocol for this study has been approved by the Ethics Committee of Psychology (ECP107) at Maastricht University, the Netherlands.\",\n",
       "    'gender': 'Unknown'}],\n",
       "  [{'age': 4,\n",
       "    'case_id': 'PMC8712131_01',\n",
       "    'case_text': 'A total of 42 eyes of 41 patients were identified. Of these, 37 eyes (20 right eyes and 17 left eyes) from 36 patients had a minimum of 1 month of follow-up and were included in the statistical analysis. 44.4% (n = 16) of patients were females. The mean age at the time of surgery was 72.0 +- 12.4 years old (range 31-92 years old). The mean follow-up period was 548.9 days (range 39-1564 days).\\nRelevant past ophthalmological history included closed-globe trauma in 12 eyes (32.4%), pseudoexfoliation (PEX) syndrome in 8 eyes (21.6%), glaucoma in 7 eyes (18.9%), previous PPV for retinal detachment repair in 5 eyes (13.5%), pathological myopia in 4 eyes (10.8%), open-globe trauma in 3 eyes (8.1%), exudative age-related macular degeneration in 2 eyes (5.4%), diabetic retinopathy without macular edema in 2 eyes (5.4%), dry age-related macular degeneration, previous penetrating keratoplasty, endophthalmitis, diabetic retinopathy with macular edema, retinal venous occlusion, toxic optic neuropathy, and Vogt-Koyanagi-Harada syndrome in 1 eye each (2.7%). Population baseline characteristics are represented in Table 1.\\nIndications for surgery included aphakia due to complicated cataract surgery (24.3%; n = 9); subluxated IOL due to closed trauma (21.6%; n = 8); non-traumatic, non-PEX-related subluxated IOL (18.9%; n = 7); PEX-related subluxated IOL (16.2%; n = 6); subluxated crystalline lens due to closed trauma (8.1%; n = 3); aphakia due to open-globe injury (5.4%; n = 2); silicone-induced IOL opacification (2.7%; n = 1); and aphakia post-endophthalmitis (2.7%; n = 1).\\nAll patients underwent scleral fixation of an Akreos AO60 IOL using Gore-Tex suture, combined with either 23- or 25-gauge PPV. 1 eye (2.7%) underwent concomitant glaucoma surgery with Ahmed valve implantation.\\nThe mean best-available preoperative logMAR VA was 1.61 +- 0.73 (0.025 decimal equivalent). The mean best-available postoperative logMAR VA was 0.57 +- 0.66 (0.3 decimal equivalent), and, globally, the improvement from pre- to postoperative best-available VA was statistically significant (P < 0.001). VA was 5/10 (logMAR 0.3) or better in 3 eyes (8.1%) preoperatively, as compared to 17 eyes (45.9%) postoperatively. Subgroup analysis considering indication for surgery revealed a statistically significant postoperative vision improvement for patients with aphakia due to complicated cataract surgery (P=0.028), subluxated IOL due to closed trauma (P=0.028), non-traumatic, non-PEX-related subluxated IOL (P=0.028), and PEX-related subluxated IOL (P=0.043). Visual improvement was noted for patients in the remaining subgroups, but this difference did not reach statistical significance. Subgroups of silicone-induced IOL opacification and aphakia post-endophthalmitis included a single eye, and statistical significance could not be calculated.\\nDuring the study period, 1 eye (2.7%) had postoperative visual deterioration of 2 lines in the Snellen chart, and 7 eyes (21.6%) had no change in VA.\\nThere were 3 eyes (8.1%) with reported intraoperative complications: one iatrogenic retinal hole done during vitrectomy; a flat peripherical serous choroidal detachment; and an intraoperative vitreous hemorrhage.\\nPostoperative complications included ocular hypertension (27.0%; n = 10), transient corneal edema (18.9%; n = 7), cystoid macular edema (18.9%, n = 7), self-limited hypotension (5.4%, n = 2), self-limited vitreous hemorrhage (2.7%, n = 1), one case of central retinal vein occlusion (2.7%), one case of late retinal detachment (2.7%), and one case of Akreos IOL opacification (2.7%). Retinal detachment was managed with PPV with gas endotamponade; Akreos opacification is awaiting surgery to replace the IOL; the central retinal vein occlusion has been receiving intravitreal injections of 1.25 mg bevacizumab and 2 cases of macular edema resolved after intravitreal injections of corticosteroids (one case with intravitreal 2 mg triamcinolone alone, and the other with 2 mg triamcinolone, followed by 0.7 mg dexamethasone intravitreal implant). All of the other complications were managed medically, with topical treatment. No suture-related complications were observed, namely, suture breakage, IOL displacements, or suture-related inflammation. Also, there were no cases of postoperative endophthalmitis, choroidal detachment, or uveitis-glaucoma-hyphema syndrome.\\nClinical outcomes are reviewed in Table 2.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 74,\n",
       "    'case_id': 'PMC6831859_01',\n",
       "    'case_text': 'A 74-year-old man presented to our hospital with dyspnea and cough in May. He had developed productive cough, sore throat, and nasal discharge three weeks before, muscle pain two weeks before, and fever and dyspnea three days before his admission. He had no medical, family, or social history of note, and no close contact with infected people. He was an ex-smoker (10 pack-years). His vital signs included a body temperature of 37.6  C, heart rate of 116 beats/min with a regular rhythm, and blood pressure of 137/84 mmHg. On physical examination, fine crackles were audible on the dorsal side of the bilateral lower lung regions, but no other remarkable findings were seen. Chest X-ray showed consolidation and reduced volume of the right lung (Fig. 1-A). Computed tomography (CT) (Fig. 2) on admission showed bilateral consolidation (right dominant), ground-glass opacities (GGOs) around the consolidations, and air-bronchogram accompanying traction bronchiectasis within the consolidations. The GGOs in part had non-segmental distribution. His arterial blood gases under ambient air showed a pH of 7.45, PaO2 of 70.2 Torr, PaCO2 of 35.7 Torr, and bicarbonate of 24.3 mmol/L, and biochemical examination of his blood and urine showed elevation of the erythrocyte sedimentation rate and C-reactive protein and aspartate aminotransferase levels. Pneumococcal and Legionella urinary antigen test, Mycoplasma antigen from throat swab specimens, and influenza antigen from nasal swab specimens were all negative. Autoantibodies were negative. No bacteria other than oral flora were cultured in the sputum cultures. We performed bronchoscopy and bronchoalveolar lavage (BAL) in the right middle lobe (with 20 of 150 mL recovered). The total cell count of the BAL fluid was 5.3 x 105 cells/mL, including 44.7% lymphocytes (cluster designation [CD]4/CD8 ratio, 3.16), 7.1% eosinophils, and 23.9% neutrophils. BAL fluid yielded no bacteria, and adequate specimens for evaluation could not be collected from transbronchial lung biopsy.\\nWe diagnosed him as having CAP and started antibiotics (ampicillin/sulbactam + clarithromycin). Consolidation and volume reduction of the right lung continued to deteriorate, reaching a peak on the 8th day of hospitalization, but they gradually improved (Fig. 1-B, C). Serum antibody titers against Mycoplasma pneumoniae, Legionella sp., Chlamydophila pneumoniae, Chlamydia psittaci, adenovirus, human parainfluenza virus, RS virus, and influenza virus in the convalescent phase did not significantly increase compared with those measured in the acute phase. Pneumonia has not recurred as of 2 years after discharge, but the reduced volume of the right lung has remained (Fig. 1-D). Multiplex real-time reverse transcriptase PCR (RT-PCR) with a commercially available kit (FTD Resp 21 Kit; Fast Track Diagnostics, Silema, Malta) for respiratory viruses using frozen-stored BAL fluid was performed later and was positive only for HPeV. We ultimately diagnosed him as having primary HPeV pneumonia.',\n",
       "    'gender': 'Male'},\n",
       "   {'age': 46,\n",
       "    'case_id': 'PMC6831859_02',\n",
       "    'case_text': 'A 46-year-old man had a fever and sore throat 10 days before hospital admission, and shortness of breath developed 6 days before admission in May. A local physician diagnosed him as having CAP and administered levofloxacin, but the symptoms did not improve and he presented to our hospital. He had no medical, family, or social history of note, and no close contact with infected people. He was an ex-smoker (15 pack-years). His vital signs included a body temperature of 37.4  C, heart rate of 81 beats/min with a regular rhythm, and blood pressure of 99/66 mmHg. On physical examination, fine crackles were audible on the dorsal side of the left middle lung regions, but no other remarkable findings were seen. Chest X-ray (Fig. 3-A) showed nodular consolidation on both sides of the lungs. Chest CT (Fig. 4) on admission showed patchy consolidation and GGOs along the bronchial vascular bundle in the upper and lower lobes of left lung and S6 of the right lung. Neither traction bronchiectasis nor volume reduction of the lungs were observed. His arterial blood gases under ambient air showed a pH of 7.46, PaO2 of 85.9 Torr, PaCO2 of 36.9 Torr, and bicarbonate of 25.4 mmol/L, and biochemical examination of his blood and urine showed an elevated C-reactive protein level of 7.62 mg/dL but no other remarkable findings. Pneumococcal and Legionella antigen test in urine, Mycoplasma antigen from throat swab specimens, and influenza antigen from nasal swab specimens were negative. Autoantibodies were negative. Sputum cultures showed no bacteria cultured other than oral flora.\\nWe performed BAL in the right middle lobe (with 69 of 150 mL recovered). The total cell count of the BAL fluid was 2.1 x 105 cells/mL, including 80.8% macrophages, 12.7% lymphocytes (CD4/CD8 ratio, 10.6), 4.9% eosinophils, and 1.6% neutrophils. BAL fluid yielded no bacteria, but transbronchial lung biopsy revealed organization, swollen pneumocytes, and alveolar septal thickening with inflammatory cells (Fig. 5).\\nWe administered antibiotics (ampicillin/sulbactam + clarithromycin), and his clinical symptoms and chest infiltrates improved promptly after admission. A follow-up chest X-ray (Fig. 3-B) was clear, and he was discharged on the 10th hospital day with no complications. Serum antibody titer against M. pneumoniae, Legionella sp., Chlamydophila pneumoniae, Chlamydia psittaci, adenovirus, human parainfluenza virus, RS virus, and influenza virus measured in the convalescent phase did not significantly increase compared with those in the acute phase. Multiplex real-time RT-PCR for respiratory viruses using BAL fluid was positive only for HPeV. We finally diagnosed him as having primary HPeV pneumonia.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 49,\n",
       "    'case_id': 'PMC4717627_01',\n",
       "    'case_text': \"A 49-year-old Japanese woman (gravida 4, para 3) was diagnosed with AIP at the age of 27. Our patient had repeatedly visited the hospital for stomachaches beforehand; however, approximately 2 years of consultations passed before she was accurately diagnosed. Afterwards, she avoided elements known to precipitate acute attacks, and had not experienced an acute porphyria attack since she was 33 years of age. In addition, she began hypertension treatment with amlodipine besylate at the age of 40 years, and her last pregnancy had spontaneously aborted 4 years prior to the present event. In July 2011, this patient visited a local private clinic for atypical vaginal bleeding and was referred to a general hospital because of suspected spontaneous abortion. She was subsequently diagnosed with a acute intermittent porphyria hydatidiform mole via dilatation and curettage (D&C).\\nOne month after D&C, our patient presented with an elevated serum human chorionic gonadotropin (hCG) level (Fig. 1). As fertility preservation was deemed impossible, she underwent an abdominal total hysterectomy. Pathological study of the resected specimen revealed an invasive mole, but no metastasis was observed. However, our patient's serum hCG level was again elevated 1 month after hysterectomy, and she was referred to Saitama Medical Center for chemotherapy to address expected AIP-associated complications. An X-ray computed tomography scan of her chest, performed at our institution, revealed a lung metastasis. The FIGO 2000 staging and risk factor scoring system indicated a stage III:41 gestational trophoblastic neoplasia (GTN) (Tables 1 and 2), and our patient was accordingly diagnosed with a low-risk GTN. Her treatment strategy included intramuscular MTX administration at a dose of 20 mg/day for 5 days every 2 weeks.\\nMTX chemotherapy was initiated after our patient provided informed consent, which included an understanding that MTX had not been implicated as either porphyrinogenic or nonporphyrinogenic. Our patient experienced small eruptions on the hands and epigastric region on day 3 of chemotherapy. However, a dermatologist did not interpret these eruptions as drug-related, and thus treatment was continued. On day 5, the eruptions expanded over her whole body and worsened, with ulcers developing on the oral mucosa (Fig. 2). Our patient was unable to eat or drink owing to the severe pain caused by mucosal erosion; moreover, she complained of painful micturition because of a sore on her vulva. A skin biopsy revealed drug eruption instead of a porphyric skin lesion. In particular, microabscesses had formed under the stratum corneum, with neutrophilic and eosinophilic invasion, and neutrophilic exocytosis was observed in the epidermis. Liquefaction was also observed between the epidermis and dermis, and eosinophilic, neutrophilic, and lymphocytic invasion from the layer between the epidermis and dermis to the superficial layer of the dermis was noted (Fig. 3). No changes in our patient's urinary coproporphyrin or uroporphyrin levels were observed despite the appearance of skin lesions (Fig. 1). She received intravenous prednisolone at 60 mg/day beginning on day 5 to treat the drug eruption.\\nOn day 11, our patient experienced febrile neutropenia (absolute neutrophil count [ANC] on day 8 was 1,380/muL but decreased to 12/muL on day 11) and was treated subcutaneously with 75 mug/day of granulocyte-colony stimulating factor (G-CSF) for 3 days beginning on day 11. However, as she was unable to recover from neutropenia (ANC remained at 12/muL on day 13), additional subcutaneous G-CSF at 150 mug/day was administered for 2 days beginning on day 13, and her neutropenia finally resolved on day 15 (ANC, 1598/muL). During that time, her skin lesions and stomatitis also began to improve, and the prednisolone dose was reduced to 40 mg/day. As she was able to eat on day 17, oral prednisolone administration at 20 mg/day was started on day 20 and tapered on day 24. She was discharged on day 25.\\nAlthough our patient's serum hCG level decreased with MTX treatment, it became elevated during treatment interruption. Chemotherapy with ACT-D was therefore considered. After providing informed consent to ACT-D treatment and acknowledging that ACT-D was not implicated as either porphyrinogenic or nonporphyrinogenic, our patient received intravenous ACT-D at a dose of 1.5 mg/day on days 1-5 of every 2-week period, starting on day 70 of her clinical course. As shown in Fig. 1, her serum hCG level effectively decreased, and the lung metastasis disappeared without any porphyric attacks. After five cycles of ACT-D, her serum hCG level stabilized at 3.2 mIU/mL. Although other chemotherapeutic drugs were considered, a negative serum hCG level was achieved and maintained for the following 3 years.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 69,\n",
       "    'case_id': 'PMC5114320_01',\n",
       "    'case_text': 'A 69-year-old woman with a history of surgical mitral valve repair for severe mitral regurgitation 12 years prior presented with a 6-month history of dyspnea on exertion (NYHA functional class II), exercise intolerance, and swelling of her abdomen and lower limbs. On jugular venous examination, giant systolic pulsations with prominent V-waves, known as the Lancisi sign or C-V waves, were noted (Fig. 1a, Video appendix 1 and 2). On auscultation, a loud first heart sound was audible, with a loud pulmonary component of the second heart sound along with an apical mid-diastolic rumble. A holosystolic murmur at the left lower sternal border that increased during inspiration was also noted. Lower limb edema, ascites and an enlarged, pulsatile liver were present. Transthoracic echocardiography demonstrated normal left ventricular function with an ejection fraction of 55 % and a normal function of the mitral valve. It also confirmed the presence of a dilated right atrium and right ventricle and a severe tricuspid regurgitation (TR) with a moderately reduced right ventricular function. The patient was referred for a surgical tricuspid annuloplasty, but given an increased operative mortality risk refused to undergo the operation. \\nTR is a relatively common abnormality. Since this condition is frequently asymptomatic and may not be detected on routine physical examination, it is often diagnosed solely by echocardiography. Usually, there are no specific signs or symptoms. Yet, in case of severe TR, giant C-V waves or the Lancisi sign can be found on the jugular venous examination. With increasing tricuspid regurgitation, there is an increased backflow of blood to the right atrium during systole. In patients with severe tricuspid regurgitation, the V wave of tricuspid regurgitation merges with the C wave forming a single prominent C-V wave that is often mistaken for the large carotid-pulse wave of severe aortic regurgitation. Other signs and symptoms include painful hepatosplenomegaly, ascites, and peripheral edema. Auscultation reveals a loud first heart sound with a loud pulmonary component of the second heart sound, an apical mid-diastolic rumble, and a holosystolic murmur at the left lower sternal border. Generally, tricuspid valve disease occurs secondary to left-sided heart valve disease, in particular mitral valve disease (i.e., functional TR) (Appendix 3). It is a marker of adverse outcome, and patients with moderate/severe TR have a worse prognosis. Primary TR (Appendix 3) is treated surgically if severe, and the patient is symptomatic. However, during concomitant left-sided heart valve surgery, a moderate/severe secondary TR with either raised pulmonary artery pressures or tricuspid annular dilatation should also be treated.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 29,\n",
       "    'case_id': 'PMC3894025_01',\n",
       "    'case_text': 'A 29-year-old primigravida started with pain and mild heaviness in the both lower limbs distally associated with occasional pins and needles sensation in 35th week of pregnancy. Her symptoms were progressive. Over the next 10 days, the patient noticed knee buckling with frequent falls and difficulty in sitting and standing from supine position. At the end of 36th week, an emergency LSCS (lower segment caesarian section) was performed for decreased fetal heart rate. LSCS was uneventful and a healthy baby was born. Second post-partum day, the patient was discharged. On third post-partum day, the patient complained of weakness all the four limbs (in addition to persisting symptoms), more in lower limbs and was not able to maintain the erect posture. In this state, the patient was brought to our accident and emergency department. A detailed history was taken which revealed initiation of symptoms during third trimester of pregnancy without any preceding illness. Subsequent clinical examination revealed sinus tachycardia, fluctuating hypertension, power of 4/5 in upper limbs, 3/5 in lower limbs, hypotonia, areflexia (lower limbs), flexor plantar response, and mild involvement of all the modalities of sensation. A working diagnosis of GBS was made and all other investigations including nerve conduction studies, arterial blood gases, electrolytes, and later cerebrospinal fluid analysis were planned.\\nArterial blood gas analysis showed pO2=89 mmHg, saturation = 94.6%, pCO2=42 mmHg, and pH = 7.39. Serum potassium was 4.1 meq/L, sodium 136 meq/L and bicarbonate 25 meq/L. Electrocardiography showed sinus tachycardia and routine blood chemistry was normal. Serological tests for campylobacter jejuni, EBV, cytomegalovirus, and mycoplasma pneumonae were negative. Electrophysiological studies revealed decreased amplitude of compound action potentials in median and common peronial nerves with decreased conduction velocity and abnormal F waves. After 7 days, lumbar puncture was performed and cerebrospinal fluid chemistry revealed raised protein of 7.8 g/L and normal cell count, confirming the diagnosis. The patient received treatment in the form of physiotherapy and close observation of symptoms and signs to which she rapidly responded with respect to power and sense of well-being over next 72 h, without the intervention of immunomodulating drugs. Sinus tachycardia and episodic hypertension was treated with atenolol. The patient was discharged after 2 weeks of hospital stay with power of 5/5 in upper limbs, 4+/5 in right lower limb, and 4/5 in left lower limb with persisting areflexia in lower limbs.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 19,\n",
       "    'case_id': 'PMC6834456_01',\n",
       "    'case_text': \"The patient is a 19-year-old female with Turner syndrome. She presented at our hospital after acute exacerbation of low back pain that had been present for one month. Her body height was 140 cm, and her weight was 39 kg. Tenderness was noted in the left buttock, but no lower limb muscle weakness or sensory disorders were observed. Plain radiographs showed an osteolytic lesion involving the left L5 vertebra with a winking owl sign observed on anteroposterior(AP) views (Fig. 1a). Computed tomography (CT) revealed pathological fractures of the L5 vertebral body and left pedicle along with osteolytic changes (Fig. 1b). Magnetic resonance imaging (MRI) revealed a lobulated lesion with fluid-fluid levels in the left vertebral arch, pedicle, and vertebral body of the L5 vertebra with high and low signal intensities on T2- and T1-weighted images, respectively. (Fig. 2a, b).\\nAn aneurysmal bone cyst (ABC) of the L5 vertebra was suspected from the image findings. We performed preoperative arterial embolization of the bilateral L4 lumbar arteries and the left iliolumbar artery to prevent intraoperative hemorrhage (Fig. 3a). Using intraoperative navigation to identify tumor margins, a thorough curettage was performed to remove the tumor (Fig. 3b). Rapid intraoperative diagnosis supported the diagnosis of ABC. The final pathological diagnosis of ABC was made by confirming the fibrous connective tissue accompanied by capillary proliferation and partial fibrin deposition, with no signs of malignancy (Fig. 3c, d). Pedicle screws were inserted into L4 and S1, and an expandable cage packed with autologous bone chips was placed between the vertebral bodies to reconstruct the lumbar spine's anterior strut (Fig. 4a).\\nAfter surgery, she had complete pain relief. At two years follow up, CT and MRI showed no apparent signs of recurrence (Fig. 4b, c).\\nABC frequency is reported to be approximately 1.4% of all primary bone tumors, with 3-30% of the cysts originating in the spinal column). In the spine, ABCs mostly occur in the thoracic or lumbar spines of young patients aged 10-20 years, with approximately 60% affecting the posterior spinal column components). The treatment options for ABC are surgical curettage and bone transplantation), embolization), radiotherapy), and drug injections). Recently, the effective treatment of ABC with embolization alone was reported), but there is a risk of spinal cord infarction due to inadvertent embolization of the Adamkiewicz artery. Therefore, surgery has been selected in most cases to treat ABC that arise in the spine, but there are reports of severe intraoperative hemorrhage,). Therefore, recent reports on ABC treatment often include accounts of surgical treatment with preoperative arterial embolization,). Along with the therapeutic effects of embolization, the reduction in intraoperative hemorrhage allows the surgeon to operate safely and precisely. In this case, arterial embolization was suitable because the ABC was localized in the L5 vertebra, where there is a low risk of embolizing the Adamkiewicz artery. Since she had a pathologic fracture of L5, we selected surgery instead of observing the effects of embolization.\",\n",
       "    'gender': 'Female'},\n",
       "   {'age': 19,\n",
       "    'case_id': 'PMC6834456_02',\n",
       "    'case_text': \"This case is rare because of the coexistence with Turner syndrome. Patients with Turner syndrome are mainly characterized by a short stature and lack of secondary sexual characteristics). The risk of gonadoblastoma, colon cancers, and central nervous system tumors have been reported to be greater in patients with Turner syndrome than in the normal population, possibly due to the allelic losses of the X chromosome which has been shown to contains genes related to immunity and cancer. Growth hormone therapy, to treat these patients' short stature, may also increase the risk of cancer). Since this patient had received previous growth hormone therapy to increase her growth rate, it is possible that the growth hormone therapy may have lead to the onset of ABC. However, there has been no report of ABC occurring in a patient with Turner syndrome, so the relationship between Turner syndrome and ABC may not be strong. The height of the present case was 140 cm, which is short compared with the mean body height (157.7 cm) of 19-year-old Japanese females. Since she was without neurological symptoms, we were able to preserve the nerve roots by locally adjusting the cage height with an expandable cage to reconstruct the anterior column).\\nHere we reported a case of ABC occurring in the spinal column of a patient with Turner syndrome who was treated with preoperative embolization, surgical curettage, and posterior fixation using an expandable cage.\\nConflicts of Interest: The authors declare that there are no relevant conflicts of interest.\\nAuthor Contributions: Tadashi Nukaga, and Akihiko Hiyama wrote and prepared the manuscript, and all of the authors participated in the study design. All authors have read, reviewed, and approved the article.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 39,\n",
       "    'case_id': 'PMC4258217_01',\n",
       "    'case_text': 'We report the case of a 39 years-old female, with no past medical history, whose complaint was a spontaneous one week evolving isolated left cruralgia. The clinical examination was unremarkable apart from an anterior thigh pain at the mobilization of the left hip. No quadriceps hypotrophy, no fever and no limitations in the joints motion were found. Plain radiographs of the pelvis and proximal femur showed hypercondensation of the medial cortex of the left femur below the calcar, the classic flowing candle wax, combined with condensation of the iliac side of the sacroiliac joints bilaterally (Figure 1). Lab tests were normal. The diagnosis of melorheostosis was raised and we completed the explorations by a whole body bone scan that showed increased uptake in the proximal left femur and both sacroiliacs. CT of the pelvis and left femur was performed and showed an hypercondensation in the medial cortex of the left femur, and a bilateral condensation of the iliac side of the sacroiliac joints (Figure 2, Figure 3). The patient was put under analgesics and nonsteroidal anti -inflammatory drugs, with improvement of symptoms from J3 of hospitalization. An MRI was performed and showed the same bone condensation without extensions to the soft tissues (Figure 4). Given these findings, biopsy was not performed, and the patient was discharged to be followed in our consultation by standard radiographs every three months, and an annual bone scan. At last follow up, two years of the first consultation, two episodes of left cruralgia have been reported, and yielded by three days anti -inflammatory treatments. Scintigraphy (Figure 5) and plain radiographies remained similar to initial assessments.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 26,\n",
       "    'case_id': 'PMC6396444_01',\n",
       "    'case_text': 'We present the case of a 26-year-old male who is referred to the digestive consultation by two episodes of spontaneous paraesophageal abscess in an interval of 2 years.\\nIt is a patient with no pathological history of interest that is presented in the Emergency Service for dysphagia for solids of 3 days of evolution that at the same time was suffering stabbing chest pain and fever of up to 38.8  C in the last 24 h. In the last year the patient had already been in the Emergency Room (ER) twice for chest pain with non-altered complementary tests. The patient denies having any traumatic history or onset of symptomatology after food impaction. The physical examination shows no abnormality on a hemodynamically stable patient. It is performed a blood test showed a C reactive protein (CRP) 190 mg/L (Normal values 0-5 mg/L), and white blood cells 12,000/muL (Normal values 4000-10,000). For that reason it is decided to perform thoracic-abdominal computed tomography (CT), where a collection of 8 x 4 x 5 cm is displayed in the third inferior-posterior of the esophagus compatible with hematoma vs mediastinal abscess (Fig. 1).\\nThe surgery service is contacted and it is decided to choose the conservative treatment with broad-spectrum antibiotics and absolute diet. During the admission, a echocardiogram with normal results was performed, an esophagogram that does not present alterations and a gastroscopy, where a linear ulcer of 5 mm in distal third of esophagus with biopsy that shows granulation tissue was found.\\nThe patient is discharged 7 days after, with the normalization of his analytical and clinical parameters, and showing a correct oral tolerance for later control in consultations.\\nAn outpatient USE is requested 3 weeks later, after being discharged, where no paraesophageal collection is displayed. Gastroscopy was repeated where the esophageal ulcer is not visualized and biopsies are taken from the distal and proximal esophagus. In those biopsies, it is noticed an eosinophilic inflammatory infiltration of 40 eosinophils per field.\\nThe patient does not attend any control, so no treatment is started.\\nOne year later the patient returns to the emergency department with chest pain and dysphagia with same characteristics, and elevation of CRP and white blood cells. Again, a toraco-abdominal CT is performed, objectivizing mediastinal collection in the same location as 1 year before, with a size of 7 x 4 x 4 cm, compatible with abscess, which is retreated in a conservative manner with broad spectrum antibiotics. After 10 days, a CT control confirms resolution of the collection.\\nAmbulatory gastroscopy is performed with biopsy-taking by objectivizing an eosinophilic inflammatory infiltrate compatible with eosinophilic esophagitis.\\nThe patient denies dysphagia, chest pain, heartburn or any other clinic between episodes of mediastinal abscess.\\nIt starts treatment with proton pump inhibitor in double doses during 8 weeks, persisting the eosinophilic inflammatory infiltrate in the biopsies. It is agreed a diet with the patient where two foods will be removed (milk and wheat), obtaining histological remission, and identifying the milk as the cause of the inflammation.\\nAfter 2 years of follow-up, the patient maintains milk and derivatives restriction, and has not shown again any episodes of mediastinal abscess.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 56,\n",
       "    'case_id': 'PMC6742877_01',\n",
       "    'case_text': 'A 56-year-old diabetic, hypertensive man on antipsychotic medications who jumped from about 30 feet height, sustained polytrauma and was admitted in a local hospital. After initial resuscitation and advanced trauma life support (ATLS) care, he was intubated and put on ventilator support. He was diagnosed with bilateral hemothorax and his right lower limb X-rays showed fracture lower one-third femur with extensive metadiaphyseal comminution and fracture ipsilateral proximal tibia extending to metaphysis. A locking distal femoral locking plate was present and had bent (Fig. 1). As per records, he had 3*2cm wound on anterior aspect of thigh which was thoroughly washed, debrided, and sutured and damage control surgery was done in the form of knee-spanning fixator (Fig. 2)and the patient was put on intravenous antibiotics. He stayed in the intensive care unit (ICU) for 7 days, after which he was shifted to our center. As a part of repeat evaluation, all his necessary X-rays were retaken(Fig. 3)which revealed resolution happening in bilateral hemothorax. The right lower limb X-rays revealed knee-spanning external fixator with fracture of lower end femur and proximal end tibia with bent implant in situ (Fig. 2). The patient was kept in the ICU till he was fit for subsequent intervention and appropriate treatment in the form of intravenous antibiotics and deep vein thrombosis prophylaxis was given. During this period, the patient had low-grade fever, but his inflammatory markers were normal and the wound over the thigh was healthy. On the 8thday, he was taken up in the operation theater with intubation on. Before removing external fixator, the wound present on anterior aspect of distal thigh was again debrided and found to be clean; then, the decision to proceed further was made and the external fixator was removed. The distal femur was opened through lateral approach using liberal skin incision(Fig. 4). After splitting the distal part of tensor fasciae latae, the distal locking screws were removed. Since the plate was bent, a bone hook was used to pull out the proximal end of plate laterally. Now, the position of the proximal screws was marked under C-arm control using an artery forceps. Each screw head was cleared causing minimal muscle damage and they were removed in a minimally invasive fashion, thus preserving the biology of zone of comminution and the plate was gently levered out. Following implant removal, we identified that there was another fracture line in coronal plane just posterior to plate application in the articular block which was identified as lateral condyle Hoffa fracture. The articular reconstruction was first done and the Hoffa fracture was fixed using single partially threaded cancellous screw. Manual linear traction was applied to the limb after reconstructing articular block and grossly comminuted fragments were seen to be aligned, so no attempt was made to open the comminuted area. The length of the limb was maintained by giving linear traction and an electrocautery was used to ensure that the center of femoral head, patella, and second toe lie in same line and checked under C-arm to maintain the correct rotation of the limb. The longest available distal femur locking plate (A.O SYNTHES) in the set was slid in a MIPPO fashion bypassing the zone of comminution after reconstructing the articular block. Same incision was extended below knee to expose proximal tibia and the longest available lateral tibia locking plate(A.O SYNTHES) was slid in a MIPPO manner bypassing the comminution. Now, after fixing both the fractures, the knee was examined for ligamentous instability and it was found to be globally unstable in both the planes. Considering the gross comminution in both femur and the tibia, and the being an open fracture, it was decided to wait for ligamentous reconstruction till bony union was achieved. Wound was sutured in layers over negative drain and a long knee brace was given to the patient since the knee was unstable in both the planes. The patient was shifted out of theater in an intubated state. Immediate post-operative X-rays revealed satisfactory alignment of both fractures, (Fig. 5). During the next 7 days, the patient remained intubated and during this period, the passive movement of joints was given, the limb was elevated and the stitch line was carefully monitored. Once the patient was extubated on the 8th day, it was found that there was an associated foot drop which was missed preoperatively since the patient was in an intubated state. The foot drop splint was applied accordingly and physiotherapy in the form of guarded ROM and muscle strengthening exercises was started. We could not ambulate the patient as he had another fracture in the wrist in the recent past, (Fig. 6). The wound healing was bit delayed but it was ultimately uneventful. An X-ray was taken at 6 weeks post-operative which revealed satisfactory alignment(Fig. 7) and toe touch weight-bearing with long knee brace was started under supervision of trained physiotherapists. The patient was further followed up at 1 month interval and during this rehabilitation period, special attention was given to his psychiatric care. At the latest follow-up of 6 months, the patient had radiological and clinical evidence of union (Fig. 8). At the last available follow-up, the ligamentous instability still persisted, and with long knee brace, he was able to stand and walk. The foot drop was also recovering and there was no extension lag and knee flexion was upto 90  (Fig. 9). At this moment, he was properly counseled and explained in detail about all the available options in the form of arthrodesis, hinged knee arthroplasty, and ligamentous reconstruction, but the patient opted for non-operative management in the form of long knee brace for the time being.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': None,\n",
       "    'case_id': 'PMC9108155_01',\n",
       "    'case_text': 'Somatically, the patient had no significant medical or surgical history, and in particular no documented drug allergy or AE. He had grade 1 obesity (99 kg, 180 cm, BMI: 30.56), was an active smoker, and had a history of addiction (cannabis) from which he had been abstinent for several years.',\n",
       "    'gender': 'Male'},\n",
       "   {'age': 19,\n",
       "    'case_id': 'PMC9108155_02',\n",
       "    'case_text': 'Psychiatrically, the patient had a history of schizoaffective disorder diagnosed at the age of 19 (illness duration of 10 years) according to DSM5 criteria, in combination with antisocial personality disorder and substance use disorder. Illness recurrences came in the form of acute manic psychosis, which were often triggered by a discontinuation of treatment and required multiple psychiatric hospitalizations (5 within the past 2 years), the most recent of which were by involuntary care.\\nTherapeutically, the initiation of long-acting injectables (LAI) in the form of Risperidone extended-release (ER) (50 mg/14 days) first of all ensured an initial period of clinical stability. However, 2 years before the onset of the current episode, a decompensation while on a single antipsychotic agent had motivated the initiation of a mood stabilizer (Valproate semisodium, 2,000 mg/d, with serum valproate concentration of 62 mg/L, within the therapeutic range of 41-100 mg/L) combined with antipsychotic treatment with paliperidone ER (100 mg/28 d). This dual therapy was then replaced by a combination of valproate semisodium (2,000 mg/day) and Risperidone (4 mg/d) in a context of absenteeism from outpatient follow-up. Six months prior to the onset of the current episode, dual therapy with valproate semisodium (2,000 mg/d) + paliperidone ER (100 mg/28 d) was re-initiated, with a well-tolerated dosage increase (to 2,500 mg/d and 150 mg/28 d, respectively, accompanied by an elevation in serum valproate levels from 67 mg/L before to 97 mg/L after drug dosage increase) without any further adjustment in the 4 months preceding this episode.',\n",
       "    'gender': 'Unknown'},\n",
       "   {'age': None,\n",
       "    'case_id': 'PMC9108155_03',\n",
       "    'case_text': 'After a short period of clinical stability however, a further interruption of both outpatient follow-up and drug treatment was accompanied by an increase in both manic (elated mood and psychomotor agitation) and psychotic symptoms (delusions of grandeur and persecution) leading to behavioral disturbances and hetero-aggressive threats against his neighbors. After police intervention, the patient was transported to the psychiatric emergency services for medical assessment, and hospitalized without consent in a psychiatric care unit, where further examinations were performed.',\n",
       "    'gender': 'Male'},\n",
       "   {'age': None,\n",
       "    'case_id': 'PMC9108155_04',\n",
       "    'case_text': 'Due to a relapse with a serum valproate level suggestive of drug non-compliance on admission (serological concentrations of valproate measured at 23 mg/l on admission, below the therapeutic range), the drug was re-prescribed at the usual doses and supplemented with diazepam, a benzodiazepine drug, and levomepromazine, a phenothiazine antipsychotic with tranquilizer properties. When clinical deterioration (acute manic psychosis with grandiose delusions and psychomotor agitation) again occurred under effective treatment [i.e., despite a serum valproate level within the therapeutic range (91 mg/l)], a change in mood stabilizer was proposed in an overlap-and-taper strategy, after pre-therapeutic assessment (with no outstanding features). Considering that the patient had many illness recurrences of manic polarity with psychotic symptoms, as well as a high metabolic syndrome risk valproate was replaced with lithium as mood stabilizer, which was initiated (day 0) at 400 mg/d. However, after the third administration of slow-release lithium salt, signs of fluctuating temporal disorientation signaled the onset of an acute confusional syndrome (d3). An iatrogenic etiology was immediately suspected, which led to the discontinuation of lithium the same day (d3) and the confusional syndrome was etiologically assessed.',\n",
       "    'gender': 'Unknown'},\n",
       "   {'age': None,\n",
       "    'case_id': 'PMC9108155_05',\n",
       "    'case_text': 'Clinically, the patient presented with psychomotor retardation, disorders of alertness and global cognitive impairment [Mini-Mental State Examination (MMSE) score of 15/30; Frontal Assessment Battery (FAB) score of 3/18 ] with no clinical signs on general or neurological examination). Biological examinations (complete blood count, electrolytes, liver, kidney, thyroid, coagulation and vitamin workup) revealed no significant abnormality (day 3). The brain computed tomography (CT) scan (day 5) showed nothing abnormal. The electroencephalogram (EEG) (d5) showed no seizure activity but presented a pattern indicating encephalopathy (fluctuating and slowing background activity with theta/alpha and delta waves, predominant in the posterior regions, reactive to verbal stimulation and with the change to eyes-open). Pharmacologically, serum lithium level measured 24 h after the third intake (day 3) showed subtherapeutic doses (undetectable <0.05 mmol/l; N: 0.8-1.2 mEq/l), whereas the serum valproate level was consistent with an overdose (130 mg/l) and was accompanied by a threefold elevation in serum ammonia level (182 mumol/l; N: 16-60). In addition, the blood toxicology screen showed cannabis use (THC-COOH: 16.9 ng/l) but did not suggest associated substance use.\\nThe diagnosis of drug-induced hyperammonemic encephalopathy (HAE) was therefore proposed, and the valproate semisodium dose was decreased under clinical supervision (2,000 mg/d on day 4, 1,500 mg/d on day 6). The neurologist recommended no other urgent course of action.',\n",
       "    'gender': 'Unknown'},\n",
       "   {'age': None,\n",
       "    'case_id': 'PMC9108155_06',\n",
       "    'case_text': 'Dose reduction resulted in rapid neurological improvement, both clinically and on the electroencephalogram [check on day 7, i.e., 3 days (steady-state) after the first valproate semisodium dose reduction], associated with normalization of serum valproate (79 mg/l on day 7; 5 mg/l on day 10) and serum ammonia (66 mumol/l on day 7; 32 mumol/l on day 10) levels. However, regression of the encephalopathic condition quickly gave way to the reappearance of psychiatric symptoms due to the lack of effective treatment, which justified a re-increase in valproate semisodium dosage (2,500 mg/d on day 12, 5 days after the regression of the neurological disorders) and a monthly injection of paliperidone, which once again stabilized the patient without any clinical or biological adverse effect observed in 1 month (serum valproate level: 61 mg/l and serum ammonia level: 27 mumol/l on day 38, on valproate semisodium 2,500 mg/d).',\n",
       "    'gender': 'Unknown'},\n",
       "   {'age': None,\n",
       "    'case_id': 'PMC9108155_07',\n",
       "    'case_text': \"After requesting an opinion from a pharmacology specialist:and in the absence of documentation in the literature regarding the possibility that lithium may have contributed to the picture presented, a change in mood stabilizer was again considered at day 46 (day 0') according to the same modalities. lithium was initiated at 400 mg/d, valproate semisodium was progressively decreased (2,000 mg/d on day 0', 1,500 mg/d on day 3' [...] discontinuation on day 12') and the patient was reassessed daily. No clinical adverse effects were reported. However, biologically, the results of the test done on day 6' showed an infratherapeutic serum lithium level (0.26 mEq/l with 400 mg/d of lithium) and a 6% increase in serum valproate level compared to the test done 2 weeks earlier (89 mg/l on day 6' compared to 61 mg/l on day 38), despite a 40% decrease in the valproate semisodium dose administered since the last test (1,500 mg/d on day 6' compared to 2,500 mg/d on day 38). In addition, this elevated serum valproate level was again associated with hyperammonemia (90 mg/l), with no proven consumption of toxic substances (negative urine toxicology screen).\\nThe first administration of lithium salts was temporally related to an elevation of valproate serum levels, which was in turn associated with hyperammonemia and signs and symptoms of encephalopathy, which resolved after lithium discontinuation and progressive reduction of valproate semisodium dosage. The rechallenge of the combination long after the first episode then enabled a more objective examination of another increase in the serum valproate level, with more moderate hyperammonemia (without encephalopathy or associated clinical signs), concomitant with the re-initiation of lithium, despite a progressive decrease in the doses of valproate semisodium administered (Figure 1).\",\n",
       "    'gender': 'Unknown'}],\n",
       "  [{'age': 21,\n",
       "    'case_id': 'PMC9302883_01',\n",
       "    'case_text': \"The patient, a 21-year-old Uygur male, had a history of fever and diarrhea for 8 days, with the highest body temperature of about 38.6 C, accompanied by chills, and sparse watery stool several times, without abdominal pain. Due to the intermittently increased temperature after taking non-steroidal anti-inflammatory drugs (NSAIDs), the patient was treated in the fever clinic but got a poor treatment effect, therefore he was admitted to the emergency department on October 10, 2021.\\nPhysical examination on admission showed a body temperature of 38 C, pulse of 102 times/min, respiration of 23 times/min, and blood pressure of 125/72 mmHg, with clear consciousness, palpable spleen under the ribs. No other significant abnormalities were found in other physical examinations.\\nEmergency laboratory analysis in the emergency department indicated the following: white blood cell count decreased from normal range to 1.56 x 109/L (reference value, RV 3.5-9.5 x 109/L), hemoglobin was 166 g/L (RV 130-175 g/L), platelet decreased from normal range to 74 x 109/L (RV 125-350 x 109/L), aspartate aminotransferase was 150u/L (RV 15-40 u/L), lactate dehydrogenase was 1249 u/L (RV 109-245 u/L), triglyceride was 2.29 mmol/L (RV 0.45-1.7 mmol/L), sodium was 124.2 mmol/L (RV 137-147 mmol/L), fibrinogen decreased from normal range to 1.27 g/L (RV 2-4 g/L), sCD25 was 25,398 pg/mL (RV < 6,400pg/mL), ferritin was 3671u g/L (RV 30-400ng/mL), natural killer cell activity was 18.48% (RV >= 15.11%). G-test (serum (1,3)-beta-D-glucan test) was positive, GM-test (galactomannan test) was negative, and blood culture, procalcitonin, c-reactive protein, erythrocyte sedimentation rate and T-SPOT.TB test were all negative. Mycoplasma pneumoniae antibody IgM (Passive Particle Agglutination, FUJIREBIO) was 1:80 positive (RV < 1:20), Legionella pneumophila antibody IgM (ELISA, Euroimmun) was 0.82 positive (RV < 0.8). The detection of Cytomegalovirus (CMV), Epstein Barr virus (EBV), Adenovirus and Coxsackievirus were all negative (real-time PCR). The oncological and immunological indexes were normal. Plain CT scan of the thoracoabdominal basin showed mild fatty liver and splenomegaly (Figure 1). There are many small lymph nodes in the hepatogastric space and retroperitoneal space.\\nReferring to HLH-2004 diagnostic criteria, the patient met the following conditions: (1) Temperature > 38.5 C for more than 7 days; (2) Hemocytopenia (WBC <10 x 109/L, PLT <100 x 109/L, hemoglobin 166 g/L); (3)Splenomegaly; (4)Low fibrinogen (FIB <1.5 g/L) and high triglycerides (2.29 mmol/L), although not meeting the diagnostic criteria (3 mmol/L); (5)Ferritin > 500u g/L;(6)sCD25 > 6,400 pg/mL. Considering the definitive diagnosis of HLH, the patient was treated with 20 g immunoglobulin QD (8 days) and 0.5 g imipenem cilastatin sodium Q8H, and his leukocytes, platelets, and fibrinogen gradually returned to normal levels. However, on day 14 after his onset, the patient developed a series of symptoms of peripheral nerve involvement, as shown in Table 1.\\nLumbar puncture was performed on the 16th day. Cerebrospinal fluid showed a low pressure and turbid appearance, containing 150 white cells/muL (90% lymphocytes, 10% neutrophils), protein 1.09 g/L, glucose 2.37 mmol/L, and chlorine 100.6 mmol/L; Bacteria, fungi, cryptococcus, and Mycobacterium tuberculosis were all negative; Rubella virus, CMV and EBV IgM antibody and DNA were later reported as negative. CSF and serum albumin data: CSF and serum albumin was 3.27 and 37 g/L, respectively (October 19); while 1.09 and 32.6 g/L, respectively (October 22). The albumin quotient (albumin in CSF/albumin in serum) indicated that an increased permeability of the blood-brain. No abnormality was found in CSF next-generation sequencing technology (NGS) implemented by Biotechnology Co., Ltd. Briefly, they optimized the internal index adapter and real-time analysis pipeline, established the optimal threshold for pathogen identification, and performed rapid metagenomic-NGS analysis. Peripheral neuropathy, demyelination, paraneoplastic tumor, autoimmune brain-related antibodies, serum antibodies IgM and IgG of C. jejuni were positive by enzyme-linked immunosorbent assay (ELISA), performed by Dr. Hao from the first hospital of Peking University, The values of IgM and IgG were greater than the negative control values (the cut-off values were 0.08 and 0.16 respectively) even after 1:160 dilution. Given the clinical presentation and CSF findings, based on intravenous dexamethasone of 20mg QD, the treatment regimen was adjusted to meropenem 1000 mg Q8H combined with acyclovir 60 mg Q8H and Mecobalamin 500 ug QD. On the 18th day, the patient's body temperature dropped to normal. On the 19th day, the lumbar puncture was performed again, and the cerebrospinal fluid became clear. CSF laboratory examination showed white blood cell count of 91/muL (92% single nucleus, 8% multiple nuclei), protein level of 3.27 g/L, normal glucose and chlorine, as well as negative NGS. Electromyography (Table 2) and cranial MRI were generally normal.\\nConsidering the peripheral nerve injury and cerebrospinal fluid protein cell separation, GBS secondary to C. jejuni infection was specifically classified as Miller Fisher syndrome (MFS) and Bickerstaff brainstem encephalitis. On the 23rd day of onset, the diameter of the right pupil gradually recovered to 4 mm the pupillary light reflex, and the closing function of the right upper eyelid gradually recovered. On the 26th day, dexamethasone was reduced to 10 mg QD. On the 27th day, the left pupil diameter recovered to about 4 mm, and the pupillary light reflex recovered. On the 28th day, the patient defecated autonomously. On the 41st day, spontaneous urination recovered, and the patient was hospitalized for 42 days. Before discharge, the patient had left bilateral facial paralysis and mild diplopia in both eyes. One month after discharge, the patient was followed up, leaving slight facial paralysis, and other symptoms returned to normal.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 44,\n",
       "    'case_id': 'PMC6205350_01',\n",
       "    'case_text': \"A 44-year-old male presented to the hospital with chief complaints of right foot pain, swelling and inability to ambulate. Medical history was significant for type 2 diabetes mellitus, diabetic foot ulcer, and osteomyelitis of right foot status post intravenous antibiotics through a peripherally inserted central catheter (PICC). On physical examination, the patient was noted to have bilateral lower extremity edema and a right foot plantar ulcer associated with erythema and warmth. Magnetic Resonance Imaging of right foot showed hallux Metatarsophalangeal (MTP) plantar soft tissue ulcer with gas locules at hallux MTP joint associated with Hallux metatarsal/proximal phalangeal osteomyelitis with septic arthritis. The patient underwent a right foot partial first ray amputation. Also, a Computed Tomography of chest obtained for shortness of breath revealed an incidental segmental and subsegmental bilateral upper lobe pulmonary emboli and a right upper lobe wedge-shaped peripheral ground glass and cavitary opacities consistent with pulmonary infarcts.\\nCultures were obtained from peripheral blood and PICC line. Both grew Achromobacter xylosoxidans/denitrificans which was resistant to meropenem, cefepime, piperacillin/tazobactam aztreonam, gentamicin, and tobramycin and sensitive to ciprofloxacin, levofloxacin, and Bactrim. A. xylosoxidans was considered MDR and the PICC was considered the primary source of bacteremia. Repeat blood cultures after three days of empiric antibiotic therapy were negative. The PICC was removed and a new PICC was placed and the patient was subsequently discharged on intravenous ciprofloxacin and vancomycin for six weeks. Also, a transesophageal echocardiogram was negative for vegetation and endocarditis was ruled out.\\nThree months later, the patient was readmitted for chest tightness associated with a productive cough and nausea which were present for four days prior to presentation. On physical examination, the patient was noted to have right sided crackles, bilateral lower extremity edema, and a right foot plantar ulcer. The patient was tachycardic with a heart rate of 112 and afebrile. Laboratory studies revealed an elevated leukocyte count of 17 k/ul with a neutrophil predominance of 79% and low hemoglobin of 8.5 g/dL. He had normal electrolytes, normal kidney function and normal liver enzymes. Initial imaging with chest x-ray showed right lung opacity with lower lobe predominance. On further imaging with a Computed Tomography of the chest revealed no evidence of PE and showed right lower lobe consolidation with small right pleural effusion, right upper lobe consolidation with partial ground glass opacity and a right upper lobe cavitary lesion measuring 3.5 x 2 cm. The effusion and consolidations were new whereas the cavitary lesion was thought to be secondary to ischemic necrosis of previous pulmonary infarction at the same location.\\nA diagnostic thoracentesis was done which showed turbid fluid with a total nucleated cell count of 36034/muL with 67% segmented granulocytes and many bacteria seen on gram stain. The Pleural fluid cultures grew E. coli which was resistant to ampicillin, gentamicin, levofloxacin, and ciprofloxacin and sensitive to ceftriaxone, Bactrim, aztreonam, cefepime, meropenem, imipenem, piperacillin/tazobactam and S. anginosus which was pan-sensitive to ceftriaxone, clindamycin, vancomycin, levofloxacin, erythromycin. E. coli was considered MDR and the patient was started on intravenous zosyn and a video-assisted thoracoscopic surgery with decortication was done for right pleural empyema. The patient's clinical condition was initially improving but after an extensive hospital stay he subsequently died after a cardiac arrest (see Fig. 1, Fig. 2, Fig. 3).\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 62,\n",
       "    'case_id': 'PMC10323808_01',\n",
       "    'case_text': \"A 62-year-old female renal transplant recipient was admitted to hospital on 20 August 2021, with a 5 week history of recurrent fevers and progressive dry cough without haemoptysis or dyspnoea. She did not report any unintentional weight loss, night sweats, fatigue or altered mentation. She had no recent sick contact exposures (including no prior risk of exposure to tuberculosis) or significant travel history. Her past medical history included deceased donor renal transplant in October 2012, stable on tacrolimus and mycophenolate mofetil without any history of rejection. Other medical and surgical history included workup for chronic hypophosphataemia and hypocalcaemia requiring weekly electrolyte replacement infusions via Groshong line (inserted March 2021), prior hemicolectomy for diverticular disease and parathyroidectomy.\\nOn examination, she was haemodynamically stable with blood pressure of 151/67, pulse rate of 69 beats min-1 and body temperature of 36.8  C. Lung auscultation was normal without any bilateral adventitious sounds, and cardiovascular examination did not reveal any murmurs or other stigmata of infective endocarditis. Groshong line site did not demonstrate purulent discharge or overlying cellulitis. Laboratory investigations showed a peripheral white blood cell count of 5.1x109 l-1 (normal range 4.5-11.0x109 l-1) with a neutrophil count of 3.4x109 l-1 (normal range 2.0-8.0 x 109 l-1). Inflammatory markers were elevated with C-reactive protein of 23.2 mg l-1 (normal <3.1 mg l-1).\\nChest radiograph followed by whole-body computed tomography (CT) scan revealed multifocal ground-glass opacities suspicious for pulmonary septic emboli, without cavitary lesions (Fig. 1). Transthoracic and subsequent trans-oesophageal echocardiography were negative for vegetations or haemodynamically significant valvular dysfunction.\\nIn the context of recurrent fevers occurring in temporal relation to weekly electrolyte infusions, outpatient blood cultures were initially obtained 2 weeks prior to admission and Gram-positive bacilli were only isolated from the aerobic bottle. The patient was initiated on intravenous (IV) vancomycin. Questions remained as to whether the positive blood culture was attributable to contamination and initially the organism was not identified using MALDI-TOF VITEK MS V3 (bioMerieux, Marcy L'Etoile, France). Subsequent repeat blood cultures collected both from peripheral draw and tunnelled Groshong line over a 2 week period continued to isolate Gram-positive bacilli only in aerobic bottles (Figs 2 and 3). The organism showed beige, non-haemolytic colonies that were mucoid in appearance and adherent to media, catalase-positive and partially acid-fast. In our local microbiology laboratory, API Coryne system (bioMerieux, Marcy L'Etoile, France) gave an identification of   Rhodococcus   spp.\\nInoculum was prepared from blood agar after incubating the isolate for 3-5 days at 35  C (+/- 2  C), with suspension made to 0.5 McFarland standard. The minimum inhibitory concentrations (MICs) were determined using E-test gradient strip (bioMerieux, France) as part of non-standardized susceptibility testing for this isolate. Findings were interpreted as per Clinical and Laboratory Standards Institute (CLSI) M24. The results showed susceptibility to amoxicillin/clavulanate, azithromycin, ciprofloxacin, linezolid, penicillin and vancomycin; it was intermediate to doxycycline. Hence, oral ciprofloxacin 500 mg twice daily was added to the patient's regimen on the third day of admission as combination antimicrobial therapy. As her Groshong line was the suspected source of bacteraemia, it was subsequently removed and the catheter tip bacterial culture isolated Gram-positive bacilli after 4 days of incubation. Repeat blood cultures after 5 days of antibiotics (1 day post-line removal) were negative.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 19,\n",
       "    'case_id': 'PMC9273775_01',\n",
       "    'case_text': \"Both the patient, a 19-year-old male who was previously healthy, and his father had weakness of the left eyelid muscle (Figures 1, 2), although their vision was normal. The patient's mother and sister were in good health. After lifting heavy objects, the patient presented with intermittent distending pain and discomfort in the right inguinal region, he did not pay attention to these symptoms and did not seek medical treatment. As the patient's symptoms worsened, a right inguinal hernia was suspected and diagnosed by the family doctor but was not treated further. 2 days later, there was skin itching in the right inguinal area, accompanied by redness, swelling and discomfort of the right scrotum, and he went to the local hospital again. Ultrasound examination showed that a contusion of the right testis may have been complicated with orchitis (no specific medical data). Rest was recommended. The pain was not relieved by oral levofloxacin but resolved on its own 3 days later; nevertheless, it became aggravated and unbearable after exercise. At the same time, the scrotal swelling had significantly increased. He came to the emergency room of our hospital, where a plain CT scan showed scrotal enlargement of unknown cause. Upon admission, the right scrotum was obviously enlarged and tender. It had a high surface temperature, normal skin color, negative scrotal elevation test, negative light transmission test, normal sex hormones and normal tumor markers (including Alpha-fetoprotein, chorionic gonadotropin, carbohydrate antigen-199, carbohydrate antigen-125, serum ferritin, and carcinoembryonic antigen). After admission, the patient was treated with levofloxacin, but the pain was still not relieved. On the second day after admission, ultrasound showed heterogenous echo of the right testis. Considering the possibility of inflammatory lesions, neither testicular tuberculosis nor a tumor could be ruled out. A plain + enhanced abdominal CT scan suggested that inflammatory lesions of the testis with necrosis were possible. In addition, there were some secondary changes in the spermatic vessels, and the spermatic vessels could be seen more clearly (Figure 3). After communicating with the patient and his family, he gave informed consent for exploration of the right scrotum, which was performed under general anesthesia.\\nWe made a right groin incision and cut the skin subcutaneously and each layer of muscle in turn, exposing the spermatic cord. We observed hyperaemia and oedema of the spermatic cord blood vessels and surrounding tissue. We rotated the testis approximately 90 degrees, lifted the testis out of the scrotum, opened the testicular sheath, and observed a small amount of bloody fluid within. We opened the tunica albuginea, where we observed a large amount of bloody fluid and a fish-like tissue bulge. The whole testicular boundary was unclear, the epididymis was enlarged, and the tunica albuginea had a visible tear of approximately 1.5 cm in length (Figure 4). Radical orchiectomy was performed on the right side, the spermatic cord was resected in a high position, and the incision was sutured step by step.\\nHaematoxylin-eosin staining (Figure 5). Immunohistochemistry results: Desmin (partly +, Figure 6), SMA (-), MyoD1 (+, Figure 7), Myogenin (+, Figure 8), CD34 (1), STAT-6 (1), S-100 (-), SOX-10 (-), CK (-), EMA (-), TLE1 (-), Ki-67 (80%+, Figure 9). The pathological diagnosis was rhabdomyosarco-ma of the right testis. The postoperative chromosome karyotype analysis showed that there was no Y chromosome microdeletion. Positron emission tomography (PET) examination showed no systemic metabolic abnormalities and no systemic metastasis. These findings suggested that the patient should be treated with a VAC regimen (vincristine, doxorubicin, cyclophosphamide). The patient refused further systemic treatment for personal reasons and is currently under follow-up.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 58,\n",
       "    'case_id': 'PMC4064426_01',\n",
       "    'case_text': \"A 58-year-old male presented with abdominal pain, jaundice and vomiting for one month. He also had associated history of weight loss and anorexia with no h/o pruritus and clay colored stool. Clinical examination revealed no abnormality except icterus. The laboratory examination revealed a serum total bilirubin level of 6.7 mg/dL, an aspartate aminotransferase (SGOT) level of 102 IU/L, an alanine aminotransferase (SGPT) level of 92 IU/L and an alkaline phosphatase of 250 U/L. USG abdomen was suggestive of periampullary mass with dilated pancreatico-biliary tree. E.R.C.P. demonstrated large deformed and bulky papilla with ulcerated lesion with infiltration in to duodenum causing 1st and 2nd part of duodenal (D1D2) stenosis. Biopsy revealed squamous cell carcinoma. Metastatic work-up did not reveal any other primary focus of disease. Contrast enhanced computed tomography scan (CECT) of the abdomen revealed a soft-tissue mass in the periampullary region with dilated distal portion of the common bile duct (CBD) and main pancreatic duct.\\nE.R.C.P. guided stent inserted in CBD. Liver function tests were repeated till the total serum bilirubin level normalized. Exploratory laparotomy proceeds Whipple's pancreaticoduodenectomy done.\\nOn exploration there was a growth at the ampullary region with involvement of CBD leading to grossly dilated CBD and main pancreatic duct. The gross specimen revealed a growth of 4 x 3 cm in the AmV (Fig. 1). Portal vein and superior mesenteric vein and artery were separate from the growth. Histopathological report was of adenosquamous carcinoma of the AmV (Fig. 2). Immunohistochemistry was planned which confirmed adenosquamous carcinoma (Figs. 3 and 4). The postoperative course was uneventful.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 31,\n",
       "    'case_id': 'PMC10415754_01',\n",
       "    'case_text': 'A 31-year-old man with a past medical history of intravenous drug use (IVDU), specifically heroin and cocaine, and untreated hepatitis C virus infection presented to the emergency department for the evaluation of chest pain. The patient\\'s chest pain began approximately 5 days prior to presentation as a sharp, non-radiating, persistent pain, which was worse with inspiration and on movement. The pain progressed to 10/10 in intensity below the nipples bilaterally. Our patient endorsed exertional dyspnea mostly because of the inability to inspire without significant pain and subjective fever. He also reported worsening cough productive of light green sputum and, at times, a scant amount of blood. Moreover, approximately a week prior, the patient missed a vein while injecting the drug in the right side of his neck which led to swelling and redness of the area. The remainder of the review of systems was noncontributory. As for his past medical history, our patient reported being informed he was positive for hepatitis C 10 years prior, but he did not seek treatment nor did he follow up with medical providers for the same. The patient has a smoking history of 15 pack years and has been injecting \"speedball\", a mixture of cocaine and heroin, almost daily for the last 10 years. Our patient reported using \"a bundle and a half\" of heroin together with \"few grams\" of cocaine in powder form with water daily. When the patient was not able to acquire cocaine, he used crack which comes in solid \"rock\" form. He reported crushing the rock form and diluting it with vinegar. He heated the mixture after filtering through cotton-wool before injecting himself using a syringe. The patient generally uses his neck and left arm veins to inject drugs. Our patient used the same syringe for up to a month. He reported that, at times, the needle tip would break off in tiny fragments and it would become difficult to acquire access through it. The patient\\'s last use of these drugs was the day of admission. Our patient admitted to being homeless and has been living on the streets for the last 3 years.\\nInitial vital signs demonstrated a temperature of 98.7  F, pulse of 135/min, respiratory rate of 19/min and blood pressure of 108/72 mmHg. He appeared to be in mild distress, with poor inspiratory effort due to pain. Physical examination was significant for poor dentition including a few chipped and missing teeth but no oral lesions or thrush. There was an area of erythema, induration and tenderness on the right side of the neck, about 4 x 10cm in size. Lungs were clear to auscultation bilaterally. Cardiac auscultation revealed normal S1 and S2, with no murmurs, rubs or gallops. Examination of the extremities revealed track marks on left antecubital fossa and onychomycosis of the nail beds. Stigmata of bacterial endocarditis were not seen.\\nInitial laboratory data was significant for a normal white blood cell (WBC) count of 8.5 K/muL, hemoglobin of 10.2 gm/dL and platelet count of 106 K/muL. The patient\\'s mean corpuscular volume (MCV) was 73.6 fL, with red cell distribution width of 15.3%. Serum sodium was 129 mEq/L, with otherwise unremarkable basic metabolic panel. Serum lactic acid was 1.2 mmol/L (normal 0.5-2.2 mmol/L) and D-dimer was 1197 ng/mL (normal 0-230 ng/mL). Erythrocyte sedimentation rate (ESR) was 95 mm/hr (normal 0-15 mm/hr) and C-reactive protein (CRP) was 15.2 ng/dL (normal <1.0 ng/dL). Urine drug screen was positive for cocaine and opiates but negative for amphetamines. Chest X-ray indicated a patchy increased density in the left lower lobe, lingula, and right middle and lower lobes (Fig. 1). Given a significantly elevated d-dimer in the setting of tachycardia, CT angiography of the chest was performed which excluded pulmonary embolism. However, multiple, fluffy, nodules of varying size and ill-defined margins were seen throughout both lungs (Fig. 2). Some of these nodules were cavitary. Larger coalescent areas were seen in the left lower lobe and the lingula. These findings were concerning for septic emboli or metastatic disease. As a result, CT abdomen and pelvis with contrast was performed which did not show any masses. The only finding was splenomegaly, measuring 18cm in length. Furthermore, given the findings of tenderness on the right side of the neck, CT of the neck with contrast performed to exclude septic jugular vein phlebitis or Lemierre\\'s syndrome was unremarkable.\\nMeanwhile, blood cultures were drawn and our patient was empirically administered intravenous (IV) Vancomycin 1 g and Piperacillin-Tazobactam 3.375 g. Emergent transthoracic echocardiogram (TTE) was performed which did not show valvular vegetation or abscess. Given a high suspicion of bacterial endocarditis (BE), trans-esophageal echocardiogram (TEE) was performed which also did not show any vegetations or abscess. Piperacillin-tazobactam was changed to IV Cefepime 2 g every 12 hours. IV Vancomycin was continued to achieve a therapeutic vancomycin trough level. Pulmonology was consulted and, based on the findings on high resolution CT scan of the chest (Fig. 3), the decision was made to perform navigational bronchoscopy to obtain endobronchial and transbronchial lung biopsies. Specimens were obtained from the right lower lobe using a needle biopsy, and near the pleura using the forceps. A few specimens were also obtained using triple needle brush. In addition, specimens from bronchial washings were sent for cytologic analysis, routine cultures, acid-fast bacilli (AFB) culture and fungal culture.\\nAdditional diagnostic evaluation included HIV testing, QuantiFeron TB, hepatitis panel, rapid plasma reagin (RPR), antinuclear antibody (ANA), anti-double stranded DNA (DsDNA) antibody, anti-glomerular basement membrane (GBM) antibody, anti-neutrophil cytoplasmic antibody (ANCA) and complement levels. Results were unremarkable.\\nHistopathology report of right lower lobe biopsy specimen was normal with no mononuclear infiltration. A brush tip specimen was also obtained from right lower lobe. Moreover, approximately 55 cc of thick pale orange fluid was obtained via bronchial wash of right lower lobe which showed scattered refractile material surrounded by dense neutrophilic and mononuclear infiltration (Fig. 4, Fig. 5). Gomori methenamine silver (GMS) stain for Pneumocystis jirovecii was negative.\\nThe patient\\'s maximum temperature was 100.1  F five days after the admission on antibiotics. The patient\\'s heart rate normalized to 70-90/min and WBC count remained in between 6 and 8 K/muL throughout admission. The patient\\'s chest pain improved over the course of days but mild discomfort with breathing persisted. Blood, respiratory and bronchial wash cultures for bacteria, AFB and fungi remained negative. Because of ongoing concern for bacterial septic emboli, the patient was continued on IV Vancomycin and IV Cefepime for a total of 6 weeks. The patient completed the final 3 weeks of antibiotics at a sub-acute facility.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 32,\n",
       "    'case_id': 'PMC4980514_01',\n",
       "    'case_text': 'A 32-year-old female patient visited the Department of Dentomaxillofacial Radiology, complaining of pain in the right mandibular second premolar tooth. After intraoral examination, panoramic radiography showed an ectopic premolar located in the left mandibular ramus (Figure 1).\\nTo identify the exact location of the tooth, Cone Beam Computed Tomography (CBCT) was taken, showing the premolar in the mandibular sigmoid notch in a vertical position (Figures 2(a) and 2(b)).\\nSurgical treatment was not seen as necessary for this patient because there were no symptoms related to the ectopic tooth. The patient was informed of the ectopic tooth and directed to clinical endodontics.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 63,\n",
       "    'case_id': 'PMC3683444_01',\n",
       "    'case_text': 'A 63-year-old male with history of untreated Chronic hepatitis C and alcohol abuse was admitted to the Internal Medicine Department with 4-day history of nausea, diffuse abdominal pain, and jaundice. On physical exam he was jaundiced with scleral icterus. The abdomen was diffusely tender with guarding. Laboratory data revealed total bilirubin 16.9 mg/dL (normal: <1.0), Alkaline phosphatase 243 IU/L, aspartate transaminase (AST) 97 IU/L (normal: <35), alanine transaminase (ALT) 69 IU/L (normal: <35), alpha fetal protein: 3.0 IU/mL, lactate dehydrogenase (LDH) 267 IU/L, albumin 2.7 g/dL (normal: 3.2-4.6), total protein 5.7 g/dL (normal: 6.4-8.3), blood urea nitrogen (BUN) 14 mg/dL (normal: 8-23), creatinine 0.85 mg/dL (normal: 0.80-1.30). CBC showed white cell count (WBC): 6.3 K/muL (normal: 5-10.2), hemoglobin 13.7 g/dL (normal: 13.5-17.5), and platelet 117 K/muL (normal: 150-450). Liver ultrasound showed a mass-like structure around gallbladder fossa, and common bile duct (CBD) diameter was 6 mm. Computed tomography (CT) of the abdomen and pelvis showed a large irregular mass at the porta hepatis. Magnetic resonance cholangiopancreatography (MRCP) revealed 5.5 x 5.4 x 4.9 cm mass and biliary ductal dilatation from extrinsic compression (Figure 1). Pathology of fine needle biopsy of mass (Figure 2) showed diffuse large B cell lymphoma, positive for CD20, BCL2, BCL6, CD79a, and PAX5 and negative for CD3, CD5, CD10, CD23, CD138, cyclin D1, CK7, CK20, and p63. Positron emission tomography (PET) scan showed multiple liver lesions and right lower lung nodule, without involvement of mediastinal lymph nodes or peritoneum. Bone marrow biopsy was negative for lymphoma. Endoscopic retrograde cholangiography (ERC) was performed for biliary decompression but CBD could not be cannulated, and limited cholangiogram showed distal CBD stricture. Percutaneous transhepatic cholangiography (PTC) was performed with successful internal and external biliary drain placement (Figure 3). His ECOG (Eastern Cooperative Oncology Group) score was 3 and chemotherapy was planned. After few days he was readmitted with acute renal failure (BUN/Cr: 100/4.1), WBC 25.1 K/muL, total bilirubin 6.4 mg/dL, intractable nausea and vomiting, and hypotension with multiorgan failure. He was found to be in septic shock. The patient died even before starting chemotherapy.',\n",
       "    'gender': 'Male'},\n",
       "   {'age': 80,\n",
       "    'case_id': 'PMC3683444_02',\n",
       "    'case_text': \"A-80-year-old nursing home female resident was admitted to internal medicine service with diffuse abdominal pain of 2-3 days duration, poor oral intake, nausea, and dark urine. PMHx was significant for dementia, hypertension, and hypothyroidism. She had cholecystectomy done at 55 years of age. She did not have history of tobacco or alcohol abuse. Physical examination revealed conjunctival icterus, confusion, tenderness in right upper quadrant, and epigastrium. No lymphadenopathy or hepatosplenomegaly was appreciated. Initial laboratory data revealed total bilirubin 12.0 mg/dL, alk phos 659 IU/L, AST 112 IU/L, ALT 86 IU/L, ammonia 35 mumol/L, LDH 650 IU/L, BUN 10 mg/dL, creatinine 0.68 mg/dL, sodium 130 mmol/L, chloride 98 mmol/L, albumin 2.4 g/dL, total protein 6.4 g/dL, prothrombin time 12.7 sec, INR 1.1, partial thromboplastin time 31 sec, and WBC 15 K/muL. Viral hepatitis panel, alpha-fetoprotein, and carcinoembryonic antigen were negative. CT abdomen was done revealing infiltrating liver mass involving the portal confluence with intrahepatic biliary dilatation, lesion in spleen, and absence of lymphadenopathy (Figure 4). The patient underwent percutaneous cholangiogram showing marked narrowing of biliary tree and unsuccessful attempt to insert drain. She underwent endoscopic retrograde cholangiopancreatography (ERCP) which showed distal common bile duct stricture secondary to extrinsic compression with dilated CBD up to 15 mm and intrahepatic ductal dilation. Biliary sphincterotomy was performed and plastic stent was placed for biliary decompression. CT guided liver mass core biopsy (Figure 5) reported diffuse large B cell lymphoma with stains positive for CD20 and CD79a and negative for CD10, cyclin D1, CD138, cytokeratin AE1/AE3, and S 100 protein. Her ECOG score was 4. Chemotherapy was not given because of patient's poor general condition. Patient's family decided to make her comfortable under hospice care and she succumbed within 3 months of diagnosis.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 20,\n",
       "    'case_id': 'PMC5846908_01',\n",
       "    'case_text': \"A 20-year old male patient with genetically confirmed DMD with known associated dilated cardiomyopathy was transferred to our supraregional stroke unit due to a wake-up stroke with severe right-sided sensomotoric hemiparesis and aphasia as he was right-hand dominant. Due to status post detection of a thrombus in the left ventricle in August 2015, the patient was on an anticoagulation regime with low molecular weight heparin (LMWH), which was interrupted in error because of a misapprehension the day before. In addition to LMWH, the patient was treated with bisoprolol, magnesium and vitamin D. A moderate- to high-grade hypotonic tetraparesis due to the DMD-related muscle weakness was already known. The acute presentation of the patient was due to a substantial worsening of the preexisting weakness on the right side, including a new facial weakness and aphasia, resulting in a formal NIHSS score of 20 points. The time at which the new symptoms were recognized was 08:15; last-seen-normal (LSN) was about 03:00. Initially the patient was brought by paramedics to the pediatric hospital at which he is best known. An immediate transfer to our department was performed, and the patient arrived at 08:56 in our emergency room.\\nVital parameters were stable, the international normalized ratio was 0.9 measured by CoaguChek  (Roche Diagnostics) in the emergency room. Cerebral CT scan revealed only slight early ischemic changes in the LMCA territory (ASPECT-Score = 8 points) but with hyperdense media sign on the left (Figure 1(a)). Subsequent CT angiography confirmed a proximal occlusion of the LMCA (Figure 1(b)).\\nPatient education took place, including the patient's mother as his legally authorized representative, so MT started quickly at 09:23 (door-to-groin time = 27 min). Considering the specific risks of general anesthesia in DMD, the procedure was performed with propofol, remifentanil and rocuronium. At 24 min after groin puncture, the recanalization was successfully completed (TICI grade 3) by direct thrombus aspiration using the Penumbra System  (Penumbra Inc. Alameda, CA, USA). Since the patient formally exceeded even the extended time window of 6 h after LSN, no additional IV thrombolysis was performed.\\nShortly after successful recanalization (Figure 1(c-d)) and directly after recovering from anesthesia, the half-sided motoric worsening of the preexisting hypotonic tetraparesis improved, but the aphasia persisted to a reduced extent (NIHSS score of 14 points). With logopedic speech therapy, the aphasia resolved almost completely in the further course of his hospitalization. The daily NIHSS score showed an improvement up to 12 points within 9 days.\\nTransthoracic and transesophageal echocardiography revealed no evidence of an intracardial thrombus, but a relevant reduced ejection fraction. No atrial fibrillation was detectable via prolonged ECG monitoring. Laboratory investigations found high creatine kinase at 1883 U/L (38-174), high lactate dehydrogenase at 321 U/L (135-225) and a high creatine kinase-muscle/brain at 144.5 U/L (<24). Due to the low muscle mass, creatinine serum level was extremely low at 0.25 mg/dl (0.70-0.12), so it could not serve as a reliable kidney retention parameter in this case. Consequently, we determined the kidney function via cystatin C, where a concentration of 1.10 mg/L (0.61-0.95) with a resulting glomerular filtration rate of 83 ml/min (>=90 ml/min) was shown. Further hemostaseological investigations revealed no thrombophilia.\\nFollow-up CT scans revealed a demarcation of the ischemia in the left area of the basal ganglia with a mild edema (Figure 1(e-f)). After discussing the specific considerations of indicated anticoagulation with the patient and his mother, oral anticoagulation with dabigatran (150 mg bid) was initiated for secondary prophylaxis.\\nAt discharge from our stroke unit and transfer to a rehabilitation center after 9 days of hospitalization, the patient showed a complete recovery from the ischemia-induced central hemiparesis. Only a slight aphasic component was present, resulting to an NIHSS score of 12 points at discharge, which was mainly due to his preexisting DMD symptoms.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 83,\n",
       "    'case_id': 'PMC10228719_01',\n",
       "    'case_text': \"An 83-year-old male patient had no family history of hypertension, chronic obstructive pulmonary disease, or malignancy. He smoked for 40 years and had a smoking index of 20 pack-years. He was admitted to the hospital for a physical examination, during which a chest computed tomography (CT) scan revealed a left hilar occupancy measuring approximately 5.9x3.6 cm, obstructive atelectasis in the left lung field, and a small pleural effusion. Further fiberoptic bronchoscopy revealed that the left main bronchus was blocked by new organisms, the surfaces of which oozed blood. This location was the site of the biopsy, which revealed lung squamous cell carcinoma ( Figure 1A ). P40 (+), CK56 (-), ki-67 > 25%, TTF-1 (-) ( Figures 1B-F ) in immunohistochemistry. The patient ceased chemotherapy because he could not endure the adverse effects of nausea and vomiting after one cycle of perfusion chemotherapy (40 mg nedaplatin via bronchial artery infusion administration) and paclitaxel systemic intravenous treatment. After 7 months, the patient developed hemoptysis with a daily volume of about 10-20 mL, and chest CT scan revealed a left deviation of the mediastinum, left lung consolidation and atelectasis, a soft tissue mass in the left hilum with a size of about 8.1x4.6 cm, left main bronchial obstruction, and enlarged lymph nodes in the left cervical root and mediastinum. No obvious metastatic lesions had been found after head MRI, whole-body bone imaging, whole-abdomen enhancement CT. We took the disease's progression into consideration (Clinical Stage, cT4N3M1a, stage IVA). Subsequently, the BRCA2 EXON15 G25085 mutation was detected by blood next-generation sequencing, and the tumor mutation load TMB was 5.98 mutations/Mb. Based on the sequencing test results, we immediately started aggressive treatment and decided to use the PARP inhibitor Olaparib (300mg twice a day) with the PD-1 inhibitor Cindilimab. After one week, the patient's hemoptysis stopped. A repeat chest CT revealed that the left hilar mass was substantially smaller than before, with a long diameter of around 4.5 cm, and that the left lung was recruiting and the pleural effusion was absorbed after receiving Olaparib for two months and PD-1 inhibitor for two immunotherapy sessions. At this time, the patient appeared new symptoms, puffy eyelids, decreased urine volume, and generalized weakness. In further testing of common serological indicators, we found that blood creatinine increased from normal value at the beginning of the disease to 163.90mumol/L. Meanwhile, urine precipitation microscopy showed urine protein (+) without a tubular pattern. Routine blood, liver function, inflammation indicators, tumor indicators were normal, and autoantibodies were negative. Following the multidisciplinary team's discussion, we took into account the kidney damage caused by immune checkpoint inhibitors, which was graded as 2, and stopped using the PD-1 inhibitor in accordance with the Chinese Society of Clinical Oncology (CSCO) 2022 recommendation. One month after quitting the PD-1 inhibitor, the serum creatinine level was back to normal. Six months after starting Olaparib monotherapy, the patient was more advanced. The therapy options, disease response, and PFS for each treatment line are summarized in  Figure 2 .\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 67,\n",
       "    'case_id': 'PMC9641636_01',\n",
       "    'case_text': \"A 67-year-old female patient was admitted to the local hospital because of epigastric pain and discomfort for one month. She was diagnosed as a malignant tumor of the gastric body by electronic gastroscopy and biopsy pathology. The abdominal enhanced CT shows multiple lymph nodes enlargement in the abdominal and retroperitoneum in the outpatient clinic of our hospital ( Figures 1A, B  ). The patient received six cycles of chemotherapy in another hospital (SOX regimen for 1 cycle; S-1 and oxaliplatin. Paclitaxel, oxaliplatin, S-1, and Sintilimab for 5 cycles). After the end of chemotherapy, the effect of chmotherapy was evaluated as partial remission (PR). The patient asked for surgical treatment in our hospital. Physical examination showed that the abdomen was flat, the abdominal muscles were soft, the upper abdomen was mild deep tenderness, there was no rebound pain, and there was no obvious abdominal mass. Laboratory results showed that hemoglobin content decreased: 97g/L (normal range 110-150g/L). CA72-4:4.90U/mL (normal range 0-6.9U/mL), AFP: 1.30ng/mL (normal range 0-8.1ng/mL), CEA:1.13ng/mL (normal range 0-10ng/mL), CA199:17.71U/mL (normal range 0-37U/mL), CA125:2.85U/mL (normal range 0-30.2U/mL). There was no significant increase in serum tumor markers. After the end of neoadjuvant chemotherapy, we performed a PET-CT examination for the patient. 18F-FDG PET-CT showed that the mass showed changes after chemotherapy, slight thickening of the lesser curvature of the stomach, the mass did not significantly absorb FDG, and it was found that the left axillary lymph node was enlarged, and the mass uptake of FDG increased slightly, but it was considered as an inflammatory lesion ( Figures 1C ). After multidisciplinary tumor consultation, we decided to perform the radical total gastrectomy on the patient, and regular examination of the enlarged lymph nodes in the left axilla. After obtaining the consent of the patient and her family, the patient underwent radical total gastrectomy (Roux-en-Y digestive tract reconstruction) in August 2021. Postoperative pathology showed that the area of ulcerative gastric cancer was about 4 x 3cm. The main tumor cells were poorly differentiated adenocarcinoma, local invasion of the deep muscular layer of the gastric wall, and tumor cells can be seen in the lymphatic vessels but no definite nerve invasion. Lauren's classification was the diffuse type ( Figure 2A ). Only one of the 21 lymph nodes had metastasis, which was located on the lesser curvature of the gastric wall, and no obvious tumor metastasis was found in the rest of the lymph nodes (ypT2N1M0 IIA). Immunohistochemical staining showed that tumor cells expressed CK8/18, individual cells expressed Syn, and did not express CgA, CD56, SALL4, Oct3/4, C-erb-B-2, and Ki-67 proliferative index was approximately 90%. The patient recovered smoothly without obvious postoperative complications and was discharged 13 days after radical total gastrectomy.\\nOne month after radical total gastrectomy, the patient found that the left axillary mass grew faster than before and was accompanied by the limitation of left upper limb movement. Physical examination showed that the left axillary mass was about 4 x 2cm in size, hard, had an unclear boundary, and had a poor range of motion. Ultrasound examination of the bilateral breast and axilla showed that there was no obvious mass in the bilateral breast, and several hypoechoic lesions were found in the left axilla, the size of which was about 4.3 x 1.9cm, the boundary was clear, the cortex was thickened, the medulla was eccentric and the blood flow signal was abundant ( Figure 3A ). No obvious abnormality was found in mammary gland molybdenum target X-ray ( Figures 3B, C  ), mediastinal and supraclavicular enlarged lymph nodes were not found in CT, and no obvious bone metastasis in whole-body bone scintigraphy ( Figure 3D ). The patient underwent the axillary lymph node biopsy in October 2021. During the operation, the enlarged lymph nodes were located next to the axillary vein, fused into clumps, hard texture, and closely combined with the surrounding tissues. Intraoperative frozen sections showed that there were 5 lymph nodes in the left axilla, and all of them had cancer metastasis. After that, we performed radical axillary lymph node dissection and 14 of the 18 lymph nodes had metastases. Pathology showed that the tumor cells were poorly differentiated adenocarcinoma. immunohistochemical staining showed that most of the tumor cells expressed Caudal-type homeobox 2 (CDX2), CK20, GATA binding protein 3 (GATA-3), and a small amount of sequence-binding protein (SATB) 2 and Mucin-5AC (MUC5AC), but no expression of CK7 and TTF-1 was found ( Figures 2B-E ). After communicating with pathologists, considering the immunohistochemical results and the history of gastric cancer, we considered that the left axillary lymph node tumor was metastasized by gastric cancer.\\nThe patient received docetaxel and fluorouracil chemotherapy after radical axillary lymph node dissection, and a progressive increase in CEA, CA19-9, and CA72-4 was found (  Figure 4  ). Three months after the second operation, the MR examination of cervical and thoracic vertebrae due to back pain revealed secondary malignant tumors of the spine, but the patient refused to undergo whole-body bone imaging. CT of the chest and abdomen showed double clavicular and mediastinal enlarged lymph nodes, considering the malignant tumor. But the patient refused any treatment and died 11 months after the second operation.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 41,\n",
       "    'case_id': 'PMC9512840_01',\n",
       "    'case_text': 'A 41-year-old woman presents to a small rural hospital emergency department at 03:00, with the abrupt onset of severe acute epigastric pain. The pain is constant; it does not radiate outside of the mid-upper abdomen. The patient is pregnant, at 35 weeks gestation, with normal prenatal examination and blood pressure each visit through 34 weeks, and this is three days after the last prenatal examination. The patient has a past medical history of asthma, a remote appendectomy, a left oophorectomy for a cyst, a pre-term vaginal delivery at 34 weeks gestation 21 years ago, and no history of hypertension. Her asthma is quiescent, not requiring medication.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 0,\n",
       "    'case_id': 'PMC10182372_01',\n",
       "    'case_text': 'Patient information: a 23-month-old female child had been diagnosed to have a moderate-sized PmVSD at four months of age.\\nClinical findings: she presented with fast, laboured breathing and poor growth and a history of three previous episodes of chest infections. She had also been delivered at a birth weight of 1.05 kg on account of a twin-twin transfusion.\\nTimeline of the current episode: she had presented a year earlier at 11 months of age for pre-surgical evaluation for a moderate-sized PmVSD and had been receiving oral diuretics since diagnosis. Dietary counsel was given, medications optimized, and parents were counselled for early closure of the VSD. She presented for the procedure a year after, and parents were counselled regarding the benefits and risks of transcatheter closure as compared to the surgical option and the family opted for the former. A written and signed informed consent was obtained.\\nDiagnostic assessment: physical examination revealed no evidence of dysmorphism, no obvious respiratory distress, cyanosis or peripheral oedema. She weighed 10.0 kg which was 85% of her expected weight. The pulse rate was 116 bpm and pulses were normal volume, regular, synchronous, and well felt in all peripheries. Her precordium was active with the apex beat localised to the fourth left intercostal space lateral to the midclavicular line. Blood pressure was 100/49mmHg (90th centile for both systolic and diastolic pressures) and first and second heart sounds were normal with a grade 3/6 pan systolic murmur at the mid left sternal border. Oxygen saturation by pulse oximetry was 98% in room air, respiratory rate was 48 per minute and breath sounds were vesicular. She had a soft, smooth, non-tender hepatomegaly, 4cm below the right costal margin and no other abdominal organ was palpably enlarged.\\nDiagnosis: electrocardiography revealed sinus rhythm with a heart rate of 112 bpm, QRS axis of +300, predominant left ventricular forces and an incomplete right bundle branch block. Echocardiography showed a 7mm perimembranous ventricular septal defect partially restricted by the tricuspid valve septal leaflet aneurysm, shunting left to right (Figure 1). The peak interventricular pressure gradient was 80mmHg and the left atrium, left ventricle and pulmonary arteries were dilated with good biventricular function.\\nTherapeutic interventions: the child underwent successful transcatheter VSD device closure with a 0608 Lifetech CeraTM duct occluder (Lifetech Scientific Corporation, Shenzhen, China) under general anaesthesia using a laryngeal mask airway. Both arterial and venous femoral accesses were obtained, and 100 units/kg of intravenous heparin was administered. The intravenous antibiotic was administered as per the institution\\'s protocol. Pre-procedure transthoracic echocardiography (TTE) showed a PmVSD measuring 7.0mm and was restricted to 4.0mm by the tricuspid septal leaflet aneurysm. A left ventriculogram done in left anterior oblique (LAO) 400 cranial 200 view using a 5Fr pigtail catheter confirmed the echocardiography findings (Figure 2). The VSD was crossed retrograde from the aorta with a 5F Judkins Right catheter and 0.035\" 260cm Terumo wire combination and the wire manoeuvred into the superior vena cava and then the innominate vein. It was then snared using a 4F 10mm LifetechTM snare catheter (Lifetech Scientific Corporation, Shenzhen, China) and exteriorised from the right femoral vein forming an arteriovenous (AV) loop. The femoral venous short sheath was exchanged for a 6F Steer Ease introducer sheath (Lifetech Scientific Corporation, Shenzhen, China) which was passed antegrade over the venous limb of the AV loop and the sheath tip placed in the left ventricle. The duct occluder device was prepared, loaded in the delivery sheath, and deployed across the PmVSD under fluoroscopic and TTE guidance and released (Figure 3). The procedure time was 77 minutes and the fluoroscopy time was 24.3 minutes.\\nFollow-up and outcome of interventions: there were no procedural complications. Post-deployment TTE showed the device in a stable position with no residual shunt and no aortic valve regurgitation (Figure 4). Post-procedure electrocardiography showed normal sinus rhythm. The child was discharged 24 hours after the procedure in good health. Oral Aspirin 5mg/kg was prescribed for 6 months. By the third month following the procedure, activity had significantly improved, and she had gained 1.0 kg. She has been seen severally on follow-up; the last being two years post-intervention and has no complications.\\nPatient perspective: \"we are happy that our child can now live a normal life after this procedure\". The parents expressed profound gratitude to the entire health team and were grateful to have had the benefit of state-of-the-art cardiovascular care in the country.\\nInformed consent: written and informed signed consent to publish de-identified data of the child was obtained from both parents.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 45,\n",
       "    'case_id': 'PMC9282702_01',\n",
       "    'case_text': \"A 45-year-old male presented with asymptomatic penile growths of 8-month duration. He first noticed it as a small elevated keratotic growth post circumcision, which was done for preexisting phimosis 10 months back. The lesions had been gradually increasing in size and number. There was no history of preceding trauma or any systemic disease. He gave no history of exposure to the risk of sexually transmitted disease. Prior treatment included the use of topical antibiotic cream without any improvement in symptoms. Clinical examination showed multiple bark-like, hard, yellowish horny masses over the glans penis sparing the urethral meatus [Figure 1]. Lesions were confined to the glans penis, whereas examination of the penile shaft and scrotum was normal. Inguinal lymph nodes were not palpable. The patient's serology was negative for HIV, syphilis, and hepatitis B and C viruses. Routine laboratory investigations which comprised basic blood counts, levels of blood glucose, and tests for renal and liver function showed normal values. Based on these findings, excisional biopsy of the lesion was performed heeding toward a diagnosis of PKMB. Histopathology of the lesion revealed pseudoepitheliomatous hyperplasia with extensive hyperkeratosis, parakeratosis, acanthosis, individual cell keratinization, and atypical cells. Dermis showed dense lymphoplasmacytic inflammatory infiltrate [Figure 2a and b]. A final diagnosis of PKMB evolving to squamous cell carcinoma of the glans penis was made, and the lesions were surgically excised with wide margins.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 50,\n",
       "    'case_id': 'PMC7439188_01',\n",
       "    'case_text': \"A 50-year-old gentleman, resident of a slum area in the outskirts of New Delhi, presented to surgery emergency with complaints of diffuse abdominal pain for 5 days, obstipation for 2 days, and abdominal distension for 1 day. There was a history of recurrent episodes of loose stools mixed with mucous and blood associated with intermittent crampy lower abdominal pain for the past 7 days. The patient was a chronic alcoholic and a known case of diabetes mellitus. On examination, the patient was dehydrated, pulse rate was 120/min, and blood pressure was 90/60 mmHg, and was maintaining a saturation of 98% on room air. The abdomen was grossly distended and tenderness was present all over. Rectal examination done later revealed distended rectum and examining finger was tinged with blood and foul-smelling mucous.\\nThe patient was resuscitated with intravenous fluids following which he improved to BP 100/72 mm Hg, PR 102/min, RR 17/min, and urine output of 200 ml over 4 hours. After stabilization, the patient was shifted for chest and abdominal X-ray, which showed gas under the diaphragm (Figure 1). ABG analysis showed mild metabolic acidosis which got corrected with fluid resuscitation. Hemoglobin was 8.2 gm%, total leucocyte counts were 24000/mm3, blood urea was 72 mg/dl, and serum creatinine was 1.8 mg/dl. Serum electrolytes and coagulation profile were within the normal range. (Na 136 mEq/L, K 4.2 mEq/L, INR 1.2).\\nThe patient was started on ceftriaxone and metronidazole as per our institutional protocol and amikacin was added after one day when KFTs became normal. The patient was taken up for emergency laparotomy. Approximately 1000 ml of feculent pyoperitoneum was present. The caecum was found to be gangrenous and had sloughed off (Figure 2) and there were multiple perforations in the ascending colon and transverse colon. Initially, right hemicolectomy was done but the resected end of the transverse colon showed multiple sloughed off ulcers in the mucosa with transmural involvement. The proximal sigmoid colon was also found to be perforated into the retroperitoneum. There was no evidence of thrombosis of mesenteric vessels. In view of intraoperative findings, the procedure was converted into subtotal colectomy with proximal ileostomy and exteriorization of the distal end of the sigmoid colon.\\nGross examination of the resected colectomy specimen showed sloughed off caecum with multiple perforations in the ascending, transverse, and descending colon (Figure 3). On cut section examination, there were patchy segments of extensive transmural necrosis with multiple defects ranging from 0.5-2 cm throughout the large bowel (Figure 4). Histopathological examination of the specimen showed findings of multiple mucosal ulcerations with liquefactive necrosis with normal intervening mucosa, associated with full-thickness perforations and extensive diffuse transmural inflammation. The ulcers were typically flask-shaped, with a narrow neck and broad, undermined base. In the colon, there was no evidence of architectural distortion or any evidence of crypt destructive colitis or granulomas to support the presence of Crohn's disease. The colonic mucosal ulcers were covered with neutrophilic debris within which E. histolytica were identified (Figure 5). Pathogenic Entamoebae trophozoites were recognized by the presence of phagocytosed ingested intracellular red cells. Periodic acid-Schiff staining was positive (Figure 6). Amoebic serology was positive with high IgM antibody titers (2.24) <0.04.\\nThe patient had an uneventful recovery and was discharged on day 8 and was continued on oral metronidazole for 2 weeks and the luminal amoebicidal agent, diloxanide furoate, for 10 days. The patient underwent surgery for restoration of continuity of the bowel after 3 months and ileorectal anastomosis was done. The patient was healthy and symptom-free up to 2 months of follow-up in OPD.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 82,\n",
       "    'case_id': 'PMC5773468_01',\n",
       "    'case_text': '82 years old male, hypertensive, admitted for sudden onset of thoracic pain. A contrast-enhanced computed tomography (CT) showed an aneurysm of the ascending aorta complicated by type A IMH, an ulcer-like projection (ULP) and pericardial effusion (Fig. 1A, B). The patient was promptly addressed to surgery.\\nDuring HCA no intimal flap was evident, a fresh IMH placed 4 cm above the non-coronary sinus was evacuated and 2 cm transverse shaped intimal tear was identified (Fig. 1C). Hemiarch procedure associated with root replacement, using two-grafts techniques, was performed. The postoperative course was uneventfully and the patient was discharged home on 10th postoperative day (POD).',\n",
       "    'gender': 'Male'},\n",
       "   {'age': 78,\n",
       "    'case_id': 'PMC5773468_02',\n",
       "    'case_text': '78 years old female, hypertensive, referred to us with CT diagnosis of aneurysm of the ascending aorta complicated by type A IMH. The CT images showed the presence of an ULP in the ascending aorta 1 cm below the origin of brachiocephalic artery (Fig. 2A, B).\\nDuring HCA hematoma was evacuated, no intimal flap was detected and 1.5 cm linear shaped intimal tear was identified 1 cm below the origin of brachiocephalic artery (Fig. 2C). Hemiarch procedure associated to root replacement using two-grafts technique was performed; the postoperative course was uneventfully and the patient was discharged home on 13th POD.\\nThe two patients have been followed for the last three years, with a CT scan and an echocardiogram every six months for the first year, and every year in the next two years. No progression of the lesions were observed.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 43,\n",
       "    'case_id': 'PMC9328801_01',\n",
       "    'case_text': \"A 43-year-old Chinese man was admitted to the hospital because of acute abdominal pain. He had no history of trauma, was in good health, and had been an intermittent alcohol user for about 20 years. Physical examination revealed no palpable mass or tenderness in the right upper abdomen. Blood routine showed that Hemoglobin was 142g/L.Alanine aminotransferase(502.6/U/L)and aspartate aminotransferase(527.9/U/L)were significantly increased. Blood coagulation tests and tumor-marker levels were normal. Abdominal enhanced computed tomography (CT) showed a round, approximately8.0cmx8.0cm mass with a slightly blurred border in the right lobe of the liver, and blood around the liver. A tumor hemorrhage was suspected ( Figure 1 ) and as continued bleeding could not be ruled out, the patient underwent hepatic arteriographic embolization in the emergency department. Intraoperative angiographic findings the tumor was stained in irregular mass, with irregular outer border and widened perihepatic shadow. During the operation, lipiodol and gelatin sponge particles were used to embolize the responsible blood supply artery of the tumor. Re-imaging after embolization showed that the imaging of tumor supplying arteries was significantly reduced, the tumor staining range was significantly reduced, and the embolic agent was well deposited and the patient's condition improved after 2 weeks of conservative treatment. After preoperative and intraoperative evaluation, the patient underwent right hemihepatectomy. Intraoperative exploration revealed that most of the tumor was located in segment VII and VIII, and a small part was located in segment V, adjacent to the right hepatic artery. Tumor size is about 8.0cmx8.0cm cm with an incomplete capsule, the boundary was clear, and an old blood accumulation was seen around the liver. The resected tumor was round, with clear boundaries and contained a hematoma. Pathologic examination of hematoxylin-eosin-stained tissue showed hepatocyte proliferation and vasodilation, and no atypical hyperplasia ( Figures 2 ). Immunohistochemistry showed focally positive CK19 and CD34 cells consistent with capillary formation ( Figures 3 ). The pathological features resulted in a final diagnosis of FNH with spontaneous rupture and bleeding. The patient recovered uneventfully and remains asymptomatic for 2 years.  Figure 4 ,  5 ,  6\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 16,\n",
       "    'case_id': 'PMC3615933_01',\n",
       "    'case_text': \"A 16-year-old female patient visited to our general internal medicine department due to asthenia, tiredness and nausea. She had been vomiting for the past 2 weeks. The patient had a history of nephrolithiasis, with dryness of mouth and eyes, frequent parotitis attacks and arthralgias since childhood, and the patient had once gone to hospital for amenorrhea. Her family history was unremarkable. Physical examination revealed general state medium, conscious, cooperative and oriented. There were conjunctival hyperemia and dryness of tongue. The patient could only sit with support. Although there was no neurologic deficit presenting ancillary symptoms, the muscle force of the patient was 3/5 in extremes, her deep tendon reflexes were decreased, her plantar reflex was casual, and there was bi-lateral horizontal nystagmus; these were evaluated as quadruple paralysis. The patient's blood pressure was 90/60 mmHg and peak heart rate was 55/min. Other systematic examination results were unremarkable. Immediate examination results are shown in Table 1. In her EKG, sinus bradycardia was (ventricular speed: 52/min.), urine alkaline (Ph: 7) and density was 1005. Routine examination made after immediate treatment are shown in Table 2. In other examinations, creatinine clearance was 60.69 ml/hr; 24-hr urine protein was 148.5 mg/day; urine electrolyte level; K: 52.97 mmol/day (25-125), Na 147.20 mmol/day (40-220), phosphorous: 126 mg/day (400-300). Plasma cortisol level was 19.7 mug/dl (5-25); and free T3, free T4 and thyroid stimulant hormone levels were all within normal values. 25-OH vit D: 7.6 ng/mL (10-50) FANA 1/640 + were found. C3, C4 levels were rather low. Anti ENA SS-A: : >100 IU/ml (n<15), anti ENA SS-B: >100 IU/ml (n<15) values were high. Hepatitis markers were negative. In abdominal US, right kidney had normal localization, normal size, and left kidney had grade 3 pelvic ectasia. It was unremarkable except for an 8 mm radius calculus in the lower pole. In urological consultation, hydronephrosis was deemed to be present due to formerly expelled kidney stones. Schirmer test was made in case of a Sjogren syndrome, 5 mm in the right eye, 8 mm in the left eye was detected and in eye consultation, intensely dry eyes and chronic conjunctivitis were observed; thus, symptomatic treatment was suggested. In examination made due to suspected growth retardation, bone age was congruent with age 14. In the cytogenetic analysis result of the patient with primary amenorrhea, 46 XX karyotype was detected. The values were somatomedin-C: 423ng/ml (226-903 for age 16), LH: 1.91 mIU/ml, FSH: 5.17 mIU/ml, Estradiol: 46.89 pg/ml (6-27); and growth retardation was attributed to the chronic disease. Echocardiography: left ventricular systolic function was normal. Salivary gland biopsy: periductal mononuclear cellular infiltration and focal destruction were detected on 2 areas in minor salivary glands.\\nAs K 1.63 and quadruple paralysis were detected in the immediate examinations of the patient, her first response was made due to hypopotassemic periodic paralysis and parenteral alkaline treatment, and potassium replacement was carried out. There was no change in urinary PH following the ammonium chloride application. Upon taking the results of medical history record, physical and laboratory examinations, the patient was diagnosed to have primary SS and thus RTA and hypopotassemic periodic paralysis. In nephrology consultation of the patient, it was decided that a biopsy would not be performed, as the patient had hydronephrosis. Parenteral alkaline treatment and potassium replacement were applied, and muscle force returned to normal on the second day of the patient's admission. She was discharged following potassium replacement and 400 mg/day hydroxychloroquine therapy to be monitored by the polyclinic. Check-out laboratory values were Na: 143 mEq/L, K: 3.85 mEq/L, Cl: 109 mEq/L.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 22,\n",
       "    'case_id': 'PMC7481816_01',\n",
       "    'case_text': 'The patient was a 63-yesr-old Japanese man. He smoked 14 cigarettes a day from the age of 22-45, and alcohol daily. He complained of fatigue and weight loss, and had lost 5 kg in weight over the previous 2 months. His condition had gradually deteriorated over the 2 months. It had difficult for him to move as usual, but he had no obvious neurological disorder. On initial consultation he was suspected to have a serious underlying disease, and was referred to our hospital.',\n",
       "    'gender': 'Male'},\n",
       "   {'age': None,\n",
       "    'case_id': 'PMC7481816_02',\n",
       "    'case_text': 'He was admitted to the department of hematology in our hospital and he had severe pancytopenia was detected. He had no respiratory symptoms and his X-ray showed no abnormal shadows. He had mild fever and reported appetite loss. He weighed 60 kg, height was 175 cm tall, the patient looked pale, and did not have congestion or butterfly shaped erythema. Blood pressure was 92/59 mmHg, heart rate was 78/min, and temperature was 37.5  C. Physical examination showed no rales, no abnormal cardiac sound. There was no lymphadenopathy. He had no clubbing and no edema of his extremities.\\nBone marrow biopsy revealed non-caseating epithelioid granulomas in the bone marrow structure. Malignant tumor, tuberculosis and fungal infections were excluded by histological findings and mycobacterial examinations. High levels of angiotensin-converting enzyme (ACE) and lysozyme suggested sarcoidosis and he was transferred to our respiratory department. His medical history included cerebral infarction, aortic valve stenosis, internal carotid artery stenosis, overactive bladder, and hyperlipidemia. However, these had been well controlled with his receiving medication including lansoprazole (15 mg, daily), carvedilol (2.5 mg, daily), mirabegron (50 mg, daily), and cilostazol (100 mg, daily).\\nLaboratory finding showed pancytopenia, mild elevation of liver and biliary enzymes and renal dysfunction. Elevation of ACE, lysozyme, and soluble IL-2 receptor were suggestive of sarcoidosis (Table). Urinalysis revealed mild proteinuria, hematuria, and granular casts.\\nChest radiographs revealed no significant findings, including bilateral hilar lymphadenopathy. Even chest computer tomography (CT) did not show hilar and mediastinal lymphadenopathy, or other significant findings in the lungs and mediastinum. Abdominal CT showed hepatosplenomegaly and renal enlargement (Fig. 1, Fig. 2). Bone marrow biopsy revealed a large number of noncaseating epithelioid granulomas within the hematopoietic area (Fig. 3). Liver biopsy was performed because of hepatosplenomegaly and mild liver dysfunction, and showed non-necrotizing small epithelioid granulomas (Fig. 4). Histological examination of renal biopsy sample showed tubulointerstitial nephritis and focal crescentic glomerulonephritis (Fig. 5). There were no epithelioid cell granulomas in the renal tissue. Immunofluorescence studies were negative for IgG, IgA, IgM, C3, and C1q. Electron microscopy revealed no electron dense deposits.',\n",
       "    'gender': 'Male'},\n",
       "   {'age': None,\n",
       "    'case_id': 'PMC7481816_03',\n",
       "    'case_text': 'Based on these serial findings we made a diagnosis of sarcoidosis. The patient was started on prednisolone 20 mg daily (0.5 mg/body), after which an improvement in pancytopenia was noted. However, creatinine rose from 1.1 mg/dL to 1.76 mg/dL and hematuria worsened. Elevation of CRP and lysozyme were considered to indicate continued activity of sarcoidosis. We increased prednisolone to 50 mg daily, after which renal dysfunction and laboratory data including CRP and lysozyme were improved (Fig. 6).',\n",
       "    'gender': 'Unknown'}],\n",
       "  [{'age': 72,\n",
       "    'case_id': 'PMC4929381_01',\n",
       "    'case_text': \"A 72-year-old Japanese male with a previous history of cerebral infarction, arrhythmia, and cholecystectomy due to cholelithiasis presented with a 1-week history of general fatigue, pollakiuria, and thirst in December 2014. An intraductal papillary mucinous neoplasm in the pancreatic head was also found during the preoperative assessment for cholecystectomy. Because hyperglycemia (565 mg/dl) was detected, the patient was diagnosed with diabetes mellitus and insulin was immediately administered. As the patient's hyperglycemia improved, his general fatigue, pollakiuria, and thirst disappeared. At first, he did not complain of any abdominal symptoms, and a physical examination showed unremarkable results, but back pain thereafter slowly appeared. A urinalysis revealed glycosuria but not proteinuria. A blood test showed a marked elevation of the patient's hemoglobin A1c level (11.8%, range 4.6-6.2%) and slightly decreased levels of hemoglobin (12.6 g/dl, range 13.6-18.3 g/dl) and amylase (36 U/l, range 39-134 U/l), but normal liver and renal function. However, his cancer antigen 19-9 (381.6 U/ml, range 0.0-37.0 U/ml) and carcinoembryonic antigen (6.6 ng/ml, range 0.0-5.0 ng/ml) levels were elevated. Because pancreatic cancer was suspected based on the rapid progression of diabetes mellitus and high level of cancer antigen 19-9, a radiological examination was also performed. Computed tomography revealed a 4.6-cm solid mass in the pancreatic tail with ring enhancement and a 4.2-cm multilocular cystic mass in the pancreatic head (fig. 1). In addition, three liver metastatic masses and three abdominal lymph node metastases with ring enhancement, which were similar to the tumor in the pancreatic tail, were detected. Therefore, we suspected unresectable pancreatic cancer with multiple liver metastases that was concomitant with intraductal papillary mucinous neoplasm of the pancreas. To get a second opinion, the patient was discharged and visited another hospital. He eventually came back to our hospital 1 month after the first administration. The patient's back pain worsened and his cancer antigen 19-9 level increased (507.8 U/ml, range 0.0-37.0 U/ml) in comparison to his first presentation. We re-evaluated his disease using computed tomography, which revealed progression of the primary pancreatic cancer and increased numbers of liver and abdominal lymph node metastases. Notably, two solid masses were detected in the gastric wall of the upper body and the antrum. Both of them were separated from the primary pancreatic cancer and seemed to be located in the submucosal layer (fig. 2). Esophagogastroduodenoscopy revealed a submucosal tumor with normal mucosa in the posterior wall of the upper body of the stomach, suggesting the gastric hematogenous metastasis of pancreatic cancer (fig. 3). Pathological examinations, such as endoscopic ultrasound-guided fine needle aspiration or percutaneous liver biopsy, had not been performed because the patient declined additional examinations and due to the seemingly rapid progression of the disease. The patient was diagnosed with pancreatic cancer metastasis to the liver, lymph node and stomach based on the elevated level of cancer antigen 19-9 and on the computed tomography image findings.\\nChemotherapy using S-1 was immediately administered. After one course, we changed the S-1 to gemcitabine after computed tomography revealed disease progression. Chemotherapy was terminated after two courses due to the deterioration of the patient's condition. The patient died 5 months after the first presentation.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 83,\n",
       "    'case_id': 'PMC8222603_01',\n",
       "    'case_text': \"The patient was an 83-year-old woman. She had been receiving treatment for hypertension and constipation for more than 20 years. However, she had no other medical history, including psychiatric disorders. There was no family history of psychiatric disorders or neurodegenerative disorders. Following graduation from high school, she began working in a nightclub. She got married in her twenties and had a daughter. She divorced a few years later. Following her daughter gaining employment, she started living alone. She was on public income support during her visit to our clinic. She gradually felt a lack of motivation for outdoor activities at the age of 82 years. Simultaneously, she started facing difficulty with housework and complained of mild amnesia. A few months later, she informed her daughter about the delusional thought that the family doctor drew her blood to kill her. Despite the delusion of persecution, she continued visiting the clinic. Her daughter pointed out that her thought was delusional as it was impossible. Despite all evidence to the contrary, it remained unchanged. However, the delusion suddenly changed a month later, without any specific cause. She believed that her family doctor had fallen in love with her and proposed marriage to her. The delusional conviction seemingly strengthened with time. Moreover, she gradually made up her mind to accept the proposal. Considering the gradual progression of cognitive impairment and apathy, her daughter proposed living together. She refused her daughter's proposal and continued living alone because she was convinced that she would live with her family doctor in the near future. Her daughter recommended that she visit a memory clinic. Although she did not have any insight into her delusional beliefs, she was aware of her cognitive impairment. Therefore, she visited our memory clinic and was admitted to our hospital for examination and treatment at the age of 83 years.\\nOn her first visit to our hospital, we did not observe any apparent depressive or manic symptoms. Neurological examinations revealed mild bradykinesia, mild rigidity of the left upper and lower limbs, and chronic constipation. The results of her cognitive assessment were as follows: Mini-Mental State Examination score was 20/30, a Japanese version of the Alzheimer's Disease Assessment Scale-cognitive subscale score was 10/70, the index of subtests of the digit span of Wechsler Adult Intelligence Scale-III was 5, and Mayo Fluctuation Questionnaire score was 5 out of 8, which indicated mild recent memory impairment, attention deficit, and cognitive fluctuation (Table 1). We conducted the Neuropsychiatric Inventory 12 to assess her neuropsychiatric symptoms. She scored 20 points, involving the categories of delusion (12/12) and apathy (8/12) (Table 1). Blood test results, including vitamins, thyroid function, and infections, were all normal. Brain magnetic resonance imaging revealed mild diffuse cortical atrophy and mild bilateral hippocampal atrophy, compatible with her age (Figure 1). Perfusion single photon emission computed tomography revealed mild hypoperfusion in the bilateral parietal lobe. Myocardial accumulation of metaiodobenzylguanidine (123I-MIBG) was low (H/M = early: 1.72, delayed: 1.34) (Figure 2). The aforementioned results indicated a probable diagnosis of DLB.\\nFollowing the examinations, she was prescribed 3 mg of donepezil, the dose of which was gradually increased to 10 mg. She was simultaneously prescribed 25 mg of quetiapine (at night) for the treatment of delusions. However, we soon discontinued quetiapine because of its adverse reactions, such as drowsiness and dizziness. We also prescribed brexpiprazole (1 mg/day) and risperidone (0.5 mg/day). However, their side effects, such as drowsiness, were extremely severe, without any amelioration of her delusion. While she did not refuse the medications, she still had no insight to her delusion. Moreover, she occasionally claimed to visit her family doctor following her discharge. We then prescribed blonanserin (4 mg/day) and continued it, with extremely mild side effects. After 2 weeks, her attitude to the delusional beliefs began to change. She gradually lost passion for her family doctor. Based on our suggestions, she changed her family doctor and was discharged from our hospital. During follow-up, she rarely talked about the previous doctor, who had been the subject of her delusion. She still lives alone, and her delusion has not recurred. She is currently on donepezil (10 mg/day) and a small amount of an antipsychotic agent, with coordination of the circumstances (non-pharmacotherapy).\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 46,\n",
       "    'case_id': 'PMC6929939_01',\n",
       "    'case_text': 'A 46-year-old male patient was admitted to the hospital who presented with systemic repeated erythema with pruritus and local necrosis (Figure 1). Thirteen months ago, this patient was diagnosed as eczema or pemphigus in other hospital; the symptoms improved after corresponding treatment, but the erythema still occurred repeatedly. During the course of treatment, abdominal enhanced MRI was performed at outside hospital, which showed that a mass occupied the tail of pancreas with multiple metastases of liver. Subsequently, the patient went to our hospital for abdominal CT examination again, and similar imaging results were found (Figure 2). Therefore, the laparoscopic pancreaticocaudal resection + splenectomy + left hemihepatectomy + right liver tumor resection + cholecystectomy + portal vein repair were performed on April 1, 2019. Complete resection of the primary tumor and hepatic metastases was obtained. The results of immunohistochemistry in primary tumor showed that the expression of PCK, EMA (weak), CgA, Syn, CD56, Vim and glucagon was positive, and the positive rate of Ki-67 (MIB-1) was 5~10% (Figure 3). Tumor cells in multiple liver metastases were observed, and the highest positive rate of Ki67 (MIB-1) in the live lesions range from 25% to 30%. Postoperatively, the skin rash gradually improved. After 10 days, erythema appeared again, accompanied by pruritus and local necrosis. Results of blood sampling showed that serum glycosylated antibody 125 was increased with a value of 62.98 u/mL, as well as the fasting blood glucose was slightly increased again with a value of 6.51mmol/l. As such, we supplemented the immunohistochemistry test, and the result indicated that the expression of SSTR2 was positive. Abdominal enhanced CT and upper abdomen MRI showed multiple liver nodules (May 2019). Thus, the first cycle of chemotherapy was given on May 11, 2019 (capecitabine: 1000mg BID day 1-14 + temozolomide 200mg QD day 10-14, 4 weeks as a cycle; octreotide 40mg QD day 1, 4 weeks as a cycle). On the 27th day of treatment, the skin lesions on the face of the patient were disappeared, and pigmentation remained on the skin of the legs. Up to now, this patient has received this therapeutic regimen for 5 cycles. On October 10, 2019, the patient underwent transarterial embolization with local anesthesia. Follow up to October 31, 2019, no tumor progression was observed for this patient. Finally, the written informed consent has been provided by this patient, and the study was approved by the Institutional Review Board of West China Hospital.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 37,\n",
       "    'case_id': 'PMC3540647_01',\n",
       "    'case_text': 'On April 16, 2001, a 37-year-old driver was admitted to the Department of Cardiology from emergency service. He had a head-on care collision a week earlier without treatment, which caused him chest tightening, pain, breathlessness, and a transient unconsciousness. His vital sign was stable (pulse rate 80 beat/min, respiratory rate 20 times/min, blood pressure 140/70 mmHg) and no signs of visible injury were found. But a CT scan revealed a widening mediastinum and a massive left pleural effusion. He had undertaken medical treatment and monitoring.\\nOn the seventh day of admission, he complained a severe chest pain. Electrocardiogram showed a ventricular fibrillation. A defibrillation was successful, but the ST segment remained elevated on the lead V1-V5, with cardiac enzyme: CK3 974 U/L and CK-MB 469 U/L. Echocardiography showed no contraction of the anterior cardiac wall and ejection fraction (EF) 36%, indicating a myocardial infarction. Coronary angiography revealed a disruption of the proximal left anterior descending artery with a 95% stenosis. A PTA was unsuccessful.\\nTwenty days later, the patient was transferred to our department, and MRI revealed a spindle-shaped aneurysm at the aortic isthmus with an irregular inner contour. A rupture of interior wall was suspected (Figure 1(a)). On May 19, 2001, from right femoral approach, a 32 mm x 120 mm individualized indigenous endograft (stainless steel stent with silk membrane) was made and successfully deployed under fluoroscopic observation. Angiography showed a successful treatment (Figures 1(b) and 1(c)). The patient was discharged in a satisfactory condition seven days later, with EF improved to 47.9%. Follow-up MRI was obtained two years later (Figure 1(d)).\\nIn October 2010, the patient came back for checkup, informing that he had resumed working shortly after discharge, not as a driver, but as a security guard. He enjoyed such a good health that it took him only six minutes to run 1000 meters. Even though his echocardiography still showed no movement of the anterior cardiac wall, he was in good shape. A computed tomographic angiography (CTA) followup confirmed that the endograft was in the same position vis-a-vis the isthmus. Although the middle portion of the graft was slightly dilated, it was acceptable at this point (Figure 2). In July 2012, eleven years after endograft deployment, he remained healthy, with all functions normal.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 44,\n",
       "    'case_id': 'PMC9500339_01',\n",
       "    'case_text': 'A 44-year-old woman presented to our department with a history of slight abdominal pain for 4 months. She had a long history of living in an area with echinococcosis, and there was no significant familial medical history for this patient. The medical examination found a mass located in the middle right abdominal region with tenderness and unclear boundaries.\\nAfter admission, the laboratory tests indicated normal white blood cell (WBC) [4.74 x 109/L, (references 3.50-9.5 x 109/L)] and absolute eosinophil counts [0.45 x 109/L, (references 0.02-0.52 x 109/L)], the serum tumor markers were normal and a positive anti-echinococcus IgG antibody status. The contrast-enhanced CT scan showed a 12 x 12 cm \"egg-shelled\" mass located in the hepatorenal area (Figure 1A). This mass had a well-distributed calcified wall wrapping around the homogeneous content with point calcifications. The content showed mild enhancements during arterial phases (Figure 1B). The primary diagnosis was abdominal AE disease. This patient underwent laparotomy surgery for a mass resection. During surgery, we found a large calcified mass located near the upper right kidney arising from the right adrenal gland adjacent to the lower right hepatic lobes. The patient had the entire mass and the right adrenal gland resected. This patient recovered smoothly and was discharged uneventfully 20 days after the operation.\\nThe resected specimen had a calculated shell (Figure 1C), which wrapped around the homogeneous necrotic content with point calcifications (Figure 1D). The pathological examination revealed calcification of the surface, necrosis and sclerotization of the contents. The immunohistochemical examination revealed positive expressions of CD-34, CD-31 and D2-40 but no expression of CK. These findings supported a pathologic diagnosis of adrenal lymphangioma with hemorrhage and hematoma formation. There were no significant findings in the follow-up 6 years after surgery for this patient.',\n",
       "    'gender': 'Female'},\n",
       "   {'age': 55,\n",
       "    'case_id': 'PMC9500339_02',\n",
       "    'case_text': 'A 55-year-old woman was admitted with a history of an abdominal mass for over 10 years. The patient had unremarkable medical and family histories, and her physical examination was normal. After admission, the laboratory evaluations indicated normal WBC (7.25 x 109/L) and absolute eosinophil counts (0.32 x 109/L), and the other significant index were negative, except her serum anti-echinococcus IgG antibody was positive. The contrast-enhanced CT scan revealed a heterogeneous, solid mass measuring 10 x 9 x 8 cm in the right hepatic lobe (Figure 2A). The mass had a clearly calcified edge wrapping around the homogeneous content with multipoint calcifications and calcified separations (Figure 2B). Furthermore, three-dimensional CT reconstructed imaging revealed that the right hepatic vein and hepatic pedicle were involved from the dorsal to the ventral part but were not invaded into or encapsulated (Figures 2C,D). The primary diagnosis was hepatic CE (CE-5 type).\\nAfter an appropriate preoperative preparation, a laparoscopic exploration was performed, and the surgery revealed that the mass arose from the retroperitoneal tissue rather than the liver. There was an obvious calcification of this mass which was pressing against the right kidney and lower right hepatic lobes (Figure 3A), the edge of which was clear (Figure 3B). A laparoscopic retroperitoneal mass resection was successful, and the patient recovered smoothly and was discharged uneventfully 7 days after the operation.\\nIt was found that the resected mass had a calcified shell (Figure 3C), which wrapped around the bleeding necrotic content with point calcifications and calcified separations (Figure 3D). During a microscopic exam, we found fibroplasia and residual cell components that expressed neuroendocrine markers. The immunohistochemical examination revealed positive expressions of syn, HMB45, CD56, CD68 (weak) and CK (weak) but no expression of SALL4. The percent for Ki-67 was 2%. These findings supported a pathologic diagnosis of paraganglioma with necrosis and cystic changes.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 59,\n",
       "    'case_id': 'PMC8407642_01',\n",
       "    'case_text': 'A 59-year-old male was urgently transferred from a dental clinic to the maxillofacial service at the referral hospital. Four implants had been placed in the mandible under local anaesthesia plus sedation. During implant site preparation on the right side, lingual cortex perforation was noticed without apparent implication, allowing to accomplish the procedure. However, in some minutes, hematoma in the floor of the mouth appeared and progressed despite tamponade attempts.\\nThe patient showed general discomfort, sweat, hoarse voice and anxiety, and referred oral swelling, dysphagia and breathing difficulty.\\nIntraoral exploration revealed a prominent, but apparently stable 5 x 4 cm hematoma in the floor of the mouth, pushing the tongue against the pharynx and palate, causing subtotal oropharyngeal obstruction [Figure 1]. Right submandibular swelling was present.\\nThe diagnosis was based on clinical exploration and monitorization, which showed an oxygen saturation of 91% and a heart rate of 104 beats per minute with tachypnea rate of 26. The hemoglobin level was 15.7 g/dl.\\nThe patient was transferred to the intensive care unit, where percutaneous tracheostomy under local anaesthesia without intubation was performed. Given that hematoma growth had ceased, neither surgical approach for hemostasis nor drainage was made.\\nComputed tomography (CT) scan [Figure 2] showed diffuse density increase in the floor of the mouth, without any blood collection nor active bleeding.\\nAfter tracheostomy, oxygen saturation increased to 97% and the heart and breath rate normalized (80 bpm and 18 bpm, respectively).\\nHematoma volume decreased gradually during the following days and the tracheostomy tube was removed on the 3rd postoperative day. The patient was discharged a day later.\\nThe follow-up (1 year) was uneventful. The hematoma resolved during the second week, and the tracheostomy wound healed spontaneously. No implant removal was necessary [Figure 3].',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 68,\n",
       "    'case_id': 'PMC10310350_01',\n",
       "    'case_text': 'A 68-year-old man suffered from dyspnea and dysphagia after a skiing accident. The patient had no past medical history. Three days later, the patient visited our hospital and was admitted because of a Jefferson fracture and basilar impression revealed during the XP, CT, and MRI of the craniocervical junction (Fig. 1). After hospitalization, lower cranial nerve palsies involving the ninth, tenth, and twelfth cranial nerves were observed. The gap in the fractured anterior arch of the atlas was over 5 mm, and CT sagittal images showed a basilar impression. The tip of the odontoid process was located above the Chamberlain\\'s line (a line from the hard palate to the base of the skull). Furthermore, strong radiating pain occurred when swallowing from the pharynx to the larynx. The pain and the dysphagia made food intake extremely difficult. As bone fusion was expected to be unlikely by external fixation with a halo vest, a posterior fixation surgery was performed.\\nOn the eleventh day after the accident, occipitocervical posterior fixation was performed (day X). The O-C2 angle was kept approximately 5 degrees wider than the preoperative O-C2 angle to prevent postoperative dysphagia and dyspnea, and the basilar impression was slightly reduced. The surgery was uneventfully; however, pharyngeal palsy and airway obstruction occurred. Consequently, tracheostomy was performed using a single-lumen cuffed tracheostomy tube.\\nOn the X+2 day, bradyesthesia and bradykinesia of his epipharynx and hypopharynx were found with a nasopharyngeal fiberscope, and tube feeding with a nasogastric tube was initiated.\\nOn the X+8 day, SLP therapy was started for tracheostomy decannulation. The conditions for decannulation (Table 1) were assessed using the \"Multidisciplinary decision chart for evaluating readiness for decannulation used in the Rehabilitation Basel\") (Table 1-A), the \"Decannulation Protocol Checkpoint\") (Table 1-B), and the Mann Assessment of Swallowing Ability (MASA; the assessment measures twenty-four different areas to gage the swallowing ability, highest possible score being 200).) In our patient, pharyngeal and swallowing reflexes were absent. He had dysphagia, velopharyngeal incompetence, vocal fold palsy, and hypoglossal nerve palsy. The strength of the sternocleidomastoid and trapezius muscles was difficult to assess because of pain. The patient did not show any facial sensory disturbance. The patient\\'s MASA score was 94/200, indicating severe dysphagia.\\nOn the X+8 day, training was initiated to induce vocalization by injecting air from the side tube (the side tube is used for vocal practice and suction of deposits on the cuff) using a 50-cc syringe. On the X+10 day, the patient could utter vocal sounds using the training tube. He could clear the 1st, 2nd, 5th, 8th, and 9th SLP criteria, all of the Nurse criteria, and the 1st-to-3rd Physician criteria of the \"Multidisciplinary decision chart for evaluating readiness for decannulation used in the Rehabilitation Basel\"); hence, the decannulation protocol proceeded to training under cuff-deflation. Moreover, on the X+12 day, the swallowing reflex improved and the MASA score increased to 115/200. The tracheostomy tube was changed to a double-lumen, fenestrated cuffed tube, and the decannulation advanced to the step of tube occlusion with a one-way valve. On the X+14 day, the patient was able to extend his tongue to the upper lip, and pharyngeal reflex appeared. The patient was able to breathe using a one-way valve during the day. On the X+17 day, his cough reflex improved and the MASA\\'s score increased to 142/200; moreover, the patient could clear all the \"Multidisciplinary decision chart for evaluating readiness for decannulation used in the Rehabilitation Basel\") criteria with the deflated cuff; hence, tube occlusion training was initiated. On the X+21 day, the patient could clear all the criteria on the \"Multidisciplinary decision chart\") during tube occlusion intervals. The patient met the \"Decannulation Protocol Checkpoint\") and was cleared for decannulation. The patient\\'s MASA score increased to 160/200.\\nOn the X+23 day, the swallowing function gradually recovered, and the swallowing reflex to water became also reliably triggered. The nasogastric tube was removed and the patient could consume soft and bite-sized foods. The patient\\'s tongue deviated to the left, so we conducted the nonspeech oral motor exercise. On the X+36 day, the patient could easily chew food and was discharged home. SLP therapy was continued at our clinic. On the X+45 day, the patient could eat regularly, and the MASA score increased to 191/200, which meant that there was no dysphagia.\\nOn the X+46 day, the patient was able to speak clearly enough that a normal listener could easily understand. Moreover, the speech rate of text and the oral diadochokinesis) were normal. However, the patient complained that he could not speak as fast as before. The alternating repetitive movements of his tongue presented incoordination of movement, thus SLP therapy was continued. On the X+171 day, the patient was able to speak more clearly than on the X+46 day. However, the patient complained of his unrecovered speech rate and his leftward tongue deviation. Fig. 2 shows the progression of the patient\\'s speech rates, alternating repetitive movements, and oral diadochokinesis.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 48,\n",
       "    'case_id': 'PMC5317073_01',\n",
       "    'case_text': 'A 48-year-old female sustained a pathological fracture in the left femur. She underwent surgical fixation (intramedullary nailing) of the fracture and histopathology revealed only necrotic bone and inflammatory tissue. Nine months later, she developed pain in the right thigh which progressively increased in severity over time. She presented with a pathological fracture in the neck of the right femur. 99mTc-methylene diphosphonate bone scan showed increased osteoblastic activity in the right humerus, iliac bones, sacrum, shaft of the right femur, and the scan findings were consistent with the diagnosis of metastatic disease. Concurrently, serum electrophoresis revealed monoclonal gammopathy. With the diagnostic possibilities of metastases from unknown primary site and myeloma, 18F-FDG PET/CT scan was done. 18F-FDG PET/CT scan revealed moderate-to-intense abnormal FDG uptake in the bulky uterine cervix with intensely FDG avid osteolytic skeletal lesions [Figure 1]. The possibility of carcinoma cervix was considered; however, extensive skeletal metastases with no lymph nodal involvement being unusual encouraged us to entertain other diagnostic possibilities. Hence, a biopsy from the uterine cervix was done which revealed diffuse large B-cell lymphoma (DLBCL). Further, the patient underwent surgical fixation of the pathological fracture of the right femur, and histopathology from this fracture site again came as DLBCL. Thus, she was diagnosed as having extranodal lymphoma (DLBCL) with skeletal and uterine cervix involvement. She was then started on steroids and chemotherapy. Unusual pattern of involvement of uterine cervix and multiple osteolytic skeletal lesions in 18F-FDG PET/CT scan triggered us to search for other differential diagnoses and also helped in guiding the site of biopsy to reach a final diagnosis and initiate the appropriate treatment.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 17,\n",
       "    'case_id': 'PMC6800088_01',\n",
       "    'case_text': 'The clinical features in trisomy 9q were first reported by. Four large families with seven individuals from the same geographical region reported by had the same duplication of chromosome band 9q34 secondary to an inverted insertion of chromosome 9. Similarly, reported a girl with a 9q34 duplication derived from a balanced translocation in the mother. Ten years later, reported our patient during infancy with a de novo duplication of 9q34-qter and monosomy 12p13.33 secondary to an unbalanced translocation. More recently, a 17-year-old female with a duplication of the 9q33.3q34.1 region was described by.\\nOnly a few subjects are reported with the 9q34 duplication, although several anomalies were in common. These include dolichocephaly, an asymmetric narrow face, deep-set eyes, small and narrow palpebral fissures, prominent beaked nose, small mouth and abnormal dental findings, arachnodactyly and digital anomalies, broad-based gait, hypotonia, and developmental delay. However, cutaneous syndactyly, hyperflexibility, low birth weight, and normally positioned digits in our patient are not in common with those reported in the literature. Thus, the phenotype observed in our patient with a 9q34 duplication does correlate with those reported in the literature thereby representing the 9q34 trisomy syndrome.\\nHigh resolution molecular cytogenetic techniques now available, such as chromosome microarray hybridization, are useful to fully characterize chromosome rearrangements. This technology allows for a more precise description of size, location, and genes involved in a chromosome region helpful in further characterizing the genetic lesion for genotype-phenotype correlations, genetic counseling, and medical management. The authors encourage the reporting of additional subjects with this rare cytogenetic syndrome using new tools for genetic testing to more precisely identify the chromosome abnormality and breakpoints.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 58,\n",
       "    'case_id': 'PMC6174749_01',\n",
       "    'case_text': 'A 58-year-old male presented to the emergency department via private vehicle with multiple complaints. Complaints included \"chest discomfort\", low back pain, shortness of breath, generalized weakness throughout all extremities, and \"numbness\" of bilateral lower extremities. These symptoms began acutely at around 10 hours prior to arrival when he awoke from a dream. The patient stated during the dream that he was in an earthquake and his legs were trapped and crushed in the earthquake; when he awoke both of his lower extremities were numb and weak. He states that all of his symptoms are progressively getting worse and now he \"can\\'t move my legs.\"\\nThe patient\\'s past medical history is significant for chronic back pain, anxiety, bipolar disorder, schizophrenia, major depressive disorder, and an episode of previous \"paralysis.\" The patient states in 1997 that he had a lumbar fusion and while in rehab he \"became paralyzed and couldn\\'t move my legs or walk\" and that episode of weakness gradually improved and paralysis resolved without any medical intervention. The patient takes a total of 23 for his medical conditions that include zolpidem, methocarbamol, hydrocodone, carisoprodol, alprazolam, and gabapentin.\\nVital signs at time of presentation are benign and reveal a temperature of 99.20 F, HR 68, BP 156/84, and Sating 95% on RA. General exam reveals a nontoxic patient in no acute distress, with a disheveled appearance. Neurological exam reveals that patient is alert and orientated X 3, with a GCS of 15, CN 2-12 intact, and 5+ bilateral upper extremity strength, normal finger to nose movement. Decreased bilateral patellar DTRs and decreased bilateral lower extremity strength 4/5. Otherwise physical exam was within normal limits.\\nA CBC, CMP, CK, sed rate, UA, UDS, Troponin-I, D-dimer, EKG, noncontrast CT\\'s of head and C-spine, and CT of chest/abdomen/pelvis with IV contrast to evaluate aorta with spinal reconstruction were ordered. Pertinent labs results include normal Troponin and D-dimer, calcium 10, sed rate of 9, CK of 437, UDS positive for benzodiazepines and opiates (both of which are chronic medications prescribed to patient), and otherwise unremarkable labs and all imaging within normal limits.\\nThe patient was now reevaluated. We discussed how his evaluation is unremarkable and cannot explain his symptoms. He responds with \"Doc, it\\'s getting worse and now I can\\'t move my legs at all.\" A repeat neurological exam revealed decreased sensation and bilateral lower extremity strength now 0/5. Pinprick sensation not detected and elicited no movement, despite pinprick drawing blood.\\nAt this point, the evaluation had ruled out electrolyte abnormalities, acute myocardial infarction, pulmonary embolism, aortic dissection, acute CVA, spinal pathology, or tick paralysis as potential causes for the patient\\'s acute weakness. The differential diagnosis continued to include Multiple Sclerosis, Myasthenia Gravis, medication reaction, conversion disorder, and Guillain-Barre syndrome. In light of the patient\\'s psychiatric history, atypical complaints, disheveled appearance, medication list, and history of onset related to a dream in which his lower extremities were crushed, the overall clinical picture suggests a psychosomatic conversion disorder. However, this is a diagnosis of exclusion after CNS, peripheral nervous syndrome, infections, vascular, cardiopulmonary, and other potentially life threatening etiologies are excluded and therefore, the medical decision was made to proceed with lumbar puncture and CSF analysis, as well as MRI to fully rule out neurological pathology.\\nThe procedure was complicated secondary to patient\\'s history of lumbar fusion surgery from L4-S1 twenty years previously. Scar tissue at the L3-L4 spinal space made the procedure difficult and failed three times. Pt was informed of the difficulty and he states \"please Doc, try one more time.\" At the insistence of the patient, a fourth attempt at lumbar puncture was made and successfully returned CSF that revealed RBC 0, WBC 2, glucose 66, and protein 73.\\nFurthermore, an MRI was performed that revealed enhancement of bilateral nerve roots throughout entire thoracic and lumbar spine consistent with Acute Inflammatory Demyelinating Polyneuropathy (AIDP), a form of Guillain-Barre syndrome.\\nThe patient was admitted to ICU, underwent 5 rounds of plasmapheresis, physical, and occupational therapy, improved, and was able to ambulate out of the hospital less than 2 weeks later. He never required intubation.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 50,\n",
       "    'case_id': 'PMC9450605_01',\n",
       "    'case_text': 'A 50 year old male, street dweller, chronic alcoholic, demented, was admitted to the hospital with multiple cranio-facial injuries, among them he had an ethmoidal fracture, small laminar subdural hematoma, internal carotid thrombosis on the right side and a foreign body that could be seen in the right external acoustic meatus (Figure 1, Figure 2). After being discharged from observation in the neurology ward he was refferred to the ENT department, where the CT scan showed a foreign body that had penetrated through the external acoustic meatus, invaded the middle ear and went down the Eustachian tube. There was an injury in the carotid canal and thrombosis in the internal carotid artery (Figure 3, Figure 4, Figure 5, Figure 6, Figure 6a, Figure 7, Figure 7a), in its furcation, proven by arteriogram (Figure 8, Figure 9, Figure 9a). The patient refused a complete audiologic workup, and we noticed only a profound hearing loss on the right side. Internal medicine doctors examined him and aproved him for general anesthesia for foreign body removal. He was conscious and able to converse, however because of his dementia he did not make sense when he spoke.\\nUnder general anesthesia we noticed a foreign body that appeared to be a wood stick used to make barbecue. With a strong forceps we mobilized it in an attempt to remove it, and because of the carotid thrombosis it would be very unlikely to have profuse bleeding. The foreign body did not move. We did a retro-auricular approach with incision in the meatus skin. Since it filled the whole space, we did a mastoidectomy, through which we noticed incus dislocation towards the mastoid cavity. It was removed, together with the malleus. We did a canal wall down approach and in the mastoid cavity we noticed that the wood stick filled the entire middle ear and seemed to progress towards the Eustachian tube. We tried to remove it again, unsuccesfully. We decided to cut it with the burr and keep on using the burr all the way to the begining of the Eustachian Tube. We did not see the stapes. At this point we noticed that the stick penetrated the tube like a locking wedge used in ship building. With the burr we proceeded in cutting all the bone around but especially the wood stick itself which was cut from inside and then pushed inside the lumen made by the burr. There were no reference points, but we saw the carotid canal erosion. We progressed like this for about six centimeters, always drilling down on the stick itself and removing a little of the adjacent bone. Our attempts to remove it were unsuccesful. After this course we noticed the bone had ended and there was soft tissue ahead (cartilaginous portion of the tube). At this point the tip of the wood stick felt loosen and could be removed. Medially we observed a small central nervous system dehiscence. Under the surgical microscope we observed a larger space that would open inferiorly and that was later confirmed as being the nasopharynx after we used the nasal endoscope to look at it. The broad cavity left behind in the tube was filled with muscle and the surgical wound was similar to that left after a canal wall down mastoidectomy (Figure 10, Figure 11, Figure 12, Figure 13, Figure 14). We rebuilt the meatus and sutured the retroauricular incision.\\nIn a later CT scan we noticed na erosion of the inferior semicircular canal and of the carotid canal, and part of the central nervous system exposure.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 69,\n",
       "    'case_id': 'PMC2925208_01',\n",
       "    'case_text': 'A 69-year-old male with acute non-ST elevation myocardial infarction, underwent off-pump coronary artery bypass grafting, with left internal mammary artery to the left anterior descending coronary artery, and vein grafts to the obtuse marginal and right coronary arteries. Intraoperatively, Doppler flows in all grafts were excellent before and after protamine administration. On postoperative day 2, the patient suddenly developed an episode of ventricular fibrillation, followed by cardiac arrest. Resuscitative efforts were instituted immediately and included closed chest massage, multiple defibrillation attempts, and inotropic support. After twenty minutes of futile closed-chest massage, the sternotomy was reopened, and open cardiac massage was initiated and continued en-route to the operating room (close to thirty-five minutes of open-chest massage). After heparinization, the right atrium and the ascending aorta were cannulated, and cardiopulmonary bypass (CPB) was initiated. The graft to the obtuse marginal artery was found to be occluded. This graft was redone, and good diastolic flow was documented by Doppler flow analysis. Attempts at weaning from CPB were unsuccessful despite inotropic support and intra-aortic balloon pump counter-pulsation. Extra-corporeal membrane oxygenation (ECMO) was initiated using the pre-existing cannulae, with venous return from the right atrium and arterial inflow into the ascending aorta. The sternotomy was left open, and the patient was transported to the ICU, where he was successfully weaned from ECMO over the following twenty-four hours. Three days later, as cardiac function steadily improved and tissue edema subsided, the sternotomy was closed at the bedside. Ensuing multiple organ system failure (renal, respiratory, and sepsis) was treated with dialysis, mechanical ventilatory support, and appropriate antibiotics. Recurrent episodes of VF and low ejection fraction (20%) required subsequent placement of an automatic implantable defibrillator device. The patient was discharged home on postoperative day 32 and has remained well on follow-up.',\n",
       "    'gender': 'Male'},\n",
       "   {'age': 57,\n",
       "    'case_id': 'PMC2925208_02',\n",
       "    'case_text': 'A 57-year old male with past history of diabetes, hypertension, and coronary artery disease presented with ventricular tachycardia and fibrillatory arrest (VF). Following resuscitation by paramedics, he continued to have recurrent nonsustained episodes of VF. Emergency cardiac catheterization demonstrated critical left anterior descending artery lesion and greater than 50% left main coronary artery stenosis. Because of recurrent VF, an intra-aortic balloon pump was placed and salvage angioplasty was attempted. Three hours after the procedure, the patient suffered an episode of VF cardiac arrest, unresponsive to closed-chest massage and multiple defibrillation attempts. Closed-chest cardiac massage was continued en-route to the operating room for emergency salvage coronary revascularization (total closed-chest massage time was seventy minutes). After sternotomy, and while closed-chest massage was being performed, the patient was heparinized and CPB was initiated using right atrial outflow and aortic inflow cannulae. Coronary artery revascularization of the left anterior descending and obtuse marginal coronary arteries was performed using saphenous veins. Doppler examination confirmed good diastolic flows in both grafts. As the patient could not be weaned from CPB despite escalating inotropic support, ECMO was initiated using pre-existing cannulae. The sternotomy was left open, and the patient was transported to the ICU. Despite ensuing severe coagulopathy, cardiac function steadily improved over the next forty-eight hours, allowing for successful weaning from ECMO. The sternotomy was closed two days later at the bedside. The postoperative course was complicated by local and systemic infections, requiring six-week course of broad-spectrum antibiotics. He subsequently had an automatic implantable defibrillator device placed and was discharged home in satisfactory condition.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 40,\n",
       "    'case_id': 'PMC8128506_01',\n",
       "    'case_text': \"Facial transformation in a 40-year-old male-to-female transgender patient (Figure 2). The patient received 12 units of onabotulinumtoxinA at the crow's feet lines to lift her eyebrows, 12 units in the glabella, and 8 units in the chin. She also received the HA dermal filler VYC-20L for left temple hollow filling (1.5 cm3), malar and zygomatic augmentation (2 cm3), nonsurgical rhinoplasty to straighten the nose (0.5 cm3), and chin sculpting (1.5 cm3). The patient also underwent lip augmentation with 1 cm3 of HYC-24L. The outcome for this patient was a subtle feminization of her face. Midface volumization brought the cheek apex into a more superolateral position, creating a soft and feminine ogee curve, as well as a more oval shape to the face. Brow elevation gave her a slight arch to the lateral one-third of her eyebrow. Her nose became smoother, straighter, and more delicate via tip elevation and camouflage of the dorsal hump. Lastly, the lower face was feminized by lip augmentation, as well as tapering and narrowing of the chin.\",\n",
       "    'gender': 'Transgender'},\n",
       "   {'age': 25,\n",
       "    'case_id': 'PMC8128506_02',\n",
       "    'case_text': 'Full-face transition in a 25-year-old male-to-female transgender patient (Figure 3). This patient, who had been on estrogen therapy for over 2 years, received 4 units of onabotulinumtoxinA at each lateral end of her eyebrows to lift them and 25 units in each masseter to reduce the muscle bulk. She received VYC-20L at each temple (1 cm3) to correct for hollowing, in the forehead (1.2 cm3 total), at each alar base (0.3 cm3), in the malar and zygomatic region for augmentation (1.8 cm3 total), and in the chin (3 cm3). Lip augmentation was also carried out using 1 cm3 of VYC-15L. The outcome for this patient was convexity of the forehead with diminished supraorbital bossing and brow elevation with improved convexity to the brow. In the midface, the cheeks were more pronounced with an enhanced ogee curve, and the nose base was more feminine. Her jawline became more V shaped with a feminine chin. Her lips were more heart shaped, which fit in with a more feminine visage.',\n",
       "    'gender': 'Transgender'},\n",
       "   {'age': 42,\n",
       "    'case_id': 'PMC8128506_03',\n",
       "    'case_text': 'Masculinization of the jawline in a 42-year-old female-to-male transgender patient (Figure 4). This patient was at the beginning of the transition process and was eager to experience how female facial looks could be transformed into desired male features without surgery. During the first treatment, he received bilateral bolus injections of VYC-20L (0.5 cm3) to the posterior part of the gonial angle; injections were placed perpendicular to the mandibular bone. He also received bilateral injections of VYC-20L (0.25 cm3 per injection site); 1 injection point was in the prejowl sulcus on the mandibular bone, and the other injection point was at the tuberculum mentale. One month later, VYC-20L (1 cm3 per side) was administered along the mandibular body using a 25G cannula; the entrance point was posterior and inferior to the foramen mentale directed along the bony rim toward the masseter insertion.',\n",
       "    'gender': 'Transgender'},\n",
       "   {'age': 19,\n",
       "    'case_id': 'PMC8128506_04',\n",
       "    'case_text': 'Female-to-male jawline and chin enhancement in a 19-year-old patient (Figure 5). This patient had been receiving testosterone for 7 months before undergoing nonsurgical lower face enhancement. A total of 6.2 cm3 of VYC-25L was distributed between the lateral lower chin, chin apex, submental region, mandible body, ramus of the mandible, and mandible angle. A masculine and well-defined jawline with prominent mandible angle was achieved. From the frontal view, the chin appeared broader and more square, in line with a masculine visage.\\nFeminization of the eyebrow using onabotulinumtoxinA in a patient in his late 20s (Figure 6). The patient presented to the clinic for treatment of the upper face rhytides. He received 10 units of onabotulinumtoxinA in the frontalis muscle. The injection pattern avoided the inferior frontalis muscle fibers in the lateral one-third of the eyebrow resulting in lateral eyebrow elevation. Two weeks after treatment, the patient developed a feminized eyebrow shape.\\nFeminization of the lips using HYC-24L in a patient in his early 60s (Figure 7). The patient received 1 cm3 of HYC-24L in both the upper and lower lips to augment and shape his lips. Subtle augmentation was performed to highlight lip shape, especially the upper-lip Glogau-Klein points.',\n",
       "    'gender': 'Transgender'}],\n",
       "  [{'age': 53,\n",
       "    'case_id': 'PMC6317835_01',\n",
       "    'case_text': \"A 53-year-old woman with a history of neurofibromatosis, Hodgkin's lymphoma, and C3-T2 fusion 4 years prior for swan-neck cervical deformity was admitted for evaluation of left frontal skull mass and progressively worsening dysphagia of solid foods and thick liquids over 6 weeks. Computed tomography (CT) of the abdomen, pelvis, and lumbothoracic spine showed multiple hypodense liver lesions and diffuse sclerotic bone lesions within the thoracic and lumbar spine, ribs, sacrum, and ischium suspicious for metastatic malignancy. Fine-needle aspiration of the liver lesions yielded immunochemistry positive for focal CA 19-9 staining suggestive of adenocarcinoma of upper gastrointestinal (GI) origin. Serum CEA and CA 19-9 were within normal limits. Esophagogastroduodenoscopy did not reveal an upper GI tumor; however, a metal object was seen in the hypopharynx just above the upper esophageal sphincter (Figure 1). It appeared to be fixed and could not be moved with grasping forceps. The adult gastroscope could not be advanced beyond the object; however, the ultraslim could. A sagittal CT view of the neck with contrast showed the offset of the anterior cervical internal fusion plate with direct communication to the hypopharyngeal airway and suggesting erosion through the posterior hypopharyngeal soft tissue (Figure 2). Given the patient's multiple comorbidities and presumably metastatic cholangiocarcinoma, neurosurgery service recommended medical management rather than surgical management. A 6-week course of intravenous ertapenem was initiated due to the high risk of abscess formation. The patient underwent gastric tube placement for feeding and was eventually discharged under hospice care.\\nDysphagia is an underrecognized but significant complication of cervical fusion surgeries. The incidence of esophageal perforation after anterior cervical spine surgery is estimated to be between 0.02% and 1.49% with a mortality rate of 6%. Most esophageal erosions occur in the intraoperative or immediate postoperative setting, although there has been an increase in cases with delayed presentation, which often lead to dramatic clinical deterioration with a higher mortality risk of 20-50%. Most esophageal injuries are due to iatrogenic injury intraoperatively from inappropriate placement or dislodgement of retractors or hardware migration. Delayed injuries are typically due to chronic compression, abscess formation, repetitive friction of the plating system, or hardware dislodgement and chronic migration. Diagnosis can be made with cervical radiographs; however negative imaging does not rule out esophageal injury. Operative intervention is recommended, but conservative medical treatment is appropriate depending on the patient and the clinical circumstances.\\nAlthough cervical endplate erosion of the esophagus has been well documented in the literature, hypopharyngeal erosion has only been reported once previously. It is imperative that health care providers are vigilant and complete a thorough workup in patients with persistent or worsening dysphagia who have undergone a previous anterior cervical surgery.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 60,\n",
       "    'case_id': 'PMC9037883_01',\n",
       "    'case_text': 'A 60-year-old female presented with complaints of fever for 1 month. The pain was progressive and associated with an inability to walk. On examination, there was a large lump in the right lumbar region. She was menopausal for 12 years and had no significant gynecological history. Her routine blood investigation revealed anemia (Hb-7.6 g/dl), leukocytosis (15,400/uL), and raised serum LDH levels (1140 u/L). Ultrasound (USG) abdomen showed enlarged retroperitoneal LNs. Guided histopathology showed high-grade lymphoma. Immunohistochemistry was noncontributory due to large areas of necrosis and marked degenerative changes. A baseline FDG PET/CT was done [Figure 1]. She received three cycles of the R-CHOP regimen (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone). Her interim FDG PET/CT after three cycles of chemotherapies revealed a partial response to the treatment (not shown).',\n",
       "    'gender': 'Female'},\n",
       "   {'age': 11,\n",
       "    'case_id': 'PMC9037883_02',\n",
       "    'case_text': 'An 11-year-old girl presented with swelling on the left side of the neck for 6 months. She had no associated fever or weight loss. On examination, the patient had palpable, firm enlarged cervical LNs. She has not attained menarche. She had no significant gynecological complaints. Her biochemical investigations were unremarkable. CT suggested bilateral enlarged cervical LNs. Excision biopsy was suggestive of NHL (diffuse large B cell lymphoma). Her baseline FDG PET/CT revealed stage-IV disease [Figure 2].',\n",
       "    'gender': 'Female'},\n",
       "   {'age': 60,\n",
       "    'case_id': 'PMC9037883_03',\n",
       "    'case_text': 'A 60-year-old female presented with swelling on both sides of the neck for 3 months. It was associated with on and off fever and generalized weakness. On examination, she had multiple enlarged bilateral cervical LNs. Biopsy was suggestive of anaplastic large cell lymphoma. The patient was given three cycles of R-CHOP. However, no clinical response was noted. She was referred to our institute for further management. She had no gynecological complaints. LDH levels were significantly raised (825 u/L). The rest of the biochemical investigations were unremarkable. HPE was suggestive of diffuse large B cell lymphoma (anaplastic variant). On immunohistochemistry, tumor cells were positive for CD-20 and CD-3. FDG PET/CT was done for restaging [Figure 3]. The patient was lost to follow-up during the COVID-19 pandemic.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 58,\n",
       "    'case_id': 'PMC9463015_01',\n",
       "    'case_text': 'A 58-year-old patient presented molar and canine Class II relationships on both sides (Figure 1). Maxillary and mandibular interincisal midlines did not coincide. Clinical intraoral examination showed the maxillary arch quite aligned, with mild rotations of the left incisors. On the other hand, the mandibular arch presented a multibraided fixed retainer bonded to all six anterior teeth with the right canine root lingually torqued. The root was exposed, almost revealing the apex, and the element was not vital. Elements 3.2 and 3.3 resulted retroclined, withdiastemas between elements 3.1-3.2 and 3.2-3.3, a 90  rotation of 3.3. Calculus in the fifth sextant, multiple recessions, and restorations were present.\\nA cone-beam computed tomography (Orthophos SL 3D, Sirona, Bensheim, Germany) was performed, confirming the former periodontal findings (Figure 2(a)). The root of the right canine was not covered by cortical bone anymore (Figures 2(b) and 2(c)).\\nClinicians suggested different solutions to the patient. The first alternative involved the extraction of all lower incisors and the right canine, followed by the placement of dental implants with guided surgery and, finally, a prosthetic rehabilitation. However, this alternative would have not solved the rotation of element 3.3. The second alternative considered every other prosthetic solution without implant placement, but it would have led to treatment failure as extracting lower cuspids would have meant removing the anchor teeth or pillars for the prosthetic rehabilitation. These alternatives were too invasive and radical, in particular, the former alternative could have led to failures and peri-implantitis.\\nThe most conservative solution was fixed orthodontic treatment with multibracket appliance aiming at preserving the affected teeth. This option was the least invasive, but it could have been complex from a biomechanical point of view and challenging for the retrieval of the right canine, with poor prognosis. Consequently, after being informed of all risks and having signed an informed consent, the patient chose to undergo orthodontic treatment only for the lower arch.\\nThe primary objective was to correctly reposition the mandibular right canine, in order to avoid the placement of a dental implant or fixed dental bridge. As the patient requested a noninvasive treatment, it was decided to start fixed orthodontic treatment only on the lower arch.\\nAfter the removal of the fixed retainer, periodontal probing, supra and subgingival professional oral hygiene was performed. Periodontal probing and supragingival oral hygiene sessions were repeated if needed for calculus accumulations during all orthodontic treatment. A multibracket treatment was performed with the MTB technique. Brackets (3M Unitek, Monrovia, CA, USA) were bonded from elements 3.5 to 4.5, and molar bands with double tubes (3M Unitek) were cemented to elements 3.6 and 4.6. On the lingual side of molar bands, Wilson 3D lingual tubes (Rocky Mountain Orthodontics, Denver, USA) with vertical insertion were welded. In order to obtain additional torque on the right mandibular canine, a lower second premolar bracket (3M Unitek) was bonded. A 0.012-in NiTi archwire 3M (Figure 3) was ligated. A Wilson 3D sectional archwire (Rocky Mountain Orthodontics) was inserted on element 4.6 (Figures 4(a) and 4(b)) as an additional lingual/apical force became necessary to help the root apex return in the alveolar bone base. Its mesial extremity was placed on the most apical point of the root of the right canine, distant from lingual mucosa. The lingual sectional was removed after three months of treatment. Meanwhile, the following arch sequence was used: 0.014-in NiTi (Figure 5), 0.016-in NiTi, and a 0.019 x 0.025-in NiTi (3M Unitek). Light archwires were used for a long time in order to achieve a good alignment; considering the age of the patient, continuous and light forces were exerted to respect periodontal tissues. Subsequently, a 0.019 x 0.025-in TMA (3M Unitek) was used. Additional torque was progressively added on the right canine for the next three months. Treatment continued with the addition of radicular-vestibular torque on the IV quadrant and an elastic chain (3M Unitek) applied to close spaces.\\nThe multibracket treatment lasted a year and a half. The mandibular right canine was repositioned (Figure 6) and a periodontal examination showed probing pocket depth values of 3 mm. In addition, the general dentist decided to perform root canal treatment of the canine one year after the beginning of orthodontic treatment as the tooth was not vital and not symptomatic. Elements 3.2 and 3.3 were repositioned too, and spaces were closed (Figure 7).\\nA spring retainer was delivered to the patient (Figure 8). It consisted of an anterior stainless-steel wire with vestibular and lingual resin components. The latter extended to the molars to improve stability.\\nThe patient was visited after 1, 5, 12, and 18 months from the end of the orthodontic treatment. The stability of the results was observed after 18 months (Figure 9). The patient was satisfied by the result of the therapy but was aware that unwanted tooth movement could occur in the upper arch anyway as she excluded every kind of retention. The patient will continue to be under close observation through regular follow-up examinations.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 21,\n",
       "    'case_id': 'PMC5055922_01',\n",
       "    'case_text': 'A 21-year-old male was found to have a left hypochondrial mass on physical examination following a trivial soft tissue injury. Ultrasound scan revealed a large retroperitoneal mass in the pancreatic tail region with a mild splenomegaly. No other abnormality was noted in the ultrasound scan. Contrast-enhanced computed topography (CT) of the abdomen showed a 10.3 x 7.6 x 10.3 cm size heterogeneous mass with mild contrast enhancement arising from the body and the tail of the pancreas with no calcifications (Figure 1). Multiple vascular channels were seen around the lesion. Splenic vein was compressed and displaced by the mass with enlargement of the spleen. Mass effect had displaced the left kidney posteriorly. All other intra-abdominal viscera were normal. All haematological investigations were normal.\\nHe underwent laparoscopic resection of distal pancreatic tumour en bloc with spleen. Patient was operated on in right lateral position with head-up tilt using five ports.  Figure 2 shows the ports arrangement. Large tumour was noted originating from the body and tail of the pancreas with dilated veins surrounding the tumour. Patient also had a large spleen and an enlarged liver. Dissection was performed using ultrasound dissector and bipolar diathermy. Splenic artery divided between clips and splenic vein was ligated and clipped before dividing. Pancreas was divided just distal to the portal vein using bipolar diathermy and ultrasound dissector. The specimen (Figure 3) was delivered in a bag through a 7.5 cm incision.\\nPostoperative period was uneventful and he was discharged on 4th postoperative day.\\nHistology revealed a tumour predominantly composed of sheets of round to polygonal cells containing sharp cytoplasmic vacuolations and bland nuclei. The eosinophilic cytoplasm was seen as a rim in the periphery. Very occasional mitotic figures were present (Figure 4). The focal pseudopapillae formation was also evident with vascular cores lined by neoplastic cells (Figure 5). The stroma was highly vascular (Figure 6). There were thick fibrous septae and focal hyalinization in the stroma. Cystic and haemorrhagic foci were present. Cholesterol clefts surrounded by a giant cell reaction were also noted. Thin fibrous capsule was noted encircling the tumour (Figure 7). Multiple foci of partial capsular infiltration were also noted (Figure 8). However, the adjacent pancreatic tissue was not infiltrated by the tumour.\\nFinal diagnosis of a clear cell variant of solid pseudopapillary neoplasm with a steatotic pattern was made. Patient was referred to the oncologist for follow-up.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 45,\n",
       "    'case_id': 'PMC7132354_01',\n",
       "    'case_text': 'A 45-year-old male patient presented with persistent pain and effusion at the lateral aspect of his right knee. He underwent an uneventful ACL reconstruction ten years before, with total functional recovery and no instability or pain symptoms after full rehabilitation postoperative program. For ACL graft fixation, a bioabsorbable crosspin was used at the femur and a bioabsorbable interference screw was used at the tibia. The patient reported that he did not suffer any trauma, increased sports activity level, or other remarkable events in the weeks or months prior to the moment when pain and effusion started. The patient was first treated at another centre where femoral crosspin loosening was noted. After a magnetic resonance image (MRI) showed an intact ACL graft and no other complications, the patient underwent surgery for the removal of a femoral crosspin.\\nOne month after femoral crosspin removal surgery, effusion and pain persisted. Then, the patient was evaluated at our hospital for the first time. Physical exploration showed swelling at the lateral aspect of the lateral femoral condyle (Figure 1). A rounded, cyst-like mass with well-defined borders was evident at palpation. No local signs of infection were found. Lachman, pivot-shift, and anterior and posterior drawer tests were negative, with a full range of motion and no valgus or varus instability at physical exploration. Plain anteroposterior and lateral radiographs of the knee showed adequate tunnel position and no tunnel widening.\\nSuspected diagnosis was postsurgical seroma. Treatment included percutaneous drainage, nonsteroidal anti-inflammatory drugs (NSAIDs), and RICE (rest, ice, compression, and elevation). Samples from the drained seroma were sent for microbiological analysis and culture, with no bacterial ingrowth. Prophylactic antibiotic treatment was prescribed until a negative result of synovial fluid cultures was obtained. Initial evolution was satisfactory, with complete symptom release for 6 months. After this period, recurrent swelling at the lateral aspect of the knee reappeared and remained despite percutaneous drainage. A cyst-like rounded mass was palpable at the same location of previous episodes. Physical exploration was similar to our first evaluation; no local or systemic infection symptoms were found.\\nMRI showed a cyst formation at the lateral aspect of the knee, with fluid signal in the graft femoral tunnel and around the crosspin tunnel entrance at the lateral cortex of the lateral femoral condyle (Figure 2).\\nSurgical treatment in collaboration with plastic surgery was carried out. With the patient in supine position and under ischaemia of the leg, standard knee arthroscopy was carried out. Full knee arthroscopic exploration showed an intact ACL graft with no meniscal or articular cartilage lesions. No widening of the femoral or tibial ACL graft tunnels was noted, and neither was there any graft loosening. During arthroscopy, as a result of fluid inflow to the knee, the lateral cyst increased in size, making it more perceptible at the lateral aspect of the knee. This finding confirmed that a fistula was connecting the knee joint to the lateral condyle; as noted in the previous MRI, this fistula was the origin of the cyst. No signs of septic arthritis were found. After knee arthroscopy, the operation proceeded with open surgery through a lateral approach using the previous surgical scarf from the crosspin removal surgery. The lateral cortex of the lateral femoral condyle was exposed. The hole at the cortical bone of the lateral aspect of the lateral femoral condyle, caused by the drilling carried out to introduce the crosspin used for femoral ACL graft fixation, persisted (Figure 3) with rounded soft tissue burn. At the lateral aspect of the femoral condyle, a cyst-like cavity was found. Once opened, it was filled with synovial fluid and no capsule or synovial tissue surrounded the cyst; however, it has dissected a cavity between bone cortical and deep muscular fascia. No signs of local infection were present. At the lateral end of the femoral tunnel, where the tunnel from the removed crosspin persisted, a burned bone was also noted. The bone tunnel end was surrounded with devitalized bone with negative paprika sign and sclerotic edges; bone edges and surrounding soft tissues were darkened due to burning during drilling. Owing to a small tunnel width of 10 mm, arthroscopic exploration introducing an arthroscope through the tunnel was not possible. The cyst was excised, and burned bone was refreshed until a bleeding marrow bone bed was obtained.\\nThe bone tunnel was filled with autologous marrow bone graft before covering the cortical bone defect with local fascial flap. Postoperative course was uneventful and total recovery was achieved.\\nThree years after the femoral tunnel revision surgery, the patient remained with full functional recovery and without any clinical symptoms, effusion, or pain recurrence.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 33,\n",
       "    'case_id': 'PMC5574252_01',\n",
       "    'case_text': \"An otherwise healthy 33-year-old African American male with an 11-year history of progressive keratoconus underwent bilateral epithelium-on collagen crosslinking at an outside clinic. His pretreatment best corrected visual acuity was 20/30-1 OD and 20/30 OS. \\nPer review of the records, crosslinking was performed in both eyes using an epithelium-on protocol. Riboflavin was instilled every 5 minutes, as was proparacaine every 10 minutes, for 90 minutes until saturation of the corneal stroma was noted using a hand light. Fractionation was performed at 15 seconds on and 15 seconds off of UV light at a 3.0 inch distance with an energy of 3.0 mW/cm2 (measured by an energy meter). There were no reported complications. The corneal epithelium was intact after the procedure. A bandage contact lens (BCTL) was placed over both eyes and the patient was prescribed moxifloxacin 0.5% QID OU for 1 week, bromfenac 0.07% QID OU for 1 week, and prednisolone acetate 1% QID OU over 4 weeks that would be tapered slowly. \\nOn post-treatment day 4, the patient returned to the outside clinic complaining of severe pain OS starting the night before. There were new superficial corneal opacities, a hypopyon, and possible corneal perforation OS. A culture was performed, the BCTL was removed, bromfenac and prednisolone were discontinued OS and the patient was transferred to the Gavin Herbert Eye Institute (GHEI) for further care.\\nWhen the patient arrived at GHEI his vision was 20/70 OD and hand motion (HM) OS. The left eye exhibited diffuse conjunctival injection, a diffuse corneal infiltrate with gross ectasia and perforation along with a diffuse hypopyon. The right eye appeared to be unaffected. An emergent penetrating keratoplasty (PKP) and anterior chamber washout was recommended. The transplantation and washout were performed without complication and the patient was started on prednisolone acetate 1% and moxifloxacin 0.5% QID OS and ordered to continue prednisolone acetate 1% QID OD and moxifloxacin 0.5% QID OD per the referring doctor.\\nOn postoperative day one from the PKP OS, the patient complained about new pain, irritation, and decreased visual acuity OD as well. He was using all recommended medications as described above. His visual acuity was HM OD and 20/80 OS. The right eye conjunctiva was injected and its cornea had a new 5 mm central infiltrate with an equally sized epithelial defect, an apical bulge and new purulent discharge. All of these findings were felt to be consistent with impending perforation. The left was healing appropriately. There was no evidence of recurrent infection OS and his IOP measured 21 mmHg by Tonopen. Given that the patient had a new epithelial defect, infiltrate and impending corneal perforation, we recommended a penetrating keratoplasty OD. \\nOn postoperative day one PKP OD, postoperative day two PKP OS, cultures returned from the first PKP OS showing many colonies of pan-resistant methicillin resistant Staphylococcus aureus (MRSA). The patient was recommended to undergo directed topical fortified vancomycin every 2 hours, topical trimethoprim/polymyxin B ointment every 2 hours OU, topical prednisolone acetate 1% QID OU, aggressive lubrication with nonpreserved artificial tears along with oral doxycycline and ascorbate. \\nGiven the severity of the patient's course and no clear source for the MRSA, we recommended that the patient and his family be tested for MRSA, noting that his daughter had a tracheostomy. The patient later reported that he and his daughter wer positive for MRSA. He was given a course of trimethoprim/sulfamethoxazol (TMP/SMX) by his primary care physician.\\nBy post-PKP month 3, his CDVA was 20/20 OU with a rigid gas permeable CTL. Specular microscopy showed healthy appearing endothelial cells bilaterally.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 63,\n",
       "    'case_id': 'PMC9294239_01',\n",
       "    'case_text': \"A 63-year-old Japanese man presented to the referring hospital with a 1-month history of fever, back pain, and macroscopic hematuria. He had been undergoing hemodialysis for past 15 years for chronic kidney disease of unknown origin. Computed tomography (CT) showed a poorly enhanced tumor within the upper pole of the left kidney measuring 1.4 cm x 3.6 cm x 2.2 cm with multiple-lymph node involvement including para-aortic, retrocrural, and supraclavicular lymph nodes ( Figure 1 ). Metastasis to distant organ was not detected. A clinical diagnosis of RCC (cT3aN1M1) was made, and the patient was referred to our hospital for treatment.\\nAs the patient was symptomatic from the local disease and was already on hemodialysis, radical nephrectomy and para-aortic lymph node biopsy were performed. The pathological characteristics of this case has already been published. Histologically, the tumor consisted of rhabdoid cells, with notable lymphocyte infiltration and large areas of necrosis. Immunohistochemically, the tumor was negative for SMARCB1, and PD-L1 expression was observed in 20% of cells ( Supplementary Data 1 ). All sampled lymph nodes were positive for malignancy. Because the patient had no evidence of sickle cell trait or sickle cell disease, he was diagnosed as having RCCU-MP (pT3a, pN1).\\nOne month after nephrectomy, the baseline CT scan showed para-aortic lymph node measuring 40 mm x 30 mm, retrocrural lymph node measuring 27 mm x 19 mm, and left supraclavicular lymph node measuring 23 mm x 21 mm. We administered a combined immune checkpoint blockade therapy with nivolumab at a dose of 240 mg and ipilimumab at a dose of 1 mg/kg every 3 weeks as induction therapy for the management of residual lesions. After four cycles of induction therapy without grade 3 or 4 immune-related adverse events, follow-up CT revealed partial responses with a substantial decrease in the size of the affected lymph nodes ( Supplementary Data 2 ). The patient became afebrile, and his performance status evidently improved by the induction therapy. In addition, there was a significant reduction in serum C-reactive protein (CRP) levels.\\nTaking the results into consideration, we considered induction therapy to be effective, and the patient continued maintenance therapy with nivolumab at a dose of 240 mg every 2 weeks. After 15 months of maintenance nivolumab therapy without disease progression, the patient presented with left lower limb edema because of left common and external iliac lymphadenopathy. Palliative radiation therapy at a dose of 50 Gy relieved the patient's symptoms.\\nHowever, after 1 month, his blood test results showed abnormal liver function, and CT revealed obstructive jaundice requiring biliary drainage. We considered this situation as disease progression, discontinued nivolumab, and switched the therapy to chemotherapy consisting of carboplatin and paclitaxel. Chemotherapy was discontinued after two cycles due to declined performance status and side effects of myalgia. The patient received best supportive care and died 2 months later due to disease progression. The total time span between diagnosis and death was 28 months.\\nTo explore the longitudinal change in the profile of circulating T lymphocytes during ICI treatment, we performed mass cytometry and multicolor flow cytometry analysis of PBMCs isolated from the patient's blood samples, which were obtained at three different time points: beginning, end of induction therapy, and when the disease had progressed. This analysis was conducted according to the protocol described by Kagamu et al..\\nPBMC samples obtained before treatment and at the completion of induction therapy, when treatment response was evident, were subjected to mass cytometry. Mass cytometry data visualized using t-distributed stochastic neighbor embedding (t-SNE) technique revealed an apparent increase in stem cell memory and central memory CD8+ T cells expressing CD62L, CCR7, and CD27 ( Figure 2A ) . This finding was supported by multicolor flow cytometry analysis showing an increase in the proportion of central memory (CD45RA-CCR7+) and naive (CD45RA+CCR7+) CD8+ T cells after induction therapy, whereas the proportion of effector (CD45RA+CCR7-) and effector memory (CD45RA-CCR7-) CD8+ T cells decreased ( Supplementary Data 3A ). A similar increase in the stem-like population was also observed in CD4+ T cells ( Figure 2B ). Upon treatment resistance, the proportion of effector T cells increased significantly and the proportion of central memory and naive CD8+ T cells decreased ( Supplementary Data 3A ). Multicolor flow cytometry analysis also revealed that the population expressing exhaustion markers such as PD-1+, LAG-3+, and CTLA-4+ consistently increased upon treatment resistance across all CD8+ T cells and Th1 CD4+ cells ( Supplementary Data 3B ). In addition, the fraction of CD62LlowCD4+ T cells among total CD4+ T cells before treatment, a parameter previously reported to be associated with response to ICI in non-small cell lung cancer, was 39.6%, classifying the present case to the responder group.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 73,\n",
       "    'case_id': 'PMC2947750_01',\n",
       "    'case_text': 'Case 1 features the left eye of a 73 year old white woman with a DPED that did not progress to either CGA or NV-AMD during 8 years of follow-up. As seen in this example (Fig. 3), eyes containing DPEDs, even in the absence of progression, can demonstrate marked changes in the size and distribution of large drusen and DPEDs. Although the overall prevalence of large drusen and hyperpigmentary changes are maintained throughout the period of observation (Fig. 2A, B), the exact location and configuration of these features in this example are seen to vary dynamically over time.\\nCase 2 is an example of an eye with DPED that progressed to CGA during follow-up (Fig. 4). Progressive fundus changes in this example include an initial decrease and disappearance of the DPED, changes in the distribution of hyperpigmentary changes, and the emergence of patchy areas of hypopigmentation that subsequently progress and enlarge to form well-circumscribed areas of atrophy involving the center of the fovea.\\nCase 3 illustrates the progression of an eye with DPED to neovascular AMD with the acute emergence of retinal edema, subretinal lipid, and recurrent subretinal hemorrhage (Fig. 5).',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 38,\n",
       "    'case_id': 'PMC5846373_01',\n",
       "    'case_text': \"A 38-year-old female with morbid obesity and chronic hypertension presented in her fourth pregnancy at 36 weeks of gestation with a 1-week history of mild headache, nausea, epigastric and right upper quadrant pain, and dark urine. The pain started gradually but was constant and sharp in nature. Upon physical examination, she was jaundiced. The abdominal exam was remarkable for hepatomegaly and a gravid uterus. The neurological exam was normal. The patient denied use of any hepatotoxic medications. Her labs were completely normal about three weeks earlier. Initial laboratory workup showed a leucocyte count of 12.0 x 109/L (70% neutrophils), platelet count of 450 x 109/L, hemoglobin of 11.5 g/dL, total bilirubin of 6.4 mg/dl (direct fraction 5.0 mg/dL), aspartate aminotransferase (AST) of 83 U/L, alanine aminotransferase (ALT) of 87 U/L, alkaline phosphatase (ALP) of 319 U/l, glucose of 66 mg/dL, LDH of 679 U/L, uric acid of 4.2 mg/dL, and total serum bile acids of 71 mumol/L (ref. 0-19 mumol). Prothrombin time was 17 seconds with an international normalized ratio (INR) of 1.4. Viral hepatitis serology, autoimmune marker, and ceruloplasmin test results were unremarkable. The urine protein-to-creatinine ratio was elevated with 24 hours of collection for urine protein, 1300 mg/day; her 24-hour urine protein was 180 mg/day prior to pregnancy. Ultrasonography showed marked hepatomegaly (~27 cm), fatty infiltration of the liver, and a right hepatic hypoechoic 2.8 cm mass (Figure 1). Moreover, the liver exhibited heterogenous echotexture along with areas of nodular contour. Given the patients' clinical presentation, biochemical profile, and imaging findings, the obstetricians suspected AFLP. The patient underwent delivery by Cesarean section; however, bilirubin and liver enzyme levels gradually increased after delivery. Magnetic resonance imaging (MRI) of the liver was obtained three days after delivery for further evaluation of the mass and worsening liver function (Figure 2). MRI showed a heterogeneous T2 hyperintense mass involving the majority of the left hepatic lobe, measuring approximately 11.2 x 9.2 x 5.8 cm. There was an additional similar, smaller lesion within the right hepatic lobe, measuring approximately 2.8 x 2.1 cm. There were additional satellite lesions within the left hepatic lobe. There was mild, diffuse intrahepatic biliary dilation. Serum tumor markers were obtained and showed elevated cancer antigen 19-9 (CA19-9) of >10,000 U/ml, CEA of 160.5 ng/mL (normal up to 5.20), and alpha-fetoprotein (AFP) of 1,135 ng/mL. US guided biopsy tissue obtained from the smaller right hepatic mass showed adenocarcinoma with an immunohistochemical profile consistent with cholangiocarcinoma. A CT scan of the chest showed multiple bilateral pulmonary nodules suspicious for metastasis. Total bilirubin started to increase gradually, up to 14.0 mg/dL. The patient underwent placement of percutaneous biliary drains with subsequent improvement of her total bilirubin to 4.0 mg/dL. She was then started on palliative chemotherapy with gemcitabine; however, this was complicated by recurrent episodes of cholangitis with multidrug-resistant organisms. She also developed progressive disease and peritoneal carcinomatosis and was subsequently transitioned into hospice care. She died around six months after her original presentation.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 24,\n",
       "    'case_id': 'PMC3135060_01',\n",
       "    'case_text': \"An unmarried 24-year-old woman (gravida 4, para 4), who had not attended any antenatal care (ANC), presented to our hospital with a complaint of abdominal discomfort. In the patient's four previous births, the first and second children were delivered by full-term spontaneous deliveries at another hospital without ANC, and the third and fourth children were delivered at the patient's home without medical assistance. The mother and her children had not been diagnosed with syphilis. During the examination, the patient appeared healthy with a blood pressure of 118/81 mmHg, a pulse rate of 78 bpm, and a body temperature of 37.2 C. The gestational age was estimated by her last menstrual period to be approximately 31 weeks. Abdominal examination revealed a soft, nontender uterus. Ultrasound evaluation confirmed a single fetus in cephalic presentation with an estimated body weight of 1,500 g and no evidence of placental abruption. Vaginal examination showed the cervix to be 30% effaced and 2 cm dilated with an intact membrane. Laboratory findings revealed elevated white blood cell counts (11,670/muL) and C-reactive protein levels (1.63 mg/dL).\\nFHR monitoring at the initial evaluation showed several early decelerations and bradycardia to 50 bpm for a one-minute period prior to recovery to normal baseline in association with a painless uterine contraction. The patient was immediately placed in the lateral position followed by the administration of oxygen via a face mask and a rapid intravenous infusion of fluid. The baseline variability was within a normal range. Twenty-five minutes later, another prolonged bradycardia to 70 bpm for a 7-minute period prior to recovery to normal baseline occurred without a uterine contraction. A decision was made to deliver immediately by cesarean section. Tocolysis was not performed during the course of treatment. A female neonate covered with a thick meconium weighing 1,423 g with Apgar scores of 2 and 8 at 1 and 5 minutes was delivered. Umbilical arterial pH was 7.28. After resuscitation, the neonate was transferred to the neonatal intensive care unit. The neonate was assessed to be 31 weeks at birth using the Dubowitz score and was diagnosed with an intrauterine infection. Routine investigations were performed to determine the nature of the infection. \\nFollowing cesarean section, the mother was diagnosed with syphilis by a serological test. Congenital syphilis was confirmed by serology of the neonate: rapid plasma region 32x, Treponema pallidum hemagglutination 1280x, and a positive immunoglobulin fluorescent treponemal antibody-absorption test. Histopathological examination of the placenta, umbilical cord, and membranes revealed severe CAM and necrotizing funisitis; inflammatory cells could be seen on the surface of the cord and within Wharton jelly. Numerous T. pallidum were detected by IHC, which uses an antibody against T. pallidum (Figure 1). Both mother and neonate were treated with penicillin with good results. The neonate did not have any skin lesions or radiological bone changes and was discharged after 56 days with no evidence of sequela.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 79,\n",
       "    'case_id': 'PMC9285893_01',\n",
       "    'case_text': 'The musicians (two females and one male, aged between 67 and 79 years old) have been part of the MNHB for 5-7 years and were considered to be at intermediate levels on their main instruments. Additional demographic information appears on Table 2.\\nIt is important to mention that Conductor A, once the interviews were completed, joined the research team to contribute to the data analysis. While she was unaware (during the time she was conducting one of the virtual bands) that the transition from in-person rehearsals to virtual ones would become a specific focus for research within this context, her contribution to the analysis provided a valuable insider perspective and significantly enriched the credibility and trustworthiness of the analysis.\\nThe virtual bands\\' rehearsals were recorded and made available to ensemble members during the semester. Permission to record was asked at the beginning of each semester and participants who felt uncomfortable being recorded were suggested to keep their camera off. Unlike regular in-person rehearsals, the majority of the online band rehearsals were held in a sectional format, with musicians being split into their instrument families (woodwinds; Brass and percussion). Full band rehearsals were held three times during the semester:one at the beginning, one approximately in the middle, and one at the end of the term. Typical rehearsals usually started with announcements (if needed) or a question period, which was followed by a brief warm-up done with the full band. While most of the time all musicians had to be muted to adequately hear the conductor\\'s sound source, for warm-ups and slower chorale-like pieces, it was possible to have everyone unmute and play together. The ensemble was then separated into break-out rooms for sectionals or stayed together during full band rehearsals to work on pieces. Repertoire chosen for online music instruction were mostly flex band1 arrangements to allow more freedom regarding parts assignments. The rehearsal ended with a run-through of a piece (time permitting) or a question period. During rehearsals, musicians played along with either the conductor on keyboards or with recordings of the repertoire. Recordings were manipulated to be slower tempi using AudioTrimmer. Occasionally, musicians also received music theory and music history lessons during rehearsals. Both bands concluded their semesters with members individually recording themselves playing a selected piece to be put together for a \"virtual concert\" video (for more details on rehearsal structure, please refer to Supplementary Appendix 1).\\nSemi-structured interviews were conducted in French or English, based on the mother tongue of participants, and lasted approximately 45 min. All interviews occurred in July 2021, during summer break, after the end of all online activities. Interviews were transcribed in their original language. French quotes that were selected for analysis were translated to facilitate interpretation using DeepL, checked for clarity by a researcher fluent in French, and validated by the research team. Quotes that were selected to be included in the analysis were then sent back to each participant individually, to ensure that the written transcriptions were a representative depiction of his/her thoughts and experience.\\nThe format of the interview consisted of 13 open-ended questions (Supplementary Appendix 2) that addressed three themes: (1) intergenerational relationships, (2) digital literacy and access in later-life, and (3) online music-making in a pandemic context. The intent was to seek participants\\' perspectives in relation to these themes, with questions such as: \"You participated in a virtual ensemble that was intergenerational. Do you feel that this intergenerational context may have improved your learning experience? If so, how?\" (Theme 1); \"How can virtual music-making maximize equitable access in later-life to creative musical expression, engagement in learning, digital literacy and quality of life amongst older citizens?\" (Theme 2); or \"What implications has the shift to an online environment had for you as a musician (or teacher)? What new skills or resources have you had to develop, in response to opportunities or challenges raised by the pandemic?\" (Theme 3).\\nFollowing the guidelines set out by, p. 83-85), theoretical thematic analysis was undertaken, meaning that data analysis was based on the researchers\\' specific areas of interest and focused on specific aspects of the data rather than the entire dataset. Analysis was undertaken primarily at the \"semantic\" (or explicit) level, establishing patterns between extracts, and then attempting to understand their significance and establish their broader meanings in an iterative process. A research assistant, in charge of coding the data, was supervised by the main researcher through the first stage of analysis. Afterward, a second researcher checked the coding process and contributed to its improvement. Codes were reorganized as needed, based on a deductive approach. Participants\\' perceptions of transitioning from in-person rehearsals to online rehearsals was examined from two perspectives: those of the teachers (adult band conductors) and those of the students (older adult band members). Results were combined to facilitate interpretation when trends were observed.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 78,\n",
       "    'case_id': 'PMC3257067_01',\n",
       "    'case_text': \"A 78-year-old woman was admitted to the emergency department in January 2008 because of fever and vomiting. In the preceding three days, she had noted asthenia and had fallen at home three times. Her past history included Crohn's disease treated by sulfasalazine and a beta-Lactam allergy. She also had congestive heart failure due to valvular disease and hypertension. She had not received influenza vaccine. Physical examination on admission revealed a temperature of 39 C. Her pulse rate was 110 beats per minute and her blood pressure was 150/60 mmHg. She had dyspnea with orthopnea, and her respiratory rate was 30 per minute. On auscultation, there were wheezing, rhonchi, and crepitations at the bases of both lungs. The remainder of the physical examination was unremarkable except for severe functional decline. Laboratory studies showed a white cell count of 14.600 x 109/L (with 12.900 x 109/L neutrophils), a C-reactive protein level of 154 mg/L and a B-type natriuretic peptide of 770 ng/L. Arterial blood gases on room air were pH 7.34, pO2 67 mmHg, pCO2 37 mmHg, and O2 saturation of 90%. Blood and urine cultures were negative. A chest x-ray showed bilateral pulmonary infiltrates. It was concluded that the patient had congestive heart failure and acute febrile illness without localizing symptoms. Therapy was initiated with oxygen, diuretics, and intravenous erythromycin.\\nOver the two next days, the patient remained febrile (38.5 C) despite antibiotic treatment and had abdominal pain. She had no signs of severe sepsis or circulatory failure. She had a blood pressure of 150/70 mmHg, pulse rate of 88 beats per minute, respiratory rate of 22 per minute, and O2 saturation of 93% on room air. On chest examination, there were persistent rhonchi with cough which produced white sputum. The remainder of the examination was unremarkable. Her white count cell was 8.100 x 109/L (6.900 x 109/L neutrophils) and the C-reactive protein level was 275 mg/L. A chest x-ray showed right basal consolidation. Urinary antigen tests for Streptococcus pneumoniae and Legionella pneumophila serogroup 1 were negative. Abdominal echography was performed and was within normal limits. It was finally concluded that the patient had pneumonia with persistent fever despite antibiotics. Antibiotic cover was extended to include ofloxacin and the patient was admitted the following day to our acute geriatric ward. On admission, her temperature was 38 C and chest examination was the same as described earlier. Sputum for viral examination was collected because the patient had a productive cough, but bacteriologic examination was not performed due to antibiotics. A rapid detection test on sputum by direct fluorescent antibody assay was positive for influenza A in a few hours, with confirmation a few days later by culture. The patient's condition deteriorated on the same day and she succumbed to fatal respiratory distress syndrome.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 11,\n",
       "    'case_id': 'PMC9261228_01',\n",
       "    'case_text': 'An 11-year-old female patient presented to the pediatric department with complaints of nausea, vomiting, and right lumbar pain lasting for 1 week, without previous symptoms and no history of trauma.\\nOn physical examination, the following was noted: The weight was 82 kg and body mass index (BMI) of 27.0 kg/m2 (above 95th percentile on the CDC (Centers for Disease Control and Prevention) age- and sex-matched BMI growth charts), active striae and acanthosis on the inner thighs; Tanner pubertal stage 4+, with menarche starting 6 months prior the admission. The blood pressure was measured routinely and was within normal range.\\nThe initial laboratory hormonal analysis and tumor markers aimed to identify hormonal activity by the tumor or possible malignancy (Table 1). The results did not reveal any deviation from the normal values.\\nThe computer tomography images showed a well-defined capsulated retroperitoneal extrarenal oval lesion with heterogeneous cystic structure measuring 7.5 x 8.5 cm, native HU 5 to 95 without change after contrast enhancement (Fig. 1).\\nUltrasound guided fine-needle aspiration biopsy was performed and a pig-tail drainage was placed due to the cystic appearance of the formation and the lack of certain diagnosis from the non-invasive diagnostic test. Cytological examination revealed a monomorphic population of cells with loose-textured cytoplasm and central lymphocytic-like cores with small nucleoli around a multitude of erythrocytes. No signs of cellular and nuclear atypism were observed. The drain discharged 80 ml of hemorrhagic fluid in the first 24 h and after being inactive in the next 24 h it was removed. The diagnosis of benign endothelial cyst with spontaneous hemorrhage was suggested due to imaging data suggesting a cystic lesion, the hemorrhagic characteristics of the drained fluid and the cytology analysis. The patient was observed for two days and discharged with no complains, normal vital signs and no significant change in the blood cell count. The hormonal status was to be evaluated on follow-up.\\nTwo months later further increase in patients BMI to 30.2 kg/m2 was observed. Striae and inner thighs acanthosis remained. Additional hormonal laboratory tests ruled out adrenal pathology (Table 2). The elevated 24 h urine cortisol was related to obesity.\\nAbdominal ultrasound and magnetic resonance imaging (MRI) were performed and demonstrated decrease of the cyst dimensions to 52 x 50 mm (Fig. 2). The patient was scheduled for elective surgery, but due to the COVID-19 pandemics and cancellation of elective surgical procedures on national scale, the treatment was postponed.\\nThe patient underwent surgery 3 months after the initial hospitalization. Despite the initial plan to perform cystectomy, the intimate adhesion of the lesion to the adrenal gland and vena cava inferior necessitated en-bloc adrenalectomy to prevent spillage of the cyst content (Fig. 3). The specimen was extracted with an EndoBag.\\nNo postoperative adverse events and complications were registered and the patient was discharged on the fourth postoperative day.\\nThe gross pathological description was of a lesion with dimensions 50 x 42 x 43 mm. The tumor appeared black-brown with a shining surface due to its cellular pigmentation (Fig. 4).\\nThe pathomorphological description was of a tumor formation with fibrous capsule composed of drained Schwann-like cells with fasciculation, vesicular nuclei with relatively small nucleoli visualized, mitosis 6/10 high-power field (HPF), with varying amount of melanin pigment in single and groups of cells. Connective tissue stroma separated tumor cell aggregates with an abundance of psammoma bodies (calcium deposits) and foci of necrosis and hemorrhage in the tumor parenchyma. The adrenal gland was intact with no tumor infiltration (Fig. 5).\\nThe markers S100 protein, melan-A and melanosome clone HMB45 had high-intensity expression in the tumor. Individual cells expressed inhibin alpha, Chromogranin A and Ki 67 to about 10 to 15% (Fig. 6).\\nThe findings were conclusive of malignant psammomatous melanotic schwannoma. The main histological differential diagnosis is malignant melanoma, which shares common features such as melanin synthesis and positive staining for melanocytic markers.\\nThe patient was followed up on the 1st and 2nd month afterwards the surgery by MRI with no signs of local recurrence and postoperative complications.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 30,\n",
       "    'case_id': 'PMC8437380_01',\n",
       "    'case_text': \"A 30-year-old female presented to our hospital on December 4, 2017 due to a 4-month-old mass on her left breast. She did not complain of pain, dizziness, headache, or any other discomfort, and did not report any relevant family history. Physical examination revealed a palpable mass, 6x5 cm in size, at 3 o'clock on the left breast. No enlarged lymph nodes were palpable in the armpit. Ultrasound light scattering breast examination revealed a hypoechoic nodule, approximately 3.68x2.77 cm in size, in the outer quadrant of the left areola and an areola with indistinct borders. Multiple, enlarged, left axillary lymph nodes were also observed and the tumor was graded as 4C according to the breast imaging reporting and data system (BI-RADS). No obvious abnormalities were observed in the right breast. A needle biopsy of the mass in the left breast was performed on December 18, 2017 and pathological analysis revealed that it was an invasive carcinoma (non-special type III) (Figure 1) that was HER-2 2+, ER 10%, PR 5%, Ki-67 30%, and FISH test positive. Therefore, further whole body assessment was performed, and computed tomography (CT) scans of the chest and head (Figure 2A) revealed a mass with abnormal density or shadows in both breasts, with bilateral multiple enlarged axillary lymph nodes and circular low-density plaques with a diameter of about 3 cm in the right frontal lobe. Moreover, because head magnetic resonance imaging (MRI) (Figure 2B) showed that the right frontal lobe was abnormally enhanced and occupied, the possibility of metastasis was considered based on her medical history.Further, needle biopsy of the tumor on the right breast and pathological test results revealed the absence of cancerous tissue. Other related tests such as bone scan and abdominal CT did not reveal any remarkable results. Based on the above observations, she was diagnosed with HER-2 positive breast cancer (left) according to the eighth edition of the American Cancer Society (AJCC) standard diagnosis. Meanwhile, the cancer was staged as T3N2M1 stage IV. As the patient was young and had no history of childbirth, Goserelin (3.6 mg, subcutaneous injection) was immediately initiated with a 28-day cycle. She also underwent four cycles of AC (cyclophosphamide + pirarubicin) chemotherapy on January 6 and 28, and February 10 and 26, 2018. Next, she was administered three cycles of TH (trastuzumab + docetaxel) chemotherapy on March 14, April 7, and April 29, 2018, along with antiemetic, white blood cell elevators, and other comprehensive treatments. Chemotherapy progressed without complications, and after seven cycles of chemotherapy, the mass in the upper outer quadrant of the left breast was found to be significantly smaller than before (2 x 1 cm) upon physical examination. CT scans of the chest (Figure 2C) suggested that the axillary lymph nodes and abnormal mass in the left breast had reduced in size. The patient underwent a modified radical mastectomy for left breast cancer on May 15, 2018, in the breast surgery department of our hospital and evaluation of resected tissue (Figure 3) showed an invasive carcinoma (non-special type, grade III). Immunohistochemically, the tissue was typed as ER 20%, PR 10%, HER-2 (2+ -3+), and Ki-67 40%, and no FISH test performed. HP (Trastuzumab + Pertuzumab) regimen targeted therapy was given on May 24, 2018 and tamoxifen 20 mg, once a day, was prescribed as endocrine therapy from July 2018 onwards. Radiation therapy was initiated on July 28, 2018, and the sites were left chest wall, left upper and lower clavicle, and left axilla. PTV was set at DT5000cGy/25f with a dose separation of 200 cGy/session, five times a week. The patient complained of headaches, mostly located on the right side, with intermittent dull pain in October 2018, and MRI of the head showed no change in abnormal enhancement of the right frontal lobe. Therefore, she was transferred to the neurosurgery department of our hospital and an intracranial mass was resected on October 23, 2018. Postoperative analysis of the resected tissue (Figure 4) showed that the tumor cells were small sized, arranged tightly, and localized, with significant proliferation of small blood vessels. Immunohistochemically, the tissue was ckp (-), GFAP (3+), Ki-67 (<5%), p53 (-). Morphology and immunohistochemistry supported glial cell proliferation, consistent with a localized glioma (WHO Grade I). The patient was regularly followed-up after surgery and her condition remained stable during this period. Further, during follow-up consultation on May 6, 2020, she did not complain of dizziness or headache. However, a repeat head MRI showed (Figure 2D) that the right frontal lobe was abnormally enhanced and that it was slightly larger than before. Therefore, a frontal lobe tumor resection was performed again in the neurosurgery department on May 14, 2020. Postoperative examination of the tissue (Figure 5) showed that the tumor cells were extremely diverse, ie, they were oval, fusiform, or star-shaped, and both sparse or dense with some having less cytoplasm and others having more. Some tumor cells were atypical, a few had large and darkly stained nuclei with visible nucleoli and occasional mitotic structures, while others showed hypertrophy or an offset nucleus, or were rich in cytoplasm or interstitial blood vessels. However, no clear necrosis was seen. Immunohistochemically the resected tissue was S-100 (3+), sox10 (mildly +), Ki-67 (5%, local 5-10%), p53 (mildly +), CD34 (vascular endothelium +), ckp (-), GFAP (small part +), and NSE (-), and when combined with morphology, these findings supported a diagnosis of diffuse astrocytoma (WHO grade II). CT imaging of the chest and abdomen performed (Figure 2E) at follow-up on November 23, 2020 revealed expected postoperative changes in the left breast with no obvious abnormal masses or shadows. However, an abnormally enhanced shadow, approximately 20x20 mm in size, was observed on the liver (S6 segment). Given the patient's disease progression, liver metastasis was diagnosed and she underwent two cycles of chemotherapy with pyrotinib and capecitabine. Repeat chest and abdominal CT performed on January 13, 2021 showed abnormal enhancement and enlargement of the right lobe of the liver. Hence, two cycles of TPH (trastuzumab + docetaxel + cisplatin) chemotherapy were administered on January 22, 2021 and February 17, 2021. A whole abdomen enhanced CT on March 11, 2021, revealed (Figure 2F) that the abnormal enhancement of the lobe was about 35x26 mm in size and larger than that seen previously. A liver biopsy was performed and pathology reported (Figure 6) that the tissue was relatively fragmented with little liver tissue seen in some areas. The tumor tissue was composed of short spindle or oval cells arranged in diffuse sheets with abundant blood vessels and a small amount of chronic inflammatory cell infiltration. Immunohistochemically the tissue was ckp (-), Her-2 (-), vimentin (+), Ki-67 (15%), SMA (-), Desmin (-), CD34 (vascular +), CD31 (vascular +), Hepatocyte (-), GPC-3 (-), CK19 (-), HMB45 (+), Melan-A (+), GFAP (-), sox10 (-), S-100 (-), GATA- 3 (-), ER (-), PR (-), and CD117 (focal 1+); therefore, a vascular tumor was suspected and the patient was transferred to the General Surgery Department of our hospital, where she underwent laparoscopic resection of the liver lesions on March 24, 2021. No tumor tissue was seen at the resection margin of the liver and the patient recovered well after surgery. Postoperative pathological report (Figure 7) described the liver structure as destroyed with unclear tumor tissue boundaries and no capsules. Tumor cells were spindle shaped with visible pathological mitoses and the nucleus was fusiform or polygonal with an increase in both cell number and volume. The ratio of nucleoplasm was also greater with more megakaryocytes and strange nuclei that were arranged in strips or were diffuse. Additionally, infiltrating growth, bleeding, and small lamellar necrosis, tissue congestion, edema, and lymphocyte infiltration were visible. The tissue was immunohistochemically characterized as Desmin (-), H-caldesmon (-), D2-40 (-), NSE (-), inhibitor-alpha (-), Syn (-), ckp (-), EMA (-), CD31 (vascular +), CD34 (vascular +), fli-1 (vascular +), ERG (vascular +), Ki-67 (10%), p53 (-), S-100 (-), Melan-A (+), HMB45 (-), CD117 (-), Hepatocyte (liver cell +), and CD68 (histocyte +). Morphological and immunohistochemical results were consistent with a malignant perivascular epithelioid cell tumor (PEComa). After discharge from the hospital, goserelin once/28 days and letrozole 2.5 mg once/day were prescribed for treatment. The patient has been currently instructed to undergo chest and abdominal CT and head MRI every 3 months. At present, the patient's overall condition is good and she remains stable However, she refused to undergo genetic testing owing to economic reasons.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 2,\n",
       "    'case_id': 'PMC3687645_01',\n",
       "    'case_text': 'Allgrove syndrome, also known as triple A syndrome (OMIM #231550), is a rare autosomal recessive disorder characterized by the triad of adrenocorticotropic hormone (ACTH)-resistant adrenal insufficiency, achalasia and alacrima. It is caused by mutations of the AAAS gene, which is located on chromosome 12q13, encoding the WD-repeat protein ALADIN (alacrima-achalasia-adrenal insufficiency neurologic disorder). Herein, we present a case of a two-year-old girl with a genetically confirmed diagnosis of Allgrove syndrome resulting from a novel homozygous mutation of the AAAS gene.',\n",
       "    'gender': 'Female'},\n",
       "   {'age': 2,\n",
       "    'case_id': 'PMC3687645_02',\n",
       "    'case_text': 'The patient is a two-year-old Japanese girl born from consanguineous parents. She was born at term after an uncomplicated pregnancy. There was a consistent history of alacrima since birth. At the age of two years, she presented with generalized tonic-clonic seizure with hypoglycemia (<20 mg/dl) and IV glucose infusion was initiated. However, she had no history of gastrointestinal problems. On admission, hyperpigmentation was observed on her lips, tongue and skin. Her speech and motor development were slightly delayed. Laboratory examinations revealed markedly elevated plasma ACTH (1,160 pg/ml), low serum cortisol (<1.1 mug/dl), low serum dehydroepiandrosterone sulfate (DHEA-S) (<2 mug/dl), normal rennin activity (8.6 ng/ml), slightly low plasma aldosterone (21.4 pg/ml) and normal serum electrolyte levels (serum sodium 140 mmol/l, serum potassium 4.2 mmol/l, serum chloride 107 mmol/l). A rapid ACTH test revealed ACTH insensitivity (Table 1). Hydrocortisone replacement therapy was therefore started. Barium esophagography was unremarkable at this time. Although she had just two main features of ACTH-resistant adrenal insufficiency and alacrima, Allgrove syndrome was suspected. Institutional review board approval for AAAS gene analysis was obtained from the National Research Institute for Child Health and Development. Blood samples from the patient and her parents were collected after informed consent. Sequencing analysis of the AAAS gene was then performed, and a novel homozygous mutation was identified in our patient, involving the first base of the donor splice site of IVS7 (IVS7+1 G>A) (Fig. 1). Her parents were heterozygous for the same mutation. A few months after the diagnosis was established, she was noted to vomit intermittently up to several times a day. Considering her genetic diagnosis and symptom, we again performed esophagography and manometry on her. Measurement of esophageal pressures showed the pattern of achalasia.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 57,\n",
       "    'case_id': 'PMC8168796_01',\n",
       "    'case_text': 'This 57-year-old man was referred for a 2-month history of progressive development of imbalance, dizziness, and vomiting. On examination, he presented with wide-based gait, uncoordinated limb movements, and nystagmus on extreme gaze. Radiological investigations disclosed two bilateral hemispheric cerebellar lesions, suggestive of metastases [Figure 1]. On April 2020, he was then admitted to the C. Besta Neurological Institute (Milan, Italy), which was appointed as reference center for the treatment of neurooncological patients from other departments in Lombardy during the COVID-19 emergency period. In line with our triage protocol, the patient performed a nasopharyngeal swab for viral RNA of SARS-CoV-2 detection with reverse transcription-polymerase chain reaction (RT-PCR) by Allplex  2019-nCoV Assay (Seegene Inc., Seoul, Korea) for amplification of RdRP, N and E genes. The test was positive and SARS-CoV-2 infection was confirmed. The patient had a history of family exposure (the two daughters tested positive) and reported in the previous month only hyposmia and hypogeusia without rhinorrhea or nasal obstruction, which had resolved at the time of admission. Blood tests at admission revealed no significant abnormalities. A chest computed tomography (CT) reported a left pulmonary lesion suggestive of tumor in the absence of inflammatory changes [Figure 2]. According to our classification of urgency in category A+, meaning patients with intracranial tumors with mass effect or with progressive neurological deficit, without deterioration of consciousness, for which treatment is deferred for up to 10 days, two swabs were resampled after 7 days and both were still positive. Considering the neurological and radiological stability, it was established to perform three new swabs after a period of 7 days with negative results, leading the way to surgery. The two cerebellar lesions were then surgically removed with a pathological result of pulmonary adenocarcinoma metastases. In the early post-operative period, the patient manifested acute onset of psychotic symptoms with hyperactive delirium. He was admitted to the intensive care unit, and antipsychotic therapy was administered with quetiapine (up to 1 g/day); chlorpromazine and sedation with propofol and dexmedetomidine until control of the neuropsychiatric picture were obtained. Four days after surgery, the patient suddenly developed fever (up to 38.5 C) and acute respiratory failure. Another chest CT scan disclosed a radiological pattern of ground-glass opacities in the lower lobes bilaterally, suggesting a viral pneumonia [Figure 2]. Laboratory findings revealed an increased inflammatory response with higher white blood cell counts (15.94 x 109/L), higher neutrophil counts (14.54 x 109/L), lower lymphocyte counts (0.79 x 109/L), lower platelet count (66 x 109/L), increased D-dimer (1.77 mg/L), and C-reactive protein (229.8 mg/L) levels. Serological tests were performed using LIAISON  SARSCoV-2 S1/S2 IgG kit (Diasorin S.p.A, Saluggia, Italy), an indirect chemiluminescent immunoassay serology test for detecting IgG antibodies against S1/S2 antigens. An antibody level of 133 kAU/L was found (positive: >15.0 kAU/L). The RT-PCR on a nasopharyngeal swab was negative. Under the strong radiological and laboratory suspicion of pneumonia from COVID-19, a new RT-PCR was performed after 72 h which confirmed SARS-CoV-2 infection. Oxygen therapy with alternating cycles of high-flow nasal cannula and low-flow venturi mask was administered until full recovery.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 14,\n",
       "    'case_id': 'PMC7262964_01',\n",
       "    'case_text': 'We identified a Chinese family with HSAN (Figure 1A). The proband (II:1) was admitted to the Department of Orthopedics, Xiangya Hospital of Central South University, for an ulcer near the left ankle and diagnosed with HSAN. The proband was a 14-year-old boy with an identical twin brother (II:2). They were born at term via cesarean section. The height and weight of the proband were 145 cm (<3%) and 26.5 kg (<3%), respectively, without any growth hormone imbalances, and his brother was 150 cm (<3%) tall, and weighed 29.0 kg (<3%), suggesting that they had growth retardation (without hormonal abnormalities).\\nThe proband had severely impaired pain sensitivity (Table 1). He consistently could not perceive noxious thermal/gelid stimuli or innocuous warm stimuli, which had resulted in the ankle ulcer and necrosis of the astragalus (Figures 1B,C). A nerve conduction study revealed peripheral nerve damage in the extremities, especially of the sensory nerves (Supplementary Table 2). The proband had moderate scoliosis (with a Cobb angle of 33 ) without centrum malformation (Figure 1D). The younger brother also exhibited HSAN, but his condition was clearly milder. The brothers presented with arthrogryposes of the fingers, foot extroversion, knee recurvation deformities, and myasthenia; hence, they achieved independent ambulation at 3 years of age (Figures 1E,F). The proband had thin blue scleras and corneal ulcers and was subsequently diagnosed with a cataract (Figure 1G). He also displays urinary incontinence. Furthermore, the proband was diagnosed with vascular structure abnormalities via centesis at 18 months of age. Their parents (I:1 and I:2) were unaffected.\\nAfter filtering the common variants from the 1000 Genomes Project, YH, ExAC, dbSNP132, and ESP databases, 571 unique SNPs were detected in the proband. The variants were filtered against 18 genes known to be involved in HSAN (Supplementary Table 1), and a set of three variants in two genes were identified in the proband (Table 2). By analyzing the bioinformatic predictions, inheritance patterns, OMIM clinical phenotypes, and American College of Medical Genetics classification (Richards et al.,) of these three genes, we strongly suspected that variants in DST (c.3304G>A, p.V1102I and c.13796G>A, p.R4599H) were the causative genetic variants in these patients.\\nSanger sequencing showed that the DST variant (c.3304G>A, p.V1102I) in the identical twins was inherited from their mother and the other (c.13796G>A, p.R4599H) was inherited from their father (Figures 2A,B). This finding indicates that the compound heterozygosity co-segregated within the affected family members. Neither variant was identified in the 200 control cohorts previously studied by our group. The amino acid sequence alignment analysis suggested that these two variants were both located in a highly evolutionarily conserved site (Figures 2C,D).\\nBy sequencing the peripheral blood RNA from I:2, II:1, and II:2 and excluding immunity-related proteins, we detected the down-regulated expression of ANKRD22, ICAM1/3, and BIRC5 in the HSAN-VI patients, suggesting changes in cell adhesion and the cytoskeleton, which is in accordance with the expectation that DST variants can alter cytoskeletal filament networks (Figure 2E and Supplementary Figure 1). However, we did not observe any change in DST expression by RNAseq or qPCR (Figure 2E).',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 5,\n",
       "    'case_id': 'PMC6388523_01',\n",
       "    'case_text': \"A five-year-old Caucasian male was referred to us with a two-year history of blurry vision and headaches; he had previously been evaluated by two ophthalmologists who diagnosed LHON. Our initial exam was on 24 October 2016. On exam, BCVA with Cycloplegic refraction were OD = -0.75-0.25 x 120 = 20/100, and OS = -0.50-0.50 x 70 = 20/100. Stereopsis was 400 seconds of arc. No relative afferent pupillary defect was noted. Intraocular pressure was 16 mmHg in both eyes. Pachymetry were 520/520 in both eyes.\\nOn fundus exam, he had 3-4+ optic disc pallor with 0.75 cupping. Macular OCT showed extensive macular thinning with normal structure [Figure 1a]. Ganglion cell layer (GCL) OCT revealed nearly complete GCL loss including central loss OU [Figures 1b and c]. This GCL loss was responsible for macular thinning. Three-dimensional OCT of the optic disc showed optic atrophy and our Pattern 4 IIH, 75% specific for IICP [Figure 1d]. In Pattern 4 IIH, there remains a hint of temporal wings, secondary to cerebrospinal fluid in the temporal retina. The average nerve fiber layer (ANFL) were 66 microns OD and 54 microns OS. Using a technique we have previously described, we measured 400 microns of papilledema in the right eye and 560 microns in the left eye on OCT. Our routine optic neuropathy workup for adults was performed. Vitamin D level was low and treated while Vitamin B12 levels were normal (678). Tests for collagen vascular disease, parathyroid hormone and Lyme disease were negative. Genetic tests for mutations in the DNA of mitochondria that are associated with LHON, including MT-ND1, MT-ND4, MT-ND4L, and MT-ND6 genes, were sent to another laboratory. Interestingly, 85% of females and 50% of males with these mutated genes never show signs of LHON.\\nBrain MRI was considered normal by radiologist. However, in one axial cut, we interpreted more than 2 mm of CSF in the optic nerve near the globe [Figures 2a and c] and a small hygroma, which is very unusual at a young age and may be a sign of increased ICP [Figure 2b]. With a tentative diagnosis of PTC, the patient was referred to a neurologist for a spinal tap. The opening intracranial pressure in lateral decubitus position was 180 mm-H2O (normal range in children is up to 210 mm-H2O).\\nAlthough this pressure was not considered high in recent reference intervals, other clinical signs were compatible with IIH, and there was no risk in initiating treatment with acetazolamide (125 mg PO QID). Two months later, the boy's headaches were completely absent and his BCVA had improved to 20/30 in each eye. At a four-month follow up, BCVA was stable at 20/30 per eye and stereopsis had improved to 80 seconds of arc. Repeat OCT of the macula showed consistent thinning as before [Figure 3a]. OCT of GCL showed improvement in GCL with a central opening, explaining the improved visual acuity in both eyes [Figures 3b and c]. On optic nerve OCT, ANFL decreased to 40 microns OD and 44 microns OS [Figure 3d].\\nExactly one year later, VA and OCTs [Figure 4] were stable, despite some increase in ANFL from the original improvement seen after four months of treatment, and some non-significant thickening of macula and thus increased GCL. Stereopsis improved to 50 seconds of arc. The patient remained on 125 mg Diamox (acetazolamide) PO QID.\\nConflict of Interest Statement: The authors have no conflict of interest in this article.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 22,\n",
       "    'case_id': 'PMC7283137_01',\n",
       "    'case_text': 'A 22 year old, previously healthy female presented with dull pain and swelling of her left ankle for five years. Although initially she had relief with analgesics, subsequently did not respond and associated with swelling over the left ankle which affected her daily work and sleep. There were no pustules or sinuses with granules at this stage. She did not have fever, loss of appetite or loss of weight and denied of previous traumatic injury to the affected site.\\nBasic investigations, X ray, ESR and full blood count, were within normal range. Her symptoms did not improve with the initial management with analgesics and she was further evaluated radiologically with the clinical suspicion of malignancy of bone or soft tissue. The MRI findings of the left ankle showed multiple linear and rounded lesions in the left calcaneous. The lesions showed a contrast enhancing center with a hypointense rim. There was hypointense dot noted at the centre of the lesion in T2 weighted image giving rise to \"dot in circle sign\" (Fig. 1: MRI of the left ankle showing \"dot in circle sign\"). Cortical erosions noted in the superior, posterior and the lateral aspect of the calcaneous. There was no sinus tract to the skin. The rest of the tarsal bone and distal tibia and fibula were normal. All the above radiological features were suggestive for maduromycosis of the foot.\\nWith the radiological supportive evidence of maduromycosis, a punch biopsy of the skin was obtained and sent for mycological evaluation. Although both direct smear and culture were negative, she was started with oral itraconazole 200 mg twice daily and cotrimoxazole. It appeared to be responding and she was informed to continue the antimicrobials further. However, after about 4 months, she noted reappearing of throbbing pain and few pustular lesions over the affected area. These pustules subsequently ruptured and secreted clear fluid containing black dots. With the new clinical picture, a repeat biopsy was obtained for fungal studies. The direct smear of the biopsy with 10 % KOH revealed septate fungal filaments.\\nAfter 2 weeks, a scanty growth of filamentous fungi was seen in the Sabouraud Dextrose agar incubated in 26  C and 37  C. The obverse view of the colony was yellowish brown with wooly consistency. Reddish brown pigment was diffusing in to the medium. The lactophenol cotton blue mount of the growth revealed sterile dense melanized mycelia. No sporulation was noted. The slide culture also showed sterile mycelium. Based on above characteristics the diagnosis of M. mycetomatis was made.\\nOral itraconazole (200 mg twice daily) and terbinafine (250 mg daily) were started and continued for 7 months while monitoring liver functions. Her symptoms subsided gradually so that itraconazole dose was reduced up to 100 mg twice daily. After 16 months from the starting therapy, she was free from pain, swelling and discharging sinuses and she is being followed up at the clinic.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 16,\n",
       "    'case_id': 'PMC3938365_01',\n",
       "    'case_text': \"Case 1: 16-year-old male, with asymptomatic periumbilical lesions since his first years of life, progressing in number and size for the last 3 years. He presented right hypoacusia, tingling in hands and feet and burning plantar pain, which worsened with hot weather and physical activity.\\nAt the dermatological exam he presented erythematous-violaceous papules of keratotic surface, grouped on the upper limbs, paravertebral, paraumbilical, inguinal, scrotum and penile regions, right thigh and knees (Figure 1). In the ophthalmological investigation the diagnosis was cornea verticillata (Figure 2). He presented hearing deficit in the right ear at audiometry. In complementary exams, he showed high 24hours proteinuria (0.14; VR < 0.05); remaining exams were normal (blood count, renal function, microalbuminuria, ECG, spirometry and cranial magnetic resonance imaging-MRI). The deficiency of alpha-Gal activity was confirmed in the plasma (0.0 umol/h of protein; > 2.5) and leukocytes through paper filter (0.16 nmol / h / mg of protein; > 1.4). The biopy of umbilical lesion resulted compatible with angiokeratoma (Figure 3).\\n Case 2: an 11-year-old boy presented burning pains in the lower limbs, which worsened with hot weather, although less intensively than in his brother's case (Case 1). During examination angiokeratomas were noticed, limited to the periumbilical region. He presented cornea verticillata, while the audiometry and other laboratory, electrocardiographic and imaging exams were normal. Enzyme alpha- Gal A deficiency was observed in the plasma and leukocytes (plasma: 0.11 umol/h; leukocytes: 0.46 nmol/mg/h).\\n Case 3: a 39-year-old female, mother of patients 1 and 2, presented with mild acroparestesia and cornea verticillata, without skin lesions. Audiometry revealed diminished hearing in the right ear and slight loss in the left, discrete proteinuria (0.09) and microalbuminuria (20.93 VR < 20 ). Normal blood count, renal function, ESR, ECG and cranial MRI. Dosage of alpha-Gal A activity in the plasma was within normal range (3.02 umol/h).\\nGenotyping of the 3 patients revealed a similar mutation: Exon 7 Arg 342 Gln. In the two-year followup, patient 1 presented worsening of lower limb pains and microangiopathy was detected in cranial MRI. Patient 2 started presenting proteinuria and increase of angiokeratomas in size, number and distribution. The mother remained stable. The three patients still have not started enzyme replacement due to family decision of postponing the beginning of treatment.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 15,\n",
       "    'case_id': 'PMC6005296_01',\n",
       "    'case_text': 'A 15-year-old Argentinian Warmblood gelding was referred for treatment of a long-standing penile lesion affected by myiasis.\\nAt referral the main complaint was a florid, cauliflower-like ulcerated mass, measuring 10 cm in diameter that enclosed the glans penis together with penile urethra (Figure 1) with malodorous purulent and blood-stained discharge together with areas of necrosis. The mass was infested by muscae spp. larvae. Poor body condition score (BCS 4/9) and strangury were also present.\\nOnce penis prolapse was obtained by intravenous administration with acepromazine 30 mug/kg, palpation of the penis revealed a diffuse thickening of the penile shaft with multiple ulcerations involving the inner and outer laminae of the preputial fold. Due to the regional anatomical alterations related to the mass (phlegmon and oedema), inguinal lymph nodes were not palpable. For the same reason ultrasonographic examination of external genitalia and regional lymph nodes was not conclusive. Transrectal examination was unremarkable.\\nUrine analysis revealed the presence of leukocytes and nitrites, consistent with urinary tract inflammation. As the clinical condition of the horse and the primary lesion were severe, suggesting complete excision in any case, fine needle aspiration or excisional biopsies were not attempted; therefore surgical removal was combined with harvesting material for histopathological examination.\\nBased on clinical findings differential diagnoses were SCC of the penis and prepuce and/or habronemiasis. Due to the infiltrating pattern and the diffusion of the disorder and to the presence of multiple nonhealing lesions, leading, respectively, to difficulty at micturition and local infection, an en bloc resection of the penis and prepuce was decided; the eventuality of a penile retroversion or a permanent perineal urethrostomy was considered according to the intraoperatory findings and the degree of infiltration of the penis body. Systemic NSAIDS (flunixin meglumine, 1.1. mg/kg i.v. q24 h) and antibiotic (sulfadiazine-trimethoprim, 30 kg/kg p.o. q24 h) therapies were initiated before surgery.\\nSurgery was performed under general anaesthesia with isoflurane with the horse in dorsal recumbence. For the en bloc resection, a fusiform 40 cm long skin incision starting at the umbilicus was made along the midline. It extended caudally encircling the preputial orifice. Blunt dissection of subcutaneous tissue was performed around the penis until the abdominal fascia was reached and the body of the penis was released from its anatomic and vascular connections. Haemorrhage was controlled with electrocauterization and ligation of the major vessels (dorsal penis arteries and veins). The dissection plane was extended to both the external inguinal rings and the external pudendal arteries and vein were ligated. The superficial inguinal lymph nodes appeared enlarged and therefore were excised. At palpation the penile body was extensively thickened suggesting amputation as proximal as possible: so penile retroversion was excluded and perineal urethrostomy was performed. To this aim, a tourniquet was applied proximally to the shaft of the penis and an extensive resection was performed close to the ischiatic arch, dividing the suspensory ligament of penis. The proximal stump showed a normal macroscopic appearance and was sutured with double transfixing sutures (2 USP absorbable multifilament) placed through the penile body in a dorsoventral direction, to obtain adequate haemostasis. Once urethral lumen was clearly visible a urinary catheter was placed. The outer perimeter of the tunica albuginea was apposed in a simple interrupted pattern with a 2/0 USP monofilament absorbable suture.\\nFor permanent urethrostomy a 8 cm skin incision was created on the perineal raphe starting about 7-8 cm below the anus, ending at the level of the ischiatic arch. Blunt dissection of subcutis, penis retractor muscles, and bulbospongiosus muscles was achieved until the urethra was visualized. The penis retractor muscles were sutured to the subcutis in a simple continuous pattern, using a 0 USP monofilament absorbable material. Then the urethral wall was incised longitudinally for about 6 cm and the mucosa sutured to the skin in a simple interrupted pattern with a 2/0 USP monofilament nonabsorbable material.\\nThe subcutis of the abdominal wound was sutured with a 0 USP monofilament absorbable suture material in a simple continuous pattern and the skin was sutured with metallic staples. A multitubular drain was applied laterally to the midline to the abdominal wall suture at the scrotal region (Figure 2).\\nAfter recovery from anaesthesia the horse showed a moderate haemorrhage from the urethrostomy, which was particularly evident at the end of urination, leading after 48 h to a marked reduction of PCV (15%) and TP (4,5 g/dL). As the haemorrhage seemed to come from the corpus spongiosum penis and surgical haemostasis was not feasible, it was successfully managed by the administration of tranexamic acid (15 mg/kg i.v. q12 h) for 2 days. Oral support with vitamin B complex and folic and pantothenic acid was given for 10 days until PCV and TP reached, respectively, 30% and 6.8 g/dL.\\nStrangury but not pollakiuria was observed 3 days after surgery.\\nThree days after surgery, the horse showed a serosanguineous collection above the abdominal wound and a moderate purulent discharge from the skin incision that were managed with daily manual massage and local disinfection. Five days after surgery, the urinary catheter and the multitubular drain were removed without complications.\\nOn day 12 standing surgical revision of the urethrostomy was required to remove some necrotic urethral mucosa leading to a partial dehiscence of the wound.\\nHistopathology of the lesions confirmed the presumptive diagnosis of SCC of the penis and prepuce invading the subcutaneous tissue, not the albuginea. Lymphocytic and neutrophilic infiltration of the corpus cavernosum suggested chronic balanitis; moderate subcutaneous eosinophilic infiltration was also detected but no evidence of Habronema spp. infestation was found. The margins of the excised tissues were free of neoplastic cells, and the regional lymph nodes were inflamed but not affected by the neoplastic process.\\nAfter skin staples removal 14 days after surgery, the horse was discharged. Urination was unremarkable from the perineal stoma. No urine scalding or subcutaneous infiltration could be observed. PCV and TP values were back to preoperatory values.\\nA clinical follow-up performed 2 months after surgery revealed reduction of the urethrostomy to a diameter of about 1.5/2 cm. Anyhow urination was unaffected with a mare attitude and no urine scalding was detected.\\nA 3-year follow-up showed no recurrence of the neoplasm with normal urination. Urethrostomy did not show any further stricture as well as no urine scalding (Figure 3).',\n",
       "    'gender': 'Unknown'}],\n",
       "  [{'age': 39,\n",
       "    'case_id': 'PMC4397223_01',\n",
       "    'case_text': 'A 39-year-old female patient complained of one-day-lasting episodes of linear-shaped pain in her right hemicranium. In the past few months she had been suffering from paroxysms of severe pain lasting 5-10 seconds, starting in the posterior parietal area of the right hemicranium and rapidly moving with a lineal trajectory to the internal canthus of the ipsilateral eye. As a rule, once the pain reached the eye, lacrimation ensued. The frequency ranged from 1 to 3 paroxysms daily, in the symptomatic days (2-3/week). In between attacks, the patient felt a continuous, moderate pain, confined to the territory where the motion was perceived. The patient clearly delineated the painful lineal area in her head and could finely draw it, thus giving a definite impression of the localization of such an interictal pain.\\nWang Y et al. described headaches with pain episodes localized in a line-shaped area of one hemicranium. Topographically, this description parallels that of our patient. However, the patients of Wang Y et al. did not report moving paroxysms. More evidences are needed before we can decipher the nosologic position of linear headaches, but as far as Epicrania Fugax is concerned, its clinical features may rarely include a linear interictal pain that may even become the main complaint.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 15,\n",
       "    'case_id': 'PMC4253035_01',\n",
       "    'case_text': 'A 15-year-old female presented to an outpatient headache clinic with a 10-year history of intractable headache, which had become daily over the past 3 months and also awakened her in the middle of the night. She noted the pain was frontal and radiated to her neck. She had migrainous characteristics including photophobia, phonophobia, nausea, vomiting but denied visual changes, numbness, tingling weakness, or focal deficits. She complained of three migraine headaches a week while the other days she described a tension type headache, which consisted of pain only. She did complain of dizziness, which typically occurred upon standing.\\nHer daily habits included at least 8-9 h of sleep during the school week but she reported nighttime awakenings, daytime sleepiness, and sleeping more hours on the weekends. She drank occasional caffeine and ate three regular meals a day.\\nShe had a history of syncope, joint, and back pain over the past 2-3 years and had evaluations in cardiology and rheumatology. Rheumatology diagnosed her with hypermobility of her joints. Cardiology diagnosed her with vasovagal syncope and she was placed on a hyperhydration protocol. She had a history of a minute patent foramen ovale, which had undergone spontaneous closure per a recent echocardiogram. She had plain films of her cervical, thoracic, and lumbar spine, which were unremarkable. She also reported easy bruising and occasional bleeding of her gums with oral hygiene. Recent labwork, including a complete blood count (CBC/diff), was unremarkable.\\nThere was a strong family history of mental health disorders. The patient had previously been referred to a psychiatrist and was subsequently diagnosed with depression and anxiety but medication intervention had not yet been initiated.\\nThe patient had a history of developmental delay and she did not walk independently until 2 years of age. She is now developmentally appropriate and is an A/B/C student in the 8th grade.\\nOn general exam, she showed elasticity of her skin, joint laxity of her extremities but no atrophic scarring. Her neurological examination was unremarkable.\\nDue to a recent history of increased headache frequency and awakening in the middle of the night with headache, she underwent an magnetic resonance imaging (MRI) brain that was unremarkable. She also revealed a history of snoring, nighttime awakenings, and daytime sleepiness. A polysomnography was ordered and demonstrated mild obstructive sleep apnea.\\nShe had an appointment to see psychiatry and discuss medication intervention for her depression and anxiety. Often, treatment of underlying depression and anxiety can help alleviate headache, thus, it was agreed that medication intervention for headache be deferred and a trial of Mg was started.\\nGiven the above history, she was referred to Genetics and, based on history and examination, the diagnosis of mild classic EDS was confirmed. Recommendations included hydrotherapy to strengthen muscles, Vitamin C and maintenance of good hydration. Genetics also noted and discussed with parents that if surgical intervention were to be considered for her apnea, she would need to be closely monitored due to an increased risk for postoperative bleeding.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 13,\n",
       "    'case_id': 'PMC6077650_01',\n",
       "    'case_text': 'Our patient is a 19 yo G1P0 with an unplanned pregnancy, who was seen for the 1st time at 20+4 weeks, with syncope and right sided chest pain. Pulmonary embolism was confirmed on a spiral CT scan.\\nPrior to the current pregnancy, she had an extensive history of emergency room (ER) visits and pediatric intensive care unit admissions for recurrent cellulitis and septic shock secondary to lymphedema. She had been noncompliant with oral suppressive antibiotics. She had also developed toxic shock syndrome secondary to Group A streptococcal cellulitis and had multiple debridements with skin grafts as a result of necrotising fasciitis. Compounding her risk of infections was her picking behavior secondary to anxiety.\\nShe had required ECMO (extracorporeal membrane oxygenation) for severe biventricular dysfunction from presumed septic cardiomyopathy; peritoneal hemodialysis for acute renal failure and multiple episodes of mechanical ventilation and aggressive vasopressor inotropic support.\\nSeven months prior to her pregnancy diagnosis, she had a bladder rupture and peritonitis after self-insertion of a pen into her urethra, requiring laparotomy. Numerous large venous bleeders were encountered in the subcutaneous tissue related to her known KTW syndrome.\\nShe was also smoking about half to one pack of cigarettes and multiple joints of marijuana since the age of 13 years. Her overall social situation was tenuous with limited resources for food, housing, family support, and a borderline personality disorder.\\nAt the time of presentation, her resting heart rate was 110/min and increased to 160/min on standing. On examination, she had an extremely large port wine stain extending from the right flank to midthigh with superficial excoriations (Figure 1(a)). Bilateral significant lymphedema to the lower extremities was noted. The toes were enlarged to about 5 cm in width and were overlapping with each other (Figure 1(b)). Over her abdomen she had a midline laparotomy scar that had healed along with multiple other scars from the debridements (Figure 1(c)). Her gait was abnormal, secondary to the severe scoliosis.\\nShe was started on therapeutic enoxaparin, with the dose being adjusted on the basis of the antifactor Xa levels (goal of 0.5-1.0). Her syncope was attributed to the significant lymphedema and venous varicosities in the lower extremities, along with the consumption of very high-glucose containing fluids (juice and pop) resulting in osmotic diuresis. She also had an ECHO done which demonstrated low left ventricular function. Her compliance as an outpatient for taking heparin and antibiotics was poor. The decision was made, therefore, to keep her as an inpatient until delivery from about 24 weeks, which greatly improved her nutrition and compliance, as all medications were given under nursing supervision.\\nShe was seen by psychiatry and social work while in the hospital. She was counselled by prenatal genetics but declined testing for herself or on her newborn.\\nAn MRI of the abdomen and pelvis performed revealed marked hemihypertrophy of the subcutaneous soft tissues on the right side at the level of the lower abdomen (Figure 2(a)); pelvis and buttock and thigh region (Figure 2(b)), which contain innumerable venous vascular malformations and varicosities. No increase in vascularity was noted in perineal or uterine area. These changes were consistent with KTW syndrome.\\nThe MRI of the spine revealed marked levoconvex scoliosis with a marked leftward pelvic tilt. A developmentally narrow spinal canal was noted. Numerous venous channels were noted to cross at the potential epidural injection sites from L1 to L5. The thickness from the skin to the thecal space was 9.4 cm (Figure 2(c)). No intracranial or intraspinal vascular malformations were noted. Once the MRI was completed, anesthesiology was consulted. Their recommendation was for extreme caution for neuroaxial anesthesia and if to be given to be performed above the level of L1. Given the increased risk of disseminated intravascular coagulation (DIC), several units of blood were to be cross-matched with two large bore intravenous access. Consideration for the use of cell-saver and the availability of a Trauma Pak if bleeding was a concern was proposed.\\nSerial scans on the fetus demonstrated as decrease in growth and along with a persistent breech presentation. A decision was made for an elective caesarian section at 37+3 weeks, given the intrauterine growth restriction with abnormal Doppler in a breech presentation. A multidisciplinary discussion between general surgery, neonatology, anesthesia, internal medicine, and nursing was arranged.\\nEnoxaparin was discontinued 24 hours prior to the elected time of the C-section. Four units of packed red blood cells had been placed in the OR in the event that there was a need to transfuse the patient. General anesthesia under fiber optic visualization was administrated. A midline vertical incision was made. Extensive varicosities were then found in the subcutaneous tissues closer to the level of the pelvis, which were ligated. The incision was extended superiorly to be away from the varicosities. The uterus was found to be bicornuate, which explained the breech presentation of the fetus. The neonate was at the 10th %ile for growth. No obvious stigmata of KTW syndrome were noted at the time of birth.',\n",
       "    'gender': 'Female'},\n",
       "   {'age': None,\n",
       "    'case_id': 'PMC6077650_02',\n",
       "    'case_text': 'The patient had been counselled regarding the placement of a MIRENA IUD in the uterus at the end of the C-section for a reliable form of contraception. However, she declined contraception. She was discharged on Day# 3 with transition on to warfarin for six months. Unfortunately, given the limited compliance, she had another pulmonary embolism four months after delivery.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 67,\n",
       "    'case_id': 'PMC10174457_01',\n",
       "    'case_text': \"A 67-year-old woman with a history of rhinitis and coblation of the nasal turbinates presented to the emergency department for recurrent epistaxis and pain after a traumatic COVID-19 nasal swab test (see  Figure 1  for timeline).\\nOn fiberoptic nasopharyngoscopy, a dark polypoid lesion was visualized between the middle and inferior left turbinates. Biopsy was performed and final pathology reported a heavily pigmented malignant melanoma involving the nasal mucosa, positive for S100 protein. Maxillofacial CT scan without contrast showed an abnormal soft tissue density in the left nasal cavity extending into the proximal upper left maxillary sinus and obstructing the left ostiomeatal complex. On metastatic workup, PET/CT revealed an FDG-avid right middle lobe lung nodule. The patient underwent bronchoscopy with fine needle aspiration (FNA) of the nodule. Pathology reported typical carcinoid, a finding managed separately and irrelevant to this discussion. After negative metastatic workup, the patient underwent mapping biopsies and nasal/sinus endoscopic tumor debulking. During resection, the tumor was found to extend along the nasal floor from the inferior meatus to the level of the inferior nasal septum, with pigmented mucosal changes involving the lateral aspect of the nasal vestibule, the superior aspect of the nasal septum extending onto the skull base, and the area of attachment of the middle turbinate. Pathology of the fragmented resection specimen confirmed SNMM. PD-L1 immunohistochemistry returned as high expression, intensity 3+, and tumor proportion score (TPS) >= 50%. The consensus recommendation at the multidisciplinary tumor board was to initiate ImT (nivolumab) and RT, to be followed by ImT (nivolumab) alone. The patient received nivolumab monotherapy (480 mg on a q4 week schedule) with concurrent intensity modulated (IM) RT to a total dose of 60 Gy in 20 fractions targeting the left nasal cavity. The patient tolerated ImT/RT well and went on to receive three cycles of adjuvant nivolumab as scheduled. However, nasal endoscopy and interval MRI identified local disease progression. Anti-CTLA-4 (Ipilimumab) was added to the ImT regimen with a plan for four cycles. After Cycle 1, the patient developed elevated liver enzymes (AST 289 U/L, ALT 301 U/L, and alkaline phosphatase 156 U/L), attributed to ImT-induced autoimmune hepatitis. ImT was discontinued and the patient was treated with intravenous solumedrol 150 mg followed by an extended course of prednisone (total duration, 30 days). Interval PET/CT showed no evidence of metastatic disease and the patient was followed closely in the clinic with radiographic surveillance. A repeat maxillofacial CT showed an increase in the size of the nodular enhancing soft tissue mass in the left posterior nasal cavity, and CT abdomen with contrast revealed a new 3.3-cm hypoenhancing liver lesion in segment 5, consistent with metastasis. CT biopsy of the liver lesion confirmed metastatic malignant melanoma. PET/CT showed rapid progression of numerous metastatic lesions within liver segments 2, 5, and 8, with the segment 5 lesion growing from 3 to 10 cm over 2 months. PET/CT also identified new FDG-avid lesions in thoracic, lumbar, and sacral vertebrae (T9, T12, L3, and S1) highly suspicious for spinal metastases.\\nAfter progression through two courses of ImT, the patient was presented again at tumor board and recommended to restart ImT with Opdualag (dual anti-PD-1 nivolumab combined with anti-LAG-3 relatlimab), and was referred to radiation oncology for concurrent stereotactic ablative radiotherapy (SBRT) of the dominant hepatic lesion. The patient received the first cycle of Opdualag with a concomitant course of SBRT, delivering 50 Gy in five fractions to the segment 5 liver tumor. SBRT was performed on a hybrid magnetic resonance/linear accelerator (MR/Linac) platform using MR-guided online adaptive radiotherapy (MRgOART) ( Figure 2  ). \\nAfter the second cycle of Opdualag, the patient developed severe keratoconjunctivitis with corneal ulcerations. The patient had a history of ImT-induced hepatitis, and systemic therapy was discontinued out of concern for another severe ImT-related adverse event (irAE). Interval PET/CT 3 months after SBRT showed a CMR with no suspicious hypermetabolic activity within the surgical cavity and complete resolution of all FDG-avid lesions in the liver (including unirradiated ones) and axial spine where hypermetabolism had previously been identified ( Figure 3 ).\\nCT chest, abdomen, and pelvis 3 months after SBRT demonstrated a decrease in the size of all liver lesions, with the segment 5 lesion measuring 2 cm in maximum diameter down from 10 cm. Six months after SBRT, the patient's treatment response persisted despite discontinuation of all therapy for 4 months.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 50,\n",
       "    'case_id': 'PMC3884199_01',\n",
       "    'case_text': 'A 50-year-old woman was referred to our hospital for treatment of a duodenal tumor. She had a 13-year history of left nephrectomy for RCC. The histologic diagnosis was clear cell carcinoma of grade 2, pT2N0M0, and pStage II (according to the current TNM staging of the Union for International Cancer Control, 7th edition). The postoperative course was uneventful, and no adjuvant therapy was administered.\\nThree years after nephrectomy, the patient underwent external beam radiation therapy (a total of 46 Gy) for a solitary metastatic bone tumor in the seventh thoracic vertebra. A further 7 years later, a solitary metastatic tumor was detected in the tail of the pancreas, and resection of the pancreatic tail and spleen was performed. Since the histologic findings of the pancreatic tumor were similar to those of the kidney, metachronous metastasis of RCC to the tail of the pancreas was assumed. A further 3 years after resection of the pancreatic tail, severe anemia was detected during a regular examination. The patient mentioned the presence of persistent tarry stools for 3-4 weeks. Esophagogastroduodenoscopy (EGD) was performed and revealed a mass in the descending portion of the duodenum.\\nThe patient was admitted to our hospital and underwent detailed examinations. Her hemoglobin level was 7.5 g/dl. A subsequent EGD revealed an ulcerated polypoid mass in the descending portion of the duodenum; the mass was adjacent to the oral side, but did not involve the papilla of Vater (fig. 1a). Endoscopic ultrasonography showed the tumor to be partially invading the head of the pancreas (fig. 1b). Duodenography revealed a protruding lesion at the wall of the pancreatic side of the descending portion of the duodenum (fig. 1c). Abdominal enhanced computed tomography depicted a well-contrasted, hypervascular mass (fig. 1d). Magnifying endoscopy showed a diminished mucosal surface pattern of the gastrointestinal epithelium across the surface of the tumor (fig. 1e). Furthermore, combined with narrow-band imaging (NBI), it also showed a highly dense assembly of microvessels on the surface of the tumor that did not form a capillary network pattern (fig. 1f). A duodenal biopsy was performed, and the histopathologic diagnosis was inflammatory granulation with no malignancy. An additional duodenal biopsy for histologic confirmation was not performed to avoid uncontrollable duodenal bleeding from the biopsy site. Although partial resection of the pancreas had already been performed for a metastatic tumor of the pancreatic tail, the remnant pancreas was of rich volume (fig. 1d). There was no evidence of metastasis to the lung, liver, lymph nodes or other organs. Enterography showed no abnormal findings suggestive of metastasis to the small intestine. Fluorodeoxyglucose (FDG)-positron emission tomography showed specific FDG uptake in the duodenal tumor (standardized uptake value [SUVmax] 6.1). No abnormally enhanced lesions were identified in the body. The levels of both carcinoembryonic antigen and carbohydrate antigen 19-9 were within normal ranges. Resultantly, our diagnosis was metachronous, solitary duodenal metastasis derived from RCC, and we therefore performed a pancreaticoduodenectomy.\\nThere were no findings of malignant ascites, carcinomatosis, omental implants or distant metastases to other abdominal organs; we therefore subsequently performed a subtotal, stomach-preserving pancreaticoduodenectomy, choledochojejunostomy, pancreaticojejunostomy, and gastrojejunostomy with preservation of the left gastric artery and vein to maintain the supply and drainage blood flow to the stomach after splenectomy. The pancreas was dissected just above the portal vein. Regional lymph node dissection was minimized.\\nMacroscopic findings of the resected specimen indicated that the polypoid mass at the descending portion of the duodenum was ulcerative and friable (fig. 2a). Histologic findings revealed that the surface of the tumor was coated by granulation tissue consisting of inflammatory cells, fibrosis and edematous stroma (fig. 2b). Furthermore, the cancerous lesion comprised clear cells containing glycogen that were arranged in an alveolar pattern (fig. 2c). The tumor had invaded the duodenal muscle and partially invaded the pancreas at a depth of 2 mm. Although the tumor was located very close to the lower common bile duct and main pancreatic duct, histologic direct invasion was not observed in either duct. Immunohistology showed that the tumor cells were positive for vimentin and CD10 and negative for CK7 (fig. 2d-f). The histologic diagnosis was metastatic RCC.\\nThe patient experienced postoperative leakage from the gastrojejunostomy. After percutaneous drainage of the intra-abdominal abscess, she recovered and was discharged on postoperative day 59. One year after surgery, the patient maintained a good glucose tolerance and received only oral hypoglycemic agents and no insulin therapy. Furthermore, she had no evidence of re-bleeding or recurrence of RCC.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 29,\n",
       "    'case_id': 'PMC8282370_01',\n",
       "    'case_text': 'The neonate was born to a 29-year-old G2P1 + 0 who attended antenatal care 6 times, starting at 3 months. She had been screened for HIV, syphilis, hepatitis B, and urinalysis, and all were negative, with a blood group of A Rhesus D negative. She received tetanus toxoid, Fansidar for malaria prophylaxis, haematinics, and deworming. She reported that the pregnancy was uneventful.\\nAbout 36 hours after delivery, the neonate developed a high-grade fever, irritability, poor breastfeeding, and yellowing of eyes and skin. The neonate was managed with unknown oral medication before referral to Jinja Regional Referral Hospital for further management.\\nAt admission, the neonate was conscious, with an axillary temperature of 38.0 C, and jaundice (Kramer stage 2). There was no respiratory distress, no pallor, no dehydration, and no dysmorphic features noted. The systemic physical examination was unremarkable.\\nMalaria rapid diagnostic test (MRDT) for P. falciparum was positive; thin blood smear showed P. falciparum malaria species with 1.846*103 malaria-infected red blood cells.\\nComplete blood count was normal with Hb of 15.2 g/dl, white blood cells 11.79*103/ul, and platelet count 244*103/ul.\\nBlood group was A Rhesus D negative.\\nTotal serum bilirubin was 200.33 umol/l with direct bilirubin 7.48 umol/l.\\nThe rapid diagnostic test for P. falciparum was negative, and no haemoparasites were seen on the peripheral smear of maternal blood.\\nInvestigations done were as follows:\\nThe neonate was initiated on intravenous artesunate at admission, 12 hr and 24 hr later, then once a day for 5 days. Intravenous empiric antibiotics (cloxacillin and cefotaxime) for presumed neonatal sepsis were also administered. After 48 hours of antibiotics, C-reactive protein (CRP) was done and it was nonreactive, and the antibiotics were stopped. Blood culture and sensitivity was not performed for this patient. A peripheral blood smear done on day 5 of antimalarial treatment revealed no malaria parasites. The neonate was discharged after 5 days of artesunate with great improvement. We were not able to follow up the patient after discharge.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 22,\n",
       "    'case_id': 'PMC4664549_01',\n",
       "    'case_text': 'A 22-year-old white female patient reported the diagnosis of RP that she had 7 years before. Having gone through many examinations along this period, 1 year ago, it was diagnosed increased intraocular pressure (IOP) in the right eye (OD). The patient had misused hypotensive eye drops: prostaglandin analogs, carbonic anhydrase inhibitors, and B-adrenergic antagonists. She had interrupted the use of eye drops for 3 months. There was no family history of either RP or glaucoma. No ethical approval was required for this procedure. Patient consent was obtained before undergoing treatment.\\nIn the ophthalmic examination, the best-corrected visual acuity was OD: 20/50 (-1,00 cyl x115) and left eye (OS): 20/25 (+2,00 sph -1,00 cyl x10). The slit lamp examination showed multiple iris holes and corectopia in OD (Figures 1 and 2), clear cornea in both eyes (OU), and no alterations in OS. IOP by Goldmann applanation tonometry was OD: 34 mmHg and OS: 16 mmHg at 3 pm. The gonioscopy revealed 360  isolated peripheral anterior synechiae in OD (Figure 3) and a visible open-angle up to ciliary body in OS. The fundoscopy (Figures 4 and 5) presented cup-disc ratio 0.9 vertical (V) x0.9 horizontal (H), visible lamina cribrosa pores, preserved macula, and peripheral pigment mobilization in OD. In OS, the fundoscopy revealed cup-disc ratio 0.3 V x0.3 H, preserved macula, and peripheral pigment mobilization. The automated perimetry (Figures 6 and 7) and manual perimetry (Figures 8 and 9) showed central island vision in OD and ring scotoma in OS. The ultrasound pachymetry was 524 microm and 530 microm in OD and OS, respectively. The specular microscopy revealed pleomorphism and polymegathism in OU (Figures 10 and 11). Fluorescein angiography featured blocked fluorescence in the peripheral pigment mobilization areas in OU.\\nAfter failure of the clinical treatment to diminish IOP in OD, trabeculectomy was performed in this eye and IOP was controlled.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 80,\n",
       "    'case_id': 'PMC9608240_01',\n",
       "    'case_text': 'A pleasant 80-year-old female with hypertension, atrial fibrillation, hypothyroidism, chronic low back pain, and chronic hyponatremia presented to our hospital with nausea, fatigue, and generalized weakness for 3 days. She reported taking salt tablets periodically for chronic hyponatremia. Previously, her serum sodium levels ranged between 128 and 133 mEq/L; a month ago, her sodium level was 129 mEq/L (reference range: 135-145 mEq/L). Two days before hospitalization, she completed 3 days of outpatient treatment for urinary tract infection (UTI) using oral TMP-SMX (160/800 mg, 1 tablet twice daily). Her home medications included spironolactone 25 mg once daily, gabapentin 200 mg twice daily, amiodarone 200 mg once daily, aspirin 81 mg once daily, losartan 50 mg once daily, levothyroxine 25 microg once daily, apixaban 5 mg twice daily, and hydrocodone/acetaminophen four times daily as needed. She denied headaches, syncope, paresthesia, seizures, abdominal pain, vomiting, constipation, or diarrhea. A detailed review of her other systems was unremarkable. On examination, her blood pressure (BP) was 188/80, heart rate (HR) 80/min, respiration rate (RR) 16/min, Spo2 95% on room air (RA), and temperature 36.8 C. She was awake, alert, oriented, and seated comfortably in bed. Her oral mucosa was moist; she had no focal neurological deficits; her breath sounds were clear with no crepitation or wheezes; her heart sounds were regular with no murmur; her abdomen was soft with normoactive bowel sounds, and her extremities were warm and perfused without edema. Her routine blood test showed sodium of 111 mEq/L (reference range: 135-145), serum osmolality 230 mOsm/kg (reference range: 275-295), potassium 5.1 mEq/L (reference range: 3.5-5), chloride 77 mEq/L (reference range: 96-106), bicarbonate 18 mEq/L (baseline 24 mEq/L, reference range: 21-32), anion gap 16 (reference range: 8-12), BUN 14 mg/dL (baseline 12-14 mg/dL, reference range: 8-23), creatinine 1.0 mg/dL (baseline 1-1.10 mg/dL, reference range: 0.2-0.7), glucose 127 mg/dL (reference range: 70-115), calcium 9.7 mg/dL (reference range: 8.6-10.2), albumin 4.1 gm/dL (reference range: 3.5-5.2), random cortisol 22 microg/dL (reference range: 5-20), TSH 14.5 uIU/mL (reference range: 0.34-4.8), and uric acid 2.4 mg/dL (reference range: 3.4-7). Her urine studies revealed sodium of 99 mEq/L and urine osmolality of 354 mOsm/kg.\\nAn initial working diagnosis was hyponatremia caused by TMP-SMX-induced natriuresis. She was started on IV normal saline (0.9% NS) with close monitoring of her serum sodium. Her serum sodium initially increased to 116 mEq/L; however, after receiving close to 2.5 L, it decreased to 112 mEq/L. At this point, we limited her 24-h oral fluid intake to 1000 ml and started her on sodium chloride tablets, 1 gm four times daily. Fluid restriction and salt supplements gradually improved her symptoms and sodium level. She was discharged on the fifth hospital day with restricted fluid intake (1000 mL daily), oral sodium chloride tablets, 1 gm four times daily, and close outpatient follow-up. At discharge, her serum sodium was 128 mEq/L, potassium 4.4 mEq/L, bicarbonate 23 mEq/L, BUN 15 mg/dL, creatinine 0.9 mg/dL with a normal anion gap of 11. Her diagnosis was hyponatremia due to TMP-SMX-induced SIADH.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 52,\n",
       "    'case_id': 'PMC4322374_01',\n",
       "    'case_text': \"A 52-year-old male was referred for evaluation of atypical chest discomfort after strenuous exercise and occasional stabbing pain in the left thorax not associated with physical activity. The patient exercised daily and he had competed in 39 marathons without any chest symptoms. He had familial hypercholesterolemia but no history of diabetes, hypertension, or smoking. The patient had discontinued cholesterol-lowering medication. The patient's blood pressure, electrocardiogram, and echocardiogram were normal. Total cholesterol and low density lipoprotein were 7.1 and 5.5 mmol/L, respectively. Due to the uncharacteristic nature of the patient's symptoms, a CCTA was performed. The calcium score was 140 and CCTA revealed calcified and noncalcified coronary atherosclerosis with a mixed, stenotic plaque in the mid left anterior descending coronary artery (LAD) [Figure 1]. Functional testing was scheduled with a rest-stress Rubidium-82 myocardial perfusion scan. Myocardial perfusion and coronary flow reserve were normal during adequate stress response to adenosine (140 mug/kg/min) [Figure 2]. Atorvastatin was prescribed and the patient continued his high level of daily physical activity.\\nOne year later, following strenuous running, the patient sustained a cardiac arrest. Cardiopulmonary resuscitation was started immediately with successful electrical cardioversion of ventricular fibrillation and return of spontaneous circulation 6 min after the alarm. The electrocardiogram showed ST-elevation [Figure 3]. Acute invasive angiography revealed occlusion of the mid-LAD. Normal coronary flow was restored after recanalization and stenting [Figure 4]. Ten days later, transthoracic echocardiography showed left ventricular ejection fraction of 40-45% with apical hypokinesis. The patient was advised cardiac rehabilitation.\\nAs a blind study, we submitted the patient's CCTA data, which had been obtained one year earlier and had revealed a highly significant ischemia-producing lesion in the mid-LAD, for FFRCT analysis [Figure 5]. FFRCT analysis was performed at HeartFlow (Redwood City, CA, USA) utilizing updated proprietary software. Computation of noninvasive FFRCT from CCTA image data requires a physiologic model of coronary blood flow. The physiologic model is based on three underlying principles as described in detail by Taylor et al.,: (i) The total resting coronary blood flow can be quantified relative to the myocardial mass, (ii) The microcirculatory vascular resistance at rest is inversely proportional to the size of the coronary arteries supplying the myocardium, and (iii) The vasodilatory response of the coronary microcirculation to adenosine infusion can be predicted, allowing computational modeling of the maximal hyperemic state. The integration of the model of coronary physiology to 3-dimensional computational models allows computation of coronary flow and pressure at each point in the coronary arteries under hyperemic conditions.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': None,\n",
       "    'case_id': 'PMC7102445_01',\n",
       "    'case_text': 'In our case, a 35-year married female presented to emergency services with the complaint of bleeding per vagina and the feeling of something inside the vagina for 15 months. She used to have per vaginal bleeding with clots in one- to two-week interval which lasts for two to five days (no separate recognizable menstrual cycle). In between intermenstrual bleeding, she had a watery discharge from the vagina without any foul smell or per vaginal itch. Regarding per vaginal mass, she used to feel mass occasionally which stays inside the vaginal canal, never came out of introitus. There were postcoital bleeding and generalized weakness with no shortness of breath, palpitation, gum bleed, or rashes. She underwent minilaparotomy for permanent sterilization eleven years back and had recanalization done five years back. She delivered three children vaginally which were all home deliveries assisted by neighbors; last childbirth was twelve years back. During these fifteen months, she visited different health institutes where she was investigated for reasons of bleeding including coagulation profile, ultrasonography of the pelvis (all were normal), and prescribed progesterone, tranexamic acid, mefenamic acid, and treatment for vaginal discharge syndrome which could not help much to improve her problems.\\nOn examination, she was well built, pale with vital signs within normal limits. The abdomen was soft and nontender. On bimanual per vaginal examination, approximately 6 x 4 cm firm globular mass was felt within the vaginal canal, separate cervical os could not be appreciated, the uterus could not be palpated, and there was active per vaginal bleeding.',\n",
       "    'gender': 'Female'},\n",
       "   {'age': None,\n",
       "    'case_id': 'PMC7102445_02',\n",
       "    'case_text': 'On investigation, her hemoglobin was 5.3 gm% and platelets and PT/INR were within the normal range. Ultrasonography (Figure 1) done by the radiologist in another center and at our center was reported normal. MRI could not be done as it was not available at our center and the patient needs to travel five to six hours for this, with so much of continuing per vaginal bleeding. Also, she did not afford the cost of an MRI. So, we decided to go for surgery without an MRI.',\n",
       "    'gender': 'Female'},\n",
       "   {'age': None,\n",
       "    'case_id': 'PMC7102445_03',\n",
       "    'case_text': \"She was resuscitated with intravenous fluid, and two units of whole blood as packed red blood cell were not available at the center. Ultrasonography was repeated in the preoperative room which was again unable to differentiate whether it was fibroid polyp or uterine inversion. She was planned for emergency operation with a provisional diagnosis of chronic inversion of uterus secondary to submucosal fibroid uterus (arising from fundus) with differential diagnosis of fibroid polyp. Haultain's procedure was planned. Foley's catheterization was done. With all standard precautions, the abdomen was opened in layers. A cup-like depression was noted in the midpelvic cavity, and bilateral round ligaments, fallopian tubes, and ovarian ligaments were coming out of the cup-like depression (Figure 2). A cyst of 5 x 6 cm in the right ovary was noted which got ruptured during the procedure, releasing serous fluid. Attempt to reduce uterine inversion abdominally was not successful. So, with the index finger of the assistant surgeon in the cup-like depression from the abdomen, the patient was repositioned in the lithotomy position; the mass was pulled out vaginally. With an index finger still in depression placed up to the fundus of the uterus from the abdominal cavity, myomectomy was done vaginally (Figure 3). The excised mass showed a whorled pattern consistent with uterine fibroid. Myometrium and endometrium were repaired. Again in the supine position of the patient, anterior and posterior edges of depression were held with Allis forceps. With sustained traction on the bilateral round ligament, a vertical incision was given in the posterior portion of depression (i.e., posterior uterus), fundus was pushed vaginally, and the uterine inversion was corrected (Figure 4). The posterior opening of the uterus was repaired (Figure 5). The ruptured ovarian cyst was removed. Approximately 30 percent of the ovary was preserved on the right side, and the left ovary was normal in appearance. The abdomen was closed in layers. The vaginal pack was kept for 24 hours. The specimen was not sent for histopathological examination as histopathological service was not available at our center and the patient could not afford to take the specimen to other centers. Besides, the gross examination of tissue was consistent with fibroid tissue.\\nThe postoperative period was uneventful. One unit of whole blood was transfused in the postoperative ward. After total transfusion of three units of whole blood (two units preoperative and one-unit postoperative), her hemoglobin level on the third postoperative day was 7.4 gm%. She was counseled regarding the decreased chance of conception as she had undergone tubal recanalization for tubal ligation done in the past. Also, she had an ovarian cyst which was removed this time with ovarian reserve of 30 percent on the right side which also decreases the chance of conception. We advised not to conceive for at least two to three years, and if she got pregnant, she will need to undergo an elective cesarean section. She was discharged on the seventh postoperative period with iron tablets.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 48,\n",
       "    'case_id': 'PMC4956902_01',\n",
       "    'case_text': 'A 48 year-old woman presented to an outpatient clinic with a two-week history of non-productive cough and general malaise. She endorsed a unilateral pruritic red palmar rash. She denied hemoptysis, fever, nasal symptoms, acid reflux, arthralgias, or constitutional symptoms. Past medical history included remote symptoms of migratory arthralgias (several months prior to her presentation), and a remote history of transient left optic neuritis. Social history revealed no tobacco, occupational, or environmental exposures.\\nOn initial presentation, her vital signs were stable and the physical examination was unremarkable. Laboratory investigations showed normal cell counts, hemoglobin, chemistry, creatinine, and liver function tests. Urinalysis was positive for moderate red blood cells, however the patient was menstruating at the time. There was no proteinuria and no casts. Her chest radiograph showed airspace disease in the right mid lung field, and she was diagnosed with a lobar pneumonia. A ten-day course of moxifloxacin was prescribed for treatment of pneumonia.\\nAt follow up 10 days later, her cough did not improve. A computed tomography (CT) scan showed a 6 cm mass-like area of consolidation with small cavities in the right middle lobe, and well defined solid nodules in the periphery of the left lower lobe (Fig. 1).\\nThe differential diagnosis for the CT findings included an atypical pneumonia, possibly fungal in origin, malignancy, septic emboli, or vasculitis.\\nSerologies for Histoplasma capsulatum and Blastomyces dermatitidis were negative. Blood cultures grew Propionobacterium acnes but only in a single culture bottle. Anti-cytoplasmic nuclear antibodies were positive with c-ANCA at a concentration of 8 AI units.\\nThe patient, still clinically stable, was admitted to hospital for further investigation of suspected ANCA-associated vasculitis. Erythrocyte sedimentation rate and C-reactive protein were elevated at 58 mm/hr and 18.3 mg/L, respectively. Anti-nuclear antibodies and extractable nuclear antigens were negative. Complement assays were normal and anti-PR3 antibodies were high, measuring 417 chemiluminescent units. Fluoroscopically guided percutaneous fine and core needle biopsies were obtained from the right middle lobe mass.\\nThe core needle biopsies showed necrotizing granulomatous inflammation. The granulomas consisted mainly of giant cells and epithelioid histiocytes surrounding areas of suppurative basophilic necrosis and embedded in a polymorphous inflammatory infiltrate. The elastic stain demonstrated areas of vasculitis with fragmentation of the elastic layer. The special stains as well as tissue cultures for fungi and mycobacteria were negative. This constellation of features was diagnostic of granulomatosis with polyangiitis (GPA) (Fig. 2).\\nFollowing a negative tuberculin skin test and normal hepatitis serology, she was started on high dose prednisone (1 mg/kg), and Methotrexate (15 mg/week). Within 4 weeks her cough and malaise improved. Further investigation with bloodwork, urinalysis, and nasal examination showed no evidence of multi- organ involvement. On repeat chest radiograph four weeks after treatment, there was interval improvement in the airspace disease density (Fig. 3).',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 18,\n",
       "    'case_id': 'PMC2628935_01',\n",
       "    'case_text': 'An 18-year-old Caucasian female presented with bilateral lower limb paraesthesias followed by increasing leg weakness and difficulty in walking over a period of 2 days. She reported an episode of an upper respiratory tract infection 3 weeks prior to the onset of her neurological symptoms. Past, personal and social history was unremarkable. Clinical examination revealed decreased muscle strength in all extremities associated with hypotonia and areflexia.\\nA diagnosis of Guillain-Barre Syndrome (GBS) was considered and a lumbar puncture was performed. Cerebrospinal fluid (CSF) revealed albuminocytologic dissociation (elevated protein with normal white blood cell count in CSF) suggestive of GBS. She was started on intravenous immunoglobulin G, but within 48 hours, she progressed to complete flaccid quadriparesis with involvement of respiratory muscles and required mechanical ventilatory support.\\nOn day 12, a cardiac electrophysiology consultation was requested for bradycardia and multiple episodes of asystole. These episodes occurred spontaneously, unrelated to tracheobronchial suctioning, blood drawing or any other intervention. The longest observed pause was 12 seconds. Electrolyte profile was normal and oxygenation was satisfactory. The result of her 12-lead ECG is shown in Figure 1.\\nIn view of the multiple episodes of bradycardia and asystole the decision was made to insert a pacemaker. The patient initially received a temporary pacemaker. However, due to an anticipated prolonged clinical course and the potential for recurrent bradycardia and asystole, an INSIGNIA Ultra DR dual chamber permanent pacemaker was implanted after 5 days. The pacemaker was initially programmed to VVI mode at 40 beats per minute to prevent pacing as much as possible. The pacemaker mode was switched to DDDR at the time of discharge because of lack of spontaneous sinus node activity. A paced rhythm was present 18 days post implant, suggesting occurrence of intermittent bradycardia.\\nThe patient returned to our office for a routine pacemaker check 3 months after implantation. The pacemaker check revealed that she was in paced rhythm for most of the time in this period. Seventy percent was atrial paced ventricular sensed rhythm with a set lower rate of 40 beats per min. Twenty percent was atrial paced ventricular paced rhythm with a set AV delay of 220 msec. Only for ten percent of the time was she in atrial sensed ventricular sensed rhythm. This may indicate prolonged influence on the autonomic tone even after complete somatic recovery and likely justifies the need for a permanent pacemaker. As far as choice of pacemaker mode is concerned, our patient received a DDDR mode. However, as the 3 month follow up interrogation showed ventricular pacing of <40%, a Managed Ventricular Pacing or the AAIsafeR would have also been a good pacemaker mode option in retrospect.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 74,\n",
       "    'case_id': 'PMC6381922_01',\n",
       "    'case_text': 'A 74-year-old woman, generally healthy, presented to the emergency room with abdominal pain. Computed tomography (CT) imaging of the chest and abdomen revealed a right ovarian mass, right adrenal mass, multiple soft tissues and lung metastases. She underwent tru-cut biopsy from the retroperitoneal mass in April 2012. Pathologic study revealed metastatic malignant melanoma. Immunostaining for s-100 and HNB-45 were positive. BRAF mutation was wild type. She refused dacarbazine treatment due to the possibility of alopecia. The patient started vinblastine 6 mg/m2 administered every two weeks in May 2012. Partial response was seen in September 2012. In February 2013 she refused to continue chemotherapy and stayed in follow-up. In May 2013 computed tomography revealed new multiple retroperitoneal masses. Second-line systemic therapy with temozolomide 200 mg/m2 for 5 consecutive days per 28-day treatment cycle was initiated. Stable disease was seen in July 2013 with subsequent progressive disease in November 2013.\\nImmunotherapy was initiated with ipilimumab 3 mg/kg every 3 weeks. After 3 cycles near complete response was seen. The patient declined to continue treatment due to side effects such as fatigue grade 3 and liver enzyme elevation grade 2. All subsequent computed tomographic scans were stable.\\nIn June 2016 she had progressive disease with appearance of new retroperitoneal, lung and bilateral adrenal metastases. Nivolumab 3mg/kg every two weeks was initiated. After the fourth treatment cycle she developed pancytopenia (hemoglobin level 6.9 g/dL, absolute neutrophil count was 1,000 uL, platelet count 13,000 uL). She started prednisone 1.5 mg/kg orally without any improvement. She was treated by blood transfusions and repeated platelet transfusions. Bone marrow biopsy has been performed. Pathology revealed severe hypoplasia of bone marrow with only isolated erythroblastic islands and almost complete absence of myeloid lineage. The stroma was \"empty,\" with only partial replacement by fatty tissue. No evidence of metastatic melanoma was found in the examined biopsy. Immunostainings for melanoma cocktail and S100 were negative. CD 20 was positive in isolated cells and CD3 highlighted small T-cell aggregates, composed of CD4 and CD8 positive cells. Alcian blue staining confirmed a picture of serous degeneration (Fig. 1). As per the recommendation of the consulting hematologist revolade 50mg/day was initiated with subsequent increased dose to 100mg/day. Despite treatment the patient continued to deteriorate and died.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 46,\n",
       "    'case_id': 'PMC9066584_01',\n",
       "    'case_text': 'A 46-year-old man was diagnosed with advanced poorly cohesive signet ring cell gastric adenocarcinoma (cT3N2M1), human epidermal growth factor receptor 2 (HER2) negative, in November 2017. He was initially treated with modified DCF regimen (Docetaxel 40 mg/m2 on day 1, Cisplatin 40 mg/m2 on day 3 and 5-Fluorouracil 2000 mg/m2 continuous infusion over 48h, every two weeks). He completed six cycles with good clinical response and partial radiological response.\\nTwo months later, he presented to the emergency department (ED) with a 6-day history of severe persistent headache, diplopia and abnormal gait. Besides ataxia, his neurological examination was unremarkable. Initial blood workup and head CT scan showed no abnormalities. Subsequently, a lumbar puncture was performed and CSF analysis was compatible with LMC (Figure 1). He was then admitted to the neurology department for further evaluation and initiated dexamethasone (16 mg/day), with partial resolution of symptoms. Brain magnetic resonance imaging (MRI) was performed, showing leptomeningeal enhancement as well as malignant infiltrates at the entire cerebrum (Figure 2).',\n",
       "    'gender': 'Male'},\n",
       "   {'age': 50,\n",
       "    'case_id': 'PMC9066584_02',\n",
       "    'case_text': 'A 50-year-old man was diagnosed with localized poorly cohesive gastric adenocarcinoma (cT2N2M0) in February 2015 and was treated with perioperative chemotherapy and surgery (total gastrectomy), according to the MAGIC trial.\\nOne month after the surgery, he presented to the ED with a 4-day history of nausea, epigastric abdominal pain and acholic stools. Laboratory data revealed elevated serum lipase (1980 U/L) and amylase (215 U/L), but the abdominal ultrasound was unremarkable. A postoperative acute pancreatitis was assumed but on day 3, he developed two brief episodes of clonic left hemi-body seizures with Jacksonian march without loss of consciousness. Head CT scan revealed a hyperintense right frontoparietal lesion with surrounding oedema, suggestive of malignancy on brain MRI (Figure 3). He suddenly began with persistent unrelieved headache, nausea and vomiting. CSF analysis revealed atypical malignant signet-ring cells and gastric adenocarcinoma LMC was assumed (Figure 4).\\nAfter discussion at the multi-disciplinary tumor board, the patient started intrathecal (IT) chemotherapy with methotrexate (12 mg) and dexamethasone (4 mg), once a week. After two cycles of IT his neurological symptoms aggravated and its performance status degraded and he was referred to palliative care, were he died two months later.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 68,\n",
       "    'case_id': 'PMC3328781_01',\n",
       "    'case_text': 'A 68-year old man was diagnosed with advanced multilocular HCC on the basis of ethyltoxic liver cirrhosis (Child-Pugh A) in September 2009. At the time of diagnosis, a moderately differentiated metastasis to the thyroid gland and several metastases to the autochthonic spine musculature and the vertebral bodies with stenoses of the spinal canal (L I) and the neuroforamina (Th XII to L I) were present (Figure 2).\\nTherapy with sorafenib at 800 mg per day was started in September 2009 and showed a mixed response in MRI scan 6 weeks after treatment start with partly necrotic or decreased lesions but also increasing and novel lesions in the liver and stable soft tissue and bone metastases. Sonography revealed a large lesion (11 cm) in the right liver lobe which was more than 75% necrotic but also 8 additional lesions up to 5 cm (Figure 3).\\nAfter obtaining informed consent, therapy with panobinostat was started in November 2009: sorafenib was continued at 800 mg daily and panobinostat at 20 mg was administered orally on days 1 and 4 for two consecutive weeks followed by one week of sorafenib therapy alone, representing a three week therapy cycle which was repeated 5 times.\\nStaging was performed after three cycles in January 2010 (Figure 4). Here, contrast enhanced sonography showed constant lesions in liver segments V, VI and VII (94*80*75 mm) as well as in segment II (29*32 mm) with signs of cirrhosis but no ascites. MRI scanning showed slightly decreasing hemorrhagic lesions with signs of liquid transformation in both liver lobes and of the soft tissue metastasis in the autochthonic spine musculature. No new lesions were discovered. The patient reported diarrhea, exsiccosis, hypocalcaemia and nausea during the last cycle that responded to supportive treatment.\\nAfter eight cycles of sorafenib and panobinostat, MRI staging in April 2010 showed a further regression of the lesions in the liver and the spine musculature. Contrast sonography showed a necrotic lesion in segment VI and a hypervascularized but still constant lesion on segment VIII.\\nBy request of the patient the therapy with panobinostat was stopped in May 2010 as the patient experienced lack of appetite and slight weight loss (3 kg since February 2010), which was perceived as increasingly wearing by the patient and lead to withdrawal of consent. Sorafenib was further continued at the standard dose.\\nAlthough transaminases and gamma-GT were initially elevated (maximum GOT 130 U/l, GPT 178 U/l, gamma-GT 167 U/l), these parameters rapidly normalized under sorafenib therapy and stayed in the normal range until the end of treatment with panobinostat (Figure 5A). Albumin and prothrombin time as markers of liver synthesis capacity were slightly decreased throughout the treatment period without signs of clinical symptoms. Interestingly, the initially elevated tumor marker alpha-fetoprotein (AFP) returned to normal values already under sorafenib therapy despite a lack of radiologic response at this stage (Figure 5B). AFP levels remained below 10 ng/ml until the end of the panobinostat treatment period, too, but raised to 36.6 ng/ml at the end of the observation period. This increase in AFP was also paralleled by an increase in transaminases and gamma-GT at this stage indicating a deterioration of liver function and progress of the tumor disease under sorafenib monotherapy. Hematologic assessment revealed leucopenia, low hemoglobin, erythrocytes and hematocrit under initial sorafenib therapy. These values remained stable also under additional panobinostat therapy with even an amelioration of leucopenia to normal range after three cycles. Differential blood count showed a stably lymphopenia and monocytosis during the whole treatment period. All other laboratory parameters remained in the normal range throughout the study period.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 51,\n",
       "    'case_id': 'PMC8531932_01',\n",
       "    'case_text': 'A 51-year-old male non-smoker was referred to the emergency room (ER) with the complaint of abdominal pain 3 days earlier,which she rated an \"8\" on a scale of 1 to 10 without any medical history and drug history. He stated that the pain worsened with movement and change in position. He denied any significant family history of the disease. During the physical examination, the patient was diaphoretic, uncomfortable, and in severe distress. His vital signs were: blood pressure, 156/87 mm Hg; respiratory rate, 19 breaths/minute; heart rate, 132 beats/minute; and temperature within normal limits. Oxygen saturation was 93% on room air. The abdominal examination revealed a distended abdomen that was severely tender to palpation. Intravenous (IV) fluids were immediately started for the patient. He was also given IV ondansetron for nausea. His pain was refractory to treatment and required multiple doses of morphine sulfate. Laboratory evaluation revealed leukocytosis with a white blood cell (WBC) count of 14.5 thou/cm. He underwent laparotomy due to tenderness in favor of acute abdominal pain. During laparotomy, not only the small and large intestine but also their vasculature was normal. After two days, the patient was discharged with no pain and symptom. With nausea, abdominal pain, and dyspnea, he came back to the ER again after 3 days. On examination, he had tachypnea (RR: 40/min), tachycardia (HR: 120/min), low-grade fever (Temp: 38 centigrade). A lung computed tomography (CT) (Figure 1) and an abdominopelvic CT (Figure 2) were done. The patient was intubated due to respiratory failure. Covid-19 RT-PCR (Everse transcription polymerase chain reaction) was performed. Lab data included complete blood count (CBC)(WBC:17000 per microliter, Hb:12:8.7 g/dL, Plt: 350,000 per microliter), urea :170 mg/dL, (creatinine) Cr:4.2 mg/dL, (Lactate dehydrogenase) LDH:504 U/L, (C-reactive protein) CRP:47mg/L, and negative viral disease (HCV Ab-hepatitis C virus antibody, HBS Ag-Hepatitis B Antigen,, HIV Ab (human immunodeficiency virus)The patient was treated with 400 mg single-dose, hydroxychloroquine sulfate, lopinavir/ritonavir 100/400mg twice daily for five days, ribavirin 1200 mg twice daily for five days, and three doses of 250 mug beta interferon (Every other day). \\n During ICU admission, on the third day, fecaloid discharged from abdominal suture appeared, and therefore the patient was on sepsis phase. Laboratory data were CBC (WBC: 24000 per microliter, Hb: 12 g/dL, Plt: 347000 per microliter), urea: 206 mg/dL, Cr: 3.2 mg/dL,and amylase: 67 U/L. \\n Re-laparotomy was performed, and after laparotomy, serosanguinous secretions with necrotic changes in the small intestine were seen, so 130 cm of it was resected (Figure 3). The day after, due to suspicion of leakage from the anastomosis site, laparotomy was performed again and due to leakage from the anastomosis site and smaller bowel necrosis,100 cm of intestine was resected so ileostomy was performed. A pathological study (Figure 4) reported intravascular thrombosis in mesenteric tissue with a necrotic margin. The RT-PCR of covid-19 was reported positive. \\n The patient was treated with heparin infusion and broad-spectrum antibiotics. After 10 days of treatment in ICU, he was extubated, and his hemodynamic was stable, but platelet count began to decrease (162,000 per microliter), and therefore the day after gastrointestinal bleeding happened. \\n Lab test were CBC (WBC: 7100 per microliter, Hb: 8.7 g/dL, plt: 162000 per microliter), Cr: 1.3 mg/dL, amylase: 65 U/L. Plt and Cr decreased to 69000 per microliter and 1.1 mg/dL, respectively, but other coagulation tests (PT and PTT) were normal the day after. Heparin infusion was discontinued. Other laboratory tests were D-dimer: 2500 ng/mL, fibrinogen: 150 mg/dL, PT: 44 sec, PTT: 44 sec, INR: 1.7. No schistocyte in peripheral blood smear was found. Unfortunately, the patient eventually developed treatment-resistant sepsis, DIC, and died of its complications.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 62,\n",
       "    'case_id': 'PMC3363304_01',\n",
       "    'case_text': 'A healthy 62-year-old Japanese woman complained of a 1-week history of frontal headaches. The headache moved to the left supra-orbital region and she noted blurred vision in the left eye. She visited the neurologic department of Kohnodai Hospital (Chiba, Japan) on March 9, 2010. The results of general physical examination were unremarkable. She was suspected of having retrobulbar optic neuritis and was hospitalized immediately. However, enhanced magnetic resonance imaging (MRI) showed a 9 mm heterogeneous intracranial lesion attached to the TS around the left optic nerve anterior to the chiasm (Figure 1A-C). Examination of the cerebrospinal fluid showed an increase of the cell counts (171/mL mononuclear cells 162, polynuclear cells 9, normal range: <45/mL) and protein concentration (61 mg/dL, normal range: 10-40 mg/dL). These findings led to a tentative diagnosis of granulomatous inflammation with optic nerve compression. She was treated with steroid pulse therapy, and then referred to the ophthalmologic department for neuro-ophthalmic examinations on March 11, 2010.\\nHer best-corrected visual acuity (BCVA) was 1.0 in the right eye and 0.3 in the left eye, and she had a relative afferent pupillary defect in the left eye. The results of ophthalmoscopic examinations were normal (Figure 2A and B). Static perimetry 30-2 with the Humphrey field analyzer (HFAII 745; Carl Zeiss AG, Oberkochen, Germany) showed an inferior temporal field defect in the left eye (Figure 2C and D). The pattern VEPs elicited by transient and steadystate stimuli to the left eye were undetectable (Figure 3). She was diagnosed with optic nerve compression. Three weeks after the steroid pulse treatment, her BCVA improved to 1.2, and the field defect disappeared. At the 1-year follow-up examination, her BCVA remained in 1.2, and the visual field was almost normal in the left eye without any treatment (Figure 2E). A thinning of the ganglion cell complex (GCC) was detected by a spectral domain OCT (Figure 4).\\nOn July 23, 2011, she began suffering from headaches again, and she noted a complete loss of vision in her left eye. She was immediately referred to the neurosurgical department. She was treated with steroid pulse therapy again, but there was no improvement. The visual acuity remained at no light perception and there was no direct light reflex in the left eye. Thin sliced enhanced MRI revealed that the intracranial lesion had extended into her left optic canal, even though the size of the main mass was almost the same as earlier (Figure 1D-F). Emergency surgery was carried out on July 29, 2011. A hemi-interhemispheric approach was used, and the tumor was successfully removed (Simpson grade 2) including the intracranial lesion by opening the optic canal (Figure 1G-I). A diagnosis of meningothelial meningioma was made by histopathological examination of the removed tissue.\\nOne month after surgery, her BCVA improved to 1.2, and a mild temporal hemianopia was detected in the left eye (Figure 2F). The pattern VEPs were present but had a prolonged P100 latency of 170 ms (Figure 3). OCT showed that the GCC was thinner than the preoperative thickness (Figure 4). At 3 months, all of the findings remained the same.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 57,\n",
       "    'case_id': 'PMC3736967_01',\n",
       "    'case_text': 'A 57-year-old man had noticed a right chest wall mass lesion for 15 years, but had ignored the lesion in the 5 years before presentation. He was admitted to our hospital without significant symptoms and with no history of tuberculosis. Magnetic resonance imaging (MRI) was performed, and a 5-cm-diameter lesion was found. The signal was isointense on T1-weighted imaging (T1WI) and hyperintense on T2-weighted imaging (T2WI) (Fig. 1). Needle biopsy was performed, and histopathology showed lymphocyte infiltration with no evidence of malignancy. The patient was followed up for the next 7 years, and during that interval he had no significant symptoms.  \\nOn MRI after 7 years of follow-up, the primary chest wall mass lesion was without any significant change, but a small subcutaneous mass lesion was found nearby. The MRI signal of this subcutaneous mass was almost identical with the original mass (Fig. 2). Diffusion-weighted imaging (DWI) was performed and both lesions exhibited high signal on DWI and a low apparent diffusion coefficient (ADC) (about 0.5) on the ADC map (Fig. 3). In light of the MRI findings, hypercellular malignant tumors (including melanoma and lymphoma), atheroma, and nodular fasciitis were suspected. Excisional biopsy was not performed since that would make definitive re-excision more extensive due to the contamination of surrounding tissue planes. Therefore an open biopsy of both lesions was performed. The mass lesions were both found to be marginal zone B-cell lymphomas (Fig. 4).    \\nIn this case, no other tumors were found, so radiation therapy only (36 Gy/20 French) was given. The patient was discharged, and follow-up found the patient in good condition with no apparent signs of recurrence after 2 years.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': None,\n",
       "    'case_id': 'PMC6902614_01',\n",
       "    'case_text': \"Between January 2014 and April 2019, A total of 35,233 pregnant women were referred to our center to perform invasive prenatal diagnosis for abnormalities based on fetal ultrasound anatomy scans or maternal serum screening. Fetal ultrasound anatomy scans were routinely performed for pregnant women by senior sonographers using GE E8 ultrasound machines (General Electric Healthcare, US). The indication included: fetus with ultrasound abnormalities (intrauterine growth restriction, increased NT thickness, cleft lip/palate, cystic cerebral lesions, abnormal nasal bone or renal hypoplasia, etc.), positive maternal serum screening test or NIPT high risk for aneuploidy, etc. This was a retrospective study and approved by the Medical Ethics Committee of the Guangxi Maternal and Child Health Hospital and written consent from the parents.\\nChorionic villi sampling, amniocentesis or cordocentesis was performed under ultrasound guidance after informed consent. Genomic DNA was extracted using QIAamp DNA Blood Mini Kit (Qiagen, Germany) according to the manufacturer's protocol. Single-nucleotide polymorphism (SNP) microarray testing was performed using Illumina HumanCytoSNP-12 v2.1 BeadChip (Illumina, USA) and the copy number variation positions were shown according to the human Feb. 2009 (GRCh37/hg19) assembly. The laboratory policy at the time of testing was not to report well established polymorphisms, CNVs that do not contain genes and categorized as benign or likely benign base on the ACMG guideline. Karyotyping was performed for the available samples according to the standard procedure as described previously.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 52,\n",
       "    'case_id': 'PMC6731353_01',\n",
       "    'case_text': \"A 52-year-old Japanese female presented to our hospital with a chief complaint of fever and swelling with tenderness in the thenar area of her right hand. She reported that three days before her visit, a stray cat had bitten her right thenar area as she was walking along a river terrace nearby her house in Wakayama City, Japan. She had no medical history and had not traveled in the last several years. She had one dog, but the dog had not bitten her in the last several months. Likewise, she had not cut any raw fish in recent memory. She began experiencing swelling and sensations of heat around the site of the bite from the day after the cat bit her.\\nHer triage vital signs were a blood pressure 153/77 mmHg, pulse 103 beats/min, respiratory rate 24 breath/min, SPO2 99% (room air), and body temperature 39.3 degrees C. She generally appeared unwell but was fully conscious and able to report her history. Her cardiovascular and respiratory examinations were normal. Redness and warmth were found around the bite site on the right thenar area. Neither pain nor swelling of the wrist joint was observed. Linear erythema extended from the bite site to the right forearm.\\nLaboratory results revealed the following: white blood cell count, 9900 /muL; platelet count, 23.1 x 104/muL; creatinine, 0.59 mg/dL; total bilirubin, 0.7 mg/dL; aspartate aminotransferase, 19 U/L; alanine aminotransferase, 19 U/L; lactate dehydrogenase, 238 U/L; CRP, 1.01 mg/dL.\\nShe was diagnosed with a soft tissue infection of the right hand, lymphangitis, and sepsis associated with a cat bite. Ampicillin/sulbactam was administered and amoxicillin/clavulanate was prescribed. A blood culture was positive for gram-positive rod on the day after her first hospital visit (Fig. 1). Although E. rhusiopathiae was detected by rapid bacterial identification and susceptibility testing (VITEK 2  , BioMerieux), further investigation was required because the cultured strain produced no hydrogen sulfate. The nucleotide sequences of the 16S rRNA genes of E. rhusiopathiae and E. tonsillarum were determined to have similarities of 99.9% and 99.7%, respectively. Tests revealed that the strain did not ferment sucrose, which enabled its identification as E. rhusiopathiae. The strain showed low minimum inhibitory concentrations (MICs) for penicillin ( 0.03) and ceftriaxone ( 0.03), and an elevated MIC for vancomycin (>4). Physical examination and echocardiography showed no signs of endocarditis. The patient's fever abated and her other vital signs stabilized 2 days after the antibacterials were commenced. The symptom of lymphangitis in her right forearm disappeared and the swelling of her right hand improved. A follow-up blood culture after 5 days of antibacterial treatment was negative.\\nThe patient was treated with oral amoxicillin/clavulanate for 12 days after a single intravenous administration of ampicillin/sulbactam and recovered fully.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 57,\n",
       "    'case_id': 'PMC9795177_01',\n",
       "    'case_text': \"A 57-year-old Chinese man was admitted to the respiratory department at a regional hospital owing to hemoptysis and cough, no obvious cause was identified, and the patient denied having chest pain, fever, shiver, and other concomitant symptoms. The patient's social history was as follows: 60-pack years and 30 years of significant alcohol intake; however, he had been sober for 10 years. There was no other relevant medical history of note, and the patient revealed no genetic, congenital, or developmental abnormalities. Unfortunately, the family genetic history was not provided. The patient had not received any prior treatment for these symptoms. Physical examination revealed that the superficial lymph nodes of the whole body were not palpable or enlarged. The breathing sounds of both lungs were clear, and no coarse or fine crackles were heard. Computed tomography (CT) scan revealed an irregular large soft tissue mass in the right hilar region, invading the right main bronchus, narrowing, and truncating with atelectasis. The tumor diameter was 52.85 mm (mediastinal window images were uniformly used for measurement and comparison) with atelectasis ( Figure 1A ). Histological examination of a transbronchial specimen confirmed that the tumor was a squamous cell carcinoma (SCC). No lymph node metastases or distant organ metastases were identified. Based on the 8th Edition Lung Cancer Stage Classification, it was diagnosed as right central lung SCC with right upper lobe atelectasis (stage cT3N0M0, IIB).\\nAs the tumor was close to the carina, a multidisciplinary team (MDT) consultation was undertaken; the team consisted of a medical oncologist, a thoracic surgeon, a radiologist, and a pathologist. As the MDT concluded that the risks associated with the surgical resection of the tumor were very high, it was not considered at the time. A treatment plan was developed for induction chemotherapy with sequential thoracic radiotherapy since the large diameter of the tumor and vascular invasion. Paclitaxel (albumin-bound) 400 mg D1 combined with carboplatin 500 mg D1 on a 21-day cycle was used for induction chemotherapy. The first treatment cycle began on October 16, 2020, and the two-cycle efficacy was evaluated as stable disease (  Figure 1B  ).\\nAt the end of the first round of chemotherapy, the patient again presented with cough with hemoptysis in the early morning of the 3rd day; the blood was dark red and of approximately 10-15 ml. Routine blood test revealed that the bleeding was not caused by thrombocytopenia, a common adverse reaction to chemotherapy. Bronchial artery embolization was performed twice during chemotherapy to address the symptoms. The first embolization was performed on October 19, 2020. The interventional doctor injected the contrast medium into the thickened artery: the trunk of the right middle and lower lobe bronchial artery; this helped to clearly stain the tumor, and the staining disappeared after poly vinyl alcohol (PVA) microspheres measuring 300-500 mm in diameter was injected into the arteries. However, the results were unsatisfactory, and the patient's hemoptysis did not reduce in intensity following the procedure. A second embolization was performed 6 weeks later (December 2, 2020). The PVA microspheres with a diameter of 100-300mm and two coils with diameter 2cm/crimp diameter 2cm (2-2) were injected into the right upper lobe bronchial artery; and four coils with diameter 2cm/crimp diameter 2cm (2-2) were injected into the right middle lobe bronchial artery. The patient's hemoptysis disappeared; no chemotherapeutic drugs were used in either procedure. The patient tolerated the intervention, and there were no adverse reactions, such as fever, headache, nausea, or vomiting. On the second day after embolization, intensity-modulated radiation therapy (IMRT) was initiated at a dose of 60 Gy for 30 fractions. On December 9, 2020, enhanced CT performed during radiotherapy to reposition the patient revealed that the tumor had significantly reduced in size to 21.16 mm (  Figure 1C  ). On December 16, 2020, after the 10th radiotherapy fractionation, an enhanced CT scan revealed that the tumor had reduced to 18.11 mm in size. It remained this size for 4 months (  Figure 1D  ). Unfortunately, the patient has since developed lymph node metastases (occurred 3 months after radiotherapy) and remains under treatment. The patient provided informed consent for publication of this case report.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 79,\n",
       "    'case_id': 'PMC5828284_01',\n",
       "    'case_text': \"A 79-year-old male patient with a long history of Parkinson disease and heart failure due to double aortic dysfunction (severe stenosis and moderate insufficiency) returned to follow-up with signs of clinical deterioration. For the past 4 years, he'd already had indications for surgical treatment but refused it. In the presence of a worse clinical condition, he consented to surgery. An echocardiogram was performed, which showed the double aortic valve dysfunction and measured a left ventricular ejection fraction of 29%. After proper pre-operatory stabilization, the aortic valve was replaced with a biological prosthesis.\\nThe patient's original aortic valve was sent to pathological analysis, confirming chronic calcified valvulopathy. An incidental finding at histological examination was an agglomerate of polyhedral cells and histiocytes admixed with fibrin and erythrocytes, and focally forming strips or tubular arrays that were not attached to the valve, which appeared to correspond macroscopically to a thrombus (Figures 1A and 1B). Immunohistochemistry was positive for calretinin in some of the cells and for CD68 in others, allowing the identification of a biphasic lesion, with mesothelial cells and macrophages, respectively (Figures 1C and 1D), and the diagnosis of a mesothelial/monocytic incidental cardiac excrescence.\",\n",
       "    'gender': 'Male'},\n",
       "   {'age': 26,\n",
       "    'case_id': 'PMC5828284_02',\n",
       "    'case_text': 'A 26-year-old patient with the previous diagnosis of epileptic seizures, cognitive deficit, chronic lymphedema of the lower limbs, bicuspid aortic valve and total atrioventricular block, who had an implanted internal pacemaker, was admitted for surgical replacement of the aortic valve by a biological prosthesis. Pathological examination of the native valve was consistent with chronic endocarditis, but in the histological analysis isolated sheets and blocks of epithelioid cells within a fibrin matrix were also found, which were associated with macrophagic reaction (Figure 2A), an incidental finding, without attachment to the valve. Immunohistochemistry was positive for pan-keratin (AE1/AE3) and WT1 in the epithelioid cells and CD68 in the macrophages. Such findings are consistent with mesothelial/monocytic incidental cardiac excrescence.',\n",
       "    'gender': 'Unknown'},\n",
       "   {'age': 45,\n",
       "    'case_id': 'PMC5828284_03',\n",
       "    'case_text': 'Our third patient was a 45-year-old male patient with precedent rheumatic fever, followed by mitral valve stenosis, which evolved with left atrial enlargement and atrial fibrillation. The patient underwent cardiac catheterization, which identified a 50% occlusive lesion of the second left marginal artery. He had heart failure and complained of dyspnea at usual efforts. A mitral valve replacement was performed.\\nDuring surgery, in the mediastinum, the surgeon described an area that grossly resembled fibrosis, which was excised and submitted for pathological study. Microscopically it was composed of fibrotic tissue with foci of calcifications and thrombi. Additionally, and apart from the fibrotic area, an agglomerate of polyhedral cells and histiocytes were found embedded in fibrin (Figure 2B), compatible with mesothelial/monocytic incidental cardiac excrescence (Figures 2C and 2D).',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 12,\n",
       "    'case_id': 'PMC6370615_01',\n",
       "    'case_text': \"The patient was a 12-year-old male who had his first seizure attack at the age of 10, and had four types of epileptic seizures. The first type of seizure was tonic axial seizures characterized by flexion of the neck and body and the extension of four extremities for several seconds. The tonic seizures could last several seconds. This type of seizure occurred predominantly at night and the frequency was about 4-5 times per week. The second type was atypical absence seizures, which manifested as a sudden loss of consciousness and the resuming of normal activity right after the seizure. This type of seizure could last about 15 s and the frequency was 4-5 times per week. The third type was the myoclonic seizure, presented as prominent myoclonic jerks of bilateral upper limbs. The frequency of this type of seizures was 2-3 times per day. The last type of seizure was the generalized tonic-clonic seizure, which could last about 5 min. The mean frequency of this type of seizure was <1 time per week.\\nThe patient was a full-term infant with no history of perinatal asphyxia, head injury, encephalitis, and febrile convulsions. His family history was unremarkable. He had a mild degree of intellectual impairment and learning disability after the onset of the disease. The physical examinations were normal. Auxiliary examinations, including blood routine examination, serum biochemical examination, thyroid function, autoimmunity antibody, and blood ammonia, were normal. The electrocardiogram was normal and the QT interval (QTc) was 372 ms. There was no lesion on the brain MRI. The Wechsler Intelligence Scale showed a borderline cognition impairment. The electroencephalogram (EEG) before treatment showed that there was a large number of 3 to 5 Hz slow waves with middle and high amplitude in the anterior region in the background. Fast rhythms bursts of 16 to 20 Hz and multiple-spike-and-slow-waves of 0.5 to 1 Hz were observed during the sleep period. Slow spike-and-slow-waves of 1.5 to 2.5 Hz were observed during awake time (Figure 1).\\nThe patient was diagnosed with Lennox-Gastaut syndrome after considering his multiple types of epileptic seizures, mental retardation, and typical electroencephalographic features. He was refractory to a multiple anti-epileptic drugs treatment, including sodium valproate (8 mg/kg/day), levetiracetam (50 mg/kg/day), clonazepam (0.0375 mg/kg/day), topiramate (3.75 mg/kg/day), and lamotrigine (2.5 mg/kg/day). Whole exome sequencing (WES) identified a novel heterozygous KCNT1 mutation (chr9:138649026; c.625C>T; p.Arg209Cys) inherited from his father. This missense mutation was highly likely to cause the dysfunction of the KCNT1 channel and led to a gain-of-function phenotype. This alteration had not been previously reported and was not found in the ExAC database (http://exac.broadinstitute.org/), and was predicted to be likely pathogenic.\\nThis study was approved by the human research ethic committees of Xuanwu hospital capital medical university. Written informed consent was obtained from all participants and guardians of minors for the quinidine therapy and the publication of this study. Additive quinidine therapy to our patient was initiated at 12 years of age. The doses of the above anticonvulsants remained unchanged. In the month before quinidine therapy, the patient had 16 tonic seizures, 12 atypical absence seizures, 10 myoclonic seizures, and 1 generalized tonic-clonic seizures.\\nAfter admission, the quinidine therapy was initiated with 5 mg/kg/day in 3 divided doses under electrocardiographic (ECG) monitoring. The QTc ranged from 361 to 415 ms, with an average of 378 ms (the normal limit of QTc is within 450 ms). After 1 month of treatment, the dose of quinidine was titrated to 10 mg/kg/day and he had 13 tonic seizures during this month. The dose was maintained during the following 2 months. QTc was in normal range (391-436 ms). There was also no other adverse effect of quinidine. At the fourth month, the dose of quinidine was increased to 13.75 mg/kg/day in 3 divided doses. The frequency of tonic seizures ranged between 4 and 6 times per month. The mean QTc interval was 383 ms. As no adverse effects were experienced, the dose of quinidine was maintained to 13.75 mg/kg/day during the following 4 months. The patient had 4 tonic seizures per month. The frequency of tonic seizures subsided by 75% (Figure 2A), whereas the frequency of the other types of seizures was not reduced significantly.\\nVideo EEG (VEEG) was performed regularly during treatment and the number of epileptic discharges was counted by four expert technicians who had not seen the patient's clinical information. One slow spike-and-wave complex or one episode of paroxysmal fast rhythms in EEGs were counted as one epileptiform discharge. 1323 epileptiform discharges were recorded during a 24-h video EEG before the treatment of quinidine. We subsequently applied the 24-h VEEG every 3 months to evaluated the efficacy of the quinidine treatment. The total number of epileptic discharges was 512, 652, and 598 in the next 3, 6, and 9 months, respectively. The epileptiform discharges decreased by 54.80% (Figure 2B).\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 22,\n",
       "    'case_id': 'PMC5864713_01',\n",
       "    'case_text': 'A 22-year-old patient underwent FNA as a nodule was detected on the outer center of the right lobe of the thyroid, and it was reported to be a Bethesda system category IV, Hurthle cell follicular neoplasia.\\nA right total thyroidectomy was performed on the patient who presented to our hospital, and a frozen section was requested. In the right total, 3.5x2-cm thyroidectomy material section, a 1.7x1.2-cm nodule, including necrotic and focal hyalinized areas, located 0.3 cm from the thyroid capsule, was observed. The frozen section analysis was reported as \"necrosis, focal papillary structures in some places around the hyalinized areas, malignant-benign differentiation was not clear, and paraffin sections were to be examined,\" and a total thyroidectomy was prevented.\\nIn the center of the paraffin sections, papillary structures composed of large oncocytic cytoplasmic thyrocytes in the focal area around intense infarct were noticed (Figs. 1, 2, 3).\\nThese papillary structures were observed in the focal areas, and because of the previous FNA diagnosis of follicular neoplasia, these structures were initially considered to be \"reactive papillary hyperplasia.\" However, when examined in detail, these papillary structures were found to be infiltrative in places in spite of being in a focal area, and their cytological evaluation suggested papillary carcinoma.\\nImmunohistochemical analysis of the papillary structures showed diffuse, strong positivity with cytokeratin 19 and focal, weak positivity with HBME-1, whereas the external control was positive with galectin-3 and no staining was observed in the case (Figs. 4, 5, 6).\\nOn this basis, BRAF V600E was studied in terms of molecular genetics, and the patient was diagnosed with a \"thyroid papillary carcinoma\" because of a positive result.\\nFNA preparations of the patient that had been previously analyzed in the external center were made available for a re-evaluation to determine the extent to which the cytology would contribute in such cases, and FNA preparations were re-evaluated.\\nCytological evaluation revealed focal groove structures with large oncocytic cytoplasm in hypercellular spreads, mostly in a microfollicular pattern; some of the structures were standing alone or in groups similar to focal papillary structures, overlapping in places, and also showed thyrocytes with intranuclear inclusion (Fig. 7).\\nIt was considered that an underdiagnosis was made in the FNA analysis, and it could be evaluated as at least category V (suspicious for malignancy) or category VI (malign aspirate).\\nThe patient presented to our hospital again with a complaint of dizziness and nausea after thyroidectomy. During MRI at our center (Fig. 8), a mass was detected in the brain stem. \"Astrocytoma,\" as a 2nd synchronous primary tumor, was detected in the patient who underwent surgery at an external center at the patient\\'s request.',\n",
       "    'gender': 'Unknown'}],\n",
       "  [{'age': 11,\n",
       "    'case_id': 'PMC6222037_01',\n",
       "    'case_text': \"An eleven-year old boy was evaluated in the Neurology clinic. He was born at 39 weeks via emergency C-section in a pregnancy complicated by preeclampsia. Maternal history was significant for three prior miscarriages. There were no teratogen exposures during pregnancy. He was healthy with the exception of severe constipation as an infant. He had global developmental delays. He sat at 6 months, walked independently at 24 months, and was unable to ride a bike. He also had fine motor difficulties, particularly with writing letters and using utensils. From a language perspective, he was nonverbal and had deficits in receptive speech. His fourteen-year old brother had a genetic microarray confirming duplication of exons 3 and 4 MECP2 and triplication of exons 1 and 2 MECP2 and also had global developmental delay, absence of speech, and hypotonia. His younger brother and proband also had a duplication of MECP2 on testing. The patient's maternal grandmother had seizures and there was a history of epilepsy and cognitive impairment in other maternal relatives.\\nThe patient presented with multiple dysmorphic features, including epicanthal folds, small palpebral fissures, long face, simplified helices, clinodactyly, small hands with poor capillary perfusion, and inverted nipples. He had mild scoliosis and kyphosis. His cranial nerve and motor exam were grossly normal. Reflexes were within normal limits. Cardiac auscultation revealed a systolic murmur at the left lower sternal border. He had a normal echocardiogram.\\nThe patient presented with a history of seizures suggestive of focal dyscognitive seizures and generalized tonic-clonic seizures. The initial episodes were characterized by unresponsiveness, focal eye deviation, and post-ictal confusion with an unknown seizure frequency. He also developed tonic-clonic episodes involving his four extremities. Later, he mainly had episodes of drop seizures, occurring 20-30 times daily and lasting minutes. As a result of these drop seizures, he lost his ability to walk independently and required significant assistance for his activities of daily living including eating, dressing, and bathing. He had several falls per week often resulting in soft tissue injuries. He was reported to have difficulty with concentration and executive functioning both at school and at home due to his uncontrolled seizures.\\nAn initial MRI was normal and an EEG noted mild nonspecific slowing (7 to 8 Hz background frequency) with no obvious epileptiform activity. A genetics referral was made with requests for chromosomal microarray, Rett syndrome testing, CK, and a metabolic work-up. Genetic testing revealed a microduplication at Xq28 of 430 megabases, involving three genes: IRAK1, MECP2 and FLNA.\\nThe patient was started on valproic acid (VPA) at 10 mL BID to be continued for two years. Since starting VPA, he was seizure-free. His brother, who was found to have the same MeCP2 duplication, also remained seizure free on VPA.\\nHowever, due to findings of thrombocytopenia and hyperbilirubinemia in the proband, the VPA was stopped. Following the discontinuation of VPA, he had a re-emergence of his epilepsy with an increase in his drop seizures. He was trialed on a multitude of other anticonvulsants, including Levetiracetam 1500 mg BID (9 months), Lamotrigine 150 mg BID (6 months), Oxcarbazepine 900 mg QAM-1200 mg QHS (4 months), Lacosamide 200 mg BID (3 months), Topiramate 150 mg BID (9 months), and Clobazam 10 mg QHS (ongoing) with no success. Given that the patient remained refractory to polytherapy and that the reported hyperbilirubinemia is a very rare occurrence, the VPA was re-started with close monitoring of transaminases and bilirubin levels. Laboratory studies showed a normalization of platelets and bilirubin levels.\\nUpon re-challenge, his convulsive seizures were controlled with a significant decrease in frequency of his drop attacks occurring 1-2 times daily. Initially he would have 20-30 drop seizures each day accompanied with unresponsiveness, greatly affecting his ability to function. However, with the reduction in seizure activity, his activities of daily living and school performance improved markedly. In addition, as per parent report, the removal of the sedating anticonvulsants made him less drowsy. Overall, his improved functioning translated in reduced caregiver stress and better quality of life for the patient.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 7,\n",
       "    'case_id': 'PMC9513563_01',\n",
       "    'case_text': \"A female infant was born at 35 5/7 weeks gestation to a 26-year-old gravida 2, para 2 mother. The infant was small for gestational age, born at 1.984 kg (ninth percentile on the Fenton growth chart for preterm girls).\\nThe pregnancy was complicated by maternal tobacco use. The mother was positive for group B streptococcus, and she received clindamycin for intrapartum prophylaxis due to penicillin allergy. She was also late to acquire prenatal care, having been seen initially at 20 weeks gestation. The remainder of the mother's prenatal testing was unremarkable, and there was no other pertinent maternal history. There were no abnormalities noted on prenatal imaging.\\nThe mother presented to the outside (referring) hospital with spontaneous preterm labor. The delivery was complicated by vacuum assistance. The infant was vigorous at delivery and did not require resuscitation.\\nThe referring hospital contacted the tertiary care facility after multiple congenital anomalies were noted on physical examination. The infant was transferred to the level 4 neonatal intensive care unit (NICU).\\nUpon arrival at the NICU, the infant was noted to have multiple congenital anomalies. Both hands exhibited brachydactyly and hypoplasia of the nail beds of the fifth digits the left hand lacked the distal phalanx of the second digit. Both feet exhibited oligodactyly of the fifth digits, with right 2-3 syndactyly and left 2-3-4 syndactyly. Bilaterally, the medial malleolus at the tibial insertion was abnormal, with circumferential narrowing of the lower leg. In the lumbosacral region, there was a caudal appendage, 3 cm x 0.5 cm, lateral and 2.5 cm to the right of midline with no apparent bony involvement (Figure 1).\\nThe infant had multiple imaging studies while in the NICU. Head ultrasound, renal ultrasound, and echocardiogram were normal. A skeletal survey confirmed the limb abnormalities noted at the physical exam. A spine ultrasound showed that the conus medullaris terminated at L2-3 (lower limit of normal) and had a thickened filum with decreased oscillation. Magnetic resonance imaging of the spine revealed a small syrinx at the distal thoracic cord. There was an elongated soft tissue appendage (caudal appendage) emanating from the level of the right iliac crest and extending inferiorly along the right gluteal region. It did not appear to involve or extend from the ileum or iliac crest. There was evidence of a central fibrous structure, but likely not fascial nor cartilaginous.\\nPediatrics subspecialties including genetics, orthopedics, neurosurgery, general surgery, and plastic surgery were consulted during the NICU hospitalization. Genetics recommended obtaining a chromosomal microarray and outpatient follow-up. The surgical subspecialists recommended no acute interventions and outpatient follow-up. The remainder of the patient's 6-day hospitalization was unremarkable. She had jaundice but did not require phototherapy. She fed well and was near birth weight at the time of discharge.\\nThe infant had multiple follow-up appointments with pediatric subspecialists over the first year of life. At 6 months of age, she was seen by a pediatric plastic surgeon, at which time the caudal appendage measured 6.5 cm x 1.5 cm (Figure 2). Additionally, there was a diffuse soft tissue mass deep to the appendage measuring 7.5 cm in diameter. Excision of the caudal appendage was scheduled for 1 year of age. Repair of the syndactyly on the left and right feet was not recommended at the time because the risks outweighed any benefit. She was noted to have plagiocephaly and torticollis, which were being treated with physical therapy.\\nAt 6 months of age, she was also seen by an orthopedic hand surgeon. Repeat X-rays of both hands were obtained and showed no change in the abnormalities previously seen on imaging. Upon evaluation, the decision was made to offer surgical webspace deepening with syndactyly release and possible full-thickness skin grafting involving the left ring and small fingers:to be coordinated with the caudal appendage excision.\\nChromosomal microarray results were non-diagnostic but showed a small deletion that included EPHA3, which has no associated phenotype. There was no consanguinity. At the 6-month follow-up, the geneticist concluded that findings were consistent with amniotic band syndrome.\\nAt 1 year of age, plastic surgery removed the caudal appendage and underlying soft tissue mass. Skin was taken from the appendage for grafting during the hand surgery repair. Gross and histologic examination of the excised caudal appendage and underlying mass revealed skin and subcutaneous mature fibroadipose tissue. After the appendage and mass were excised, the orthopedic hand surgeon performed full separation of the fourth and fifth digits of the left hand, with full-thickness skin grafting; a cast was placed on the left upper extremity.\\nThe patient was evaluated by a general pediatric orthopedic surgeon shortly after the procedures described above. Radiographic imaging at that time showed no changes in the abnormalities of her feet bilaterally. Given that the patient was not experiencing functional limitations due to the toe abnormalities, observation was recommended. Of note, she was found to have bilateral acetabular dysplasia, for which she was fitted with an abduction brace.\\nPostoperative follow-up with the pediatric orthopedic hand surgeon showed appropriate wound healing at the site of the syndactyly release and skin grafting, with no evidence of infection. She had full digital range of motion at that time.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 93,\n",
       "    'case_id': 'PMC8437821_01',\n",
       "    'case_text': \"A 93-year-old Japanese man with moderate aortic stenosis, fever, and disturbed consciousness was transferred to the emergency department. His measured vital signs were: body temperature, 41.4  C; blood pressure, 113/54 mmHg; pulse rate, 124 beats/min; oxygen saturation, 99% (under 90% oxygen inhalation); and Glasgow coma scale, E2V1M4 (seven points). A physical examination revealed crackles in his right lower chest, and laboratory findings revealed his white blood cell (WBC) count (14.8 x 103/muL; 74.4% neutrophils), C-reactive protein (CRP) concentration (13.0 mg/dL), prothrombin time-international normalized ratio (1.41), activated partial thromboplastin time (36 seconds), and fibrinogen concentration (475 mg/dL). Chest radiography showed homogeneous opacity consolidation in the right mid and lower zones (Fig. 1A), and chest CT showed consolidation, with an air bronchogram in the middle lobe of the right lung (Fig. 1B).\\nHence, the patient was admitted with a diagnosis of pneumonia and treated with intravenous sulbactam/ampicillin (3 g every 8 h). A sputum culture obtained upon admission was positive for both Klebsiella pneumoniae and Pseudomonas aeruginosa; the latter was believed to have settled in his respiratory tract and not be pathogenic. On day 9, the patient's chest CT showed necrosis inside the consolidation; we continued intravenous sulbactam/ampicillin (3 g every 6 h) and diagnosed a lung abscess. Additionally, we administered intravenous ciprofloxacin (200 mg every 24 h), given that Pseudomonas aeruginosa was considered to be related to the lung abscess. Over the following days, the patient's general status improved, including defervescence of the fever with decreases in his WBC counts and CRP levels. On day 29, the patient suddenly demonstrated massive hemoptysis. The following day, MDCTA indicated an enhanced nodule inside the abscess, suggestive of a PAP (Fig. 2A and B). We urgently performed pulmonary angiography, which confirmed the presence of a PAP (Fig. 2C). We guided a 5-Fr Goodtec(R) angiographic diagnostic catheter (Goodman Co., Ltd., Nagoya, Japan) and a 1.7-Fr Nadeshiko(R) micro-catheter (JMS, Shinagawa, Japan) to the PAP and subsequently performed embolization with two 0.018-inch embolization coils (3-2 and 4-2 mm coil diameters) (Tornado(R); Cook Medical, Bloomington, IN), Histoacryl(R) (B. Braun Aesculap, Melsungen, Germany), and Lipiodol(R) Ultra Fluid (Guerbet, Villepinte, France) (Fig. 2D).\\nOn day 35, MDCTA revealed a collapsed PAP, and the patient was discharged on day 45. Approximately 2 months after the embolization, the patient had not experienced recurrent hemoptysis, and a repeat chest CT was unable to detect the abscess (Fig. 3).\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 31,\n",
       "    'case_id': 'PMC3934774_01',\n",
       "    'case_text': \"A 31-year-old white male with a known history of colon carcinoma was referred to the Interventional Pulmonary service for right lower lobe infiltrates and mucous plugging on computed tomography (CT) with concern for pneumonia (fig. 1). Bronchoscopy was performed revealing a broad based mass completely obstructing the bronchus intermedius (fig. 2). It was possible to pass a probe into the right lower lobe, and subsequent photoablation and mechanical debulking revealed that the mass was arising near the origin of the superior basal segment of the right lower lobe (RB6) and could be resected (fig. 3). Pathology confirmed that this was consistent with the patient's known primary colon carcinoma.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': None,\n",
       "    'case_id': 'PMC8580735_01',\n",
       "    'case_text': \"A female patient presents with a perineal finding, which we suspected was a posterior anal duplication ( Fig. 1A, B ). The native anus, located anteriorly, appears to be of normal caliber and surrounded by the sphincter muscle complex. The abnormal orifice is located at the 6 o'clock position, posteriorly. When probed ( Fig. 1B ), it appeared to be communicating with anal canal distal to the dentate line and just proximal to the anal verge. Plain film anteroposterior pelvic X-ray shows a sacral abnormality ( Fig. 1C ). A magnetic resonance imaging (MRI) of the pelvis demonstrated a presacral mass consistent with an anterior meningocele and a conus at L2 but without spinal cord tethering ( Fig. 1D ). These features suggested that there is an ACD as part of a CS. Genetic testing was provided to the family, given the CS.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 83,\n",
       "    'case_id': 'PMC3542952_01',\n",
       "    'case_text': \"Here, we report a case of an 83-year-old Hispanic male with end-stage renal disease (ESRD) on dialysis three times a week who presented to the emergency department with the chief complaint of bilateral lower extremity weakness. The patient noted the weakness in his leg after having his early dinner around 3PM. He first noticed weakness in his knee joint and later he had trouble getting out of his chair and walking to the restroom. Initially he managed to walk with help. Over the next several hours the weakness in his legs persisted and became so severe that he decided to come to the hospital.\\nThe patient stated that he had similar problems 3 days prior to presentation and on the day of his dialysis and the symptoms resolved after a 3-hour dialysis. Prior to these events and in between the two episodes the patient had normal, age appropriate activities of daily living. He walked without help and without any difficulty.\\nHis past medical history included was significant for end-stage renal disease on hemodialysis three times a week, hypertension, and coronary artery disease with stent placement, myocardial infarction, and seizure disorder.\\nThe patient had undergone a colectomy for perforated bowel with colostomy several years ago.\\nThe patient denied cough, fever, diarrhea, and change in bowel or urinary habits. There was no prior history of trauma.\\nHis home medication list included Aspirin 81 mg per day, Clopidogrel 75 mg per day, Simvastatin 40 mg per day, Metoprolol 25 mg per day, Multivitamin one tablet a day, folic acid one tablet twice a day, Calcium acetate 667 mg two tablet with each meal daily, Phenytoin 100 mg twice a day, and Omeprazol 20 mg per day.\\nThe review of systems was significant for a recent history of new-onset seizure that required intubation for air way protection. Patient was admitted to Medical Intensive Care Unit (MICU). Patient was later discharged home on Phenytoin. Shortly before this admission, patient has presented to the hospital multiple times with serum potassium levels as high as 8.3 milliEquivalents/liter (mEq/L).\\nPhysical examination was remarkable for bilateral lower extremity weakness pronounced at the hips (motor strength 2/5 in both legs). Furthermore, cogwheel rigidity was appreciated bilaterally, more pronounced in the knee joints. Sensory system examination and the reflexes were within normal limit. No saddle anesthesia was appreciated on neurological examination. Motor strength and cranial nerve examination were essentially unremarkable.\\nECG revealed peaked T-wave and the serum chemistry study was remarkable for potassium of 7.8 mEq/dL (Figure 1(b)).\\nA portable chest radiograph showed no acute infiltration or fluid overload.\\nThe patient's diet includes rice, beans, pork chops, beef, chicken, and salad.\\nIn the emergency department, the patient was given 10 cc of Calcium gluconate, 5 units of regular insulin, 25 cc of Dextrose 50%, and 60 mg of oral Sodium polystyrene sulfonate immediately based on the ECG and laboratory abnormalities.\\nPatient was attached to the monitor and observed with serial neurological exam, ECG and serial labs.\\nAfter an hour, patient's weakness and cogwheel rigidity partially improved and the patient was able to stand with help. The patient was transferred to the MICU service for close monitored observation. Patient was subsequently dialyzed. Repeat laboratory values and the ECG returned to previous values (Figures 1(a) and 1(c)), and the patient was able to stand up and walk without difficulty maintaining his preevent status.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 21,\n",
       "    'case_id': 'PMC9391998_01',\n",
       "    'case_text': 'Patient information: a healthy 21-year-old Saudi man without relevant medical, family, and psychosocial history was stabbed with a knife by an unknown person on the left side of his lower neck around 7 pm on July 13, 2021, and presented to the nearest Al-Aflaj Hospital emergency department by a private vehicle. At Al-Aflaj Hospital, he was hemodynamically stable with active bleeding from the wound. The initial trauma resuscitation was done according to the Advanced trauma life support (ATLS) protocol. In the emergency department, they intubated him to control the airway, applied pressure dressings over the wound, and inserted a left intercostal tube (ICT) to drain the hemothorax. He was then shifted to the operating room (OR) immediately. The general surgeon extended the supraclavicular wound and applied multiple bulldogs (vascular clamps) to get temporary bleeding control (Figure 1). The patient was then transferred to KSMC trauma center as a life-saving case for definitive surgical management.\\nClinical findings: the patient arrived at KSMC at 02:30 AM on July 14, 2021. The emergency department physician activated the trauma team, and the trauma team evaluated the patient immediately. On presentation, he was intubated and mechanically ventilated, with oxygen saturation of 100%. His heart rate was 92 beats per minute, and his blood pressure was 109/63 mmHg without isotropic support. He was sedated with reactive pupils. His left hand was cooler than his right hand, but well perfused (oxygen saturation 98-99% in all fingertips). There was no palpable pulse, but a Doppler signal was present in his left upper limb. Chest X-ray showed a left hemothorax (Figure 2 A), and the left ICT drained 700 ml of blood. The venous blood gases showed a pH of 7.35, bicarbonate of 21.7, PCO2 of 36.1, a base deficit of 3.4, lactate of 2.2, and hemoglobin of 7.6 gm/DL. The massive transfusion protocol was activated, and the OR personnel was alerted.\\nTimeline of current episode: the patient was stabbed in the left neck in the evening at 7 PM on 13 July 2021 and presented to KSMC in the early morning at 02:30 AM on 14 July 2021. After initial trauma assessment, resuscitation, and investigations, he was taken to the emergency OR on the same morning at 5 AM. He was discharged from the hospital on 25 July 2021 and had an outpatient clinic follow-up on 2 August 2021.\\nDiagnostic assessment: the patient was hemodynamically stable. He was shifted for computed tomography (CT) brain and CT angiography (CTA) for the chest, neck, and left upper limb. The CT brain was unremarkable. The neck and upper limb CTA showed a complete cutoff at the left SCA after its origin. A severe metallic beam-hardening artifact was causing difficult evaluation of the second part of the left SCA. There was also a hematoma surrounding the left axillary vein with a patent lumen (Figure 2 B). The left AA and brachial artery appeared patent. There was also a left moderate to a large amount of hemothorax (Figure 2 C). After returning from the CT, the patient became hypotensive and a transient responder to fluid resuscitation in the emergency department. The left intercostal drain output increased to 1.2 l in the next 2 hours.\\nDiagnosis: hemodynamically unstable penetrating left subclavian vessel injury.\\nTherapeutic interventions: the patient was shifted immediately to the OR. Intraoperatively, a left supraclavicular incision with clavicular division was performed. Proximal control of the left SCA was difficult, and there was evidence of continuous blood oozing in the chest cavity. He became unstable on the OR table, requiring inotropic support to maintain hemodynamics despite ongoing blood transfusion. Immediate median sternotomy was performed (Figure 3). Two to three liters of blood were evacuated from the left chest cavity. The ligation of the injured subclavian vessels achieved hemostasis. The left upper limb showed good perfusion throughout the procedure, as evidenced by good pulse oximetry signals. His left upper limb was not significantly swollen, and there was no emergent sign of compartment syndrome. Therefore, we did not proceed with upper limb fasciotomy. The patient received seven units of packed red blood cells, four units of fresh frozen plasma, and four units of platelets during the procedure. Postoperatively, he was shifted to the intensive care unit for close monitoring.\\nFollow-up and outcome of interventions: his postoperative course was uneventful. After gradual weaning from inotropes, he was extubated on the second postoperative day. He was moved to the general ward the following day. The ICT was removed on the ninth postoperative day. The limb was mildly swollen compared to the right limb, perfused throughout, and there was no neurological deficit. A follow-up CT angiography showed postsurgical intervention, with a finding of ligation of the proximal left SCA. Refilling of the SCA s distal segment and its branches was noted down to the left upper limb (Figure 4 A). On the eleventh postoperative day, the patient was discharged with advice to use left upper limb compression stockings (class 2) for swelling. The outpatient clinic s follow-up showed a well-perfused and neurologically intact left upper limb. His left upper limb swelling had reduced significantly and become almost normal. The chest radiograph was also unremarkable (Figure 4 B).\\nPatient perspective: the patient had no complaints when he was examined in the clinic following surgery, and the checkup was unremarkable. He conveyed his heartfelt appreciation for the surgical team.\\nInformed consent: written informed consent was obtained from the patient for publishing the article.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 54,\n",
       "    'case_id': 'PMC6514481_01',\n",
       "    'case_text': 'Individual 1, is a 54-year-old patient with stage IV non-small cell lung cancer and cerebral metastases. He has OI type 1 (classic non-deforming OI with blue sclerae), which was diagnosed early because of a fractured clavicle at birth and confirmed with DNA analysis (c.588 + 5G>A pathogenic variant in the COL1A1 gene). The clinical manifestations consisted of multiple fractures of the pelvis and the long bones (more than 10 since childhood), the presence of blue sclerae and dentinogenesis imperfecta. The most recent DEXA scan showed low BMD with a T-score of -2.3 for the lumbar spine and a T-score of -3.5 for the left hip. There was a positive family history with his mother and sibling being affected with OI type 1 as well.\\nThe patient was diagnosed with cT3N2M1c non-small cell lung cancer with ipsilateral and mediastinal lymph nodes and multiple brain metastases after analysis for headache, dysarthria, apraxia and memory loss. Because of the relatively young age of the patient and absence of extracranial metastases, the multidisciplinary tumor board decided to treat the brain metastases with stereotactic radiotherapy for a long-lasting effect, but with a palliative intent.\\nDepending on the volume of the metastases, a stereotactic dose of 1 x 18 Gy, 1 x 21 Gy or 1 x 24 Gy was prescribed for five metastases using Volumetric Modulated Arc Therapy (VMAT) with three 6 MeV photon Flattening Filter Free (FFF) beams. In this example, the adjacent skull received a mean dose of 7 Gy without special dose planning restrictions on the skull (Fig. 1).\\nBecause of the high complications risk, due to chest deformities that may cause respiratory problems, cervical fragility that may lead to difficulties during intubation and due to possible hyperthermia caused by anesthesia, surgery for the lung tumor was not recommended. The patient was therefore referred for sequential radiotherapy. A dose of 25 x 2.6 Gy was prescribed to the lung tumor and the hilar and mediastinal lymph nodes, using one 10 MeV photon VMAT arc. No extra radiotherapy dose planning constraints for the bone of the chest or other tissue types were prescribed.\\nDuring and after brain irradiation and lung radiotherapy, the patient did not experience any extra acute side effects or difficulties regarding OI.',\n",
       "    'gender': 'Male'},\n",
       "   {'age': 46,\n",
       "    'case_id': 'PMC6514481_02',\n",
       "    'case_text': 'Individual 2 is a 46-year-old patient with osteogenesis imperfecta, who was diagnosed clinically with OI type 3 or 4 at the age of 1 year. This diagnosis has not been confirmed with DNA analysis. She sustained multiple fractures for which she underwent multiple surgical procedures including osteotomies. Because of extensive bone deformities, she has been wheelchair-bound since childhood. The most recent DEXA scan showed low BMD of the lumbar spine with a T-score of -6.0. In addition to the bone fractures, this patient is also under surveillance of the cardiologist because of a mildly dilated ascending aorta and aortic root of 38 mm.\\nAt the age of 12, the patient experienced painful swelling of his left femur due to hyperplastic callus formation after a femoral fracture. To slow down and eventually resorb the callus formation, the patient was referred for radiotherapy. The left femur received a prescribed dose of 5 x 4 Gy, using anterior posterior-posterior-anterior (AP-PA) fields of 6 MeV photons to the whole left femur. Shortly after the treatment, the swelling and pain in the left femur decreased.\\nTwenty-three years later, at the age of 35 years, the patient was again referred to the radiotherapy department, now because of pain due to callus formation of the medial side of the right femur. A dose of 5 x 4 Gy was prescribed to the right femur using an AP-PA field of 10 MeV photons (Fig. 2). During and after the treatment no acute side effects were noticed and again the pain and swelling responded very well to the radiotherapy.\\nAt age of 59, the patient was again referred to the radiotherapy department because of recurrent pain of his right femur. A radiotherapy planning-CT was conducted, but because of the mild character of the pain, and after shared decision making with the patient, radiation therapy was eventually not performed.\\nWe aimed to measure effects of radiotherapy on BMD of the 2 patients in skull and femur. Although the gold standard for measuring BMD is the DEXA scan, several reports show Hounsfield Units (HU) derived from CT scans to be an accurate estimate for BMD. To put findings in perspective, mean HU of ten occipital skulls and ten right femora of healthy patients of matching age were assessed.\\nComparison in mean HU of exactly matched areas of bones of our patients could be made prior and post radiotherapy, using the radiotherapy planning-CT scans that were conducted sequentially in both patients. In individual 1, mean HU were measured in the high dose (1 x 7 Gy) area of the adjacent skull to the occipital brain metastasis (Fig. 1). In individual 2, mean HU were measured in the target area of the right femur (Fig. 2) and in a non-irradiated area of the right femur. See Table 1 for the results.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 23,\n",
       "    'case_id': 'PMC4735458_01',\n",
       "    'case_text': 'A 23-year-old African American woman developed an abscess in the right anterior chest wall just lateral to the sternum 1 month after a normal vaginal delivery under epidural anesthesia. She was admitted elsewhere and underwent incision and drainage of the abscess. A culture from the abscess grew MRSA sensitive to vancomycin (MIC less than 1), trimethoprim-sulfamethaxazole, clindamycin, tetracycline, and linezolid. She received intravenous vancomycin (MIC less than 1) for 10 days with apparent resolution. The abscess recurred in the same location 7 and 15 months after the initial episode. These recurrences were managed with incision and drainage, and oral trimethoprim-sulfmethoxazole. Cultures of the drainage consistently grew MRSA with the same susceptibility pattern. The patient reported that the wound healed with treatment each time.\\nNineteen months after the initial episode, the abscess recurred and she was seen in our emergency department. Computerized tomography of the chest showed right upper and middle lobe parenchymal abnormalities suggestive of granulomatous infection, paraspinal abscess formation, periosteal thickening and osseous changes involving the 3rd to 6th vertebral bodies and right 3rd rib. She noted a mild cough. She denied back pain and neurological symptoms. Incision and drainage was performed and she was referred to the pulmonary clinic. Multiple sputum cultures were negative for bacteria and acid fast bacilli. Magnetic resonance imaging showed changes similar to those on the CT scan. She received oral trimethoprim-sulfamethazole for 5 months but repeat CT showed minimal improvement. She was admitted to the hospital for further evaluation and management.\\nHer past medical history included intermittent asthma managed with albuterol inhaler as needed. She smoked one pack per day for 5 years but stopped 1 year prior to admission. She denied alcohol or drug abuse. There was no family history of recurrent infections. She was afebrile. Physical examination was normal except for a 2 cm x 2 cm fluctuant mass on the right upper chest. There was mild tenderness at the site, but no erythema. She had coarse facial features and a wide nasal bridge. Her appearance was notably different from her sister.\\nComplete blood count and serum chemistries were normal except for mild eosinophilia. Drainage of the abscess grew MRSA. A tuberculin skin test and HIV testing were negative. Culture for acid fast bacilli from the abscess was negative. Serum IgE level was 1489 IU/mL (normal 0-180 IU/mL). IgG and IgA levels were mildly elevated. IgG subclasses, complement CH50, hemoglobin electrophoresis, and neutrophil oxidative burst test were normal. Computerized tomography again showed a paraspinal collection now extending from the 2nd to the 8th thoracic vertebrae, with mild bone destruction also involving the right third rib (Fig. 1).\\nIntravenous vancomycin was started and continued for 5 weeks via PICC line on discharge, followed by oral linezolid for 6 months. The chest wall abscess resolved rapidly and she remained asymptomatic, but there was no improvement in the radiographic abnormalities on CT scanning.\\nSix months later she was readmitted with right shoulder pain, upper back pain and fever. Computerized tomography and MRI showed enlargement of the paraspinal collection. Transesophageal echocardiography showed no evidence of endocarditis. Gallium and bone scans were normal. Under CT guidance, she underwent transcutaneous aspiration of the paraspinal collection. The drainage was grossly purulent and grew MRSA. Two weeks later, video-assisted thoracic surgery (VATS) was attempted but due to extensive adhesions was converted to open thoracotomy to permit debridement of the paravertebral collections. Her antibiotic regimen was changed to daptomycin plus rifampin for 6 weeks followed by linezolid and rifampin.\\nThree months postoperatively she was improved with resolution of the back pain and a weight gain of 14 pounds. Repeat MRI with gadolinium showed significant improvement with no areas of enhancement and no residual abscess formation. Therapy was continued with oral trimethoprim-sulfamethoxazole and rifampin. A study was negative for signal transducer and activator of transcription 3 (STAT3) mutation.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 90,\n",
       "    'case_id': 'PMC8242995_01',\n",
       "    'case_text': \"A 90 year old man was referred with a 7 cm thoracic aneurysm seen on MRI spine performed for increasing upper back pain over six months. Apart from hypertension and dyslipidaemia, he had no smoking history or any known major coronary or cerebrovascular disease. He also had no neurological signs or symptoms and was able to carry out his activities of daily living independently.\\nComputed tomography (CT) angiography confirmed the 7.2 cm fusiform aneurysm of the distal aortic arch, with an ectatic ascending aortic segment measuring up to 3.7 cm in diameter and a descending thoracic aneurysm measuring 4.2 cm (Fig. 1). Arch branches had atheromatous changes but were patent without significant stenosis. The abdominal aorta was also aneurysmal at 4.3 cm but the patient did not have any abdominal symptoms or lower back pain.\\nBased on symptomatology, age, rupture risk, and CT imaging, a plan was proposed for a percutaneously inserted 226 mm by 38-44 mm (diameter) custom made device (CMD) with an 8 mm diameter left common carotid artery (LCCA) fenestration and an innominate artery (IA) scallop (Fig. 2), along with occlusion of the left subclavian artery (LSA).\\nDuring the procedure, access was obtained using ultrasound (US) guided puncture of the right and left common femoral arteries (CFA) for insertion of 6 and 8 F sheaths, respectively. LCCA puncture, sited above the left clavicle, was performed in a retrograde fashion with US using a 4 F micropuncture set before insertion of a 6 F sheath. Intra-arterial heparin 5000 units was administered and an arch aortogram was performed with a pigtail catheter in the ascending aorta.\\nThe LSA was next occluded by deployment of a 14 x 10 mm Amplatzer Vascular Plug II, proximal to the vertebral artery origin. Next, the Cook CMD was introduced via the right groin and positioned proximal to the origin of the IA. Its preloaded wire was snared from the LCCA access to obtain through and through passage before continued deployment to expose the LCCA fenestration fully. A 10 x 27 mm BeGraft was deployed via the LCCA across the CMD fenestration and flared. The final check angiogram showed a patent IA and LCCA along with an occluded LSA origin without obvious leak. The left VA and distal SCA could be seen to be perfused via collateral flow (Fig. 3).\\nHaemostasis of both groin accesses was obtained with suture tightening of prior inserted Abbott Perclose ProGlide suture mediated devices in preclose fashion. For the LCCA access, the patient's head was first rotated to the right and a single Perclose ProGlide device was inserted under fluoroscopy with standard manufacturer technique over a short Terumo 0035 wire positioned above the aortic cusps. Intra-venous protamine was given for reversal and manual compression further applied. Haemostasis was confirmed visually and using sonography. Operative time was two hours and ten minutes.\\nThe patient recovered well and was discharged on post-operative day two. Follow up CT a month later showed that the stent graft, LCCA fenestration and IA were patent, and that the proximal LSA had been occluded as planned with collateral perfusion of the left VA and LSA distal to the vascular plug (Fig. 4). No endoleak was shown and the patient reported an improvement in his symptoms.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': None,\n",
       "    'case_id': 'PMC10369008_01',\n",
       "    'case_text': 'In this section, we summarise what is known of the case. Ramsey was transferred from his home in Cambridge to Guy\\'s Hospital on 10 January 1930 for investigation and management of worsening jaundice. His medical history was essentially unremarkable. He had neonatal jaundice and ill-defined \"digestive\" issues as a child. But by adolescence, he was a competent athlete and as an adult appeared to enjoy good health. He was a tall man tending towards weight gain:in his early 20\\'s, he weighed nearly 17 stone: 240 lbs/108 kilos. Assuming his height was around 6 feet 4 (1.93 metres), his body mass index was about 29: overweight but not obese. He was physically active, including vigorous hiking and wild swimming. He was described as having \"tremendous vitality\". He was a member of the Bloomsbury set:a group of intellectuals and artists who lived life to the full and were known to have open marriages, as did Ramsey and his wife, the former Lettice Cautley Baker, who became a renowned photographer. While Lettice had multiple sexual partners, Ramsey appears to have had only one other: Elizabeth Denby, a senior civil servant and social housing reformer.\\n In mid-November 1929 Ramsey developed an acute febrile illness after a College feast (a formal occasion involving many courses of rich food, washed down with much alcohol). Nobody else attending the feast is known to have become ill, and there seem to have been no sick contacts, though Lettice developed a brief febrile illness in late November from which she recovered uneventfully. Within 10 days of the onset of fever, Ramsey developed jaundice with malaise, but no abdominal pain and no signs of bleeding or bruising. Progressive jaundice and malaise persisted for over six weeks. His cognitive status remained more or less normal throughout this period (no suggestion of encephalopathy), though he sent notes apologising to academic colleagues that he was unable to focus on his work.\\nOn January 10, 1930 Lettice contacted her uncle, Robert Davies-Colley, a senior surgeon at Guy\\'s Hospital, who arranged for Ramsey\\'s admission. He was evaluated by a physician and a surgeon who apparently concurred on proceeding with a laparotomy to evaluate for biliary stones or other treatable cause of obstruction. Lettice wrote to Wittgenstein with an account of her understanding on Wednesday, January 15:\\nFrank was operated on Saturday afternoon, because, after 8 weeks in bed he showed no improvement. My uncle, who\\'s a surgeon, came from London to see him and thought that he should be brought to London to Guy\\'s hospital. So we took an ambulance & came. Then there was a consultation with a physician (as opposed to a surgeon) & firstly they agreed that an op would be best. They found his gall bladder very inflamed & are draining it. There was no stone. I have seen Frank twice today, for a few moments. He is still too much under the effect of drugs to like any company . . . The dose of morphia that is always given after an op had a bad effect on him & he had to have something to counteract it. ( : 418)\\nThe above quote contains what appears to be an error by Lettice, since the actual date of the operation was Tuesday 14 th; Ramsey died on Sunday 19 th. While the surgery did not reveal an obstruction, \"the whole liver and kidneys were found in a frightful condition\". ( : 425)\\nThe records suggest that a partial autopsy (\"P.M. Examination of the abdominal organs\") was performed but no findings from this are available. The death certificate simply read:\\n      Cause of Death:      1 (a) Cholangitis (b) Infection of smaller bile ducts\\n                                      2 Hepatitis.\\n                                                      P.M. Examination of abdominal organs\\nLettice said that Frank \"died of an infected liver\". Davies-Colley told Ramsey\\'s father it was \"a degenerative disease of the liver which was bound to end fatally\". Lionel Penrose (father of British genetics and himself a medical doctor) was one of Ramsey\\'s best friends, and apparently had a different view. He would later allude to the possibility that medical malpractice was the cause of death and he was wracked with guilt about not having been around to step in and save his friend ( : 425).',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 9,\n",
       "    'case_id': 'PMC7712411_01',\n",
       "    'case_text': \"In June 2016, a 9-year-old girl (elementary school student of Caucasian race, weighing 42 kg) was referred for consultation with an interdisciplinary team in the Vascular Anomalies Center of Guarneri Clinic (Rome, Italy) to address a painful and progressively increasing mass in the right thigh. The consultation team included vascular surgeons, interventional radiologists, hematologists, oncologists, plastic surgeons, and pathologists.\\nThe patient had an unremarkable medical history.\\nAt clinical examination, the girl showed functional impairment of the right knee (limited flexion of 30%), muscle contracture, and localized pain (Figure 1). In the days before her hospitalization, the reported daily mean visual analog scale (VAS) score for chronic pain was 7  +-  1. Neurologic examination revealed normal patellar tendon reflex, full strength of the surrounding musculature, and normal superficial and deep sensitivities. Dermatological examination revealed normal skin characteristics.\\nIt was reported that no therapeutic procedure had been carried out previously, and the pain symptoms had been controlled with pain relievers, when necessary.\\nLaboratory blood tests for coagulation were performed, according to the high rate of variations in coagulation states that are found in patients with vascular anomalies. No abnormalities were observed in our young patient.\\nIn addition to clinical signs, diagnosis of FAVA was based on both ultrasound and magnetic resonance imaging (MRI) examinations. Both imaging modalities showed a complex mass of 11 cm x 8 cm x 8 cm in the right thigh, a finding compatible with FAVA malformation, located in the vastus medialis muscle and marginally in the rectus femoral muscle. The T1-weighted MRIs showed heterogeneous and hyperintense signal related to the fat component (Figure 2), and the injection of intravenous contrast clearly revealed the malformed venous component. The solid mass was found to have partially replaced the normal vastus medialis muscle fibers, with fibrofatty overgrowth and varied appearances of clusters of thick-walled muscular vessels; multiple soft-tissue planes were found to be involved as well, showing hypoechoic intralesional clots or development of phleboliths, with low-flow venous parameters that were also barely detectable by Doppler sonography.\\nFollowing discussion and consensus by the interdisciplinary team, differential diagnoses of other commonly confused vascular lesions (i.e., venous or arteriovenous malformations or vascular tumors) were ruled out.\\nThe primary end point of this patient's treatment was radical FAVA treatment. The secondary end points were pain relief (assessed by VAS) and recovery of functional impairments.\\nPrevious clinical experiences in the literature describe the frequent use of sclerotherapy and percutaneous cryoablation procedures for FAVA and the high risk of blood loss and nervous system damage related to primary surgery in FAVA. Thus, the multidisciplinary team proposed an original hybrid treatment strategy of primary percutaneous ethanol embolization of the FAVA and a secondary surgical excision of the mass.\\n Informed consent statement: Written consent was obtained from both parents of the patient, because she was a minor at the time of hospitalization.\\n Institutional review board statement: The Institutional Review Board of Guarnieri Clinic provided approval for this study (IRB No. 19/1721).\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 84,\n",
       "    'case_id': 'PMC3347879_01',\n",
       "    'case_text': 'A case study illustrates differences in structural and functional imaging findings with mild neuropsychology findings (please refer to Case 3 inside table 4). For this 84-year-old White woman, the neuropsychology test results, presented in figure 1, show some mild decreased performance on measures of executive function (CLOX1, FAS, TMT B), speed (TMT A), working memory (WAIS Digit span), and on the attention index score of the RBANS. No depression (GDS) or decreased daily functioning (PCS, MCS) was reported, beyond difficulty with managing a large house. While the decreases in cognitive performance are mild, they include areas typically affected by cerebral small vessel disease.\\nThe MRI report for this case study described no significant intracranial abnormality, and no abnormality of perfusion. Nonetheless, the SPECT imaging report noted a mild to moderate multifocal pattern of hypoperfusion in the white matter, patchy hypoperfusion in the left lenticular nucleus, and regional hypoperfusion in the anterior temporal cortices (trace to mild) with some generalized increased heterogeneity of cortical perfusion bihemispherically, all consistent with small vessel disease. No pattern of hypoperfusion on SPECT was seen that would be suggestive of large vessel disease, neurodegenerative disease, or psychiatric disorder. This case illustrates the potential usefulness of functional imaging in identifying changes in perfusion in the absence of structural abnormalities identified on MRI.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 76,\n",
       "    'case_id': 'PMC5698921_01',\n",
       "    'case_text': 'A 76 year old man was admitted to our University Hospital \"Ospedale Vittorio Emenuele\" and seen in our surgical department. He presented with a 3 cm tumefaction of the right hypochondrium, surrounded by an erythematous skin area, with small secretion of a yellowing-green material, attributable to a bile leaking ( Figure 1). The patient\\'s medical history was clear from previous medical disease and surgery; he only referred to previous upper right quadrant pain and nonspecific dyspeptic disorder.\\nAn abdominal ultrasound examination revealed the presence of a lesion in the aponeurotic muscle wall, but the possible underlying pathology was unknown. No other signs of pathology were observed. Routine blood work was normal.\\nAbdominal computed tomography scan with contrast media showed the gallbladder walls had diffuse thickened and blurred edges, and the right and transverse abdominal muscles were almost covered and embedded with minute hypo-dense ailments compatible with relapsing phlogistic processes ( Figure 2). Hepatobiliary MRI detected that the gallbladder had anteriorly shifted and adhered to the right abdominal muscles. The side wall showed a break through with consensual purulent collection, which extruded through the thick abdominal wall ( Figure 3). Eventually, several different-sized stones were revealed inside the cholecyst. Consequently, a diagnosis of spontaneous cholecystocutaneous fistula was made.\\nThe patient underwent cholecystectomy surgery 10 days after diagnosis, with an open laparotomy with en block aponeurotic muscle, skin and fistula orifice excision. In order to have a good abdominal wall reconstruction, a properly shaped Prolene Prosthesis was placed using fibrin glue - . The patient received broad-spectrum antibiotics after surgery (Piperacillin/Tazobactam 4.5 g, 3 times a day for 5 days via IV).\\n Considering the patient\\'s good general condition and good post-operative course, discharge was on the seventh day post-surgery. Surgical wound re-dressing was made one week after discharge in our facility, where the surgical stitches were removed. Scar appearance was good and without concern. No other dressing was needed and the scar was covered with a bandage. The first follow-up was scheduled 15 days after discharge, second one 60 days from discharge. For both follow-ups, routine blood work and surgical scar checking were performed, the results of which were normal and the scar was healing normally. \\nA histological examination confirmed the diagnosis of chronic cholecystitis with gallstones and cholecystocutaneous fistula.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 32,\n",
       "    'case_id': 'PMC10395095_01',\n",
       "    'case_text': 'A 32-year-old lifelong non-smoker Caucasian woman was referred to the G.B. Morgagni:L. Pierantoni Hospital in April 2023 due to a severe respiratory failure caused by PAP syndrome complicated by a right pneumothorax.\\nSince an early age, the patient has been followed by the pediatric department of her hometown hospital, where in 2002 she received the diagnosis of lysinuric protein intolerance. The diagnosis was definite because of the patient\\'s clinical and biochemical situation, as well as molecular analysis, which revealed the presence of mutations in the SLC7A7 gene. The patient also has a homozygous mutation of the MTHFR gene, which codes for methylenetetrahydrofolate reductase, resulting in high homocysteine levels which lead to blood vessels damage and finally strongly increase the risk of blood clots.\\nHer past medical history was also remarkable for a Fanconi-like tubulopathy, low stature secondary due to GH deficit, hyperlipidemia, osteoporosis, and gastritis; from 2010, the patient suffered a progressive accumulation of lipoproteinaceous material in the lungs, resulting in dry cough and slight exertional dyspnea, with diffuse ground glass opacities (GGOs) on HRCT scans, which remained stable during radiological follow-up. On the last follow-up visit, only 1 month previously, the last pulmonary function tests (PFTs) revealed a restrictive respiratory disorder (forced vital capacity:FVC: 57% predicted; forced expiratory volume in the first second:FEV1: 55% predicted; Tiffeneau Index 89% predicted; the patient was not able to perform diffusion capacity for carbon monoxide:DLCO).\\nThe patient was referred to the G.B. Morgagni:L. Pierantoni Hospital in April 2023 due to a rapid onset of acute respiratory failure, complicated by a right pneumothorax. Two weeks before our admission, the patient experienced a respiratory tract infection treated with broad-spectrum antibiotics and chest tube insertion.\\nOn admission, physical examination revealed a blood pressure of 120/75 mmHg, a heart rate of 85 bpm, a respiratory rate of 26 breaths/min, and a hemoglobin oxygen saturation of 78% on oxygen (FiO2 40%) delivered through the nasal cannula; she was afebrile. Subsequently, arterial blood gas (ABG) analysis showed a severe acute type 1 respiratory failure (pH 7.37, pO2 34.5 mmHg, pCO2 40.9 mmHg, PaO2/FiO2 85). The patient was quickly adapted to a high-flow nasal cannula (HFNC) with a FiO2 of 55% and a flow of 60 L/min, which rapidly improved gas exchange and increased hemoglobin oxygen saturation to 91%. Chest auscultation revealed severely reduced respiratory sound and bilateral crackles, while cardiac auscultation was normal. Chest x-ray (Figure 1) showed a right apical pneumothorax (with chest tube previously inserted) and extensive diffuse bilateral consolidations with bronchus sign.\\nSubsequently, high-resolution computed tomography (HRCT) of the chest (Figure 3A) showed areas of diffuse ground glass with superimposed interlobular septal thickening (\"crazy paving\" pattern) and a right pneumothorax.\\nBlood tests showed increased neutrophil count (WBC 16.7 x 109/L, neutrophils 14.9 x 109/L) and reduced hemoglobin levels (Hb 8.0 g/dl). LDH was markedly elevated (1,404 U/L), while CRP and procalcitonin were within normal range.\\nTherefore, the decision was made to proceed with WLL, which was performed on two different days. Under general anesthesia, airway management and lung isolation were achieved using a double-lumen endotracheal tube (DL-ETT). Bronchoscopy confirmed the correct placement of the DL-ETT; a bronchoalveolar lavage revealed a foamy, thick, whitish material, which on rapid on-site evaluation (ROSE) was shown to contain lymphocytes and acellular proteinaceous eosinophilic material.\\nAfterward, the patient was positioned on left lateral decubitus, and single lung ventilation was set with FiO2 100%. During the first procedure, a total of 5,500 mL, in aliquots of 1,000 mL, of warm (37 C) sterile saline solution (0.9% NaCl) were instilled in the right lung (Figure 3B). At each cycle, physiotherapists performed chest percussion maneuvers to optimize proteinaceous fluid clearance over a period of 2 min when the maximum volume has been infused and during the drainage phase.\\nFluid input and output were carefully monitored and registered. However, for safety reasons, the procedure was prematurely discontinued because the patient showed a SpO2 of 42% during the fifth aliquots infusion, probably due to a rapid worsening of mismatch in ventilation/perfusion ratio (V\\'A/Q\\') during the filling phase.\\nThe patient was immediately supinated, and bilateral lung ventilation was restored with a rapid increase of SpO2 up to 91%. The ABG performed showed severe respiratory acidosis (pH 7.07, pO2 94.2 mmHg, pCO2 114.5 mmHg, HCO3- 25.3 mmol/L); blood pressure was 115/65 mmHg, heart rate 98 bpm. Subsequently, the patient was admitted to the intensive care unit and, after the normalization of gas exchange and resolution of respiratory acidosis, extubated in 36 h. During the second procedure, a complete left lung lavage and a partial right lung lavage were performed (Figure 2). The second procedure was better tolerated, and after 24 h ICU, the patient was extubated. In total, 8 L of saline solution (for the right lung) and 7 L of saline solution (for the left lung) were needed to complete the lavage. Chest HRCT (Figure 3C) performed after the WLL showed a dramatic improvement of the GGO and the appearance of a left pleural effusion, possibly secondary to intraoperative hydro trauma, which rapidly responded to diuretic therapy with furosemide.\\nThe patient was discharged without the need for long-term oxygen, with a SpO2 of 97% while breathing room air.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 38,\n",
       "    'case_id': 'PMC9560591_01',\n",
       "    'case_text': \"A 38-year-old woman presented with a slight proptosis. CT scanner and MRI revealed an extra-axial, hyperostotic tumor, suspected to be a spheno-orbital meningioma (Fig. 7 and A; Fig. 7 and B). Observation was initially decided. After 1-year, the tumor grew significantly with worsening of periorbital pain and exophthalmia. There was no history of progestin intake. Ophthalmological examination was normal. An eyebrow incision (Fig. 8 and A) with a crescent-shaped orbital rim craniotomy was performed (Video 1). The eyebrow incision and the entire surgery were performed under the microscope without the need of an endoscope. The endoscope was used at the end to explore the surgical cavity. The small craniotomy was reattached to the skull with miniplates and screws.\\nSupplementary video related to this article can be found at https://doi.org/10.1016/j.bas.2022.100891\\nThe following is the supplementary data related to this article:\\nThe patient's postoperative course was uneventful, without post-operative morbidity. CT and MRI confirmed the complete resection (Fig. 7 and C). The suture was removed on postoperative day 6, and the patient was discharged in perfect clinical condition with a hardly visible scar and regression of proptosis (Fig. 8 and B).\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 46,\n",
       "    'case_id': 'PMC6886636_01',\n",
       "    'case_text': \"A right-handed 46-year-old woman with a history of previously treated peripheral venous insufficiency, and not on any daily medication, was admitted to the Emergency Department 12 hours after the sudden onset of focal hypoaesthesia of her upper left limb. She also referred a frontal, tension-type headache, of moderate intensity with no signs of intracranial hypertension. There were no other focal neurological symptoms, fever or infection, chest pain, epistaxis, haemoptysis or telangiectasias. Family diseases were denied.\\nThe patient was haemodynamically stable (blood pressure 138/42 mmHg; pulse 78 bpm, regular and rhythmic). Her Glasgow Coma Scale was 15/15. Neurological examination revealed touch and pain hypoaesthesia of the left upper limb with no further findings. The patient's National Institutes of Health Stroke Scale (NIHSS) score was 1. Electrocardiogram showed sinus rhythm, without any alterations. Head CT and supra-aortic and intracranial CT angiograms were performed and revealed a recent fronto-insular right infarction.\\nA stroke was assumed and the patient was admitted to the medical ward. No cardiovascular risk factors were identified during hospitalization. Immunological, infectious, endocrine and hypercoagulable states were ruled out. Magnetic resonance imaging (Fig. 1) was performed to assess the extent of cerebrovascular disease and revealed several recent cortical embolic infarctions in both hemispheres: in the bilateral fronto-insular cortex, right posterior temporal lobe and right post-central parietal gyrus. No embolic source was identified on transoesophageal echocardiogram. Venous Doppler ultrasound of both lower extremities carried out 5 days after admission revealed varicose dilatations in both popliteal veins and the right external saphenous vein, absence of the left external saphenous vein, and no evidence of thrombi in the veins.\\nThe physical examination was also remarkable for labial cyanosis and discreet digital clubbing. Blood gas analysis demonstrated hypoxaemia, and an increased alveolar-arterial gradient (AaG) with no response to oxygen therapy, indicating a shunt. Platypnoea was denied, but orthodeoxia was found, with a desaturation of 4% in the supine position. Laboratory findings showed polycythaemia (Hb 17.7 g/dl, Hct 48.6%), erythropoietin (EPO) was elevated, and testing for the JAK2 mutation was negative. D-dimers were elevated at admission (894 ng/ml). Chest x-ray did not show any abnormalities (Fig. 2).\\nContrast-enhanced transthoracic echocardiography (TTE) revealed a right-to-left shunt, with simultaneous opacification of the right and left cavities during the fourth cardiac cycle, indicating an extra-cardiac shunt (Video 1). Patent foramen ovale (PFO) was excluded by transoesophageal echocardiography.\\nFollowing discovery of the shunt, a contrast-enhanced thoracic CT scan was performed, which demonstrated a pulmonary arterio-venous malformation in the right lower lobe, showing communication between the subsegmental branch of the right inferior lobar artery and the tributary vein of the right inferior pulmonary vein, with a diameter of 25x21 mm in the axial plane (Video 2).\\nNeurological deficits stabilized, but left upper limb hypoaesthesia remained. The patient was discharged under oral anticoagulation with warfarin, and was later referred for embolization of the lesion by the Interventional Radiology department. No new events had occurred at the time of follow-up consultation.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 24,\n",
       "    'case_id': 'PMC8327232_01',\n",
       "    'case_text': 'It is about a 24-year-old male patient suffering a dental trauma at the level of the anterior upper teeth. The patient presented with fractured upper central teeth and a mobility of the coronal fragment of tooth 12 due to the trauma.\\nIn this article, we focused on the maxillary right lateral incisor, with respect to the patient constent. Inspection revealed the presence of a healthy periodontium with pulpal exposure. The retro alveolar radiograph showed a long root of the tooth with no fracture and no apical radiolucency (Figures 1 and 2). After removing the coronal fragment, we noticed a lack of supragingival tooth structure required to guarantee a reliable long-lasting restoration. The next steps consisted in evaluating the radicular length, the absence of an apical curvature, and the width of the remaining radicular and coronal walls to discuss the feasible treatment options for saving the tooth.\\nAfter a global clinical examination, surgical tooth extrusion, consisting in crown lengthening technique, was performed to maintain a healthy supracrestal healthy tissue, thus offering to the patient a reliable long-term outcome. The clinical procedures involved, at first, endodontic treatment. It was conducted prior to surgical extrusion. Canal preparation was carried out using rotary instrumentation system (Revo S , Micro Mega, France). It was accompanied by intracanal irrigation using 2.5% NaOCL and 17% EDTA as a final irrigation. At the same clinical consultation, the canal was dried with sterile paper points. The root canal was filled with gutta-percha (ProTaper Universal Gutta Percha Points, Meta Biomed, South Korea) and root canal sealer, using the lateral condensation technique. The coronal seal was provisional. After 1 week, the surgical extrusion procedure was performed.\\nAfter disinfection of the area using mouthwash of 0.12% of chlorhexidine (KLOREX fort, STODERMA, Tunisia), local anesthesia with 2% of lidocaine was administered. Syndesmotomy was performed using a syndesmotome, placed in both the buccal and palatal sides. A fine elevator was used to carry out tooth luxation. It was placed in the periodontal space and manipulated in a walking motion all around the tooth without causing surgical trauma. Minimally, traumatic luxation forces were applied just at the first 4 mm of the radicular structure to avoid periodontal ligament damage.\\nThe tooth was carefully extruded to the desired situation using root forceps and it was placed at a level such that the fractured margin would be situated at least 3 mm from the alveolar crest, while being kept inside the socket. It is important to limit the extrusion quantity to preserve an adequate crown-root ratio that should always be inferior to 1.   The tooth was maintained at the radicular portion, supposed to be kept in a supra-bony position after the procedure. A slight pressure was applied in a bucco-palatal direction, using a gauze, to obtain hemostasis and to keep the tooth in the right position. Simple interrupted sutures were placed to stabilize the tooth. A 0.3-mm diameter monofilament (violet braided of PGA Lac Synthetic Absorbable Suture, NEOFIL+) was used to achieve primary stabilization, thus obtaining a correct reorganization of the periodontal ligament fibers.   After that, a semi-rigid splinting was placed using a flowable nano-hybrid composite (Reflectys Flow, ITENA, France) on the adjacent teeth. Special attention was exerted to release the interdental septum so that it would be easy for the patient to keep it clean. The patient was instructed to use a daily mouthwash with 0.12% of chlorhexidine for 1 week to thoroughly clean the area. Only analgesic was prescribed post-operatively (Figure 3). The sutures were deposed after 10 days to avoid surgical site infection. In fact, microbes adhere to the suture filament and form biofilms. The knot is the principal site of infection. Typically, they should be left in place no longer than 2 weeks.   Splinting was removed 15 days post-operatively. In fact, the risk of ankylosis increases when the splint is kept for more than 3 weeks.   Actually, a slight mobility during the periodontal healing period is favorable.   Six weeks later, the extruded tooth mobility was clinically acceptable. In fact, the periodontal ligament acquires its characteristics 45 days post-operatively.   Then, a fiber post (Fiber Post Refill Dentoclic, ITENA Clinical Dental Post, France) was placed to ensure correct height to the core preparation. It was cemented with a dual core composite cement (Dentocore Body, Core Build-up, ITENA) that was utilized as a core build-up material to rebuild the missed coronal tooth structures (Figure 4). A crown preparation was performed and a temporary crown was cemented. Six months post-operatively, impressions were taken and a final ceramic crown was placed (Figures 5 and 6). After 2-year follow-up, complete periapical bone formation is observed with a periodontal tissue repair (Figure 7).',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': None,\n",
       "    'case_id': 'PMC5109712_01',\n",
       "    'case_text': 'We report a case of a man in his 80s who initially noted a lesion on his right back thought to be an infected cyst in 2014. Evaluation noted right axillary adenopathy, which prompted a biopsy of the mass and of the cyst-like lesion. Pathology demonstrated morphologic and immunohistochemical (strongly cytokeratin-20, neuron specific enolase and CD56 positive and thyroid transcription factor-1 negative) findings in both lesions consistent with MCC. Polymerase chain reaction performed on deoxyribonucleic acid extracted from formalin-fixed, paraffin-embedded tumor tissue alongside appropriate controls using a previously described protocol demonstrated that the tumor lacked detectable Merkel cell polyomavirus (MCPyV) large T antigen and small T antigen. Staging fluorodeoxyglucose-positron emission tomography/computed tomography (FDG-PET/CT) revealed lesions in right upper lung, right upper back, right axilla and right adrenal gland consistent with metastatic disease (Fig. 1a, b and c). Subsequent biopsy of the right lung confirmed metastatic MCC. Following extensive discussions regarding the implications and options, he refused chemotherapy. At that time, no clinical trial was available to him, but programmed death-1 (PD-1) inhibitor therapy was being tested on trial (ClinicalTrials.gov. NCT02267603). Nivolumab, a humanized IgG4 monoclonal anti-PD-1 antibody, was obtained from Bristol-Myers-Squibb outside of a clinical trial, and he was subsequently treated with nivolumab 3 mg/kg intravenously every 2 weeks for six cycles in 2015. Following two cycles, he had an excellent partial response on physical exam with decreased adenopathy. After five cycles, he achieved a marked partial metabolic response by FDG-PET/CT (Fig. 1d, e and f). He continued on therapy, but after cycle six, treatment was complicated by pneumonia and autoimmune hepatitis. He improved on intravenous steroids at an outside hospital and was discharged on prednisone 1 mg/kg per day. He completely recovered with a slow steroid taper, and no further treatment with nivolumab was given. He continued on surveillance alone for 8 months, and his disease remained well controlled with no recurrence on physical exam and at least an excellent partial response in his distant metastasis with no new sites of disease.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 18,\n",
       "    'case_id': 'PMC2828432_01',\n",
       "    'case_text': \"An 18-year-old Caucasian, Italian girl, with a history of occasional use of inhaled drugs, was admitted to the Tor Vergata University Hospital emergency room because of fever, nausea, malaise, and difficult walking. The patient had been healthy until three days before admission, when she developed fever. She had no history of intravenous drug use, recent dental procedures, heart murmurs or cardiac abnormalities. Six months earlier, she had had her nasal septum pierced, and subsequently she frequently removed her jewellery to hide it from her parents, putting it back in place again later.\\nOn admission, physical examination revealed hypotension, dehydration and a clinical presentation suspicious for sepsis, with multiple Janeway lesions on the volar surface of her feet and hands, furunculosis on the legs and Osler lesions on the periungual area of two fingers. Neurological examination revealed a mild cognitive deficit, left extremity weakness and incapacity to coordinate the left side of her body. At the level of the nasal septum, an erythematous, ulcerative bleeding lesion was present in the mucosa previously perforated by a nasal piercing.\\nBlood cultures obtained on admission were strongly positive for a blood-borne staphylococcus aureus (S. aureus) infection. Whole body computed tomography (CT) (Figure 1a) revealed two contrast-enhancing lesions within the left cerebellar and occipital cerebral regions, suggestive of septic emboli. Multiple similar lesions were observed in the liver, spleen and kidneys (Figure 1b). Fundus oculi revealed septic emboli (Roth lesions). Serial trans-thoracic echocardiography showed a pedunculated 15 x 13 mm vegetation sitting on the anterior mitral leaflet at the level of the postero-medial commissure, which was considered embolizing, according to the brain magnetic resonance imaging (MRI) findings. A mild mitral valve incompetence was also detected (Figure 2).\\nBroad-spectrum antibiotic therapy with gentamycin, vancomycin and linezolid was initiated. When the antibiotic assay demonstrated a methicillin-sensitive S. aureus strain (MSSA), vancomycin was replaced with oxacillin. After 6 days of treatment, the patient remained febrile, with blood cultures still positive for MSSA, prompting the addition of tigecycline to the antibiotic regimen.\\nOn the eighth day following the admission, a whole body CT demonstrated reduction in spleen, kidney and liver size and number of lesions. However, MRI of the brain revealed abscessualization of the cerebellar lesions (Figure 3).\\nOn day 11 of treatment, the patient's condition improved and fever had disappeared. In order to remove the vegetation dangerously fluctuating in the left atrial cavity and correct the mitral valve incompetence, although the duration of antibiotic therapy was deemed not yet complete, surgical intervention was performed on April 1, 2008 by means of median sternotomy, cardiopulmonary bypass and antegrade tepid blood cardioplegia. The vegetation was removed and a posteromedial commissuroplasty was performed.\\nThe immediate postoperative course was uneventful, and echocardiographic controls revealed a well functioning mitral valve. However two weeks after surgery heart failure developed and the patient presented with increasing dyspnoea, tachycardia and a new systolic murmur. Transthoracic echocardiography revealed massive mitral insufficiency with concomitant pulmonary hypertension. For these reasons, a new surgical procedure was required and performed on April 23, 2008. The anterior leaflet of the mitral valve, partially destroyed by the infection, was repaired with an autologous pericardial patch and an A3-P3 edge-to-edge valvuloplasty technique was employed to complete the mitral valve repair. A prosthetic ring was then sutured to the posterior segment of the mitral annulus to stabilize the repair.\\nPostoperatively, linezolid, tigecycline and oxacillin were administered for 40 days. Subsequently ceftriaxone and rifampicin were administered until the cerebellar lesions were no longer evident on MRI.\\nThe patient was uneventfully discharged on the fortieth postoperative day. A long term antibiotic treatment was prescribed in order to completely eradicate the cerebellar abscesses. Serial echocardiographic examinations were performed. At one year follow-up the patient appeared to have fully recovered and the mitral valve was functioning showing only trivial regurgitation.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 50,\n",
       "    'case_id': 'PMC5484424_01',\n",
       "    'case_text': 'A 50-year-old female with body mass index (BMI) of 36 kg/m2 and untreated hypertension presented to an outside facility with left arm numbness and weakness and new-onset seizure. She was treated with levetiracetam. Computed tomography (CT) of the head along with CT angiography (CTA) was obtained which showed a right basal ganglia hemorrhage measuring about 3 cc (Figure 1). Her blood pressure was initially 157/100 mmHg and controlled with nicardipine infusion. Subsequent blood pressure was 132/70 mmHg. Her international normalized ratio (INR) was 1.0. She was not taking anticoagulants or antithrombotics. While in the emergency department, her neurological examination rapidly worsened. She was intubated for airway protection and was transferred to the neurosciences intensive care unit (NSICU).\\nOn arrival to the NSICU, she was on a nicardipine infusion for blood pressure control. Her blood pressure was well controlled initially in the 130/90 s range but acutely fell to 80/50 s. The infusion was immediately stopped. Patient was bolused with normal saline and started on norepinephrine infusion. She subsequently became unresponsive to central or peripheral noxious stimulation. She had absent brainstem reflexes except for over breathing the respirator. She was hyperventilated and given 100 g of mannitol. Train-of-four was then performed and showed four twitches. Repeat CT of the head showed hematoma expansion to 47 cc with intraventricular extension (Figures 2 and 3). There was now effacement of the basilar cisterns as well as uncal, central, and tonsillar herniations (Figures 2 and 3).\\nOver the course of the next day, she stopped breathing over the ventilator. Confounding variables on the neurological examination were excluded (Table 1). Brain death testing ensued. She was found to have brainstem areflexia. Prior to apnea testing, her core temperature was 36.1 C, systolic blood pressure was 141 mmHg, and PaCO2 was 39.6 mmHg. After pre-oxygenation, her PaO2 was 83 mmHg. With continued pre-oxygenation, the PaO2 increased to 279 mmHg (Table 2). She was subsequently disconnected from the ventilator with 5-6 liters per minute of oxygen delivered via red rubber catheter to the carina. During testing, there were no cardiopulmonary complications. Her systolic blood pressure remained 140 mmHg without any vasopressors. Her oxygen saturation remained 96.2%-99.3%. There were no cardiac arrhythmias or respiratory movements. However, the duration of the apnea testing was 110 min before PaCO2 reached the required level of >60 mmHg and serial blood gas analysis was obtained during this entire 110 min (Table 2).\\nAt the end of the apnea testing, she was reconnected to the ventilator. It was then noticed that she had tidal volumes of 30-35 cc with a \"respiratory rate of 44\" which corresponded to her heart rate on telemetry (Figure 3). Given the unusual duration of apnea testing, ancillary testing was subsequently completed. Four-vessel cerebral angiography confirmed cerebral circulatory arrest (Figure 4). Autopsy was declined.\\nThis case report was approved by the institutional review board.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 67,\n",
       "    'case_id': 'PMC6348503_01',\n",
       "    'case_text': 'A 67-year-old female visited our hospital after having oliguria for 1 week without other symptoms. She had no history of tobacco use or other toxic exposures. She had hypertension and well-controlled diabetes. No fever or lymphadenopathy was found on physical examination. Routine hematological and biochemical tests revealed anemia (hemoglobin 10.1 g/dL), a high level of serum lactate dehydrogenase (307 U/L), and renal dysfunction (blood urea nitrogen 71.1 mg/dL and creatinine 9.8 mg/dL). Ultrasonography and computed tomography (CT) demonstrated an irregular thickening of the posterior wall of the bladder and bilateral hydronephrosis (Figure 1(a) and (b)). Growth of a non-papillary tumor in the posterior wall of the bladder was noted on cystoscopy. After percutaneous nephrostomy placement, transurethral biopsy of the bladder tumor was performed for histopathological diagnosis. The hematoxylin- and eosin-stained biopsy specimen presented diffuse heterotypic lymphocytes with irregularly shaped nuclei. The tumor cells were positive for the B-cell markers CD20 and LCA on immunohistochemistry (Figure 2). Additional immunohistochemical stains showed that the tumor cells were positive for CD10 and BCL6, but negative for MUM1. Based on these results, the patient was diagnosed with DLBCL of the bladder and classified as germinal center B-cell (GCB) subtype according to Hans algolism. For further investigation, 18F-fluorodeoxyglucose-positron emission tomography (FDG-PET/CT) was performed, revealing abnormal accumulation in the right iliac internal lymph nodes (Figure 1(c)). No leukemia or lymphoma was found on bone marrow biopsy. These findings indicated that the patient had stage IV (Ann Arbor classification) advanced bladder lymphoma.\\nAfter the patient returned to the normal renal function, the patient underwent six 5-day cycles of R-CHOP (rituximab 350 mg/m2, cyclophosphamide-750 mg/m2, doxorubicin 50 mg/m2, vincristine 1.4 mg/m2, and prednisone 70 mg/day) every 3 weeks, followed by two cycles of rituximab alone. The lesions in the bladder, right internal lymph nodes, and bilateral hydronephrosis had completely regressed without nephrostomy stents at the end of treatment. Subsequent follow-up evaluation, including cystoscopy and CT of the abdomen and pelvis, was performed at 3-month intervals for 3 years. Recurrence was not noted on any of these follow-up examinations.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 5,\n",
       "    'case_id': 'PMC3447230_01',\n",
       "    'case_text': \"When observing the twins' audiograms at 3.5 years old, just after CI, (Figure 3), the pure tone thresholds for most frequencies were very similar. Thus, it would be reasonable to assume their auditory and oral performance scores would also be similar. However the speech perception tests performed after 5 years of CI use (Figure 4), show that the twin girl (ICC88, III : 7) had an overall good performance throughout the tests while the twin boy (ICC89, III : 6) got poorer results, had difficulties regarding some of the age appropriate tests that are part of the standard evaluation, and was not even able to respond to some of the tests.\",\n",
       "    'gender': 'Female'},\n",
       "   {'age': 6,\n",
       "    'case_id': 'PMC3447230_02',\n",
       "    'case_text': \"Could the differences in auditory and oral outcomes on post-CI rehabilitation be related to the different DFNB1 genotypes? Further analysis of the family history showed that other factors could be playing an important role and contributing for the differences observed. The twins had not lived together in the same hearing environment as previously assumed. On the contrary, each of them came from a different social background. The twin girl has lived since she was 6 months-old with their hearing aunt, and uncle (II : 1 and II : 2) and has been educated in a regular school with special education and speech therapy while the twin boy lived until 7 years-old with the hearing impaired parents, who only used sign language as mode of communication, thus in a poor auditory stimulating environment, only having contact with other deaf children, and with some household problems. In 2009, through legal decision, he moved in with his sister, aunt and uncle (II : 1 and II : 2) and integrated regular school with special education and speech therapy. The audiological tests from the last three years revealed the twin boy's favourable evolution since this social alteration (Figure 5). The positive effect of the auditory and oral stimulation observed in the twin since he moved to his aunt highlights the importance of the auditory stimulating environment in the success of the post-CI rehabilitation.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 24,\n",
       "    'case_id': 'PMC5491809_01',\n",
       "    'case_text': 'A 24-year-old woman with UC diagnosed 2 years previously was transferred to our hospital due to a 1-week history of a high-grade fever, bloody diarrhea, frequent bowel movements, and severe pain on the left side of the abdomen. Her UC was not well controlled with an oral 5-ASA therapy, so she was started on IFX in July 2014. She had already received the induction doses as well as 8 maintenance doses at 5 mg/kg, and she had maintained clinical remission for about 1.5 years. The final administration was 8 weeks prior to the start of the above-mentioned symptoms. She had neither history of travel nor any recent exposure with sick individuals, and her medical history was unremarkable except for UC. On a physical examination, the patient was febrile (39.5 C) with mild tachycardia, and an abdominal examination revealed moderate tenderness with hyperactive bowel sounds and mild rebound tenderness in the left side of the abdomen.\\nHer laboratory examination revealed a decreased albumin of 3.4 (g/dL), elevated C-reactive protein of 8.53 (mg/dL), elevated erythrocyte sedimentation rate of 47.1 (mm), elevated white blood cell count of 124 (102/muL), with 81.0% neutrophils (normal range: 42-77%), hemoglobin within normal limits at 13.0 (g/dL), blood platelet count within normal limits at 29.9 (104/muL), negativity for hepatitis B virus antigen and antibody, negativity for hepatitis C virus antibody, negativity for chlamydia trachomatis antibody, negativity for syphilis, beta-D-glucan within normal limits at <6.0 (pg/mL), negativity for tuberculosis bacterium specific interferon gamma, and negativity for cytomegalovirus antigen. Polymerase chain reaction analyses were negative for both cytomegalovirus and tuberculosis bacterium genes in the colon lesions. No significant pathogens, including bacteria, fungi, viruses, and parasites, were isolated from her blood or were found in the contents of her colon. She tested negative for HIV and human T-lymphotropic virus type (HTLV)-I viruses.\\nColonoscopy on admission revealed widespread shallow ulcers in the rectum and coarse mucosa with mucous, pus, and blood in the sigmoid colon (Fig. 1A and B). The mucosal vascular pattern disappeared, and the erythematous mucosa was friable and bled easily. Although there were no active UC findings from the cecum (terminal ileum) to the splenic flexure (Fig. 1C), we found long luminal edematous swelling and multifocal discharge of pus throughout the descending colon (Fig. 1D and E). The mucosa of the descending colon appeared to be nearly intact. Computed tomography immediately after colonoscopy showed a diffusely thickened wall with a narrowed lumen and intramural air-filled abscess cavities and multifocal low-density areas of abscesses (Fig. 2), particularly within the wall of the descending colon. There were no diverticula of the colon, which was confirmed by the prior findings of colonoscopy and computed tomography. Antimicrobial therapy with doripenem hydrate 0.5 g intravenously every 8 h was started, as well as intravenous hyperalimentation. 2 weeks after starting treatment, she became afebrile and pain-free, and her C-reactive protein level was normalized. Oral intake was restarted with an elemental diet, and she was later discharged home after confirmation of the improvement of her condition via colonoscopy (Fig. 3A and B) and computed tomography (Fig. 3C). She is still being followed up at our out-patient department, and both oral and anal administration of 5-ASA have maintained clinical remission of her UC. IFX has not been reintroduced.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 59,\n",
       "    'case_id': 'PMC8329603_01',\n",
       "    'case_text': 'Our patient is a man aged 59 years, and is currently employed in an office, who suffers from an asymmetric overgrowth of the lower limbs. This pathology is benign and localized. The abnormal growth process of the left leg began at the age of 18 months and led to the amputation of the distal phalanx of the second finger, which was repeated for recurrence at the age of 4 years. At 35 years the patient underwent subtotal amputation of the first finger and the removal of calcification of the back of the left foot. At the age of 40, he underwent surgical revision of the first finger and amputation of the distal third and fourth finger phalanges.\\nOver the years, cerebriform connective tissue nevi (CCTNs) has developed on the left upper limb and has undergone surgical treatment of the suspected malignant nevi.',\n",
       "    'gender': 'Male'},\n",
       "   {'age': None,\n",
       "    'case_id': 'PMC8329603_02',\n",
       "    'case_text': \"The patient's speech is fluent and his understanding complete. He presents with good personal and social fulfillment (there are no malformations that can disturb the aesthetic appearance of the face). General conditions of the patient are good, from the diagnostic tests performed (medical visit, E.K.G., ultrasonography, spirometry) there are no alterations of the cardio-circulatory system, pulmonary or sensory apparatus. Laboratory tests are normal.\",\n",
       "    'gender': 'Male'},\n",
       "   {'age': None,\n",
       "    'case_id': 'PMC8329603_03',\n",
       "    'case_text': 'Currently the patient presents with malformations of the lower left limbs (hip, knee and ankle), evident on the articular and periarticular level, where there are diffuse exostoses. At the hip level, the exostotic formations do not result in reductions of the joint range of motion (ROM). More serious is the situation proceeding distally, where the knee malformations reduce the ROM in a range between 27 and 90 degrees in flexion-extension. At the level of the medial tibial segment a bone exostosis is found on the deep planars, ~4 cm of diameter ( Figure 1, Figure 2).\\nIn 1989 the tibial area was the site of surgical removal of an intra and extra capsular fibrolipomatous bulk, about 5 cm in diameter, excision of an intra-articular mobile body, medial transposition of the patellar tendon with insertion of metal plaque and transposition of the tendon insertion of the vast medial. The ankle condition appeared even more severe, with full ankylosis in plantar flexion of 32 degrees. Both the ankle and the foot appeared to be twice the size of the contralateral limb for bone hyperplasia and connective tissue ( Figure 3, Figure 4).',\n",
       "    'gender': 'Unknown'},\n",
       "   {'age': None,\n",
       "    'case_id': 'PMC8329603_04',\n",
       "    'case_text': 'Movement of the patient. The patient has a gait abnormality (limp, asymmetrical, slower than normal), which currently does not require aids on level ground. Uphill movement causes bending of the torso with increased effort, therefore where the risk of falling increases (e.g. while descending the stairs) support with a stick is required.',\n",
       "    'gender': 'Unknown'},\n",
       "   {'age': None,\n",
       "    'case_id': 'PMC8329603_05',\n",
       "    'case_text': 'The patient, due to the high risk of falling while using the stairs, has to be highly concentrated and a handrail is required. The deficit is increased by the sharp decrease in proprioceptive and exteroceptive sensitivity of the left foot plantar, which is housed in custom-made orthopedic footwear.\\nThe impairment of walking leads to functional overload of the lower right limb with episodes of low back pain and homolateral coxalgia.',\n",
       "    'gender': 'Unknown'},\n",
       "   {'age': None,\n",
       "    'case_id': 'PMC8329603_06',\n",
       "    'case_text': 'Our patient reported that based on the clinical characteristics, a diagnosis of proteus syndrome was issued at 18 months.',\n",
       "    'gender': 'Unknown'},\n",
       "   {'age': 54,\n",
       "    'case_id': 'PMC8329603_07',\n",
       "    'case_text': \"However, a recent genetic study performed in the patient at the age of 54 years highlighted the absence of the characteristic mutation present in proteus syndrome, suggesting a different diagnosis. The detection of the PIK3CA gene mutation (c.3140A> G), together with the clinical aspects of the patient, suggests a diagnosis of fibro-adipose hyperplasia syndrome (FHS), characterized by a congenital, progressive and localized overgrowth of fibrous and adipose tissue and bone. The FHS is part of the broader category of syndromes termed PIK3CA-related overgrowth spectrum (PROS), which includes LOVES, FHS, macrodactyly and megalocephaly syndrome. To date, the only treatment expected to slow down uncontrolled tissue growth is surgical resection. The aim of genetic research is to use 'target therapies', such as molecular inhibitors of the PI3K/AKT /mTOR pathway, currently used in oncology, which may slow down if not reverse the characteristic hyper-growth of these syndromes. Objective assessment of neuromuscular function can help the occupational medicine specialist to better evaluate global impairment and the presence of symptoms .\\nWe performed no therapeutic intervention since no health issue was present at the clinical evaluation. However, since the patient's job had recently changed from administrative tasks to an activity characterized by more frequent contact with the public (more standing up and moving around for the worker), we ergonomically evaluated and adjusted the patient's workplace.\",\n",
       "    'gender': 'Unknown'},\n",
       "   {'age': None,\n",
       "    'case_id': 'PMC8329603_08',\n",
       "    'case_text': \"The patient's work environment consists of an office on the second floor where the patient carries out activities on a PC connected to the administration of the library where he works. His work chair is comfortable, allows height adjustment and an inclination of the backrest; the desk is spacious, ergonomically organized and allows comfortable housing of the legs of the subject. To allow the comfortable support of the foot, a stool was provided to the patient.\",\n",
       "    'gender': 'Male'},\n",
       "   {'age': None,\n",
       "    'case_id': 'PMC8329603_09',\n",
       "    'case_text': \"Movements at the workplace are very limited and of short duration; however, given the limitations of the patient's movement, the use of the stairs must be limited and the use of a dedicated elevator is required. Therefore, to allow travel to and from the workplace, the patient was reserved a flat parking space, and an elevator located at the parking level to his workstation was provided, as well as to the entire library area and related offices.\",\n",
       "    'gender': 'Male'},\n",
       "   {'age': None,\n",
       "    'case_id': 'PMC8329603_10',\n",
       "    'case_text': 'The main occupational concern that could create critical issues with patients with this type of syndrome with restricted movement would be in the event of an emergency exodus, e.g. fire. Therefore, various measures and simulations were put in place to assess and reduce the risk for this patient in an event such as this.',\n",
       "    'gender': 'Unknown'},\n",
       "   {'age': None,\n",
       "    'case_id': 'PMC8329603_11',\n",
       "    'case_text': \"For our patient, the maximum distance between a safe place to go to in event of an evacuation (as determined by the fire department, which was on a level) and the patient's workstation or other places of work the patient occasionally frequented, such as reading room and book store, was <30 meters. A simulation was carried out at the patient's workplace by the patient to assess the time taken for arrival at the safe place from the usual workstation (30 seconds) and from a more distant location (45 seconds), which seem to be acceptable times for the worker to keep in safe.\",\n",
       "    'gender': 'Unknown'},\n",
       "   {'age': None,\n",
       "    'case_id': 'PMC8329603_12',\n",
       "    'case_text': 'The presence of an automatic fire detection and extinguishing system may constitute a risk element for our patient as it maked the floors more slippery, increasing the risk of falls. Therefore, a training plan aimed at emergency evacuation and a specific exercise was planned for the entire staff. In addition, two work colleagues were trained specifically for the assistance of the patient, and a tested evacuation and transport chair (model PRO-SKID by SPENCER) was purchased to descend the external fire escape stairs.',\n",
       "    'gender': 'Unknown'},\n",
       "   {'age': None,\n",
       "    'case_id': 'PMC8329603_13',\n",
       "    'case_text': 'We assessed the outcomes of the change in workstation at 6 months. The patient reported increased work comfort and a regular use of the elevator located at the parking level to reach his workstation. He reported no falls during the last 6 months and no accidents have occurred.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 50,\n",
       "    'case_id': 'PMC6450236_01',\n",
       "    'case_text': 'A 50-year-old man referred to cardiological examination for exertional dyspnea lasting several months. He was always been fine, so he had never made any medical evaluation. He never smoked, and he never got any drugs. He was asymptomatic at rest. The vital signs were heart rate - 75 beats/min (bpm), blood pressure - 135/80 mmHg, and oxygen saturation - 94% on room air. He had mild reduced breath sounds on both lungs, cardiac auscultation showed a soft systolic murmur, and mild peripheral edema was observed. Electrocardiogram (ECG) demonstrated sinus rhythm, heart rate - 75 bpm, right bundle branch, and left anterior fascicular block. Transthoracic echocardiography showed normal left ventricular chamber size and wall thicknesses (end-diastolic diameter 48 mm, interventricular septum 10 mm, and posterior wall 9 mm) [Figure 1] and normal systolic function (Simpson rule ejection fraction 60%); right ventricle was dilated (basal diameter 46 mm) [Video 1] with preserved longitudinal systolic function (TAPSE 24 mm, S\\': 12 cm/s). There was paradoxical movement of interventricular septum due to volume overload in right ventricle. Estimated systolic pulmonary pressure resulted increased (55 mmHg). There was no pericardial effusion, and inferior vena cava was mild dilated (21 mm) with reduced respiratory excursions. Color-Doppler showed a significant left-to-right shunt both at interatrial and interventricular septum [Figure 2], and moderate mitral valve regurgitation was present probably due to a cleft in the anterior leaflet [Figure 3]. We suspected an atrioventricular (AV) canal diagnosis, but unfortunately, the acoustic window did not allow the whole understanding of cardiac defect anatomy. Thus, a transesophageal echocardiography (TEE) was performed in every echocardiographic sections, providing detailed anatomical information. Unluckily, poor tolerance of patient on the probe did not allow a good quality of transgastric view. It demonstrated: A 25 mm ostium primum defect with hemodynamically significant left-to-right shunting, a \"cleft\" in the anterior leaflet leading to moderate regurgitation of AV valve, a restrictive small ventricular septal defect [Figures 4,5 and Videos 2,3]. Diagnosis of transitional AV defect was done. Three-dimensional (3D) echocardiography might be useful to provide better visualization and understanding of the anatomy of the cardiopathy than 2D imaging. Unluckily, our center has no 3D echocardiography yet. However, 2D TEE allowed the correct diagnosis. Thus, oral diuretic therapy was recommended. The patient was inserted on the waiting list for an elective hospitalization to perform right cardiac catheterization, coronary angiography, and reparative cardiac surgery.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 70,\n",
       "    'case_id': 'PMC4276263_01',\n",
       "    'case_text': 'A 70 year old man presented to our hospital with a painful left-sided inguinal swelling of one day duration. The patient gave history of asymptomatic left inguinal swelling from past 20 years and absence of the right testis since birth.',\n",
       "    'gender': 'Male'},\n",
       "   {'age': 4,\n",
       "    'case_id': 'PMC4276263_02',\n",
       "    'case_text': 'The patient was phenotypically male with normal secondary sexual characters. He had been married for fifty years and was having 4 children, the youngest one being 38 year old female. General physical examination revealed a man of sub-average built with well developed secondary sexual characters. His urethra and penis were fully developed with a poorly developed right hemi-scrotum and no palpable right testis in the scrotum or inguinal canal. The left hemiscrotum was well developed and left testis was palpable in scrotum.\\nThere was a non-reducible, tender swelling measuring approximately 10 x 8 cm in the left inguinal region with absent cough impulse. Baseline investigations were normal. Patient was prepared for surgery after obtaining a written consent. Exploration of the inguinal canal revealed an indirect inguinal hernia containing a globular structure resembling uterus, fallopian tubes with an atrophic right testis embedded in the broad ligament and attached to pelvis with a thick fibrous band [Figs. 1 and 2]. Total excision of the uterus with fallopian tubes and atrophic right testis was performed and the operation was completed with left inguinal hernioplasty [Figs. 3 and 4]. Our patient had an uneventful post-operative period. Grossly, the specimens removed were identified as a uterus with patent endometrial and endocervical linings and two fallopian tubes. The right testis measuring 2 x 1 x 1 cm, was atrophic and embedded in the right broad ligament. The specimen was sent for histopathological examination which revealed uterine muscular tissue with its cavity lined by endometrial tissue and congested fallopian tubes. No ovarian tissue was seen. Sections from right testes showed atrophic semineferous tubules, Sertoli cells and Leydig cells. No evidence of malignancy was seen in tissue samples from testicle. Post-operative karyotype analyses of the patient revealed 46, XY.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 25,\n",
       "    'case_id': 'PMC9282816_01',\n",
       "    'case_text': \"A 25-year-old female presented with the left dull mid-back pain for 3 months' duration. The pain was moderate and radiated to the left breast/precordium. The physical examination just revealed focal tenderness over the inferior angle of the left scapula/7th costovertebral junction, without swelling or erythema.\\nThe patient had a raised erythrocyte sedimentation rate of 40 and C-reactive protein of 6. Serological testing for HIV, hepatitis B, and hepatitis C was all negative.\\nThe anteroposterior X-rays of the thoracic spine showed that the T7 vertebral body was scalloped on the left side, and there erosion of the T7 left pedicle and adjoining rib [Figure 1]. The MR showed; a left-sided T7 enhancing periarticular erosive lesion, marrow edema in the posteromedial portion of the left 7th rib, the left posterolateral portion of the T7 vertebral body, and lateral left T7 pedicle. There was also thickening/ enhancement of the synovium of the left 7th costotransverse joint with enhancing soft tissue elevating the overlying pleura, and abutting the descending aorta [Figure 2]. A CT-guided biopsy was diagnostic for TB; it demonstrated caseous necrosis with epithelioid and Langerhans giant cells [Figure 3]. In addition, GeneXpert detected Mycobacterium tuberculosis that showed sensitivity to both isoniazid and rifampicin.\\nATT for the first 4 months included rifampicin, isoniazid, pyrazinamide, and ethambutol (HRZE) (intensive phase). For the next 8 months, the patient received rifampicin and isoniazid (HR) (continuation phase). At follow-up (12 months), the patient showed clinical and radiological signs of healing [Figure 4].\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 40,\n",
       "    'case_id': 'PMC10084577_01',\n",
       "    'case_text': 'The comparative results of clinicopathological characteristics of patients under 40 years old and over 40 years old are exhibited in Table 3. The tumor distribution pattern, interstitial inflammatory infiltration (Degree and Distribution pattern), concomitant or non concomitant breast tumor and lymph node metastasis between patients younger and older than 40 years old were various (P < 0.05). The 2 groups are basically the same in the lymphovascular embolization and the prognosis (P > 0.05).',\n",
       "    'gender': 'Unknown'}],\n",
       "  [{'age': 14,\n",
       "    'case_id': 'PMC6332946_01',\n",
       "    'case_text': 'A 14-year-old boy, who was initially examined for continuous coughing, was referred to our hospital owing to an anterior mediastinal mass identified on chest X-ray (Figure 1). Systematic examination revealed a 20 x 10 cm sized mass at the right anterior mediastinum that involved the right pulmonary vein and elevated levels of alpha fetoprotein (AFP), a tumor marker, at 3825 ng/ml. Needle aspiration was performed, but only necrotic tissue could be collected. We did not analyze the karyotype since the symptoms suggesting the Klinefelter syndrome were not observed. Therefore, a clinical diagnosis of malignant teratoma was made, and three courses of cisplatin-based chemotherapy were administered because AFP levels continuously increased. After chemotherapy, AFP levels decreased, although the size of the tumor did not change, as evident in a computed tomography (CT) scan. Next, tumorectomy and total right lung extraction were performed. The pathological diagnosis of the extracted tumor was malignant teratoma with areas of yolk sac tumor (Figure 2). No cancer cells were found at the edges of the area where the tumor was removed. Two courses of cisplatin-based postoperative chemotherapy were administered until AFP levels were normal.\\nAfter 3 months of follow-up, the patient experienced pain in his right hip joint while AFP was still normal. The 99mTc-methylene diphosphonate bone scan showed increased tracer uptake at the left forehead and right hip joint (Figure 3). Head and pelvic MRI also revealed signs of metastasis at the left forehead and right hip joint. Abdominal CT showed a metastatic region in the liver. Bone biopsy was performed at the left forehead. The pathological diagnosis was metastatic malignant melanoma originating from an immature teratoma of mediastinum (Figure 4). Large heteromorphic cells with melanin were found in the original mediastinal malignant teratoma by retrospective re-examination. This suggested that a section of the malignant melanoma in the original malignant teratoma, which was composed of various components, metastasized. Because of the very fast disease progression, after consultation with the family, aggressive treatment was discontinued, and palliative therapy was provided. He died 15 months after diagnosis of the original malignant teratoma.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 27,\n",
       "    'case_id': 'PMC4866062_01',\n",
       "    'case_text': 'A 27-year-old woman presented to a local physician with an intermittent epistaxis and a facial pain around her nose. Her medical history was unremarkable. Computed tomography (CT) scan demonstrated a heterogeneously enhanced mass lesion centered in the left nasal cavity [Figure 1a].\\nShe was referred to our institute for surgical treatment of a nasal cavity tumor. On admission, she suffered from anosmia and diplopia. CT scan, performed 3 months after the first scan, demonstrated that the enlarged mass lesion breaking through the medial wall of the left orbit and pushed the eye laterally [Figure 1b]. We considered this might be the reason for her diplopia. For tissue diagnosis, the patient underwent endoscopic exploration from the nasal cavity. Because of heavy nasal bleeding, we combined midfacial degloving approach. Although we could control the bleeding, we could not resect the complete tumor.\\nHematoxylin and eosin-stained sections showed neoplastic cells forming small intracellular lumina that included red cells. The endothelium covering blood vessels was hyperplastic. No mitosis and necrosis were observed [Figure 2a]. The Ki-67 labeling index was 28%. Immunohistochemical analysis was positive for factor VIII-related antigen, vimentin, CD34, and CD31 [Figure 2b]. EHE was diagnosed on the basis of the aforementioned findings.\\nMagnetic resonance images indicated that the tumor had invaded the anterior skull base dura matter [Figure 3]. Digital subtraction angiography indicated bilateral ethmoidal arteries as major feeding arteries to the tumor. Because of the aggressive nature of EHE, the cancer board of Tohoku University Hospital agreed radical surgery of the tumor utilizing anterior skull base dissection and endonasal endoscopic exploration.\\nBefore the operation, spinal drainage was introduced to reduce brain retraction. Neurosurgeons conducted bilateral frontal craniotomy and excised the anterior skull base dura where the tumor had invaded. The left anterior and posterior ethmoidal arteries were coagulated and cut. Following skull base dissections, otolaryngologists achieved complete removal of the tumor through the canine fossa using an endoscope. We confirmed that the tumor was adhesive but had not invaded into the orbit. Intraorbital component was left intact as we had planned preoperatively. Following resection of the tumor and the dura matter, skull base reconstruction was performed using the pericranial flap, fascia lata, and titanium mesh plate.\\nThe patient recovered uneventfully from the radical resection of the tumor. Her diplopia improved. She has been free from local recurrence or distant metastasis for 26 months after the surgery.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 68,\n",
       "    'case_id': 'PMC8243102_01',\n",
       "    'case_text': \"A 68-year-old right-hand dominant woman was referred for evaluation of a right brachial plexus mass. Prior to presentation in our hand surgery clinic, the patient had a history of bilateral shoulder pain following a motor vehicle collision status post left rotator cuff repair; the patient elected to defer right shoulder replacement until she was more symptomatic. Approximately 5 years after her initial injury, she experienced worsening pain in her right shoulder. A large effusion was drained and an arthroplasty was scheduled. However, she continued to have progressive swelling, weakness, and numbness of her right upper extremity. A duplex ultrasound ruled out deep venous thrombosis. Due to concern for lymphedema, she was fitted with a compression sleeve and began physical therapy. She was referred to a hand surgeon who preliminarily diagnosed her with bilateral carpal tunnel syndrome and right-sided cubital tunnel syndrome, but advised a second opinion given her lymphedema and unusual clinical presentation. Her sensory and motor function continued to worsen over the course of 6 months, involving both the ulnar and median nerve distributions of the right hand; electrodiagnostic testing was performed with equivocal results, as the report noted that the diagnostic quality of the exam was limited by right upper extremity lymphedema. She was also noted to have neck pain that was relieved by cervical traction so additional imaging was obtained. Magnetic resonance imaging (MRI) revealed a soft tissue mass encasing the right brachial plexus divisions and cords without axillary lymphadenopathy, as well as severe chronic rotator cuff arthropathy with a large shoulder effusion (Figure 1).\\nOn evaluation, the patient demonstrated profound deficits of the right upper extremity. Motor function was notable for shoulder abduction limited to 10  and inability to abduct, adduct, or cross her fingers. Sensation was absent in the fourth and fifth digits and diminished with paresthesia in the index and middle fingers. Her thumb sensorimotor exam was normal.\\nThe patient was referred to interventional radiology for an image-guided fine-needle aspiration biopsy, but the specimen obtained was non-diagnostic. Due to concern for malignancy, an open excisional biopsy of the mass was performed. Intraoperatively, the lateral and posterior cords of the brachial plexus appeared very swollen and a heavy, fibrotic perineurium was noted. A tissue sample of the epineurium was obtained, as well as two lymph nodes, one infraclavicular and one supraclavicular. External neurolysis of the lateral and posterior cords was performed.\\nHistological examination of the brachial plexus mass and adjacent tissue revealed adipose tissue infiltrated by low-grade carcinoma. Immunostaining was consistent with primary breast cancer that was estrogen receptor (ER) and progesterone receptor (PR) positive, and Her2/neu negative (Figure 2). Both lymph nodes that were resected were negative for carcinoma. Full oncologic workup included a staging positron emission tomography-computed tomography (PET/CT) scan, which was negative for an FDG-avid primary mass but showed multiple foci of bony sclerosis in the thoracolumbar spine and sacrum without FDG avidity, as well as focal FDG uptake in the left L5 transverse process, indeterminate for metastasis. No breast abnormalities were noted on PET/CT scan, and no breast MRI was performed as part of her workup. Carcinoembryonic antigen (CEA) and cancer antigen 15-3 (CA15-3) levels were not elevated.\\nOf note, the patient had been up to date with annual screening mammograms, all of which had been negative including the most recent one performed several months after the onset of her right upper extremity symptoms, 5 months prior to her excisional biopsy. Interestingly, she had a 15-year history of oral contraceptive use, followed by a 20-year history of hormone replacement therapy after total abdominal hysterectomy and bilateral salpingo-oophorectomy. Her family history was notable for Hodgkin's lymphoma, prostate, lung, and colon cancer. Comprehensive genetic testing with the Invitae Common Hereditary Cancers Panel was negative for all 46 tested genes, including BRCA1, BRCA2, CHEK2, PTEN, and PALB2.\\nIn the setting of metastatic disease to the brachial plexus without imaging findings of a primary tumor or nodal involvement, treatment focused on medical and radiation therapy rather than surgical resection. The patient was treated first with palliative radiation (37.5 Gy in 2.5 Gy daily fractions) to her right brachial plexus, followed by letrozole and palbociclib. These treatments were well tolerated, and she showed improvement in right upper extremity strength, sensation, range of motion, and pain.\\nAfter completion of radiation treatment and 2 months of letrozole and palbociclib, she was reevaluated in our hand surgery clinic. On motor exam, she demonstrated significant improvement of right shoulder abduction to 80 , as well as normal strength and range of motion of the elbow. She had normal wrist extension but moderate weakness with wrist flexion. Most notably, she lacked active flexion of her right thumb and digits at both the metacarpophalangeal and interphalangeal joints; however, finger extension was preserved. On sensory exam, she endorsed subjective paresthesias of the thumb and index finger with two-point discrimination of 7 mm and numbness in the remainder of the digits with two-point discrimination >20 mm. Due to these significant functional limitations, she underwent a brachialis to anterior interosseous nerve transfer to restore active thumb, index, and middle finger flexion.\\nOverall, the patient has been doing well and has been stable on letrozole and palbociclib. From a functional standpoint approximately 1 year after surgery, she notes improved range of motion, sensation, and active movement of her right hand. She was started on zoledronic acid due to concern for bony metastases, but her most recent restaging imaging was negative for breast mass, axillary lymphadenopathy, enlargement of the brachial plexus mass, or osseous or other distant metastasis.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 56,\n",
       "    'case_id': 'PMC3716026_01',\n",
       "    'case_text': 'This patient is a 56-year-old African American female who still works as an elementary school principal with a history of IGG kappa multiple myeloma diagnosed 15 years prior to admission, refractory to chemotherapy treatment. Previously, in 1992, she was diagnosed with monoclonal gammopathy of undetermined significance (MGUS) but was then diagnosed with multiple myeloma in 1997 when she was found to have a lytic lesion and compression fracture of the T7 vertebra. Subsequent treatment included radiation, dexamethasone, thalidomide, bortezimide, lenalidomide and bendamustine between 1997 and 2012. She was then treated with carfilzomib. Over the years, she developed chronic kidney disease due to Bence Jones proteinuria, anorexia, chronic anemia (requiring multiple blood transfusions), multiple electrolyte abnormalities and herpes zoster for which she remained on prophylaxis. She had widespread lytic bone lesions and pathological fractures, which remarkably had not been accompanied by significant pain.\\nPatients with myeloma commonly present with malaise and bone pain, and not uncommonly with a fracture that may result from a neoplastic mass or may result from osteoporosis induced by the plasma cell effect on bone marrow. Myeloma plasma cell infiltration results in bone resorption and osteolysis. The balance of bone osteoblastic and osteoclastic activity is upset. Osteoclast-activating factors secreted by the plasma cells begin a vicious cycle of osteolysis and tumor growth resulting from released cytokines. Imaging studies, old and new, are employed to diagnose the cause of bone pain, to help establish staging in the Durie-Salmon System, and to follow treatment. Radiographic skeletal surveys, computed tomography (CT), nuclear medicine, and MRI are all useful in an evaluation. Newer modalities, such as positron emission tomography (PET), have been used to study relapse.\\nOur patient suffers from one of four patterns of bone involvement, myelomatosis or diffuse skeletal involvement. Other forms are solitary plasmacytoma, diffuse skeletal osteopenia, and sclerosing myeloma. Radiographic skeletal survey, though insensitive for early disease, is positive in 75% of patients by the time a diagnosis is established. The axial skeleton, the spine, skull, pelvis, and ribs are more often affected than the limbs (Figs. 1-3). Lesions are almost always lytic. More than two clearly defined lytic lesions place patients like ours in Durie-Salmon Stage III disease. Therefore, the skeletal survey is recommended in all cases of newly diagnosed myeloma.\\n Computed tomography (CT) has a role in clarifying ambiguous lesions, in assessing fracture risk by demonstrating the amount of residual cortical bone, and in guiding biopsy when needed. Magnetic resonance imaging (MRI) is used to establish the burden of disease, especially in the spine, that is prone to myeloma, and therefore at risk of fracture and spinal cord compression. In Stage III disease, patients with normal spine marrow pattern respond better to therapy and achieve remission more often. MRI is best and CT is second best in assessing the presence, the level, and the severity of myeloma-related spinal cord compression. The two techniques may be complementary in clarifying ambiguous lesions. Both MRI and CT detect extra osseous extension of disease.\\nStandard radionuclide bone scan with technetium 99-m relies on osteoblastic activity for tracer uptake, and myeloma is nearly exclusively osteoclastic. As many as half of myeloma lesions visible on radiographs are normal on the bone scan.\\nPositron emission tomography (PET) has a role in assessing the extent of extramedullary disease, and follow-up of these patients, but not in routine follow-up of treated myeloma in bone.\\nSpine fractures may be treated with vertebroplasty/kyphoplasty, and helpful in treating pain and spinal deformity. MRI is important to evaluate for potential pre-procedure spinal cord compression by a mass.\\nMultiple myeloma is becoming a more chronic disease, with life extended by successful chemotherapy. Knowing when, where, and why to use the full range of imaging described above will allow for accurate staging of the disease and to modify therapy as necessary, and to decrease the morbidity associated with fractures and spinal cord compression.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 63,\n",
       "    'case_id': 'PMC6421597_01',\n",
       "    'case_text': 'We present the case of a 63-year-old male of African origin (Kenya) with an occupational work exposure to boilers, and with a known medical history of uncontrolled hypertension, diabetes mellitus type 2, brain aneurysm that developed after a motorcycle accident, and a large left testicular hydrocele (8 x 3 cm) developing for over 1 year. The patient was seen at another hospital with complaints of testicular enlargement but did not receive medical treatment at that time. More recently, the patient underwent a spectral and color Doppler ultrasound revealing a large complex left hydrocele with a 1.7 cm regular, heterogeneous solid structure within the upper anterior aspect possibly representing the left testis. Surgery was then performed a month later, 1300 cc of straw-colored fluid was noted, and the hydrocele sac and left testicular nubbin were removed via scrotal orchiectomy. After pathological review and consultation, the specimen was confirmed to be malignant mesothelioma, epithelioid type. The tumor demonstrates predominantly an exophytic papillary growth although in areas it is solid and invasive into the underlying tunica vaginalis. The neoplastic cells are epithelioid with cuboidal to oval nuclei and eosinophilic cytoplasm (Figures 1-3). By immunohistochemistry, the tumor cells are positive for WT-1, calretinin, and focally for D2-40, while BAP-1 is retained.\\nFollow-up for positron emission tomography/computed tomography scan did not reveal any hypermetabolic foci except for a small 9 mm hypodense nodule in the right lobe of thyroid gland.\\nRadical excision is planned and chemotherapy planned after more extensive surgery.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 0,\n",
       "    'case_id': 'PMC2718207_01',\n",
       "    'case_text': 'A 3-month-old boy presented with a palpable abdominal mass. Radiographs of the abdomen disclosed that in the left upper quadrant, a large lesion causing inferomedial displacement of the bowel loops was present. US revealed a large, mixed-echoic, solid and cystic mass in this same area (Fig. 1A), while unenhanced abdominal CT scans depicted a well-defined heterogeneous mass with intratumoral nodular calcifications (Fig. 1B) and a suspicious focal area of fat density. Enhanced abdominal CT scans showed a large, exogastric, solid and cystic mass arising from the greater curvature of the stomach, with continuity between this curvature and the intraluminal extension of the mass. These scans also indicated that the solid portion of the mass was well enhanced (Fig. 1C). The differential diagnosis was germ cell tumor such as teratoma or stromal tumor of the stomach, neuroblastoma, or a mass originating in the tail of the pancreas. A pre-operative diagnosis of teratoma was based on the presence of intratumoral calcification and mixed cystic and solid components of the mass.\\nThe tumor was totally excised, involving partial gastrectomy, and the defect in the stomach was repaired. The gross specimen of the round exogastric mass thus obtained measured 14 x 9 x 6.5 cm and originated from the posteroinferior wall of the stomach along its greater curvature (Fig. 1D). The protruding intraluminal polypoid mass, measuring 7 x 5 x 3 cm, formed a continuation of the exogastric mass and was entirely covered by serous membrane. It contained multiple cystic areas filled with serous and mucinous material, keratin, and hemorrhagic foci. Histologically, the tumor contained not only mature components such as chondroid tissue, squamous epithelium, and keratin, but also multifocal aggregates of immature neural tissues of neuroblasts. The pathologic diagnosis was immature teratoma of the stomach. Three months later, follow-up CT revealed neither evidence of tumor recurrence nor distant metastasis.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 63,\n",
       "    'case_id': 'PMC8164024_01',\n",
       "    'case_text': 'A 63 years old man presented to our emergency department with a right sided headache and vertigo of one week duration along with right sided decreased hearing. There was no ear discharge. Review of systems were unremarkable. The past medical history was significant for a long-standing type 2 diabetes mellitus with secondary complications of retinopathy, dyslipidemia, and systemic hypertension. Drug history included insulin in addition to linagliptin, perindopril, and rosuvastatin. The patient has no history of smoking or alcohol consumption. Family history included diabetes mellitus and hypertension.\\nVital signs were within normal limits. Physical examination was unremarkable apart from partial left sixth cranial nerve palsy with no associated nystagmus or other cerebellar signs. Local examination of the ears, nose, and throat showed no significant tenderness, color change, or pre or postauricular swelling in affected ear. Tympanic membranes were intact. Neck and head examination revealed no associated swellings or palpable lymph nodes, and the temporomandibular joint were normal.\\nInitial tests showed WBC of 8.8 x 103/L, C-reactive protein of 15.3 mg/L, HbA1C of 7.2 %, normal kidney function tests, and a negative HIV serology. Radiological assessment with CT head (Fig. 1) demonstrated thickening of the external auditory canal and middle ear with an ill-defined soft tissue mass pacifying the right mastoid air cells cavity. Subsequent MRI (Fig. 2 and Fig. 3) showed an extensive diffuse multi-compartmental enhancement with bone involvement suggestive of osteomyelitis.\\nA provisional diagnosis of MOE with SBO was made and the patient was commenced presumptively on antipseudomonal therapy in the form of parenteral then high dose oral ciprofloxacin therapy at 750 mg BID.\\nAfter 10 weeks of discharge, the patient represented with progression of symptoms complaining of worsening headache, dizziness, and double vision. Local examination showed swelling of the right ear canal and intact tympanic membrane with no accompanying discharge. In the view of disease progression while on treatment, PET -CT (Fig. 4) was arranged to rule out potential underlying neoplasms; but was furthermore supportive of an underlying infectious process. Subsequently, multiple microbiological and histological samples from the right ear canal, bone biopsies of the temporomandibular joint and soft tissues from the base of the skull demonstrated no evidence of malignancy or granulomas while extended culture yielded yeast eventually identified as Candida orthopsilosis matched from multiple sites. It was sensitive to amphotericin B (MIC 0.5 mug/mL) and fluconazole (MIC 0.5 mug/mL).\\nThe patient was treated with two weeks induction course of liposomal amphotericin B (5 mg/Kg) followed by oral fluconazole (400 mg daily for a planned 6 months duration). Despite favorable initial response with the disappearance of the 6th nerve palsy, the patient had subsequent relapse with recurrent emergency visits and hospital admissions for worsening dizziness and vomiting. MRI was repeated and revealed persistent disease with increase in surrounding pachymeningeal enhancement. Accordingly, reinduction course of Amphotericin was considered followed by extended higher dose of fluconazole therapy of 800 mg daily scheduled for a prolonged duration of 12 months. During which, follow up MRI was repeated twice in 8 weeks interval, but showed no significant interval changes. One year following initial presentation, the patient is frail but stable.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 45,\n",
       "    'case_id': 'PMC10421585_01',\n",
       "    'case_text': \"The patient was a previously healthy 45-year-old male who had never undergone surgery before and sought hospital care for intense epigastric abdominal pains irradiating to the back and weakness. The possibility of acute appendicitis was ventured during the consultation, because of involuntary guarding at the iliac fossa during physical examination and leukocytosis. It was decided to supplement work up with abdominal computed tomography (CT). The CT report described arteriopathy of the celiac trunk, with caliber reduced by approximately 73%, and arteriopathy of the superior mesenteric artery, with 40% narrowing; enlarged retroperitoneal lymph nodes; and thickened gallbladder. The patient was scheduled for exploratory laparoscopy in view of the refractory nature of his pain. No abnormalities that could explain the patient's pain were identified during this procedure and all possible causes of acute abdomen were ruled out. The patient was discharged from hospital promptly, with improved symptoms.\\nAfter the tomographic findings from the previous admission, the patient was scheduled for abdominal angiotomography the following month, which found stenosis of the celiac trunk (50%) (Figure 1). After around 6 months, another angiotomography study was performed, which is when thickening of the median arcuate ligament of the diaphragm was observed for the first time, with compression and 80% stenosis of the proximal third of the celiac trunk.\\nThe patient underwent laparoscopic surgery to relieve compression of the celiac trunk. During the operation, the common hepatic artery was dissected in the direction of the celiac trunk, where the fibers of the arcuate ligament were released and the adjacent celiac ganglion was removed. While releasing the celiac trunk, it was necessary to partially section the splenic and common hepatic arteries to gain access to the fibers of the arcuate ligament, since these vessels were intrinsically linked to the filaments, which caused moderate bleeding, that was controlled with primary arteriorrhaphy (Figure 2). The patient was given intraoperative blood transfusion with packed red blood cells and was taken to intensive care for postoperative recovery, progressing to hospital discharge 3 days later.\\nThe patient remained asymptomatic during the postoperative period and underwent a control angiotomography (Figure 3) 2 months after surgery, which showed improved celiac trunk stenosis at 60-70%, in addition to critical stenosis of almost 100% of the proximal segment of the splenic artery, with distal flow fed via collateral circulation originating from the gastroduodenal artery. Currently, 1 year after the surgical intervention, the patient remains asymptomatic and has chosen not to undergo further imaging exams, in view of his stable condition.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 41,\n",
       "    'case_id': 'PMC4897088_01',\n",
       "    'case_text': 'A 41-year-old woman presented to the emergency department complaining of a three-day history of left-sided chest pain. The pain was described as pressure-like, pleuritic, made worse with ambulation and when supine. It was constant, increasing in intensity and not associated with any alleviating factors, hence her request for evaluation. She had denied any history of trauma, fevers, cough, night sweats nor hemoptisis. She denied any dyspepsia, and noted no relief of her symptoms with over-the-counter antacids.\\nSix weeks prior to the onset of her chest pain she had complained of right hip pain, radiating down the leg. This was diagnosed as radicular pain secondary to sciatica for which she had been under bed rest and analgesics. This slowly improved, and she had reinitiated full ambulation about two weeks preceding her presentation.\\nHer past medical history was remarkable for depression and occasional migraine headaches, both of which had been controlled. She was gravida 2, status-post two cesarean sections, the last of which was performed five years prior. She was started on oral contraception five months earlier, Yaz , in addition to Topiramate and Escitalopram. She denied any life-long toxic habits. Her family history was remarkable for lymphoma in her mother. She had no known family history of coagulopathy or other hematological conditions.\\nUpon presentation to the hospital she was evaluated for her chest pain by way of cardiac enzymes and complete blood count, which were both normal. An initial chest radiograph was also noted to be normal, as was an EKG. Nonetheless, a CT scan of the chest using a protocol to evaluate for a pulmonary embolism was performed which was remarkable for a large filling defect involving the left main pulmonary artery and extending into all sub-branches, most pronounced in the left lower lobe (Figure 1A, Figure 1B, Figure 1C). There appeared to be a mass extending outside the vessel wall. In addition, there was evidence of focal infiltration into the adjacent lung parenchyma with pre and post contrast Hounsfield units of 15 and 60, respectively. This was suggestive of a pulmonary angiosarcoma.\\nIn view of the pulmonary artery occlusion, she was admitted and closely monitored. She had an unremarkable hospital course, which included a negative work up for coagulapathy. With improvement of her chest pain, she was sent home on anticoagulation with warfarin. An FDG-PET scan was later performed, which did not reveal any FDG-avid lesions. A subsequent bronchial-alveolar lavage and pulmonary function testing were also unrevealing. Interestingly, she underwent open thoracotomy for excision of the left thoracic mass, and at the time of surgery no mass was found. There was only evidence of a chronic pulmonary embolism of the left pulmonary artery which was evacuated. Following her surgery, she developed pleural effusions managed with diuretics. Due to progressive dyspnea, even at rest, she was reevaluated in the emergency department. A repeat CT scan of the chest was then positive for bilateral pleural effusions, greater on the left, with adjacent atelectasis, but no evidence of pulmonary embolism. A thoracentesis was performed with cytology negative for malignancy and findings consistent with a transudate.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 2,\n",
       "    'case_id': 'PMC2719788_01',\n",
       "    'case_text': \"An eighty-two-year old female presented to the urology outpatient clinic with a short history of fecaluria, pneumaturia, and passage of urine per rectum. She had an indwelling urethral catheter inserted, because of the total urinary incontinence, for a period of over eight years. This catheter was last changed twelve weeks prior to her visit to the urology clinic by her district nurse. The patient had positive MSUs in the year prior to her admission demonstrating mixed growth of enteric organisms, but no prior febrile urinary tract infections were reported.\\nShe received radical radiotherapy alone for a muscle-invasive bladder tumor (stage T2b) in 1991 and underwent abdominal exploration for drainage of an appendicular abscess when she was in her early twenties. The patient had a background history of cerebrovascular disease, hypertension and ischaemic heart disease. She was felt to be an unsuitable candidate for radical surgery for her invasive bladder cancer due to these comorbidities. The decision to manage her incontinence with an indwelling urethral catheter was made having discussed available treatment options with the patient. A long-term indwelling catheter was felt to be the most appropriate option for her given her other extensive comorbidities. She did not have urodynamic testing prior to urethral catheterization. The exchanges of the catheter were being carried out every three months in the community and there had been no reported difficulty with her previous catheter changes. The patient was not undergoing routine cystoscopic surveillance of her bladder. \\nOn physical examination she was generally unwell with low-grade fever and pallor. Her abdomen was soft, mildly tender with no palpable masses and no signs of peritonitis. Her urethral catheter drained feculent material mixed with urine.\\nLaboratory investigations showed a low hemoglobin of 7.8 gm/dL, white cell count of 17 109/L with a C reactive protein of 233. Magnetic resonance images (MRIs) of the abdomen and pelvis were performed urgently and were reviewed by a senior consultant radiologist and his impression was that those images confirmed the presence of the inflated balloon of the indwelling urethral catheter in the lumen of a bowel segment (Figures 1  and 2). \\nIn enterovesical fistulas treatment is undertaken depending on the aetiology, clinical status and general condition of the patient. Enterovesical fistulae seldom close spontaneously. Given the nature of the pathology in this case and the presence of a foreign body in the fistulous tract (the urethral catheter), it was felt that the only way forward was to perform an urgent laparotomy and removal of the foreign body with excision of the fistulous tract. The situation was explained to the patient and she was consented for laparotomy, with all the risks and potential complications of surgery fully explained including both urinary and faecal diversion. On laparotomy there were severe adhesions, and the catheter balloon was found to have penetrated through the bladder wall and was lying in a terminal ileal segment adherent to bladder wall. Excision of this segment and urinary diversion by fashioning an ileal loop conduit was performed. A Hartmann's procedure was carried out due to the high clinical suspicion of presence of another separate colovesical fistula. The patient was transferred postoperatively to the intensive care unit and was moved afterward to the urology ward for 10 days. She had a smooth postoperative course with no recorded complications and is currently on regular urology outpatient clinic followup. Histology from the resected segment of terminal ileum demonstrated chronic inflammation only with no evidence of tumor recurrence.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 43,\n",
       "    'case_id': 'PMC2838360_01',\n",
       "    'case_text': 'A 43-year-old black woman presented with a 3-month history of symmetric, diffuse and yellowish hyperkeratosis of palms and soles. Plantar surfaces were the most affected, with painful fissures (Figures 1 and 2). A progressive worsening was seen in the last 2 months, despite treatment with topical antifungals, oral terbinafine and topical corticosteroids. Dry skin with generalized pruritus was also observed. Neck examination was unremarkable. The remainder physical examination (including nails, mucosae and hair) was normal. Asthenia, mood changes with emotional lability, constipation and menstrual irregularities were present for the last 4 months. Her past medical history was unremarkable. She denied the use of any medication. Family history was negative for dermatological diseases.\\nA complete laboratory and imaging evaluation was performed in order to investigate possible infectious, systemic, or malignant conditions. Routine laboratory tests were normal, except for elevated total cholesterol (295 mg/dL) and LDL cholesterol (205 mg/dL). Thyroid function tests revealed an elevated thyroid stimulating hormone (17,5 U/mL; normal range 0,35-4,94) and diminished free triiodothyronine (1,45 pg/mL; normal range 1,71-3,71) and free thyroxine (0,46 ng/dL; normal range 0,7-1,48). Circulating antibodies to thyroid peroxidase were elevated (534 U/mL) and thyroglobulin antibody was negative. Other immunological tests (rheumatoid factor, antinuclear antibodies, antidouble stranded DNA antibodies, antiextractable nuclear antigen antibodies and complement) were also normal or negative. Infections by hepatitis B and C viruses, human immunodeficiency virus 1 and 2, Treponema pallidum and intestinal parasites were excluded. Fungal cultures from skin and nails were negative. Tumor markers (CEA, CA 19-9, CA-125, CA 15-3, beta2-microglobulin and AFP) were normal. Abdominal and pelvic ultrasound, mammography and chest radiograph were unremarkable. A thyroid ultrasound showed a homogeneous ultrasonographic thyroid image and excluded nodules and goitre. The patient refused to give consent for a skin biopsy.\\nInitially, empirical treatment with emollients, topical keratolytics (urea, salicylic acid) and isotretinoin 20 mg/day was started. Despite those treatments, worsening of palmoplantar keratoderma was observed. Skin xerosis improved after treatment with topical emollients. Later, with the diagnosis of primary hypothyroidism secondary to autoimmune thyroiditis, the patient was referred to Internal Medicine Department and therapy with levothyroxine (0, 1 mg/day) was started. A slow and progressive improvement was seen, with partial and complete clinical remission of cutaneous findings at 3 and 9 months of hormonal replacement therapy, respectively (Figures 3 and 4). Systemic symptoms had also an excellent and sustained response to the treatment. After 24 months of follow-up, she continues levothyroxine with normal thyroid function tests and no recurrences of the dermatosis.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 13,\n",
       "    'case_id': 'PMC8710692_01',\n",
       "    'case_text': 'A 13-years-7-months-old Chinese girl was adopted shortly after birth, who showed normal growth and development. At 3 years and 5 months old, the patient presented with febrile convulsion. The brain magnetic resonance imaging (MRI) and electroencephalogram (EEG) were performed, the results of which were normal.\\nAt 8 years and 9 months old, the patient developed a febrile respiratory infection. She was treated with amoxicillin granules, but the treatment did not work. Two days later, the fever persisted at 39.3 C and the patient showed an acute neurological deterioration including drowsiness, agitation and ataxia. A series of auxiliary tests were carried out after she was admitted to our department. Laboratory parameters, including blood glucose, electrolytes, ammonia, blood cell count, toxic and drug screen, liver and kidney function tests, were normal. A semi-quantitative urine ketones body test was positive (2+). Normal cell count and glucose were found in cerebrospinal fluid (CSF) analysis, with no elevated protein concentration and oligoclonal band. Extensive viral and bacterial testing ruled out the infectious meningoencephalitis. Brain MRI showed bilateral, symmetric signal abnormalities in the white matter (WM) of the centrum semiovale and the periventricular regions, signal abnormalities in the splenium of the corpus callosum, and the head of the caudate nucleus (Figure 1). The WM showed hyperintense in the T2-weighted axial (Figures 1A-C) and FLAIR axial (Figures 1D-F) views, and restricted diffusion in the diffusion-weighted imaging (Figures 1G-J). Brain magnetic resonance spectroscopy (MRS) was performed, the result of which showed normal lactate and NAA peaks. No other urine test abnormalities were observed, except for an increased urinary excretion of alpha-ketoglutaric acid. The acyclovir and intravenous cefotaxime sodium were administered to treat the suspected intracranial infection. After a few days, the patient returned to an almost complete normal clinical status. Brain MRI was performed 45 days later, and the WM abnormalities were almost completely subsided (Figures 2A-I).\\nTwo years later, after experiencing a fever (38.8 C) from tonsillitis for 2 days, the patient presented with an acute neurological dysfunction including drowsiness, agitation, dizziness and fatigue. She started intravenous cefotaxime sodium and acyclovir. CT scans of the brain were normal. The brain MRI of WM in the T2-weighted axial and FLAIR axial views were similar to that observed in the first acute episode (Figure 3). Results of CSF analysis, including protein, glucose, cell count, and oligoclonal band were normal results. While an increase in urinary excretion of alpha-ketoglutaric acid was observed in the urine again. She recovered within 2 days.\\nOur patient was seen in the outpatient clinic 1 month, 1 year, and 3 years after the second acute event with satisfactory clinical follow-up. The clinical status and examination results were normal.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 73,\n",
       "    'case_id': 'PMC9990775_01',\n",
       "    'case_text': 'A 73-year-old woman presented with subarachnoid hemorrhage (SAH). She was found unconscious at home and transferred to the hospital. She had a history of hypertension and hyperlipidemia. Her consciousness level was Glasgow Coma Scale E3V4M5. The SAH grade was Hunt and Hess Grade 3 and WFNS Grade 4. The thickest hematoma of the SAH was noted in the interhemispheric fissure on computed tomography (CT) [Figure 1a]. CT angiography and digital subtraction angiography (DSA) showed an azygos ACA with hypoplasia of the A1 segment of the right ACA [Figure 1b]. Three-dimensional rotational angiography indicated a small and conical aneurysm measuring 0.7 mm in height, with a 1.2 mm neck located on the bifurcation of the distal azygos trunk. This small aneurysm was arising from the distal end of the azygos trunk to the left pericallosal artery [Figure 1c]. This aneurysm was considered to be ruptured because of the absence of obvious aneurysms on other angiography and the distribution of the SAH in the CT. DSA after waiting for 4 days under sedation showed obvious enlargement of the aneurysm [Figure 1d]. This small aneurysm was diagnosed as a ruptured BLA located on the distal bifurcation of an azygos trunk based on its size, shape, and growth. Direct clipping and endovascular treatment using simple coiling and balloon-assisted coiling seemed to have a high risk for intraoperative rupture due to the BLA. Trapping with an anastomosis was also difficult because the aneurysm was located on the azygos trunk. Therefore, it was decided to perform stent-assisted coiling (SAC) on the same day as the follow-up DSA. Immediately after the follow-up DSA, dual antiplatelet agents were administered in loading doses (aspirin 200 mg and clopidogrel 300 mg) 4 h before the start of the endovascular treatment. First, a 6-Fr FUBUKI guiding sheath (Asahi Intec, Aichi, Japan) was inserted into the right femoral artery and advanced to the left cervical ICA. A Headway 17 microcatheter (Microvention, Aliso Viejo, CA, USA) was navigated over a CHIKAI 0.35-mm (0.014-inch) microwire (Asahi Intec, Aichi, Japan) into the left pericallosal artery with a 3.4-Fr Tactics (Technocrat, Aichi, Japan) placed on the A1 segment of the left ACA as an intermediate catheter [Figure 2a]. An Excelsior SL-10 (Stryker Neurovascular, Kalamazoo, MI, USA) shaped by steam on a 45-degree curve was placed in the proximal part of the aneurysm using a Traxcess 0.30-mm (0.012-inch) microwire (Microvention) because of the difficulty of placing the microcatheter inside the aneurysm. After a 2.5-mm * 17-mm low-profile visualized intraluminal support (LVIS) Jr (Microvention) was deployed to just the distal neck of the aneurysm, a Galaxy G3 mini 1-mm * 20-mm (Cerenovus, Irvine CA, USA) was poured into the aneurysm. Two loops of the coil were placed inside the aneurysm by the microcatheter placed in the proximal of the aneurysm, which moved gradually with the coil protruding from the tip. The half-deployed stent was placed across the neck of the aneurysm to the end [Figure 2b]. Final postembolization DSA showed that the contrast effect of the aneurysm disappeared [Figure 2c]. Because a thrombus was found at the origin of the right pericallosal artery [Figure 2d], the patient was administered 80 mg of ozagrel sodium, and no blood vessels occluded. No new postoperative neurological deficits were found, and magnetic resonance imaging-diffusion-weighted imaging showed multiple spotty high intensities in the ACA region bilaterally [Figure 3], and magnetic resonance angiography showed no vessel occlusion. Follow-up DSA 14 days after onset showed residual aneurysm with contrast inside the dome. However, the findings showed stagnation of contrast in the venous phase and did not show contrast along the aneurysm wall, so follow-up was continued [Figure 4a]. Follow-up DSA 30 and 90 days after onset showed that the aneurysm thrombosed gradually and reached complete occlusion 90 days later [Figures 4b and c]. The patient had a good outcome, with a 90-day modified Rankin Scale (mRS) score of 2 and mild disturbance of memory as a sequela.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 35,\n",
       "    'case_id': 'PMC4000300_01',\n",
       "    'case_text': \"A 35-year-old Japanese male presented to the Emergency Department of Okinawa Chubu Hospital with right hemiparesis. He had awakened from sleep with severe, sharp chest pain that was not accompanied by dyspnea. The chest pain subsided within 1 min without treatment, but medical evaluation was sought due to obvious dysarthria and weakness of the right upper and lower limbs. The patient was previously healthy, with no prior hospital admissions, surgeries, medications, or allergies, but bilateral pedal edema had developed 3 months prior to presentation. He had no dyspnea or ambulatory dysfunction and did not seek medical intervention. He worked as a house painter and lived with his wife and children. He had 15 pack-years of exposure to tobacco, and consumed 400 ml of Okinawan spirits nightly. There was no family history of cardiovascular disease, thromboembolism, or chronic kidney disease.\\nPhysical examination revealed that the patient was alert with no distress. He was not obese (BMI 21.4 on admission, when he was edematous), and he was afebrile with a blood pressure of 140/90 mm Hg, a regular pulse of 85 beats/min, and a respiration rate of 25 breaths/min. Oxygen saturation in the room air was 100%. An examination of the head revealed a marked, right-sided facial droop, but was otherwise normal. Carotid upstrokes were symmetric without bruits. The heartbeat was regular without gallops or murmurs, and the lungs were clear; the abdominal examination was also normal. Bilateral pitting edema was present to the knees. There were no rashes or petechiae. Neurological examination revealed intense dysarthria, which made it difficult for him to communicate with others, and right-sided central facial nerve palsy. Both the right arm and leg were at Brunnstrom stage 1, with complete flaccidity and no voluntary movement. Pain and light touch sensation were absent on the right side of his body.\\nTable 1 contains initial laboratory data. Blood counts revealed leukocytosis and hemoconcentration. Serum albumin was markedly low at 1.8 g/dl. Serum cholesterol, triglyceride, and low-density lipoprotein cholesterol were elevated. The urine protein to creatinine ratio was 7.5 g/g Cr, indicative of high-grade proteinuria. The examination of the urine sediment revealed oval fat bodies, and testing for anti-nuclear antibodies, anti-neutrophil cytoplasmic antibodies, and anti-phospholipid antibodies were all negative. Hepatitis B and C serologies were negative.\\nDiffusion-weighted magnetic resonance imaging showed high-intensity areas consistent with acute infarction in the left basal ganglia, left corona radiata, and left cerebral cortex (fig. 1). Contrast-enhanced computed tomography of the neck revealed collateral blood flow around a large embolus in the left carotid artery (fig. 2). Ultrasound of the left carotid revealed the embolus without any plaques or ulcers at the vessel wall (fig. 3). There were no aortic dissections, pulmonary emboli, renal vein thromboses, or deep vein thromboses on the computed tomography. A transthoracic echocardiogram showed normal contractility without dilated chambers, valvular disease, vegetations, intraluminal thrombi, or any findings suggesting pulmonary embolism, such as pulmonary hypertension or right ventricular stress.\\nA presumptive diagnosis of ischemic cerebrovascular accident caused by a left carotid thromboembolism was attributed to a hypercoagulable state due to NS. Because of the lack of any findings of atherosclerosis or plaques at the left carotid, we believed that embolism was more likely than thrombosis. The origin of the embolus was not detected despite a thorough cardiovascular evaluation. Immediate anticoagulation with unfractionated heparin was employed, and the renal biopsy was deferred. Intravenous methylprednisolone was administered empirically at 1,000 mg/day for 3 days, followed by oral prednisone at 60 mg/day. Cyclosporine was added 30 days later in response to persistent nephrotic-range proteinuria (5.5 g/day on the 28th day). The patient was transferred to a rehabilitation hospital 47 days after first admission.\\nHowever, the blood examination performed after transfer revealed abnormal liver function on the 74th day from the first admission, the results of which are detailed in table 1. Serological studies and abdominal ultrasound excluded viral hepatitis or biliary obstruction. He was immediately readmitted under suspicion of drug-induced hepatotoxicity. Medications on admission included prednisolone (50 mg/day), warfarin (2.75 mg/day), cyclosporine (70 mg b.i.d.), sulfamethoxazole/trimethoprim (400/80 mg daily), eicosapentaenoic acid (900 mg b.i.d.), atorvastatin (10 mg/day), lansoprazole (30 mg/day), alfacalcidol (0.25 mug/day), andronate (35 mg/week), and calcium lactate (1 g b.i.d.). All medications except for prednisone were subsequently withheld, and warfarin was replaced by intravenous heparin. The liver test results normalized, but they deteriorated upon rechallenge with warfarin.\\nAt this time, heparin therapy was briefly interrupted to permit a renal biopsy to evaluate refractory NS, with hypoalbuminemia (2.1 g/dl) and proteinuria (5.7 g/day). The biopsy showed MN at stage III of the Ehrenreich and Churg classification. Continued anticoagulation was deemed necessary due to severe persistent hypoalbuminemia and the severe cerebrovascular accident. Warfarin appeared to be clinically intolerable due to idiopathic hepatotoxicity despite a negative lymphocyte stimulation test. Intravenous heparin therapy was incompatible with outpatient rehabilitation.\\nWe discussed the indication of dabigatran, the only available novel oral anticoagulant in Japan at that time, with the patient and also with cardiologists, a neurologist, and the vice-principal of our hospital, all of whom were responsible for the prescription of dabigatran, and we decided to initiate treatment. We also explained and discussed the risks and benefits of dabigatran with the patient and obtained his written and informed consent in advance. Oral dabigatran was administered at a dose of 110 mg b.i.d., and MN was treated with oral prednisone and cyclophosphamide according to Jindal's regimen. Proteinuria decreased from a ratio of 5.1 to 1.6 g/g Cr, and serum albumin rose from 2.3 to 3.7 g/dl over 7 months. He was transferred to the rehabilitation hospital 137 days after stroke onset. At the outpatient clinic, his renal function remained stable, and he did not experience any episodes of edema, bleeding, or thromboembolism. We monitored the activated partial thromboplastin time (aPTT) to predict the risk of bleeding due to excessive anticoagulation. The aPTT values taken 4 h following administration of dabigatran in the morning were stable at around 40 s (standard aPTT was 30 s). A carotid echogram performed 2 years after the initiation of dabigatran revealed a reduced embolus, although it did still occlude the internal carotid.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 49,\n",
       "    'case_id': 'PMC7256205_01',\n",
       "    'case_text': \"A 49-years-old woman presented with alteration of her right foot shape, cracking sensation, and progressing difficulty while walking in the last six months. She never consulted any physicians about her right foot before. There was no history of trauma and infection, but there was a history of uncontrolled type 2 DM in the last two years. She did not consume her oral antidiabetic drugs routinely; her diabetic medication was switched to insulin therapy in the last six months to better control her disease.\\nPhysical examination revealed rocker-bottom deformity, but there was no edema, ulceration, or local rise in temperature (Fig. 1). There was a foot tenderness with visual analog scale (VAS) score of 2-3, a decrease of distal sensory perception, a capillary refill time of less than 2 seconds, and limited ankle range of motion (ROM). CT-scan and plain radiographs revealed the bone deformity of the forefoot with Meary's angle of 22 , Bohler angle of 88 , and Gissane angle of 125  (Fig. 2).\\nAfter establishing the diagnosis, the patient underwent forefoot arthrodesis by using screws and K-wire fixation (Fig. 3). The initial AOFAS score was 45 out of 100, then two months after surgery the score increased to 61. Furthermore, the radiological union of talus was obtained three months after surgery (Fig. 4); the AOFAS score further improved to 69. The AOFAS score continued to increase in the fourth and sixth months follow-up after surgery with a score of 78 and 86, respectively. The foot pain was absent sixth months after the surgery while physical and radiological examination showed improvement of the foot arch and the Meary's angle improved to 8  (Fig. 5). The patient was compliant to post-surgical advices. Thus, there was no complication, and there was an improvement of her overal quality of life.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 0,\n",
       "    'case_id': 'PMC8428556_01',\n",
       "    'case_text': 'In the previous reports with other mydriatics, abdominal adverse effects have been reported. A 2-month-old girl had episodes of apnea, vomiting and distension after a screening for ROP with cyclopentolate 0.5% and phenylephrine 2.5%. Bonthala et al. reported that ocular instillation of 0.2% cyclopentolate and 1.0% phenylephrine eyedrops inhibited duodenal motility and delayed gastric emptying in 11 infants; this might have been caused by a reduction in peristaltic movement of the gastrointestinal tract. ROP screening using cyclopentolate, therefore, might be associated with increased gastric residuals and cyclopentolate was detected in the blood of infants, whereas phenylephrine was not detected in the blood. In another report, the incidence of gastric residual increased after ROP screening with another type and/or dose of mydriatic. In these reports, cyclopentolate was used for ROP screening; therefore, it may cause abdominal adverse effects.\\nIn the present study, neonatal infants with lower body weight at the ROP screening had higher scores of abdominal distention. However, because those infants also had higher scores of abdominal distention before ROP screening, we should be careful about attributing the abdominal adverse effects to the mydriatic (alone). Jiang et al. reported that the incidence of gastric residuals increased after ROP screening in infants with postconceptional age < 31 weeks. Gronlund et al. reported that, in neonatal lambs, the sympathetic nervous system is a major regulator of cardiovascular interactions and that the autonomic nerves are immature. The immaturity of autonomic nerves in neonatal infants might contribute to abdominal adverse effects.\\nIn the current study, compared with the period before examination, there was a significant increase in the number of infants with decreased pulse rate during the period after examination. In some previous reports, pulse rate did not significantly change after ROP screening. However, Khoo et al. reported that pulse rates decelerated below the baseline values after ROP screening. Rosales et al. stated that stress and pain during ophthalmic examinations are known to precipitate apnea and bradycardia. Stress and pain during ophthalmic examination may affect pulse rate until at least 1 day after ROP screening.\\nIn the current study, the volume of stool, respiration rate, blood pressure and number of episodes of apnea did not change significantly after ROP screening (p > 0.05 paired-t tests). In a previous report, a significant elevation in systolic blood pressure was observed in 8 of 10 infants. In a different study, percutaneous oxygen saturation and pulse rate changed significantly from baseline values following ROP screening with 2.5% phenylephrine and 0.5% tropicamide eyedrops. There were no significant changes in blood pressure, temperature, or respiration rate. Jiang et al. reported significant increases in blood pressure after administration of phenylephrine 0.5% and tropicamide 0.5%. Lees et al. reported that blood pressure was significantly elevated but pulse rate was unchanged after ROP screening with 2.5% phenylephrine and 0.5% tropicamide eyedrops. Isenberg et al. also reported significantly elevated blood pressures after ROP screening with 2.5% phenylephrine and 0.5% tropicamide eyedrops, but blood pressure did not change after ROP screening with the same types and doses of eyedrops in a study by Bolt et al.. Thus, there are still controversies about changes in pulse rate, respiration rate, blood pressure and periods of apnea, which may be due to differences in the kind and/or dose of mydriatics used and/or the time of ophthalmic examination.\\nThe current study had some limitations in that it was a retrospective study, with a small sample size and without control cases. Because we evaluated data only up to 1 day after screening, any long-term effects are unknown. Finally, the cause of the abdominal adverse effects was unclear and not only the mydriatics, but also the ophthalmic examinations themselves, might contribute to the changes seen.\\nIn conclusion, screening for ROP with 0.5% phenylephrine and 0.5% tropicamide eyedrops may have adverse effects on systemic conditions such as abdominal distention, milk consumption and pulse rate. Careful observation for abdominal conditions should be performed after ROP screening with mydriatic.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': None,\n",
       "    'case_id': 'PMC9432856_01',\n",
       "    'case_text': 'The animal in this report was a mixed-breed male dog, aged approximately 1 year and 6 months from Belford Roxo, Rio de Janeiro state. The dog was taken for veterinary assistance in a local clinic on May 4, 2021, due to a \"stiff neck,\" open mouth, and excessive salivation. The veterinarian suspected a foreign body obstruction and degenerative disk disease. However, the owner was not confident regarding the diagnosis, so she visited another clinic located in Duque de Caxias City for a second opinion. The animal presented with a stiff neck, left-sided head tilt, and salivation.\\nInitially, the second veterinarian assumed that the salivation was a consequence of a previous morphine injection, which was administered in the first clinic to induce vomiting as the previous veterinarian suspected a foreign body obstruction. The animal was very calm, which made performing the physical examination easy. Gloves were used for protection while evaluating the dog, and upon examination, no neck or mouth injury was detected. Following standard practice, several questions were asked: for example, if the animal had previous contact with bats, and the owner answered affirmatively. When asked regarding vaccine protocols, the owner answered that the animal was not vaccinated against rabies. Hence, she was advised to take the animal for radiographic examination as required in the first clinic to evaluate the neck and return as soon as possible. The veterinarian searched for diagnostic information on rabies, and the radiographic report did not indicate any injuries in the vertebral column or temporomandibular joint.\\nOn the following day, May 5, the owner sent a message and a video through \"WhatsApp\" informing that the animal had a staggering pace. The veterinarian requested that the animal be brought to the clinic immediately for hospitalization and explained his clinical suspicion and severity.\\nUpon admission, the animal entered the clinic at a staggering pace. Venous access was made to inject medications and antibiotics as the blood test revealed signs of infection. A sample was collected for the distemper polymerase chain reaction test, which was later reported to be negative.\\nThe animal then stayed under supervision, and as the hours passed, serious signs of aggressiveness and hostile behavior started to appear, complicating the medical team in handling his attendings. The dog growled and hit the canine box whenever someone attempted to approach it. Incoordination worsened during the night, and the dog struggled to stand and fell repeatedly. Then, it spent the rest of the night lying on the box. On May 6 at 10 am, the dog died after 24 h of hospitalization.\\nThe veterinarian on duty was oriented to put on personal protective equipment (PPE), while handling the animal to place it inside a plastic bag and keep it refrigerated until the veterinarians from the municipal government of Duque de Caxias took the animal to the Rabies Laboratory of Diagnostics.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 38,\n",
       "    'case_id': 'PMC7336214_01',\n",
       "    'case_text': 'A 38-year old man presented with dysarthria lasting for about one hour, two days after returning from holidays from the island of Corfu, where he had spent several days exposed to strong sunshine. The day after the presentation, the symptoms of dysarthria recurred and lasted about two hours before completely resolving. There were no other neurological symptoms such as headache, dizziness, confusion, or weakness (except from the baseline weakness due to the polyneuropathy). During his holidays, he was exposed to the sun for more hours than usual, but he did not report excessive use of alcohol or other substances.\\nThe patient was examined on the second day of symptom appearance when he was found to be afebrile with no other signs of infection. His dysarthria had resolved, and the rest of his neurological examination was normal with the exception of the baseline weakness of the lower extremities due to his polyneuropathy.\\nBlood tests including inflammatory parameters as well as an immunological screen were normal and so was urine analysis and cerebrospinal fluid (CSF) analysis. CSF oligoclonal bands were absent.\\nMagnetic resonance imaging (MRI) of his brain was obtained (Figure 1) which showed a diffuse symmetric deep white matter involvement of the centrum semiovale posterior frontal and parietal, with T2/FLAIR hyperintensity and restricted diffusion an ADC map images (first row of images).\\nThe findings extended continuously to the splenium of the corpus callosum (second row of images). No major mass effect was recognized. No hemorrhagic changes on T2/GRE images and no postcontrast enhancement on enhanced T1 images were seen (not shown here).\\nDue to the transient recurrence of the symptoms on the second day of presentation, the patient was treated empirically with corticosteroids (1 gram of intravenous methylprednisone per day for 3 consecutive days). His neurological examination returned to baseline.\\nRepeat MRI examination performed one month later showed significant symmetric improvement of the findings on T2, FLAIR, and DWI images (Figure 1). The FLAIR abnormalities were hardly recognized on the second MRI and had improved both in volume of involvement and intensity. Subtle increased signal could still be traced on DWI images, with no actual restricted diffusion on ADC map images (ADC map normalization).\\nFurther questioning revealed two similar episodes in the past, one at the age of eleven years and one at the age of 21 years. The first episode preceded the diagnosis of CMTX, which was established at the age of sixteen, following the diagnosis of his older brother. The c.381C>G base change in the GJB1 gene resulting in the Ile127Met amino acid substitution in Cx32 was identified in this family. He had experienced recurrent episodes of weakness of the right lower extremity lasting 2-3 hours over the course of 3 days. The medical history had revealed no evidence of infection, travel, intense exercise, or presence of any other provoking factor. MRI was not available at that time, and no medical record of laboratory examinations could be obtained.\\nTen years later, at the age of twenty-one, the patient experienced a more severe episode of dysarthria lasting 4-5 hours. Over the course of the next 4 days, he continued to experience transient dysarthria attacks which subsequently progressed to paresis of the right lower limb. At that time, he had once again been exposed to strong sunshine for prolonged periods of time in the days prior to the presentation due to his work at the beach. Once again, laboratory investigation was entirely normal and he was treated with corticosteroids.\\nThe MRI which, at that time, reported it as a possible acute disseminated encephalomyelitis (ADEM) in retrospect showed very similar findings to the one performed at our institution. The follow-up MRI was done one month later and revealed significant improvement.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 60,\n",
       "    'case_id': 'PMC6604042_01',\n",
       "    'case_text': \"In 2008, a 60-year-old Japanese man was first diagnosed with cT2N0M1 stage IV adenocarcinoma of the lung and multiple metastases including the brain and the 12th thoracic vertebra (Th12) (Fig. 1). Irradiation of the Th12 with a total dose of 45 Gy and gamma knife radiosurgery for the brain was performed, followed by treatment with carboplatin and paclitaxel as first-line therapy, cisplatin and S-1 as second-line therapy. The patient next received treatment with erlotinib from 2009 to 2014. After the disease progression of lung lesion was detected in computed tomography (CT) in 2014, a lung rebiopsy revealed an activating EGFR mutation (exon 19 deletion) without a secondary mutation (T790M) in exon 20. The patient decided to receive the treatment with afatinib in addition to docetaxel or pemetrexed from 2014 to 2017, even though EGFR-TKI failed to control the disease's progression.\\nSince pelvic pain, caused by bone metastases in 2nd lumber vertebra (L2) and 2nd sacral vertebra (S2), was occurred in 2013, irradiation of L2 and S2 was performed with a total dose of 30 Gy, respectively (Fig. 2). In 2017, the disease progression of lung lesion was further developed in CT, and a liquid biopsy showed a secondary mutation (T790M) in exon 20 of EGFR. Treatment with osimertinib thus has been administered with partial remission.\\nIn 2018, the patient, now aged 70 years, complained of right mild back pain, caused by the lesion with abnormally enhanced signals in right iliopsoas muscle in CT (Fig. 3A). Positron emission tomography (PET)-CT also confirmed the lesion with highly enhanced signals (Fig. 3B). Other lesion still showed partial remission with no change in serum tumor markers for lung cancer, whereas the lesion in right iliopsoas muscle progressed rapidly. A CT-guided biopsy and subsequent surgery of the tumor were performed.\\nA pathological examination revealed proliferation of atypical spindle cells in a random growth pattern (Fig. 4A). On immunohistochemical examination, most of the tumor cells were positive for CD34 (Fig. 4B), and only limited number of the tumor cells was faintly positive for EMA or desmin. By contrast, AE1/AE3, SMA and S-100 were negative. These findings indicate that the tumor does not have noticeable histologic features, and carcinoma with sarcomatous change is unlikely. In light of the morphological and immunohistochemical findings, undifferentiated pleomorphic sarcoma was diagnosed. Importantly, no EGFR mutations was detected by RT-PCR, indicating that the detected sarcoma is unrelated to the primary lung cancer. As the locoregional recurrence occurred 7 months later after the surgery, the patient received the radiation therapy, and is now under outpatient follow-up.\\nIn summary, this patient had undergone radiation therapy, and the sarcoma histologically different from the primary tumor arose from the irradiated field, both of which are consistent with the disease definition of radiation-induced sarcoma.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 24,\n",
       "    'case_id': 'PMC6949674_01',\n",
       "    'case_text': \"In July 2015, a 24-year-old woman was referred to our Department of Internal Medicine for a high fever (39 C) lasting 3 days, fatigue, myalgias, chills, and vomiting. She had been followed since 2008 for primary ITP, initially treated with oral prednisone (1 mg/kg/day), which achieved complete remission. Because of occasional severe relapses (two between 2009 and 2012, with gynecological bleeding), she was subsequently treated with Intravenous Immunoglobulin (IVIg) with good responses. In January 2012, at age 21, she suffered a severe relapse, again justifying the use of IVIg and corticosteroids. At that time, she had detectable autoimmunity with an antinuclear antibody titer of 1 : 250 (anti-SSA specificity but without any sign suggestive of lupus) and platelet-directed anti-glycoprotein IIb/IIIa antibodies. In June 2012 (baseline), a new IVIg cycle was administered, followed by RTX (375 mg/m2 once-a-week for 4 consecutive weeks). A complete platelet response was obtained within 6 weeks and, at the last follow-up (March 2015), her blood platelet level was normal (321 x 109/L) without treatment. Before RTX infusion (June 2012), her blood total gamma-globulin level >3 months before IVIg infusion had been normal (8.9 g/L) but she was lymphopenic (total lymphocytes: 0.513 x 109/L), while her peripheral blood lymphocyte count had been normal at ITP diagnosis (1.199 x 109/L). The previously available phenotype profiles of her peripheral circulating lymphocytes are reported in Table 1. No infection occurred during the 3 years following the last RTX administration and she remained clinically well at biannual consultations in our department.\\nAt admission, in July 2015, at age 24, her temperature was 39.2 C and she complained of lower abdominal pain, vomiting but without diarrhea; her physical examination was normal. Laboratory tests showed elevated C-reactive protein (CRP: 114 mg/L, normal range (NR): <5 mg/L), hepatic cytolysis (aspartate aminotransferase: 144 U/L, NR: 7-40 U/L; alanine aminotransferase: 265 U/L, NR: 5-50 U/L) and cholestasis (alkaline phosphatase: 389 IU/L, NR: 40-130 U/L; gamma-glutamyltranspeptidase: 698 U/L, NR: 5-38 U/L). The hemogram revealed agranulocytosis and thrombocytopenia (leukocytes: 4.9 x 109/L; neutrophils: 0.02 x 109/L; hemoglobin: 14.5 g/dL; platelets: 46 x 109/L). Bone-marrow aspirate showed normal density, several megakaryocytes but hypoplastic granulopoiesis in blocked maturation, without blasts. Computed-tomography (CT) scans of the thorax and abdomen were normal. Once urine and blood samples had been collected, empirical ceftazidime and gentamicin were begun, and achieved apyrexia within 48 h. After 46 h, blood cultures came back positive for Campylobacter jejuni, and the identical strain isolated from the patient's feces; amoxicillin-clavulanic acid (1 g 3 times a day for 2 weeks) was prescribed. Seven days postadmission, CRP, neutrophil and platelet levels returned to normal (3 mg/L, 6.61 x 109/L and 521 x 109/L, respectively); blood cultures were negative; and liver function was improved.\\nLaboratory evaluation for immunodeficiency yielded: negative serology for human immunodeficiency viruses-1 and -2, very low serum Ig levels (Table 1) and no circulating B cells. Flow-cytometry quantification of T-cell subsets found expansion of circulating CD4+ T lymphocytes expressing surface DR, suggesting their activation; low natural killer cells and CD8+ T-lymphocyte levels. Urine immunofixation electrophoresis was negative. Ig-replacement therapy was started but not pursued by the patient.\\nTen months later (May 2016, age 25) she was hospitalized for a 15-day low-grade fever, weight loss, nonproductive cough and progressive dyspnea. CRP, lactate dehydrogenase and beta2-microglobulin levels were 40 mg/L, 340 U/L (NR 5-240 U/L) and 3.53 mg/L (NR 1.2-2.5 mg/L), respectively. As shown in Table 1, hypogammaglobulinemia, CD19+ B lymphopenia and low peripheral CD8+ T-cell count persisted but without T activation, as assessed by HLADR-positivity. CT scans visualized bilateral diffuse infiltrates, ground-glass opacities and large nodules. Bronchoalveolar lavage analysis revealed Pneumocystis jiroveci cysts with positive polymerase chain reaction (PCR) (4,000 copies/mL); high-dose trimethoprim-sulfamethoxazole and corticosteroids were prescribed. Searches for other pathogens, including Mycobacterium tuberculosis, atypical mycobacteria, cytomegalovirus, Cryptococcus and Aspergillus species, were negative. At that time, her bone-marrow biopsy was normal.\\nDespite appropriate antibiotics and clinical improvement, thoracic CT scans revealed worsened dense infiltrates (Figure 1(a)), pleural effusions, hepatosplenomegaly and nodular lesions of both kidneys (Figure 1(b)). A new bronchoscopy with biopsies found CD20+ large lymphomatous cell infiltration (Figure 2) in bronchi. Those large atypical lymphoid tumor cells were CD10-BCL-6- and MUM1+BCL-2+, with an 80% Ki-67-proliferation index on immunolabeling. EBV, as assessed by in situ hybridization with an EBV-encoded small RNA probe, was diffusely positive in about 80% of tumor cells (Figure 2). The FISH assay for MYC gene rearrangement (MYC FISH DNA Probe, Split Signal, (Y5410), Dako, Locus 8q24) was negative. EBV-positive DLBCL with a nongerminal center phenotype was diagnosed without bone-marrow infiltration. Circulating EBV-DNA was positive (2,430,000 IU/mL). DLBCL treatment consisted of RTX, cyclophosphamide, doxorubicin, vincristine and prednisone. Even with EB viremia becoming negative, she developed fever, cytopenias, liver damage and neurological manifestations, as a consequence of her prominent bone-marrow hemophagocytosis. Unfortunately, she died of multiorgan failure at age 25.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 40,\n",
       "    'case_id': 'PMC8639588_01',\n",
       "    'case_text': \"A 40-year-old woman with a history of asthma presented to the emergency department with severe upper abdominal pain. The patient's blood pressure was 155/115 mmHg, heart rate was 75 beats/min, and body temperature was 36.4 C. The patient had marked tachypnoea, oxygen saturation was 94% at room air. According to the patient's report, she had regular bowel habits and denied any vomitus, nausea, diarrhea, or constipation. There was no history of previous trauma and no surgical history. Clinical examination revealed a soft abdomen with some slight tenderness and markedly lowered breath sounds over the right lung. Laboratory findings revealed elevated white blood cells (11.14G/L, reference: 3.50-9.80G/L) with negative C-reactive protein. Ultrasound of the abdomen was negative for bilious attack or appendicitis. Pleural ultrasound described pleuritic alterations suggestive of pulmonary infarction. Computed tomography (CT) imaging was added and showed a right-sided Bochdalek hernia with right-sided lung compression, pleural effusion on the right, and mediastinal shift to the left (Figures 1A,B). First, all available findings and the critical situation were discussed with the anxious patient. Imaging results were used to explain the necessary surgical procedure. The patient had sufficient time to ask all relevant questions. Finally, she felt well informed and agreed to the surgical intervention due to lacking alternatives. An emergency median laparotomy was performed under general anesthesia in supine position. A 2 cm right posterolateral diaphragmatic hernial orifice containing an incarcerated and partially necrotic loop of the ascending colon without any intraabdominal signs of infection was detected (Figure 1C). The hernia content was reduced and fecal pleural fluid drained into the abdominal cavity from the chest. Multiple intraabdominal and right-sided thoracic lavages through the hernia defect were performed and the hernial orifice was closed with a non-absorbable 2-0 continuous suture. Right-sided hemicolectomy and a side-to-side anastomosis from the ileum to the transverse colon was necessary due to intestinal ischemia and colon perforation (Figure 1D). A right-sided 24 charierre chest tube was placed and antibiotic treatment with meropenem was started. Histopathological work-up revealed ischemic colon perforation with severe hemorrhagic peritonitis. Initially, the chest tube drained fecal fluid. Drainage reduced over time and the chest tube was removed on the fourth post-operative day. Post-operative pain improved under combined intense intravenous and oral pain medication, which allowed stepwise mobilization.\\nThe further post-operative course was complicated by a right-sided pleural effusion. A thoracentesis was performed, but only a small amount of purulent effusion could be evacuated. Pigtail catheter insertion remained unsuccessful. A thoracic CT scan was added and revealed a pleural effusion rim enhancement with distributed gas suspicious of infected effusion. A 24 charriere chest tube was inserted, which was complicated by multiple pleural adhesions. The chest tube was removed four days later after drainage reduced significantly. As laboratory infection signs remained elevated and the patient became febrile a further thoracic CT scan was performed, which showed increasing rim enhancement now suspicious of pleural empyema (Figures 2A,B). The actual situation was discussed in detail with the patient. Initially, she did not understand why a second surgical intervention was necessary. Once again imaging was presented. The patient gave consent for thoracic surgical intervention on the 13th post-operative day. For explorative video-assisted thoracoscopy (VATS) the patient was intubated with a double lumen endotracheal tube for single lung ventilation and placed in the left lateral decubitus position. A mini thoracotomy was performed at the sixth intercostal space. Due to solid pleuritic formations this approach had to be converted to open thoracotomy following empyema (stage II-III) evacuation (Figures 2C,D) and right-sided pleural decortication. After extensive intrathoracic lavages a 24 charriere right-sided chest tube was placed apical-dorsal and another chest tube in the costodiaphragmatic recess. Antibiotic treatment was switched to levofloxacin and linezolid. The further post-operative course was uneventful and the chest tubes were removed on the fifth and seventh post-operative day, respectively. The early post-operative chest X-ray revealed a small residual right-sided pleural effusion and opacity due to basal hypoventilation accompanied by a moderate elevation of the right hemidiaphragm. No signs of residual empyema or hernia recurrence were detected (Figures 3A,B).\\nThe patient was discharged in a stable condition one month after admission. Follow-up clinical examination and chest X-ray one year after initial surgical repair of right-sided Bochdalek hernia did not show any signs of recurrence and only slight right-basal hypoventilation (Figures 3C,D). The summary of the preoperative workup, hospitalization, and follow-up is shown in Figure 4.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 34,\n",
       "    'case_id': 'PMC9946755_01',\n",
       "    'case_text': 'An active 34-year-old male presented with bilateral symptomatic medial OCD lesions. Body-mass index was 30 kg/m2 with genu varum, no muscular atrophy, and mild effusions bilaterally. Range of motion (ROM) was 0  of hyperextension, 0  extension, and 135  flexion bilaterally. Menisci and ligamentous examinations were normal, with medial femoral condyle pain on palpation in the right greater than the left knee. Preoperative radiographs demonstrated underlying genu varum with large medial femoral OCD lesions and a right knee Kellgren-Lawrence (KL) grade 2 and left knee KL grade 1 (Figures 2(a), 2(b), and 2(c)).\\nHip-to-ankle radiographs demonstrated femoral-tibial angles of 8  on the right and 3  on the left (Figure 3(a)). There was no patellofemoral involvement on Merchant\\'s views (Figure 3(b)).\\nNo preoperative magnetic resonance imaging (MRI) was available due to work-related issues and timing. The patient decided to proceed with diagnostic arthroscopy and if indicated, planned biopsy from the intercondylar notch. At arthroscopy, a loose body was removed from the lateral compartment (Figures 4(a) and 4(b)).\\nA large, irregular OCD lesion with a femoral chondral fragment with necrotic bone and medial tibial wear was seen in the medial compartment (Figures 5(a), 5(b), 5(c), and 5(d)).\\nAn unstable irreparable osteochondral fragment was removed, and pathology assessment revealed a cartilaginous fragment with osteonecrotic bone base (2.0 x 1.5 x 0.5 cm). Intra-operative measurements demonstrated a lesion size of 3.0 x 4.5 cm with a bony depth of 2 cm. A cartilage biopsy from the right knee intercondylar notch was obtained (Figures 6(a), 6(b), 6(c), and 6(d)), and due to the large defect size, two MACI membranes were automatically ordered.\\nBased on the preoperative work-up, diagnostic arthroscopy, bony depth, and lesion size, the decision was made to proceed with right knee MACI \"Sandwich\" technique with concomitant HTO followed by left knee surgery, allowing adequate time for recovery.\\nA 6 cm anteromedial subvastus approach and HTO with 10  correction were performed (Figures 7(a), 7(b), 7(c), 7(d), and 8(a)).\\nA large, poorly contained lesion measuring 3 x 4.5 cm was demonstrated (Figure 8(b)). The periphery of the lesion was demarcated with a # 15 blade, and ringed curettes were used to remove damaged cartilage to normal vertical borders. A shelf was created between normal subchondral bone plate level and bone defect. Sclerotic bone and intralesional osteophytes were removed with a high-speed burr creating a healthy bleeding base (Figure 8(c)). The site was drilled with a 1.5 mm drill bit at 3 mm increments to increase blood flow into the lesion (Figure 8(d)).\\nIliac crest ABG was obtained, and bone impacted into the defect up to, but not above, the subchondral bone plate level demarcated by the previously created shelf (Figure 9(a)). Three absorbable micro-anchors were placed along the poorly contained region of the intercondylar notch. A Keith needle was used to create osseous tunnels incrementally along the medial border of the lesion. The lesion required the entire MACI graft. Fibrin sealant was placed over the base of the lesion (Figure 9(b)). The first graft was placed smooth-side facing towards the bone graft and sewn into position using the micro-anchors along the intercondylar notch region (Figure 9(c)); additional 5-0 vicryl sutures were placed using the osseous tunnels previously created with the Keith needle, and 6-0 vicryl sutures were placed proximally and distally at the normal articular cartilage margins (Figure 9(d)).\\nThe second graft was placed with the cell layer facing into the defect and sewn into position using the same sutures (Figures 10(a), 10(b), and 10(c)). Fibrin sealant was placed around the periphery of the lesion (Figure 10(d)). Standard closure was performed.\\nContinuous passive motion (CPM) machine with ROM to 30  flexion increasing by 15  per week was started on post-operative day (POD) # 1 with full active-assisted ROM initiated and CPM machine discontinued at 4 weeks; full ROM and immobilization were discontinued at 6 weeks. Toe-touch weight-bearing was allowed locked in extension on POD # 1, 25% partial weight-bearing (PWB) at 2 weeks, 25-50% PWB at 4 weeks, and full weight-bearing as tolerated at 6 weeks. Exercycle, elliptical, and core muscle strength programs were initiated at 6-8 weeks.\\nPost-operative radiographs at 3 (Figures 11(a) and 11(b)) and 6 months (Figures 12(a) and 12(b)) revealed improved medial joint space, appropriate contour, fill, and bone incorporation.\\nAll patient-reported outcome measures (PROMs) significantly improved from baseline at 13 months. Lysholm and International Knee Documentation Committee (IKDC) scores improved by 37 and 54 points, respectively (Figure 13(a)). Knee Injury and Osteoarthritis Outcome Score (KOOS) pain and symptom scores improved 47 and 35 points, respectively, while KOOS sports improved by 75 points and quality of life increased by 81 points at the 13-month follow-up (Figure 13(b)). The PROMs delta augmentation prevails over the minimum clinically important difference (MCID).\\nLeft knee pain improved as right knee pain improved (Figure 14).\\nThe left knee PROMs stabilized (Figures 15(a) and 15(b)) and PSF-12 measurements improved by 21 points at 9 months (Figure 16).',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 68,\n",
       "    'case_id': 'PMC10318351_01',\n",
       "    'case_text': \"A 68-year-old female patient was referred to our institution for AS. She has a past medical history of hypertension and hypothyroidism as well as a recent diagnosis of urothelial carcinoma. She is a chronic smoker with a 30-pack-year history. Routine transthoracic echocardiography (TTE) reported a left ventricular ejection fraction of 60%-64% and a calcified aortic valve with a mean gradient (MG) of 40 mmHg and an aortic valve area of 0.8 cm2. Virtual basal ring sizing showed a perimeter of 70.2 mm2 with an area of 378.4 mm2 and a sinutubular junction of 24.6 mm. Pre-procedural cardiac catheterization showed non-obstructive coronary artery disease (Figure 1A). Further assessment with computed tomographic (CT) angiography demonstrated atherosclerotic calcifications of the aortic root, thoracic aorta, and coronary arteries and an incidental kidney tumor. Consequently, the heart team opted for TAVI given her need to undergo an urgent nephrectomy for her urothelial carcinoma.\\nA 25 mm Navitor valve was successfully deployed under local anesthesia with procedural coronary angiography showing no evidence of obstructive CAD. She had a transient third-degree atrioventricular block that resolved on the table with a normal ECG when she arrived at the cardiac care unit next day. TTE showed an MG 18 mmHg and trivial paravalvular leak. The patient was discharged home one day post-TAVI with a single antiplatelet therapy (SAPT), 100 mg of aspirin daily.\\nShe was doing well until 10 days after the procedure when she presented with acute severe chest pain (Figure 2). Immediate ECG showed evidence of inferior myocardial infarction (MI) with ST elevations in leads II and III and ventricular fibrillation (aVF). High sensitivity troponin level was elevated reaching 50,000 pg/ml. She also had an elevated c-reactive protein and white blood count; however, she did not have any fever or positional chest pain. Her blood pressure was 120/60 mmHg. TTE showed evidence of inferior wall hypokinesis. Emergent coronary angiography revealed a thrombus occluding the second segment of the right coronary artery (RCA) (Figure 1B). Angioplasty was performed with implantation of one drug-eluting stent (Figure 1C). The patient's symptoms, ECG changes, and troponin elevations provided evidence in favor of MI instead of other differentials such as pericarditis or aortic dissection following the procedure. She was stabilized and discharged on 75 mg of clopidogrel, 100 mg of aspirin, 5 mg of amlodipine twice daily, and 2.5 mg of bisoprolol twice daily.\\nThe etiology of the MI was investigated with a follow-up CT angiography given that the patient did not have evidence of CAD before the procedure. The CT showed a small thrombus between the right coronary and left coronary cusp (Figure 3). The patient was then put on for two weeks on triple therapy: 100 mg of aspirin, 75 mg of clopidogrel, and 15 mg rivaroxaban. This was followed by clopidogrel and rivaroxaban for six weeks. There were no further cardiac or embolic clinical presentations, and the patient was cleared for her nephrectomy.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 74,\n",
       "    'case_id': 'PMC4802983_01',\n",
       "    'case_text': 'Our patient was a 74-year-old woman, without any particular pathological antecedents, presenting intermittent and badly systemized bilateral sciatica, along with weaknesses in both lower limbs, gradually progressing for 2 years. This symptomatology got complicated by sphincter disorders characterized by urinary incontinence and constipation. The clinical examination objectified incomplete paraplegia without sensory loss. Patellar and Achilles reflexes were reduced on both the lower limbs. MRI showed an intradural fusiform lesion at L3-L4, with an isosignal on T1 and T2, associated with a central nodular hypersignal on both sequences. The lesion took up the whole spinal canal, making a scallop shape on the vertebral body and laminating its posterior arch. The tumor homogenously enhanced following a gadolinium injection [Figure 1]. The diagnosis for neurinoma was highly suspected. Through an L3 and L4 laminectomy and an opening of the dura mater, the tumor appeared to be grayish red, closed, very hemorrhagic, and tied to the filum terminale. The lesion retracted nerve roots on the back and on the left side without any invasion. The tumor was attached to the filum terminal and his section has facilitated total removal. The patient fully recovered her motor function after a sphincter and motor function rehabilitation. Macroscopically, the anatomopathological examination showed an encapsulated proliferative tumor, lobulated and surrounded by tiny fiber tracts. It was vascularized with large plaques of hemorrhagic suffusion. Microscopically, we showed lobulated cells with eosinophilic cytoplasms, sharply demarcated, with dense and rounded nuclei, pointing in immunohistochemistry neuron-specific enolase (NSE) and chromogranin A (CgA) [Figure 2].',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 83,\n",
       "    'case_id': 'PMC4007786_01',\n",
       "    'case_text': 'An 83-year-old male patient had a DDD pacemaker (Medtronic Kappa 733) implanted in 1995, because of complete atrioventricular (AV) block. Due to progressive heart failure, the pacemaker was upgraded in 2004 to an ICD with cardiac resynchronization therapy (Guidant Contak Renewal M179, CRT-D). For this purpose a Guidant 0138 ICD shock lead was implanted in the right ventricle and a Medtronic Attain 4194 in a posterolateral branch of the coronary sinus for left ventricular pacing. The preexisting Medtronic 4524 atrial lead was used for atrial pacing and sensing, and the bipolar right ventricular lead was abandoned. \\nA hospital admission because of ventricular tachycardias showed successful termination of these tachycardias by ICD shock therapy. Except shock therapy, the patient complained of dizzy spells, which at that time were attributed only to the ventricular tachycardias. However, at the time of device interrogation, the ECG showed intermittent ventricular inhibition.  Figure 1 demonstrates intermittent ventricular sensing followed by inhibition after atrial pacing. The interval between atrial pacing and ventricular sensing was estimated from 60 to 70 ms in this recording. Practically sensing is anticipated immediately after time out of the ventricular blanking period, which was programmed at 65 ms. \\nInhibition did not occur during atrial sensing, which is a strong indicator of cross-talk sensing. A Holter recording performed 24 hours prior to the device checkup revealed several periods of asystole with duration up to 7.4 seconds as a consequence of cross-talk sensing (Figure 2). The chest X-ray showed normal lead positions; there was no evidence of lead damage which was confirmed by unchanged values of lead impedances.\\nThe pacing parameters were DDD 65 till 110 beats/min and dynamic AV delay 160 ms/100 ms pacing output in atrial and RV 2.6 V at 0.06 ms, and LV 3.0 V at 0.5 ms, the RV-blank after A-pace was 65 ms, and the RV sensitivity was set to nominal.\\nNeither prolongation of the ventricular blanking period to 85 ms nor decreasing atrial output to 1.0 V at 0.5 ms could eliminate cross-talk sensing. Finally, cross-talk sensing disappeared after programming right-ventricular sensitivity from nominal to the least sensitive setting (Figure 3). Proper sensing during intrinsic rhythm and ventricular fibrillation during DFT testing was confirmed at this sensitivity setting.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 9,\n",
       "    'case_id': 'PMC8337056_01',\n",
       "    'case_text': \"A 9-year-old girl was admitted to Dongguan Children's Hospital 6 months ago due to breast development. Since the patient had no other obvious symptoms, we did some laboratory tests to help diagnose. A gonadotropin releasing hormone (GnRH) stimulation test showed that the peak values of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) were 8.03 and 14.97 IU/L, with an LH/FSH ratio of 0.53. Based on her premature breast development, test results and the absence of relevant personal or family history, she was diagnosed with precocious puberty and treatment with a monthly intramuscular injection of triptorelin (decapeptyl) was initiated. The patient also received imaging examinations to exclude underlying diseases. Unexpectedly, ultrasonography indicated a single, solid, focal liver lesion in S5. Enhanced computed tomography (CT) showed hyperenhancement of the lesion in the arterial phase, which was 17mm x 18mm in size, with a hypodense central stellate scar visible inside the region (Figure 1A). The lesion became isodense in portal venous and delayed phases, and the stellate scar showed slight enhancement. A diagnosis of FNH was considered. CT re-examination 6 months later showed that the lesion had increased to 23mm x 19mm x 18mm in size. According to ultrasound, the lesion was non-homogeneous, slightly hyperechoic with an unclear boundary, and located 1mm away from the gallbladder and 3mm away from the colon. Color Doppler ultrasound revealed spoke-wheel blood flow, with the feeding artery being from the S5 hepatic artery branch (Figure 1B). Contrast-enhanced ultrasound (CEUS) indicated a radiant artery and hyperenhancement of the lesion, which was 29mm x 25mm in size, in the arterial phase (Figure 1C), portal phase and delayed phase.\\nAn APLIO I700 ultrasound system with a PVT-674BT 10C3 abdominal probe (Canon, Japan, 2020), incisive CT (PHILIPS, 2020), and definition flash CT (SOMATOM, 2017) were used for diagnosis. A 100A1 microwave generator (2,450 MHz) and an ECO-100CI10 MWA antenna (Yigao, Nanjing, China) were employed for MWA. SonoVue (Bracco, Italy) was utilized as the contrast agent for ultrasound and was prepared as a suspension with 5 ml of 0.9% normal saline (N.S.). For transvenous use of the contrast agent, 1 ml of SonoVue was injected through a central venous catheter, followed by 5 ml of N.S. For intracavitary use, the ratio of N.S. and SonoVue was 100:1. A coaxial needle (15 G) and an automatic biopsy gun (18 G, BARD, USA) were applied for biopsy and a central venous catheterization set (Arrow, USA) was used for abdominal cavity intubation.\\nArtificial ascites-assisted ultrasound-guided MWA and biopsy were carried out under general endotracheal anesthesia. Under ultrasound guidance, we performed abdominal cavity intubation, and SonoVue in N.S. at 40 C was infused into the abdominal cavity. Under CEUS, we observed hyperechoic contrast agent distribution between the gallbladder and the hepatic margin close to the lesion, indicating that this fluid could provide a cooling effect during thermal ablation (Figure 2). We also inserted a guide wire near the position of the gallbladder and then inserted an expansion tube, which were used together to push the gallbladder wall away to avoid thermal injury.\\nUnder color Doppler ultrasound guidance, the microwave antenna was inserted directly to the site of the feeding artery (Figure 3A), and after 2 min of ablation at 60 W, CEUS showed no blood flow perfusion in the tumor (Figure 3B). Three biopsy specimens were then collected using a coaxial needle and an automatic biopsy gun. The microwave antenna was inserted through the coaxial needle to ablate the biopsy needle track after ablating the lesion. After biopsy, the tumor border near the gallbladder was ablated, followed by the peripheral part of the tumor and, finally, the interior of the tumor. After ablation, complete ablation of the whole lesion was observed by CEUS. Additionally, the gallbladder wall showed blood perfusion, indicating that the thermal ablation procedure did not cause necrosis in the gallbladder wall (Figure 4A). Moreover, the contrast agent did not enter the ascites, which indicated no needle track bleeding.\\nPost-operative medications included cefixime granules as an anti-inflammatory agent and compound glycyrrhizin capsules to protect liver function. The abdominal drainage tube was removed on the second day after the operation, and the patient was discharged on the sixth day. Examination by magnetic resonance imaging (MRI) 1 month later showed that the tumor was completely ablated and that the gallbladder was not injured (Figure 4B). Based on ultrasonography after another 3 months, there were no significant changes in the ablation zone and no blood flow signal inside it. Additionally, the gallbladder exhibited no obvious abnormity.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 28,\n",
       "    'case_id': 'PMC7166055_01',\n",
       "    'case_text': 'Table 1 shows the main results extracted from the case series and case reports. A total of 521 cases of pregnant women with laboratory-confirmed brucellosis were reported in the included 27 publications. The median of sample size of these seven case series studies was 33, ranging from 19 to 242. The mean/median maternal ages were basically the same (about 28 years old, respectively), ranging from 16 to 50 years. Pregnant women presented symptoms across all the trimesters, the proportion of pregnant women with brucellosis presented symptoms at the first trimester ranged from 12.9% to 57.9%, while it ranged from 22.2% to 51.6% at the second trimester. The most commonly used laboratory tests for brucellosis were serum agglutination test (SAT) and blood/bone marrow culture, which were used in 85.7% and 71.4% studies among the case series, respectively, and 66.7% and 45.5% cases were diagnosed with brucellosis using SAT and blood/bone marrow culture respectively among the case reports. The incidence of brucellosis occurred in pregnant women ranged from 1.5% to 5.8%. As for the adverse obstetric outcomes, the rate of abortion ranged from 2.5% to 53.0%, the rate of preterm delivery ranged from 3.4% to 31.3% and the IUFD rate ranged from 2.1% to 9.8%.  \\nMost pregnant women with brucellosis had a history of consumption of cheese or non-pasteurized dairy products (92.3% in the study by Kurdoglu et al and 90.8% in the study by Vilchez et al) or living in a low socioeconomic class or rural areas. There were no neonates infected with brucellosis in the included case series study in Turkey, while the rate of congenital brucellosis was 6.4% in the included case series study in Peru. Regarding the severity of brucellosis, a 31-week pregnant woman who presented with a 3-week history of the disease died on the disseminated intravascular coagulation (DIC) in the study by Vilchez et al.\\nTable 2 shows the detailed clinical manifestations, diagnostic methods and obstetric outcomes of pregnant women with brucellosis, which were extracted from the included case reports. The duration of delayed diagnosis could only be speculated for eight cases, ranging from 7 days to 5 months.\\nAnd we recorded the clinical manifestations as the frequency of occurrence and percentage (%) in the descending order in Table 3, the pooled proportions were calculated. A total of 36 clinical manifestations were extracted from the included articles, and the most common clinical manifestations were fever (400, 76.8%), joint pain/swelling/arthralgia (389, 74.7%), sweats (382, 73.3%), fatigue/asthenia/weakness (262, 50.3%) and back pain (189, 36.3%). Among the seven case series, the study by Vilchez et al reported the largest varieties of clinical manifestations (20/36, 55.6%), and the top three were fever (97.0%), malaise (85.1%) and sweats (77.2%). Among the 33 individual cases, a total of 29 (85.3% of 36) kinds of clinical manifestations were reported, the most common clinical manifestations were fever (66.6%), sweats (51.5%), joint pain/swelling/arthralgia (39.4%) and vaginal bleeding (24.2%). There were five (13.7% of 36) kinds of clinical manifestations that were only reported in the case reports, such as membrane rupture, oligohydramnios and breast pain, while there were no records about such as constipation, rash and depression in the included case reports. It is worth mentioning that one patient from the included case reports complained of both auditory hallucinations, dull/delirious, hand tremors and insomnia. \\nAs for the clinical manifestations of the involved body systems among pregnant women with brucellosis, osteoarticular system was mostly involved, 74.7% of the pregnant women with brucellosis presented joint pain/swelling/arthralgia. A proportion of 12.3% of the patients presented the symptoms of cardiovascular system as hypoxia. For the clinical manifestations of reproductive system, vaginal bleeding (9.0%) was the most common clinical manifestation, followed by abdominal pain/distension/pelvic pain (7.5%).\\nAmong the 32 included individual cases that with available obstetric outcome information, 10 (31.3%) women suffered preterm delivery, 12 (37.5%) had an abortion and 3 (9.8%) had intrauterine fetal death. And among the 12 patients who had an abortion, 5 (41.7%) of them experienced vaginal bleeding.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 59,\n",
       "    'case_id': 'PMC5818931_01',\n",
       "    'case_text': \"The patient was a 59-year-old male former smoker with a past medical history of stage 1-2/4 type I left sided renal cell carcinoma status after robotic partial nephrectomy, parathyroid adenoma status after resection, history of probable idiopathic thrombocytic purpura status after splenectomy, hypertension, diabetes mellitus type 2, coronary artery disease with past myocardial infarction and stent placement, and internal pacemaker-defibrillator placement. The patient had begun complaining of progressive fatigue, arthralgias, myalgias, and back pain beginning approximately one year before diagnosis at his primary care provider's office, which initially seemed to be associated with his, at the time, recent parathyroid resection. Lyme's disease, endemic in the patient's geographic region and often considered in nonspecific presentations with these symptoms, was ruled out by antibody assay. On retrospective analysis of the patient's history, he apparently had worked at a local university in maintenance and did not have a known history of employment in manufacturing or significant chemical handling. There was no known family history of genetic conditions that would predispose the patient to multiple malignancies.\\nThe patient progressively worsened over months; he developed nausea, dry heaving, and decreased appetite. CT of the chest and HIDA scan had been performed which revealed nonobstructive cholelithiasis with normal gallbladder function. The patient subsequently underwent a noncontrast CT of abdomen and pelvis, which revealed a large abdominal mass measuring 7 cm x 5.5 cm abutting the mid portion of the transverse colon, with numerous metastatic foci in the liver, lymphadenopathy adjacent to the pancreatic head, a large lytic lesion involving the tenth rib, and scattered lytic areas throughout the spine and left iliac wing (Figure 1). The patient then underwent core biopsy of the abdominal mass.\\nInitial core biopsy of the abdominal mass revealed highly vascular tissue, the majority necrotic, with small atypical cells seen on frozen section. Immunohistochemical staining for RCC was negative. CD10 was equivocal with chromogranin A and podoplanin (D240) both being negative. Vimentin was strongly positive. A consult was made, an additional staining including Cam 5.2, CD31, and ERG. Cam 5.2 revealed rare mesothelial cells and the vascular proliferation was positive for both CD31 and ERG. It was concluded that the degree of necrosis precluded a definitive diagnosis but that a vascular neoplasm or well-differentiated angiosarcoma could not be excluded.\\nRepeat core liver biopsy and immunohistochemical staining were performed at an outside institution. The liver biopsy delineated a very hypercellular specimen (Figure 2(a)). The tumor was comprised of a prominent vasoformative network (Figure 2(b)). The endothelial lining cells were plump and pleomorphic. They had high nuclear to cytoplasmic ratio with hobnailing hyperchromatic nuclei. The cytoplasm was eosinophilic with indistinct cell borders. The cytology delineated a hypercellular aspirate (Figure 3). The cells formed a tightly cohesive cluster of epithelioid cells. The cells harbored hyperchromatic nuclei with eosinophilic cytoplasm. On occasion, the cytoplasm demonstrated cytoplasmic vacuoles and intracytoplasmic lumina. Focally, the clusters were composed of very atypical spindle cells. The cytology specimen stained negative for cytokeratin AE1/AE3 and positivity for CD31 and CD34. Since the specimen stained for two vascular immunohistochemical stains (CD31 and CD34) in conjunction with pancytokeratin negativity, a diagnosis of angiosarcoma was rendered (Figures 2(c) and 2(d)).\\nThe patient was scheduled for systemic chemotherapy with doxorubicin as well as palliative, single modality radiation therapy of the spine. Radiation was completed first. The patient's chemotherapy regimen was changed to taxol rather than doxorubicin due to low ejection fraction seen on MUGA scan. However, prior to initiation of chemotherapy the patient was hospitalized for confusion, lethargy, and enterococcal bacteremia. The decision was made to discharge the patient with hospice care and he died 13 days later.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 0,\n",
       "    'case_id': 'PMC8081048_01',\n",
       "    'case_text': \"A 2-month-old male infant was admitted to our hospital with a 1 month history of persistent white stools.\\nThe meconium of the child was dark green. Three days later, his stool turned yellow. After that, the stool color gradually became white stool over the next month. The test results of the infant's liver function were: albumin 16.5 g/L, total bilirubin (TB) 35.2 mumol/l, direct bilirubin (DB) 27.7 mumol/l, and total bile acid (TBA) 63.0 mumol/l. The child had taken probiotics and the symptoms did not improve.\\nThe patient had no significant past medical history. And the mother's pregnancy was uneventful.\\nAt the time of admission, the infant's body weight was 3400 g (<3rd percentile) and his height was 60 cm (50-70th percentile). The physical examination revealed hepatomegaly (4 cm below the ribs with soft texture) and pitting edema of both lower limbs. No abnormality was revealed for the consciousness, cardiopulmonary examination, and nervous system examination.\\nRoutine laboratory testing upon admission showed hemoglobin was 63 g/L, packed cell volume 19.9%, normal mean-cell volume, mean cell hemoglobin concentration was at the lower end of normal, and platelets 304 x 109/L. The patient was tested negative for hepatitis A, B, and, C, syphilis, HIV, TORCH, EBV-IgM antibody, and EBV DNA; his thyroid function and blood coagulation function were within the normal range. The patient's blood glucose during admission was normal and blood and urine tandem mass spectrometry showed that the amino acid and acylcarnitine spectrum analysis were normal. Cytomegalovirus IgM test was positive. Liver function tests revealed slightly elevated levels of TB, DB, and gamma-glutamyltransferase (gamma-GT) (shown in Table 1).\\nThe cardiac ultrasound showed no abnormalities. The chest radiograph was normal. Abdominal ultrasound showed hepatosplenomegaly, liver parenchyma echoes, but the gallbladder and pancreas were normal.\\nIn order to differentially diagnose whether there is biliary atresia (BA), we perfected the examination of liver, gallbladder, spleen color Doppler ultrasound, and gallbladder contraction. In order to differentially diagnose cardiogenic edema, we perfected the cardiac color Doppler ultrasound. The infant's parents refused to permit cholangiography and a liver biopsy. Due to the unclear diagnosis, we performed a genetic test. The infant's genetic analysis showed a CFTR hemizygous mutation site (c.223C>T) in exon 3 and exon 2-3 heterozygous deletion mutation. A genetic verification of the infant's parents was also performed; the father had a point mutation and the mother had a CFTR gene exon 2-3 heterozygous deletion mutation (shown in Figure 1). To further verify whether the child had pancreatic exocrine insufficiency, we tested fecal pancreas elastase 1 and the result was 0.6 mug/g, significantly lower than the normal value of 200 mug/g. Stool testing showed fat globules of 70-80/HP. These findings, combined with the manifestations of cholestasis, supported the diagnosis of CF. Because our hospitals and other testing institutions cannot perform a sweat chloride test, we did not perform it.\\nAfter hospital admission, the infant was placed on a lactose-free fortified medium-chain fatty acid milk powder feeding, oral ursodeoxycholic acid (UDCA) 30 mg/(kg.d), and supplemented with fat-soluble vitamins A, D, E, and K. The stool color remained unchanged. Fecal pancreas elastase 1 suggested that the child had insufficient pancreatic exocrine function, so aspergillus oryzae pancreatic enzymes tablets (half a tablet once, three times per day) were added 2 weeks after diagnosis. Two weeks after the oral pancreatic enzyme tablets were administered, the color of the infant's stool changed to yellow and his weight increased (shown in Figure 2).\",\n",
       "    'gender': 'Male'},\n",
       "   {'age': 0,\n",
       "    'case_id': 'PMC8081048_02',\n",
       "    'case_text': 'On follow-up, liver function test was performed every 1 month and abdominal ultrasound every 2 months. The oral medication was well-tolerated by the child without adverse reactions. Two months after diagnosing the infant with CF, his TB, DB, and TBA decreased to normal levels (shown in Table 1), but the infant had a cough for 1 month, and his chest CT scan showed he had sacculus expansion of the lungs. The infant\\'s physical examination revealed an enlarged liver (4 cm below the ribs with soft texture) in a 6-month old. Now, he is 1 year old with yellow soft stools, his body weight is 8500 g (3rd percentile), his height is 72 cm (3rd percentile). He has not had a cough for nearly 4 months, but still has an enlarged liver (2 cm below the ribs with soft texture).\\nUsing \"cystic fibrosis,\" \"* stool,\" and \"infant*\" as keywords, we found three relevant articles in PubMed consisting of a total of four case reports with white stool as the first symptom; one was a domestic case report (seen in Table 2). Including this infant, there are a total of five children (three males and two females) with an average age of 2 months that have presented with white stools and diagnosed with CF. Anemia was present in all five children, edema and hypoproteinemia in four, changes in stool color in five (pistachio-green in two patients, pale colored stool one, acholic stool in one, and white stool in one patient), cholestasis in two patients, delayed meconium discharge in one, delayed growth in three, hepatomegaly in three, and splenomegaly in two infants. One child presented with respiratory symptoms at the onset.\\nTwo children had an abnormal sweat test: one had a F508del compound heterozygous mutation and the other child had three mutation sites (C.214G>G/A, P.A72T; C.650A>A/G, P.E217G, and C.3406G>G/A, P. A1136T), which was a compound heterozygous mutation.\\nThe female infant (the fourth case) died because of a massive pulmonary hemorrhage. The stool changed to yellow in two infants after oral pancreatic enzymes were administered. The prognosis of the male infant (the third case) was good by UDCA and supporting treatment.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 31,\n",
       "    'case_id': 'PMC6743703_01',\n",
       "    'case_text': 'A 31-year-old male fell from a balcony approximately 40-50 feet height. On admission with a GCS score of 5, he was unable to move his extremities and had no rectal tone. A computed tomography (CT) scan of the cervical spine demonstrated bilateral locked facets at C6/C7 [Figure 1a-d] and C7/T1 [Figure 1f-i] with Grade 1 anterolisthesis at C7/T1. There was also a C6/C7 arthroplasty that was performed a few weeks before the event [Figure 1e].\\nThe magnetic resonance imaging (MRI) scan demonstrated injury to the C6/C7 and C7/T1 ligaments: the ligamentum flavum and interspinous, anterior, and posterior longitudinal ligaments [Figure 1j]. This was accompanied by severe canal narrowing and a high intramedullary cord signal/edema at these levels, plus a small C5-T1 epidural hemorrhage. The brain MRI also demonstrated several foci of punctate hemorrhage consistent with diffuse axonal injury requiring placement of an intracranial pressure monitor.\\nThe patient underwent emergent posterior spinal decompression with fusion from C4 to T2. The pedicles of C7 were fractured bilaterally and several attempts to achieve reduction were unsuccessful. The posterior elements of C7 were considerably loose due to the bilateral pedicle fractures. Ultimately, removal of the superior facets of C7 and T1 allowed for C6-C7 and C7-T1 reduction. The left C8 nerve root was entirely exposed due to the lateral mass fracture at C7 and was exposed further to ensure decompression of the C8 roots. A postoperative CT scan demonstrated adequate localization of the instrumentation and alignment despite slight unilateral facet subluxation at C6/C7 and minor unilateral facet subluxation at C7/T1 [Figure 2]. Postoperatively, the patient was monitored closely in the ICU. He had upper extremity function but appeared plegic in the lower extremities without sphincter tone. He ultimately expired secondary to his severe brain injury.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 25,\n",
       "    'case_id': 'PMC6345152_01',\n",
       "    'case_text': \"Diana (a pseudonym) is a young woman of 25 years old that reached the Eating Disorders Centre, Division of Endocrine and Metabolic Diseases, San Luca Hospital in Milan, following a dramatic weight loss. Diana reached the Centre with a BMI of 16.06 kg/m2 reporting several disruptions in her eating patterns and several distressful alterations in her body image perception. As reported in the clinical history, Diana's first eating related crisis was dated back 2 years before her current admission, with a subtle episode when she started a diet to lose some weight after health issues related to her thyroid. During that period, Diana was located abroad for work and - under moderate stress - she began a restrictive diet with a low caloric intake that brought her to lose 10 kg in 6 months. Diana's weight remained constant in the following months but she developed an obsessive attention to the caloric intake along with intrusive thoughts regarding her weight and regarding specific types of foods. Diana also reported body-related image distortions such as overvaluation of her weight, mirror and body checking, and avoidance of body exposure. Moreover, during the crises, she reported frequent crying spells observing her body in front of a mirror.\\nIn the last year, Diana reported a stressful situation at the University that heightened her psychological symptoms. Following these new difficulties, Diana re-enacted the restrictive conducts, reducing the caloric intake with a consequent weight loss of 4 kg in a month. In the period before the admission, the restrictive conduits were accompanied by self-induced vomit and daily binge episodes.\\nDiana matched all the DSM-5 criteria for a diagnosis of AN, binge-purge subtype. Compatible with the diagnosis, Diana presented distortions in her body perception and obsessive thoughts regarding her weight and her body image; for these reasons, she was considered as an optimal candidate for the interoceptive assessment.\\nAt the begin of the rehabilitative protocol, Diana's blood panels showed no signs of metabolic distress, with values in normal ranges. At her admission, Diana's thyroid levels were within normal range and they remained within the normal range during the curse of the treatment. Endocrinologist suggested a chronic autoimmune normal-functioning condition. The psychiatric assessment indicated mood alterations toward a depressive condition accompanied by severe sleep difficulties and insomnia.\\nThe rehabilitative program was composed of a multidisciplinary approach that included several experts in different fields: endocrinology, psychiatry, psychology, and nutrition. The specialists collaborated in an outpatients service tailored to the specific users' needs. The rehabilitative program could extend from two to four cycles of treatment. Diana followed a two-cycle rehabilitative protocol with a frequency of 3 sessions a week for a total of 37 sessions. The protocol was composed of psychological intervention with group psychotherapy and individual sessions focused upon a psyco-corporal therapy approach (body-oriented psychotherapy). Psychological intervention was accompanied by psychiatric and pharmacological support (citalopram and mirtazapine), to moderate Diana's mood alterations. The rehabilitative protocol was integrated with alimentary education sessions provided by the nutritionist. Additionally, the protocol was also accompanied by a nutritional program with fixed meals (both in quantity and composition) that Diana consumed under supervision. Scheduled assessment sessions ensured an adequate monitoring of the progress.\\nFrom the beginning, Diana showed a deep insight regarding her condition. Nonetheless, from her first session, Diana showed severe difficulties in following the assigned rehabilitative diet due to obsessive thoughts connected to her body weight and to certain types of food. In the following weeks, Diana improved her adherence to the recovery protocol with a better ability to follow the changes in the diet both on quantitative both on the qualitative level (e.g., types of foods consumed). Diana reached a BMI of 19.00 kg/m2 at the end of her second cycle of rehabilitative treatment. Considering the noticeable improvements regarding her eating behaviors and her general clinical condition, Diana was dismissed from the Centre and continued her program following only monthly assessments accompanied by individual psychotherapy.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 27,\n",
       "    'case_id': 'PMC6167587_01',\n",
       "    'case_text': \"A 27-year-old male with underlying congenital hydrocephalus and paraplegia was admitted to the hospital due to infected sacral sore. He had a placement of a ventriculoperitoneal shunt when he was a child. Upon admission, he also complained of progressively having difficulty in passing urine and leaked urination but he denied dysuria, hematuria, and pyuria. On examination of his genitalia, the prepuce was deformed and enlarged with phimosis. To our surprise, there was a huge stony hard foreign body under the prepuce measuring 5 x 5 cm in size (Figure 1). It was visualised through the stenosed prepuce. Otherwise, the testes were normal and abdominal examination revealed no significant finding.\\nA pelvic radiograph was arranged and revealed a well-rounded radiopaque lesion in his penile region representing a large stone (Figure 2). Ultrasound of the kidney, ureter, and bladder (KUB) revealed an absence of proximal tract stone. A Foley's catheter was inserted to assist his urination, and it drained minimal amount of clear urine. His serum creatinine level was elevated initially but resolved after hydration. He was then planned for circumcision and removal of the preputial stone once his sacral sore improved. After almost a month in the ward, he finally underwent the circumcision. A flexible cystoscopic examination beforehand showed a trabeculated and small contracted bladder with no urethral stricture seen. The circumcision was undertaken using a dorsal slit technique. A huge preputial stone measuring 4 x 4 cm was uneventfully retrieved (Figures 3 and 4). His recovery went well without any complication postoperatively.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 46,\n",
       "    'case_id': 'PMC6111644_01',\n",
       "    'case_text': \"A 46-year-old male patient presented to the dermatology outpatient department with 1-year history of sensory loss and paresthesia over bilateral lower legs. He was admitted and evaluated for Hansen's disease. On examination, there was no cutaneous lesion suggestive of leprosy. Peripheral nerve trunks were not thickened. Sensory loss to touch, pain, and temperature was present over the distal part of legs and feet bilaterally. Ankle jerk was diminished bilaterally. No trophic ulcer was present. Higher mental function and cranial nerve examination were within normal limits. There was no sign of meningeal irritation. Motor examination did not reveal weakness in any major muscle groups. Slit skin smear taken from earlobes did not demonstrate any acid-fast bacilli. A skin biopsy was taken from hypoesthetic skin of the right leg and sent for histopathology. Initial investigations including complete blood count, liver and renal function tests, fasting plasma glucose, and urine examination did not reveal any abnormality. In such a clinical scenario, the possibility of Hansen's disease was remote, and therefore, a neurologist's opinion was sought. The patient was then advised to go for HIV serology and to our surprise found to be reactive for HIV-1 with CD4 count of 160 cells/mm3. On retrospective questioning, the patient gave a history of on-and-off fever, fatigue, weight loss, and recurrent pyodermas. He also had multiple high-risk sexual exposures several years back. He was diagnosed as a case of HIV neuropathy-distal symmetric polyneuropathy (DSP) type and started on antiretroviral therapy (ART).\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 0,\n",
       "    'case_id': 'PMC8313121_01',\n",
       "    'case_text': 'To further investigate possible central nervous system abnormalities, when he was 8 months old, the boy underwent a brain Magnetic Resonance Imaging (MRI), which showed typical signs of hypoxic-ischemic encephalopathy, in association with a diffuse white matter myelination delay:more pronounced in both optic radiations:and pons hypoplasia (Figure 1). A muscle biopsy, performed at the age of 9 months, revealed signs of muscle damage including round and small fibers and the presence of cytoplasmic vacuoles. In addition, using specific staining, we also detected enlargement and abnormality on the shape of the neuromuscular junctions (NMJ; Figure 2).\\nSoon after his first birthday, he was admitted to the Emergency Department for a prolonged seizure lasting for ~10 min, and not resolving after endorectal diazepam administration. During admission, severe hypoglycemia (<1.1 mmol/L) and low plasmatic cortisol levels were detected. Hence, the boy was diagnosed with central hypoadrenalism, and replacement therapy (hydrocortisone) was started. A Growth Hormone Releasing Hormone (GHRH)-arginine stimulation test was then performed: growth hormone levels resulted in the normal range of response.\\nGenetic studies, including karyotype, array-Comparative Genome Hybridization (CGH), Sanger sequencing of the MAGEL2 gene (due to a clinical suspect of Schaaf-Yang disease), and a gene panel including n = 52 genes associated with neurodevelopmental disorders and epileptic encephalopathies, were all reported as normal. To investigate the molecular etiology of the phenotype in the affected individual, we then performed exome sequencing (ES) of the proband and his parents. This led to the identification of a pathogenic hemizygous variant in ZC4H2 [NM_018684.4: c.593G>A (p. R198Q)], predicted as deleterious by several in-silico tools, including CADD, SIFT, PolyPhen, and MutationTaster. The variant is also regarded as pathogenic in ClinVar (VCV000050981.1; https://www.ncbi.nlm.nih.gov/clinvar, last accessed May 31, 2021).',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 11,\n",
       "    'case_id': 'PMC7527615_01',\n",
       "    'case_text': 'An 11-year-old male presented with gradual left breast enlargement for one year duration. Frequently he visited pediatricians and provisionally diagnosed as a case of gynecomastia with reassurance and observation. Past medical, surgical, family and drug history, all were negative.\\nA firm swelling involving left anterior chest wall elevating the nipple and areolar region. The swelling was ill-defined, non-tender, non-fluctuating, non-illuminating with normal overlying skin. Vital signs were with the normal ranges.\\nHematological tests were normal. Ultrasound examination showed a thick wall cystic lesion with internal debris and bone erosion suspecting chronic infection. CT scan of chest revealed a cystic lesion with fluid content measuring 12 x 8 cm in size connecting with a similar cystic lesion in the substernal area through a hole in the fifth rib (Fig. 1, Fig. 2).\\nUnder general anesthesia, in supine position, through anterolateral incision, a thick wall cystic lesion under the skin with a very thick pus content was found connecting to another similar lesion in the anterior mediastinum through a hole in the fifth rib with localized thickening of the pleura. Both of the lesions, the fifth rib with a part of fourth rib and a piece of pleura were resected and sent for histopathological examination which revealed multiple granuloma with caseating material, typical for TB. The wound was closed in layers after insertion of intrathoracic drain (Fig. 3).\\nThe postoperative course was uneventful. The patient was put on anti-TB regular regimen for three months.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 61,\n",
       "    'case_id': 'PMC9170507_01',\n",
       "    'case_text': 'A 61-year-old gentleman with no significant medical history presented with the three weeks history of intermittent epistaxis, nasal block, and loss of weight. Physical examination was unremarkable, and he did not have lymphadenopathy or hepatosplenomegaly. Rigid nasal endoscopy revealed a smooth surface mass covering the entire left nasal cavity, pushing the nasal septum to the right and bleeds easily on contact. Subsequently, a CT scan of the paranasal sinus, neck, and thorax revealed a mass over left frontal and ethmoid sinuses which occupied almost the entire left nasal cavity. Incidentally, there was a well-defined heterogeneously enhancing mass at the left paravertebral region (7.1 x 7.8 x 7.8 cm) with extension into left T7/8 neural foramina (Figure 1). Initial laboratory investigation showed white blood cell (WBC) count of 14.2 x 103/uL, hemoglobin (Hb) of 13.8 g/dL, and platelet count of 377 x 103/uL, with normal renal and hepatic function. His lactate dehydrogenase (LDH) was 141 U/L (upper limit of normal: 246). Hepatitis B, hepatitis C, and HIV serologies were nonreactive. Nasopharyngeal mass biopsy was performed, and histological examination highlighted diffuse infiltration by the atypical medium to large lymphoid cells and exhibited multiple membrane bound nucleoli. Immunohistochemistry (IHC) showed that the neoplastic cells were diffusely positive for CD79a, MUM-1, and CD56 and focally positive for PAX-5 (Figure 2). These cells were negative for CD20, CD30, ALK-1, CD3, CD5, CD10, Bcl-2, Bcl-6, CD138, HMB45, and S-100. Nuclear proliferation as assessed by Ki-67 was almost 100%. Unfortunately, Epstein-Barr virus (EBV) encoded RNA by IHC was not performed. Based on the morphological and IHC characteristics, diagnosis of PBL was made. Bone marrow biopsy did not show any marrow infiltration. CT-guided biopsy of the paraveterebral mass was done to rule out possible neurogenic tumour as PBL has rarely been associated with a paravertebral mass. However, the results were inconclusive due to the inadequate sample. He was scheduled for a repeated CT-guided biopsy of the paravertebral mass, and his histopathological examination results came back later which revealed ancient schwannoma. Surprisingly, he reported resolution of his symptoms after the first biopsy of the paravertebral mass, and hence, treatment for PBL was not initiated. Spontaneous regression of his PBL was further confirmed by a repeat rigid nasal endoscopy, which showed good patency of both nasal cavities, and a repeat CT scan of the paranasal sinuses, which revealed spontaneous regression of his left nasal mass (Figure 3). A watch-and-wait approach was employed, and he was followed up closely to look for any evidence of recurrence. He remained in remission during his last follow up after 4 years from diagnosis.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 54,\n",
       "    'case_id': 'PMC5320041_01',\n",
       "    'case_text': 'A 54-year-old Hispanic male presented to the clinic with chronic dyspepsia and uncontrolled reflux symptoms not responding to acid-suppression therapy with a proton pump inhibitor (PPI). His past history was remarkable for sleeve gastrectomy one year previously. PPI therapy was stopped two weeks prior to endoscopy to promote the yield of a Helicobacter pylori (H. pylori) test. Esophagogastroduodenoscopy revealed gastric-like mucosa 2 cm in diameter in the proximal esophagus, suggestive of an inlet patch (Fig. 1). The biopsy of the esophageal lesion confirmed the gastric mucosa, showing mild chronic inflammation and a positive immunohistochemical stain for H. pylori (Fig. 2). Biopsies from the gastric mucosa were only significant for chronic gastritis, with a negative H. pylori stain.\\nGutierrez et al suggested that 73% of cases of H. pylori gastritis were associated with H. pylori infection of an inlet patch and that such an infection is highly related with the density of H. pylori colonies in the stomach. To our knowledge and to date, this report is the first case of isolated H. pylori infection in a cervical inlet patch without concurrent H. pylori gastritis.\\nThe case is also unique because of the prior history of sleeve gastrectomy. The mechanism of isolated H. pylori infection in patients who have undergone sleeve gastrostomy remains unclear; our proposed theory is that the altered stomach anatomy reduces its isolation and promotes H. pylori colonization in other parts of the gastrointestinal tract.\\nFurther studies are warranted to confirm the mechanism of isolated H. pylori colonization in a cervical inlet patch and its association with sleeve gastrectomy.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': None,\n",
       "    'case_id': 'PMC10201373_01',\n",
       "    'case_text': \"A male infant with a history of a prenatally detected left suprarenal mass was addressed to the surgical unit. Antenatal ultrasonography at 22 WA disclosed a cystic left suprarenal mass about 2 cm in diameter. The fetal magnetic resonance imaging (MRI) showed a 20x13 mm non-calcified cystic mass of the left adrenal gland, compatible with a neuroblastoma (Figure 1). Vaginal delivery was uneventful.\\nResults of routine laboratory tests including complete blood count, blood biochemistry, and urinalysis were normal, except for a major iron-deficiency anemia. Ultrasonography at 1 months of life showed an anechogenic image of the left adrenal gland of 17x12 mm, with thin walls (Figure 2).\\nIn the 9 months interval between the birth's ultrasound and the last imaging, the mass minimally diminished in size and stabilized at about 2 cm.\\nThe infant was closely monitored during his first year of life and in the absence of symptomatology or significant regression of the mass, we decide to proceed with its removal.\",\n",
       "    'gender': 'Male'},\n",
       "   {'age': None,\n",
       "    'case_id': 'PMC10201373_02',\n",
       "    'case_text': 'We performed a preoperative CT which showed a partially cystic 20 x 22 mm mass in the left adrenal region, non-enhanced, without calcification (Figure 3). It was therefore decided to surgically remove the tumor. An uneventful laparoscopic adrenalectomy was performed. The patient was monitored for 24 hours, restarted alimentation immediately after surgery, and was discharged in good general conditions at 48 hours. The patient had no symptoms during 5 months of follow-up.\\nThe pathological result described a mass with mixed composition of ciliated columnar epithelium of the respiratory type, well differentiated cartilaginous structures as well as small seromucous glands. The specimen was diagnosed as a mature cystic adrenal teratoma, without any suspicious sign of malignancy, which was completely resected (Figure 4).',\n",
       "    'gender': 'Unknown'}],\n",
       "  [{'age': 8,\n",
       "    'case_id': 'PMC7406448_01',\n",
       "    'case_text': 'Our patient was an 8 years old child with a history of epilepsy. She experienced her first seizure at the age of 5 years. She had a normal neuropsychological development. There was no family history of epilepsy. The physical examination was normal. Her seizures began with what it was described as <<weird feeling>> and then followed by automatism (chewing). This seizure lasted about 1 minute and 30 seconds. Our patient expressed total amnesia of her seizures. 1.5 Tesla MRI revealed a small round cyst in the right choroidal fissure of the temporal horn compressing the hippocampus. The signal intensity of the cyst was hyposignal T1 (Figure 1), hypersignal T2 (Figure 2), no restriction of apparent diffusion coefficient (ADC), identical to that of the cerebrospinal fluid (CSF). There was no peripheral contrast enhancement or surrounding edema (Figure 3). Based on the MR features, the presumptive diagnosis of a choroidal fissure cyst was made and seizures were medically controlled by Carbamazepine.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 24,\n",
       "    'case_id': 'PMC7204375_01',\n",
       "    'case_text': 'A 24-year-old Hispanic male presented to outpatient clinics with a past medical history of a persistent cough and shortness of breath for 10 years. Recently, his symptoms progressively worsened to chronic hypoxemic respiratory failure. He required long-term supplemental oxygen therapy of 5 liters/minute by nasal cannula and high flows of up to 15 liters/minute during pulmonary rehabilitation. His pulmonary function tests revealed a markedly decreased forced vital capacity (FVC) and diffusing capacity of the lung for carbon monoxide (DLCO), which were only 35% and 34% of predicted, respectively. Computed tomography (CT) of the chest revealed diffuse ground glass opacities, punctate calcifications, and extensive subpleural cysts consistent with PAM (Figure 1). A prominent pulmonary trunk, right cardiac chamber dilation, and mild interventricular septum straightening suggested a component of pulmonary artery hypertension. Right heart catheterization confirmed pulmonary artery hypertension with normal cardiac output and cardiac index. Because of his progressive symptoms with significant oxygen requirements, he underwent bilateral lung transplantation.\\nGross examination of the bilateral pneumonectomy specimens revealed enlarged lungs (right lung 1750 grams, left lung 1438 grams). The pink-tan pleural surfaces had multiple small plaque-like structures. The cut surfaces were pink-red and spongy with a gritty, sand-like texture (Figure 2). Hematoxylin- and eosin-stained sections revealed the characteristic diffuse intra-alveolar lamellar microliths (Figure 3). The background lung parenchyma showed interstitial fibrosis, numerous hemosiderin-laden macrophages, interstitial inflammation, and acute pleuritis.\\nHis lung transplantation was complicated by intraoperative hemorrhage requiring >20 units of red cells and various other blood products. His hospital course was complicated by persistent leukocytosis and stenosis to the left mainstem bronchus, mucosal ischemia, and recurrent mucous plugging requiring repeated bronchoscopies. At 1 year post transplant, his pulmonary function tests revealed an improved FVC and DLCO of 50% and 76% of predicted, respectively. Since PAM has an autosomal pattern of inheritance, family screening was being considered for this patient.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 26,\n",
       "    'case_id': 'PMC5757404_01',\n",
       "    'case_text': 'A primiparous 26-year-old patient, with unremarkable personal medical history, was referred to our center. In her family history, we noted that her sister has esophagus atresia associated with situs inversus and primary ciliary dyskinesia.\\nThe first-trimester ultrasound screening at 12 weeks and 4 days of gestation revealed a hyperechoic aspect of the entire right lung, which led us to suspect a unilateral pulmonary pathology (Figure 1A, 1B). Nuchal translucency was measured at 0.9 mm for a cranio-caudal length at 62.5 mm. Regarding the precocity of this abnormality, the retained hypothesis was bronchial atresia, pulmonary sequestration, or CCAM.\\nThe second-trimester test was based on the level of the maternal serum free-beta-hCG (1.04 multiples of the median [MoM]) and on alpha-fetoprotein (AFP) (0.90 MoM).\\nAn ultrasound scan at 21 weeks described the same hyperechoic aspect of the entire right lung associated with discrete mediastinal and heart deviations with hydramnios. The patient was then referred to our department at 25 weeks of gestation. A hyperechoic right intra-pulmonary image, with left heart and aorta deviations, a right diaphragmatic dome eversion, and hydramnios, were confirmed. The color Doppler imaging showed homolateral pulmonary vessels vascularization. There was no Doppler flow evidence of a systemic arterial supply to the lesion. The left lung was compressed by mass effect (27x14 mm) (Figure 1C, 1D).\\nAn amnio-drainage of 2500 ml of amniotic fluid and a karyotype were performed the same day. A few hours after puncture, a premature rupture of membranes was observed and the patient requested a medical pregnancy interruption. The biochemical analysis of amniotic fluid and the karyotype were normal (46 XY). Medical pregnancy interruption was accepted in accordance with the French laws and was performed uneventfully.\\nOn autopsy, the fetus was discovered to be a male weighing 1550 g. The external examination revealed abdominal distension. On internal examination, all organs were in situ. The pulmonary parenchyma of the right lung lower lobe consisted in microcysts of variable size; most of them were 0.5 cm, inducing a major right lung hypertrophy (49.1 g vs. 5.5 g of the left lung, normal=27+-7 g). This tumor compressed and latero-deviated to the left the mediastinum (heart, thymus, left lung) and caused an eversion of the right diaphragmatic dome. On histology, right lungs showed multiple cysts relatively uniform in size, lined by stratified columnar epithelium, and having thin fibromuscular septa. All other visceral organs were congested but well-developed and revealed no anomalies. Based on these features, a pathological diagnosis of CCAM Stocker type 3 was confirmed (Figure 2A-2C).',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 32,\n",
       "    'case_id': 'PMC3924740_01',\n",
       "    'case_text': 'A 32-year-old woman (gravida 4, para 2) visited our institution due to dyspareunia lasting for 5 months after her second delivery. Seven years before her visit, she delivered her first baby by Cesarean section due to progression failure. However, she succeeded in vaginal birth after a Cesarean delivery (VBAC) for her second delivery at another institution. She reported that during her second labor, she underwent numerous pelvic examinations because her labor did not progress smoothly. Finally, she underwent a vaginal delivery of a female infant weighing 3,580 g without applying vacuum or forceps. She did not visit at her scheduled postpartum examination after her second delivery, therefore, her perineal area was not explored after her vaginal birth.\\nAfter her second birth, she experienced dyspareunia and her husband could not resume his sexual activity due to inability to achieve full penile insertion. Also, she reported the immediate leakage of semen after intercourse. In addition, her menstruation did not resume, but she attributed this phenomenon to breastfeeding. There was no abnormal finding in her vital signs and laboratory tests. However, it was hard to insert the speculum fully into her vagina because of her blind vagina canal. Also, her cervix could not be visualized by speculum examination. As a result of a thick transverse vaginal septum blocking her vaginal cavity, we could insert a speculum only 2 to 3 cm into her vagina (Fig. 1A). Transvaginal ultrasonography (Voluson 730 Expert, GE Medical Systems, Zipf, Austria) showed a transverse vaginal septum measuring 0.94 cm thick and a fluid-filled cavity beyond it (Fig. 1B). Vaginal adhesion was diagnosed and she was admitted for treatment of this rare condition.\\nAfter hospitalization, prophylactic intravenous antibiotics (3rd-generation cephalosporin with metronidazole) were administered first. After the day of admission, the fluid in the obstructed vaginal cavity was aspirated and examined. This fluid was turbid and had a foul odor but no bacteria were found upon culture examination. With this aspiration, we excised the vaginal septum and sutured the remained edge of this septum to the vaginal wall using 2-0 Vicryl (Ethicon Inc., Somerville, NJ, USA) (Fig. 2). After the operation, we inserted Vaseline gauze into the vaginal cavity to prevent re-adhesion and hemorrhage. This packed gauze was maintained during the whole hospitalization period and changed every day. Antibiotics were administered intravenously for 5 days and she was discharged on day 5 after the operation. Three months following surgery, she noticed an improvement in her dyspareunia and resumed sexual activity. Pelvic examination revealed a well-maintained vaginal cavity.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 40,\n",
       "    'case_id': 'PMC8571307_01',\n",
       "    'case_text': 'A 40-year-old male presented with spontaneous onset of SIH characterized by positional headaches for several months. His neurological exam was normal. The enhanced MRI of the brain showed diffuse pachymeningeal enhancement consistent with SIH [Figure 1]. The routine MRI of the lumbar spine was unremarkable; he had two blood patches performed, both with only transient relief of symptoms. However, the MR myelogram with digital subtraction images finally correctly documented a right-sided CVF at the L2 level [Figure 2]. The patient successfully underwent endovascular transvenous embolization (i.e., through the Azygous vein), and within two post procedural weeks, was asymptomatic [Figure 3].',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 61,\n",
       "    'case_id': 'PMC3991122_01',\n",
       "    'case_text': 'A 61-year-old male presented with recent-onset seizure. MRI revealed a non-enhancing 7.0 x 5.0 cm right frontotemporal mass. He did not receive any adjuvant therapy and the tumor subsequently recurred 3 years later at the age of 64 for which he underwent a second resection. The study was conducted in accordance with Institutional Review Board guidelines.\\nImmunohistochemistry was performed using antibodies against glial fibrillary acidic protein (GFAP; prediluted, rabbit monoclonal; Ventana, Tucson, AZ, USA), p53 (clone BP53-11; Ventana; prediluted), Ki-67 (MIB1; Ventana; 1:1,000), and IDH1(R132H) (clone H09; Dianova; 1:50). Tissue macrodissection was performed on formalin-fixed paraffin embedded tissue, from the precursor low-grade glioma and from the glioma and sarcomatous components during progression. Samples were hybridized separately to a SNP array with 300,000 SNPs (Illumina, San Diego, CA, USA) as described elsewhere. Genes localized to regions with copy number alterations unique to the recurrent tumor were searched using the UCSC genome browser.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 84,\n",
       "    'case_id': 'PMC7368181_01',\n",
       "    'case_text': 'An 84-year-old male ex-farmer was admitted to the orthopaedic department due to an inflamed subcutaneous mass in his left palm over the heads of the 3rd and 4th metacarpal bones (Figure 1). The lump was slightly tender on palpation without interfering with finger flexion. Mass was noticed 3 months before without trauma history and kept growing since then.\\nRoutine blood investigation was normal. Plain radiographs revealed a nonradiolucent object 5 x 2 mm in size, located in the region of the mass. A well-defined, avascular, mass was depicted in the MRI.\\nPatient was scheduled to be operated for an excisional biopsy of a hand soft tissue tumor. Intraoperatively, a thick-wall cyst containing brown-colored fluid, a metallic object, and various particles resembling rusty products, was excised (Figure 2).\\nAfter describing our findings to the patient, he recalled a long-forgotten incidence during World War II, 75 years ago: a \"superficial\" gunshot injury in the palmar aspect of the wrist near its crease. Ricochet of a bullet caused a wound that was healed with no complication, leaving a hardly noticed scar.\\nHistological examination of the excised mass confirmed our suspicion. The residual foreign body was a bullet which, being deposited subcutaneously in the palm of the hand for more than 70 years, had been subjected to excessive corrosion in the biological environment and progressively isolated in a granulomatous tissue capsule.\\nThe postoperative healing was uneventful. On the follow-up examinations at the 1st, 3rd, and 6th month, no sign of inflammation or recurrence has been noticed and hand function was unproblematic. Further follow-up was considered unnecessary.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 47,\n",
       "    'case_id': 'PMC4492508_01',\n",
       "    'case_text': 'A 47-year-old male presented with gradually progressing bilateral lower limb weakness and urinary incontinence for the past five months. No muscle wasting was noted on examination. Muscles of the calves and the thighs showed bilaterally increased tone with exaggerated ankle and knee jerk reflexes. Muscle power was assessed as grade 3-4 out of 5 according to Medical Research Council (MRC) grading. Patient had paresthesia in both lower limbs in non-dermatomal distribution. Laboratory investigations including a hemogram, renal, liver and thyroid function tests were unremarkable. Serum vitamin B12 levels were normal.\\nMagnetic resonance imaging (MRI) of the dorsolumbar spine performed with a 1.5T scanner (Signa Excite 1.5T, GE) revealed bulky lower lumbar cord and conus medullaris with high T2 signal. Multiple intradural extramedullary areas signal void were seen from Th6 to S1 level (Figure 1), more abundantly on the left side of Th10-Th12, causing rightward displacement of the lower part of the spinal cord. Spinal cord exhibited intense, relatively homogenous enhancement after intravenous gadolinium injection (Figure 2). Subsequent spinal computed tomography angiography (CTA) was performed with a 16-slice scanner (Philips Brilliance 16, Philips Medical Systems) with nonionic iodinated contrast agent (Iohexol, 350 mg/mL) at dose of 2 mL/kg injected into the antecubital vein through pressure injector at a rate of 4 mL/sec with bolus tracking, with ROI placed over the abdominal aorta (scanning parameters: increment 1.0 mm, reconstruction interval 0.75 mm, slice thickness 2.0 mm, pitch 1.188, rotation time 0.75s, kVp 120, mA 200) CTA revealed an intradural extramedullary arteriovenous malformation (AVM) from Th10 to Th12 level (Figure 3) supplied by a branch of a great radicular artery (artery of Adamkiewicz). In our case it originated from the abdominal aorta on the left side and ran subcostally, entering the spinal canal through the Th12-L1 intervertebral foramen (Figures 4-6). The AVM drained into the right internal iliac vein through an elongated, tortuous venous channel. Adiagnosis of intradural perimedullary AVM with congestive myelopathy (Foix-Alajouanine syndrome) was made based on the findings.\\nThe patient underwent digital subtraction angiography (DSA) - guided embolization of the AVM with 20-percent cyanoacrylate glue. Immediate postoperative period was uneventful. Postoperatively, over a period of 8 months of regular physiotherapy, the patient showed gradual mild improvement of symptoms, with muscle power of 3 to 4 acc. to MRC grading in both lower limbs. Postoperative MR imaging performed at eight months showed mildly thinned lower cord and conus medullaris with irregular surface and persistent intramedullary signal, which was likely due to gliotic changes in the cord.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 5,\n",
       "    'case_id': 'PMC7796826_01',\n",
       "    'case_text': 'A 5-year-old male underwent a transanal laparoscopic assisted Soave pull-through as a newborn. At 1 year of age, he presented with daily obstructive symptoms of distention and bloating. He suffered from three episodes of enterocolitis, each requiring hospital admission. At an outside hospital, he underwent an examination under anesthesia and a full thickness rectal biopsy with findings of an intact dentate line, no anastomotic stricture, and a palpable Soave cuff on the anterior rectal wall only. His rectal biopsy showed ganglion cells, normal size nerve fibers, normal anticholinesterase reaction, a normal calretinin staining pattern, and his contrast study was felt to be normal. The patient also underwent colonic manometry testing which showed diffuse colonic dysmotility. Based on this result, an ileostomy was recommended.\\nThereafter, the patient thrived. The patient then returned for a planned repeat manometry study 6 months later which now showed normal motility, and the recommendation was to close the ileostomy. Prior to closing the ileostomy, the family sought a second opinion.\\n Our review of the post pull-through contrast enema ( Fig. 1 ) came to a different conclusion. We felt the study showed a 180-degree twist in the distal pull-through ( Fig. 1 ). This was demonstrated by the shift in the antimesenteric border of the colon. We also felt that the twist was intermittent since the contrast study did not demonstrate bowel dilatation proximal to the twist. Since this patient had a previous Soave pull-through, it was also important to note the presence of presacral space widening ( Fig. 2 ), which could be indicative of a Soave cuff; however, this was not evident on the physical exam. Our repeat examination under anesthesia and rectal biopsy confirmed the findings from the outside hospital of no circumferential Soave cuff; however, we were unable to pass a digit or a Foley catheter freely into the pelvis. Given the recurrent obstructive symptoms that occurred prior to the ileostomy and the concerns on the contrast study and exam, we offered the patient a reoperation. We performed a Swenson type redo transanal only pull-through and upon transanal mobilization the distal pull-through was noted to have a 180-degree twist, with the mesentery on the anterior side when it should have been either medial or posterior ( Fig. 3 ). We untwisted the pull-through and redid the coloanal anastomosis and confirmed no twist by freely passing the foley catheter into the pelvis. The patient did well postoperatively and was discharged home on postoperative day 4. He was seen for a follow-up at 1 month, which showed a well-healed pull-through with no anastomotic stricture and his ileostomy was closed. He continues to thrive with no distention or bloating, and stools one to two times daily with control, now 1 year after his ileostomy closure.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 1,\n",
       "    'case_id': 'PMC4150516_01',\n",
       "    'case_text': \"This is a fifty-one-year-old obese and hypertensive female who presented with a painful mass at her left upper abdominal quadrant and lower chest for about 24 hours. In addition to pain, she complained of nausea but denied vomiting or changes in bowel habits. She reported a history of stab injury to her left chest about fifteen years ago. She has had this mass for several years but had remained asymptomatic. Workup by her primary care in the past including a computed tomography (CT) scan concluded that the mass was most likely a lipoma.\\nOn physical examination, the patient was noted to be obese with a tender, firm, and nonreducible mass at the left upper quadrant and lower chest measuring about 8 x 8 cm. A new CT scan was obtained showing an abdominal intercostal hernia between the 11th rib and 10th rib. The hernia content was comprised of omentum, and no evidence of a diaphragmatic defect was seen on CT (Figures 1 and 2).\\nThe patient was taken to the operative room where she was placed in a right lateral position. Under general anesthesia an incision was made over the hernia along the intercostal space. The hernia sac was identified and dissected clean of the surrounding subcutaneous tissue (Figures 3 and 4).\\nThe hernia sac was opened and found to contain omentum, which was reduced back into the peritoneal cavity. The sac was subsequently excised, exposing a clear defect between the tenth rib and eleventh rib (Figure 5).\\nA self-expanding polypropylene and ePTFE hernia patch (VENTRALEX Hernia Patch) (Figure 6) was then used to secure the defect, and the fascia of the intercostal and external oblique was approximated on top of the mesh using interrupted Vicryl stiches (Figure 7). The patient's postoperative course was uneventful and was discharged home on postoperative day two.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 85,\n",
       "    'case_id': 'PMC5922340_01',\n",
       "    'case_text': 'An 85-year-old female of English heritage presented with a 3-day history of increasing right-sided pleuritic chest pain associated with increased shortness of breath and increased non-productive cough. There was no fever or increased sputum production. The patient did not report diarrhoea, abdominal or flank pain on admission, or in the 12 months leading to admission. Significant past medical history included left ventricular heart failure complicated by previous presentations with right-sided pleural effusions requiring thoracocentesis. Thoracocentesis 1 month before this admission had shown a transudative picture with no bacterial growth on culture. Other clinical history included ischaemic heart disease, severe mitral valve stenosis, atrial fibrillation, hypertension, mild neutropenia (1.25 x 109/l), pending bone marrow aspirate, and Streptococcus gallolyticus subsp. gallolyticus infective endocarditis in 2010. There was no suggestion of prior S. enterica infection, cholelithiasis or urolithiasis. There was no history of travel outside Australia in the preceding 12 months.\\nPhysical examination revealed an oxygen requirement (4 litres to maintain saturations greater than 95%), respiratory rate of 16 breaths/min, tachycardia (100-120 beats/min, irregular), normal blood pressure (120/70 mmHg) and afebrile. Cardiovascular examination revealed a jugular venous pressure elevated at 7 cm and a Grade 3 pansystolic murmur over the mitral region, radiating to the axilla. Respiratory examination revealed dullness to percussion in the right middle to lower zones, with reduced breath sounds noted in the same area. The abdomen was soft on palpation and no tenderness was elicited. There was bilateral pitting oedema to the level of the knees. Initial pathology revealed a normal white blood cell count of 2.7 x 109/l with 46% (1.25 x 109/l) neutrophils and 30% (0.82 x 109)/l lymphocytes. C-reactive protein (CRP) was elevated at 268 mg/l.\\nThe chest radiograph revealed opacification of the lower two-thirds of the right hemithorax, with loss of the right costophrenic angle. Underlying collapse was also noted. The chest radiograph can be viewed in Figure 1. A thoracocentesis was subsequently performed. Analysis of pleural fluid revealed a white cell count of 1,350 x 106/l, a protein concentration of 35 g/l, and a lactate dehydrogenase level of 590 U/l. These values were consistent with exudate. The pH of the sample was 7.1, indicating empyema. Gram-negative bacilli were seen in a Gram-stained film of the fluid. A second thoracocentesis was performed 2 days later, again showing Gram-negative bacilli. Subsequent cultures grew S. enterica serovar Typhimurium. Three sets of blood cultures and 2 stool cultures taken prior to starting antibacterial therapy were negative for S. enterica. \\nThe intended management of the patient included insertion of a chest tube (tube thoracostomy), and a 4-to 6-week course of ceftriaxone, depending on clinical response. However the patient declined a chest drain, and wished to cease ceftriaxone after two days. The patient received palliative care aiming for symptom control. Challenges included the management of severe right sided pleuritic chest pain, dyspnoea and nausea, requiring continuous subcutaneous infusion of fentanyl, haloperidol and maxalon. Hydromorphone was used for breakthrough analgesia. The patient passed away comfortably in the palliative care unit 5 days after stopping the antibiotics.\\nThis case report complies with the current policies of Gold Coast Hospital and Health Service, Gold Coast, Queensland, Australia (GCHHS) for a deidentified patient who is deceased. Patient consent for publication was obtained and recorded in the electronic medical records. For the purpose of publication the HREC reference number is: HREC/15/QGC/190.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 70,\n",
       "    'case_id': 'PMC8589514_01',\n",
       "    'case_text': 'A 70-year old man with previous history of three vessel coronary artery bypass graft surgery (left anterior descending to left internal mammary artery (LIMA to LAD), SVG to posterior descending artery (PDA), and SVG to obtuse marginal (OM)) was admitted to the Cardiology Department of Nicosia General Hospital with unstable angina. The patient complained of tight precordial pain (lasting for 15-20 minutes), radiating to the left arm, and accompanied by sweating. Other medical problems include type 2 diabetes, dyslipidaemia, and hypertension.\\nOn physical examination, the blood pressure was 115/78 mmHg, the heart rate 87 beats per minute, and the respiratory rate 16 breaths per minute.\\nHis auscultation revealed normal first and second heart sounds with no murmurs. No third or fourth heart sounds were heard.\\nElectrocardiogram on admission showed normal sinus rhythm with T-wave inversions in leads II, III, aVF.\\nChest X-ray was clear, and serial cardiac enzymes were negative.\\nThe transthoracic echocardiogram revealed normal left ventricular size with mildly reduced ejection fraction (LVEF: 45%) and severe hypokinesis of the inferior wall. The aortic valve was trileaflet with mildly thickened leaflets. The mitral valve annulus was calcified with no mitral stenosis or regurgitation.\\nThe patient underwent coronary angiography which demonstrated total occlusion of mid LAD after giving rise to the first diagonal branch that had a separate severe stenosis at its origin. LCx (left circumflex) was totally occluded from its proximal part after giving off the first obtuse marginal artery that was subtotally occluded at the ostium. RCA (right coronary artery) had a severe stenosis in the proximal segment and was totally occluded at the midportion. The LIMA to LAD graft was patent and flowing into distal native artery. The SVG to OM was occluded ostially, and the SVG to PDA had two consecutive critical stenoses located in the distal segment (Figure 1).\\nAd hoc PCI to SVG to PDA was performed using a Judkin\\'s right 4 (JR4) guiding catheter and a 0.014\" balanced middleweight (BMW) guide wire. An everolimus eluting-stent (Xience Pro 4.0 x 33 mm) was directly deployed at the lesion site in the distal segment of the SVG (Figure 2(a)). Subsequent contrast injection revealed a focal aneurysm formation at the site of the stent implantation (Figure 2(b)). The patient maintained a stable hemodynamic condition with a BP = 132/72 and HR = 92. Considering the potential risk of rupture, we decided to seal the aneurysm with a PTFE-covered stent. A Graft Master 4.0 x 26 mm covered stent was deployed within the aneurysmal segment of the stented SVG at an inflation pressure of 10 atmospheres (Figure 3(a)). Postcovered stent angiogram showed total exclusion of the aneurysmal sac with good distal flow (Figure 3(b)). After the procedure, the patient remained hemodynamically stable and a control echocardiogram excluded pericardial effusion. The postoperative period was uneventful, and the patient was discharged after 2 days on 75 mg of aspirin and 75 mg of clopidogrel for at least one year. The patient was planned to have a control coronary angiogram at 6 months.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 53,\n",
       "    'case_id': 'PMC7288206_01',\n",
       "    'case_text': \"A 53-year-old male with history of alcohol abuse presented with new-onset seizure/syncope, six painless maroon stools, and coffee-ground emesis. The patient admitted to frequent diclofenac use and ketorolac injections. He did not have a history of varices. Vital signs demonstrated tachycardia (heart rate 111 beats/min) and hypotension (79/59 mmHg). Physical exam revealed pale conjunctiva, dry mucous membranes, and maroon colored stool. He was found to be anemic with a hemoglobin of 7.9 G/dL and had an elevated INR of 1.2. He was transfused two units of packed red blood cells and was started on a pantoprazole drip.\\nOnce stabilized, initial EGD revealed an island of tissue growth in the mid-esophagus and a bleeding duodenal ulcer that was injected with epinephrine, cauterized with gold probe and clipped. Biopsy of the esophageal lesion was deferred to outpatient follow-up given the severity of the patient's presenting condition. He had no further signs of gastrointestinal bleeding. Two weeks later, a repeat EGD was performed. Biopsies were taken of the stomach mucosa and mid-esophageal mass (see Figure 1). Gastric biopsy demonstrated mild chronic gastritis without dysplastic changes or Helicobacter pylori. Esophageal biopsy demonstrated findings consistent with squamous papilloma (see Figures 2 and 3).\",\n",
       "    'gender': 'Male'},\n",
       "   {'age': 61,\n",
       "    'case_id': 'PMC7288206_02',\n",
       "    'case_text': 'A 61-year-old female with history of uncontrolled diabetes mellitus type 2 complicated by gastroparesis, prior esophageal dilation, and ileostomy was being evaluated with endoscopy as outpatient for worsening dysphagia. EGD was significant for a small nodule in the proximal esophagus (see Figure 4), normal GEJ (gastroesophageal junction), mild gastritis, and normal duodenum. Gastric biopsy demonstrated mild chronic gastritis without dysplastic changes or Helicobacter pylori. Esophageal biopsy demonstrated findings consistent with squamous papilloma.',\n",
       "    'gender': 'Female'},\n",
       "   {'age': 54,\n",
       "    'case_id': 'PMC7288206_03',\n",
       "    'case_text': \"A 54-year-old female with history of fibromyalgia, chronic opioid dependency, cyanocobalamin deficiency, vitamin D deficiency, and GERD with previously noted Los Angeles class C esophagitis was being evaluated with endoscopy as outpatient for dysphagia and abdominal pain. EGD was significant for an exophytic wart-like growth in the distal esophagus, minimally irregular Z-line noted at GEJ, mild gastritis without ulcers, and normal duodenum. GEJ biopsy demonstrated focal intestinal metaplasia suggestive of Barrett's esophagus without dysplastic changes. Esophageal biopsy demonstrated findings consistent with squamous papilloma (see Figures 5 and 6).\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 72,\n",
       "    'case_id': 'PMC7374222_01',\n",
       "    'case_text': 'A 72-year-old man presented with a two-month history of weight loss, worsening abdominal discomfort, fatigue, and acute onset of oliguria.\\nThe patient has had a history of psoriasis for forty years treated with topical steroids and tacrolimus. Eight years prior to this event, he was diagnosed with psoriatic arthritis with peripheral involvement. He was first treated with naproxen followed by the addition of methotrexate during the next 8 months. Because of liver toxicity, methotrexate was discontinued. Etanercept 50 mg weekly was given for the next 7 years, and his disease was well controlled.\\nHe was also treated with allopurinol and probenecid for gout and with losartan for hypertension. On examination, he had bilateral flank tenderness, and the rest of the examination was unremarkable. His lab investigations showed Hg 11.5 gm/dl, WBC 8.29 per microliter, platelets 312 per microliter, urea 76 mg/dl, and creatinine 12.4 mg/dl. Urine examination was unremarkable and negative for Bence Jones protein. The C-reactive protein (CRP) was 100 mg/l. A computed tomography (CT) scan revealed diffuse hyperattenuation throughout the retroperitoneum and mesentery and bilateral mild hydronephrosis, with dilated ureters proximally thought to be due to retroperitoneal fibrosis (Figure 1). Bilateral ureteric stenting was performed resulting in good urine output, the kidney function improved, and repeat kidney parameters were normal. A laparoscopic biopsy was performed, which showed nonspecific inflammatory changes without granuloma or neoplastic cells (Figure 2). Immunoglobulin class 4 in the serum was normal. Etanercept was stopped, and a systemic steroid, prednisone 1 mg/kg, was recommended. The patient refused treatment with prednisone due to concern for side effects. Despite this, one year later, his CT scan showed marked improvement in the retroperitoneal mass (Figure 1). The patient denied arthralgias, and his inflammatory markers were normal as was his serum creatinine.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 70,\n",
       "    'case_id': 'PMC7376414_01',\n",
       "    'case_text': 'A 70-year-old male with a past medical history of low testosterone, hypertension, benign prostatic hyperplasia, and no known travel history presented with confusion and headache in South Carolina. The patient had been recently treated for community-acquired pneumonia and completed a 5-day course of amoxicillin/clavulanic acid as an outpatient. He presented 5 days later after developing a frontal headache and short-term memory deficits. Vital signs were significant for a fever of 100.4. Physical exam revealed lethargy without any focal neurological deficits. A CT scan of the head was normal. Lumbar puncture showed a cerebrospinal fluid (CSF) WBC of 103 K/mm3 with a differential of 55% lymphocytes, 7% neutrophils, 8% monocytes, glucose 56 mg/dL, and protein 180 mg/dL. Opening pressure was 15 cm H2O. The patient was started on vancomycin, ceftriaxone, ampicillin, and acyclovir for empiric treatment of meningitis and encephalitis. CSF studies were negative for cryptococcal antigen, Lyme IgM antibody, Toxoplasmosis IgG antibody, varicella, VDRL, and CMV. Viral HSV PCR was pending and bacterial gram stain, culture, and fungal culture revealed no growth on day 3 of hospitalization. The patient rapidly improved and was discharged with suspected viral meningitis on acyclovir.\\nThe patient returned to the hospital one day after discharge with new onset right-sided weakness and dysarthria. MRI of the brain revealed T2/flair signal abnormalities in the left frontal lobe with associated parenchymal enhancement (refer to Figure 1). Repeat LP was performed and CSF showed a WBC of 621 mg/dL with a differential of 85% lymphocyte, 29% PMNs, 16% monocytes, CSF glucose 21 mg/dL, and CSF protein 127 mg/dL. Opening pressure was 19 cm H2O. CSF fungal cultures from the previous admission grew Cryptococcus gattii after 5 days. HIV and hepatitis B and C were negative; serum IgA, IgM, and IgG levels and ANA were normal. Repeat CSF antigen was obtained but not resulted, and gram stain and bacterial cultures showed no growth. Fungal cultures grew C. gattii in 3 days. The patient was started on induction therapy of IV liposomal Amphotericin and Fluconazole for four weeks. A third LP was performed after two weeks of induction therapy with LFA-confirmed positive cryptococcal antigen and a titer of 1 : 2560 on LA. There was no growth on fungal culture. Repeat weekly LPs showed decreasing CSF antigen to 1 : 80 titers and continued sterile fungal cultures. The patient was transitioned and discharged on oral Fluconazole for maintenance therapy. Ten days later, the patient returned to the hospital after suffering a large brainstem lacunar stroke (refer to Figure 2). He was transitioned to inpatient hospice and later expired.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 7,\n",
       "    'case_id': 'PMC5774598_01',\n",
       "    'case_text': 'A 7-year-old girl was presented to the pediatric emergency department with a sudden onset of progressive abdominal pain lasting for 12 hours prior to presentation. No fever, nausea or vomiting was present, and normal bowel habits were determined. No urinary symptoms were present, and there were no recurrent abdominal pain.\\nThe pain was located more to the right iliac fossa and was associated with tenderness, rebound tenderness and guarding. She was adequately growing in accordance to the 50th centile for weight and height.\\nLaboratory findings included leukocytosis (white blood cell count of 15.4 x 109/L with 76.5% neutrophils) and an elevated C-reactive protein level (24 mg/L).\\nConsidering the differential acute abdominal pain, an abdominal ultrasound (US) was requested and was reported as normal.\\nA pediatric surgeon reviewed and observed the child; however, the clinical picture persisted despite adequate conservative management and analgesia. As a consequence, the decision was made to perform laparoscopic appendectomy surgery with the consideration of acute appendicitis being the likely cause.\\nThe intraoperative findings were a normal looking appendix and infarcted omentum in the right upper quadrant adherent to the liver. This was confirmed following a histopathology report.\\nThe child was discharged home after 12 hours; however, she subsequently represented with a wound infection as a postsurgical complication and was treated accordingly. She remained well after discharge.\\nWritten informed consent was obtained from the father of the child for publication of this case report and accompanying images.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 15,\n",
       "    'case_id': 'PMC6491627_01',\n",
       "    'case_text': 'The patient is a now 15-year-old Arab-Qatari male born full term with no complications, the fifth of six children of a non-consanguineous union. At 8 days of life, he developed diffuse cutaneous pustules starting in the groin and then spreading across the body. The lesions failed to improve with topical antibiotics necessitating hospitalization at age 44 days for intravenous (iv) antibiotics and incision and drainage (I&D). He was diagnosed with infantile eczema and a superimposed bacterial infection; wound cultures were positive for Staphylococcus aureus.\\nAt 4 months of age, the patient was again admitted to the hospital with a recurrent abscess requiring I&D and iv antibiotics. Throughout his early childhood he continued to develop recurrent skin and soft tissue infections almost monthly and usually without fevers, including at 4 years of age when he had another I&D of a facial abscess with cultures growing methicillin resistant Staphylococcus aureus. At age 5 he was admitted to the hospital with pneumonia complicated by a parapneumonic effusion and multiple cavitary lung lesions (Figure 1). He was treated with drainage of the lung nodules and prolonged iv antibiotics.\\nGiven his recurrent infections at an early age of onset requiring repeated hospitalizations and iv treatments, the immunology service was consulted. The patient had several immune evaluations at age 2 and 4 that were normal and included immunoglobulin levels with undetectable IgE and normal lymphocyte subsets, CD11 and CD18 expression, nitroblue tetrazolium testing and myeloperoxidase staining.\\nAt 7 years of age, the patient was admitted to the hospital with superinfection of his eczema lesions and his IgE was then found to be elevated at 4,409 kU/L (normal 0-63 kU/L). Given his history of recurrent staphylococcal infections and elevated IgE, AD-HIES was suspected. A de novo, heterozygous missense mutation in STAT3 (c.1934T>A, p.L645Q) was detected (Figure 2A). This novel mutation is located in the SH2 domain, adjacent to amino acids previously reported to contain STAT3 mutations associated with AD-HIES. It is not reported in publically available databases.\\nThis mutation changes a polar glutamine for a non-polar leucine. Reduction of transcriptional activity of STAT3 p.L645Q to 85% of wild-type was confirmed using a luciferase assay (Figure 2B). The patient also had decreased CD3+CD4+ T cells expressing IL-17 (Figure 2C). Furthermore, STAT3 phosphorylation in patient-derived cells was impaired in response to cytokine stimulation (Figure 3), which has been reported in patients with AD-HIES and STAT3 mutations in the SH2 domain.\\nThe patient did not have a history of mucocutaneous candidiasis. He did have eosinophilia (10.7%, 560 cells/muL), a common finding in AD-HIES. His peak serum IgE has been 10,665 kU/L. At 14 years of age, the patient sustained a non-displaced fracture in his ankle following a ground level fall. Bone densitometry showed osteopenia. He did not manifest other non-immunologic features of AD-HIES such as coarse facies, high-arched palate, scoliosis or joint hyper-extensibility, although he was noted to have retained primary upper incisors. He did have two separate and resolving episodes of facial nerve palsy at age 5 and 15 years not clearly associated with a viral infection.\\nAfter the diagnosis of AD-HIES, the patient was started on prophylactic cephalexin but continued to struggle with recurrent abscesses. After his response to pneumococcal vaccination was judged insufficient, his prophylactic antibiotic was changed to levofloxacin and he was started on immunoglobulin replacement therapy. He has subsequently experienced a significant decrease in the frequency of his infections and improved quality of life.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 48,\n",
       "    'case_id': 'PMC3583069_01',\n",
       "    'case_text': \"Lower limb dystonia (five right, four left) was triggered by ambulation in all nine patients and was not present at rest. Six patients had distal extremity involvement, two patients demonstrated proximal involvement (i.e., hip flexion, hyperextension, and abduction), and one patient exhibited both proximal and distal extremity involvement (i.e., hip flexion with foot plantar flexion). Foot inversion was the most common pattern (4/9 patients), with two patients having concomitant plantar flexion. One patient (Patient 9) had involvement of the toes along with foot inversion. Walking backward or simply imagining walking backward while walking forward often improved symptoms. One patient (Patient 7) had coincident R wrist 'yips' or golfer's cramp. Treatment with L-dopa (0/5 patients) was ineffective, but one of two patients treated with botulinum toxin injections improved.\\nAdding our cases to those published previously yielded a total of 48 patients (37 female, 11 male) diagnosed with idiopathic FTSD of the LE. Comparative analysis of these patients (Table 2) revealed that 36 had distal extremity involvement (75%), 5 demonstrated proximal (10%), and 7 both proximal and distal (15%). The average age of symptom onset was 48 years old, and family history of dystonia was rare. Among 33 patients in whom the side of the dystonia was known, 20 were affected on the left (61%). Routine ambulatory tasks (e.g., standing, walking, ascending or descending stairs) were triggers of the dystonic limb posture, and only six patients (13%) had dystonia at rest. Concomitant upper extremity dystonia was observed in three patients, and one had cervical dystonia.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 78,\n",
       "    'case_id': 'PMC10387763_01',\n",
       "    'case_text': \"A 78-year-old male patient presented to Emergency Medical Department of University of Gondar Hospital, Northwest Ethiopia, with generalized body swelling of 2 weeks duration associated with shortness of breath, orthopnea, productive cough, and palpitation. He had waxing and waning bilateral leg swelling for the last 3 years. He had recurrent episodes of respiratory tract infections in the past 6 years. He had no previous hospital admissions for similar complaints. Upon physical examination, blood pressure (BP) = 150/75, pulse rate (PR) = 50 beats/min, respiratory rate (RR) = 24 breaths/min, and temperature (T ) = 36.7  C. His arterial oxygen saturation (SaO2) was 92% while breathing ambient air. On respiratory system examination, he had grade two clubbing but no evidence of cyanosis. He had decreased air entry with relative dullness on left basal lung field. Cardiovascular examination revealed a mean heart rate of 50 bpm with irregularly irregular pulse rhythm, raised JVP, pansystolic murmur at left lower sternal border, but no summation gallop. On abdominal examination, he had ascites and tender hepatomegaly. He had bilateral pretibial and pedal pitting edema. No skeletal abnormalities were detected on locomotor system examination. Complete blood counts, liver biochemical tests, renal function tests, and serum electrolytes were within normal limits. Chest X-ray showed cardiomegaly, prominent pulmonary trunks, and left-sided pleural effusion (Figure 1). Electrocardiography revealed atrial fibrillation, bifascicular block (right bundle branch block and left anterior fascicular block) with mean heart rate of 50 beats/min (Figure 2). 2-D transthoracic echocardiography showed an absence of interatrial septum with SA diameter measuring 106 mm. No mitral valve defect or cleft was seen. The atrioventricular valve attachments to the interventricular septum were on the same anatomic plane. No interventricular communication. Left ventricular ejection fraction was 55%. There was also severe tricuspid regurgitation [tricuspid regurgitation pressure gradient (TRPG) = 68 mmHg] and dilated main pulmonary artery (Figure 3). Diagnosis of congestive heart failure secondary to congenital heart disease (SA) with atrial fibrillation and bifascicular block was made. The patient was treated with furosemide (40 mg po twice daily), spironolactone (25 mg po daily), and anticoagulated with warfarin (5 mg po daily). His cardiac symptoms improved and edema subsided, and INR value was within the therapeutic range. He was referred to a cardiac center in Addis Ababa, capital of Ethiopia, for surgical evaluation. Patient's follow-up after referral to cardiac center was not available.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 52,\n",
       "    'case_id': 'PMC5841115_01',\n",
       "    'case_text': \"A 52-year-old healthy Hispanic male presented to an outpatient urology clinic with an elevated prostate-specific antigen (PSA) of 4.1 along with mild obstructive lower urinary tract symptoms. There was no family history of prostate cancer. The physical examination including the digital rectal examination was unremarkable. The patient was seen again 3 months later with a PSA of 4.3 and after discussion with the patient he elected to undergo a 12-core TRUS PNBx. The following month when the biopsy was performed, the PSA had slightly decreased to 3.4. The prostate was visualized in the sagittal and transverse planes via ultrasound probe and was unremarkable. Volume was measured to be 33 cm3 (PSA density of 0.10 ng/mL/g). Final pathology demonstrated blue nevus in one out of six cores on the right and two out of six cores on the left. On microscopic analysis with hematoxylin-eosin stain, individual heavily pigmented spindle cells distributed in between prostatic stroma and glands were noted (Figures 1 and 2). The remaining specimen consisted of benign prostatic tissue with postatrophic hyperplasia and chronic inflammation. The patient's voiding symptoms improved with terazosin and no further workup was undertaken. The patient is now being followed up for routine prostate cancer surveillance as per the American Urological Association (AUA) guidelines.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 72,\n",
       "    'case_id': 'PMC6475553_01',\n",
       "    'case_text': \"A 72-year-old woman presented with a two-year history of a light brown pigmented lesion located on the lateral segment of her right inferior eyelid. She had no history of nevi, rashes, or scaling of the area. The patient had a past medical history significant for a basal cell carcinoma, melasma, and numerous solar lentigines of the face and neck. She admitted to significant sun exposure and tanning in the past but denied any family history of skin cancer. Three months earlier, she had received laser therapy to the face and neck for skin rejuvenation, using the fractional resurfacing laser at a wavelength of 1,550 nm. Her only reaction to laser therapy was slight erythema and mild swelling. Otherwise, she healed well.\\nOn examination, the lesion was a flat, well-circumscribed macule, measuring 3 mm x 2 mm, colored tan to dark brown involving the lateral segment of the right inferior eyelid (Figure 1). It appeared similar to many other lentigines on the patient's sun-exposed areas and was clinically correlated to be a solar lentigo. Due to the low clinical suspicion for malignant lesions and sensitive area, biopsy was not obtained. The patient sought cosmetic treatment of the right inferior eyelid lesion and the 1,064 nm QS Nd:YAG laser was used, pulse durations were not recorded.\\nThree months after targeted laser treatment of the right inferior eyelid patch, the patient returned complaining of recurrence of the lesion, which appeared to have grown to be a 4 mm x 2 mm asymmetric macule colored tan to dark brown to black (Figure 2). A shave biopsy was taken and returned positive for atypical lentiginous and nested melanocytic proliferation with severe atypia, extending to the lateral margin. The lesion was subsequently excised and final pathology was reported as a desmoplastic melanoma, Clark's level IV, Breslow's thickness 2.5 mm with negative margins. Subsequent follow-up appointments at 2 months, 3 months, 6 months, and 8 months were all negative for clinical recurrence.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 62,\n",
       "    'case_id': 'PMC6925741_01',\n",
       "    'case_text': 'A 62 year-old-woman, complaining from micturition lipothymia for six months, was admitted in our hospital. She had no significant past medical history, and there was no history of headaches, palpitations, profuse sweating, hypertension or gross hematuria. Her family history was unremarkable.\\nPhysical examination was normal, and blood pressure was within normal range at 120/80 mmHg. Cytobacteriological examination of the urine was negative. The patient was not anemic and the white cell count was within normal range. There was no renal failure.\\nAn abdominal ultrasonographic examination was performed initially, which depicted an approximately 40 mm heterogeneous mass along the anterior wall of the bladder with abundant internal flow at Doppler interrogation (Figure 1).\\nAn abdominal computed tomography (CT) scan, with intravenous administration of contrast medium, revealed a 32 mm heterogenous lobulated anterior bladder wall mass. The mass showed intense uniform enhancement with contrast study. There was no sign of any lymphadenopathy or metastatic invasion (Figure 2).\\nFurther imaging with Iodine-123-meta-iodobenzylguanidine (I-123 MIBG) scintiscan confirmed the presence of bladder pheochromocytoma without metastatic disease (Figure 3).\\nThe 24-hour urine metanephrine and normetanephrine measurement was within normal levels.\\nThe patient underwent a complete and deep transurethral resection of the bladder tumor. A solid submucosal mass was seen on the left lateral wall near the neck of the urinary bladder, with normal mucosal covering. The resection was complete and tissue was submitted to histopathological examination. During the procedure, the patient became severely hypertensive. Her blood pressure raised up to 236/118 mmHg and pulse rate dropped to 46/min. This episode was controlled with intraoperative intravenous antihypertensive and atropine. Postoperative recovery was uneventful.\\nThe histological examination of the tumor confirmed the diagnosis of vesical paraganglioma showing tumorous small cells with a positive immunostaining for synaptophysin and anti-CD 56 (Figure 4).\\nThe patient underwent partial cystectomy (Figure 5). The surgical margin of the removed specimen was negative. Postoperative recovery was uneventful.\\nOn a recent follow-up at 12 months, her cystoscopy examination did not reveal any evidence of recurrence. Her radiological assessment (thoracic-abdomino-pelvic CT) was negative for metastatic disease.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 5,\n",
       "    'case_id': 'PMC5480228_01',\n",
       "    'case_text': 'A 5-year-old girl was admitted to our hospital for assessment of abdominal pain and fever up to 39.2  C. She had a cough from 3 days before admission, but no rhinorrhea, vomiting, diarrhea, or rash.',\n",
       "    'gender': 'Female'},\n",
       "   {'age': 36,\n",
       "    'case_id': 'PMC5480228_02',\n",
       "    'case_text': \"She was born to a 36-year-old mother by normal spontaneous vaginal delivery after a full-term, uncomplicated pregnancy. However, placental abruption resulted in neonatal asphyxia; Apgar scores were 1 and 1 at 1 and 5 min, respectively. Hypoxic-ischemic encephalopathy and ischemic nephropathy were diagnosed, and automated PD (APD) was started at age 11 days. H. influenzae type b (Hib) vaccination was administered in a three-dose primary series with one booster dose by age 2 years.\\nOn physical examination, her abdomen was tense and tender with signs of peritoneal inflammation. The site of peritoneal catheter insertion was slightly reddish, exudate was present. Peritoneal fluid from the catheter was cloudy and had a white blood cell count of 18,710/muL. Blood creatinine level was 3.62 mg/dL, BUN was 55 mg/dL, and C-reactive protein was 11.98 mg/dL. White blood cell count was 11,510/muL, with 83% neutrophils. IgG was 548 mg/dL (23% subclass 2).\\nH. influenzae was isolated from peritoneal fluid culture and was found to be highly susceptible to all tested antibacterials, including ampicillin and cefepime. A slide agglutination kit (Denka Seiken, Tokyo, Japan) classified the isolates as non-typeable H. influenzae (NTHi). The isolate was identified as sequence type (ST) 3 (allele adk-atpG-frdB-fucK-mdh-pgi-recA: 1-1-1-1-1-1-5) by multilocus sequence typing (MLST) (PubMLST, https://pubmlst.org/hinfluenzae/). The gene sequence IS1016, which may be associated with severe infection, was not detected by PCR. The isolate had hia:a homologue of the hsf gene, which is ubiquitous among Hib strains:and hmw1 and 2, adhesin genes that are common in NTHi but absent in encapsulated H. influenzae .\\nBlood cultures obtained on the day of admission and a nasal swab sample obtained on day 3 of illness showed no growth. H. influenzae was previously isolated from the patient's nasal cavity upon routine screening 6 months before onset; however antimicrobial resistance patterns differed from those identified in peritoneal isolate.\\nThe patient was empirically treated with intraperitoneal cefepime, in accordance with the International Society for Peritoneal Dialysis guidelines/recommendations. The APD catheter was not removed. Her antimicrobial was changed to intraperitoneal cefazolin after H. influenzae was identified.\\nWritten informed consent for publication of this case report was obtained from her legal guardian.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 65,\n",
       "    'case_id': 'PMC8107669_01',\n",
       "    'case_text': 'Patient 1 is a 65-year-old man who received a right hemicolectomy in October 2019. Histologic and genetic examination revealed a pT4apN1b RAS and BRAF wild-type, MSS (microsatellite stable) adenocarcinoma and he presented with liver metastases. Disease stabilization (with no change in tumor size) was obtained after 7 months of first-line chemotherapy FOLFOX/BEVA [oxaliplatin on day 1 at the dose of 85 mg/m2 as a 2 h infusion, concurrently with leucovorin 400 mg/m2, followed by a bolus of 5-fluorouracil 400 mg/m2 (FU), and a 48 h infusion of 5-fluorouracil 2400 mg/m2 (FA) and bevacizumab 5 mg/kg (BEVA) on day 1, every 2 weeks] as documented by CT (computed tomography) in August 2020. Following therapy was FU/FA/BEVA every 2 weeks as maintenance/depotentiated treatment, with the last cycle performed on 2 October 2020, for a total of three cycles. Thereafter, he developed severe COVID-19, from which he recovered in November 2020 when the CT scan showed complete response with regression of hepatic lesions (Figure 1). The immunoglobulin G (IgG) anti-SARS-CoV-2 titer was 1455 U/ml.',\n",
       "    'gender': 'Male'},\n",
       "   {'age': 58,\n",
       "    'case_id': 'PMC8107669_02',\n",
       "    'case_text': 'Patient 2 is a 58-year-old man who underwent a left hemicolectomy in February 2019. The histologic and genetic assessment showed a pT3pN0 RAS mutated, BRAF wild-type, MSS adenocarcinoma. At diagnosis, he presented with three unresectable liver metastatic lesions treated with pre-operative FOLFOX/BEVA (6 months) followed by multiple metastasectomies in November 2019. Thereafter, the patient refused post-operative chemotherapy. In August 2020, he progressed at liver segments VI and VII as documented with CT scan; concomitantly, he developed mild symptomatic COVID-19. CT scan in December 2020 reported reduction of the liver metastatic lesion at segment VII (15.3 x 14.0 mm versus 10.9 x 10.5 mm) and disappearance of the lesion at segment VI (Figure 1). The IgG anti-SARS-CoV-2 titer was 188.40 U/ml.',\n",
       "    'gender': 'Male'},\n",
       "   {'age': 60,\n",
       "    'case_id': 'PMC8107669_03',\n",
       "    'case_text': 'Patient 3 is a 60-year-old woman who received a left hemicolectomy in March 2019 for a pT3pN2a RAS and BRAF wild-type, MSS adenocarcinoma followed by 6 months adjuvant FOLFOX therapy (oxaliplatin on day 1 at the dose of 85 mg/m2 as a 2 h infusion, concurrently with leucovorin 400 mg/m2, followed by a bolus of FU and a 48 h infusion of FA). In June 2020, the disease progressed on positron emission tomography and CT total-body scan, with multiple measurable nodules on the peritoneum surface (standard uptake value >3) and a small nodule in the right lung. The patient started first-line chemotherapy with FOLFIRI/PANI (irinotecan 180 mg/m2 on day 1 plus leucovorin 400 mg/m2, followed by an FA bolus and an FU infusion, and panitumumab 6 mg/kg on day 1, every 2 weeks). After six cycles, CT scan in September 2020 displayed disease stabilization (with no change in tumor size) and, concomitantly mild COVID-19. She recovered from COVID-19 at the end of October. Unexpected reduction of peritoneal and lung disease was reported at the CT scan following COVID-19 (Figure 1). IgG anti-SARS-CoV-2 titer by Electro-Chemi-Luminescence Immuno Assay (ECLIA) was 1216 U/ml.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 68,\n",
       "    'case_id': 'PMC3862226_01',\n",
       "    'case_text': 'A 68-year-old Japanese woman, gravida 2 para 2 (G2P2), was referred to our institution with a complaint of irregular genital bleeding. Her medical and family history was unremarkable. The last gynecologic examination and cervical smear had been performed 3 years previously, and the findings were normal.\\nOn physical examination, we observed a palpable goose-egg sized tumor in the lower abdomen. Magnetic resonance imaging revealed a hard, abnormal cystic tumor mass in the pelvis, 100 x 103 mm in size, suggesting a malignant ovarian tumor. Computed tomography (CT) of the lower abdomen revealed bulging lymph node swellings, each 10 mm in size, along the bilateral common iliac arteries with lesions to both the external and internal arteries. The CT scan also revealed a > 10-mm lymph node swelling in the dorsal pancreas (Fig. 1a) and multiple low-density areas in the spleen (Fig. 1b). These findings suggested metastasis from a primary ovarian cancer. Following whole body 18F-fluorodeoxyglucose positron emission tomography (FDG-PET), elevated FDG uptake was reported in the left adnexa, in the lymph nodes along the iliac arteries, in the dorsal pancreas and spleen (Fig. 2a,b).\\nWith evidence of malignancy originating from the left ovary and subsequent multiple lymph node metastases and metastasis to the spleen, we performed abdominal hysterectomy, bilateral salpingo-oophorectomy, pelvic para-aortic lymphadenectomy, and splenectomy. During surgery, no remarkable dissemination was detected in the abdominal cavity. As observed on CT and FDG-PET, enlarged lymph nodes were visible around both bilateral common iliac and external/internal iliac lesions as well as around the pancreatic lesion, and these were all resected.\\nHistopathological findings showed the growth of tumor cells in papillary, tubulocystic, and focally solid pattern composed of cells with clear cytoplasm, hyperchromatic nuclei and mitotic features. Specifically, a distinct hobnail pattern was observed (Fig. 3a). No tumor cells were recorded on the right side of the ovary. Histopathological examination of the resected lymph nodes and spleen revealed a non-caseating epithelioid cell granuloma (Fig. 3b), wherein no tumor cells were identified. On the basis of these findings, we concluded that this was a case of clear cell adenocarcinoma of the left ovary, p-T1aN0M0. The patient received adjuvant chemotherapy with paclitaxel [180 mg/m2] and carboplatin [AUC 5], q3 weeks x 6 courses. After 2 years of follow-up, no recurrence of disease was noted.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 52,\n",
       "    'case_id': 'PMC7737542_01',\n",
       "    'case_text': \"A 52-year-old woman presented at a local hospital's emergency department after being discovered by her family with sudden-onset vomiting and loss of consciousness. Head CT showed bilateral basal ganglia hemorrhages (data not obtained). The patient was immediately transferred to our hospital. Vital signs on arrival were unremarkable except for markedly elevated blood pressure (180/100 mm Hg). The patient had a 2-year history of hypertension without any history of diabetes, trauma, surgery, or taking oral anticoagulant drugs. Her Glasgow Coma Scale (GCS) score was 6 (E1V1M4). Neurologic examinations revealed coma, quadriplegia, and bilateral positive Babinski sign. Bilateral pupils were 3 mm but sluggish to light. Head CT showed bilateral basal ganglia hemorrhages of about 18 mL on the right and 27 mL on the left side (Figure 1A). Hematoma volume was calculated using the ABC/2 method. Chest CT showed bilateral mild pleural effusion and infection in bilateral lungs. Laboratory tests were within normal ranges including complete blood cell counts, bleeding time, activated partial thromboplastin time, prothrombin time, liver and renal function, and blood glucose level. We decided to remove the hematomas by aspiration to reduce intracranial pressure (ICP). We pasted CT markers on the frontal and temporal areas of the patient's head for head CT to indicate the puncture points for aspiration (Figure 1B). The patient later underwent MIS for ICH under general anesthesia. The neurosurgeon performed hematoma catheter injections using a standard sterile technique. The catheter diameter was 4.8 mm. Frontal and temporal catheters were placed, and 10 and 5 mL of blood clots were aspirated from the left and right sides, respectively. Immediate postoperative head CT confirmed the catheter track and residual hematomas (Figure 1C and D). The patient was sedated and transferred with an endotracheal tube and mechanical ventilation to the Neurosurgical Intensive Care Unit.\\nUrokinase injection and clot aspiration were performed for the residual hematomas. On postoperative day 1, the 2 catheters were clamped after infusion of urokinase (20,000 U dissolved in 3 mL normal saline) for 2 h. However, at 1.5 h, the patient exhibited the Cushing reflex and bilateral pupils were 5 mm and unresponsive to light. We opened the catheter valve, which alleviated the patient's signs and symptoms. GCS score improved, and the patient started responding to commands starting from postoperative day 2. We infused urokinase every 12 h up to 4 doses instead of performing a single injection, and the patient was stable during the process. On postoperative day 3, head CT showed a residual clot (10 mL on the right and 2 mL on the left side) and the patient was extubated (Figure 1E and F). Human albumin and furosemide were administered to control ICP and cerebral edema. The patient's pneumonia continued to worsen after the operation, requiring assisted ventilation. She underwent tracheotomy by general anesthesia on postoperative day 10. On postoperative day 19, the ventilator was removed and head CT revealed absorption of the intracranial hematoma (Figure 1G and H). Over the 2 years of follow-up, there was no recurrence of ICH. The non-fluent aphasia improved but speech did not return to normal. The patient suffered mild disorder of the left and right limb muscles, but she was able to walk unassisted. The patient's modified Rankin Scale score was 3 on postoperative day 90 and 2 at the 2-year follow-up. This case was approved by the medical ethics committee of the First Affiliated Hospital of China Medical University to publish the case details. Written, informed consent was obtained from the patient for publication of case details and accompanying images.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 0,\n",
       "    'case_id': 'PMC6585220_01',\n",
       "    'case_text': 'A 3-month-old female child presented with a progressively expanding mass in the upper jaw for 1 month of age. There were apparently no associated feeding or breathing difficulties. The full-term, transvaginally delivered baby had no relevant medical, social, or family history attributable to the current affliction. On examination, a single, spherical bluish mass in the anterior maxillary vestibule was seen extending on to the upper lip. There was considerable elevation of the alar base and obliteration of the right nasal cavity [Figure 1]. This sessile mass measuring about 2 cm x 2 cm was soft in consistency and was neither expansile nor pulsatile. Aspiration was inconclusive. A wide bore 48 channel 1.5 T-high-field magnetic resonance imaging (MRI) revealed a soft-tissue mass in the central aspect of the right maxilla extending into nasal cavity with cranial displacement of the deciduous central incisor [Figure 2a]. The child was subsequently taken up for excision of the nasomaxillary mass under general anesthesia [Figure 2b and c]. Histopathological analysis reported IFS (Grade 1) and that the margins were free of tumor. Microscopy revealed densely packed spindle cells arranged in fascicles and demonstrating herringbone pattern [Figure 3]. Immunohistochemical staining reported positivity for vimentin [Figure 4], smooth muscle actin, and CD 34 while being negative for S100, CD99, BCL-2 myogenin, and desmine. Postoperatively, the child was referred to medical oncologist who deferred chemotherapy considering low-grade and tumor-free margins. The patient was hence planned for close observation and follow-up. The patient is being followed up for the last 2 years and has remained disease free so far [Figure 5].',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 69,\n",
       "    'case_id': 'PMC10166216_01',\n",
       "    'case_text': \"This is a 69-year-old gentleman with a past medical history of coronary artery disease status post two stents placement, the first one in 2012 and the second one in 2016, who presented to the Emergency Room on 01/06/2022, complaining of chest pain for three days before admission. The patient complained of pressure-like, intermittent chest pain, 8-10 in intensity, located on the left-sided chest and radiated to the left arm and shoulder. Each episode had a duration of 30 min with 5 min between each episode. Initially, the pain was exacerbated upon physical activity and alleviated with rest, however, a few hours before presentation to the Emergency Room, the patient also experienced pain at rest.\\nHe had not been compliant with his medication regimen for the last two years before the presentation and he chose to treat his medical conditions exclusively with ginger.\\nPertinent negatives included diaphoresis, orthopnea, paroxysmal nocturnal dyspnea, lower extremity edema, dizziness, and syncopal episodes. His family history was remarkable for his father with cardiac disease status post stents placement.\\nIn the Emergency Room, the patient was found to be hypertensive with a blood pressure of 154/83 mmHg, non-tachycardic or tachypneic, and saturating 97% on room air. The initial troponin I level was 0.12 [<0.5 ng/ml], but the follow-up troponin I was 0.51 [<0.5 ng/ml]. Initial ECG showed sinus rhythm, first-degree AV block, incomplete right bundle branch block, biphasic T-wave inversion in V2 and V3, and T-wave inversion in anterolateral leads.\\nIn the setting of the patient's clinical presentation associated with troponin leakage and ECG changes concerning for ischemia, he was started on full acute coronary syndrome (ACS) protocol including loading dose of aspirin, and clopidogrel, therapeutic anticoagulation, and statin therapy along with monitoring ECG changes and troponin I levels.\\nThe following day, the patient remained hemodynamically stable, and the chest pain was resolved. However, the repeat troponin I level was 0.80 [<0.5 ng/ml], and follow-up ECG showed sinus bradycardia with a heart rate of 55 beats per min with first-degree A-V block, incomplete right bundle branch block, and biphasic T waves in V2 and V3 which in that clinical setting was consistent with Type-A T waves seen in Wellens syndrome (Fig. 1). An echocardiogram was also performed, and it revealed a left ventricular ejection fraction of 50-55% and mildly hypokinetic changes on the apical septal and apical anterior segments.\\nThe patient was taken to the catheterization laboratory for left heart catheterization, coronary angiography, and left ventriculography. During the intervention, it was found that the LAD had a proximal to mid stent and a distal stent in place. There was proximal 90% in-stent restenosis at the proximal edge of the first stent. There was also a 90% in-stent restenosis at the proximal edge of the second stent into the mid-segment, which was a tubular lesion. Also, there was a distal 70% discrete stenosis in the distal LAD.\\nBecause of the above findings, a total of three stents were placed. The first stent was placed in the mid to distal LAD to cover the second 90% lesion. The second stent was placed to cover the proximal lesion and was placed at the proximal edge of the previous stent. A third stent was placed in the distal LAD at the level of the distal 70% discrete stenosis. The repeat angiographic shots showed excellent results with no residual angiographic stenosis and no dissection, perforation, or complications.\\nFurther recommendations included aggressive guideline-directed medical therapy for coronary artery disease, including dual-antiplatelet therapy with aspirin and clopidogrel for minimally one year, a beta-blocker, and a statin. Furthermore, the patient was counseled extensively on medication compliance after stent placement.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 0,\n",
       "    'case_id': 'PMC7680930_01',\n",
       "    'case_text': 'In our routine screening of 340 children, aged 6-35 months old and enrolled in an iron supplementation trial (namely IHAT-GUT, ClinicalTrials.gov identifier: NCT02941081), we found the case of a 29-month-old child with moderate infection of Hymenolepis nana. As part of the trial protocol, we examined 521 stool samples from study participants for intestinal parasites, using the Kato-Katz method based on duplicate slides as per current WHO recommendation. The child with the stool sample harbouring H. nana eggs (Figure 1) was unique amongst the 72 children out of 340 (21%) in whom intestinal parasites were present. The child presented with an infection intensity of 144 eggs/gram of stool and was mildly anaemic, with an Hb value of 10.8 g/dl, and iron deficient, with ferritin of 12.9 microg/l. The child also had a high white blood cell count and high granulocyte count, indicative of infection (Table 1). Otherwise, the child was growing normally (Table 1) and, upon examination by the study nurses, was considered as an asymptomatic carrier of hymenolepiasis.\\nTo prevent the spread of the infection, and irrespective of the asymptomatic status, the infected child was treated with praziquantel 20 mg/kg in a single oral dose following WHO guidelines, and was re-assessed 2 weeks later and considered free of the cestode.',\n",
       "    'gender': 'Unknown'}],\n",
       "  [{'age': 61,\n",
       "    'case_id': 'PMC5066193_01',\n",
       "    'case_text': 'A 61 year old African American male currently receiving chemotherapy for multiple myeloma presented with a 3 month history of a non-healing wound on the finger that occurred after a puncture wound from a rose thorn while gardening. He reported some pain and tenderness, and denied any fever or malaise. He applied triple antibiotic ointment with no relief.\\nOn his left 4th digit, just proximal to the nail fold, was a tender 1.4 x 1.2 cm hyperpigmented, hyperkeratotic plaque with an area of shallow erosion. There was no deformity or hyperpigmentation of his nail. A saucerization biopsy of the lesion was performed for histology and tissue cultures. The patient was treated with itraconazole 200 mg PO daily for presumed sporotrichosis infection. Tissue cultures for bacteria and fungi grew only Candida parapsilosis. Histology revealed full thickness epidermal keratinocyte atypia consistent with squamous cell carcinoma in-situ (SCCis) and it resolved with excision (Fig. 1, Fig. 2).',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 28,\n",
       "    'case_id': 'PMC6743686_01',\n",
       "    'case_text': 'A 28-years-old female at the 14th week of gestation was admitted in April 2016 due to headache, vomiting, and progressive asthenia in the previous 3 weeks. A brain magnetic resonance imaging (MRI) demonstrated a large right thalamic tumor [Figure 1], and the MRI-spectroscopic study showed a high level of choline and low level of N-AcetylAspartate consistent with a high-grade glioma. She presented fully awake, with a slight left hemiparesis and headache. Later on, due to progressive neurological deterioration, she underwent in May 2 external ventricular drainage (EVD) in local anesthesia and 1 week later craniotomy and partial removing of the tumor under general anesthesia, with continuous fetal heart rate (FHR) monitoring, maintaining good fetal conditions during the operation. At the end of the month, she was discharged following the gynecological evaluation who revealed good clinical conditions of both, mother and fetus. 2 weeks later, she deteriorated neurologically presenting vomiting, stupor, and severe hemiparesis. A brain computer tomography scan showed hydrocephalus and she underwent on the left side, a ventricular-peritoneal shunt. The brain-MRI performed 2 days later showed a light improving the hydrocephalus. The abdomen ultrasonography was normal and she was discharged in good clinical conditions except a moderate left arm paresis. In July 5, a brain MRI showed a large thalamic tumor. In July 7, she had elective cesarean section and the day later, underwent a gross debulking of the tumor. Her clinical conditions improved progressively and in August she began CTX with temozolomide (TMZ) and XRT in a standard way. 12 months after surgery the patient had a moderate left arm paresis with small residual tumor showed on the brain-MRI [Figure 2]. The baby was born with a retinopathy and bronco dysplasia due to the premature birth. He was treated with retinal laser therapy bilaterally and Lucentis intravitreous on the right side successfully. He was also treated with Synagis 15 mg/kg in 1/month and is growing normally under surveillance by pediatricians. The patient died 16 months after delivery.',\n",
       "    'gender': 'Female'},\n",
       "   {'age': 38,\n",
       "    'case_id': 'PMC6743686_02',\n",
       "    'case_text': 'A 38-years-old female, on the 28th week of gestation, presented in November 15, 2014, at the emergency department due to general asthenia associated with a headache, as well as left arm paresis and dysesthesia and a slight left facial deficit. A brain MRI showed a large right frontal tumor [Figure 3]. She moved to the department of obstetrics-gynecology and after team counseling (oncologist, neurosurgeon, gynecologist, and neonatologist), 2 days later, she underwent an elective cesarean section. 5 days later she underwent craniotomy and exeresis of the tumor with intraoperative neuronavigation and ultrasound. The histology revealed GBM. The patient was evaluated by the oncologists and radiotherapists and began chemotherapy (CTX) and radiotherapy (XRT) (Stupp protocol). 12 months after surgery her clinical conditions progressively deteriorate with signs of regrowth on MRI [Figure 4]. The baby was born with low birth weight and needed 2 months to stay in the neonatal intensive care unit; he was also treated with Synagis for 4 months. At the age of 4 months he was operated for hypertrophic pyloric stenosis; at present, he suffers epilepsy and sometimes tremor but has a normal psychomotor development. The patient survived 46 months after delivery.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': None,\n",
       "    'case_id': 'PMC8110827_01',\n",
       "    'case_text': 'The male patient was born to healthy consanguineous Syrian parents with a normal birth weight after an uneventful pregnancy.',\n",
       "    'gender': 'Male'},\n",
       "   {'age': None,\n",
       "    'case_id': 'PMC8110827_02',\n",
       "    'case_text': \"The patient has an older sister who is healthy and heterozygous carrier of the SPTBN4 mutation and a younger sister who was also diagnosed with ssIV-spectrin deficiency and described as patient II below. According to the patients' mother no other family member is known to present with a similar phenotype or symptoms.\",\n",
       "    'gender': 'Unknown'},\n",
       "   {'age': 5,\n",
       "    'case_id': 'PMC8110827_03',\n",
       "    'case_text': 'After birth the patient presented with general muscular hypotonia and areflexia, as well as global muscular atrophy. Twelve months later, the patient had not reached any milestone and did not show any muscular movements (Table 1).\\nTo identify the cause of his severe psychomotor delay, a muscle biopsy was taken at the age of 5 month which showed unsuspicious skeletal muscle without indication of any myopathic, neurogenic or inflammatory changes. Muscular biopsy from vastus muscle at the age of 2 years showed slightly widened fiber caliber spectrum which has been classified as mild hypertrophy of the muscle fibers.\\nElectron microscopic examinations of nerve biopsies at the age of 2 years showed membrane inclusions in the swan cells of myelinated axons, as well as demyelinating changes, raising the suspicion of a lysosomal storage disease (Figure 1).\\nA mitochondrial association was considered owing to the symptom complex of severe psychomotor delay, cardiomyopathy and visual involvement. Biochemical examination of the muscle biopsy revealed a disturbed mitochondrial energy generating system, with reduced activities of complexes II, III, II+III and, in particular, of complex I (Table 2).\\nLaboratory parameters like lactate and CK in serum were always within the normal range.\\nAt the age of 16 months, electroencephalogram (EEG) recordings showed predominant delta and theta activity but no seizure activity.\\nCranial magnetic resonance imaging (MRI) at the age of 18 months showed a global cerebral atrophy, while cranial MRI at the age of 10 years showed signs of progressive, focal brain atrophy and a continuing but not age-appropriate myelination. In particular, the MRI revealed an atrophy of the occipital cortex accentuated in the occipitotemporal medial gyrus, an almost entire loss of the cerebellar vermis and a significant loss of substance of the cerebellar hemispheres and a temporopolar dilation of the subarachnoid cavity and corpus callosum hypoplasia (Figure 2).\\nElectroneurography (ENG) of the ulnar and the tibial posterior nerve was performed at the age of two and a half years and was difficult to evaluate. However, ulnar nerve showed a nerve conduction time of 6,08 m/s (norm: 59,8), slight muscular reaction in both muscles was observed up to 30 mA. ENG showed a deceleration of nerval conduction.',\n",
       "    'gender': 'Male'},\n",
       "   {'age': None,\n",
       "    'case_id': 'PMC8110827_04',\n",
       "    'case_text': 'The patient shows severe optic atrophy causing blindness.',\n",
       "    'gender': 'Unknown'},\n",
       "   {'age': 1,\n",
       "    'case_id': 'PMC8110827_05',\n",
       "    'case_text': 'Additionally, the patient suffers from deafness.\\nHe suffers from chronic respiratory insufficiency due to failure of the ventilatory motor function with a high production of mucus and an insufficient cough reflex. Tracheostomy and a home ventilation device were necessary already at the age of 1 year. Pulmonary parenchyma infections with fever have been occurring in regular intervals since birth.\\nEchocardiography at the age of 1 year revealed a non-obstructive hypertrophic cardiomyopathy.\\nDue to muscular hypotonia and a sluggish sucking reflex, he had to be fed by nasogastric tube after birth. At the age of 1 year he showed a malnutritional status caused by dysphagia, which indicated the application of a percutaneous endoscopic gastrostomy tube.',\n",
       "    'gender': 'Male'},\n",
       "   {'age': 8,\n",
       "    'case_id': 'PMC8110827_06',\n",
       "    'case_text': 'In the sequel of a cardia insufficiency the patient developed a duodeno-gastro-esophageal reflux disease at the age of 8 years. Furthermore, the patient had a corpus and a fundus gastritis.\\nOrchidectomy had to be performed due to haemorrhagic necrosis of his inguinal testis at the age of 12 years.',\n",
       "    'gender': 'Male'},\n",
       "   {'age': None,\n",
       "    'case_id': 'PMC8110827_07',\n",
       "    'case_text': 'Due to an inactivity osteoporosis and after two fractures of the femur, patient I receives a bisphosphonate therapy. He developed a thoracolumbar scoliosis, thoracic hypokyphosis and lumbar hyperlordosis (Table 1).',\n",
       "    'gender': 'Male'},\n",
       "   {'age': 17,\n",
       "    'case_id': 'PMC8110827_08',\n",
       "    'case_text': \"Currently, at the age of 17, the patient shows severe psychomotor developmental arrest, myopathic facies, a long-drawn face with a high forehead and a palate column. He has a gingiva hyperplasia with a malformation of his teeth, growing out of his palate. The patient's mouth is always open and he has a macroglossia in relation to his oral cavity. Moreover, he has a vertical and horizontal gaze palsy and hypertelorism (Figure 3). Since he is unable to communicate verbal and non-verbal by eye movements or mimics, the only reactions to his environment that can be detected are the changing of his heart rate or respiratory rate. Unspecific movements, for example, of his tongue or his extremities can be observed seldom. The patient is in a wheelchair and unable to perform any basic actions.\",\n",
       "    'gender': 'Male'},\n",
       "   {'age': None,\n",
       "    'case_id': 'PMC8110827_09',\n",
       "    'case_text': 'The younger sister of patient I was born with a birth weight of 3,920 g after 40 weeks of an uneventful pregnancy.\\nShe presented as a floppy infant, with distinct muscular hypotonia and missing sucking reflex. Clinical examination showed sparse symmetrical spontaneous motoric function.\\nMRI showed an external more than internal hydrocephalus leading to global cerebral atrophy, in particular of the periventricular space and the corpus callosum. The myelination was age-appropriate.\\nClinically she showed microcephaly.\\nLike her older brother, she was suspected to have a lysosomal storage disease.\\nPatient II was diagnosed with chronic global respiratory insufficiency since she suffered from recurrent pulmonary parenchyma infections with poor mobilization of secretions.',\n",
       "    'gender': 'Female'},\n",
       "   {'age': 14,\n",
       "    'case_id': 'PMC8110827_10',\n",
       "    'case_text': 'Because of her missing sucking reflex, feeding was difficult and she developed a severe malnutrition necessitating gastric tube feeding. Furthermore, the patient developed a duodeno-gastro-esophageal reflux disease (Table 1).\\nPatient II died at the age of 14 months due to a bronchopulmonary infection in the course of which she developed a rapidly decreasing oxygen saturation and an increasing bradycardia.\\nWhole exome sequencing of patients I and II revealed the homozygous stop mutation c.6016C>T (p.R2006*protein with 2564 aa, Mut. Ex 28 of 36) in the SPTBN4 gene in both patients. Homozygous carrier status was confirmed by Sanger sequencing in both patients.\\nHeterozygous carrier status of the mother and the healthy sister was confirmed by Sanger sequencing as well.\\nDNA of the father has been unavailable.',\n",
       "    'gender': 'Female'},\n",
       "   {'age': None,\n",
       "    'case_id': 'PMC8110827_11',\n",
       "    'case_text': 'Other genetic variants that were found in both patients included variants in the genes BNIPL, FBLN7, GABPB2 (homozygous) and PLEC (heterozygous). After using the above mentioned analyses parameter and additional prediction programs (PROVEAN, SIFT, Polyphen2), these mutations were excluded as they were either predicted to be benign by the majority of prediction programs or due to publication data that revealed gene functions that were not indicative for the disease of patient I and II.\\nBiochemical examination of muscle tissue revealed a disturbed energy generating system.\\nA severely reduced substrate oxidation and ATP + CrP production rates were detected in the muscle tissue. At the enzymatic level, a clearly reduced activity of complex I was observed. Also complex II, III, and II+III showed reduced activities, although not as severe as complex I. The activities of complex IV and V were normal. Activity of the reference enzyme citrate synthase was around the lowest control value. There was not enough material left to measure PDHc.',\n",
       "    'gender': 'Unknown'}],\n",
       "  [{'age': 54,\n",
       "    'case_id': 'PMC7171645_01',\n",
       "    'case_text': 'A 54-year-old male patient with severe aortic valve stenosis (strongly calcified bicuspid valve) undergoing mechanical aortic valve replacement developed injection-site erythemas after 5  days of therapeutic LMWH (enoxaparin 40  mg BID). An allergic hypersensitivity reaction to heparin was suspected, and enoxaparin was switched to another LMWH (fraxiparin) followed by intravenous unfractionated heparin since hypersensitivity reactions continued. In parallel, oral anticoagulation with a vitamin K antagonist (phenprocoumon) was started at a dose of 9 mg on 2 consecutive days. On the seventh day after surgery, all LMWH injection sites became increasingly painful and inflamed and showed necrotic central lesions and blisters, with the first site at the left thigh being the most severely affected (Figure 1). In addition, the patient described a tingling sensation in the tips of his fingers and toes.\\nThere was a perioperative drop in the platelet count with recovery 4 days after surgery (398 G/l). On day 6, platelet count decreased to 160 G/l but remained within the normal range (Figure 2). However, based on the criteria of the 4 Ts score, more than 50% drop of platelet count together with the onset of the symptoms, platelet count fall between 5 and 10 days after the start of heparin, gangrenous skin lesion, and no apparent other causes for thrombocytopenia indicate a high probability for HIT (8 points).\\nHeparin and phenprocoumon were immediately stopped, vitamin K was administered at an INR of 1.5, and argatroban at an initial dosage of 0.15 mug/kg/min IV was started as an alternative anticoagulant. The occurrence of HIT correlates with higher optical density in specific ELISA tests. On the seventh postoperative day, ELISA tests showed highly positive antibody levels/OD, 2.0 with lysate (HIT), and 0.8 without lysate (PIT) (optical densities from Zymutest  HIA IgG enzyme-linked immunosorbent assay (ELISA) test (Hyphen Biomed)) (Figure 3). Platelet count increased steadily thereafter, and the local injection sites recovered (Figure 1). After normalization of the platelet count, phenprocoumon was restarted, and argatroban was discontinued once an INR above 2.0 was reached.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 23,\n",
       "    'case_id': 'PMC6446130_01',\n",
       "    'case_text': \"A 23-year-old man with a medical history of treated TB presented to the emergency department with hemoptysis for one week. His symptoms started with a dry cough that progressed from blood-tinged sputum to frank blood over three weeks. He had associated fever, chills, night sweats and subjective weight loss. His previous symptoms had completely resolved and he moved to the United States from Nepal one year prior to the hospital admission.\\nOn physical examination, the patient was afebrile, hemodynamically stable with a generalized cachectic appearance and diffuse rhonchi bilaterally on pulmonary auscultation. His labs were notable for a normal leukocyte count, a hemoglobin of 11.7 g/dL, and normal chemistries. The chest x-ray, Fig. 1, had a lucency in the left suprahilar region and bilateral peribronchial thickening of the upper lobes. A follow up CT scan, Fig. 2, showed multiple cavitary lesions at the superior segment of the left lower lobe.\\nOn hospitalization day 2, a microscopic smear of his sputum showed many acid-fast bacilli that was later identify in cultures as Mycobacterium tuberculosis complex. He was started on a 5-drug regimen with rifampin, isoniazid, pyrazinamide, ethambutol and moxifloxacin due to his prior history of possible resistant TB. He continued to have persistent hemoptysis and worsening anemia requiring a transfusion due tachycardia and dyspnea, suggesting massive hemoptysis. Four days after the anti-tuberculosis medication was initiated, he developed respiratory distress and was transferred to the medical intensive care unit and was placed on non-invasive positive pressure ventilation but did not improve. Thus, he underwent an urgent bronchoscopy, revealing a significant burden of blood clots in the left main bronchus that did not allow for a complete survey of the airway. As a result, an endobronchial blocker was placed and the patient was evaluated by interventional radiology. He underwent urgent left bronchial artery angiography with embolization of two abnormally hypertrophied left bronchial arteries.\\nThe following day, he underwent repeat bronchoscopy that showed persistent clot burden in the left main bronchus. Given his active tuberculosis, difficulty with oxygenation, and multiple cavitary lesions, the decision was made to proceed with left lower lobectomy. On gross examination, the lobe of lung was severely congested weighing 645 g (normal weight of a complete left lung: 395 g). There was widespread consolidation with nodules containing caseous material, Fig. 3A. It corresponded to necrotizing nonsuppurative granulomas with a peribronchial and subpleural distribution in a miliary pattern, Fig. 3B. The granulomatous inflammation extended around medium sized vessels causing destruction of the vasa vasorum and secondary obliterative endarteritis, Fig. 3C. Numerous cavities developed in relation to necrotizing granulomas with suppuration and hemorrhage, Fig. 3D. Round foreign particles were deposited in the arterial lumina, consistent with a prior embolization procedure. Intra-alveolar hemorrhage emerged after bleeding into the cavitating granulomas due to destruction of vessel walls, Fig. 3E and F. Few acid-fast organisms consistent with L-shaped mycobacteria were identified on FITE stain, Fig. 3G-I. Other special stains including Kinyoun cold procedure, auramine-rhodamine staining, and mycobacterium immunostaining, were negative for acid fast bacilli.\\nOn hospitalization day 6 the patient's family, who was previously unable to contacted, arrived at the hospital and the team was able to provide additional history regarding his previous TB therapy. He was diagnosed with multidrug resistant (MDR) TB seven years prior to admission and treated for 18 months with rifampin, isoniazid, pyrazinamide, ethambutol, moxifloxacin and an injectable medication, the name of which they could not recall. The following day, the Health Department confirmed fluoroquinolone-resistant tuberculosis by nucleic acid amplification testing (NAAT). Rifampin, isoniazid, and moxifloxacin were discontinued and the patient was started on amikacin, linezolid, meropenem, clavulanate, para-aminosalicylic acid and ethionamide. Bedaquiline was requested from the Centers for Disease Prevention and Control (CDC). After his lobectomy, he required persistent intensive care unit monitoring because he would not tolerate extubation trials along with multiple episodes of mucous plugging, which required multiple bronchoalveolar lavages. He was successfully extubated on hospitalization day 14. The patient was transferred to the regional TB center of Florida on hospitalization day 21.\\nAfter an additional two months of being monitored and treated at the regional tuberculosis center, the patient was discharged to the community and continued his treatment under directly observed treatment through the department of health.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 0,\n",
       "    'case_id': 'PMC4131002_01',\n",
       "    'case_text': \"Stromal cells are important systems that support tumor cell growth and metastasis. We used 18-month-old BALB/cBy mice (obtained from the National Institute on Aging) orthotopically implanted with 4T1 breast cancer cells as a model to study the effect of exercise on stromal cell populations. The 4T1 breast cancer cell line in mice is highly invasive, with the ability to metastasize to lungs, brain, liver, bone, lymph nodes, and blood, similar to triple negative invasive breast cancer in women.\\nMice were randomly selected, with 15 mice in the running group. Runners were given access to free running wheels in individual cages as previously described. We monitored the running activity continuously for 60 days. 4T1 cells (ATCC, Manassas, VA), cultured under standard laboratory conditions, were injected at a concentration of 1x104 cells into the 4th mammary fat pad of each mouse. Mice were allowed to run another 30 days when the experiment ended. Running wheels (measuring 15.5 cm by diameter) transmitted electronic signals wirelessly to a monitoring hub (Med Associates ENV-044, Vermont) and raw data were exported to Microsoft Excel for processing. The distance ran by each mouse was calculated as (3.14x15.5 cmxnumber of revolutions)/(100 cm per mx1,000 m per km). Mice were housed in a standard rodent room within a specific pathogen-free (SPF) barrier facility with 12-hour light and dark cycles. Ambient temperature in the room was kept at 70-74 F. Mice were fed standard rodent chow (5,053; Picolab, Richmond, IN) and water ad libitum. The experimental protocol was reviewed and approved by the Institutional Animal Care and Use Committee at the University of Washington, Seattle.\\nAt 30 days post-tumor cell injection, mice were euthanized by CO2 asphyxiation. Carcasses and mammary tumors were weighed to obtain tumor burden, defined as tumor weight normalized to carcass weight. The breast tumor from each mouse was fixed in 10% neutral-buffered formalin. Immunohistochemistry was performed as previously described using paraffin-embedded tumor sections. Primary antibodies to specific markers were incubated at 1:50 for 1 hour. Sections were blocked in 15% goat/5% mouse serum. BGA rat secondary antibodies (Jackson ImmunoResearch Labs Inc., West Grove, PA, USA) were used and incubated at 1:200 for 30 min and slides then counterstained with hematoxylin. Digital images were captured using a Nikon Eclipse E400 bright field microscope (Nikon Corporation, Tokyo, Japan) attached with a Nikon Coolpix 995, digital camera (Nikon Corporation, Tokyo, Japan; 3.3 megapixels, resolution 2,048x1,536 pixels). Five random images at 60x magnification were captured per tumor sample under blinded conditions and saved in JPG (Joint Photographic Experts Group) format. The number of labeled cells was also determined blindly and independently by two co-authors of this paper (CPB and WL) by counting positive cells in a grid of eight squares encompassing the entire plane of view at 20x magnification per slide using five random field views. The labeling index was calculated as the average percentage of stained cells relative to unstained cells. Student's t-test was used to detect significant differences between groups.\\nDuring the tumor progression phase of 4T1 breast cancer in old BALB/c mice, we observed significant differences in labeling for F4/80, a marker for mouse macrophages, and CD34, a marker for vascular endothelial cells, in primary tumors from mice that ran higher average distances compared to mice that ran lower average distances, p<=0.05, N=2, from four mice (Table 1). It can be seen that macrophages are much less frequent in a tumor from a long-distance runner (Fig. 1a) compared to a tumor from a short-distance runner (Fig. 1b). The decrease in CD34 labeling in a long-distance runner (Fig. 1c) compared to a short-distance runner (Fig. 1d) suggests that increased running distance was also associated with decreased vascularization. There were no significant correlations between running distance and labeling for cell proliferation (Ki-67) or apoptosis (Caspase 3) in primary tumors (Table 1), suggesting that exercise training might be targeting stromal cell populations. Even though pre-tumor running was associated with an anti-tumor effect in a distance dependent manner, no correlation was seen between tumor burden and running distance during the tumor progression period. It is possible that the rapid and aggressive tumor growth may have overwhelmed any anti-tumor effects by suppressed stromal cells. However, there were no significant correlations between distance ran before tumor injection and labeling for F4/80 and CD34 as well as for Ki67 and Caspase 3 in primary tumors collected at the termination of the study (data not shown) suggesting other unknown mechanisms are likely responsible for the antitumor effects of pre-tumor running.\\nThese observations suggest that immunohistochemistry can be used to monitor stromal cell populations in tumors from old mice under exercise conditions, and further support the concept of using old mice for modeling in preclinical cancer studies.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 33,\n",
       "    'case_id': 'PMC2718185_01',\n",
       "    'case_text': \"A 33-year-old housewife with primary Sjogren's syndrome was admitted for the evaluation of dyspnea and general weakness which had persisted for two years. The patient claimed to have no history of smoking, allergies or occupational exposure to noxious agents. Physical examination revealed coarse breathing sounds with inspiratory crackle extending over the whole of the both lung fields. However, the results of blood analysis were normal.\\nChest radiographs demonstrated the presence of bilateral, diffuse, reticulonodular densities in both lungs (Fig. 1A). Thin-section CT scan showed diffusely distributed mosaic pattern of inhomogeneous attenuation extending over the entirety of lung zones, without zonal predominance. There was no difference in the extent of mosaic attenuation between inspiratory (Fig. 1B) and expiratory thin-section CT scans (Fig. 1C). As compared with more highly attenuated areas of the lung, however, the caliber and number of pulmonary vessels in areas of the lower attenuation were reduced. There were several foci of bronchial wall thickening, and these were more frequently found in areas of lower attenuation. In the right lower paratracheal area and subcarinal area, the presence of several small lymph nodes less than 1 cm in short axis diameter was noted.\\nFlexible fiberoptic bronchoscopy revealed no remarkable finding, though transbronchial multiple biopsies obtained from the right anterior segmental bronchus showed some lymphocytic infiltration. Cytologic analysis showed that the composition of bronchoalveolar lavage fluid was 45% lymphocytes, 1% eosinophils, and 54% macrophages. Open lung biopsy was performed in areas of both higher and lower attenuation. Histologic examination disclosed focal collections of lymphoid cells around bronchioles and extension of lymphoma cells from bronchiolar epithelium toward alveolar space. Immunocytochemically, the neoplastic cells reacted positively for CD 20 antigen and were focally positive for UCHL 1 antigen. Monoclonal antibody against cytokeratin indicated multiple lymphoepithelial lesions. The histologic diagnosis was consistent with low grade marginal zone B-cell lymphoma originating in BALT.\",\n",
       "    'gender': 'Unknown'}],\n",
       "  [{'age': 14,\n",
       "    'case_id': 'PMC5925949_01',\n",
       "    'case_text': \"A 14-year-old girl was referred to the Danish Center of Interstitial Lung Disease, Aarhus University Hospital for specialized treatment due to a newly diagnosed aPAP. She complained of a constant cough and dyspnea on exertion starting a year before referral. Neither antibiotics nor inhaled corticosteroids improved the patient's condition and further investigations were performed at another hospital. High resolution computed tomography (HRCT) showed bilateral changes typical for PAP with not a classical crazy paving pattern (Fig. 1). A surgical biopsy revealed alveoli filled with a granular proteinaceous material, strongly eosinophilic on hematoxylin-and eosin staining (HE) and positive with the periodic acid-Schiff stain and diastase-resistant (PAS + D), which is considered characteristic for PAP (Fig. 2). Blood assays showed elevated high levels of GM-CSF antibodies. There was no suspicion of rheumatological or hematological diseases. Based on these results a diagnosis of aPAP was confirmed and the patient was referred for treatment.\\nAt the time of referral to our department the patient reported regular cough and dyspnea upon physical exertion. She had no weight loss, fever or recurrent infections. She had no family history of lung disease and was a never-smoker. Physical examination was normal. Pulmonary function tests revealed a forced expiratory volume in one second (FEV1) of 2.23 L (62%), forced vital capacity (FVC) of 2.64 L (70%), total lung capacity (TLC) of 72% and carbon monoxide diffusing capacity (DLCO) of 54% of predicted. Arterial gas analysis showed pO2 within a normal range of 14.3 kPa. According to the classification proposed by Inoue et al. her disease severity score (DSS) was 2 (symptomatic and PaO2 over 70 mmHg). After evaluation of the patient's history she was treated with WLL without improvement. After the third WLL, supporting treatment with inhaled GM-SCF was therefore initiated. Firstly, sargramostim (Leukine; Sanofi-Aventis; 250 mug x 2 per week) was used for a short period, but when molgramostim became available in a named patient program, it was decided to change the inhalations to rhGM-CSF - molgramostim (Molgradex; Savara Pharmaceuticals). We chose the following treatment protocol: 300 mug daily in seven days repeated with seven days of pause. After seven months, the therapy was intensified to 300 mug daily. HRCT one year after the treatment did not reveal significant regression of the crazy-paving pattern. Nevertheless, there was a significant clinical improvement with remission of all her symptoms, as well as in her pulmonary function, which almost normalized. After 17 months of molgramostim inhalations her FEV1 was 2.58 (79%), FVC 3.05 (79%), TLC 77% and DLCO 74% of predicted. No adverse effects of the molgramostim inhalations were observed. The patient is now stable, and the inhalations have been discontinued.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 52,\n",
       "    'case_id': 'PMC9124883_01',\n",
       "    'case_text': \"A 52-year-old woman without a family history of migraine and dystonia was admitted to our department due to intractable migraine for about 5 days and walking difficulties for 1 day. She has had a history of headaches for over 20 years with one or two attacks per year described as a throbbing or swelling pain in the occipital region or even the whole brain with an intensity of 6 to 9/10. There was no significant aura before the attack. The headache attack was accompanied by numbness and coldness of the painful area and stiffness of the neck, and nausea and vomiting without photophobia or phonophobia. At worst, she could not take in any food or medicine because of vomiting. The headache usually lasted for 5-6 days and could last up to 15 days, and was slightly relieved by ibuprofen and flunarizine. On the fourth day of this attack, she suddenly suffered an inability to walk lasting for 1 day. She could stand on her own without any dizziness. However, every time she tried to start walking, she felt stiffness in both lower extremities and was unable to step and walk, but could only maintain an upright position. And, it did not change with prolonged standing time. In addition, no movement other than walking was affected. When she was lying down, the movement of both lower extremities was not restricted and she could raise and lower her legs and move them in any direction at will. The same symptom happened once 6 years ago, and it resolved on its own after lasting for 1 h.\\nThe physical examination and vital signs were unremarkable, and the neurologic examination was normal. The patient showed a task-specific lower limbs dystonia, characterized by the appearance of sustained dystonic extension of both knees induced by stepping or walking attempts. Magnetic resonance imaging (MRI) scan of the brain showed no significant abnormalities (Figure 1). The patient underwent a lumbar puncture, the cerebrospinal fluid (CSF) pressure was 125 mm H2O (normal range: 80-180 mmH2O), and the biochemistry and cytology of the CSF were negative. Her blood tests were regular, including routine blood work, liver function, kidney function, ions, D-dimer, and markers of myocardial damage. The contrast transcranial doppler echocardiography (cTCD) showed a latent and massive right-to-left shunt (RLS), that was, more than 25 microbubbles were detected using insonation of the left middle cerebral artery (LMCA) after the release of the Valsalva maneuver (Figure 2). No microbubble was seen in the resting state. Right heart contrast echocardiography confirmed the result. Her echocardiography revealed no abnormalities in the structure and function of the heart at rest.\\nFinally, the patient was diagnosed with migraine and dystonia of the lower extremities induced by it. The cTCD and right heart contrast echocardiography suggested that she had a patent foramen ovale (PFO). Transesophageal echocardiography (TEE) was required to clarify her heart condition further. The patient's headache lasted for 12 days and was relieved with oral ibuprofen (two capsules per day) and flunarizine (10 mg per day). The symptom of the inability to walk cleared spontaneously staying for 1 day, and she was capable of walking slowly and awkwardly during the consultation. Other than medicines for headaches, no additional treatment was given, similar to the situations 6 years ago. Considering the presence of PFO, we recommended she avoid actions that would increase chest pressure, such as diving, violent coughing, and strenuous exercise, which would be of considerable benefit for preventing her headaches. At a follow-up 6 months after the attack, the patient had no episodes of headache and walking difficulty. Unfortunately, owing to financial problems, the patient did not undergo a relevant genetic test, making it difficult to explore the etiology of her condition further.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 63,\n",
       "    'case_id': 'PMC4789418_01',\n",
       "    'case_text': 'We report a case of a 63-year-old Caucasian female found to have high grade endometrial carcinoma while undergoing evaluation for postmenopausal bleeding. The initial suspicion was from an abnormal pap smear done 3 years ago showing possible adenocarcinoma cells. Endometrial biopsy was done and showed high grade endometrial adenocarcinoma with serous features. The patient underwent surgical staging 4 months later with total abdominal hysterectomy, bilateral salpingo-oophorectomy, pelvic lymphadenectomy, and omentectomy. Out of the total 21 resected lymph nodes, one was involved with cancer and the carcinoma was staged at T3aN1M0, Stage 3.\\nFollowing surgical staging and tumor resection, the patient underwent chemotherapy with three cycles of carboplatin and paclitaxel at 21-day intervals, followed by pelvic radiotherapy (planned total dose 5040 cGy), and finally three additional cycles of carboplatin and paclitaxel. Initial doses of carboplatin were targeted at 750 mg/cycle (AUC = 6) and paclitaxel at 175 mg/m2. Because of extended duration radiation related Grade 3 colitis, radiation therapy was stopped after receipt of 1980 cGy. Patient then underwent 3 more cycles (cycles 4-6) of chemotherapy with carboplatin and paclitaxel. The total cumulative dose of paclitaxel was 1511 mg and that of carboplatin was 4312 mg.\\nPrior to beginning chemotherapy, the patient had normal blood counts except for a mild iron deficiency anemia (hemoglobin 11.2 gm/dL, white blood cell count 7200/mm3, and platelets 168,000/mm3). Her platelet count after completion of radiation therapy was 120,000-140,000/mm3, with mild anemia and a normal white blood cell count. After receiving the sixth and final dose of chemotherapy, her platelet count fell to 80,000/mm3 and did not recover.\\nSix months after last cycle of chemotherapy, patient was hospitalized thrice over a period of two months with high grade fevers. She had worsening anemia and thrombocytopenia during this period which prompted a bone marrow biopsy. This revealed a hypercellular marrow with overall 5% myeloblasts with megaloblastic changes in the red cells and myeloid series and normal appearing megakaryocytes (Figures 1 -3). The peripheral blood showed marked anisocytosis with moderate normocytic normochromic anemia and left shifted myeloid series and thrombocytopenia (Figure 4). The findings were consistent with treatment related myelodysplastic syndrome with refractory anemia and excess blasts. Karyotyping revealed abnormal female karyotype: 45,XX,add(3)(p13),del(3)(q23q25),-5,add(5)(q13),add(7)(q11.2),der(17)t(5,17)(q15;q25).\\nWithin six weeks of the diagnosis of myelodysplasia, she had progressed to acute leukemia. Initial lab work revealed leukocytosis up to 76000 with 22% blasts; anemia with Hb 6.4 g/dL; and thrombocytopenia with counts of 15,000/mm3. She was given a provisional diagnosis of therapy related AML. A bone marrow biopsy revealed hypercellular marrow with 29% of cells blasts. The blasts exhibited both myeloid and monocytic features and a diagnosis of acute myelomonocytic leukemia (AML; FAB classification: M4) was made. Peripheral smear also showed persistent leukocytosis with blasts >27% along with anemia and thrombocytopenia which eventually required transfusions.\\nPatient was offered treatment options including chemotherapy for AML and then possible stem cell transplant but decided not to pursue chemotherapy and opted for supportive treatment. She died a week later due to pneumonia and respiratory failure.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 35,\n",
       "    'case_id': 'PMC7711970_01',\n",
       "    'case_text': \"A 35-year-old woman presented with a 3-month history of waist and back pain. Examination revealed a tumescent left supraclavicular lymph node (no mass was touched in the breast). Imaging revealed multiple hypermetabolic foci of FDG in the proximal axial bone and appendage bone as well as multiple and tumescent lymph nodes on the bilateral pulmonary hilum. There was no sign of viscera metastases. Core biopsy showed poorly differentiated metastatic breast carcinoma that was estrogen receptor positive, progesterone receptor negative, and strongly human epidermal growth factor receptor (HER2) positive (3+).\\nPalliative chemotherapy with docetaxel (75 mg/m2), cisplatin (75 mg/m2), and trastuzumab (6 mg/kg, first treatment using 8 mg/kg) was started for 6 cycles, followed by two cycles of docetaxel and trastuzumab treatment. After the treatment, CT scanning showed that all the lymph nodes disappeared and symptoms of pain all over the body had also been relieved. Nevertheless, the patient's platelet count decreased to 48 x 109/L before the 9th treatment. Docetaxel-induced bone marrow suppression was suspected, and trastuzumab and capecitabine (1.5 g, bid, 1-14 d) were used for the 9th treatment. Meanwhile, recombinant human thrombopoietin (TPO) was injected to increase the platelet level. As anticipated, the platelet count returned to normal in 3 days.\\nBefore the 10th treatment, the platelet count of the patient was 99 x 109/L (Figure 1a). Trastuzumab and capecitabine were used again for the 10th treatment. The patient felt tiredness and nausea and all-over body petechiae, and gums bleeding occurred after a 6 h trastuzumab infusion. Blood examination showed that the platelet count was 1 x 109/L. Blood smear examination showed severe thrombocytopenia with no schistocytes, spherocytes, clumps, and giant platelets. Bone marrow biopsy showed normal megakaryocytopoiesis without signs of tumor infiltration. Heparin had never been used and other causes of thrombocytopenia such as disseminated intravascular coagulation, thrombotic thrombocytopenic purpura, hereditary thrombocytopenia, and hemolysis were excluded because of her normal clotting, D-dimers, immunoglobulins, hemoglobin, renal function, bilirubin, and lactate dehydrogenase as well as lack of schistocytes. After consultation with the hematologist, drug-induced thrombocytopenia was suspected. Given the treatment effect of trastuzumab, capecitabine was withdrawn and 3 weekly trastuzumab was maintained. After treatment with platelet transfusion, TPO, and corticosteroids, the platelet count returned to the normal level (Figure 1b). Trastuzumab alone was used for the 11th treatment. Dental bleeding, diffuse petechiae and ecchymosis occurred again in 24 h after the infusion and the platelet count decreased to 5 x 109/L (Figure 1c). The new bone marrow biopsy results were consistent with the previous one. After reviewing the treatment process and referring to relevant literature, a diagnosis of trastuzumab-induced thrombocytopenia was finally made. After treatment with platelet transfusion, TPO and corticosteroids, the platelet count returned to normal.\\n Consent: Written consent was obtained from the patient for publication of this case report.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 45,\n",
       "    'case_id': 'PMC8176203_01',\n",
       "    'case_text': \"A 45-year-old male patient presented with complaints of a nasal forehead mass which had gradually increased in size over the past 5 years and influenced his appearance.\\nThe patient found the nasal-root mass 5 years ago. The mass was the size of a peanut, soft, of normal skin color and with a swollen smooth surface, often exhibiting self-absorption with no other discomfort. In October 2018, nasal mass resection was performed at a local hospital and postoperative pathology was unclear. A relapse occurred in January 2019 and the mass gradually increased in size over the next 10 months, to approximately the size of 5 cm x 2.5 cm. The patient came to our department for a clear diagnosis and treatment.\\nThe patient was in good health and had no history of chronic disease. In 2012, he underwent appendectomy in a local hospital due to acute appendicitis.\\nPhysical examination of the nose upon admission showed that the shape of the nose was normal. The left part of the nasal-root mass was about the size of 5 cm x 2.5 cm. It was soft, with a smooth surface, no redness or swelling, no ulceration, and no tenderness.\\nNo abnormalities in terms of renal function, erythrocyte sedimentation rate (ESR), rheumatism, serum complement (C3/C4), quantitative immunoglobulin determination, immunoglobulin IgG4, antinuclear antibodies or ANCA were found. The possibility of Kimura's disease was not considered before surgery, and IgG4 and IgE levels were not detected before the operation. Positive laboratory results are shown in Table 1.\\nAfter admission, computerized tomography (CT) and magnetic resonance imaging (MRI) examination of the patient's paranasal sinuses were performed. MRI showed an iso-intense signal in the T1 sequence, iso- and hyper-intense signal in the T2 sequence (Figures 1A-C) and enhancement in the T1 enhanced sequence with an unclear boundary. CT showed a soft tissue signal in the nasal forehead with an unclear boundary (Figure 1D).\\nThe pathological findings were as follows: in the hyperplastic fibrous tissue, there were hyperplastic lymphoid tissues, lymphoid follicles, a large number of eosinophils between follicles and small hyperplastic blood vessels in the follicles, which focally infiltrated striated muscle (Figure 2). Immunohistochemistry findings were as follows: CD3(+), CD20(+), CD21(FDC+), CK(-), and Cyclin D1(-).\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 64,\n",
       "    'case_id': 'PMC7218215_01',\n",
       "    'case_text': 'A 64-year old man presented for evaluation of chronic shortness of breath associated with recurrent episodes of lower respiratory tract infections. He also reported two episodes of expectoration of frothy, bloody streaked sputum 3 days ago. He was a never smoker and worked as a constructor and welder. He denied having symptoms of dry eyes or dry mouth. There was a history of arterial hypertension, hypercholesterolemia and gastroesophageal reflux disease. His medication included nifedipine 5mg o.d., nebivolol 2.5mg o.d. and esomeprazole 40mg o.d. There was no family history of lung diseases.\\nOn examination the patient was afebrile, with a heart rate of 63 beats/min, respiratory rate of 12 breaths/min, BP of 130/70 mm Hg and oxygen saturation of 97% on ambient air. Chest auscultation revealed expiratory wheezing. There were also multiple whitish papules in the face, nose and retroauricular area (Fig. 1). According to the patient they were attributed to his welding history and were considered a manifestation of allergic/photosensitive dermatitis. The rest of the physical examination was normal.\\nComplete blood count (CBC) revealed a mild increase in eosinophils (420/mm3). Rest of CBC and metabolic panel were within normal limits. Pulmonary function test revealed an obstructive pattern with significant bronchodilator reversibility: FEV1/FVC ratio was of 69%. FEV1 pre bronchodilation was 2.82 lt (81% predicted), FVC was 4.09 lt (100% predicted) and FEV1 post bronchodilation was 3.28 lt (+460ml, +16.3%). DLco and TLC were within normal limits, 88% and 94% predicted respectively. Chest X-Ray was reported as normal but because of the history of hemoptysis multidetector Computed Tomography (MDCT) of the thorax was performed. It revealed multiple lung cysts with lower lung predominance. Some cysts appeared to be septated, elliptical and the majority of them were located in the subpleural and paramediastinal region (Fig. 2). Due to the reported hemoptysis bronchoscopy with BAL was performed. Airways were patent and there were no signs of active or recent hemorrhage. BAL revealed 74% macrophages, 21% lymphocytes, 1% eosinophils and 4% neutrophils. Cultures were negative for common pathogens, fungi, Mycobacterium Tuberculosis and Nontuberculous Mycobacteria.\\nThe combination of isolated diffuse cystic lung disease (with the aforementioned morphological and distribution characteristics) and skin findings raised suspicion of BHDS. Biopsy of the skin lesions revealed follicular epithelium proliferation surrounded by perifollicular fibrous sheaths, diagnostic of fibrofolliculomas (Fig. 3). Thus, the diagnosis of BHDS was established.',\n",
       "    'gender': 'Male'},\n",
       "   {'age': 55,\n",
       "    'case_id': 'PMC7218215_02',\n",
       "    'case_text': 'A 55-year old man presented for evaluation of abnormal findings on his thorax CT. The latter was performed for investigation of chronic cough. He was an ex-smoker (quitted 7 months ago) with a total of 45 pack years. He denied xerostomia or xerophthalmia. He reported a history of arterial hypertension under treatment with irbesartan 150 mg o.d. There was no family history of lung or kidney diseases.\\nOn examination the patient was afebrile, with a heart rate of 76 beats/min, respiratory rate of 14 breaths/min, BP of 110/60 mm Hg and oxygen saturation of 98% on ambient air. Chest auscultation was clear. There were limited white dome shaped papules on the forehead and the temporal region of the face (Fig. 4). The patient never conceived the presence of these \"white spots\" as a sign of skin disorder. Complete blood count (CBC) revealed and metabolic panel were within normal limits. Pulmonary function test was normal: FEV1/FVC ratio was of 77%, FEV1 was 85% predicted, FVC was 88% predicted, DLco was 73% predicted and TLC was 91% predicted.\\nThorax MDCT revealed multiple thin wall cysts, some of which were bilobated and in relation to the fissures (Fig. 5). Skin biopsy revealed fibrofolliculomas and the diagnosis of BHDS was made.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 50,\n",
       "    'case_id': 'PMC3014856_01',\n",
       "    'case_text': 'A 50-year-old male presented with a fifteen day history of multiple painful lesions on the soles. He reported a \"burning sensation,\" pruritus, and progressive pain with marked limitation in walking. He denied history of insect bite or trauma to the affected area. He had been traveling in Guinea-Bissau, were he walked in bare feet on a beach. There were pigs and goats. His prior medical history was unremarkable. On physical examination multiple 1 cm, round, white papular lesions with a small brown-black central core where distributed on the soles and lateral aspect of the third and fifth toes of the right and left foot, respectively (Figures 1 and 2). A diagnosis of tungiasis was suspected based on the clinical history and physical findings. Surgical incision of the lesions with deep removal of the content was performed under local anesthesia (Figure 3). The content from the wound was analyzed throught optic microscopy and showed multiple Tunga penetrans eggs (Figure 4). The patient went on topical fusidic acid cream with healing of the lesions.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 30,\n",
       "    'case_id': 'PMC5869570_01',\n",
       "    'case_text': 'Our patient was a 30-year-old woman who was diagnosed with stage III (T4bN1a) superficial spreading melanoma of the hollow of the right knee in 2009. She was treated with excision and underwent lymphadenectomy. No other adjuvant treatment was initiated. In 2015, she was diagnosed twice with a solitary \"in-transit\" metastasis on the right leg for which excision was performed. At the end of 2015, a third solitary in-transit metastasis on the right leg was diagnosed, which was also excised, unfortunately without achieving histological radicality. Due to the persistent recurrences of metastatic disease, BRAF mutation was analysed and showed BRAF V600 positivity of the tumour. At that time, ultrasound showed a viable, intrauterine monochorionic-diamniotic twin pregnancy with a gestational age of 65/7 weeks. Intralesional chemotherapy was indicated due to the non-radical excision, but was deemed unsafe considering the early pregnancy. Instead, re-excision under local field block anaesthetic was performed. One month later, another two in-transit metastases on the right leg were excised.\\nTwo months after the last excision, she presented to the emergency room with abdominal pain, persistent vomiting, and constipation. Ultrasound and MRI showed an intussusception of the jejunum over a length of 10-15 cm, para-aortal lymphadenopathy, and a viable pregnancy of 18 weeks. She underwent a laparotomy, confirming the diagnosis of intussusception. The affected jejunum was resected. Histologic examination of the resected bowel and a sample of the tumours palpable in the mesentery showed metastatic melanoma. A PET/CT scan at 216/7 weeks of gestation (low-dose 18F-FDG, with bladder catheter) showed multiple cutaneous and breast metastases. An MRI of the brain showed solitary metastases in the temporal lobe. Due to the high tumour load, non-viable gestational age with the wish to continue her pregnancy and a BRAF V600 pathogenic mutation of the tumour, the patient was started on vemurafenib (twice a day, 960 mg) at a gestational age of 225/7 weeks after extensive counselling. At that time, both fetuses had normal weight on ultrasound, and no congenital anomalies were seen. Twelve days after commencing vemurafenib, our patient reported some mild skin toxicity, starting with some erythema on the face and back. The skin lesions rapidly worsened within 9 days with profound erythema and blisters on the neck, thorax, and arms covering over 70% of her body surface area, and purulent discharge from the eyes. Following this rapid progression of skin toxicity, our patient was admitted to the hospital and vemurafenib was immediately discontinued. Skin biopsy showed toxic epidermal necrolysis (TEN).\\nThe patient was admitted to the intensive care unit the next day, where she was sedated and intubated for pain management. She required extensive rehydration due to significant insensible loss. In addition, betamethasone for fetal lung maturation was given in anticipation of preterm delivery because of maternal deterioration. There were no signs of spontaneous preterm labour or intrauterine infection. At a gestational age of 262/7 weeks, 25 days after the start of vemurafenib and within 1 day after intubation, the patient was transferred in a sedated state to an academic centre with both a neonatal intensive care unit (NICU) and burn specialty unit to provide optimal care for her second-degree TEN lesions, which now covered 98% of her body and oral mucosa (Fig. 1). On arrival, she was found to be in labour and she delivered both children while still sedated (first baby by forceps extraction, second baby by breech extraction). Two baby boys were born with birth weights within the normal range; one with a birth weight of 950 g and an APGAR score of 2 and 3 at respectively 5 and 10 min and one with a birth weight of 900 g and an APGAR score of 6 at 5 and 10 min. Both children were admitted to the NICU.\\nDuring the burn centre hospitalization, some re-epithelialization occurred, but unfortunately, the patient suffered several episodes of wound infection which delayed the wound healing. Initial topical treatment with alginate dressing was replaced by silver sulphadiazine upon diagnosis of pseudomonas wound infection. The mucosal lesions in the mouth caused significant bleeding. Oral rinsing with povidone solutions seemed effective but caused a iodide intoxication with hypothyroidism and a high anion gap acidosis. Corneal erosions and conjunctival adhesions were treated intensively in collaboration with the ophthalmologist. The first weeks were characterized by fluid loss and oedema, and pleural effusion complicated weaning from the ventilator. Once stabilized, the patient responded well to diuretics. Renal function remained normal throughout the burn centre stay. After delivery, oncological treatment with pembrolizumab would have been indicated once the TEN had improved and clinical condition improved. However, 53 days after delivery and 78 days after the start of vemurafenib, and before our patient could start with pembrolizumab, she died of an intracranial haemorrhage due to metastatic disease.\\nBoth children were discharged from NICU to special nursery care 59 days after delivery and were discharged home 95 days after delivery. At a corrected age of 15 months, physical examination showed no abnormalities. Mental development was assessed using the Bayley Scales of Infant and Toddler Development (BSID). The first-born boy (birth weight 950 g) is developing normally, with a Bayley cognitive development score of 82 (developmental age of 15 months). The second boy (birth weight 900 g) was not able to undergo cognitive testing due to persisted crying, but his family did not notice any developmental delay. Long-term follow-up is needed to evaluate their long-term neurodevelopment.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 46,\n",
       "    'case_id': 'PMC4744614_01',\n",
       "    'case_text': 'A 46-year-old female was referred to t department with pain and edema of her right leg. She was a known case of hypertension and hyperlipidemia and had a history of left leg DVT about two years ago. In previous admission she was discharged on warfarin but after few months of treatment, warfarin had been stopped due to active peptic ulcer disease. Collagen vascular markers such as antinuclear antibody (ANA), anti-double stranded DNA (anti-dsDNA), anticardiolipin and lupus anticoagulant antibodies were negative in first admission which were requested due to recurrent abortions (three times) in her past medical history. Doppler ultrasound was performed to evaluate her leg pain and edema. Findings revealed popliteal and superficial femoral vein thrombosis. She was admitted again and anticoagulant therapy was started. During her admission, dyspnea was developed; so pulmonary computed tomography angiography (CTA) was performed and pulmonary emboli was demonstrated (Figure 1). In addition to dyspnea she was complaining of abdominal pain and non-bloody diarrhea. Thrombosis of intra-abdominal vessels was ruled out with magnetic resonance venography (MRV). Since her abdominal pain was resistant to analgesics and she had a past surgical history of appendectomy, abdominal CT scan was performed which showed sub-mucosal bleeding and thickness of jejunum indicating probable IBD diagnosis. The patient underwent colonoscopy due to abdominal pain, past medical history, intermittent non-bloody diarrhea, and abdominal CT findings. Unexpectedly, patchy ulceration was seen coincident of IBD (Figure 2). The patient was treated by intravenous un-fractionated heparin and discharged on warfarin. Follow up in out-patient clinic for international normalized ratio (INR) level monitoring (target between 2 and 3) was arranged.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 54,\n",
       "    'case_id': 'PMC4821156_01',\n",
       "    'case_text': \"A 54-year-old male visited the emergency department because of fatigue and fever a day before admission. He did not have any respiratory or abdominal symptoms. The patient's medical history revealed that he had started treatment for hypertension 3 years ago and that he had been prescribed valsartan (80 mg/day) and amlodipine (5 mg/day). Physical examination showed a BMI of 27.5 kg/m2, blood pressure of 156/96 mm Hg, pulse rate of 137 bpm, temperature of 40.1 C, oxygen saturation of 95% (room air), and crackles at the base of the right lung.\\nCT was performed, and ground-glass opacities were detected in the right middle and lower lobes. Considering these clinical findings together with a positive urinary test for Legionella antigen (Binax, Portland, Maine, USA), a diagnosis of Legionella pneumonia was confirmed. Laboratory data on admission are summarized in table 1. The patient had mild renal dysfunction and hypophosphatemia, while the other electrolytes were within the normal range. Glycemic control was within the ideal range. Arterial blood gas measurement demonstrated hypoxemia and mild respiratory alkalosis. Furthermore, urinary analysis revealed proteinuria, glycosuria, panaminoaciduria, and phosphaturia. Urinary N-acetyl-D-glucosaminidase (U-NAG) and urinary beta2-microglobulin (U-beta2-MG) levels were also elevated.\\nAfter initiation of antibiotic therapy, serum C-reactive protein (CRP) levels improved (fig. 1). The elevation of U-NAG and U-beta2-MG also improved with recovery from pneumonia. Glycosuria, proteinuria, panaminoaciduria, and phosphaturia also improved rapidly. Serum phosphate and ratio of maximal tubular reabsorption of phosphorus/glomerular filtration rate (TmP/GFR) levels reached the normal range on the 5th day after admission.\",\n",
       "    'gender': 'Male'},\n",
       "   {'age': 71,\n",
       "    'case_id': 'PMC4821156_02',\n",
       "    'case_text': 'A 71-year-old male presented with fever, nausea, and fatigue 3 days before admission. He did not have any respiratory or abdominal symptoms. He had been previously healthy and had not taken any drugs. Physical examination showed a BMI of 21.7 kg/m2, blood pressure of 140/90 mm Hg, pulse rate of 102 bpm, temperature of 40.1 C, oxygen saturation of 95% (2 liter/min, nasal cannula), and crackles in the left lung.\\nChest CT showed ground-glass opacities in all lobes of the left lung. A urinary test for Legionella antigen was positive, and the diagnosis of Legionella pneumonia was confirmed. Laboratory analyses on admission are summarized in table 1. Serum creatinine levels were within the normal range (0.88 mg/dl), and estimated GFR was 65.6 ml/min/1.73 m2. Arterial blood gas measurement revealed hypoxemia and mild respiratory alkalosis. Hypophosphatemia, phosphaturia, and renal tubular dysfunction were also present. As for mineral homeostatic regulators, serum FGF-23 level was unmeasurably low, 1,25(OH)2 vitamin D was within the normal range (57.2 pg/ml, normal range: 20.0-60.0), and intact PTH (i-PTH) was not elevated (30 pg/ml, normal range: 15.0-68.0) on admission.\\nAfter administration of ciprofloxacin at 600 mg/day, the levels of serum CRP, U-NAG, and U-beta2-MG improved (fig. 2). Renal tubular dysfunction, including glycosuria, proteinuria, panaminoaciduria, and phosphaturia, improved with recovery from pneumonia. Delayed elevation of 1,25(OH)2 vitamin D levels was present on the 3rd day after admission. Serum FGF-23 levels gradually increased with improvement in renal tubular dysfunction, serum phosphate, and TmP/GFR levels. Serum i-PTH levels did not increase during the whole period.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 8,\n",
       "    'case_id': 'PMC3551515_01',\n",
       "    'case_text': 'An 8 year-old girl with a past medical history of constipation presented with a history of vomiting for nine months. The vomiting was intermittent, non-bloody, at times bilious, and occasionally contained food particles. An abdominal ultrasound was performed which demonstrated debris within a dilated proximal duodenum. The superior mesenteric artery (SMA) and superior mesenteric vein (SMV) were visualized with the SMA lying to the left of the SMV with normal anatomic alignment [Figure 1]. No large solid or cystic masses were seen.\\nA standard barium single contrast upper gastrointestinal (UGI) series was performed with the contrast entering the antrum and duodenal bulb. The proximal duodenum and descending duodenum were markedly dilated in caliber with apparent tapering of the third part of the duodenum. There was an abrupt cutoff with no contrast extending beyond approximately the mid abdomen [Figure 2]. Delayed images were obtained while the patient was supine with contrast never extending beyond the third portion of the duodenum [Figure 3].\\nPatient was subsequently placed prone for several minutes with eventual slight transit of contrast [Figure 4]. Thirty minute delayed prone images demonstrated contrast in the proximal small bowel, however proximal duodenum remained markedly dilated and contrast/debris filled [Figure 5]. Additionally delayed overhead images demonstrated contrast extending to the distal small bowel after patient had been upright for greater than 30 minutes [Figure 6]. Markedly dilated proximal duodenum with abrupt cutoff in the third portion of the duodenum raised concern for a questionable mass like positionally dependent extrinsic compression of the third portion of the duodenum.\\nA subsequent computed tomography (CT) of the abdomen and pelvis was performed with oral and intravenous contrast. The duodenum was distended with the third part of the duodenum tented downward [Figure 7]. The duodenal/jejunal junction was severely narrowed and coursed distally anterior to the right common femoral artery below the bifurcation [Figure 7].\\nThe patient was taken for an exploratory laparotomy and found to have dense vascularized bands without intestinal malrotation. Upon entering the abdomen, the cecum was noted to be in normal anatomical position. Further exploration in the abdomen revealed the proximal jejunum tethered by dense vascularized bands running from approximately five inches distal to the ligament of Treitz down into the pelvis. The cecum was incidentally noted to be folded back on itself and adherent to this tented portion of the jejunum. After these adhesions were ligated, the bowel was examined and no other anatomical abnormalities were discovered. The patient experienced a normal post-operative course with subsequent complete resolution of symptoms.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 31,\n",
       "    'case_id': 'PMC6452554_01',\n",
       "    'case_text': 'A 31-year-old woman (gravida 5, para 2) was referred to our hospital due to labor pain. She was suspected to have SLE because of facial erythema at age 29 years, but clinical and serological findings failed to satisfy the diagnosis criteria for SLE. She gave birth to two boys without any problems at age 23 years (birth weight, 2822 g) and 26 years (birth weight, 2946 g). The fetal heart monitor showed non-reassuring fetal status. A female neonate was born by emergency cesarean delivery at 35 weeks and 3 days. The neonate weight was 1,909 g. She had fetal growth restriction (FGR) and Apgar scores of 5 and 7 (1 minute and 5 minutes). Her skin was pale. She had congenital erythematous and scar lesions on the face, back, and upper and lower extremities (Figure 1). An examination revealed a slight elevation in hepatic transaminases, thrombocytopenia, and mild cardiac failure. No heart blockage was detected. The serological examination of the neonate showed elevated anti-SSA/Ro (281 U/mL) and anti-SSB/La antibodies ( 1000 U/mL). Other antibodies were normal range (anti-DNA antibody  2.0 IU/mL, anti-RNP antibody <2.0 U/mL), and complements were not reduced (C3; 92 mg/dl, C4; 22 mg/dl). The serological examination of the mother also showed elevation of these antibodies, and a histological examination demonstrated lymphocytic infiltration of the minor salivary gland; therefore, a diagnosis of Sjogren syndrome was made. The symptoms of the neonate had almost resolved by 7 months of age.\\nThe placenta was 17 x 13.5 x 2 cm and weighed 285 g. The amnion color was green, and the cut surface showed anemia. Histological examination revealed collapsed capillaries in the terminal villi (Figure 2(e)). No apparent inflammatory cells or thrombus formation was found in the fetal vessels. Partial focal maternal vessel thrombosis was noted, but no apparent infarction was seen. A meconium stain with amnion degeneration was observed in the amnion. Focal maternal thrombosis and increased syncytial knots were also present.\\nImmunohistostaining of a normal placenta (Figure 2(b)), placenta with maternal SLE (Figure 2(d)), and the placenta involved in this case (Figure 2(f)) was performed using C4d (ABGENT, San Diego, CA, USA). In the normal placenta, focal or weak C4d deposits were present at the syncytiotrophoblasts, but not in the lumen of the vessels (Figure 2(b)). C4d deposits were strongly observed at the syncytiotrophoblasts in SLE cases (Figure 2(d)). The placenta with NLS showed C4d deposition in the lumen of the capillaries of the terminal villi (Figure 2(f)). C4d deposition was also seen in the stem vessels, chorionic vessels, and umbilical vessels in this case. C4d deposition was not detected in the maternal vessels.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 81,\n",
       "    'case_id': 'PMC5771727_01',\n",
       "    'case_text': \"An 81-year-old man with a history of multiple KCs, including SCC of the left forehead, sought treatment for recurrent stage III (T4, N0, M0) SCC with orbital invasion. Prior treatment included Mohs micrographic surgery and skin grafting. The patient underwent resection by an otolaryngologist, and the tumor was found within the orbit, with extension into the frontal sinus, posterior orbital wall, ethmoid sinus, and inferiorly into the superior edge of the medial maxillary wall. The orbital wall was reconstructed using titanium mesh embedded within a polyethylene implant, and, in 2012, a free flap was performed, followed by radiation and left eye enucleation.\\nThe patient recovered from surgery but, over the next few years, continued to develop additional primary KCs at sites separate from the location of reconstruction, including SCCs on the right submental neck, right forehead, and left ear. Acitretin was taken for 2 months for chemoprevention of KC but was discontinued in early 2016 because of poor wound healing. One month later, the patient had significant pain and a small erosion of his left medial orbital rim, which he attributed to chafing from the bridge of his eyeglasses. Given concern for possible SCC recurrence with supratrochlear nerve involvement, a shave biopsy was obtained at the site of the patient's pain (Fig 1, A). There was a white linear plaque lateral to the biopsy site. Initially, this clinically appeared to be lichenification caused by recurrent friction from the patient's eye patch. The biopsy performed to rule out recurrent SCC showed spongiotic psoriasiform dermatitis likely of multifactorial etiology from past radiation therapy and erosive pustular dermatosis. He soon developed a 2-cm ulcer with clear exposure of the implant (Fig 1, B). Continued expansion of the ulcer while awaiting surgical resection raised concern for infection, recurrent SCC (assuming sampling error of the previous biopsy), poor wound healing secondary to prior usage of acitretin, and inflammatory dermatoses such as pyoderma gangrenosum or a variant of erosive pustular dermatosis (Fig 1, C). Treatment consisted of removal of hardware, left orbital exenteration, and free-flap reconstruction (Fig 1, D). The patient remains free of recurrent SCC at this site and without further surgical complications 14 months after the initial skin breakdown.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 65,\n",
       "    'case_id': 'PMC4831491_01',\n",
       "    'case_text': \"A 65-year-old, non-obese male, a diabetic for the last 10 years on oral hypoglycemic agents (OHA), was admitted in the emergency department with the chief complaint of progressive breathlessness for last 15 days. Patient had history of paroxysmal nocturnal dyspnea and orthopnea for the last 10 days. History of pedal edema was present during that period. There was no history of chest pain, palpitations, syncope, fever, cough, wheeze, and abdominal distension. He was a non-smoker and normotensive. Patient did not report any recent weight gain. Review of other systems was normal. No significant past history was present. No records of previous ECG or echocardiography were available.\\nIn treatment history, patient was taking combination of pioglitazone 30 mg, metformin 1 g, and glimepride 2 mg for the last 1 year. At the time of admission, pulse was 100/minute and was regular. No special character was noted. Blood pressure was 160/100 mmHg in the right upper limb. Respiratory rate was 24/minute. Jugular venous pressure was raised up to 6 cm above the angle of Louis. Bilateral pedal edema was present. Patient was afebrile. Examination of the cardiovascular system was normal. On chest auscultation, vesicular breath sounds were heard with extensive fine end-inspiratory crackles up to the interscapular area. Palpation of abdomen revealed tender hepatomegaly. Further examination was normal. On investigations, hemoglobin was 11.6 g% and total leukocyte count was 11,200/mm3. Biochemistry revealed the following values: Random blood glucose- 276 mg%, blood urea nitrogen- 20 mg%, serum creatinine- 0.9 mg%, serum aspartate aminotransferase- 58 U/l, serum alanine aminotransferase- 68 U/l, alkaline phosphatase- 215 U/l, and serum albumin 3.6 g%. Serum electrolytes and lipid profile were normal. Cardiac troponins were normal and D-dimer was negative. Urine examination was normal. Serial electrocardiograms were normal. Chest X-ray revealed picture of pulmonary edema with evidence of bilateral pleural effusion [Figure 1a]. A contrast-enhanced computed tomography (CECT) of chest done in a secondary care hospital was brought by the patient, which revealed ground glass opacities, particularly in the perihilar area, thickened interlobular septa, and bilateral pleural effusion [Figure 1b]. With this clinical and investigational profile, possibility of biventricular failure was suspected.\\nPatient was started on heart failure treatment protocol. Intravenous diuretics and angiotensin converting enzyme inhibitors were added. OHA were stopped and patient was started on premixed insulin (30:70) for control of blood glucose. On the 2nd day of admission, patient's symptoms improved and 2D echocardiogram was done which documented normal systolic and diastolic functions, normal cardiac chambers, and no regional wall motion abnormality. The measurements on M-mode were: IVSed- 10, IVSes- 13, LVed- 56, LVes- 35, PW (LV) ed- 10, and PW (LV) es- 13. The left ventricular ejection fraction was 65%.\\nOver the next few days, his symptoms improved gradually. On chest examination, the crackles disappeared, and pedal edema and raised jugular venous pressure resolved. Serial chest X-rays and repeat CECT chest showed radiological clearance [Figure 2a and b]. As no other cause for biventricular failure could be made and patient was on pioglitazone for the last 1 year, possibility of pioglitazone-induced pulmonary edema was suspected. This possibility also gains significance as the patient improved on stopping the drug. Patient was discharged on premixed insulin (30:70) and pioglitazone was not rechallenged. The adverse drug reaction (ADR) was reported to the hospital ADR monitoring center.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 19,\n",
       "    'case_id': 'PMC9380446_01',\n",
       "    'case_text': 'Efforts in domestic HIV prevention prioritize working with disproportionately affected groups, including youth as a priority group, to meet national goals to reduce new HIV infections, increase engagement of infected persons in care, and decrease HIV-related health disparities. National and local data suggest that among youth aged 13-24, Black/African American and Hispanic/Latino youth carry the largest burden of disease, especially during the time of this study (see Figure 1a). For example in 2015, Black youth only made up 14% of the 13-19 year old population in the U.S., yet these youth accounted for 64% of new HIV diagnoses. The causes of these disparities are multi-level, including the role of mental health and emotion regulation in youth\\'s sexual decision making and neighborhood-level poverty and disadvantage. These data underscore that research and program efforts with racial/ethnic minority youth, including individual and macro-level approaches, are urgently needed for domestic HIV prevention.\\nTo facilitate routine HIV/STI testing and treatment and access for youth, all 50 states and the District of Columbia have laws in place that allow most minors (aged 12-17) to consent for their own sexual health care without parental permission:31 states explicitly include HIV testing and treatment as part of services accessible to youth. Despite these supportive HIV/STI care access policies for youth, and an ethical context which supports HIV/STI prevention and control with at-risk populations, controversy about parental permission and minors\\' \"maturity\" remain in research. According to the; see 45 CFR 46.402): \"assent\" is defined as a child\\'s affirmative agreement to participate in research; \"permission\" is defined as the agreement of parent(s) or guardian(s) to the participation of their child or ward in research; and \"informed consent\" occurs when someone who is legally able to consent (> age 18 years) gives permission after having the knowledge of the possible risks, probable consequences, and alternatives. Empirical data support minors\\' competence to consent to research from the age of 12 and above, with recommendations for a dual child and parent consent only when the child has not reached the age where he/she is allocated rights for independent consent. Before the age of 12, or if the child has not reached the age of independent consent, minors may assent to research along with their parents\\'/guardians\\' consent for their participation (; see 45 CFR 46.408).\\nValid medical, legal and ethical concerns exist regarding parental permission, waivers of permission, assent or consent by youth, and the definition of \"child\"/\"minor\" (someone under the age of majority, usually less than 18 years) in youth-focused practice and research. These issues are complex and often challenging for investigators, institutional review boards (IRBs), parents, youth, and community advisors. In addition, federal and local laws should be considered and balanced with the goals of protecting youth from risks. Understanding youths\\' evolving maturity and autonomy and the importance of low-risk, biobehavioral and clinical research activities for youth-focused public health practice warrant consideration.\\nAt the intersection of ethics and law, two key areas potentially cause controversy in IRB determinations for sexual health research with youth: 1) level of risk, and 2) whether minors are emancipated for medical decision making under state or local law. Minimal risk studies are those in which the \"probability and magnitude of harm or discomfort anticipated in the research are not greater in and of themselves than those ordinarily encountered in daily life or during the performance of routine physical or psychological examinations or tests\" (; see 45 CFR 46.102(i)). note that in the absence of empirical data on the risks of daily life and routine examinations among children, IRB members may default to intuitive judgement of these risks, which can lead to systematic errors in interpretation and implementation of federal regulations. An IRB\\'s assessment of minimal risk may also vary by institutional setting (e.g., academic center or hospital). In addition to risk determination, federal, state and local laws regulate issues such as the age of medical emancipation which determines whether minors can make medical decisions in the absence of a parent/guardian. From a research perspective, conflict can arise when IRBs disagree on the interpretation of state law in relation to a study\\'s level of risk.\\nDuring research collaborations, when multiple IRBs provide study oversight, the views and perspectives of IRB members may differ. These IRB disagreements can be challenging if they potentially lead to research delays, especially if the research is addressing public health prevention priorities, such as sexual health. noted the potential negative implications of local and federal IRB disagreements and suggested lessons learned to facilitate future adolescent sexual health research. Our current experiences (2012-2013) suggest that more still needs to be done to improve timeliness of human subjects\\' reviews, reduce IRB disagreements, and improve synergies among multiple entities in a youth-focused research team.\\nIn this paper, we describe challenges and successes in the pre-research, human subjects\\' local and federal review processes that were undertaken before beginning a youth-focused, HIV/STI prevention research project with sexually active youth. The case study explains the issues we faced when seeking approval for a minimal risk study involving Black youth of minority age, all of whom were receiving outpatient mental health care services. At center stage was the controversy surrounding whether or not a waiver of parental consent was legally or ethically necessary under the federal rules for human subjects protection. Final approval was received by the federal funding agency, the local health department, and the University after reaching an understanding about the level of risk of the study and the fact that the youth were medically emancipated minors who were competent to consent to research participation under applicable state law. We believe the lessons learned through working with two IRBs and federal-level reviewers, and seeking a non-IRB-affiliated youth-expert legal opinion, may provide important contextual information for others working with youth in HIV/STI prevention research. Additionally, given youth-related consent challenges in both clinical research and practice, this topic may have implications for broader health-related strategies with youth, which are especially important given the urgent context of HIV/STIs among racial/ethnic minority youth.\\nPhiladelphia, Pennsylvania is a northeastern city whose large, urban school districts ranked second nationally (after Memphis, Tennessee) among similar school districts on percentage of high school students who ever had sexual intercourse (61.0%, 95% CI: 56.1-65.6%) and who first had sexual intercourse before 13 years of age (15.1%, 95% CI:13.0-17.5%). Data from Philadelphia high school districts also ranked their high school students first among similar school districts regarding the percentage reporting four or more sex partners during their lifetime (27.2%, 95% CI:23.9-30.8%) and sexual activity during the most recent three-month period (44.9%, 95% CI: 40.4-49.6%). At the time of our study (2011), the rate of diagnoses of new HIV infections among youth aged 13-24 in Philadelphia was 56.1 per 100,000 population, over twice the national rate of 26 per 100,000 for persons aged 13-24 (; see Figure 1b).\\nGiven the high rates of sexual risk behaviors among youth with mental illnesses and behavioral disorders, our HIV/STI risk-reduction study focused on youth receiving care in outpatient mental health treatment programs who reported current sexual activity. At the time of the study, the most common psychiatric diagnoses among Black youth in mental health treatment in Philadelphia were: attention deficit/hyperactivity disorder (43%), adjustment disorder (36%), oppositional defiant disorder (23%), disruptive behavior disorder (14%), and depression (11%); none of which are barriers to consenting for one\\'s own care if under age 18 and assessed as competent by the mental health care providers. Due to the local epidemiology in Philadelphia, with Black youth being disproportionately affected by HIV/STIs, we sought to enroll youth aged 14-17 years who self-identified as Black (any racial or ethnic designation throughout the African diaspora) to develop and test an HIV/STI prevention intervention for at-risk Black youth receiving mental health treatment in an urban area.\\nIn the state of Pennsylvania, minors (youth aged 14 to 17) can legally consent to both mental health treatment and HIV/STI testing and treatment without parental consent (Juvenile Law Center, 2006). This is especially important in the context of biobehavioral research, because under federal regulations, children are \"persons who have not attained the legal age for consent to treatment or procedures involved in the research, under the applicable law of the jurisdiction in which the research will be conducted\" (; see 45 CFR 46.402(a)). This has been interpreted to mean that if a minor is able to consent to medical health services under state law, the minor is also able to consent to participate in medical research. Therefore, the informed consent of minors in Pennsylvania is legally sufficient for participation and no parental permission or waiver is required.\\nWe proposed to develop and test a HIV/STI risk-reduction intervention with sexually active Black youth receiving outpatient mental health treatment in Philadelphia. We established a youth-led community advisory board (CAB) and a youth advocate/ombudsman to ensure that the perspectives of the target population were infused through each aspect of the study. The youth CAB also created the study name: \"We are Kings and Queens.\"\\nFor the group-level behavioral intervention (Authors), participants were randomized to either the HIV/STI risk-reduction program (treatment; n = 51) or general health promotion program (control; n = 57). The intervention consisted of a two-day, six- hour, skills-based, interactive educational program. The study procedures included focus group discussions (to inform the intervention content), electronic surveys (to collect demographic and behavioral data), diagnostic case ascertainment with the Mini-International Neuropsychiatric Interview, urine specimen collection for Chlamydia and Gonorrhea testing, and an oral swab for OraQuick ADVANCE  Rapid HIV-1/2 antibody testing (unless declined by the participant). Laboratory testing was conducted for participants in both intervention conditions.\\nThese research procedures were specific to the study and not part of routine care at the treatment programs. Two of the partnering agencies, however, did have relationships with outside providers to offer HIV testing onsite, reflecting moves toward the integration of HIV and behavioral health treatment. The primary outcome was consistent condom use. Secondary outcomes included sexual activity (frequency of vaginal, anal and oral sex), the number of concurrent and sequential sex partners, and laboratory confirmed HIV/STIs. We performed assessments at baseline, immediately post-intervention, and at 3-, 6-, and 12-month follow-ups.\\nBefore beginning the study, human subjects approval was required from three groups: 1) the IRB of the academic home institution; 2) the IRB of the local health department; and 3) the reviewers at the federal agency that funded the study. The study materials were submitted to each group and revised several times to clarify wording and address concerns. Changes made to meet the requirements of one agency were resubmitted to the other agencies for their review and approval. Full board review was required given the study\\'s complexity, which meant (at minimum) month-long waiting periods between review meetings. Some of the discussion points included: the appropriateness of mixed-gender focus groups for adolescent sexual health research, confidential recruitment of adolescent participants in clinics when parents/guardians are present, and actions to be taken for positive HIV/STI test results (e.g., linkage to care procedures). Additionally, given our target group of youth with mental illnesses, there was increased attention to human subjects\\' protections due to concerns regarding competency to provide consent and whether parents/guardians would be notified if their child tested positive for HIV/STIs.\\nThrough a series of face-to-face meetings and email exchanges, we worked to address the concerns. We advocated for mixed-gender focus groups to preserve the richness of data that stems from the interactive dialogue between heterosexually-active males and females. We emphasized the high caliber training our facilitators received and created a behavioral management plan, at the IRB\\'s request, to indicate how we would handle potentially challenging group dynamics. For participant recruitment when a parent/guardian was present, we agreed that recruiters would directly address both the parent/guardian and adolescent, identifying himself/herself as a research team member for a study on teen relationships. The adolescent was then informed that he/she could call the number on the business card for additional information. Adolescents were not screened in the presence of parents/guardians, and parents/guardians were not given details about the study. However, if a parent/guardian stated they did not want their child to participate in the study (at the time of approach or any time thereafter) we conceded to the IRBs request that we would not contact or enroll the adolescent in the study, even if he/she independently expressed interest in participation. Given that our target population of youth had all provided consent for their mental health treatment, the IRB approved our determination of competence to provide consent by study personnel as part of the screening process for enrollment. All participants were notified of their HIV/STI results. Those who tested positive for Chlamydia or Gonorrhea (n = 8, 7.4% at baseline) were notified of their results and referred to receive free treatment through the local department, or from their primary care provider. No participants tested positive for HIV, but positive cases would have been followed by the AIDS Service Organization that conducted the testing for confirmatory tests and linkage to care. While we were able to resolve these issues, there was a fundamental disagreement in the interpretation of the state law between the investigators and the review entities. The research team did not believe parental permission was warranted/applicable, while several local IRB members required parental permission, or at minimum, a solid justification for the appropriateness of a waiver.\\nBased on Pennsylvania minor consent laws, the participants in this study did not qualify as minors (they did not meet the regulatory definition of minor) for purposes of human subject review; when minors do not meet these qualifications, they can participate in research as adults. Despite the documented legal guidance, obtaining approval became a challenge when the local and federal agencies disagreed about whether parental permission was required for the study. More specifically, the minors\\' consent to medical health services was not viewed by all parties as sufficient to justify research consent. In the opinion of several IRB members, medical/mental health care was a necessity, while research involvement was a voluntary procedure that they believed would require parental involvement. In other words, at the intersection of ethics and law, some reviewers believed that while the minor was medically emancipated under state law to make decisions, the ethical risk associated with research participation outweighed the state regulations.\\nWe had multiple discussions with the committee members to provide context and accurate data regarding the Health Information Portability and Accountability Act (HIPAA) and the protected confidentiality of medical data, the urgency of the HIV epidemic among young people in Philadelphia (see Figure 1b), and the legal ramifications of sharing adolescent test results with parents without youth consent. We also provided information to the local and federal review agencies about the state laws and federal guidance in support of minors\\' consent for their own mental health and sexual health services. For example, the stated that \"...assent of such mature minors should be considered sufficient with respect to research about conditions for which they have legal authority to consent on their own treatment\" (pg. 18). Thus, although parental permission was not technically applicable under state law and federal guidance (Juvenile Law Center, 2006), our ethical review process required that we address the issue of parental permission/involvement.\\nWe advocated to consent participants in the absence of parental involvement for several reasons: 1) to protect the youth participants\\' privacy regarding their involvement in consensual sex; 2) to ensure youth receive HIV/STI testing and treatment (if needed); 3) to encourage participants to give honest answers to the study questions (without fear of parent/guardian reactions); and 4) to be in line with state and federal guidance on the issue. Previous research with youth suggests that requiring parental permission may decrease their interest in participating in biobehavioral research, especially when STI testing is involved. In addition, some parents/guardians may request to receive their child\\'s test results, which would be counter to the youth\\'s desires and legal precedent for maintaining their confidentiality. Requiring parental permission would also violate local and federal rights and breach confidentiality for youth whose parents/guardians did not know that they were receiving mental health treatment, engaging in consensual sexual activity and possibly seeking sexual health services.\\nDespite eleven separate meetings and discussions, the local and federal approving agencies were unable to reach initial consensus about parental involvement. The federal funding agency waited to consider the decisions of the two local IRBs before completing its review. The local IRBs suggested obtaining a youth-focused third party review of the protocol to help support a decision. We contacted attorneys at the Juvenile Law Center, a non-IRB-affiliated youth-legal expert firm in Philadelphia. They reviewed the study materials and concluded that the study\\'s consent provisions were consistent with the Mental Health Procedures Act and HIPAA:a minor in Pennsylvania age 14-17 did not need parental consent to participate in the study. After several review and feedback sessions, both the academic institution and local health department IRBs approved written informed consent by the adolescent participants and waivers of parental permission for their parents. Approval by the local IRBs facilitated the green light by the federal agency to begin the study. The study was approved by all required local and federal bodies in March 2013; overall, a 14-month timeline for full review and approval of this protocol with associated suboptimal use of human and fiscal resources due to the lengthy delay.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 65,\n",
       "    'case_id': 'PMC7682142_01',\n",
       "    'case_text': 'This procedure was applied in a case of 65-year-old woman with recurrent squamous cell carcinoma of the anus infiltrating the posterior wall of the vagina. After multidisciplinary staff decision, we performed an abdominoperineal excision of the rectum with en-bloc resection of the vaginal posterior wall in order to achieve tumor-free margins. It resulted in a large perineal defect surrounded by scar tissue damaged by radiotherapy. In the present case, the whole posterior wall of the vagina could be reconstructed.\\nShe was asked to remain on bed rest for five days following surgery and was encouraged to be out of bed and ambulating on the sixth day. Postoperative monitoring was done exclusively by clinical examination (color and time for recapilarization). Postoperative course was uneventful and she was discharged home from hospital at postoperative day 9. Final pathologic report showed a rpT4N0 6.5x6.5cm squamous cell carcinoma with invasion of the vaginal submucosa. Resection was considered R0. \\nAt six-weeks after surgery, clinical examination showed a solid anterior abdominal wall (Figure 2C) and a very satisfying vaginal reconstruction allowing the potential for normal function, i.e.: 1) vagina was >10 cm long; 2) vaginal opening easily admitted two fingers during examination; 3) the relationship of the posterior vagina and the perineum was almost perpendicular, and 4) there was no buildup of perineal skin above and beyond the flap.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 62,\n",
       "    'case_id': 'PMC8392798_01',\n",
       "    'case_text': 'A 62-year-old male with past medical history of hypertension, hyperlipidemia, coronary artery disease, and arthritis was readmitted via emergency department for worsening chest pain, productive cough, and shortness of breath. His chest pain was pleuritic. He was discharged a week earlier from a 1-day hospital stay on a 10-day course of dexamethasone for coronavirus disease-2019 (COVID-19) infection, which he was unable to take. He was maintaining oxygen saturation of 88% on 6 L nasal cannula. Initial blood work was remarkable for leukocytosis 25.86 (ref: 3.1-8.50 x 103/uL) with bands elevated at 9%, anion gap 15, lactic acid elevated 3.3 (ref: 0.5-2.0 mmol/L), mild transaminitis with aspartate aminotransferase (AST) 113, and alanine aminotransferase (ALT) 153. Physical examination was remarkable for decreased air entry with bilateral crepitation. Computed tomography pulmonary embolus study confirmed presence of bilateral acute pulmonary emboli with possible right heart strain and bilateral infiltrates consistent with COVID-19 pneumonia. He was treated with heparin infusion, remdesivir, dexamethasone, 1 dose of vancomycin, and piperacillin-tazobactam as well as supportive breathing treatments consisting of albuterol nebulization as needed. He was then admitted to the medical floors for further management.\\nEchocardiogram obtained later was resulted as normal left ventricular function with ejection fraction 55% to 65% with normal right ventricular pressure and no evidence of right ventricular dysfunction. Heparin infusion, remdesivir, and dexamethasone were continued. Vancomycin and piperacillin-tazobactam were given the initial 2 days to cover for superimposed bacterial pneumonia and later deescalated to amoxicillin-clavulanic acid on days 3 and 4 of hospitalization. Ultrasound abdomen done on day 4 showed no abnormalities within the liver or gallbladder.\\nDuring hospitalization, patient was noticed to have worsening of liver enzymes which peaked at ALT 721 IU/L (normal <55 U/L) and AST 305 IU/L (normal value < 35 U/L). Other laboratory values were gamma-glutamyl transferase 114 IU/L (ref: 12-64 IU/L), albumin 2.7 g/dL (ref: 3.4-4.8 g/dL), alkaline phosphatase 49 IU/L (ref: 56-119 IU/L), and international normalized ratio 1.5. Further workup showed pro-calcitonin minimally elevated at 0.28 (ref: <0.05 ng/mL), d-dimer elevated at 12.89 (ref: <0.5 mg/dL), and fibrinogen was normal. His blood alcohol and acute hepatitis panel were negative on day 2 of hospital admission. Acetaminophen levels obtained on hospital day 4 were <0.6 (ref 0.00-50.0 microg/mL). At that point, remdesivir was discontinued on day 2 of admission as it was thought to have contributed to worsening of liver function. Antibiotics were discontinued as bacterial infection was less likely and it was thought amoxicillin-clavulanic acid could also have contributed to liver enzyme abnormalities. Computed tomography abdomen and pelvis with contrast (day 8) showed mild splenomegaly with no abnormalities noted in the liver or gall bladder.\\nDespite discontinuation of remdesivir, antibiotics, and improving oxygen requirements, his liver function continued to worsen (see Table 1) and additional workup including autoimmune work up with anti-smooth muscle antibodies, systemic lupus erythematosus, and vasculitis panel were done and reported negative. Further testing with EBV and cytomegalovirus (CMV) serology were done, which revealed EBV viral capsid antigen (VCA) IgM positivity. He was also positive for EBV VCA IgG, EBV early antigen (EA) IgG, and EBV nuclear antigen (NA) IgG. EBV polymerase chain reaction was reported positive. CMV IgM antibody was negative; however, CMV IgG antibody was positive with reported value >10 (ref: 0.00-0.059). He remained stable with improving oxygen requirements and was eventually discharged home without the need for supplemental oxygen.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 10,\n",
       "    'case_id': 'PMC4862798_01',\n",
       "    'case_text': 'Hydroa vacciniforme is a rare idiopathic photodermatosis uncommon in dark skinned patients, which usually begins in childhood before the age of 10 years old and disappear in adolescence, it begins symmetrically in photo exposed areas as a sensation of skin burning in less than 24 hours of sun exposition, and then a vesicular rash develops, become umbilicated and secondarily crusted. Within weeks, the scars heal and leave a residual varioliform scar appearance, the condition generally improves with regular use of high protection sunscreens and resolves during adolescence. In patients who do not respond to conservative treatment, use of systemic agents has been reported like psoralen with exposure to ultraviolet A [PUVA], ultraviolet B TL-01phototherapy, antimalarial agents and immunosuppressive medication. Our patient is a 10-year-old child -without pathological antecedents- who consulted for atrophic depressed scars after a vesicular rash, which begin with a sensation of skin burning a day after intense sun exposure. These scars are covered by hemorrhagic crusts in some areas and appear on exposed areas: face, ear, hands and forearms with erosive lesions of the lower lip. The Child reports that this is the second episode with an interval of 6 months between the 2 episodes.',\n",
       "    'gender': 'Unknown'}],\n",
       "  [{'age': 0,\n",
       "    'case_id': 'PMC5719537_01',\n",
       "    'case_text': 'For a sample that was detected as G10P[14] from an unvaccinated 30-month old boy with acute gastroenteritis, large volumes of the 10% stool suspension were prepared and used for RNA extraction and sequence independent amplification as recently described  to amplify all the 11 gene segments. The amplicons were sequenced by next-generation sequencing using the Illumina MiSeq 150 paired end method (Genomics Lab, Hudson Alpha Institute for Biotechnology, Huntsville, Alabama).\\nIllumina sequence reads were analysed using CLC Genomics Workbench 6.0. A combination of de novo assembly and subsequent mapping to reference strain was used to obtain the full-length genome of the strain. The assembled gene sequences were aligned with reference rotavirus gene sequences using the ClustalW program within MEGA 5.05 package. Once aligned, the optimal evolutionary model that best fit each sequence dataset was identified using AICc criterion implemented in jModeltest2. The best models identified were TIM3+I (NSP1), TPM2uf+G (NSP2), TIM2+G (NSP3), TPM2uf+I (NSP4), TrN+I+G (NSP5, VP6), TIM2+I (VP1), GTR+I (VP2, VP3), GTR+G (VP4), and TIM3+I+G (VP7). Phylogenetic trees were constructed using PhyML version 3.0 with aLRT statistics computed for estimation of branch support, and p-distances were computed in MEGA 5.05 to determine the similarities of the genes to reference strains in GenBank. The scale bars on the phylogenetic trees represent proportion of substitution on a branch of each tree. The gene sequences were submitted to RotaC (http://rotac.regatools.be/) for genotype assignments. All the gene sequences of the G10P[14] genome has been deposited into the GenBank sequence database under accession numbers KU956006 through KU956016.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 74,\n",
       "    'case_id': 'PMC8415387_01',\n",
       "    'case_text': 'A 74-year-old patient with known severe ischemic cardiomyopathy was admitted for congestive heart failure and atrial fibrillation with type 2 myocardial ischemia. The initial 12-lead ECG (Figure 1A) was obtained with limb leads placed on the torso position and reported as \"ST elevation and possible acute inferior wall myocardial infarction (MI)\". Repeat ECG with limb leads placed in standard, distal limb positions showed resolution of \"ST elevation\" in the inferior leads (Figure 1B).',\n",
       "    'gender': 'Unknown'},\n",
       "   {'age': 76,\n",
       "    'case_id': 'PMC8415387_02',\n",
       "    'case_text': 'This ECG (Figure 2A) with torso limb leads placement was obtained in a 76-year-old patient which showed the presence of a Q wave in lead aVL suggestive of an old lateral wall MI. When the limb leads were moved from torso position to standard distal limb positions, a repeat ECG (Figure 2B) showed resolution of Q waves in lead aVL.',\n",
       "    'gender': 'Unknown'}],\n",
       "  [{'age': None,\n",
       "    'case_id': 'PMC4531616_01',\n",
       "    'case_text': \"In 1997, the patient was diagnosed with MCTD after developing right knee arthritis, sclerodactly, Raynaud's phenomenon and digital vasculitis. She took 10 mg of prednisolone after diagnosis of interstitial lung disease in October 1998. In May 2000, the patient received intra-articular injections with triamcinolone in the right knee because of relapsing arthritis. She was admitted to Wallace Memorial Baptist Hospital in September 2001 with right knee pain and swelling, as well as calf swelling.\\nOn admission, her temperature was 37.8 C. Physical examination showed swelling and mild tenderness in the right knee and calf. Both hands also revealed sclerosis with loss of skin flexibility and ulcerations on the tips of her fingers.\\nOn admission, laboratory data was WBC 6,400/mm3, Hb 12.9 g/dL and platelets were 205,500/mm3. At that time, erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) were 46 mm/h and 1.7 mg/dL. Assays for antinuclear antibody (ANA) with fluorescein-labeled ANA method resulted in high titer (1:5120) and a speckled pattern. Specific autoantibody studies showed a high titer of U1-RNP antibody (3678 IU/mL). None of anti-ds DNA, anti-SS-A/Ro antibody, anti-SS-B/La antibody, anti-Sm antibody, anti-Scl 70 and anti-centromere antibody was positive. Rheumatoid factor was also negative.\\nSerologic tests for human immunodeficiency virus (HIV) and Venereal Disease Research Laboratory (VDRL) were negative.\\nChest computerized tomography (CT) showed mild esophageal luminal dilatation through the whole length and bilateral subpleural pulmonary fibrosis in both lower lobes of the lungs. Ultrasonography and magnetic resonance image (MRI) around the right knee showed a poorly defined mass lesion laterally to the semi-membranous tendon, anteriorly to the gastrocnemius muscle on the right leg (Figure 1). This extra-articular abscess extended from politeal fossa to the upper end of the Achilles tendon.\\nAnalysis of the abscess showed decreased viscosity and was yellowish to bloody in color. WBC counts were 700 cells/mm3 and the differential form showed 50% polymorphonuclear leukocyte and 50% lymphocyte. Acid fast bacillus (AFB) stain showed strong positive but polymerase chain reaction (PCR) for mycobacterium tuberculosis was organisms negative. Gram stain was neither positive, nor was growth of on the culture.\\nTotal excision of the abscess was attempted. A small window connected between synovial cavity of the knee and the huge cystic mass included multiple separated rooms. Pathologic findings of the specimen disclosed caseous central necrosis surrounding the granuloma (Figure 2).\\nWe initially used the following anti-tuberculosis medications: isoniazide, rifampicin, ethambutol and pyrazinamide. Two months later, the culture for AFB disclosed M. avium in the PCR RFLP assay (PRA) and was resistant against multiple anti-tuberculosis drugs, except cycloserin, in sensitivity testing.\\nAfter 9 months of anti-tuberculosis therapy, including cycloserin, we followed up with monthly ultrasonography. Some small cysts persisted between the soleus and the gatrocnemius muscle. We aspirated fluid using a guided ultrasonography. Aspirated fluid was clear of serosangious. Stain for AFB were negative. Culture for Mycobacterium was also negative. We continued the anti-tuberculosis therapy for 12 months and regularly followed up with ultrasonography after discontinuing the medication.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 54,\n",
       "    'case_id': 'PMC5118371_01',\n",
       "    'case_text': 'A 54-year-old female was referred to our institution with a 1-week history of headaches. Her past medical history was unremarkable. Magnetic resonance imaging (MRI) revealed a large, partially necrotic and calcified tumor in the parenchyma of the left frontal lobe with marked surrounding edema and mass effect on midline structures, but without any dural attachment. The tumor appeared hypointense on non-contrast T1-weighted images (Fig. 1a) and iso-to hyperintense on T2-weighted images (Fig. 1b). The enhancement of the tumor was irregular and most prominent at its periphery (Fig. 1c-e). The preoperative clinical diagnosis was meningioma or calcified glial tumor. She underwent incomplete resection of the tumor and histopathologic examination revealed a malignant mesenchymal neoplasm displaying a poorly differentiated spindle cells with interspersed eosinophilic osteoid production, calcification intimately associated with the malignant cells, and localized new bone formation (Fig. 1f). Immunohistochemistry was negative for epithelial membrane antigen (EMA), glial fibrillary acidic protein (GFAP), CD34, desmin and neurone specific enolase (NSE) but positive for vimentin (Fig. 1g), P53 (Fig. 1h), osteopontin (Fig. 1i) and osteonectin (Fig. 1j). Antisera against the proliferation marker Ki-67 revealed very variable immunoreactions (80%). Given the microscopic appearance a histopathologic diagnosis of primary intracerebral osteosarcoma was made. \\nExtraskeletal osteosarcoma is rare and is defined as a malignant mesenchymal neoplasm that produces osteoid as well as bone or chondroid material and is located in the soft tissue without any bony attachment (Chung and Enzinger). Primary intracranial osteosarcoma most often represent intracranial invasion from a tumor arising from the skull (Salvati et al.), and meningeal osteosarcomas which arise from the mesenchymal components of the meninges are also reported (Dagcinar et al.). However, primary intracerebral osteosarcoma is rare with very few reported cases in literature.\\nWe performed a PubMed search for all cases of primary intracerebral osteosarcoma up to September 2016. Cases were analyzed for basic demographic features including age, sex, chief complaint, location, treatment, and clinical outcome (Table 1).',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 35,\n",
       "    'case_id': 'PMC8010170_01',\n",
       "    'case_text': 'A 35-year-old male presented with diarrhea and abdominal pain after eating seafood and drinking 5 months before admission. The abdominal pain could be relieved after defecation. Two weeks later, he began to have a fever, up to 39.8 C, accompanied by chills. He was admitted to the local hospital and broad spectrum antibacterial drugs were started empirically. Despite antibiotics, the fever continued to occur repeatedly, in peaks up to 41 C, and the diarrhea persisted. Then the patient was suggested to be transferred to our institution.\\nLaboratory tests showed leukocytosis (20.79 x 109/L), moderate anemia (69 g/L), increased percent of neutrophils (91.6%), increased C-reactive protein (CRP) (80.90 mg/L), procalcitonin (PCT) (5.87 ng/ml) and erythrocyte sedimentation rate (ESR) (106.0 mm/h) level, and mild hypoalbuminemia (31.0 g/L). Stool routine revealed Leukocyte ++++/HP, pus cell ++++/HP, stool blood was positive. Amoeba cysts were found after repeated stool examinations, but no trophozoites. Blood cultures, HBV, CMV-DNA, TORCH-IgM, G/GM, TB-IGRA, parasite antibody were negative. The plasma biochemistry of liver and kidney functions were normal. A total of three colonoscopes and biopsies were performed for the patient, and the results showed multiple irregular ulcers in the whole colon (Figure 1). Colonic biopsies diagnosed Epstein-barr virus-associated lymphoproliferative disorder, but the sample was inadequate for definitive diagnosis. Bone marrow examination showed the proliferation of hematopoietic cells were active, mainly granulocytes, and immature granulocytes increased. Findings of CT images of chest and neck were normal. Contrast-enhanced CT scan of the whole abdomen revealed multi-segmental intestinal wall thickening and enhancement (Figure 2A). 18F-FDG PET/CT demonstrated increased FDG uptake in the whole colon, bone marrow and spleen (Figure 3).\\nTreatment of the patient was provided with anti-infective (moxifloxacin, rifaximin, metronidazole and imipenem, vancomycin, and cefperazone-sulbactam, tigecycline were given successively). However, he still had diarrhea and recurrent fever, the body temperature fluctuated at 39-40 C. Blood cultures were still negative. No positive bacilli was found by acid fast staining and no DNA fragment of Mycobacterium tuberculosis was found by qPCR. During the hospitalization, the patient developed a fierce abdominal pain, CT indicated gastrointestinal perforation (Figure 2B). An emergency surgery was performed. During surgery, it was found that there were two 0.5 cm breaks in the ileocecal junction, a 3 cm break in the descending colon, three perforation holes of varying sizes were seen in the sigmoid colon with a diameter of about 0.5-1 cm, and three 0.5-4 cm breaks in the upper rectal segment 3 cm from the peritoneal reflection. The intestinal wall around the breaks was edematous and congestive. He underwent total colectomy and enterostomy. ENKTL was diagnosed for pathological diagnosis of surgical samples. Histologically, the tumor cells were medium in size with irregular nuclei (Figure 4B). There were mixed inflammatory infiltrated mainly including lymphocytes and plasmacytes. The tumor cells infiltrated the whole wall of the intestinal wall with ulcer, necrosis (Figure 4A). Immunohistochemical staining showed that CD3, CD2, CD43, granzyme B (GB), TIA-1 were positive, while CD20, CD5, CD7, CD4, CD8, CD56 were negative (Figures 4B-G). CD30 was focally positive. The Ki-67 labeling index was 60% (Figure 4I). EBV-encoded small RNA (EBER) analysis showed positive (Figure 4H). Gene rearrangement test found the low amplification peak of TR gene.\\nAfter recovering from surgery, the patient was treated with two courses of etoposide 50 mg and dexamethasone 5 mg (ED) regimen. Gemcitabine was added on the third day of the second course of therapy. Two weeks later, PD-1 monoclonal antibody 100 mg was used to replace ED regimen because his general condition and the expected chemotherapy tolerance were poor (A total of 3 times, each interval of 3 weeks). Fortunately, the patient was discharged the next day after the last treatment with PD-1 monoclonal antibody. By the time he was discharged from the hospital, his general condition improved significantly. PD-1 monoclonal antibody 100 mg was used on day 23, 56, 85 after discharged. To date, the patient has treated with a total of six courses of PD-1 monoclonal antibody. Eleven months follow-up was uneventful.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 30,\n",
       "    'case_id': 'PMC9490482_01',\n",
       "    'case_text': 'A 30-year-old gravida 2, para 1, sexually active married female presented to the emergency department complaining of redness and swelling of the left labia, along with painful sexual intercourse and vaginal discharge for 1 month. She reported a regular menstrual period. Physical examination revealed a solid, erythematous mass arising from the left lateral vaginal wall. The uterus and adnexa appeared within normal limits on bimanual examination and transvaginal ultrasonography. There were no urinary or bowel symptoms. The patient had no relevant family history. Routine lab values like complete blood count (CBC), coagulation, electrolytes, C-reactive protein (CRP), and renal function were all within the normal range. With the mass initially highly suspicious of Bartholin abscess, antibiotics including ceftriaxone and metronidazole were started and the patient was scheduled for a Bartholin abscess drainage surgery. Intraoperatively, a solid mass was noted confluent with the left lateral vaginal wall. This lesion was surgically excised and was sent for histopathological examination. The findings were consistent with a benign leiomyoma, as the microscopy revealed smooth muscle bundles that vary in size and run in multiple directions without necrosis, and each cell is spindle-shaped with an eosinophilic cytoplasm and an elongated nucleus with no mitotic activity (Figures 1 and 2).\\nThe patient was discharged the next day with an uneventful postoperative course, and her follow-up visit showed a healthy operation site with no complications.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 56,\n",
       "    'case_id': 'PMC7472830_01',\n",
       "    'case_text': \"A 56-year-old male was diagnosed with multiple HCCs in Barcelona Clinic Liver Cancer (BCLC) stage B. The patient had chronic viral hepatitis B and received standard antiviral therapy. He had no medical history of glucose intolerance, autoimmune diseases, thyroid dysfunction, or other systemic diseases (e.g., Cushing's syndrome), and no evidence of acute infection, trauma, or drug poisoning. He also had no family history of diabetes, autoimmune diseases, and hereditary diseases. Psychosocial assessment showed that the patient had no mental, physical, or emotional health issues. After unsuccessful treatment with trans-hepatic arterial chemotherapy and embolization (TACE), the patient voluntarily participated in the CISLD-1 trial, provided signed informed consent in July 2019, and started to receive Sintilimab at a dose of 200 mg every 3 weeks. Five months after receiving Sintilimab, tumor marker examination and imaging scans showed that the treatment was effective. The patient's alpha-fetoprotein (AFP) level decreased to 40.4 mug/L from a baseline level of 9829.9 mug/L (Figure 1A). Magnetic resonance imaging (MRI) showed that the tumor nodule in the liver had shrunk dramatically with a response evaluation of partial regression (PR) according to Response Evaluation Criteria in Solid Tumors (RECIST) version 1.1 (Figure 1B). During these months, the patient felt mild fever regularly; however, there was no fatigue, nausea, erythema or any other side effect found.\\nAt 24 weeks, after 8 courses of Sintilimab, the patient presented with increased urination and drinking for 1 week, and blood tests showed that his fasting plasma glucose was as high as 22.2 mmol/L, with an HbA1c value of 7.8%. Considering the high risk of diabetic ketoacidosis, blood gas analysis was performed, which revealed that he had severe metabolic acidosis, with an arterial pH of 7.27, serum bicarbonate of 12.9 mmol/L, and lactate of 1.8 mmol/L. The blood ketone body determination was positive. Therefore, the patient was suspected to have new onset diabetes mellitus with ketoacidosis and was admitted to our hospital. Further blood assessment showed that the patient's fasting insulin was as low as 1.5 mIU/L and fasting C-peptide was 1.12 ng/mL (0.78-5.19 ng/mL), which further decreased to 0.21 ng/mL 4 days later. The oral glucose tolerance test (OGTT) revealed that the fasting, 1-, 2-, and 3-h plasma glucose levels were 12.34, 18.32, 28.38, and 25.41 mmol/L, respectively, accompanied by a 2-h postprandial C-peptide level of 0.30 ng/mL and a serum insulin level of 10.4 mIU/L. In addition, the patient's serum inflammatory cytokines, measured using an enzyme-linked immunosorbent assay (ELISA), demonstrated an interleukin-6 (IL-6) level of 786.32 pg/mL, which decreased to 338.70 pg/mL 2 months later (Table 1). There was no infection, medication, thromboembolic event, or other factor (Autoimmune diseases, Cushing's syndrome, or drug poisoning) that could cause hyperglycemia. Consequently, Sintilimab-induced new-onset autoimmune diabetes was diagnosed. However, the anti-glutamic acid decarboxylase 65 (GADA) antibody, anti-islet cell antibody (ICA), and anti-insulin (IAA) antibody tests were all negative. In addition, the type 1 diabetes-related alleles of human leukocyte antigen (HLA) class I and II, which were explored at the loci of HLA-A, B, C, DRB1, DQA1 and DQB1 by sequence-based typing primed PCR (Table 2), revealed that the most relevant allele was HLA-A*0201. For other endocrine function assessments, thyroid hormones showed that the patient's serum total triiodothyronine (TT3) and free triiodothyronine (FT3) were slightly decreased, but later become normal without oral thyroxine treatment (Table 1). Moreover, the levels of anterior pituitary hormones and their regulated hormones were all normal (Table 1). The patient received insulin therapy delivered by micropump, maintaining water and electrolyte acid-base balance and other supportive treatment to correct acidosis. Thereafter, he was treated with insulin therapy subcutaneously, which was adjusted daily to the dose of once-daily basal insulin glargine (long-acting insulin, 30 units) plus thrice-daily prandial insulin aspart (fast acting insulin, 14 units) during his hospital stay. The patient's plasma glucose returned to normal levels gradually and he was discharged 10 days later (Figure 2). Subsequently, the patient's plasma glucose was monitored in the outpatient setting and the insulin therapy was gradually adjusted to once-daily basal insulin glargine (28 units) plus thrice-daily prandial insulin aspart (15 units). Then, the patient received continued Sintilimab administration, which resulted in a further decreased in his AFP level (Figure 1A). And the patient's plasma glucose level was stable during follow-up visits.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 21,\n",
       "    'case_id': 'PMC7700966_01',\n",
       "    'case_text': 'A 21-year-old male presented to our emergency department with the complaints of peri-umbilical pain, migrating to the right lower quadrant which started two days ago. The pain was mild to moderate in intensity and associated with nausea, vomiting. The patient had a history of similar pain in the last few months. The past medical history was not significant and the patient had no history of associated co-morbidity. The family history and drug history were unremarkable. Initial assessment demonstrated that the patient was febrile (38  C) with blood pressure of 120/80 mmHg and pulse rate was 88 beats per minute. On examination, right lower quadrant and inguinal canal tenderness were found. There was no evidence of abdominal distension. Laboratory findings included elevated inflammation markers: White Blood Cells count: 13 x 103 g/L and granulocytes of 88 % and C-reactive protein level of 8 mg/dl. Renal function tests and electrolytes was normal. Plain abdominal radiography was unremarkable. Urgent computed tomography of the abdomen and pelvic demonstrated a tubular blind-ended structure originated from the cecum wall and extends to the hernia sac which made suspicion of inguinal hernia (Fig. 1). The patient underwent a diagnostic laparoscopy and operative finding was an inflamed appendix in the right inguinal canal suggesting amyand hernia (Fig. 2, Fig. 3). Laparoscopic appendectomy was performed. Due to sever inflammation and congestion op parietal peritoneum at site of inguinal canal following the extraction of appendix from umbilical canal, an open tissue repair of inguinal floor in Bassini manner, was performed by attending surgeon. The patient underwent antibiotic treatment and routine surgical wound care. No immediate postoperative complications were seen, so the patient was discharged after a 48 h and returned for the follow-up at the days ten as well as one month after with no complication. Histopathology revealed acute appendicitis.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 34,\n",
       "    'case_id': 'PMC6026916_01',\n",
       "    'case_text': 'A 34-year-old woman attended our hospital complaining of a palpable mass in the superior lateral quadrant of her right breast. Physical examination revealed a painless and relatively hard, removable mass measuring ~2.6x3.5 cm, with no palpable axillary lymph nodes. Her breast had no nipple discharge, skin ulcers, orange-peel appearance, or nipple retraction. Her medical history included AML (classification: M2) diagnosed 3 years earlier, based on nasosinal space-occupying lesions. She underwent six cycles of chemotherapy with cytosine arabinoside and achieved satisfactory disease control and remission, indicated by postchemotherapy bone marrow examination. The patient had no other symptoms or signs and no relevant family history.\\nA mammogram showed a ~2.5x2.4 cm round mass with well-defined, irregular margins in the superior lateral quadrant of the right breast, 4.5 cm from the nipple, with a thick blood vessel passing through the tumor from the chest wall. Another mass was detected in the inferior lateral quadrant of her right breast, 2.1 cm from the nipple, measuring ~1.4x1.1 cm. Several axillary lymph nodes could be observed on the right side, the largest being ~1.9 cm in diameter (Figure 1). Breast ultrasound clearly demonstrated a hypoechoic mass measuring ~3.7x2.6 cm in the superior lateral quadrant of the right breast (Figure 2). The mass was lobulated with an unclear edge, with numerous low-speed bloodstream signals within and close to the mass (resistive index: 0.60). There was another homogenous, hypoechoic mass below the nipple, measuring ~1.8x1.1 cm in diameter, with a clear edge and an irregular shape. Color Doppler flow imaging showed rich blood supply signals from the surrounding soft tissue. There was a well-defined, hypoechoic nodule ~1.8 cm in diameter within the right armpit. No other focal masses were observed on the ultrasonographic image.\\nA complete blood count demonstrated a white blood cell count of 8.07x109/L, a neutrophil count of 5.81x109/L, the hemoglobin levels of 137 g/L, and a platelet count of 188x109/L. The results of chest radiography and abdominopelvic computed tomography were normal. Fine needle aspiration of the two tumors was performed, and inflammatory cell infiltration and granular calcification with several atypical epithelial cells in the background were identified, suggesting possible malignancy. Considering the differential diagnosis between breast cancer and lymphoma, we performed a bone marrow aspirate examination, which revealed no abnormalities. A lumpectomy was therefore performed under local infiltration anesthesia. The cut surface demonstrated two tumors, well-circumscribed in relation to the adjacent structures. The tumors were ~3x3x2.5 cm and 2x2x2 cm and were located ~0.5 cm apart. Based on the examination of frozen sections, the patient was diagnosed with poorly differentiated malignant tumor.\\nPostoperative paraffin-based histopathology showed dense myeloid cellular proliferation with breast tissue invasion. Immunohistochemical examination demonstrated that the tumor was strongly positive for myeloperoxidase, CD43, and human leukocyte common antigen (Figure 3); weakly positive for CD20, kappa, lambda, and progesterone receptor; and negative for CD79-alpha, CD3, CD38, CD10, CD5, CD56, AE1/AE3, estrogen receptor, and C-erbB-2. The histological features were consistent with breast GS. The patient was treated with four cycles of consolidation chemotherapy postoperatively (12 mg/m2 idarubicin once a day on days 1 and 2, plus 1 g/m2 cytarabine per half a day on days 1-3) and achieved remission. She was followed up by bone marrow aspiration and breast Doppler ultrasound examinations every 3 months and remained in good health at the 1.5-year follow-up.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 74,\n",
       "    'case_id': 'PMC8097002_01',\n",
       "    'case_text': 'A 74-year-old man, in complete remission of a chronic lymphoid leukemia (CLL) after 6 cycles of rituximab and bendamustin (last therapy administrated in December 2019), presented to our emergency unit on April 1st 2020 with asthenia, loss of weight, dry cough and diarrhea since a month. He was otherwise healthy with well-controlled arterial hypertension and type 2 diabetes mellitus. SARS-CoV-2 RNA was detected (7x106 copies/ml) from a nasopharyngeal swab (defined as day 1). Laboratory analyses showed a moderate neutropenia, but severe T (114 cell/mm3) and B (1 cell/mm3) lymphopenia with reduced total immunoglobulin (Ig) G and IgM levels (Supplementary Figure 1A), while inflammatory markers (C-reactive protein and ferritin) were elevated (Figure 1A). Chest computed tomography (CT) revealed bilateral multifocal subpleural and peribronchial ground-glass opacities typical of COVID-19 pneumonia (Figure 1B and Supplementary Figure 2). The clinical condition gradually deteriorated with sub-febrile episodes, persisting dry cough and diarrhea, and progressive weight loss and cognitive dysfunction (Figures 1C, D and Supplementary Information). Inflammatory parameters and blood cell counts remained abnormal (Figures 1A, E), while persisting SARS-CoV-2 infection was confirmed (Supplementary Figure 1B). Complementary investigations excluded other diagnoses (Supplementary Information). No specific antiviral agents were introduced given the mild symptoms of COVID-19 (e.g. absence of hypoxemia).\\nIn summary, the patient developed a long-lasting SARS-CoV-2 infection likely related to his severe immunosuppressive status. Consequently, we hypothesized that convalescent plasma could be beneficial in this particular case, by providing virus-specific neutralizing antibodies as well as a potential anti-inflammatory effect. Plasma units (3x200 ml/donor) were obtained from three selected donors, who had fully recovered from mild COVID-19 disease (Supplementary Information). Each donor presented relatively high IgG antibody titers against the S1 (spike)-protein using Euroimmun ELISA (Supplementary Figure 3A). The first cycle of ABO-compatible plasma transfusion (two units on two consecutive days) was given on days 72 and 73 after diagnosis of SARS-CoV-2 infection, followed by three additional cycles, administered 10 to 15 days apart (Supplementary Figure 3A).',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 31,\n",
       "    'case_id': 'PMC6744724_01',\n",
       "    'case_text': 'A 31-year-old female presented with orthostatic headache and neck pain, exacerbated by standing. The magnetic resonance imaging showed diffuse pachymeningeal enhancement. The CT myelogram revealed a CSF leak at C7-T1 level [Figures 1 and 2]. The target level of the EBP was set to C7-T1. With the patient prone, using CB-CT, the targeted spinal cord level was confirmed. The trajectory for insertion of the epidural needle was documented on reconstructed CB-CT sagittal images. The distance from the entry point on the skin to the spinolaminar line was measured and the epidural needle was advanced up to 10 mm behind the spinolaminar line [Figures 3 and 4]. Once the inner needle was removed, the outer cannula, attached to a syringe filled with saline, was slowly advanced until one could feel a \"loss of resistance\" (e.g., within the epidural space, about 4 mm behind the spinolaminar line). The needle position was then confirmed with biplane epidurography (i.e., documenting the spread of contrast dye evenly and symmetrically) [Figure 5]. Next, about 20 cc of autologous blood was gradually injected through the needle. The patient\\'s symptoms of SIH progressively and rapidly improved. Fourteen months later, the patient was asymptomatic.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 28,\n",
       "    'case_id': 'PMC9845397_01',\n",
       "    'case_text': 'Case 1 is a 28-year-old woman with HoFH receiving low-dose lomitapide combined with apheresis for 8 years. Her initial complaints started with chest pain at 8 years of age. She had undergone coronary artery bypass grafting (CABG) due to severe three-vessel coronary artery disease (CAD) at 10 years of age, when she was diagnosed with HoFH with an untreated LDL-cholesterol level ranging between 490 and 549 mg/dl. Her family history was remarkable for early-onset CAD and high cholesterol levels. She had received weekly or biweekly LDL-apheresis therapy since 10 years of age. As her LDL-cholesterol levels were far from the treatment goals, oral lomitapide 5 mg/dl was introduced on top of atorvastatin (80 mg/day) and ezetimibe (10 mg/day) at 20 years of age. The dose was titrated up to 20 mg/dl and has been maintained without adverse events. An additional 31% LDL-cholesterol reduction was observed in the first month of low-dose lomitapide (5 mg/day) therapy. At a dose of 20 mg/day, the LDL-cholesterol reduction reached 49% at the end of 6 months. As she declined to be weaned off apheresis, we reduced the apheresis frequency and she received low-dose lomitapide (20 mg/day) plus concomitant bimonthly apheresis. However, during the pandemic for 1 year, she could not access apheresis. Throughout the 8-year lomitapide treatment, she did not experience any increase in serum liver enzyme levels, weight loss, or liver steatosis. Moreover, no change was observed in hepatic fibro scans. She followed a fat-restricted diet compatible with lomitapide therapy to prevent steatorrhea, with concomitant supplementation of fat-soluble vitamins and essential fatty acids. Since the commencement of lomitapide therapy, the patient has remained stable at functional class (NYHA-I) without any adverse cardiovascular events.\\nImaging work-up at diagnosis revealed mild aortic stenosis [aortic peak gradient (AoPG) of 30 mmHg-mean (AoMG) 23-18 mmHg] and mild aortic regurgitation with a normal ejection fraction (EF). During the 8-year follow-up, the AoMG was stable at around 25-30 mmHg. In 2022, cardiac catheterization revealed an AoPG of 30 mmHg with normal EF. The computed tomography (CT) angiography showed almost identical coronary and aortal involvement between the baseline (2013) and follow-up (2022) images (Figure 2A). These findings were confirmed by coronary angiography in 2022. Similarly, both the Achilles tendon thickness (ATT) on ultrasonography and carotid intima-media thickness (IMT) significantly decreased with lomitapide treatment. Moreover, the minor soft plaque at the orifice of the right carotid artery became calcified with no progression with lomitapide therapy.',\n",
       "    'gender': 'Female'},\n",
       "   {'age': 33,\n",
       "    'case_id': 'PMC9845397_02',\n",
       "    'case_text': 'Case 2 is a 33-year-old man with a remarkable history related to HoFH. His first symptoms were xanthomas on his ankles and xanthelasma which appeared at 3 years of age. However, he was not diagnosed with HoFH until 20 years of age. He has presented with exertional angina and angiographically extensive ostial coronary stenotic lesions and had undergone CABG accompanied by aortic root dilation at 20 years of age. One year later, he was referred to our lipid clinic for extremely high LDL-cholesterol levels ranging between 420 and 540 mg/dl. Xanthomas were apparent on his elbows, knees, and ankles. He was already prescribed rosuvastatin (40 mg/day) and ezetimibe treatment, and we introduced LDL-apheresis. He lived a 14-h drive from our center; therefore, he receive monthly apheresis. As his LDL-cholesterol levels were still >200 mg/dl post-apheresis, we introduced lomitapide in June 2014, when he was 25 years of age. At the initial dose of oral 5 mg/day, mild nausea was observed. With the up-titrated dose of 20 mg/day, his nausea did not increase; however, after 6 months, he declined to take his pills as he experienced an 8 kg weight loss. For the next 3 years, he continued monthly apheresis but no lomitapide. We re-introduced lomitapide in November 2017 due to persistent LDL-cholesterol levels >500 mg/dl. However, this time he was compliant with the low-fat diet and lomitapide. He did not experience any adverse symptoms or weight loss with an up-titrated dose to 40 mg/day. No alteration was observed in transaminase levels, and a recent hepatic fibroscan was normal. We observed an additional 27% LDL-cholesterol reduction for a 5 mg daily dose of lomitapide at the end of the first month, which increased to 49% at the end of 6 months at a dose of 20 mg daily. The patient has been taking the current dose of lomitapide (40 mg/day) for almost 5 years and concomitant apheresis (every 2-3 months). During the pandemic, his access to apheresis was disturbed for 1 year; however, he maintained his lomitapide therapy. He also received supplementation with omega 3-6-9 and vitamin E. However, he reported several times reasons other than adverse effects for not being adherent to lomitapide therapy. During the follow-up, his coronary lesions and aortic stenosis progressed, and he underwent aortic valve replacement (Benthal operation), carotid endarterectomy, and repeated CABG in 2021. Figure 2B depicts the comparison of 2014 and 2019-DeltaDeltaCT angiograms showing significant progression of calcifications in the aortic root.\\nAccording to the sequencing results, Case 1 was heterozygous for LDLR [c.664T>C, (p.Cys222Arg)], while Case 2 was homozygous for LDLR [c.1760dupG, (p.Ser587ArgfsTer16)]. No clinically significant mutation was found in the APOB, PCSK9, and LDLRAP1 regions in both patients. Additionally, 16 different MTTP variants were detected in the two patients. Cases 1 and 2 shared 2 MTTP variants (rs3816873 and rs1061271). Case 2 also showed one mutation (c.*450A>G) with uncertain clinical significance in public databases, while Case 1 showed 13 mutations (rs11944749, rs17029189, rs11944752, rs17029213, rs17029215, rs2306985, rs2718684 rs34734558, rs41275719, rs7667001, rs881981, rs982424, and rs991811) in MTTP. Twelve of these 13 mutations were categorized as benign/likely benign in public databases; only MTTP c.3G>A (rs11944752) was associated with elevated plasma glucose, insulin (MAGIC Consortium HGVM 4589669), and cholesterol levels.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 55,\n",
       "    'case_id': 'PMC4708069_01',\n",
       "    'case_text': \"A 55-year-old man without any previous comorbidity was admitted to the intensive care unit in Ravenna after a motorcycle accident, in which he experienced sternal and humeral lesions and D4 and D9 vertebral fractures. A hypertensive pneumothorax and a Glasgow Coma Score of 14/15 were also present, accompanied by intracapsular spleen haematoma with multiple fractures of the pelvis. Five days later, empirical therapy with ceftazidime and gentamicin was administered for 18 days. Four days after that, an abrupt onset of fever (temperature >38.5 C) accompanied by clinical features of septic shock appeared (with severe leucocytosis and low platelet count), and the patient was provided vasoactive amines with mechanical ventilation. No hemodialytic treatment was applied. A monolateral purulent pleural suffusion was also present on the right, as demonstrated by tomography, and thoracic drainage was applied, with copious purulent leakage.\\nTwo sets of blood samples were taken for culture via a central arterial catheter as a result of the poor condition of peripheral veins. After 82 hours of incubation (Virtuo system; bioMerieux, Marcy l'Etoile, France), one bottle (anaerobic) showed growth of pleomorphic Gram-positive microorganisms. Identification by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF), performed following standard and rapid procedures, failed several times because no spectra matched with the isolate. Identification was achieved by 16S rRNA PCR amplification and sequencing. BLAST analysis (http://blast.ncbi.nlm.nih.gov) showed 100% identity with C. hongkongensis (strain HKU16, accession no. 115269.1). The metabolic profile was evaluated by API20A (bioMerieux), showing a similar pattern to already published data. The antimicrobial susceptibility testing was performed by Etest and interpreted following European Committee on Antimicrobial Susceptibility Testing criteria (http://www.eucast.org/clinical_breakpoints/). This was hampered by the slow and difficult growth of the isolate, which took over 10 days. The AST results are summarized in Table 1. After 2 weeks, empirical treatment with vancomycin and meropenem was discontinued, and the patient recovered from sepsis.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 28,\n",
       "    'case_id': 'PMC4900306_01',\n",
       "    'case_text': 'A 28-year-old female patient presented with a history of breathlessness on exertion and palpitation for 6 years. On examination, there was pansystolic murmur in the precordium. Her electrocardiogram was normal, and chest X-ray showed no cardiomegaly. Transthoracic echocardiography (TTE) revealed bileaflet prolapse with non-coaptation and posteriorly directed eccentric jet. Left atrium was dilated. Both the ventricles were normal in size and function. She was posted for mitral valve replacement. Intraoperative transesophageal echocardiogram (TEE) confirmed preoperative findings. There was a band like structure seen in the midcavity of left ventricle connecting the two walls (Figure: 1, Video: 1). Mitral valve replacement with 27ATS valve and false tendon (FT) excision was done under cardiopulmonary bypass with moderate hypothermic cardioplegic arrest. However, postoperative TTE showed that the midcavity FT was still intact (Figure: 3). Retrospective interpretation of intra operative TEE images showed the presence of two false tendons. Along with first FT in LV mid-cavity (Figure: 1, Video: 1), a second FT was faintly seen below the mitral valve (Figure: 2, Video: 2) coursing towards the left ventricular outlet. Only the second FT was excised by the surgeon. The patient recovered from the surgery uneventfully.\\nFalse tendons are benign anatomic variants present in 40% of people. When LVFTs are oriented perpendicular to the flow of blood, they vibrate like the strings of an Aeolian harp. These vibrations are seen as fine fibrillations on M-mode images [Figure 3]. Patients with LVFTs are said to have violin heart as they frequently have musical systolic murmurs on precordial examination. Echocardiographically LVFTs can be differentiated from LV thrombus, LV hypertrophy, hypertrophic cardiomyopathy and trabeculations by the presence of echo-free space on both sides of the tendons. LVFTs have systolic laxity and become taut during diastole. LVFT may be cut by the surgeon as in our case or may rupture spontaneously or after an myocardial infarction, after percutaneous trans luminal mitral commissurotomy. Ruptured LVFT must be differentiated from ruptured chordae, vegetations or thrombi.\\nThe presence of LVFT carries both merits and demerits. Its presence can prevent left ventricular (LV) remodeling. However it may be a causative factor in the development of discrete subaortic stenosis (DSS)\\nLeft ventricular false tendons were first described by Sir Turner, a British anatomist and surgeon who proposed that they retard LV enlargement. In dilated cardiomyopathy or after myocardial infarction, LV dilates due to remodelling. Dilated ventricle increases wall stress and leads to LV failure. Increased wall stress also increases metalloproteinase activity that degrades myocardial extracellular matrix causing further LV dilatation. Transverse midcavity LVFTs absorb the distorting forces resulting in less remodelling, less mitral annular dilatation and LVEDD. In patients with dilated cardiomyopathy, Coapsys device (Myocor, inc) is utilized to reduce the LV wall stress. It is a flexible cord that is attached to the LV walls by epicardial pads and contains a cord that traverses the LV cavity anteroposteriorly. It is considered as a prosthetic false tendon. LVFT produces atrial natriuretic peptide(ANP) similar to left atrium when LV filling pressure are increased which promotes natriuresis, diuresis and vasodilatation resulting in reduced LV wall stress. ANP also retards LV remodelling by inhibiting endothelins, angiotensin-II and aldosterone, all of which promote cardiac fibrosis and remodelling. LVFT also produces ANP.\\nDilated and ischemic cardiomyopathy cause functional mitral regurgitation (FMR) by LV remodelling. The papillary muscles are displaced away from the mitral annulus as measured by tenting height and area. Incomplete mitral coaptation occurs due to the traction on the chordae tendinae. Coaptation device or surgical struts help to preserve the subvalvular anatomy and reduce the degree of FMR. In a study conducted by Bhatt et al., transversely oriented LVFTs were found to produce less FMR by having less coaptation depth and area.\\nLeft ventricular false tendons may contain Purkinje fibres, which have a gating mechanism that may inhibit or promote re-entry from ventricular tachycardia. In patients with dilated ventricles, conduction of the electrical impulse through LVFTs may produce a more homogenous LV depolarization similar to biventricular pacing and improve LV dP/dt.\\nThe presence of LVFTs in patients with DSS may add to the flow turbulence across the LVOT. Some surgeons excise LVFTs during DSS excision.\\nIn our patient, there were two false tendons, one was traversing LVOT and it was excised by the surgeon. The transverse midcavity tendon was left intact, which may protect the patient from future possibility of FMR. People with LVFTs may be at evolutionary advantage due to reduced LV remodelling after MI and reduced the degree of FMR.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 27,\n",
       "    'case_id': 'PMC4367057_01',\n",
       "    'case_text': \"A 27-year-old unbooked G3P1L1A1 at 39 weeks 5 days of gestational age with previous one live vaginal birth and one first trimester spontaneous abortion was admitted in the labor room with pain in the abdomen. She had no history of prior antenatal care and belonged to a tribal community with lower socioeconomic status. There was history of tobacco use both before and during pregnancy. She was otherwise healthy with no known history of genetic or congenital anomaly in her family.\\nOn examination, she was observed to be in the second stage of labor with cephalic presentation and regular fetal heart rate. She delivered a term 2.5 kg baby with multiple congenital anomalies. The Apgar score was 3 at 1' and 0 at 5 min. The baby died within 30 min postbirth in spite of resuscitation attempts by neonatologist. On physical examination, the infant showed narrow chest, bilateral hypoplastic thumb, fused lower limbs with a single foot and 5 toes, absent external genitalia, imperforate anus and umbilical cord with single umbilical artery [Figure 1]. There were also prominent epicanthal folds, hypertelorism, downward curved nose, receding chin, low-set soft dysplastic ears and small slit-like mouth suggestive of Potter's facies [Figure 2]. Autopsy was declined by the parents. Intrapartum and the postpartum period of mother was uneventful.\",\n",
       "    'gender': 'Female'},\n",
       "   {'age': 34,\n",
       "    'case_id': 'PMC4367057_02',\n",
       "    'case_text': \"A preterm baby weighing 1.6 kg was delivered vaginally at 34 weeks gestation by a 23-year-old primigravida with an unsupervised pregnancy. Postpartum investigation revealed the presence of diabetes mellitus. There was no history of drug intake and radiation exposure. The Apgar score was 3 at 1' and same at 5 min following which the baby was shifted to neonatal intensive care unit, but died 12 h postbirth due to severe respiratory distress. There was very scanty amniotic fluid drained at the time of delivery. The new born baby had gross anomalies like narrow chest indicating lung hypoplasia, fused both lower limbs and feet with 10 toes, absence of external genitalia, imperforate anus and single umbilical artery [Figures 3 and 4]. Examination of the fused lower limbs showed the presence of all thigh and leg bones thus classifying our patient as Type I of Stocker and Heifetz classification. The infant also had features of Potter's facies including prominent infraorbital folds, small slit-like mouth, receding chin, downward curved nose, and low-set ears. Ultrasonography revealed bilateral renal agenesis. On autopsy, there was an absence of both kidneys, ureters, urinary bladder, seminal vesicle, and urethra. The gastrointestinal system ended in a blind loop at the rectosigmoid area and was filled with meconium. Two pea sized gonads suggestive of testes were seen bilaterally posterior to pubis. Right pneumothorax with collapsed right lung was evident. Examination of brain, heart, liver, adrenal glands, and pancreas revealed normal anatomy.\",\n",
       "    'gender': 'Unknown'}],\n",
       "  [{'age': 39,\n",
       "    'case_id': 'PMC4341321_01',\n",
       "    'case_text': \"Mr. A 39-yr-old male was brought to our OPD with 4 weeks history of talking excessively even to unfamiliar people, being irritable to others, overspending, singing, dancing and reduced need for sleep. There was family history of bipolar disorder in a first degree relative.\\nOn exploration it was reported that he had a manic episode with psychotic symptoms 15 years back and was on lithium prophylaxis till 5 years ago. Four months ago, the patient consulted a psychiatrist with history of excessive sadness, inability to sleep, easy fatiquability, anhedonia, not being able to carry out his job and reduced libido, and was diagnosed to have moderate depressive episode and was restarted on lithium 900 mg/day. Two months ago, as patient did not improve on lithium monotherapy with serum lithium level of 0.7 Meq/litre, opipramol 50 mg/day was added along with lithium. And after 1 month on opipramol treatment patient was brought to us with the current symptoms. Patient's investigations showed serum lithium level of 0.7 mEq/litre and thyroid function was normal. On mental status examination, he was found to be intrusive and overtalkative with euphoric mood. Patient was diagnosed as a case of bipolar affective disorder, current episode being treatment emergent manic switch due to opipramol as per the International Society for Bipolar Disorders (ISBD) criteria and patient was admitted.\\nOpipramol was stopped and patient was continued on lithium 900 mg/day and risperidone titrated up to 4 mg/day. His manic symptoms started resolving by second week and remitted by fourth week and the patient was discharged. The total manic score on Young's mania rating scale was 39 at the time of admission and it dropped to 28, 17 and 6 at the end of first, second and fourth week of treatment, respectively.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': None,\n",
       "    'case_id': 'PMC8267556_01',\n",
       "    'case_text': 'A Japanese boy with healthy non-consanguineous parents was delivered at 39 wk of gestation by emergency cesarean section due to arrest of labor. No fetal distress was observed. The birth height and weight of the newborn were 53.5 cm [+ 2.59 standard deviation (SD)] and 4762 g (+ 4.25 SD) with an Apgar score of 9/10. At 1 h of life, hypoglycemia (11 mg/dL) was detected without symptoms. Despite the initiation of intravenous dextrose, the neonate had persistent hypoglycemia.',\n",
       "    'gender': 'Male'},\n",
       "   {'age': None,\n",
       "    'case_id': 'PMC8267556_02',\n",
       "    'case_text': 'The boy was transferred to our neonatal intensive care unit on the first day of life and managed with intravenous dextrose at a glucose infusion ratio (GIR) of 4-6 mg/kg/min. After initial treatment, he experienced recurrent hypoglycemia and required higher GIR (maximum 12.5 mg/kg/min) to maintain euglycemia. A diagnosis of hyperinsulinemic hypoglycemia was made based on critical samples at the time of hypoglycemia on the first day of life (Table 1) in accordance with the clinical practice guidelines for congenital hyperinsulinism of The Japanese Society for Pediatric Endocrinology. Diazoxide treatment was initiated at 8 mg/kg/d on the first day of life. His blood glucose levels gradually stabilized; therefore, glucose infusion and diazoxide dosage were gradually decreased on day 10 and then weaned off on the 20th day of life. Blood glucose levels remained at 60-70 mg/dL without diazoxide, and he was discharged on the 20th day of life. During hospitalization, there were no findings suggestive of cholestasis. He was treated with phototherapy for jaundice on day 7, which was subsequently resolved. There were no special findings on the physical examination. Genetic testing for congenital hyperinsulinism was performed after obtaining informed consent, wherein all coding exons of ABCC8 and KCNJ11 were amplified by polymerase chain reaction and directly sequenced. The results revealed no pathogenic sequences.',\n",
       "    'gender': 'Male'},\n",
       "   {'age': None,\n",
       "    'case_id': 'PMC8267556_03',\n",
       "    'case_text': \"The child experienced recurrent hypoglycemia at 3 mo of age. Blood test results were as follows: blood glucose, 47 mg/dL; insulin, 2.1 microIU/mL; IGF-1, 16 ng/mL; TSH, 0.743 microIU/mL; free T3, 3.39 pg/mL; and free T4, 1.36 ng/dL. Diazoxide treatment was initiated. The patient was not hypoglycemic, especially during the morning fasting. Convulsion and disturbance of consciousness were not observed. However, hypoglycemia occurred particularly when the patient remained fasting in the morning. Even after restarting diazoxide, the patient was inactive in the morning and blood glucose levels were unstable. Therefore, diazoxide was increased to 15 mg/kg/d. Cornstarch and frequent meals were started as a medical nutrition therapy. Despite the introduction of these treatments, hyperinsulinemic hypoglycemia persisted. We suspected the possibility of syndromic persistent hyperinsulinemic hypoglycemia and consulted a medical geneticist for additional genetic analysis. Peripheral blood samples were collected, and DNA was extracted. Array comparative genome hybridization (CGH) was performed after obtaining informed consent using the SurePrint G3 Human CGH 4 x 180 K Microarray kit (Agilent Technologies, Santa Clara, CA, USA) according to the manufacturer's instructions. The data were analyzed using the Agilent Cytogenomics software (ver 2.9) and the UCSC genome browser (http://genome.ucsc.edu). Chromosomal microarray analysis revealed a 2.48-Mb deletion of chromosome 20p11.23-p11.21, which encompassed FOXA2 (Fig. 1).\\nA combined pituitary stimulation test was performed to evaluate pituitary function at 1 yr 8 mo because his growth rate declined after 11 mo of age, and hypopituitarism with deletion of chromosome 20p11 has been reported. GH stimulation tests revealed severe GHD (Table 2). Magnetic resonance imaging of the brain revealed an ectopic posterior pituitary and pituitary stalk interruption (Fig. 2). Based on these results, GH replacement therapy was initiated at 0.175 mg/kg/wk. At this time, his physical appearance was characterized by a broad forehead and saddle nose that were not clear at birth. After GH replacement therapy, blood glucose levels were approximately 70 mg/dL in the morning fasting period, and his previously noted inactivity resolved.\",\n",
       "    'gender': 'Male'},\n",
       "   {'age': None,\n",
       "    'case_id': 'PMC8267556_04',\n",
       "    'case_text': \"At 6 yr and 4 mo of age, diazoxide was decreased to 5 mg/kg/d (previously, the maximum dosage was 15 mg/kg/d). The patient exhibited no side effects owing to the treatment. A combined pituitary stimulation test has been performed each year, and no central hypothyroidism or central adrenal dysfunction has been revealed. His developmental stage was age-equivalent and normal. Informed consent for publication of this case was obtained from the patient's mother because the patient was underaged.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 41,\n",
       "    'case_id': 'PMC8184239_01',\n",
       "    'case_text': 'A 41-year-old Indonesian male came to our outpatient clinic due to swelling in fingers and toes for the last nine months. He had limitations in activities of daily living. There was no history of shortening of the digits and joint stiffness in the mornings. Upon physical examination, the patient had leonine facies and madarosis. Hypesthetic hypopigmented macules were found on the right side of the back. (Figure 1) Sensory nerves examination revealed glove and stocking hypesthesia. Fingers and toes were swollen, without redness, warmth, and tenderness on the overlying skin. (Figure 2A) The range of motion was limited in the proximal and distal interphalangeal joints of the fingers. Claw fingers, drop wrist, muscle atrophy, or contracture of the hands was not detected. Claw toes, drop foot, muscle atrophy, or contracture of the feet was not found. A slit-skin smear showed a bacterial index of 4.38+ (Figure 3) and a morphological index of 79%. We referred the patient to the Department of Orthopedic and Traumatology to perform synovial fluid aspiration from the interphalangeal joint of the hand (Figure 4A). Acid-fast staining of synovial fluid from the interphalangeal joint of the hand revealed numerous acid-fast bacilli (Figure 4B). Histopathological examination on a hypesthetic macule from the back showed epidermal atrophy with Grenz zone. The dermis was minimally infiltrated with lymphocytes and foamy histiocytes, which confirmed the diagnosis of lepromatous leprosy. Radiographic features showed osteolysis and destruction of some phalanges of the hands, bone erosion and destruction of some phalanges of the feet, as well as destruction and subluxation of some hand joints (Figure 2B). These bone changes were concluded as osteomyelitis. The final diagnosis was lepromatous leprosy, osteomyelitis and chronic arthritis due to leprosy, with hand and foot deformities. The patient received multidrug therapy (MDT) for multibacillary (MB) leprosy. Improvements in swollen fingers and toes were observed within two months after the start of treatment. The patient could move hands more freely to do daily activities. There were no changes on skin lesions.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 25,\n",
       "    'case_id': 'PMC4330689_01',\n",
       "    'case_text': 'A 25-year-old man presented with a history of recurrent UTI. He had undergoing augmentation ileocystoplasty with cutaneous diversion by Mitrofanoff principle for pelvic fracture distraction urethral defect and rectourethral fistula following road traffic accident ten years ago. His physical examination, including per rectal examination, revealed normal findings. The routine investigations were done and revealed normal hemoglobin level, total leukocyte count of 11 x 109/L, and normal findings on renal function tests (serum creatinine, 97.24 mumol/L; and urea 8.93 mmol/L). Further imaging studies such as ultrasonography, X-ray, and computed tomography of abdomen and pelvic showed the massive stone burden in urinary bladder (Figure 1). The urine macroscopic and microscopic examination showed presence of pus cells with white blood cells. The culture and sensitivity report of urinary sample showed growth of Escherichia coli that was highly sensitive to amikacin, gentamicin, cefoperazone, ceftriaxone, imipenem, and ciprofloxacin.\\nPatient was planned for elective surgery after treating the urinary sepsis. He underwent open cystolithotomy under general anesthesia and a total of 42 stones, weighing 1400 g, were removed. Stone were sent for chemical analysis and they turned out to be of struvite type (Figure 2). Postoperative period was uneventful and he was discharged under satisfactory condition. He was followed up on outpatient department basis and was doing well.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 60,\n",
       "    'case_id': 'PMC7876995_01',\n",
       "    'case_text': \"A 60 years-old Caucasian male came to emergency room with diffuse abdominal pain, leukocytosis on blood tests (WBC 19 x 103/mmc) and increased C-reactive protein (120 mg/L). The patient suffered from hypertension and he had a medical history of previous appendectomy and repair of umbilical hernia. Family history was negative for other diseases. He underwent an urgent contrast enhanced CT abdominal scan that showed a dilated stomach with hyperdense material of hematic nature in the lumen. At the level of the pyloric portion we found irregularly thickened walls associated with a small fluid collection and bubbles of free air (Fig. 1). These radiological and clinical findings appeared compatible with diagnosis of complicated peptic ulcer with covered perforation. Because of the worsening of the patient's clinical condition, we carried out an emergency surgery with distal gastrectomy for the large diameter and position of perforation. The procedure was performed by a young surgeon in urgent setting. We decided for a laparoscopic approach with pneumoperitoneum via trans-umbilical open Hasson technique. We used a 12-mm trocar in the left hypochondrium and other two 5-mm trocars respectively in the right flank and in xiphoid region. On exploratory laparoscopy we found a large perforation (about 5 cm of size) in the first duodenum portion (Fig. 2). We converted the procedure to open surgery in consideration of the extension and position of the lesion that did not allow us to continue safely in laparoscopy. We achieved a distal gastrectomy with Roux-en-Y side-to-side gastro-jejunostomy. The patients were satisfied with the treatment received, the postoperative course was uneventful and the patient was discharged on POD 7. The intraoperative findings appeared to be not unequivocal, configuring on the one hand the hypothesis of perforation on a large peptic ulcer or on a chronic pancreatitic process but we could not exclude the presence of a neoplasm by a gastro-duodenal origin. The histopathological examination described, 2 cm from the distal pyloric margin and in the context of the pyloric type mucosa, a centimetric neoformation with histological and immunophenotypic characteristics of well-differentiated neuroendocrine tumor (NET G.1 s. WHO 2019 classification, Synaptofisina + and Chromogranina +). In the adjacent mucosa we saw multiple erosion/ulceration phenomena, with bleeding spillage and vascular congestion. The gastric wall was all affected by outbreaks of chronic inflammation, sometimes in follicular aggregation and with fibrosis also extended to the subserosa. These aspects, in relation to the presence of a NET G1 and multiple erosive/ulcerative areas near the pyloric margin, were suggestive of a clinical picture of Zollinger Ellison syndrome.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 49,\n",
       "    'case_id': 'PMC5315209_01',\n",
       "    'case_text': 'A 49-year-old, right-handed man visited our memory clinic in April 2013 with memory complaints, which were noticed in 2011 by the patient and his family members. His memory disturbances were gradually increasing, frequently making him lose his belongings without noticing and exhibiting severe memory loss. Other personality changes appeared, such as forgetting important promises to his friends, easily confusing the detailed \"must do-lists\" or difficulties in the calculations. Prominent naming impairment combined with hesitation to speak became apparent. Sometimes, he asked other people to repeat their conversations due to his failures in comprehending the talks. Geographic disorientations and visuospatial difficulties were also observed during driving with the family members.',\n",
       "    'gender': 'Male'},\n",
       "   {'age': 14,\n",
       "    'case_id': 'PMC5315209_02',\n",
       "    'case_text': 'The patient was working as a physical education teacher in a middle school, and showed significant impairments and carried out inappropriate decision making and social functions. He could not manage his work as a teacher, for example, creating tests and making decisions at school. Impairments appeared in his daily life activities, such as mistakes in transferring money through telebanking. He presented abnormal behavioral symptoms with an obsessive personality, for example, being stingy with money and also did not allow anyone to spend his money without prior discussions and permission. Patient did not have any medical disease prior to his cognitive decline, and family history was unremarkable since neither his parents nor his siblings showed any cognitive impairment or dementia so far. However, his 14-year-old daughter was mentally handicapped (Figure 1).\\nNeurologic examination did not reveal any focal or lateralizing neurologic deficit. Routine laboratory tests, including blood chemistry, electrolyte, and urine analyses, were normal. Serum Venereal Disease Research Laboratory (VDRL) results, including those for Treponema pallidum particle agglutination assay (TPHA), were negative. Thyroid function tests were normal, as with vitamin B12 and folic acid levels. The patient\\'s apolipoprotein E (APOE) genotype was epsilon3/epsilon3. This patient was diagnosed according to the diagnostic criteria for \"probable AD\" by the National Institute of Neurological and Communicative Diseases and Stroke/Alzheimer\\'s Disease and Related Disorder Association, which were ascertained by clinical features, neuropsycho-logical test, and brain magnetic resonance imaging (MRI) imaging with single-photon emission computed tomography (SPECT). Brain MRI revealed mild cortical atrophy without any ischemic change or other lesions (Figure 2A). Brain SPECT showed moderate hypoperfusion in the frontal, limbic, and temporal areas (Figure 2B). The reduced cerebral blood flow from the images of brain SPECT also supported the AD diagnosis.\\nThe patient underwent comprehensive neuropsychological tests, and he scored 23 out of 30 (2 percentile) on the mini-mental state examination. The subscores for time orientation and seven-serial calculations were 4 out of 5 and 1 out of 5, respectively. The delayed word recall score was 1 out of 3, and he scored 1 out of 3 in the task of clock drawing (Figure 3). His score fell in the abnormal range on the attention task of backward digit span (2.5 percentile). Significant impairment appeared in his confrontation naming ability (<0.01 percentile). Performances in copying the intersecting pentagon test and Rey-Osterrieth Complex Figure test were normal, but his performances on clock drawing were severely impaired (5 percentile). On the Seoul verbal learning test, he was able to recall 13 items (0.02 percentile) in three consecutive immediate recall trials, but only 3 items (0.3 percentile) in the 20-minute delayed recall. Poor visual memory score of 10 out of 36 (1 percentile) was obtained in the delayed recall of the Rey-Osterrieth Complex Figure test. He showed abnormal performances in several tasks of frontal and executive functions, especially in the controlled oral word association test, Stroop test, and trail making test.\\nPatient was diagnosed as probable EOAD, based on clinical assessment, detailed neuropsychological tests, and neuroimaging studies including brain MRI and SPECT.\\nGenetic tests were performed in the patient to evaluate possible mutations. We were unable to make segregation analysis, since all family members and relatives refused the genetic test. The patient declined the genetic test for his children too. None of his family members presented any cognitive decline or dementia phenotypes, but they did not agree in releasing other family information. This patient was included in the Clinical Research Center for Dementia of South Korea study, which screened potential causative mutations in 100 patients with EOAD. Details of the clinical and scientific analyses of EOAD mutations in the Clinical Research Center for Dementia of South Korea study have not been included previously. A detailed clinical investigation of this patient with detailed personal interview, MRI, SPECT imaging data, and bioinformatic analyses are presented.\\nVenous blood samples (5 mL) were collected from the patient with an ethylenediaminetetraacetic acid blood drawing tube. Blood sample was centrifuged at 1,500 x g for 5 min, followed by separation of white blood cells (buffy coat) for its storage at -80 C. DNA was purified using GeneAll Blood Protocol kit (GeneAll Biotechnology, Seoul, Korea), and purified DNA was kept at -20 C until the analysis.\\nA polymerase chain reaction (PCR)-based analysis was performed using primers, as previously described. Targeted potential EOAD genes were as following: APP exons 16 and 17, PSEN1, and PSEN2. Since the diagnosis of EOAD is complicated due to the pathologic overlaps within diverse neurodegenerative disorders, this patient was also screened for progranulin (PGRN), microtubule-associated protein tau (MAPT), and prion (PRNP) genes.\\nThe PCR products were purified using GeneAll Expin PCR kit (GeneAll Biotechnology). Single-strand conformation polymorphism was performed. Samples were mixed with formamide and incubated for 10 minutes at 95 C to generate single-stranded DNA bands. For separation, native polyacrylamide electrophoresis (BioRad, Seoul, Korea) was performed for 21 hours. SYBR Gold (Thermo Fisher Scientific, Waltham, MA, USA) staining was used to visualize the DNA bands.\\nTo confirm the mutation, all PCR products were sequenced with the same primer sets in both directions by BioNeer Inc. (Dajeon, Korea). Before sequencing, we purified the PCR products by using GeneAll PCR kit (GeneAll Biotechnology). Big Dye Terminator Cyclic sequencing was performed with the ABI 3730XL DNA Analyzer (http://eng.bioneer.com/home.aspx; BioNeer Inc.). Sequencing data were screened with DNA BASER (http://www.dnabaser.com) software. Sequence variants were identified by NCBI (http://www.ncbi.nlm.nih.gov/gene) and UniProt (http://www.uniprot.org) databases.\\nMutations were analyzed by PolyPhen-2 (http://genetics.bwh.harvard.edu/pph2/) online in silico prediction program, which predicted the pathogenic nature of missense mutations. PolyPhen-2 used homology search, multiple sequence alignment, profiling, identity-based scores, and structure-based search parameters (such as accessible surface area and hydrophobicity features). These predictions could define the putative role of missense variants and could predict whether they were probably/possibly damaging or benign. PolyPhen-2 also provided the multiple sequence alignment, which compared the homologous sequences from different organisms. Two types of datasets were used for the prediction: HumDiv and HumVar scores. HumDiv was used for testing the pathogenicty of rare alleles, where mildly damaging variants must be treated as possibly damaging. HumVar was used in case of Mendelian disorders, where more damaging alleles should be distinguished from the less damaging ones.\\nWe also analyzed the mutation with SIFT algorithm (http://sift.jcvi.org/), which used several databases such as SWISS-PROT, SWISS-PROT/TrEMBL, and NCBI Protein Database. The software analyzed the possibility on the pathogenic properties of mutations by comparing the mutant and normal variants. SIFT scores of point mutation were calculated for weighting the mutations as possibly damaging allele or tolerated (nondamaging), with a dividing score of 0.05, respectively.\\nProtein structure prediction analysis of PSEN2 was performed by Raptor X program at the University of Chicago (http://raptorx.uchicago.edu). Normal PSEN2 was composed of 488 amino acids, starting at 61 residues and continuing till residue 448. The prediction was performed at Raptor X web server for both normal PSEN2 and R62C mutation. Based on PSEN2 information from the UniProt database, R62C mutation belonged to the topological domain, positions 1-87, including the mutation site. Superimposed images were visualized by Discovery studio 3.5 software from Accelrys.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 40,\n",
       "    'case_id': 'PMC4711340_01',\n",
       "    'case_text': \"Case 1 was a 40-year-old woman, and she underwent a mastectomy and sentinel node biopsy for left breast cancer. Immediately after the surgery, a tissue expander was implanted under the pectoralis major muscle for breast reconstruction. Prophylactic antibiotics (piperacillin, 4 g per day) were administered for 9 days following the surgery, until all drains were removed. On postoperative day 10, the patient presented with a fever of 39.3 C, a diffuse rash on her upper extremities, hypotension, and diarrhea (Fig 1). The site of operation showed no drainage or erythema. We first suspected that the patient's symptoms were due to a viral infection or allergic reaction. Her general condition worsened, and she was admitted to the intensive care unit.\",\n",
       "    'gender': 'Female'},\n",
       "   {'age': 54,\n",
       "    'case_id': 'PMC4711340_02',\n",
       "    'case_text': 'Case 2 was a 54-year-old woman, and she underwent a mastectomy and sentinel node biopsy for left breast cancer. Immediately after the surgery, a tissue expander was implanted under the pectoralis major muscle for breast reconstruction. Prophylactic antibiotics (cefazolin, 2 g per day) were administered for 7 days following the surgery, until all drains were removed. On postoperative day 8, the patient presented with a fever of 40.0 C, a diffuse rash on the upper part of her body, hypotension, and vomiting (Fig 2).',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 60,\n",
       "    'case_id': 'PMC5097962_01',\n",
       "    'case_text': 'A 60 year old man presented to our department with pain and swelling over lateral end of left clavicle (Fig. 1, Fig. 2). The selling was gradually increasing in size since past 4 months. On palpation the swelling was tender, lobulated and hard in consistency. The overlying skin was non adherent and freely mobile. The pain was insidious in onset, non radiating and had no diurnal variations and was aggravated on shoulder movements and relieved on taking medications. The local temperature was elevated and superficial veins were engorged. There was no regional lymphadenopathy and no neurovascular deficit in left upper limb. We got a plain radiograph which revealed which an expansile radiolucent lesion arising from lateral end of left clavicle (Fig. 3). The swelling demonstrated geographic type destruction without any soft tissue component or periosteal reaction. MRI was obtained which also suggested giant cell tumour (Fig. 4). To aid in the diagnosis fine needle aspiration cytology was done which revealed a predominantly cellular lesion having sheets of plump, oval mononuclear cells with mild pleomorphism. The cells had moderate cytoplasm, oval to elongated nucleus with moderate anisokaryocytosis with irregular nuclear membrane. Amongst these cells, many multinucleated giant cells were also which were distributed evenly. Storiform pattern was not seen. FNAC also diagnosed it as a giant cell tumour. The differential diagnosis which were kept in mind are aneurysmal bone cyst, non ossifying fibroma, eosinophilic granuloma and tuberculous osteomyelitis.\\nSince the clavicle does not necessary require reconstruction and the patient was a retired school teacher, not engaged in any physical work so surgical resection of the tumor was planned. After proper investigations and pre anaesthetic clearance, a wide excision of the mass along with 3 cm of the healthy tissue was done (Fig. 5, Fig. 6). The excised mass was sent for histopathological examination which also confirmed it to be a giant cell tumor. No radiotherapy or chemotherapy was given post operatively. Wound healing was uneventful. A post operative x-ray was obtained (Fig. 7). The range of motion of the left shoulder was normal and post operatively there was no neurovascular deficict. The patient was happy with the surgical outcome and at 1 year follow up there was no evidence of recurrence or metastasis.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 25,\n",
       "    'case_id': 'PMC10368104_01',\n",
       "    'case_text': 'A 25-year-old previously healthy man was admitted to a local hospital for progressive hypersomnolence preceded by 1 week of fever and 2 days of headache. General convulsions developed the next day after admission, therefore, he was transferred to our hospital. On examination, his body temperature was 38.6 C, blood pressure 143/94 mm Hg, and he was in a stuporous status with prominent nuchal rigidity and bilateral rales on chest auscultation. His chest X-ray showed patchy consolidation over the right lower lung zone (shown in Fig. 1). The initial brain MRI showed prominent leptomeningeal enhancement at bilateral brainstem, cerebellum, and right cerebral sulci (shown in Fig. 2a, b) and a non-enhanced oval shape lesion at the SCC with increased signals in diffusion-weighted imaging (DWI), low signals in apparent diffusion coefficient (ADC), and hyperintensity in T2-weighted fluid-attenuated inversion recovery (T2-FLAIR) (shown in Fig. 3a-d). The cerebrospinal fluid (CSF) analysis revealed turbid appearance, significantly high pressure (420 mmH2O), lymphocyte-predominant pleocytosis (white blood cells 148/muL, lymphocytes 95/muL), reduced glucose (43 mg/dL), and elevated protein (519 mg/dL). The biochemistry assay was all normal, including sodium, which was 136 mmol/L. The CSF pathogen studies were negative in bacteria, syphilis, fungus, tuberculosis, and virus via multiple polymerase chain reaction (FilmArray Meningitis/Encephalitis). The viral serology surveys including varicella zoster virus, herpes simplex virus, cytomegalovirus, and Japanese encephalitis virus were also negative. Serology detection for M. pneumoniae using rapid immunochromatographic test (Biocard  M. penunoniae IgM kit, Labsystems Diagnostics, Finland) showed IgM positive at a titer of 1:320 (normal value <1:40) on the 2nd admission day, indicating an acute M. pneumoniae infection. Neither polymerase chain reaction analysis nor antibody detection of M. pneumoniae in the CSF was available in our hospital. He was treated with empirical antibiotics, antiviral agents, antiseizure medications, osmotic diuretics, and steroids. Resolution of the pneumonic patch was noted in the subsequent chest X-ray. The repeated CSF analysis 10 days later showed improvement, with a white cell count of 1/muL and a normal protein level at 13.2 mg/dL. However, his neurological condition deteriorated into a comatose state with full-dilated unreactive pupils, flaccid quadriplegia, and ventilator support. The follow-up MRI 3 weeks after admission revealed apparent regression of the leptomeningeal inflammation (shown in Fig. 2c, d), but emergence of symmetric confluent hyperintensities on T2-weighted fluid-attenuated inversion recovery images involving the whole corpus callosum, bilateral internal capsules, and adjacent subcortical areas were without enhancement (shown in Fig. 3e-g). The extensive and symmetric white matter changes on the MRI did not conform to the typical findings in ADEM. Moreover, a nerve conduction velocity study disclosed severe amplitude reduction of compound muscle action potentials and mild reduction in sensory action potentials, compatible with a critical-illness polyneuropathy. Under the presumption of extensive inflammation affecting the central nervous system, we tried immunotherapies with intravenous methylprednisolone pulse therapy and intravenous immunoglobulin successively. His pupil responses recovered rapidly 2 days after completing the immunotherapies, and the consciousness and brainstem reflexes improved gradually within 2 weeks. The ventilator-support was weaned off successfully. The follow-up MRI on the 44th and the 79th admission day displayed continuing regression of the cytotoxic change in the corpus callosum and the white matter (shown in Fig. 3h-m). Three months after admission, he was discharged to a rehabilitation institution with clear consciousness and paraplegia. Six months after discharge, he could speak, eat, and move his upper limbs without efforts but still continued his rehabilitation for the moderate paraparesis.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 50,\n",
       "    'case_id': 'PMC5726742_01',\n",
       "    'case_text': 'A 50-year old male presented to the consulting clinics of a University Hospital with right flank pain since the last 2 months. Family history showed that the mother had bullous lung disease. Moreover about 10 years back the patient presented with complain of shortness of breath and was diagnosed with cystic lung disease and underwent video assisted thoracoscopy (VAT)/apical pleurectomy/pleurodosis. On examination his vitals were stable and systematic examination was unremarkable except there was decrease air entry in middle and lower zone bilaterally. His laboratory test showed anemia and raised C reactive protein. The Computed Tomography (CT) presented ill-defined infiltrating right infrahilar and lower pole renal lesion with a partly exophytic component along with multiple enlarged adjacent centrally located necrotic lymph nodes in the aortocaval and retrocaval locations (Fig. 1) and enlarged mediastinal lymph nodes. Moreover emphysematous changes in the lungs with patchy fibrotic changes and scattered nodularity was found representing sequel of old infection with typical cyst in the lungs bilaterally. A biopsy was performed on the right renal mass that indicated clear cell type renal cell carcinoma with significant lymphadenopathy. Histopathology showed multiple cores comprising of fibro collagenous tissue infiltrated by neoplastic lesion comprising of polygonal cells showing clear to eosinophilic cytoplasm and round to oval hyperchromatic nuclei. Focally, papillary like structure was noted. The lesion was surrounded by lymphocytic population. However, no definite lymphoid was observed. Special PAS stain highlighted abundant intracytoplasmic glycogen in the neoplastic cells. The CT and biopsy findings of renal cell carcinoma in combination with the past history of cystic lung disease and pneumothorax and a positive family history of bullous lung disease suggested Birt-Hogg-Dube (BHD) syndrome. The patient underwent right radical nephrectomy and lymph node dissection which was performed by the urologist. On discharge the patient was referred for chest physiotherapy as he had low lung compliance. Standard of care was given according to institutional policies and intervention according to EAU guideline Two months post- surgery the patient again presented with cough and chest X- ray revealed right pneumothorax. He was admitted for chest tube insertion and was treated for lower respiratory tract infection. His follow up CT three months following radical nephrectomy indicated disease recurrence (Fig. 2). He is being referred for consideration of systemic treatment.\\nThe work has been reported in line with the SCARE criteria.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 26,\n",
       "    'case_id': 'PMC3757911_01',\n",
       "    'case_text': 'A 26-year-old Caucasian male presented to our center with a 1-week history of severe colicky epigastric pain heralded by significant nausea for 3 weeks. He had approximately 20 episodes of bilious vomiting daily with numerous bouts of retching. He admitted to smoking 4 \"joints\" or marijuana cigars every day for the last 2 years, and denied alcohol and tobacco use. He had 4 similar episodes over the last 6 months. During these admissions, he was rehydrated and abdominal imaging revealed no abnormalities. His ongoing nausea was relieved by taking hot showers, of which he took up to 15 times per day, sometimes for more than an hour.\\nHis vital signs were within normal limits and he was found to have mild epigastric tenderness with no peritonism. He was admitted for intravenous fluid rehydration and antiemetics.\\nBlood investigation revealed no abnormalities with his complete blood count and renal and hepatic function. An abdominal computerized tomography (CT) scan revealed no abnormalities. An esophagogastroduodenoscopy and biopsy revealed mild gastritis negative for Helicobacter pylori. His symptoms initially remained refractory to morphine and antiemetics.\\nOver the ensuing 48 hours, his symptoms improved and he was slowly weaned off medication. He had no access to marijuana.\\nThe diagnosis of CHS was made and he was counseled on abstinence from marijuana. Though he refused to enter a substance abuse program, he remained cannabis-free and on follow-up at 1, 3 and 6 months revealed no recurrence in symptomatology.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 71,\n",
       "    'case_id': 'PMC4242899_01',\n",
       "    'case_text': \"A 71 year-old woman had intermittent pyrexia (>38 C) for 1 week in May 2009. Her family doctor treated her with a course of antibiotics to no effect. Computed tomography (CT), cardiac ultrasonography, and tuberculosis skin test detected no abnormalities. General malaise gradually developed, and hemoglobin (Hb) level fell from 10.2 g/dL to 9.0 g/dL over 2 weeks. She was admitted to our hospital as a case of fever of unknown origin. On admission, pyrexia was the only abnormality on vital signs. She was taking no medications other than verapamil and digoxin for paroxysmal supraventricular tachycardia. Meticulous physical examination detected anemic conjunctivae and edema of the bilateral lower extremities. No skin lesions, palpable lymph nodes, or neurological abnormalities were evident. Laboratory findings showed anemia (Hb, 8.8 g/dL) and elevated levels of lactate dehydrogenase (454 IU/L) and soluble interleukin-2 receptor (sIL2-R, 6,030 U/mL). Commonly used autoantibodies and tumor markers for assessment of collagen diseases and cancers were all negative. CT scan revealed no lymphadenopathy, hepatosplenomegaly, or abnormal lung lesions. Gallium scintigraphy showed no abnormal accumulations. Brain magnetic resonance imaging (MRI) revealed a non-enhancing, high-intensity area of 17 mm in diameter in the pons on T2- and diffusion-weighted imaging (Figure 1A and B); however, no abnormal neurological signs were observed. Cerebrospinal fluid examination likewise found no abnormalities. Based on the high sIL2-R level, IVLBCL was suspected. A bone marrow biopsy showed a normocellular marrow with no apparent lymphoma cells. Genetic analysis of the bone marrow specimen showed no clonal rearrangement of T-cell receptor Cbeta1 or the immunoglobulin heavy chain JH region gene. We took healthy-appearing skin randomly from the forearm, lower abdomen, and thigh for biopsy although no skin lesions were observed. All specimens revealed large B lymphoma cells within small veins and capillaries of the subcutaneous fat tissues but not outside the vessels (Figure 2A and B). Immunohistochemical studies showed that lymphoma cells were positive for CD20 (Figure 3), a B-cell marker, and negative for CD3, a T-cell marker. Based on these findings, a diagnosis of IVLBCL was made. The patient's poor general condition required a less toxic regimen, thus conventional R-CHOP therapy, consisting of rituximab (375 mg/m2), cyclophosphamide (750 mg/m2), doxorubicin (50 mg/m2), vincristine (1.4 mg/m2), and prednisolone (60 mg/m2), was started within 1 month of initial symptoms. After the first lumbar puncture for spinal fluid examination, the patient did not accept repeating it due to its invasiveness. For this reason, we treated the patient without any intrathecal treatment. After the first cycle of systemic chemotherapy, the patient had resolution of fever and peripheral edema, as well as improvement in Hb, lactate dehydrogenase, and sIL2-R levels. After eight cycles of R-CHOP therapy, the pontine lesion had completely disappeared (Figure 4A and B). Therefore, the asymptomatic reversible pontine lesion was considered as IVLBCL involvement. During follow-up, the value of sIL2-R had been within reference range. Currently at 5 years after diagnosis, the patient has been doing well with no recurrence and returned to work without any neurological disorders.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 64,\n",
       "    'case_id': 'PMC4379640_01',\n",
       "    'case_text': \"A 64-year-old female with multiple comorbidities of diabetes mellitus, hypertension, hypercholesterolemia, renal impairment, and rheumatic mitral valve disease; had recently undergone mitral valve and ascending aortic aneurysm repair electively, a month prior to her presentation. She presented to our emergency department in acute respiratory distress of a few hour's duration.\\nHer preliminary clinical assessment revealed a distressed morbidly obese woman, unable to lie flat with a low oxygen saturation of 47% on room air. Her vital signs on presentation were: Temperature - 37.1 C; pulse - regular, 129 beat/min.; blood pressure (BP) - 130/88 mmHg; and respiratory rate - 35/min. Chest examination showed decreased air entry bilaterally with scattered crepitations and wheezes. Cardiovascular exam showed normal S1, S2 with mitral regurgitation murmur grade 4/6 heard loudest at left midclavicular fifth intercostals space radiating to the axilla. Jugular venous pressure (JVP) was distended. Her peripheries were edematous and cool, but good capillary refill. Abdominal examination was unremarkable. She had no focal neurological deficit.\\nChest X-ray showed diffuse pulmonary congestion. Electrocardiogram (ECG) showed sinus tachycardia without significant changes. An urgent echocardiography revealed an echogenic mass attached to the posterior leaflet of the mitral valve measuring 2.3 cm x 1.3 cm [Figure 1] with a pulmonary artery pressure of 44 mmHg. The repaired mitral valve was seen in situ with a mean gradient of 12 mmHg with a mild mitral regurgitation. The estimated left ventricular ejection fraction was 60%.\\nHer initial laboratory investigations showed a leukocyte of 26.5 x 109/L, hemoglobin (Hb) - 11.3 g/dl, erythrocyte sedimentation rate (ESR): 75 mm/h, international normalized ratio (INR) - 3.28, urea - 14.4 mmol/l, creatinine: 288 mmol/l, B-type natriuretic peptide (BNP) - 23,300 IU. Multiple sets of blood cultures were sent.\\nThe patient was admitted for stabilization and initially managed conservatively as acute pulmonary edema secondary to acute prosthetic mitral valve thrombus. She was managed with antifailure medication and anticoagulation therapy with heparin.\\nDespite therapy, her clinical condition deteriorated with compromising hemodynamics requiring inotropes. A subsequent echocardiography further showed a severe mitral regurgitation jet. A decision for an emergency redo sternotomy and mitral valve replacement was taken. Intraoperative transesophegeal echocardiography confirmed an echogenic mass on the prosthetic mitral valve with severe mitral regurgitation [Figure 2].\\nDuring surgery, the mitral valve was covered by an apparent layer of fibrinous tissue and old thrombi. There was a large mass on the ventricular surface of the mitral valve [Figure 3]. The annuloplasty ring was dehisced from the posterior leaflet annulus. The mass extended all along the posterior leaflet and was infiltrating into the annulus to the ventricular septal free wall. The valve was not suitable for repair. Full debridement was done and the valve was replaced with a CE Magna ease tissue valve, size 27 mm. She was sent back to cardiovascular intensive care unit (CICU) in a stable condition on minimal inotropic support.\\nIn CICU, empiric antimicrobial therapy (vancomycin and gentamycin) was initiated. A few days later, tissue valve culture report came back as Aspergillus fumigatus. Consequently, therapy was changed to intravenous voriconazole.\\nShe had a protracted, prolonged postoperative period complicated with acute on chronic renal failure requiring renal replacement therapy and subsequent upper gastrointestinal bleeding that was treated conservatively with proton pump inhibitors and blood transfusions. She was discharged in reasonably good condition and doing well afterward.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 29,\n",
       "    'case_id': 'PMC4483173_01',\n",
       "    'case_text': \"On 1 November 2013, a 29-year-old Japanese woman in the 34th week of her first pregnancy began to experience acute vision loss in both eyes, coupled with the appearance of metamorphopsia. She visited our hospital on the following day with bilateral blurred vision with meningismus. The patient's best corrected visual acuity (BCVA) was 0.5 in her right eye and 0.3 in her left eye. The patient had mild iridocyclitis in both eyes. Ophthalmoscopic examination revealed multi-focal serous retinal detachment (Figs. 1 and 2, day 2). The intraocular pressures were 18 mmHg (right eye) and 12 mmHg (left eye). B-scan ultrasonography was not performed, and choroidal thickness was unclear. The patient refused fluorescein angiography. Her blood pressure was 116/60. Based on these clinical findings and the revised criteria for diagnosis of VKH, she was diagnosed with incomplete VKH. We recommended the use of systemic high-dose corticosteroids for the treatment of VKH disease. However, the patient refused treatment because she was worried about adverse effects to the fetus. We therefore administered only topical ophthalmic betamethasone. Because she had rheumatoid arthritis, the patient had been receiving prednisolone 5 mg daily for the past 8 years. The patient had no history of any other medical disorders, including hypertension. She was a non-smoker and did not drink alcohol while pregnant. Her pregnancy had, up to this point, been uneventful. She underwent all routine laboratory and ultrasound tests, and the fetus had developed normally. Blood cortisol levels during pregnancy were not investigated.\\nOn 12 November 2013, the patient returned, presenting with progressive vision loss in both eyes that had begun 4 days earlier. The patient's BCVA was 0.3 in her right eye and 0.2 in her left eye. Ophthalmic examination revealed bullous retinal detachment in both eyes (Figs. 1 and 2, day 12). Intraocular pressures were 10 mmHg (right eye) and 11 mmHg (left eye). However, she continued to refuse treatment. At a subsequent visit on 19 November 2013, she reported visual improvement in both eyes. Ophthalmic examination on that day revealed the disappearance of subretinal fluid from both eyes (Figs. 1 and 2, day 19). Her BCVA was 0.8 in her right eye and 0.9 in her left eye. Intraocular pressures were 19 mmHg (right eye) and 16 mmHg (left eye). On 27 November 2013, she delivered a healthy female baby (gestational age 37 weeks and 5 days, 2294 g) by spontaneous vaginal delivery. The baby's birth weight was low, but not small for her gestational age. A subsequent examination on 1 April 2014 revealed that the patient's BCVA was 1.0 in both eyes, and examination of her fundus revealed typical sunset glow fundus, without subretinal fluid (Figs. 1 and 2, day 152). Intraocular pressures were 14 mmHg (right eye) and 10 mmHg (left eye). She exhibited alopecia and poliosis. After reviewing all of the patient's clinical findings, we diagnosed her with complete VKH. On 11 May 2015, our final meeting with the patient, she did not exhibit any recurrence of VKH. The patient was still receiving 5 mg prednisolone daily for rheumatoid arthritis. Prior to and during her pregnancy, the patient's blood pressure stayed within normal limits, and she never exhibited hypertension.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 63,\n",
       "    'case_id': 'PMC3338239_01',\n",
       "    'case_text': 'A 63-year-old gentleman was scheduled for repair of a 7 cm abdominal aortic aneurysm; his past medical history was significant for chronic hypertension and prolonged tobacco abuse. He had undergone femoral-popliteal bypass surgery just three months prior to this admission. His preoperative vital signs were essentially normal and physical examination was unremarkable. A twelve-lead electrocardiogram showed normal sinus rhythm with non-specific ST-T changes; echocardiography performed two days previously revealed normal-sized ventricles, mild anterior hypokinesis, with normal wall motion, and a left ventricular ejection fraction of 55%.\\nA proposed plan of general endotracheal anesthesia, with invasive hemodynamic monitoring, was discussed with the patient; cell saver services, and four units of packed red cells, were made available for the surgery. After premedication with intravenous midazolam (2 mg), the patient was transferred to the operating suite; routine monitors revealed a baseline BP of 122 / 97 and normal sinus rhythm in the mid 60s. Following preoxygenation and induction with fentanyl (3 mcg / kg) and etomidate (0.2 mg / kg), endotracheal intubation was facilitated with cisatracurium (0.2 mg / kg); general anesthesia was maintained with oxygen : air (50 : 50), fentanyl, and isoflurane (0.4 - 0.8%).\\nAfter left radial artery catheter placement, a 7-Fr percutaneous sheath was introduced via the right internal jugular vein. Using waveform analysis, a balloon-tipped, flow-directed PA catheter was then slowly advanced through the sheath. Right atrial tracing, followed by right ventricular waveform, were duly noted until the catheter tip reached 55 cm, when the EKG monitor suddenly demonstrated asystole; systolic BP decreased precipitously from 110 to < 50 mmHg, and the arterial waveform disappeared. The PA catheter was immediately deflated and withdrawn completely, without any improvement. Cardiopulmonary resuscitation was initiated with chest compressions and intravenous administration of epinephrine (1 mg) and atropine (1 mg). The patient responded to this management in two to three minutes, with a quick return to sinus tachycardia, with occasional premature ventricular contractions (PVCs) and ST-segment depression. An intraoperative cardiac consultation was obtained; the cardiologist recommended urgent cardiac catheterization and rescheduling of the surgical procedure.\\nThe patient was transferred to the Intensive Care Unit, where he continued to do well, and was extubated later that evening. A coronary angiogram performed the following day showed no new pathology; he underwent open repair of the aortic aneurysm three days later without any further incident.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 47,\n",
       "    'case_id': 'PMC4782661_01',\n",
       "    'case_text': \"White, 47-year-old male patient with prior systemic hypertension, had been taking captopril as daily medication. He was referred by the Neurology department because he had presented a clinical picture of anhidrosis over the right hemiface and hemithorax for 25 years, associated with diminished visual acuity in the left eye. Ten years ago it progressed with extension of the area with anhidrosis to the left hemibody and onset of hyperchromatic macule, intense hyperhidrosis involving the lower abdomen, lumbar region, flanks and right lower limb (Figure 1). The Minor's test was carried out to show profuse sudoresis contrasting with the anhidrotic areas (presence of blue color on places where there is sudoresis - Figure 2). Examination of the pupil revealed anisocoria, with the left pupil larger than the right one. At the physical examination no sensitive or motor neurological alterations were observed. The histopathologic test did not demonstrate significant difference in the quantity of sweat glands between the anhidrotic and hyperhidrotic areas, or in the population of melanocytes and melanosomes, revealing absence of pigment leakage.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 84,\n",
       "    'case_id': 'PMC7568180_01',\n",
       "    'case_text': 'Case 1: An 84-year-old Caucasian man was diagnosed with T-LGLL in 2006. He was initially treated with cyclophosphamide and prednisone for cytopenia in 2007 with a durable hematologic response. However, he developed progressive dysphagia, mild dysarthria, and bilateral ptosis in July 2017, more than ten years after completion of the treatment for T-LGLL. Work-up showed elevated AChR binding antibodies level of 8.35 nmol/L (normal <0.4 nmol/L), AChR blocking antibody with 57% inhibitor (normal <26%), and AChR modulating antibody 88% binding inhibition (normal <45%). No antibodies to the muscle-specific kinase were found. Neither a Tensilon nor EMG was performed. A CT scan of thorax did not show thymoma or an enlarged thymus. Flow cytometry of both peripheral blood and bone marrow showed abnormal T-cell population co-expressing CD3+/CD8+/CD57+/ TCRab+ consistent with the diagnosis of T-LGLL. Clonality studies revealed positive TCR beta/gamma gene rearrangement. In addition to pyridostigmine 60mg TID, he was placed on prednisone 60mg TID for MG and then transitioned to cyclophosphamide 100 mg QD, with the resolution of his neurological symptoms. Follow-up evaluation in March 2019 revealed persistent low titer of AChR binding antibody level of 0.7 nmol/L, stable hematologic parameters and the absence of neurological symptoms.',\n",
       "    'gender': 'Male'},\n",
       "   {'age': 64,\n",
       "    'case_id': 'PMC7568180_02',\n",
       "    'case_text': \"Case 2: A 64-year-old Caucasian male with a history of resolved right sided Bell's palsy twenty-four years previously, presented with a three-month history of dyspnea on exertion, dysphagia, fatigable dysarthria, and right fatigable ptosis. Initial labs showed severe anemia with a hemoglobin of 6.1g/dL and mild leukopenia. Dyspnea on exertion improved after a blood transfusion. Pulmonary function testing was not done. Peripheral flow cytometry revealed a small population of CD3+/CD57+/TCRab+ T cells. The clonal origin of cells was confirmed with positive TCR beta/gamma gene rearrangement studies. Subsequent bone marrow biopsy revealed infiltration of marrow with T- LGLL. Neurologic workup showed elevated AChR binding antibody level of 75 nmol/L (normal <0.3 nmol/L) without enlarged thymus on CT. A MRI brain was normal. Tensilon testing and EMGs were not done due to the rapid improvement of symptoms. He was initially treated with methotrexate and then oral cyclophosphamide 100 mg QD and prednisone 40mg QD. Six weeks later, his neurologic symptoms resolved. Three months later, his hemoglobin normalized. He completed six months of therapy with cyclophosphamide and prednisone. Subsequently, he was placed on mycophenolate mofetil per neurology without any recurrence for at least four years. Repeat MG panel testing after five months showed a low titer of AChR binding ab of 3.9 nmol/L, AChR blocking antibody with 37% inhibitors, and AChR modulating antibody 46% binding inhibition.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 80,\n",
       "    'case_id': 'PMC6691664_01',\n",
       "    'case_text': \"This is a case report with literature review. Informed consent was obtained from the patient for publication. An 80-year-old gentleman was referred to our eye unit for assessment of bilateral cataract. His past medical history included type 2 diabetes and seropositive rheumatoid arthritis controlled by sulfasalazine. The corrected distance visual acuity (CDVA) was 20/25 in the right eye (OD) and 20/50 in the left eye (OS). Slit-lamp examination showed bilateral grade 3 nuclear sclerotic cataract (based on the Lens Opacities Classification System III) with no other ocular abnormality detected. He underwent an uneventful phacoemulsification with intraocular lens implant and was started on topical prednisolone 1% TID, ketorolac 0.5% TID and chloramphenicol 0.5% TID postoperatively. Topical ketorolac was started postoperatively to reduce the risk of macular oedema after cataract surgery in view of the history of diabetes.\\nAfter 1 week, the patient presented to the eye emergency department with an acute left eye pain and hand movement vision. Slit-lamp examination showed a left inferior, noninfiltrated, crescentic corneal melt with epithelial defect, spanning 4-8 o'clock position (away from the temporal primary corneal incision), with a small Seidel-positive corneal perforation and flat anterior chamber. There was severe corneal punctate staining in the left eye and mild punctate staining in the right eye, suggestive of underlying DED. A left emergency corneal suturing and reformation of anterior chamber was performed. All postoperative drops, such as topical preservative-free sodium hyaluronate 0.2% Q2H, levofloxacin 0.5% Q2H and dexamethasone 0.1% BD, were discontinued. Oral prednisolone 40 mg was started in view of the possibility of peripheral ulcerative keratitis associated with the underlying seropositive rheumatoid arthritis. On the next day, there was a mild persistent leak at the perforated site, which warranted a corneal gluing using cyanoacrylate glue (Histoacryl; B. Braun Medical Ltd, Sheffield, UK) and insertion of a bandage contact lens (BCL). Bilateral lower lid punctal plugs were inserted. Blood tests, including the inflammatory markers, were all normal. The oral prednisolone was stopped after 2 days as there was no convincing evidence of vasculitis or peripheral ulcerative keratitis and the corneal melt was likely attributed to DED. No flare-up of rheumatoid arthritis was reported.\\nAfter 1 week, the anterior chamber had successfully reformed. However, the corneal glue and BCL spontaneously dislodged after 2 weeks, resulting in a recurrent pinpoint corneal wound leak with iris plugging. He underwent a repeat corneal gluing and the eye stabilized within a week with a formed anterior chamber. CDVA was 20/50. The cornea successfully re-epithelialized under the glue 2 months later (Figure 1), and the BCL and glue were subsequently removed. The patient complained of ongoing grittiness and discomfort in the left eye. Slit-lamp examination showed mild meibomian gland dysfunction with right moderate and left severe inferior/central corneal punctate staining consistent with uncontrolled DED. The tear breakup time was 6 s, corneal sensation was normal and Schirmer's test (with topical anaesthesia) was 0 mm/5 min in both eyes. All the inflammatory and serologic markers for Sjogren's syndrome were negative, except for a moderately raised rheumatoid factor (53.1 IU/ml; normal: 0-14). Topical preservative-free sodium hyaluronate 0.2% Q2H, lacrilube nocte, cyclosporine 0.1% nocte and an 8-week tapering regime of prednisolone 0.5%, starting from QID, were given. Bilateral lower lid punctal plugs were re-inserted. Two years after cataract surgery, the DED had improved significantly, with the left eye remaining settled with an inferior corneal scar (Figure 2a and b) and a CDVA of 20/30 (-3.25/+3.75 x 70).\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 60,\n",
       "    'case_id': 'PMC4276086_01',\n",
       "    'case_text': 'A 60 year-old-man with a positive fecal occult blood test was diagnosed with early rectal cancer and underwent endoscopic mucosal resection at another hospital. Pathological findings showed well-differentiated adenocarcinoma with submucosal invasion(SM; 3500 mum), lymphatic infiltration (ly1), and no venous invasion (v0). A horizontal and vertical cut margin was negative (Fig. 1). According to the Japanese Society for Cancer of the Colon and Rectum (JSCCR) 2010 guidelines for the treatment of colorectal cancer, the patient underwent laparoscopic low anterior resection with D2 lymphadenectomy. Final pathological findings revealed no residual tumor cell in the rectum and one metastasis in regional lymph nodes (1/15).\\nThe patient received postoperative adjuvant chemotherapy with uracil-tegafur (UFT) plus leucovorin for six months. Two years after radical rectal surgery, a metastasis in left lung was detected by computed tomography (CT). No metastases were detected in other organs. The patient underwent thoracoscopic partial pulmonary resection. Pathological findings revealed metastatic tubular adenocarcinoma in the lung and the surgical cut margin was negative.\\nSix months after pulmonary resection, the patient experienced left sided myodesopsia, examination for which showed a white and yellow choroidal mass. CT scan of the brain demonstrated a metastatic lesion in the left eye (Fig. 2a and b). A repeat CT scan of chest demonstrated the presence of multiple metastases in both lungs (Fig. 3a and b). No other metastatic lesions or recurrences were detected. The patient elected to undergo radiotherapy for his choroidal metastasis. After radiotherapy (45 Gy/25 fr) to the left eye, bevacizumab + CapeOX (capecitabine + oxaliplatin) was initiated for 18 months and bevacizumab + FOLFIRI was continued for 9 months until the time. The patient has survived for 2 years and 3 months without signs of recurrence in the left eye and is receiving ongoing systemic chemotherapy for multiple lung metastases.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 40,\n",
       "    'case_id': 'PMC6130174_01',\n",
       "    'case_text': \"A 40-year-old male presented with a 3-year history of sensory changes involving the S2-S3 distribution in the right leg (e.g., hypoesthesia without motor weakness or dysuria). The lumbosacral MRI showed a noncontrast enhancing right-sided cystic mass at the S2-S3 level; it had the same intensity as CSF on both the T1- and T2-weighted images [Figure 1]. Coronal fat-suppressed T2-weighted images revealed the mass likely originated from the right S3 nerve root and was additionally compressing the right S2 nerve root [Figure 2].\\nA laminoplastic laminotomy was performed at three levels using an ultrasonic bone curette. At surgery, the S3 nerve root was enveloped within cyst wall and the S2 nerve root was clearly compressed [Figure 3a and b]. Partial resection of the cyst wall and imbrication of residual tissue was performed [Figure 3c]. An inlet from the subarachnoid space was identified, and its obliteration was confirmed by a Valsalva maneuver [Figure 3d]. This subarachnoid connection was sealed with adipose tissue and fibrin glue [Figure 3e]. Plication of the cyst wall was performed with nonpenetrating titanium clips (Vascular Clip System; LeMaitre Vascular Inc., Burlington, MA) [Figure 3f]. No postoperative CSF leakage occurred, and spinal lumbar drainage was not warranted. The patient's preoperative sensory disturbance resolved. The postoperative MRI showed a reduction in the cyst's size [Figure 4a and b] and no residual compression of the S2 nerve root [Figure 4c]. Histopathological examination confirmed collagen connective tissue without nerve fibers, findings consistent with a Tarlov cyst [Figure 5]. The patient remained asymptomatic 6 months later, and the 6-month postoperative sacral MRI demonstrated no cyst recurrence.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 5,\n",
       "    'case_id': 'PMC7393219_01',\n",
       "    'case_text': 'We present the case of M., a child affected by a congenital disorder of the primary visual pathway, specifically retinal dystrophy (Leber Congenital Amaurosis), diagnosed at the age of 5 months on the basis of a poor vision from birth, abnormal eye movements, macular atrophy attenuated retinal vessels, and severely reduced scotopic and photopic electroretinogram and abnormal Visual Evoked Potentials (De Laey\\'s criteria). He was enrolled in our re-habilitation intervention since his first admission at our clinic (9 months of age). At admission, we performed clinical and instrumental evaluations (i.e., electrophysiological exams, EEG, and brain MRI) to specifically define the visual impairment and investigate possible comorbidities and syndromic forms of retinal dystrophy. Neurophthalmological examination showed sluggish pupillary reactions, nystagmus, roving eye movements, and a deficit of fixation and pursuit that improved with the addition of sound; fundus oculi examination confirmed the presence of macular atrophy and attenuated retinal vessels; no refractive errors were also reported. Binocular grating acuity (Teller Acuity Cards) testable only at the distance of 38 cm, was of 0.60 cy/deg, revealing severe perceptual deficit with residual close-up visual acuity; contrast sensitivity, evaluated with Hiding Heidi Low Contrast Face Test, was also altered (close-up response only for high contrast stimuli). Oculo-digital signs such as \"eye-pressing\" were present. Central Nervous System involvement was excluded, along with other comorbidities. A panel gene testing confirmed the diagnosis of inherited congenital non-syndromic retinal dystrophy involving NMNAT1 gene.\\nNeurological examination was normal except for mild aspecific hypotonia, frequently described in severely visually impaired children. The child had good relational competences and attention span for his age, with some degree of emotional stress, expressed through motor hyperactivity and emotional lability, probably due to the necessity to adapt to the environmental requests. Head control and sitting position were acquired, rolling over was rarely observed and improved with the aid of auditory stimulus. Reaching and grasping of objects were performed only with audio-tactile integration, and subsequent occasional integration of visual information. The child functionally used both hands and showed a preference for specific textures. Neuropsychomotor development, evaluated by Reynell-Zinkin Scale (RZS), was characterized by a slight decline in the area of environment exploration and expressive language.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 65,\n",
       "    'case_id': 'PMC4118727_01',\n",
       "    'case_text': 'A 65-year-old male patient presented with a painless, polypoidal lesion over the tongue, rapidly grown over a period of one month. Physical examination revealed a non-tender, non-ulcerated pedunculated exophytic mass arising from the right lateral border of the tongue. The mass was adherent to underlying structures. The patient did not have a history of pre-existing SCC or radiation therapy, and there was no regional lymphadenopathy. Clinical diagnosis of lingual SCC was made. An excisional biopsy was done and sent for histopathological examination.\\nGrossly, the mass was 2 x 2 x 1 cm polypoidal, grey-white, and hard in consistency. The cut surface was grey-white solid homogeneous [Figure 1]. Microscopic examination revealed a tumour composed of proliferating atypical bipolar spindle cells and small nests of squamous epithelial cells [Figure 2]. Malignant spindle cells, arranged in fascicles [Figures 3 and 4], formed the main bulk of the tumour. The cells had increased nuclear-cytoplasmic ratio with round to oval nuclei and prominent nucleoli and a moderate amount of eosinophilic cytoplasm. In between, the spindle cell numerous proliferating capillaries and inflammatory cells were also noted. At a few foci, small nests of malignant squamous epithelial cells and epithelial pearls were seen [Figure 5]. The tumour showed surface ulceration and areas of haemorrhage. The lesion was diagnosed as spindle cell neoplasm. On immunohistochemistry, vimentin was strongly positive in the spindle cell component [Figure 6] and negative in the epithelial component. Cytokeratin was focally positive in spindle cell component [Figure 7] and strongly positive in the epithelial component [Figure 8].',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': None,\n",
       "    'case_id': 'PMC3447225_01',\n",
       "    'case_text': \"The patient is the son of nonconsanguineous parents of Turkish origin. Family history revealed only familial hypercholesterolemia in the mother's family. After an uneventful pregnancy, the child was born at term with a birth weight of 2,315 g and a birth length of 47 cm. At birth, a partial cleft left lip and a complete cleft right lip and palate were found. The patient had several surgical corrections during the first 18 months of life.\",\n",
       "    'gender': 'Unknown'},\n",
       "   {'age': 3,\n",
       "    'case_id': 'PMC3447225_02',\n",
       "    'case_text': 'At the age of 3 6/12 years the patient was referred because of the presence of a moustache. Height was 101.7 cm (+0.5 SDS) and weight 15.5 kg (-0.1 SDS). After an initial catch-up growth between birth and the age of 2 years, height followed the +0.5 SD-line, in agreement with target height of 183.2 cm (+0.4 SDS). Bone age, according to Greulich and Pyle was 4.0 yrs. Pubertal score according to Tanner was A1P1G1, with only some downy pubic hair, a testicular volume of 2 mL and penile length of 4.7 cm (-0.9 SDS). There was no sebaceous skin. Blood pressure was 110/60 mmHg. Except the moustache with dark pigmented hair all over the upper lip (Figure 1) and the scars of the cleft lip operations, physical examination was normal. \\nHematological parameters and serum electrolytes were within normal limits. Early morning levels of adrenocorticotropine (ACTH: 26.8 pmol/L [<22 pmol/L]; normal levels between [  ]), adrenal androgens (dehydroepiandrosterone 7.6 mmol/L [<1.2 mmol/L]; androstenedione 1.26 nmol/L [<0.9 nmol/L]); as well as of 17-alpha-hydroxyprogesterone (72.7 nmol/L [<1.0 nmol/L]) were elevated. Serum concentrations of cortisol (491 nmol/L) and testosterone (<0.15 nmol/L) as well as plasma renin concentration (31.2 ng/L) were normal. After a 0.25 mg intravenous bolus of tetracosactide (Synacthen), cortisol levels increased slightly to 596 nmol/L, whereas 17-alpha-hydroxyprogesterone levels increased to 140.8 nmol/L [<6.0 nmol/L]. Baseline and stimulated 17-alpha-hydroxyprogesterone levels were compatible with NCAH according to the nomogram of New et al..',\n",
       "    'gender': 'Unknown'},\n",
       "   {'age': None,\n",
       "    'case_id': 'PMC3447225_03',\n",
       "    'case_text': \"Genomic DNA was extracted from peripheral lymphocytes of the patient and his mother after informed consent. The father was not examined. The CYP21A2 gene, encoding for the 21-hydroxylase enzyme, was PCR amplified in two segments as described by Ohlsson and Schwartz using Expand Long Template PCR System (Boehringer Mannnheim). PCR products were visualized on a 1% ethidium bromide stained agarose gel and purified with JET quick from Genomed. The two segments were sequenced in both directions, using an Applied Biosystems 310 automated DNA sequencer ABI Prism and BigDyeTM terminator Cycle sequencing Ready Reaction Kit from AB Applied Biosystems, according to the manufacturer's specifications. The obtained sequences were compared to the normal sequence, and in the patient 2 mutations were found: R132C in exon 3 and R339H in exon 8 (Figure 2). The observed mutations were confirmed by resequencing (R132C) or by restriction analysis (R339H). A PCR product of 296 bp was obtained by the following primers: R339H-F: 5'-TTGCTGAGGGAGCGGCTGGA, and R339H-R: 5'-AGCCTAGACACCCCTGGGTT, spanning the site of the R339H mutation. The mutation destroys a ApaI restriction site, while the normal sequence is cut into two fragments of 144 + 153 bp. The normal sequence has a ApaI site 144 + 152 bp. Restriction of the PCR product from the patient confirmed the heterozygosity, showing both 296 (mutant) + 144 + 152 (wild-type) (Figure 3). The mother was heterozygous for the R132C mutation, but did not carry the R339H mutation.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 61,\n",
       "    'case_id': 'PMC4939985_01',\n",
       "    'case_text': 'A 61-year-old man with a history of smoking was diagnosed with left lung cancer and mediastinal lymph node metastases. From May 2013 to December 2014, the patient was treated with erlotinib hydrochloride targeted therapy, two regimens of chemotherapy, and thoracic radiation therapy at a dose of 4,020 cGy/5 f/1 wk. In March 2015, disease progression was observed in the left lung and humerus lesions; thus, radiotherapy was administered at a dose of 3,600 cGy/12 f/3 wk. In July 2015, he was transferred to our hospital. Further examinations, including nuclear magnetic resonance imaging of his head, pathological examination, and positron emission tomography-computed tomography were conducted, showing multiple metastases in his brain, lymph nodes, liver, spleen, adrenal gland, and humerus (Figure 1A-E). A pathological analysis of the liver biopsy revealed a moderate-low differentiation squamous cell carcinoma with necrosis. The tumor exhibited the following immunohistochemical characteristics: CK5(+), p40(+), CK7(-), CK20(-), TTF-1(-), Napsin A(-), CDX2(-), CK19(+), and GPC3(-).\\nAfter integrated consideration and informed consent, we concluded that palliative treatment was appropriate. Anti-PD-1 antibody was a suitable choice. At the request of the patient for further treatment, we administered nivolumab, in an effort to control the advanced disease and prolong survival and quality of life. Nivolumab was administered at 3 mg/kg for 1 hour, once every 2 weeks, as a total of three infusions from August 6, 2015, to September 4, 2015. On the second day after the first infusion, the patient developed an intermittent fever, with a maximum body temperature of 39.6 C, and the routine blood examination showed that his white blood cell count had increased to 15.72x109/L with 96.8% neutrophil granulocytes and the C-reactive protein had elevated to 156 mg/L, which indicated a severe infection (grade 3, National Cancer Institute Common Terminology Criteria for Adverse Events 3.0). Bacterial and fungal cultures of sputum showed Acinetobacter baumannii and Candida albicans infections. Then, meropenem (0.5 g q8h) and fluconazole (200 mg qd) were administered intravenously on August 8, according to drug sensitivity tests. After treatment with antibiotics, further bacterial and fungal cultures of sputum were conducted on August 16 and were negative for A. baumannii and C. albicans. The white blood cell count had decreased to 9.0x109/L and the C-reactive protein had dropped to 65 mg/L, suggesting that the infection was controlled. As a result, meropenem and fluconazole infusions were discontinued. Subsequently, the patient had a fever every other day, which was relieved each time by administration of dexamethasone. He experienced mild hemoptysis of ~10 mL of blood on September 11 and slightly blood-stained sputum on the following 3 days. We gave him hemostasis and coagulation. Moreover, the patient had a progressive aggravation of thrombocytopenia (platelet count dropped to 28x109/L), although it was normal before the therapy. Chills, cough, sputum expectoration, and shortness of breath were observed after each antibody infusion. These symptoms were alleviated through anti-infection therapy with meropenem and fluconazole, as well as dexamethasone. A chest computed tomography examination revealed that the treatment was effective and the lung lesions had shrunk after the therapy (Figure 1F), but the patient passed away on September 26 without other severe symptoms.\\nCellular immunity was monitored during the treatment. The proportion of lymphocyte (Lym) subpopulations, including T, B, natural killer (NK), regulatory T (Treg), cytotoxic T Lym (CTL; CD3+CD8+CD28+), and suppressor T Lym (Ts; CD3+CD8+CD28-), and the expression of several immunoregulatory molecules (inhibition and activation), including CD25, CD28, CTLA-4, PD-1, Foxp3, TGF-beta, and IL-10 in the peripheral blood, were analyzed (Figure 2A and B). Of the Lym proportions, NK cells and Ts were significantly upregulated and CTLs were moderately downregulated, whereas the other Lyms did not vary notably during the observation. The expression of CD25, CD28, CTLA-4, PD-1, and IL-10, but not of Foxp3 and TGF-beta, reduced after the first infusion and then rebounded sharply after the second infusion. The Human Ethics Committee of the Affiliated Hospital of the Academy of Military Medical Sciences approved the case report and the patient provided written informed consent.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 62,\n",
       "    'case_id': 'PMC9133385_01',\n",
       "    'case_text': 'A 62-year-old woman was admitted to the neurology department of Tianjin Huanhu Hospital. The patient complained of paroxysmal falls accompanied by impaired consciousness for the last nine days and paroxysmal limb twitch accompanied by gibberish speech for four days. Initially, the patient experienced tonic-clonic seizures, accompanied by impaired consciousness. Later, the patient experienced tonic seizures with head turning to the right and retained consciousness similar to faciobrachial dystonic seizures (FBDS) (Supplementary Materials S1). These incidences occurred more than ten times in a day. The patient was first seen in another hospital, and a brain MRI was done. The MRI showed no abnormalities. The patient was started on sodium valproate, diazepam, and levetiracetam (drug doses unknown). Due to no clinical improvement, the patient was referred for further management. The patient had no previous history of hypertension, coronary heart disease, diabetes, cerebrovascular disease, mental illness, hepatitis, tuberculosis, and no family history of any hereditary disease.\\nOn admission, the patient had a body temperature of 36.3 C, a heart rate of 91 beats/min, a respiratory rate of 20 breaths/min, and a blood pressure of 162/85 mmHg. The neurological assessment revealed that the patient had cognitive dysfunction (poor memory and poor calculation ability). However, other categories of the neurological examination, including cranial nerves, motor system, reflexes, sensation, coordination, movement, gait, and signs of meningeal irritation, were normal.\\nThe serum testing of routine blood tests, coagulation profile, liver function and kidney function tests, blood sugars, lipid profile, and serological testing for hepatitis B, syphilis, and HIV were negative. In addition, the results of anti-nuclear antibodies, antineutrophil cytoplasmic antibodies, rheumatoid factors, thyroid-stimulating hormone receptor antibodies, anti-thyroglobulin antibodies, and serum tumor markers, including carcinoembryonic antigen, squamous cell carcinoma antigen, cytokeratin-19 fragment, carbohydrate antigen 199, carbohydrate antigen 125, and neuron-specific enolase were normal. The patient had abnormal serum chloride levels of 95mmol/L. Further, the serum AE-related antibodies determined with both tissue-based and cell-based indirect immunofluorescence (IIF) assay in V-Medical Laboratory (Guangzhou, China), including anti-N-methyl-D-aspartate receptor (NMDAR), anti-leucine-rich glioma-inactivated 1 (LGI1), anti-contactin-associated protein-like 2 (CASPR2), anti-gamma-aminobutyric-acid B receptor (GABABR), anti-dipeptidyl-peptidase-like protein-6 (DPPX), and anti-glutamic acid decarboxylase 65 (GAD65) and paraneoplastic neurological syndrome (PNS)-related antibodies including anti-Hu, anti-Ri, anti-Yo, anti-Ma2, anti-CV2, and anti-amphiphysin, was remarkable only for positive anti-LGI1 antibody with a titer of 1:16 (normal <1:10). The CSF showed slight leukocytosis of 10 x 106 / L with lymphocytic predominance. However, the pressure, color, turbidity, glucose levels, chloride levels, Gram staining, acid-fast staining, ink staining, metagenomic next-generation sequencing (mNGS), AE-related antibodies which were also determined with both tissue-based and cell-based IIF assay in V-Medical Laboratory (Guangzhou, China), and PNS-related antibodies of the CSF were normal. The patient had a positive RPR with a serum titer of 1:16 and a positive TPPA. Subsequently, TPPA and RPR in CSF were tested, and both results were positive.\\nThe electroencephalography (EEG)showed irregular slow waves with medium to high amplitudes in the right temporal lobe, which spread to the other lobes and showed sharp waves (Figure 1). The brain MRI showed increased signals on T2-weighted and FLAIR imaging in the medial temporal lobe (Figure 2A). The gadolinium-enhanced MRI of the brain showed mild to moderate cord enhancement in the right temporal lobe (Figure 2B). Syphilis can cause multiple system damage. Therefore, magnetic resonance angiography (MRA) was carried out to investigate vascular stenosis or vasculitis-like changes. However, the results revealed no abnormalities (Figure 2C). Moreover, CT of the chest, echocardiography, abdominal ultrasound, urinary tract ultrasound, electromyography, and nerve conduction velocities of the limbs were normal.\\nTherefore, uncertainty arose as to whether the patient had both anti-LGI1 encephalitis and NS or whether the LGI1 antibody and LE manifestations were due to the NS. The patient received intravenous penicillin sodium 3.5 million units every 4 h for 14 days to treat the NS. Furthermore, the patient was initiated on intravenous sodium valproate 400 mg two times daily and oral levetiracetam 500 mg two times daily. The drugs were then changed to oral sodium valproate 500 mg two times daily and oral levetiracetam 750 mg two times daily. Improvement was noted with no convulsions and normal cognitive function. Two months later, the serum TPPA was still positive. In addition, the serum RPR was still positive with a titer of 1:8, while the serum LGI1 antibody was positive with a titer of 1:10. Furthermore, a revaluation of the CSF showed that the CSF TPPA and RPR were positive. However, the other CSF tests remained negative. In addition, a repeat of the EEG showed no epileptiform wave emission (Figure 3). Moreover, a repeat of the brain MRI showed no abnormality (Figure 2D). A second course of intravenous penicillin G sodium 3.2 million units every 4 h for 14 days was started. After another four months, the serum TPPA was still positive, the serum RPR test was positive with a titer of 1:8, while the serum LGI1 antibody was negative. Changes in TPPA, RPR, and LGI1 antibodies during the syphilitic treatment are shown in Figure 4. A repeat of the EEG and brain MRI showed normal findings. The third course of intravenous penicillin G sodium 3.2 million units every four hours, was given for 14 days. In addition, oral doses of sodium valproate 500 mg two times daily and levetiracetam 750 mg two times daily were continued. The patient was then followed up for additional three months. The patient reported no further convulsive episodes. In addition, the memory and calculation ability were noted to be normal.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 35,\n",
       "    'case_id': 'PMC8355995_01',\n",
       "    'case_text': 'A 35-year-old, para 2, Afro-Caribbean woman, with no significant past medical history, presented on several occasions with abdominal pain during early pregnancy. An ultrasound (USS) scan was performed at 11 weeks gestation to exclude an ectopic pregnancy, which demonstrated a singleton viable intrauterine pregnancy with 2 small cervical fibroids (<4 cm) and a small amount of free fluid in the pouch of Douglas (Figure 1). A diagnosis of fibroid red cell degeneration was determined as an explanation for the abdominal pain. A routine anomaly USS was performed at 20 weeks which was unremarkable (Figure 2).\\nDue to ongoing episodes of abdominal pain, an abdominal USS was performed at 21 + 4 weeks gestation which demonstrated normal abdominal and pelvic organs and an intrauterine gestation with anhydramnios. On referral to the obstetric team, a bedside USS performed was unable to identify the fetus.\\nA subsequent USS was performed in the fetal medicine unit, which proved challenging due to severe oligohydramnios and uterine fibroids. The fetus could be identified and was noted to be lying laterally in the pelvis.\\nInitial management for preterm rupture of membranes was implemented; however, an USS 2 days later demonstrated an empty uterus with the fetus situated near the liver.\\nThe patient was referred for an urgent MRI which confirmed the diagnosis of suspected abdominal pregnancy (Figure 3).\\nThe patient was transferred to a tertiary center for specialist multidisciplinary management at 22 + 1 weeks gestation, with access to interventional radiology services. She was extensively counselled regarding her options for conservative management or surgical termination of the pregnancy. This included discussions with the neonatal team regarding fetal outcomes at extreme prematurity as well as obstetric and anesthetic input regarding maternal risk of major hemorrhage. The patient remained committed to the pregnancy and was admitted for observation.\\nAt 24 + 4 weeks gestation, the patient collapsed with clinical signs of acute intraabdominal bleeding. A laparotomy performed revealed 2 liters of hemoperitoneum. The placenta was embedded at the left cornua, continuous with the left fallopian tube and ovary, and adherent to the omentum.\\nThe baby was identified extrauterine and delivered alive but in poor condition. Placental tissue continued within the myometrium; therefore, the left cornua were excised and the uterus repaired, with a blood loss of 4000 ml. Postnatally, the woman was managed in ICU and discharged on day 12. Sadly, the baby died at 24 hours of age.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 41,\n",
       "    'case_id': 'PMC4742477_01',\n",
       "    'case_text': 'A 41-year-old secundigravida with normal thyroid function, referred with 34 weeks of gestation after ultrasound exam showed a suspected fetal goiter, which proved to be a solid anterior neck mass with uniform vascularization throughout, particularly in the central region (Fig. 1). Three-dimensional ultrasound in rendering mode clearly showed the neck mass. The subsequent ultrasound showed macroglossia and increased cardiac area and amniotic fluid volume. Fetal MRI was conducted and corroborated the diagnosis of goiter (Fig. 2). Cordocentesis was recommended to assess thyroid function and fetal karyotype because of the maternal age and macroglossia, but the parents opted not to perform the invasive procedure. We then opted for conservative management with strict ultrasound monitoring because the findings suggested fetal goiter associated with hyperthyroidism (central vascularization of the mass in color Doppler and early onset of ossification nuclei, as well as cardiac failure). The ultrasound monitoring showed modest increase in the size of neck mass (34 weeks, 66x35x29 mm; 35 weeks, 70x23x35 mm; 37 weeks, 76x30x45 mm), always the vascularization was evident throughout the mass, mainly in the central zone. The cardiothoracic ratio was slightly elevated, ranging from 0.61 to 0.55.',\n",
       "    'gender': 'Unknown'},\n",
       "   {'age': 0,\n",
       "    'case_id': 'PMC4742477_02',\n",
       "    'case_text': \"The birth occurred with 38 weeks of gestation by cesarean section. The newborn, a male, weighing 3,445 g, had Apgar scores of 6/8, atypical face shape, and a solid mass in the anterior neck region. The karyotype performed on the umbilical cord blood was normal. The newborn initially had generalized hypotonia, was intubated, and received mechanical ventilation for eight days. Thyroid function tests performed on the second day after birth were normal. Anteroposterior chest X-rays showed slight cardiomegaly. There were no signs of heart failure and no need for vasoactive drugs during hospitalization. The patient's respiratory condition progressively improved, and he was weaned off the mechanical ventilator and then discharged at 22-days-old.\",\n",
       "    'gender': 'Male'},\n",
       "   {'age': 1,\n",
       "    'case_id': 'PMC4742477_03',\n",
       "    'case_text': 'In the early neonatal period (three days) the mass was confirmed by ultrasound exam as an asymmetric goiter and its measurements were 61x40x33 and 45x34x24 mm to the right and left lobes, respectively. At the end of the first month, the respective measurements were the followed: 46x29x37 and 40x33x33 mm to the right and left lobes, respectively. Ultrasound monitoring showed progressive decrease in the size of the thyroid, reaching normal dimensions at six months after delivery. Currently, the infant is one year old, and the function and volume of thyroid gland are normal.',\n",
       "    'gender': 'Unknown'}],\n",
       "  [{'age': 54,\n",
       "    'case_id': 'PMC9852504_01',\n",
       "    'case_text': \"A 54-year-old male, a ceramic worker with no previous history of immune dysfunction, was admitted to the hospital with persistent fever for 19 days. The patient had a cough occasionally and joint soreness but denied any other symptoms. On initial clinical evaluation, the patient's body temperature was 38.4  C, and other signs were within normal limits. Pulmonary, abdominal, cardiac, and neurologic examinations showed unremarkable findings. Laboratory tests revealed that the patient had leukocytosis (20.72 x 109/ml) with 87.4% neutrophils. His C-reactive protein level was high (90.61 mg/L), and a procalcitonin level was slightly increased (0.173 ng/ml). Contrast-enhanced chest CT revealed a large mediastinal mass measuring approximately 7.76 x 4.55 cm (Figure 1A). The rest of the examination was regular.\\nAt initial admission, the patient was treated with empiric antibiotic therapy, including piperacillin and sulbactam. However, he still had a recurrent fever, and there was no significant improvement in inflammatory indicators and blood routine examination. To determine the etiology, the patient underwent Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) on the fifth day of admission. The Virtual bronchoscopic navigation (VBN) system is a method to guide the bronchoscope to the lesion by making a bronchial path on a virtual image. The digitized information from the patient's CT scan was imported into the Archimedes VBN system, in which multislice views of the chest and virtual bronchoscopy images were reconstructed. The VBN system shows the bronchial tree, the anatomical structure of the mediastinal mass and visualizes the best path to reach the mediastinal mass (Figures 2A-E). With the guidance of the VBN system, the bronchoscope was navigated to the target bronchus and advanced to the lesion, and then EBUS-TBNA was performed to obtain purulent exudate (Figures 3A-D). Biopsy showed more purulent secretions and a few lymphocytes and macrophages (Figure 4A). Microscopic analysis revealed numerous weakly acid-fast and branching filamentous rod bacteria were identified from the samples on the aspirate smear, and a presumptive microbiological diagnosis (Nocardia) was made (Figure 4B). Metagenomic next-generation sequencing (mNGS) subsequently identified the pathogens as Nocardia species (Nocardia arizonensis and Nocardia cyriacigeorgica). And after seven days of culture, the cultures of purulent exudates ultimately grew the Nocardia species (Figure 4C).\\nAfter microscopic examination and mNGS confirmed Nocardia, intravenous imipenem/amikacin was given. The clinical symptoms of the patient were significantly improved after 6 days of treatment. Then he was switched to intravenous imipenem with oral trimethoprim/sulfamethoxazole (TMP/SMX, 80 mg of TMP, and 400 mg of SMZ/tablet) 3 tablets q6h. One month after treatment, the patient improved, and their Chest CT showed a decrease in the size of the mediastinal mass (Figure 1B). He was discharged and continued to be treated with oral TMP/SMX 3 tablets q8h and sodium bicarbonate for 3 months. Over the next 3 months, he continued on oral TMP/SMX 2 tablets q8h and sodium bicarbonate. After six months of treatment, the patient was asymptomatic. His CT showed significant improvement in the mediastinal mass size (Figure 1C). At one and a half years of follow-up, the patient recovered well, and no complications were noted (Figure 1D).\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 72,\n",
       "    'case_id': 'PMC9597005_01',\n",
       "    'case_text': 'A 72-year-old non-smoking African American woman, with no personal or family history of cancer, was diagnosed with squamous cell carcinoma of the right maxillary sinus in 2012 and was initially treated with transoral resection. The cancer recurred in 2015 and the patient underwent right total maxillectomy including resection of the right orbital floor with reconstruction, and right neck dissection. She was staged as pT3N0 with positive margins and perineural invasion. PD-L1 tested in the primary tumor by IHC (using Dako 22C3 pharmaDx antibodies) was 70% by tumor proportion score. Tumor DNA analysis by the FoundationOne platform (Foundation Medicine, Cambridge, MA, USA) measured a tumor mutation burden (TMB) of 9, two TP53 mutations and a BRCA1 mutation, among others (Figure 1(c)). Genetic evaluation was negative for any inherited genetic abnormalities.\\nFollowing surgery, she underwent adjuvant radiochemotherapy with 66 Gray and weekly cisplatin. Follow-up imaging demonstrated progression of metastatic cancer with lesions in the mediastinum, lung, and liver. The patient started palliative chemotherapy with weekly carboplatin and paclitaxel but progressed after 6 months with increased number and size of the metastases including a 3.5 cm mediastinal mass, a 3.8 cm left lower lobe (LLL) mass, and multiple liver masses measuring up to 5 cm (Figure 1A). Given her recurrent and metastatic status with progression on a platinum-based regimen, she was recommended palliative treatment with single-agent pembrolizumab (given at a dosage of 200 mg/m2 every 3 weeks) and began treatment in October 2016.\\nAfter the third administration of pembrolizumab, the patient presented to an outside hospital with a vesicular skin rash associated with severe neuropathic pain and pruritis of the left lower extremity from the thigh down to the shin in a L4-L5 dermatomal distribution. The patient was not vaccinated against herpes zoster virus (HZV). Given the typical clinical presentation (unilateral vesicular skin rash in a restricted dermatomal pattern associated with severe neuritis), the patient was diagnosed with herpes zoster infection and was prescribed valacyclovir. After 7 days of treatment, the skin lesions and pain continued leading to extension of valacyclovir treatment. Given the acute viral infection, pembrolizumab was held. The vesicles gradually improved, but the patient had persistent pain and ultimately developed new open wounds. She was admitted in the hospital where Infectious Disease and Dermatology services were consulted. A biopsy was performed, which was consistent with pyoderma gangrenosum. This was considered to be an isomorphic reaction related to the previous zoster infection. The patient was started on treatment with prednisone. She gradually recovered and prednisone was tapered over 2 months.\\nFollow-up computed tomography (CT) scans performed 1 month after the diagnosis of herpes zoster infection (going along with discontinuation of pembrolizumab application) showed improvement in all targeted metastatic lesions. At this time, the mediastinal mass measured 2.7 cm, the LLL mass was replaced with an area of consolidation, and the liver lesions sizes decreased with the largest now measuring 1.7 cm (Figure 1(a)). After another 4 months, the skin lesions healed, and plans were made to resume immunotherapy due to concerns for tumor progression during the long treatment break. Repeated imaging, however, demonstrated stable tumor disease, and as the patient was recovering with limited performance status, resumption of ICI treatment was paused in favor of close imaging monitoring.\\nFollow-up CT scans were obtained after another 3 months and demonstrated further decreased sizes of the lung and liver lesions and no measurable disease in the mediastinum or LLL. At this time, the largest liver lesion measured 1.1 cm. On this basis, the decision was made to continue active surveillance and resume treatment only upon progression. From then on, imaging was repeated every 3-4 months, and at the 1-year post-treatment scans a complete disappearance of mediastinal and liver lesions was observed, beyond that the residual LLL lesion was considered atelectatic.\\nIn February 2019, concerns for recurrence in the LLL were raised due to the increase in size of the lung lesion with increased metabolic activity on a positron emission tomography scan. However, the patient still was completely asymptomatic. Two lung biopsies, one transbronchial and one transthoracic, were found to be completely negative for tumor cells; on the contrary, only signs of an acute inflammation (first biopsy) as well as a chronic inflammation (second biopsy) were detected. Further follow-up imaging showed that the lung lesion decreased in size to baseline, and the associated metabolic activity had resolved spontaneously. The patient remains in complete imaging remission to date, now 5-year post-treatment (Figure 1(a)). Circulating tumor mutations have been monitored using the Guardant360 platform (Guardant Health, Redwood City, CA, USA) over the last 4 years and the patient continues to present a circulating TP53 clone, although the percentage has been slowly decreasing (Figure 1(b)).',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 5,\n",
       "    'case_id': 'PMC8683245_01',\n",
       "    'case_text': 'We present a 5-year-old female child who was symptomatic since the early neonatal period with skin lesions, intermittent painless vaginal bleeding, and breast enlargement. For these complaints, the parents took the child to the nearby health facility, but they were reassured. Compared to her peers, her growth in length was fast since her early childhood, but she had poor weight gain. At the age of 3 1/2 years, she presented to an orthopedic clinic with bowlegs for which she was seen and sent home without any intervention. But after one week, she had a trivial fall down accident, and she sustained pathological fractures on both upper and lower extremities. Plaster of Paris (POP) cast was applied for the lower left arm, and open fixation with plate was done for the left femur.\\nDuring the procedure, tachycardia was detected, for which she was investigated and diagnosed to have hyperthyroidism. She was initially put on propylthiouracil (PTU) and propranolol. After eight months of the procedure, there was displacement of the plate. The orthopedic surgeon decided to revise the operation, but the thyroid function was not controlled for which she was referred to a paediatric endocrinology clinic for better management of hyperthyroidism.\\nOn physical examination at the paediatric endocrinology clinic, she was emaciated. Her weight was 16 kg (between 10th and 25th percentiles) and her height was 115 cm (on the 95th percentiles). Weight for height was far less than 5th percentile (underweight), based on CDC growth charts. Her pulse rate was 123 bpm, and she had protruded eyes. CAL spots were noticed on her face, neck, and trunk (Figure 1(a)). There was a 5 cm by 3 cm anterior neck mass with an irregular surface (Figure 1(b)). There was also breast enlargement. She had a grade III early systolic murmur best heard at the left upper sternal border. There was swelling and tenderness at the right midshaft of the humerus and short POP on the left lower arm. She had a wide gait. Based on her clinical findings, she was diagnosed to have MAS.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 64,\n",
       "    'case_id': 'PMC3420475_01',\n",
       "    'case_text': \"A 64-year-old male presented with fatigue, bilateral leg swelling, and a painful lower extremity rash for one month. Examination revealed 1 to 5 millimeter macules that were tender, violaceous, and nonblanching. The patient had no history of recent infections, new medications, or other systemic complaints. Treatment of the rash with topical steroids was not successful.\\nComplete blood count, creatinine, liver enzymes, urinalysis, prothrombin time, partial thromboplastin time, thyroid function tests, and lactate dehydrogenase levels were all within normal limits. Hepatitis B and C serologies and human immunodeficiency virus tests were negative. Antinuclear antibodies and subsets, rheumatoid factor, and antineutrophilic cytoplasmic antibodies were negative. Erythrocyte sedimentation rate was 47 mm/hr, C-reactive protein was 1.8 mg/dL, beta-2 microglobulin was 3.1 mg/L (0-3 mg/L), C3 was 139 mg/dL, and C4 was 18.8 mg/dL (20-47 mg/dL). Serum cryoglobulins were present at 14%. Quantitative serum immunoglobulin testing showed an elevated IgM of 1770 mg/dL, and serum viscosity was normal at 1.56. A skin punch biopsy revealed leukocytoclastic vasculitis with cryoglobulin deposits (Figure 1). Computed tomography of the chest, abdomen, and pelvis was normal as was a bone marrow aspirate.\\nTreatment for presumed essential mixed cryoglobulinemia with oral prednisone 40 mg and azathioprine 150 mg daily resulted in only a partial response, and attempts at tapering steroids were unsuccessful. The lack of response after two months of therapy prompted further testing including a serum protein electrophoresis which revealed an IgM kappa monoclonal gammopathy (0.7 gm/dL). Electrophoresis of the cryoglobulin precipitate was then performed which revealed an IgM kappa monoclonal gammopathy (5.98 gm/dL) consistent with type 1 cryoglobulinemia. At our request, a repeat bone marrow aspiration was performed which demonstrated a 1% abnormal population of monoclonal B cells consistent with early Waldenstrom's macroglobulinemia. Treatment with four weekly doses of rituximab 500 mg IV resulted in a gradual resolution of the rash coupled with a decreased IgM kappa to 0.2 gm/dL within three months, and prednisone was subsequently tapered off.\\nAfter six months of remission, macules reappeared on the lower extremities but did not respond to a second course rituximab and steroids. Other unsuccessful therapies included methotrexate, two cycles of bortezomib 1.3 mg/m2 IV, and a combination of melphalan, thalidomide, and prednisone. After being lost to follow up for one year, he was admitted with lower extremity ulcerations secondary to worsening cutaneous vasculitis and received solumedrol 80 mg IV daily plus plasmapheresis. Quantitative cryoglobulins decreased from 17.5% to 2%, and the patient improved clinically. Anticoagulation was also initiated for a right lower extremity deep venous thrombosis. He was readmitted eight months later for infected cutaneous ulcers and severe sepsis that necessitated intravenous antibiotics and surgical debridement. As a result of sepsis, he developed new-onset renal failure requiring chronic dialysis. Presently, the patient continues to receive periodic plasmapheresis for cryoglobulinemic vasculitis.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 65,\n",
       "    'case_id': 'PMC6350017_01',\n",
       "    'case_text': 'A 65-year-old male, with a past medical history of glaucoma, cataract, squamous cell carcinoma of the right eyelid, hyperplastic polyp and hyperlipidemia, was diagnosed with Rai stage 0 CLL by absolute monotypic B-cell lymphocytosis >5 x 109/L on normal peripheral flow cytometry, in the year 2000. He did not have any high-risk markers, with CD38 negative disease that showed del 13q on fluorescent in situ hybridization (FISH) and normal beta-2-microglobulin (B2M) as well as lactate dehydrogenase (LDH). He remained asymptomatic and under observation for several years but was noted to have rapidly increasing lymphocytosis, progressive lymphadenopathy, symptomatic splenomegaly and thrombocytopenia in 2015 (Table 1 and Figure 1). Bone marrow biopsy revealed hypercellular marrow with diffuse involvement by lambda light chain-restricted small lymphocytes occupying 95% of the marrow space. First-line treatment was planned with obinutuzumab (1000 mg) and chlorambucil as per standard guidelines but the patient never started chlorambucil due initially to a concern of tumor lysis syndrome from significant disease burden, and later due to development of prolonged neutropenia and thrombocytopenia on obinutuzumab alone. The dose of obinutuzumab was reduced by 20% for cycle 4 and he was given daily G-CSF for three days after the obinutuzumab dose for that cycle only. After completion of six planned cycles of single-agent obinutuzumab, the patient achieved partial response (PR) to therapy as measured by greater than 50% reduction in absolute lymphocyte count (ALC) and splenomegaly as well as a platelet level greater than 100 x 109/L, as per iwCLL guidelines. Disease was detectable as minimal residual disease (MRD) only, by CLL specific MRD peripheral flow cytometry 0.37%, 2 months after completion of treatment, without residual blood, spleen or lymphadenopathy detected. His CLL remained stable over the next 2 years with only slight increase in lymphocytosis. Approximately two-and-a-half years after initial treatment, thrombocytopenia and rapid increase in lymphocytosis were noted (Table 1 and Figure 1).\\nA repeat flow cytometry confirmed monoclonal B-cell population along with an upward trending ALC, confirming disease relapse. A repeat FISH once again showed a 13q deletion. Retreatment was initiated due to worsening fatigue and concern for infections as Absolute neutrophil count (ANC) was trending downward. After discussing several treatment options, a shared decision of reintroducing obinutuzumab was taken based on the prolonged initial response of over 2 years with this as a single agent. Lymphocyte count normalized after only one cycle of retreatment and the patient eventually achieved partial response again per the same iwCLL guidelines. Grade 2 IRR was noted at initial treatment but not at retreatment while grade 2 neutropenia and thrombocytopenia were noted at initial as well as retreatment with obinutuzumab. The patient continues to follow up 1 year after the relapse for surveillance and provided informed consent for reporting.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 7,\n",
       "    'case_id': 'PMC4629570_01',\n",
       "    'case_text': 'At the Wild Animal Park Planckendael of the Royal Zoological Society of Antwerp, an adult, male Asiatic lion, 2.7 years old, was found dead in his inside enclosure without preceding clinical abnormalities. Gross post-mortem examination revealed a normal body condition with a body weight of 140 kg and the following salient findings: anaemic mucosae; 10 litres of blood in the abdominal cavity; pale-coloured pancreas and spleen; multiple nodular lung masses (a few mm to 10 cm diameter, filled with blood clots) (Fig. 1); multiple (2 mm - 8 mm diameter) kidney cysts (filled with clear transparent liquid); multiple liver nodules (a few mm to 10 cm diameter, filled with blood clots, some with grapelike appearance, others were ruptured) (Fig. 2). An additional macroscopic finding, i.e. an extensive proximal diaphyseal new bone formation on the right humerus, was identified later after the preparation of the skeleton at the Royal Belgian Institute of Natural Sciences in Brussels. No anomalies were detected in any other organ.\\nA set of tissue samples (liver, lung, spleen, kidney, bronchial lymph node) was collected and fixed in 10% neutral buffered formalin, embedded in paraffin, sectioned at 4 mum, and stained with haematoxylin and eosin and Prussian blue for histologic examination. Immunohistochemistry was performed on 4-mum sections using Factor VIII-related antigen or von Willebrand factor (vWf) (polyclonal rabbit antibody, reference A0082, Dako, Glostrop, Denmark) and the platelet-endothelial cell adhesion molecule or cluster of differentiation 31 (CD31) (monoclonal mouse antibody, Clone JC70A, reference M0823, Dako, Glostrup, Denmark). External positive controls for the immunohistochemical stainings were spleen from a pig for vWf and mesenteric blood vessels from a dog for CD31. Internal controls consisted of normal endothelial cells in the examined tissues. No non-specific staining was observed in any of the slides.\\nIn the liver, there were multifocal areas where the normal architecture was lost and most of the parenchyma had been replaced by non-encapsulated, poorly demarcated, infiltrative and moderately cellular masses. The masses were composed of loosely arranged streams and poorly defined capillary-like channels, supported by a moderate amount of eosinophilic stroma and occasionally large vascular channels, filled with variable amounts of blood (Fig. 3a). Neoplastic cells were mainly polygonal to spindle shaped, with indistinct cell borders, moderate amounts of eosinophilic cytoplasm with a round to oval, centrally placed nucleus with a finely stippled chromatin pattern and 1 nucleolus. There was moderate anisokaryosis and anisocytosis. Mitotic figures ranged from 1 to 4 per high power field. There were larger areas of haemorrhage and necrosis. The neoplastic cells labelled strongly positive for vWf and CD31 (Fig. 3b). In the lung similar neoplastic foci were observed, which also labelled positive for vWf and CD31. There was mild fibrosis of the renal capsule. There were no neoplastic lesions in the kidney. The capsule of the spleen showed focal mesothelial cell proliferation without signs of neoplastic masses in the spleen. In the bronchial lymph node, and especially in its subcapsular sinuses, there was a multifocal mild infiltration of macrophages. Many of those macrophages had an intracytoplasmic accumulation of a yellowish-brown granular pigment. Prussian blue staining confirmed the pigment as haemosiderin. Other macrophages showed erythrophagocytosis. The lesion in the humerus, detected during the preparation of the skeleton, was not examined histopathologically.\\nTissue impression smears of bronchial lymph node, liver, lung and also of the abdominal blood were made for bacteriological examinations. Giemsa stain, Gram stain and Ziehl-Neelsen stain were all negative. Cultivation on tryptone-soya-agar and blood agar demonstrated no growth of bacteria.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 30,\n",
       "    'case_id': 'PMC10352529_01',\n",
       "    'case_text': 'A woman about 30 years old, with no systematic health issues and non-smoker, consulted the Odontology Department of University Hospital Center of Montpellier (Montpellier, France) to manage aesthetic damages due to congenital missing lateral incisors. After being well informed of every alternative treatment, the patient consented to be treated with an orthodontic treatment associated with delayed implant fixed crowns and provided written informed consent.\\nTreatment initially involved mesializing the canines to open up the spaces and reshaping the cuspids with ameloplastia. The choice of opening spaces was required after an accurate clinical radiographic analysis. Indeed, the patient presented several diastemas as well as a mesioposition of canines before orthodontic treatment (Figure 1). In addition, the patient had asymmetry in her wisdom teeth with agenesis of tooth number 16, therefore, excluding the possibility of mesialising molars (Figure 2). Finally, the cephalometric analysis showed a skeletal Class III (angle ANB = 1 ) as well as a normodivergence with a tendency to hypodivergence (angle FMA = 23 ) (Figure 3). Because of the sagittal skeletal relationships, the solution of opening spaces was selected. Mediation of the canines in place of lateral incisors was performed, and canines were rehabilitated with implants. This solution does not accentuate the negative overjet already present in Class III patients. A 2-year multibracket orthodontic treatment in the vestibule area closed the diastemas by repositioning the incisors with maximum bimaxillary anchorage.\\nAt the end of the orthodontic treatment, prosthetic and bone spaces were sufficient for the placement of 6 and 11 implants. A subtractive coronoplasty was realized to make up the canines as lateral incisors. During this treatment, lingual rehabilitation was performed to perpetuate the results. Ultimately, a retention was performed to maintain the spaces before the implants were placed. At the end of the orthodontic treatment, patient was addressed to the Implantology Department to restore edentulous spaces with implant-supported crowns.\\nUpon extraoral examination, the patient presented an average smile line with visibility of her interdental papilla and partial edentulous spaces in canine area (Figure 4).\\nOn intraoral examination, a healthy periodontal status with a thick maxillary phenotype presenting gingival pigmentations was observed. Restorative spaces were about 7.5 mm and were maintained with fixed retainers and maxillary removable resin injected retainer in canine area (Figure 5).\\nRegarding the panoramic radiography realized at the end of the orthodontic treatment, canines\\' root axes were divergent, reducing mesiodistal bone space. But root axes were parallel to bicuspid ones, making the implant placement easier (Figure 6).\\nA pre-operative computed tomography was performed to analyze ridge dimensions for implant placement surgery. The mesiodistal bone spaces were about 7 mm in canine position 6 and 6 mm in position 11. On both sides, alveolar crest was narrow (7 mm) and presented a buccal undercut (Figure 7).\\nThe patient, with no contraindications to surgery, was informed that a ridge augmentation could be necessary during the surgical phase to avoid vestibular fenestration, and narrow implants have been chosen to fit the ridge width and maintain a minimum of 1.5 mm peripheric bone around implant.\\nImpressions of the maxilla and mandible with irreversible hydrocolloid (Alginoplast , Kulzer Mitsu Chemicals Groups, Hanau, Germany) were practiced, and the diagnostic setup for the final restoration was made in order to prepare a composite injected resin tray as interim restoration (Figure 8). Careful attention was taken to maintain space between gingiva and tray, in order to avoid healing interactions.\\nDuring surgery, full thickness flap was raised, and two implants were placed with an insertion torque of more than 30 N cm (3.1 x 10 mm; Eztetic , Zimmer Biomet, Palm Beach Gardens, FL, USA) on the region of teeth numbers 6 and 11. Because of the underestimated alveolar ridge dimension visualized on the computed tomography, guided bone regenerations were not indicated and vestibular fenestration have been avoided. Surgical healing screw (CCNSP, Zimmer Biomet, Palm Beach Gardens, FL, USA) was placed on each implant, and operative sites were primarily closed using resorbable sutures 4.0 (Vicryl , Ethicon) (Figure 9).\\nResin tray immediate interim rehabilitation was placed to ensure patient\\'s cosmetic satisfaction and maintain edentulous space during early healing process (D + 15). After that, a removable partial denture was placed for 3 months, until osseointegration.\\nMucogingival management during second stage implant surgery was performed after osseointegration, and healing collars were placed at the same time (CHCNP33, Zimmer Biomet, Palm Beach Gardens, FL, USA).\\nBecause of a lack of keratinized tissue (KT) around implant number 6, a connective tissue graft using envelope flap technique was performed in this site using crestal harvesting to avoid changing gingival pigmentations (Figures 10 and 11).\\nIn implant site number 11, a simple incision allowed the placement of the healing collar. The two surgeries were practiced at the same time, and control visits were realized at 2 weeks and 3 weeks (Figures 11, 12, and 13).\\nAt D + 21 after second stage implant surgery, the maxilla was impressed using open-tray procedure and dual-mix technique with silicones of different viscosities. First, healing collars were removed, and direct transfers were placed using retaining screw (CHCNP33, Zimmer Biomet, Palm Beach Gardens, FL, USA). Then, light silicone was charged around transfers, and a tray filled with heavy silicone was inserted in the upper jaw. After impression time, transfers were unscrewed and trial disinserted. Finally, implant analogs (CIANP, Zimmer Biomet, Palm Beach Gardens, FL, USA) were screwed to direct transfers into the impression. The mandible impression was classically realized with irreversible hydrocolloid (Alginoplast , Kulzer Mitsu Chemicals Groups, Hanau, Germany). Occlusion cire and teeth color were finally recorded, and information were sent to the laboratory.\\nTemporary implant directly fixed crows were tried, and occlusion was adjusted in order to obtain canine guidance in lateral movement but no interdental contact in static occlusion (Figure 14). With these temporary crowns, patient had function and aesthetic rehabilitation, and profile emergence was modeled with resin adjunction for the future definitive crowns (Figure 15).\\nAfter orthodontic treatment, the patient was complaining about teeth color, with a \"yellow\" aspect. A step of at-home tooth bleaching was performed between temporary and definitive restoration and using 10% carbamide peroxide with adaptable trays (Polanight , SDI).\\nTeeth color was visually measured by the patient and clinicians: the initial teeth color was 3M2 (Figure 16) and after 7 days of overnight at-home bleaching, the final teeth color was 2M2 (Vita 3D-Master , Vita) (Figure 17). Patient was satisfied by the aspect of her teeth, more luminous and less saturated. The bleaching treatment was continued for one more week, and tint stabilization was reached at 1 month, allowing final implant fixed restoration in positions 6 and 11.\\nOnce soft tissue has matured and teeth color was stabilized, final implant fixed crowns have been realized. Impression technique was similar to the interim phase except the first step. In fact, a record of the emergence profile was made using flowable resin on the direct transfer (Figure 18).\\nDue to the available prosthetic height, individualized milled direct-implant frameworks were made (Zfx, Germany, company of the ZimVie Group) (Figure 19). They allow better management of the emergence profile and passivity, compared to a conventional cast framework or standardized abutment. The coping and the implant abutment are then one piece, reducing the risk of gaps between the different components.\\nThe crowns were tried before finishing to check the emergence profile, interdental contact points, static and dynamic occlusions, and ceramic color (2M2 using Vita 3D-Master , Vita) (Figure 20). When placing the direct-implant crowns, all previous points were checked, and crowns were then screwed with an insertion torque equal to 30 N cm (Figures 21 and 22).\\nThe patient was satisfied with this rehabilitation, both from a functional and aesthetic point of view.\\nControls were realized at 2 weeks and 1 month in order to check occlusion, insertion torque, plaque index, and patient comfort. All static occlusion contacts were deleted on implant fixed crowns, and canine guidance was carefully calibrated in lateral movements.\\nCalibrated interdental toothbrushes were prescribed in order to control plaque around implant-supported crown, especially in distal of crown in position 6.\\nA 1-year follow-up showed a total integration of crowns with profile emergence and volume apical to crowns fitting natural adjacent structures (Figure 23).\\nPatient was completely satisfied by the aesthetic and smile results (Figure 24).\\nIn the future, regular follow-up examinations will be carried out to ensure good tissue integration, proper plaque control, and peri-implant health.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 5,\n",
       "    'case_id': 'PMC5228701_01',\n",
       "    'case_text': \"We present the case of a 5 years and 9-month-old female patient, who was admitted in our clinic for inferior limb pain and painful edema of the right index finger. The anamnesis revealed that the patient's mother had complained of joint pain during childhood, and she was diagnosed with acute articular rheumatism. The patient's personal history underlined that she had complained of inferior limb pain for approximately 1 year, but in the last month she associated painful edema of the right index finger, therefore she was referred to a pediatric surgeon, who suspected a proximal interphalangeal subjoint dislocation and requested a hand X-ray. The X-ray showed 2 opaque lesions in the right radial metaphysis, therefore she was admitted in our clinic for further investigations.\\nThe clinical exam performed at the moment of admission revealed the following pathological elements: weight and height deficit, W: 17.6 kg (-0.88 SD), H: 109.5 cm (-1.02 SD), BMI: 14.7 (-0.78 SD), deformity of the proximal interphalangeal joint of the right index finger (Fig. 1), abnormal position of the inferior limbs (genu valgum), and bilateral flat feet.\\nThe laboratory test performed during admission, namely CBC count, transaminases, immunity status (IgA, IgM, and IgG) tests, peripheral smear, but also thyroid hormones, rheumatoid factor, antistreptolysin O titer, anticitrulinated protein antibodies, antinuclear antibodies, circulating immune complexes, parathormone, and serum phosphorus, were all within normal limits. The X-ray of inferior limbs revealed multiple metaphyseal osteochondromas of the distal femur, proximal tibia, and fibula of the 3rd right metatarsal bone, and proximal and medial phalanges of the 2nd, 3rd. and 4th right toes (Fig. 2, 3 and 4).\\nWe also performed a thorax and a spinal column X-ray, but no pathological aspects were identified. We referred the patient to an endocrinologist, but both clinical and ultrasound exams of the thyroid gland were normal. We also requested a genetic consultation, and the genetics specialist suggested a radiological investigation of parents and also periodic radiological assessment of bone lesions with pediatric monitoring.\\nBased on all these clinical and radiologic findings, we established the diagnosis of multiple osteochondromas.\\nWe assessed both parents radiologically in order to identify a possible hereditary transmission of these bone tumors. The mother X-rays revealed multiple osteochondromas of the left radius, bilateral femur, tibia, and peroneus, and also bilateral metatarsals.\\nTherefore, the final diagnosis was of HME.\\nWe discharged the patient with the recommendation of radiological monitoring at least once a year or if any clinical sign of complications appears, taking under consideration the risk of malignant transformation. The radiological aspect at 6 month follow-up did not reveal any additional modifications.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 28,\n",
       "    'case_id': 'PMC5139886_01',\n",
       "    'case_text': \"A 28 year old, healthy Thai male, employed in Israel as an agricultural worker, presented to the emergency room with complaints of nausea, vomiting and diffuse abdominal pain starting 3 days earlier. Past medical history was unremarkable and without mention of recent illness. On presentation, the patient was well oriented in no severe distress, physical examination was notable for epigastric tenderness with guarding. Heart rate was 116 beats/minute, blood pressure 94/59 mm/Hg and a temperature of 37.4 C. The patient was admitted to the surgical department for evaluation. A chest and abdomen CT revealed marked liver enlargement with fatty change, and minimal amounts of pleural and pericardial fluid. No surgical etiology was recognized and due to laboratory findings of renal failure (Creatinine 3.88 mg/dl BUN 119.7 mg/dl), the patient was transferred to the medical department.\\nShortly after arrival, the patient's condition deteriorated rapidly to a state of agitation and shock and he was transferred to the intensive care unit. On arrival blood pressure measured 79/45 mm/Hg, pulse 170 beats/minute with episodes of SVT. In addition, the patient developed dyspnea, with a respiratory rate of 48 breaths/minute and anuria. Core temperature measured 33.1 C. Examination revealed marked peripheral cyanosis, distended jugular veins with cool extremities. Air entry to both lungs was reduced and palpation of the abdomen was noted for tenderness and an enlarged liver. Laboratory analysis showed lactic acidosis (pH 7.22, lactate 129 mg/dl), renal failure (creatinine 2.11 mg/dl), and rhabdomyolysis (CPK 3,205 IU/l). Liver function tests and coagulation indices were also disturbed ( total bilirubin 2.74, direct bilirubin 1.03 mg/dl, AST 1169 IU/l, ALT 890 IU/l, LDH 1743 IU/l, INR 1.7, factor V level 18%,). Erythrocyte sedimentation rate was within normal limits. Factor V levels continued to decline to a nadir of 5%. The above laboratory results, in combination with encephalopathy, indicated fulminant hepatic failure accompanied by multi-system organ failure.\\nThe patient failed a trial of positive pressure ventilation and was subsequently intubated and ventilated mechanically. A Swan-Ganz catheter was inserted and fluid resuscitation started, steroids and vasopressors were given. Echocardiography was used to rule out pericardial tamponade; normal ventricular and valvular function was demonstrated. Continuous hemodiafiltration was started and switched to standard hemodialysis a week later. A tracheotomy was later performed due to the need for prolonged ventilation. Blood, urine, sputum and peritoneal fluid aspirate were cultured and gram and Ziell-Nielsen stained. Empiric antibiotic therapy was then started. Culture results were negative. Serologic testing for acute or chronic infection with viral hepatitis types A, B and C, HIV, Epstein-Barr virus, Cytomegalovirus returned negative. Further serologic testing for Ricketsia conorii, Coxiella burnetii were also negative. A thick film smear for blood-borne parasites and stool collection for ova and parasites were negative. Due to a high osmolar gap, levels of methanol, ethylene glycol and acetyl salicylic acid were checked and no traces were found.\\nA health bureau inspector was sent to the residence of the patient and found a stock of canned food the patient consumed almost exclusively for a period of months. Specimens were examined at the ministry of health. AFB1 was found at a level of 19.6 ppb (allowed level < 5 ppb). The patient's condition gradually improved on supportive treatment. Vasopressors were stopped and dialysis discontinued after blood pressure, renal function and CPK values returned to normal. Liver function tests improved markedly. After 21 days of mechanical ventilation the patient was weaned and the tracheotomy closed on the 36th day. The patient was returned to the medical department for observation and physiotherapy. No apparent sequels were observed other than mild residual hypertension. The patient was discharged on day 45.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': None,\n",
       "    'case_id': 'PMC4303471_01',\n",
       "    'case_text': \"The proband first came to medical attention at one month of age when, after an uneventful gestation and delivery, he was noted to have abnormal movements characterized as myoclonic seizures. Over the ensuing months, seizures evolved to consist of both generalized tonic clonic and myoclonic events, with frequent status epilepticus, which was exacerbated by febrile events, resulting in several dozen hospitalizations. Seizures are now better controlled, but on a regimen of Oxcarbazepine, Topiramate, Levetiracetam and Zonisamide. At approximately two years of age, the patient developed truncal and head titubation and adventitious movements characterized as choreathetoid, which intruded on sleep and residual neurologic function. Upon initial observation and subsequently, the patient showed no evidence of dysmorphic facies, though he was microcephalic (orbitofrontal head circumference >2 standard deviations below the mean). The patient has also suffered from severe developmental stagnation and now, at age 10 years, is able to only minimally communicate with his care providers, is unable to sit or walk and does not have any self-help skills. Neuroimaging, first obtained at several months of age, and repeated serially over the course of his care, showed an initial severe deficit in the development of age appropriate myelination that has never normalized. Indeed, the most recent MRI, performed at 7 years of age, has shown evidence of progression of myelination but at levels that are still severely reduced (Figure 1A-C), consistent with severely delayed myelination.\\nElectroencephalogram telemetry done at age two years was characterized by high voltage background slowing (delta range, 0.5-2.5 Hz) and superimposed multifocal interictal sharp discharges with occasional periods of burst-suppression. Habitual clinical events were recorded as myoclonias involving the extremities with associated oral dyskinesias followed by a motionless appearance, without changes in the electrographic background, most consistent with subcortical events. Subsequent EEGs have continued to show an absence of normal background organization with multifocal epileptiform discharges during wakefulness and with activation in sleep, although without ictal events (Figure 1D).\\nThe patient's seizures were refractory to medical management until approximately 7 years of age when the patient was placed on multiple anticonvulsants, at which point they became infrequent. The underlying cause of the seizures and delayed myelination, however, remained enigmatic. Extensive biochemical and genetic testing revealed no abnormalities other than mildly increased levels of sialic acid in the CSF and urine, and subsequent fibroblast and genetic studies of sialic acid metabolism were unremarkable.\\nThe patient's presentation and severely delayed myelination were consistent with an inherited leukoencephalopathy, and he was therefore enrolled prospectively in a Myelin Disorders Bioregistry Project study on unclassified leukoencephalopathies at Children's National Medical Center (CNMC). To investigate the possible genetic origin of the patient's disease we performed whole exome sequencing on DNA collected from the proband and the unaffected parents. We produced > 19 Gb of sequence for each individual, yielding a mean depth of 57 fold coverage with an average 90.4% of target bases sequenced at least 18 times. Using a custom-developed pipeline that integrates parental variant calls into the analysis of the affected child, a heterozygous de novo mutation in KCNT1 (MIM 608167; NM_020822.2) was identified in the proband (NM_020822: c.2794T>A, p.F932I; Figure 1E). Sanger sequencing of the trio confirmed that this mutation was specific to the patient, and further analysis showed that it is not present in dbSNP135, the 1000 Genomes Project database or the NHLBI Exome Sequencing Project database. This was the only de novo mutation identified in this screen that passed our filtering criteria. KCNT1 p.F932 is highly conserved (phyloP score of 0.989744), and the p.F932I change is, in principle, the most damaging non-synonymous change found in our screen, with a PolyPhen2 score of 0.998, a SIFT score of 0.99, and MutationTaster score of 0.78.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 57,\n",
       "    'case_id': 'PMC5012799_01',\n",
       "    'case_text': 'A 57-year-old female, with a history of severe hypertension presented with interscapular pain with a sudden onset. On physical examination, she had a high blood pressure 220/120. On electrocardiogram there was a sinus rhythm with a left ventricular hypertrophy. Initial non-contrast CT and transoesophagel echography (TEE) (Figure 1) showed a Stanford type B hematoma formation in the descending thoracic aorta with internal deviation of intimal calcification. Two weeks later, after blood pressure stabilization, a control CT scan and TEE (Figure 2 A, B) revealed ULP, appearing as an intimal tear, with a reperfusion area in the hematoma. Contrast CT scan showed the importance of the reperfusion area (Figure 2 C). On the 3 months follow up contrast CT scan (Figure 3), there was no aortic dissection or aneurysm. The hematoma was stable with an ectasic aorta.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 56,\n",
       "    'case_id': 'PMC4049038_01',\n",
       "    'case_text': \"We present a case of a 56-year-old right-hand dominant builder. He gave a weeks' history of worsening pain around his right shoulder joint. There was no history of trauma or injection. He had been feeling feverish and also had complained of a sore throat a few weeks previously. His past medical history included diverticular disease and osteoarthritis of the right knee. He had no history of being immunocompromised. He was HIV negative and did not have diabetes.\\nOn examination, the patient held the right shoulder in internal rotation. No active movement was possible and any attempted passive movement was significantly uncomfortable. The overlying skin displayed no cellulitis, erythema or puncture wounds. Palpation did not reveal any obvious subcutaneous collections, and there was no neurovascular deficit. The shoulder area was globally very tender to touch.\\nThe patient demonstrated signs of systemic sepsis with a tachycardia and a temperature of 39.1 C. Hematological and biochemical investigation revealed an elevated white cell count at 13.88 x 109 /L (normal range: 4.00-10.00 x 109 /L), as well as a raised C-reactive protein at 267 mg/L (normal range: Less than 5 mg/L) .\\nShoulder radiographs were unremarkable. Both anterior and posterior glenohumeral joint aspirations were performed in the emergency department which produced a small amount of turbid fluid which was initially thought to have come from the joint. It is possible that this had penetrated the abscess in the deltoid which was to be discovered later. Microscopy of the aspirate demonstrated numerous white cells but no organisms were seen on Gram stain. No bacterial growth was identified after 40 h of incubation. The patient was commenced on intravenous flucloxacillin for a presumed native joint septic arthritis.\\nAn ultrasound of the right shoulder was performed which failed to identify any significant intra-articular effusion. An MRI scan of the shoulder girdle demonstrated a moderate joint effusion, extensive swelling and abnormal signal within the subscapularis and teres minor [Figures 1 and 2]. The initial suspicion was of septic arthritis.\\nA posterior portal arthroscopic washout the shoulder was subsequently performed. A moderate amount of turbid fluid was discovered and multiple samples were sent. The joint was irrigated until clear with 6 L of saline. The immediate Gram stain of the turbid fluid failed to identify any bacteria.\\nFurther surgical exploration was undertaken 3 days later because of poor clinical response. The lack of specific clinical signs made this clinical decision difficult. A posterior abscess could not be excluded. A deltopectoral approach was performed. No clear edema was encountered down to subscapularis. A subscapularis split failed to show pus in the joint. A finger sweeping under deltoid (laterally and posteriorly) opened an abscess which drained 500 mls of foul smelling, dark green pus. A large cavity of pus was identified between infraspinatus, teres minor and deltoid. Multiple samples were again taken. One was referred for 16s rRNA PCR.\\nA further debridement was undertaken 3 days later. The shoulder was approached posteriorly and pus was identified between the deltoid and infraspinatus muscle bellies. The anterior incision was also re-opened and further pus drained. The posterior and lateral deltoid was necrotic and was resected. Again multiple biopsies, including both muscle and fat were sent for analysis. The antibiotic regimen was modified to intravenous piperacillin/tazobactam, however, shortly afterwards the specimen from the third surgical washout grew mixed anaerobes. Antibiotics were changed accordingly to gentamicin and then further to metronidazole and ciprofloxacin when sensitivities were available. Shortly afterwards the 16s rRNA PCR identified a mixed trace with fusobacterium species and Prevotella species. This suggested a primary upper airway focus.\\nThe patient's inflammatory makers transiently improved and then deteriorated once again. A repeat MRI scan was performed to ensure no other source of infection. It demonstrated no significant deterioration in the joint since open surgery. There was a small amount of joint fluid but no significant effusion. However, there was gross deterioration and swelling in the appearances of the surrounding musculature with gas and fluid in the soft tissues. This was highly suggestive of a rapidly progressive soft tissue infection. A fourth open debridement of the right deltoid area was undertaken on day 16 for failure of the inflammatory markers to improve. Pus was again identified and mixed anaerobes grown. Thorough debridement was carried out on the first episode so the re-accumulation was surprising.\\nThe reason for recurrence was investigated. In order to exclude causes of an impaired immune response, a global immune screen, in addition to HIV and diabetes testing, was performed. It is of note that he was investigated with a CT on admission that showed no obvious collection making seeding from diverticulitis unlikely. It is postulated that, given his upper airway viral prodrome and the causative organism that this gentleman had a rare complication of Lemierre's syndrome.\\nHe was discharged on ciprofloxacin and reviewed at day 14 and day 21 after discharge. At both points he remained well and his inflammatory markers remained normal. At 6 months he remained systemically well and had full range of movement in his right shoulder.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 71,\n",
       "    'case_id': 'PMC6395856_01',\n",
       "    'case_text': \"A 71-year-old woman presented with a chest computed tomography (CT) finding of left upper (Fig. 1A) and right lower (Fig. 1B) lung field nodules. Left upper lung field nodule was diagnosed by endobronchial ultrasound with a guide sheath as squamous cell carcinoma with high programmed death-ligand 1 (PD-L1) expression (70%) (Fig. 2A). 18F-fluoro-2-deoxyglucose positron emission tomography showed uptake in both nodules. The cancer stage was determined as cT3N0M1a. After 13 cycles of pembrolizumab every 3 weeks, chest CT revealed a dramatic decrease in the size of the lesion in the left upper lobe (Fig. 1C), but the size of the lesion in the right lower lobe was significantly increased (Fig. 1D). Because the treatment effect differed between the bilateral lung lesions, a definitive right lower lung nodule diagnosis was obtained with CT-guided transthoracic needle biopsy (CTNB) (Fig. 2B).\\nSamples were obtained from the right lower lesion by CTNB. Pathological findings revealed squamous cell carcinoma with nonexpression of PD-L1. Therefore, treatment of the right lower nodule was ineffective because of PD-L1 nonexpression. Following discussion with the cancer board, right lower lobectomy was recommended.\\nHowever, although surgery was recommended in this case, the patient's bronchial asthma was severe. She had with a history of refractory asthma for approximately 20 years. She was treated with ICS, long-acting beta-agonists (LABA), long-acting muscarinic antagonists, and antiallergic drug therapy. She was occasionally treated with oral or systemic corticosteroids for exertional dyspnea.\\nThese treatments were all determined to be insufficient if the patient was to undergo lung surgery. On physical examination, her peripheral arterial blood oxygen saturation was 95% in room air, but chest auscultation revealed diffuse expiratory wheezing. The maximum blood eosinophil count was 680/muL. The forced expiratory volume in 1.0 second (FEV1) was 1280 mL (%FEV1, 76.3%), vital capacity (VC) was 2080 mL (%VC, 94.8%), and peak flow was 196 L/min in a pulmonary function test.\\nBenralizumab was administered before surgery. No adverse events occurred. Two days after benralizumab administration, her asthma symptoms (wheezing, cough, and dyspnea) disappeared. Pulmonary function tests and eosinophil count were performed again 4 days after benralizumab administration. Her peak flow was improved from 196 to 210 L/min, and her eosinophil count was reduced to 0/muL. Surgical resection by video-assisted thoracic surgery was performed 5 days after benralizumab administration. The eosinophil count in surgical tissue was markedly reduced compared with that in preoperative CTNB tissue (Fig. 3A and B). No severe asthma attacks occurred after surgical resection and benralizumab administration, and the patient was discharged from the hospital. Respiratory function tests 6 weeks after surgery showed FEV1 of 1120 mL (%FEV1, 70.9%), VC of 1740 mL (%VC, 80.0%), and peak flow of 240 L/min. The patient was administered benralizumab continuously after surgery, and no asthma attacks or cancer recurrence occurred for 6 months after surgery.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 0,\n",
       "    'case_id': 'PMC3401649_01',\n",
       "    'case_text': 'A young nine-month-old boy of Asian origin presented to our hospital with 1 day history of mild temperature, vomiting, and coryzal symptoms. He was born out of nonconsanguineous marriage and is the only child of his parents. He had a normal birth and development, and was up to date with his immunizations. There was no family history of any serious neurological conditions or strokes. On initial examination his temperature was 38.5 C and heart rate of 100 beats per minute. Hydration was normal. He was noted to be very pale and had a systolic murmur over the precordium. Liver was 1 cm below the costal margin with no other masses palpable.\\nLaboratory investigations showed that his hemoglobin (Hb) was 4.1 g/l, platelets 866, white cell count 14, mean corpuscular volume (MCV) 48, mean corpuscular hemoglobin (MCH) 11, reticulocyte count 22, and total iron of 7 mug/l. Liver functions, renal profile, and C reactive protein were normal. His urine was clear. Chest X ray was unremarkable with no cardiomegaly. Blood film demonstrated severe microcytosis and \"pencil cells.\" Hemoglobin electrophoresis showed Hb A2 of 2.2% and Hb F 1.7%.\\nChild was admitted due to severe anemia and started on oral Iron. He developed mild diarrhea over the next few days which completely settled. Blood transfusion was not required and he was never unwell or in cardiac failure. After 7 days of hospitalization, he suddenly became drowsy and encephalopathic with GCS of 9/15. Urgent CT scan of his brain showed extensive cerebral sinus thrombosis with venous infarction. MRI brain demonstrated bilateral thalamic infarction with hemorrhagic transformation. MR Venogram (MRV) confirmed extensive thrombosis of internal cerebral vein, vein of Galen, straight sinus, sigmoid sinus, and basal vein of Rosenthal [Figure 1].\\nHe was started on low molecular weight heparin (LMWH). He later developed mild left hemiparesis which resolved within days. Repeat CT brain did not show any extension or new hemorrhage. Cardiac echogram was normal. He remained well and was discharged from the hospital with no focal deficit.\\nRepeat MRI after 3 months showed partial recanalization of venous sinuses. Neurologically he has remained well and his development is normal. Extensive investigations to determine any other underlying prothrombotic disorder were negative.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 57,\n",
       "    'case_id': 'PMC6243306_01',\n",
       "    'case_text': 'A 57-year-old female visited a nearby clinic with a chief complaint of sharp pain and taut skin in the left breast. After examination, the lesion was diagnosed as primary breast cancer (invasive carcinoma of no special type), which was immunohistochemically negative for oestrogen receptor, androgen receptor and human epidermal growth factor receptor Type 2. The cancer clinical stage was T4bN1M0 Stage IIIB (Union for International Cancer Control guidelines). Neoadjuvant systemic chemotherapy together with mastectomy was recommended as a therapeutic option. However, she refused all treatment and left the lesion untreated for approximately 10 months. When the tumour increased in size and the pain became intolerable, she expressed a strong desire to receive minimally invasive treatment, such as TACE. Thus, she was referred to our clinic.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 34,\n",
       "    'case_id': 'PMC6900946_01',\n",
       "    'case_text': \"In July 2012, a 34-year-old man presented to the Emergency Department with a 4-month history of headaches, paroxysmal vertigo, nausea, and photophobia, with acute worsening of symptoms over the previous week. His past medical history was unremarkable, and there was no significant family history or any occupational exposure potentially associated with sarcoma.  Figure 1 provides a timeline of events including diagnostic assessments and interventions. Computed tomography (CT) and magnetic resonance imaging (MRI) of the brain demonstrated a 2.4 x 2.5 cm mass in the right lateral to midtemporal lobe and associated area of hemorrhage (Figures 2(a) and 2(e)). Dexamethasone was prescribed for cerebral edema and levetiracetam for seizure prophylaxis. A subtotal resection was achieved using a right temporal craniotomy and stealth-guided tumor resection. Pathologic review identified a WHO Grade II Astrocytoma (Figure 2(i)). The patient was treated with localized radiation therapy (RT) with 5040 cGy which was well-tolerated. No chemotherapy regimen was started at this time.\\nRepeated MRI at 4 and 5 months after completion of RT showed a growing nodule of contrast enhancement in the right frontal lobe and associated vasogenic edema despite dexamethasone treatment (Figure 2(b)). MRI perfusion studies showed increased blood flow to these new areas (Figure 2(f)), and a second tumor resection was performed. Pathologic assessment revealed a mixture of radiation necrosis and WHO Grade III Astrocytoma (Figure 2(j)) with no isocitrate dehydrogenase (IDH) mutation. The patient began a regimen of temozolomide (cycle 1 : 150 mg/m2, days 1-5 each 28-day cycle; cycle 2 : 175 mg/m2). After two cycles of temozolomide treatment, the patient presented to the Emergency Department with a 1-week history of acute headache, nausea, and vomiting. MRI revealed a 4.4 x 3.5 x 4 cm heterogeneously enhancing mass lesion with perfusion, consistent with progressing tumor. Imaging also showed a significant increase in surrounding vasogenic edema which proved difficult to manage due to increasing complications from dexamethasone treatment, including persistent folliculitis and myopathy.\\nThe patient's treatment regimen was changed to bevacizumab (10 mg/kg every 2 weeks) to treat the underlying tumor and vasogenic edema, in an effort to reduce corticosteroid exposure. The patient tolerated 6 cycles of bevacizumab well, and his clinical condition began to improve. However, a follow-up MRI showed increased enhancement of the right frontal lobe mass and new dural-based nodular areas of enhancement (Figure 2(c)). Clinically, the patient appeared to be responding to bevacizumab. As expected, there was reduced cerebral blood flow observed on MRI perfusion; however, the increased enhancement was concerning as this is typically reduced with bevacizumab treatment (Figure 2(g)). An initial concern was there may be dissemination of high-grade glioma. A lumbar puncture was deferred due to mass effect. A biopsy of a right frontal dural-based nodule was pursued, and the pathologic assessment was consistent with a high-grade sarcoma lacking any further differentiating features (Figures 2(k) and 3(a)-3(c)). While the type of sarcoma could not be determined, it was specifically not gliosarcoma. After presentation of the sarcoma, the patient was referred to a genetic counselor with concern for a genetic predisposition (specifically, Li-Fraumeni syndrome). However, genetic testing revealed no pathogenic mutations in the TP53 gene or any other known mutations.\\nFurther imaging of the neuroaxis was completed to ensure there was no spread of the sarcoma through the subarachnoid space. MRI of the cervical, thoracic, and lumbar spine showed no areas of abnormal enhancement, and a CT PET of the body revealed no other new hypermetabolic lesions. Multidisciplinary discussions with medical and radiation oncologists ensued regarding the number and spread of the dural-based lesions, and chemotherapy was considered to be the best treatment option for the sarcoma. The patient was started on a regimen consisting of ifosfamide (3750 mg/m2 days 1-2 each 21-day cycle) and doxorubicin (30 mg/m2 days 1-2 each 21-day cycle), continuation of bevacizumab (10 mg/kg every 2 weeks; 4 additional cycles), and initiation of NovoTTF (Optune) treatment for the malignant glioma. The chemotherapy treatment was not well-tolerated, and the treatment course was complicated by neutropenic fever and fatigue despite growth factor support and dose reduction. Thus, the patient only completed 3 cycles. Data from the Optune device showed sporadic use, averaging less than 18 hours per day.\\nUltimately, the patient's condition began to further deteriorate. Follow-up MRI revealed an increase in dural-based nodules involving the entire right hemisphere and left cerebellum, as well as an increase in size of the centrally necrotic mass in the right frontal lobe (Figures 2(d) and 2(h)). The recommendation was made to initiate hospice care. The patient received a second opinion at another institution, where he received a gemcitabine/docetaxel regimen, but only completed one dose of gemcitabine due to thrombocytopenia and clinical worsening. The patient received one additional dose of bevacizumab (15 mg/kg). He continued to decline and eventually succumbed to glioma and sarcoma less than 2 years after his initial diagnosis.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 83,\n",
       "    'case_id': 'PMC9539137_01',\n",
       "    'case_text': \"An 83-year-old man presented with a 6-month history of dull pain in the right abdomen. Serological examination revealed that he was negative for hepatitis B surface antigen and hepatitis C virus antibodies. On computed tomography examination, irregular and slightly low-density (~26 HU) shadows were observed in the right lobe of the liver, near the top of the diaphragm, representing a tumor measuring 29 x 23 mm with clear boundaries (Figure 1). Serological tests revealed that the patient had a carcinoembryonic antigen level of 5.38 microg/L (normal range, 0-5.0 microg/L), alpha fetoprotein level of 3.36 microg/L (normal range, 0-20 microg/L), carbohydrate antigen 19-9 level of 36.97 micro/ml (normal range, 0-37 micro/ml), and cancer antigen-125 level of 11.42 micro/ml (normal range, 0-35 micro/ml).\\nDuring the operation, the tumor was found to be located in the eighth segment of the right lobe of the liver; thus, the right hepatic lobe was partially resected. The tumor was a grayish-yellow mass (2.5 x 2 x 2 cm) located under the liver capsule with a clear boundary from surrounding tissues. Microscopic observation revealed that it was moderately differentiated hepatocellular carcinoma with a cord-like, trabecular structure and a pattern of local pseudoglandular growth. Some tumor cells were translucent, and multiple satellite nodules were found around the main tumor nodule (Figures 2A,B). An area of liver tissue (~0.3 cm) located 0.5 cm from the main tumor had a benign-appearing follicular thyroid structure (Figures 2B,C). The lesion was too small to appear on CT images. The follicles contained colloid tissue and were lined with low cuboidal cells with scant cytoplasm; lymphatic tissue was also present in the area.\\nImmunohistochemical (IHC) analysis of the hepatocellular carcinoma revealed hepatocyte antigen positivity, cytokeratin-19 negativity (Figure 2D), and glypican-3 (GPC-3) positivity (Figure 2E). Epithelial cells in the area with a follicular thyroid structure showed no atypia; they were negative for hepatocyte paraffin 1 (Hep Par-1) and positive for thyroglobulin (TG) (Figure 2F), PAX8 (Figure 2G), and thyroid transcription factor-1 (TTF-1; Figure 2H).\\nThe patient had no history of a thyroid tumor, and thyroid function test results were normal. Thyroid hormone levels were in normal ranges (triiodothyronine, 1.27 ng/mL; thyroxine, 10.5 g/dl; free triiodothyronine, 3.84 pmol/L; and free thyroxine, 17.76 pmol/L).\\nUltrasound examination showed no primary thyroid tumor. The final diagnosis was moderately differentiated hepatocellular carcinoma with heterotopic thyroid tissue in the liver. One month after surgery, all of the patient's serological markers were normal; no tumor recurrence or metastasis has been detected for 7 postoperative months.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 16,\n",
       "    'case_id': 'PMC9271968_01',\n",
       "    'case_text': \"Female patient, 16-year-old, single, brown, student, born in rural area of Pernambuco/Brazil, referred to the neurology and neurosurgery service of the Hospital da Restauracao with a history of frontal, pulsing and progressive headache, worsening over weeks, associated with emetic episodes and fever. The condition evolved with progressive growth of a painful, adhered and fibroelastic consistency mass in the central region of the forehead of the skull, eight days before admission. Report of fever stopped two days after admission, with no signs of meningism, rhinorrhea or any focal neurological deficit. No traumatic event, past or recurrence of sinusopathy or other comorbidity that was related. Patient also referred no use of antibiotics. Laboratory tests also did not present alterations of hematimetric indices or inflammatory tests.\\nBlood culture was not performed. CT scan of the skull was performed, which showed an expansive hypodense lesion in the frontal region with intracranial extension associated with perilesional edema (Figure 1), and then transferred to the neurosurgery department with suspicion that the identified expansive formation would have neoplastic origin.\\nThe patient underwent brain MRI, which revealed an expansive lesion in the frontal subcutaneous tissue, extending through a bone defect in the frontal sinus that communicated with an extra-axial nodular formation with intra-axial component and circumcision edema with important compressive effect, suggesting a complicated PET with concomitant cerebral abscess (Figure 2). Empirical intravenous antibiotic therapy with ceftriaxone (2 g administrated 12 h/12 h) and metronidazole (7,5 mg/kg administrated each 8 h) was initiated, for eight days before the surgery. Intranasal corticosteroid therapy was not prescribed for our patient.\\nThe patient was submitted to neurosurgical approach by bicoronal incision and, as cutaneous flap was rebalanced, granulation tissue, bone erosion with dural adhesion and spontaneous extravasation of purulent secretion was identified. Drainage of the abscess by puncture initially. Performed 5 x 5 cm frontal craniotomy resecting the entire osteomyelitis area. Resected the residual abscess and capsule, a fistulous hole (Figure 3B) was verified communicating purulent contents of the frontal sinus with brain abscess. After cranialization of the frontal sinus, evacuation of the subdural empyema and subgaleal abscess, exhaustive cavity washing was performed with 1,500 mL of saline plus gentamicin. Cranial reconstruction performed with autologous bone part, after curettage and drill of the internal eroded plate of the frontal bone flap and resected material (pus, granulation tissue and frontal sinus mucosa) sent for microbiological analysis and culture, but it was not identified any organism's growth. This sterile culture result was probably due to empirical use of preoperative antibiotics, but anaerobic causative agents, destroyed after contact with oxygen, are also a possibility. Similarly, access to histological examination of the frontal sinus mucosa and the granulation tissue collected was not obtained. This type of intervention - surgical approach, associated with antibiotic therapy, was determined based on characteristics such as continuous abscess growth, intracranial mass effect, risk of complications, and neurological deficits.\\nThe patient followed a prolonged course of intravenous antibiotic therapy, ceftriaxone, and metronidazole (7 weeks). A new MRI was performed, 28 days after surgery, and showed the surgical a marked reduction of the frontal extra-axial collection. Meningeal thickening and residual frontal abscess surround by perilesional edema were observed, as shown in the pre and postoperative comparative images in Figure 4.\\nDue to the significant improvement of our patient condition, she was discharged after 43 days of post-surgical follow-up, with complementary oral antibiotic therapy with ciprofloxacin. It was chosen due to their broad spectrum, low cost, affordability and recommendation by the Hospital Infection Control Committee. The patient was subsequent outpatient follow-up at the service during the first 9 months, in three consultations, with satisfactory clinical, functional, and radiological control. Diagnosis and hospital therapy did not involve an otolaryngologist, but the patient was referred to a professional in the area.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 0,\n",
       "    'case_id': 'PMC7756012_01',\n",
       "    'case_text': 'A 32-day-old male with recent diagnosis of X-linked CGD, dihydrorhodamine (DHR) stimulation index (SI) of 1 and known family history (brother with hemizygous mutation in CYBB c.742dupA), developed low-grade temperatures (37.8 C). Laboratory evaluation on day 1 of illness was notable for 8% bands without leukocytosis on complete blood count (CBC). Chest x-ray, urinalysis, blood, and urine cultures were not revealing. Low grade temperatures continued, and on day 4 he had temperature to 38.8 C, associated with leukocytosis 16.4 k/mm, elevated C-reactive protein (CRP) 11.7 mg/dl, and procalcitonin 0.51 ng/ml. He was hyponatremic 133 mEq/L, hypoalbuminemic 2.7 g/dl, and had elevated transaminases (AST 171 U/L, ALT 164 U/L). Infectious evaluation with blood, urine, and cerebral spinal fluid (CSF) cultures and respiratory pathogen panel by PCR were unrevealing. Empiric treatment was initiated with cefepime and ampicillin. On day 8 of illness, leukocyte count (15.6 k/microl) and CRP (21.5 mg/dl) had further increased and bandemia (15%) was noted. Computed tomography (CT) scan was obtained and demonstrated multifocal pulmonary and splenic nodules measuring up to 13 and 8 mm, respectively ( Figures 1A, B ). Biopsy of the right lung lesion was obtained, and antimicrobials were broadened to meropenem, voriconazole, and micafungin. Fungal etiology was suspected, therefore double anti-fungal coverage was used. Over the next day, bilateral lower extremity mottling and right lower extremity edema with delayed capillary refill were noted. Within hours, the patient progressed to cardiac and respiratory failure requiring mechanical ventilation and multiple vasopressors to maintain adequate perfusion. Hydrocortisone was added as well for vasopressor refractory shock. Repeat laboratory evaluation demonstrated cytopenias, elevated transaminases, and coagulopathy compared to less than 24 h prior ( Table 2 ).\\nOver the next 24 h, the patient deteriorated rapidly despite broadening anti-microbials to include vancomycin and amphotericin in addition to meropenem and aggressive resuscitation with multiple blood products. A presumptive diagnosis of HLH was considered based on presence of four of eight known criteria ( Table 1 ) and high dose dexamethasone was added to treat his inflammatory response. Despite these efforts, the patient succumbed to multiorgan failure. Blood and tissue biopsy cultures returned post-mortem, yielding Burkholderia cepacia. Autopsy confirmed hemophagocytosis within the spleen, liver, and bone marrow ( Figure 2 ). Post-mortem next generation sequencing ruled out mutations in genes associated with familial HLH.\\nA half Seminole Indian, half African American male was diagnosed with X-linked CGD (DHR SI 1, CYBB, c.492delA), after presenting with Burkholderia gladioli cervical lymphadenitis at 16 months of age. At 23 months of age, he presented with fevers, diarrhea, and mild cough. Workup revealed a small perianal fistula and mild splenomegaly with tiny subcentimeter T2 hypointense lesions, consistent with granulomas. A biopsy was deemed not possible due to size and location of lesions. Bronchoscopy was normal while endoscopy and sigmoidoscopy showed moderate inflammation of the colon, consistent with CGD-associated colitis. Bronchoalveolar lavage fluid and blood cultures remained without growth at that time. Patient was empirically treated with meropenem, concurrently treated for Clostridium difficile infection with oral vancomycin, and corticosteroids 1 mg/kg were initiated for treatment of colitis. Fevers improved and he was discharged home to complete 10 days of antibiotic treatment.\\nTwo days after discharge, he returned with fevers and abdominal distension. He was empirically treated with meropenem and voriconazole. Imaging of the chest and abdomen revealed hepatosplenomegaly with small ascites ( Figure 1C ). He was found to be anemic (hemoglobin 6.9 g/dl) and given blood transfusion. Because of fever, hepatosplenomegaly, and anemia, a diagnosis of HLH was considered. Hyperferritinemia and hypertriglyceridemia were found so methylprednisolone 2mg/kg and high dose intravenous immunoglobulin (IVIG) 2 gm/kg were initiated. Over the next several days, he developed pancytopenia and liver failure with coagulopathy, liver synthetic dysfunction, and elevated liver enzymes ( Table 2 ). Laboratory evaluation remained consistent with HLH with high ferritin, CXCL9, and elevated soluble IL-2R (CD25) and no source of infection identified on extensive evaluation. Anakinra was added as adjunct therapy. Three weeks after initial presentation, (1,3)-beta-D-glucan assay returned elevated (234 pg/ml) and bronchoalveolar lavage fluid culture from first admission began growing Penicillium sp. Amphotericin B was added for additional fungal coverage. On hospital day 10, he developed acute respiratory distress necessitating intubation; imaging was consistent with diffuse pulmonary hemorrhage. Despite aggressive ventilator management, he ultimately progressed to cardiac arrest and resuscitation efforts were not successful. The parents declined autopsy; no further analysis of genes associated with familial HLH was performed.\\nAn 8-week-old Mexican American boy presented with 2 days of fever (39 C) and 1 week of erythematous rash. The patient was admitted for a sepsis-rule out, empirically placed on ampicillin and cefotaxime following CSF, blood, and urine culture collection. All cultures were negative. His past history was remarkable for contracting pertussis at 10 days of life for which he was treated without complications.\\nDespite antimicrobial therapy, while still hospitalized, his fevers (38.5-40 C) continued and he developed leukopenia, neutropenia, and anemia. His clinical course further deteriorated with the development of seizures; ceftriaxone and vancomycin were added for empiric meningitis coverage. Hepatosplenomegaly was noted on physical exam and a diagnosis of HLH was considered. Laboratory evaluation showed hyperferrtinemia, hypertriglyceridemia, hypofibrinogenemia, and elevated soluble IL2R level, all consistent with HLH ( Tables 1  and  2 ). Perforin expression was normal and NK cell function was inconclusive due to an inadequate sample. A bone marrow biopsy revealed increased histiocyte number with evident hemophagocytosis. HLH treatment was initiated with dexamethasone, cyclosporine, and IVIG. The patient received 8 weeks of therapy and ultimately recovered. However, at week 7 of treatment for HLH, he developed shock and respiratory failure in the setting of abdominal distention with ascites. Blood and peritoneal cultures yielded Candida lusitaniae; he was treated with amphotericin B and flucytosine. Additionally, he received eight infusions of granulocytes. Seizures persisted and a brain MRI revealed diffuse infra- and supratentorial leptomeningeal enhancement. Examination of CSF showed pleocytosis, but cultures were negative. He was diagnosed with presumptive fungal meningoencephalitis. Seizures were managed with levetiracetam. An enlarged cervical lymph node was also biopsied which revealed multiple granulomas, many of which had central caseating necrosis and degenerating fungal pseudohyphae.\\nGiven the lymph node histopathology, a DHR assay was performed and noted to be markedly abnormal (SI 1). Next generation sequencing of genes associated with familial HLH was negative; however, assessment for CGD relevant genes revealed a hemizygous mutation in CYBB (c.1557delA) and confirmed the diagnosis of X-linked CGD. Profound developmental delays related to his severe illness and fungal meningoencephalitis remained. However, with steady developmental progress he ultimately underwent a matched sibling hematopoietic stem cell transplant (HSCT) following conditioning with busulfan, fludarabine, and alemtuzumab. Now at 7 years of age, he is well and requires no immunosuppression. Seizures are controlled on levetiracetam.',\n",
       "    'gender': 'Male'},\n",
       "   {'age': 17,\n",
       "    'case_id': 'PMC7756012_02',\n",
       "    'case_text': \"A 17-year-old previously healthy male presented with several days of fever and increased work of breathing, in the setting of 2 weeks of progressive generalized fatigue and episodic changes in mental status. He was empirically treated with ceftriaxone, vancomycin, and acyclovir for presumed sepsis. Initial laboratory evaluation showed pancytopenia and elevated inflammatory markers. Imaging revealed a large consolidation in the right upper lobe and enlarged lymph nodes ( Figure 1D ). Over the next 2 days, his respiratory distress worsened, and he developed hepatosplenomegaly. He was transitioned to doxycycline and ampicillin-sulbactam for treatment of pneumonia. Given lack of clinical improvement despite broad-spectrum antibiotics, a lung biopsy was performed which revealed necrotizing granulomas. Inflammatory markers continued to rise and a diagnosis of HLH was made with the patient meeting the following criteria: persistent fever, splenomegaly, cytopenia, hypertriglyceridemia, elevated ferritin, and elevated soluble IL-2R levels ( Table 1 ); however bone marrow evaluation was normal with no evidence of hemophagocytosis. Because of the patient's clinical findings and recently revealed family history of X-linked CGD in two nephews, a diagnosis of CGD was suspected and amphotericin was added for fungal coverage. CGD was confirmed with abnormal DHR and next generation sequencing of a panel of genes associated with immunodeficiency identifying pathogenic hemizygous variant c.3G>A in CYBB, with no reported variants in primary HLH genes. He was then transitioned to piperacillin-sulbactam and amphotericin, with minocycline for MRSA coverage, followed by initiation of dexamethasone and IVIG, that was met initially with defervescence.\\nNineteen days after presentation, he had recurrence of fever and despite treatment with anti-microbials, IVIG, and corticosteroids, he developed profound hypoxemia associated with pulmonary infiltrates and an embolism. Micafungin was added but respiratory failure persisted eventually requiring extracorporeal life support (ECMO) for persistent hypoxemia. On the day of ECMO initiation, his blood culture grew Burkholderia multivoran and trimethoprim-sulfamethoxazole was added for additional therapy. Over the next 10 days, inflammatory markers continued to rise, and blood cultures remained persistently positive. Piperacillin-sulbactam was changed to meropenem, levofloxacin was added, and trimethoprim-sulfamethoxazole continued. Because of persistently rising inflammatory markers and marginal clinical improvement, basiliximab, a monoclonal antibody that antagonizes the IL-2 receptor, was administered with drop in ferritin levels from >100,000 to 70,745 ng/ml after administration. A second dose of basiliximab was administered one day later, and ferritin dropped further to 34,075 ng/ml. However, the patient clinically decompensated on this day and developed pulmonary hemorrhage. Basiliximab was administered a third time 6 days later but ferritin levels subsequently rose to 65,027 ng/ml ( Table 2 ). Because of the patient's critical status and uncontrolled inflammation, emapalumab, a humanized monoclonal antibody that binds and neutralizes interferon-gamma (IFN-gamma), and granulocyte transfusions were administered as life saving measures. Clinical parameters did not improve, and ferritin remained >100,000 ng/ml after emapalumab. Despite these interventions, the patient developed progressive hypotension and died after failed resuscitation from cardiac arrest, 33 days after initial presentation.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 68,\n",
       "    'case_id': 'PMC8799927_01',\n",
       "    'case_text': \"A 68-year-old male with past medical history significant of RA (on Methotrexate and Sulfasalazine), polycythaemia, high BMI with performance status of 1, presented with one week history of fever and cough, lymphopenia and raised C-reactive protein (CRP) accompanied by bilateral peripherally-dominant opacities on chest X-ray (Figure 1).\\nHe subsequently tested positive for COVID-19 and was admitted to ICU two days later with type 1 respiratory failure. Initially he was treated with Non-invasive ventilation (NIV) but due to further deterioration, he required intubation and ventilation for adequate respiratory support and mild inotropic support. Hence, the intubation was carried out as planned by an expert physician without any immediate complications and he was ventilated on SIMV mode with PEEP of 12, FiO2of 60% on which he was able to maintain his PaO2 of at least 8. Otherwise his cardiovascular and renal function were stable requiring only minimal vasopressor support. There was also acceptable inflammatory response to pre-emptive broad-spectrum antibiotics cover.\\nSubsequently, and nearly 2 days later it became apparent that he developed a substantial surgical emphysema over the face, front of upper chest and back, shoulder and upper arms which was progressive. Additionally, oxygen and ventilator requirements were increased needing FiO2 of 100% and PEEP 16 to maintain previously described respiratory parameters. Clinical examination and urgent chest X-ray did not support any deterioration from the COVID-19 previously noted infiltrates neither provided a plausible cause for the surgical emphysema (Figure 2A). Therefore, an urgent CT thorax was carried out which demonstrated significant pneumomediastinum and subcutaneous emphysema with air under diaphragm. There was no suspicion to suggest gastrointestinal tract perforation. Additionally, no pneumothorax was diagnosed and the previously noted COVID-19 infiltrates were stable (Figure 2B).\\nIn view of increased respiratory requirements and lack of imaging evidence of any cause for the surgical emphysema and the clinical deterioration, a flexible bronchoscopy was performed, at high suspicion, which exhibited glassy like residue/laceration at 5 o'clock position approximately at 6th tracheal ring measuring 2 cm x 2 cm, possibly from previous clot or laceration. No other signs of penetration through the airways were noted (Figure 3).\\nThe most probable cause of his deterioration initially was thought to be secondary to trauma because of his previous intubation but based on its delayed presentation, the fact that the intubation was uneventful and that it was performed by a specialist, a ulcerative lesion related to the active disease process (COVID-19 and/or RA) could not be overlooked, although biopsies were not performed because of the deteriorated condition of the patient and hence no direct evidence of this could be provided. It seems more probable however, that a trauma to the trachea was caused during intubation which was sealed by the endotracheal tube balloon which got moved later on, despite the fact that the patient was not turned to prone position as he has been unwell for this.\\nNext, the endotracheal tube position was adjusted (i.e., positioned more peripherally inside the trachea closer to the carina past the laceration under direct vision) and bilateral pectoral fasciotomies were performed with application of two negative suction dressings pumps (Vacuum Assisted Closure - VAC), which helped improve the extent of surgical emphysema. His O2 requirements and ventilation improved importantly and a conservative treatment for his tracheal laceration was decided based on the situation and his clinical condition.\\nThe requisite thus far had been a single organ support. However, a few days later, patient's clinical condition deteriorated again by developing atrial fibrillation (AF) and acute kidney and liver injury with hemodynamic compromise. He required increased vasopressor support with moderate doses of noradrenaline, pharmacological cardioversion of AF and hemofiltration was also performed. Despite multi-organ support and accepted management of COVID-19 pneumonitis at the time, his respiratory function deteriorated with increasing oxygen requirements, an increased alveolar to arterial oxygen gradient and worsening of radiological findings of acute respiratory distress syndrome (ARDS) secondary to COVID-19 pneumonitis.\\nUnfortunately, the patient did not recover from multi-organ failure and subsequent to multidisciplinary discussion and family involvement, the difficult decision was made to withdraw organ support on the tenth day of critical care admission in the context of worsening multi-organ failure (lung, cardiovascular and renal) caused by COVID-19 infection in a immunosuppressed state.\\nAll procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee(s) and with the Helsinki Declaration (as revised in 2013). Written informed consent was obtained from the patient's next of kin.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 56,\n",
       "    'case_id': 'PMC6744794_01',\n",
       "    'case_text': \"A 56-year-old woman had experienced trigeminal neuralgia (TN) and was treated using GKS. She received 45 Gy at 50% isodose at the proximal cisternal extent of the left trigeminal nerve [Figure 1]. After GKS, she showed no symptoms for 18 years.\\nShe experienced a sudden onset of consciousness disturbance and right hemiparesis (National Institutes of Health Stroke Scale score = 20 points). Brain magnetic resonance imaging was performed at the primary hospital. Diffusion-weighted images revealed a hyperintensity in the left insular cortex and a slight hyperintensity in the left MCA territory [Figure 2a]. Magnetic resonance angiography (MRA) revealed occlusion of the horizontal segment of the left MCA [Figure 2b]. She received an intravenous injection of t-PA (Alteplase: 0.6 mg/kg) and was transferred to our hospital. At the time of arrival, no intracranial hemorrhage was noted on brain computed tomography (CT). We subsequently performed digital subtraction angiography (DSA) for only the left internal carotid artery and confirmed the presence of MCA occlusion, even after t-PA injection [Figure 2c]. Mechanical thrombectomy was then performed using the Solitaire FR/2 revascularization device (Medtronic, Minneapolis, MN, USA; onset to reperfusion time: 3 h 13 min), and complete recanalization was achieved [Figure 2d]. Brain CT performed immediately after mechanical thrombectomy revealed subarachnoid hemorrhage (SAH) with a hematoma in the left cerebellar hemisphere [Figure 3a and b]. As CT angiography (CTA) could not confirm the presence of an aneurysm [Figure 3c and d], DSA of the posterior cerebral circulation was performed, and it revealed a small irregular-shaped aneurysm at the branching site of the left circumflex branch of the anterior inferior cerebellar artery [Figure 4a]. Since the aneurysm was located at the radiation field of the previous GKS, it was considered as a GKS-induced aneurysm, and it represented the bleeding source. Thus, we treated it using coil embolization [Figure 4b and c] and performed surgical hematoma removal and decompressive craniectomy. One month after the ischemic attack, she was transferred to a rehabilitation hospital, with a modified Rankin Scale score of 5.\\nThe patient's family provided consent for the publication of this case report.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': None,\n",
       "    'case_id': 'PMC7970248_01',\n",
       "    'case_text': 'An adult spayed female domestic shorthair cat was found crouching down in a yard of a private house. The cat was rescued as it was non-ambulatory in the pelvic limbs and had seemingly been abandoned. The cat was taken to the local veterinary clinic. Therefore, its age and history were unknown except that it had an operation scar on its abdomen. Its body weight was 3.1 kg. Screening tests for feline immunodeficiency virus antibody and feline leukaemia virus antigen were negative. Flea parasites were seen and the haircoat was matted throughout the body. Pain was not obvious when palpating the body. Episodes of head and neck scratching were elicited by palpating the upper cervical region (see Video 1 in the supplementary material), and resembled phantom scratching commonly seen in canine syringomyelia. It was sometimes accompanied by urination. The skin of this region was unremarkable.\\nAt the time of the rescue, complete blood count (CBC) and serum chemistry indicated dehydration and inflammation or infection. Under sedation, the haircoat was cut short. The general condition of the cat improved with nutrition support and a flea treatment using a topical formulation of selamectin (Revolution 6%; Zoetis JP). Prior to advanced diagnostic imaging that was conducted 1 month later, CBC and serum chemistry were performed again and the results were unremarkable.\\nNeurological examination was performed before advanced diagnostic imaging. Mentation was normal. The cat had non-ambulatory paraparesis in the pelvic limbs without urinary or faecal incontinence (see Video 2 in the supplementary material). Postural reaction of all four limbs was decreased. Spinal reflexes were normal in the thoracic limbs and hyper-reflexia was seen in the pelvic limbs. Nociception was normal in all four limbs. The perineal reflex was intact. Cranial nerve examinations were unremarkable. Neuroanatomical localisation revealed multifocal lesions, including in the C1-C5, C6-T2 and T3-L3 segments of the spinal cord, and/or brain.\\nSkeletal survey radiography revealed vertebral exostoses and extensive osteophytes from the upper cervical vertebra to the lower thoracic vertebra (C2-T10) (Figure 1). Changes were more severe at the ventral aspect of the spine, although changes were also found at the dorsal aspect. Morphological asymmetry of the pelvis was also found. No scoliosis or kyphosis was found, but dorsal extension of the neck was observed. Ultrasonography of the abdomen was performed and findings were unremarkable except for the absence of ovaries.\\nFurthermore, CT and MRI were performed under general anaesthesia to investigate the causes of the pelvic limb paresis and episodes of head and neck scratching.\\nCT of the axial skeleton was conducted using a 16-slice scanner (Supria; Hitachi Medical Systems). CT confirmed vertebral exostoses and extensive osteophytes between C2 and T10 and at the L7-S1 junction with higher CT values (Figure 2a-c), as well as radiographs. A pelvic fracture was also identified (Figure 2d), although this was not considered to be the cause of the pelvic limb paraparesis. CT-based three-dimensional volume rendering (Figure 3) and virtual endoscopy (see Video 3 in the supplementary material) were generated using an imaging workstation (AZE Virtual Place; AZE). CT-based virtual endoscopy revealed stenosis of the vertebral canal of the cervical and the rostral thoracic spine caused by hyperostosis along the spinal canal and protruded calcified intervertebral discs that may have been involved in hyperostosis (see Video 3 in the supplementary material). No ovaries were seen with CT in addition to ultrasonography.\\nMRI of the brain and spinal cord was performed with a 0.3-Tesla MRI scanner (AIRIS Vento; Hitachi Medical Systems). Sagittal T2-weighted (T2W) and transverse T2W imaging were obtained for brain MRI. Spinal MRI included the spinal cord between C2 and T11 for the sagittal T2W imaging, and between T2 and T7 for the transverse T2W, T1-weighted (T1W) and subsequent contrast-enhanced T1W imaging. Intravenous administration of a gadolinium-based MRI contrast agent, gadoteridol (0.15 mmol/kg [ProHance; Bracco Diagnostic]), was used for the contrast enhancement.\\nBrain MRI showed normal findings. Spinal MRI of the cervicothoracic region revealed a mild dilation of the central canal of the spinal cord with T2 hyperintensity and T1 hypointensity without contrast enhancement at the T4-T5 region (Figure 4). In addition, multiple intervertebral disc protrusions and decreased T2 signal intensities of intervertebral discs were observed in the cervical and thoracic spine.\\nBased on the radiographic findings, differential diagnoses included hypervitaminosis A, mucopolysaccharidosis (MPS), diffuse idiopathic skeletal hyperostosis (DISH), osteochondromatosis (also known as multiple cartilaginous exostoses) and infectious spondylitis. However, MPS, DISH, osteochondromatosis and infectious spondylitis were thought to be unlikely for the reasons described in the discussion. Therefore, hypervitaminosis A was considered the most likely diagnosis.\\nAfter CT and MRI examination, serum concentrations of vitamin A from the affected cat, as well as two healthy cats used as controls, were measured using high-performance liquid chromatography by a commercial laboratory (Sanritsu Zelkova). The serum vitamin A concentrations of the affected cat and two healthy cats were 1.04, 0.46 and 0.66 micromol/l, respectively, all of which were unremarkable. The reference interval (RI) for serum vitamin A in cats was not available from the laboratory. The serum vitamin A RI in cats is reported to be 1.75-6.77 micromol/l, and plasma vitamin A levels of cats receiving liver diets ranged from 15.74 to 44.71 micromol/l in a study by Seawright et al.\\nThe progression of clinical signs such as neurological deficits and pain was not seen in 7 months of follow-up after the rescue, at the time of manuscript submission. Because non-ambulatory paraparesis in the pelvic limbs remained, a wheelchair for cats was put on, which assisted the cat with walking (see Video 2 in the supplementary material).\\nFor the treatment of episodes of head and neck scratching that were elicited by palpating the upper cervical region, pregabalin (2.5 mg/kg PO q24h for 1 week and q12h for 1 week [Lyrica; Pfizer]) was used; however, the therapeutic effect was not obvious. Then, oclacitinib (1.3 mg/kg PO q12h [Apoquel; Zoetis JP]) was initiated and clinical improvement was achieved (see Video 1 in the supplementary material). After discontinuing the drug, the sign recurred; thus, it was used as a maintenance treatment for the episodes.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': None,\n",
       "    'case_id': 'PMC10416632_01',\n",
       "    'case_text': 'Till today, there are six clinical cases (Table 1) that have reported abnormalities resulting from CUL3 mutations, with developmental delay (DD) as the primary phenotype. Nakashima et al. first reported three cases of de novo CUL3 variants resulting in global DD, with or without epilepsy. Two of the patients had infantile spasms, while the other had short stature with mild to severe intellectual disability. Whole-exome sequencing identified one missense variant (c.854 T > C, p.(Val285Ala)) and two frameshift variants (c.137delG, p.(Arg46Leufs*32) and c.1239del, p.(Asp413Glufs*42)). In another case report, Iwafuchi et al. detected a stop-gain mutation in the CUL3 gene from a Japanese patient with ASD. This patient was presented with febrile status epilepticus that led to developmental regression, including the loss of verbal ability, eye contact, and ability to do activities of daily living. Exome sequencing revealed a de novo double base insertion into the CUL3 gene (c.1758_1759insTG, p. (Thr587*)). Furthermore, Kato et al. reported a novel CUL3 gene mutation (c.158G > a, p.Ser53Asn) that resulted in dysmorphic features, such as macrocephaly, characteristic facial features, and stony skin, in a child with global DD. Most recently, Vincent et al. reported the first case of NDD caused by CUL3 splice site variants. The patient presented with congenital hip dysplasia and global DD. Whole-exome sequencing identified splice site variants in CUL3 (c.379-2A > G). These case reports reveal a pattern of global DD and ID associated with CUL3 de novo mutations.',\n",
       "    'gender': 'Unknown'},\n",
       "   {'age': None,\n",
       "    'case_id': 'PMC10416632_02',\n",
       "    'case_text': \"Large cohort case-control studies have revealed various de novo mutations in CUL3 are associated with NDDs, including ASD, ID, and DD-like phenotypes.\\nNonsense and missense mutations of CUL3 have been identified mainly in ASD patients. Severe de novo nonsense mutations of CUL3 in ASD were found in 2012 when O'Roak et al. performed exome sequencing on 677 ASD individuals from 209 families. Codina-Sola et al. reported CUL3 de novo mutations in a cohort of male idiopathic ASD patients (n = 36). Larger cohorts were carried out thereafter. De Rubeis et al. analyzed rare coding variants in 3,871 ASD cases and 9,937 ancestry-matched or parental controls, which identified CUL3 as one of 107 high-risk ASD genes that cause de novo loss of function (LoF) mutations in more than 5% of ASD. Sanders et al. reported CUL3 de novo CNVs in patients with ASD (10,220 patients from 2,591 families) in the Simons Simplex Collection (SSC) data. The largest array of SPARK analysis findings to date (including 42,607 autism cases) identified CUL3 as a genetic high-confidence LoF variant. The latest release of whole-genome sequencing (WGS) data from the Autism Speaks MSSNG resource1 identified CUL3 as one of the 134 ASD-associated genes, with a false discovery rate (FDR) of <0.1, in 5,100 ASD and 6,212 non-ASD parents and siblings. In the Chinese ASD cohort, Wang et al. conducted a study of recurrent de novo and likely gene-disruptive (LGD) mutations (n = 1,543), which identified CUL3 de novo LGD recurrences.\\nMissense mutations in CUL3 have also been identified in cohorts of ASD combine with ID, DD, or NDDs. Hormozdiari et al. analyzed exome sequencing data from 1,116 individuals with ASD and ID, which identified patients with severe Cul3 missense mutations have more significant intellectual impairment. Wang et al. performed an integrated gene analysis of de novo variants in 15,560 ASD and 31,052 DD, identifying CUL3 as one of the de novo variance-rich genes in 138 NDDs combinations. In a targeted sequencing study of 208 candidate genes in 11,730 patients and 2,867 controls, CUL3 was found to reach de novo significance and identified as one of the 91 NDDs risk genes with ASD and DD biases. da Silva Montenegro et al. performed a meta-analysis with more than 20,000 patients from NDDs cohorts and found mutations in CUL3.\\nOverall, the above evidence supports the notion that CUL3 is a high-risk gene for NDDs, especially ASD.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 66,\n",
       "    'case_id': 'PMC5648305_01',\n",
       "    'case_text': 'Written consent was obtained from the patient for the publication of his case and images. A 66-year-old Indian male patient presented to the Tuberculosis Control Unit after sudden onset of near syncope, nausea, diaphoresis, light-headedness, and a wide-staring gaze with upward and lateral deviation of eyes 30 minutes after consuming newly-prescribed RHEZ. These symptoms resolved on the administration of diphenhydramine 25 mg intravenously at the Emergency Department. The patient was referred, initially, to the Department of Rheumatology, Allergy and Immunology based on the suspicion of a reaction to RHEZ. A diagnosis of anaphylaxis-like and possibly idiosyncratic reaction to rifampicin was made.\\nOn further questioning by the primary team, the patient reported that while he was aware of his surroundings and was able to hear conversations around him, he felt \"physical blocked\" in that he was unable to respond with purposeful voluntary movements or speech; he additionally described abdominal discomfort and generalized weakness.\\nThe patient had just been prescribed daily rifampicin 600 mg, isoniazid 300 mg, ethambutol 1.6 g, pyrazinamide 1.75 g (i.e., standard RHEZ combination therapy for TB of uncertain origin and resistance, according to his weight of 98.3 kg) and pyridoxine 10 mg after increased nodular opacities in the left upper zone were observed on sequential chest X-rays (Figures 1 and 2), suggestive of granulomata. A small calcified pleural plaque was also noted. Blood cultures, sputum cultures, and Mycobacterium tuberculosis polymerase chain reaction were negative.\\nOn his initial presentation after the near syncope, the patient\\'s vitals were stable and physical examination, including neurological examination, did not reveal any conclusive findings. A full blood count, liver function test, thyroid function test, drug screen, troponin I, electrocardiogram (Figure 3), and a two-dimensional echocardiography were performed.\\nHowever, the diagnosis was subsequently changed to OGC based on the more complete history recorded. Another possible cause of OGC would include trauma. However, the patient did not suffer from any trauma recently.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 48,\n",
       "    'case_id': 'PMC8733335_01',\n",
       "    'case_text': \"Our patient is a 48-year-old male with intrahepatic cholangiocarcinoma (ICC) with a history of psoriasis for more than 20 years. After receiving multi-line treatment, including surgery, chemotherapy, and radiotherapy, among others, the effect was not good and the patient's disease progressed. According to the results of clinical trials on biliary tumors, PD-1 antibody combined with lenvatinib was tried. There was no obvious abnormality in urine routine during baseline examination; meanwhile, the patient's psoriasis was also in an inactive period, which has been stable for a long time and did not require drug control. However, after combination treatment with lenvatinib and nivolumab, psoriasis recurred, with scattered rashes all over the body, and skin toxicity symptoms aggravated with the increase of the cumulative dose of the PD-1 antibody. The patient developed urinary tract irritation after three cycles. Urine examination revealed 375/mul white blood cells (WBCs) in the urine ( Figure 1 ). Although no bacteria were found in the urine culture, the possibility of bacterial cystitis was still considered after consultation with the urology department based on the patient's symptoms at that time. After antibiotic treatment, laboratory tests had indeed improved, but the patient's symptoms did not get better. Therefore, the treatment was discontinued. However, the patient's tumor indicators increased due to the discontinuation of lenvatinib and PD-1 antibody ( Figure 1 ). Imaging examinations also revealed new lesions located on the right posterior lobe of the liver and above the duodenum on the right side of the pancreatic head in the abdominal cavity ( Figure 2 ). In general surgery consultation, this patient was considered to have a chance of surgery, so an operation was performed. One month after the second operation, the patient's tumor indicators decreased and then increased again ( Figure 1 ). Except for a slight thickening of the local omentum, no lesions were found on imaging. At the same time, the patient's urinary tract symptoms improved after the drug has been withdrawn for more than 3 months. Therefore, Gemox chemotherapy (gemcitabine+oxaliplatin) was considered after the operation. Meanwhile, the patient's immunohistochemistry was positive for PD-L1. Taking the improvement of curative effect into account, and with the patient's insistence on trying, the treatment plan was finally determined as Gemox combined with the PD-L1 antibody. The patient then did not develop skin toxicity. After three cycles, the tumor markers dropped significantly, but bladder irritation reoccurred, which was significantly worse than before. Urine examination revealed that WBCs were 2,818/mul ( Figure 1 ) and bacteria were 512/mul. After consultation with the Department of Urology and Nephrology, bilateral ureteral stent implantation and cystoscopy and biopsy were decided. The result of the bladder biopsy indicated chronic inflammation of mucosal tissue, mucosal erosion in some areas, and proliferation of granulation tissues and fibroblasts ( Figure 3 ). After the multidisciplinary consultation, immune-related cystitis was considered; treatment with steroid hormones was given, which started at 2 mg/kg, then slowly decreased. The urinary tract irritation symptoms were relieved, and the laboratory examination was also significantly improved. After 4 weeks, the urine routine was reviewed, and the WBC count was 66/mul. At present, during the hormone reduction period, urine routine and carbohydrate antigen 19-9 (CA19-9) are continued to be monitored, and imaging examinations are performed regularly (including MRI and PET-CT). In the follow-up treatment, it was considered that this patient cannot tolerate the side effects of immunotherapy. Whether hormones affect the efficacy of immunotherapy is currently controversial, so chemotherapy only was considered.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 19,\n",
       "    'case_id': 'PMC4891586_01',\n",
       "    'case_text': 'A 19-year-old female fell 20 feet from a roof and presented with a complete laceration of the lower lip and bilateral otorrhagia. A maxillofacial computed tomography (CT) exam (Fig. 1) revealed a nondisplaced fracture at the mandibular symphysis and bilateral temporomandibular joint (TMJ) fractures. The right TMJ fracture was at the condylar neck. The left TMJ fracture was within the intracapsular portion of the condyle. There was lateral displacement of the left TMJ. There were comminuted fractures of the anterior walls of both external auditory canals (EAC) with acute blood in the canals (Fig. 2). The EAC fracture fragments were more inferiorly and posteriorly displaced on the left (Fig. 3).',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 55,\n",
       "    'case_id': 'PMC10408600_01',\n",
       "    'case_text': 'A 55-year-old female with no significant medical history was initially evaluated because of the right-sided radiculopathy in a C6 distribution. She complained of constant mild neck pain. Her symptoms had been persistent for approximately 9 months. She had no neurological deficits on physical examination and had no signs of myelopathy. Before evaluation, she had tried physical therapy, acupuncture, oral steroids, chiropractic care, gabapentin, and topical analgesics without relief. In addition, she underwent C7-T1 interlaminar injection of steroids with no change in symptoms.\\nInitial noncontrast computed tomography (CT) image demonstrated a bony destructive process involving the right C5 pedicle and superior facet, concerning for an aggressive neoplastic process. Follow-up contrast-enhanced magnetic resonance imaging (MRI) demonstrated extradural enhancement along the right side at C4-C6, within the right C5-C6 neuroforamen partially insinuating into the bone. Several MRI sequences also demonstrated flow related artifact within the area of extradural enhancement [Figures 1a and b].\\nAt this time, she had been evaluated by an orthopedic surgeon who initially planned C4-C7 anterior cervical discectomy and fusion. However, because the MRI suggested vascular lesion, neurovascular consultation and further imaging studies were instead pursued. CT angiography (CTA) was then obtained demonstrating multilevel asymmetric venous epidural enhancement spanning C4-C6 with a focal extradural venous pouch at the C5-C6 level [Figures 1c and d]. This further supported the presence of a vascular lesion, specifically an extradural AVF. Because of this, she then underwent outpatient angiography followed by embolization of the cervical foraminal AVF.\\nThe digital subtraction angiography (DSA) revealed an AVF supplied from the deep cervical branch of the costocervical trunk. There was a smaller contributor from the inferior thyroid branch of the thyrocervical trunk [Figure 2a].\\nOne week after DSA, she underwent embolization of the fistula. A transradial approach was used with a Bernstein select catheter and a 256 cm 027 Headway microcatheter. The microcatheter was wedged in the distal most part of the deep cervical branch. A single coil was deployed at the neck of the venous varix (distal to the fistula) to prevent filling densely packing the varix with embolic material and preserving its mass effect. Onyx 18 was then infused upstream of the coil and allowed to disperse throughout the fistulous network in the typical fashion of \"lava flow.\" At the conclusion of the embolization, the fistula appears completely obliterated [Figure 2b].\\nPostoperatively, she was started on a short decadron taper over 5-day course. She was discharged to home the following day having met all expected postoperative milestones. At 1-week postoperatively, she had no change in her radicular pain and remained full strength. She continued to take gabapentin for pain relief but was weaning off. An MRI and CTA were repeated at 6-week postoperatively which demonstrated complete obliteration of the C6 AVF [Figures 3a and b]. Her symptoms at this time entirely resolved and she was off of all her preoperative analgesics and muscle relaxants.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 0,\n",
       "    'case_id': 'PMC9123637_01',\n",
       "    'case_text': \"An 87-day-old female infant presented to the hospital with increasingly frequent non-bilious vomiting and regurgitation in addition to failure to gain weight and weight loss according to her mother. She was a well-baby with no diseases or anomalies and weighed 2.7 kg at birth. During the last 20 days prior to admission, she experienced frequent and increasing regurgitation and vomiting, causing the loss of 400 grams more of her weight. At the time of admission, the patient weighed 4.5 kg with a Z-score of -2 (weight for length). She was afebrile with stable vital signs for her age, including a pulse rate of 120 beats/min, a respiratory rate of 23 breaths/min, and blood pressure of 90/60 (mm Hg). Initial physical examination revealed nothing but failure to thrive. She was neither ill, nor toxic, nor cyanotic. Her heart sounds were normal and rhythmic without any murmurs. Respiratory sounds were clear. The abdomen was soft with active bowel sounds. The rest of her physical examination and electrocardiogram (ECG) were also normal. All laboratory findings including complete blood count, urine, and stool exams were normal. The abdominal ultrasound revealed stomach contents passing through a non-hypertrophied pylorus that was seen to open and close normally. A small amount of free fluids was detected in the Morrison space with a spleen size of 61 mm on midclavicular line. Pelvic and prominent mesenteric lymph nodes were estimated to be up to 4 mm. The infant's upper gastrointestinal (GI) series showed nasopharyngeal regurgitation and compression effect on posterior aspect of esophagus at the level of aorta arc, which was suggestive of double aortic arch or, less probably, aberrant right subclavian artery (Figure 1). A barium meal study revealed severe gastroesophageal reflux, and her small bowel follow through revealed a nodular filling defect in the ileac loops, suggestive of nodular lymphoid hyperplasia. Echocardiogram, which was highly recommended due to her barium study results, showed a right-sided aortic arch with a small atrial septal defect (ASD). Cardiac function and pulmonary artery pressure (PAP) were reported to be normal. \\nThe patient underwent a multi-slice spiral computerized tomography (CT) angiography of the heart and vasculature using a non-ionic contrast and a saline chaser via dual injector through the intravenous route. Multiple axial and sagittal images with multi-planar reformation (MPR), maximum intensity projection (MIP), and volume rendering technique (VRT) reconstruction showed a SDS levo-cardiac heart with atrioventricular and ventriculoarterial concordance and intact ventricular septum (IVS) with no sign of permeant ductus arteriosus (PDA). It also revealed a right-sided aortic arch with an aberrant left subclavian artery with notable compression on the esophagus. The main pulmonary artery and its branches were prominent due to a left-to-right shunt. All pulmonary veins returned to the left atrium with no sign of left superior vena cava (LSVC) (Figure 2).\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 69,\n",
       "    'case_id': 'PMC3700967_01',\n",
       "    'case_text': \"A 69-year-old woman presented to our hospital with a 2-week history of nausea, abdominal pain, extreme generalized weakness and fatigue, and a 1-week history of poor oral intake. Additionally, she had noticed a new onset of pruritic rash over the abdomen, spreading over the trunk. Two weeks prior to the onset of her symptoms, she had presented with dysuria to her primary care physician and was treated with a week's course of ciprofloxacin for presumed urinary tract infection, but, despite this, her symptoms persisted.\\nHer past medical history was significant for atrial fibrillation, lumpectomy for breast cancer, done six years previously, and diverticulosis.\\nOn examination at our institution, her temperature was 37.2  C, her blood pressure was 110/70 mmHg, and her pulse rate was 156 beats per minute. Positive physical examination findings were a diffuse, predominantly truncal, maculopapular, erythematous rash. This was nonpalpable and nonblanching. Cardiovascular exam was positive for rapid atrial fibrillation. Examination of her lower extremities revealed severe tenderness over both calf areas but no pedal edema. A separate petechial rash was noted over the shins. Abdominal examination revealed no masses, but she demonstrated generalized tenderness on palpation.\\nLaboratory data revealed hemoglobin (Hb) 9.7 g/dL, hematocrit 32.2%, leukocyte count of 9300 cells/UL (differential: granulocytes 91%, lymphocytes 2%, monocytes 6%, and eosinophils 1%), platelets of 276,000/mm3, blood urea nitrogen (BUN) of 134 mg/dL (normal, 10-20 mg/dL), creatinine, 11.6 mg/dL (her baseline creatinine a month prior to her presentation was 1.1 mg/dL). In addition, her sodium was 125 mmol/L (normal, 135-146 mmol/L); chloride, 88 mmol/L (normal, 96-106 mmol/L); potassium, 4.2 mmol/L (normal, 3.5-5.1 mmol/L); phosphorus, 7.5 mg/dL (normal, 2.7-4.5 mg/dL); and bicarbonate, 18 mmol/L (normal, 24-32 mmol/L). Urine analysis showed specific gravity of 1.010; trace proteins, 3 to 5 dysmorphic red blood cells; no casts and no leucocytes; and glucose, 50 mg/dL. The 24-hour urine microalbumin/creatinine ratio was 797 mcg/mg with a urine creatinine of 30.6 mg/dL. Although there was no peripheral eosinophillia, her urine was positive for eosinophils by Wright's stain. Liver function tests were normal.\\nSerum protein electrophoresis was normal, while her antinuclear antibody and serologies for hepatitis B and C were all negative. Her Complement component3 (C3) was normal at 112 and Complement component 4 (C4) was mildly depressed at 15.1.\\nEnzyme-linked immunosorbent assay (ELISA) was used to test for presence of serum myeloperoxidase-antineutrophil cytoplasmic antibodies (MPO-ANCA); this was found elevated to 54 EU, (normal value is <20 EU). Her P-Anti-neutrophil cytoplasmic antibody titer was 1:40.\\nHuman immunodeficiency virus was negative, so was the Antinuclear antibody (ANA). C-Reactive Protein (CRP) was 22.9 mg/dL and Erythrocyte sedimentation rate (ESR) was >140 mm/hr, the results of tests that were done after the biopsy diagnosis was made.\\nA renal biopsy was performed after admission, and it showed acute necrotizing intrarenal vasculitis with diffuse acute ischemic tubular injury. Low magnification showed an interlobular or arcuate artery showing full-thickness fibrinoid necrosis with luminal occlusion. One glomerulus out of 25 in the specimen showed a fibrocellular crescent and global glomerulosclerosis. The other glomeruli were unaffected. Additionally, there was no evidence of acute interstitial nephritis on the biopsy specimen.\\nAn magnetic resonance image of the brain at that time revealed nonspecific white matter signal changes, likely representing small vessel ischemic disease but vasculitis could not be definitively ruled out. Renal arteriogram was negative for micro aneurysms.\\nGiven her severe uremia, she was placed on intermittent hemodialysis via a split-tip tunneled hemodialysis catheter. In addition, she was started on a daily oral cyclophosphamide at a dose of 1 mg/kg/day and daily oral prednisone at a dose of 1 mg/kg/day initially. Six weeks into her treatment, her creatinine fell to 1.9 mg/dL and intermittent hemodialysis was discontinued (Table 1).\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 9,\n",
       "    'case_id': 'PMC6347510_01',\n",
       "    'case_text': 'Here we describe a 9-year-old girl with microcephaly and mild cerebellar hypoplasia with severe intellectual and motor disability (Fig. 1A,B). She was born full term after an uneventful pregnancy. Parents noticed delay in achieving milestones. She rolled over at 6 months, sat at 12 months and walked at 5 years. She is a happy and social child with global developmental delay. She is ataxic, with motor incoordination in both upper and lower extremities which is more pronounced on left side. She has good core stabilization of the trunk with spinal exaggeration in extensor muscles, suggesting some truncal weakness. She exhibits atypical gait pattern and foot drop during walking and running. In addition, she internally rotates her left lower extremity likely due to decreased tone associated with left hip extensors. From a motor function perspective, she appears to be delayed in both gross and fine motor skills, with greater delays in fine motor abilities. Although she exhibits a clear desire to communicate, there is no verbal communication; only occasionally does she respond with appropriate syllable production. She responds to simple commands and demonstrates some self-stimulation behaviors.\\nIn addition to the psychomotor and intellectual delays described above, the subject also has bilateral epicanthus and bilateral retinal dystrophy. The patient was first seen at the institution for an eye examination at 5 years of age. She had a history of myopia and an oculodigital reflex but no nyctalopia or photosensitivity. Paternal family history was positive for myopia and retinal detachment. Examination showed no paradoxical pupillary constriction in the dark or visual field constriction to confrontation and the optic nerves were pink with a scleral crescent, but the retinal arterioles were attenuated. However, the optic nerve looked normally developed at this stage (Fig. 1C). The girl also had ptosis and epicanthus. In view of the oculodigital reflex and arteriolar attenuation, an ERG was performed that showed severe loss of rod greater than cone photoreceptors, indicating a retinal dystrophy (Fig. 1D-E). She developed photosensitivity and difficulty adapting indoors after being outside. The optic nerves showed evidence of mild to moderate atrophy two years later, but the ERG remained relatively stable. At no time did she have nystagmus or strabismus. Examination remained relatively stable at age 9 years except for an increase in her myopia. She was unable to perform optotype acuity testing. Upon exome sequencing a single mutation in the CASK gene is observed (NM_003688.3(CASK):c.626T>C (p.Leu209Pro); Variation ID: 432816). The variant was not observed in either parent, indicating that the mutation was de novo.\\nThis mutation has been previously reported as a loss-of-function mutation, although the mechanism underlying the pathogenicity is not clear. The substituted leucine in CASK\\'s CaMK domain (Fig. 2A) at position 209 is highly conserved in all species surveyed (Fig. 2B), indicating that it may be a critical part of CASK\\'s primary structure. The leucine is situated in the alphaF helix of the C-terminus lobe of the CaM-kinase domain (Fig. 2D). None of the CaM-kinases in the human kinome contain a cyclic amino acid at this site. A change in the side chain at this position is thus likely to alter intra-molecular interactions and produce secondary and tertiary structural defects. Molecular dynamics (MD) simulations were done to computationally model the movement of CASK at the atomic level over a period of time at room temperature in an aqueous environment; MD simulations can provide insight into the impact of a mutation on a protein\\'s structure, if an atomic model of the wildtype structure is available. When MD simulations were done on the isolated CaM-kinase structure (a previously solved crystal structure, an analysis of the simulations indicates that the addition of a proline at this position does not destabilize the overall structure of the isolated domain, as indicated by the nearly identical average radii of gyration (19.37398A+- 0.20033 and 19.5173A +- 0.254 for wildtype and CASKL209P, respectively) and root mean square deviation of the backbone relative to the starting structure (1.57455A +-0.31 and 1.52034A +- 0.29 for wildtype and CASKL209P, respectively) over the course of the 100 ns MD trajectories for CASKL209P structure as compared to the wildtype structure (Fig. 2C). MD simulations, by their very nature, yield millions of individual protein conformations, but most of these conformations differ from each other very little. A cluster analysis allows investigators to identify and then examine the most common structure(s) populated during an MD simulation. When the two structures representing the most populated cluster are superimposed using the MatchMaker tool in Chimera, the root mean square deviation between the two structures is 1.252A; for comparison, structures of identical proteins within the Protein Databank can exhibit RMSDs up to 1.2 A, due to variability arising from inherent protein flexibility as well as the resolution limits of the methods used to determine protein structure. From the MD trajectories, calculations of the root mean square fluctuation (RMSF) of the alpha-carbons for both wildtype and CASKL209P were done to, in turn, calculate B-factors at each amino acid position within the CAMK domain. B-factors provide a measure of mobility at a given site, and a comparison between B-factor values by sequence position revealed very few dramatic differences throughout the domain due to the L209P mutation, with the exception of increased mobility in two specific regions (Fig. 2D,E), both located in the activation loop of the CAMK domain: residues 166-168 and 174-176. Both the alphaF helix, where the L209P mutation is located, and the activation loop, which is predicted by the MD simulations to be impacted by the L209P mutation, are considered critical structural components of the core kinase domain, but these changes do not point, in isolation, to a global unfolding of CASK\\'s CAMK domain due to the L209P residue. These simulations are done on an isolated domain of CASK, however, making it impossible to rule out the possibility of disruption of native inter-domain contacts.\\nWe have previously published a simple assay to test structurally unstable CASK mutations. This involves transient over-expression of a GFP-CASK fusion protein using a strong cytomegalovirus promoter (CMV) in human embryonic kidney (HEK 293) cells. Typically GFP-CASK can be visualized using a confocal microscope and is evenly distributed throughout the cytoplasm but excluded from the nucleus (Figure 3A). Misfolding of CASK leads to formation of visible \"cotton-wool\"-like aggregates in the cytoplasm. Upon overexpression of CASKL209P, aggregates are readily observable, indicating that the protein has a tendency to misfold and aggregate (Figure 3B). In cells where large aggregates are not observed (67%) (Figure 3C), we observe a small punctate distribution not previously seen with the other mutations that we have tested. CASKL209P thus may also be producing much smaller aggregates, thereby resulting in an underestimate of the amount of protein aggregation caused by this mutation. We therefore tested the solubility of CASKL209P by transfecting HEK293 cells with GFP, GFP-CASK and GFP-CASKL209P and solubilizing after 2 days in culture using a solubilizing buffer. Both endogenous CASK and GFP-CASK exhibited a high degree of solubility with little protein left in pellet (Figure 3D). CASKL209P, however, was less soluble, with large amounts remaining in pellet. Thus our data indicate that the L209P mutation results in a propensity for CASK to misfold in a disordered manner, reducing the amount of soluble and possibly functional protein present in the cell.\\nTo determine if the small amount of solubilizable CASKL209P retained any functionality, we examined the biochemical competence of CASKL209P. In previous work, we demonstrated that CASK mutations associated with microcephaly disrupt the interaction between CASK and neurexin. We therefore first tested the interaction between CASKL209P and neurexin in a cellular milieu using a previously described recruitment assay. The assay relies on the ability of membrane-bound neurexin to recruit the cytosolic protein CASK. The recruitment can be easily observed using a confocal microscope in a large, flat cell (with a high cytosolic-to-nuclear ratio) such as HEK293 cells (Figure 4B). Although CASKL209P aggregates in many cells, neurexin is still able to recruit some CASKL209P, indicating that soluble CASKL209P retains its capacity to interact with neurexin (Figure 4D). This finding was confirmed using a GST pull-down experiment (Figure 5A). The cytosolic tail of rat neurexin-1 fused with GST was expressed, purified, and immobilized on glutathione beads. GST-neurexin cytosolic tail (GST-Nx-CT) beads were used to precipitate CASK (both wild-type and CASKL209P) that was expressed in HEK 293 cells. The results from the pull-down experiment confirm that the soluble population of CASKL209P retains its ability to interact with neurexin.\\nCASK is a scaffolding protein involved in an evolutionarily conserved ternary complex with Mint1 and Veli. Veli interacts with CASK via its L27 domain whereas Mint1 interacts with CASK via its CaMK domain. To determine whether CASKL209P is capable of forming this ternary complex, GFP-CASK was expressed in HEK293 cells, and the lysate from these cells was combined with rat brain lysate to allow the exogenous CASK to form complexes with brain-derived proteins (Figure 5B). GFP-CASK was then immunoprecipitated with GFP antibodies, and immunoprecipitates were blotted for Veli and Mint1 (Figure 5D), revealing that CASKL209P can still bind to Veli, but its interaction with Mint1 is disrupted. The L209P mutation in CASK is thus likely to disrupt its regulatory scaffolding function that links neurexin to molecules like Mint1.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 60,\n",
       "    'case_id': 'PMC5998277_01',\n",
       "    'case_text': 'A 60-year-old male with nonalcoholic steatohepatitis-induced cirrhosis complicated by portal hypertension and esophageal varices presented to the hospital for shortness of breath and respiratory distress. He had multiple prior hospitalizations and was undergoing evaluation for liver transplant. His MELD score was 19 on admission. There was a concern for pneumonia on presentation and he was started on empiric reatment with broad-spectrum antibiotics. On hospital day four, he experienced worsening respiratory distress and developed hypoxic respiratory failure. This occurred despite optimal use of diuresis, noninvasive ventilation and paracenteses. He was intubated on hospital day five. On the day of intubation, his total bilirubin was 2.1, serum creatinine 1.65, international normalized ratio (INR) 2.4 and serum sodium of 142 (MELD of 16). Mechanical ventilation was with assist control with tidal volumes of 350 mL, rate of 32, PEEP of 16 on 90% FiO2. Arterial blood gas showed a pH of 7.25, CO2 of 55, and O2 of 116.\\nAfter intubation, he had progressive and refractory hypoxemia requiring increasing PEEP with high FiO2 to maintain oxygenation. Four days after intubation, he was found to have large apical bilateral pneumothoraces that required emergent bilateral chest tube placement. The development of bilateral pneumothoraces was in part due to increasing PEEP to meet the oxygenation demands. He had progressive coagulopathy during his ICU course as his INR was 4.2 and PT 46.8. It was felt that urgent correction of coagulopathy was required prior to the procedure, and that it should be done without excessive volume administered. Therefore, he was given 2.9 million units of 4-factor prothrombin complex concentrate (4F-PCC) (based on weight) and within 1 h following administration his INR was measured at 1.5. Subsequently, bilateral chest tubes were placed. There was an immediate improvement of oxygenation, and there were no bleeding complications. One day after the placement of the bilateral chest tubes the patient died from ongoing hepatic decompensation.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 33,\n",
       "    'case_id': 'PMC6586124_01',\n",
       "    'case_text': 'A 33-year-old Caucasian female, Gravida 2 Para 2, presented to the emergency department with sudden onset of moderate sharp left-sided pleuritic chest pain and SOB for one day. She had a past medical history of factor V Leiden (diagnosed at age 16) and a family history of factor V Leiden and deep venous thrombosis (DVT) in her mother. She denied any previous VTE, recent surgery, prolonged immobilization, anticoagulant use, smoking or cancer. On further questioning, she admitted having a progestin intrauterine device placed nine months ago.\\nReview of systems was positive only for the chief complaints. Physical exam showed shallow breathing due to pain on deep inspiration. Heart rate was 88 beats/minute and temperature 98.8 F; lung exam revealed bilateral normal vesicular breath sounds with no wheezes or crepitation; no leg edema, or calf tenderness. The rest of the physical exam was unremarkable.\\nFirst sets of labs including, complete blood count (CBC), complete metabolic panel (CMP), troponin, arterial blood gas (ABG) and urine toxicology were within normal limits.\\nElectrocardiogram (EKG) (Figure 1) showed sinus rhythm with a rate of 78, T wave inversion in Lead 3 and V3. Echocardiogram showed normal ejection fraction (55-60%) with no right ventricular strain pattern. Her D-dimer level was elevated,1440 ng/ml, (normal limits 0-500 ng/ml). Lower extremity venous Doppler showed no evidence of deep venous thrombosis.\\nDue to the high suspicion of PE, computerized tomography pulmonary angiography (CTPA) (Figures 2 and 3) was done which revealed bilateral subsegmental pulmonary embolism. It also showed mild subsegmental pulmonary infarctions of the lower lobes. She was started on subcutaneous enoxaparin and later transitioned to apixaban (Eliquis). During her hospital stay, she was hemodynamically stable. Her chest pain persisted for a couple of days and ultimately resolved with analgesia. She was discharged on the 3rd day, to follow up as outpatient.\\nShe was counseled about avoidance of risk factors and to follow up with hematology and gynecology clinic for removal of her IUD on discharge.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 39,\n",
       "    'case_id': 'PMC5899866_01',\n",
       "    'case_text': 'A 39-year-old otherwise healthy male with newly diagnosed mixed-lineage acute monocytic and B-cell lymphoblastic leukemia was transferred to our institution for initiation of chemotherapy. Prior to transfer, he had received intrathecal methotrexate and oral dexamethasone, as well as vancomycin and cefepime for neutropenic fever and positive blood cultures growing gram-positive cocci. At our institution, the patient was started on GRAALL (Group for Research on Adult Acute Lymphoblastic Leukemia) 2003 chemotherapy. He received cefepime and vancomycin for persistent neutropenic fevers. Eventually, cefepime was switched to meropenem due to development of multifocal pneumonia during his hospital course. Shortly thereafter, liposomal amphotericin was initiated for presumed invasive pulmonary aspergillosis after a bronchoalveolar lavage (BAL) from a diagnostic bronchoscopy revealed a positive galactomannan antigen; however no organisms were seen on gram stain or identified on culture. He was treated with vancomycin for 8 days and meropenem for 17 days, after which he defervesced. Nevertheless, fevers recurred on hospital day 20 and shortly after; blood cultures returned with gram-negative rods at which point vancomycin and cefepime were reinitiated.\\nThree days later (hospital day 23), the patient reported pain and developed swelling and erythema of his left forearm. On physical examination, the left forearm was swollen, tense, and erythematous, but there were no areas of fluctuance, subcutaneous crepitance, or bullae noted. Duplex ultrasound of the upper extremities showed no evidence of deep vein thrombosis. However, given the acute onset of pain and swelling, orthopedic surgery was consulted for possible necrotizing infection and compartment syndrome. Laboratory testing disclosed a c-reactive protein (CRP) of 12.90 mg/dL, a white blood cell count of less than 0.1 x 109/L, a sodium of 142 mmol/L, a glucose of 110 mg/dL, a hemoglobin of 7.2 g/dL, and a creatinine of 0.96 mg/dL, yielding a LRINEC score of 2. It was felt, partly due to this low score, that the patient had a severe cellulitis without necrotizing infection or compartment syndrome. Moreover, based on the patient\\'s clinical picture and the available data at the time, invasive testing for compartment syndrome was deemed unnecessary by the orthopedics service. No additional imaging was ordered at this point. Within 10 hours, the swelling and pain had progressed to his entire left upper extremity (Figure 1) and the patient developed hypotension. He was then transferred to the intensive care unit for refractory septic shock and severe metabolic derangement. At this time, laboratory studies were notable for a CRP of 18.80 mg/dL, a white blood cell count of 0.2 x 109/L, a sodium of 142 mmol/L, a glucose of 116 mg/dL, a hemoglobin of 5.9 g/dL, and a creatinine of 1.06 mg/dL yielding a LRINEC score of 6. The patient continued to clinically decline rapidly despite broadening of his antibiotic regimen (vancomycin, meropenem, gentamicin, and amphotericin B) and was taken to the operating room by the orthopedic surgery service due to concern of a rapidly progressing NSTI.\\nIn the operating room, the entire left upper extremity was prepped, and an initial incision was made over the dorsum of the hand. Exploration of the surrounding tissue revealed necrotic fat, hemorrhagic changes, and gross edema. The expressed fluid was tan but did not have the classic \"dishwater\" appearance of necrotizing fasciitis, nor was it malodorous. The fascia was thickened and opaque. A counterincision was then made proximally over the biceps muscle in the proximal brachium (Figure 2). This region displayed the same tan drainage with associated fat necrosis, and thrombosed vessels were also appreciated in the subcutaneous tissue. Regions of the thickened, diseased-appearing fascia were excised, revealing that the underlying musculature appeared necrotic, noncontractile, and nonviable.\\nAt this point during the procedure, the anesthesiologist noted that multiple vasopressors were being used to maintain the patient\\'s blood pressure, and there was concern that he was clinically deteriorating. Given the extensive involvement of, essentially, the entire limb and the concern that the bacterial load could not be adequately controlled in this hemodynamically unstable patient, the decision was made to proceed with an emergent glenohumeral amputation. The deltoid muscle remained healthy-appearing and contractile, and thus a lateral-based flap composed of the deltoid and overlying skin and soft tissue was planned. Once the amputation was performed, the wound was copiously irrigated using several liters of normal saline to minimize the remaining bacterial load. Hemostasis was subsequently achieved, a drain was placed, and the flap closure was completed. The patient\\'s hemodynamic status improved during closure, and he was transferred back to the intensive care unit for continued care.\\nThe previously drawn blood culture returned on postoperative day (POD) 0, growing Stenotrophomonas maltophilia in both aerobic and anaerobic cultures, at which point trimethoprim-sulfamethoxazole was initiated. Pathology of the surgical specimen confirmed the diagnosis of a NSTI, and multiple tissue cultures grew only S. maltophilia. Despite appropriate antibiotic therapy and surgical intervention, the patient remained persistently bacteremic and in refractory shock despite aggressive medical therapy. On POD1, new necrotic skin areas were noted at the surgical site, and cardiothoracic surgery was consulted to evaluate further surgical intervention. The team decided against this, given the patient\\'s very poor prognosis. After discussion with the family, the patient was transitioned to comfort care and passed away shortly thereafter.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 66,\n",
       "    'case_id': 'PMC6180851_01',\n",
       "    'case_text': 'A 66-year-old female with a history of endometrioid endometrial carcinoma was sent to our institution with abdominal and pelvic pain. The physical examination and laboratory results were unremarkable. The creatinine level was 0.81 mg dl-1. A contrast-enhanced abdominal and pelvic CT scan was performed that revealed a mass with a fatty density within the right upper kidney and a tumour thrombus that extended through the right renal vein up to the point of confluence with the inferior vena cava (IVC).\\nrenal angiomyolipoma (AML)\\nperirenal liposarcoma\\nrenal cell carcinoma (RCC)\\nrenal oncocytoma.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 62,\n",
       "    'case_id': 'PMC5771915_01',\n",
       "    'case_text': \"A 62-year-old woman was referred to the emergency department in our hospital due to a body height fall. She was presented with severe pain in her left hip and the inability to walk. Her following examination revealed a 30-year-old femoral neck fracture. The option of treatment at that time was an arthrodesis of the left hip. Having presented with the history of trauma, we did not take into consideration a proximal femoral malignancy. However, Ungureanu et al. stated in their study that tumoral growths can be kept hidden under adipose tissue or local swelling located at the thigh level and they could appear concurrently with trauma 3. Therefore, the differential diagnosis was made using the patient history and the CT description given by the radiology specialist. A standard emergency anteroposterior radiograph revealed an intertrochanteric fracture, severe deformity of the left hip joint, and the migrated implants used for the arthrodesis (Fig. 1). Computed tomography (CT) imaging of the left hip joint showed a displaced intertrochanteric fracture distal to the ankylosed hip joint, some artifacts due to the osteosynthesis material, and marked atrophy of the gluteus muscles (Fig. 2). Due to the rarity of the pathology, several discussions with fellow surgeons were needed to establish what the best therapeutic option was. We decided to perform a surgery to remove the osteosynthesis material used for arthrodesis of the left hip and then perform the internal fixation using a locking plate and locked screws (Fig. 3). The patient was positioned in dorsal decubitus; we used a lateral approach (a skin incision reaching approximately 5 cm proximal and 15 cm distal from what used to be the tip of the greater trochanter). Intraoperative passive mobilization of the limb was realized to outline some intraoperative anatomical landmarks. After initial hardware removal, normal femoral rotation was re-established and checked intraoperatively using the C-arm. A rigid secondary fixation was realized using a locked plate and 13 locking screws. Postoperatively, the patient's evolution was good, and after 2 weeks, she could walk using double crutches. Postoperatively after 3 months, the fracture showed signs of consolidation.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 63,\n",
       "    'case_id': 'PMC6267726_01',\n",
       "    'case_text': 'A 63-year-old woman with short stature (148 cm) was admitted because of a sudden onset confusion. One week ago, the patient started developing auditory and visual hallucinations, as well as disorganized speech. She was unable to communicate at that time. However, symptoms improved without treatment 1 day later. Her past medical history was notable for well-controlled hypertension and diabetes mellitus. She had a history of \"cerebral infarction\" 2 years ago and developed stroke-related psychotic symptoms including agitation and confusion. With the diagnosis of stroke at that time, she was treated then and improved afterward. For family history, her older sister died from \"stroke\" at the age of 45. Her mother also died at an early age for unknown reasons.\\nThe neurological examination was unremarkable except for bilateral hearing loss and bilateral positive Babinski sign. Routine laboratory investigations revealed no abnormalities excepted for a slightly elevated creatine kinase (214 U/L, reference range: 15-195 U/L). The head computed tomography scan on admission showed a lesion with low density in the left occipital lobe. The diagnosis of ischemic infarction was given considering the patient\\'s presentation and a history of hypertension and diabetes mellitus. Treatment with aspirin and atorvastatin was started. Brain MRI afterward, however, showed a lesion in the left temporal-occipital lobe with long T1 and T2 signals, and high signals on flow attenuated inversion recovery (FLAIR) sequence (Figure 1) as well as a slightly increased signal on diffusion weighted imaging (DWI). The brain magnetic resonance angiography was normal. Unexpectedly, the patient\\'s symptoms suddenly deteriorated 2 weeks after admission. She developed acute psychosis and right-sided hemiparesis (muscle strength of the right limbs 1/5). Mixed nonfluent aphasia was also identified on further evaluation. The patient underwent another MRI showing lesions with abnormally high signals on FLAIR and DWI with poorly defined margins along the gyri in the left occipital-temporal lobe, which was slightly enhanced after gadolinium enhancement (Figure 2). Similar episodes of psychotic symptoms and aphasia relapsed five times ever since, each lasting hours to days, and she completely recovered every time. Other tests including cerebrospinal fluid examination, autoimmune encephalitis-related antibodies, and long-term electroencephalography were nonrevealing.\\nOn further investigation of the history, the patient recalled a progressive decline of bilateral hearing from 2 years ago and was almost deaf since last year. The lactate of venous blood was measured, showing 3.7 mmol/L at rest (reference range: 0.5-2.2 mmol/L), and the lactic acid after exercise was not obtained because the patient refused to undergo further investigations. The patient was suspected of mitochondrial disease due to the combination of recurrent stroke-like episodes, short stature, hearing loss, and an elevated lactic acid at rest. The blood genetic test suggested a low-frequency (<20%) mutation of m.3243A.G. After being treated with arginine, vitamin E, and coenzyme Q10 for 1 week, the patient dramatically improved. The muscle strength recovered, and there were no residual psychotic symptoms or aphasia on discharge.\\nThis case study was approved by the institute ethics committee of the Hangzhou Red Cross Hospital. Written informed consent was obtained from the patient to publish the case details.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 10,\n",
       "    'case_id': 'PMC7661465_01',\n",
       "    'case_text': 'A 10-year-old previous health boy was presented with intermittent dyspnea and chest pain over one month without syncope. His older brother was diagnosed with cardiomyopathy in 2001, characterized with enlarged right ventricle and perforated RV, and suddenly died at 16 years old after running in 2007. His mother occasionally had chest tightness. Her ECG reveals T wave inversion in leads of III, V1,V2, and V3, and her Echo revealed a slight decrease of diastolic function, other measurements are in normal range.\\nAbout one month ago, he felt labored dyspnea, and 1 week later he was diagnosed with myocarditis in a local hospital and treated with digoxin, diuretic and myocardium nutrition. Then his symptom released. One week after that, he had dyspnea again and 10 days later was admitted in our pediatric cardiology department. Physical examination showed he was in a general state, Heart Rate 88 bpm, Respiratory Rate 19 bpm, BP 112/72 mmHg, weight 44 kg. No edema on the face and legs, heart sounds strong, without murmur, but rhythm was irregular, auscultation revealed 5 premature beats in 1 min. The liver was 3 cm below right costal margin. Admission blood test revealed normal cTnI, hs-cTnT, CK-MB mass, and NT-pro BNP. Echo showed the right ventricular (RV) was significantly dilated (RV diameter 31.8 mm), RVED/LVED = 0.67, the wall of the RV became thinner, interwoven reticular muscle fiber structure can be seen in the RV (Figure 1). ECG showed epsilon wave and paired PVC (Figure 2a). Holter showed paired PVC and premature atrial contractions (PAC). Cardiac magnetic resonance imaging (CMRI-in local hospital) revealed a dilated right ventricular outflow tract, thin right ventricular wall with reduced wall motion, and foci of fatty deposit in the right ventricular free wall (Figure 1). Genetic testing finds DSG2 mutation (R49H), which has been indicated to be associated with ARVC. The patient was diagnosed of ARVC.\\nHis father rejected the prescription of betaloc as a treatment for its side effect in reducing sexual function. The patient was treated with aspirin (50 mg, qd po), propafenone (200 mg, q8h), enalapril (5 mg qd), furosemide (20 mg qd, oral 4 days a week), and spironolactone (20 mg qd, oral 3 days a week). At admission, his ECG showed QRS was nearly normal, 118 ms (Figure 2a). QRS duration in this article is measured with V5 andII leads. But on the second day after taking oral propafenone, he developed dizziness and his ECG showed QRS was 158 ms. On third day of oral propafenone, QRS was increased to 170 ms (Figure 2b). We reduced the dose of propafenone by half, and on next day, QRS was reduced to 120 ms (Figure 2c). After 1 month treatment, his ECG showed QRS was 164 ms. Therefore, we discontinued propafenone and replaced with sotalol (80 mg, q12 h), and gradually increased the dose to 120 mg. q12 h. At 3 month of illness, QRS was 114 ms; AECG showed PVC 3001/d with paired PVC. Sotalol was then reduced to 80 mg q12 h. At 6 months of illness, QRS returned to normal:ECG showed QRS was 124 ms (Figure 2d). The boy felt better, and the symptoms of dyspnea and chest pain were released.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 17,\n",
       "    'case_id': 'PMC2787018_01',\n",
       "    'case_text': 'A 17-year-old male was referred to the pediatric gastroenterology clinic due to elevated transaminases noted during standard screening blood work. The patient had a history of type I diabetes mellitus (T1DM) diagnosed since 5 years of age with the patient having multiple hospital admissions for diabetic ketoacidosis secondary to noncompliance with insulin therapy. Past medical history was significant for pyloric stenosis repair at 4 weeks of age and a prior history of tonsillectomy and adenoidectomy. Family history was noncontributory. His current medication consisted of Humalog Mix 75/25 insulin (Eli Lilly and Company) with the patient receiving approximately 1.3 units of insulin per kilogram body weight. \\nThe patient had no history of jaundice or scleral icterus, and he denied right upper quadrant pain, pruritis, weight loss, ascites, hematemesis, or rectal bleeding. A review of his blood glucose monitoring demonstrated a range of 250-310 milligram per deciliter (mg/dL), and he had a hemoglobin A1c of 12.3% suggesting poor glycemic control. \\nA liver ultrasound showed normal hepatic echotexture and minimal sludge in the gallbladder (Figure 1). A complete blood count, prothrombin time, activated partial thromboplastin time, lipid panel, free thyroxine level, and tissue transglutaminase serum IgA level were normal. However, transaminases were elevated with an aspartate aminotransferase (AST) and alanine aminotransferase (ALT) consisting of 63 international units per liter (IU/L) and 209 IU/L, respectively. Direct bilirubin, alkaline phosphatase, and gamma-glutamyl transpeptidase levels were normal. A viral hepatitis panel, serum ceruloplasmin, and alpha 1-antitrypsin phenotype were normal. The patient was noted to have an elevated ANA titer (1 : 160 in a homogenous pattern). Screening for smooth muscle antibody was negative, and it was decided that a percutaneous liver biopsy should be performed due to the possibility of type 1 autoimmune hepatitis. \\nA subsequent liver biopsy demonstrated normal portal tracts (H&E 100x, Figure 2(a)); however, hepatocytes demonstrated cytoplasmic clearing secondary to increased intracellular glycogen and microvesicular fat (H&E 200x, Figure 2(b)). This biopsy was consistent with Mauriac syndrome and the importance of improved adherence to insulin therapy was expressed to the patient and his family.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 66,\n",
       "    'case_id': 'PMC7391113_01',\n",
       "    'case_text': 'A 66-year-old man was admitted to our hospital with complaints of severe pain in the abdomen, which persisted for over 48 hours. The medical history included a splenectomy after trauma and a posttotal gastrectomy for gastric cancer. On admission, tenderness and involuntary guarding were observed in all quadrants of the abdomen. Additionally, the patient developed fever (temperature of 39 C) and was hemodynamically unstable with a blood pressure of 90/50 mm Hg and a heart rate of 120 bpm. On physical examination, skin discoloration was observed around the right side of the abdomen with tense edema. Laboratory tests revealed a C-reactive protein level of 18.0 mg/dL (range, 0-0.30 mg/dL), white blood cell count of 2700/mm3 (range, 3300-8600/mm3), and an elevated serum creatine kinase level of 1977 U/L. Abdominal contrast-enhanced computed tomography (CT) showed fluid collection, an air pocket in the subcutaneous fat layer of the abdominal wall, and edematous changes in the adipose tissue in the peritoneum and abdominal wall (Figure 1(a)). Inflammatory changes were observed around the ascending colon (Figure 1(b)). Based on a diagnosis of peritonitis resulting from a perforated ascending colon, an emergency operation was performed. Extensive necrosis of the retroperitoneal fat was observed around the ascending colon where the inflammation was severe. In addition, necrotizing fasciitis was suspected in the abdomen due to an infection caused by the perforated ascending colon. The patient was immediately managed with an intravenous administration of a broad-spectrum antibiotic (meropenem at 1.5 g/day). A right hemicolectomy, ileostomy construction, and debridement of necrotic tissues were performed (Figure 2(a)). The stump of the ascending colon was closed without colostomy. The pathological findings of the resected specimen revealed peritonitis and ischemic changes, and the ascending colon was noted to be very thin; however, no malignancy was detected. (Figure 2(b)).\\nTwo days following the initial operation, the skin discoloration around the right side of the abdomen reappeared, which indicated widespread necrosis of the abdominal wall fascia (Figure 3(a)). The follow-up CT showed necrotizing fasciitis spreading up to the right lateral chest wall, along the right lateral abdominal wall, and extending to the right groin. A second operation was performed, and the necrotic tissue was debrided from the level of the right abdominal wall to the damaged skin and subcutaneous tissue on the right side of the chest wall (Figure 3(b)). This resulted in a significant abdominal wall defect. The intestine, inferior vena cava, and right kidney were exposed (Figure 3(c)). A closure of the wound defect was planned using the ABThera  System to remove exudate and promote wound healing (Figures 4(a)-4(d)). Under local anesthesia, repeated surgical debridement was performed, and the NPWT dressing was changed 3 times a week for 4 weeks. Following the application of NPWT set at 125 mmHg of continuous negative pressure, extensive debridement and NPWT successfully contributed to the wound bed healing. The size of the open wound with visible granulation tissue significantly reduced with no complications such as an enteric fistula (Figures 5(a)-5(c)). After 4 weeks of NPWT, the wound beds were sufficiently developed for plastic surgery. Finally, the defect in the abdominal wall was covered by a mesh split-thickness skin graft and an anterolateral thigh flap (Figure 5(d)). The patient was discharged 63 days after admission and was regularly followed up at the outpatient department for 6 months without complications (Figure 6).',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 76,\n",
       "    'case_id': 'PMC4763553_01',\n",
       "    'case_text': 'A 76-year-old male with a past medical history of coronary artery disease, status post coronary artery bypass graft and chronic anemia presented to the emergency department after he developed episodes of chest pain and pre-syncope. He denied any non-steroidal drug or alcohol use.\\nOn presentation, he was normotensive with a sinus tachycardia. His hemoglobin was 6.1 mg/dL, and the platelet count was 202.0 mg/dL. Initial fecal occult blood test was negative. He received multiple blood transfusions for his symptomatic anemia with a goal hemoglobin of greater than 7.0 mg/dL. There was a transient increase in his hemoglobin. A computerized tomography (CT) scan of the abdomen and pelvis without contrast did not reveal any bleeding source.\\nThe following day the nurse witnessed him having a significant amount of hematochezia. Subsequent upper and lower endoscopy was done that revealed two 5 mm blue venous blebs in the esophagus and multiple patches of blue venous blebs throughout the colon (Figs. 1 and 2). Given the absence of active bleeding, no endoscopic intervention was undertaken. Through the course of his hospitalization, the patient received a total of five units of blood. He was managed medically with oral iron and periodic monitoring of his hemoglobin.\\nOne year after initial diagnosis, the patient is doing well on oral iron supplementation, and his hemoglobin is being closely monitored by his primary care physician.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 68,\n",
       "    'case_id': 'PMC3546216_01',\n",
       "    'case_text': \"One month before visiting our pain clinic, a 68-year-old female patient with vesicles and pain on the left side around the navel was diagnosed with herpes zoster and received treatment at a local hospital. Although the skin rash improved, the patient, at times, felt squeezing sensations on her left flank. When the patient was referred to the pain clinic, the patient had a squeezing pain and scars of vesicles on the T10 dermatome level on the left side and her numeric rating scale (NRS) was 5 (out of 10). She felt the squeezing pain several times for approximately one minute each time. Aside from a history of hypertension, there was no other unusual medical history or a history of prior surgeries. She was 152 cm tall and 51.2 kg in weight. Laboratory examinations showed no signs of bacteria or viral infection. Complete blood cell count, prothrombin time and activated partial thrombin time tests showed normal results, and there were no abnormal results in the serologic tests (HBs Ag/Ab, HIV Ag/Ab, quantitive VDRL).\\nAfter diagnosis of postherpetic neuralgia, the patient received an epidural block once a week for a total of six weeks. We performed the epidural block with 8 ml of 0.8% mepivacaine with the paramedian approach to T10-T11 with the 'loss of resistance' method. Out of six total procedures, only the first procedure included 20 mg of triamcinolone with local anesthetics, and the rest were composed of local anesthetics only. Any signs or symptoms suggestive of dural puncture, such as cerebrospinal fluid (CSF) aspiration through the block needle, headache, paresthesia or sensory impairment were not observed during each epidural block. Pregabalin 150 mg and amitriptyline 5 mg were also prescribed for twice a day. After each epidural block, a pain free period continued for two or three days but she felt numbness like prior to the procedure. Additionally, the squeezing pain reappeared but the pain intensity was reduced to NRS 3. Thus, we expected full recovery by repetitive epidural blocks and by an additional root block or transforaminal epidural block.\\nTwo days after the sixth epidural block, the patient was admitted to the department of neurology, through the emergency department, because the patient felt continuous dizziness and motor weakness in both lower extremities. Five days prior to receiving the sixth epidural block, the patient began to feel slightly dizzy. However, the continual dizziness became extreme by the time the patient was admitted to the hospital. Motor weakness of the lower extremities was felt by the patient two days after the final epidural block. In addition, the patient had symptoms of nausea and vomiting. The patient also could not stand or walk alone. The patient's body temperature was 38.3C and she did not have any abnormalities on her skin. Physical examination showed a grade III motor weakness in both of the lower extremities, but the deep tendon reflex and cerebellar function tests were normal. Sensory impairment was not observed. She was referred to our pain clinic, because a complication during an epidural block was considered by neurologists. We reviewed the sixth epidural block, examining for any evidence of dural puncture, aspiration of blood and other abnormal events, but there were none. However, in order to be certain, we performed Magnetic Resonance Imaging (MRI) and CSF tests on the first day of admission. The MRI showed no signs of hematoma, abscess, or arachnoiditis (Fig. 1). No bacteria were detected upon CSF analysis. Considering the results, we were able to exclude the possibility of an epidural block complication. The CSF analysis results showed, however, a mild increase in the WBC count (49,000 count/mm3) and a protein level of 97 mg/dl. Virus serology test of the blood and the CSF showed negative anti-IgG and negative anti-IgM antibodies for herpes simplex virus (HSV) and herpes zoster. Two days after the patient was admitted, the patient complained of urinary difficulty and a Foley catheter was inserted, resulting in discharge of 1,200 ml of urine through the catheter. The patient felt squeezing pain on the T10 dermatome level on the left side during her entire stay at the hospital.\\nConsidering her clinical progressions and the increase in protein level in the CSF analysis, herpes zoster myelitis was diagnosed by the neurologist and appropriate treatments commenced. Three days after the patient was admitted, the patient was given intravenous acyclovir 1.6 g and dexamethasone 20 mg daily for two weeks. The patient also received exercise rehabilitation treatment while she was on the medication. After receiving treatment for one week, the patient was able to walk but had difficulty in standing up. The patient showed gradual improvement and four weeks later made a full recovery in motor function. The patient's urinary difficulty improved through urinary training and she fully recovered in eight weeks.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 57,\n",
       "    'case_id': 'PMC3350111_01',\n",
       "    'case_text': \"The patient was a 57-year-old female who presented to the trauma bay of a university trauma center via intrafacility transfer after a motor vehicle collision in which her vehicle rolled down an embankment. She was hemodynamically stable and with a Glascow Coma Score of 15. Computed tomography of her chest abdomen and pelvis revealed an aortic injury consistent with transection and left hemothorax with associated atelectasis. Her blood pressure was stable, and her hemoglobin and hematocrit were within normal limits. She had several comorbidities which included chronic obstructive pulmonary disease, diabetes mellitus, hepatitis C, hypertension, history of thyroid cancer status post thyroidectomy, and asthma. \\nShe was admitted to the surgical critical care unit for strict blood pressure control and went to the endovascular suite with vascular surgery the following morning for a thoracic endovascular graft repair of the aortic injury. The case resulted in a midline laparotomy after deployment of the graft, lengthy lysis of adhesions, injury to the left gonadal vein resulting in one liter of blood loss, and finally retroperitoneal dissection and exposure of the infrarenal aorta and iliac arteries. Due to the extensive calcifications of the iliac vessels, the aorta was cannulated and the stent graft was deployed. Her abdomen was closed, and she was returned to the critical care unit.\\nThe patient's course in the critical care unit was long and complicated to include acute respiratory distress syndrome and prolonged mechanical ventilation. Due to high oxygen and positive end-expiratory pressure requirements, patient did not undergo a tracheostomy until hospital day number twenty-four. She subsequently had a PEG tube inserted a few weeks later. We continued to attempt to wean the patient from mechanical ventilation. Her Glasgow Coma Score improved significantly over the following weeks to the point she was alert and able to follow commands, attempting to verbalize. However, when patient was placed on tracheostomy collar trials, she became very anxious and tachypneic. This was felt initially to be due to anxiety. After several days of similar symptoms despite anxiolytics, patient developed a wheeze. She had no changes in her chest radiograph. We decided at that time to perform a flexible bronchoscopy and found tracheal collapse distal to the tracheostomy tube.\\nWe ordered a dynamic computed tomography scan of the chest to evaluate the extent of the tracheomalacia. Imaging revealed significant collapse of the distal trachea and main stem bronchi. It was decided to take her for video bronchoscope, rigid bronchoscopy, Dynamic Y-stent placement, and exchange of tracheostomy tube with a regular Shiley size 8 tracheotomy tube (Figure 3).\\nVideobronchoscopy was performed through the distal XLT (Extended Length) tracheostomy tube, and severe tracheobronchomalacia was noticed. The patient had almost complete collapse of the trachea distal to the tracheostomy tube and almost complete collapse of the left mainstem bronchus. Distal XLT tracheostomy tube was exchanged to regular Shiley size 8 tracheostomy tube. Videobronchoscopy was performed through the newly placed Shiley tracheostomy and measurements for the Y-stent taken. Rigid bronchoscopy was then done to ascertain that patient was rigidly intubatable for the deployment of dynamic Y-stent (Figure 2). After successful rigid bronchoscopy Y-stent was deployed under fluoroscopic guidance. The Y-stent limbs were well seated in the trachea left main stem bronchus and right main stem bronchus. \\nPostoperatively patient did well and was able to be weaned from mechanical ventilation. At three-month followup, patient is doing well with tracheostomy and stent in place. The plan is to follow the patient for stent and/or tracheostomy removal or replacement.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 81,\n",
       "    'case_id': 'PMC9705577_01',\n",
       "    'case_text': 'Our patient is an 81-year-old female was referred to our clinic by her endocrinologist after noticing that her right thyroid nodule had increased in size over the last 6 months. She has a medical history of renal cell carcinoma, hyperlipidemia, and type 2 diabetes. She had previously undergone an L nephrectomy in 1999 and a hysterectomy in 1990. She denied any previous use of tobacco, alcohol, or illicit drugs. She had a family history of stomach cancer in her mother.\\nThe original pathological diagnosis was mixed clear/granular cell adenocarcinoma, which is now labeled clear cell renal cell carcinoma (CC-RCC). At the time of diagnosis, the tumor was confined to the kidney, without angiolymphatic invasion. The nuclei were given a Fuhrman grade 4 due to the bizarre and often multinucleated nuclei, with heavy chromatin clumps and prominent nucleoli. One lymph node was examined and found to be negative for malignancy. Because the tumor was 7.8 cm in greatest dimension and limited to the kidney, it was a pathologic stage pT2a. In November 2016, the patient underwent a fine needle aspiration of her right thyroid. The specimen was adequate with follicular epithelial cells and scattered colloid, consistent with a benign follicular nodule. There was no evidence of malignancy; however, sampling bias is always an issue.\\nWith the recently reported increase in size, a repeat ultrasound was completed by her endocrinologist, and she was found to have a large right-sided nodule that was hypervascular measured 5.7 x 3.4 x 4.5 cm, and had increased in size from her previous ultrasound in 2018. She also noted occasional dysphagia. Her thyroid function testing reported normal levels of thyroid stimulating hormone and thyroxine. She denies any hoarseness or difficulty breathing. She was notified during the examination that she has a large nodule within the right thyroid that was irregular but without tenderness.\\nThe patient underwent a right-lobe partial thyroidectomy in June 2020. The history of CC-RCC was noted in previous pathology reports. The gross examination of the resected specimen demonstrated a \"well-circumscribed golden-yellow-tan mass\" in which there were areas of hemorrhage present. Histologic sections showed a partially encapsulated, nodular proliferation composed of monotonous, intermediate-sized cells, embedded within benign thyroid parenchyma (Figure 1). At higher power examination, the mass is composed of clear cells with centrally located nuclei, prominent nuclei, and abundant vascular capillary network (\"chicken wire\") characteristic of clear cell renal cell carcinoma (Figure 2). Immunohistochemical stains were performed to further evaluate the site of origin for the neoplastic cells. The renal markers PAX8 and RCC were positive, while the parathyroid and thyroid markers (PTH and TTF1) were negative. Pancytokeratin was focally reactive and the neuroendocrine marker synaptophysin was negative excluding an endocrine neoplasm. The morphologic and immunohistochemical features of this neoplasm, along with her known history, were most consistent with metastatic clear cell renal cell carcinoma.\\nThe patient\\'s PET/CT scan did not demonstrate any signs of residual or metastatic disease. Due to her advanced age and the 21 years between her initial disease and metastatic disease, our multidisciplinary tumor board elected to observe the patient with repeat PET in 4 months and not initiate chemotherapy at this time.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 12,\n",
       "    'case_id': 'PMC7687474_01',\n",
       "    'case_text': 'Mao et al. reported 36.4% of the 214 study participants hospitalized with COVID 19 had neurological manifestations. In our knowledge, there have been seven cases of Guillain-Barre syndrome [GBS] reported so far with five in Italy, one in Iran and one in the United States in patients with COVID 19 infection. In Italy, the first symptoms noted were lower limb weakness and paresthesia in four patients and facial diplegia followed by ataxia in one patient with symptoms of GBS occurring within 5-10 days from first onset of symptoms of COVID 19. Virani et al. reported a SARS-CoV-2 positive patient who developed progressive, ascending weakness consistent with GBS while in Iran is where the first case was reported describing symptoms of GBS in an infected patient with COVID 19. GBS is an acute immune mediated demyelinating disease which is progressive, ascending, symmetrical and involves flaccid paralysis of the limbs with areflexia or hyporeflexia with or without cranial nerve involvement with history of preceding respiratory or gastrointestinal infection 2-4 weeks prior in two third of cases. In this report, we describe GBS symptoms in a 12 year old infected patient with COVID-19 for the first time in Tanzania and Africa as a whole.',\n",
       "    'gender': 'Unknown'},\n",
       "   {'age': 12,\n",
       "    'case_id': 'PMC7687474_02',\n",
       "    'case_text': 'LB, 12 year old young man presented to the Emergency Department with symptoms of acute progressive symmetric ascending quadriparesis with bilateral facial paresis. He was asymptomatic a week prior and then he developed a low grade fever and a dry cough. He was managed conservatively and treated symptomatically. He complained of lower back pain 5 days prior to arrival to the ED which was rapidly followed by weakness of both lower limbs. He was able to walk initially and was taken to a local dispensary where he was administered an intramuscular analgesics and discharged. The next morning, he lost function of both lower limbs with associated weakness of bilateral upper limbs as well and could not get out of bed and this prompted the family to seek further medical attention. He was taken to the same facility again and advised to start physiotherapy with a provisional diagnosis of lumbar spondylitis. He was referred when he developed facial paresis bilaterally and an altered level of consciousness associated with an increased respiratory rate. In the emergency department, the mother provided the additional information of the low grade fever and cough from the week before which they had managed conservatively at home. There was no history of recent travel or contact with a positive case of COVID 19. There was no significant past history or any known co-morbidities.\\nVital signs on presentation were remarkable with a respiratory rate of 24 breaths per minute with oxygen saturation of 88% [hypoxic] on room air with a heart rate of 150 beats per minute and a blood pressure of 150/100 mmHg. The patient was barely conscious with a Glasgow Coma score of 6/15 and had signs of shock with cold extremities and diaphoresis. The child was placed on nasal prongs at 6L of high flow oxygen and connected to a cardiac monitor. Blood was drawn for lab investigations, an ECG was done and a chest X-ray ordered. Physical examination revealed decreased lower extremity strength and muscle tone compared to upper extremities with a score of 1/5 in lower extremities versus a score of 2/5 in upper limbs as per Medical Research Council [MRC] scale. Deep tendon reflexes were absent in all four limbs. Meningeal irritation signs and upper motor neuron disorder signswere absent. The bedside blood glucose was 11.0 mmol/L. His lab results showed a white blood cell count of 17.3 x103 cells/mL, hemoglobin of 14.6g/dL and platelet count of 361 x 103 cells/mL with an otherwise normal differential. Electrolytes and renal profile were within normal ranges with a blood urea nitrogen of 5.6 mmol/L, creatinine of 54.4micromol/L, sodium of 142, potassium of 4.6 and chloride 100. Chest X-ray revealed bilateral basilar opacifications suggestive of consolidation with diffuse infiltrates bilaterally. ECG showed a sinus arrhythmia with slightly tall and tented T waves (Figure 1). Bedside ultrasound revealed good cardiac contractility with a full Inferior vena Cava [IVC] and no pericardial or pleural effusion.\\nGiven the existing epidemiological scenario and preceding symptoms of fever and cough, COVID-19 infection was suspected. Appropriate isolation precautions were implemented, and a respiratory viral panel testing [nasopharyngeal PCR] was sent. Antibiotic coverage was done empirically and other treatment modalities done as required. Just prior to transfer to Pediatric Intensive Care [PICU], child lost pulse and Cardio-Pulmonary Resuscitation [CPR] was initiated with return of spontaneous circulation [ROSC] achieved within 1 cycle of the CPR. Child was intubated and ventilated and started on positive inotrope infusion. A diagnosis of GBS was made and patient was immediately started on 400mg/kg of intravenous immune globulin [IVIG] therapy for a planned 5-day course according to clinical manifestations related to GBS. The reverse transcription-polymerase chain reaction [RT-PCR] for COVID-19 was positive and further evaluation and management was continued in the ICU. Given the classic clinical picture of GBS in absence of other identifiable etiology for his neurologic disease and strict infection control measures, additional supportive testing was not pursued. His clinical course showed improvement in his respiratory status, neurological status as well as his consciousness level with an improvement of the GCS to 14/15 within 5 days. Neurologically, his upper extremity weakness resolved after completion of the course of IVIG. Lower extremity power and tone improved significantly. He was planned for weaning off ventilation and extubation on day 6, and eventual rehabilitation and discharge. During the night preceding the planned weaning, the child self extubated accidentally and rapidly decompensated. Cardiac arrest ensued and attempts to resuscitate after CPR were futile and child died.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 5,\n",
       "    'case_id': 'PMC3535818_01',\n",
       "    'case_text': 'We present a case of a five-year-old boy who presented with a slightly raised, painless lesion on base of the nose near the medial side of a the left eyebrow (Figure 1) since 6 months. On examination, there was nontender, firm nodule, measuring 0.5 cm in diameter. A fine needle aspiration cytology (FNAC) was performed with 23 G needle, and provisional diagnosis of mesenchymal neoplasm was rendered. The patient was advised excision biopsy for final diagnosis and behavior of neoplasm. Subsequently an excision biopsy was performed, and final diagnosis of DFSP was made based on the histopathological findings. \\nThe patient was then advised reexcision surgery with wide margins. Patient was lost to followup and later turned up after two months with recurrence of similar swelling at same site.\\nPathological Finding: May-Grunwald Giemsa (MGG) stained cytological smears showed scanty cellularity comprising few cohesive clusters and singly dispersed oval to spindle cells in hemorrhagic background (Figures 2 and 3). Tumor cells had oval hyperchromatic nuclei, inconspicuous nucleoli, and poorly defined cytoplasmic borders (Figure 2 inset). Provisional diagnosis of mesenchymal neoplasm was rendered. The patient was advised excision biopsy. \\nSubsequently an excision biopsy was performed. We received tiny skin covered soft tissue, measuring 0.8 x 0.6 x 0.4 cm. Hematoxylin and eosin stained sections showed cellular and poorly circumscribed tumor in the dermis comprising interwoven bundles and fascicles of uniform spindle shaped cells arranged in \"storiform\" or \"cartwheel\" pattern (Figure 4). The tumor cells had monotonous appearance with oval nuclei, vesicular chromatin, inconspicuous nucleoli, and scanty to moderate cytoplasm (Figure 4 inset). The mitotic activity was moderate (3-5/10HPF). The tumor was seen infiltrating into the underlying subcutis. Diagnosis of DFSP was made. A panel of immunohistochemistry (IHC) comprising vimentin and CD-34 was applied. Tumor cells were positive for both vimentin and CD-34 (Figure 5).',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 23,\n",
       "    'case_id': 'PMC5937516_01',\n",
       "    'case_text': \"A 23-year-old male presented to the primary care clinic to establish care after relocating to Arizona. His past medical history was significant for severe, mostly spontaneous, keloid formation since puberty. He complained of a right ring finger mass and a left ring finger deformity, bilateral foot pain, and worsening keloids and skin nodules.\\nOver the last four months, he had noticed a spontaneous, slowly enlarging mass on his right ring finger. It bothered him when directly pressed upon or during rock climbing. There were no associated neurological symptoms, redness, or erythema. He also reported a contracture in the left ring finger over the last six months. He had undergone a left small finger proximal interphalangeal joint arthrodesis for presumed camptodactyly at age 16. This surgery was complicated by fibromatosis and keloid scar formation, ultimately leading to amputation of the small finger. He now complained of excessive scar formation at that amputation site.\\nHe gave a two-year history of bilateral forefoot pain. His right fourth toe was the most painful. He reported that this toe had become very stiff over this time. Other toes were involved as well, and prolonged standing exacerbated the symptoms. He did not report any redness, warmth, or swelling. He denied any acute joint pain episodes and hand or back pain.\\nWith respect to his keloids and skin nodules, he had had them since puberty. He noted that some were related to sites of minor trauma, and others were spontaneous. He had multiple large keloids involving the chest, back, arms, and legs. Recently, some had involved the toes as well. He denied any genital involvement. Past treatments included intralesional steroid injections and radiation therapy with temporary improvements.\\nHe was a lifelong nonsmoker and drank alcohol socially. He was an avid rock-climber. His family history was significant for keloid formation in his grandfather. A maternal cousin had rheumatoid arthritis. On review of systems, he denied any fatigue, morning stiffness, night sweats, weight loss, inflammatory eye disease, cough, shortness of breath, back pain, nephrolithiasis, Raynaud's phenomenon, or blood dyscrasias. He did not take any chronic medications.\\nOn examination, he was afebrile with normal vital signs and appropriate weight. There was no glandular swelling or gingival hypertrophy. Hand examination showed severe left ring finger proximal interphalangeal (PIP) joint contracture of 80 , with palmar fibromatosis and keloid scar formation (Figures 1 and 2). There was no intrinsic degeneration of the PIP joint on X-ray or MRI. The right ring finger demonstrated a firm and immobile mass extending for the length of the middle phalanx on the ulnar aspect. Ring finger movement was intact. At the distal aspect of his prior amputation, he had a thickened scar. Mild tenderness to flexion and extension of his bilateral fourth and fifth digits was present. He had prominent fifth metatarsal heads bilaterally which were tender to palpation. Ankle and subtalar joint exam was normal. Ambulation was unrestricted. Multiple large areas of hypertrophic scarring and keloid formation involving the central chest (Figure 3), arms, and legs as well as some discrete nodules on the upper back were present.\\nLaboratory testing was unremarkable. He tested negative for rheumatoid factor, anticyclic citrullinated peptide, C-reactive protein, erythrocyte sedimentation rate, anti-nuclear antibody, HLA-B27 gene, and hepatitis serology. Routine laboratory markers including complete blood count, renal function, liver function, thyroid and parathyroid gland function, and uric acid and urinalysis were normal. A chest radiograph was unremarkable. A right hand X-ray film showed nonspecific soft tissue swelling of the right ring finger. The left hand film showed amputation of the small finger at the level of the proximal to mid fifth metacarpal and a flexion deformity of the ring finger at the PIP joint. Sacroiliac joints showed minimal degenerative changes on X-rays. Feet radiographs showed multiple erosions. Axial (Figure 4) and coronal (Figure 5) magnetic resonance imaging (MRI) of the feet obtained with gadolinium contrast administration demonstrated marginal erosions, synovitis, and bone marrow enhancement. Enhancing inflammatory changes in the plantar soft tissues and heterogeneous enhancement of keloids was also seen.\\nTo treat the contracture, the patient underwent a left ring finger palmar fasciectomy. Operative findings included severe fibromatosis of the left middle and ring finger and keloid formation that was confirmed by histopathology. After excision of diseased palmar fascia, the finger was able to be fully extended. A residual skin deficit required skin grafting for closure. The entire palmar surface of the proximal phalanx was resurfaced with a full thickness skin graft. His nonoperative skin lesions were treated with a combination of intralesional methylprednisolone, 5-fluorouracil, and pulsed dye laser treatments. He was initiated on 15 mg of oral methotrexate for his erosive disease.\\nAggressive occupational therapy was pursued after the surgery. At six-month follow-up, he reported improvement in his joint pain as well as keloids. The ring finger PIP joint flexion contracture had improved from 80  to 35 . However, continued keloid formation persisted over the surgical scars. His skin graft healed completely. Due to the scarring and keloids, no further surgery was recommended.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 73,\n",
       "    'case_id': 'PMC6116301_01',\n",
       "    'case_text': \"A 73-year-old female with a past medical history of a previous cerebrovascular accident, breast cancer, and vulvovaginal adenocarcinoma was admitted for diplopia and generalized weakness. Regarding the patient's malignancy history, she was diagnosed with advanced stage vulvar cancer 8 years previously and underwent a total abdominal hysterectomy and bilateral salpingo-oophorectomy the following year. She was diagnosed with left breast cancer the following year and underwent breast conservation surgery and radiotherapy. She was placed on anastrazole therapy thereafter and followed regularly with her oncologist. Her recent imaging studies did not demonstrate new disease.\\nThe patient's initials symptoms were irritation of her left eye, and after seeing her primary care provider, she was started on tobramycin eye drops (0.3% solution, every 2-3 h) for a possible ocular infection. Three days after initiating tobramycin she began experiencing diplopia, generalized weakness (primarily in the neck), and increasing respiratory distress. The patient did not recall ever having symptoms like this before and denied a history of MG. Her laboratory studies were significant for AchR-binding antibody positive at 82 nmol/L, AchR-blocking antibody positive at 56% inhibition, AchR-modulating antibody positive at 95% inhibition, and a positive striate muscle antibody titer of 1:160. A computed tomography of her chest did not show the presence of a thymoma in the mediastinum.\\nThe patient was started on pyridostigmine therapy with improvement of her symptoms. However, while she initially responded well to pyridostigmine, she begin experiencing increasing weakness and fatigue after receiving intravenous and oral magnesium the following day, despite an increase in the dosage of pyridostigmine. She subsequently underwent six cycles of plasma exchange therapy with improvement in her symptoms however she did not tolerate nasal cannula for long periods of time. She continued to require pressure support ventilation via facemask throughout her admission. Her long-term plan was to undergo weekly PLEX therapy for 3-6 months at a long-term acute care facility, with continued ventilator support through a tracheostomy.\\nUnfortunately the patient's clinical status continued to deteriorate as she developed an upper GI bleed, developed a significant anemia due to blood loss, and was intubated for respiratory failure due to prolonged periods of apnea. Shortly thereafter she went into a pulseless electrical activity cardiac arrest and underwent 30 min of cardiopulmonary resuscitation. Her family made the decision to withdraw care and she died shortly after.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 23,\n",
       "    'case_id': 'PMC6180860_01',\n",
       "    'case_text': 'Phyllodes tumour was first described in 1838 by Johannes Muller. These tumours are uncommon and comprise < 0.5% of all breast neoplasms. Among the three histological subtypes:benign, borderline and malignant:the malignant variety is the most uncommon. Giant phyllodes tumours measure > 10 cm in their largest dimension. Overall prognosis for these lesions is poor, with high recurrence rates. Surgery with post-operative adjuvant chemoradiotherapy is the main treatment for malignant giant phyllodes tumours. We present a rare case of malignant giant phyllodes tumour of the left breast in a 23-year-old female patient with retrosternal extension and invasion of the pericardium.',\n",
       "    'gender': 'Female'},\n",
       "   {'age': 23,\n",
       "    'case_id': 'PMC6180860_02',\n",
       "    'case_text': 'A 23-year-old female patient presented to the oncosurgery department with complaints of a large left breast mass for 3 years (Figure 1). The mass initially presented as a small lump, which gradually grew in size. During this time, she felt no pain or discomfort. In the past few months, the patient noticed rapid growth in the size of the lump along with discolouration of the breast skin.\\nClinical examination revealed an enlarged breast completely replaced by a lobulated mass that measured approximately 21 x 12 x 13 cm. No enlarged axillary lymph nodes were noted. The contralateral right breast was normal in appearance as well as on palpation.\\nInitial chest radiograph (Figure 2a) showed a multilobulated soft tissue density lesion involving the left breast. Bilateral lung fields and the bony thoracic cage appeared normal. On ultrasound (Figure 2b), the lesion appeared as a circumscribed, multilobulated, heteroechoic solid lesion, with internal vascularity on colour Doppler (Figure 2c). As the lesion was massive in size and could not be adequately assessed by radiography or ultrasound, the patient was referred for CT scan of the chest for further evaluation. Post-contrast CT scan of the chest (Figures 3 and 4) revealed a heterogeneously enhancing aggressive lesion measuring 21 x 15 x 13 cm with central areas of necrosis, with evidence of sternal erosion and invasion of the pericardium. The adjacent vessels, lungs and cardia appeared normal with no evidence of invasion. There was no evidence of lymphadenopathy. The patient underwent left mastectomy followed by adjuvant chemoradiotherapy. Histopathological evaluation of the excised specimen confirmed the diagnosis of malignant phyllodes tumour.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 70,\n",
       "    'case_id': 'PMC4769045_01',\n",
       "    'case_text': 'The patient was a 70-year-old male who presented with a 6-month history of vomiting, epigastric pain and weight loss. A gastroscopy revealed a large submucosal lesion originating in the fundus of the stomach and the biopsies were inconclusive. CT study revealed a 12x10x9 cm partially calcified mass with heterogeneous contrast enhancement on the fundal region and greater curvature of the stomach (Figure 1). The patient underwent a total gastrectomy associated to a distal splenopancreatectomy and segmental transverse colectomy (Figure 2). The final pathologic diagnosis was collision tumor of gastric GIST and pancreatic adenocarcinoma (Figure 3, Figure 4).',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 55,\n",
       "    'case_id': 'PMC9354553_01',\n",
       "    'case_text': 'A 55-years-old gentleman presented with chronic progressive course of walking difficulty for 8 years and dysarthria for 3 years. He also complained of heaviness and stiffness of both lower limbs while walking. He was taking multiple stuttering in-place steps before starting, and was walking in broad base with hesitant steps with difficulties in turning. He used bizarre dance-like bilateral upper limb movements to compensate and steer forward (Video 1). The problem increased when he was given a mental task like counting backwards from 100. A graduate, he was born of non-consanguineous marriage of Indian parentage with normal birth and developmental history.\\nHe scored 82 in Addenbrooke\\'s Cognitive Examination and 15 in Frontal Assessment Battery. He showed mild attentional deficit and poor delayed recall in word list memory task, that improved with cues with preserved other cognitive domains. His examination revealed slurred speech, mild spasticity of four limbs, normal limb power with brisk deep tendon reflexes (DTRs). He could perform complicated coordinated motor activities by lower limbs while lying down like drawing numbers in the air or cycling in midair (Video 2). However, his gait problem did not improve with visual cues. His MRI (magnetic resonance imaging) of brain showed bilateral posterior predominant periventricular white matter hyperintensities in T2 and FLAIR sequences suggestive of leukodystrophy (Figure 1A-E and 1I-L). Investigations including complete blood count, blood biochemical parameters, serum lactate, creatinine phosphokinase, electrocardiogram and 2D echocardiogram were normal. Tests for arylsulphatase A, urinary metachromatic granules and very long chain fatty acids came negative. There was no family history, but on examination, his brother was found to have dysarthria with mild spasticity and brisk DTRs in lower limbs. His brain MRI also showed posterior predominant white matter hyperintensities (Figure 1 F-H). Clinical exome of the index case by next generation sequencing revealed likely compound heterozygous mutations of the AARS2 gene namely NM_020745.4 (AARS2):c.1874G > A (p.Arg625His) and NM_020745.4 (AARS2):c.179C > A (p.Pro60His) which were classified as being \"likely pathogenic\". Parental study could not be performed in this patient and thus there was no data regarding trans or cis position of the mutated alleles in the compound heterozygous state. In-silico prediction found both the variants to be damaging. No other variants in any gene causing leukodystrophy were found. He was put on coenzyme complex therapy and other supportive treatment, and is now under follow-up. His brother denied permission for genetic testing.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': None,\n",
       "    'case_id': 'PMC4345035_01',\n",
       "    'case_text': 'Capecitabine is originally indicated for the treatment of breast cancer and colorectal cancer as stated in the drug label. In this case study, we aimed to seek alternative indications for Capecitabine. We searched for Capecitabine with RxCUI \"194000\" from the CPN to identify novel indications. In total, there are 120 disease nodes that are at most 3 nodes away from Capecitabine. Of these 120 diseases, 12 possible novel indications including Hyperbilirubinemia, Mesothelioma, Bladder Neoplasm, etc. associated with Capecitabine are supported by published studies. The following example illustrates the identification process of the new indication, bladder neoplasm for Capecitabine.\\nFrom the CPN 50 directly relevant nodes have been retrieved for Capecitabine including the gene CYP1A1, from which \"Urinary Bladder Neoplasms\" have been identified subsequently. A sub-network of Capecitabine visualized by Cytoscape in the CPN is shown at the right lower corner in Figure 1, where the edges in red indicate all associations with Capecitabine, and the green edges indicate DPYD and C18orf56 are linking to Capecitabine respectively. The zoomed out network is shown in Figure 3. The association between \"Urinary Bladder Neoplasms\" and \"Capecitabine\" could be inferred through multiple paths as shown in Figure 3. Among all paths between these two, the shortest path is Capecitabine-CYP1A1-Urinary Bladder Neoplasms, of which the association could be proved by literatures: (1) \"CYP1A1 rs1048943 A > G (Ile462Val) polymorphism is a potential prognostic marker for survival outcome after docetaxel plus capecitabine chemotherapy\"; (2) active CYP1A1 and CYP1B1 overexpression is revealed in bladder cancer; (3) the combination of Capecitabine and radiation therapy offers a promising treatment option for bladder cancer patients who are not candidates for surgery or cisplatin-based chemotherapy; (4) a patient with metastatic bladder cancer responded well to second-line capecitabine with a clinically meaningful progression-free survival. Through this validation chain, the inference that the breast and colorectal cancer drug, \"Capecitabine\" might be used for urinary bladder cancer could be made. Evidently urinary bladder cancer may be a novel indication of Capecitabine via the network-based analysis of the CPN.',\n",
       "    'gender': 'Unknown'}],\n",
       "  [{'age': 76,\n",
       "    'case_id': 'PMC9577112_01',\n",
       "    'case_text': 'A 76-year-old woman reported a history of progressive sensorimotor disturbance in both lower limbs for the past 2 years. Initially, the patient\\'s condition was misdiagnosed as \"lumbar disc herniation\" in the local hospital, and she received conservative treatment. However, her symptoms did not improve and became more serious. When referred to our hospital, she complained of inability to walk and bladder and bowel control loss. A neurological examination revealed a diminished sensation below the T7 level. The strength of both lower limb muscles was 1/5. Her neurological status was diagnosed as Nurick Grade 6. Magnetic resonance imaging (MRI) revealed multiple intradural extramedullary tumors at the T7-T11 level compressing the spinal cord (Figure 1A). Computed tomography (CT) scans showed five high-density masses of varying sizes in the spinal canal at the T7-T12 level, and the dural sac was significantly compressed (Figures 1B,C). Three large high-density masses (13.4 mm*8.4 mm, 21.7 mm*13.0 mm, and 14.9 mm*12.5 mm) were observed in the T7-T9 segment, located in the dorsal left rear spinal cord with clear boundaries and ossification signals (Figures 1D-F). The other two high-density masses (8.7 mm*5.3 mm and 11.1 mm*6.73 mm) of different sizes were found in the T10-T12 segment.\\nThe patient underwent tumor resection through T7-T11 laminectomy. The tumors occupied >90% of the transverse diameter of the spinal canal and were entirely ossified. As the vertebral fenestration was too small, it was challenging to remove the tumors. Hence, the bilateral facet joints were removed to enlarge the window. To maintain the stability of the spine, we performed T7-T12 long-segment pedicle screw fixation and posterolateral bone graft fusion simultaneously. Bilateral facetectomy provides advantages over simple laminectomy or laminoplasty in terms of width of the operative corridor and long-term preservation of the spinal alignment. As the dura mater had severely adhered, a fine right-angled hook was used to dissect the neural tissue dorsally away from the neoplasms, which were then resected en bloc, together with parts of the dura mater and arachnoid. After a complete separation of multiple OSMs, the dura mater became normal and it was sutured. The drainage was routinely placed, and the wound was closed layer by layer.\\nThe paraffin sections were stained with hematoxylin and eosin (H/E). A histopathological examination revealed a large number of psammoma bodies in the stroma with significant signs of ossification [World Health Organization (WHO) Grade I]. In addition, there were many mature bone tissues around the tumor cells, including trabecular bone, as well as bone marrow with hematopoiesis (Figures 2A-C). Immunohistochemical findings revealed EMA (+), Vim (+), P53 (-), S-100 (+), and Ki67 (approximately 5%) (Figures 3D-F).\\nPostoperative neurological improvement was significant, and no complications were found. The patient was discharged 2 weeks after surgery. After the 2-year follow-up, she was able to walk without assistance. Her neurological status recovered to Nurick Grade 3. CT scans showed a total resection of the tumors, and there was no recurrence 2 years after surgery (Figures 3A-E).',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 4,\n",
       "    'case_id': 'PMC8113859_01',\n",
       "    'case_text': 'In 2015, a 4-year and 6-month-old boy was admitted to our hospital for recurrent lung infections and hematuria for more than 2 years. Physical examination on admission revealed visible tonsils; cervical, axillary, and inguinal lymphadenectasis; dry rales in his both lungs; no murmurs in the heart; abdominal softness, no hepatosplenomegaly; no positive signs on nervous system. He had a BCG vaccination at birth with no adverse effects. Epstein-Barr (EB) virus IgM and cytomegalovirus (CMV) IgM were detected. High titers of anti-neutrophil cytoplasmic antibody (ANCA) for PR3 were detected (see  Table 1 ). Chest CT showed pulmonary nodules with cavity formation, bronchiectasis, and patchy infiltration. Bilateral maxillary and ethmoid sinusitis were also seen in paranasal sinuses CT ( Figures 1A, B ). Ultrasound suggested the enlargement of liver, spleen, and superficial lymph nodes. Urine routine revealed increased urine red blood cells. Renal biopsy pathology indicated slight glomerular lesions ( Figure 1C ). Lymph node biopsy only demonstrated reactive hyperplasia. Bronchoscopy revealed no obvious abnormalities. Lung biopsy suggested an uneven distribution of lesions, and infiltrations of lymphocytes around the bronchiole with hyperplasia of collagen fibers ( Figure 2 ). Bone marrow aspiration indicates hyperplasia of granulocytes.\\nThe boy was diagnosed as GPA based on upper airway, lung, and kidney involvements, and positive ANCA (refer to EULAR/PRINTO/PRES criteria). He was treated with oral prednisone at the initial dose of 1 mg/kg/day, tapered to 0.2 mg/kg/day by month 6, and 0.15 mg/kg/day as maintenance therapy. At the same time, he was given monthly intravenous cyclophosphamide infusion at the dose of 500mg/m2 for 6 months, and then mycophenolate mofetil was started as maintenance therapy. His hematuria improved. However, he still experienced recurrent lung infections within 2 years of follow-ups, and repeated bronchoscopy showed mucosal nodules. This patient was suspected of having lymphoproliferative disease and accepted genetic testing with the consent of his mother (his father not available). A mutation E1021K (c.3061 G >A) in the PIK3CD gene was found in this boy, while his mother had no mutation. He was then diagnosed with APDS1 and received regular immunoglobulin (400 mg/kg/month) and rapamycin treatment with the improvements of lung infection and hematuria. Considering his pulmonary infections, he was treated with piperacillin and Tazobactam, and then received Trimethoprim/Sulfamethoxazole prophylaxis for 6 months.',\n",
       "    'gender': 'Male'},\n",
       "   {'age': 7,\n",
       "    'case_id': 'PMC8113859_02',\n",
       "    'case_text': \"Another patient was a 7-year and 9-month-old girl who presented with recurrent lung infections and hematuria for more than 6 years. During the past 6 years, she suffered from recurrent sinusitis, lung infections, and hematuria. The girl had positive ANCA and diagnosed as GPA. Although she received prednisone, her clinical manifestation failed to improve. Therefore, she was admitted to our Department of Rheumatology & Immunology in 2018. Physical examination revealed visible tonsils and cervical lymphadenectasis, but no clinical features suggestive of autoimmune disease. She had mild developmental retardation. CT also showed pulmonary nodules with cavity formation, and patchy infiltration, and bilateral maxillary sinus and ethmoid sinusitis ( Table 1 ,  Figures 1D, E ). Abdominal ultrasound suggested hepatosplenomegaly and enlarged lymph nodes. Due to recurrent and refractory lung infections, she underwent bronchoscopy during hospitalization, showing mucosal nodule lymphoid hyperplasia in the entire airway ( Figures 1G-I ). Bone marrow and lymph node biopsies had no abnormal findings. Lung biopsy suggested inflammatory cells infiltration ( Figure 2 ) and absence of granulomatous lesions, and renal biopsy pathology indicated mild glomerular disease ( Figure 1F ).\\nDue to mucosal nodules of the airway, the patient was suspected of lymphoproliferative disease, and accepted genetic testing with the consent of her parents. Whole exome sequencing showed that she had a de novo mutation E1021K (c.3061 G >A) in the PIK3CD gene, while none of her parents had this mutation. In the end, she was diagnosed as APDS1, and received regular immunoglobulin (400 mg/kg/month) with reluctance to use rapamycin by her parents. In view of her pulmonary infections, she was treated with Cefoperazone and Sulbactam, and then received Trimethoprim/Sulfamethoxazole prophylaxis for 6 months. At present, her lung infections significantly improved.\\nImmunohistochemical staining of p110delta, CD3, and CD20 were performed in biopsy tissues of both patients taken previously ( Figure 2 ). Increased expression of p110delta was found in histological sections of the lung and lymph node compared with the control, indicating increased recruitments of p110delta expressing cells ( Figures 2B, C, E, F ). Notably, significantly increased numbers of inflammatory cells were observed around airways and in the lung parenchyma, especially the infiltrations of CD3+ T cells ( Figures 2H, I, K, L ). This study was approved by the Ethic Review Board of Children's Hospital, Zhejiang University School of Medicine (2019-IRB-105). Written informed consent was obtained from their legal guardians for the publication of any potentially identifiable images or data included in this article.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 37,\n",
       "    'case_id': 'PMC4065704_01',\n",
       "    'case_text': 'A 37-year-old woman presented with a 3-month history of fullness and progressive hearing loss in the left ear. There was no tinnitus, otalgia, otorrhea, vertigo, or facial nerve paralysis. Otomicroscopy of the left ear showed the presence of a reddish, easily bleeding hypotympanic mass, extending to the medial third of the external auditory canal. Examination of the facial nerves, nasopharynx, oral cavity, larynx, and neck was normal. Neither the symptoms nor a family history of VHL disease was found in the patient. The pure-tone audiometry revealed a moderate, pantonal, conductive hearing loss in the left ear (Figure 1). Computed tomography (CT) demonstrated an irregular, hypodense, and expansile lytic lesion of the mastoid process of the left petrous bone extending to the middle ear, with a subtotal erosion of ossicular chain and the \"tegmen tympani.\" The mass did not appear to affect the semicircular canals, the canal of the facial nerve, and the internal auditory canal (Figure 2). Cerebral magnetic resonance (MR) confirmed the presence of a lesion of increased signal on T1-weighted sequences, enhanced in the medial portion of the middle ear and in the tubaric region (Figure 3). The patient underwent a canal wall-down tympanoplasty and complete removal of the tumor. The facial nerve was exposed to a tract of about 3 mm at the level of the second genu. The postoperative follow-up was uneventful. Histopathology was consistent with ELST. The tumor presented the architecture of a papillary adenocarcinoma of low histologic grade. There was no evidence of mitosis or necrosis (Figure 4). Immunohistochemical studies were positive for CK MNF116 (cytokeratin wide spectrum:types 5, 6, 8, 17, and 19) and chromogranin A (Figure 5), with a Ki67 not being significant. The tumor did not stain with GFAP (glial fibrillar acid protein), synaptophysin, S100, calponin, vimentin, and thyroglobulin. Genetic testing for the von Hippel-Lindau disease (mutation of chromosome 3p25/26) was negative. A postoperative MRI revealed no residual tumor. Radiological and clinical evaluations at 36-month follow-up demonstrated no evidence of recurrence and a pure-tone audiometry identified any worsening of hearing loss (Figure 6).',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 65,\n",
       "    'case_id': 'PMC6477499_01',\n",
       "    'case_text': 'A 65-year-old Caucasian male presented with painless horizontal diplopia on left gaze. His past history included coronary artery stents, hypercholesterolaemia, and he was an ex-smoker of 20 cigarettes/day. He denied intravenous drug use and having sex with men. His daily medications included amlodipine, valsartan, clopidogrel, and rosuvastatin. He had an ophthalmic history of left herpes simplex keratitis. Best corrected visual acuity was 6/9 (right) and 6/24 (left). The right cornea appeared normal; the left had stromal scarring without neovascularisation. Lenses, pupils, optic discs, and vitreoretinal examination were normal. He had left esotropia and left lateral rectus underactivity, with right gaze-evoked nystagmus. Hardy-Rand-Rittler colour plates tested all plates correct bilaterally. Automated visual field testing (Humphrey, Zeiss, Oberkochen, Germany) was full in both eyes. Full blood examination, CRP, ESR, fasting lipids, and renal function were normal. MRI of the brain showed minor bilateral pontine ischaemic changes. He was not tested for syphilis. He was diagnosed with microvascular left 6th nerve palsy. Diplopia resolved spontaneously over the next 3 months and his 6th nerve palsy remained detectable for 6 months before fully resolving.\\nHe represented 6 months later with 8 weeks of painless \"smeared vision\" with yellow, red and orange colours seen vividly in both eyes. On further questioning, he reported previous treatment for gonorrhoea, presence of a primary chancre 12 months earlier, and having had sexual intercourse with a same-sex partner for 2 years. Visual acuities were 6/12 (right) and left 6/30 (left) (vision summarised in Table 1). Anterior segment examination was unchanged. Both pupils were dilated with no constriction in response to light, accommodative targets or 0.1% topical pilocarpine. Optic discs had developed mild temporal pallor (Fig. 1). Vitreoretinal examination remained normal. Motility testing was full. Automated field testing suggested a right superior defect (Fig. 1), although reliability indices were low. Optical coherence tomography scan of the retinal nerve fibre layer and ganglion cell layer demonstrated thinning in both eyes. MRI of the brain was unchanged. Serum treponemal antibodies and Treponema pallidum particle agglutination were reactive, with rapid plasma reagin reactive titre of 1,280. Further testing is summarised in Table 2. He did not have a lumbar puncture at this time. He was diagnosed with neurosyphilis and admitted to hospital. He reported allergy (rash) to penicillin and was treated by penicillin desensitisation followed by high-dose intravenous (IV) benzylpenicillin (1.8 g 4-hourly) for 16 days. He received 50 mg oral prednisolone for 3 days for Jarisch-Herxheimer reaction prophylaxis. Despite antibiotic treatment, serial examination showed the vision loss progressed to 6/60 in both eyes by June 2014 (Table 1).\\nOn review in July 2014, 4 months after diagnosis and antibiotic treatment, visual loss had progressed further to 2/60 (right) and 3/60 (left), optic nerve pallor had increased, and a central scotoma had developed in both eyes. Lumbar puncture showed CSF weakly reactive to T. pallidum antibodies (EIA, fluorescent) and T. pallidum particle agglutination. Skin biopsy showed non-specific IgE, IgM and C3 immunofluorescence in the basement membrane and dermis. He was diagnosed with autoimmune optic neuropathy, re-admitted to hospital and treated with a second course of IV benzylpenicillin after repeat desensitisation, together with IV ceftriaxone 2 g daily given his earlier lack of response to penicillin, along with a 3-day course of IV methylprednisolone 1 g daily. He commenced immunosuppression and was discharged taking a tapering course of oral prednisolone, initially 75 mg daily, oral doxycycline 100 mg twice daily for 28 days and azathioprine 75 mg daily, and 1 month later given a 3-day course of IV immunoglobulin (Octagam 5% 45 g daily).\\nWhen last reviewed, there had been no response to sustained immunosuppression. Visual acuity was 3/60 bilaterally and optic discs were atrophic. Pupils remained non-responsive to both light and accommodative targets. The patient withdrew from medical care and ceased all treatment.\\nOur patient has CSF-positive neurosyphilis with bilateral optic neuropathy and tonic pupils. Although he presented with only 8 weeks of visual symptoms, it is possible that the seemingly typical microvascular 6th nerve palsy 1 year earlier was early neurosyphilis. He denied risk factors and was not tested for syphilis at the time. Notwithstanding the uncertain onset of infection, his optic nerve function was normal at presentation with cranial nerve palsy, and he was treated appropriately within 8 weeks of first optic neuropathy symptoms with two courses of IV penicillin, IV high-dose steroids, and subsequent immunosuppression, but suffered progressive visual loss in the right followed by left eye with optic atrophy.\\nWe hypothesise his progressive visual loss was due to the development of autoimmune optic neuropathy. This is supported by the relentless course despite appropriate treatment confirmed on serological response, skin biopsy positive for immunoreactant deposition, the most consistent marker of autoimmune optic neuropathy, and the development of autoantibodies (cardiolipin IgG, anti-smooth muscle). Multiple reports have linked post-infectious immune dysregulation with the development of autoimmune disease targeting the nervous system and the optic nerve. Syphilis is well known to induce autoantibody production. Although not all autoantibodies are necessarily pathogenic, this supports our case for autoimmune optic neuropathy complicating our patient\\'s syphilitic optic neuropathy.\\nOphthalmologists play an important role in diagnosing ocular and neurosyphilis. A high index of suspicion is necessary. Patients with syphilitic optic neuropathy need to be warned that visual loss may develop despite optimum therapy. Further research is needed to understand the mechanisms of visual loss in patients with syphilis.\\nThe authors have no ethical conflicts to disclose.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 45,\n",
       "    'case_id': 'PMC5492790_01',\n",
       "    'case_text': 'A 45-year-old lady presented to the emergency room (ER) with severe neck pain radiating to the left shoulder and arm, torticollis, and dysphagia for about two days. A clinical examination revealed limited cervical movement in all directions with exacerbation of pain on extension of the head. The primary clinical diagnosis in ER was cervicobrachialgia. The laboratory investigations revealed a leukocyte count of 11.5 x 103/mm3 (normal range 3.80-9.80 x 103/mm3) and C-reactive Protein (CRP) value of 7.8 mg/dL (normal range 0-5.0 mg/dL). Computed tomography (CT) and magnetic resonance imaging (MRI) were done and showed prevertebral soft tissue swelling and calcifications anterior to C1 at the insertion of the longus colli especially affecting the left side (Figure 1). After radiological confirmation of the diagnosis, non-steroidal anti-inflammatory drugs (NSAIDs) and a soft cervical collar were prescribed. The patient showed complete remission of symptoms after five days.',\n",
       "    'gender': 'Female'},\n",
       "   {'age': 50,\n",
       "    'case_id': 'PMC5492790_02',\n",
       "    'case_text': 'A 50-year-old man was referred to our hospital with severe occipital headache (VAS 9), odynophagia. The CRP was 38 mg/dL. The main differential diagnosis was a retropharyngeal abscess, so the patient was first admitted to the ENT department where a clinical examination revealed posterior pharyngeal edema. Antibiotics and anti-inflammatory drugs were prescribed. A contrast-enhanced CT was done and revealed the prevertebral calcifications. The neuroradiologist suggested the diagnosis of longus colli tendinitis that was confirmed with contrast-MRI. A soft cervical collar and analgesics were prescribed. Symptoms rapidly improved after three days that the patient could be discharged. The patient reported complete remission of symptoms after seven days.',\n",
       "    'gender': 'Male'},\n",
       "   {'age': 63,\n",
       "    'case_id': 'PMC5492790_03',\n",
       "    'case_text': 'A 63-year-old lady was presented to the ER with acute neck pain and dysphagia. She was afebrile. Laboratory investigations showed elevated CRP (39.7 mg/dL). MRI with contrast was done and showed inflammatory changes and contrast enhancement at the insertion of longus colli without prevertebral effusion. CT revealed the calcifications and confirmed the diagnosis of LCT.',\n",
       "    'gender': 'Female'},\n",
       "   {'age': 48,\n",
       "    'case_id': 'PMC5492790_04',\n",
       "    'case_text': 'A 48-year-old man referred to our center with severe left-sided neck pain and dysphagia. Severe limitation of movements in all directions was evident on examination. The leukocyte count and CRP were elevated (15.6 x 103/mm3 and 51.3 mg/dL consecutively). Contrast-MRI revealed prevertebral edema, prevertebral effusion, and bone marrow edema of the anterior arch of atlas at the insertion of the upper oblique fibers of the left longus colli muscle mimicking spondylitis. CT scan was done and revealed the prevertebral calcifications. Under NSAIDs the inflammatory parameters were decreasing. Soft cervical collar helped to alleviate discomfort. Remission of symptoms was complete after 10 days.',\n",
       "    'gender': 'Male'},\n",
       "   {'age': 51,\n",
       "    'case_id': 'PMC5492790_05',\n",
       "    'case_text': 'A 51-year-old lady presented to the ER with neck pain and rigidity. She had normal body temperature and normal leukocyte count and CRP. CT and MRT revealed calcifications at C1/2 level, prevertebral effusion, and soft tissue edema extending to the level of C4 (Figure 2). The case was diagnosed as LCT and NSAIDs were prescribed. Symptoms completely improved after two weeks.\\n Table 1 summarizes the epidemiological, clinical, laboratory, and diagnostic findings in the five cases from our institution.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 28,\n",
       "    'case_id': 'PMC5822820_01',\n",
       "    'case_text': 'A 28-year-old man presented with a painless palpable mass in the right scrotum. Scrotal ultrasound revealed a normal testicle and multiple 3 to 7 mm hyperechoic lesions adjacent to the right testis (Figure 1(a)). Contrast-enhanced computed tomography (CT) revealed high-density paratesticular tumors (Figure 1(b)). The surface coil magnetic resonance imaging (MRI) with a 1.5 tesla scanner (GE Healthcare Signa HDxt 1.5T) revealed iso- and low-intensity paratesticular tumors on T1- (Figure 1(c)) and T2-weighted MR images (Figure 1(d)), respectively. Short TI inversion recovery MRI showed low-intensity paratesticular tumors (Figure 1(e)). Water MRI showed high-intensity tumors (Figures 1(f) and 1(g)). The levels of testicular tumor markers such as alpha-fetoprotein, beta-human chorionic gonadotropin, and lactate dehydrogenase were normal. We planned tumor biopsy combined with intraoperative rapid diagnosis. Scrotal incision was performed to explore the scrotum, and paratesticular white pedicle masses were observed (Figure 2(a)). Over 20 nodules were observed at the tunica vaginalis. The maximum size of nodule was approximately 15 mm. Frozen section assessment was performed, and intraoperative rapid diagnosis suggested a fibrous pseudotumor without malignancy. We excised the paratesticular white masses (Figure 2(b)) and successfully performed testicular-sparing surgery. Pathological findings revealed the proliferation of typical fibroblasts that were distributed in multidirectional bundles of dissociated collagen fibers (Figure 2(c)). Lymphocyte infiltration including immunoglobulin G4- (IgG4-) positive plasma cells was observed. Tissue IgG4 counts and IgG4/IgG ratios were 10 positive cells per high-power field on average and 10%, respectively. Ki-67 labeling index was 2%. Immunohistochemical staining was negative for D2-40 (mesothelioma, Figure 2(d)), calretinin (mesothelioma, Figure 2(e)), beta-catenin (desmoid-type fibromatosis, Figure 2(f)), and anaplastic lymphoma kinase (ALK) (inflammatory myofibroblastic tumor, Figure 2(g)). No recurrences have been noted after 12 months of follow-up.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 45,\n",
       "    'case_id': 'PMC4312440_01',\n",
       "    'case_text': 'Male patient aged 45 years at the time of diagnosis.\\nChronic fatigue and pain in both shoulders and the lower back.',\n",
       "    'gender': 'Unknown'},\n",
       "   {'age': None,\n",
       "    'case_id': 'PMC4312440_02',\n",
       "    'case_text': 'The patient visited a local clinic due to headache, dizziness, malaise, fatigue, and pain in both shoulders and the lower back. Symptoms persisted for several days and did not ease with medication. The patient underwent a complete blood count test; his white blood cell count was elevated to 34,100/mm3. The vital signs of the patient were normal, and the patient was stable without any fever. The clinical impression was leukemia, and the patient was referred to the hemato-oncology department of a university hospital. After admission, he underwent a bone marrow biopsy and a cytology exam. The results are reported in Table 1. Based on the biopsy results, he was diagnosed with CML and was started on chemotherapy.',\n",
       "    'gender': 'Male'},\n",
       "   {'age': None,\n",
       "    'case_id': 'PMC4312440_03',\n",
       "    'case_text': 'The patient had never smoked and rarely drank alcohol.',\n",
       "    'gender': 'Unknown'},\n",
       "   {'age': None,\n",
       "    'case_id': 'PMC4312440_04',\n",
       "    'case_text': 'The patient did not have hypertension, diabetes, tuberculosis, viral hepatitis, or human immunodeficiency virus infection.\\nThere was no family history of hemato-oncologic diseases.',\n",
       "    'gender': 'Unknown'},\n",
       "   {'age': None,\n",
       "    'case_id': 'PMC4312440_05',\n",
       "    'case_text': \"The patient started his job as a diagnostic radiographer in November 1990 and had continued working until he was diagnosed with CML. His job history is summarized in Table 2.\\nThe patient's main jobs involved obtaining simple radiographs, including chest and abdominal radiographs. He also performed special radiography such as gastrointestinal series radiography and measuring bone marrow density. The working environment and the equipment he used are shown in Figures 1 and 2. The one-time exposure amount of the relevant diagnostic tools are listed in Table 3.\\nThe patient's work profile also included fixation and development of the exposed films. We investigated the chemicals used to fix and develop the film, but we found no known compound that could be considered to have initiated oncogenesis.\\nRecords of the patient's personal exposure dose from 1997 to 2012, measured by the TLD, were available. This is the official record provided by the Korea Workers' Compensation and Welfare Service (Table 4).\",\n",
       "    'gender': 'Male'},\n",
       "   {'age': None,\n",
       "    'case_id': 'PMC4312440_06',\n",
       "    'case_text': 'The patient mentioned that he was very stressed specifically from 2002 to 2006 because several cases of radiography had to be performed and there was no assistant to help with the workload. With regards to the missing records from 1990 to 1996, the patient estimated that the accumulated radiation would be comparable to that of 2003 to 2005, or even higher. Conventionally, younger workers tend to take more jobs than senior workers. Furthermore, the working environment then was worse than the present working conditions, and past radiologic shield methods were not as effective.\\nBased on these assumptions, the PC was calculated by applying both the highest value (17.48 mSv) and the mean value (6.02 mSv) of annual radiation for the period of 1997-2012 (Table 5). The PC was calculated by the Radiation Health Research Institute-Program for Estimating the Probability of Causation (RHRI-PEPC), under the consultation of the Korea Hydro and Nuclear Power Company. The results showed that the point estimation of PC, i.e., the 50th percentile, was 58.83% for the highest estimation, and 57.28%, using the assumed mean value for the missing records.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 18,\n",
       "    'case_id': 'PMC8361550_01',\n",
       "    'case_text': 'An 18-year-old female with a past medical history of migraine headaches presented to the hospital with chief complaints of persistent nausea, vomiting, inability to tolerate oral feeds, and significant weight loss for the past 2 months. The patient reported that she vomited after every meal, and vomitus mainly consisted of undigested food particles without blood. The patient also had intermitted constipation; however, she had no diarrhea. She also observed substantial weight loss despite good appetite but was unable to quantify the weight loss. The patient did not take any medications for her migraine headaches and her last flare-up was about 1 year ago. She reported multiple outpatient visits for similar complaints in the last 2 months; however, on this visit with her primary care provider, she was referred to the hospital. On clinical evaluation, she had stable vital signs. Physical examination revealed dry mucous membranes and abdominal examination was positive for mild epigastric tenderness along with decreased bowel sounds. The patient was started on intravenous (IV) fluids. Laboratory investigations such as complete blood count and comprehensive metabolic panel were ordered, which revealed a low hemoglobin level of 10.2 g/dL, hematocrit 30.2%, serum sodium 132 mEq/L, and serum potassium 3.3 mEq/L. An abdominal X-ray did not reveal mechanical obstruction. Due to concerns for gastroparesis (GP) as the underlying etiology, a Gastric Emptying Study was ordered, which revealed markedly delayed gastric emptying time as the tracer was distributed in the stomach on initial views with activity not appearing in the duodenum until 45 minutes and emptying half time was not reached with 77% of initial gastric contents remaining at the end of the examination. Hence, a diagnosis of GP was established. The patient was started on metoclopramide, which led to improvement of her presenting symptoms, and she was eventually discharged home with recommendations to taper the doses of metoclopramide as needed.\\nOne month after discharge, the patient presented to the hospital with similar complaints as her initial presentation despite metoclopramide therapy. Laboratory investigations were similar to initial hospitalization and revealed hemoglobin level of 10.7 g/dL, hematocrit 31.9%, serum sodium 133 mEq/L, and serum potassium 3.2 mEq/L. An abdominal X-ray was ordered, which revealed dilated bowel segments with high burden of stool in the colon without obvious mechanical obstruction. A diagnosis of severe GP and chronic intestinal pseudo-obstruction (CIPO) was established. Over the next month, the patient was given an extensive trial of numerous prokinetic agents such as mirtazapine, ondansetron, pyridostigmine, octreotide, and promethazine, but she failed to show clinical improvement. With failure of medical therapy, a nasojejunal feeding tube was placed for nutrition; however, the patient noted worsening nausea despite the slow feeding rate of 10 mL/h. Hence, after detailed discussions with the patient, a decision was made to start her on total parenteral nutrition (TPN) after which she was transferred to a tertiary center for higher level of care. At the tertiary care center, she was continued on TPN and underwent extensive evaluation. Laboratory investigations were within normal limits except mild elevation of the liver enzymes. Additionally, antinuclear antibody, extractable nuclear antigens panel, paraneoplastic antibody panel, and acetylcholine receptor binding antibodies were found to be negative, thereby ruling out an autoimmune etiology. A right upper quadrant ultrasound revealed the presence of gallbladder sludge and normal liver architecture. An esophagogastroduodenoscopy (EGD) and colonoscopy were found to be negative. A small bowel follow-through ruled out mechanical obstruction. Magnetic resonance enterography and computed tomography angiography of the abdomen were noted to be unremarkable. Furthermore, a deep rectal biopsy was performed, which was negative for amyloidosis. However, antroduodenal manometry, a diagnostic tool for GI motility disorders, showed paucity of contractile activity with very low amplitudes highly suggestive of a myopathic etiology. This was followed up with a laparoscopic full-thickness intestinal biopsy, which revealed decreased actin staining in the circular muscles of the muscularis propria of small intestine consistent with a diagnosis of HVM. During the course of the hospital stay, the patient developed recurrent bacteremia, the source of which was identified to be the central venous catheter used for TPN. She was treated with appropriate antibiotics, which led to resolution of the bacteremia. Eventually, she underwent isolated small intestine transplant and was started on mycophenolate 500 mg daily, everolimus 5 mg daily, and prednisone 10 mg daily. This led to eventual resolution of her presenting symptoms, and she was discharged home. The patient continues to be asymptomatic and follows up with Gastroenterology and Transplant Surgery regularly.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 25,\n",
       "    'case_id': 'PMC7160736_01',\n",
       "    'case_text': \"A 25-year-old G2 P0010 Caucasian female with past medical history of super morbid obesity (BMI 55.2), depression, and multiple sclerosis presented to us with bilateral lower extremity weakness and right-sided flank pain. At the time of presentation, she was at 18 weeks' gestation.\\nShe was diagnosed with multiple sclerosis at age 17 after she developed right optic neuritis. Over a 3-year period, she tried multiple modifying agents including interferon beta 1-b which was associated with ovarian cyst formation requiring surgery and interferon beta 1-a, which had intolerable side effects and glatimer acetate. While on glatimer acetate, she had 2 relapses in 6 months. She was eventually transitioned to fingolimod with a single relapse shortly after initiation of therapy and treated with a 5-day course of solumedrol. Fingolimod was used successfully for 5 years and was discontinued 4 weeks prior to conception. Her pregnancy was complicated by a threatened abortion and persistent vaginal bleeding. She was placed on bed rest. During bed rest, she developed fever, flank pain, and severe paraparesis requiring hospitalization. She was diagnosed with an acute MS flare in the setting of pyelonephritis.\\nAntibiotics and intravenous methylprednisolone 1,000 mg daily were initiated. A noncontrast MRI of the brain and cervical spine revealed a new extensive demyelinating lesion from C1 to C4. After the completion of 6 days of intravenous (IV) methylprednisolone, her lower extremity function had moderately improved, and she was able to ambulate with a walker and was discharged to an acute inpatient rehabilitation center.\\nThree weeks later, she re-presented to the hospital with right-sided flank pain, generalized weakness resulting in a fall, and a tingling sensation in her extremities. Given the early recurrence, neurology was consulted. In the neurological exam, mental state was normal, pupils were normal symmetrical, and reactive to light. There was no facial asymmetry and the other cranial nerves were normal. Muscle tone was increased in her left upper extremity and bilateral lower extremities. In the motor exam, there was an asymmetrical moderate/severe tetraparesis mainly in the lower limbs and more pronounced distally. There was generalized hyperreflexia with bilateral clonus and bilateral Babinski. Sensation was impaired with decreased sensation to light touch, pinprick, and vibration without a clear sensory level.\\nUrinalysis was consistent with a urinary tract infection and a urine culture grew out pan-sensitive Escherichia coli. A new MRI of the head (Figure 1) showed progression T2 hyperintense signal abnormality in the craniocervical cord. To exclude other differentials, her vitamin B12 and ACE levels were checked and were within normal limits. To rule out a possible diagnosis of neuromyelitis optica, an aquaporin 4 AQR4 antibody was tested and was negative.\\nThe patient was started on antibiotics for suspected pyelonephritis, which was eventually changed to oral amoxicillin after urine culture sensitivities resulted.\\nThe patient was started on IV methylprednisolone 250 mg every 6 hours. After five days of steroid treatment, she showed minimal motor improvement. At this time, rescue plasmapheresis (TPE) was initiated. Five treatments of TPE were performed every other day, alternating treatment days with IV methylprednisolone. The patient tolerated her therapy well and had progressive improvement in her neurologic symptoms with near complete resolution of her tetraparesis and mild residual sensory loss in her left arm. She was discharged to the acute rehabilitation service.\\nFor the reminder of her pregnancy, she was treated with methylprednisolone 1000 mg as a single infusion every 3 weeks. She presented to the hospital at 36 weeks' gestation with contractions, vaginal spotting, hypertension, headache, and lower extremity edema. She was taken to the operating room for a cesarean section due to concerns of severe pre-eclampsia and preterm labor. She delivered a 2495 g male with APGARs of 8 and 9. After delivery, fingolimod was reinitiated in the outpatient setting.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 4,\n",
       "    'case_id': 'PMC6907107_01',\n",
       "    'case_text': 'We found that the number of quadrants visualized positively correlated with age, confirming that younger patients are more difficult to image. Younger patients may be less cooperative. Positioning in the chin rest and fixating on a target can be challenging. Most quadrants could be captured by obtaining serial images with positive encouragement and assistance from the parents. Several patients aged 3-4 years old were included in our study to demonstrate the feasibility of acquiring high quality images at an early age. We feel that the child friendly protocol developed in our Medical Photography department at UCLA increases the success rate of pediatric retinal imaging. Interestingly, 2 patients with nystagmus were successfully imaged in our study. Our findings corroborate those of previous case reports suggesting ultra-wide field imaging of patients with nystagmus is possible due to the rapid (0.25 s) image acquisition time.\\nWe also found more quadrants of the retina were visualized during the later phases of UWF-FA.\\nChildren often require consolation following a needle stick for the fluorescein dye resulting in an increased time to image capture and difficulty in capturing choroidal filling. In addition, the delay in positioning the patient in the chin rest results in increased artifacts in the early phases. If the early phase of angiography is of interest, intravenous access can be acquired prior to injecting fluorescein which can eliminate the transition time. In addition, Ali et al. described using oral fluorescein as an alternative to intravenous dye to obtain UWF-FA in children.\\nUWF-FAF was useful in capturing abnormal autofluorescence patterns in the macula and the periphery. Increased or attenuated autofluorescence patterns involved the periphery in 23 of 24 (96%) patients highlighting the usefulness of capturing the peripheral retina with UWF imaging. UWF-FAF has been described in case reports previously in Stargardt disease, pigmented paravenous chorioretinal atrophy, and long-chain 3-hydroxyacyl-CoA dehydrogenase retinal dystrophy. The peripheral extent of lesions and autofluorescence patterns may be useful to diagnose heredodegenerative disorders and monitor disease activity, particularly in inflammatory conditions.\\nLastly, in our series, the indications for obtaining imaging were quite varied as seen in Table 1 which reflects the heterogenous nature of pediatric retinal disease. In addition, in children who reported floaters or visual disturbances with a normal eye exam, UWF imaging was useful to confirm and document a normal funduscopic examination. Several studies have demonstrated that UWF is useful as a screening modality for diabetic retinopathy with a sensitivity of 94% and specificity of 100% between UWF imaging and clinical examination. The use of UWF imaging as a screening modality can be applied to the pediatric retinal population as well.\\nSimilarly, UWF-FA was particularly useful to confirm lack of activity or guide targeted panretinal photocoagulation in retinal vascular diseases. Moreover determining if a child who was previously treated requires additional treatment can be challenging. A negative UWF-FA, meaning one without significant ischemia or leakage, can guide the decision to observe with serial examinations and photographs and eliminate the need for an exam under anesthesia as shown in Fig. 4. On the contrary, a UWF-FA with active leakage or neovascularization as in a patient with proliferative diabetic retinopathy or Coats disease may indicate the need for additional panretinal photocoagulation (Fig. 5).\\nThis study is limited by its retrospective nature. Another limitation of UWF-FA is that early vascular filling may not be imaged due to transition time from injection to photography. In addition, the periphery may be obscured by lash or nose artifacts. However, a strength of our study is the relatively large number of subjects included and we overcame challenges in positioning with coaching and parent involvement.\\nFuture prospective studies can be considered to evaluate the time it takes to image subjects by age and compare UWF imaging with standard non-wide field cameras in the pediatric population. In addition, cost/benefit analysis of population screening in children using UWF technology can be considered.',\n",
       "    'gender': 'Unknown'}],\n",
       "  [{'age': 34,\n",
       "    'case_id': 'PMC6159306_01',\n",
       "    'case_text': \"A 34-year-old Caucasian female, who had originally undergone an uneventful laparoscopic adjustable gastric band 4 years ago, presented to the bariatric surgery clinic with inability to tolerate solids. A work-up revealed that the laparoscopic band remained in good position but the patient had oesophagitis and gastritis, causing swelling of the mucosa at the band site. The fluid was removed from the reservoir, and the patient was treated conservatively with anti-reflux medication and a full liquid diet. After 2 weeks of treatment the patient's symptoms improved. After careful consideration, she wished to undergo revisional surgery converting the laparoscopic adjustable gastric band to a laparoscopic vertical sleeve gastrectomy. The patient moved through the appropriate multidisciplinary team approach and was found to be an appropriate candidate for surgery. She underwent laparoscopic removal of the adjustable gastric band and conversion to a laparoscopic vertical sleeve gastrectomy without complications. Her post-operative course was uncomplicated and she was discharged on post-operative day 3.\\nOn post-operative day 12, the patient was readmitted to an outside tertiary care hospital for lightheadedness and shortness of breath and was found to have leukocytosis, with white blood cell count of 18,000 cells mul-1. The work-up included a CT scan with intravenous contrast of the chest, abdomen and pelvis, and the patient was diagnosed with a pulmonary embolism. The patient was immediately transferred to our centre for definitive care. When the patient arrived at our centre, the CT films from the outside hospital were reviewed by our radiologists and there was concern that there was air and a faint suggestion of oral contrast outside of the suture line (Figure 1). Given this finding, an UGI evaluation was ordered. During the early phase, no leak was observed, owing, in part, to the slow passage of 30 ml oral non-ionic contrast (Figure 2a). Some residual contrast from the outside hospital CT was present in the transverse and descending colon. Only after delayed imaging and with administration of additional non-ionic contrast for a total of about 65 ml (approximately 2 h after the start of the fluoroscopic examination) was there a faint suggestion of extravasated contrast, best seen below the left hemidiaphragm (Figure 2b). Follow-up CT scan with oral contrast confirmed the obvious leak (Figure 3).\\nThe patient was treated definitively with endoscopic stent placement and clipping using an Ovesco clip (Ovesco Endoscopy AG, Tubingen, Germany) to close the leak. After an extended hospital course, she was discharged and is presently doing well.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 76,\n",
       "    'case_id': 'PMC6465717_01',\n",
       "    'case_text': 'A 76-year-old woman had a history of left NECB, which was classified as pT2N1M0 stage IIB according to the Union for International Cancer Control (UICC) tumor node metastasis (TNM) classification. The patient was admitted to our hospital with complaints of a mass in the right breast without axial lymph node swelling on computed tomography (CT) (Fig. 1a). No associated pain, nipplagnete discharge, skin change, or palpable lymphadenopathy was noted. Contrast-enhanced mic resonance imaging (MRI) showed a mass with early arterial enhancement and gradual washout measuring 9.3 x 5.8 x 10.7 mm (Fig. 1b). Right breast mastectomy and axillary lymph node dissection were performed. The final pathologic diagnosis was NECB with small polygonal cells having a small amount of cytoplasm, high nuclear-cytoplasmic ratio, and finely granular chromatin (Fig. 2). According to the UICC TNM classification, it was classified as pT1N0M0 stage IA. A diagnosis of non-intramammary metastasis was made based on the results of immunostaining: chromogranin A (-), synaptophysin (+), Leu7 (-), CD56 (-) in the left NECB, and chromogranin A (-), synaptophysin (-), Leu7 (+), CD56 (-) in the right NECB. Six months after the operation, the patient initially underwent HD owing to unexplained chronic renal failure and continued the treatment as an outpatient. Forty months after a right breast mastectomy, CT revealed anterior mediastinal lymph node recurrence (Fig. 3a). Hence, we considered the recurrence of NECB and decided to initiate chemotherapy to prevent further recurrence. Based on the past literature on the chemotherapy dosage for patients on HD, a chemotherapy regimen with six cycles of FEC 100 - consisting of fluorouracil (5-FU, 500 mg/m2), epirubicin (EPI, 70 mg/m2), and cyclophosphamide (CPA, 350 mg/m2) - and three cycles of docetaxel (DTX, 60 mg/m2) was initiated (Table 1). After the third course of DTX treatment, grade 3 neutropenia was observed; hence, the chemotherapy was discontinued. CT was performed after the chemotherapy and anterior mediastinal lymph node recurrence was not detected (Fig. 3b). The patient responded well to the chemotherapy. Forty-two months after the chemotherapy, no tumor recurrence was detected on CT.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 85,\n",
       "    'case_id': 'PMC8084685_01',\n",
       "    'case_text': \"An 85-year-old man with pancytopenia was diagnosed with MDS with multilineage dysplasia (MDS-MLD) based on bone marrow aspiration (BMA), which revealed 2.6% myeloblasts with trilineage dysplasia and normal karyotype. Based on these findings, the case was categorized as intermediate-1 or low risk according to the International Prognostic Scoring System (IPSS) or Revised IPSS (IPSS-R), respectively. At this point, the patient had been treated with vitamin K2 (menatetrenone) and active vitamin D3 (calcitriol) because combination therapy of these two drugs was reported to be effective against low-risk MDS. At 87 years of age, the patient undertook BMA again because his pancytopenia had progressed, and he was diagnosed with MDS with excess blasts-2 (MDS-EB-2) based on the BMA findings, which revealed 11% myeloblasts and multilineage dysplastic changes of bone marrow cells (Figures 1(a)-1(d)), with a normal karyotype. The disease status was categorized as intermediate-2 risk according to the IPSS and high risk according to the IPSS-R; thus, AZA treatment was initiated on hospitalization at the standard dose of 75 mg/m2/day, subcutaneously, for 7 days every month. The patient achieved a hematological improvement (HI) with manageable adverse events (AEs), including constipation and general malaise after the first cycle of AZA. The second cycle was therefore administered in an outpatient setting. However, the treatment was discontinued due to septic shock after the second cycle of AZA. The patient became dependent on red blood cell (RBC) transfusions due to a clinical progression of MDS because one year after the discontinuation of AZA (at 88 years of age), we did not perform any histological examinations, such as BMA. Therefore, additional 3 cycles of AZA were administered in an outpatient setting with a reduced dose of 37.5 mg/m2 (50% dose reduction) daily. The dose of AZA was decided according to the prescribing information for AZA based on the nadir absolute neutrophil count <0.5 x 109/L in the preceding (second) cycle. Treatment with AZA was discontinued again because the patient refused to continue the treatment due to the AEs, which included constipation and general malaise, as well as the inconvenience of going to the hospital.\\nAt eight months after the second discontinuation of AZA (at 89 years of age), a painful cutaneous tumor, the top of which showed yellow-colored necrosis (Figure 2(a)), developed at the left groin lesion. Laboratory tests revealed the following: white blood cell count, 2,900/muL, with 63.6% neutrophils, 32.6% lymphocytes, 3.5% monocytes, 0.3% eosinophils, and no blast cells; hemoglobin, 6.6 g/dL; platelet count, 8.7 x 104/muL; and C-reactive protein, 0.57 mg/dL. No treatments, including oral and topical antibiotics, topical tacrolimus hydrate, and analgesics, had any effect on the tumor. A biopsy of the tumor was performed one month after its development. Histological examination revealed the proliferation of tumor cells with a high nuclear/cytoplasmic ratio (Figure 3(a)). Immunohistochemically, the neoplastic cells were positive for myeloperoxidase (Figure 3(b)), partially positive for cluster of differentiation (CD) 68 (Figure 3(c)) and CD33, but negative for CD3, CD4 (Figure 3(d)), CD20, CD34, CD56, CD117, and CD123 (Figure 3(e)). A diagnosis of MDS-associated MS was made. One month after the development of the first cutaneous lesion, another cutaneous tumor appeared on the left cheek (Figure 2(b)). BMA revealed a hypercellular marrow with 25% myeloblasts, which were positive for CD13, CD33, CD34, and HLA-DR; a G-band analysis revealed a normal karyotype. A diagnosis of AML secondary to MDS was made.\\nConsidering the patient's age, clinical conditions, and the previously experienced AEs, treatment with AZA was started again at a dose of 37.5 mg/m2/day, subcutaneously, for 7 days every 4-6 weeks (in total, this was the 6th cycle of AZA treatment) during short-term hospitalization, which consisted of 9 days of inpatient treatment per cycle, in order to manage the acute-phase AEs caused by AZA. The cutaneous MS lesion located on the left groin (Figures 4(a)-4(c)) and that on the left cheek (Figures 4(d)-4(f)) promptly disappeared after the 6th and 7th cycles of AZA treatment. Although myeloblasts had appeared in peripheral blood after several cycles of retreatment with AZA, the treatment was continued because of persistence of the response on MS, and the pain caused by his lesions remained relieved, with tolerable AEs, by AZA. The patient had received 16 cycles (over a 22-month period) of AZA treatment with the same dose on repeated short-term hospitalization until he died of progression of AML. He eventually received 21 cycles of AZA treatment in total. No exacerbation of cutaneous MS had been confirmed during AZA treatment.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 66,\n",
       "    'case_id': 'PMC9846588_01',\n",
       "    'case_text': 'A 66-year-old postmenopausal lady, presented with palpable, bilateral neck lymphadenopathy and difficulty swallowing. She also had left leg lymphoedema and complained of having poor appetite, fatigue, and lost 4 kg within 4 weeks. Patient denied having fever and night sweats. All these difficulties lasted approximately 1 month. Complete blood count (CBC) showed mild anaemia while all other laboratory findings were within normal limits. Also, HBV, HCV and HIV serology were negative. Colour doppler of lower extremities showed no signs of deep vein thrombosis and cardiac ECHO showed ejection fraction of 65%. Abdominal ultrasound showed para-aortic, bilateral pelvic and inguinal lymphadenopathy.\\nAn excisional biopsy of enlarged axillary and cervical lymph node was performed. The cervical lymph node measured 1.8 x 1 x 0.7 cm and axillary node measured 3.6 x 2.6 x 2 cm. Nodes had firm consistency with no signs of necrosis or haemorrhage. Histological examination of lymph nodes showed effaced architecture, due to infiltration of polymorphic tumour lymphoid cells. The interfollicular area of lymph node was infiltrated with medium to large sized lymphocytes, having blastoid morphology indicative of centroblasts and immunoblasts and intermingled with plasmablast-like cells. Also, there were scattered large bi-nucleated cells similar to Reed-Sternberg cells. In between there were many eosinophils, histiocytes and plasma cells. Furthermore, within interfollicular areas, many mitoses and apoptosis were found. Four-micrometer sections from paraffin-embedded blocks were stained with each antibody listed below, using the streptavidin-biotin complex method. By immunohistochemistry, large atypical lymphoid cells were CD1a-, CD2-, CD3-, CD4-/+, CD5-, CD8-, CD20-, CD79a+, PAX-5-, CD38+, CD138-, CD30-/+, CD56-, MUM1+, PD-1-/+, Bcl-2-, ALK-, c-myc-, TdT-, CD45+, Bcl-6-, CD10- and HHV-8-. The Epstein-Barr encoding region (EBER) in situ hybridisation was negative (Figure 1). Kappa and lambda light chain in situ hybridisation did not show restriction. CD68 staining showed lot of histiocytes and Ki-67 proliferation index was high, approximately 65% (Figure 1).\\nDue to the unusual morphology, as well as the immunophenotype of large, polymorphic cells, with blast and plasmablast-like appearance (CD20-/PAX-5-/CD79a+/CD38+/MUM-1+/CD4-/+) a multiplex polymerase chain reaction (PCR) analyses of B-cell and T-cell receptor rearrangement were performed using BIOMED-2 protocol. Briefly, BIOMED-2 multiplex PCR reactions using fluorescently labelled oligonucleotide primers were performed in triplicates with 50 ng and 200 ng of DNA per 50 microL reaction. Following PCR amplification, the PCR products were resolved using capillary electrophoresis on the SeqStudio (Applied Biosystems, USA) genetic analyser. GeneMapper software (Applied Biosystems, USA) was then used to analyse PCR products by peak height and size determination. The clonality analysis of IgH gene in FR2 and FR3 regions showed polyclonal distribution of PCR products (gaussian distribution of multiple peaks representing multiple PCR products) while the IgKappa gene clonality analysis showed only one prominent peak (monoclonal result consisting of one type of PCR product) (Figure 2). However, the T cell receptor analysis of TCR gamma region showed bi-clonal and TCR beta region monoclonal distribution of PCR products (Figure 3).\\nConsidering histological, immunohistochemical and clonality analysis results our final diagnosis was primary nodal CD20 and PAX-5 negative DLBCL with dual IgK and TCR rearrangement. The whole-body computer tomography (CT) scan showed generalised lymphadenopathy and bone marrow biopsy showed no evidence of infiltration. Thus, a stage IIIB of disease was confirmed. Considering, poor prognosis of primary CD20 negative DLBCL, patient was treated with 6 cycles of the R-DA-EPOCH (dose adjusted rituximab, etoposide prednisolone, vincristine, cyclophosphamide, doxorubicin) chemotherapy protocol. The subsequent follow up laboratory tests as well as positron emission tomography and computed tomography scans (PET-CT) showed no evidence of lymphoproliferative disease 4 years after initial diagnosis. The collateral finding at the last control PET-CT scan was diffuse thickening of the large colon at sigmoid region. A colon surgery was performed, and histological examination showed colon adenocarcinoma (pT2, pN0). Other than that, patient did not have any health-related difficulties.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 74,\n",
       "    'case_id': 'PMC9053256_01',\n",
       "    'case_text': 'FNH is rarely associated with HCC, however, the risk of malignant transformation from FNH to HCC has been already suggested. In this study, we describe a 74-year-old female patient with an FNH and a concomitant HCC nodule in a non-cirrhotic liver. The nodule consisted of two HCC components with distinct histopathological features. We demonstrated, using whole-exome sequencing (WES), that the FNH and the HCC share a common phylogenetic origin.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 39,\n",
       "    'case_id': 'PMC9829981_01',\n",
       "    'case_text': 'A 39-year-old female premenopausal, P4 +0, presented to the breast surgery clinic with right breast swelling for ten years. The swelling started gradually following the excision of a right axillary lump. The mass was diagnosed as a right axillary CH of about 2cm x 1cm in dimensions. Just before her presentation, the swelling became big enough to disturb her daily activities. She had no family history of breast cancer. There were no other swellings elsewhere in her body. She was not a smoker or alcoholic, and there was no previous surgery or chronic illnesses. Examination revealed a swollen right breast with \"peau d\\' orange\" and erythema around the right nipple-areola complex (NAC). There was asymmetry in the shape of the right breast compared to the left and right breast ptosis. The skin was thickened and red but no hotness or tenderness. No masses were felt in the right breast. The right NAC appeared normal. Apart from the linear scar of the previous CH excision in the right axilla, the axilla was normal. Left breast and axilla examination revealed no obvious or palpable abnormalities (Figure 1). Ultrasound examination of the breast and axilla revealed mild skin thickening. The breast parenchyma was dense and showed an anechoic tubular and round structure. The right breast showed a loculated cystic area with internal septations. It measured 3.4cm x 1.2cm x 5.1cm and multiple smaller cyst (Figure 2A). The mammogram showed marked skin thickening with edema (Figure 2B).  \\nWe attempted needle aspiration away from the cysts, and the fluid was easily aspirated from the edematous breast tissues. The fluid was watery and clear yellowish. The laboratory result of the fluid was lymphatic fluid. Aspiration trials were repeated twice with almost a complete resolution of the edema, but there was a recurrence within two weeks in every aspiration attempt. Subsequently, the patient consented to a shunt catheter placement between the edematous breast and the peritoneal cavity, a relatively new technique for breast edema secondary to CH. There was a partial resolution of the breast edema after the shunt surgery. The patient was followed up for five years. The last ultrasound and mammogram showed recurrence of cysts of the same axilla, and new cysts appeared in the breast (Figure 3A and B).',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 2,\n",
       "    'case_id': 'PMC5295181_01',\n",
       "    'case_text': 'A 21/2 year-old girl presented with an asymptomatic painless mass in the right upper abdomen. On physical examination, a 7x6 cm, nontender, firm and well-defined mass with smooth surface was noted in the right hypochondrium extending to the epigastric and umbilical regions as well as to the right iliac fossa. Family history of paternal twinning was present. On imaging, a frontal radiograph of the abdomen showed multiple dense radio-opacities in the right upper quadrant of the abdomen resembling well-formed limb bones and spine (Figures 1, 2). On abdominal ultrasound, there was evidence of a heterogeneous right suprarenal mass with coarse calcifications and solid areas. On contrast-enhanced computed tomography of the abdomen (Figures 3, 4) with a 3D-volume-rendering technique (Figure 5), a heterogenous, well-circumscribed soft tissue mass was noted in the right anterior pararenal space in a suprarenal location. It showed multiple bony densities resembling a spine, limb bones, ribs and pelvic bones. These bony densities were surrounded by soft tissue and fat. No obvious contrast enhancement in the soft tissues was noted. Radiological diagnosis of FIF was considered and the child was referred to a surgical ward.\\nOn laparotomy, a right upper quadrant retroperitoneal mass (Figure 6A),~10x12 cm in size, covered with a sac was noted displacing the liver towards the left side and the right kidney anteriorly, stretching the right renal vessels. Venous drainage from the mass was enabled by a direct tributary of the inferior vena cava (IVC). On opening the sac (Figure 6B, 6C), 50 ml of vernix caseosa, along with a malformed fetus with an anencephalic head, spine, upper and lower limb buds with nails and partially differentiated digits were noted.\\nOn the histopathological examination, the gross specimen showed a partially developed fetus with partial differentiation of the four limbs, skull and spine with palpable vertebrae, bones, scapula and ribs. Microscopic sections showed mature derivatives of the ectoderm, mesoderm and endoderm. No immature components were identified. There was no evidence of somatic or germ cell malignancy. A final diagnosis of fetiform teratoma was made. The child is on a regular follow-up and at 11/2 years following surgery there is no evidence of recurrence.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 18,\n",
       "    'case_id': 'PMC10098112_01',\n",
       "    'case_text': 'The proband, a girl, is the only child of healthy, non-consanguineous parents. She was first referred to our Unit of Clinical Pediatrics at the age of 18 months for a diagnostic workup regarding her microcephaly. She was born at 39 weeks of gestation by caesarean section; the pregnancy was characterized by an ultrasonography diagnosis of microcephaly, reduced gyral pattern, and agenesis of the corpus callosum at gestational age 25 weeks. Serological screening for congenital infections (i.e., Cytomegalovirus, Toxoplasma gondii, Varicella-Zoster Virus, and Hepatitis C Virus) during pregnancy and at birth (in the mother and her daughter) was negative, as was the proband neonatal extensive screening for inborn errors of metabolism. Her birth weight was 2.6 kg, height was 47 cm, and head circumference was 32 cm (all below the 3rd percentile). Neonatal history was negative, and she was not breast-fed by the mother.\\nAt our first diagnostic workup, at age 18 months, her weight was 8.4 kg (<3rd percentile), height was 74 cm (<3rd percentile), and head circumference was 38.5 cm (<3rd percentile, -5.6 standard deviations). Three small hyperpigmented maculae (1-cm diameter each) were present on her abdomen. The mother reported irritability and sleep disorders (insomnia). She underwent a new heart examination by means of ECG and echocardiography, abdominal ultrasound, and full ophthalmological examination, all of which were normal. Her eye-to-eye and social interaction with parents and other people was within normal limits, but she was not able to walk alone and spoke only a few words. Brain MRI and additional laboratory and instrumental investigations were planned but the family was temporarily lost to follow-up due to the Covid-19 pandemic.',\n",
       "    'gender': 'Female'},\n",
       "   {'age': 3,\n",
       "    'case_id': 'PMC10098112_02',\n",
       "    'case_text': 'At the age of 3.5 years, the family again referred the child for completion of her diagnostic work-up. At that stage, brain MRI showed microcephaly with a small brain, simplified parieto-temporal gyral pattern, hypoplasia of the corpus callosum, with a residual draft of the genu, and enlargement and flattening of the ventricles, with colpocephaly and ectasia of the temporal horns (Figure 1). At the age of 4 years, her general conditions were good. Her weight and height were 12.1 kg and 89 cm, respectively (<3rd percentile), head circumference was 40 cm (<3rd percentile, -5.6 standard deviations), the girl was able to walk, did not present any seizures, and showed moderate intellectual disability [IQ by means of WPPSI-III = 67; verbal comprehension index = 61; visual spatial index = 72; fluid reasoning index = 63; working memory index = 70; processing speed index = 69]. She was assisted by a support teacher at school and was under speech-language therapy twice a week.',\n",
       "    'gender': 'Female'},\n",
       "   {'age': None,\n",
       "    'case_id': 'PMC10098112_03',\n",
       "    'case_text': 'The girl and her parents underwent next-generation sequencing (NGS) testing with a panel of 161 genes related to brain malformations. A novel variant (c.611G > A), in one copy of the TSC1 gene, was found in the child, and not in her parents (interpreted as a de novo variant). An in-silico analysis was performed using VarCards, ProAffiMuSeq, and Mutation Taster tools (see the following sections). Over the following months, the variant was confirmed by Sanger sequencing of the gene; the girl and her parents were also submitted to a further whole exome sequencing analysis, which confirmed the results of the NGS panel and failed to find additional variants in other genes. The TSC1 variant was hypothesized to cause a gain-of-function effect on hamartin, and consequent hyperactivation of its downstream effectors.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 26,\n",
       "    'case_id': 'PMC3323263_01',\n",
       "    'case_text': \"The index patient, a 26-year-old woman, was admitted to the infectious disease ward of a university hospital with a temperature of 40 C and myalgias 3 days after she returned from a 3-week trip to Cambodia and Thailand. Dengue virus infection was subsequently diagnosed, and mild hepatitis and a rash developed. She was discharged in good condition after the fever subsided. On the day of admission of the index patient (day 0i), a nurse sustained a needlestick injury with a hollow needle that had been used for drawing blood from the index patient. The needlestick resulted in a bleeding puncture wound that was immediately treated with an antiseptic. The index patient did not report any high-risk activity for HIV or hepatitis B virus, and the nurse had been immunized against hepatitis B virus. Therefore, no specific postexposure prophylaxis was performed. The nurse had previously been in good health and had not traveled outside Germany in the preceding 12 months.\\nFour days after the needlestick, headache, myalgias, and arthralgias developed in the healthcare worker, for which she took ibuprofen. Seven days later, when she was experiencing an intense headache and noticed a macular rash on her trunk, she sought treatment from a local doctor (day 0n). Physical examination showed bilateral cervical lymphadenopathy. On day 2n, she visited our service, where dengue virus infection was diagnosed by using a Light Cycler (Roche Diagnostics, Mannheim, Germany) polymerase chain reaction (PCR) method. Her symptoms lessened gradually over the course of 4 weeks, and she was on sick leave for 5 weeks. The time frame of the respective clinical presentation and the virologic results of the index patient and the nurse are shown in the Figure; laboratory data are presented in the Table.\\nSerologic studies were performed with the PanBio dengue immunoglobulin (Ig) M capture enzyme-linked immunosorbent assay (ELISA) and PanBio dengue indirect IgG ELISA (PanBio Ltd., Brisbane, Australia); arbitrary units relative to a simultaneously measured calibrator >11 were considered positive. For detecting virus RNA, RNA was prepared from 140 microL of serum by using the QIAamp Viral RNA Mini Kit (Qiagen, Hilden, Germany), according to the manufacturer's instructions. To detect specific dengue virus RNA, we adapted a TaqMan-reverse transcription (RT)-PCR to detect any of the four serotypes by using the following: degenerated forward primer (DEN FP), reverse primer (DEN RP); and probe (DEN P): DEN FP 5 AAggACTAgAggTTAKAggAgACCC3 , DEN RP 5 ggCCYTCTgTgCCTggAWTgATg3  and the probe DEN P 5  FAM-AACAgCATATTgACgCTgggARAgACC-TAMRA-3 . RT-PCR conditions for the Light Cycler (Roche Diagnostics) were: RT at 61 C for 20 min, activation at 95 C for 5 min, and 40 cycles of PCR at 95 C for 15 s, 60 C for 60 s. We used the RNA Master Hybridization Probes Kit (Roche Diagnostics) with 500-nM primers and 200-nM probes. The kit includes an aptamer-blocked Thermus thermophilus DNA polymerase, which performs RT and, once the aptamer drops out at activation, hotstarts PCR amplification.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 85,\n",
       "    'case_id': 'PMC3726520_01',\n",
       "    'case_text': \"An 85-year-old man was referred to the Aberdeen Royal Infirmary in September 2011 for consideration of corneal grafting due to his poor visual acuity and increasing difficulty with his activities of daily living. He had a history of dry age-related macular degeneration, and FECD. He underwent bilateral phacoemulsification with intraocular lens implants in 1996, and 4 years later was diagnosed with bullous keratopathy. On clinical examination, his best-corrected visual acuities (BCVAs) were OD hand movement and OS 20/200. He had bilateral bullous keratopathy, which was more marked in the right eye. The cornea was edematous with pannus and multiple scars. There was no fundal view but B-scan ultrasonography excluded gross vitreoretinal pathology. The patient was given a guarded prognosis as to the outcome as pre-operative retinal examination was not possible.\\nIn November 2011, he underwent an uncomplicated right PK under general anesthetic using a 7.5 mm donor and recipient punch. A vacuum trephine was used to cut through the cornea in a controlled rotatory manner until the anterior chamber was penetrated, confirmed by evidence of aqueous eruption at the wound site. Scissors were used to separate and remove the button and 10.0 nylon interrupted and continuous sutures were placed. Sub-conjunctival dexamethasone and cefuroxime were administered intra-operatively, along with chirocaine in the sub-Tenon's space. Dexamethasone Minims  0.1% and chloramphenicol Minims  0.5% (Bausch + Lomb, Rochester, NY, USA) were prescribed four times daily for the post-operative period. On day 1 and 2 postoperatively, his BCVA OD was hand movement and postoperative anterior chamber inflammation of 3+ cells was found, based on the standard uveitis classification system. At that stage, his steroid treatment was increased to six times a day, along with a Maxitrol  ointment (dexamethasone, neomycin sulphate, polymyxin B sulphate; Alcon Eye Care UK Ltd, Surrey, UK) at night. Fundal examination revealed atrophic age-related macular degeneration, which was expected to affect his visual outcome.\\nOn the ninth post-operative day, BCVA remained hand movement only in the right eye. A clear gap was apparent between the healthy graft and a thin, transparent sheet of tissue in the anterior chamber. The graft was otherwise clear and this sheet was presumed to be retained DM, as confirmed on histopathology (Figure 1, arrow). Steroid drops were tapered on a monthly basis and his review was arranged for two months with in vivo confocal microscopy testing.\\nAt the next clinical review, the graft had remained clear and in vivo confocal microscopy (IVCM) testing, confirmed the presence of DM and healthy endothelial cell count. This was diagnosed as retention of the host's DM rather than a detachment of the donor's DM (Figure 2) as the latter would have been associated with endothelial loss and corneal decompensation. The patient underwent a further uneventful operation for extraction of the retrocorneal membrane under local anesthetic in April 2012.\\nPost-operative recovery was uneventful and 2 weeks later, a clear healthy graft with an improved BCVA of OD 20/200 was noted, with the limited acuity more likely related to his atrophic macular degeneration rather than the graft. Further clinical reviews have shown that the graft has remained clear and healthy without any signs of rejection.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 28,\n",
       "    'case_id': 'PMC8526214_01',\n",
       "    'case_text': 'Case 1. A 28-year-old woman with no subjective symptoms but had undergone an intrauterine fetal death at 14 weeks gestation. Histopathological examination of the autopsy specimen revealed the presence of Toxoplasma cysts in the placenta, heart, adrenal gland, and brain, so this case was diagnosed as congenital toxoplasmosis. Analysis of antibody levels revealed the following: phyto-hemagglutinin (PHA) antibody:20480 (<160), IgG:5120 (<20), and IgM:20 (<10). There was a serial measuring of antibodies in case 1. IgG and IgM gradually increased, peaked on the 150th day, and IgM became negative on the 310th day.',\n",
       "    'gender': 'Female'},\n",
       "   {'age': 32,\n",
       "    'case_id': 'PMC8526214_02',\n",
       "    'case_text': 'Case 2. A 32-year-old woman had a left cervical tumor in five years. She had developed this tumor gradually increased in size recently. We resected swollen lymph nodes and examined microscopically. The lymph node findings showed reactive follicles, clusters of epithelioid cells, and patches of monocytoid cells, which is the triad of Toxoplasma lymphadenopathy. IgG: 320, and IgM: 40; therefore, Toxoplasma lymphadenitis was presumed (case 2, Figure 1).',\n",
       "    'gender': 'Female'},\n",
       "   {'age': 20,\n",
       "    'case_id': 'PMC8526214_03',\n",
       "    'case_text': 'Case 3. A 20-year-old woman had developed bilateral cervical tumors that had gradually increased in size over a six-month period. We resected swollen lymph nodes and examined microscopically. The lymph node findings showed reactive follicles, clusters of epithelioid cells, and patches of monocytoid cells, which is the triad of Toxoplasma lymphadenopathy. IgG: 320 and IgM: 20; therefore, Toxoplasma lymphadenitis was presumed (case 3, Figure 1).',\n",
       "    'gender': 'Female'},\n",
       "   {'age': 44,\n",
       "    'case_id': 'PMC8526214_04',\n",
       "    'case_text': 'Case 4. A 44-year-old woman had had right cervical tumors for three days. We resected swollen lymph nodes and examined microscopically. The lymph node findings showed reactive follicles, clusters of epithelioid cells, and patches of monocytoid cells, which is the triad of Toxoplasma lymphadenopathy. IgG: 320 and IgM: 40; therefore, Toxoplasma lymphadenitis was presumed (case 4, Figure 1).',\n",
       "    'gender': 'Female'},\n",
       "   {'age': 23,\n",
       "    'case_id': 'PMC8526214_05',\n",
       "    'case_text': 'Case 5. A 23-year-old man had lymphadenopathy in both posterior neck and left axilla starting one month previously. PET-CT (positron emission tomography-computed tomography) showed strong accumulation of 18F-FDG (18F-fluoro-2-deoxy-D-glucose), which was consistent with a diagnosis of malignant lymphoma. A 15 mm-sized lymph node was resected from the left axilla and examined microscopically. The lymph node findings showed reactive follicles, clusters of epithelioid cells, and patches of monocytoid cells, which is the triad of Toxoplasma lymphadenopathy. Toxoplasma lymphadenitis was suspected. IgG (EIA): 45 IU/mL (less than 6), and IgM: 8.99 (cutoff index) (<0.80) (case 5, Figure 1).\\nThe details of each clinically diagnosed case are as follows:',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 0,\n",
       "    'case_id': 'PMC10076737_01',\n",
       "    'case_text': 'An 8-month-old girl was admitted to the pediatric department of our hospital after first presenting at the age of 3 months with abnormal facial features that had been noticed within 4 weeks of birth (Figure 1A). Her parents were healthy first cousins. Her prenatal ultrasound examination showed no obvious abnormalities. Because the age of the mother at the expected delivery date was more than 35 years, chromosome microarray analysis by amniocentesis had been performed. The chromosome microarray analysis showed no chromosome number abnormalities or pathogenic copy number variation, and detected eight loss of heterozygosity regions of unknown significance. The mother refused whole-exome sequencing of amniotic fluid owing to the high cost. The patient was born after a full-term pregnancy with a birth weight of 2860 g and an Apgar score of 9-10-10. She had no significant family history and had a healthy 9-year-old sister.\\nAt the age of 3 months, physical examination revealed a progeroid facial appearance of coarse facial features with prominent cheekbones and a triangular chin, a low frontal and posterior hairline, and facial hirsutism. She also had hepatomegaly (7 cm in the midclavicular line) with no subcutaneous fat, marked hypertrophy of muscles in the limbs, and acanthosis nigricans. A 3/6 systolic murmur was heard in the precardiac region. Echocardiography showed normal ventricular wall thicknesses (Figure 2A). (interventricular septum (IVS) measured as 4.5 mm, Z score +1.62; left ventricular posterior wall (LVPW) measured as 4 mm, Z score +0.24) and slightly accelerated blood flow in the right ventricular outflow tract (Figure 2B). The preliminary diagnosis was progeria without further treatment.\\nAt the age of 5 months, the physical examination findings were similar to the findings at 3 months (Figure 1B). Standard conventional echocardiography performed at the age of 5 months showed myocardial hypertrophy (Figure 2C). (IVS measured as 13 mm, Z score +23.21; LVPW measured as 8.5 mm, Z score +9.1) and an obstructive pattern in the left ventricular outflow tract (Figure 2D) but a normal ejection fraction of 70%. Because the ventricular wall thickness was significantly thicker at the age of 5 months than it was at the age of 3 months, we ruled out the diagnosis of classic hypertrophic cardiomyopathy and considered that the ventricular wall hypertrophy was caused by metabolic factors. Two-dimensional speckle-tracking (2D-STE) was performed to assess strain parameters in the left ventricle and revealed a global longitudinal strain of -16.79% (Figure 3A), a global radial strain of 65.67%, and a global circumferential strain of -14.04%. Abdominal ultrasound showed hepatic steatosis with hepatomegaly. An electrocardiogram revealed sinus rhythm and a prolonged QTc interval (Figure 4). Her blood pressure was 123/65 mmHg. Additional fasting blood testing showed an increased free fatty acid concentration (1.39 mmol/L), normoglycemic hyperinsulinemia (glycemia concentration, 4.60 mmol/L; insulin concentration, 58.53 microIU/mL), dyslipidemia (increased triglycerides [10.14 mmol/L], total cholesterol [5.33 mmol/L], and low-density lipoprotein cholesterol [3.8 mmol/L]), and decreased high-density lipoprotein cholesterol (0.69 mmol/L) indicating insulin resistance. CGL was considered based on the physical characteristics and investigations.\\nAt the age of 8 months, 2D-STE showed a decrease in several left ventricular strain parameters (global longitudinal strain, -13.50% (Figure 3B); global radial strain, 37.63%; and global circumferential strain, -14.76%) compared with the values recorded at the age of 5 months despite the findings on conventional echocardiography showing no significant change (IVS measured as 13.5 mm, Z score +23.34; LVPW measured as 8.5 mm, Z score +9.7). Combined with the typical clinical manifestations (severe insulin resistance with lipoatrophy and hypertrophic cardiomyopathy, and hirsutism), exon group of single gene disease-customized capture sequencing test at the age of 9 months identified a homozygous mutation in the BSCL2 gene: c.166_184del (p.Tyr56fs*) (reference sequence NM_032667.6) on 11q12.3, confirming a diagnosis of type 2 CGL (OMIM # 269700).. Both her mother and sister were confirmed to be heterozygous carriers. Dietary modification was introduced to restrict her fat intake to 25% of the total dietary energy. Follow-up biochemistry at the age of 14 months showed progressive improvement in the fasting lipid profile (triglycerides, 4.13 mmol/L; total cholesterol, 5.10 mmol/L; insulin concentration, 29.49 microIU/mL) with normal glycemia concentration [4.5 mmol/L]. Her blood pressure at the age of 14 months was normal. Conventional echocardiography showed no significant changes (IVS measured as 13 mm, Z score +20.55; LVPW measured as 8.5 mm, Z score +7.75) from the findings at the age of 8 months, and the left ventricular strain parameters measured by 2D-STE tended to remain stable (global longitudinal strain, -13.38% (Figure 3C); global radial strain, 34.60%; global circumferential strain, -14.41%).',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': None,\n",
       "    'case_id': 'PMC10266800_01',\n",
       "    'case_text': 'The present study is a clinical case, associated with the research project approved by the Ethics Committee of the Bauru School of Dentistry - University of Sao Paulo, reference number 2235918-CAAE: 71680017.0.0000.5417. The female client was duly informed of the aims and procedures to be adopted in the study and signed the Free and Informed Consent.\\nThe client decided to participate in the study due to wanting to undergo a non-invasive treatment to reduce facial wrinkles, having met the following exclusion criteria: realization of invasive facial procedures (plastic surgery, facial filler, botulinum toxin application, laser application) and non-invasive (drainage; massages; medication; new creams, different to those routinely used) in the year prior to the treatments and during participation in the research, a history of skeletal dentofacial deformity, absence of temporomandibular dysfunction, presence of snoring, absence of more than one dental element.\\nA speech therapy evaluation was performed before and after the therapeutic intervention. The same physical space, equipment, patient position and room lighting were used to collect the images, as recommended by Frazao and Manzi. The aesthetic and orofacial myofunctional aspects were analyzed using photographic documentation and in video, by two previously trained speech therapists, specialists in orofacial motricity, applying the Orofacial Myofunctional Evaluation Protocol MBGR and the validated scales described in the literature. Following the initial evaluation, we performed nine sessions undertaking electromyographic biofeedback training associated with chewing, swallowing and mild smiling without labial sealing. During this period, isometric and isotonic exercises were also realized in therapy, to condition the cheek, tongue and suprahyoid muscles (3 series of 20 seconds, using the Facial Plus and Lingual-Pro-FonoR exercisers), the palpebral portion of the orbicularis oculi muscle (3 series of 5 seconds, asking the client to open her eyes wide and hold them open, holding the palpebral portion of the orbicularis oculi muscle firmly) and a speaking exercise with a wine cork between the teeth (opening held at the diameter of the cork - requesting the production of three phrases), as a technique for pronunciation (\"speaking with cork\"). The client was asked to carry out these exercises daily at home (eye exercises, twice a day, facial and lingual exercisers and \"speaking with cork\", once a day), as well as using a TransporeTM inelastic bandage once a day while sleeping at night, over the frontal portion of the right and left occipitofrontal muscle, of the right and left eyebrow corrugator muscle and over the inferior orbital portion of the orbicularis oculi muscle (external corner of the eyes - right and left) and during the day, a small strip of latex (2cm long and 5mm in diameter) in the oral vestibule (intersection between the mentalis muscle and the lower lip) except at meals and while sleeping.\\nDuring the electromyographic feedback training we used the Biotrainer software on the New Miotec Miotool Face USB NM600FO device. It has eight channels connected to differential active sensors, with 16bit resolution, a 2Khz sampling frequency, 20Hz low pass filter, 500Hz high pass filter, 60Hz notch, a clamp connection, and a reference electrode (ground). To capture the electric signal, we used the same device with Double Trace LH-ED4020 differential passive dual electrodes, with dimensions 44 mm long, 21 mm wide, and 20 mm from center to center, placed over the muscles engaged when chewing, swallowing, and smiling (right and left masseter muscles; major, minor zygomatic region, risorius muscles; orbicularis oris (upper lip); suprahyoids; inferior orbital portion of the orbicularis oculi muscle). The reference electrode (ground) was positioned over the styloid process of the ulna of the right arm. The facial areas and regions where we positioned the electrodes were sterilized with cotton wool soaked in alcohol 77% GL (70% INPM) prior to placing the electrodes for all sessions when electromyographic biofeedback was employed.\\nIn the initial evaluation, no alterations to chewing function were observed (a score of zero out of 10, for the MGBR Protocol). For swallowing, a marked contraction of the orbicularis oris and mentalis muscles, during routine swallowing of chewed, solid food and guided swallowing of liquid was observed (score 8 out of 28). The analysis of signs of facial aging showed an absence of static perioral wrinkles (score zero), moderate dynamic perioral wrinkles (score two out of four), moderate nasolabial grooves (score two out of four) and mild labiomentonian grooves (score one out of four). The smile evaluation score obtained using video image capture of the dynamic periorbital wrinkles, in the third execution of the \"open smile\" and of the photographic image of the static periorbital wrinkles in diagonal position (45o), showed accentuated dynamic periorbital wrinkles (score of three out of four) and moderate static periorbital wrinkles (score of two out of four).\\nFor training with electromyographic biofeedback, the electrodes were placed in a sequence favoring progressive control by the client of the movements of the different muscle groups when executing trained orofacial functions. As such, to train alternating unilateral chewing in the second session, the electrodes were positioned parallel to the direction of the muscle fiber, over the right and left masseter muscles. For the third and fourth sessions, the electrodes were placed over these muscles as well as over the orbicularis oris muscle (upper lip). This position was maintained for the fifth to the ninth sessions, to train alternating bilateral chewing. To train the swallowing function, initiated in the third session with swallowing pasty food (Greek yogurt), the electrodes were initially placed over the suprahyoid muscle region; in the fourth and fifth sessions electrodes were placed over the orbicularis oris muscle (upper lip); these electrodes were maintained to train liquid swallowing in the fifth session, and chewed solid food in the sixth session, when an electrode over the right and left masseter muscles was added and kept until the ninth session. Figure 1B shows the position of the electrodes for training of chewing and swallowing functions. For smile training initiated in the fifth session, an electrode was placed over the region of the risorius muscle and, for the sixth to the ninth sessions, an electrode on the lower orbital portion of the orbicularis oculi muscle was added. Despite placing the electrodes in the risorius region, the possibility of capturing an electric signal from the adjacent muscles cannot be overlooked (cross talk). Even so, during training it was possible to compare the contraction of the risorius region muscles and the inferior orbital portion of the orbicularis oculi muscle. As such, the client managed to reduce the muscle contractions in the eye region while smiling, with consequent reduction of static and dynamic periorbital wrinkles.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 0,\n",
       "    'case_id': 'PMC8605226_01',\n",
       "    'case_text': \"A-3 months-old-boy presented with severe malnutrition, known cholestatic jaundice diagnosed as congenital cytomegalovirus infection and contact of his father who was diagnosed with MDR-TB but was not compliant with his treatment. His tuberculin skin test was positive, chest radiograph revealed right perihilar infiltrate and X-pert MTB/RIF on gastric aspirate was positive for M. tuberculosis complex with resistance to rifampicin. Other baseline investigations revealed a small atrial septal defect on echocardiography, mild to moderate hearing loss on audiology, normal vision and retinas on ophthalmological evaluation, raised bilirubin and liver enzymes (alanine and aspartate transaminases) and positive cytomegalovirus (CMV) IgM with a negative CMV PCR. He was HIV-unexposed and his HIV ELISA was negative, but CD4% was low (19%). Culture of the gastric aspirate eventually was positive, confirming M. tuberculosis resistant to isoniazid and rifampicin on line-probe assay as well as resistant to second-line injectable agents with second-line LPA, but susceptible to the fluoroquinolones. He was therefore confirmed as pre-XDR-TB. The mother's sputum was X-pert MTB/RIF negative. The chest x-ray showed active tuberculosis with infiltrates at the right upper-middle lung field with an increased of bronchovascular marking (Fig. 1). We treated him with five kind of less hepatotoxic anti tuberculosis drugs by individualized treatment based on the updated WHO 2018 guidelines. He commenced the treatment with moxifloxacin (10 mg/kg/day divided in tow dose), linezolid (10 mg/kg/day once daily), cycloserin (10 mg/kg/day once daily), ethambutol (20 mg/kg/day once daily) and para-aminosalysilic acid (200 mg/kg/day divided in two dose). After seven days receiving the pre- XDR-TB treatment, the liver enzymes improved, no adverse reaction such as vomiting, dhiarrea was reported. He also recieved gancyclovir for the CMV infection. He was followed every one month, he shows weight increment to 5.8 kg from 3.6 kg in 3 months and increased gradually every month. His nutritional status improved to normal from severe malnutrition after 20 months of treatment. No adverse reaction such as vomiting nor dhiarrea was reported. The growth and milestones development were appropriate. Laboratory evaluation showed improvement of liver function. Hematologic and neurologic (peripheral and toxic optic neuropathy) adverse effects were monitored during linezolid treatment. No anemia nor thrombocytopenia was found. For the optic toxic neuropathy evaluation, normal vision was concluded through examination of response to light, pupil response, ability to follow a target and ophthalmoscopy examination of the retina was also done to exclude CMV retinitis symptom and the result was normal. The M.tuberculosis culture evaluation result was negative on the first and third month of treatment.\",\n",
       "    'gender': 'Male'},\n",
       "   {'age': 14,\n",
       "    'case_id': 'PMC8605226_02',\n",
       "    'case_text': 'A-14 years-old-girl presented with severe weight loss (severe malnutrition), with chief complaint of fever since 1 month and hemoptysis since 2 days prior. Her parents showed negative for TB screening. History of tuberculosis contact is her neighbour identified MDR-TB and received treatment in our hospital. Her X-pert MTB/RIF revealed positive Mycobacterium tuberculosis with Rifampicin resistant. Culture M. tuberculosis was positive, confirming M. tuberculosis resistant to isoniazid and rifampicin on line-probe assay as well as resistant to second-line injectable agents with second-line LPA, but susceptible to the fluoroquinolones. The chest x-ray showed active tuberculosis with opacity at the right hilar, lobulated infiltrate in the left apex, nodular at left hilar, and enlarged bilateral peri-hilar lymph nodes (Fig. 2). Before starting the therapy she was consulted to the Psychiatry, Ophthalmology and Ear, Nose and Throat department. Baseline electrocardiography (ECG) showed normal QT interval. HIV screening was negative. She started on individualized drugs regimen for pre-XDR TB with levofloxacin (10 mg/kg/day once daily), ethionamide (15 mg/kg/day once daily), cycloserine (10 mg/kg/day once daily), pyrazinamide (35 mg/kg/day once daily), para-aminosalicylic acid (PAS 200 mg/kg/day divided in two dose), bedaquiline (200 mg once daily for 2 weeks). On the second day receiving bedaquiline, the ECG showed prolonged QT interval >500 ms without any electrolyte imbalance, so bedaquiline was stopped and ECG was examined every day. She started to receive linezolid 400 mg per day (10 mg/kg/day once daily) replacing bedaquiline. There was no more prolonged QT after given linezolid. Laboratory examination and clinical manifestation was monitored due to the side effects of the therapy. During hospitalization no other adverse reaction occurred. The laboratory examination is within normal limit. After two weeks hospitalized, she was discharged. She was followed every one month, no adverse reaction of nausea, vomit, jaundice was reported. Linezolid toxicity was also observed during treatment, hematologic value was normal, no anemia nor thrombocytopenia was found, there were no vision loss and color vision test result was normal (evaluated through Ishihara test). No peripheral neuropathy signs (paresthesia, numbness in extremities) were reported. Her weight increased 2 kg after 3 months treatment and her nutritional status improved to normal weight from severe malnutrition after 20 months of treatment. The M.tuberculosis culture result was negative on the first and third month of treatment.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 14,\n",
       "    'case_id': 'PMC7474778_01',\n",
       "    'case_text': 'A 14-year-old male patient presented to our rheumatology clinic with a 4-month history of left hip pain. The pain was more severe in the morning and sometimes woke him up at night and also increased with practicing sports (hockey and lacrosse). His pain is 1-2 of 10 when he is resting and 7-8 of 10 when he is playing sports. There was no history of trauma. There was no associated swelling or morning stiffness, and no pain in any other joints.\\nThe patient was initially evaluated in the orthopedics clinic. Initial blood work revealed normal complete blood picture (CBC), erythrocyte sedimentation rate (ESR), and C-reactive protein (CRP). Left hip X-ray was normal. Initial MR arthrogram of the left hip showed marked edema of the medial and posterior walls of the left acetabulum (Figure 1). The patient was started on naproxen 220 mg (3.5 mg/kg) once daily, with limited improvement in terms of less frequent waking up at night from pain, knowing this is not optimal dose.\\nWith persistence of pain, CT-guided biopsy of the left acetabulum was performed and revealed unremarkable flow cytometry, and histopathology showed cortical bone with rare foci of marrow elements and a mild chronic inflammatory component and no evidence of malignancy. The patient was referred to the rheumatology clinic for further evaluation. Initial examination showed pain with flexion and external rotation with mild limitation of full external rotation of the left hip. JIA and CRMO could not be ruled out given his clinical examination and the histopathology result. The patient was started on prednisone 50 mg (0.7 mg/kg) once daily (that was gradually tapered), and naproxen dose was increased to 375 mg twice daily. Two months later, left hip pain continued, and he started to experience pain of the right hip, right metacarpophalangeal (MCPs), and left clavicle. He was started on weekly methotrexate in addition for presumed diagnosis of JIA and/or CRMO. Bone scan was unremarkable apart from focal increased uptake in the left acetabulum (Figure 2).\\nAfter two months of methotrexate treatment, the patient reported improvement in the intensity and frequency of the left hip pain; however, he was still experiencing pain with certain positions. The pain of the right hip, left clavicle, and right MCPs resolved completely. Due to persistence of the left hip pain, adalimumab 40 mg subcutaneous every 2 weeks was added, with no significant improvement in pain. He reported increased need for NSAIDs (twice daily almost every day). Repeat contrast-enhanced MRI showed left hip effusion that decreased from before, with medial focal synovial enhancement and edema of the acetabulum (Figure 3). These findings are not typical for JIA where more diffuse synovial process would be anticipated. Pain was refractory to treatment for presumed JIA and CRMO with NSAIDs, steroids, methotrexate, and adalimumab. Subsequently, CT scan of the left hip was done for further evaluation. It showed 11 x 6 mm low attenuation focus with subtle internal nidus in the posteromedial aspect of the acetabular rim suggestive of intra-articular OO (Figure 4). Steroids, adalimumab, and methotrexate were discontinued. Uncomplicated radiofrequency ablation of the left acetabular OO was performed with complete resolution of the left hip pain.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 78,\n",
       "    'case_id': 'PMC8077606_01',\n",
       "    'case_text': \"A 78-year-old man initially presented to our Oncology Unit with an elevated PSA level of 23.3 ng/mL.\\nPatient subsequently underwent a transrectal ultrasound guided prostate biopsy which revealed high-risk adenocarcinoma of the prostate with a Gleason score 5 + 5 = 10 involving 60% of the tested tissue.\\nMetastatic workup consisting of bone scan showed abnormal concentrations at the level of sacroiliac bones and some metamerians of possible reference to repetitive osteoblastic lesions.\\nTo manage bone metastases, the patient had been treated with zoledronate (4 mg).\\nHe was then started on ADT (combined androgen blockade therapy using an anti-androgen drug and LH-RH agonist) with leuprolide, as a monthly dose and bicalutamide (150 mg/day) with disease control for 22 months and progressive decrease in PSA value up to 0.22 ng/mL.\\nDue to progressive increase in PSA values up to 62.11 ng/mL, treatment was switched to Abiraterone (1,000 mg/day) combined with LH-RH antagonist and prednisone (10 mg/day).\\nAfter 3 months of administration of abiraterone, he showed progressive increase in PSA values up to 444 ng/mL, worsening of clinical conditions as asthenia, anorexia, edema and onset of widespread pain.\\nThe patient had performance status (PS) with an Eastern Cooperative Oncology Group Grade (G) 2/3.\\nA bone scan was performed showing increased bone lesions (Fig. 1a).\\nAs a result of poor control of disease with abiraterone, treatment with enzalutamide (160 mg/day) was started.\\nAfter 1 month of the administration of enzalutamide, PSA decreased to 3 ng/mL, with improvement in clinical conditions (PS 0) and near-disappearance of pain (Fig. 2).\\nThe patient experienced general fatigue while receiving enzalutamide treatment. We evaluated the patient's general fatigue and clarified the quantitative information about this. The patient continued treatment with reduced dosage because of fatigue (80 mg/day). After the administration of reduced dosage of enzalutamide, PSA decreased to 0.3 ng/mL, and the patient reported noticeable improvement in fatigue. A bone scan was performed and showed a favorable response to treatment with overall reduction of pathological bone uptake (Fig. 1b). Treatment with enzalutamide, first at full dosage and then at a reduced dosage, has shown good disease control and a significant improvement in the patient's clinical condition. At time of writing, patient is continuing treatment with enzalutamide with excellent disease control.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 5,\n",
       "    'case_id': 'PMC6005275_01',\n",
       "    'case_text': \"We were contacted by a local farmer who kept a cheetah on his farm, which exhibited a slow growing alopecic dermal mass at the height of the left shoulder blade that began to grow approximately 1.5 years earlier (Figure 1). The animal was a castrated 3.5-year-old wild born male cheetah, living since the age of 3 months in a large fenced area surrounding the farmhouse. He had been vaccinated yearly against rabies (Rabisin ), feline calicivirus, feline panleukemia virus, feline viral rhinotracheitis virus (Feligen CRP , Virbac), and feline leukemia virus (Tricat, Nobivac). The surgical option was made. A fine needle aspirate of the mass was not attempted before surgery, as this would have required an additional anesthesia. During the clinical investigation, the cheetah was found in a good health status with a body weight of 47 kg.\\nThe cheetah was immobilized with a mixture of ketamine (3.2 mg/kg, Ketavet , Kyron Laboratories, Benrose, RSA) and medetomidine (0.06 mg/kg, Novartis, Spartan, Republic of South Africa) administered with a dart shot from a dartgun (Telinject, Dudenhofen, Germany). The skin around the mass was shaved and the surgical field was washed and disinfected with 70% ethanol. The mass and covering skin were excised from the adjacent tissue. The neoplasia was well encapsulated and no infiltrative growth into the surrounding tissue was visible, but it had one large supportive blood vessel, which was ligated and cut. The wound was closed with a subcutaneous consecutive suture and several cutaneous suture stiches both with absorbable material. The animal was treated prophylactically with 2 mg/kg ketoprofen (Ketofen , Merial) as anti-inflammatory and pain medication and with a combination of 15.000 IU/kg procaine benzyl penicillin and 15.000 IU/kg benzathine benzyl penicillin (Peni-LA Phenix , Virbac) to prevent a wound infection. To keep the wound clean from dust and dirt, we dressed the animal with children's shirt, which was removed by the farmer seven days after surgery. The immobilization was reversed with Atipamezole (0.11 mg/kg, Antisedan , Pfizer, RSA). The wound remained uninfected and was nearly invisible at the annual medical check-up one year after the surgery and the cheetah was still alive 3.5 years after removal of the tumor without any signs of recurrence.\\nThe excised neoplasia was fixed in 10% buffered formalin and shipped to Germany in full compliance with the Convention on International Trade in Endangered Species (CITES) for histological examination at the Leibniz Institute for Zoo and Wildlife Research in Berlin.\\nThe tumor presented itself as an exophytic firm encapsulated broad based nodular dermal to subcutaneous mass measuring 5.5 cm x 4.5 cm x 2.5 cm, covered by intact sparsely haired dark pigmented skin. Cut surfaces revealed multiple small lobules separated by fine white strands of connective tissue (Figure 2). Lobules were mottled light to dark grey or whitish with multinodular solid growth pattern and they did not exceed the surgical excision margins. Microscopically, some lobules were populated by high numbers of heavily dark brown, pigmented cells, while others contained lightly pigmented cells, which were mostly distributed in the periphery of each lobule (Figures 3(a) and 3(b)). Within the lobules, cells were oriented in cords and trabeculae or small islands separated by thin collagen, while distinct sheets of collagen-rich connective tissue surrounded the entire lobules (Figure 3(c)). Rarely, small assemblies of dark pigmented cells (melanophages) were found in the separating connective tissue septa. The neoplastic cells were cuboidal to polygonal with uniformly large round to ovoid central nuclei with stippled chromatin and 1-2 nucleoli (Figure 3(d)). Cytoplasm was scant to moderate, pale eosinophilic, sparsely stained and finely granular. The majority of the tumor cells had indistinct cell borders (Figures 3(c) and 3(d)). Occasionally, single mitotic figures were found (one per 10 high power fields). The overlying epidermis was made of five to six even layers of unremarkable keratinocytes containing some melanosomes in the basal cells as well as some cells of the stratum germinativum. There was mild orthokeratosis and a few remaining hair follicles. The superficial dermis contained mild nodular perivascular neutrophilic infiltrates and dermal collagen was markedly thickened as a response to the expanding tumor, but no other pathological changes were apparent.\\nA panel of immunohistochemistry stains was applied and revealed tumor cells being positive for pancytokeratin but negative for MelanA, S100, and vimentin. Although the dark pigmentation and nests and islands of polygonal cells prompted the differential diagnosis of a melanocytoma, the immunohistochemistry results lead to the final diagnosis of a moderately pigmented basal cell tumor.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 5,\n",
       "    'case_id': 'PMC6472062_01',\n",
       "    'case_text': 'A young first time mother at 36 weeks period of gestation was seen in a health clinic in Kuching, Sarawak with regards to her ability to breastfeed. She was referred from a clinic in a small district located around 31 km from the nearest tertiary hospital. She had history of a flame burn at the age of 5 years old to her chest, abdomen, upper limb and part of her trunk. She was admitted for about 4 months in the Burn Unit in a tertiary hospital where skin grafts were done in 3 stages on her whole chest and abdomen. Despite the injuries, she noticed pubertal breasts development. During this pregnancy, she had further breast development which increased in size and her abdomen was able to stretch to accommodate her pregnancy. Physical examination showed a pregnancy which corresponded to her date. The skin over her chest and abdomen appeared tight with areas of hyperpigmentation and hypopigmentation due to scarring from the skin graft. There were normal breasts swelling and breast tissues palpable over her chest with the absence of areola and nipple. Sensations over the skin grafted area were intact. The breasts and abdomen (antenatally) are shown in Fig. 1 (Antenatal: Right breast), Fig. 2 (Antenatal: Left breast) and Fig. 3 (Antenatal: Breasts and abdomen).\\nA counselling session was conducted to explore her expectations and hopes regarding her ability to breastfeed her baby. Further counselling was done to prepare her that she might not be able to breastfeed her child due to her physical condition and may need lactation suppression post-birth. Alternative methods of feeding were discussed.\\nShe birthed her infant at 36 weeks and 5 days via spontaneous vaginal delivery without any complications. Oral cabergoline 1 mg was given on the first postpartum day to suppress lactation. The baby was given infant formula via bottle feeding as the feeding method of choice. On subsequent days, she noticed her breasts reduced in size.\\nAt day 6 postpartum, her breasts reduced in size almost to the pre-pregnancy stage as shown in Fig. 4 (Postnatal Day 6: Breasts).\\nA breast ultrasound was done at day 6 postpartum. It showed dilated lactiferous ducts at retroareolar region bilaterally, consistent with lactating ducts of the breasts. The normally appearing vague shadow of the nipple was not seen. However, the tightly packed ducts seen parallel to the ultrasound beam are suggestive of major ducts to the possible location of the nipple as shown in Fig. 5 (Ultrasound: Right breast) and Fig. 6 (Ultrasound: Left breast).\\nA discussion with the plastic surgeon was made regarding the possibility of surgery to enable her to breastfeed in her future pregnancies. However, patient was not keen for any surgeries as she was made aware of the risks and complications. She also felt contented with her decision to bottle feed her child with infant formula.\\nScheduled home postnatal visits were done to ensure that mother and baby were coping well. She had fully accepted that she was not able to breastfeed her child due to her physical limitations. Her husband and family were very understanding and supportive towards her. The baby was doing well with infant formula feeding. There were no signs and symptoms of postpartum depression.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 9,\n",
       "    'case_id': 'PMC6390555_01',\n",
       "    'case_text': 'A forty-nine-year-old female from a suburban community in Sri Lanka presented with insidious high grade intermittent fever with chills and rigors for 2 months. She experienced one to two febrile episodes daily with complete defervescence in between. She also had anorexia, weight loss, sore-throat and symmetrical large joint arthritis without morning stiffness. Small joints and axial skeleton were spared. She also noticed an itchy desquamating erythematous rash over back of the trunk and proximal limbs. Erythematous patches were transient and recurring but did not temporally correspond to febrile peaks. The patient did not have any symptoms referable to a focus of infection and did not report photosensitivity, Raynaud phenomenon, past history of tuberculosis, or high risk sexual behaviours.\\nThe patient was averagely built (BMI: 23.1 kg/m2), febrile (39.9  C), ill and pale. A firm 1.5 cm lymph node in the right posterior cervical group was noted. Throat was non-inflamed. Erythematous macules noted over the trunk and proximal limbs were transient. Symmetric arthritis affected elbow, wrist and knee joints. A smooth non-tender 2 cm hepatomegaly was noted. The rest of the examination was unremarkable.\\nInvestigations revealed a normocytic normochromic anaemia, neutrophil leukocytosis with toxic changes, reactive thrombocytosis, elevated ESR (110 mm 1st hour), CRP (165 U/L) and ferritin (3200 U/L). Renal function was normal and liver enzymes were mildly elevated (AST 66 U/L, ALT 57 U/L). Auto antibody panel, including rheumatoid factor, antinuclear antibodies (ANA), dsDNA antibodies, pANCA and cANCA were negative. Contrast enhanced computerized tomography of the neck, chest, abdomen and pelvis demonstrated enlarged cervical lymph nodes and fatty liver. Radiographs of large joints were normal. Biopsy of the lymph node showed reactive lymphoid hyperplasia with no evidence of neoplastic changes, suppuration or granuloma. Bone marrow aspiration and trephine showed no abnormalities. Blood and bone marrow cultures for bacteria, tuberculosis, brucellosis, melioidosis and fungi were negative. Serum protein electrophoresis showed polyclonal gamma-globulinaemia and reduced albumin fraction. As she had been exposed to flood water 2 weeks prior to symptom onset (compatible with incubation period of 1-3 weeks) and several cases of melioidosis had been reported in her residential area, antibodies against Burkholderia pseudomallei were tested. It turned positive (1:640, indirect haemagglutination) and titre continued to rise over time (Fig. 1).\\nFebrile illness, possible exposure to infectious agents during floods and elevated inflammatory markers necessitated consideration of empiric antibiotic therapy. The patient was treated with ceftazidime (2 g 6 hourly IV) and imipenem (1 g 8 hourly IV) for 14 days and ceftazidime and cotrimoxazole (1440 mg bid orally) for another 14 days, due to positive serology for melioidosis. However she did not show clinical improvement. Fever persisted and inflammatory markers remained elevated. Serum ferritin and melioidosis antibody titre continued to rise exponentially. However repeated peripheral blood cultures for melioidosis did not isolate any bacteria and repeated imaging did not reveal a focus of infection.\\nDespite a month of broad spectrum antibiotics she remained febrile with persistently elevated inflammatory markers. In retrospect, AOSD was considered as a possible diagnosis. She showed partial response to NSAIDs, further favouring this diagnosis. Subsequently, she was commenced on high dose steroids (prednisolone 1 mg/kg/day). Within 2 days she achieved complete defervescence and made a good clinical recovery. Serum ferritin level and melioidosis antibody titre declined over time (Fig. 1). After one month of steroid therapy she remained afebrile, but had mild residual large joint arthritis with minimal functional impairment. Methotrexate was commenced and steroids were tapered over next 2 months and at 6 months she remained asymptomatic on methotrexate with normal inflammatory markers. Long term follow up was arranged.\\nThe final diagnosis of AOSD was made based on clinical features and exclusion of other connective tissue disorders, neoplasms and infections. During the course of her illness the patient did not develop Macrophage Activation Syndrome, a serious complication of AOSD.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 25,\n",
       "    'case_id': 'PMC4678526_01',\n",
       "    'case_text': 'A 25-year-old female presented with a painless and mobile lump in breast measuring 2.5 cm x 2.5 cm. Aspiration cytology of the lump revealed moderately cellular smears comprising of few branching fragments of benign ductal epithelial cells intimately mixed with spherical acellular homogenous hyaline globules [Figure 1a and b]. A few dispersed bare, bipolar cells were also seen in the background. A cytological diagnosis of CS associated with benign proliferative breast disease was given.',\n",
       "    'gender': 'Female'},\n",
       "   {'age': 59,\n",
       "    'case_id': 'PMC4678526_02',\n",
       "    'case_text': 'A 59-year-old female presented with a lump in the upper-outer quadrant of left breast measuring 5 cm x 5 cm. The magnetic resonance imaging revealed a heterogeneous noninfiltrating lesion in the left breast. The axilla was clear. The fine-needle aspiration cytology from the left breast lump revealed cellular smears composed of epithelial cells and acellular basement material. The epithelial cells were small and basaloid forming cohesive, spherical, and tri-dimensional structures with a central core of acellular homogenous basement membrane substance [Figure 1c and d]. A cytological diagnosis of ACCB was given. The patient underwent left mastectomy. Mastectomy specimen revealed a 4.5 cm x 4.5 cm x 3.5 cm lesion in the upper-outer quadrant of the left breast. Microscopic examination revealed tumor cells arranged in solid nests, proliferating glands, and cylideromatous differentiation containing eosinophilic basement membrane-like material and basophilic secretions. The areas of cribriform pattern were also seen in the desmoplastic stroma. All resection margins, nipple, and areola, were free from tumor invasion. The histopathology confirmed the cytological diagnosis of ACCB.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 56,\n",
       "    'case_id': 'PMC8791849_01',\n",
       "    'case_text': \"A 56-year-old Chinese woman was admitted to our hospital emergency room in September 2020 with repeat fatigue, abdominal distension, and melena for 1 month. Abdominal computerized tomography (CT) suggested obviously uneven thickening and strengthening of the gastric body and gastric antrum wall, possibly accompanied by ulcers and multiple lymph nodes adjacent to the stomach enlarged. Gastroscopic examination revealed a giant ulcerative lesion located in the posterior wall of the gastric antrum, with the invasion of stomach angle and pylorus. Subsequent pathological examination of the biopsy showed poorly differentiated adenocarcinoma. On September 19, 2020, she underwent radical gastrectomy for distal gastric cancer and D2 lymphadenectomy. Pathohistological results of distal gastric cancer resection showed that the tumor was poorly differentiated adenocarcinoma with lymphoid stroma component ( Figure 1 ), without any cancer in the surgical margin and metastasis to regional lymph nodes. An EBV-encoded RNA (EBER) assay demonstrated strong positive staining parallel to the tumor harboring EBV infection ( Figure 1 ). Meanwhile, the immunohistochemistry indicated that MLH1, MSH2, MSH6, and PMS2 were overexpressed (pMMR) and human epidermal growth factor receptor 2 (HER2) was not amplified. The tumor was confirmed as pT4bN0M0 poorly gastric antrum differentiated adenocarcinoma with lymphoid stroma component (EBER-ISH+ and HER2-). The outcomes of next-generation sequencing (NGS) verified fifteen gene mutations ( Table 1 ), a high tumor mutation burden (TMB) with 10.8 Muts/Mb, and microsatellite stable (MSS) status. Immunohistochemical (IHC) data of the tumor tissue suggested that the positive expression of PD-L1 protein and the tumor proportion score (TPS) was 70% and the combined positive score (CPS) was 75 ( Figure 1 ). The immune microenvironment was examined by multiplex immunohistochemical staining and quantitative analysis ( Figure 1  and  Table 2 ). Two months after the operation, abdominal CT showed enlargement of mass located in the gastrocolic ligament ( Figure 2 ), which indicated metastatic lymph node (LN). Oxaliplatin 200 mg on day 1 plus oral S-1 60 mg twice a day, from days 1 to 14, along with camrelizumab 200 mg on day 1, repeated every 3 weeks, was administered as first-line treatment. Then, radiographic evaluation was performed every 8 weeks by enhanced CT. The significant resolution of the lymph node was observed after two cycles' exposure of regimen SOX combined with camrelizumab, and the best efficacy evaluation was PR based on RECIST 1.1. Early tumor shrinkage was observed after 8 weeks, and persistent shrinkage of LN was achieved after 4 cycles ( Figure 2 ). From then on, she had been exposed to SOX combined with camrelizumab up to 8 months and still achieved continuous PR. Moreover, the quality of life of the patient was good. Chemotherapy-associated AEs (grade 1 nausea, vomit and grade 2 anemia, grade 2 decreased neutrophil count, and decreased white blood cell count) were observed, and grade 1 reactive cutaneous capillary endothelial proliferation (RCCEP) was presented without any other immune-related adverse event. After 7 cycles' SOX plus camrelizumab, the lesion was still unresectable due to whole abdominal adhesions. After multidisciplinary team (MDT) consultation, the patient underwent external-beam radiotherapy (EBRT) and received 50 Gy/25 fractions. She received S-1 and camrelizumab as the maintenance therapy up to 10 cycles followed by EBRT. Tumor is gradually and continuously shrinking in the latest visit and in deep response with a >80% decrease in size ( Figure 2 ). Until now, PFS reached at least 12 months and the duration of response was beyond 10 months with manageable toxicity.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 42,\n",
       "    'case_id': 'PMC4663175_01',\n",
       "    'case_text': 'A 42 year-old Caucasian female was referred for metamorphopsia in the left eye. She had no previous past medical history, did not take any oral or topical medication, and denied travel abroad. Visual acuity was normal in both eyes and examination of the posterior segment revealed a large tortuous choroidal vessel involving the fovea with mild overlying RPE changes (Figure 1A). The red channel of the color fundus photograph clearly highlighted this structure (Figure 1B). Early phase fundus angiography showed early filling of the vessel, confirming its arterial origin (data not shown). Near infrared reflectance (NIR) showed a subtle hyperreflective serpentine-shaped structure temporal to the fovea (Figure 2, left panels). EDI-OCT revealed a thickened choroid and an enlarged vascular structure that spanned the entire thickness of the choroid, from the choriocapillaris to the choroid-scleral junction (Figure 2). Near the fovea, there was an abnormal ellipsoid zone (EZ), including retinal pigment epithelium (RPE) hyperreflectivity, and focal EZ compression with reduced outer nuclear layer (ONL) thickness, as well as an indented choroidal-scleral junction (CSJ, Figure 2). Transverse EDI-OCT sections of the choroidal macrovessel demonstrated its narrowing as it coursed temporally through the macula (Figure 2). False-color en face SD-OCT imaging at the level of the choroid was overlayed on the NIR image, which revealed the path of the macrovessel through the temporal macula (Figure 3).',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 65,\n",
       "    'case_id': 'PMC6701301_01',\n",
       "    'case_text': 'The patient is a 65-year-old female who was previously diagnosed with moderately differentiated, invasive adenocarcinoma after a right upper lobectomy in 2013. The tumor was positive for EGFR mutation, KRAS wild type, ALK negative, CK7 positive, CK20 negative, and TTF negative. At that time, no chemotherapy or radiation was required. In 2014, the patient had a recurrence of her disease with a metastasis to mediastinal subcarinal lymph node. Over the next four years due to disease progression or inability to tolerate agents (e.g., development of acute pancreatitis from erlotinib), the patient was treated with multiple antineoplastic agents including bevacizumab, pemetrexed, durvalumab, tremelimumab, erlotinib, and afatinib. These were all discontinued over 6 months prior to this admission to the hospital. She also received palliative radiation to the right mediastinal mass as well as to several metastatic spine lesions in the cervical and thoracic spine during 2017. Follow-up staging imaging did not show any evidence of radiation pneumonitis or fibrosis. In early 2018, she underwent biopsy of metastatic liver lesions, found to be adenocarcinoma of the lung primary with EGFR exon 19 deletion and T790M mutations. In April 2018, she was started on Osimertinib 80 mg daily, which she tolerated well for approximately four months. A staging CT was completed in June of 2018, which showed response to therapy as evidenced by a decrease in size of the right infrahilar mass, adenopathy, pulmonary nodules, and hepatic metastases. In addition, her previously noted brain metastasis was no longer seen on her brain MRI. In August 2018, she required an admission to an outside facility due to symptoms suggestive of congestive heart failure. She was diuresed and diagnosed with nonischemic cardiomyopathy. Her heart failure remained well compensated on goal-directed medical therapy and diuretics. Other past medical history is notable for hypertension, acid reflux, emphysema, and iron deficiency anemia. She is not prescribed any antiplatelet or anticoagulation agents. She has several allergies to antibiotics and was previously intolerant to subcutaneous heparin.\\nThe patient was admitted to our facility in September 2018 due to progressive dyspnea, fatigue, and weakness of several weeks of duration. She was initially managed as hospital-acquired pneumonia in an immunocompromised host with broad-spectrum antimicrobials, aggressive bronchodilators, and intravenous corticosteroids. Within 24 hours of admission, transfer to the intensive care unit was facilitated due to worsening respiratory distress requiring noninvasive positive pressure ventilation which eventually progressed to require mechanical ventilation. At this time, her exam was remarkable for predominant left-sided rhonchi and rales. Laboratory analysis was unremarkable except a severe acute respiratory acidosis of pH 7.18 and PCO2 of 54 mmHg. Upon arrival, her WBC count was 7.6 x 103/muL, hemoglobin was 8.5 g/dL, and platelets were 305 x 103/muL, and she had normal coagulation panel and B-type natriuretic peptide (BNP). A CT chest with contrast demonstrated a consolidation in the left lung suspicious for pneumonia and small effusions bilaterally with associated atelectasis (Figure 1). Her antibiotics were continued.\\nDue to the progressive respiratory failure, a bronchoscopy was performed. The bronchoscopy revealed inflamed airways (left>right) and increasingly hemorrhagic return on sequential lavages (Figure 2) from the lingular segment of the left upper lobe. Bronchoalveolar lavage (BAL) RBC counts were increasing significantly in sequential samples (42,000/muL, 190,000/muL, and 230,000/muL). She was diagnosed with DAH with predominant left-sided parenchymal involvement. She was initiated with pulse dose methylprednisone 250 mg IV every 6 hours for 3 days. Her ventilator settings improved significantly after the initiation of pulse dose systemic steroids. After three days of IV steroids, we decided to repeat the bronchoscopy due to continued small amount of blood-tinged tracheal aspirates requiring in-line suction. On repeat bronchoscopy, the airway inflammation had diminished considerably. There was no visible bleeding. We elected to repeat a sequential lavage in the lingular segment, which was dramatically less hemorrhagic (Figure 3). The RBC counts from the sequential lavage were 5,250/muL, 6,750/muL, and 11,500/muL. Microbiology from BAL was unremarkable. The patient was transitioned to oral prednisone 1 mg/kg daily. She was successfully weaned from mechanical ventilation and eventually discharged from the hospital without a need of any supplemental oxygen.\\nA comprehensive standard etiological assessment for DAH was unremarkable including ANCA vasculitis panel and anti-GBM antibodies. Despite her diagnosis of nonischemic cardiomyopathy, the patient was not clinically in decompensated heart failure at any point in her admission. Upon medication review, Osimertinib 80 mg daily was the only new medication the patient had initiated in the prior four months. Osimertinib was discontinued in consultation with medical oncology and was held at her discharge from the hospital. She was discharged on a prolonged prednisone taper. A follow-up CT of the chest demonstrated resolution of the opacities in the left upper lobe (Figure 4).',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 21,\n",
       "    'case_id': 'PMC5015501_01',\n",
       "    'case_text': 'A 21-year-old man, working as a priest, presented with a history of generalized raised nodular lesions for 2 years. The patient was apparently asymptomatic 2 years back when he started developing reddish raised small lesions over the right knee. The lesions gradually increased in size and then ruptured with blood-stained purulent discharge. There was no loss of sensation. Lesions were not accompanied by pain, itching, or burning sensation. Similar lesions gradually developed over other sites such as left knee, both elbows, and ears. Other symptoms, such as joint pain, swelling of joints, or fever, were absent. The patient consulted a local doctor who advised a biopsy of the lesions. This biopsy report was suggestive of fungal infection; hence, the patient was treated with itraconazole and amoxicillin-clavulanic acid but without any relief. No acid-fast Bacilli (AFB) staining was done.\\nOn clinical examination, multiple erythematous nodules and plaques of varying sizes ranging from 3 mm to 3 cm in diameter were seen on bilateral ear pinna and bony prominences of the extremities, i.e., elbows, knees, malleoli, and dorsal aspect of bilateral feet [Figure 1]. Some lesions were covered with hemorrhagic crusts. The lesions were nontender and firm to hard in consistency. The patient had neither oozing of fluid, discharge, sinus, nor ulcers. No history of contact with leprosy patients could be elicited.\\nThe blood parameters were within normal limits. Slit skin smears and biopsy from multiple lesions were collected and processed for bacterial and fungal culture since a provisional diagnosis of subcutaneous mycoses was considered. Microscopy as well as culture for both was negative. Slit skin smear received for detection of Mycobacterium leprae was stained by modified Ziehl-Neelsen (ZN) staining using 5% sulfuric acid. Examination of stained smear revealed characteristic AFB in large numbers [Figure 2]. A bacterial index of 4+ (10 AFB per oil immersion field) was recorded. Histopathological examination of skin biopsy showed an unremarkable epidermis with underlying dermis showing a diffuse polymorphous inflammatory infiltrate coexisting with foamy histiocytes, neutrophils, plasma cells, and lymphocytes, extending from dermis to subcutis [Figure 3]. AFB were highlighted by Fite-Faraco stain [Figure 4]. Standard nerve stimulation test was done which showed evidence of mild axonal sensory mononeuritis multiplex in bilateral upper limbs and axonal sensory polyneuropathy affecting bilateral lower limbs with bilateral greater auricular, ulnar, common peroneal nerves showing thickening. This finding supported the microbiological diagnosis of leprosy.\\nBased on ZN stain results and histopathological report, the patient was considered as a case of lepromatous leprosy and started on multidrug therapy (MDT). Two months after commencement of MDT, the patient showed improvement with reduction of the nodular lesions.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 55,\n",
       "    'case_id': 'PMC4444167_01',\n",
       "    'case_text': 'A 55-year-old male with liver cirrhosis was admitted due to bleeding from gastric varices. Ascites and chronic occlusion of the portal vein (PV) were diagnosed on CT of the abdomen and the patient was referred for TIPS combined with PV recanalization.\\nFollowing informed consent and initiation of general anesthesia, a 4 F Cobra catheter (Cordis, Johnson&Johnson, Miami Lake, FL, USA) was placed through the left transjugular access and wedged with a tip in the branch of the right hepatic vein. CO2 injection showed partly patent but very small intrahepatic PV branches and occlusion of the main PV to the confluence of the superior mesenteric vein and the splenic vein. Following replacement of the catheter with a 10-F introducer sheath, several unsuccessful attempts of transjugular transhepatic puncture of the intrahepatic PV branches were carried out using a Rosch-Uchida transjugular liver access set (Cook Inc., Bloomington, IN, USA).\\nIn order to facilitate transjugular, transhepatic access to PV, a trans-splenic puncture of the splenic vein branch was performed using a 22-G needle, and a 5-F introducer sheath was placed. Subsequently, a 4-F Cobra catheter jointly with a 0.035-inch glidewire (Terumo, Tokyo, Japan) was manipulated through the splenic vein and into the occluded part of PV in the liver. That catheter was exchanged over the wire for a 6x20-mm dilation balloon (Powerflex Pro, Cordis), and then via the transjugular access, a transhepatic puncture towards the balloon was performed from the right hepatic vein using the transjugular access set. With the use of that access, the tip of the glidewire was advanced into the balloon, and then by pulling back the balloon, the glidewire was advanced to the splenic vein. Following dilation of the tract with a 4x40-mm balloon (Powerflex Pro), a 10-F transjugular sheath was advanced through the transhepatic tract and the recanalized segment of PV. Two Viatorrs (8x80+20 mm and 8x60+20 mm) were deployed coaxially, connecting the SMV/splenic vein confluence with the right hepatic vein. Contrast-enhanced examination showed a short stenosis at the cranial end of the created shunt and repeated balloon dilation was attempted. The 8 x40-mm balloon (Powerflex Pro) inflated partly into the Viatorr was accidentally moved in the cranial direction, causing dislodgement of the cranial part of the endoprosthesis to the right atrium.\\nAfter replacing the previous sheath with an 18-F sheath (Cook Inc.), a GooseNeck Snare (EV3, Plymouth, MN, USA) with a 15-mm loop was introduced over the guide wire. The loop of the snare was placed over the cranial edge of the Viatorr (Figure 1). The Viatorr was squeezed and the sheath was advanced over the endoprosthesis. The Viatorr was withdrawn into the sheath and was removed together with the sheath. However, during that withdrawal, the second (coaxially placed in the first one) Viatorr followed into IVC and the removal procedure was repeated as described above (Figure 2). Thereafter, two new Viatorr endoprostheses (8x80+20 mm) were placed in an adequate position, with subsequent good function of the TIPS. The trans-splenic tract was embolized with tva 3x10-mm coils (Cook Inc) and gelfoam pledgets.',\n",
       "    'gender': 'Male'},\n",
       "   {'age': 43,\n",
       "    'case_id': 'PMC4444167_02',\n",
       "    'case_text': 'A 43-year-old male with alcohol-related cirrhosis, ascites and bleeding from the varices was referred for TIPS to the Department of Endovascular Surgery of a nearby hospital. CO2 portography was performed in there through a balloon catheter placed in the branch of the middle hepatic vein, showing patent PV.\\nDuring transjugular, transhepatic attempt to puncture PV, a bile duct was accidentally entered (Figure 3). That was misinterpreted by the physician performing the procedure, who placed a Viatorr connecting the bile duct to the right hepatic vein. The physician reported later that \"the flow from the SMV was good, the gradient was=0 mmHg, and the TIPS was created successfully\".\\nOn the following three days the patient\\'s condition deteriorated and on the fourth day he showed signs of general sepsis and abdominal distension requiring urgent ICU care. The inflammatory parameters were high and the laboratory tests were critically elevated (P-bilirubin=466 mumol/L; CRP=43mg/L; P-creatinine=435 mumol/L). At that time the error was identified and a percutaneous biliary drainage catheter was placed percutaneously through the right liver lobe bile ducts to the duodenum.\\nAfterwards, the patient was transferred to the Department of Hepatic Surgery at our hospital, for urgent treatment. Following an interdisciplinary decision and discussion with the patient and his family, it was undertaken to attempt removal of the Viatorr. With the patient under general anesthesia, a paraumbilical vein was punctured using ultrasonographic guidance, and a 4-F Cobra catheter was advanced to the right portal vein branch. CO2 portography through that catheter showed a hepatofugal flow in the portal vein but no connection with the bile duct (Figure 4). The percutaneous biliary drainage catheter was removed over the guidewire and replaced with a 8-F sheath. Through the left jugular vein, a 4-F Cobra catheter was introduced jointly with a 0.035-inch glide-wire through the Viatorr to the common bile duct. After confirmation of their position, the sheath was exchanged over the 0.035-inch Amplatz wire for a 45-cm-long 16-F sheath. The loop of the 15-mm GooseNeck Snare was placed over the wire. Subsequently, a 10x40-mm dilation balloon was advanced into the Viatorr in order to facilitate placement of the snare over the cranial edge of the Viatorr. However, only a part of the cranial portion of the Viatorr could be grasped with the snare.\\nThe balloon was deflated and attempt to withdraw the Viatorr into the sheath was performed. About 50% of the Viatorr could be retrieved into the sheath, but then the Viatorr become partly disintegrated and could not be further retracted in the sheath. However, the entire Viatorr could be pulled back from the transhepatic tract to the right atrium (Figure 5).\\nThe Amplatz wire tip was withdrawn from the bile duct and advanced to the inferior caval vein (IVC). The right common femoral vein was accessed and another 45-cm-long 16-F sheath was placed with the tip in the IVC. The Amplatz wire was grasped with a 15-mm snare and withdrawn through that sheath. The snare was then advanced over the caudal edge of the Viatorr, which was squeezed and the entire endoprosthesis was pulled back into the sheath in the IVC.\\nThe sheath with the endoprosthesis was removed (Figure 6) and hemostasis was obtained with manual compression. A puncture of the portal vein was performed from the transjugular approach towards the tip of the catheter inserted through the paraumbilical vein (PV). The 10x2+8-mm Viatorr was placed in the tract and dilated with a 10x40-mm balloon. CO2 portography confirmed good flow through the TIPS channel and no flow to the bile duct.\\nThe sheath in the right lobe bile duct was replaced with an 8-F biliary drainage catheter. Following percutaneous puncture, a left liver lobe internal-external biliary drainage catheter was placed to optimize bile outflow. There were no immediate complications.\\nIn the following three weeks, the patient recovered substantially and his laboratory test results normalized. The follow-up evaluation at six weeks showed normal bile ducts and biliary catheters were removed.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 18,\n",
       "    'case_id': 'PMC7537644_01',\n",
       "    'case_text': \"An 18-year-old female patient, who was fit and well, presented to the hospital with a three day history of urticarial skin rash that was followed with arthritis and tenosynovitis. Her presentation started with urticaria that failed to improve with antihistamine use. Two days later, she started to have multiple joint pain affecting knees, elbows, shoulders, and ankles in addition to small joints of the right hand. There was no history of preceding insect bite, recent vaccination or medication use. She could not link her symptoms to any particular food. There was no history to suggest any connective tissue disease. The patient had on and off bouts of diarrhea with 5 kg weight loss over five months before her presentation. Two weeks before presenting to the hospital, she had an episode of watery diarrhea with mild abdominal cramps. On examination, there were scattered wheels of urticarial rash. She had tenosynovitis of both the achilles tendons and arthritis with redness, hotness, and detectable effusion mainly in her left wrist and both ankles. In addition to the tenderness of the knees and some of her MCPs.\\nHer complete blood count, liver and kidney function tests were normal except for mild microcytic anemia. Her inflammatory markers were high with ESR of 55 mm/1st hour and CRP of 35 mg/L. Autoimmune workup, including rheumatoid factor, antinuclear antibody, and anti-cytoplasmic antibody were negative. Her HLA B27 was negative as well as her serology for brucella, parvovirus, hepatitis B, hepatitis C and HIV. PCR for adenovirus, CMV, EBV was also negative. Urine analysis was normal. Her iron profile showed evidence of iron deficiency anemia with hemoglobin of 9.1 gm/dL. Her stool microscopy showed blastocystis cysts. The patient was started on oral metronidazole 750 mg three times per day for ten days. Her symptoms were controlled by naproxen and prednisolone 30 mg daily, which were tapered off after two weeks with complete resolution of her joint and skin symptoms. Upper and lower endoscopies were done to rule out inflammatory bowel disease (IBD) and were unremarkable except for mild nodular gastritis. Biopsies from the duodenum, ileum and colon showed normal histological appearance. The patient's diarrhea later improved, and she gained 4 kg after five months of follow up with normalization of the inflammatory markers.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 35,\n",
       "    'case_id': 'PMC5380828_01',\n",
       "    'case_text': 'A 35-year-old nulliparous patient at 36 weeks of gestation presented to labor and delivery complaining of sudden onset, left sided back pain which radiated anteriorly. She denied any other gastrointestinal or urinary symptoms. The patient had a past medical history significant only for chronic hypertension and a past surgical history of laparoscopic Roux en Y gastric bypass two years priorly. She denied any prior complications related to this surgical history. The pregnancy was further complicated by gestational diabetes class A1. On presentation the patient had a blood pressure of 162/80 and heart rate of 70 beats per minute and was saturating 99% on room air. Initial exam revealed the abdomen to be tender to palpation in left upper quadrant with no guarding and no peritoneal signs. There were no symptoms of labor and fetal status was reassuring.\\nComplete blood count, coagulation studies, liver function tests, amylase, and lipase were all within normal limits with a hemoglobin of 12.4 g/dL. A urinalysis demonstrated rare bacteria and calcium oxalate crystals, but no blood. A renal ultrasound showed no evidence of hydronephrosis, mass, or stone. An obstetrical ultrasound revealed a live singleton fetus with a normal appearing anterior placenta and appropriate fetal growth. Intravenous narcotics were required for adequate pain control. General surgery was consulted given her history of gastric bypass and concern for a possible related complication. A CT scan of the abdomen demonstrated a mildly enlarged left adrenal gland with areas of hyperdensity consistent with acute left adrenal hemorrhage (Figure 1). This was a new finding compared with a CT scan performed one year priorly. The patient denied any history of abdominal trauma or anticoagulation. She was admitted to the Surgical Intensive Care Unit where she was comanaged by Maternal Fetal Medicine and General Surgery. She was monitored with serial hemoglobin assessments and abdominal examinations and remained clinically and hemodynamically stable. She was discharged home at 37 weeks of gestation after a 4-day hospitalization and returned for induction of labor at 39 weeks of gestation due to chronic hypertension and gestational diabetes. The patient had an uncomplicated, spontaneous vaginal delivery of a female neonate weighing 7 pounds and 4 ounces with APGARs of 8 at 1 minute and 9 at 5 minutes. Her postpartum course was uncomplicated and interval imaging study to assess resolution of the adrenal hemorrhage was planned.',\n",
       "    'gender': 'Female'},\n",
       "   {'age': 27,\n",
       "    'case_id': 'PMC5380828_02',\n",
       "    'case_text': \"A 27-year-old multiparous patient presented to labor and delivery at 38 weeks of gestation for evaluation of sudden onset, left upper quadrant pain that radiated to the midline. The patient also reported regular, painful contractions. She had a past medical history significant for nephrolithiasis during her previous pregnancy, bipolar disease, and migraines. Prior surgeries included a diagnostic laparoscopy for chronic pelvic pain, Loop Electrosurgical Excision Procedure, and 2 elective terminations of pregnancy. The patient was a 5-6-cigarette/day smoker. On admission vital signs were within normal limits. Physical examination revealed her abdomen to be soft and minimally tender to palpation. A complete blood count was within normal limits with a hemoglobin of 12.4 g/dL. A urine drug screen was negative and a urinalysis revealed no blood or evidence of infection. Fetal status was reassuring and an obstetric ultrasound revealed no apparent pathology. The patient's pain improved with intravenous narcotics, antacids, and a muscle relaxer and was attributed to a likely musculoskeletal etiology. However, the patient was found to be in spontaneous labor and progressed to deliver a male infant without complication. Intrapartum pain relief was provided via epidural. On the first postpartum day the patient again complained of left sided flank and upper abdominal pain and was presumptively treated for nephrolithiasis, given the clinical presentation and history, with intravenous narcotics and hydration. Despite treatment, the pain worsened and was associated with nausea and two episodes of emesis. A CT scan of the abdomen revealed enlargement and mild heterogeneity of the left adrenal gland with surrounding fat stranding consistent with acute left adrenal hemorrhage. An MRI performed at the request of the attending physician confirmed these findings as seen in Figure 2. She denied any trauma or use of anticoagulants. Total cortisol level was normal at 14.7 ug/dL with a low ACTH of 5.0 pg/mL. The patient was monitored with serial assessments of hemoglobin and remained clinically and hemodynamically stable. Her pain was controlled with intravenous narcotics. She was discharged on postpartum day 4 with a plan for short interval follow-up. A CT scan performed 8 months later revealed unremarkable adrenal glands with complete resolution of the previously identified hemorrhage.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 88,\n",
       "    'case_id': 'PMC2778822_01',\n",
       "    'case_text': \"An 88-year-old female with insidious onset of dyspnea on exertion and occasional nonproductive cough was found to have a 5.7 cm right hilar mass on chest x-ray. A CT-guided biopsy of the soft tissue mass showed a diffuse, monotonous infiltrate of small to medium-sized lymphocytes. Mitotic figures were not significantly increased, with only approximately 5% of the tumor cell nuclei exhibiting Ki-67 reactivity. The predominant lymphocytes were positive for CD20, CD10, and Bcl-6 and negative for CD3 and Cyclin D1 markers. \\nBone marrow biopsy was performed to assess systemic involvement. The core biopsy revealed a normocellular marrow for age with a single, paratrabecular lymphoid aggregate (Figure 1), demonstrating similar immunohistochemical staining pattern to that of the right hilar mass. The characteristic features of the malignant cells in the mediastinum and bone marrow were consistent with a stage IV, low-grade, follicular B-cell lymphoma. \\nRadiation to the mediastinal mass was initiated with concomitant rituximab treatment (375 mg/m2 for four weeks). No adverse reactions were noted during the first two weeks of rituximab induction. However, the patient developed mild, bilateral ocular pruritis and lacrimation three to four weeks within the induction cycle. Maintenance treatment with rituximab (four weekly doses of 375 mg/m2 every six months) was pursued since the patient tolerated the induction cycle without severe complications. Nevertheless, the bilateral eye inflammation became more pronounced after the second cycle of maintenance therapy. In addition to the pruritis and lacrimation, she also developed intense, bilateral periocular erythema, moderate edema, and pain as well as gradual blurring of vision. These manifestations were more prominent in the left eye. She had neither new lymphadenopathy nor any other systemic symptoms. She was then referred to an ophthalmologist for abatement of symptoms and was given topical steroid drops.\\nConcurrent CT of the chest, abdomen, pelvis, and bilateral orbits revealed no evidence of malignancy or disease recurrence. A left eye conjunctival biopsy was performed to further exclude the possibility of an underlying neoplasm. The biopsy showed an intact epithelium, prominent lymphatic channels with increased stromal lymphocytes (Figure 2). The majority of the lymphocytes expressed CD3, a T-cell marker (Figure 3), with only rare cells reactive for CD79a, a B-cell marker (Figure 4). The CD20 stain was negative (Figure 5). \\nThe severe ocular symptoms gradually subsided within approximately four to six weeks after the last dose of the second rituximab maintenance cycle. However, mild inflammation of the left eye persisted. Moreover, exacerbation of the left eye conjunctivitis was noted one week after the patient received her initial rituximab dose on the third cycle of maintenance regimen. Rituximab was discontinued, and a followup ophthalmology visit was made. Topical antibiotic and steroid drops were utilized for approximately seven days. Two to three weeks after the termination of rituximab, the patient's conjunctivitis has markedly subsided and has completely resolved in the succeeding eight weeks.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 18,\n",
       "    'case_id': 'PMC7458500_01',\n",
       "    'case_text': 'An 18-year-old male was born to consanguineous parents (first-grade cousins) after an uneventful pregnancy by caesarean section (2900 gr birth weight). He had normal early development until 4 years of age. His first symptoms included falls at age 4 years, which became more frequent by 6 years of age and he developed difficulty in climbing stairs. At age 7 years, he progressively lost motor skills. Vision loss and cognitive decline started at around age 8 years.\\nNeurological examination showed bilateral optic atrophy, swallowing problems and dysarthria. He had proximal and distal weakness with upper limb amyotrophy, foot deformity and spastic tetraparesis with increased deep tendon reflexes and positive Babinski sign bilaterally. Coordination was impaired, he had limb ataxia and difficulty in walking. He showed urinary and bowel incontinence. He had learning difficulties with dysarthria, delayed speech and language development (Fig. 1).\\nElectromyographic findings showed myogenic changes and muscle biopsy revealed cytochrome c oxidase (COX) negative fibers. Laboratory blood results (including CK, ALT, AST, lactic acid) were all normal. Metabolic examinations showed normal organic acids, amino acids and lysosomal enzymes. Cranial MR revealed progressive cerebral atrophy and profound T2 hyperintense periventricular white matter lesions. Additionally, abnormalities of visual and auditory evoked potentials were recorded.',\n",
       "    'gender': 'Male'},\n",
       "   {'age': 39,\n",
       "    'case_id': 'PMC7458500_02',\n",
       "    'case_text': 'The patient is a 39-year-old female, born after an uneventful pregnancy without complications to consanguineous parents, both originating from the same small village in Turkey. Her psychomotor development was delayed and she tended to walk on tiptoes. From age 4 years her spastic gait disturbance worsened significantly. At 15 years of age she was still able to walk independently for few meters while requiring a wheelchair to navigate longer distances. At age 27 years her ability to walk was reduced to <10 m with walking aids, around age 30 years she became wheelchair-bound. Her cognitive development was also delayed with delayed speech and language development and a learning disability; after leaving school at 20 years of age she started working at a sheltered workplace.\\nNeurological examination at age 39 years showed severely reduced visual acuity, dysarthria, cerebellar ataxia with saccadic pursuits and upper limb ataxia with intention tremor. She had brisk upper limb reflexes, pyramidal signs and reduced fine motor skills of the upper limbs and severe spastic paraplegia of the lower limbs with adductor and knee extensor spasticity (  3-4 on the Ashworth scale), generalized lower limb weakness (~3/5 on the MRC scale), brisk reflexes and extensor plantar sign. Ophthalmological examination confirmed an optic atrophy, progressive over time; no retinal changes were noted on fundoscopy (Fig. 2). Motor evoked potentials confirmed affection of the corticospinal tracts to upper and lower limbs. Visually evoked potentials demonstrated prolonged P100 latency. Nerve conduction studies were reported normal at age 28 years but indicated a sensorimotor peripheral neuropathy later in the disease course (first noted at age 34, progressive at age 39). Electromyography of the extensor carpi radialis muscle revealed small, short and polyphasic potentials with early recruitment and a full interference pattern, indicating myopathic changes (age 27 years).\\nCranial MRI showed slowly progressive confluent T2 hyperintense signal changes of the periventricular and cerebellar white matter and middle cerebellar peduncles with multiple cystic defects, internal cerebral atrophy with dilatation of the lateral ventricles and thin corpus callosum. In the white matter, several areas with disturbed diffusion were noted, only some of which corresponded to areas of ADC reduction. No morphological or signal changes were noted in the area of the basal ganglia (Fig. 2). MRI spectroscopy revealed a strong lactate peak, indicating mitochondrial disease.\\nThe probands and unaffected family members were consented for research that was approved by Dokuz Eylul University, School of Medicine Institutional Review Board (family 1) and the University of Tubingen School of Medicine Institutional Review Board (family 2). Informed consent was obtained from all family members that were recruited to the study prior to participation including for whole exome sequencing and the publication of medical information.\\nDNA isolation from peripheral blood was done according to a standard protocol. Whole exome sequencing (WES) was performed on DNA obtained from index, unaffected siblings and parentsof family 1 at the Broad Institute of MIT and Harvard, using Illumina Exome Capture Kit (38 Mb target) and in family 2 at the Hussman Institute for Human Genomics (HIHG) at the University of Miami, using Agilent SureSelect Capture (v4, 51 Mb). Sequencing data was processed at the Centro Nacional de Analisis Genomico (CNAG), Barcelona, and data analysis carried out on the RD-Connect Genome-Phenome Analysis Platform (https://platform.rd-connect.eu/genomics) for family 1 and analyzed on the Genesis web-based analysis and collaboration platform (https://www.genesis-app.com) maintained by the Genesis Project Foundation (https://www.tgp-foundation.org) for family 2 using standard filtering criteria for rare diseases, including Minor Allele Frequency (MAF) <0.01, Variant Effect Predictor (VEP) = moderate/high and Combined Annotation Dependent Depletion (CADD) >20.\\nWe selected 18 SNPs in TACO1 and in the surrounding genes in the proximity of the c.472insC, p.His158ProfsTer8 mutation. the Sequence information surrounding each of 18 SNPs of interest (and TACO1) was obtained via the USCS genome browser (https://genome-euro.ucsc.edu/index.html) (GRCh37/hg19 assembly) and primers to amplify these regions were designed using the Primer3web application (http://primer3.ut.ee/) (available on request). Purified PCR products were sequenced with an Applied Biosystems 3730xl DNA Analyser. Sequences were analysed using Chromas version 2.6.6.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 42,\n",
       "    'case_id': 'PMC6197703_01',\n",
       "    'case_text': \"A 42-year-old woman presented to the clinic with a palpable mass in her left inguinal region which was noticed 1 month prior. The mass had not been present in infancy oradolescence. History of trauma and operations were not found in the patient's history. There was a cyst aspiration story from 2 months ago. On physical examination, a soft-consistency, mobile mass of about 4 cm in size was seen in the left inguinal region. During the Valsalva maneuver, the mass did not change in size and shape. The patient's laboratory findings (complete blood count, urinalysis, blood biochemistry) were within the normal range. Ultrasonography revealed a hypoechoic cystic mass with a size of 40 x 50 mm in the left inguinal area without any vascular flow and no peristalsis (Picture 1).\\nAbdominal magnetic resonance imaging (MRI) was performed to examine the communication between the cystic mass and peritoneal cavity, and the precise anatomy around the cystic mass.\\nIt was found that the cystic mass in the inguinal canal included thin septa, and hydrocele of the canal of Nuck was suspected because of the low and high signal intensities observed on the T1- and T2-weighted images, respectively. Only the wall and septa were contrast-enhanced. The cystic lesion which was seen to be originated from the inguinal canal was excised in the exploration made by suspending the round ligament by passing through the anatomical folds with the incision made from the left inguinal region (Picture 2, Picture 3).The defect was repaired with prolene mesh after high ligation. Histopathologic examination was evaluated as Simple cystic structure with cubic epithelium (Picture 4). Patient was discharged on the 1 st postoperative day. The patient provided written consent to utilize her medical record with no patient identifiers.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 58,\n",
       "    'case_id': 'PMC4109119_01',\n",
       "    'case_text': 'A 58-year-old woman operated with proctocolectomy and an ileal J-pouch 11 years earlier due to ulcerative colitis complicated by colonic cancer presented at a local hospital because of abdominal pain and failure of faecal evacuation. There was a previous history of similar but short and self-resolving episodes of obstruction without clear explanation. A CT-scan aroused suspicion of twisting of the pouch along its longitudinal axis causing an obstruction at the ileoanal anastomosis. An intestinal tube was passed into the pouch for decompression which resulted in relief of symptoms lasting also the day after removal of the tube. She was therefore discharged and referred to our hospital for follow-up with pouchoscopy. However, on the same day as she had been discharged, she presented as an emergency case at our hospital with identical symptoms of obstruction and was admitted to a surgical ward after the application of a tube into the pouch for deflating. Repeated CT-scans at presentation and after application of the tube showed again volvulus of the pouch, which resolved after tube insertion as did the symptoms (Figure 1). Endoscopy of the pouch including 50 cm of the afferent loop was easily done with no signs of ischemia or obvious twisting. The following day a laparotomy was done in order to fixate the pouch to prevent further episodes of twisting. The pouch was found to be enlarged but in its regular position without twisting and not surprisingly there were no adhesions, either in the pelvis or in the abdomen, which made the pouch completely mobile. A loop of the distal ileum was also found to be twisted behind the mesentery of the afferent loop of the pouch as a remaining part of the volvulus (Figure 2). After reduction of the distal ileum a pouchopexy was made with one row of multiple interrupted nonabsorbable monofilament sutures (Prolene) to the presacral fascia as well as closure of the open space behind the mesentery of the afferent loop in the same manner. The postoperative course was uneventful and the patient was discharged.\\nTwo months later the patient presented with identical symptoms and a CT-scan showed again volvulus of the pouch. Insertion of a tube on this occasion did not fully relieve symptoms, so this led to a decision to proceed to laparotomy. A volvulus of the pouch along its longitudinal axis was found intraoperatively as well as an accompanying volvulus of the small bowel behind the afferent loop similar to the previous laparotomy (Figure 3). No new adhesions had been formed since that laparotomy and all the sutures to the presacral fascia and retroperitoneum were completely detached except for one. The mildly ischemic pouch and small bowel were derotated and fixated once again to the sacral fascia and retroperitoneum but this time with two rows of continuous multifilament sutures (Ethibond) on either side of the pouch. The sutures were also extended upwards to again close the open space behind the afferent loop mesentery (Figure 4). Furthermore the upper corners of the pouch were sutured to the lateral walls of the pelvis. After an uncomplicated postoperative course, the patient was discharged. At follow-up ten months later she was doing well and was free of symptoms.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 25,\n",
       "    'case_id': 'PMC6744365_01',\n",
       "    'case_text': \"A 25-year-old man, previously healthy, was initially admitted due to slowly progressive headache with blurry vision and fever for nine months. The patient recalls ingesting raw camel milk, which is a major risk factor for brucellosis. There was no previous contact with a tuberculosis case. The headache worsened one week before his admission and the patient lost vision in the left eye. His vital signs and cognitive function were normal. Pupils were reactive, but the patient was barely seeing the flash light with his left eye. Ophthalmologic examination revealed an atrophic optic disc mainly with decreased visual acuity bilaterally. Extraocular muscles were intact. The remaining neurological examination was unremarkable.\\nHis diagnostic work up showed total white blood cell (WBC) count of 5.61 x 109 cells/mm3 and a C-reactive protein (CRP) level of 3.76 mg/L. His cerebrospinal fluid (CSF) acid fast bacilli (AFB) stain and Mycobacterium tuberculosis polymerase chain reaction (MTB-PCR) were both negative. Blood and CSF cultures were positive for Brucella spp. His serum serological test was positive for B. melitensis and B. abortus. Antibody titers were 1:640 for both strains, just at the cutoff level for the serological diagnosis of the infection. CSF analysis showed elevated WBC count (170 cells/mm3 with 34.9% lymphocytes) and decreased glucose level (34.2 mg/dL). Serum glucose level at that time was 99 mg/dL. CSF protein level was 1.5 g/L while red blood cell (RBC) count was 7 cells/mm3. A magnetic resonance imaging (MRI) of his brain showed multiple, bilateral small dural-based nodular enhancements in both upper frontal lobes (Image 1). The patient was diagnosed with neurobrucellosis. Unfortunately, the patient has completely lost his vision in the left eye with weakened vision in the right eye because of a late presentation and delayed diagnosis. As such, the patient was immediately started on ceftriaxone 2 g intravenously (IV) every 12 h, doxycycline 100 mg orally every 12 h and rifampin 900 mg orally once daily for six weeks along with amikacin 400 mg IV every 12 h for the first three weeks. Three weeks after treatment was initiated, both antibody titers remained at 1:640, which was expected as Brucella antibodies may persist for months after conclusion of therapy. His repeated blood and CSF cultures returned negative a few days after treatment. A repeated MRI of the brain showed interval decrease in the number of the previously reported bilateral frontal leptomeningeal enhancing foci. However, small residual abnormal enhancing foci were still noted. Fortunately, no interval development of new lesions was seen (Image 2).\\nUpon completion of the IV regimen (amikacin and ceftriaxone), the patient was discharged on oral doxycycline 100 mg every 12 h and rifampin 300 mg every 8 h to be taken for 6 months. In an outpatient follow up visit three months later, the patient's vision on the right side was slightly improving. While B. melitensis antibody titer slightly decreased to 1:320, B. abortus antibody titer remained at 1:640. Three months later (six months after discharge), a repeated lumbar puncture showed improved CSF analysis with WBC count of 6 cells/mm3, RBC count of 1 cell/mm3, protein level of 0.55 g/L and glucose level of 46.8 mg/dL (serum glucose level was not obtained at the time of this test). Brucella antibody titer in the serum declined from 1:640 to 1:40 for both strains. At this visit, the decision was made to extend the treatment to 3-6 more months to ensure full recovery. Three months later, a repeated brain MRI showed no more meningeal enhancement and CSF analysis was normal; therefore, antibiotic treatment for brucellosis was stopped.\",\n",
       "    'gender': 'Male'},\n",
       "   {'age': 54,\n",
       "    'case_id': 'PMC6744365_02',\n",
       "    'case_text': 'A 54-year-old woman, known case of type 2 diabetes mellitus and hypertension, was admitted to the hospital due to fever, severe neck and back pain, as well as nausea and vomiting for 2 weeks. She admitted drinking a small amount of raw milk several weeks before her presentation. She had no signs of meningitis and her neurological examination was normal. A lumbar puncture revealed no bacterial growth with CSF protein level of 0.7 g/L and glucose level of 126 mg/dL (serum glucose level was 268.2 mg/dL). CSF WBC count was <1 cell/mm3 and RBC count was 8 cells/mm3. AFB stain showed no Mycobacteria, and CSF MTB-PCR did not detect M. tuberculosis. Urine culture came back negative for any bacterial growth. However, a blood culture was positive for Brucella spp. In addition, both B. melitensis and B. abortus antibody titers in the serum exceeded 1:1280. An abdominal ultrasound was unremarkable. A transthoracic echocardiography followed by a transesophageal echocardiography were both normal. The patient was immediately started on ceftriaxone 2 g IV every 12 h, streptomycin 1 g intramuscularly (IM) once daily, doxycycline 100 mg orally every 12 h and rifampin 300 mg orally every 8 h daily for a total duration of 6 weeks. Her nausea and vomiting were treated with metoclopramide and ondansetron. Her back pain appeared to be due to disc prolapse rather than Brucella spondylodiscitis as was concluded from the MRI of her cervical and lumbosacral areas. After the patient completed 12 days of therapy, she was discharged on doxycycline 100 mg orally every 12 h and rifampin 300 mg orally every 8 h for 30 days and to continue her parenteral antibiotics as an outpatient. Upon follow up one month later, both Brucella antibody titers declined to 1:1280 in the serum. CRP level was 6.93 mg/L (no level was obtained at baseline). The patient was advised to continue the oral antibiotics for 6 more weeks while streptomycin and ceftriaxone were stopped. Two months later (three months post discharge), CRP level increased to 31 mg/L; nonetheless, antibody titers of B. melitensis and B. abortus declined to 1:640 and 1:320, respectively. As the patient appeared asymptomatic and clinically well, her antibiotics were stopped; though, she was advised to remain under supervision and to return for follow up in case of a potential relapse.',\n",
       "    'gender': 'Female'},\n",
       "   {'age': 31,\n",
       "    'case_id': 'PMC6744365_03',\n",
       "    'case_text': \"A 31-years-old man who was otherwise healthy presented to the emergency department with high grade fever that persisted for a week but was manageable with acetaminophen (paracetamol). The patient also suffered from headache for three days which he described as being band-like surrounding his head. He reported regular contact with camels and occasional consumption of their raw milk. Three weeks before presentation, he was on vacation in Turkey where he consumed raw dairy products at a rural farm. He was febrile but his physical examination was normal otherwise. Lab investigations revealed a CRP level of 13.5 mg/L and CSF analysis showing a WBC count of 59 cells/mm3 (polymorphonuclear cells of 23% and lymphocytes of 71%), RBC count of 3 cells/mm3, protein level of 0.43 g/L and glucose level of 54 mg/dL (serum glucose was 100 mg/dL). His blood and CSF cultures were negative for Brucella spp. and so were the AFB satin, culture, and MTB-PCR. Nevertheless, his Brucella serum serology revealed an antibody titer of 1:1280 for both, B. melitensis and B. abortus. He was admitted as a case of neurobrucellosis and was started on ceftriaxone 2 g IV every 12 h, amikacin 720 mg (7.5 mg/kg) IV every 12 h, doxycycline 100 mg orally every 12 h and rifampin 900 mg orally once daily. Ten days later, he stared having spikes of fever reaching 40  C, a thorough physical examination and work up were done and they were negative for any potential infection or reason for fever. Thus, antibiotic-induced fever was suspected due to ceftriaxone, thus, it was discontinued despite the overall improvement of the patient's central nervous system symptoms. Ceftriaxone was replaced with ciprofloxacin 400 mg IV every 8 h. As the fever persisted and liver enzymes were noted to increase, rifampin was stopped as well. In less than a week, rifampin was reintroduced. However, 90 min after the dose, the patient experienced shortness of breath, rash, swelling and redness of skin. His reaction was managed immediately with antihistamine and hydrocortisone. This allergic reaction was presumed to be attributed to rifampin; hence, it was stopped and never introduced again. Moreover, the patient also complained of reduced hearing in his right ear which was suspected to be due to an ototoxic effect of amikacin which resulted in its discontinuation. In order to enhance the management of neurobrucellosis, trimethoprim/sulfamethoxazole (TMP/SMX) double strength was started orally; yet, the patient had an episode of vomiting, so it was switched to IV which was well tolerated. Later on, as the patient was being prepared for discharge, IV TMP/SMX was stepped down to the oral formulation again. A lumbar puncture was repeated before discharge and showed an improvement from baseline with WBC count of 4 cells/mm3 (lymphocytes of 86%), RBC count of 9 cells/mm3, 0.33 g/L of protein and 61.2 mg/dL of glucose (serum glucose was not available at this point of time). Repeated antibody titers for B. melitensis and B. abortus were 1:640 and 1:320, respectively. The patient was discharged on doxycycline 100 mg orally every 12 h, ciprofloxacin 750 mg orally every 12 h and TMP/SMX double strength orally every 12 h. In his first outpatient visit one month after discharge, the patient admitted to voluntarily discontinuing TMP/SMX due to severe episodes of vomiting and refused to take it again; however, he continued taking doxycycline and ciprofloxacin which resulted in clinical success (after a total of 18 weeks on doxycycline and 16 weeks on ciprofloxacin).\",\n",
       "    'gender': 'Male'},\n",
       "   {'age': 25,\n",
       "    'case_id': 'PMC6744365_04',\n",
       "    'case_text': \"A 25-years-old man who was previously healthy came to the hospital complaining of left lower limb pain that progressed to limb weakness with decreased ability to walk. Physical examination revealed moderate lower limb weakness with foot drop. It was worse on the left side with lower motor neuron lesion findings. He had normal sensory exam. He reported drinking raw camel milk three months before the first episode of pain with a family member who was diagnosed with brucellosis recently. There was no tuberculosis contact. Since the patient was suspected to have neurobrucellosis, lumbar puncture was done. CSF analysis showed a WBC count of 420 (polymorphonuclear cells of 4% and lymphocytes of 90%) cells/mm3, RBC count of 18 cells/mm3, elevated protein level at 2.45 g/L and glucose level of 21.6 mg/dL (serum glucose was 81 mg/dL). The CSF culture was positive for Brucella species. The acid fast bacilli stain and culture were negative, as well as the MTB-PCR. Other investigations including tests for hepatitis B and C viruses and human immunodeficiency virus (HIV) 1 and 2 were all negative. Serologically, antibody titers results from the CSF for B. melitensis and B. abortuswere 1:160 and 1:80, respectively. His serum titers were not obtained initially. His CRP level was within normal limits. The patient refused to have a tuberculin skin test. An MRI of lumbosacral spine revealed enhancement of cauda equina nerve roots and surface of thecal sac, as well as L5-S1 degenerative changes with central posterior disc bulge indenting the ventral aspect of the thecal sac with no significant neural compromise associated with intervertebral disc dehydration (Image 3). He was admitted as a case of cauda equina syndrome secondary to neurobrucellosis and was started on ceftriaxone 2 g IV every 12 h, amikacin 500 mg IV every 8 h, doxycycline 100 mg orally every 12 h and rifampin 900 mg orally once daily. The initial plan was to continue the antibiotics with daily physiotherapy then re-evaluate after 6 weeks. However, two weeks into the treatment, the patient's status deteriorated significantly, from difficulty walking to being completely bed bound. Repeated work up showed no other significant findings. Furthermore, after 4 weeks of treatment, the patient started complaining of decreased hearing and pain in both ears resulted in discontinuation of amikacin. Six weeks into therapy, a repeated lumbar puncture did not show a significant improvement with a CSF analysis showing a WBC count of 315 cells/mm3 (polymorphonuclear cells of 41% and lymphocytes of 45%), RBC count of 15 cells/mm3, protein of 3.73 g/L and glucose level of 23.4 mg/dL (serum glucose was 82 mg/dL). Serum antibody titers were 1:320 and 1:80 for B. melitensis and B. abortus, respectively. Since the CSF repeated culture returned negative for Brucella spp., prednisone 1 mg/kg tapering dose was added aiming to reduce further nerve impingement. Luckily, the patient started to show clinical improvement and the IV ceftriaxone was discontinued after completing six weeks of treatment. The patient continued to restore his lower limb power and he was able to transfer to the wheelchair independently. Hence, he was discharged on doxycycline 100 mg orally every 12 h and rifampin 900 mg orally once daily for one year. The patient was scheduled for follow up in both the infectious diseases and neurology clinics. On his outpatient visits, the patient showed remarkable improvement of his lower limb weakness and he restored the ability to walk again using a cane. Serum antibody titers for both Brucella strains were at 1:80 and CRP remained within the normal range.\",\n",
       "    'gender': 'Male'},\n",
       "   {'age': 60,\n",
       "    'case_id': 'PMC6744365_05',\n",
       "    'case_text': 'A 60-year-old woman with a history of severe osteoporosis and previously treated tuberculous lymphadenitis, presented to the emergency department with fever she was experiencing daily for a month that did not respond to antipyretics. This was associated with frontal headache, night sweats, rigors, chills, generalized body ache, unintentional weight loss of 3-4 kg and pain in the lower back and right leg. She reported regular consumption of raw cheese. Investigational workup was done upon admission where a CSF analysis showed 8 cells/mm3 of WBCs (no differential was done), 12 cells/mm3 of RBCs, 0.36 g/L of protein and 54 mg/dL of glucose (serum glucose was not obtained). Blood CRP level was 36 mg/L. She was admitted as a case of possible bacterial meningitis with suspicion of neurobrucellosis. The patient was started on ceftriaxone 2 g IV daily. Three days later, her blood culture returned positive for Brucella spp., However the CSF culture was negative, as well as the AFB stain. Serological testing for hepatitis B and C viruses and HIV 1 and 2 were all negative. High antibody titers for both B. melitensis and B. abortus of 1:1280 were found in the serum whereas it was negative in the CSF. Ceftriaxone 2 g IV every 12 h was continued and prescribed for 6 weeks along with amikacin 400 mg IV every 12 h for the same duration, as well as doxycycline 100 mg orally every 12 h for 6 months and rifampin 900 mg orally once daily for 6 months. After about two weeks of treatment, lumbar puncture was repeated and the CSF showed no significant changes with WBC count of 7cells/mm3, RBC count of 1 cells/mm3, protein of 0.33 g/L and glucose of 55.8 mg/dL (serum glucose was not available). During hospitalization, the patient felt generally better and became afebrile. After completing the IV antibiotics course (ceftriaxone and amikacin), lumbar puncture was ordered, but the patient refused to undergo the procedure. Consequently, the patient was discharged on doxycycline 100 mg orally every 12 h and rifampin 900 mg orally once daily for 6 months. During her follow up visits, the patient reported feeling well and afebrile with remarkable improvement of the headache. The follow up antibody titer was 1:320 for both Brucella strains, which continued to decrease until it reached 1:160 after completing 6 months of antibiotic therapy. As such, treatment was discontinued.',\n",
       "    'gender': 'Female'},\n",
       "   {'age': 44,\n",
       "    'case_id': 'PMC6744365_06',\n",
       "    'case_text': \"A 44-year-old man with a history of recurrent epididymo-orchitis presented to the emergency department complaining of an on-and-off scrotal pain for the last 15 days and low grade fever for which he was given ciprofloxacin for 10 days and acetaminophen (paracetamol) from another hospital. This regimen helped managing his symptoms; however, they were not resolved rendering him seeking medical help at our institution. There were no histories of contact with a tuberculosis patient or raw milk consumption. On physical examination, his scrotum was enlarged, swollen and tender. An ultrasound revealed both testes were of normal size; however, there was bilateral significant increased vascularity in both testicles and both epididymal heads. The scrotal skin was not thickened. There was a slightly increased echogenicity of both testes and a small left hydrocele was identified.\\nThere were a few (about four) tiny echogenic foci noted within the left testicle likely representing small calcifications. Physical examination findings of regional lymph nodes and skin were not significant. While awaiting other investigations, the patient was started on ciprofloxacin 400 mg IV every 12 h as an empiric therapy. Blood culture came back negative for Brucella spp.; however, antibody titers were positive for B. melitensis and B. abortus at 1:1280 for both strains. CRP level was 6.8 mg/L. The patient was diagnosed with Brucella epididymo-orchitis, but refused to undergo lumbar puncture for further investigation. Due to lack of clinical improvement, ciprofloxacin was discontinued three days later and was replaced by ceftriaxone 1 g IV every 12 h, doxycycline 100 mg orally every 12 h and rifampin 900 mg orally once daily. After two doses of 900 mg rifampin, the dose was decreased to 600 mg orally once daily though nothing in the patient's notes indicated the reason for the dose change nor the liver enzymes were elevated. After ten days of treatment, ceftriaxone was stopped and the patient was discharged on doxycycline 100 mg orally every 12 h and rifampin 600 mg orally once daily for a minimum period of three months. Before discharge, the patient was clinically improving as demonstrated by the decreased swelling and tenderness of his scrotum. On his first visit as an outpatient 2 weeks after discharge, the patient reported no new complications and appeared clinically well. Tests showed no signs of drug-induced hepatotoxicity, so the rifampin dose was increased to 900 mg orally once daily. On examination, his scrotum appeared to be relieved of the swelling and decreased in size. CRP level decreased slightly to 5.21 mg/L. A week later, the patient came again for follow up. While the patient did not show up for the next visit, his Brucella epididymoorchitis was deemed cured based on the improved clinical findings and decreased CRP. No repeated serology was done.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 45,\n",
       "    'case_id': 'PMC5460377_01',\n",
       "    'case_text': 'A 45-year-old female referred to our tertiary care hospital complaining of bilateral knee pain associated with swelling, intermittent generalized body pain that affected her daily activity, progressive painless visual loss in the left eye, and mild headache for one year. She was treated in another hospital symptomatically for bone pain with no improvement. Her past medical history was irrelevant except for vitamin D deficiency.\\nOn initial examination, she was afebrile, both knees were tender at joint line, with swelling over the anteromedial aspect of upper part of tibia with erythematous overlying skin. Patellar tap and ballottement tests as well as crepitus test were negative. Visual field testing revealed left homonymous superior quadrantanopia with normal visual acuity. Detailed slit lamp examination was insignificant and showed no involvement of retina. Complete blood count was normal at the time of presentation. Creatinine, urea, and electrolytes were within normal limits. High alkaline phosphatase and normal lactate dehydrogenase were present. Plain X-ray of both knees showed multiple sclerotic patches of the distal femur and upper parts of both tibiae (Figure 1) while bilateral tibia magnetic resonance imaging (MRI) showed bilateral lesions replacing the normal fatty signal intensity in the T1 weighted images (Figure 2). Initial brain MRI showed bilateral well-defined round intensely enhancing lesions located in the temporal poles lateral to the amygdala and anterior to the temporal horns with thickened enhanced pituitary stalk (Figure 3), in conjunction with partially empty sella and absent bright signal of the neurohypophysis (Figure 4). Whole body positron emission tomography (PET) scan showed increased FDG uptake in temporal lobes and facial and long bones (Figures 5(a) and 5(b)). She was further investigated for malignancies, paraneoplastic, autoimmune, neurodegenerative, and toxic causes. All tumor markers were within normal limits.\\nLeft tibial biopsy was performed to rule out malignancy and showed marrow infiltration with sheets of foamy histiocytes with the presence of sclerosed trabeculae. The immunohistochemistry showed CD-1a negative histiocytes; however, molecular pathology showed negative BRAF mutation. The clinical, radiological, and immunohistochemical characteristics were consistent with ECD. The patient was started on standard interferon alpha 135 mg per week for a duration of 3 weeks and methylprednisolone with improvement of her symptoms after 1 week.\\nOne year later, the patient presented with double vision and left ophthalmoplegia. On examination, she was found to have unequal pupils and papilledema. Brain MRI showed new enhancing lesion in the vicinity of the left cavernous sinus (Figure 6), with pachymeningeal thickening along the tentorial leaflets and interval regression of the mesial temporal lobe lesions.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 55,\n",
       "    'case_id': 'PMC8486010_01',\n",
       "    'case_text': 'A 55-year-old-woman with a history of multiple TMJ surgeries presented to our clinic with a chief complaint of limited mouth opening and difficulty bringing her teeth together. Her surgical history was significant for the placement of bilateral PTIPIs in the 1980s, followed by bilateral total joint replacement with Kent-Vitek Inc. (Houston, TX) TMJ prostheses, and most recently removal of the right total joint prosthesis. Her medical history was relevant for fibromyalgia, for which she was on gabapentin 300 mg three times daily, as well as anxiety and depression, which was treated with bupropion 150 mg once daily, duloxetine 60 mg once daily, and alprazolam 2 mg as needed. She also had a history of a large cutaneous ulcer over the right temporal region which was initially thought to have been caused by a foreign body reaction to the implant material, though an incisional biopsy showed findings consistent with trichotillomania.\\nExamination revealed right cranial nerve VII deficit, treated with an eyebrow lift, with persistent weakness of the right upper and lower lids of approximately 25-30%. She had bilateral preauricular swelling and well-healed preauricular and submandibular incisions. Her interincisal range of motion was 14 mm, with a gap of 2 mm in her maximally closed position. Her pain score was 7/10 intensity using the Visual Analogue Scale (VAS), with her pain reportedly worst in the right jaw. Radiographic examination with both panoramic radiograph and computed tomography (CT) scan showed partial edentulism of the maxilla and mandible. There was a mass of hypertrophic bone in the right TMJ area. The left mandible showed a total joint prosthesis with the condylar component displaced. Figure 1 shows a panoramic radiograph taken at initial consultation.\\nOver the course of a year, she underwent three separate surgeries: (1) prior embolization of the adjacent right maxillary artery, removal of the right heterotopic bone, removal of the left TMJ prosthesis, bilateral TMJ reconstruction with temporary condylar implants (DuPuy-Synthes, Westchester, PA) and abdominal fat grafts to the dead spaces, (2) removal of the temporary implants and placement of custom-made total TMJ implants (TMJ Implants, Ventura, CA) (3) revision of the left TMJ hardware due to instability. The surgical pathology from each of these surgeries showed evidence of foreign material consistent with retained Proplast-Teflon particles with an associated foreign body giant cell reaction. Following the surgeries, the patient showed significantly improved function with an improved range of motion of 34 mm mouth opening as well as the ability to fully occlude her teeth. Figure 2 shows a panoramic radiograph following her series of surgeries. Despite the improved ability to open and close her mouth to speak and eat, she reported persistent pain scored as a 7/10 intensity. She also developed synkinesis of the facial muscles, which responded to treatment with tizanidine 2 mg twice daily.\\nThe patient returned three years later with a chief complaint of persistent right-sided pain. Her range of motion was maintained at 35 mm, and her dental occlusion was stable Examination revealed pain on palpation of the right preauricular area and coronoid process. A CT scan revealed no signs of hardware failure. Metal allergy testing for a potential allergy to the prostheses was negative. Serology showed negative rheumatoid factor, antinuclear antibody, and HLA-B27, as well as vitamin D levels within normal limits. Her erythrocyte sedimentation rate and C-reactive protein levels were mildly elevated.\\nTo diagnose and treat her pain, collaborative care between her TMJ surgeon, orofacial pain specialist, and neurologist led to various trials of injection therapy (nerve blocks, trigger point injections, and Botox to the right masticatory muscles) and pharmacotherapy (gabapentin, pregabalin, amitriptyline, baclofen, oxcarbazepine, and lamotrigine). The only treatments that brought her relief were right-sided occipital nerve blocks and right inferior alveolar nerve blocks, which reduced her pain from 7-8/10 down to 4-5/10 intensity for several hours. As part of her comprehensive treatment for chronic pain, she was referred to a pain psychologist; however, after undergoing an initial consultation, the patient declined follow-up care.\\nOver the course of a year, the patient\\'s pain became more lancinating in nature predominantly in the distribution of the cranial nerve V2 and V3 branches, with pain triggered by touch and cold air, which was concerning for right-sided trigeminal neuralgia. An MRI of her brain revealed no mass lesions or vascular contact leading to compression of the trigeminal nerve. After consultation with a neurosurgeon, she underwent a balloon compression rhizotomy of the right Gasserian ganglion which resolved the lancinating pain.\\nFollowing this procedure, she reported a flare of a different type of pain emanating from the right TMJ area. She rated this pain as 8/10 intensity and described it \"like a bad ear infection,\" with pain radiating to \"[her] right cheek, sinus, eye, and forehead.\" She continued on tizanidine 2 mg twice daily, which helped with the muscle pain, as well as baclofen 10 mg three times daily, which reduced pain in the occipital region. She most recently returned to our practice in severe distress with right-sided jaw pain, requesting inpatient admission for pain management and mentioning suicidal thoughts due to her constant pain.\\nDiscussion with her primary care physician (PCP) revealed that she had suffered from chronic pain for the 20+ years he had known her, with consequences of social isolation and suicidal ideation having been present throughout this time. Her PCP also stated that trials with different anti-depressants had not been helpful in improving her mood or quality of life. Her orofacial pain team confirmed that suicidal ideation had been a recurring theme and that her long clinical course was in part due to her distrust of medical and surgical providers, the failure of multiple attempts to relieve her pain, and the complications that she suffered from each surgical intervention. Consultation with a psychiatrist specializing in chronic pain led to recommendations of long-term psychological support to help her cope with the pain, with an emphasis on helping her understand the neurobiological connection between depression and chronic pain. Her Prescription Drug Monitoring Program data showed that over the past two years, her opioids and benzodiazepines had been predominantly prescribed by her PCP and she had used one pharmacy. Her mean morphine milligram equivalency (MME) was 62 per day, with occasional spikes to 125 MME, and her mean lorazepam milligram equivalency (LME) was 8.6 per day, with occasional spikes to 17 mg LME.\\nUltimately, because she had re-gained a functional range of mandibular motion, no additional surgical intervention was recommended. For pain control, it was recommended that she remain on hydromorphone 2 mg every 4 hours as needed as well as engage in a longitudinal psychiatric program with an emphasis on behavioral health and skills to cope with her pain. The patient agreed that further hospital care would be contingent upon involvement in behavioral health modalities.\\nIn 1934, Costen, an otolaryngologist, published an article stating that TMJ symptoms were caused by mandibular displacement as a result of missing posterior teeth. Various iterations of this theory have permeated clinical practice since then and continue to distort our thinking today. Over the following decades, a progressively more scientific approach has been advocated, recognizing the biopsychosocial etiology of these symptoms and the complex nature of these chronic pain conditions, now called temporomandibular disorders.\\nOriginally, our understanding of one of these disorders - the painful clicking and locked jaw - was based on our knowledge of anatomy. With the development of imaging techniques, such as arthrography, computed tomography (CT), and magnetic resonance imaging (MRI), surgeons gained the ability to visualize the meniscus of the TMJ at rest and in motion. These imaging modalities supported the notion of internal derangement of the meniscus as pathology and popularized open joint surgery for meniscal repair or repositioning. Thus, presented with a patient in pain with limited range of motion, an image demonstrating derangement and pathology persuaded oral and maxillofacial surgeons (OMFSs) to contemplate surgical repair, although the rationale of these decisions was suspect. Repositioning of the meniscus became a popular intervention but proved to be unreliable in some cases. Accordingly, starting in the mid-1980s, meniscal replacement came into vogue and a variety of materials were used, including ear cartilage, dura, fascia, temporalis myofascial flaps, metal, Silastic, and Proplast-Teflon. It is the PTIPI which is the subject of this review.\\nIn 1967, a biochemist named Dr. Charles Homsy was working at DuPont, a chemical and manufacturing company, where he was warned by the company about the dangers of implanted Teflon in the body.  In 1968, he developed a material called Proplast, which he would later patent. Dr. Homsy ultimately left DuPont and founded Vitek, Inc. (VI), a small company located in Texas, to develop, manufacture, and market PTIPIs. Proplast was utilized as it is a porous form of polytetrafluoroethylene (PTFE) that allows for infiltration of soft tissue, thereby stabilizing the implant. Teflon, manufactured by DuPont, is a dense form of PTFE and was added to the TMJ interpositional implant to provide a smooth gliding surface across which the mandibular condyle could move. Many years prior, in 1963, a British orthopedic surgeon, Dr. John Charnley, warned against the use of PTFE in joints stating, \"Surgeons, and especially orthopedic surgeons, should be warned that tissue reactions are likely to follow the implantation of polytetrafluorethylene if this material is subjected to abrasion and that these reactions may not be manifest for two years.\" In March 1983, VI notified the United States Food and Drug Administration (FDA), which had authority over the use of implantable medical devices, stating that VI was planning to market the PTIPI for the TMJ, based on the claim that it was substantially equivalent to an existing product (silicone sheeting) that was also being used as a TMJ implant. Its biocompatibility was based on in vitro studies and alveolar ridge augmentation studies. No animal or biomechanical studies were performed until after its introduction into clinical practice, at which time the adverse effects came to light. The FDA agreed, and the PTIPI was allowed to be marketed. \\nInitially, there were encouraging reports, with success rates estimated in the 90% range. However, problems were soon reported on the damage that these implants were causing. In 1985, Ryan published a series of 105 joints in 67 patients studied for 25 months, finding that patients who originally had no radiographic or surgical evidence of arthrosis developed varying degrees of arthrosis, and those who had had arthrosis developed progression of their disease subsequent to implantation with PTFE-aluminum oxide implants. In cases of severe arthrosis, MRIs demonstrated loss of signal in the condyle, loss of temporal bone, presence of large soft tissue masses, and fragmentation of the implants. At surgery, all implants were found to be perforated, 50% were folded, and 17% were fragmented or separated into two components. Four cases demonstrated perforation through the temporal bone with exposure of the dura. Histologic studies of the peri-implant tissue yielded exuberant foreign body giant cell reactions with secondary features of chronic inflammation.\\nIn 1987, the US Air Force reported problems to VI and the FDA, and in the following year, the FDA conducted its first inspection of VI. Symptoms including pain, radiographic evidence of severe bone loss in the condyle and glenoid fossa, bite changes, limited jaw motion, joint noises, nausea, dizziness, ringing in the ears, fragmentation and/or displacement of the implant, infection, vision and hearing changes, sinus infections and flu-like symptoms were noted. Subsequently, many papers have documented radiographic changes, pathologic reactions, and clinical symptoms.\\nAs no complete registry of patients was maintained, the exact number of patients who had PTIPIs implanted is uncertain. Originally VI stated that 12,500 implants were distributed, but an analysis by the District Court of Dallas indicated that the implants were distributed in packs of two, and on that basis, approximately 26,000 units were manufactured and distributed. Data from insurance companies showed a disproportionate number of patients who underwent TMJ surgery were young women between 18-44 years of age. There were also regional differences, with the South being over-represented compared to the Midwest and West/Northeast. Ironically, insurance companies may have contributed to the problem by denying noninvasive treatment modalities for their insureds\\' TMJ symptoms but covering the surgical procedures.\\nThe clinical consequences of the failure of PTIPIs have become quite apparent. Many of these patients now suffer from chronic pain, mandibular hypomobility, and malocclusion because of multiple surgeries. These symptoms affect their activities of daily living, such as talking, eating, toothbrushing, and receiving regular dental care. Severe limitation of mouth opening may also put them at risk of choking if they require emergency intubation. Other studies have documented the subsequent problems that these patients face when they undergo reconstruction of their damaged TMJs. From 1984 through 1998, the FDA received 434 adverse event reports for TMJ implants (all types), 58% of which were associated with patient injuries and 28% of which were device malfunctions. Over 75% of these reports cited two manufacturers, Dow Corning and VI - both of which have ceased production of TMJ implants. The most frequent patient problems reported include surgery to remove the implant, pain, foreign body reactions, and loss of range of motion. A pilot study of surgically retrieved TMJ alloplastic implants similarly demonstrated that pain was a significant symptom associated with perforation of the implants.\\nOur own review of 95 patients with end-stage TMJ disease that underwent TMJ replacement with total joint prostheses demonstrates clearly that a subset of patients who had a history of failed PTIPI fared less well than those with other diagnoses (for example, ankylosis, inflammatory disease, and trauma). While on average, the TMJ replacement patients experienced increased range of motion and decreased pain, the subset of 27 patients exposed to PTIPIs was older, had almost twice the number of prior surgeries, had greater limitation of mouth opening prior to surgery, and achieved less range of motion postoperatively, with all of these differences reaching statistical significance.\\nThe general health consequences of these failed implants have also been documented. A non-profit patient advocacy organization, the TMJ Association, has documented patient reports of the presence of flu-like symptoms, chronic sinus infections, skin reactions, local and distant lymphadenopathy, as well as immune system problems. In 1999, Baird and Rea reported a small series (n=14) of chronically ill, chemically sensitive patients with multisystem end-order disease and labeled this \"Implant Syndrome Complex.\" Severe pain was the predominant symptom, with all of the 3 patients whose histories were described in detail reporting severe pain.\\nFrom the patient\\'s perspective, the aftermath of this event was not properly handled. Many complained that they had not been fully informed of the consequences of the implant surgery or that they were unaware of the recall and need for follow-up. When they were seen by their OMFSs, the evaluation was usually limited to a panoramic radiograph, leading to false reassurances that all was well. When they requested their records, oftentimes they were lost or missing due to office fires or flooding. Patient advocacy groups, newspaper articles, and patient blogs have also told the story of failed implants, multiple surgeries, and continuing symptoms.\\nWhile Dupont manufactured and supplied Teflon for the PTIPI, they played no part in the design, specifications, sales, or distribution of the implants. However, they faced 650 lawsuits by 1500 patients in 42 states in the United States and Canada. In almost all of the US cases, they were found not liable for the safety of the VI product and not considered negligent, as \"suppliers of safe multi-purpose raw materials have no duty to warn the ultimate consumer of a finished product about dangers that may exist when the raw materials are integrated into the final product.\"\\nVI, on the other hand, which had manufactured and marketed the PTIPI, was the subject of personal injury lawsuits beginning in 1987. They successfully defended the first two suits in jury trials and lost the third in late 1989. The company ultimately declared bankruptcy in 1990. The founder, Dr. Charles Homsy, fled the US and now lives in Switzerland. He blamed the oral and maxillofacial surgery community and patients for the failure of the implants, and the FDA for its restrictive practices. In 1991, the FDA seized the remaining implants and buried them in a landfill in Houston, TX. In 1997, the bankruptcy court settlement with the litigants awarded funds amounting to less than $10,000 per patient. The Judicial Arbitration and Mediation Service/Endispute, Houston reported that 2217 legal claims were made against VI, excluding over 500 who accepted the $1000 settlement as final compensation, with a maximum settlement of approximately $8000. In reviewing the Referee\\'s Report, the example given provided a settlement of approximately $2800 (worth approximately $4769 today).\\nOne of the VI OMFS consultants conducted animal experiments after the implant failures were reported. The results were \"essentially catastrophic.\" In a letter to Dr. Homsy, he stated that VI might have a \"calamity of unbelievable proportions on our hands.\" The consultant owned 21,000 VI shares and collected royalties and wrote articles praising VI implants, but eventually conceded that the implants had a predicted in vivo life span of only 3 years.\\nThe role of the FDA has been critically evaluated by several authors, and chronologies of these events are available from the FDA among other sources. Figure 3 provides a timeline of the initial manufacturing and clinical application of the VI PTIPI and the role of the FDA in regulating its use, as well as scientific literature published on PTIPIs throughout the years. Since the 1976 Medical Device Amendments were instituted, the FDA has had jurisdiction over medical devices entering the market. Despite PTFE having been condemned by Charnley for joints in 1982, VI filed intent to market PTIPI claiming it to be \"substantially equivalent\" to Silastic, which was already being used in TMJ surgery. Its biocompatibility was based on in vitro studies and alveolar ridge augmentation studies. In 1983, FDA notified VI that the IPI is equivalent to devices marketed prior to the FDA\\'s 1976 Medical Device Amendment and granted 510(k) premarket notification status. Later that year, VI initiated commercial distribution of the implants.\\nIn 1987, the US Air Force reported problems to VI and the FDA. In 1988, the FDA became aware of complaints about the PTIPI implants and explants showing bone resorption, implant fragmentation, and delamination, and as a result, conducted its first inspection of VI. In 1989, the FDA issued VI a regulatory letter for medical device reporting and good manufacturing practices violations. In January 1990, the FDA issued a letter to VI advising it to warn all OMFSs against implanting further devices and monitoring their patients until further clinical data were available. Thus, in March 1990, VI issued a \"Dear Doctor\" letter to OMFSs, informing them of the hazards associated with the PTIPI product and advising them to closely monitor all patients through clinical and radiographic examination. The FDA classified this action as a voluntary safety alert. Consequently, VI filed for bankruptcy in June 1990. Shortly thereafter, the FDA issued VI a letter stating that its voluntary safety alert was ineffective, as an audit check had disclosed that some consignees were never notified. In December 1990, FDA reclassified VI\\'s voluntary status alert to a class I recall and issued a safety alert to all OMFSs, urging them to refrain from using the devices and to return all unused devices to the VI bankruptcy trustee. The FDA also rescinded 510(k) status for VI PTIPI, seized the remaining implants and issued a safety alert to all OMFSs. In 1991, the FDA recalled the VI PTIPI - the first recall for this agency - and issued a medical alert to patients. The United States Congress held hearings on TMJ implants in 1992. In 1994, FDA reclassified TMJ Implants as class III devices, subject to premarket approval.\\nFDA oversight of the PTIPI has been called into question pertaining to several issues. Because TMJ implants were classified as 510(k) status, they avoided critical review for several years. There was no system to track the devices, as this was not a component of the FDA inspection process. MedWatch was a voluntary reporting system, and in 1986, reports on VI PTIPI were dismissed. The FDA \"seems to have missed several opportunities to intervene and head off the IPI disaster,\" with one oral surgeon reporting, \"The FDA was asleep at the switch.\"\\nIn his 1995 Hastings lecture, then FDA Commissioner Dr. David A. Kessler discussed some of the challenges that faced the agency regarding the introduction of medical devices and the role of the FDA \"in piloting their path from the bench to the bedside.\" Citing Shiley heart valves, silicone gel-filled breast implants, and TMJs as examples of problem devices, he explained the several areas for which the FDA was strengthening its activities in product approval, post market surveillance, enforcement, research, and education, noting that \"health care practitioners, too, have a responsibility to let us know when they see problems with a device.\".\\nDr. Charles Homsy worked at the Methodist Hospital in Houston, Texas, and developed Proplast in a laboratory there. A lawsuit was filed against the hospital in 1994. The suit was settled in 1996 for $30 million and $975 million in costs. Individual patients were paid between $15,000 and $100,000, in addition to 3% for loss of consortium. The Baylor College of Medicine and the Methodist Hospital were also sued, as tests on components of the PTIPI had been conducted in their facilities and the Methodist Hospital had licensed the manufacture of Proplast to VI. Baylor did not settle and most of the cases were dismissed.\\nIn a review of mass tort cases in 1999 based on published sources, TMJ injury claims that PTIPIs led to fragmentation, pain, and bony and soft tissue damage were compared to claims of damage due to breast implants and orthopedic screws. PTIPI claims were far fewer than those against manufacturers of breast implants or orthopedic screws, as the total number of estimated exposures was considerably smaller. However, in the case of PTIPI, the cause of damage was highly identifiable. Notably, PTIPI defendants had a low ability to pay following VI filing for bankruptcy, whereas breast and orthopedic screw implant defendants had a higher ability to pay. By 1999, the PTIPI cases were closed, with the other two categories remaining open. The claims to exposure ratio was similar for the PTIPI and orthopedic screw categories, and much higher for the breast implants.\\nThe American Dental Association (ADA) published the FDA safety warning without comment. The American Association of Oral and Maxillofacial Surgeons (AAOMS) sent the FDA safety alert, public health advisory, and TMJ implant advisory to members both in 1992 and 1993. However, the organization took no official advisory position. In 1992, the AAOMS held a workshop on the issue, chronicling the history of AAOMS involvement, reviewing the literature, and offering recommendations for managing patients with alloplastic TMJ implants. The workshop furthermore stated that \"the recommendations presented represent a consensus of the workshop participants and are not an official statement of AAOMS.\" AAOMS later published its first document describing the parameters of care in 1992. Now in its 6th version, the section on TMJ surgery recognizes \"that many patients undergoing TMJ surgeries have unique pain control requirements,\"\\' and that \"this field has undergone a considerable evolution in the past 15-20 years.\" In regard to alloplastic materials, the document states that \"when alloplastics are used, they should be employed following the manufacturer\\'s instructions and consistent with indications approved by the US Food and Drug Administration.\"\\nIn legal disputes, the AAOMS Risk Management group (Oral Surgery National Insurance Company-OMSNIC) defended the profession. At the time, it was headed by an OMFS who had authored an article on 301 patients who had been implanted, and the article blamed the OMFSs and the patients for the implant failures. It was the last article to be published that defended the implant. Many lawsuits were brought against OMFSs who had implanted the device and were vigorously pursued. Figure 4 shows the premise for each side of the debate.\\nIn one example of a class action suit brought by 21 plaintiffs and 13 spouses, the plaintiffs filed complaints asserting claims of product liability, breach of warranty, negligence, and loss of consortium. Three of the claims were dismissed; however, negligence both prior and subsequent to the implant surgery was re-evaluated and subsequently hinged on whether the defendants \"failed to include as part of their informed consent process before surgery any mention of all the reports of foreign body tissue reactions, bone resorption, immune reaction, or long-term immunological response.\" After the surgery, the defendants failed \"to provide adequate information from which the claimants could make informed judgments about whether and when to have the Vitek implants removed.\" The case languished in the courts and was ultimately dismissed.\\nThe positive and negative results of PTIPI were predominantly published in peer-reviewed OMFS journals. The editor of the Journal of Oral and Maxillofacial Surgery at the time stated that starting in 1986, doctors knew of patients suffering from \"extensive resorption of bone and marked tissue inflammation\" as well as \"intense pain, jaw dysfunction, and occasional changes in the bite.\" He reviewed the FDA\\'s response \"in the instance of the Teflon/Proplast (Vitek Inc., Houston, TX) fiasco\" and concluded \"One can no longer use the issue of FDA approval as an excuse if a device eventually proves to be ineffective.\" In defense of the publication of scientific articles which subsequently turn out to be inaccurate, it can argued that journal editors rely on their reviewers when deciding to publish articles and those views can be biased, ill-informed, or erroneous for a variety of reasons. Furthermore, it is clear that science changes over time and that our view of scientific authenticity can change as a result of new scientific observations as well as other factors.\\nAll clinicians are bound by ethical standards that define the framework within which they work. Many articles and guidelines have been published to define these principles, with the four core bioethical principles being respect for patient autonomy, beneficence, non-maleficence, and justice. Embedded within these principles are several items that apply to the PTIPI incident, including: informed consent, truth-telling, good communication skills, ability to exercise sound judgement, research and innovation in surgery, responsible conduct, minimizing harm, recognizing the limitation of one\\'s professional competence, research and auditing, disclosure and discussion of surgical complications including medical errors, and whistle blowing. A full discussion of each of these points is beyond the scope of this article, although in a statement that speaks more directly to this affair, Adedeji and colleagues wrote, \"The surgical profession as a whole has the obligation to improve surgical outcomes and reduce complications by conducting research and participating in systematic programs of quality improvement. This requires keeping detailed and accurate data on the incidence of adverse events.\" Adedeji additionally suggests that the burden of proof for any innovative surgical technique lies with the surgeon, who should be prepared to justify such medical decisions to professional colleagues. Establishing these protocols within an ethical framework is the role of Institutional Review Boards which regulate such activities within medical institutions. Several of the principles were seemingly ignored and ethical issues were insufficiently addressed in the PTIPI affair.\\nThe issue of financial reward associated with PTIPIs has attracted very little attention. The companies involved in the manufacture and distribution of these implants as well as their officers, shareholders, and consultants were legitimately in the business for financial gain. Likewise, the OMFSs and the hospitals at which they worked expected to be compensated for their efforts to help patients. For OMFSs, it was \"a bona fide business opportunity.\" It has been suggested that a conflict of interest existed when oral surgeons owned the implants and were subsequently the distributors, as well as the implanting surgeons. The VI recall notice requested that OMFSs \"do not implant any more of these devices if you have any of them in your possession. These implants should be returned for credit. Return these implants to the address below in their original boxes, if available, a copy of the corresponding shipping memorandum.\"\\nIt has been reported that the chief VI clinical consultant owned less than 1% of the company\\'s stock and received a royalty payment of 2-4% of the price of certain products sold, amounting to \"about $50,000 a year, he says (although Dr. Homsy pegs it closer to $100,000 some years).\" Hospitals now have conflict of interest policies to which medical staff and surgeons are expected to abide. These typically contain questions regarding financial interests in pharmaceutical and medical equipment companies.\\nCurrent thinking about the cause of accidents, adverse events, and near misses in the healthcare field focuses on the several events that need to coincide to create an adverse situation. In any event, hazards exist, and the layers of defense can be breached by latent conditions or active failures, as noted in the \"Swiss Cheese model\" of failure (Figure 5). In the chain of events leading up to the harm that PTIPIs caused, specifically where were the failures?\\nSome of the disturbing aspects of the PTIPI incident include the lax regulatory environment at the time, particularly the lack of oversight by manufacturers, such as DuPont, whose products were brought to market by independent companies, such as VI. Importantly, there was a failure of the developers of the PTIPI to recognize or acknowledge the unique features of the TMJ and the empirical literature indicating that this material would fail under loading forces in the joint. In addition, there was a slow and inadequate response of professional organizations, including the AAOMS and ADA, in protecting the public. Furthermore, there was an insistent reliance upon poorly understood technology and an unproven procedure to treat articular disc derangements of the TMJ, which we now know to be a generally self-limiting with a natural history that can resolve over time. The fact that this episode affected a small subspecialty surgical group and a small number of patients, at least in comparison to other implant controversies, in no way mitigates the tragedy of the situation, nor the federal, institutional, and professional responsibilities that were not met.\\nThe contrary view supports the decisions made at the time by the OMFSs involved, based on current knowledge and the imperative to treat patients who were in pain, had dysfunction, and were demanding relief. The legal concept of \"standard of care\" evolves over time and is generally considered to be \"what a minimally competent [surgeon] would do in the same situation, with the same resources,\" which turns out to be a fairly low bar in this situation. TMJ surgeries represented relatively simple procedures, with doctors describing the procedure with phrases such as, \"We\\'ll slip this little disc, and you\\'ll be out of the hospital in two to three days.\" The surgeries often presented an alternative to prolonged and ineffective non-surgical treatment modalities that were either failing to alleviate the symptoms or expensive (for example, extensive orthodontic and/or restorative treatment and orthognathic surgery to provide a \"better occlusion\"). In addition, indications for surgery were justified by imaging (CT or MRI) that showed derangement or pathology of the TMJ. Thus, it could be said that the failure of the PTIPI was not so much a problem with the implant material as it was with the OMFSs and patients who did not follow instructions.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 72,\n",
       "    'case_id': 'PMC4488956_01',\n",
       "    'case_text': \"A 72-year-old, previously well, woman was found to have left ocular uveal melanoma on ophthalmology review (Fig. 1). She had previously been noted to have 'freckles' on her left retina. At the time of diagnosis the patient was asymptomatic, suffered no visual impairment and declined further investigation, radiotherapy or enucleation. A one-year follow up showed growth of the uveal melanoma with staging undertaken prior to intended radiotherapy. An abdominal CT scan demonstrated a lesion within segments 4 and 7 of her liver (Fig. 1). A Further PET scan showed a focal area of FDG avidity within segment 4 but no increased FDG uptake in liver segment 7,\\nA diagnostic laparoscopy was performed for the liver lesions of unknown origin. Intraoperatively, no free intraperitoneal fluid was seen but numerous peritoneal nodules were noted on the diaphragmatic and peritoneal surfaces, particularly in the right upper quadrant. There was no obvious omental disease. These peritoneal nodules along with the liver lesion were biopsied. The liver biopsy showed focally necrotic poorly differentiated adenocarcinoma. Immunohistochemical labeling was in keeping with cholangiocarcinoma and in the absence of a primary site in the extrahepatic biliary system or upper gastrointestinal tract the lesion was considered to likely represent a primary intrahepatic cholangiocarcinoma. The lesion did not label for any immunohistochemical markers for melanoma. The peritoneal biopsy showed nodular proliferations of mesothelial cells with infiltration into the submesothelial adipose tissue indicative of malignant mesothelioma of epithelial type. Immunohistochemistry was positive for mesothelial markers and negative for carcinoma markers.\\nThe patient's father and brother had both died of malignant mesothelioma (Fig. 2) having had occupational exposure to asbestos. The patient herself had no occupational exposure to asbestos but may have had ongoing household exposure since the 1970s. Her past medical history was unremarkable besides beta thalassemia minor and a previous hysterectomy for benign disease. The patient was of Greek descent. She was a non-smoker and only occasionally drank alcohol. The patient had four children, and two of these had passed away with renal cell carcinoma and acute lymphocytic leukaemia at ages 41 and 17 respectively (Fig. 2).\\nElective surgical resection was deemed appropriate for the patient's primary liver mass. A CT prior to resection demonstrated no change in the liver lesion and no evidence of extrahepatic spread. Intraoperatively, a firm porta hepatic node was identified with frozen sectioning confirming metastatic adenocarcinoma. Fine needle aspiration of the segment 7 also showed adenocarcinoma and in view of positive intra- and extrahepatic disease the liver resection was abandoned. A strip of peritoneum was also removed which again demonstrated malignant mesothelioma.\\nIn light of her uveal melanoma and malignant mesothelioma, combined with her family history of mesothelioma it was suspected that the patient might have BAP1 hereditary cancer predisposition syndrome. Testing for BAP1 mutations by immunohistochemistry showed loss of nuclear BAP1 labeling in the primary biliary tract adenocarcinoma, but nuclear labeling for BAP1 was retained in the malignant mesothelioma (Fig. 3). No biopsies were taken from the uveal melanoma. Germline DNA sequencing was performed and revealed the patient to carry a germline missense mutation in the catalytic domain (g.52441252A > G, p.Tyr173Cys) located in exon 7 of the BAP1 gene (Fig. 4). This mutation is predicted to generate a non-functional full-length protein, due to impairment of its ubiquitin hydrolase activity.\\nFurther CT surveillance of the patient demonstrated an enlarging liver mass, development of new liver lesions and increasing portacaval lymph nodes. No other distant sites of metastasis where identified on CT. The patient become symptomatic 23 months after the diagnosis of cholangiocarcinoma and mesothelioma and was commenced on palliative chemotherapy. She passed away 31 months after diagnosis of cholangiocarcinoma and mesothelioma due to progression of her intraabdominal malignancies.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 63,\n",
       "    'case_id': 'PMC6402212_01',\n",
       "    'case_text': \"A 63-year-old man with chronic kidney disease presented with elevated baseline creatinine. He had no urologic symptoms and no history of flank pain or hematuria. Family history was notable for renal malignancy in the patient's grandmother. The physical examination was unremarkable, with no palpable flank mass or tenderness. Laboratory studies were notable for a creatinine of 2.02 (eGFR = 34 ml/min), up from a baseline of 1.60 (eGFR = 42 ml/min). Renal ultrasound revealed a 12 x 15 cm predominantly solid mass in the right kidney with internal cystic changes and central flow. In the left kidney renal ultrasound revealed a solid-appearing mass in the upper pole measuring 6.5 x 6 x 5.5 cm, a hypoechoic structure measuring 4.8 x 4.1 x 4.6 cm in the lower pole, and an adjacent 6.1 x 5.8 x 6.4 cm solid left lower pole renal mass with a small amount of central flow. Computed Tomography (CT) revealed a 14 x 13 x 16 cm right renal mass almost completely replacing the interpolar region, with significant mass effect on the right kidney (Figures 1 and 2). Adjacent tissue nodularity in the perinephric fat was concerning for satellite nodules or metastatic disease (Figure 1). Right retroperitoneal adenopathy measuring 2.4 x 2.7 cm at the level of the renal hilum was identified. In addition, multiple 2-3 cm hyper- and isodense indeterminate soft tissue lesions were identified in the right kidney. The left kidney was notable for multiple solid renal masses measuring 6.3 cm at the upper pole and 4.6 cm at the interpolar region (Figure 3). A left paraaortic soft tissue mass measuring 4.6 x 4.6 cm with associated calcification was concerning for adenopathy (Figure 3). Whole body positron emission tomography (PET)/CT imaging was obtained to evaluate for metastatic disease. PET/CT revealed bilateral metabolically active solid renal masses concerning for malignancy and metabolic activity in a left paraaortic soft tissue mass concerning for lymphadenopathy. Magnetic resonance imaging (MRI) revealed no evidence of inferior vena cava thrombus.\\nThe patient was discussed in a multidisciplinary oncology meeting and the decision was made to proceed with surgical extirpation of the right kidney and the paraaortic mass. We performed an open right radical nephrectomy with right retroperitoneal lymph node dissection and excision of left paraaortic mass.\\nGrossly, the right kidney contained a spherical, encapsulated, and homogenous maroon-colored mass with a gray-white lobulated central scar (Figure 4). Two additional smaller masses with similar gross appearance but without central scar were also present. Histologic examination revealed nests of round and polygonal cells with granular, eosinophilic cytoplasm (Figure 5) consistent with oncocytoma. Immunohistochemical staining of the right renal mass with colloidal iron, CD117, CK7, RCC, and CD10 was performed. The tumor cells were positive for CD117, CK7 (Figure 6), and weakly positive for CD10. The tumor cells were negative for Hale colloidal iron and RCC.\\nCross sections of the left paraaortic mass revealed a smooth, encapsulated mass with a pearly and glistening tan-white surface (Figure 7). Histologic examination revealed multiple regions of cystic degeneration, positive staining for S100, and Antoni A and Antoni B areas. The final pathologic diagnoses were renal oncocytoma and left paraaortic ancient, benign schwannoma.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 45,\n",
       "    'case_id': 'PMC6497487_01',\n",
       "    'case_text': \"A 45-year-old male patient was referred to the prosthodontics clinic to complete the restoration of a dental implant (3.7 mmx11 mm, Zimmer implant, Standard Plus, regular neck, Zimmer Dental, Carlsbad, CA, USA), at the site of tooth #21. The dentist had placed an implant 3 months previously and then started the construction process of a cement-retained crown for restoring implant #21 and fabricated a gold customized implant abutment. Before completion of the implant restoration, the patient was referred to our clinic to continue the treatment.\\nDuring the first visit, patient medical and dental history was reviewed. According to the American Society of Anesthesiologists (ASA) physical status classification system, the patient is ASA1. The patient's chief complaint was to continue the treatment of his anterior teeth. Upon smiling, the patient has a low to average smile line. The apparent teeth have a homogenous shade that the patient was satisfied with. Intraoral examination revealed adequate periodontal health, tooth #11 had a provisional crown, and tooth #21 is an implant with a healing abutment. The patient has thin gingival biotype. Radiographic examination displayed the current process of external root resorption for tooth #11. The patient was provided with complete information regarding treatment options to make a decision for tooth extraction and implant placement of #11 (Figure 1). The patient signed an informed consent to proceed with the treatment plan. \\nThe cone-beam computed tomography (CBCT) image for the patient displayed sufficient sound buccal, lingual, and apical alveolar bone around tooth #11. A surgical guide was developed as a duplicate for the prior master cast for the prosthodontist with self-cure acrylic resin. The surgeon was guided through predetermined mesiodistal and buccolingual center channel for tooth extraction #11 in the patient's mouth. The implant mount attachment was facilitated with the help of an acrylic transfer jig to assure the cast fabrication for quick succession to fabricate the fixed dental prosthesis after placing an implant. In addition, the vacuum-formed template for provisional restoration fabrication was used for fabricating a 1.5 mm thermoplastic material.\\nThe surgical process was performed by the periodontist by giving local anesthesia to the patient. Tooth #11 was removed by performing flapless and atraumatic extraction, followed by normal socket saline rinsing, debridement, and curettage. In addition, during implant drilling, the mouth of the patient was secured through the teeth-supported surgical guide. By using the standard protocols for the Zimmer system, implant placement and bone preparation were performed in the patient's mouth. The placement and torquing of a Zimmer implant were ensured at 40 N cm (Figure 2). In contrast, there was no essential requirement made by the dentist toward soft tissue suturing. \\nAfter the implant placement, the transfer jig was secured on the adjacent teeth and the implant mount was carefully connected to the jig by adding autopolymerizing acrylic resin. The implant mount was retrieved from the patient mouth with the attached jig, screwed to an implant lab analog and then transferred to the cast. Two implant temporary abutments from Zimmer (Zimmer Dental, Carlsbad, Calif) were placed on the cast and prepared using the clear vacuum-formed shell template (Figure 3). \\nThe implant supported fixed provisional restoration was constructed to develop the preferred emergence profile using acrylic resin. The provisional fixed dental prostheses were appropriately finished and polished.\\nThe temporary abutments were screwed to the implants in the patient's mouth, and Teflon tape was used to block both temporary abutments' access holes. Afterward, the minimum amount of non-eugenol temporary cement was used to cement the provisional restoration and excess cement was safely removed. Occlusion was adjusted to ensure minimal contacts during eccentric and centric occlusion (Figure 4). \\nPost-operative instruction was given to the patient and recall visits were done after 7 days, 4 weeks, 8 weeks, 12 weeks, and 16 weeks. On each follow-up appointment, the healing was assessed with no signs of inflammation or infection. Also, the development of the soft tissue emergence profile around the implant was monitored and the provisional restoration was adjusted if required. Esthetics and phonetics were evaluated and the patient displayed a complete satisfaction with the outcome (Figure 5). \\nA definitive open tray impression was done by using Impergum Penta-Soft after 4 months of healing (Figure 6). The customization of impression copings was based on the transference of the emergency profile of the soft tissue. The soft tissue emergence profile was transferred to the mastercast using light body polyvinyl siloxane material (Figure 7). \\nFull contour wax up was made for crowns #11 and 21 on the master cast. The clear vacuum-formed shell template was used to adjust the old gold custom abutment of implant #21. Afterward, mounted master casts, gold abutment #21, and the clear template were sent to Astra Tech (Molndal, Sweden) to design and fabricate a customized milled CAD/CAM Atlantis abutment. Abutment design of implant #11 was requested to match the design of gold abutment #21 except in material. The abutment designed for implant #11 was fabricated from zirconia for comparison purposes. An approval from the prosthodontists was taken via email for the abutment design (Figure 8). A one-piece customized abutment which consisted entirely of zirconia was milled and shipped to the clinic. \\nUpon arrival, both abutments were checked on the cast for exact duplication. Full contour acrylic resin crowns were constructed on both abutments to confirm the equal thickness of both crowns on all sections. Thickness evaluation was made using a polygauge and all the readings were equal on both crowns in all sections (Figure 9). \\nNext, crowns with porcelain fused to zirconia were constructed for implant abutments #11 and #21. Again, the buccal thicknesses of the final crowns were measured and compared using a polygauge. All readings were comparable for both crowns (Table 1). Afterward, abutments were screwed to both implants and final crowns were checked in the patient's mouth to evaluate esthetics and phonetics. Shade evaluation of both crowns was carried out by the treating prosthodontist on their buccal surfaces (incisor, middle, and cervical thirds) using VITA Easyshade Advance System (VITA Zahnfabrik, H. Rauter GmbH & Co. KG, Bad Sackingen, Germany). All readings were comparable in relation to CIE L*a*b* color space, Classical Vita Shade Guide and 3D Master Shade Guide. The shades of both crowns were comparable and rated clinically satisfactory by the treating prosthodontist and patient. Finally, customized abutments were torqued to 30 N cm, access hale were blocked with Teflon tape, and the final crowns were cemented with non-eugenol temporary cement (Temp Bond NE, Kerr; Orange, CA, USA) (Figure 10).  \\nTwo experts in fixed prosthodontics who had not taken part in the patients' treatment performed the clinical evaluation. Both observers had good eyesight that will assist in comparing the esthetic appearance of both implants supported all-ceramic crowns with gold and zirconia abutment side by side. Variations were detected using artificial diffuse light and the Vita 3D Master shade guide by standing 50 cm from the mouth of the patient where the head of the patient was positioned upright. There was no difference observed in the color aspect by prosthodontics.\\nThe recall visits were done after 2 weeks, 1 month, 3 months, and 1 year from delivery of final restorations. Both implants and their restorations were assessed. The patient was satisfied with the esthetics and functional outcome of the final restorations, as was the prosthodontist (Figure 11). A written informed consent has been provided by the patient to have the case details and accompanying images published. The institution allows publication of the patient's treatment and images for scientific purposes.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 42,\n",
       "    'case_id': 'PMC4257017_01',\n",
       "    'case_text': 'A 42-year-old Caucasian woman was referred to our department complaining of sudden vision loss, watery discharge from her right eye (RE), and pain. She had a complex past ocular history that included the implantation of Retisert in her RE to treat persistent uveitis-associated cystoid macular edema on the background of psoriatic arthritis 18 months earlier. In addition, according to her notes, she had undergone combined phacoemulsification and vitrectomy with epiretinal membrane peeling 2 years before the FA implant. One year after the Retisert implantation, she underwent right trabeculectomy to treat persistently high intraocular pressure.\\nOn examination, the intraocular pressure (IOP) was 2 mmHg, the anterior chamber was flat, and the visual acuity was counting fingers in the RE. An anterior segment examination revealed scleral melt with active leaking (positive Seidel test) at the site of the FA implant. The patient underwent urgent surgical repair under general anesthesia. Intraoperatively, an anterior chamber maintainer was used and surgical exploration confirmed significant scleral melt at the site of implantation with leaking aqueous humor (Figure 1). A scleral patch graft was sutured over the leaking sclerotomy.\\nOn the following day, the IOP was 9 mmHg and the fundus examination revealed that the FA implant had detached from the scleral sutures and was free floating in the vitreous cavity.\\nThree weeks later, the IOP was 18 mmHg, the visual acuity recovered to 20/30, and the patch graft was in good position (Figure 2). Benefits and risks of vitrectomy to remove the Retisert implant were discussed with the patient; however, she decided against surgery.\\nTwo years later, visual acuity remained 20/30 with no recurrence of the cystoid macular edema, and IOP within normal limits, without additional medication.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 53,\n",
       "    'case_id': 'PMC4996063_01',\n",
       "    'case_text': \"A 53-year-old wheelchair-bound man presented with a cT4aN0M0 right lower gingival squamous cell carcinoma (53 x 36 x 40 mm). He had suffered from childhood-onset poliomyelitis that was complicated with atrophy of both the lower extremities. His medical history included pure motor lacunar infarction with left hemiplegia for 5 years, with preoperative, bilateral, Grade 4 lower limb muscle power using the Medical Research Council's grading system. Tumor ablation, segmental mandibulectomy from the symphysis to the right ramus, and a right supraomohyoid neck dissection were performed, resulting in a through-and-through right buccal defect. A reconstruction plate was used to reinforce the strength of the mandible (Figure 1). The right buccal defect was reconstructed using a left ALT-free flap with a portion of the vastus lateralis muscle and six cutaneous perforators. The skin paddle for the mucosa defect measured 8 x 8 cm and for the cheek defect measured 11 x 9 cm in a snowman configuration. The descending branch of the lateral circumflex femoral artery was anastomosed to the right superior thyroid artery, and the two comitant veins of the descending branch of the lateral circumflex femoral artery were anastomosed to the right superior thyroid vein and a branch of right internal jugular vein. A split-thickness skin graft was harvested from the left medial thigh and was used to close the donor site defect. The flap survived, and the patient's post-operative course was uneventful. The total duration of hospitalization was 11 days. After 2 years and 11 months of follow-up, the flap has a bulky appearance but there is no exposure of the reconstruction plate or trismus, and the grafted donor site is unobtrusive (Figure 2). The bilateral lower limb muscle power remained at Grade 4.\",\n",
       "    'gender': 'Male'},\n",
       "   {'age': 51,\n",
       "    'case_id': 'PMC4996063_02',\n",
       "    'case_text': \"A 51-year-old man with atrophy of the muscles in both the lower extremities (Figure 3) presented with a cT4aN0M0 left buccal squamous cell carcinoma (35 x 23 x 20 mm) with skin invasion. He had suffered from poliomyelitis in his childhood, which was followed by a flexion contracture of both the hips and knees. He underwent operations to release the flexion contracture of his hips and knees approximately 40 years ago and could walk well with calipers and crutches. The preoperative muscle power in his right and left lower limbs was Grade 0 and 1, respectively. Wide tumor excision, marginal mandibulectomy, and left supraomohyoid neck dissection were performed, resulting in a through-and-through left buccal defect. An ALT-free flap that included a portion of the vastus lateralis muscle was harvested from his right lower limb to reconstruct the buccal defect. The skin island measured 20 x 10 cm and included two cutaneous perforators (Figure 4). The descending branches of the lateral circumflex femoral vessels were anastomosed in an end-to-end fashion to the left superior thyroid artery and two comitant veins. The donor site was resurfaced using a split-thickness skin graft that was harvested from the right medial thigh. Arterial vasospasm occurred intraoperatively and was subdued using 2% xylocaine irrigation. The flap became pink in color, and the capillary refill returned to a normal level (Figure 5). Post-operatively, intravenous infusion of prostaglandin E1 was prescribed to promote skin flap blood flow. The flap survived, and the patient's post-operative course after 17 days of hospitalization was uneventful. At the 3-month follow-up, the patient was satisfied with the reconstructed cheek and there were no donor site complications. The muscle power in the right lower limb remained at Grade 0 and he could walk well with calipers and crutches (Figure 6).\\nA line was drawn between the anterior superior iliac spine and superolateral corner of the patella, and a longitudinal skin incision of approximately 3-4 cm was medially made using normal procedures. A skin incision down to and through the thigh fascia will expose the rectus femoris in the normal lower limb but may encounter the vastus medialis muscle in a patient with poliomyelitis because of significant muscle atrophy. The quadriceps muscle had a pale, yellowish, fat-like color (Figure 4), and the intermuscular septum was not clear. Inexperienced surgeons may mistake the vastus medialis muscle for the rectus femoris muscle. In a patient who has had poliomyelitis, a lateral 1-2 cm subfascial dissection is required to clearly identify the rectus femoris muscle. Following identification, the dissection proceeded along a subfascial plane laterally toward the intermuscular septum between the rectus femoris and vastus lateralis muscles. Medial retraction of the rectus femoris muscle revealed the vascular pedicle with a descending branch of the lateral circumflex femoral vessels. In our experience, the diameter of the vascular pedicle is less than 1 mm and smaller in patients with a history of poliomyelitis compared with patients without a history of poliomyelitis. The thigh skin was then raised and laterally retracted by a subfascial plane dissection, exposing the septocutaneous and/or musculocutaneous perforators. The number and size of cutaneous perforators were similar to normal ambulating limbs. Distal to proximal intramuscular dissection of the musculocutaneous perforator was then initiated. The intramuscular dissection was easier and more rapid than in a normal limb because there were fewer vastus lateralis muscle branches and less muscle bleeding. The distal end of the descending branch of the lateral circumflex femoral vessels was ligated, and a thigh fasciocutaneous or myocutaneous ALT flap was well prepared for harvesting.\\nOn pathological examination of the paralytic limbs in Case 2, the thigh skin tissue revealed chronic inflammatory cell infiltration and fibrosis. As expected, the evaluation of the vastus lateralis muscle revealed degeneration and fibrosis (Figure 7).\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 29,\n",
       "    'case_id': 'PMC8795594_01',\n",
       "    'case_text': \"A 29-year-old Chinese woman was referred to the ophthalmology clinic, complaining of gradual painless visual loss associated with intermittent episodes of whiteout of vision in both eyes for 1 month. Her visual disturbance was more prominent in the left eye and worsened upon standing. She also experienced headaches, dizziness, weakness in the left extremities, and jaw claudication while chewing. Two years prior to presentation, she had noted diminished left radial pulse. There was no contributory family history. She had been diagnosed with Type 5 TA 1 month prior to our ophthalmology clinic and received two courses of intravenous cyclophosphamide (CTX) with a 4-week interval followed by oral prednisone.\\nAt presentation, general physical examination disclosed the absence of left radial arterial pulses, along with feeble arterial pulses on her right side. Carotid and subclavian bruits were heard on both sides. Her blood pressure was 145/71 mmHg in the lower extremities. Ocular examination revealed a decimal best-corrected visual acuity (BCVA) of 0.02 and 0.4 in the right and left eyes. Intraocular pressure (IOP) was 6.3 mmHg in both eyes. Slit-lamp examination showed that anterior segment was unremarkable. Fundus examination revealed mildly distended veins in both eyes ( Figure 1 ).\\nFFA of the left eye showed delayed choroidal filling, leading edge of fluorescein dye in the arteries, prolonged arm-to-retina circulation time of 38 s, and arteriovenous transit time of 32 s. Diffuse microaneurysms were noted in the midperipheral area. In the late phase, retinal vessels were markedly stained. Similar changes were detected in the right eye. There was no evidence of capillary non-perfusion, arteriovenous shunts, or retinal neovascularization ( Figure 2 ). Spectral domain OCT (SD-OCT) did not detect any significant macular changes. OCTA showed extreme rarefaction of perifoveal vascular density at the level of superficial capillary plexus (SCP) ( Figures 3A, G ) and deep capillary plexus (DCP) ( Figures 3D, J ) in both eyes. Disruption of the perifoveal vascular arcade was also noted predominately in DCP.\\nBlood testing on admission revealed normal erythrocyte sedimentation rate (8.0 mm/h), C-reactive protein (2.40 mg/L), and moderate eosinophilia (7,460 cells/mul). Chemical profile, liver and renal function, antinuclear antibody, antineutrophil cytoplasmic antibodies, and rheumatoid factor were normal. On vascular imaging, a carotid Doppler showed diffuse wall thickening with associated luminal stenosis involving bilateral common carotid arteries and subclavian arteries. High-grade stenosis of the bilateral proximal subclavian artery was noted. Marked luminal narrowing was seen in the right tibial artery in a peripheral ultrasound. A subsequent CT angiogram (CTA) disclosed circumferential thickening of thoracic aorta, complete occlusion of bilateral common carotid arteries, and critical stenosis of bilateral proximal subclavian arteries ( Figure 4 ).\\nBased on the patient's past history of TA, ocular symptoms, and relevant eye examinations, stage II TR was diagnosed according to the Umaya and Asayma classification. She was referred to a vascular surgeon and underwent balloon angioplasty of bilateral subclavian arteries. During the procedure, dilation of bilateral subclavian arteries was carried out with a 4 x 40 mm balloon through right femoral artery approach. Post-angioplasty angiogram showed markedly improved flow of pre-vertebral subclavian artery, predominately in the left side. She was put on prednisone (40 mg/day), CTX (50 mg/day), aspirin, and vasodilators afterward to induce remission in TA.\\nOne month after surgery, the patient reported a slight improvement in her vision. Her blood pressure is 72/55 mmHg in the upper extremities. FFA revealed improved retinal blood flow, with a persistent number of microaneurysms and late-phase dye leakage in both eyes. Paralleled to FFA findings, OCTA showed considerably increased vascular density in the SCP ( Figures 3B, H ) and DCP layer ( Figures 3E, K ). She remained on tapered prednisone (35 mg/day), CTX (50 mg/day), vasodilator (40 mug twice daily), and aspirin.\\nOn follow-up of 6 months, she continued to sustain good improvement in symptoms. Her BCVA improved to 0.6 in the right eye and remained stable at 0.4 in the left eye. IOP was 9 mmHg in both eyes. A fundus examination revealed a superficial hemorrhage in the peripheral retina of the left eye. Repeated FFA of the left eye showed a decrease of arm-to-retina circulation time and arteriovenous transit time to 16 and 8 s, respectively. The number of microaneurysms decreased, with less evident dye leakage in the midperipheral area. Right eye angiogram showed similar improvement ( Figure 5 ). No capillary non-perfusion and retinal neovascularization were observed. Notably, OCTA revealed further normalization of vascular density, along with restoration of perifoveal anastomotic capillary arcade ( Figures 3C, F, I, L ). CTA revealed moderate restoration of flow in the bilateral common carotid arteries and subclavian arteries.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 12,\n",
       "    'case_id': 'PMC9850095_01',\n",
       "    'case_text': \"A 12-year-old boy with a one-year history of muscle weakness and gait disturbance that progressed slowly presented to our hospital. He had no remarkable past medical history or family history of metabolic bone disease. Roentgenographic examination revealed a deficiency of mineralization like that seen in rickets patients in the epiphysis of the bilateral proximal tibias and distal femurs ( Figure 1A ), and a radiolucent lesion with endosteal scalloping and marginal sclerosing in the left fibula ( Figure 1B ). Blood examination revealed a low serum phosphorus level of 2.3 mg/dL (reference range: 3.0-4.7 mg/dL), and a markedly high serum FGF23 level of 329 pg/mL (reference range: <50 pg/mL), and so we suspected PMT with TIO caused by the tumor-like lesion in the left fibula.\\nWe resected the tumor en bloc by preserving the periosteum of the fibula after confirming its benignity by intraoperative frozen section diagnosis, and the cavity of the tumor was filled with beta-tricalcium phosphate (beta-TCP) ( Figure 1C  and  Supplemental Figure 1 ). The muscle weakness gradually improved, and the gait disturbance normalized within two months. In the postoperative 21-month follow-up, he had no symptoms, and hypophosphatemia was not detected. Roentgenographic examination revealed absorption of the beta-TCP and bone formation and union of the fibular shaft ( Figure 1D ).\\nHistopathological examination of the resected tumor revealed irregularly deposited osteoid and osteoblast-like tumor cells scattered between the osteoid and reactive osteoclastic giant cells ( Figure 1E  and  Supplemental Figure 2 ). In immunohistochemistry, expression of FGF23 was shown in the cytoplasm of the osteoblast-like tumor cells ( Figure 1F ), CD56 was diffusely positive on the cell membrane of the tumor cells and SATB2 was diffusely positive on the tumor cells ( Supplemental Figure 2 ).\\nAfter resecting the tumor, the serum FGF23 level started to decrease immediately and normalized within 3 hours ( Figure 1G ). It was also within the normal range five days after surgery. The increase in serum phosphorus level was slightly delayed as compared with that of the FGF23 level, and was observed 6 days after the operation ( Figure 1H ).\\nWe performed RNA sequencing using a resected specimen from the patient and identified a novel in-frame fusion involving NIPBL (encoding Nipped-B gene product and fungal Scc2-type sister chromatid cohesion proteins) and BEND2 (encoding a protein which has two BEN domains in the C-terminus) ( Figure 2A ). The fusion protein contained the phosphorylation site derived from NIPBL and the BEN domain derived from BEND2 ( Figure 2B ). Whole-exome sequencing identified three point mutations (IFT172:NM_015662:exon3:c.A263G:p.N88S; VAF = 0.22, GAB2:NM_080491:exon6:c.A1409G:p.D470G; VAF = 0.15, and PRKCH : NM_006255:exon14:c.A1996T:p.I666F; VAF = 0.17), none of which\\nwere reported as driver mutations. In polymerase chain reaction, the amplification of target regions containing breakpoint of the chromosomal structure was confirmed using two primer sets in tumor DNA of the PMT ( Supplemental Figure 3 ).\\nWe cloned and transfected the NIPBL-BEND2 fusion gene to HEK293T and MG63 osteoblast lineage cell line. The NIPBL-BEND2 transfected cells showed faster proliferation at 48 hours after transfection (p = 0.001 and 0.003, Student's t-test, respectively). ( Figures 2C, D ). A gene set enrichment analysis of the fusion gene-introduced HEK293T cells identified a significant enrichment of MYC-target genes, consistent with faster proliferation ( Figure 2E ). However, the expression of FGF23 (log2 fold change; 0.031) and FGFR1 (log 2 fold change; 1.59) was not changed significantly by the transfection in addition to the KL/KLB, SPP1, SFRP4, and MEPE ( Supplemental Data 1 ), even though the tumor mRNA showed relatively high FPKM in these genes ( Supplemental Table 3 ).\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 15,\n",
       "    'case_id': 'PMC4150428_01',\n",
       "    'case_text': 'A 15-year-old male patient reported with the chief complaint of swelling on the left side of lower jaw since 9-10 months. He noticed a swelling in the lower jaw in the posterior region, which was initially small in size and gradually increased to the present size. It was initially painless, but the patient now complains of mild intermittent pain, occasionally. The patient was prescribed antibiotics and analgesics by a general practitioner 3-4 times in the last 9 months.\\nExtraoral examination revealed a solitary swelling in the left mandibular ramus area. The swelling was roughly oval in shape with approximate size of 2 cm x 3 cm. The margins of the swelling were diffuse. The skin overlying the swelling was smooth and normal in color (Figure 1).\\nOn palpation, temperature of overlying skin of swelling was slightly elevated. The consistency of the swelling was bony hard. Medio-lateral expansion of the cortical plates was noted at angle of mandible. A single left submandibular lymph node of size approximately 1 to 1.5 cm was noted, which was slightly tender and mobile.\\nIntraoral examination revealed a single small swelling in retromolar area, slightly obliterating the pterygopalatine raphe. Expansion of buccal and lingual cortical plate was noted. A deep periodontal pocket was noted distal to 37 (Figure 2).\\nProvisional diagnosis on clinical examination was made as benign odontogenic lesion. Differential diagnosis of ameloblastoma, odontogenic keratocyst, dentigerous cyst associated with 38, calcifying odontogenic cyst, calcifying epithelial odontogenic tumor, and ameloblastic fibroma was considered.\\nRadiographic examination of the lesion showed a well-defined unilocular radiolucency involving the left side of the mandible which extended anteroposteriorly from the distal surface of the left mandibular second molar to the posterior border of ramus of mandible and superoinferiorly from coronoid notch to the inferior border of mandible. It showed well corticated borders. Resorption of the distal surface of root of the mandibular second molar was also noted (Figure 3).\\nCT and 3D CT scan of the lesion showed a unilocular osteolytic lesion in the posterior part of body and ramus of the mandible. Bilateral cortical plate expansion was noted. Perforation of the lingual cortical plate was also revealed (Figures 4 and 5). Radiologic examination showed that mandibular left third molar was absent. So the possibility of \"dentigerous cyst associated with 38\" which was considered in the provisional diagnosis was ruled out.\\nRoutine hemogram was performed and all the blood indices were within normal limits. An incisional biopsy was then performed, which on histopathologic examination revealed a cystic cavity lined by odontogenic epithelium and a connective tissue capsule. Epithelium shows palisaded basal layer resembling ameloblast-like cells and a superficial layer showing stellate reticulum-like cells. The connective tissue was dense, fibrous with collagen fibers arranged haphazardly. Numerous engorged and dilated blood vessels were seen (Figure 6).\\nFrom the above clinicopathological features, a diagnosis of unicystic ameloblastoma was made. The patient then underwent a mandibular segmental resection involving condyle and reconstruction was done with 2.7 mm titanium reconstruction plate and iliac crest graft, under general anesthesia. Healing was uneventful. Patient was followed up after 1 month with radiographic evaluation which showed complete healing of wounds and well maintained graft (Figure 7).\\nWe received a segmental resected specimen involving condyle, coronoid process, upto ascending ramus, which showed perforation in the anterior border of ascending ramus. Histopathological examination of the excisional biopsy specimen showed lesional tissue that consisted of a cystic cavity lined by odontogenic epithelium and connective tissue capsule. The epithelium showed cuboidal or columnar basal cells with hyperchromatic nuclei, nuclear palisading with polarization, cytoplasmic vacuolization with intercellular spacing, and subepithelial hyalinization and superficial layer showing stellate reticulum-like cells. There was also proliferation of these cells in cystic lumen in a plexiform pattern. The cells are arranged in interconnecting strands and cords with peripheral palisaded layer and central stellate reticulum-like cells (Figure 9). Tissue material resembling an odontogenic keratocyst lining was not observed, even with serial sections of tissue. So possibility of ameloblastic transformation of odontogenic keratocyst was also excluded.\\nAccording to the classification suggested by Ackermann et al., it was classified as unicystic ameloblastoma subgroup 1.2 which is also known as plexiform unicystic ameloblastoma.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 22,\n",
       "    'case_id': 'PMC8233070_01',\n",
       "    'case_text': 'A 22-year-old male was brought to the emergency department (ED) for cough and progressive shortness of breath for the last six days. His past medical history is unremarkable except for daily vaping. A week ago he also tested positive for influenza B when he had chills, fatigue, and sore throat. He did not take oseltamivir due to a late prescription from his primary care physician. He had low-grade fever with nausea and vomiting with fierce cough four days before presentation to ED. He also felt crepitus in the neck. He did not have any prior chest surgical history or any history of illicit drug abuse. In the ED, his temperature was 99.1 degrees Fahrenheit, blood pressure of 150/95 mmHg, heart rate of 136 beats/min, and a saturation of 91% on 3 L nasal cannula (NC) oxygen. On physical examination, subcutaneous emphysema was noted in the anterior cervical region. Blood work showed leukocytosis of 18,000/mL and a procalcitonin level of 0.21 ng/mL. Chest X-ray (CXR) showed pneumomediastinum with subcutaneous emphysema extending into the cervical region with bilateral pneumonia (Figure 1).\\nChest computed tomography (CT) showed severe pneumomediastinum with subcutaneous emphysema and diffuse pneumonitis (Figure 2).\\nThe patient was admitted to the medical floor. He was treated with supplemental 3 L NC supplemental oxygen, and oseltamivir and antibiotics were discontinued. A gastrografin esophagogram was done, and esophageal rupture was ruled out. Repeat CXR two days later showed improvement of pneumomediastinum and subcutaneous emphysema (Figure 3). He was counseled extensively against vaping and was discharged home on room air.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 28,\n",
       "    'case_id': 'PMC3523579_01',\n",
       "    'case_text': \"A 28-year-old nonsmoking male was referred for diagnostic evaluation of recurrent mild haemoptysis associated with a right upper lobe solitary pulmonary nodule of 8 weeks duration. Chest radiograph revealed a 1.5 x 2 cm coin lesion in the posterior segment of the right upper lobe of the lung (Figure 1).\\nThe medical history was noncontributory. A computed tomographic (CT) scan of the chest confirmed the chest radiograph findings; a solid mass was noted in the posterior segment of the right upper lobe of the lung with an area of central lucency (Figure 2).\\nThere was no hilar lymphadenopathy. Sputum microscopy, culture, and cytological examination were noncontributory. The ESR was 14, the haemoglobin 14.6 g/dL, and the leukocyte count of 8.8 x 109/L. The other serum haematological and biochemical results were normal.\\nIn view of the patient's ongoing haemoptysis and lack of response to antibiotics he was subjected to an exploratory thoracotomy and wedge resection of the lesion in the right upper lobe. A solid mass in the posterior segment of the right upper lobe was noted and it was excised. No associated lymphadenopathy was noted. Frozen section of the mass revealed no evidence of carcinoma or tuberculosis. The patient developed a right upper lobe lung abscess postoperatively, and underwent a complete right upper lobe lobectomy.\\nMacroscopically, a well-circumscribed tan-coloured nodule measuring 35 x 15 mm was present. The cut surfaces of the tumour revealed a haemorrhagic necrotic centre. Microscopically, the mass consisted of a heavy inflammatory cell infiltrate composed predominantly of lymphocytes, with plasma cells and histiocytes. Foamy histiocytes with macrophages were also seen, as well as occasional eosinophils and neutrophils. Focal areas of micro-abscess formation with necrosis were also noted. A marked degree of fibrosis of the interstitial tissue was present with proliferating myofibroblasts. The histological characteristics were compatible with an inflammatory myofibroblastic pseudotumour (organising pneumonia-like type; Figure 3).\\nThe postoperative course was uneventful, the patient was discharged from the hospital one week later, and three years after surgical resection the patient remains well and free of disease.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 77,\n",
       "    'case_id': 'PMC6122280_01',\n",
       "    'case_text': \"A 77-year-old male patient presented with low back pain alone for 3 years duration. He had a history of prostate cancer, skin melanoma, and an MRI-incompatible DDI pacemaker implanted for sick sinus syndrome.\\nThe enhanced lumbar computed tomography (CT) showed an inhomogeneously enhancing intramedullary mass, located at the L3 level, measuring approximately 1.3 x 1 x 1 cm [Figure 1a].\\nSurgical resection required an L3 hemilaminectomy; the lesion was fully excised. Macroscopically, the tumor was mulberry-shaped, purplish in color, and well demarcated, but tightly adhered to a nerve root of the cauda equina [Figure 2]. Intraoperative monitoring (e.g. somatosensory and motor evoked potentials) indicated that the involved nerve root innervated the anal sphincter and adduction of the toe. Nevertheless, the root had to be sacrificed as it was enveloped by tumor. The histologic examination documented dilated vessels lined by endothelial cells without atypia. Of interest, in the periphery of the mass, neurons of the peripheral nervous system were seen [Figure 3].\\nImmunohistochemical examination of the specimen demonstrated that the endothelial lining was composed of a rich network of cavernous vessels (CD34 - Figure 3b, CD31 - Figure 3c, ERG - Figure 3d). The tissue stained negative for prostate cancer (PSA, PSAP), melanoma (HMB-45, S-100), lymphoma (D2-40), meningioma (EMA, progesterone receptors), and Kaposi's sarcoma (HHV-8) markers; it also demonstrated a low mitotic index (Ki-67 2-3%, Figure 3e). Rather, findings were consistent with a cavernous hemangioma.\\nPostoperatively, the patient's immediate and 6-month postoperative CT scans documented complete removal of the tumor, and he remained neurologically intact [Figure 1b].\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 55,\n",
       "    'case_id': 'PMC4533487_01',\n",
       "    'case_text': \"A 55-year-old man had an 8-year history of invasive thymoma. He had undergone resection of a mediastinal tumor via thoracoscopy and irradiation of 40 Gy total to the mediastinal region 8 years before. Thereafter, pleural disseminations and multiple bone metastases, including to the spine, rib, and pelvis, had developed 4 years and 6 months before, respectively. The patient had received multiple debulking surgeries with chemo-radiotherapy. The pathological diagnosis was type B3 invasive thymoma (non-cancerous).\\nSix months after bone metastases was detected, he presented with sudden onset of left hemiparesis. His Glasgow Coma Scale score was 15 and neurological examination revealed severe left hemiparesis. Computed tomography (CT) showed right frontal lobe intracerebral hemorrhage (Fig. 1). Contrast-enhanced magnetic resonance (MR) imaging showed an unremarkable enhanced intraaxial mass with slight perifocal edema appearing to be acute hematoma, but the possibility of hemorrhagic metastasis could not be rejected (Fig. 2). Digital subtraction angiography showed no tumor stain. The patient underwent removal of the hematoma. Small corticotomy was performed at the premotor area and hematoma located in the motor cortex was observed. Histological examination showed brain metastasis from invasive thymoma. Pathological findings revealed a small quantity of epithelioid cells inside the hematoma (Fig. 3A). There were no tumor cells in the perifocal damaged brain. Immunohistochemical studies showed that these cells were positive for keratin (Fig. 3B) and negative for CD5 and CD117 (not shown), which were useful for differential diagnosis of thymoma or thymic carcinoma. These features were compatible with metastases from type B3 thymoma.\\nThe patient's postoperative course was uneventful. Postoperative MR imaging showed no residual tumor and no other metastases. His hemiparesis improved and he was able to walk aided by a walker. His systemic metastases progressed slowly and became resistant to therapy. He underwent palliative care and was transferred to a rehabilitation hospital.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 30,\n",
       "    'case_id': 'PMC6195931_01',\n",
       "    'case_text': 'A 30-year-old primigravida with no significant past history of medical, surgical or endovascular interventions, presented at 34 weeks of gestation with a history of waking up with sudden onset of stabbing abdominal pain that was not suggestive of labour pain, vomiting and feeling faint. The patient reported that she could not perceive any foetal movements, but denied any history of recent trauma or per vaginal bleeding. She was hypotensive (blood pressure 70/40 mmHg) with a normal heart rate and was immediately fluid resuscitated.\\nOn examination, the patient had a diffusely tender abdomen with cold, clammy peripheries. The obstetric assessment showed no signs of labour, closed cervix and absent foetal heart sounds. An artificial rupture of membranes was performed that showed clear liquid. Bedside obstetric ultrasound performed in the emergency room confirmed the absence of foetal heart activity and movements. A provisional diagnosis of placental abruption with foetal demise was made. The stillborn baby and placenta were delivered vaginally 6 h later.\\nA few hours postpartum, the patient complained of severe abdominal pain similar to the pain earlier in the day. The patient was noted to become hypotensive and tachycardic, with generalized abdominal distension and tenderness. Full blood count analysis revealed a significant drop in haemoglobin and platelets but normal coagulation profile.\\nThe patient was transferred to the high dependency care unit and was transfused three units of packed red cells and two units of platelets. Bedside ultrasound was performed that showed free fluid around the liver. Spontaneous rupture of the liver was suspected and a non-contrast CT scan of the abdomen was performed that showed haemorrhagic fluid around the liver, which was intact. Clinically, the patient continued to show signs of bleeding over the next few hours, with low haemoglobin levels on repeat analysis despite the transfusion. However, she remained haemodynamically stable with mild tachycardia.\\nThe obstetric team sought the advice of the on-call interventional radiologist to explore the possibility of embolization in view of the suspected diagnosis of ruptured liver. A CT angiogram of the abdomen and pelvis was advised as the initial investigation to localize the bleeding site, as the patient remained clinically stable. This revealed a focal dilatation of the ascending segment of the right uterine artery measuring 6 mm, suggestive of a pseudoaneurysm and extensive haemoperitoneum within the abdomen and pelvis (Figures 1 and 2). Following discussion between the gynaecologists and the interventional radiologist, the patient was transferred immediately within the next hour to the interventional suite. A pelvic angiogram was performed followed by selective bilateral uterine arteriograms. A right uterine artery pseudoaneurysm was demonstrated on the right iliac angiogram (Figure 3) corresponding to the CT angiogram findings with no active bleeding. A selective right uterine artery angiogram demonstrated active contrast extravasation, which was probably owing to the disruption of the clot surrounding the pseudoaneurysm due to the pressure from the contrast injection directly into the mid-uterine artery as opposed to the non-selective earlier angiograms (Figure 4). Immediate embolization of the uterine artery proximal to the pseudoaneurysm was performed using fibred platinum coils (035\" 5 mm x 4.5 mm VortX  35, Boston Scientific Corporation, Hemel Hempstead, UK). The final angiogram showed no evidence of the previously demonstrated pseudoaneurysm or bleeding and stasis of flow in the right uterine artery (Figure 5). Subsequently, the patient remained haemodynamically stable and asymptomatic with no evidence of further bleeding and was transferred back to the maternity unit for grievance counselling. Histology of the placenta confirmed an intact placenta with no evidence of abruption and findings compatible with foetal demise within 24 h prior to delivery. The patient remained asymptomatic and well at 3-month outpatient follow-up.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': None,\n",
       "    'case_id': 'PMC5514622_01',\n",
       "    'case_text': 'Three patients (two females & one male) with ages ranging from 12 to 50 years were treated for SAVMs in our institution which is a tertiary care, state run teaching institute. All patients presented with pulsatile mass over scalp with associated headache. Preoperative angiography (internal and external carotid) was performed in all patients to determine the feeding vessels and anatomical extent of lesion (Fig. 1). None of the patients had an intracranial extension of pathology. Patient details are enumerated in Table 1.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 83,\n",
       "    'case_id': 'PMC2719756_01',\n",
       "    'case_text': 'A 83-year-old woman presented to the emergency room with a 3-weeks history of watery diarrhoea up to 5 times a day, dehydration, and a weight loss of 4 kg. No significant changes of the inflammatory parameters were found. The patient had a history of presacral immunocytoma treated by radiotherapy and chemotherapy. A plain radiograph and ultrasound of the abdomen at the emergency were unremarkable. The preliminary diagnosis was radio-enteritis. After 10 days of hospital the patient developed fever and an acute onset of abdominal pain. Computer tomography of the abdomen revealed 3 inflammatory mesenteric masses containing few air bubbles involving several jejunal loops and the colon transversum. Some contrast-filled and air-filled diverticula were present in the jejunum adjacent to the inflammatory mass, and the diagnosis of jejunal diverticulitis was suggested (Figure 1). At surgery a perforated jejunal diverticulum with associated abscess was found, and resection with end-to-end anastomosis was performed.',\n",
       "    'gender': 'Female'},\n",
       "   {'age': 73,\n",
       "    'case_id': 'PMC2719756_02',\n",
       "    'case_text': 'A 73-year-old woman presented with a 3-day history of left lower quadrant pain. Physical examination revealed left lower quadrant tenderness with rebound pain. There was a weight loss of 10 kg over 5 months. A plain radiograph was nonspecific with a few air-fluid levels. Computer tomography of the abdomen revealed multiple jejunal diverticula, surrounding inflammatory changes in the mesenteric fat adjacent to several jejunal loops with symmetric wall thickening. There were some minimal signs of pneumoperitoneum and some free intra-abdominal fluid (Figure 2). The diagnosis of jejunal diverticulitis with contained perforation was made. At surgery a resection of the involved area with primary jejunojejunal anastomosis and drainage of the abscess was performed.',\n",
       "    'gender': 'Female'},\n",
       "   {'age': 74,\n",
       "    'case_id': 'PMC2719756_03',\n",
       "    'case_text': 'A 74-year-old man presented to the emergency room with an acute onset of epigastric and periumbilical pain, described as being a continous pain more severe at the left side with rebound tenderness. His temperature was 39.3 C. There was no vomiting nor nausea. The patient had a history of stomach ulcer, appendectomy, and a cholecystectomy. A plain radiograph was nonspecific with a few air-fluid levels. The CT of the abdomen revealed the diagnosis of jejunal diverticulitis with limited signs of perforation (Figure 3(a)). The patient was treated with bowel rest and broad spectrum IV antibiotics. A barium study after three weeks revealed several jejunal diverticula without signs of stenosis or fistulisation (Figure 3(b)).',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': None,\n",
       "    'case_id': 'PMC9377306_01',\n",
       "    'case_text': 'A male newborn patient, third child. Intrauterine diagnosis of hypoplastic left heart syndrome, having undergone prenatal care with an obstetrician specialized in fetal medicine and congenital malformations and with a pediatric cardiologist. During the monthly prenatal consultations, the possibilities of surgical treatment, risks of complications, and statistical data regarding prognosis and death were discussed. The parents centralized the decisions although they had family support, and together with the prenatal team, they took into consideration the risks and benefits of each surgical technique. They opted for a hybrid procedure (stent implantation in the arterial canal topography and selective banding of the pulmonary arteries), but were against extracorporeal membrane oxygenation (ECMO), due to the associated risk of neurological sequelae.\\nHe was born by vaginal delivery, at 38 6/7 weeks gestational age, weight 3,380g, Apgar score 8/9, and no intercurrent events. He was placed in skin-to-skin contact with his mother and had a late umbilical cord clamping. Accompanied by the father, he was examined, warmed up, maintaining oxygen saturation (SatO2) 85% at room air.\\nAn immediate echocardiogram confirmed hypoplastic left heart syndrome with mitral stenosis and aortic atresia with restrictive atrial septal defect (ASD). A balloon catheter atrioseptostomy was indicated, with an increase of the ASD from 1.5mm to 5mm, and reduction of the trans-septal gradient from 29mmHg to 4mmHg.\\nIn the NICU, he remained on invasive mechanical ventilation (IMV), analgesia, continuous prostaglandin infusion, and maintenance saline. Continuous adrenaline was introduced as a vasoactive drug after umbilical catheterization, with adequate volemia, and metabolic disorders were corrected. It was necessary to adjust the inspired oxygen fraction (FiO2) below the physiological value (21%) to improve the systemic and pulmonary flow (Qp/Qs) ratio. To this end, nitrogen was added to the mixture of ventilatory gases, obtaining FiO2 of 19%, with improvement of coronary perfusion and systemic output.',\n",
       "    'gender': 'Male'},\n",
       "   {'age': None,\n",
       "    'case_id': 'PMC9377306_02',\n",
       "    'case_text': \"The parents had free access to the newborn, the mother was encouraged to carry the baby, according to the NICU routine. Knowing about the early surgical schedule, the multiprofessional team also focused on parental care. Constant contact between parents and the newborn was promoted, psychological parental support was provided, and continuous dialogue was maintained regarding doubts and feelings experienced by the parents. The mother was encouraged to attend the milk bank, so that breastfeeding would be preponderant as soon as possible, always aware of the seriousness of the situation and of the newborn's prognosis. All along, the decisions about type of treatment were centered on the parents, with all risks being clarified by the attending physician. After parental consent and clarification of all doubts, the parents' decision was respected considering their autonomy aiming at ethics and patient safety.\\nA hybrid procedure was performed on the second day of life, which included selective banding of the pulmonary arteries via sternotomy and stenting of the arterial canal in the cath lab; invasive blood pressure monitoring; placement of a central venous catheter; and allocation of a mediastinal drain, and pacemaker wires.\\nHe returned to the NICU on adrenaline and IMV, requiring volume and metabolic adjustment and transfusion of blood products. Two hours later, he presented sudden instability with cardiac arrest.\\nNeonatal resuscitation was initiated, with chest compressions, manual ventilation, use of standard doses of vasoactive drugs, and volume expansion. The echocardiogram showed severe dysfunction, no pericardial effusion, and radiography ruled out air leak syndrome. The probable diagnosis considered was acute myocardial infarction, considering the anatomy of the congenital heart disease and physiology after the surgical procedure. Starting on ECMO was considered, but the previous parental resolution regarding the non-use of this method of hemodynamic support was respected.\\nThe mother was summoned to the NICU and arrived during the resuscitation process, which lasted approximately 40 minutes with no response, and death was confirmed. Upon being informed about the clinical progression, with prolonged resuscitation and no effective response, the mother immediately agreed to interrupting the procedures and requested to remove the newborn from the incubator. The mother physically distanced herself from the healthcare professionals, remained with her son on her lap, and tried to remove all invasive devices from her son (catheters, drains, accesses, and probes).\",\n",
       "    'gender': 'Female'},\n",
       "   {'age': None,\n",
       "    'case_id': 'PMC9377306_03',\n",
       "    'case_text': \"Slowly, the nursing staff explained to the mother, in her native language, the need and importance of assisting her in this process. Respecting the organizational protocols, the trained professionals removed the patient's devices, following the good practices and safety standards for the patient, the family member, and the health professionals. Thus, the nursing and medical staff, with the active participation of the mother, removed the devices, one by one. The mother was welcomed, held the newborn in her arms, and received the comfort of the team's words in her language of understanding. On her lap, the newborn remained for about 90 minutes, when the mother then requested the opportunity to change the newborn's diaper. Faced with such a simple request, which resulted in the diaper changed by the mother, the multiprofessional team could see the great significance of such apparently small attitudes. There were several benefits brought by this practice, among them answering a last request from a grieving mother, humanizing the moment of death, and bringing a new look to issues that are so difficult to be addressed - since this practice was innovative in the NICU.\\nBecause family and religion are two entities that can help in the grieving process, the parents were offered the possibility of the team contacting other family members, but the parents chose to conduct the communication with the grandparents. Regarding the possibility of counseling or religious ceremony, the parents refused such support.( )\\nFollowing the protocol of the event, the newborn would be transferred to the morgue, where it would remain until transportation for the wake and burial. However, knowing that culturally, in her country of origin, the mother would take her newborn to be mourned at home and only then be sent to the cemetery, the team understood the mother's request to keep her son wrapped in her scarf and in her arms until the removal to the wake, allowing the newborn and mother to be safe and accompanied until the moment of transfer - which is hospital standard - and enabling the mother's aspiration to remain with her son as long as desired.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': None,\n",
       "    'case_id': 'PMC4821441_01',\n",
       "    'case_text': \"A man in his 40s born in Aomori prefecture, Japan, had been feeling mild malaise. He was first found to have thyroid dysfunction at another hospital 17 months before admission and was referred to our hospital for investigation of the cause of thyroid dysfunction. On admission, his body temperature was 36.8 C, blood pressure was 136/78 mmHg, and heart rate was 82 bpm. Physical examination revealed no exophthalmos, finger tremors, skin wetness, or goiter. After the diagnosis of FDH, the patient's mother was also found to have FDH.\\nSerum TSH, FT4, FT3, total thyroxine (TT4), and total triiodothyronine (TT3) levels were measured using automated immunoassay systems (Architect from Abbott Diagnostics, Elecsys  from Roche Diagnostics, or Lumipulse  from Fujirebio). Laboratory data on admission revealed SITSH (Table 1). Negative results were obtained for TSH receptor antibody, thyroid-stimulating antibody, antithyroglobulin antibody, and antithyroid peroxidase antibody. The three-hour thyroid I-123 uptake value was 6.2%, which was within the normal range. Ultrasonography of the thyroid gland revealed no tumor, and blood flow and thyroid size were both normal. Magnetic resonance imaging of the pituitary gland revealed no tumor (Fig. 1). Based on these investigations, we considered that SITSH might be due to RTH, but ruled out TSH-secreting pituitary tumor. Then, a genomic DNA sample was obtained for clinical diagnosis, after receiving informed consent. However, genomic DNA sequencing of exons 4-10 of the thyroid hormone receptor beta (TRbeta) gene showed no mutation. Therefore, we investigated the possibility of albumin gene mutations. Direct genomic sequencing of exon 7 of the albumin gene revealed a substitution of cytosine (C) for guanine (G) in the second nucleotide of codon 218 in one of the two alleles, leading to the replacement of arginine by proline (Fig. 2). Therefore, we diagnosed FDH caused by R218P heterozygous point mutation.\",\n",
       "    'gender': 'Male'},\n",
       "   {'age': None,\n",
       "    'case_id': 'PMC4821441_02',\n",
       "    'case_text': 'Since the diagnosis of FDH, the patient has been followed up without pharmacotherapy. The symptom of malaise disappeared spontaneously over time, but serum thyroid function tests remained unchanged. The symptom of malaise was therefore considered unrelated to thyroid hormone levels. Thyroid hormone data from admission to 18 months after admission are shown in Table 2. Serum TT4 concentration was markedly increased, but serum TT3 concentration was only slightly elevated. We evaluated the effect of a polyethylene glycol (PEG) precipitation test in the serum of FDH patients as previously reported. The results of PEG precipitation testing in FDH patients and healthy controls were almost the same (Table 3). Therefore, the possible effect of anti-triiodothyronine antibody or anti-thyroxine antibody was denied, but the PEG precipitation test was not able to reveal the exact value of FT4 in the serum of FDH patients. Thyroid hormone levels measured by Architect, Elecsys , and Lumipulse  systems 21 months after admission are shown in Table 4. Thyroid hormone levels measured by Architect and Elecsys  showed similar results and suggested SITSH-like laboratory findings, but those measured by Lumipulse  showed almost normal ranges of FT4 and FT3 levels.',\n",
       "    'gender': 'Unknown'}],\n",
       "  [{'age': 9,\n",
       "    'case_id': 'PMC5360453_01',\n",
       "    'case_text': 'The index patient was a 9-year-old boy (Figure 2, II-3), corrected for myopia since 3 years of age, who always had difficulty watching television and reading. He never complained of night blindness, peripheral vision loss, and dyschromatopsia, but he had moderate photophobia and wore photochromic glasses. The disease course seemed not progressive. Visual acuity was 20/30 in both eyes with -1.75(-2.25)40  oculus dexter (OD) and -6.25(-1.50)5  oculus sinister (OS). The anterior segments were normal, and the lenses were transparent. The fundus showed a moderate overall depigmentation, absence of the foveal reflex with a slight narrowing of the retinal vessels, and moderate pallor of the optic disc but no atrophy or pigment deposits, which was also confirmed with infrared reflectance images (Figure 3A,B). The retinal autofluorescence images were almost normal except a moderate perifoveal hyperautofluorescence (Figure 3C). Optical coherence tomography (OCT) showed a normal peripheral retina, but we noted bilaterally moderate macular thinning with the ellipsoid zone moderately decreased in the thickness in the temporal part of the fovea (Figure 3D). Color vision testing with Lanthony D-15 HUE color tests showed a bilateral moderate blue-yellow axis of color confusion (not shown). In mixed kinetic and static perimetry, the peripheral isopter IIIc was normal on each side, 90  in temporal and 45  in nasal, but there was a medium decrease in the retinal sensitivity of the central 30 , including in the macular area (Figure 3E). On the ISCEV ERG, the amplitude of the scotopic responses was normal (Figure 3F). However, the photopic responses to a single flash were reduced and showed a moderate electronegative aspect. The 30 Hz flicker responses were reduced to about 30% of the normal value. In the oscillatory potentials (OP), OP1 was absent; in the others, OPs were present but diminished in amplitude (not shown). Due to the reduced photopic responses, the decreased visual acuity, presence of myopia, no obvious disease progression, and absence of night blindness, it was concluded that the patient had an atypical type of icCSNB. Although the name incomplete CSNB is misleading, patients with this disease often reveal the absence of night blindness. Two older sisters had no particular visual difficulties. His parents, both unaffected, were second cousins of Swiss origin. There was no history of this disease in the family. Therefore, the patient was an isolated case, which, given the parental consanguinity, suggested an autosomal recessive mode of inheritance. X-linked heredity could not be excluded, but as the mother had five unaffected brothers, this mode of inheritance was not supported.\\nMutation screening showed that none of the known genes underlying icCSNB and the other CSNB candidate genes presented any disease-causing variant. Therefore, WES was performed for the trio, and sequence filtration isolated 15 putative variants (Appendix 1) from 194 insertions/deletions (InDels) and 1,597 single nucleotide variants (SNVs), as the splice-site mutation in intron 3 of the TTLL5 gene, c.182-3_182-1delinsAA (Appendix 2) selected for further cosegregation studies. For all subjects, the overall sequencing coverage of the captured regions was 92% and 88% for 10X and 25X depth of coverage, respectively, resulting in a mean sequencing depth of 109X per base (Appendix 3). Both unaffected parents were found to be heterozygous for this variant, at 40% and 48% in the mother and father, respectively, and the proband was homozygous for this variant, at 99%. The sequencing depth at this position was 132X and 124X in the mother and father, respectively, and 141X for the proband (Appendix 2). This c.182-3_182-1delinsAA mutation in TTLL5 was validated in the index patient and the unaffected parents with direct Sanger sequencing (Figure 2).',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': None,\n",
       "    'case_id': 'PMC10414553_01',\n",
       "    'case_text': 'The clinical aspects of the analysed case of inflammatory active paraganglioma with associated AA amyloidosis has already been published elsewhere. For a better understanding, we briefly summarize the case study and include additional in-depth details on organ response pattern: A glomus tumour close to the bifurcation of the carotid artery was surgically removed in 1990. Seven years later, metastases were detected for the first time. Since then, ongoing treatment with octreotide resulted in stable disease. An acute phase reaction since at least 1995 was finally interpreted as paraganglioma-associated, but octreotide showed no effect on tumour associated inflammation. As long-term complication of the ongoing inflammation the patient developed rapid progressive systemic AA amyloidosis with multi-organ involvement including cardiac and renal, hepatic, gastrointestinal, spleen and thyroid gland involvement within less than one year according (Fig 1).',\n",
       "    'gender': 'Unknown'}],\n",
       "  [{'age': 26,\n",
       "    'case_id': 'PMC5366803_01',\n",
       "    'case_text': \"A 26-year-old man came to the emergency room in our tertiary eye hospital 1 day after his right eye was hit by a nail while hammering. The patient was referred from a district hospital with an IOFB in the right eye. He received an injection of anti-tetanus serum at initial admission. \\nThe general examination was within normal limits. An ophthalmological examination was conducted; best corrected visual acuity (VA) was 6/5 in each eye, ocular motility was full in all directions, and digital intraocular pressures were normal for both eyes. The anterior segment of the right eye showed a hyperemic conjunctiva with a nail lodged at the temporal limbus (Figure 1 (Fig. 1)). Corneal edema was present, but other anterior segment findings were normal (round pupil, no synechiae or lens opacities, and anterior chamber formed with no flare or cells). The anterior segment of the left eye was within normal limits. Fundoscopic examination of the right eye revealed clear media with a visible foreign body (nail) in the vitreous, a round and sharp border of the optic disc, a flat retina, and good foveal reflex. The posterior segment of the left eye was within normal limits. \\nThe patient was diagnosed with an IOFB in the right eye. His treatment plan included intravenous cefotaxime injection (1 g) twice daily and hourly ofloxacin eye drop for the right eye in addition to being scheduled for IOFB extraction and intravitreal antibiotic (IVAB) injection. \\nUltrasonography examination showed an IOFB located in the limbus/pars plana that had penetrated into the vitreous cavity and posterior segment inflammation (Figure 2 (Fig. 2)).\\nThe surgery was performed 6 hours after administered. The nail was lodged at the limbus (9 o'clock) and had penetrated into the vitreous cavity, contacting the edge of the lens. It was removed with forceps, and measured 9 mm in length. Anterior vitrectomy and vitreous tap were then performed around the wound and the vitreous contents were subjected to Gram staining and culture. The wound was sutured, and vancomycin (1 mg) and amikacin (0.2 mg) were injected intravitreally. The patient was also given oral paracetamol (500 mg) three times daily and prednisolone acetate eye drops six times daily for the right eye. \\nOn the first postoperative day, the uncorrected VA for the right eye was count fingers. Anterior segment examination showed a closed wound and two in-place sutures at the temporal limbus (Figure 3 (Fig. 3)). Corneal edema, a hyperemic conjunctiva, subconjunctival bleeding, and a moderate depth anterior chamber with inflammation were noted. As before, the pupil was round and no synechiae or lens opacities were observed. The posterior segment examination revealed clear media, a normal optic disc, a flat retina, and macular edema with decreased foveal reflex. Gram stain of the vitreous tap revealed the presence of Gram-positive cocci, while the KOH stain was negative. The previous therapies were continued with the addition of 48 mg of methyl prednisolone orally once a day. \\nAngiographic examination of the right eye revealed hypofluorescence in the arteriovenous phase due to a vascular filling defect at the macula. Angiographic examination of the left eye was within normal limits. Based on the angiogram results, we diagnosed macular ischemia of the right eye (Figure 4 (Fig. 4)).\\nOptical coherence tomography (OCT) examination of the right eye revealed increased retinal thickness with reduced intraretinal reflectivity, although the signal strength was ambiguous. OCT examination of the left eye was within normal limits (Figure 5 (Fig. 5)).\\nThree days after surgery, the uncorrected VA of the right eye was still count fingers, although there was a decrease in subconjunctival bleeding, corneal edema, and anterior chamber inflammation. The posterior segment examination continued to show macular edema. Previous therapies were continued with the addition of oral ciprofloxacin (750 mg) twice daily. The patient was discharged from the hospital with a review scheduled 1 week later.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 33,\n",
       "    'case_id': 'PMC9922378_01',\n",
       "    'case_text': 'A 33-year-old woman presented to our orthopedic clinic with a five-year history of right shoulder pain. The pain was localized to the right shoulder without any weakness, numbness, or associated neck pain. The pain was worse after any activity involving the use of the right shoulder. The patient also reported that the pain occurred at night and disturbed her sleep. She recalled an injury during a scuba diving session five years earlier when she dove into the sea in an awkward position, hitting the water with her right shoulder. The pain began at this point, but it was not severe enough for her to seek medical attention. The pain was affecting her more frequently and with worsening intensity in the year and a half prior to coming to our orthopedic clinic.\\nOn physical examination, no obvious deformity, swelling, or erythema of the shoulder was observed. Active forward flexion of the right shoulder was from 0  to 130  and abduction was from 0  to 150 . The range of movement was limited because of pain and not weakness. All special tests for the shoulder yielded negative results.\\nA plain radiograph did not show any abnormalities, and MRI was subsequently ordered. MRI showed a subchondral bone cyst at the glenoid fossa (Figure 1). Preoperatively, a supplementary CT scan was also obtained (Figure 2).\\nDiagnostic arthroscopy of the left shoulder was done through surgical exploration. The patient was placed in a beach chair position under general anesthesia. The surgery started with a diagnostic scope of her right shoulder. The diagnostic arthroscopy revealed a loose body measuring about 1.0 cm x 1.0 cm, which was identified as a piece of cartilage detached from the defect area (Figure 3), and a defect over the glenoid fossa at the lower anterior quadrant measuring 1.0 cm x 1.0 cm (Figure 4). The surgery was then converted to open surgery using the deltopectoral approach, and the cyst was curetted (Figure 5) and packed with an autologous bone graft (Figure 6) harvested from the left iliac crest. Postoperatively, the patient wore a slingshot shoulder brace and had complete immobilization of the right shoulder for two weeks. After two weeks, she was instructed to do a one-plane range of movement over the shoulder, which involved forward flexion and extension. Six weeks postoperatively, the patient was instructed to start doing full range of motion of the right shoulder. Immediately post-surgery, the patient reported that she did not have any resting pain or night pain.\\nHistopathology examination of the tissue sample revealed a combination of benign tissue composed of bone, cartilage, and fibrous tissue.\\nThe patient was followed up regularly in our clinic postoperatively, and she has not experienced any pain since the surgery. She has a full range of movement for the shoulder after completing physiotherapy. An MRI of the shoulder was repeated six months postoperatively and showed that a callus had formed at the location of the cyst (Figure 7).',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 65,\n",
       "    'case_id': 'PMC8077721_01',\n",
       "    'case_text': 'A 65-year-old female, known case of hypertension, who had been diagnosed and treated as COVID-19 infection two months ago presented to the rheumatology outpatient clinic with complaints of pain in both hands, including the small joints of hands, for the last one month. The pain was intermittent and was more marked in the morning upon waking up. She used nonsteroidal anti-inflammatory drugs (NSAIDs) for this which provided her temporary relief.\\nGrade 2 synovitis in bilateral metacarpophalangeal (MCP) joints 2 and 5 and Grade 1 synovitis in bilateral PIP joints 2 to 4\\nGrade 2 synovitis in both wrists\\nPower Doppler negative\\nNo bony erosions seen\\nOn examination, there was tenderness present bilaterally in her proximal interphalangeal (PIP) and wrist joints. Upon investigations, her RA factor and anti-CCP were negative. Before this, she has never had an episode of similar joint pain. She was advised musculoskeletal ultrasound, findings of which are as follows (Figures 1 and 2 ):',\n",
       "    'gender': 'Female'},\n",
       "   {'age': 35,\n",
       "    'case_id': 'PMC8077721_02',\n",
       "    'case_text': 'A 35-year-old male, healthcare worker with no prior known comorbid, presented to the rheumatology clinic with complaints of pain in multiple joints for the last 2 weeks. Six weeks earlier, the patient was diagnosed with COVID-19 infection after he had contracted exposure with an affected individual.\\nGrade 2 synovitis in bilateral MCP joints\\nGrade 1 synovitis in bilateral PIP joints 2 to 5\\nGrade 2 synovitis in both wrists\\nBilateral ankle Grade 2 synovitis\\nGrade 2 synovitis in bilateral metatarsophalangeal (MTP) joints 2 and 5\\nPower Doppler negative\\nNo bony erosions seen\\nOn examination, he had pain and tenderness in his wrist and MCP joints bilaterally. There was evidence of active inflammation (warmth, tenderness, and swelling) in both his ankle joints. His RA factor and anti-CCP turned out to be negative. Results provided by musculoskeletal ultrasound are as follows (Figures 3 and 4 ):\\nGrade 1 synovitis in bilateral MCP joints 2 to 5 and Grade 1 synovitis in bilateral PIP joints 2 to 5\\nGrade 1 synovitis in both wrists\\nBilateral ankle Grade 2 synovitis and bilateral Achilles tendonitis\\nGrade 2 synovitis in bilateral MTP joints 2 and 5\\nPower Doppler negative\\nNo bony erosions seen',\n",
       "    'gender': 'Male'},\n",
       "   {'age': 25,\n",
       "    'case_id': 'PMC8077721_03',\n",
       "    'case_text': 'A 25-year-old female otherwise healthy, a doctor by profession, presented to the rheumatology outpatient clinic with complaints of generalized joint pains for the last 15 days, associated with morning stiffness of 40 minutes. According to the patient, she was diagnosed with COVID-19 infection 2 months back after a history of recent travel. Her pain temporarily subsided on potent analgesics. On examination, there were signs of inflammation (swelling, warmth, and tenderness) over her ankles and MTP joints bilaterally. There was also tenderness noted in her MCP and wrist joints bilaterally. Her RA factor and anti-CCP were negative. Musculoskeletal ultrasound findings are as follows (Figures 5-7 ):',\n",
       "    'gender': 'Female'},\n",
       "   {'age': 32,\n",
       "    'case_id': 'PMC8077721_04',\n",
       "    'case_text': 'A 32-year-old female with no known comorbid had suffered from COVID-19 infection 2.5 months ago. She presented to the rheumatology clinic with complaints of pain in small joints of her hands for the last 6 weeks which started 2 weeks after completely recovering from her disease process. Initially, the pain was intermittent but later became continuous, associated with morning stiffness of 20 minutes, due to which she was compelled to seek medical attention.\\nGrade 2 synovitis in bilateral MCP joint 2 and Grade 2 synovitis in bilateral PIP joints 2 to 5\\nGrade 2 synovitis in both wrists\\nPower Doppler negative\\nNo bony erosions seen\\nOn examination, there was tenderness and swelling in her PIP and wrist joints bilaterally. Her RA factor and anti-CCP were negative. Musculoskeletal ultrasound findings are as follows (Figures 8 and 9 ):',\n",
       "    'gender': 'Female'},\n",
       "   {'age': 40,\n",
       "    'case_id': 'PMC8077721_05',\n",
       "    'case_text': 'A 40-year-old male patient who is a known case of type II diabetes mellitus on oral hypoglycemic drugs had presented to the rheumatology outpatient department after recovering from COVID-19 infection which he had encountered 1.5 months ago. His chief complaint was a pain in both his wrist joints for the past 2 weeks, more severe in the morning.\\nGrade 2 synovitis in bilateral MCP joints 1-5\\nGrade 2 synovitis in both wrists\\nNo synovitis in any of the PIP joints\\nPower Doppler negative\\nNo bony erosions seen\\nOn examination, there was tenderness in a few of the MCP joints bilaterally, but the wrist joint in both hands was markedly tender and swollen. RA factor and anti-CCP turned out to be negative. Musculoskeletal ultrasound was consistent with the following findings (Figures 10 and 11 ):\\nAll of these 5 patients had remained clinically stable during their course of the primary disease with no event/episode of hypoxia (SPO2 > 95%). They were advised to self-quarantine and were treated by their primary healthcare physician.\\nBased on clinical examination and finding of the musculoskeletal ultrasound, these patients were diagnosed as seronegative post-COVID-19 inflammatory arthritis (polyarticular) which phenotypically resembled rheumatoid arthritis. Interestingly, the specific pattern observed in these patients was the involvement (synovitis) of small joints of hands and wrist joints bilaterally which was common in all five patients. This very much resembles the clinical presentation of rheumatoid arthritis. All patients were prescribed a common treatment plan. They were commenced on low-dose tapering corticosteroid (prednisone 10 mg/d) along with etoricoxib. Amongst disease-modifying antirheumatic drugs (DMARDs), leflunomide (20 mg/d) and hydroxychloroquine (400 mg/d in 2 divided doses) were commenced. Patients were advised to follow up after three weeks.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 55,\n",
       "    'case_id': 'PMC8013978_01',\n",
       "    'case_text': \"In April 2020, a 55-year-old female with a medical history of classical HL diagnosed on February 2011 was diagnosed with COVID-19. Patient's treatment history for HL included ABVD (doxorubicin, bleomycin, vinblastine, dacarbazine) at initial diagnosis (February 2011), IVE (ifosfamide, epirubicin, etoposide) as salvage chemotherapy for refractory disease (January 2012) followed by autologous hematopoietic stem cell transplantation (autoHCT) with BEAM (carmustine, etoposide, cytarabine, melphalan) as the conditioning regimen in September 2012. Nivolumab was administered for relapse after autoHCT (April 2016). She developed papillary thyroid cancer in January 2017 and was cured by thyroidectomy and radioactive iodine (RAI) treatment. As salvage chemotherapy, the patient also received brentuximab + bendamustine (February 2017) and GDP (gemcitabine, dexamethasone, cisplatin) (May 2017). Partial remission (PR) was achieved and in March 2018, alloHCT was performed from HLA-matched sibling donor with Fludarabine + melphelan as the conditioning regimen. The source of stem cells was peripheral blood and GVHD prophylaxis included cyclosporine combined with methotrexate. In August 2018, severe chronic graft-versus-host-disease (GVHD) with skin and liver involvement developed. Complete remission (CR) of chronic GVHD was achieved with steroid, cyclosporine, mycophenolate mofetil and methotrexate. In November 2018, she was diagnosed with EBV associated post-transplant lymphoproliferative disorder (EBV associated PTLD) and CR was obtained after eight doses of weekly rituximab. Intravenous immunoglobulin (IVIG) 400 mg/kg/day per 3 weeks was started for acquired hypogammaglobulinemia. In November 2019, the patient developed EBV viremia and was treated with rituximab, valganciclovir and foscarnet. In January 2020, relapse of HL was diagnosed with concurrent appearance of EBV viremia (EBV DNA load 34,694 copies/ml). Brentuximab 1.8 mg/kg and DLI (CD3:5 x 106/kg) every 3 weeks was initiated. He completed three cycles of brentuximab and DLI on March 2020. After three cycles, EBV DNA load decreased to 788 copies/ml and PR was obtained. In April 2020, she presented with shortness of breath and fever. She reported a five-day history of cough. On physical examination, she was pale, her body temperature was 38.3 C and she had hypoxia, with oxygen saturation as low as 88% on room air. Lung auscultation revealed fine bibasilar crackles. Chest computed tomography (CT) showed patchy peripheral bibasilar ground glass opacities in both lungs, findings compatible with severe COVID-19 pneumonia (Figure 1). Reverse transcriptase polymerase chain reaction (PCR) assay detected the presence of SARS-CoV-2 RNA in the nasopharyngeal swab. Favipravir, hydroxychloroquine, azithromycin and piperacillin/tazobactam were initiated. IVIG 400 mg/kg was administered. Her complete blood count (CBC) at admission showed the following: Hgb 10 g/dl, Htc 32%, total leukocyte count 4,320/mm3, neutrophil 520/mm3, lymphocyte 2,940/mm3 and platelet count 97,000/mm3. Prothrombin and activated partial thromboplastin time were normal. Serum ferritin level was 164 ug/L (23-336). Fibrinogen level was 548 mg/dl (normal range, 200 to 400) and D-Dimer was elevated (1.72 mug/ml; normal range, 0 to 0.5). Low-molecular-weight heparin (LMWH) was started. On biochemical tests, the following were abnormal: lactate dehydrogenase (LDH) 554 U/L (135-248), albumin 2.4 g/dl (3.4-4.5), pro-BNP 2,050 ng/L (70-133). ESR was elevated (48 mm/h; normal range, 2 to 20). C-reactive protein was elevated at 12.6 mg/L (normal range, 0-5) with normal procalcitonin level (0.13 ng/ml; normal range <0.5). During follow-up, she had worsening lymphopenia and her pro-BNP continued to increase. She was transferred to the ICU for respiratory failure and required invasive mechanical ventilation. Her chest X-ray revealed widespread bilateral alveolo-interstitial infiltrates (Figure 2). The patient succumbed to severe acute respiratory distress syndrome (ARDS) on the 6th day of admission to the ICU 10 days after initial admission to the hospital.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 0,\n",
       "    'case_id': 'PMC9555291_01',\n",
       "    'case_text': 'The SCA diagnosis was confirmed by HBB sequencing showing homozygosity for c.20A>T and negative HBB duplication/deletion analysis, ruling out hereditary persistence of fetal hemoglobin. He was started on penicillin V potassium prophylaxis at 1 month old. Due to concern that chronic anemia would adversely impact his cardiac function, and that any SCA vaso-occlusive complications such as acute chest syndrome or splenic sequestration in infancy would be poorly tolerated, chronic red blood cell transfusion therapy was chosen as his primary disease-modifying therapy. His first transfusion was administered at 2 months of age when Hb decreased to 8.4 g/dl. His transfusion therapy goal is to maintain Hb >9.5 g/dl to minimize the physiological stress of anemia. At 2 months of life, the patient was noticed to have new-onset left ventricular dilation in addition to cardiac hypertrophy (Figure 1C). Due to concerns for a decrease in left ventricular systolic function the patient was started on enalapril to prevent cardiac remodeling.',\n",
       "    'gender': 'Male'},\n",
       "   {'age': 0,\n",
       "    'case_id': 'PMC9555291_02',\n",
       "    'case_text': 'He has had 3 readmissions for respiratory decompensation due to viral infections: dual SARS-CoV-2 and respiratory syncytial virus infection at 3 months old (requiring high-flow nasal cannula), human metapneumovirus infection at 5 months old (requiring high-flow nasal cannula in the ICU setting) and rhino/enterovirus at 6 months old (requiring BiPAP in the ICU setting). At 7 months old, his outpatient ERT dosing was noted to having been based solely on birth weight, which resulted in a progressively decreasing ERT dose per kg body weight; on his most recently outpatient infusions this was ~13 mg/kg, and was corrected to 20 mg/kg. He was admitted subsequently at 7 months old due to respiratory failure with concern for an aspiration event requiring admission to the intensive care unit for non-invasive respiratory support. A repeat echocardiogram showed resolution of left ventricular hypertrophy with continuing dilation (Figure 1D). Evolution of systolic function and cardiac indices are presented in Figure 2. He has received a lifetime total of 10 pRBC transfusions at the time of this report, with a hemoglobin nadir of 7.7 g/dL. He remains gastrostomy-dependent. He continues to exhibit very low axial and appendicular muscle tone. He has required ~150-160 kcal/kg/day of enteral nutrition since birth for growth; non-etheless, he was at <1% (Z-score = -2.53, WHO Boys 0-2 years) for weight and <1% (Z-score = -3.57, WHO Boys 0-2 years) for weight-for-length at his most recent admission.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 9,\n",
       "    'case_id': 'PMC4879337_01',\n",
       "    'case_text': \"Patient 1: A 9-year-old girl had presented at the age of 3.5 years with fever, cutaneous vasculitis and myalgia. Biological analyses demonstrated inflammation on both C reactive protein (CRP) (100 mg/L) and erythrocyte sedimentation rate (ESR) (40 mm), elevated antinuclear antibodies (ANA 1/800), a transient lupus anticoagulant, low IgM and IgA level, mild CD19 B cells, CD8 T cells and natural killer (NK) lymphopenia. Nailfold capillaroscopy showed no vessels due to a severe vasculitis. Muscle testing was abnormal with a predominant proximal muscle weakness. The creatine kinase level was normal. Muscle MRI and positron emission tomography (PET) scan revealed inflammatory lesions of the limbs (figure 1A). Muscle biopsy identified focal necrotising angiitis compatible with periarteritis nodosa.\\nAt the age of 5 years, she had presented with two episodes of severe vertigo, vomiting and encephalopathy. Cerebral MRI was normal, but a cerebrospinal fluid (CSF) pleocytosis was identified (16 lymphocytes/mm3). Clinical symptoms and vertigo improved on 2 mg/kg of prednisone. Following steroid treatment withdrawal, a cutaneous vasculitis appeared, necessitating the introduction of cyclosporine. The patient then developed an ileitis and cyclosporine was switched to azathioprine.\\nAt the age of 7 years, a period of 2 months of persistent headache had been followed by an encephalopathy and, a few weeks later, despite the increase of steroids, by left internuclear ophthalmoplaegia. Cerebral MRI with diffusion was again reported as normal. Treatment was changed to cyclophosphamide, but the patient then developed ataxia with right body hemiparesis, left facial paresis and aphasia, 2 months later. MRI showed gadolinium-enhancing lesions with subtle abnormality diffusion sequences suggestive of a vascular stroke (figure 1B), which was later confirmed by their evolution into lacunar lesions a few months later (figure 1C). During follow-up, the patient developed moderate hypertension. Despite immunosuppressive therapy, her pyramidal syndrome worsened and systemic inflammation persisted. After switching to anti-tumour necrosis factor (anti-TNF) therapy (etanercept), the biological abnormalities resolved, with no further evidence of disease activity 1 year later. The recent MRI showed the occurrence of another asymptomatic lacunar lesion of the internal capsule (figure 1C).\\nPatient 2: The younger sister had been followed for uncharacterised microcytic anaemia since the age of 1 year, with a mild inflammatory syndrome of unknown origin. IgM and IgA levels were low, with mild CD19 B lymphopenia. ANA was positive (1/200). The patient had neither cutaneous, visceral nor muscle signs, nor fever. At the age of 3 years, she presented with a transient paralysis of the right extrinsic third cranial nerve, with persistent systemic inflammation. Cerebral MRI with diffusion sequences and CSF were normal. At the age of 5 years she presented again, with transient gait disturbance, unexplained fever and mild biological inflammation. A provisional diagnosis of viral vestibulitis was made. Cerebral MRI showed a 2 mm lacunar stroke of the internal capsule. CSF was again normal. Treatment with anti-TNF was started, associated with a rapid normalisation of the inflammation and no other symptoms over the following year.\\nCECR1 sequencing revealed a heterozygous c.1358A>G; p.Tyr453Cys mutation in both siblings (figure 2A). This variant is predicted to be pathogenic by in silico analysis, and has been described previously. Furthermore, real-time quantitative PCR revealed a heterozygous deletion of exon 7 (c.973-?_1081+?del; p.Val325Thrfs*7), predicted to lead to a frameshift and truncated protein in both children (figure 2B). Parental analysis (father's genotype: c.[973-?_1081+?del];[=]; mother's genotype: c.[1358A>G];[=]) confirmed that the sisters were compound heterozygous for these two lesions.\\nADA2 activity was measured on two occasions and was consistently reduced to 50% of wild-type levels in both children (figure 2C).\\nIFN and neutrophil signatures were evaluated in unstimulated patient cells from whole blood samples. The expression of a panel of IFN-stimulated genes was significantly elevated in both patients (figure 3A), though for the older sister the second sampling showed no elevation of IFN-stimulated genes.\\nNeutrophil-stimulated genes were not overexpressed (figure 3B). The expression of a panel of other cytokine transcripts was not significantly altered (see online supplementary figure S1).\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 37,\n",
       "    'case_id': 'PMC9551989_01',\n",
       "    'case_text': 'A 37-year-old male patient was referred to our center by his general practitioner who had incidentally found a 3.8-cm mass in the right adrenal area on computed tomography (CT) scan. The indication for a thoracic CT scan was suspicion of chronic pulmonary lesions or pulmonary embolism after a previous history of COVID-19 infection 3 months prior. Six months before the COVID-19 infection, the patient had complained of dizziness as well as chronic fatigue and profuse sweating with accentuation of symptomology over the summer of 2020 ( Figure 1 ).\\nThe patient had no history of hypertension and no previous complaints. In December 2020, he was diagnosed with COVID-19 after presenting with typical symptoms, such as persistent cough, as well as headaches, concentration difficulties, and severe fatigue. He also complained further of profuse sweating and general weakness on a daily basis. He denied any medication or drug intake. On the thoracic CT scan, a right inhomogeneous adrenal mass was identified. An abdominal MRI confirmed the right inhomogeneous mass, presenting no signal loss on out-of-phase imaging, findings that raised the suspicion of a catecholamine-producing tumor ( Figure 2 ). Biochemical diagnosis revealed a raised concentration of plasma normetanephrine, and the patient was referred to our endocrine clinic for further investigation.\\nClinical examination on referral to our center revealed a well-oriented, afebrile patient with normal body weight (BMI 25 kg/m2). His blood pressure was 118/74 mmHg with a pulse rate of 84/min. Cardiac examination revealed rapid but normal heart sounds with no murmurs. Abdominal examination was unremarkable.\\nA 24-h blood pressure monitoring revealed normal values (122/81 mmHg daytime and 118/75 mmHg over the night). Biochemical evaluation further documented normal renal and thyroid function with normal glycemia. Hepatic enzymes were increased 2-fold. There was no evidence of hypercortisolism (morning cortisol = 402 nmol/L, ACTH 4.3 pmol/L) or primary aldosteronism (aldosterone/renin ratio 39, N < 52). The plasma concentration of normetanephrine, at 731 pg/ml, showed a more than 5-fold increase above the age-specific upper cutoff for this metabolite, while metanephrine was 30 pg/ml (N < 84 pg/ml), clearly indicating a noradrenergic PCC.\\nPreoperative preparation with phenoxybenzamine was initiated followed by beta-adrenergic receptor blockade with bisoprolol. Right retroperitoneoscopic adrenalectomy was performed under general anesthesia. The patient showed an uncomplicated postoperative course and was referred to the surgical ward after 24 h of ICU monitoring. Blood pressure was stable and all antihypertensive treatment was terminated.\\nHistopathological examination confirmed the diagnosis of a 4.0 x 3.6 x 2.8 cm PCC, expressing synaptophysin and chromogranin, S100-positive cells, and SDHB positivity with a mitosis rate of 1/10 HPF/2.4 mm2 with the absence of atypical mitoses. The Pheochromocytoma of the Adrenal gland Scaled Score (PASS) was 0, indicating a very low risk of malignancy.\\nPostoperatively, the patient complained of right facial paresthesia as well as inguinal pain and hypoesthesia of the ventral side of the right limb and, to a less extent, on the left limb. Neurologic examination could not identify any deficits. Cerebral MRI excluded acute events such as hemorrhage or stroke ( Figure 3 ). Completeness of resection was confirmed by normalized results of plasma normetanephrine (84 pg/ml) at 1-month follow-up after surgery. Next-generation sequencing revealed no mutations in over 20 known tumor susceptibility genes, either at the somatic or germline level, including the most prominent genes such as SDHX, RET, and VHL. Postsurgical normalization of plasma normetanephrine, together with the absence of genetic mutation as well as a PASS of 0, led to no further suspicion of metastatic disease. The profuse sweating as well as the dizziness was resolved within the next 6 months after the right adrenalectomy, while the pain, hypoesthesia, and headaches remained. The patient still complained of fatigue, headaches, and loss of concentration within the next months after adrenalectomy but to a more reduced degree than previously experienced. Further neurologic examination showed again no abnormalities aside from hypoesthesia of the ventral side of the right lower limb. The lumbar MRI showed broad-based subligamentous disc protrusion L5-S1 and a slight compression of the sciatic nerve. The inguinal pain was more severe when walking, suggesting degenerative changes in the sacroiliac joint. In the pelvic MRI, there was evidence of a rheumatic inflammatory genesis with slight edema ventrocaudal at the sacroiliac joint.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 55,\n",
       "    'case_id': 'PMC6120592_01',\n",
       "    'case_text': 'A 55-year-old woman was admitted to the neurocritical care unit with a large left thalamic intracranial hemorrhage with intraventricular extension after found down by her husband. Her past medical history was significant for diabetes mellitus, hypertension, ovarian cancer, hysterectomy, and oophorectomy. On initial presentation she was afebrile, tachycardic, hypertensive (237/98), and neurological exam was positive for left gaze preferences, inability to follow commands, and lack of spontaneous movement of her right lower extremity. She was intubated secondary to obtundation and inability to protect her airways. Her neurological status began to stabilize within four days, but her ICU course was complicated by failed extubation trials.\\nAfter initially being intubated for a period of 10 days, she failed extubation and was reintubated twice due to stridor and increased respiratory effort. The otolaryngology head and neck service performed laryngoscopy which revealed pyriform sinuses with copious secretions, erythematous and edematous arytenoids, mildly edematous vocal cords with a shallow ulcer, and bilateral vocal cord paresis with 2 mm glottic gap. She was given dexamethasone 24 mg for 24 h and a 3-day course of methylprednisone. Three days later, the patient was taken to the OR for placement of a tracheostomy tube. Fibrinoid material was seen along the posterior glottis and palpation of vocal processes showed them to be immobile. Biopsies taken during the procedure revealed ulcerative herpes laryngitis with pathology showing large multinucleated cells with atypia under the ulcerated epithelium (Fig. 1), and strong positive HSV immunostaining (Fig. 2). Patient was started on a two-week treatment course of acyclovir 5 mg/kg IV every 8 h, similar to successful regimens in reported literature. Three days later, chest CT revealed bibasilar opacities consistent with aspiration, and the patient was noted to have erythema of the anterior neck and brownish drainage emanating from underneath her tracheostomy tube. Both conditions resolved after treatment with ampicillin/sulbactam and piperacillin/tazobactam and our patient was discharged for acute rehabilitation two weeks later.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 25,\n",
       "    'case_id': 'PMC4879802_01',\n",
       "    'case_text': 'A full term female neonate born out of a nonconsanguineous marriage by cesarean section (indication-previous cesarean section with polyhydramnios) to a 25-year-old (weight - 58 Kg, height - 155 cm) booked G3P1L1A1 with unremarkable antenatal history. There is no significant history of drug intake. Family history revealed that the father has radial ray deformity of left upper limb without any cardiac anomaly.\\nPhysical examination revealed an active baby weighing 2790 g and length of 49 cm, heart rate of 146/min, blood pressure of 70/30 mm of Hg, respiratory rate of 40/min, and systemic oxygen saturation of right upper limb being 83% in room air and that of right lower limb being 74% in room air [Figure 1]. On musculoskeletal examination, left upper limb shortening was noticed with absent radius bone, radial flexion deformity of the wrist and also absent thumb [Figure 2]. Triphalangeal thumb was seen in the right upper limb [Figure 3]. No obvious deformities were noticed elsewhere. On cardio-vascular system examination, the pansystolic murmur of grade III at the mitral and left parasternal area was heard. Per abdominal and respiratory system examination was within normal limits.\\nOn further investigation, chest X-ray showed normal thoracic situs with cardiomegaly, plain radiograph of both upper limbs revealed absent radius on left side with absent carpal bones and absent first metacarpal bone and phalanges (thumb), right side showing absent carpal bones and triphalangeal thumb [Figure 4]. No obvious bony deformities elsewhere were noted.\\nThe baby developed cyanosis couple of hours after delivery, following which an ECG was done which was normal and a 2D echocardiography was done which revealed severe aortic atresia with hypoplastic arch, large perimembranous VSD and ASD as well [Figure 5]. These findings were confirmed by coronary angiography. The neonate was referred to a cardiac center for further management, however due to lack of resources the baby died on day 4 of life.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 38,\n",
       "    'case_id': 'PMC9622464_01',\n",
       "    'case_text': 'A 38-year-old male was referred to an Australian tertiary hospital for consideration of systemic treatment of confirmed human monkeypox (MPX) infection, with suspected ocular involvement. He presented with painful anogenital and upper and lower limb vesicular lesions, arthralgia, fevers, and bilateral inguinal lymphadenopathy. Ten days after the onset of the initial symptoms, he developed conjunctival injection of his right eye with associated epiphora, foreign body sensation and intermittent blurring of vision. He had recently returned from overseas where he had engaged in unprotected anal and oral sex with other men. Past medical history included depression and regular medications were duloxetine and HIV pre-exposure prophylaxis. A recent sexually transmitted infection screen was negative. He had no previous ophthalmic history.\\nOn examination, the visual acuity was 6/6 unaided in both eyes (Snellen chart). Intraocular pressures measured 11 mmHg in the right eye and 12 mmHg in the left eye. Slit lamp examination of his right eye revealed upper and lower lid edema and erythema, and conjunctival hyperaemia without tarsal papillae or follicles, consistent with blepharoconjunctivitis. A small vesicle at the medial canthus of the lower lid was present (Fig. 1). The cornea demonstrated minimal superficial punctate epithelial erosions but was otherwise clear. There was no intraocular inflammation. Dilated fundus examination was normal. Examination of the left eye was unremarkable.\\nA dry swab was taken from the conjunctiva and the medial canthal vesicle of the right eye, which returned a positive result for MPX virus DNA on polymerase chain reaction (PCR). In consultation with public health officials, the patient was treated by infectious disease physicians with systemic oral tecovirimat 600 mg twice a day for two weeks. Ocular involvement contributed to the decision to use tecovirimat. Ophthalmic treatment was with preservative free lubricating eye drops (carmellose sodium 0.5%) six times a day and as required, and a lubricating ointment (paraffin + retinol palmitate 135 mcg/g) at night. Prophylactic antibacterial cover was provided with topical chloramphenicol drops 0.5% four times a day. At one week review he had complete resolution of ocular symptoms and clinical signs (Fig. 2).',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 61,\n",
       "    'case_id': 'PMC3678502_01',\n",
       "    'case_text': 'A 61-year-old right-hand-dominant mechanic was examined for a recurrent thumb lesion present for approximately 5 years. The patient has no history of trauma to the thumb. Over the past 4 years, he was unsuccessfully treated with multiple courses of antibiotics and antifungals, one partial nail plate excision, and one complete nail plate excision for presumed chronic paronychia. The thumb lesion bled intermittently was painful to pressure, scaly, and consumed the lateral eponychial fold. His examination was otherwise unremarkable.\\nAfter a thorough history and examination, what is your differential diagnosis?\\nWhat will you do to work up this lesion to determine the correct diagnosis?\\nWhat anatomic feature of the nail bed should raise concern for involvement of underlying structures?',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 47,\n",
       "    'case_id': 'PMC5820864_01',\n",
       "    'case_text': 'A 47-year-old previously healthy male presented to our Emergency Department with complaints of 1 week of progressive headaches and 3 days of dizziness, unsteady gait, nausea, and emesis. He reported no history of head trauma. There patient was not on any anticoagulants or antiplatelet. On admission, his neurological exam was unremarkable. A computed tomography (CT) of the brain demonstrated a large left-sided SDH with significant mass effect and midline shift. Magnetic resonance imaging (MRI) demonstrated a separate collection along the left sphenoid wing of the lateral ventricle, consistent with an AC with intracystic blood and surrounding SDH [Figure 1]. Craniotomy and evacuation of the SDH and intracystic hemorrhage were performed. Upon opening the dura, acute, and subacute SDH was visualized. A middle cranial fossa AC with significant hemorrhage and a small hole communicating with the subdural space was visualized. [Figure 1]. Postoperative CT demonstrated interval improvement in midline shift following the evacuation of the hematoma [Figure 1]. The patient was discharged home and was neurologically intact at follow-up with complaints of occasional left-sided headaches.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 66,\n",
       "    'case_id': 'PMC6178910_01',\n",
       "    'case_text': 'A 66 year old African-American male presented to the Emergency Room (ER) complaining of a 2-hour history of chest pain. Chest pain was described as left-sided, non-pleuritic, non-radiating, retrosternal, squeezing in character and persistent. Pain was reported as 9 on a 10-point pain scale and relieved by taking 0.4mg tablet of nitroglycerin sublingually. It was associated with shortness of breath, dizziness and sweating, but the patient denied loss of consciousness, cough, palpitation or swelling of the extremities. He denied any use of illicit substances. A week prior to this hospitalization he presented to the hospital with a similar complaint. At that time, chest pain was relieved by 325mg dose Aspirin taken orally; troponin was normal and EKG did not show any significant change from baseline. His echocardiogram was also normal and he was discharged with scheduled outpatient stress test. Medical history was significant for poorly-controlled diabetes type 2, hypertension, dyslipidemia and obesity.\\nOn this visit, his pulse rate was 84 beats per minute; BP 119/66 mm/Hg; respiration rate 16 breaths per minute and his oxygen saturation was 98% on room air. Initial troponin was elevated at 0.19ng/ml (reference 0.00 - 0.05ng/ml); hemoglobin of 14.4g/dl (reference 13-17g/dl) and platelet count of 210 x 10 3/ul (reference 130-400 x 10 3/ul).\\nEKG showed deep T wave inversions in leads V1-V6 and the inferior limb leads ( Figure 1). We assumed an assessment of non-ST elevation myocardial infarction and a loading dose of Aspirin (325 mg) and Plavix (300 mg) were given orally in the ER along with Atorvastatin (80 mg) and a weight-based dose of Enoxaparin. Repeat troponin 6 hours later was 1.05. Cardiac catheterization revealed normal coronaries ( Supplementary file 1). While the patient was still lying on the cardiac cath table, his oxygen saturation dropped to 91%. There was no chest pain, tachypnea or tachycardia at this time. Supplemental oxygen at 2l/min via nasal cannula improved saturation to 97%. A repeat EKG showed a Q 3T 3 pattern in lead III ( Figure 2). In view of these new findings (low oxygen saturation and a change in the EKG pattern), a computerized tomography of the chest with angiogram (chest CTA) was ordered. This revealed a saddle pulmonary embolus which extended into the right and left pulmonary arteries and involved all lobar branches of the pulmonary arteries ( Figure 3).\\nTreatment was continued with Enoxaparin (100mg subcutaneously every 12 hours) for 6 days, at which time he became stable and maintained oxygen saturation above 96% even when supine. He was discharged on Apixaban (10mg po bid for 7 days followed by 5mg po bid) with plan to complete 3 months of therapy. Follow up visits were scheduled with the Cardiology and Hematology clinics.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 67,\n",
       "    'case_id': 'PMC5723361_01',\n",
       "    'case_text': 'A 67 year old diabetic lady presented with left groin pain for three weeks off and on associated with fever to the Orthopedic Clinic at the Aga Khan University Hospital, an academic tertiary care hospital in Karachi, Pakistan. She underwent un-cemented unipolar hemiarthoplasty of the left hip 8 years back. On examination, she was unable to elicit active movements at left hip. Personal and family history was negative for tuberculosis and wound infection at the index hip surgery. There was no relevant drug, family and genetic and psychosocial history.\\nLab workup was done which showed raised serum infective markers. White cell count was 11.9 x 109/L, erythrocyte sedimentation rate was 118 mm/h (0-20) and CRP was 13.45 mg/dl (0-0.5). Urine culture was negative. Chest radiograph was normal. Hip radiographs demonstrated uncemented unipolar left hip arthroplasty with no evidence of any radiolucency or prosthetic loosening (Fig. 1). Moderate degenerative changes were found on radiograph of lumbosacral spine more marked at L4-L5 and L5-S1 level. Ultrasound of hip joint was performed before proceeding with surgery. Two ml pus was aspirated and culture showed growth of E. coli. Due to left groin pain, markedly elevated ESR and CRP and positive culture from hip aspiration, patient was planned for left hip arthrotomy. The surgery was performed by a consultant orthopaedic surgeon. The previous Moore approach was used for left hip arthrotomy. Hip joint appeared normal and implant was noted to be well fixed. Clear fluid was noted in hip joint at the level of psoas muscle. Pus was debrided at the lesser trochanter. Tissue sample was sent for culture and sensitivity which showed E coli and histopathology reported with psoas abscess. Computed tomography scan of abdomen was performed showing bilateral perinephritic fat standing with dilated ureters suggestive of Pyelonephritis (Fig. 2).\\nPatient was seen by infectious disease service. Patient tolerated the procedure well and there were no postoperative complications. Post operatively she was started on antibiotics which were continued for three months. She was mobilized weight bearing as tolerated with support postoperatively.The range of motion was restored with normal gait, initially ambulating with support followed by progressive improvement in her range of motion to 70  flexion, 30  abduction, 10  internal rotation and 15  external rotation within two weeks.\\nESR and CRP returned to normal limits. Twenty months later, she remains asymptomatic without evidence of infection.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 43,\n",
       "    'case_id': 'PMC2732509_01',\n",
       "    'case_text': \"On June 30, 2001, a 43-year-old woman (the patient with the index case), living in Kosovska Mitrovica, Kosovo, became severely ill and was admitted to the hospital with high fever, headache, nausea, generalized myalgia, and disorientation. Two days later her condition rapidly deteriorated; bleeding from the gastrointestinal tract, she was transferred to the Institute for Tropical and Infectious Diseases in Belgrade, where she died a few hours after admission.\\nBlood cultures were negative for bacterial pathogens. C-CHF and hemorrhagic fever with renal syndrome (HFRS) were suspected, considering the clinical picture of the patient and the epidemiology of the diseases in this geographic area. A serum sample collected before death was tested for immunoglobulin (Ig) G and IgM specific for a variety of microorganisms (including hantaviruses, rickettsiae, and leptospira) by enzyme-linked immunosorbent assay and indirect immunofluorescent assay (IFA). No specific antibodies were detected.\\nTo detect C-CHFV antibodies, the patient's serum was tested in twofold dilutions (initial dilution 1:8) with fluorescein-labeled goat anti-human immunoglobulin (Gibco-BRL Diagnostics, Madison, WI) on spot slides containing Vero E6 cells (ATCC CRL 1586), with approximately 50% of the cells infected with the prototype Nigerian C-CHFV strain (IbAr 10200). Titers were recorded as the greatest dilution of serum at which characteristic cytoplasmic immunofluorescence is detected. No specific antibodies were detected.\",\n",
       "    'gender': 'Female'},\n",
       "   {'age': 38,\n",
       "    'case_id': 'PMC2732509_02',\n",
       "    'case_text': \"On July 6, the 38-year-old physician who had intubated the index patient when she was admitted became severely ill, with high fever, asthenia, petechiae, exanthema of soft palate, pneumonia symptoms, leukopenia, and thrombocytopenia (leukocyte count: 3x109/L; erythrocyte count: 80x109/L). No evidence of disseminated intravascular coagulation was observed.\\nTo detect antigen in the secondary patient's serum, the immunoprecipitation procedure was used. Patient's serum sample and sera from known C-CHF-positive patients, as well as hyperimmune human gamma globulin against C-CHFV, were placed in the wells in agar plates and left overnight to diffuse; precipitin lines were formed where the concentration of the antigen and antibodies was serologically equivalent.\\nWe extracted viral RNA from serum and whole blood samples from both patients. Complementary DNA was amplified by nested polymerase chain reaction (PCR) by using primers from the small (S) RNA segment of C-CHFV. We found a specific 260-bp band in both cases. Nucleotide sequence analysis was performed by using the OpenGene automated DNA sequencing system (Visible Genetics Inc., Toronto, Canada). As expected, the two sequences were identical. We compared the resulting sequences with those available in the GenBank database using the BLAST tool (available from: URL: http://www.ncbi.nlm.nih.gov/BLAST/). We observed a similarity to C-CHFV S segment sequences.\\nSince strong evidence exists that ribavirin is effective for treating C-CHF, oral ribavirin was given to the second patient (800 mg three times on day 1, followed by 600 mg three times a day for the next 11 days). He responded successfully and, after 48 hours, became afebrile; his hematologic and biochemical parameters returned to normal. No side effects of ribavirin were present. On July 10, low titers (1:64) of IgM antibodies were detected, while on July 16, high titers (1:2,048) of IgG antibodies were detected in patient's serum samples.\\nThe patient was placed in isolation, and all personnel wore protective clothing, such as gowns, masks, and gloves. All contact persons in the hospital were informed and advised to contact a physician if any symptoms occurred. No additional persons became ill. Samples taken from the driver and the nurse who transferred the woman from the local hospital to Belgrade were tested by IFA for the presence of antibodies to C-CHFV and were found negative, even a month after the woman's death.\\nWhole blood of both C-CHF cases (10% suspension in phosphate-buffered saline) was injected separately into 25-mL flasks containing Vero E6 cells. The cells were checked for C-CHFV antigen by immunofluorescence assay with hyperimmune human globulin against C-CHFV (strain Hodja). Positive cells were detected in both flasks on the 6th day after injection. The supernatant of the cells was used to infect fresh E6 cultures, and the virus was passaged six further times. We designated the virus from the fatal C-CHF case as C-CHFV/Kosovo/9553/2001, and the virus from the infected physician as C-CHFV/Kosovo/9717/2001.\\nExtraction of viral RNA of cell culture supernatants, amplification, and phylogenetic analysis showed that the obtained sequences were identical to each other and to the sequences amplified from the clinical samples. The nucleotide sequences were submitted to GenBank and assigned accession numbers AF428144 (for the index case) and AF428145 (for the secondary case). Phylogenetic analysis showed that these sequences clustered together with Drosdov strain (a C-CHFV strain isolated from blood of a patient in Russia), differing from it by 4%, while the genetic difference from the prototype C-CHFV Nigerian strain IbAr 10200 was 17% (Figure).\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 37,\n",
       "    'case_id': 'PMC6010925_01',\n",
       "    'case_text': 'A 37-year-old Iranian male patient was admitted to the Shohadaye Ashayer Hospital, Khorramabad, Iran, in 2016 with the complaints of weakness, anorexia, fatigue, weight loss along with fever and chills. The fever was dramatically exacerbated at nights and it was accompanied with sweating, dyspnea, and nonbloody sputum. The patient had been bothered by anal pain and discharge. The symptoms had started 7 days prior to his referral to the hospital. The patient added that all of the above-mentioned symptoms emerged a week (2 weeks before his referral to the hospital) after he had undergone anal fistula surgery and pilonidal sinus surgery due to rectal bleeding that had lasted for 9 months. He had also lost weight up to 12 kg over the previous 5 months. He had received antimicrobials and analgesia in the aftermath of his anal surgery, including metronidazole, ciprofloxacin and acetaminophen. The patient had a history of smoking, opium use and IV drug injection. Historically, he was not known to be immunocompromised and had no close contact with a case of tuberculosis.\\nOn physical examination, he was fully alert and conscious and could actively participate in a conversation. His vital signs were as follows: temperature: 37.9C, heart rate: 86 beats/min, blood pressure: 100/70 mm/Hg, and respiratory rate: 18 breaths/min. In general, he seemed well. Thoracic and abdominal examinations were completely normal, respiratory and cardiac sound were normal and jugular venous pressure was not raised, nor was any lymphadenopathy detected. On the examination of the anus, anal erythema and swelling as well as discharge near the site of surgery were observed.\\nStandard blood tests are shown in Table 1. A PPD was negative. He was found be HIV antibody positive as well as anti hepatitis C positive. Chest X-ray did not reveal any abnormalities and the CT of the chest was also negative. The CT scan of the abdomen/pelvis with contrast revealed thickening of the rectum (Fig. 1). A colonoscopy revealed grade 2 internal hemorrhoids, many small aphthous ulcers in the rectum and normal sigmoid and descending colon (Fig. 2, Fig. 3). An AFB stain of the ulcers was negative. The biopsy showed chronic granulomatous proctitis (Fig. 4). Staining was positive for acid fast bacilli. The patient was then begun on standard four drug therapy for TB. The cultures for TB were positive and his symptoms and lesions healed.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 13,\n",
       "    'case_id': 'PMC6449812_01',\n",
       "    'case_text': \"A 13-year-old female spayed domestic shorthair (DSH) cat was presented for polyphagia, polyuria and polydipsia (PUPD) and weight loss (day 1). The cat weighed 4.3 kg (body condition score 4/9) and had lost 1 kg in body weight over the previous 6 months. A grade II/VI left parasternal systolic murmur was auscultated, the haircoat was unkempt with a heavy flea burden and the abdomen appeared mildly pendulous. Six weeks previously, the cat had presented with pollakiuria and polydipsia. Bacterial cystitis due to Escherichia coli was diagnosed and pollakiuria resolved after a single dose of cefovecin subcutaneously (8 mg/kg) (Convenia; Zoetis). At that time, there was mild azotaemia (creatinine 187 micromol/l and urea 11.46 mmol/l; reference intervals [RIs] 90-180 micromol/l and 7.2-10.7 mmol/l, respectively) and hypokalaemia (3.1 mmol/l; RI 4.0-4.6 mmol/l), and urine specific gravity (USG) was 1.014.\\nHaematology results on day 1 were within the RIs. Abnormalities on serum biochemistry included hypokalaemia (3.1 mmol/l; RI 3.7-5.4 mmol/l), metabolic alkalosis (bicarbonate 25 mmol/l; RI 12-24 mmol/l) and elevated creatinine kinase (CK; 5569 IU/l [RI 64-400 IU/l]). Urea (9.1 mmol/l; RI 5.0-15.0 mmol/l), creatinine (110 micromol/l; RI 80-200 micromol/l) and symmetrical dimethylarginine (8 microg/dl; RI 0-14) were not elevated. Primary hyperaldosteronism was suspected owing to the presence of PUPD, weight loss, persistent hypokalaemia, metabolic alkalosis and elevated CK. Further investigation, including systolic arterial blood pressure (SABP) measurement, abdominal ultrasonography and plasma aldosterone:renin measurement were recommended.\\nTwo days later (day 3), the cat re-presented with marked cervical ventroflexion and was mildly dehydrated (body weight 4.23 kg). SABP (Doppler method) was 150 mmHg and fundoscopy was unremarkable. On urinalysis, USG was 1.015 and urine sediment was benign. Blood was collected for basal aldosterone, progesterone and renin assays. On abdominal ultrasonography the right adrenal gland was enlarged, rounded and discrete (19 mm diameter) (Figure 1). The left adrenal gland appeared normal (cranial pole height 3.4 mm, caudal pole height 3.5 mm, length 11 mm).\\nThe cat was hospitalised (day 3) and treatment was commenced with spironolactone (6.25 mg PO q24h) and potassium gluconate (4 mmol PO q12h). Intravenous fluid therapy (IVFT) was not administered owing to financial constraints and the cat ate on admission to hospital. However, on day 4, weakness and dehydration worsened (body weight 4.1 kg). Despite a stable packed cell volume (PCV; 0.30 l/l [RI 0.30-0.45]), total serum protein (TSP) increased (90 g/l; RI 39-78 g/l), hypernatremia developed (167 mmol/l; RI 147-156 mmol/l) and hypokalaemia worsened (2.9 mmol/l; RI 4.0-4.6 mmol/l). SABP was also elevated at 180 mmHg. Crystalloid IVFT (Hartmann's solution) at 13 ml/h and potassium chloride (KCl) at 0.4 mmol/kg/h IV was commenced. Spironolactone was continued and potassium gluconate was increased to 4 mmol PO q4h. After 4 h, potassium was 3.9 mmol/l and KCl supplementation was reduced to 0.13 mmol/kg/h IV.\\nOn day 5 body weight had increased by 400 g, and the cat became tachycardic (heart rate 260 beats/min) and tachypnoeic (respiratory rate 60 breaths/min). Initially, fluid overload was suspected. However, on physical examination several hours later mucous membranes were pale, PCV (0.13 l/l) and TSP (52 g/l) had decreased markedly, and SABP was 150 mmHg. Serum potassium was 3.6 mmol/l and sodium was 160 mmol/l. Acute haemorrhage from the adrenal mass was suspected. Repeat abdominal ultrasonography revealed a new 5 cm diameter heterogeneous area, in the right retroperitoneal space adjacent to the enlarged right adrenal gland (17 mm diameter). Free fluid was also present in the right retroperitoneal space, and there was scant free fluid between liver lobes. These findings were consistent with a periadrenal haematoma and haemorrhage into the retroperitoneal space and peritoneal cavity. Possible causes were considered to be rupture of the mass or neoplastic invasion of adrenal vessels with erosion of the vessel wall. There was no evidence of coagulopathy - prothrombin and partial thromboplastin times and platelet count were within the RIs.\\nBlood typing was performed (Quick Test; Alvedia Veterinary Diagnostics) and the cat was blood type B, for which no immediate donor was available. Supportive therapy with IVFT, KCl and spironolactone were continued, and the flea burden was treated with nitenpyram 11.4 mg PO (Capstar; Novartis), then topical imidacloprid (Advocate; Bayer). From days 6 to 8 the cat was clinically stable, cervical ventroflexion resolved, polyphagia returned, SABP ranged from 110-140 mmHg, PCV and TSP increased to 17 l/l and 75 g/l, respectively, and the median serum potassium was 3.8 mmol/l.\\nResults of endocrine testing confirmed hyperaldosteronism and hyperprogesteronism; plasma aldosterone was 38,100 pmol/l (RI 60-980 pmol/l), plasma renin activity was 422 fmol/l/s (RI 130-2350 fmol/l/s) and the aldosterone:renin ratio was markedly increased (69.9; RI 0.4-1.5). Basal progesterone was also elevated (30.6 nmol/l; RI <2.0 nmol/l).\\nOn day 8, a blood type B donor was sourced, and 52.5 ml of whole blood was administered preoperatively. On day 9, preoperative PCV was 0.28 l/l, potassium was 3.8 mmol/l, sodium was 153 mmol/l and SABP was 145 mmHg. CT of the abdomen and thorax was performed under general anaesthesia. There was ventral displacement and compression of the caudal vena cava by the right adrenal mass and no evidence of vena caval invasion or tumour thrombi. There was a large, localised right retroperitoneal effusion with marked mass effect and no evidence of abdominal or thoracic metastases (Figure 1). At surgery to remove the right adrenal gland (Figure 1), via a ventral midline approach, a haematoma (45 mm diameter) was observed in close proximity to the right adrenal gland, just ventral to the caudal vena cava.\\nAnalgesia consisted of a ketamine constant rate infusion (CRI; 0.5 mg/kg/h IV) and methadone (0.1 mg/kg IV q4h). A hydrocortisone CRI (0.5 mg/kg/h) was administered to manage a potentially hypofunctional left adrenal. Within 8 h postoperatively the cat was eating, and serum potassium was 4.2 mmol/l. On day 11, spironolactone, hydrocortisone and IVFT were ceased and oral prednisolone (1.25 mg q24h) was prescribed until day 50. On day 14 PCV was 0.26 l/l and TSP was 74 g/l. Oral potassium was tapered and ceased on day 15. No further electrolyte abnormalities were documented. The cat was discharged from hospital on day 16.\\nHistopathology revealed an adrenal adenocarcinoma (ACC) with no evidence of vascular invasion. The periphery of the mass was necrotic and considered the likely site of the haemorrhage. There was no haemorrhage within the tumour.\\nAt rechecks 5 weeks postoperatively body weight, gait, posture, vital signs and serum potassium were normal, and anaemia had resolved. At a recheck 8 months postoperatively the cat was reported to be in good health by the owner, body weight was stable (4.3 kg) and SABP was 160 mmHg, but International Renal Interest Society (IRIS) stage 2 chronic kidney disease (CKD) was diagnosed (urea 10.01 mmol/l [RI 7.2-10.7 mmol/l], creatinine 181 micromol/l [RI 90-180 micromol/l], USG 1.018).\",\n",
       "    'gender': 'Female'},\n",
       "   {'age': 13,\n",
       "    'case_id': 'PMC6449812_02',\n",
       "    'case_text': 'One of the authors (VRB) was presented with a similar case in 2003. A 13-year-old male castrated DSH collapsed acutely indoors one evening, preceded by vomiting once. The cat vocalised continuously after the event, and appeared to be in pain when picked up by its owner, a veterinary nurse. The cat had a history of polyuria, polydipsia and weight loss for several months beforehand.\\nOn clinical examination, the cat was hypothermic (37.0 C), tachycardic and had pale mucous membranes. The cat was stabilised with crystalloid IVFT overnight. On presentation at referral several days later the cat had a body condition score of 3/9, pale mucous membranes and was tachycardic with a IV/VI parasternal systolic heart murmur, SABP of 220 mmHg and normal fundoscopy. Abnormalities on haematology and biochemistry included a PCV of 18 l/l, TSP of 59 g/l, serum potassium of 2.17 mmol/l (RI 3.7-5.4 mmol/l), creatinine 468 micromol/l (RI 9-190 micromol/l) and a USG of 1.021. Plasma sodium was within the RI (149 mmol/l; RI 144-157 mmol/l). Abdominal ultrasonography confirmed the presence of an irregular, large right adrenal mass, which measured 5 x 2.7 cm diameter at the largest dimension and displaced the caudal vena cava to the right side. Partial attenuation of the caudal vena cava was assessed to be a consequence of haematoma formation at the site of the adrenal mass, although invasion of the caudal vena cava could not be excluded. Thoracic radiographs were unremarkable.\\nSpironolactone (6.25 mg PO q24h) and amlodipine (1.25 mg PO q24h) were commenced. Serum aldosterone was elevated (1916 pmol/l; RI 60-980 pmol/l), renin activity was 0 fmol/l/s; RI 130-2350 fmol/l/s), and a diagnosis of hyperaldosteronism was confirmed. An exploratory ventral midline celiotomy was performed 1 week later. The cat was blood typed (type A [Rapid-H; DSM Laboratories]) and given a 50 ml type A blood transfusion preoperatively. At surgery the right adrenal mass was adherent to, but not invading, the vena cava. A right adrenalectomy was performed. The adrenal mass contained a large amount of intratumoral haemorrhage and necrosis on cut section (Figure 2). Histological examination confirmed an ACC arising from the zona glomerulosa with extensive intratumoral necrosis and haemorrhage. The cat recovered well postoperatively.\\nAt a recheck examination 9 months later, the PCV was 32 l/l, TSP was 75 g/l and the cat was diagnosed with IRIS stage 3 CKD. It lived for approximately 18 months after surgery.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 0,\n",
       "    'case_id': 'PMC4005093_01',\n",
       "    'case_text': 'A 2-day-old, term female neonate, presented with a U-shaped cleft of the upper half of the sternum, with central area of ulcerated area of overlying skin through which pulsating heart was visible (Fig. 1). There was no history of maternal infection or medication during early pregnancy. Dimensional and Doppler echocardiography showed a sternal cleft, PDA, ASD, and a normal aortic arch. Abdominal ultrasonography was normal. The patient underwent surgery at 3rd day of life. The necrotic fibrous tissue (ACC) on the sternal cleft area was completely resected without opening the pericardium. Fasciocutaneous flaps were raised on either sides and both sternal bars were approximated with 2/0 PDS and covered by fasciocutaneous flaps.\\nAfter 8 months, she was readmitted because of the severe respiratory distress and stridor. On examination, there was a hemangioma involving the lower lip, oral mucosa, and right parotid region. Urgent spiral CT-scan of head and neck revealed subglottic hemangioma. A tracheostomy was performed to relieve the respiratory distress. She underwent laryngoscopy and bronchoscopy a week later and subglottic hemangioma was treated by KTP532 laser. Tracheostomy tube was removed subsequently. She had no respiratory distress or subglottic hemangioma at four year follow-up (Fig. 2).',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 45,\n",
       "    'case_id': 'PMC9082205_01',\n",
       "    'case_text': 'A 45-year-old woman with FMD and essential hypertension was referred to ophthalmology clinic for 3 weeks of decreased vision in her right eye. She was previously diagnosed with FMD after presenting to the emergency room 12 years prior with a headache and left-sided paresis and was found to have a right internal carotid dissection and right middle cerebral artery occlusion. A four-vessel arteriogram of the head demonstrated multifocal narrowing of the right vertebral artery consistent with a diagnosis of FMD. Renal ultrasound and MRA did not show involvement of the renal vasculature. Her severe hypertension was treated with an angiotensin-converting enzyme (ACE) inhibitor and monitored by her primary care provider. One week prior to presentation to ophthalmology, the patient was found to be mildly hypertensive to 144/80. Three weeks prior to presentation to our ophthalmology clinic, the patient had been seen by an outside provider who documented elevated intraocular pressure (IOP) of 34 mmHg and 26 mmHg in the right and left eyes, respectively. She was treated with brimonidine and referred to our clinic.\\nOn examination at our clinic, the patient had best-corrected visual acuity of 20/60 in her right eye and 20/25 in her left with IOP of 15 mmHg and 13 mmHg in the right and left eyes, respectively. Extraocular movements and confrontational fields were normal. Pupillary response was sluggish, but no afferent pupillary defect was noted. Her anterior segment exam was normal. Dilated fundus exam of the right eye revealed disc edema, flame hemorrhages radiating from the optic disc extending into the midperiphery, diffuse dot-blot hemorrhages, and tortuous, engorged retinal veins (Fig.1). Fluorescein angiography identified delayed arterial filling and late optic disc staining (Fig.2). Optical coherence tomography (OCT) revealed intraretinal cysts and subretinal fluid with distortion of the foveal contour (Fig.3). Her left eye showed no evidence of retinopathy or abnormalities in fluorescein angiography or OCT.\\nThe patient was diagnosed with CRVO and received intravitrealbevacizumab. Over the next year, the patient received monthly bevacizumab injections with resolution of her macular edema and improvement of her vision to 20/40 in the right eye. She then chose to switch to aflibercept for ongoing therapy. She was referred to a glaucoma specialist and started on latanoprost with adequate IOP control. Her primary care physician also reinitiated an ACE inhibitor for blood pressure control.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 66,\n",
       "    'case_id': 'PMC5635244_01',\n",
       "    'case_text': 'A 66-year old female housewife (BMI: 24.1 kg/m2), from a remote city of Pakistan, presented to the surgical OPD with the presenting complaint of intermittent flank pain for the past two years with a history of recurrent renal stones. She had undergone a percutaneous nephrolithotmy (PCNL) 14 years back for nephrolithiasis secondary to calcium oxalate stones. She later had a right extracorporeal shock wave lithotripsy (ESWL) for a residual stones 2 years ago. CT scan of the kidneys showed non-obstructing bilateral renal calculi along with cholelithiasis in the gall bladder. Patient also had multiple gastroenterology clinic visits with the complaints of postprandial bloating and recurrent oral ulcers. Bone densitometry showed marked osteopenia. Her serum calcium level was found elevated at 12.6 mg/dl. The constellation of her symptoms and the elevated calcium levels warranted further workup. Serum PTH was 403 pg/ml (16-87) and serum phosphorus was 2.2 mg/dl (2.5-4.5) respectively; she was diagnosed with primary hyperparathyroidism, aka, PTH dependent hyperparathyroidism causing malignant hypercalcemia. In order, to rule out the possibility of parathyroid adenoma, a high resolution CT scan of chest and neck where carried out, but, there was no abnormal enlargement of the parathyroid gland present, however, 99mTc-MIBI scintigraphy scan was done that showed a well defined area of abnormal tracer deposition in anterior mediastinum just below the manubriosternal junction confirming the diagnosis of mediastinal ectopic PA, furthermore, parathyroid adenomas were outlined over lower pole of right thyroid in anterior mediastinum as well. (Fig. 1a and b).\\nPre-operatively, injection pamidronate was administered three week prior to surgery. Repeat chemistry showed a serum calcium level of 10.2 mg/dl. She, subsequently, underwent VATS where right lower parathyroid tissue was identified and excised. The histopathology report established parathyroid parenchyma composed of chief and oxyphil cells with intervening fibroadipose tissue. There was no evidence of malignancy. The ectopic PA was excised as a whole from anterior mediastinum just behind the sternum and right inferior parathyroidectomy was also carried out. Postoperatively, serum calcium level was repeated every 12 hourly and calcium with vitamin D supplements were administered. Follow up chemistry panel showed a serum calcium in decreasing trend from 9.2-8.2 mg/dl. Her PTH levels also remarkably dropped to 23 pg/dl. She had a complete recovery. Upon return to clinic her serum calcium level and PTH level were found within the normal ranges; 8.9 mg/dl and 86.90 pg/dl respectively. Post operative MR imaging also showed no residual tumor. Patient remained asymptomatic at 6 month follow up as well.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': None,\n",
       "    'case_id': 'PMC8685438_01',\n",
       "    'case_text': 'This study enrolled 10 patients with ICI-related cardiac cardiotoxicity who were admitted to the hospital between January 1, 2018, and August 30, 2021. The detailed descriptions of each case are provided in the Supplementary Materials, and the characteristics are displayed in Supplementary Table 1.\\nAs shown in Table 1, the median age of patients was 62.5 (55.0-73.0) years old. Half of the cases were male. Four (40%) patients were diagnosed with lung cancer and 2 patients were diagnosed with thymoma. Other cancer types included cervical cancer, pyriform sinus squamous cell carcinoma, gallbladder carcinoma, and hepatocellular carcinoma. Furthermore, one patient diagnosed with cervical cancer had a previous history of breast cancer, and one patient with lung adenocarcinoma was once diagnosed with papillary thyroid carcinoma. Before ICI treatment, 70% of the patients were treated with surgeries, and 80% had received chemotherapy. Radiotherapy was performed on 60% of the patients, and two (20%) patients also received angiogenesis inhibitors. Only two patients were found to have previous cardiovascular disease, one was diagnosed with hypertension and the other was diagnosed with coronary heart disease.\\nThe most frequent ICIs treatment for the cases were sintilimab (30%) and camrelizumab (30%). Nine patients were treated with anti-PD-1 therapy, while the remaining one received anti-PD-L1 therapy. Median time from the use of the first dose of ICI to onset was 28.5 (17.8-63.5) days and symptoms at onset varied markedly. The most common symptoms presented in our cases were chest tightness, which occurred in 50% of the patients. Palpitations and fatigue were presented in 30% of the patients. Neuromuscular symptoms also occurred in ICI-related cardiac irAE. Forty percentage of the patients presented with blepharoptosis, one patient showed diplopia and one patient developed conscious disturbance during the disease.\\nBased on the diagnosing criteria proposed by Marc P. Bonaca et al., only two patients were classified as having definite myocarditis. Six cases were classified as other myocardial injury and two patients were regarded as having possible myocarditis, mainly due to the lack of confirmed examinations such as coronary angiography to rule out acute coronary syndrome. Sixty percentage of the patients were mild cases classified as G1-2.\\nLaboratory, electrocardiogram, and echocardiogram findings for the patients with cardiac irAE were shown in Table 2. Lymphopenia was frequently found in the cardiac irAE (7, 70%). The elevated level of serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) was observed in six (60%) and nine (90%) patients, respectively. Markedly evaluated levels of creatinine kinase (CK), creatinine kinase-muscle and brain type (CK-MB), and troponin I (TnI) were found in nine (90%) patients. B-type natriuretic peptide (BNP) tests were available in eight patients, and levels were significantly elevated in four (50%) of them. The serum levels of C-reactive protein (CRP), an important biomarker in systemic inflammation, were available in five patients, and CRP levels were elevated in four (80%). Four heart-specific autoantibodies were measured in two patients (Case 1 and 4, see Supplementary Material 1) by enzyme-linked immunosorbent assay, and both of their serum samples were positive.\\n12-lead ECG and transthoracic echocardiography were performed in all cases. Cardiac conduction disorders including atrioventricular block (AVB) and bundle branch block were found in seven (70%) patients. One patient presented I-II AVB, which eventually progressed to complete AVB (case 1, Supplementary Material 1). Systolic function was preserved in seven (70%) patients, and only three (30%) patients developed systolic dysfunction with left ventricular hypokinesia.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 65,\n",
       "    'case_id': 'PMC4821151_01',\n",
       "    'case_text': 'The patient was a 65-year-old African-American man with a history of hypertension, diabetes, coronary artery disease, and ischemic cardiomyopathy (ejection fraction 30-35%) who presented to the emergency department with moderate-to-severe mid-abdominal pain, nausea, vomiting, and constipation for 4-5 days. He had demonstrated a decreased appetite and an about 70- to 80-pound weight loss in the preceding 2 months. His medical history was also significant for atrial fibrillation, left ventricular thrombus, and cerebral aneurysm with prior intraventricular hemorrhage. He had a 40-pack-year smoking history, a history of chronic alcoholism for over 40 years, and prior cocaine and marijuana use. He denied any family history of cancer. His physical examination was notable for abdominal distention and mild epigastric tenderness, but his abdomen was soft and he had normoactive bowel sounds. He had no hepatosplenomegaly and his examination was otherwise unremarkable.\\nHis workup included laboratory tests, which showed normal serum amylase and lipase levels. Liver function tests revealed alkaline phosphatase at 172 U/l (normal = 30-165), alanine transaminase at 12 U/l (normal = 0-55), aspartate transaminase at 49 U/l (normal = 0-50), bilirubin at 1.3 mg/dl (normal = 0.2-1.2), and albumin at 2.8 g/dl (normal = 3.2-5.5). His other serum chemistries were normal. Serum tumor markers were obtained, which showed carcinoembryonic antigen (CEA) at 10,400 ng/ml (normal = <2.5 for nonsmokers, <5 for smokers), cancer antigen 125 at 358 U/ml (normal <35), and alpha-fetoprotein (AFP) at 4,970 ng/ml (normal = <6.1). A contrast-enhanced computed tomography (CT) of the abdomen and pelvis showed a markedly dilated, debris-filled stomach with no contrast beyond the gastric antrum, and a mass-like density in the gastric antrum or proximal duodenum measuring approximately 4 cm in diameter (fig. 1a). Multiple hypodense hepatic lesions (the largest being 6 cm in the right hepatic lobe) were also seen, which was consistent with metastatic disease (fig. 1b).\\nThe patient subsequently underwent upper endoscopy, which showed distal esophageal varices and undigested food in the stomach. A circumferential, friable mass at the duodenal bulb was noted, obliterating 80% of the lumen and preventing scope advancement beyond the second portion of duodenum (fig. 2). Biopsies were obtained. He underwent colonoscopy as well, which was essentially normal. The gastric antrum biopsy showed mild chronic inactive gastritis, and the pyloric antral biopsy showed mild chronic active gastritis with foveolar hyperplasia; a Giemsa stain was negative for Helicobacter pylori. A biopsy of his duodenal mucosa showed mild chronic active inflammation of the lamina propria with no significant villus blunting. The biopsy of the visualized duodenal mass, however, showed a moderately differentiated adenocarcinoma with glandular formation, which was confirmed by mucin-positive staining. There were also areas with trabecular and nested patterns seen (fig. 3a). A comprehensive immunostain panel showed that the tumor cells were negative for Hep Par 1 and glypican-3, essentially ruling out hepatocellular carcinoma. The tumor cells were positive for CEA, AFP, CK18, CK19, and CDX-2, but were negative for CK7, CK20, and synaptophysin (fig. 3b, c).\\nThe patient also underwent a CT-guided biopsy of his liver lesions, which showed invasive, moderately differentiated adenocarcinoma with striking morphological and immunohistochemical similarity to the duodenal bulb mass biopsy, suggesting that the duodenal bulb was the most likely primary origin. Given the pathological and laboratory findings of adenocarcinoma of the duodenum with AFP-positive tumor staining and elevated serum AFP levels in the absence of hepatocellular carcinoma, he was diagnosed with stage IV HAC of the duodenum.\\nHis course subsequently was notable for pyloric stent placement to help relieve his gastric outlet obstruction. He unfortunately continued to have nausea and bilious vomiting despite stent placement, and required total parenteral nutrition. Chemotherapy was deferred due to his poor performance status (ECOG PS 4), and he was managed supportively. His hospital course was further complicated by septic shock due to Escherichia coli bacteremia and fungemia, acute hypoxic hypercapnic respiratory failure requiring mechanical ventilation, and loculated empyema. Unfortunately, he died from multiorgan failure within 1 month of his diagnosis.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 75,\n",
       "    'case_id': 'PMC6393948_01',\n",
       "    'case_text': 'The patient is a 75-year-old male who presented to our clinic in 2017 with progressive weight loss over prior 2 years, night sweats, pruritus, early satiety, and left upper quadrant pain. Physical examination was pertinent for hepatosplenomegaly. His white blood cell (WBC) count was 23 200 cells/mm3 with 92% neutrophils, hemoglobin 14.3 g/dL, and platelet count 741/mm3. He had no blasts in peripheral blood. Per chart review, we noted that he had started to develop neutrophilia and thrombocytosis in 2013 and 2014, respectively. Quantitative reverse transcription polymerase chain reaction was positive for both b2a2 and b3a2 transcripts at 2.1% and 1.2%, respectively. Imatinib was started. Eight weeks later, WBC count was 16.8 cells/mm3, hemoglobin 14.5 g/dL, platelet count 649/mm3, and reverse transcription polymerase chain reaction negative for BCR-ABL transcripts. The fact that the patient had complete molecular response without hematologic response triggered further workup. JAK2 V617F mutation was checked in peripheral blood and was positive. Erythropoietin was low at 1.3 mIU/mL. Examination of the bone marrow showed hypercellularity (90%) with myeloid/erythroid ratio of 7.7, proliferation of atypical megakaryocytes, <1% blasts, and widespread grade 2 reticulin fibrosis. No BCR-ABL translocation was detected by fluorescence in situ hybridization. DIPSS (Dynamic International Prognostic Scoring System) Plus score was 1. Myelofibrosis mutational profile analysis was not available. Hydroxyurea was added on top of imatinib (Figure 1).\\nIncluding our case, 11 patients had PMF, 10 had PV, and 5 had ET. In 8 cases, the exact nature of the myeloproliferative disorder was not clear. MPD preceded CML in 10 cases, CML preceded MPD in 9 cases, and both were diagnosed concomitantly in 15 cases. Interestingly, when MPD preceded CML, the mean time interval between the diagnoses of the 2 entities was 10.6 years compared with 5.4 years when CML preceded MPD. Interaction between JAK2 mutation and BCR-ABL transcripts levels varies. In most cases, JAK2 and BCR-ABL levels moved in opposite directions. In the remaining cases, JAK2 level decreased or remained constant while BCR-ABL level decreased.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 76,\n",
       "    'case_id': 'PMC8017431_01',\n",
       "    'case_text': 'A 76-year-old man undergoing treatment with anti-PD1 antibody (pembrolizumab) for lung adenocarcinoma consulted in the Emergency Department for fever and 1 week of dyspnea. Physical examination revealed peripheral oxygen saturation < 90%, requiring supplemental oxygen. No infiltrates were found on the chest X-ray, despite a positive polymerase chain reaction (PCR) for SARS-CoV-2 in nasopharyngeal swab. Initial blood test results are shown in Table 1. During admission, he received treatment with hydroxychloroquine and respiratory support for 10 days, being discharged upon resolution of fever and respiratory symptoms. Two weeks later, he returned to the hospital, due to high unremittent daily fever up to 39 . No clear etiology was evident in the anamnesis, and the physical examination was unremarkable, excepting the fever. Broad-spectrum antibiotics were initiated (meropenem, linezolid, and trimethoprim-sulfamethoxazole). Blood cultures were negative on several occasions; cytomegalovirus and Epstein-Barr virus viral loads were undetectable; serologies for syphilis, HIV, hepatitis B, hepatitis C, Mycoplasma pneumoniae, Coxiella burnetti, and Parvovirus B19 were negative; and Interferon Gamma Release Assay (IGRA) tested negative. However, SARS-CoV-2 PCR remained positive in the nasopharyngeal swab. Despite antibiotic treatment, daily fever persisted, and clinical and analytical parameters worsened presenting pancytopenia, organomegaly, and elevation of ferritin and cytokine profile (Table 1). A positron emission tomography performed was unremarkable. At that point, calculated Hscore score was 211, conferred a 93.65% probability of his clinical condition being caused by hemophagocytic lymphohistiocytosis. Bone marrow examination was not obtained. High-dose intravenous immunoglobulins (IVIG) (1 g/Kg x 2 days) were started, with fever disappearance, hemodynamic improvement, and attenuation of acute phase reactants (Table 1). The patient improved and was discharge without presenting recurrence in the follow-up.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 26,\n",
       "    'case_id': 'PMC6796728_01',\n",
       "    'case_text': \"Patient is a 26-year-old female with a past medical history of HIV. She was infected at age 15 and showed poor adherence to antiretroviral medication. She reported the combined use of Tenofovir, Emtricitabine, and Efavirenz intermittently, mostly because she did not seek adequate healthcare due to feelings of shame about being associated with the disease. She also missed most of her follow-ups in the last year, and had no CD4 counts or viral load tests performed in over 6 months. She also suffered from intermittent episodes of coughing, bloody stools, and weight loss during this time; however, she didn't seek any medical attention.\\nShe presented to our emergency room with a 10-day history of intermittent lower abdominal pain, nausea, biliary vomits and asthenia. Approximately 24 h prior to admittance, the pain became worse. On clinical examination, a dehydrated, hypotensive and tachycardic patient was encountered. Her abdomen was diffusely tender, and the pain became more intense on touch. Laboratory exams revealed mild leukocytosis and neutrophilia. An arterial gasometry revealed metabolic acidosis with hyperlactatemia.\\nIn view of these findings, surgical consultation was requested and a diagnosis of diffuse peritonitis was reached. Aggressive fluid resuscitation with crystalloids was started and an emergency laparotomy was decided. At surgery, the peritoneal cavity was filled with 500 ml of pus and 2 bowel perforations were identified: a 1 x 1 cm perforation in the terminal ileum, 50 cm proximal to the ileocecal valve, and a 3 x 2 cm perforation in the cecum (Fig. 1A-C).\\nA right colectomy was decided, however, the surgical team had doubts about restoring bowel continuity. Nonetheless, since the patient became stable after reanimation and surgery, restoration was considered feasible. Given the context of an HIV patient with poor controls who would be unlikely able to handle an ileostomy, a primary anastomosis with close surveillance was decided. Resection began 10 cm proximal to the ileal perforation and ended near the hepatic flexure of the colon. Then, a side-to-side ileotransverse anastomosis was performed with 75 mm staples (ETHICON Linear Cutter NTLC75, Johnson & Johnson). Extensive washing of the peritoneal cavity was completed and the remainder of the procedure was performed without complications. Based on the historical, clinical, and laboratory data obtained, we initially considered intestinal perforation due to cytomegalovirus (CMV) infection as the probable etiology of peritonitis, and the differentials included, mycobacterial infections, fungal infections, neoplastic disease or Kaposi sarcoma. However, definitive pathology tests for the cause of the perforation were delayed due to the unavailability of an in-house pathologist. Furthermore, other essential tests including CD4 counts and HIV viral loads and antibodies (both IgM and IgG) were not available at our institution.\\nThis situation was further complicated by the lack of resources from the patient and our hospital; nonetheless, we managed to send a blood sample to a nearby hospital for testing. Even under these harsh conditions, the patient had a good recovery. She was placed under broad-spectrum antibiotics (Piperacillin/Tazobactam) and was given a 3-day cycle of Ganciclovir. Antiretroviral Therapy (ART) was initiated as well. Meanwhile, sips of liquids were initiated on the second postoperative day without complications. She didn't have any episodes of fever, nausea, vomiting or signs of anastomosis leak.\\nAt the 7th postoperative day, the patient requested to leave against medical advice (AMA), she signed the hospital consents and left our facility.\\nTwo days after the patient went AMA, CD4 and HIV viral load results arrived along with the pathology report, revealing chronic inflammation of the resected bowel, and multiple ulcers affecting the mucosa of the ileum and the cecum. Also, multiple granulomas surrounded by inflammatory tissue were recognized, as well as some granulomas within the lymph nodes. Bowel perforation due to tuberculosis was confirmed as the final diagnosis, CD4 cell counts were estimated at 94 cells/mm3, and the viral load was estimated at over 106 genome copies (Fig. 2A-C).\\nSince tuberculosis in Ecuador is a mandatory declaration disease, we searched for the patient and found her in the coastal region of the country. Fortunately, she was stable and without complications. She was taken by the national healthcare system and admitted to a tertiary hospital for HIV and tuberculosis treatment.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 42,\n",
       "    'case_id': 'PMC4427155_01',\n",
       "    'case_text': 'A 42-year-old African-American male with a history of (h/o) end-stage renal disease (ESRD) of unknown etiology, hypertension (HTN), who was on hemodialysis for 7 years, received a deceased donor renal transplant in July 2005 (fig. 1a). The renal allograft was procured from a 38 year-old Caucasian female who had received a SPK 3 months before (D-/R+) and died of intracranial bleed. Her posttransplant course was notable for fever and diarrhea and she was treated with IV GCV for presumed CMV colitis. At the time of the kidney procurement from the first transplant recipient, she was noted to be CMV IgM negative. The second recipient was induced with antithymocyte globulin and received a total of 7 doses in the setting of DGF. His maintenance immunosuppression consisted of tacrolimus, MMF, and prednisone. For CMV prophylaxis, he was given IV GCV (50 mg IV daily for 2 weeks) followed by VGCV (450 mg daily). However, he was found to have leukopenia and CMV viremia on postoperative day (POD) 38 (307,000 copies/ml) while he was still on VGCV. He was switched to IV GCV but his viral load continued to rise, and IV foscarnet (3 gm BID) was started on POD 51. The genetic mutation study was notable for UL97 mutation. Viremia was cleared on POD 72, and IV foscarnet was continued until POD 179. Leflunomide was started on POD 185, and he still remains on it. His renal allograft is still functioning (serum creatinine, Scr 1.7-2.1 mg/dl) 10 years later, and he has not had a recurrence of CMV viremia/disease.',\n",
       "    'gender': 'Male'},\n",
       "   {'age': 34,\n",
       "    'case_id': 'PMC4427155_02',\n",
       "    'case_text': 'A 34-year-old Hispanic male with h/o ESRD, type 1 diabetes mellitus, HTN, and hyperlipidemia, who was on hemodialysis for 3.5 years, underwent a SPK (D+/R-) in August 2008 (fig. 1b). His induction treatment consisted of daclizumab. He was on tacrolimus, MMF, and prednisone, and there was no DGF. He was given a 3-month course of VGCV for CMV prophylaxis. He developed CMV viremia (67,000 copies/ml) on POD 373 and was symptomatic with malaise and diarrhea. Although he was started on IV GCV treatment, the CMV viral load continued to rise, and IV foscarnet was started on POD 378. The CMV viral load peaked at 214,000 copies/ml on POD 383, and the virus became undetectable on POD 401. IV foscarnet was discontinued on POD 436. Leflunomide was started on POD 528 and discontinued on POD 1,106 when his liver function tests were found to be elevated [AST 118 (normal range 15-37) and ALT 248 (normal range 8-35)]. A liver biopsy showed steatohepatitis (grade 1, stage 1). A normalization of the liver enzymes was seen 10 weeks after leflunomide was discontinued. The patient has remained free of CMV viremia/disease, and his renal allograft is still functioning (Scr 2.8-3.0 mg/dl).',\n",
       "    'gender': 'Male'},\n",
       "   {'age': 43,\n",
       "    'case_id': 'PMC4427155_03',\n",
       "    'case_text': \"A 43-year-old, highly sensitized (PRA: Class I 56%, Class II 85%) African-American male with h/o of ESRD secondary to posterior urethral valve syndrome, s/p DDRT (06/1987), s/p LRRT (10/1987) underwent a third renal transplant (D+/R-) with an ileal conduit on January 27, 2011 (fig. 1c). He was induced with antithymocyte globulin (100 mg x 4 doses). He received a 100-day course of VGCV (900 mg daily) for CMV prophylaxis. His posttransplant course was complicated by an intra-abdominal abscess requiring surgical drainage and prolonged bowel rest except for his medications. CMV was first detected on POD 146 when the patient presented with diarrhea and weakness. He was treated with VCGV (900 mg BID) but continued to have low-grade viremia for the next 5 months. UL97 mutation was detected, and leflunomide was started on POD 297. An investigational oral analogue of cidofovir (CMX001, now known as brincidofovir) obtained from Chimerix for compassionate use was added on POD 322 and discontinued on POD 439. The patient's renal allograft function remains stable (Scr of 1.3-1.4 mg/dl), and he continues on leflunomide.\",\n",
       "    'gender': 'Male'},\n",
       "   {'age': 45,\n",
       "    'case_id': 'PMC4427155_04',\n",
       "    'case_text': 'A 45-year-old, highly sensitized (PRA 88-100%) African-American male with h/o of ESRD of unknown etiology, HTN, who was on hemodialysis for 7 years, received a paired deceased donor kidney transplant from a 67-year-old deceased donor in December 2002 (fig. 1d). He received 1 dose of antithymocyte globulin and 2 doses of basiliximab for induction. His posttransplant course was complicated by DGF. He received VGCV for CMV prophylaxis but developed leukopenia and CMV viremia while still on VGCV prophylaxis on POD 80. He was treated with an increased dose of VGCV and was switched to IV GCV treatment on POD 110 when the CMV DNA hybrid capture test results continued to rise. Foscarnet was started on POD 134, and CMV was undetectable on POD 154, at which time foscarnet was replaced with leflunomide. There was no recurrence of CMV viremia/disease, but the patient had gradually worsening renal allograft function. A renal biopsy on POD 145 showed acute tubulointerstitial nephritis (due to foscarnet), and a subsequent biopsy on POD 318 showed a type 1A rejection and chronic allograft nephropathy with 40% tubular loss. He was restarted on dialysis in July 2004.',\n",
       "    'gender': 'Male'},\n",
       "   {'age': 51,\n",
       "    'case_id': 'PMC4427155_05',\n",
       "    'case_text': 'A 51-year-old African-American male with h/o of ESRD, type 1 DM, and HTN underwent a SPK in May 2001 (fig. 1e). He was induced with 1 dose of antithymocyte globulin and 2 doses of basiliximab and was maintained on sirolimus/MMF/prednisone. His CMV prophylaxis consisted of 3 months of GCV treatment (mostly IV). His posttransplant course was complicated by DGF and three episodes of acute rejection (two type 1B rejections (on POD 21 and 43) and one type 2A rejection (on POD 184) and required treatment with IV antithymocyte globulin as well as pulse steroids. Viremia, first detected on POD 458, was accompanied by diarrhea and malaise, and the patient was treated with IV GCV. Although his viral load improved as estimated by a CMV hybrid capture study, he was unable to eradicate the viremia, and a 2-week course of IV foscarnet was started on POD 595 to achieve viral clearance. He had a recurrence of CMV viremia on POD 811 and was treated with IV GCV but without viral clearance. IV foscarnet was started on POD 884, and leflunomide was added on POD 942. His last detectable CMV viremia occurred on POD 1,420. He died on POD 3,359 of a myocardial infarction. His renal allograft function ranged from 1.7-2.0 mg/dl in the last 3 months of his life.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 55,\n",
       "    'case_id': 'PMC5994735_01',\n",
       "    'case_text': 'We present the case of a 55-year-old woman underwent bariatric surgery in 2014, after which she lost 55 kg of weight (Fig. 1). The patient did not have associated co-morbidities. Given the significant weight loss, with a stable body weight for about 1 year, the patient showed a common skin laxity, especially represented in the abdominal region. The cutaneous laxity of the abdominal region, with ptosis of the dermo-adipose tissues, classified the patient as a grade 3 according to Matarasso, also had a diastasis of the rectus muscles of the abdomen, with indication for surgical intervention. We decide to perform an abdominoplasty with transposition of umbilicus and strengthening of the rectus abdominis muscles by plication of the muscular fascia. Given our experience with patients undergoing bariatric surgery, we decided to perform an abdominoplasty with preservation of the Scarpa Fascia. In fact, this technique seems to have a positive impact on reducing seroma formation, reducing the amount of drained fluids and the drainage time. In our experience, patients undergoing massive weight loss show a greater tendency in the formation of seromas for which it is decided to conduct this procedure.\\nWe evaluated the following variables: age, BMI, comorbidity, drainage removal times, total volume of drained fluids, length of hospital stay. The follow-up was 18 months.\\nIn our clinical practice, we perform antibiotic prophylaxis with cefazolin 2 g iv 30 min before surgery. According to the literature the abdominal flap was sculpted in two different planes, superficial prefascial (above the Scarpa Fascia) in the infraumbilical region and preaneurotic region in the epigastric portion. The skin incision is made according to the preoperative design (Fig. 2), then the abdominal flap is sculpted with ultrasound scalpels. During this maneuver we prefer a manual traction of the flap taking care to preserve the Scarpa Fascia up to about 1 cm below the umbilical scar as described in the literature. Once this level is reached, dissection is carried out according to a premuscular (preaponeurotic) plane. The dissection up to the xiphoid process is confined to the area between the medial margins of the rectus abdominis muscles in order to preserve the perforating vessels of the upper abdomen. The trabecular ligament of the xyphoid process, in our case has been sectioned so the sliding of the abdominal flap is facilitated. Once the tunnel has been completed, the muscle fascia of the rectum is plicated with its approach in the upper abdominal portions, then a medial portion of the adipofascial tissue is removed and the premuscular plane is exposed (Fig. 3). Reposition of the umbilical scar approximately 2 cm above the projection on the abdominal flap. With the patient in semi-Fowler position the abdominal flap is approached at the suprapubic margin and positioning of 2 suction drains JP (Jackson Pratt). Sutures in 3 layers in latero-medial direction and dressing with steri-strip. The patient wore a compressive sheath for 40 days. Drains were removed in second day when the amount drained in 24 h was less than 30 ml.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 27,\n",
       "    'case_id': 'PMC10326381_01',\n",
       "    'case_text': \"In February 2022, a 27-year old male with SCD was transplanted with an ABO-mismatched HLA-identical sibling donor (patient O positive, donor B positive). He received alemtuzumab 1 mg/kg total dose and total body irradiation (3 Gy) as conditioning, followed by peripheral blood stem cell infusion. Graft versus host-disease (GvHD) prophylaxis consisted of sirolimus. The conditioning regimen was preceded by a 3 month long preconditioning phase with azathioprine 150 mg/day and hydroxyurea 25 mg/kg/day. In the months before HSCT, the patient developed a serious delayed hemolytic transfusion reaction (DHTR). In the past, the patient was diagnosed with anti-Jk(b) antibodies, which had disappeared at the time of the DHTR. However, new anti-Wr(a) antibodies and nonspecific cold auto-antibodies were detected at the time of DHTR. The patient was successfully treated with prednisolone and immunoglobulins. Subsequently, 3 weeks before a planned pre-transplant RBC exchange transfusion, he was treated with rituximab (375 mg/m2) to reduce the risk of another episode of DHTR. Blood group genotyping of the matched sibling donor was performed, which was positive for Jk(b) and negative for Wr(a). No antibodies to the donor's RBC antigens were present before the transplantation. After transplantation, rapid engraftment of leukocytes and platelets occurred. However, the patient remained anemic with profound reticulopenia, for which he needed regular RBC transfusions, receiving a total of seven RBC units before resolution of PRCA. Physical examination revealed no abnormalities. Donor myeloid chimerism was >95%, ruling out primary rejection of the allograft. A PCR for parvovirus B19 DNA was negative. Post-allogeneic HSCT isohemagglutinin titers remained present (IgG anti-B 1:32, IgM anti-B 1:8). No other RBC antibodies were detected at the time of the PRCA. Pure red cell aplasia was diagnosed and treatment with 4 weekly doses of daratumumab (1800 mg subcutaneously, fixed dose) was started on day +60 post-transplantation. Daratumumab was tolerated fairly well by the patient, besides an episode of fever grade 2 (CTCAE v.5) and headache grade 1 (CTCAE v.5), which occurred after the second dose. After 4 doses of daratumumab, prompt increases of hemoglobin and reticulocyte counts ( Figure 1 ) and the disappearance of anti-B isohemagglutinins were observed. Chimerism analysis 12 months post-transplantation showed stable donor myeloid chimerism (>95%) and 69% donor T-cell chimerism. Peripheral blood B-cell count had reconstituted to normal values (absolute count 0.104x109/L, 21.7% of lymphocytes). In the 12 months follow-up period after initiation of daratumumab to date, no transfusions or other immunosuppressive therapies have been necessary, and anti-B isohemagglutinins remain undetectable.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 42,\n",
       "    'case_id': 'PMC4724686_01',\n",
       "    'case_text': 'A 42-year-old married female was admitted in a tertiary care hospital with history of breathlessness on exertion of 2 months duration, which was associated with productive cough without any prior history suggestive of respiratory tract infection or viral prodrome. The patient also gave history of occasional palpitations of same durations, and did not have any significant past history. Her physical and systemic examination was normal. The investigative profile of the patient revealed: hemoglobin of 12.7, platelets, and erythrocyte sedimentation rate (ESR) with normal counts. Biochemical parameters like kidney and liver functions were normal. Echocardiography was normal but the x-ray chest parasternal axis view revealed cardiomegaly. Transthoracic echocardiography revealed a large pericardial mass measuring 10.6 x 4.8 cms (Figure 1 & 2), honeycombed in appearance, compressing the right atrium and right ventricle, and was associated with moderate pericardial effusion. The possibility of hydatid pericardial cyst was made, but hydatid serology was negative. Ultrasonography of abdomen was also normal. She was then extensively worked up with all forms of imaging including contrast enhanced CT (CECT) chest and cardiac MRI (Figure 3). Her CECT thorax revealed isodense non-enhancing lesion in pericardial cavity with pericardial fluid. The CECT possibility of organized exudative collection was made, and pericardial tumor like mesothelioma/teratoma was less likely in view of non-enhancing lesion. Cardiac MRI shows multicystic lesion in the right atrioventricular groove of heterogeneous hyperintense signal on T1 weighted images and bright signal on T2 weighted and gradient echo images with indistinct myocardial wall along the pericardial lesion. Lesion shows hypointense septae, and is compressing the right atrium and right ventricle. The MRI possibilities of pericardial lymphangioma, complex pericardial effusion, hemangioma/teratoma were made. The uncertainty of diagnosis was explained to the patient and her immediate family (husband and brother), and due to this uncertainty, no prognostication was performed. They understood the risk and consented for the operation. Finally she was subjected to surgery with surgical notes revealing the operative findings as pinkish brown mass covering the entire right ventricle on opening the pericardium. At no place did it feel hard and nodular, and was arising entirely from the right ventricular myocardium, and approximately 10 ml of clear straw colored fluid was aspirated from 2 cystic areas of the mass, and was sent for cytology and biochemistry. A categorical report of absence of malignancy from frozen section made the surgeons to excise as much as possible of the mass using the cardiopulmonary bypass support, and unfortunately, while excising the mass in the atrioventricular (AV) groove her right coronary artery (RCA) got excised with the tumor, which was given left saphenous vein graft. The whole operative and postoperative periods were otherwise uneventful. Screening echo revealed residual mass seen 4/2.8 cm at the junction of right atrium (RA)/right ventricle (RV)without pericardial effusion. Histopathology report of excised RV mass came as cystic lymphangioma (Figure 4 & 5).',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 4,\n",
       "    'case_id': 'PMC8573117_01',\n",
       "    'case_text': 'A 4-year old, male-castrated, mixed breed dog was presented to a primary care veterinarian for a routine wellness examination (day 1). The dog was adopted 7-months prior and the previous medical history was unknown. The owner reported that the dog exercised daily without limitation, lived indoors only, and had no history of trauma. The dog was fed a commercial kibble diet and not administered any medications or supplements. The physical examination, which included thorough neurologic, musculoskeletal, and cardiopulmonary evaluations, was unremarkable. A complete blood count, serum biochemistry, symmetric dimethylarginine (SDMA), and urinalysis were performed. Clinically relevant abnormalities on the serum biochemistry performed at that time included a severe hyperCKemia (15,137 IU/L; reference interval 10-200 IU/L), and moderate increases in alanine transaminase (ALT; [432 IU/L; reference interval 180-121 IU/L]) and aspartate aminotransferase (AST; [404 IU/L; reference interval 16-55 IU/L]) enzyme activities. The complete blood count, SDMA, and urinalysis were unremarkable. A serum biochemical profile was repeated 7-days later, which revealed persistently increased serum CK activity (10,301 IU/L) as well as ALT (409 IU/L) and AST (290 IU/L) enzyme activities (Figure 1). Recommendations for additional diagnostic testing were declined by the owner in favor of empirical treatment for potential toxoplasmosis/neosporosis with clindamycin (22.7 mg/kg, PO, q12 h for 14 days).\\nThe dog was presented for evaluation on day 55. The owner reported no clinical changes in the dog and the physical examination remained unremarkable. A serum biochemistry was repeated and revealed relatively unchanged serum CK, ALT, and AST enzyme activities (Figure 1). A commercial ELISA-based kit (4DX SNAP Plus Test kit, IDEXX Laboratories Inc., Westbrook, ME) was negative for detection of antibodies for Ehrlichia sp., Anaplasma phagocytophilum, Anaplasma platys, Borrelia burgdorferi C6 peptide, and Dirofilaria immitis antigen. Differential diagnoses considered by the primary care veterinarian at that time included infectious polymyositis (Toxoplasma gondii or Neospora canis [potentially resistant to clindamycin], Hepatozoon canis or americanum), immune-mediated polymyositis, paraneoplastic polymyositis, congenital myopathy, or a hereditary muscular dystrophic disorder. The following diagnostic tests were recommended; skeletal muscle biopsy, electromyogram (EMG), echocardiogram, serum antinuclear antibodies, and additional infectious disease testing. The owner declined these recommendations because the dog was subclinical and instead opted for an additional course of clindamycin (22.7 mg/kg, PO, q12 h for 30 days). The dog was presented for evaluation on day 97. Again, the owner reported no abnormalities and the dog had an unremarkable physical examination. A serum biochemistry revealed relatively unchanged serum CK, ALT, and AST enzyme activities (Figure 1). All additional diagnostic testing recommendations were declined and the dog was discharged without medications.\\nThe dog was presented to the primary care veterinarian for a wellness examination on day 602. The owner reported no abnormalities since the dog was last evaluated (day 97). The dog continued to exercise daily without limitation. Physical examination was unremarkable. There was no pain elicited with muscle palpation. A complete blood count, serum biochemistry, and urinalysis were performed. The serum biochemistry revealed persistence in severe hyperCKemia and mild to moderate increases in ALT and AST enzyme activities (Figure 1). The complete blood count and urinalysis were unremarkable. The owner declined additional diagnostic tests or empirical therapies at that time because the dog did not demonstrate any clinical abnormalities.\\nThe dog was then presented to the Midwestern University Companion Animal Clinic (MWU-CAC) on day 1,036 for a second opinion regarding the severe hyperCKemia and mild-to-moderate increase in ALT and AST enzyme activities. The dog remained subclinical and exercised daily without limitation. A physical examination performed by a boarded small animal internist (JAJ) was unremarkable. The dog had a normal muscle conditioning score and pain was not elicited with deep palpation of musculature. A neurologic examination performed by a boarded neurologist (JE) revealed the dog was bright, alert and responsive. The dog was ambulatory with no signs of stilted gait, lameness or paresis. There was no overt exercise intolerance after several minutes of walking and trotting. Postural reactions, spinal reflexes and cranial nerves were normal. Serum biochemistry revealed an unchanged severe hyperCKemia and persistent mild-to-moderate derangements in ALT and AST enzyme activities (Figure 1). The dog was negative for detection of antibodies (IgM and IgG) for Toxoplasma gondii or Neospora canis (Protatek Reference Laboratory) and nucleic acids associated with Hepatozoon spp. (Texas A&M Veterinary Medical Diagnostic Laboratory) were not detected. An abdominal ultrasonogram performed by a boarded small animal internist (JAJ) trained in ultrasonography was unremarkable. Differential diagnoses considered at that time in order of likelihood was hereditary muscular dystrophy, and less likely necrotizing myopathy, generalized or focal inflammatory myopathy. Additional diagnostic tests including EMG, echocardiogram, or skeletal muscle biopsies were offered but declined by the owner.\\nThe dog was evaluated on day 1,516 at the MWU-CAC for a pre-anesthetic examination for a dental prophylactic procedure. The owner reported no abnormalities since the dog was last evaluated (day 1,036) and the physical examination remained unremarkable. The dog had no muscle loss and remained active at home. A serum biochemistry revealed an improved, but persistent moderate hyperCKemia and mild-to-moderate increase in ALT and AST enzyme activities (Figure 1). A complete blood count and urinalysis were unremarkable. Next, an echocardiogram and electrocardiogram were performed by a boarded cardiologist (CP) in light of the persistent and unknown cause of severe hyperCKemia to ensure the dog did not have clinically relevant heart disease before undergoing anesthesia. Based on the echocardiographic findings, ACVIM Stage B1 degenerative valvular disease was detected, and demonstrated mild mitral and mild tricuspid regurgitation. The global systolic function appeared preserved. During the echocardiogram, Lead II electrocardiographic monitoring revealed a normal sinus rhythm with no evidence of ectopy.\\nThe last in-hospital recheck examination took place on day 1,807 (5 years from initial evaluation). The owner reported no clinical abnormalities and the physical examination was unremarkable (Supplementary Video). The neurological examination was again normal. A serum biochemistry revealed a moderate hyperCKemia (4,601 IU/L) and mild-to-moderate increases in ALT (225 IU/L) and AST (165 IU/L) enzyme activity (Figure 1). Electrophoretic identification of serum CK isoenzymes (Antech Diagnostics, Irvine, CA, USA) revealed that CK-MM was the predominant electrophoretic fraction (83.7%), followed by CK-MB (10.3%) and CK-BB (6.0%). No injections were administered to the dog at or near the time serum total CK was measured at any of the examination time-points.',\n",
       "    'gender': 'Unknown'}],\n",
       "  [{'age': 80,\n",
       "    'case_id': 'PMC6201379_01',\n",
       "    'case_text': 'An 80-year-old woman was admitted to the hospital after a fall. Her prior history was notable for coronary artery disease status post percutaneous intervention, poorly controlled type 2 diabetes mellitus, congestive heart failure, hypothyroidism, and atrial fibrillation. She had had multiple mechanical falls in the past with cervical spine and right-sided rib fractures. She had no recent hospitalization in the last 90 days and has been living at home prior to presentation. There was no history of exposure to the farm animals. During this hospitalization, she developed progressive dyspnea and hypoxia. Computed tomography (CT) revealed a bilateral pleural effusion, right more than left, with diffuse interlobular septal thickening. Note was also made of a diffuse, mosaic-like attenuation of the lung parenchyma, likely related to air trapping or obstructive small airway disease. There was no pleural enhancement, septations, or air noted within the pleural space (Figure 1(a)). She was noted to have new fracture of right posterior seventh, eighth, and ninth ribs. Laboratory data at admission revealed a white blood cell (WBC) count of 9.7 x 1000/microL (with 83% neutrophils and 1% eosinophils). Her hemoglobin was 11.09 g/dL, hematocrit 40.6%, platelets 143 x 1000/microL, total protein 5.1 g/dL, blood urea nitrogen (BUN) 31 mg/dL, serum creatinine 1.51 mg/dL, serum sodium (Na) 145 mEq/L, chloride (Cl) 102 mEq/L, potassium (K) 3.6 mEq/L, aspartate aminotransferase (AST) 24 IU/L, and lactate dehydrogenase (LDH) 472 IU/L. Serum procalcitonin levels were elevated to 0.59 ng/mL (normal 0.00 - 0.08 ng/mL) and hemoglobin A1C (HbA1C) to 8.9%.\\nBlood cultures prior to initiation of antimicrobial therapy returned negative. Sputum culture was negative for bacteria, including acid-fast bacilli. Transthoracic echocardiography was unremarkable.\\nThe patient was treated initially with levofloxacin and ampicillin/sulbactam for a pneumonia and parapneumonic pleural effusion. Despite antimicrobial therapy, her respiratory status continued to deteriorate and within 48 hours of hospitalization required endotracheal intubation and ventilatory support. A thoracentesis yielded 250 ml of pus (WBCs more than 50,000 with 95% neutrophils, elevated protein 3.6 g/dL (normal 0.0-2.4 g/dL), LDH 13461 IU/L, glucose 6 mg/dL, and pH 6.94). A right-sided thoracostomy was performed to facilitate evacuation of the empyema using a 32 French (F) thoracostomy tube. Postprocedure chest X-ray confirmed the optimal placement of the tube (Figure 2). Gram stains obtained from the pleural fluid collected under sterile conditions revealed gram-positive cocci, and her antibiotics were changed to vancomycin. The final isolate on culture and sensitivity was identified as S. simulans with heavy growth, susceptible to vancomycin and clindamycin only. A repeat CT scan of the chest revealed a persistent collection of right-sided empyema (Figure 1(b)). Ultrasound imaging of the pleural collections did not demonstrate any septations or loculated pockets on either side. Second attempt was made to evacuate the pleural collection with the use of intrapleural fibrinolytic tissue plasminogen activator (t-PA) with little success. The patient was considered a high-risk candidate for surgical intervention considering her frailty and other medical comorbidities. Her course was further complicated by circulatory shock requiring vasopressor supports and atrial fibrillation with rapid ventricular response requiring multiple rate-controlling drugs. After about 3 weeks of a tenuous course, her family elected to withdraw care and she passed away very shortly thereafter.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 48,\n",
       "    'case_id': 'PMC3350232_01',\n",
       "    'case_text': 'SM. A 48-year-old white female presented for evaluation of possible laser vision correction.\\nDescriptions of her eye findings: 20/20 best corrected vision, normal intraocular pressure, simple myopia, normal cornea thickness, normal pupil size, and normal topography. The significant ocular findings: chronic bilateral optic disk edema for ten years.\\nIn the consideration for the selection of either PRK or LASIK as the procedure for this patient, it is necessary to search relevant evidences to support the decision.\\nPRK and LASIK are laser eye surgery procedures intended to correct a person\\'s vision to reduce dependency on glasses or contacts.\\nIn PRK, the surgeon removes the outer layer of epithelium with various techniques, then an excimer laser ablates and reshapes corneal tissue. Anesthetic drops are used to reduce pain. LASIK uses a microkeratome device or a femtosecond laser under suctioning to increase intraocular pressure to about 65 mmHg up to 100 mmHg for 45 second to cut epithelium and stroma to a thickness of 100-180 microns, and then, an excimer laser ablates corneal tissue under the epithelial/corneal tissue flap.\\nPRK is an excellent alternative when LASIK is not an option. It is suitable for those with less corneal tissue, because it can preserve more corneal tissue. There will be no complications of stromal flap in PRK. Unlike LASIK, it does not require pressure suction on the eye ball. Nevertheless, the drawbacks are more discomfort than LASIK in the first 24 hours after procedure, it requires more healing time than LASIK, trauma may cause complications after surgery, and long-term outcomes are not as well established as older corrective procedures such as LASIK.\\nLASIK is appropriate for people who have more corneal tissue. The benefits are less discomfort than PRK, almost no pain, 20/20 vision or better is typically achieved by the first day, corneal haze is very rare, immediate clear vision, and follow-up enhancements are easier if needed. However, the drawbacks are contraindicated with thinner corneas, flap may dislodge with trauma, increases higher-order aberrations (HOA), nonsmooth flap may lead to astigmatism, flap may result in scars, and postoperational treatment is needed in approximately 5% of patients.\\nA search strategy was developed to search evidence in the literature to support the decision in the selection of the better procedure for this patient.\\nPopulation: patients have sick optic nerve undergoing refractive laser surgery.\\nIntervention: PRK.\\nComparison: LASIK.\\nOutcome: no damage to optic nerve after procedure.\\nBoolean operators are the using of combining words and methods to search in electronic databases. The combining words used here are AND, OR.\\nAccording to Boolean operators:\\nAND:will produce references that include both keywords.\\nOR:will produce references that contain at least one of the keywords\\n refractive laser surgery\\n PRK\\n LASIK\\n optic disc\\n#1, and #4 include refractive laser surgery and optic disc\\n#2, and #4 include PRK and optic disc\\n#3, and #4 include LASIK and optic disc\\n#2, and #5 include PRK and refractive laser surgery and optic disc\\n #3, and #5 include LASIK and refractive laser surgery and optic disc\\nrandomized control trial\\nsystematic reviews\\nqualitative studies\\n#9, #8, and #12\\n#9, #8, and #10\\n#9, #8, and #11.\\n Limits: English, research.\\nThe search was conducted over Pubmed, Medline and Cochrane Library. 1492 articles were found, and 5 papers were selected for this case report. Pubmed had 83 articles, and none was selectedfrom Cochrane library review.\\nThere were three observational case reports and two experimental studies (see Tables 1 and 2).\\nLASIK-induced optic neuropathy by Cameron et al. clearly described the case of a subject with a previously normal optic nerve who developed bilateral optic neuropathy after LASIK surgery. The neuropathy manifested with visual field defects. Valid test such as complete eye exam with detailed evaluation of the optic nerve, detail medical history, stereodisc photographs, GDx nerve fiber analyzer, was used rigorously to confirm the diagnosis associated with LASIK pre-op and post-op. Other possible causes of optic neuropathy were also carefully ruled out. The author concluded that optic nerve neuropathy is a dangerous complication of LASIK. It may be due to barotrauma or ischemia from elevation of intraocular pressure by the suction ring during the LASIK procedure. Lee et al. and Montezuma et al. also reported similar cases with the same conclusion. Lee et al. even reported two cases that experienced chronic disc edema pre-op similar to this case pre-op. The two cases he reported had LASIK and suffered acute visual loss. Nevertheless, the experimental parallel control trial of Lester demonstrated no statistically significantly different measurement between before and after a compression of 100 mmHg to the eye for 45 second (as in suction ring pressure of LASIK procedure) in the mean RNFLT (retina nerve fiber layer thickness). This quantitative study showed that the acute increase in intraocular pressure during LASIK did not significantly change the thickness of retina nerve fiber layer in normal eyes. Furthermore, Hamada conducted a prospective consecutive study of 53 normal eyes to compare the RNFLT before LASIK and after LASIK. He concluded that transient extreme elevation of intraocular pressure (IOP) during LASIK does not affect RNFLT in normal myopic eyes for at least one year after surgery.\\nThere were two case reports and one case series. Although these are poor-quality studies and rank near the bottom of hierarchy of evidence, these cases provide valuable insights and warning for potential sight-threatening conditions.\\nThe two experimental studies were appraised according to the CASP framework.\\nBoth studies have a clear focus:\\nP: patients undergoing refractive laser surgery\\nI: LASIK (will receive 100 mmHg of pressure for 45 seconds during the procedure) or 100 mmHg of pressure for 45 seconds.\\nO: change in RNFLT (retina nerve fiber layer thickness).\\nThese were not randomized trials but were prospective consecutive cases.\\nParticipants were appropriately allocated to intervention. The groups appeared equivalent (all normal eyes) and had low risk of selection bias with strong internal validity.\\nIt was not possible to \"blind\" due the nature of intervention. However, the outcome measures are objective that will reduce the threat to internal validity.\\nAll the participants in these two studies were accounted for at the conclusion. The follow-up rates were 100% that increase both the internal and external validity.\\nThe data collection and the follow-up were done in the same way. (This increases internal validity.)\\nThe power calculations were not mentioned in the either of the two studies. It is a decrease of external validity. However, Hamada\\'s.Study may have enough power with 53 participants for a single outcome measurement.\\nThe result showed no statistically difference in RNFLT (retina nerve fiber layer thickness) before and after the application of pressure (100 mmHg) to the normal eye ball during LASIK or for the experiment for 45 seconds in 2 minutes, one month, 7 month, and 13 month.\\nNo confidence interval was reported in the two studies.\\nThe internal and external validities were good in the studies for using locally.\\nSince glaucoma patients are contraindicated for LASIK surgery and it is a rare to see patients having sick optic disc desire laser refractive surgery, there are neither systematic reviews nor randomized control studies available as reference for this case. Furthermore, the alternative laser refractive procedure such as PRK is available for those suspicious cases; most surgeons will choose the alternative way to avoid catastrophic result.\\nThe two experimental studies showed no statistically difference in RNFLT (retina nerve fiber layer thickness) before and after the application of pressure (100 mmHg) to the eye ball during LASIK or for 45 seconds in normal eyes. It revealed the safety of LASIK to normal eyes with the application of 100 mmHg pressure for 45 seconds during surgery by quantitatively measuring the change of nerve fiber thickness using scanning laser tomography or nerve fiber analyzer (laser diagnostic technology).\\nAll the cases that report with abnormal optic nerve showed severe vision decrease due to LASIK. The case series of Lee had two identical conditions of this case (optic disc edema) and suffered severe vision loss after LASIK. However, in Cameron\\'s case with normal optic nerve before operation, there was development of optic neuropathy after LASIK.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 43,\n",
       "    'case_id': 'PMC8464216_01',\n",
       "    'case_text': 'A 43-year-old female patient with no significant medical history consulted for a headache of abrupt onset and rapidly increasing intensity and resistant to analgesics. She was not known to be hypertensive or addicted to drugs and had no personal or family history of bleeding disorders. She was conscious on admission and had no signs of focalization or meningeal syndrome. Her blood pressure, heart rate and temperature were respectively of 140/80 mmHg, 120 beats/min and 37 C. Non contrast cerebral CT scan revealed a compressive left fronto-parietal subdural hematoma (Figure 1). Routine hemostasis tests showed a platelet count of 130 giga/l, a prothrombin level of 70% and an activated partial thromboplastin time (aPTT) of 12 seconds. Surgical evacuation had been performed but the success of the procedure was short-lived as the hematoma had rapidly reconstructed to indicate neurosurgical re-intervention under massive infusion of fresh frozen plasma associated with repeated injections of tranexamic acid. In addition, cerebral magnetic resonance angiography did not show any underlying arteriovenous abnormalities (Figure 2). We maintained daily infusions of fresh frozen plasma (600 mL/d) and tranexamic acid and the post-operative clinical course was satisfactory (Figure 3).\\nThe spontaneous nature of the subdural hematoma associated with a normal hemostasis assessment suggested the hypothesis of an underlying \"occult\" coagulopathy. We measured factor XIII activity by photometric method and found a low rate of 41% (normal value: 70-140); the biological assessment showed a non-regenerative normochrome normocytic anemia at 7 g/dl, leuko-neutropenia at 3.6 giga/l without thrombocytopenia, C3/C4 hypocomplementemia and polyclonal hypergammaglobulinemia. Bone marrow biopsy and thoraco-abdomino-pelvic CT scan were unremarkable. Antinuclear antibody testing was positive at a rate of 1/1280 with specificity for anti-dsDNA, anti-SSA/Ro and anti-SSB/La (Figure 4). The antiphospholipid antibody test was negative. Liver function, renal function and 24-hour proteinuria were normal.\\nAll clinical and immunobiological findings were consistent with the diagnosis of systemic lupus erythematosus (SLE) with hematologic tropism. Biopsy of the accessory salivary glands was discussed, looking for Gougerot syndrome associated with SLE. However, due to the hemorrhagic risk associated, this invasive procedure was not performed. The discovery of SLE had raised the possibility of an anti-factor XIII autoantibody, but this had not been sought in our context. The patient received an initial bolus of methylprednisolone 15 mg/kg/day for 3 days followed by oral relay at a dose of 1 mg/kg/day of prednisone combined with hydroxy chloroquine 200 mg twice daily at patient s discharge. She was seen 1 month later and then every 3 to 6 months. The treatment was well observed with good tolerance. Three years later, the patient is free of treatement with no recurrence of hemorrhage, a normal blood count and a factor XIII level of 143%.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 76,\n",
       "    'case_id': 'PMC6915124_01',\n",
       "    'case_text': 'A 76-year-old male with stage IV, small bowel NET metastatic to the liver had been followed by our institution for 4 years with stable hepatic metastatic disease on octreotide long-acting release (LAR) therapy. Originally, the tumor Ki-67 index was 5% and 24-hour urine 5-hydroxyindole acetic acid (5-HIAA) was 105 mg. The patient presented with mild progression of disease on abdominal magnetic resonance imaging (MRI) (Figure 1) after approximately 4 years of stable disease. Six months following this abdominal MRI, the patient developed bilateral lower extremity swelling, weight gain, and bloating lasting over 1 month. The serum brain-natriuretic peptide (BNP) value was 161 pg/ml (normal range < 100 pg/ml). N-terminal proBNP and other cardiac biomarkers were not available. Transthoracic echocardiogram showed tricuspid regurgitation and right ventricular wall thickening with an echogenic mass in the RV free wall extending to the RV outflow tract. There was severe malcoaptation of the thickened tricuspid valve leaflets. Tricuspid regurgitation was described as widely open regurgitation with a peak regurgitant flow velocity of 203 cm/s. Of note, the aortic and mitral valves were structurally normal without stenosis or regurgitation. Cardiac magnetic resonance (CMR) was obtained for further evaluation.\\nCMR (Figure 2) showed a 2.6 cm lesion in the right ventricular free wall and a 2.4 cm lesion in the left ventricular anteroseptal wall. These lesions demonstrated high T2-weighted signal and isointense T1-weighted signal with postcontrast perfusion, findings compatible with myocardial metastases. Of note, the RV free wall lesion extended superiorly near the base of the tricuspid valve annular region. Balanced cine steady state free precession (bSSFP) images showed abnormal thickening of the anterior tricuspid valve leaflet, and the leaflet did not coapt normally during systole contributing to severe tricuspid regurgitation. The right atrium was moderately dilated.\\nThe patient underwent bioprosthetic tricuspid valve replacement and biopsy and debulking of the myocardial tumors. The myocardial tumors were histologically confirmed as NET metastases. The patient recovered well from surgery, and follow-up clinical visits demonstrated significant improvement in his carcinoid heart disease. As of the latest visit, the patient has excellent cardiac function with resolution of tricuspid regurgitation. His 9-month postoperative follow-up CT scan showed relatively stable disease, and his urine 5-HIAA was improving. The patient is continuing on octreotide LAR 30 mg.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': None,\n",
       "    'case_id': 'PMC3201100_01',\n",
       "    'case_text': \"An elderly male patient in his 60's with a 150 pack year history of smoking, chronic obstructive pulmonary disease, hiatal hernia, gastroesophageal reflux disease, and coronary artery disease presented to the emergency room complaining of a three-week history of incessant forceful cough and right-sided chest pain in the absence of trauma. He required emergent uneventful endotracheal intubation and mechanical ventilation for hypoxic respiratory failure upon arrival to the emergency room. Pertinent medications included oral aspirin 325 mg and clopidogrel 75 mg daily.\",\n",
       "    'gender': 'Male'},\n",
       "   {'age': None,\n",
       "    'case_id': 'PMC3201100_02',\n",
       "    'case_text': \"Physical examination revealed an obese male with a heart rate of 110 beats per minute and blood pressure 135/80 mmHg. Decreased breath sounds over the right lung with overlying severe right anterior chest wall ecchymosis and subcutaneous edema were noted. No clinical signs of heart failure were present on physical exam.\\nLaboratory testing included an arterial blood gas with a pH 7.28, PaO2 107 mmHg (100% FiO2), PCO2 43 mmHg, HCO3 20 meq/L, hemoglobin 11.5 g/dL, and white blood cell count 23,100 cm2. Chest X-Ray (CXR) on presentation (Fig. 1) revealed minimal opacity at the right lung base and blunting of the left costophrenic angle. Computed tomography (CT) of the chest (Fig. 2) revealed a dramatic lateral herniation of the right lung at the seventh intercostal space without evidence of any overlying rib fractures. Current radiologic findings were compared to images from a prior CT scan performed five months earlier which demonstrated symmetrically developed thoracic cage muscles without evidence for fracture or herniation.\\nInitial management in the medical Intensive Care Unit (ICU) included intravenous sedation and low tidal volume ventilation with attention to peak airway pressures and permissive hypercapnea given the high risk for incarceration and potential advancement of the lung herniation. An initial conservative strategy was opted for given the patient's overall co-morbidities contributing to high surgical risk and having no evidence for impending lung incarceration.\",\n",
       "    'gender': 'Male'},\n",
       "   {'age': None,\n",
       "    'case_id': 'PMC3201100_03',\n",
       "    'case_text': 'Repeat CT chest in 24 hours revealed multi-lobar infiltrates. The previously identified lung herniation was no longer visualized but an extensive extra pleural collection consistent with a large hematoma remained. Patient remained on intravenous antibiotics during this time but blood and sputum cultures showed no growth of organisms. Repeat chest CT eight days later showed right anterior abdominal intramuscular hemorrhage. Examination showed expanding hematoma (Fig. 3). Radiological studies supported evidence for contralateral acute lung injury, making mechanical ventilation and oxygenation very challenging.',\n",
       "    'gender': 'Unknown'},\n",
       "   {'age': None,\n",
       "    'case_id': 'PMC3201100_04',\n",
       "    'case_text': 'Other ICU complications included persistently high fevers despite broad-spectrum antibiotics, intra-cerebral hemorrhage due to cerebral amyloid angiopathy, and ST segment elevation myocardial infarction. His hospital course was further complicated by anoxic encephalopathy due to inability to maintain adequate gaseous exchange. Aggressive medical care was stopped after several weeks of ICU care. The patient expired soon after.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 36,\n",
       "    'case_id': 'PMC7086418_01',\n",
       "    'case_text': \"A 36-year-old male presented to the emergency department with complaints of acute (approximately 1-hour evolution) and painless visual loss of the right eye. He was promptly observed by ophthalmology that determined a fully preserved (6/6) visual acuity of the left eye but near blindness of the right eye (6/60). The patient was agitated but had no other complaints. At inspection, the eye had no signs of infection or trauma. Neurological exam did not identify any change: sensory and motor examinations were normal and there was no facial asymmetry, aphasia, dysarthria, or dysmetria. Oculomotor movements and pupillary reflexes were preserved.\\nPrevious medical history included a known bicuspid aortic valve disease. 2 years later, and after a dental procedure, the patient developed an aortic valve endocarditis due to an infection from Streptococcus sanguinis. This led to an ischemic stroke, from which the patient recovered completely. He was under antibiogram-directed antibiotic therapy for 1 month when a second stroke happened, and he was then submitted to an urgent surgical replacement of the aortic valve for a mechanical prosthesis that went well. He was discharged with a transthoracic echo referring a normofunctional prosthesis with no other significant alterations and an indication for warfarin therapy for INR target between 2 and 3. At the time of presentation of this case, the patient had medical records available that confirmed INR values between 2 and 2.5 for the last year.\\nDifferential diagnosis for single eye acute visual loss includes an acute stroke/transient ischemic accident, compressive lesion, trauma, infection, Purtscher retinopathy and occlusion of the central retinal artery due to either atherosclerotic disease, embolism, arteritis or the presence of a hypercoagulable state (due to neoplastic disease or inherited pro-coagulative diseases, for example).\\nA fundoscopic exam was immediately performed and identified the foveola assuming a cherry red spot-like image with retinal whitening, which suggested that the visual loss had been caused by a central retinal artery occlusion (Figure 1(a)). Due to the patient's previous medical history, cardiology observation was required to search for a cardiac source of embolism. The patient's physical exam was normal, with cardiac auscultation identifying a clear metallic click as the second cardiac sound and a slight nonradiating systolic murmur (I/VI). A TTE was performed, showing a nonobstructive aortic prosthesis and a periprosthetic echolucent pulsatile region with a hyperechogenic mobile round structure inside (Figures 1(b) and 2). To better characterize these findings, a TOE was performed (Figures 1(c), 1(d), 3, and 4) revealing a free hyperechogenic highly mobile structure suggestive of a free thrombus inside a pseudoaneurysm in the mitral-aortic intervalvular fibrosa, protruding into the left ventricular outflow tract through a small communication orifice (supplementary material  and ).\\nIn the acute setting in the emergency department, treatment consisted of the intermittent digital massage of the affected eye and the use of ocular hypotensive drugs and intravenous acetazolamide. The patient had a partial recovery of right eye visual acuity to 6/12. After 3 months of INR-adjusted warfarin treatment for target 3.0-3.5, the patient was submitted to a surgical pseudoaneurysm closure with a synthetic patch.\\nSince surgical pseudoaneurysm closure, and after the 1-year follow-up, the patient had no other embolic event. Visual acuity had no further improvements.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 24,\n",
       "    'case_id': 'PMC8039197_01',\n",
       "    'case_text': 'A 24-year-old lady on APD for almost two years secondary to type 1 diabetes mellitus. She was first diagnosed with type 1 diabetes mellitus at the age of 7. She has diabetic proliferative retinopathy and diabetic neuropathy with no previous history of peritonitis. She had two previous admissions 10 years ago due of diabetic ketoacidosis. She presented to our PD Unit on April 2020 with a history of lower abdominal pain for 3-days duration. The pain was moderate in severity, non-radiating, with no relieving or aggravating factors. It was not associated with fever, nausea, vomiting or turbid discoloration of PD fluid. There was no history of urinary symptoms or diarrhea or previous episodes of peritonitis.\\nThe patient was vitally and clinical stable Her physical examination showed blood pressure of 125/70 mmHg, pulse rate of 90/min, respiratory rate of 18/min and temperature of 37.8 C. She has left eye diabetic proliferative retinopathy in addition to bilateral legs neuropathy and dermopathy. Her abdominal examination showed no evidence of hepatosplenomegaly. Her superficial palpation revealed mild tenderness in hypogastric area. The rest of her clinical examinations were unremarkable. Her investigations were normal apart from white blood cell count of 4500/microliter, hemoglobin of 10.6 gm/dL and glycated hemoglobin of 6.7%. She was well controlled on glargine 20 at bedtime and aspart insulin 3 units with meals.\\nThe PD fluid was clear with no exit site discharge. PD fluid analysis, gram stain and culture were requested, and the patient was treated as a case of peritonitis and 1gm of ceftriaxone IP and 1gm of vancomycin IP were given as per our protocol. Her PD fluid analysis confirmed the presence of peritonitis with WBC >200, however, the initial results of PD fluid gram stain and cultures as well as exit site cultures all came negative.\\nThe patient was receiving her daily dose of IP ceftriaxone when the second aerobic culture of the peritoneal fluid confirmed the presence of Bacillus licheniformis. Upon further questioning, she admitted having a cat and a dog at home. The antibiotic regimen was changed to 1000 mg of Vancomycin at 4 days interval and adjusted according to Vancomycin blood level with target of 10-15 mg/liter. The patient recovered completely from her peritonitis and did not develop any recurrence of her peritonitis over 6 months follow up following her course of treatment with Vancomycin.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 27,\n",
       "    'case_id': 'PMC6376526_01',\n",
       "    'case_text': 'A 27-year-old Caucasian gentleman was referred to the plastic surgery outpatient clinic with a 7 month history of pain and swelling of his left middle toe. The cause of his symptoms was unclear, with the patient linking the episode to minor trauma. Initially, he had seen a chiropodist who diagnosed him with an in-grown toenail. The toenail was subsequently removed; however, his symptoms worsened. At this stage, he was noted to have subungual discolouration. A punch biopsy was performed with histology demonstrating a pigmented keratinous disc, and he was subsequently referred to our service as a possible case of malignant melanoma.\\nHe has no other significant past medical history and did not take any regular medication. He smoked approximately 10 cigarettes per day since aged 15.\\nUpon review in clinic, he was found to have an ulcerated area over the dorsum of his left middle toe with associated erythema and swelling, which was actively discharging pus but good peripheral pulses. He also reported a 6-week history of similar symptoms on his left index finger, over the dorsum of the proximal inter-phalangeal joint (PIPJ) which had appeared spontaneously. He had been treated with several courses of oral antibiotics by his general practitioner with no improvement. He was admitted acutely for intravenous antibiotics, surgical exploration and washout of both digits, and a biopsy of the left middle toe for microbiology and histology to rule out osteomyelitis and malignant melanoma. Initial biopsy of the nail bed excluded malignancy and instead showed acute inflammatory changes. The index finger defect was further debrided and closed with a local flap.\\nFollowing this initial surgical intervention, the patient went on to have a long and protracted clinical course from complications of poor wound healing and necrosis, with multiple hospital admissions over a 15-month period. He was reviewed by the vascular team with full assessment of peripheral vasculature using ankle-brachial pressure index and computed tomography (CT) angiography which did not identify a specific cause for his necrotic digits. He developed osteomyelitis of both the left third toe and left index finger, which required amputation to prevent proximal spread of infection. A clinical diagnosis of TAO was suspected when he developed similar symptoms in the adjacent left second toe 2 months after initial presentation. Negative autoimmune, vasculitic and coagulopathy screening blood tests, including anti-neutrophil cytoplasm antibodies (ANCA), erythrocyte sedimentation rate, anti-cardiolipin antibodies, anti-thrombin, proteins C and S, supported the diagnosis. Genotyping for prothrombin mutations was negative; however, the patient was positive for homozygous factor V Leiden mutation. Verbal smoking cessation advice was reinforced frequently; however, the patient found complete abstinence difficult. This ultimately resulted in a Ray amputation of the second and third toes due continued non-healing (Figure 1). Following this, he underwent a short period of remission. Unfortunately due to ongoing use of tobacco, symptoms recurred in the contralateral and dominant right hand affecting his index and middle finger tips (Figure 2A and B). The right index finger became gangrenous and required amputation. During the procedure, a segment of digital artery was biopsied. Histopathologic analysis showed evidence of chronic inflammation with lymphocytic arteritis and thrombosis, confirming a diagnosis of TAO (Figure 3).',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': None,\n",
       "    'case_id': 'PMC9148238_01',\n",
       "    'case_text': 'Our patient is a 32 y/o male with end-stage renal disease secondary to DM type 2. Past medical history was significant for congestive heart failure (CHF), diabetic neuropathy with foot ulcer, and obstructive sleep apnea (OSA). He was on hemodialysis (HD) since 10/2017. He was evaluated by our multidisciplinary team and approved for a kidney transplant. A suitable donor became available, and he underwent kidney transplant in March 2021.\\nThe surgery was performed using the standard technique; the renal artery was anastomosed to the external iliac artery in an end to side fashion. The renal vein was anastomosed to the external iliac vein in an end to side fashion. The ureter was anastomosed to the bladder and imbricated to form a nonrefluxing anastomosis.',\n",
       "    'gender': 'Male'},\n",
       "   {'age': None,\n",
       "    'case_id': 'PMC9148238_02',\n",
       "    'case_text': 'The surgery was uneventful. Intraoperatively, the patient remained hemodynamically stable with no episodes of hypotension; the patient had an average MAP (mean arterial pressure) of around 75 mmHg. Reperfusion of the kidney perfused well.',\n",
       "    'gender': 'Unknown'},\n",
       "   {'age': None,\n",
       "    'case_id': 'PMC9148238_03',\n",
       "    'case_text': 'On postoperative day 1, the patient complained of weakness of both his legs and loss of sensation. On examination, the patient had normal muscle tone, power of 0/5 throughout his lower limbs, and absent lower limb reflexes.\\nLight, touch, temperature, and pin-prick sensations were absent below the midthigh bilaterally while vibration was reduced throughout bilaterally.\\nA CT AP was done, which was normal.\\nAn MRI of the brain and the spine was done which showed a small basal ganglia infarct and an infarct of the spinal cord at the level of T5-6 (Figures 1 and 2)',\n",
       "    'gender': 'Male'},\n",
       "   {'age': None,\n",
       "    'case_id': 'PMC9148238_04',\n",
       "    'case_text': 'Neurology and neurosurgery were consulted; based on their recommendation, the patient was planned to be managed conservatively and maintain his MAP > 85 mmHg.\\nA MR angiogram of the cerebrospinal vessels was performed which did not show any significant stenosis Figure 3.\\nAn echocardiogram was done which was significant for left ventricular hypertrophy. A bubble study done at the time did not demonstrate any shunts.',\n",
       "    'gender': 'Male'},\n",
       "   {'age': None,\n",
       "    'case_id': 'PMC9148238_05',\n",
       "    'case_text': 'The patient received induction immunosuppression with ATG and prednisone taper as per our institution protocol and maintenance immunosuppression with mycophenolate and tacrolimus (Figure 4).\\nHe had delayed graft function and required dialysis twice, and kidney function stabilized without the need for dialysis by the time of discharge.',\n",
       "    'gender': 'Male'},\n",
       "   {'age': None,\n",
       "    'case_id': 'PMC9148238_06',\n",
       "    'case_text': 'The patient was discharged to a rehab facility for spinal cord rehab. At the time of discharge, he had a power of 1/5. He needed intermittent straight catheterizations to drain his bladder and required suppositories every few days to help with his defecation.\\nHe was readmitted twice, for a UTI the first time. He was evaluated for a diabetic foot ulcer with concerns for osteomyelitis in this admission; a foot MRI was done which showed osteomyelitis of the fourth and fifth metatarsal heads. He was not willing for debridement and resection of the infected bone and instead preferred prolonged IV antibiotics to treat this.\\nHe was admitted for the second time with worsening sacral decubitus ulcers, and a diverting loop colostomy was done to aid with healing. His nonhealing diabetic foot ulcer was again reassessed. He underwent wound debridement and ray amputation of the fourth and fifth toes during this admission.\\nHe continues to be followed up in clinic. At the time of submission, he continues to live in a rehab facility; his kidney function is at his posttransplant baseline.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 11,\n",
       "    'case_id': 'PMC9344096_01',\n",
       "    'case_text': 'A previously healthy 11-year-old girl presents with a 4-week history of postprandial abdominal pain. Outside hospital labs were significant for leukocytosis with predominant eosinophilia, hypoalbuminemia, and elevated lipase. Computed tomographic scan revealed large ascites and a mildly dilated pancreatic duct. Ultrasound showed neither gallstones nor dilated bile ducts. Due to her history of epigastric abdominal pain with elevated lipase level, she was diagnosed with acute pancreatitis complicated by ascites and was subsequently transferred to our institution for further evaluation and management.\\nUpon arrival, her physical examination was significant for an ill, dehydrated, and cachectic-appearing prepubescent white girl. She was found to have abdominal distention with fluid wave. She was nontender to palpation without peritoneal signs. Her history was significant for associated fever and decreased appetite with 10 lb weight loss since the onset of her abdominal pain. She had no significant past medial history with no known medication ingestion prior to presentation and no history of trauma. She had no known family history of GI diseases, malignancy, or pancreatitis. She had no history of alcohol use, smoking, or illicit drug use.\\nHer baseline labs at time of admission confirmed leukocytosis with white count 16 300/mm3 with 40% eosinophils and absolute eosinophil count of 6520/mm3. Her lipase was elevated at 862 U/L and albumin was low at 2.4 g/dL. All other labs were grossly within normal limits on admission.\\nOur patient subsequently underwent a workup for eosinophilic-predominant pancreatitis of unknown etiology complicated by large ascites.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 23,\n",
       "    'case_id': 'PMC4898292_01',\n",
       "    'case_text': 'A 23-year-old female was discharged from inpatient medical care following treatment for thyrotoxicosis with secondary electrolyte abnormalities. She returned 24 hours after discharge with recurrent vomiting and several episodes of nonbloody diarrhea, profuse drooling, and repeated falls when she attempted to stand or walk. The patient had not been able to tolerate any oral medications since discharge secondary to emesis. An admission CT scan revealed a small-bowel obstruction, possibly due to superior mesenteric artery syndrome. She was considered unstable for surgical management at the time and was treated conservatively, including placement of a nasogastric tube. On hospital day 16, a weighted-tip nasoenteral feeding tube (Corflo-Ultra NG, 8Fr x 43\" 7gm, CorPak MedSystems, Wheeling, IL) was passed under fluoroscopic guidance beyond the obstruction. Subsequent feeds were well tolerated. A CT scan on the day of discharge demonstrated the radio-opaque weighted tip of the feeding tube in the proximal jejunum. She was discharged on hospital day 26 with the feeding tube for nightly feeds until her scheduled followup with the surgery service.\\nThirty-eight days after discharge:47 days after placement of the nasoenteral tube:the patient returned for an outpatient KUB and upper GI series to re-evaluate the small-bowel obstruction. Fluoroscopy showed eight metallic-density foreign objects dispersed throughout the ascending and descending colon (Fig. 1). The weighted tip of the enteral feeding tube showed additional metallic-density disks malaligned within the casing and contour irregularity, suggesting a defect in the casing wall. The upper GI series showed resolution of the small-bowel obstruction. The company confirmed that the weighted tip of an intact enteral feeding tube contains 23 titanium disks. Although requested by the radiology service, the patient has not returned the defective tube for further evaluation. At the time of contact, she was not having further gastrointestinal difficulties.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 41,\n",
       "    'case_id': 'PMC10276592_01',\n",
       "    'case_text': 'The patient was a 41-year-old male (body weight of 70 kg) who was admitted to the Kidney Critical Unit of Jiangsu Province Hospital due to recurrent fever for more than 10 days. The patient had a history of uremia for more than 10 years. He had been receiving continuous renal replacement therapy via hemodialysis. The patient got a fever (38.6  C) and chills for unknown reason about 10 days prior. Oral prednisone and ibuprofen suspension were used to help control the fever of unknown origin but only contained the temperature temporarily. Echocardiography and laboratory tests confirmed the diagnosis of acute IE caused by MRSA, which was isolated from sputum and blood culture. A local hospital had used vancomycin plus moxifloxacin to treat IE which failed. The patient also had a history of restless leg syndrome for 9 years and thoracic trauma in March 2021.\\nAt the time of admission, the patient had a clear mind in thinking. Physical examination showed body temperature of 36.8 C, respiratory frequency 25 breaths per minute, heart rate 124 beats per minute, and blood pressure 107/75 mmHg. Wet rales were heard on both lungs. Chest CT scan identified multiple patchy nodular opacities with cavities in both lungs. Systolic heart murmur was heard over the tricuspid valve area. Echocardiography revealed the presence of tricuspid valve vegetation along with left heart enlargement and abnormal ventricular wall movement. Moderate reflux of mitral valve and tricuspid valve and reduction of left ventricular contractile function were also confirmed (Supplementary Video 1). The left ventricular ejection fraction was about 20%. Initial laboratory tests showed significant leukocytosis (WBC 21.4x109/L) and neutrophils predominance (90.1%), decreased lymphocytes (1.1x109/L), anemia (hemoglobin of 6.8 g/dL), and platelet count of 260x109/L. Serum procalcitonin was elevated to 1.55 ng/mL (normal range: 0-0.5 ng/mL) and N-terminal pro-B-type natriuretic peptide (NT-proBNP) was also significantly higher (>35,000 pg/mL) than normal range (<125 pg/mL). MRSA was isolated from sputum and blood culture repeatedly (on July 8, July 17, and July 24). This clinical evidence confirmed the diagnosis of right heart IE due to MRSA (Table 1).\\nVancomycin (1.0 g q12h) and moxifloxacin were used to control infection initially in accordance with the guideline for management of IE and the results of antimicrobial susceptibility testing. However, the patient had recurrent fever up to 39.0 C until admission to our hospital. After admission, moxifloxacin was switched to daptomycin (420 mg qd) plus cefoperazone-sulbactam (3.0 g q8h) empirically considering the potent activities of daptomycin against MRSA and possible Gram-negative bacterial infection. Emergency surgical procedures were carried out to remove the vegetation on the tricuspid papillary muscle and replace the tricuspid valve. Unfortunately, fever remained after the operation, which was considered partly due to bloodstream and pulmonary MRSA infection. Secondary Acinetobacter baumannii infection was also possible because a new infection was detected by chest radiography. Vancomycin was combined with daptomycin to control MRSA infection because daptomycin alone was insufficient. Considering the severe underlying disease of the patient, nephrotoxicity of vancomycin, and possible bleeding tendency due to oral anticoagulants after surgery, the anti-MRSA regimen was further adjusted. Contezolid 800 mg was administered orally twice daily to replace vancomycin to target MRSA. Tigecycline and meropenem were also used to deal with the secondary pulmonary infection caused by A. baumannii. The clinical symptoms were resolved and the temperature was normlalized 15 days after contezolid add-on therapy (Figure 1). The subsequent blood culture was negative. \\nAt the 3-month follow-up since the diagnosis of IE, no relapse of infection or drug-related adverse reaction was reported. The latest follow-up laboratory tests on February 14, 2022 (6 months after discharge from hospital) did not show any symptoms or signs of IE. The liver function and coagulation tests were generally normal except slight bleeding tendency, evidenced by prothrombin time of 15.9 seconds (normal range: 10.2-12.9) and international normalized ratio of 1.35 (normal range: 0.87-1.16). Overall, the refractory IE caused by MRSA was successfully treated with oral contezolid 800 mg every 12 hours (twice daily) for 45 days.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 0,\n",
       "    'case_id': 'PMC9990766_01',\n",
       "    'case_text': 'A male infant was born at term through uncomplicated vaginal delivery without instrument-assistance or fetal scalp electrodes. A left-sided CH was noted post-partum. At 3 weeks old, he presented to an outside institution with 1-day of fever, emesis, and diarrhea. He was started empirically on IV ampicillin and gentamicin, and infectious workup later revealed pan-sensitive E. coli bacteremia, urinary tract infection, and meningitis. After initial clinical improvement, he was transitioned to monotherapy with IV ampicillin. Shortly thereafter, he became febrile again, so cultures were redrawn and a head ultrasound performed, which was largely unrevealing. The patient was transferred to our institution for further management [Table 1].',\n",
       "    'gender': 'Male'},\n",
       "   {'age': None,\n",
       "    'case_id': 'PMC9990766_02',\n",
       "    'case_text': 'On arrival, he was noted to have a large, benign-appearing CH, and a reassuring physical examination, despite being febrile with a rising C-reactive protein (CRP). Magnetic resonance imaging (MRI) of the brain did not reveal any acute intracranial processes or definitive signs of CH infection [Figure 2]. Over the following days, the patient was transitioned to IV ceftriaxone for an up-trending fever curve [Figure 3]. A sterile bedside tap was performed with return of 2 mL of bloody aspirate; cultures and gram stain were negative. The patient remained intermittently febrile and after a multidisciplinary discussion, he was taken for an I&D. Intraoperatively, no gross purulence or abnormalities of the underlying bone were identified. Histopathological examination confirmed a diagnosis of CH without infection or organisms. All surgical cultures and gram stain were negative. The patient tolerated the procedure with no complications.',\n",
       "    'gender': 'Male'},\n",
       "   {'age': None,\n",
       "    'case_id': 'PMC9990766_03',\n",
       "    'case_text': 'Our patient became afebrile on postoperative day (POD)1 and remained clinically improved for the remainder of his hospitalization [Figure 3]. After surgical drain removal and PICC line placement, he was discharged on POD6 with a 21-day course of IV ceftriaxone. The patient was seen in clinic on POD12 and noted to be doing well with no reaccumulation of the CH.\\nA MEDLINE search was conducted using the keyword \"cephalohematoma.\" Full-text, English-language articles were reviewed for management and outcomes of infected CH. This resulted in 25 publications, documenting 58 cases [Table 2].\\nThe majority of cases 52% (n = 30) had one or more concurrent infections, while 48% (n = 28) did not have any. E. coli was the most common organism isolated (n = 32; 55%), followed by polymicrobial infections (n = 8; 14%). Only one case reported no growth in the CH culture despite Gram-negative rods noted on gram stain.\\nAll patients were treated with IV antibiotics; some followed by a course of oral antibiotics. Duration varied from 10 days to 6 weeks, depending on concerns for osteomyelitis or other concurrent infections. The majority were treated with needle aspiration alone (n = 34/58). Surgical I&D was performed in 23 cases, sometimes after needle aspiration (n = 13). One case was successfully treated with IV antibiotics alone. The most common complications of infected CH were osteomyelitis (n = 10), and overlying scalp necrosis or abscess (n = 9). The mortality rate of cases reported in our literature review was 8.6% (n = 5/58; range 0-11%).',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 60,\n",
       "    'case_id': 'PMC3350277_01',\n",
       "    'case_text': 'A 60-year-old male reported with the complaints of throat pain and hoarseness of voice for 3 months. The patient had been smoking 2 packs of cigarette per day for the past 25 years. Direct laryngoscopy revealed a 2 cm growth below the vocal cords. Contrast Enhanced Computed Tomography (CECT) of neck showed growth in subglottic region, and CECT thorax and abdomen showed multiple hypodense lesions in both the lobes of liver suggestive of metastasis (Figure 1). \\nA biopsy was taken from the lesion, and histopathological examination revealed small round cells with scant amount of cytoplasm and hyperchromatic nuclei suggestive of a round cell tumor (Figure 2).\\nImmunohistochemistry (IHC) examination showed that the tumor cells were positive for synaptophysin (Figure 3) and cytokeratin. CD-20, CD-3, and LCA were negative. So the diagnosis of small cell carcinoma was made.\\nThe patient was given palliative external radiotherapy in a dose of 20 Gy in five fractions over one week. After the completion of radiotherapy the patient was given combination chemotherapy with cisplatin and etoposide. The general condition of the patient improved initially with therapy and he remained asymptomatic with disease for almost 10 months after which he developed bone pains. A radioisotope bone scan revealed multiple skeletal metastases. The general condition of the patient was too poor to tolerate any chemotherapy. He was offered best supportive care but he succumbed to his disease 12 months after diagnosis.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 46,\n",
       "    'case_id': 'PMC4422723_01',\n",
       "    'case_text': 'This 46-year-old, right-handed woman reported, at the age of 20, experiencing several brief episodes characterized by abnormal hearing followed by loss of consciousness on one occasion, after which she was discharged from the hospital with a diagnosis of partial epilepsy. Since then, she has had no more auditory symptoms, later classified as auras, despite having 5-6 seizures per month that she describes as sudden moments during which she cannot speak but is aware of her environment. After an attack, however, she often finds herself on the floor, unaware that she has fallen. Witnesses recalled right-sided mouth deviation, right-hand fiddling, and dystonic posturing of the left hand, followed by generalised convulsions. Standard EEG showed runs of sharp waves and rarer slow waves over the right frontotemporal leads. The MRI scan revealed no morphological abnormalities. The sEEG, subsequent to other imaging exams (hdEEG and ASL), pointed to an epileptogenic zone located over the right temporal pole, mainly involving the superior (T1) and middle (T2) temporal gyri. The patient underwent surgical removal of these portions, and has been seizure-free ever since (7 months).',\n",
       "    'gender': 'Female'},\n",
       "   {'age': 62,\n",
       "    'case_id': 'PMC4422723_02',\n",
       "    'case_text': 'This 62-year-old, right-handed woman suffered repeated episodes of febrile convulsions at the age of 23 months. She remained seizure-free until age 18 years, when she began experiencing brief, sudden episodes of loss of contact that went unnoticed at that time. At the age of 32, she presented a generalized seizure, and a diagnosis of epilepsy was made. Currently, she has 3-4 seizures per month characterized by oral automatism, right-hand fiddling, and left dystonic hand posturing. On repeated occasions, relatives reported brief episodes of incongruous activity, during which she is unresponsive. Standard EEG showed runs of fast, spiky activity over the frontotemporal right leads, sometimes with bilateral expression over the frontal areas. Repeated MRI scans were reportedly normal.',\n",
       "    'gender': 'Female'},\n",
       "   {'age': 68,\n",
       "    'case_id': 'PMC4422723_03',\n",
       "    'case_text': 'This 68-year-old, right-handed woman began suffering, at the age of 20, brief, sudden episodes of flushing, sensation of something rising from the stomach to the head followed by intense asthenia. The episodes clustered during a few months every year, then disappeared at the age of 35. Around age 60, they started again, this time associated with pervasive fear: she was initially referred for psychiatric evaluation because of suspected panic attacks. Standard EEG revealed right frontotemporal spikes, and a diagnosis of epilepsy was made. Fluid attenuated inversion recovery (FLAIR) MRI images showed bilateral hippocampal hyperintensity that was more evident on the right side.',\n",
       "    'gender': 'Female'},\n",
       "   {'age': 48,\n",
       "    'case_id': 'PMC4422723_04',\n",
       "    'case_text': 'This 48-year-old, right-handed man suffered febrile convulsion episodes at the age of 2 years. At the age of 18, after a secondary generalized seizure, a diagnosis of temporal epilepsy was made. With hindsight, he referred always having had brief episodes of altered sensation associated with something rising from the stomach; witnesses also reported oral automatism. Since then, he has continued to experience weekly seizures despite appropriate drug treatment. Standard EEG showed the presence of sub-continuous spiky activity over the frontotemporal left leads. The MRI scan revealed no morphological abnormalities. The patient has been seizure-free since surgical resection of the left temporal lobe (1 year ago).',\n",
       "    'gender': 'Male'},\n",
       "   {'age': 48,\n",
       "    'case_id': 'PMC4422723_05',\n",
       "    'case_text': 'This 48-year-old, right-handed man reported having suffered during childhood brief and sudden episodes of nausea misinterpreted as gastric disturbances at that time. At the age of 30, during hospitalization for injuries sustained in a car accident, a diagnosis of focal epilepsy was made based on EEG data and history. A few partial seizures occurred over the following months, then remitted for 15 years while he was on carbamazepine. At the age of 45, seizures reoccurred weekly, characterized by a rising gastric sensation, tachycardia, and subsequent depersonalization. Witnessed episodes were described as the patient fiddling with his right hand, dystonic posturing of the left arm, oral automatism, and inability to speak. Standard EEG showed only rare anterior temporal spikes, with right predominance. FLAIR MRI images showed mild bilateral hippocampal hyperintensity.',\n",
       "    'gender': 'Male'},\n",
       "   {'age': 28,\n",
       "    'case_id': 'PMC4422723_06',\n",
       "    'case_text': \"This 28-year-old, right-handed woman had a positive family history for generalized epilepsy (maternal aunt). At the age of 26, she began experiencing repeated deja vu episodes and uncomfortable feelings sometimes associated with anxiety and tachycardia. She was unaware of subsequent vocalizations, left head version and bilateral hand fiddling, and referred suffering headaches after the symptoms resolved. Antiepileptic treatment was only partially effective. Standard EEG showed left frontotemporal spikes. MRI scans revealed altered signal areas in the right lateral frontobasal lobe, left anteroinferior frontal lobe, medio-posterior portion of the left hippocampus, and at the left frontoparietal junction.\\nHdEEG was performed using 256 channels (Electrical Geodesic, Inc., Eugene, OR). The net was adjusted so that Fpz, Cz, Oz, and the pre-auricular points were correctly placed according to the international 10/20 system. The net's geodesic tension structure is such that all electrodes could be evenly distributed over the scalp at approximately the same location in all patients. The data were recorded against a vertex electrode reference (Cz) at a sampling rate of 250 Hz. Patients were seated in a relaxed position; the total EEG recording time was around 40 min.\\nThe experiment was performed using a 3T MRI scanner (Allegra, Siemens, Erlangen, Germany) with a standard transmit/receive head coil. For the ASL data, a pulsed PICORE sequence (proximal inversion with a control for off-resonance effects) with the Q2TIPS scheme (QUIPSS II with thin-slice TI1 periodic saturation) was used. Interleaved control and label images (80 volumes) were acquired using a 2D gradient-echo echo-planar imaging (GRE-EPI) readout with the following scan parameters: TR/TE = 3500/16 ms; TI1/TIs/TI2 = 700/1400/1600 ms and 90  flip angle. Sixteen axial slices in ascending order were prescribed and positioned parallel to the anterior-posterior commissure line (3.5x3.5x5 mm3, with an inter-slice gap of 1 mm) in order to cover the presumed focus location. The labeling slice was 10 cm thick and was separated from the proximal slice of the acquisition volume by a 20-mm gap. A calibration scan with the same parameters as the ASL sequence but longer TR (10 s) was also acquired to estimate the equilibrium magnetization of arterial blood (M0b). The overall acquisition time for ASL was approximatively 6 mins, including the additional calibration scan. A high-resolution whole brain anatomical scan was acquired for each subject using a 3D T1-weighted magnetization prepared rapid acquisition gradient echo sequence ([MPRAGE], TR/TE = 2300/3.9 ms; FOV = 192 x 192; matrix = 256 x 256; 176 sagittal slices 1.0 mm in thickness). Other high-resolution anatomical images, including T2-weighted, FLAIR and inversion recovery with 2D readout, were also acquired in order to assess for the presence of structural alterations such as hippocampal sclerosis or malformations of cortical development.\\nHdEEG data were analyzed using Cartool software (http://sites.google.com/site/cartoolcommunity/). The T1-weighted anatomical images were used to create a realistic model of the brain for source localization. In each patient, the hdEEG and MRI data and the solution space were restricted to the gray matter. The solution space for the distributed source model contained from 3,028 to 3,088 points uniformly distributed over the gray matter of the brain and mapped onto the spherical head model with anatomical constraints (SMAC) space. The peak of the spike was used as a trigger for averaging in epochs of +-500 ms. Two time frames were chosen to characterize spike topography: the first, from the beginning of the spike to the time point at 50% of the rising phase, was defined as an epoch characterizing a possible source of the spike generator; in the second, an epoch at the peak of the spike was defined as indicating propagation. A standardized source imaging procedure, ([LORETA] low resolution brain electromagnetic tomography) constrained to the individual gray matter, was applied to the averaged spikes. From the ESI, the current density (CD) was quantified at each solution point [muA/mm3].\\nASL data were preprocessed and analyzed using FSL 5.0.1 (FMRIB, Oxford, UK) and Matlab 7.14 (MathWorks, Natick, MA) with a dedicated home-made code created for this study. Motion correction was applied separately to the Control and Label volumes using the MCFLIRT tool and taking the first volume as reference. In particular, a six-parameter 3D rigid-body registration with a normalized correlation cost function was used. The ASL calibration scan was used for estimating the coregistration parameters from ASL to the individual T1-weighted image by applying a 3D rigid-body registration with a normalized mutual-information cost function and 7 degrees of freedom.\\nAfter these pre-processing steps, surround subtraction was applied to the Control and Label volumes to obtain a 4D matrix representing the perfusion-weighted maps. Unlike what is usually done in ASL studies, DeltaM represents the whole set of perfusion-weighted maps (one volume per repetition) instead of a single perfusion-weighted map obtained by averaging across the repetitions. In this way, a 4D matrix for the CBF parameter can be estimated for each subject and the temporal information given by the different repetitions will allow measurement of the within-subject variance. The standard kinetic model was applied to the 4D DeltaM matrix to estimate the blood flow maps in physiological units [ml/100g/min]. The CBF values were calculated as follows:  where DeltaM is the difference signal, TI 1 and TI 2 are the sequence time parameters described above, n is the slice number, slice time is the time taken to acquire each single slice (~ 50ms), T 1B is the longitudinal relaxation time of blood (1664 ms at 3T), and alpha is the inversion efficiency (0.95 for pulsed ASL). M ob was calculated as the ratio between the mean tissue equilibrium magnetization value in a cerebrospinal fluid (CSF) region (from the calibration scan) and the brain-blood partition coefficient.\\nFor each subject, the mean and variance values over all repetitions were calculated for the CBF parameter. These maps in ASL space were affine-registered to the individual high-resolution anatomical images by applying the previously estimated transformation matrix. Each T1-weighted image was then registered to the Montreal Neurological Institute (MNI) space with 1x1x1 mm3 resolution using a non-linear method (FNIRT tool in FSL). Finally, the joint ASL/T1-weighted and T1-weighted/MNI space transformation parameters were used to spatially normalize the CBF maps representing the mean and variance values.\\nFor each subject, the CBF images in MNI space were intensity normalized to compensate for mean inter-subject perfusion variations. Indeed, voxel-wise ASL detection studies, where the focus is on local variations across the brain, have shown that an intensity normalization step is advised to increase the sensitivity, also due to the large inter-subject variability in global CBF values. The value used for the intensity normalization was equal to the mean CBF in gray matter, applying a threshold of 70% for detecting pure gray matter voxels, similarly to. The partial volume estimates for gray matter were derived from segmentation of the normalized anatomical image using the FAST tool in FSL. In addition, the non-physiological negative perfusion estimates present in the gray matter normalization mask were excluded from the mean CBF calculation in order to define a more reliable reference value.\\nFor comparing each patient to the control group, a two-step procedure was performed: construction of a normal perfusion template and then a one-versus-many statistical analysis. The heteroscedastic approach was used in the analysis (mixed-effect model).\\nThe first step entailed CBF template construction from the control group images. The template was created using the FLAME 1 (FMRIB's local analysis of mixed effects-stage 1) tool available in FSL software, which uses Bayesian modeling and explicitly accounts for the within-subject variance. For each subject, normalized CBF images representing the mean CBF estimates and the CBF within-subject variance were supplied to the FLAME 1 tool. The data from the healthy subjects were pooled into one group, and the group maps (mean and variance) were estimated with this tool. In a heteroscedastic model, the group variance will reflect both the within-subject and the between-subject variability.\\nIn the second step, comparison of the control group versus each single patient was carried out using an unpooled-variance unpaired two-sample t-test in order to consider both the group variance and the patient variance. The t-statistic, for testing whether the estimated patient versus control group means were different, was calculated as:  where mu and sigma 2 represent the estimated mean and variance for the patient (p) and the control group (c) respectively, and N represents the number of subjects (17 and 1 for N c and N p, respectively). A negative tvalue indicates that, at the voxel of interest, the mean is higher in the patient than in the control group, thus identifying possibly hyperperfused areas (patient > controls). Conversely, a positive tvalue indicates possible areas of hypoperfusion (patient < controls).\\nThe simplest approximation was adopted for defining the degrees of freedom (df), assigning df = n-p-1, where n is the total number of subjects and p the number of fixed (dummy) variables such as subject-specific covariates like age or behavioral data. The same approach was also implemented in the statistic test in FLAME 1 of FSL. A false discovery rate (FDR) correction (q < 0.05) for multiple comparisons was applied to the statistical results to detect the areas of statistically significant alterations in perfusion.\\nThe procedure for the automatic detection of patient-specific perfusion abnormalities was applied to the 6 new patients and to the 6 patients evaluated in the previous study in order to further confirm the results and the observations from the region of interest (ROI) analysis.\\nFor each patient, the mean CBF map from ASL and ESI results was overlaid on individual T1-weighted anatomical MRI images to combine all of them in the same anatomical space using FSL tools. As in the previous study, a series of ROIs was identified using the Harvard-Oxford Atlas to compare the ESI and ASL results in terms of CD and CBF inside the same areas, using the spatially normalized data. Quantification was restricted to the gray matter, including voxels whose probability to belong to the gray matter was at least 80%. All measures were compared to the contralateral side. The five ROIs with the highest differences in CD and CBF values are reported here. This was done to quantitatively compare the information provided by ASL and ESI and to evaluate the agreement with the results of the statistical analysis. Areas over the epileptic focus are expected to be characterised by high CD values and low CBF values in comparison to the correspondent contralateral ROI, if the patient is in interictal phase.\\nIn patients undergoing surgical resection, freedom from seizure following the operation can be considered the ground truth and the most unambiguous proof of correct localization of the epileptogenic focus. In order to assess the localization reliability of the ESI and ASL results, the presurgical information were overlaid on the postoperative MRI scan of each patient to determine whether or not the ESI and ASL maps were congruent and overlapped well with the resected tissue areas. Importantly, although the extension of a resected area tends to be overestimated and larger than the actual epileptogenic zone in most patients, seizure freedom following resection can be taken as proof of correct localization on a sublobar level. Therefore, the preoperative anatomical MRI scan was coregistered with the postoperative scan, and the estimated coregistration parameters were inversely transformed in order to project the postoperative image over the original preoperative scan. To assess the ESI and ASL results, the rising phase of epileptiform activity and the statistical maps were used, respectively, and were overlapped on the coregistered postoperative anatomical image.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 63,\n",
       "    'case_id': 'PMC5551466_01',\n",
       "    'case_text': \"A 63-year-old male with ischemic cardiomyopathy and severe left ventricular dysfunction was admitted with chest pain and dyspnea at rest. He was on maximal medical therapy and had received multiple prior percutaneous coronary interventions and two previous coronary artery bypass surgeries. Recent coronary angiography revealed no possibility of further revascularization. He was evaluated for Orthotropic Heart Transplant (OHT) and listed as Status 1A-e (urgent need). His worsening intractable angina and dyspnea necessitated IABP placement via left axillary artery, which significantly improved his condition. Axillary artery was the chosen site of insertion (as opposed to femoral artery) in order to enable ambulation and prevent deconditioning, as the patient was awaiting transplant. The IABP was placed under fluoroscopic guidance, with the tip of the IABP placed few centimeters below the aortic arch, as confirmed radiologically. Following the procedure, the patient complained of new-onset, persistent, throbbing, and burning left-sided frontoparietal pain above the left lateral eyebrow that radiated to the left orbit, with an intensity of 7/10 on the numerical pain scale. It was aggravated by movement and relieved by pressure, with frequent watery eyes without visual changes. He had a remote history of traumatic brain injury due to motor vehicle accident but he denied any subsequent headache.\\nExamination revealed tender and bulging left temporal artery suspicious of temporal arteritis (TA); however, his normal erythrocyte sedimentation rate minimized TA as a likely diagnosis. Nonetheless, he was offered prophylactic prednisone, which he refused. Pain management service was consulted and multimodal treatment including acetaminophen, oxycodone, citalopram, and tizanidine was initiated, while nitrates were withheld. The patient reported limited relief and continued to complain of a persistent pain in the same distribution. Subsequently, left supraorbital neuralgia was hypothesized, and gabapentin was initiated with limited benefit. A supraorbital block was offered, which was refused, and patient insisted on discontinuing the IABP.\\nIn accordance with patient's wishes, the IABP was weaned and removed, and nitrates were initiated for angina prophylaxis. On postremoval assessment, the patient's headache had completely resolved with no future recurrence. He subsequently received OHT and was discharged with normal EF and no further headaches.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 67,\n",
       "    'case_id': 'PMC8794318_01',\n",
       "    'case_text': \"A 67-year-old female patient, complaining a history of poorly responsive bronchitic episodes and atrial fibrillation, underwent radiological work up after detection on January 2018 of a suspicious right upper lobe pulmonary lesion at chest X-ray. CT scan confirmed a right S1 irregular solitary nodule with signs of both mediastinal and parietal pleura involvement with concomitant multiple bilateral lymphadenopaties (stations 3, 4, 5) (February 2018). According to findings, an EBUS-TBNA bronchoscopy was performed on March 2018. The immediate postoperative period was uneventful as no intraoperative injuries, such as vascular or parenchymal ones, were reported. The hospital stay was uneventful and the patient was discharged on POD1. Twenty-four hours later, she was admitted to the Emergency Room Department due to the onset of relapsing episodes of haemoptysis. At admission, no impelling signs of cardiovascular impairment were reported (BP: 145/80 mmHg, HR: 88 beats per minute, T: 36.5  C, SaO2: 95%), as far as neither laboratory nor radiology highlighted any suggestive element for post-procedural complication.\\nAt a rapid worsening of patient's clinical conditions requiring emergent oro-tracheal intubation, an urgent fibro-bronchoscopic evaluation showed the presence of an obstructive and non-viable subglottic formation with unsuccessful attempts of disobstruction till the onset of an irreversible cardio-circulatory arrest (Figure 1) due to acute respiratory distress and airway engorgement asphyxia. On autopsy, both lungs presented evident bloody polygonal areas alternating with compensatory emphysema ones. After en-bloc sampling of the airways, esophagus and heart, the section of the tracheal pars membranacea highlighted the presence of a blood clot that extended from the middle third of the tracheal lumen to the terminal bronchioles of both lungs (Figures 2,3).\\nAll procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and national research committees and with the Helsinki Declaration (as revised in 2013). No written informed consent has been obtained as anonymous data have been reported.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 60,\n",
       "    'case_id': 'PMC8463768_01',\n",
       "    'case_text': 'A 60-year-old male smoker with hypertension and hyperlipidemia presented with a 1-week history of intermittent left hemi-facial numbness and left arm dysmetria. He had difficulty gripping objects and tying his bandana. Review of systems were otherwise negative and initial labs were unremarkable. He had a 60 pack-year smoking history and significant daily alcohol consumption for more than 20 years.\\nNon-contrast head CT demonstrated a right parietal lobe mass. MRI of the brain revealed a heterogeneously-enhancing 2.8-cm mass with irregular, nodular rim enhancement and extensive perilesional edema (Fig. 1). The patient was subsequently initiated on high-dose dexamethasone.\\nA CT of the chest/abdomen/pelvis revealed a 3.3-cm spiculated mass in the left lower lobe and a 1.7-cm lesion in the right upper lobe along with mediastinal and left peribronchial lymphadenopathy. These findings were suspicious for primary lung cancer with metastases. CT-guided lung biopsy of the left lower lobe lesion revealed adenocarcinoma. Evaluation with PET-CT demonstrated markedly increased FDG activity in both the left lower lobe mass with associated satellite nodules and the right apical mass as well as metastatic mediastinal and left peribronchial lymphadenopathy (Fig. 2). The tumor cells demonstrated high expression of PD-L1 and no driver mutations were detected.\\nA diagnostic and therapeutic right parietal craniotomy was performed with excision of the lesion. Histopathology did not show any malignant cells but instead demonstrated an abscess with surrounding reactive gliosis. Gram-staining revealed gram-positive branching rods surrounded by many neutrophils (Fig. 3). Cultures resulted negative and did not identify any acid-fast bacilli. Given the gram stain results, MALDI-TOF mass spectrometry was done and revealed Nocardia species.\\nConsidering these findings, a right upper lung nodule biopsy was performed to evaluate for pulmonary nocardiosis. The biopsy revealed normal lung parenchyma in a background of inflammatory cells and reactive pneumocytes but no evidence of malignancy. Gram stain and cultures for anaerobes, acid-fast bacilli including Nocardia, and mycobacteria were all negative; as a result, mass spectroscopy was not performed.\\nThe patient was treated with imipenem, cilastatin, and minocycline and fully recovered from his nocardial abscess. He eventually started chemotherapy with carboplatin, pemetrexed, and pembrolizumab for his lung adenocarcinoma. He achieved a complete response and remains cancer-free 41 months after his initial diagnosis.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 52,\n",
       "    'case_id': 'PMC4166343_01',\n",
       "    'case_text': \"This study was approved by the ethics committee of Kanazawa University Graduate School of Medical Science and followed the tenets of the Declaration of Helsinki. A 52-year-old man with endothelial dysfunction of unknown cause in the right eye was selected as the recipient. Slit-lamp examination revealed an opaque cornea due to advanced endothelial dysfunction (Figure 1A). The left eye was normal on slit-lamp examination without any guttata. There was no history of ophthalmic intervention in the past in either eye.\\nThe donor cornea from a child 2 years of age after brain death was supplied from a domestic eye bank. The time from cardiac death to enucleation was 3 hours, and the time to processing was 1 hour. The donor was transplanted 2 days later. The endothelial cell density of the infant donor was as high as 4,291 cells/mm2. The central thickness of the donor measured by ultrasound pachymeter was 561 mum. Since the elasticity and tenderness of the infant donor tissue were extremely high, there were no striae on the surface of the endothelial cell layer after the donor sclerocorneal tissue was harvested (Figure 2).\\nIntraoperative and postoperative complications, including iatrogenic primary graft failure, donor graft dislocation, and pupillary air block glaucoma were documented. Best corrected visual acuity and donor central endothelial cell density were recorded preoperatively and at 6 months and 1 year postoperatively. The decimal visual acuity were used as measures of visual acuity and converted to the logarithm of the minimum angle of resolution (logMAR). The central endothelial cell density was measured with noncontact specular microscopy (Noncon Robo; Konan Medical, Hyogo, Japan), using the center method as outlined by the manufacturer's software. The postoperative cell loss rate was calculated as a percentage of the preoperative donor endothelial cell density as provided in the information from the domestic eye bank.\\nThe surgery was performed at the Department of Ophthalmology, Kanazawa University Graduate School of Medical Science, using a technique as reported previously. The patient read and signed an informed consent form prior to surgery.\\nThe donor cornea was dissected with a microkeratome (ALTK Cbm; Moria, Antony, France) equipped with a 300 mum head. The donor tissue was extremely elastic and soft compared with the adult tissue. After microkeratome dissection, the donor tissue was transferred to a punching system and cut with an 8.0 mm diameter punch (Barron Donor Cornea Punch; Katena Products Inc., Denville, NJ, USA). The central corneal thickness of the infant donor cornea and the residual corneal stromal bed left after lamellar microkeratome cut was not measured.\\nPhacoemulsification and a single-piece acrylic intraocular lens insertion procedure was performed via a 3 mm clear corneal temporal incision just before nDSAEK. Since the cornea was too opaque to obtain a clear surgical view during phacoemulsification, trypan blue staining of the anterior capsule, corneal epithelial debridement was performed for better visualization of the anterior chamber. Since the cornea was too opaque to remove the Descemet membrane, we decided not to remove the membrane in this case (nDSAEK). The surgical procedure of nDSAEK was described previously. In brief, three corneal fenestrations were performed to drain the interface fluid. A small inferior iridectomy at the 6 o'clock position was then routinely created with a 25-gauge vitreous cutter (Medical Instrument Development Laboratories, San Leandro, CA, USA). Continuous irrigation from a 25-gauge anterior chamber maintainer (25 gauge DSAEK Chamber Maintainer, Catalog number AE-7802; Asico, Westmont, IL, USA) was used. An ophthalmic viscosurgical device (Viscoat; Alcon Laboratories, Fort Worth, TX, USA) was applied to the endothelial surface of the graft, and the donor graft was inserted using a Busin glide and an intraocular lens sheet glide (double glide technique). After insertion of the donor graft, the wound was secured with three interrupted 10-0 nylon sutures. Air was injected into the anterior chamber to press the donor graft against the recipient cornea. Corneal massage was performed to adjust the centered position of the donor graft and to eliminate residual fluid at the donor graft-recipient interface. Residual interface fluid was also drained through corneal venting incisions. The anterior chamber was left full of air, and the patient was instructed to lie on his back for at least 1 hour.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 52,\n",
       "    'case_id': 'PMC7433960_01',\n",
       "    'case_text': 'A 52-year-old female presented to the Department of Oral and Maxillofacial Surgery with a painless swelling in the floor of the mouth on the right side since 1-year, with no obvious increase in size. The swelling was not associated with any changes in salivation, but she had difficulty in articulation due to its size. Her medical history was insignificant. She had no history of tobacco use or any other adverse habits.\\nOn retraction of the tongue, a solitary 5 cm x 4 cm swelling was noted in the floor of the mouth on the right side, crossing the midline till the lower left central incisor, completely obliterating the lingual vestibule and occupying the entire floor of the mouth on that side [Figure 1]. The mucosa overlying the swelling was adherent to the lingual gingiva in the region of the lower right premolars [Figure 2]. On palpation, the swelling was well defined, firm in consistency, regular surface, nontender, nonpulsatile, and not bimanually palpable. The mucosa overlying the swelling was freely movable except at the region of attachment to the gingiva. The submandibular ducts were patent and milking of the gland yielded normal saliva.\\nThere was no evidence of salivary calculi or bony erosion in the mandibular occlusal radiograph. Contrast-enhanced computed tomography (CT) showed an enhancing mass lesion in the right sublingual region [Figures 3 and 4]. In view of the history, clinical features, and CT findings, we came to the diagnosis of a salivary gland tumor in the sublingual region. Fine-needle aspiration cytology was reported as sialadenitis of minor salivary gland. An incisional biopsy was thus carried out, which revealed the presence of mucous acini suggestive of minor salivary gland showing periductal inflammation and a very small portion of tumor cells arranged in cribriform pattern and cystic spaces filled with eosinophilic coagulum [Figure 5]. Hence, we came to a diagnosis of salivary gland tumor arising from the minor salivary gland with high suspicion of malignancy. Excisional biopsy of the lesion was hence planned under general anesthesia. Intraoperatively, the swelling was found to be submucosal and well-encapsulated [Figure 6]. Wide excision of the lesion, including the overlying mucosa and the distal portion of the submandibular duct was carried out. On gross examination of the excised specimen, there was no evidence of major salivary gland seen. Histopathological examination showed areas with features of PA with an overlying capsule containing ducts and acini. The ducts showed an inner epithelial cell layer and outer myoepithelial cell layer embedded in myxohyalinous background matrix, presence of transitional zones showing capsular invasion with cells arranged in cribriform and tubular pattern having cytomorphologic features of adenoid cystic carcinoma. Invasion into the surrounding capsule as well as adjoining minor salivary glands was evident, with no perineural invasion. Based on the histopathological findings, we arrived at a diagnosis of Carcinoma ex pleomorphic adenoma (CXPA) of the minor salivary gland with capsular infiltration. The patient was hence referred for postoperative radiotherapy. The patient is doing well and no evidence of recurrence has been noted after 1-year.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 9,\n",
       "    'case_id': 'PMC8046462_01',\n",
       "    'case_text': 'This was a 9-year-old female patient referred from Kibuye Hospital in the Western province of Rwanda for further investigations and management of the left calcaneal mass suspected to be an osteosarcoma. The condition had persisted for 4 months before consulting our clinic at Kigali University Teaching Hospital CHUK for the left heel pain and swelling. The examination noted a history of fever, weight loss and swelling of the left foot extending to the whole lower limb without cough. Consulted, as structured health system, Birambo Health Centre, then Kirinda district hospital where she received different treatment (that we are unable to get their records for proper identification), without improvement. After 2 weeks, a pus discharging sinus appeared on the heel mass. Two months later, the patient noted right hip swelling with inability to stand and walk. She consulted Kibuye Referral Hospital, from where she was referred at CHUK on December 1, 2017, for further management of possible osteosarcoma of the left calcaneus. No history of trauma nor TB contact.\\nOn physical examination: Temperature was 37.6 C, respiratory rate of 20 cycles/min, pulse of 97 beats/min; two ulcerated wounds on the lateral aspect of left ankle and heel, swollen and tender ankle joint, two mobile, non-tender, small inguinal lymph nodes on the left side, limited range of motion of right hip joint with tenderness and mild shortening of right lower limb.\\nCOM of the left calcaneum with pus discharging sinuses\\nLeft foot synovial sarcoma/Ewing sarcoma\\nTB of the left calcaneum and right hip.\\nAs management, she received analgesics, daily wounds care and different clinical pathology tests were requested (Table 1). Imaging studies including computed tomography (CT) scan of the left foot (Fig. 1a, b and d) and pelvic X-ray (Fig. 1c).\\nCT scan results (December 8, 2017): Lytic and sclerotic calcaneal tumor consistent with osteogenic sarcoma, the differential diagnosis is COM.\\nShe was admitted on December 14, 2017, on December 18, 2017, curettage and biopsy were performed under general anesthesia and pre-operative chest X-ray was normal. The patient was discharged home on December 20, 2017.\\nOn January 10, 2018, microscopic examination of the calcaneal mass curettings (Fig. 2) revealed rare poorly formed granuloma, rare multinucleated giant cells, and mixed acute and chronic inflammatory cell infiltrates in favor of possible extrapulmonary TB. The special auramine-rhodamine stain was positive for acid-fast bacilli (Fig. 2).\\nOn February 8, 2018, the patient was referred to pediatric outpatient department (OPD) seen in OPD for TB treatment, as follows: Rifampicin, isoniazid, pyrazinamid, and ethambutol (R75 mg H50 mg Z50 mg E100 mg) 8 tablets per dose for 12 days and then for 48 days. Rifampicin, isoniazid (R75H50) for the remaining period. Pyridoxine 25 mg/day was associated for the two 1st month.\\nOn July 9, 2018, she was reviewed in OPD with persistent small sinus on the left heel. Walking with axillary crutches. The X-rays showed sequestrum and sclerosis of calcaneum, distal tibia, and fibula (Fig. 1d).\\nWe did a sequestrectomy under general anesthesia at Kibuye Hospital in citizen outreach program. She was discharged and advised to continue anti-TB.\\nOn November 29, 2018, she was reviewed and had significantly improved and gained weight; sinuses healed, mild limping with limb length discrepancy of around 1 cm (right being short) and she could stand and walk with the aid of one axillary crutch. Had a limb length discrepancy of around 1 cm (right being short). The liver function test, renal function test, and hemogram test were normal. Control X-rays and morphology picture of the limb were obtained at the same time (Fig. 3).',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 30,\n",
       "    'case_id': 'PMC5390662_01',\n",
       "    'case_text': \"We present the case of a 30-year-old woman who came to the hospital emergency department in September 2015, referring a week of progressive dyspnea, accompanied by sharp pain in left hemithorax and chest tightness. She didn't refer other symptoms.\\nShe had multiple food allergies, controlled by the Allergology department, and allergic rhinitis and asthma that was treating with terbutaline and antihistamines on demand. She has never had toxic habits, and works as a graphic designer at a printing press.\\nPhysical examination only highlighted an abolition of the vesicular murmur and vocal vibrations in the left lung base.\\nThe blood test performed in the emergency room was strictly normal. In the chest X-ray, a large left paracardiac mass was observed, which in the lateral projection was located in the anterior mediastinum (Fig. 1). Thoracic echography revealed a paracardiac mass of about 10 cm in diameter.\\nThe patient was admitted to the Pneumology Service with the suspicion of an anterior mediastinal tumor. During admission, a CT scan of chest, abdomen and pelvis was performed, confirming the presence in the left anterior mediastinum of a 10 x 11 cm of diameter tumor located to the left of the heart and in front of the left lung. The lesion had an intimate contact with the adjacent pericardium with effacement of the fat planes (Fig. 2). A CT-guided needle biopsy was performed. The biopsy was informed as compatible with a low grade myofibroblastic tumor. During admission, a PET-CT was performed, which showed that the mass had a heterogeneous metabolic behavior, with a SUV max. of 4.83 g/mL. The remaining structures showed no increase in glucose metabolism (Fig. 3). Thoracic MRI was also performed, which showed that the tumor had a broad contact with the pericardium, but without signs of infiltration.\\nWith the diagnose of a low grade myofibroblastic tumor, the patient was referred to the Thoracic Surgery Service. A thoracoplasty was performed, dissecting the mass and part of the pericardium where it was not possible to dissect. The main complication was an intense bleeding which needed the transfusion of 2 units of red blood cells. The resected piece was submitted to the Pathological Anatomy Service and analyzed by the same team of the previous needle biopsy, which provided the definitive diagnosis of a dedifferentiated liposarcoma with bone metaplasia. The surgical margins were free of tumor and no lymphatic or vascular invasion was identified. The chest X-ray two months before surgery can be observed in Fig. 4.\\nAfter surgery, the patient was referred to the Medical Oncology Service, who proposed her to start adjuvant chemotherapy treatment with four cycles of ifosfamide-adriamycin. The possibility of concomitant local radiotherapy was considered, but it was rejected because of the high risk of toxicity and sequelae.\\nThe chemotherapeutic treatment was administrated between December 2015 and April 2016. One month later, a new PET-CT scan was performed, which showed no increase in glycolic metabolism at any level.\\nThe patient currently follows periodic check-ups at the Medical Oncology Service, performing chest CT every 6 months. The last one was performed in February 2017, and was strictly normal. Until date, she has not developed a recurrence of the ML.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 29,\n",
       "    'case_id': 'PMC6304870_01',\n",
       "    'case_text': \"A 29-year-old military male basic trainee (71 inches, 200 pounds, BMI 27.89) presented with a one-month history of atraumatic bilateral leg pain. He reported pain within the first week of initiating running at basic training. He was diagnosed with bilateral proximal tibia stress fractures at three weeks with instructions to stop impact activities. After failure of his symptoms to improve, he was referred to our facility. On presentation, he had tenderness about the medial aspect of each proximal tibia. Radiographs obtained at that time demonstrated bilateral proximal tibia stress fractures with varus alignment about each knee and articular collapse of the left tibial plateau. Metabolic labs were obtained and significant for a low vitamin D (15), but the remainders of labs including calcium, thyroid-stimulating hormone (TSH), and testosterone were unremarkable. MRI of the left knee demonstrated a medial tibial plateau fracture with two millimeters of articular depression and extension of the fracture to the tibial spine (Figure 1(a)). MRI of the right knee demonstrated a hypointense linear T2 signal surrounded by diffuse hyperintense signal suggesting a medial tibial plateau stress fracture with surrounding bone edema, without articular collapse or extension (Figure 1(b)). These fractures were at the level of the physis, and there was surrounding sclerosis on plain radiographs. Given the collapse of the articular surface in his left knee, the patient was indicated for open reduction internal fixation with allograft bone. The patient underwent the aforementioned procedure without complication, and the patient remained nonweight bearing to his bilateral lower extremities (Figure 2(a)). At the time of surgery, the bone at the fracture distal to the articular surface was softer and more friable in composition than expected for the stress fracture. It was easily debrided back to stable, healthy bone edges, and we were interested in analyzing its composition, so a biopsy was obtained and sent to the lab for analysis. Histology demonstrated nonossifying hyaline cartilage with admixed fibroconnective tissue consistent with a persistent physis (Figure 3(a)).\\nAt the six-week follow-up visit after the procedure on his left knee, the patient was still having significant pain in his right lower extremity and, after extensive counseling, elected to undergo the same procedure on the contralateral limb in an effort to return to running and continue his military career (Figure 2(b)). We suspected that a similar pathology of a persistent physis was present in the right proximal tibia and that this was contributing to his slow healing progression. Similar intraoperative pathology specimens were again obtained at the fracture site distal to the articular surface (Figure 3(b)), and these demonstrated fragments of purple to purple-gray staining matrix with chondroid metaplasia. This presence of cartilage distal to the articular surface was consistent with a persistent physis.\\nAt four-and-a-half months from the index procedure (three months from the staged procedure), the patient was ambulating without assisted devices and had painless range of motion from 0 to 120  in each knee with well-healed incisions, maintained hardware and alignment, but had not returned to impact activities. Due to his status as a basic trainee, he was released from active duty at six months' time postoperatively and was lost to follow-up.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 26,\n",
       "    'case_id': 'PMC5219585_01',\n",
       "    'case_text': \"A 26-year-old man with end-stage renal disease was scheduled for renal transplantation. During his preanesthetic checkup it was noted that he had DRESS syndrome in response to antibiotics that had been prescribed for a catheter-related infection. He had high grade fever and erythematous maculopapular rash all over the body with intense scaling and edema over the face (Fig 1). All the investigations were normal except for leukocytosis (WBC 23,000/mm3) with 10% eosinophils and an abdominal CT showing reactive retroperitoneal lymphadenopathy and hepatomegaly. Dermatological opinion confirmed the diagnosis of DRESS after noting elevated serum LDH and IgE levels. All the antibiotics were discontinued. He became afebrile with resolution of skin rashes. He was scheduled for renal transplantation under regional anesthesia. Prior to the surgery, skin prick and intradermal tests were done with antibiotics, lignocaine, bupivacaine, ropivacaine, fentanyl, and tramadol:the drugs most likely to be used during regional anesthesia according to standard protocols. After confirming negative results, the drugs were used. He was dialyzed before his surgery. All his preoperative investigations were normal. In the operation theatre, the right internal jugular vein was cannulated for central venous pressure measurement. Epidural catheter was placed in the L3-4 interspace and kept 6 cm inside the epidural space. A test dose of lignocaine+adrenaline was given epidurally. Spinal anesthesia was given in L4-5 interspace with Quincke's needle; 17.5 mg bupivacaine heavy was given after free flow of CSF to achieve a T6 sensory level. Intra-operative monitoring included temperature, pulse, NIBP, ECG, CVP, and urine output. We also remained alert for signs and symptoms of anaphylaxis including skin rash, tachycardia, hypotension, bronchospasm, and edema of lips or tongue. Epidural mixture of 7 mL of bupivacaine 0.5% and 7 mL of lignocaine 2% was given epidurally after 90 min of spinal anesthesia. Supplemental doses of local anesthetics were given epidurally hourly until the end of the surgery.\\nThree liters of normal saline was given and CVP was kept between 12 and 15 mm Hg. Intra-operatively, 500 mg methylprednisolone and 100 mL mannitol 20% were given just before release of the vascular clamps. Anastomosis time was 20 min and urine output was established immediately on release of the vascular clamps. The patient remained stable throughout the surgery. Post-operatively, the patient was transferred to ICU for further observation. Tramadol plus 0.125% bupivacaine were given epidurally for post-operative pain relief.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 74,\n",
       "    'case_id': 'PMC8639279_01',\n",
       "    'case_text': 'A 74-year-old male patient with a known case of benign prostatic hyperplasia (BPH) presented on 17 October 2020 to the emergency department (ED) with fever and progressive generalized fatigability for 10 days. He had a history of dysuria for two weeks, in addition to polyuria, mild night sweating, and weight loss of 10 kg in one month. There was no history of upper respiratory tract infections, nausea, vomiting, diarrhea, or abdominal pain. He reported a history of drinking unpasteurized milk and contact with farm animals but denied any history of contact with tuberculosis (TB) patients. There was no history of diabetes mellitus (DM). There was no family history of malignancy or rheumatologic disease. Prior to this presentation, he had frequent visits to the ED due to increased fatigability and joint pain. However, no diagnosis was established, and the treatment was often conservative. On this admission, he was managed empirically with intravenous (IV) tazocin and IV paracetamol, given his history. A septic workup was also performed. Laboratory investigations revealed positive serology for Brucella abortus and Brucella melitensis, elevated erythrocyte sedimentation rate (ESR) (58 mm/hr), C-reactive protein (CRP) (165.08 mg/dl), and leukocytosis (23.32x103/muL). Chest X-ray (CXR) was unremarkable. The patient was diagnosed with brucellosis and, eventually, discharged on doxycycline and rifampin. In addition, he was scheduled for a neurological follow-up to assess his progressive fatigability.\\nAfter one month, on 17 November 2020, he was seen in the neurology clinic. The diagnosis of Guillain-Barre syndrome (GBS) was suggested as radiculoneuropathy, and axonal sensorimotor polyneuropathy was proven by electromyography (EMG) and nerve conduction study (NCS). Accordingly, the patient was admitted and received immunoglobulin (IVIG) as recommended by the neurologist. After one week of receiving IVIG, his condition was still not improving and he was referred to the outpatient rheumatology clinic to exclude possible vasculitic processes. Later on, the patient was seen in the rheumatology clinic complaining of multiple joint pain and swelling of wrists, fingers, elbows, knees, ankle, and foot, which started four weeks earlier to his visit.\\nThe pain and swelling in the knees and elbows almost completely improved after brucellosis therapy. However, he was still complaining of pain and swelling in the other joints, which usually worsened at night and improved with movement. Perinuclear anti-neutrophil cytoplasmic antibodies (p-ANCA) was strongly positive (131), ESR was 53 mm/1 hr, and CRP was 132.83 mg/dL. Rheumatoid factor (RF), anti-citrullinated protein antibodies (ACPA), antinuclear antibodies (ANA), cytoplasmic anti-neutrophil cytoplasmic antibody (C-ANCA), and ferritin were all normal. Despite being on appropriate antibiotics treatment for brucellosis, his fever did not subside. It was recurring in episodes, with each episode lasting 20 minutes per day. The fever was not associated with sweating, shivering, or other constitutional symptoms. Furthermore, based on the constellation of several findings, which include the persisting fever despite appropriate antibiotic therapy, the EMG/NCS finding of axonal sensorimotor polyneuropathy, the persistence of elevated inflammatory markers, the positive P-ANCA, and imaging that did not show any masses or fluid collection, the likelihood of underlying systemic vasculitis was high according to the rheumatology team. Therefore, prednisolone 50 mg PO OD was started. In addition, he was continued on doxycycline and rifampin for another set of 11 days to complete six weeks of the brucellosis treatment course.\\nAfter one week of being on steroids, his fever totally subsided and other symptoms had significantly improved. Also, his CRP started to decrease, reaching 79.59 mg/dl. However, P-ANCA was still high (119.4). Therefore, the decision was made to continue on prednisolone 50 mg for another week, followed by 40 mg for two weeks and then 30 mg for two weeks. On the next visit after four weeks on 27 December 2020, he reported significant improvement in his symptoms with no more joint pain and resumed his normal activities independently. Also, lab results showed decreased P-ANCA to 57.8 and CRP to 19.36 mg/dL. Azathioprine 50 mg PO twice a day was added while he continued taking steroids with a tapering dose. After four weeks, on 26 January 2021, he reported that he was no longer experiencing fever, fatigue, joint swelling, or pain. However, he could not actively flex or extend his left index finger or right thumb, which was attributed to his peripheral neuropathy. Therefore, azathioprine dose was optimized to 50 mg three times a day. The patient was reevaluated on 7 March 2021. He was found to be asymptomatic, with no active complaints. Subsequently, azathioprine dosage was reduced to 50 mg PO BID.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 58,\n",
       "    'case_id': 'PMC8247706_01',\n",
       "    'case_text': 'A 58-year-old female with a history of metastatic small cell lung cancer (SCLC) with known recurrent brain metastases and bone metastases status post multiple rounds of radiation and chemotherapy treatments presented with weakness in her right arm and leg, lethargy, and confusion over 1 week. Magnetic resonance imaging (MRI) revealed a growing peripherally enhancing 1.2 cm mass (0.8 cm 2 months prior) in the left precentral gyrus that had previously received linear-accelerator-based stereotactic radiosurgery (SRS) to 20 Gy 9 months prior (with 99% coverage of the target volume), a new left cerebellar 0.4 cm lesion, and a growing left posterior temporal/medial occipital 0.6 cm lesion (0.4 cm 2 months prior) [Figure 1]. The patient was awake and alert with cranial nerves grossly intact. She had an Eastern Cooperative Oncology Group (ECOG) performance status of 1.\\nThe patient had a complicated oncological treatment history, including a previous diagnosis of right breast adenocarcinoma status post breast-conserving surgery and adjuvant chemoradiation, concurrent definitive chemoradiation for her originally diagnosed limited-stage SCLC, prophylactic cranial irradiation (PCI), and SRS to multiple brain metastases. [Figure 2] provides a timeline summarizing her major treatments.\\nFollowing discussion at a multidisciplinary tumor board, the patient underwent craniotomy and resection of her left precentral gyrus lesion, with pathology demonstrating metastatic SCLC. Given that the target area had previously received radiation therapy with PCI and SRS, the patient was given 35 Gy in 100 fractions over the course of 3 weeks, using PRDR for re-irradiation treatment at an apparent dose rate of 0.178 Gy/min for a cumulative dose of 80 Gy. TomoHDA  Planning Station Version 5.1.1.6 (Accuray Inc., Sunnyvale, CA, USA) was used [Figure 3]. [Figure 4] provides a cumulative dose-volume histogram on the organs at risk along with the PRDR targets based on the treatments to the brain using MIM software (MIM Software Inc., Cleveland, OH, USA).\\nAt follow-up in 3 months after PRDR treatment, the patient noted improved motor function of her right hand and foot. MRI brain showed improvement with marked reduction in enhancement in the lesions in the left precentral gyrus, left occipital, and left cerebellar lesions. The patient was started on palliative carboplatin and etoposide. In 5 months following the PRDR treatment, the patient maintained good motor function of her right hand but developed progression of disease with two new 3 mm brain metastases in the right temporal and left parietal regions that were outside the previously treated PRDR field. She received 24 Gy SRS to those lesions. She then developed progression in the mediastinum and retroperitoneum, although there was no evidence of recurrence within the PRDR-treated radiation field. The patient was started on palliative pembrolizumab but in the coming months had a gradual decrease in her overall performance status with increased altered mental status and hospitalizations. After discussion with neurosurgery and palliative care, the patient switched her care to home hospice, which she continues with 14 years elapsing since her initial diagnosis.',\n",
       "    'gender': 'Female'},\n",
       "   {'age': 41,\n",
       "    'case_id': 'PMC8247706_02',\n",
       "    'case_text': '[Figure 5] provides a flowchart summary of this case. A 41-year-old male was referred to our outpatient radiation oncology clinic with recurrent glioblastoma of the thoracic spinal cord. He had originally been diagnosed 3 years prior after presenting with progressive back pain and left leg weakness. At that time, imaging revealed a T11-12 intramedullary tumor measuring 5 x 1.3 x 1.2 cm in dimension. There were multiloculated cystic components which had peripheral enhancement. He underwent a thoracolumbar laminectomy and microsurgical resection of the spinal cord tumor 3 weeks later. Final pathology was consistent with a WHO grade 4 glioblastoma, KI-67-10%, IDH-1 negative, and ATRX expression retained, to which concurrent chemotherapy and radiation were recommended. He underwent adjuvant 50.4 Gy in 28 fractions of radiation to the thoracic resection cavity with 12 cycles of temozolomide.\\nTwo and a half years after the original resection, his left leg weakness progressed, and an MRI of the thoracic spine showed definite tumor progression. Additional chemotherapy with temozolomide, Avastin, isotretinoin, and lomustine did not slow the progression of the tumor. At the time of evaluation, the patient reported a 6-month history of a 20-pound weight loss, worsening bilateral leg weakness, numbness and tingling in both legs, erectile dysfunction, inability to ambulate with both legs causing wheelchair use, increased urinary frequency, and occasional difficulty holding bowel movements. He denied any pain. His ECOG performance status was 3.\\nMRI thoracic spine revealed a recurrent thoracic lesion 2.2 x 1 x 0.8 cm [Figure 6]. His bevacizumab and lomustine were placed on hold due to myelosuppression, with the bevacizumab restarted after a break. The patient was retreated with palliative radiation in the same area at 50 Gy in 250 fractions over the course of 6 weeks, using PRDR technique at an apparent dose rate of 0.0562 Gy/min for a cumulative dose of 100.4 Gy. TomoHDA  Planning Station Version 5.1.1.6 (Accuray Inc., Sunnyvale, CA, USA) was used [Figure 7]. Bevacizumab 10 mg/kg every 2 weeks was given concurrently with radiation with the goal of decreasing the risk of radiation-induced injury, including edema and radiation necrosis, in the context of re-irradiation with PRDR.\\n[Figure 8] provides a cumulative dose-volume histogram on the organs at risk along with the PRDR targets based on the treatments to the brain using MIM software (MIM Software Inc., Cleveland, OH, USA).\\nImaging showed the lesion as stable at the 1-month follow-up appointment. He was able to walk with the assistance of a walker, which was an improvement from previously being bound by a wheelchair. Overall, the patient did not develop significant acute radiation side effects and reported to be very satisfied with his response to treatment.\\nEight months after completion of radiation treatment, the patient remained on bevacizumab under the care of his oncologist. The patient reported progressive weakness in his lower extremities and ongoing fatigue. MRI of the spine revealed worsening leptomeningeal carcinomatosis, and the patient was discharged with home hospice. He died 2 months later, about 42 months after his initial diagnosis.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 77,\n",
       "    'case_id': 'PMC6240727_01',\n",
       "    'case_text': \"A 77-year-old man was admitted to a local hospital because of melena and exertional chest compression. He had two hospitalization records in the past 1.5 years due to GI bleeding of unknown origin. Upon admission, the patient's blood pressure was 105/56 mmHg, and his heart rate was 115 beats/min. Physical examination revealed palpebral conjunctival pallor and a Levine 4/6 systolic murmur at the second right intercostal space. Blood test results (hemoglobin, 5.5 g/dL; hematocrit, 16.2%) indicated advanced anemia, and fecal occult blood reaction was positive. GI endoscopy could not reveal the origin of GI bleeding. Conservative therapy including fasting and transfusion improved the anemia, and fecal occult blood reaction also became negative. Echocardiography showed severe AS, with a peak aortic pressure gradient of 88.0 mmHg and effective orifice area of 0.52 cm2 (Fig. 1). The left ventricular ejection fraction was 0.61. Although the serum level of von Willebrand factor (vWF) activity was in the normal lower limit of 51% (normal range 50-150%), further hematologic examination by gel electrophoresis showed deficiency of high-molecular-weight multimers of vWF (Fig. 2). Although the origin of GI bleeding was unknown, the patient was diagnosed with Heyde syndrome because of the presence of AS and deficiency of high-molecular-weight multimers of vWF. He was transferred to our institution for further treatment. Considering a low risk of intraoperative death (logistic EuroSCORE of 2.56% and risk of mortality from the Society of Thoracic Surgeons adult cardiac surgery risk score of 0.788%), the patient was considered a suitable candidate for surgical aortic valve replacement (SAVR).\\nThe patient underwent elective surgery. SAVR using a 21-mm bioprosthesis was performed with standard cardiopulmonary bypass (CPB), for which we selected unfractionated heparin anticoagulation. Aortic cross-clamp time was 71 min, and CPB time was 116 min. During the operation using heparin, there was no unexpected volume loss in which GI bleeding was considered. The postoperative course was uneventful. Under anticoagulant control of prothrombin time-international normalized ratio at 2.0-2.5, the patient did not develop recurrent anemia in the perioperative period (Fig. 3). The patient was discharged without subjective symptoms on postoperative day 18. The 20-month follow-up was unremarkable, with no episode of recurrent GI bleeding.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 1,\n",
       "    'case_id': 'PMC8128129_01',\n",
       "    'case_text': 'A thirty-one-year old with her second pregnancy was admitted to labor ward at 38 weeks of gestation because of premature rupture of the membranes, she had a history of normal first delivery, PARA 1011, no known chronic disease or previous surgery. In the delivery room, when the cervix had dilated 3 centimeters, epidural anesthesia for pain relief was administered. The patient was placed in the sitting C-shaped position and the skin was prepared with betadine solution. After local anesthesia, a needle, 18G Tuohy, was introduced into the palpation-identified L3-4 interspace, with confirmation by loss of resistance (LOR) technique. The epidural catheter was inserted to a depth of 5 cm cephalad without difficulty. A bacterial filter was attached. After a test with 60 mg of Lidocaine was negative, 0.1% bupivacaine and 2 mcg/mL fentanyl were infused with 8 mL/h. The other elements of the procedure were sterile, the anesthetist used a face mask and sterile gloves. However, a sterile gown was not worn during the whole procedure. Three hours later, cesarean section was indicated for the patient due to signs of fetal failure. The anesthetist administered a bolus of 400 mg lidocaine and 100 mcg fentanyl via the bacterial filter for the cesarean section. During surgery, the patient was completely stable and a 3300 g baby girl was delivered with the first- and fifth-minute APGAR score of 8 and 10 respectively. No surgical or anesthetic complications had been detected at this time. The epidural catheter remained in for the first 48 hours after surgery for infusion of 0.1% bupivacaine and 2 mcg/mL fentanyl at 6 mL/h through the filter, and was then removed. In the following days, the patient complained of backache that got worse gradually, but no fever was noted. However, on the fifth postoperative day, she had continuous high fever ranging from 39 to 40 degrees Celsius, fatigue, irritation, dyspnea, abdominal distention, backache radiating to the left thigh. General examination showed that she was conscious with a temperature of 39 degrees C and other vital signs within normal ranges. Neurological examination revealed no motor deficit of the lower extremities, normal tendon reflexes, normal bilateral muscle strength, and negative meningeal syndrome.\\nGynecological examination showed a good systaltic uterus and dry incision. The lumbar area at the epidural puncture site was swollen, painful, hot, and red. As shown by serum biochemistry there was prominent infection status with white blood cell count of 16.6G/l, CRP 112.7mg/L, procalcitonin 0.42 ng/mL. After 7 days, there were signs of increased infection including high fever, fatigue, irritability, regular dyspnea, shortness of breath (30 times/minute), drainage of pus from the puncture site of epidural anesthesia, tense abdomen; weakness, numbness and sensory disturbances in lower limbs. Results of blood culture showed that the pathogenic bacteria was Staphylococcus aureus. Antibiogram revealed appropriate antibiotics including vancomycin, carbapenem, cephalosporin and quinolone groups.\\nWe then transferred the patient to a hospital capable of spinal surgery where the lumbar spine MRI scan was obtained and showed an abscess at lumbar L3-4 and subarachnoid inflammation (Figures 1 and 2).\\nSince there were no changes in symptoms in the patient after using antibiotics, after two days, surgery was indicated to remove the absces and, clean the epidural area (Figure 3). Right before surgery, the patient developed numbness and sensory disturbances in lower limbs. Regarding motor deficit, the patient had weakness of muscle strength in lower limbs, ie, 2/5 on the left and 3/5 on the right, as well as reduced tendon reflex of bilateral legs, and negative meningeal syndrome. She was treated with antibiotics according to antibiogram after surgery.\\nFive days after neurosurgery, she had completely recovered. She had no fever, fully recovered movement, and had no sensory disturbances.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 38,\n",
       "    'case_id': 'PMC5046003_01',\n",
       "    'case_text': 'A 38-year-old Caucasian male with Goltz syndrome presented for elective surgery for removal of a left thigh papillomatous mass. He was born with webbed fingers and toes, as well as \"splotchy skin.\" He was diagnosed with Goltz syndrome with skin manifestations as an infant. In his late 20s, he started developing warts and skin tags over his body, and, later in his 30s, he started developing a papillomatous mass on his left inner thigh. His wife reported that the patient has been snoring for about 4 years; however, his snoring had significantly improved in the last 6 months. Other past medical history included obesity with a BMI of 43 and uncontrolled hypertension. Surgical history included a tonsillectomy as a teenager with no mention of anesthetic problems. He denied dysphagia and shortness of breath. Upon airway examination, he had a Mallampati score of 1 and full range of motion of his neck and mandible. The patient\\'s physical examination was significant for a scattered, reticular rash across his chest, as well as a large papillomatous skin mass on his left inner thigh. Induction of anesthesia was accomplished with fentanyl, lidocaine, propofol, and rocuronium. A two-handed mask ventilation technique was required due to his body habitus, though no signs of airway obstruction were noted. Oxygen saturation during mask ventilation was maintained at 100%. Direct laryngoscopy was attempted with Macintosh 4 blade, a grade 2 laryngeal view was obtained, and a mass at the base of the tongue was visualized pulling the vocal cords to the right and obstructing the view of the vocal cords. A glidescope was then used in order to better visualize the mass. With optimal visualization, a friable, large, papillomatous mass was noted at the right base of the tongue (Figures 1(a) and 1(b)). The trachea was intubated with an 8 mm endotracheal tube. General anesthesia was maintained with sevoflurane, and the otolaryngology service was consulted intraoperatively for evaluation of the tongue mass. A small biopsy was taken, and then the surgical removal of the soft tissue mass on his thigh was performed. Upon completion of the thigh mass removal, the otolaryngology serviced returned for debridement of the tongue lesion to obtain a more clear view of the larynx and vocal cords. Upon completion of the debridement, the epiglottis and surrounding soft tissues were noted to be edematous. It was therefore decided to admit patient to the surgical intensive care unit and leave the trachea intubated overnight to safely allow the swelling to subside. After completion of three doses of dexamethasone 8 mg in the surgical intensive care unit, the trachea was uneventfully extubated and the patient was discharged home on postoperative day 2.\\nThe pathological report for the debrided mass was interpreted as papillary lymphoid hyperplasia. The patient presented back to the operating room three weeks later for an elective removal of the remaining obstructing lesions. He was electively extubated the next day in the surgical ICU, just as the previous procedure, to allow for airway edema recovery. At a follow-up clinic visit with otolaryngologist one week later, the patient was breathing well, with no areas of concern for residual or recurrent pharyngeal disease.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 40,\n",
       "    'case_id': 'PMC5131811_01',\n",
       "    'case_text': 'A 40-year-old woman with past medical history of type 2 diabetes mellitus and gastroesophageal reflux disease (GERD) presented to the emergency department because of increasing erythema, swelling, and pain in her right groin. She denied any fevers, chills, sexually transmitted disease history, or inguinal lymphadenopathy. On examination, there was redness with swelling on the right side of her mons pubis radiating down into the right labia majora with no associated lymphadenopathy. A diagnosis of cellulitis was made for which incision and drainage was performed and patient was started on IV antibiotics. Drainage culture showed methicillin-resistant Staphylococcus aureus (MRSA) and antibiotics were tailored accordingly. Her baseline investigations at the time of admission were unremarkable except for elevated white cell count of 19,000 cells/microL/cu mm. She was responding well to treatment; however, on the second day of hospitalization, her bicarbonate level dropped to 7 Meq/L. Arterial blood gas was ordered which revealed pH of 7.2, PCO2 of 21 mm Hg, and HCO3 of 8 mmol/L. Anion gap was calculated to be 18 mmol/L, but lactic acid, urine electrolytes, and kidney and liver functions were within normal limits. She was given IV fluid with bicarbonate without any improvement in her bicarbonate level. In the mean time, she started having labored breathing for which she was admitted in the intensive care unit (ICU). Beta hydroxybutyrate was ordered which was remarkably high (8.86 mmol/L). Surprisingly, her blood glucose levels were consistently below 250 mg/dL throughout the hospital stay. Her home medications included pantoprazole and canagliflozin, which were continued during the hospital stay. She had been on the same medications for years except canagliflozin that was started 1 year ago. Canagliflozin was immediately stopped and she was given supportive treatment. He bicarbonate level improved to normal within 2 days.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 81,\n",
       "    'case_id': 'PMC5457933_01',\n",
       "    'case_text': \"An 81-year-old man was admitted to our hospital with abdominal distension, lightheadedness, and bilateral leg edema. He had previously been independent, but lightheadedness had occurred two months previously, after which he required a crutch to walk. Bilateral leg edema had developed three weeks prior to his admission, but there was no dyspnea. Although his appetite was good, he had noticed abdominal distension on the day before his hospitalization. The patient had a history of hypertension and had been diagnosed with type II diabetes mellitus 20 years previously. Furthermore, he had been admitted to hospital seven years previously for sudden deafness of the right ear. He had no occupational history of asbestos exposure, and he had worked as a bank employee between the 20 and 57 years of age. At presentation, his vital signs were as follows: blood pressure, 118/67 mmHg; pulse rate, 95 beats/minute; body temperature, 36.9C, and oxygen saturation (measured by pulse oximetry) while breathing room air, 100%. On examination, he had pallor of the palpebral conjunctiva. While there were no abnormalities of the thorax, the patient's abdomen was distended and there was bilateral flank dullness without tenderness or abnormal bowel sounds. He also had bilateral leg edema. Laboratory tests showed that his renal and liver functions were normal, but he had microcytic anemia (hemoglobin, 8.6 g/dL; mean corpuscular volume, 78.9 fL), hypoalbuminemia (albumin, 1.9 g/dL), and his C-reactive protein level was elevated to 15.8 mg/dL.\\nA chest radiograph showed cardiomegaly (cardiothoracic ratio: 50%) without pleural effusion or pulmonary congestion, while an abdominal radiograph showed air limited to the epigastrium. He was admitted because of anemia, inflammation, and abdominal distension. His serum iron level was low (13 mug/dL) and his ferritin level was high (1,050 ng/mL), indicating disordered iron utilization and suggesting that his microcytic anemia had occurred secondarily to systemic inflammation. His urine was negative for protein, while his serum protein fractions showed a chronic inflammatory pattern that was characterized by a decrease in albumin and an increase in alpha1-globulin, alpha2-globulin, and gamma-globulin (polyclonal gammopathy). We performed enhanced abdominal computed tomography (CT) to investigate the cause of abdominal distension, which revealed massive ascites, thickening of the anterior peritoneum, and shortening of the mesentery (Fig. 1). Neither abdominal lymphadenopathy nor abnormalities of the solid viscera were observed. Paracentesis revealed cloudy yellow ascites with a high total protein concentration of 3.0 g/dL, indicating that it was an exudate. The serum-to-ascites albumin gradient was 0.6 g/dL, demonstrating the absence of portal hypertension. The glucose concentration was 98 mg/dL and the cell count was 150/muL (mainly lymphocytes and histiocytes without neutrophils). A bacterial culture of the ascites was negative, which made bacterial peritonitis unlikely. Tuberculous peritonitis was excluded by the normal adenosine deaminase level (16.7 IU/L). Because his cytology was class III, malignant ascites was suspected. His serum tumor marker levels, including carcinoembryonic antigen and carbohydrate antigen 19-9, were normal. A gastrointestinal tract work-up revealed reflux esophagitis and chronic gastritis on endoscopy, but no malignant lesions were found. The patient vomited after endoscopy and developed chemical pneumonia due to the aspiration of gastric acid. The patient's respiratory insufficiency required ventilation, but he was subsequently weaned from the ventilator. However, he had recurrent vomiting and aspiration due to paralytic ileus. Cytological examinations of the ascitic fluid were repeated three times, but remained class II after the initial finding of class III. Because the patient's abdominal distension persisted, we performed the drainage of approximately 3 L of fluid; however, the re-accumulation was rapid and weekly drainage was required. The patient's hemoglobin level decreased to 6.9 g/dL and a transfusion of packed red cells was planned. A direct Coombs test was positive and warm antibody was detected in the blood examination before transfusion, despite the patient having no history of transfusion. We did not perform transfusion because agglutination occurred with all of the red cell products that were stored at our hospital. The patient died of aspiration pneumonia secondary to paralytic ileus on the 52nd day of hospitalization and an autopsy was performed with the consent of his family. The abdominal cavity contained 3,200 mL of clear yellowish ascites and the entire peritoneum was thickened with scattered small granules and nodules. Severe adhesion of the digestive tract was observed, which formed a cluster with the abdominal organs (Fig. 2). The entire peritoneum, gastrointestinal tract, and gallbladder showed prominent thickening, and there was also partial involvement of the liver and pancreas. A histological examination of the Hematoxylin and Eosin (H&E) staining sections revealed neoplastic cells with a tubulopapillary appearance (Fig. 3A), as well as tightly packed spindle cells (Fig. 3B), which represented epithelioid and sarcomatous tumor components, respectively. The tumor cells were negative for carcinoembryonic antigen (a marker of adenocarcinoma), but were positive for HBME-1 (Fig. 4A), calretinin (Fig. 4B), cytokeratin, CAM 5.2, and cytokeratin 5/6 (markers of mesothelioma) on immunohistochemical staining. Biphasic MPM was diagnosed based on these findings.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 59,\n",
       "    'case_id': 'PMC7090256_01',\n",
       "    'case_text': 'A 59-year-old male presented with a right symptomatic reducible inguinal hernia. The patient had no abdominal or urinary symptoms. His previous medical history was uneventful. On clinical examination, a reducible small-sized right inguinal hernia with normal testes was found. The patient had a colonoscopy as a screening test 4 months prior to the surgery, and the result of the procedure was unremarkable. The patient underwent open right indirect inguinal repair (Lichtenstein procedure) under general anesthesia. During dissection of the indirect inguinal hernia sac, two tubular structures were identified as the vas deferens (Figure 1). Examination of the scrotum showed a single testes and epididymis; both vas deferens communicated with the epididymis. We followed the two vas deferens from the deep inguinal ring until they fused in the epididymis of the testis. We performed the Lichtenstein procedure, and the patient tolerated the procedure without post-operative complications. He was discharged the next day and followed up 2 weeks post-operation as a surgical outpatient. The patient reported no complaints during his outpatient visit, and no complications related to the procedure were noted. Due to the financial status of the patient, we were unable to perform a CT scan or MRI of the pelvis to assess whether the duplication was bilateral or unilateral.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 2,\n",
       "    'case_id': 'PMC6299974_01',\n",
       "    'case_text': 'The index patient (IV.1) was referred to our dedicated immunology clinic (McGill University Health Centre-MUHC) at 18 months of age for evaluation of dermatitis and recurrent infections. He was treated with oral antibiotics at 5, 8, and 13 months of age for balanitis. He also suffered from chest X-ray-documented pneumonia and an acute otitis media, which occurred at 6 and 12 months of age, respectively. At 14 months, he was admitted to the hospital for febrile neutropenia with pneumonia and treated with intravenous antibiotics. The neutropenia resolved, but marked persistent lymphocytosis persisted. Small reactive lymphocytes were present on the peripheral blood smear. The physical examination revealed dry lichenified erythematous skin lesions with no palpable lymphadenopathy and no appreciable splenomegaly. Dermatology confirmed a diagnosis of pustular psoriasis, which was complicated by a superimposed recurrent molluscum contagiosum affecting his abdomen, back, perianal and leg areas as well as streptococcal perianal dermatitis.\\nInitial blood analyses performed at MUHC in 2012 showed a lymphocyte count of 20.4 x 109/L and composed predominantly of CD19+ B-cells (12.4 x 109/L, 61.0%), with a decreased proportion of CD3+ T-cells (6.7 x 109/L, 33.0%) and normal CD16+CD56+ NK-cells (0.6 x 109/L, 3.0%). An extended flow cytometry panel performed in 2015 (MUHC) revealed increased proportions of naive CD19+sIgM+ B-cells (24.9 x 108/L, 72.0%) and CD19+CD5+ B-cells (20.0 x 108/L, 58.0%). The proportion of class-switched CD19+CD27+IgD-memory B-cells (0.2 x 108/L, 0.6%) was decreased. IgH gene rearrangement analysis demonstrated a polyclonal B-cell lymphocytosis pattern (Supplementary Figure 1). The patient had mild hypogammaglobulinemia (IgG 3.1 g/L) associated with slightly decreased serum IgA levels (0.19 g/L), absent serum IgM (< 0.25 g/L) and normal IgE levels (63 mug/L). IgE levels increased to 444 mug/L (normal 0-240 mug/L) later when the patient reached 4 years of age. Although, the patient received all recommended vaccines for age (including live attenuated vaccines against measles, mumps, rubella and varicella), he had no specific antibody responses against Haemophilus influenzae type B (IgG < 0.1 mug/mL) and Streptococcus pneumoniae (0/14 IgG serotypes were above 1.3 mug/mL). The specific antibody responses were normal for tetanus (IgG above 4.0 IU/mL) and diphtheria toxoids (IgG above 3.0 IU/mL). Lymphocyte proliferation responses to phytohemagglutinin, concanavalin A, and anti-CD3 were also normal. Pokeweed mitogen proliferative response was decreased (stimulation index of 23.2 compared to 85.6 in healthy control). Mild splenomegaly (8.5 cm) was confirmed on abdominal ultrasound. The CT scan showed small bilateral cervical lymph nodes. Blood serology and PCR for EBV and cytomegalovirus (CMV) were negative. The patient was treated with weekly subcutaneous immunoglobulin (scIg) injection therapy (equivalent to 0.65 g/kg/month). At 5 years of age, he suffered from two consecutive pneumonias with the second episode associated with rhinovirus infection, which required hospitalization and oxygen supplementation. Among other relevant medical problems, he is known for mild bilateral conductive hearing loss and atopy IgE-mediated milk allergy (milk specific IgE: 9.95 IU/L and positive skin prick test to cow\\'s milk extract at 2 years old) and allergic rhinitis to birch and cat.\\nThe family reported that parents were not related and were of Caucasian origin (Figure 1A). The father (Patient III.1, 29 years old) was investigated as a child for splenomegaly, atopic dermatitis, mild intermittent asthma, molluscum contagiosum (on buttocks, legs, and arms from age 1-5 years old) and \"high total B-cell number.\" No diagnosis was established at the time. Over the years, he developed recurrent warts and persistent finger onychomycosis (since age 4-5). He had chickenpox at 11 years old followed by shingles as a young adult. More recently, he was treated with intravenous antibiotic for recurrent knee effusions and recurrent folliculitis of the forearms and thighs. Staphylococcus aureus was isolated on the initial bacterial culture. Further immunological investigations revealed a polyclonal B-cell lymphocytosis (absolute lymphocyte count of 3.4 x 109/L with 33.0% of circulating CD19+ B-cells). B-cell subpopulation analysis also demonstrated an increased proportion of naive CD19+sIgM+ B-cells (7.9 x 108/L, 74.0%) and CD19+CD5+ B-cells (5.3 x 108/L, 50.0%), while the proportion of class-switched CD19+CD27+IgD-memory B-cells (0.1 x 108/L, 1.0%) was severely decreased. The father had a mild decrease in serum IgM level (0.48 g/L), but otherwise normal serum immunoglobulins (IgG 12.7 g/L, IgA 1.8 g/L, IgE 37-107 mug/L) and specific antibody responses against tetanus (0.9 IU/mL), diphtheria (0.6 IU/mL), and Haemophilus influenzae type B (HIB, 1.9 mug/mL) post vaccination. The specific humoral response against polysaccharide antigens was suboptimal with < 50% of pneumococcal serotypes above 1.3 mug/mL despite Pneumovax booster. Numbers and proportions of peripheral blood T and NK cells populations were within normal range for age. Lymphocyte mitogen proliferation assays were also normal. The father was closely monitored for the occurrence of possible lymphoproliferative disorder; he had persistently positive EBV PCR (46 774 copies/mL, EBV VCA positive >=1/4000, EBV EBNA < 1/10) with enlarged axillary lymph nodes (up to 1.7 x 1.2 cm on the left size) and prominent fluorodeoxyglucose activity on PET-CT scan. His spleen size was at the upper limit of normal (13.3 cm). He was treated with frequent boosters of conjugated pneumococcal vaccines (e.g., Prevnar-13) and use of immunoglobulin replacement therapy was considered by the medical team.\\nThe grandmother (II.1) reported frequent otitis externa and colds as a child. As an adult she had two pneumonias and two episodes of shingles, and was treated for Hodgkin\\'s lymphoma (2A, mixed cellularity) at 33 years old. She has allergic rhinitis to dust and molds, frequent rhinosinusitis, persistent warts, and persistent onychomycosis. The great-grandmother (Patient I.1, 78 years old) suffered from recurrent warts, shingles and sinusitis over the years. A clinical evaluation was offered to the great grandmother at MUHC but never performed. The index patient, father and grandmother were subsequently evaluated at the NIH Clinical Center in 2015 and again in 2017. On physical exam, warts were noted on the index patient (one on toe) and father (multiple on hands). The most recent flow cytometric evaluation of PBMC confirmed expansion of naive and immature B cells in the index patient, with few class-switched memory B cells detected (Table 1). The same pattern was evident in the father and grandmother, although circulating B cell counts decreased inversely with age. PCR indicated moderate EBV viremia in both father and grandmother (3.13 and 4.45 Log10 IU/ml). Serum IgE levels were slightly elevated in the index patient; otherwise total immunoglobulin levels were normal for all subjects. For the father, random antibody titers against rubella, measles, and VZV were normal, but absent against mumps. The grandmother showed normal antibody titers to measles, rubella, mump, tetanus and HIB, with poor responses to Pneumovax (5/23 serotypes detected).\\nAffected patients displayed multiple clinical hallmarks of B cell Expansion with NF-kappaB and T cell Anergy (BENTA) disease, including (a) splenomegaly, (b) polyclonal B cell lymphocytosis, featuring elevated naive/immature B cells with few class-switched memory B cells, (c) poor responses to pneumococcal vaccines, (d) bacterial/viral infections including pneumonias, molluscum contagiosium/warts, and moderate EBV viremia. Because BENTA is caused by gain-of-function (GOF) variants in the lymphocyte scaffold molecule CARD11, we focused on CARD11 as a potential candidate gene. Sanger sequencing was first performed on genomic DNA isolated from peripheral blood mononuclear cells (PBMC) from the index patient (IV.1) and his father (III.1). This analysis revealed a heterozygous four amino acid deletion and missense mutation within exon 5 of CARD11 (NM_032415.3 c.701_713delinsT, p.His234_Lys238delinsLeu, hereafter referred to as H234LDelta235-8) (Figures 1B,C). The grandmother and great-grandmother were later confirmed to carry the same pathological mutation (Figure 1B). A CARD11 expression plasmid of this variant was constructed and expressed in a variant of the Jurkat human T cell line (JPM50.6) that lacks endogenous CARD11 expression and harbors an NF-kappaB-driven green fluorescent protein reporter (GFP). Similar to a confirmed gain-of-function (GOF) CARD11 mutation (E134G), H234LDelta235-8 induced constitutive NF-kappaB activation in unstimulated cells, increasing slightly upon TCR/CD28 crosslinking (Figures 2A,B). However, unlike E134G, co-expression of H234LDelta235-8 with WT CARD11 sharply reduced constitutive NF-kappaB activity. Strikingly, H234LDelta235-8 also significantly reduced WT CARD11-dependent NF-kappaB activation following TCR/CD28 stimulation (Figure 2B). Protein expression of WT, E134G and H234LDelta235-8 CARD11 were similar in transfected cells (Figure 2C). Co-immunoprecipitations in WT Jurkat transfectants revealed a substantial reduction of total CARD11 association with BCL10 and MALT1 following stimulation in the presence of H234LDelta235-8 but not WT or E134G CARD11 (Figure 2D). This decrease in CARD11-BCL10-MALT1 (CBM) complex formation was comparable, but slightly less pronounced, than that noted with a bona fide dominant negative (DN) CARD11 variant R47H. Moreover, FLAG-tagged CARD11 variants co-precipitated with WT GFP-tagged CARD11 when co-expressed in JPM50.6 cells, indicating WT CARD11 can directly associate with mutant CARD11 protein regardless of stimulation (Figure 2E). Taken together, these results suggest the H234LDelta235-8 CARD11 mutant can disrupt normal activation-induced CBM complex assembly and NF-kappaB signaling in T cells through DN interference. Similar to other patients harboring CARD11 DN variants, we also observed marked defects in NF-kappaB p65 phosphorylation and IkappaBalpha degradation in stimulated primary CD4+ T cells from patients III.1 and IV.1 relative to healthy control subjects (Figure 2F).\\nAt baseline, the patient (IV.1) and his father (III.1) showed marked B-cell lymphocytosis: 51.6% and 44.5%, respectively, of their PBMC were CD19+ B-cells, compared to 13.8% for the patient\\'s mother (healthy control, HC) and 10.2 +- 4.4% for a reference cohort. The majority were naive IgM+IgD+ B-cells (IV.1 74.9%, III.1 52.1%, HC 8.4%). To assess in vitro B-cell differentiation, PBMC (1 x 106/mL) were cultured for 7 days with anti-CD40 (1 mug/mL), IL-4 (200 U/mL), and IL-21 (50 ng/mL) at 1 x 106 PBMC/mL in complete medium [RPMI 1640 + 10% FBS, 2 mM glutamine, 1 mM sodium pyruvate, 15 mM HEPES buffer (pH 7.0), and 100 U/ml penicillin/streptomycin]. IL-21 promotes B-cell differentiation into class-switched (CS) memory and antibody-secreting plasma cells in the presence of CD40 signaling, and IL-4 enhances these effects. Cells from patient (IV.1) and father (III.1) not only displayed poor short-lived plasma cell differentiation (Figure 3A, top panel) compared to the healthy mother (IV.1 0.6%, III.1 2.4%, HC 12.1%), but also decreased CD27+ memory B-cell differentiation including IgM- CD27+ CS memory B-cells (IV.1 2.4%, III.1 4.4%, HC 20%) (Figure 3A, bottom panel). B cell differentiation phenotypes were quantified in Figure 3B. These results were associated with marked decreases in production of IgM (IV.1 0.2 mg/L, III.1 0.4 mg/L, HC 3.7 mg/L), IgA (IV.1 0.0 mg/L, III.1 0.1 mg/L, HC 1.7 mg/L), and IgG (IV.1 0.4 mg/L, III.1 2.1 mg/L, HC 6.5 mg/L) (Figure 3C). Purified T cells from affected family members showed impaired proliferation in response to anti-CD3/CD28 Ab stimulation in vitro, which was largely rescued by more robust stimuli (Ab crosslinking or Ab-conjugated beads) (Figures 3D,E). Nevertheless, patient T cells secreted less IL-2 in response to all stimuli (Figure 3F, Supplementary Figure 2). These results are consistent with previous work demonstrating that BENTA patient B-cells exhibit intrinsic differentiation defects despite enhanced survival in vitro, whereas T cells from both BENTA (CARD11 GOF) and CARD11 DN patients are hyporesponsive in vitro.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 14,\n",
       "    'case_id': 'PMC9479491_01',\n",
       "    'case_text': \"We report a 14-year-old male patient who has experienced progressive gait disturbance characterized by difficulty in maintaining balance since the age of 4 years. He is the first child of healthy, non-consanguineous Chinese parents with no family history of gait disorders. The boy was referred to have had normal development until 4 years of age, when parents started noticing unsteady gait with frequent falling down, cognitive, and speech worsening. At age 7 years he presented ataxia increasing with effort, dysarthria, gait disorders, slowness, learning difficulties, exercise intolerance and fatigue needing to rest. The boy at the age of 10 years was admitted for his first neurological examination, which revealed markedly cerebellar syndrome with gait ataxia and dysarthria attention, and mild cognitive and executive function decline. Physical examination revealed pes cavus, but no scoliosis or other musculoskeletal deformities. Deep tendon reflexes of the lower extremities were disappeared and the plantar response was flexor bilaterally. Light touch, pinprick, and vibration sensation were absent, and the Romberg test was positive. Neurological examination was characterized by gait imbalance and absence of dystonia, chorea, tremor and dyskinesia (Supplementary Video 1). His extraocular range of motion was adequate in all directions, with no apparent OMA on reflex saccade examination. The boy at the age of 14 was screened by a trained neurologist and were noted a mild cognitive impairment. The clinical manifestations were consistent with AOA1.\\nBiomedical tests for ceruloplasmin, serum immunoglobulin, alpha-fetoprotein, ferritin, urethane lactate, pyruvate, liver and kidney function, electrolytes, hemoglobin, vitamin E and B12 were performed. No results were abnormal except for hypoalbuminemia (30.5 g/L, normal range 40-55 g/L) and mildly elevated cholesterol (6.1 mmol/L, normal range <5.2 mmol/L). Serum alpha-fetoprotein (AFP) level was normal. The patient's visual evoked potentials were abnormal in low-amplitude responses on binocular and monocular tests, although it was not appreciated on history or physical examination. Nerve conduction study showed reduced nerve conduction velocities and low sensory and motor action potentials indicating sensorimotor axonal polymorphic peripheral nerve damage. The lower extremity muscles were biopsied, and histological analysis showed that the size of muscle fibers varied slightly, showing neurogenic pathological changes. Magnetic resonance imaging (MRI) of the head showed atrophy of the cerebellum with no involvement of the brainstem or cerebral cortex, and low signal loss in the cerebellar dentate nucleus on sensitivity-weighted imaging (SWI) (Figure 1). MRI scan was evaluated by an experienced radiologist. Written informed consent was obtained from the parents for publication and accompanying images.\\nGiven the tentative diagnosis of cerebellar ataxia, genetic evaluations for spinocerebellar ataxia (SCA1, 2, 3, 6, 7, 8, 10, 12, 17, 36), dentatorubral-pallidoluysian atrophy (DRPLA), and the autosomal recessive ataxias Friedreich's ataxia (FRDA) were performed and shown to be negative.\\nWe then performed WES to identify the genetic lesions responsible for the disease phenotype of the proband. The main part of WES was provided by the Novogene Bioinformatics Institute (Beijing, China). The exomes were captured using Agilent SureSelect Human All Exon V6 kits (Agilent Technologies, Sta Clara, CA, USA), and high-throughput sequencing was performed using Illumina HiSeq X-10 (Illumina, San Diego, CA, USA). The basic bioinformatics analysis including Reads, Mapping, Variant detection, Filtering, and Annotation were also endowed by Novogene Bioinformatics Institute. The strategies of data filtering refer to Figure 2. Sanger sequencing was applied to validate the candidate variants identified in whole-exome sequencing. Cosegregation analysis was conducted in all family members of this study. The primers were as follows: c.739C>T (forward: 5'-AAGTCAGGCAGAGAGGTGGA-3', reverse: 5'-CGTTACCATTGGCTGGTCTT-3'); c.501dupG (forward: 5'- CAAGGCAGAGGGGATATTCA-3',reverse: 5'- GAGGCAGGAGAATCACTTCG-3'), and the sequences of the polymerase chain reaction (PCR) products were determined using the ABI 3100 Genetic Analyzer (ABI, Foster City, CA).\\nAfter data filtering, a nonsense mutation in exon 7 (c.739C >T; p.Arg247*) and a frameshift mutation in exon 6 (c.501dupG; p.Ser168Glufs*19) were identified by using WES,and they were co-segregated with the affected members (Figure 3). The patient's father carried a single heterozygous mutation (c.501dupG), and his mother carried a single heterozygous mutation (c.739C>T). Mutation in APTX c.501dupG, which has not been reported previously, located at Chr9:32,986,011(Exon 6).\\nCurrently, the patient has accepted medicine (Idebenone20 mg daily and CoQ10 30 mg daily) and supportive procedures including rehabilitation therapy, and speech therapy. However, the boy experienced no significant clinical improvement following the procedure.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 20,\n",
       "    'case_id': 'PMC8599274_01',\n",
       "    'case_text': \"A 20-year-old Quarter Horse gelding weighing 510 kg was referred to the University of Pennsylvania's New Bolton Center Large Animal Hospital with a history of acute, severe, non-Weight-bearing lameness of the right front limb. His pain level was severe enough to be mistaken for colic or an acute neurologic event. A physical exam revealed that the gelding was tachycardic at 80 beats per min. He was tachypneic at 44 breathes per min. His rectal temperature was within normal limits at 100.7  Fahrenheit. Colic and neurologic exams revealed no abnormalities in these body systems. Muscle fasciculations of the right triceps brachii muscle were present, and the caudal antebrachium was diffusely firm, with edema present medially from the olecranon to the accessory carpal bone (ACB). Radiographs of the cubital joint, radius, and radiocarpal joint were unremarkable. An ultrasonographic evaluation of the antebrachium revealed increased echogenicity of the superficial digital flexor (SDF) muscle from the musculotendinous junction proximally. There was loss of the normal architecture of the musculotendinous junction of the SDF. The disruption in the tendon fibers was most severe at 23 cm proximal to the ACB where 80% of the SDF muscle fibers were disrupted with loss of regularity and longitudinal orientation. The percentage of damaged fibers decreased but remained abnormal distally to the level of the ACB. The flexor carpi ulnaris muscle had interrupted muscle fibers in approximately 40% of the cross-Sectional area with the severity distributed similarly to the SDF muscle. In addition to fiber pattern disruption, many areas of mixed echogenicity and fluid pocketing were seen, consistent with hemorrhage, in both the SDF muscle and the flexor carpi ulnaris. A diagnosis of traumatic SDF and flexor carpi ulnaris muscle tears was made. The gelding was treated with phenylbutazone (4.4 mg/kg IV q12 h; VetOne, Boise, ID, USA), and a compression bandage was placed. The lameness remained unchanged following three doses of 4.4 mg/kg phenylbutazone IV every 12 h. Based on recorded findings in the medical record, 36 h after presentation, the gelding was spending more than 50% of the time recumbent.\\nDue to the lack of adequate responsiveness to systemic treatment and the > 50% of time spent recumbent, the decision was made to provide spinal analgesia by epidural morphine treatment. The gelding was sedated with detomidine (0.02 mg/kg IV, Zoetis, Parsippany, NJ, USA) for placement of a cervical epidural catheter as previously described. A 20 x 20 cm area to the right of the mane, caudal to the right ear, centered over the first cervical (C1) and second cervical (C2) intervertebral space was clipped and aseptically prepared. Ultrasound was used to localize the space between C1 and C2 and visualize the spinal cord, subarachnoid space, and paraspinal tissues. The skin and musculature deep to the proposed insertion site was locally anesthetized using 5 ml 2% mepivacaine (Carbocaine , Zoetis, Parsippany, NJ). The ultrasound probe (Philips Lumify, C5-2 broadband curved array 2-5-MHz probe) was covered in a sterile plastic shield containing ultrasound transmission gel. A single operator (SDH) then controlled both the ultrasound probe and the 17-gauge 6-inch curve-tipped spinal needle with stylet (Tuohy). Using ultrasound guidance, the Tuohy needle was advanced dorsal to the probe until just adjacent to the dura. The stylet was removed, and 0.9% saline was placed in the hub. Next, the needle was advanced until loss of resistance and a positive hanging drop were observed. The epidural catheter (FlexBlock , 19-gauge, 60 cm, Arrow International Inc., Reading, PA, USA) was then advanced through the spinal needle by a second operator (KH). The Tuohy needle was then withdrawn, removing the stylet of the epidural catheter with it. The first placement attempt was unsuccessful. There was increased resistance to passage of the catheter, and contrast radiography revealed subdural placement. This catheter was removed, and the horse was re-sedated. The second attempt with a new catheter was successfully placed in the epidural space with 6-7 cm of the catheter passed through the Tuohy needle. Correct positioning of the catheter was confirmed based on the loss of resistance, the hanging drop technique, the ability to pass the catheter caudally, and contrast radiography. The epidural catheter was then secured with cyanoacrylate glue at the insertion site, and the external length was sutured to the skin and secured using adhesive dressings.\\nStarting 36 h after the gelding's admission to the hospital, his pain was scored using a composite measure pain scale that has been previously described. This scoring system accounts for weight bearing, head carriage, location within the stall, gross pain behavior, and response to interaction. In addition to epidural morphine, the gelding was maintained on phenylbutazone (2 mg/kg PO every 12 h; VetOne, Boise, ID) for 7 days then 1 mg/kg PO every 12 h for 7 days.\\nPain assessment and scoring were performed four times per day by a board-certified anesthesiologist (KH). The pain scores from just prior to epidural catheter placement until hospital discharge are depicted in detail in Figure 1. Prior to epidural catheter placement, the pain score was at the maximum allowed by the scale at 22. Thirty min following epidural catheter placement, 50 mg morphine sulfate (0.1 mg/kg BW; Henry Schein, Melville, NY, USA) diluted to a total volume of 5 ml with sterile saline was administered. Preservative-free morphine was not available at the time that this case was hospitalized. The morphine was administered with the gelding's head in an elevated position over a 30-min period to promote caudal movement of the epidural drug. The gelding's head remained elevated for 20-30 min following each morphine administration throughout his hospitalization. Twenty-four h after the second treatment, the morphine dose was reduced to 25 mg diluted to 5 ml with sterile saline over 20 min (0.05 mg/kg BW). This resulted in a pain score of 2/22 which increased to 5/22 by 12 h post-Administration; therefore, the same dose was repeated. The pain score remained acceptably low initially; however, by 12 h after the preceding morphine dose, a slight increase in pain was noted (score 5/22) and 25 mg diluted to 5 ml in sterile saline was administered a third time over 30 min. The gelding's time spent recumbent dropped to <10% 6 h after the first morphine dose. Throughout the remainder of the gelding's hospitalization, his pain score remained low (1-2/22) and no further morphine doses were administered. In response to epidural morphine, the heart rate decreased and remained within physiological limits for the remainder of his hospitalization (Figure 2).\\nThe cervical epidural catheter was removed 48 h after the last morphine administration. There was no swelling or discharge from the catheter site while indwelling or following removal while in the hospital. At the 2-month telephone follow-up, the gelding was walking without lameness. The owner confirmed no heat, discharge, swelling, or pain at the insertion site of the catheter.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 31,\n",
       "    'case_id': 'PMC4038000_01',\n",
       "    'case_text': 'A single case was selected from a larger group study. This study was approved by the Institutional Research Ethics Committee, and written informed consent was provided by the subject, a 31-year-old male who had been screened for pre-existing medical conditions, was selected as he suffered from vasovagal pre-syncope during a challenge that comprised induction of isocapnic hypoxia with a target arterial oxygen saturation (SpO2) of 80 %.\\nThe pHOS, described in more detail elsewhere, combines frequency domain (FD) and broadband (BB) components. Changes in chromophore concentration were estimated by using the changes in light attenuation as measured by the BB spectrometer, using the UCLn algorithm to resolve for three chromophores - oxyhaemoglobin (HbO2), deoxyhaemoglobin (HHb) and oxCCO - between 780 and 900 nm. A fixed differential path length factor (DPF) of 6.26 was used to enable comparison with previous studies. The FD component measured the absolute absorption and scattering coefficients (mua and mus, respectively) at discrete wavelengths 690, 750, 790 and 850 nm, allowing the estimation of DPF at each of these wavelengths using the diffusion approximation. The pHOS optode was placed over the FP1 point on the right side of the forehead.\\nOther monitoring included beat-to-beat SpO2, continuous non-invasive arterial blood pressure, and transcranial Doppler (TCD) ultrasonography was used to measure middle cerebral artery flow velocity (Vmca), insonating through the right temporal window, ipsilateral to pHOS monitoring. Estimated relative cerebral oxygen delivery (ecDO2) was calculated as the product of changes in SpO2 and Vmca (relative to their initial values). Synchronization between the pHOS and other monitors was performed by means of a signal voltage output by the frequency domain spectrometer for the length of recording; all data were resampled to a sample period of 3.2 s across the length of recording. Twenty-second data windows were selected for the reporting of summary data. Changes in hemoglobin species concentration are expressed as total hemoglobin ( [HbT] =  [HbO2] +  [HHb]) and hemoglobin difference ( [HbDiff] =  [HbO2] -  [HHb]). All analysis was carried out in Matlab  2011b.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 38,\n",
       "    'case_id': 'PMC9019075_01',\n",
       "    'case_text': \"The patient, a 38-year-old Chinese female, presented to the general surgical outpatients clinic with a 18-month history of intermittent right upper abdominal pain, back pain, nausea and vomiting. The examination of the patient's medical history revealed good general health, absence of systemic diseases, and smoking habit. The physical examination was normal. These symptoms were not decreased in patient treated with oral acid-inhibitory drug and cholagogue at the local hospital.\\nUltrasound of the abdomen showed a retroperitoneal tumor measuring 4.8 x 2.3 cm (Figure 1). To further confirm the diagnosis, Abdominal contrast enhanced computed tomography (CT) revealed a retroperitoneal mass 34 mm x 27 mm in size, near right renal veins extending to inferior vena cava, and it was pushing the pancreas forward (Figure 2). Abdominal contrast enhanced CT did not reveal any evidence of retroperitoneal enlarged lymph nodes. The border between the tumor and IVC was indistinct at the arterial phase, the venous phase and the delayed phase (Figure 2). To determine the primary site of the tumor and whether metastasis had occurred, The patients' complete examination included head magnetic resonance imaging (MRI), chest CT and cardiac ultrasound. The patient refused to undergo PET-CT due to financial constraints. The cardiac ultrasound and brain MRI were normal. The CT scan of the chest showed a tumor in the lingual segment of the upper lobe of the left lung, consisting of ground-glass nodules with unclear boundaries; The tumor was approximately 1.3 cm x 1.1 cm in size and multiple short burls can be seen around the edges of the tumor. There were no enlarged lymph nodes in the mediastinum (Figure 3). Bronchoscopy was performed to clarify the nature of the tumor, showing acute inflammation of the bronchial mucosa. Pulmonary tumor may be metastases of inferior vena cava tumors, primary lung cancer or benign pulmonary nodules. Therefore, the patient was discussed in the multidisciplinary tumor board meeting to determine the best treatment strategy. Discussion the results suggest surgery as the only effective treatment for inferior vena cava tumors and pulmonary tumor. The patient first underwent resection of IVC sarcoma. And 1 month later, the patient underwent wedge resection of pulmonary by thoracoscope without preoperative pulmonary biopsy.\\nThe patient underwent resection of IVC sarcoma, which was located at the confluence of the renal vein into the inferior vena cava. After the proximal and distal clamp, the tumor and the involved IVC were completely removed from the infrahepatic IVC to just above the right renal vein. In order to save operation time, the inferior vena cava was reconstructed with artificial blood vessels. Blood loss was around 400 ml during the operation. Post operatively, patient made a good recovery without serious complications.\\nThe postoperative pathological specimens showed that the size of the tumor was 6 x 4 x 3 cm, which was lobulated, the capsule was intact, and there was no metastasis in the surrounding lymph nodes. The histopathological examination showed a well-circumscribed mass composed of spindle cells arranged in interlaced and bundles (Figure 4). The tumor cells are fusiform, slender and rich in cytoplasm. The nucleus is deeply stained, the end is blunt, located in the center, with a certain degree of heteromorphism and pleomorphism (Figure 4). A few fused nuclei were also seen. Immunohistochemistry analysis revealed the tumor to be positive for smooth muscle actin (SMA), myoglobin, desmin, Epithelial Membrane Antigen (EMA), Transducin-Like Enhancer of split 1 (TLE-1), h-caldesmon, vimentin, CD99 and Ki-67:40%, and negative for CD 117, CKp, CK7, Bcl-2, S100, CD31, CD34, Dog-1 and STAT-6. These findings support the diagnosis of IVC sarcoma.\\nAfter 1 month, the patient underwent thoracoscopic wedge resection of the upper lobe of left lung. The lung tissues 20 mm from the edge of the nodule, including the nodule, was removed with a linear cutting closure device. There were no obvious blood loss and complications during or after the operation. Blood loss was around 50 ml during the operation. Post operatively, patient made a good recovery without serious complications.\\nGrossly, the resected lung tissue was approximately 6 x 4 x 3 cm in size with an solid mass measuring 0.8 x 0.8 cm in the central area. Patient underwent pathologically confirmed complete anatomical resection of the primary tumor, therefore the surgical margin was >2 cm. There were no enlarged or suspected lymph nodes in the mediastinum during the operation, so mediastinal lymph node dissection was not performed. The histopathological examination of the excised mass showed lung adenocarcinoma (Figure 5). Immunohistochemical staining of the tumor cells revealed positive expression for CK7, napsin A, TTF-1 and Ki-67:20%, and negative expression for CK5/6, p63, p40, Syn, CgA, CD56 and LCA. Cells from a squamous cell carcinoma are generally CK5/6, p40 and P63 positive and TTF-1 and Napsin A negative whereas adenocarcinoma cells are generally CK7, Napsin A and TTF-1 positive while being negative for p40 and CK5/6. In addition, the patient's lung tissue specimens were consulted by pathologists in Fudan University Cancer Hospital and Gansu Cancer Hospital, and the pathologists of the two hospitals agreed on the diagnosis of lung adenocarcinoma. The patient received gefitinib tablets (250 mg per day) as a maintenance therapy during the perioperative period. Follow-up based on patient's recent medical history, chest and abdominal physical examination, complete blood count, liver function tests, tumor markers monitoring, ultrasound scan of the abdomen every 3 months, CT scans of the lung, abdomen and head every 6 months. 20 months after resection of inferior vena cava leiomyosarcoma, the contrast-enhanced CT images show two lump about 1.2 and 0.7 cm in diameter in upper lobe (Figure 6) and lower lobe of the right lung (Figure 7). According to the examination results, it may be metastasis of inferior vena cava sarcoma or recurrence of lung adenocarcinoma. Thoracoscopic wedge resection was performed in patient after the discussion by thoracic surgery department. The immunohistochemical results of postoperative specimens were consistent with the metastasis of inferior vena cava leiomyosarcoma (Figure 8). Immunohistochemical staining of the tumor cells revealed positive expression for SMA, desmin, vimentin and h-caldesmon and Ki-67:70%, and negative expression for CD117, S100, CD34, and Dog-1. Histopathological examination of the right lung mass confirmed the diagnosis of the inferior vena cava leiomyosarcoma metastasis. The patient received oral anlotinib treatment (12 mg once daily) after the last operation. The follow-up items are the same as before. During on-going regular follow-up visits no evidence of recurrence or metastasis was observed from December 2020 to October 2021 (Figure 9).\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 42,\n",
       "    'case_id': 'PMC4901150_01',\n",
       "    'case_text': \"A 42-year-old male, recently diagnosed with acquired immune deficiency syndrome (AIDS) and a CD-4 count of 35 cells/mm3, presented with abdominal pain, nausea, vomiting, and anorexia. During the course of his hospitalization, the patient's abdominal pain and associated symptoms improved, but he became more somnolent and fatigued. He fell twice while ambulating and after the falls reported having occipital headaches without vision changes. There was no other significant change in mental status, but a new right-eye lateral-gaze palsy was identified. The patient denied having any history of visual disturbances and, other than previous gastrointestinal symptoms with weight loss, the review of systems was negative.\\nThe examination most notably identified an afebrile, somnolent patient with the ability to arouse when stimulated, focus on questions, and follow commands. He demonstrated a right sixth-nerve palsy manifested as a lateral-gaze defect in that eye, in conjunction with both horizontal and vertical nystagmus bilaterally. Muscle tone and strength was slightly reduced in all extremities (measuring 4/5 on the Medical Research Council's grading system).\\nDue to the repeated falls and possible brain trauma, a noncontrast CT scan of the head (Figs. 1A and 1B) was obtained and was concerning for a subarachnoid hemorrhage (SAH). This finding lead to a neurosurgical evaluation with a subsequent CT angiogram of the brain (obtained due to the possible presence of a ruptured aneurysm). The angiogram failed to identify an aneurysm or other source of intracranial bleeding. An external ventricular drain was placed (due to suspicions of hydrocephalus) and allowed for cerebrospinal fluid sampling.\\nThe patient's initial CSF was clear, without xanthochromia, with a white-blood-cell count (WBC) of 2 cells/mm3, red-blood-cell (RBC) count of 73 cells/mm3, and total protein of 5 mg/dL. A second tube's WBC count was 1 cell/mm3, and the RBC count 12 cells/mm3. The CSF culture grew cryptococcus neoformans, with a positive cryptococcal antigen in the blood.\\nThe findings on the CT scan were therefore felt to be consistent with a pseudosubarachnoid hemorrhage (PSAH). This is based on the fact that decreasing RBC count between the first and second tube typically indicates a traumatic tap as the source of the red blood cells. The only way to definitively rule out SAH would be to document clear CSF on a repeat lumbar puncture, which was not performed in this instance. We feel strongly, however, that the combination of a decrement in RBC count in the CSF coupled with a lack of xanthochromia, a negative CT angiogram, and a documented infectious explanation for the findings, provides strong and sufficient evidence against SAH as the mechanism for this patient's CT scan findings.\\nThe patient's mental status continued to deteriorate, and an MRI of the brain (Figs. 2A and 2B) suggested rhomboencephalitis with cerebellar swelling contributing to effacement of the fourth ventricle. His intracranial pressure continued to rise uncontrollably, leading to his death.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 55,\n",
       "    'case_id': 'PMC7332490_01',\n",
       "    'case_text': 'A 55-year-old male patient with a medical history of systemic arterial hypertension was admitted to the neuroemergency department, after being transferred from another service, with a report of sudden, intense thunderstorm headache, associated with the left eyelid ptosis and diplopia. During the neurological examination, the patient was awake, lucid, and oriented. He had complete palsy of the left oculomotor nerve, with no other focal neurological deficits. Neck stiffness was present.\\nCranial CT performed on the day following the headache showed no SAH, but showed an expansive process in the sella turcica associated with sellar enlargement [Figure 1]. SAH was then confirmed by lumbar puncture (Fisher I). A cranial angio-CT was made and revealed an intradural saccular aneurysm in the cavernous segment of the left internal carotid artery (ICA) [Figure 2].\\nThe patient underwent cranial microsurgery for cerebral aneurysm clipping that confirmed the intradural location of the aneurysm, arising from a tortuous cavernous ICA [Figure 3].\\nHe underwent control cerebral angiography on the 2nd postoperative day that demonstrated complete aneurysm occlusion [Figure 4], with no residual neck and no vasospasm and complemented the study with magnetic resonance imaging (MRI) of the sella turcica that was consistent of pituitary macroadenoma with apoplexy [Figure 5]. He was discharged on the 21st day after the hemorrhage, maintaining complete left oculomotor nerve dysfunction, but with no other complaints and no neurological deficits.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 72,\n",
       "    'case_id': 'PMC6302554_01',\n",
       "    'case_text': 'A 72-year-old female presented with a Fisher Grade 3 and World Federation of Neurological Societies Grade V aneurysmal subarachnoid hemorrhage (SAH) and an acute left traumatic subdural hematoma (SDH) post fall [Figure 1a and b]. Cerebral angiography showed a superiorly projecting 5.5x3.4x3.7 mm3 aneurysm arising from the supraclinoid internal carotid artery (ICA) [Figure 2a]. The aneurysm incorporates the origin of the right ophthalmic artery and has a 2.5 mm neck. A left ophthalmic artery aneurysm and bilateral cavernous ICA aneurysms were also found.\\nShe underwent balloon assisted coiling of the right paraophthalmic aneurysm using microvention coils one day after the SAH [Figure 2b]. The right ophthalmic artery remained patent with partial contrast opacification of a loosely packed anteroinferior aneurysm adjacent to the ophthalmic artery origin.\\nAngiography one week post coiling showed severe vasospasm of the bilateral A1s and its distal branches [Figure 3a and b]. The patient was treated with intra-arterial verapamil and nimodipine. Repeat angiography one day later showed ongoing severe stenosis in bilateral A1s and the patient was again treated with intra-arterial vasodilators with improvement in the anterior cerebral artery (ACA) vessel caliber and perfusion to the ACA territory. She remained clinically stable with ongoing mild left hemiparesis post-procedure.\\nThree weeks after the intra-arterial treatment, the patient became hemodynamically unstable and developed a right sided hemiparesis. CT scan showed evolution of the left acute SDH into a chronic SDH with mass effect. She underwent an uneventful burr hole evacuation of the left SDH with resolution of her right-sided hemiparesis.\\nHer post-treatment course was complicated by vasospasm requiring two take backs for endovascular intra-arterial treatment and evacuation of the left SDH. CT one month after admission showed a new 27x25 mm2 low density area in the right posterior frontal lobe suggestive of ischemia. She remained a febrile with no signs of meningism, however, developed worsening left-sided hemiparesis and confusion. Magnetic resonance imaging (MRI) showed significant enhancement around the coil mass and multiple ring-enhancing lesions in the right frontal, parietal, and occipital lobes with surrounding edema [Figure 4a-c]. Magnetic resonance angiography (MRA) showed a small anterior protrusion into the supraophthalmic portion of the right ICA.\\nIntra-arterial blood distal to the coils was obtained for culture. Attempted biopsy of the emboli was abandoned after post sampling angiography showed a filling defect at the right middle cerebral artery (MCA) bifurcation. Repeat right ICA angiography showed clearance at the MCA bifurcation with migration of the thrombus to a single M2/M3 branch. Thrombectomy was not attempted because of the risks of hemorrhage in the setting of possible infective arteritis. Peripheral and intra-arterial blood cultures were negative. White cell count WCC, C-reactive protein (CRP), and chest X-Ray (CXR) were unremarkable. Transesophageal echocardiogram was negative for valvular vegetations. She was commenced on dexamethasone and intravenous vancomycin 1g BD, ceftriaxone 2g BD, and fluconazole 400 mg. Tissue biopsy was not taken in light of antibiotic commencement and the likelihood of obtaining a sterile sample.\\nOne month after the commencement of antimicrobial therapy, MRI brain demonstrated resolution of many of the enhancing foci with significant decrease in the size of the surrounding vasogenic edema [Figure 4d-f] despite corticosteroids being ceased two weeks prior. Patient remained clinically stable with significant improvement in her left-sided hemiparesis and was discharged to rehabilitation for further therapy.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 63,\n",
       "    'case_id': 'PMC7351623_01',\n",
       "    'case_text': 'A 63-year-old man attended our hospital with heavy abdominal pain in January 2016. The CT revealed a mass with elevation of tissue fascia and free air near the cecum (Figure 1A). Accordingly, the patient was diagnosed with perforation of the cecal diverticulum, and open drainage and construction of ileostomy was performed. After 3 months, the patient received right hemicolectomy and closure of the ileostomy. We did not detect the mass from the resected specimen (Figure 1B), and pathological examination revealed no malignancy.\\nThe patient experienced a palpable mass in the left abdomen from May 2017 and attended our department in December 2017. The enhanced CT revealed a 38-mm mass, resembling a dyeing ring in the left rectus abdominis muscle. The mass was located near the scar of ileostomy closure (Figure 2). The size of hernia orifice from the epigastrium to the pubic bones was approximately 20 cm.\\nAfter 4 months, the MRI revealed a 40-mm mass in the left rectus abdominis muscle. T2 weighted image showed a low intensity area similar to muscle (Figure 3A), and the tumor was uniformly enhanced (Figure 3B).\\nWe performed endoscopic ultrasound (EUS) and fine needle aspiration of the mass and reached the pathological diagnosis of desmoid tumor. Because the patient had pain at the mass and at the point of abdominal incisional hernia, we planned resection of the abdominal desmoid tumor and repair of incisional hernia.\\nWe performed a midline incision similar to the previous scar and cut a spindle shape around the mass at 2-cm margin from the mass (Figure 4A). There was no exposure of the tumor at the abdominal side. We used the Harmonic ScalpelTM (Ethicon Endo-Surgery, Cincinnati) to cut the muscle to prevent bleeding (Figure 4B). Next, we removed the rectus abdominis muscle from the left lateral end. The abdominal wall defect measured 10 cm x 10 cm (Figure 4C). The hernia was repaired with a simple closure using anterior layer of rectus sheath and the defect was closed by suturing the right anterior layer of rectus sheath to the left aponeurosis of external oblique muscle (Figure 4D). Considering the risk of recurrence of abdominal wall hernia at the defect site, we decided to repair the defect with autologous fascia. We used a fascia lata patch measuring 15 cm x 5 cm (Figure 4E) to repair the defect in the left abdomen (Figures 4F and 5A-C).\\nThe size of the mass was 45 mm x 45 mm, and it was a solid tumor. The macroscopic view of the resected tumor revealed its whitish color (Figure 6A). Pathological analysis revealed the growth of fibroblasts, defect of the nuclear heteromorphism, and presence of abundant collagen fibers between fibroblasts (Figure 6B). Additionally, a nuclear-positive image of beta-catenin was observed on immunostaining (Figure 6C). The pathological diagnosis was desmoid-type fibromatosis. No recurrence of incisional hernia and desmoid tumor was detected 22 months after surgery.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 24,\n",
       "    'case_id': 'PMC4759896_01',\n",
       "    'case_text': 'A 24-year-old healthy male presented to King Khalid Eye Specialist Hospital, Riyadh, Saudi Arabia, complaining of blurred vision in his right eye for 1-week. Best corrected visual acuity was 20/70 in the right eye and 20/20 in the left eye. Intraocular pressures were normal bilaterally. In the right eye, there were no keratic precipitates and the anterior chamber was quiet with no cells or flare. Vitreous cavity was quiet and clear. Clinically, evident exudative retinal detachment was visible on dilated fundus exam and documented with optical coherence tomography (OCT). The exudative retinal detachment included the macula with deep creamy yellow choroidal infiltrates adjacent to an old chorioretinal scar along the superior temporal arches. The left eye was unremarkable. Fluorescein and indocyanine green angiography revealed two areas of early hypofluorescence at the choroidal level, which persisted to the final phase with surrounding hyperfluorescence on fluorescein angiography. Late indocyanine green showed defined areas of hypofluorescence corresponding to a scar and recent choroidal ischemia [Figure 1]. IgG and IgM were positive for toxoplasmosis.\\nBased on the clinical presentation, fluorescein angiography, OCT, and serology, the patient was diagnosed with atypical ocular toxoplasmosis with exudative retinal detachment and choroidal ischemia. The patient was managed with Bactrim and clindamycin for 6 weeks. Oral prednisolone 1 mg/kg was initiated after 48 h of antiparasitic therapy.\\nThree months after initiating treatment, the clinical presentation improved with complete resolution of subretinal fluid and restoration for vision to 20/20. 6 months from initial therapy, vision remained 20/20 with complete remission of signs and symptoms [Figure 2].',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 36,\n",
       "    'case_id': 'PMC9263511_01',\n",
       "    'case_text': \"A 36-year-old Han-Chinese right-handed man (patient III-10, the proband) developed anxiety, depression, sleep disorder, and tremor in his hands after a panic attack but without known medical history. His cognitive state declined, and he was unable to perform job duties due to memory loss. At 11 months after onset, the patient became withdrawn, and more deterioration of his cognitive function was observed, indicated by the difficulty in calculating, being lost at home, and frequently forgetting the names of acquaintances. Besides, the tremors spread to bilateral limbs, which led to difficulty in cake decoration (the patient's profession). After 16 months of onset, he was diagnosed with depression and anxiety and was prescribed sertraline, fluphenazine, and piracetam. At 17 months after onset, he was scored 20 of 30 on the Chinese Mini-Mental Status Examination (MMSE), and 15 of 30 on the Montreal Cognitive Assessment (MoCA Beijing Version). The Hamilton's Depression Scale was 7. At 19 months after onset, he developed hallucinations, which made him see his sons as enemies, and occasionally, he protected himself via aggressive behaviors.\\nIn the clinic, the diagnosis of possible behavioral variant Frontotemporal Dementia (bvFTD) was considered because of the abnormal neuropsychological profile, such as early apathy and executive/gene deficits with relative sparing of memory and visuospatial functions.\\nA thorough neurological examination 20 months after the onset revealed a total deterioration of the cognitive state, dysarthria, slight hypermyotonia, and deep tendon hyperreflexias in the bilateral limbs, and the patient presented cogwheel-like rigidity. He had difficulty finishing the finger-to-nose test and heel-knee-tibia test due to tremors in his limbs. The patient was unsteady when walking on a straight line. No involuntary movement was observed. He scored 15 of 30 on the Chinese MMSE, and 9 of 30 on the MoCA Beijing Version. The Hamilton's Depression Scale was 7.\\nTo our surprise, the brain MRI demonstrated abnormal intensities in the bilateral caudate nucleus, putamen, and cerebral cortex. A series of laboratory examinations were performed for the rapidly progressive early-onset dementia. The autoimmune screening and tumor marker identification were shown to be unremarkable or negative. An extensive panel for paraneoplastic antibodies including Amphiphysin, CV2, PNMA2 (Ma2/Ta), Ri, Yo, Hu, titin, SOX1, recoverin, zic4, GAD65, and Tr (DNER) were tested, and all were negative. Serology and cerebrospinal fluid (CSF) tests for HIV, cryptococcus, syphilis, tuberculosis, bacteria, fungus, and virus showed no evidence of inflammation. In addition, CSF 14-3-3 protein was tested to be negative. RT-QuIC tests of skin and CSF were also negative (Figure 2).\\nDiffusion-weighted imaging (DWI) sequences displayed restricted diffusion in the bilateral frontal and parietal cortex (Figures 3A-D). DWI hyperintensities were revealed in the bilateral basal ganglia, bilateral pulvinar, and dorsomedial thalamus (Figures 3E-J). Fluorodeoxyglucose PET (FDG-PET) exhibited hypometabolism in the bilateral cerebral cortex and right basal ganglia (Figure 4).\\nAn empiric course of pulse IV gamma globulin was tried without notable improvement.\\nAt 22 months after onset, the hypermyotonia of the patient in the bilateral limbs became more obvious. He had occasional urinary incontinence, and his ability to study was relatively reserved when he scored 21 of 30 on the Chinese MMSE. The MRC Scale score was 13 of 20. The Hamilton's Depression Scale was 6. EEG showed diffuse slow waves. MRI scanning indicated no obvious change compared to images 2 months earlier.\\nA follow-up study with the MRC Scale revealed gradually developed aphasia, gait disorder, and fecal incontinence 30 months after onset. The patient is still alive, 4 years after the onset, while the MRC Scale score was 2 of 20, and his swallowing function and mobility were still preserved (Table 1).\\nThe clinical features indicated that the patient might have prion disease. To determine the etiology of the disease, we extracted genome DNA from peripheral blood leucocytes of the patient and performed a direct DNA sequencing of the PRNP coding sequence. Unexpectedly, a rare mutation of G114V and 1-OPRD of the PrP in the patient was identified (Figure 5). Given that only a few patients with gCJD were reported to carry the G114V PRNP variant, we suspected that the mutation in the patient might be inherited from his parents, and we, thus, enrolled his immediate family members in this study for a genetic investigation.\\nAlthough the medical record was not available, the maternal grandmother (patient I-2) of the proband was found to have progressive dementia in her 60s, which was within 1 year before her death, and subsequently developed a tremor in her last few months. The proband's mother (carrier II-8) received examination when she was 61 years old, but no neuropsychiatric symptoms were observed. She scored 29 of 30 on the Chinese MMSE and 21 of 30 on the MoCA (Beijing Version). Although the EEG showed slow waves in the left temporal lobe, both cranial MRI (including DWI) and FDG-PET were unremarkable. A follow-up study revealed that she suffered an acute cerebral infarction in the callosum 18 months after the first examination. No cortical ribbon was found by DWI to date (Table 2). Whereas DNA sequencing revealed a G114V mutation and 1-OPRD of PrP in this individual. The elder son of the proband (carrier IV-1) received DNA sequencing at age 10, and G114V mutation and 1-OPRD were also found, although he did not show any clinical symptoms. No further examination was performed due to his age. No autopsy or biopsy were performed on any of the patients.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 50,\n",
       "    'case_id': 'PMC7358707_01',\n",
       "    'case_text': \"A 50-year-old male presented to our center with a one-month history of progressive right-sided weakness and urinary incontinence. He also reported intermittent neck and right-sided body pain, fever and night sweats. He unintentionally lost around 18 lbs. in weight. Systemic review was unremarkable, particularly for headaches, vomiting, dysphasia, dysphagia, altered sensorium, seizures, cognitive impairment and change in vision. On clinical examination he was found to be emaciated and depressed. No signs of instability, pallor, jaundice, palpable lymph nodes or meningism were identified but oral thrush was noted. Examination of cardiovascular system, chest, and abdomen revealed no abnormality. Neurological examination revealed diffuse muscle wasting, global hypertonia and hyperreflexia as well as significantly reduced power on the right side. Sensation was diminished on the right side of body. Initial blood investigations including basic hemo-gram and biochemical profile were unremarkable except for mild relative lymphopenia.\\nMagnetic Resonance Imaging (MRI) of the brain showed multiple, bilateral and asymmetrical ring enhancing (T1 hypo-intense, T2 and FLAIR hyper-intense) lesions of varying sizes in cerebral hemispheres, right basal ganglia and cerebellum with perilesional edema. The largest lesion was located on right frontal lobe and measured 30 x 24 mm, surrounded by vasogenic edema and causing mass effects (Fig. 1: A). HIV tests panel reported as following: positive antibodies screening test; viral load = 317,077 RNA copies/mL; helper cells (CD4) Count 7/muL, CD4:CD8 ratio = 0.03. Screening for Cryptococcus and TORCH (Toxoplasmosis, Rubella, Cytomegalovirus and Herpes) was negative. Lumbar puncture is thought to be unsafe in view of increased intra-cranial pressure.\\nThe patient underwent diagnostic brain biopsy. No organism was seen on gram, India ink and acid-fast stains. 24 h later, some whitish dry non-hemolytic colonies were observed on 5% sheep blood agar and chocolate plates. Gram staining of the colonies revealed medium to long beaded, non branching gram-positive rods, which were positive for modified acid-fast stain as well. At this stage and considering the clinical presentation, suspicion of Nocardia or other aerobic Actinomyces was raised. However, 48 h later, the growth looked slightly pinkish with undulating margins. Using API  Coryne strip (BioMerieux SA, Marcy l'Etoile, France), the isolate was identified biochemically as Rhodococcus species. However, as this was inconsistent with morphological observations, we performed 16S rRNA gene sequencing which matched that of Gordonia sputi. The E-test minimum inhibitory concentration (MIC) was reported as following (in mug/mL): vancomycin 1.5; ceftrixone 1.5; imipenem 0.023; amikacin 0.19; gentamycin 0.032; meropenem 0.19; ciprofloxacin 0.125.\\nThe patient was empirically begun on meropenem, vancomycin and rifampicin at admission to hospital. In light of antibacterials sensitivity tests, consensus opinion was to continue on this regimen for extended period of at least 4-6 weeks. Anti-retroviral (efavirenz, emtricitabine and tenofovir) treatment was started 2 weeks later. Repeated MRI after a month of treatment showed interval resolution of most of the lesions with remaining few lesions in the upper cerebrum with development of right frontal subdural hematoma adjacent to the previously noted large lesion and post-biopsy related changes (Fig. 1: B).\\nThe patient showed slow but apparent clinical improvement and remained clinically stable and afebrile. Unfortunately, after a month of hospitalization he developed progressive shortness of breath, hypoxemia and hypotension and was shifted to ICU with hospital acquired pneumonia. Chest radiograph showed bilateral infiltrates. Acinetobacter sensitive to colistin was isolated from sputum. Accordingly, colistin was added as well as trial of corticosteroids for possibility of Immune Reconstitution Inflammatory Syndrome (IRIS). Patient continued to deteriorate despite all supportive measures and, unfortunately, died few days after admission to ICU.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 79,\n",
       "    'case_id': 'PMC5738199_01',\n",
       "    'case_text': \"A79-year-old Haitian man with a three-year history of painful oral ulcerations, progressive dysphagia, and weight loss who presented to our medical center directly after arrival from Haiti. On evaluation, the patient complained of acute worsening of oral pain, odynophagia, dysphagia and a two-week history of hoarseness. He also described weight loss, generalized weakness, and an intermittent non-pruritic, non-vesicular rash. The patient's past medical history was significant for hospitalization three years prior for diffuse oral ulcerations, dysphagia, and a wide-spread non-pruritic, keloid-like rash present on his torso and bilateral upper extremities. Nonspecific gastritis and a hiatal hernia were found on endoscopy; no further evaluation was performed and the patient was lost to follow-up. The patient traveled frequently between Haiti and New Jersey and had been a plantation farmer in Haiti since childhood. He worked primarily with vegetable crops, but had exposure to chickens, cows, and pigs. His sexual history was significant for multiple female sexual partners with only occasional condom use. He denied prior history of sexually transmitted diseases. He denied tobacco, alcohol, or illicit drug use.\\nOn initial examination the patient was cachectic and appeared chronically ill. Vital signs included a temperature of 37.3  C, heart rate of 84 beats per minute, respiratory rate of 16, and blood pressure of 221/105 mmHg. Oxygen saturation was 100% on room air. His weight was 42.9 kg with a body mass index of 14.8. He had pronounced bitemporal wasting, bilateral erythema of the forehead and cheeks and diffuse left-sided facial swelling. Multiple 3-5 mm ulcerations were present throughout the oral cavity, including on the hard and soft palates, tongue, and buccal mucosa. There was diffuse oropharyngeal edema and mucosal pallor and dryness. He was breathing comfortably with no stridor or wheezing. Additional findings included bilateral anterior cervical chain lymphadenopathy and hypopigmented and hyperpigmented areas of skin on the thorax, abdomen and extremities, including the soles of both feet.\\nSignificant laboratory findings included hyperkalemia (potassium 5.2 mg/dL), anemia (hemoglobin 11.6 g/dL) and hypoalbuminemia (albumin 3.3 mg/dL). Chest radiographs demonstrated pronounced airway narrowing and neck radiographs severe oropharyngeal and hypopharyngeal airway narrowing with subepiglottic stenosis. Computed tomography of the neck was performed and revealed diffuse thickening of the mucosal oropharynx, supraglottic larynx, aryepiglottic folds, piriform sinuses, and true/false vocal cords (Fig. 1, Fig. 2). Subsequent evaluation by otolaryngology with laryngoscopy revealed a granular edematous epiglottis, right aryepiglottic fold, and nasal vestibules without evidence of any distinct masses.\\nMalignancy, autoimmune, and infectious etiologies were considered and further diagnostic studies were obtained. HIV antigen/antibody testing, HTLV, HSV, CMV, and RPR antibody tests were negative. His CD4 count was 345 cells/muL (normal 300-1400 cells/muL) with a decreased CD4 percentage of 21.3% (normal 28-57%) and an inverted CD4/CD8 ratio of 0.35 (normal 1.0-3.6). Histoplasma urine antigen and serum complement fixation antibody were negative. Interferon-gamma release assay (QuantiFERON -TB Gold) was negative. Epstein-Barr virus IgM and IgG were both positive. ANA was positive at a low titer (1:160) with a non-specific pattern. C3 and C4 values were within normal limits. Anti-smith, anti-RNP, anti-SSA/SSB, and C1 esterase inhibitor antibodies were negative. Serum protein electrophoresis was notable for an elevated IgG level of 1964 nmg/dL, of which 30.7% was composed of gamma globulin. His sedimentation rate was 59 mm/h and C-reactive protein was 10 mg/L. Blood cultures, including fungal blood cultures, were negative. Throat cultures grew Klebsiella pneumoniae and Serratia marcescens.\\nOral pharyngeal squamous cell carcinoma was considered the leading diagnosis and a biopsy of a labial mucosal ulcer was performed. Histologic examination of the biopsy revealed granulomatous mucositis with multinucleated giant cells containing multiple budding yeast forms (Fig. 3) that stained with Grocott's methenamine silver (Fig. 4) and were consistent with histoplasma species. Staining for acid-fast organisms was negative. Histoplasma was not recovered from tissue fungal cultures.\\nOn histologic identification of yeast consistent with Histoplasma, therapy with daily intravenous liposomal amphotericin B (5 mg/kg daily) was initiated. Despite aggressive intravenous saline hydration, acute kidney injury developed after only three doses of amphotericin, necessitating a change in antifungal therapy to itraconazole suspension. Due to the patient's extensive oropharyngeal inflammation and failed fiberoptic endoscopic swallow evaluations, a percutaneous endoscopic gastrostomy was placed for nutrition and administration of itraconazole. Computed tomography of the chest, abdomen and pelvis obtained to evaluate for disseminated histoplasmosis were unremarkable. The patient had rapid clinical improvement in his symptoms with initiation of antifungal therapy. His serum itraconazole levels were measured and were therapeutic. He was discharged home with a planned 12-month course of itraconazole.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 57,\n",
       "    'case_id': 'PMC7255984_01',\n",
       "    'case_text': \"A 57-year-old woman, a pharmacist with considerable exposure to COVID-19 patients, presented to a clinic in Tehran with headache and malaise with the onset of 5 days prior to admission. She did not report any respiratory symptoms, fever, chills or gastrointestinal symptoms and was previously healthy, not taking any medications. Laboratory work-up was ordered in an outpatient visit by a general practitioner. The results showed significant thrombocytopenia with a platelet count of 48,000 (per/mm3) associated with a normal, neutrophil dominant (75 %) white blood cell count of 7100 (per/mm3) and relatively decreased lymphocytes (14 %). Based on laboratory findings she was admitted to a referral hospital in Tehran for evaluation of severe thrombocytopenia. Upon admission she had a core body temperature of 36.9 C, a 81 bpm pulse rate (PR), a 14/min respiratory rate (RR) and a peripheral capillary oxygen saturation (SPO2) of 95 % while breathing room air. No abnormalities were detected during the physical examination and auscultation and chest radiological studies were unremarkable.\\nIn the following laboratory studies, patient's platelet count continued to decline to 16,000 (per/mm3), as shown in Table 1, and a peripheral blood smear (PBS) taken on the 2nd day of admission showed considerable left shift with myeloid predominance and a platelet count of less than 10,000 (per/mm3).\\nAbdominal pelvic sonography was normal without organomegaly and other viral markers including HCV-Ab, HBs-Ag, HBc-IgM and HIV-Ab and serum protein electrophoresis were unremarkable. Given the hematopoetic abnormalities, a bone marrow aspiration and biopsy was under consideration. Also, considering her high-risk work environment, COVID-19 diagnostic testing was performed and a nasopharyngeal swab was positive for COVID-19 in a RT-PCR test. The complete blood count (CBC) of the patient was re-checked twice daily and after 1 day of admission the platelet count started to increase slightly (Table 1). The PBS of the 4th day of admission showed no platelet aggregation or giant platelets. Her platelet levels returned to normal by the 5th day of admission at which point she was discharged and with the remission of platelet levels, a bone marrow aspiration and biopsy was no longer necessary. One-week follow-up revealed a platelet count of 270,000 (per/mm3).\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 81,\n",
       "    'case_id': 'PMC6831797_01',\n",
       "    'case_text': \"We present the case of an 81-year-old patient from England with a history of arterial hypertension, atrial fibrillation anticoagulated with Warfarin, and obesity. She also took antihypertensive drugs and beta-blockers, but no bisphosphonates. She had no history of previous fractures due to fragility. She had previously undergone right total hip resurfacing arthroplasty due to osteoarthritis when she was 65. While on holiday, she fell down some stairs and was sent to A&E due to pain and functional deficit of the right hip. During the examination, it was discovered that her right lower limb was shortened and externally rotated. There were no distal neurovascular alterations. Plain radiographs revealed a periprosthetic fracture with a spiral pattern, which started in the cervical area and reached the subtrochanteric area (Fig. 1).\\nAfter the 4-day Warfarin washout period, the patient's fracture was surgically treated by means of open reduction and internal fixation with trochanteric plate and three cerclages. The prosthesis was not removed, as it was not mobilized. Postoperative radiographs revealed a satisfactory reduction of the fracture (Fig. 2, Fig. 3).\\nPostoperative recommendation given to patient was walking with crutches in discharge of the limb affected for two months, and after that progressive support.\\nThe follow up period of this patient was limited because of her nationality (she returned to England one month after surgery). On his first consultation, three weeks postoperative, wound was well healing with no evidence of infection and radiographic control was satisfactory, but the patient should continue in discharge of that limb for five weeks more.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 5,\n",
       "    'case_id': 'PMC5566717_01',\n",
       "    'case_text': 'A 5-year old boy presented to the pediatric plastic surgery clinic for hypernasal speech. He was born with a cleft palate and underwent repair at 11 months of age. A short velum was noted (Fig 1), so he underwent palatal lengthening with double-opposing buccal flaps. Postoperatively, his hypernasality was corrected.\\nWhat is velopharyngeal dysfunction (VPD)?\\nHow is velopharyngeal insufficiency (VPI) diagnosed?\\nWhat treatment options are available for VPI?\\nWhat is the palatal lengthening with double-opposing buccal flaps procedure?',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 80,\n",
       "    'case_id': 'PMC7472920_01',\n",
       "    'case_text': 'An 80-year-old man was diagnosed with lung adenocarcinoma carrying the EGFR point mutation at L858R; he was admitted to our hospital for treatment. He had no history of smoking or drinking and no allergic constitution. Lung computed tomography (CT) scan showed left upper lung tumor and hilar and mediastinal lymph node enlargement (Fig. 1). There were no metastatic regions; therefore, the clinical stage was characterized as cT3N3M0 stage IIIc. Normally, chemoradiation is performed. However, considering his age and complications such as hypertension, paroxysmal atrial fibrillation, and pneumoconiosis, osimertinib therapy was initiated at a dose of 80 mg per day. Two months later, he showed symptoms of fever and anorexia. His left axillary was swollen with pain. The levels of C reactive protein (6.79 mg/dl), serum immunoglobulin G (IgG) (1888 mg/dl), G4 (IgG4) (137 U/ml), and E (IgE) (603 U/ml), and serum soluble IL-2 receptor (1150 U/ml) were elevated. Although the size of the primary tumor clearly reduced (Fig. 2A), multiple lymph nodes including the left axillary around the abdominal artery were enlarged, and the fat around the aorta to pelvic area was cloudy (Fig. 2B). To confirm metastatic lymphadenopathy, ultrasonography-guided biopsy of the axillary lymph node was performed. Histological analysis showed infiltration of lymphocytes and plasma cells with fibrosis (Fig. 3C and D). Immunohistochemistry indicated IgG4-positive plasma cell infiltration with an over 30 cell count per high-power visual field (HPF) and an IgG4 to IgG ratio of more than 40% (Fig. 3E and F). According to these findings, multiple swollen lymph nodes were diagnosed with IgG4-related disease. Prednisolone (0.6 mg/kg/day) was administered, and improvement of his symptoms and multiple lymphadenopathies was observed (Fig. 4).',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 66,\n",
       "    'case_id': 'PMC10077779_01',\n",
       "    'case_text': \"A 66-year-old man (height: 158 cm; weight: 67 kg) underwent removal of a right knee cyst. He had type 2 diabetes mellitus with chronic kidney disease (glomerular filtration rate [GFR]: 50) and a history of myocardial infarction that occurred 12 years prior, with a stent inserted in the right coronary artery. He was diagnosed with BS with a type 1 Brugada pattern on an electrocardiogram (ECG) five years ago and has been followed up with a cardiologist regularly. He had no syncope history or family history of sudden cardiac death. In the preoperative examination, all blood tests, including cardiac enzymes, were normal. Chest radiography revealed no active lung or heart disease. The ECG showed a coved V1 pattern, which remained unchanged [Figure 1]. Transthoracic ECG revealed normal-sized cardiac chambers with normal left ventricular systolic function (ejection fraction: 60%) and concentric left ventricular hypertrophy without regional wall motion abnormality. He stopped aspirin five days before surgery but continued beta-blockers and other diabetes medications.\\nThe anesthesiologist planned a peripheral nerve block for surgical anesthesia. In the operating room, ECG, pulse oximetry, and noninvasive blood pressure were monitored throughout the surgery, and a defibrillator was prepared. Initially, blood pressure was 130/80 mmHg, heart rate was 68 beats/min, and oxygen saturation was 98%. Oxygen at a rate of 2 L/min was delivered via nasal cannula.\\nPeripheral nerve blocks were performed under ultrasound guidance, and needles with a nerve stimulator were used. Local anesthetic (55 cc) was prepared in aseptic conditions, which included 0.75% ropivacaine (15 cc), 2% lidocaine mixed with 0.3 mL of epinephrine (25 cc) and normal saline (15 cc). The patient was placed in the supine position, and the hip was slightly abducted and externally rotated. The femoral, lateral femoral cutaneous, and the obturator nerve were identified by ultrasound. A 22-gauge, 2-inch stimulating needle was advanced to the target nerves and the nerve stimulator was used to localize the nerves by twitching the corresponding muscle. Then, a bolus of local anesthetic was injected for femoral nerve block (20 cc), lateral femoral cutaneous nerve block (5 cc), and obturator nerve block (5 cc). All injection was done slowly with intermittent aspiration. For sciatic nerve block (SNB) and posterior femoral cutaneous nerve block (PFCNB), the patient was laterally positioned and knee was flexed. Both nerves were identified by ultrasound and a 22-gauge, 4-inch stimulating needle was advanced to the target nerves. The nerve stimulator was used by same way and 20 cc for SNB, 5 cc for PFCNB was injected. The patient's position was changed to supine again, and the surgery was initiated. The surgery took 25 min and the cyst was successfully removed. No hemodynamic or ECG pattern change were observed during surgery. The patient's visual analogue scale (VAS) score was 0/10 in post-anesthesia care unit. After 6 hours, the VAS was 3/10. The patient was discharged the day after surgery without any complication.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 12,\n",
       "    'case_id': 'PMC5887785_01',\n",
       "    'case_text': 'A 12-year-old left hand dominant boy, with no chronic illnesses presented to the University Hospital of the West Indies after being involved in a motor vehicle accident. He had been traveling in a minivan with his right upper limb dangling through the window, when a car, ran into the side of his vehicle resulting in a complete transection midway through his right arm.\\nHe arrived at hospital some 45 min postinjury accompanied by the amputated extremity which had not been cooled in ice. After resuscitation, he was immediately transferred to the operating theatre. The stump and the amputated extremity were not significantly contaminated. There was, however, moderately devitalized tissue.\\nBoth ends were debrided and then irrigated with normal saline. An arterial shunt was placed across the brachial artery. The humerus was shortened 2 cm and then fixed with a dynamic compression plate (see figure 1). Definitive arterial, then venous repair was then performed, followed by epineural repair of the major peripheral nerves. All repairs were done primarily with the aid of magnifying loupes. The muscles of the anterior and posterior compartments were repaired. The repairs were protected in an above elbow dorsal plaster for 6 weeks. Postoperative potassium and other electrolytes were found to be normal. Physical therapy was commenced with passive range of motion exercises of the major joints and splinting in a functional position.\\nFour years postoperatively, he had 5-80 degrees of active range of motion (AROM) of elbow flexion. He had a 40 degree wrist flexion contracture and AROM was 40-60 degrees of wrist flexion. There was an inability to abduct or adduct all fingers. The fingers were all 40 degrees hyperextended at all of the metacarpophalangeal joints. He had fixed deformities of 90 degrees at the proximal interphalangeal joints and 45 degrees at the distal interphalangeal joints (see figures 2-4). All myotomes in which there was movement had either grade two or three power. He had partial sensation of the median and ulnar nerve autonomous zones. There has been no sensation in the radial nerve autonomous zone. Peripheral pulses were normal.\\nHe had to repeat a year (grade) in school, but was currently passing all of his classes at school. He participates in sporting activities in a very limited capacity; however, this was not much different to his preinjury activity level.\\nAlthough there was suboptimal function, both patient and parents were satisfied with the overall surgical result as their main concern was preservation of the limb. They had no interest in secondary procedures being performed to improve function. He and his parents were satisfied with the appearance of his pain-free limb. He enjoyed a good relationship with his peers.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 8,\n",
       "    'case_id': 'PMC8349526_01',\n",
       "    'case_text': 'An 8-year-old boy suffered significant swelling and blistering of his penis at 24-h post-circumcision. A medical practitioner performed the circumcision. The circumcision was performed using a sterile instrument and suture material (plain catgut 3/0) with circumcision technique and local anesthetic nerve block with lidocaine hydrochloride 20 mg/mL and epinephrine 12.5 mcg/mL per 2 mL ampoule. The anesthetic solution was administered using the penile nerve block technique. The pain sensation and swelling were apparent approximately 1 h after the circumcision and became prominent 3-4 h after circumcision. Five hours after the circumcision, the swelling had worsened, and a blister appeared at the skin of the penile corpus. At 24-h post-circumcision, the swelling had improved, but the blister remained (Figure 1). The penile glans was paler (an ischemic sign), with incarcerating crust. Proper wound care with normal saline compress and wound crust cleansing was performed. On the second day after the circumcision, the blister had subdued, and the superficial ulcer was observed at the wound bed. On the third day, yellowish-necrotic tissue was observed on the lateral side of the glans (Figure 2). Neither gangrene nor pus was observed at the penis. One week after the circumcision, the wound at the glans and corpus was improved. Four months after the circumcision event, the penis had healed without any cicatrix (Figure 3). There was no disturbance in micturition or erection.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 8,\n",
       "    'case_id': 'PMC3047773_01',\n",
       "    'case_text': 'An 8-year-old boy presented with a history of ingestion of a metallic screw about 3 months back, and otherwise asymptomatic. The physical examination and the laboratory investigations were within normal limits. Plain radiographs [Figure 1] of the abdomen showed a metallic screw in the right lower quadrant. At laparotomy, the screw was located inside the appendix. An appendicectomy was performed. The appendicular lumen was opened with a scalpel, and the screw was seen to be lodged inside it. The postoperative period was uneventful.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 15,\n",
       "    'case_id': 'PMC10345200_01',\n",
       "    'case_text': \"A 15-years-old girl with an underlying history of epilepsy was sent to our hospital because of intermittent mood dysregulation and agitation for 4 months. The patient had no family history of epilepsy or autoimmune disease. She experienced her first episode of generalized tonic-clonic seizure, which lasted for over 30 minutes, at the age of 8 years. She was diagnosed as having encephalopathy related to Mycoplasma pneumoniae infection. She then received intravenous methylprednisolone, followed by a short course of low dose oral prednisolone. No further seizure was noted after the treatment, and the patient was lost to follow-up with no further medical treatment. No personality change or cognitive dysfunction was noted in the intervening years.\\nOne year before her current admission, the patient noticed a progressive decline in confidence, insomnia, and poor memory, leading to difficulties in her interpersonal relationships and academic performance. She suffered from low mood, general fatigue, poor concentration and several somatic complaints such as headaches and extremity weakness. She visited a psychiatric clinic and took bupropion 150mg, and aripiprazole 20mg/day. Three episodes of generalized tonic-clonic seizure occurred during her depressive periods, which prompted her to seek medical attention. She underwent electroencephalography (EEG) at our pediatric neurology clinic, and the EEG results revealed right centroparietal spikes. She was then administered a regimen of topiramate 200mg/day, and she claimed to have complete remission of her mood and could return to school after treatments.\\nFour months before the current admission, the patient complained of depressed mood, insomnia, poor appetite, poor concentration, and thoughts of helplessness. Moreover, she presented with sudden-onset agitation and self-harm behaviors, such as head banging or arm scratching, which she could not recall afterwards. The episodes occurred 3 times a day and lasted for 10 to 30 minutes each time. An aura involving machine sounds or flashes of light, occasionally preceded the mood and behavioral changes. She was admitted to our pediatric ward under the suspicion of seizure-induced behavioral change. Lamotrigine 10mg/day was added to her existing regimen of topiramate. A comprehensive neurological survey revealed no structural lesion on her brain magnetic resonance imaging scans and no abnormal findings in a cerebrospinal fluid (CSF) examination, but her 24-hour EEG revealed epileptiform discharges during the mood swings. Immunologic screening showed positive antinuclear antibodies (ANA, 1: 1280 speckled) and mildly decreased C3. Thyroid function, ovarian sonography, and tumor markers were within normal range. Surveys for viral infections were all negative. Under the impression of immune-mediated encephalopathy, methylprednisolone pulse therapy 1g/day was administered for 3 days, followed by oral prednisolone. However, her mood remission was only partial, and the involuntary agitation and self-harm behaviors occurred 2 months after discharge. She could not attend school owing to her depression and behaviors. When she later developed Steven-Johnson syndrome, lamotrigine was stopped and was replaced by valproic acid.\\nBecause of her aggravated clinical agitation and self-harm behaviors, the patient was again admitted to our pediatric ward. Prolonged QTc (479ms) was noted during evaluation for chest tightness. EEG revealed paroxysmal focal spikes over the right frontoparietal area. Her serum sample was positive for ANA with a titer of 1:1280, suggesting autoimmune encephalitis. She received topiramate 150mg/day and valproic acid 400mg/day for epilepsy control. She also received fluoxetine 10mg/day and aripiprazole 5mg/day for depression. Further survey for an autoimmune etiology revealed positive serum anti-SSA antibodies (67.2 U/mL), positive serum cryoglobulin IgG, IgM, and positive ANA in her CSF ( Figure 1 ). Anti-Cardiolipin IgG, IgM, ribosome-P, anti-beta2-glycoprotein I IgG, anti-RNP, anti-SMD, MPO, PR3, rheumatic factor, anti-double stranded DNA, C3, and C4 levels were within normal limits, and HBsAg, anti-HBs, anti-HBc, anti-TPO, anti-THYG, anti-TSHR, anti-HCV levels were all negative. Anti-neuronal autoantibodies including aquaporin-4 (AQP4) antibodies, myelin oligodendrocyte glycoprotein (MOG) antibodies, glutamate acid decarboxylase (GAD) antibody, anti-N-methyl-D-aspartate receptor (NMDAR) antibody, Voltage gated potassium channel (VGKC)-associated protein (CASPR2) antibodies, VGKC-associated protein (LGI1) antibodies, Glutamate receptors (type AMPA1 and AMPA2) antibodies, gamma-aminobutyric acid type B (GABAB) receptor antibodies, Dipeptidyl aminopeptidase-like protein 6 (DPPX) antibodies were all negative. In accordance with her symptoms of dry eyes and dry mouth, the Schirmer's test was positive (2mm). Single photon emission computed tomography (SPECT) revealed cortical hypometabolism at the bilateral prefrontal, bilateral parietal, and bilateral visual cortices. We assessed her CSF again for anti-SSA antibodies and had a positive finding (0.4 U/mL). The CSF/serum ratio of anti-SSA antibodies (0.006) was three times higher than that of IgG (2.88 mg/dl/1470 mg/dl = 0.002). This result suggested local production of antibodies in the CNS rather than only passive transmission of antibodies from serum. On the basis of patient's clinical symptoms of ocular and oral dryness, positive findings for serum and CSF anti-SSA antibodies, and the Schirmer's test results, SS was diagnosed in accordance with the 2017 ACR-EULAR classification criteria.\\nUnder the impression of SS-related autoimmune encephalitis and QTc prolongation, intravenous methylprednisolone 1g/day was administered for 3 days. The frequency and intensity of agitation decreased from approximately eight times per day to twice a day. After the QTc returned to normal, rituximab 500mg was infused intravenously. She had no further agitation or self-harm behaviors after the treatment of methylprednisolone and rituximab. We kept her antidepressants and antipsychotics and discharged her. She did not exhibit any involuntary agitations during outpatient follow-up. The patient reported an improvement in mood and began to bring life back on track.  Figure 2  showed specific historical events and information in sequence.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 45,\n",
       "    'case_id': 'PMC6390208_01',\n",
       "    'case_text': 'A 45-year-old man, who presented with left extremity edema after a 24-h trip and a deep vein thrombosis documented, was treated with anticoagulation with subcutaneous enoxaparin. The general condition was good, without weight loss. The patient did not have a medical history of relevancy, only smoking suspended 10 years ago. Routine blood cell counts and biochemical investigations were within the reference range. Serological tests for hepatitis B and C were negative. The computed tomography reported hypodense focal lesions with a predominantly peripheral enhancement to the administration of intravenous contrast in segments V and VI, the largest of 26 mm. Magnetic resonance imaging (MRI) reported five hypointense nodular lesions in T1, hyperintense in T2, which restricted in the diffusion sequence and in the dynamic phase presented target enhancement, said lesions located in segments V and VI, the largest of up to 22 mm. The tumor markers, including Alpha-fetoprotein (AFP), human chorionic gonadotropin (GCh), carcinoembryonic antigen(CEA), prostatic specific antigen (PSA), CA 125, and CA19-9, were within normal limits; after these findings, ultrasound-guided biopsy of liver segment V lesion was performed (Figure 1).\\nThe decision of the multidisciplinary board was to begin primary monotherapy with thalidomide. MRI was performed 4 months later, documenting the progression of the disease with an increase of 20% in the size of the lesions; in the same month, a right hepatectomy without complications was performed, resecting all the visible lesions, and the histopathological report remained the same. Baseline 68Ga-DOTA-RGD PET/CT scan was performed (October 2015) that reported two residual lesions in the left lobe with a focal uptake of the radiotracer as well as an increase of 20% in the liver lesions. The therapy is modified to nintedanib 150 mg for 12 h for 6 months, and a control 68Ga-DOTA-RGD PET/CT scan is performed (January 2016) which documents progression of the disease. The treatment is continued without modification and the control 68Ga-DOTA-RGD PET/CT scan is repeated (July 2016), which again reports progression, which is why the dose of nintedanib is increased to 200 mg every 12 h and cyclophosphamide 100 mg is added every 24 h; 4 months later, a 68Ga-DOTA-RGD PET/CT scan was repeated to assess response to treatment reporting stable disease; meanwhile, functional status was poor (November 2016). Changes were decided in the treatment of combined immunotherapy Ipilimumab plus nivolumab posterior and 5 months 68Ga-DOTA-RGD PET/CT scan was performed for assessment of documented partial response (April 2017). With the same treatment, after 8 months, the patient presented a clinical improvement on PET/CT (December 2017; Figure 2); the patient remained clinically asymptomatic.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 47,\n",
       "    'case_id': 'PMC7727623_01',\n",
       "    'case_text': 'A 47-year-old black male entrepreneur who frequently travelled between Portugal and Angola, returned from Africa 10 days before hospital presentation. He was admitted to the emergency department due to a 5-day history of diarrhoea (>5 episodes daily), worsening malaise, high fever, diaphoresis and occasional dry cough. He had no previous medical history, did not use drugs, did not have any addictions, and had not been in contact with anybody infected with COVID-19.\\nAt hospital admission, the patient was conscious, febrile and tachycardic but haemodynamically stable. Physical examination was normal, without signs of dehydration, respiratory changes or abdominal discomfort. The initial blood work revealed mild anaemia (haemoglobin 12.1 g/dl), lymphopenia (lymphocytes 1260x109/l), thrombocytopenia (platelets 91x109/l) and elevated inflammatory parameters (C-reactive protein 25.1 mg/dl, ferritin 789 ng/ml), but no other abnormalities such as renal or hepatic changes. An HIV test was negative. A nasopharyngeal swab for SARS-CoV-2 PCR testing was positive, as were total antibody titres against SARS-CoV-2 detected using chemiluminescence assays (CLIA). A chest x-ray did not show any pleural effusions, lung consolidation or interstitial patterns.\\nAfter he was diagnosed with SARS-CoV-2 infection, the patient was admitted to a COVID ward for further observation and symptom control. On the third day, he was still myalgic, generally unwell and febrile, despite being on antipyretics. Given the epidemiological history and the persistence of symptoms, a rapid diagnostic test for malaria parasite antigens was requested, and showed a positive result. Blood smear identified trophozoites of Plasmodium falciparum with a parasitaemia of 3.1% (parasite level of 83,520 parasites/mul). The patient did not meet any of the criteria for severe disease, and therapy with a combination of artemether and lumefantrine was administered. After 24 hours of treatment, symptoms completely resolved and the patient became afebrile. The platelet count normalized, and there was a consistent reduction in inflammatory parameters. Three days later, control microscopy revealed a parasitaemia of 0.3%, and on the sixth day the blood smear was negative for P. falciparum. The patient did not show any progressive respiratory symptoms, including decreased oxygen levels, or radiographic findings suggestive of SARS-CoV-2 infection. He was discharged completely asymptomatic 14 days after COVID-19 diagnosis.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 7,\n",
       "    'case_id': 'PMC6436336_01',\n",
       "    'case_text': 'This is a 7-year-old male patient, with a diagnosis of Bruck syndrome proven by genetic testing (gene FKBP10 mutations: c.449G>A, p.Trp150Ter). He has no family history of OI or AMC, parental consanguinity, dentinogenesis imperfecta, blue sclera, or hearing loss and a birth weight of 3.2 kg. He was treated with bisphosphonates (pamidronate, 1 mg/kg/dose intravenously for three days per cycle with a cycle every four months) for five years and his most recent DEXA scan showed a lumbar z-score of -7, 4. Currently, he is nonambulatory and uses a power wheelchair. He has flexion contractures of both hips with a range of motion to 45 degrees on the right and 35 degrees on the left. Knee contractures limited the range of motion to 60 degrees on the right and 70 degrees on the left. His right ankle was dorsiflexed to neutral, and his left ankle to 30 degrees of dorsiflexion and 30 degrees of plantarflexion. Finally, his right foot had -10 degrees of abduction and 10 to 40 degrees of adduction, and his left foot had -10 degrees of abduction and 10 to 50 degrees of adduction.\\nHe developed multiple orthopedic problems. His cervical spine developed progressive kyphosis with no basilar invagination. He required a spinal fusion from occiput to C4 at the age of 4 years, and recurrence of the deformity required revision spinal fusion from C1 to C5 at the age of 5 years (Figure 1). Kyphoscoliosis and thoracic deformity (\"barrel chest\" deformity) developed and progressed during growth to 45 degrees by the age of 7 years.\\nFlexion contractures of the upper limbs were present at birth with limited elbow range of motion to 5 degrees on the right and 15 degrees on the left, wrists bilaterally, and left fifth finger. At the age of 7 years, he had a right ulna fracture that was treated by casting.\\nIn his lower limbs, he had flexion contractures of the hips and knees at birth and bilateral clubfoot. Subsequently, he had multiple fractures in his lower extremities that were treated by operative intramedullary stabilization and had subsequent recurrence of deformities with growth requiring revisions. At the age of 2 years, he had intramedullary Rush rod fixation in the left femur and tibia. At the age of 3 years, the left femur recurred and he underwent revision with new intramedullary Rush rod fixation. At the age of 5 years, he had intramedullary stabilization of the right femur and revision of the left femur as well as left tibia intramedullary Rush rod fixation. At the age of 6 years, he underwent right tibia intramedullary Rush rod fixation and revision of the right femur with dual Rush rods. At the age of 7 years, he underwent left femoral and tibial rod exchange with Fassier-Duval rods (tibia with dual-locking plates and bone grafting). He had bilateral clubfoot treated with serial casting using the Ponseti method as an infant with deformity that relapsed until at the age of 7 years when he underwent bilateral Achilles tenotomies (Table 1).',\n",
       "    'gender': 'Male'},\n",
       "   {'age': 24,\n",
       "    'case_id': 'PMC6436336_02',\n",
       "    'case_text': 'This is a 24-year-old female patient with Bruck syndrome proven by genetic testing (defects in PLOD2, mutation: c.517G>C; p. Alal73Pro). She has no family history of OI or AMC, parental consanguinity, dentinogenesis imperfect, blue sclera, or hearing loss and a birth weight of 2.5 kg. However, she has micrognathia. She ambulates with bilateral ankle-foot orthotics. She received bisphosphonate (pamidronate, 1 mg/kg/dose intravenously for three days per cycle with a cycle every four months) therapy for five years. Her last DEXA scan was normal for her age.\\nJoint contractures were present in the upper and lower limbs from birth. The range of motion of both shoulders was limited to 90 degrees of flexion. Her hips were in 90 degrees of flexion with limited hip abduction, and her knees were in -30 degrees of extension. At 12 years of age, coliosis developed in the spine with a thoracic curve of 51 degrees and lumbar curve of 27 degrees. She also had spondylolisthesis at L5 and lumbar hyperlordosis (Figure 2). At the age of 13 years, she had a posterior spine fusion from C7 to T10.\\nIn her upper limbs, she fractured her right olecranon at the age of 14 years. This fracture was treated by casting. At the age of 16 years, she fractured her right proximal humeral shaft, which was treated by an intramedullary flexible nail. Subsequently, at the age of 23 years, she developed left ulna nerve compression (cubital tunnel syndrome), which was treated by operative decompression and subcutaneous transposition.\\nIn the lower limbs, she had bilateral clubfoot treated by casting. Operative realignment was performed on her right foot at the age of 2 years. At the age of 9 years, she fractured her right femur, which was treated by two intramedullary flexible nails. At the age of 11 years, she refractured the diaphysis of the right femur and bent the intramedullary rod, which required revision with repeat intramedullary flexible nailing. Her left femur was fractured when she was at the age of 12 years; this was treated with two flexible nails. At the age of 14 years, she developed left acetabular protrusio (Figure 3). At the age of 21 years, her right femur was fractured in the diaphysis, which was treated by a locking plate-intramedullary rod construct. The plate was removed when she was at the age of 22 years (Table 1).',\n",
       "    'gender': 'Female'},\n",
       "   {'age': 6,\n",
       "    'case_id': 'PMC6436336_03',\n",
       "    'case_text': 'This is a 6-year-old male patient, with a suspected diagnosis of Bruck syndrome at the second day of life, proven by genetic testing (defects in PLOD2 and FKBP10, mutation: c.831dupC). There is no family history of OI or AMC, dentinogenesis imperfecta, blue sclera, parental consanguinity, or hearing loss and a birth weight of 2.8 kg. This child is also nonambulatory and uses a wheelchair in the community. He has hip flexion contractures of 15 degrees on the right and 25 degrees on the left). He has knee flexion contractures with popliteal angles of 30 degrees on the right and 40 degrees on the left. He has bilateral elbow flexion contractures of 10 degrees. His right foot is internally rotated, and his left foot is externally rotated. He uses bilateral knee-ankle-foot orthotics for support. He was treated with bisphosphonate (pamidronate, unknown dosage) from the age of 6 months to 3 years at another hospital. His last DEXA scan was normal for this age.\\nAt 6 weeks of age, he developed fractures in the vertebral bodies and six right ribs, right clavicle, right radius, and bilateral femurs. The fractures healed with voluminous callus (Figure 4). Subsequently, the callus remodeled normally, and the limb bones grew into a gracile shape, appearing narrow at the cortex (Figure 5). At the age of 3 years, he had a right midshaft femoral fracture treated with spica casting. He had a left midshaft femoral fracture at the age of 4 years treated with splinting (Table 1).',\n",
       "    'gender': 'Male'},\n",
       "   {'age': 4,\n",
       "    'case_id': 'PMC6436336_04',\n",
       "    'case_text': 'This is a 4-year-old male patient with a diagnosis of Bruck syndrome at birth. There is no family history of OI or AMC, parental consanguinity, dentinogenesis imperfecta, blue sclera, or hearing loss and a birth weight of 2.9 kg. Currently, he is nonambulatory and uses a wheelchair for all mobility activities. In his upper limbs, he had flexion contractures at birth of the elbow and wrist. The left upper limb is the most involved with contractures. His left elbow is unable to be extended past 90 degrees and the wrist beyond 30 degrees. In his lower limbs, he had a right midshaft femur fracture at birth and midshaft nondisplaced right tibia fracture at the age of 4 years. Both fractures were casted and no orthopedic surgeries have been required (Table 1). There was no treatment with bisphosphonates.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': None,\n",
       "    'case_id': 'PMC4823498_01',\n",
       "    'case_text': \"All three patients (one male and two females) who presented with a history of heavy snoring and excessive daytime sleepiness, indicated by a high Epworth Sleepiness Scale score, were referred to our department by a medical practitioner. They requested surgical treatment to enlarge their pharyngeal airway. Before surgical treatment, all three patients underwent a complete otorhinolaryngological physical examination that was conducted by a researcher. Body mass index, tonsil size, and palate grade were recorded for analysis. Body mass index was calculated as weight (kg)/height (m)2. Tonsil size and palate grade were evaluated according to the scale proposed by Friedman et al.. All patients were examined with overnight nocturnal polysomnography in our sleep laboratory in the standard manner, and each had an apnea hypopnea index >20 events/hour, indicating moderate-to-severe OSAS.\\nBecause the patients had bilateral large tonsils, the UPPP surgical procedure to enlarge the pharyngeal airway was performed by a sleep surgeon under general anesthesia, according to the originally described technique. The large tonsils were removed bilaterally and the tonsil's weights were measured. All patients tolerated the surgery without complications.\\nBody mass index and Epworth Sleepiness Scale score were evaluated both before and 3 months after UPPP. Polysomnography and 3D CT scanning were also performed at both time points. Postoperative polysomnography revealed moderate-to-great improvement in the severity of OSAS (Table 1).\\n3D CT was performed under the same condition before and after UPPP. 3D CT was performed using a 64-row multidetector CT scanner (Brilliance 64 , Phillips, Cleveland, OH, USA) under routine neck examination conditions at the end of inspiration while the patients were holding their breath. Thin axial sections of 0.9 mm thickness at 0.45 mm intervals were obtained to reconstruct multiplanar reformation images and 3D CT images. Multiplanar reformation and 3D CT image reconstructions were performed at an image workstation (Ziostation2, Ziosoft, Tokyo, Japan), which enabled us to visualize and objectively quantify the dimensions and volume of the airway. Axial-view multiplanar reformation images were used for this analysis. The 3D CT images of the velopharyngeal and glossopharyngeal airway were constructed from images of areas in which the CT number was -400 Hounsfield units or less.\",\n",
       "    'gender': 'Female'},\n",
       "   {'age': None,\n",
       "    'case_id': 'PMC4823498_02',\n",
       "    'case_text': 'Axial and sagittal images of the glossopharynx before (Figure 1(a)) and after (Figure 1(b)) UPPP in patient 1 were shown in Figure 1. The maximal diameter of the glossopharynx in the transverse dimension and the minimal diameter in the anteroposterior dimension were recorded for analysis.',\n",
       "    'gender': 'Unknown'},\n",
       "   {'age': None,\n",
       "    'case_id': 'PMC4823498_03',\n",
       "    'case_text': 'In patient 1, the transverse diameter of the glossopharynx was enlarged from 6.4 mm preoperatively to 25.2 mm postoperatively, whereas the anteroposterior diameter was reduced from 27.8 mm to 17.6 mm. In like manner, in patients 2 and 3, the transverse diameter was enlarged, whereas the anteroposterior diameter was reduced postoperatively. To provide a better understanding of these morphological changes, the anterior-view 3D CT images of the velopharyngeal and glossopharyngeal airway in patient 1 before (Figure 2(a)) and after (Figure 2(b)) UPPP were shown in Figure 2. In addition, 3D composite images from before and after UPPP in patient 1 were also generated at an image workstation (ParaView , Kitware, Clifton Park, NY, USA). 3D images were adjusted for their opacities and displayed by superimposition in Figure 3.\\nThe following limits were adopted when measuring the velopharyngeal and glossopharyngeal airway volume: the superior margin was the posterior nasal spine, and the inferior and anterior margins were the hyoid bone in the midsagittal view. The dimensions of the glossopharynx and the volume of the velopharyngeal and glossopharyngeal airway before and after UPPP in each of the three patients were summarized in Table 2. In all patients, the transverse diameter of the glossopharynx increased after UPPP, whereas the anteroposterior diameter decreased. Thus, morphological changes were observed after UPPP; however, the change in total air volume was negligible (Table 2).',\n",
       "    'gender': 'Unknown'}],\n",
       "  [{'age': 44,\n",
       "    'case_id': 'PMC483056_01',\n",
       "    'case_text': 'A 44-year-old woman with secondary progressive MS was diagnosed at age 20 yr, per Lublin and Reingold. During the next 15 years she had 8 documented relapses which resolved with intravenous glucocorticoid therapy. The relapses decreased in frequency during this time, after which her clinical status deteriorated, with progressive development of quadriparesis, ataxia, fatigue and cognitive decline. In 1994, a trial of interferon beta-1b was discontinued because of increased spasticity, and she was not a candidate for glatiramer. She had no history of diabetes, cardiovascular, liver or kidney disease.\\nWhen seen in 1999 her weight was 29.5 kg, down from 54.5 kg in 1976. She was paraplegic, wheelchair-bound, and exhibited paresis of the upper extremities with OMS (Oxford Muscle Strength) score of 2-3 out of 5 (Table 1) and an EDSS score of 8.0. Neurological presentation included paraplegia, bilateral central scotomata with visual-field loss, dysphagia, chronic fatigue, cognitive impairment similar to mild dementia, and depressed mood. In June 2000, having explained the rationale and risks, she consented to a trial of pioglitazone, which was initiated at 15 mg daily and increased by 15 mg biweekly to 45 mg. Improvement was evident within 4 weeks as increased appetite, cognition and attention span. Her weight increased from 27.3 to 35.9 kg (32%) after 12 months treatment, which was maintained between 34.6 to 36.2 kg throughout an additional 18 months. Weight gain was evident as increased muscle mass and peripheral fat, mainly in the hips, gluteal area, and limbs. Upper extremity strength and coordination progressively improved (Table 1). Improved fine coordination was noted unilaterally after 8 months (left finger-to-nose execution), and bilaterally after 15 months. Before pioglitazone, repetitive statements and forgetfulness, reminiscent of dementia, were problematic. After 8 months therapy, cognitive assessment demonstrated improvement in orientation, short-term memory (recall increased from 0/3 to 2/3 objects), attention span, registration and insight, and is consistent with clinical improvement. According to DSM IV criteria, her depression also improved significantly, along with the progressive gain in weight and improvement in neurological function as a whole. She was progressively able to tolerate outdoor social activities for several hours at a time, with improved stamina and well-being.\\nDuring the study, two MRI studies with gadolinium (Gd) were performed, one 18 months after initiation of pioglitazone and the second 10 months later (Figure 1). There was no perceptible change in overall brain atrophy, extent of demyelination, or in Gd-enhancement indicating that at least over the 10 months between the MRI studies, the disease was quiescent. This also suggests that the beneficial effects of pioglitazone treatment were not associated with any overt improvement in pathology. After 3 years on pioglitazone, she continues to be clinically stable. There have been no adverse events, and her metabolic profile has remained normal throughout the study.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 36,\n",
       "    'case_id': 'PMC9584726_01',\n",
       "    'case_text': 'A 36-year-old male patient, middle eastern descent, presented with left elbow swelling, persistent pain, and gradual restriction of range of elbow motion for 8 months. Prior to that, he had visited a series of other facilities and had an open biopsy, done in another facility, which had already confirmed the diagnosis of PVNS. There was no history of injury or trauma, and his past medical history was uneventful.\\nPhysical examination showed a healed scar from the open biopsy on the extensor side of his left elbow. The range of motion was restricted from 5 degrees of extension to only 90 degrees of flexion, (FE: 90.5.0), in comparison to the contralateral side with 0-degree extension to 140-degree flexion (FE: 140.0.0). Pronation and supination were free, he did not have any signs of ligament instability, and his neurovascular status was normal.\\nRadiographs were normal, and MRI revealed a soft tissue tumor in the anterior joint compartment with extension to the olecranon fossa and the radiocapitellar joint, with the signal intensity consistent with PVNS. There were no osteolytic lesions or osseous erosions visible on MRI.\\nAs the suspected diagnosis of PVNS was already confirmed via biopsy, elbow arthroscopy, tumor excision, and synovectomy were indicated.\\nUnder general anaesthesia, the patient was positioned in prone position with the left elbow supported and free for mobilisation. Tourniquet was not used. Under routine antibiotic coverage and surgical site preparation, anteromedial, anterolateral, posterolateral, and posterior portals were established. The anterior compartment was addressed first. Arthroscopic exploration showed a large soft tissue tumor, exactly as the MRI demonstrated, with the typical appearance of a nodular form of PVNS (Figure 1). The synovium showed a diffuse form of PVNS. Firstly, we removed the tumor-like nodules, followed by total synovectomy, which was performed with an arthroscopic shaver and with a radio frequency ablation device to keep bleeding to a minimum. The joint cartilage showed grade 2 changes on the distal humerus as well as on the radial head. The annular ligament was intact. After the anterior compartment was finished, the posterior compartment was addressed in a similar manner. There was some scar tissue which needed to be debrided first due to the open biopsy that had been done previously. Then, a total synovectomy was performed in the same way as for the anterior compartment. A drain was put in the anterior compartment, the wounds were closed, and the arm was immobilised in a sling for comfort.\\nThe postoperative course was uneventful; rehabilitation was initiated in the first week after a few days of rest, focusing on gain of passive and active range of motion. The patient presented with a little pain but showed local swelling that persisted for two weeks. Range of motion was near normal at the end of the sixth week postoperatively (Figure 2). At the most recent follow-up six months postoperatively, the patient was pain free and had regained full range of motion, and the follow-up MRI did not reveal any recurrence (Figure 3).',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 56,\n",
       "    'case_id': 'PMC7226668_01',\n",
       "    'case_text': 'A 56-year-old female was referred to hospital by her dentist with a 3-month history of right sided facial swelling. This had been slowly increasing in size and was associated with intermittent paraesthesia to the lower lip and tongue. Only mild pain was reported, satisfactorily relieved by paracetamol and ibuprofen when needed. Her general medical practitioner (GP) had previously prescribed a course of antibiotics that had not improved the facial swelling.\\nHer medical history was remarkable only for hypertension and anxiety, for which she was taking lisinopril and citalopram respectively. She was on no other regular medication and had no known allergies. She was a current smoker on presentation. She denied any weight loss or reduction in appetite. Her past medical and family history were otherwise insignificant.\\nExamination showed a marked right-sided swelling (Fig. 1). The lesion was tender to palpate and, despite it being firm and fixed, there were no overlying skin changes. The swelling extended 4 cm laterally and was associated with a reduced mouth opening of 28 mm (inter-incisal). Intraorally, it was also tender to palpate the external oblique ridge and adjacent teeth. Facial and trigeminal nerves appeared intact.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 82,\n",
       "    'case_id': 'PMC7269521_01',\n",
       "    'case_text': \"An 82-year-old man presented with cough and weakness and admitted to our clinic. His body temperature was 380 C, heart rate 93 beats/min, respiratory rate 22 breaths/min, blood pressure 100/60 mmHg, and oxygen saturation 86% (oxygen mask 5 L/min). His blood leukocyte, neutrophil, lymphocyte, D-dimer, fibrinogen, c-reactive protein, ferritin, and procalcitonin levels were 8.56 x 103/microL, 7.4x103/microL, 0.62x 103/microL, 2304 ng/mL, 638 mg/dL, 183 mg/L, 720 ng/mL, and 0.2 ng/mL, respectively. Computed tomography of the thorax revealed a suspected diagnosis of coronavirus disease (COVID-19) (Figure 1). Antiviral (Favipavir 2 x 1600 mg loading, 2 x 600 mg maintenance) and antibacterial (levofloxacin 500 mg/day) therapies were initiated. The patient's oronasopharyngal swab specimen was positive for severe acute respiratory syndrome coronavirus 2 nucleic acid. Weakness and loss of muscle tone developed in the left arm on day 3 of treatment. Brain diffusion magnetic resonance imaging showed multiple advanced stage infarctions (Figure 2). Enoxaparin 0.5 mg/kg once every 12 hours and acetylsalicylic acid 100 mg 1x1 were added to treatment. The laboratory parameters improved. The patient was discharged on day 20.\\nCOVID-19 can result in cerebral infarction and death in the elderly  . Anticoagulants are useful in elderly patients with high D-dimer due to the risk of coagulation dysfunction and cerebral infarction. Thromboembolic complications must be considered in COVID-19 patients with known risk factors and abnormal laboratory findings.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 14,\n",
       "    'case_id': 'PMC3585775_01',\n",
       "    'case_text': \"On February 11, 2011, a 14-year-old male initially presented with pain in the right thigh muscle without trauma and was subsequently found to have purely osteosclerotic lesions of the skull, vertebrae, ribs, bilateral and nearly symmetric proximal humerus, pelvis, ilium, sacrum, proximal and distal femurs, and proximal tibiae (Figs. 1 and 2). The lesions were particularly evident in the right distal femur (Fig. 3). Laboratory tests revealed hypocalcaemia, elevated parathyroid hormone, alkaline phosphatase (ALP), and lactic dehydrogenase (LDH) (Table 1). A lumbar intervertebral disc protrusion was also found by computed tomography (CT). \\nA blood gas analysis, repeated twice, showed a mild generation of acid; however, other laboratory values were all within normal ranges. The detected levels of serum phosphorus, 24 h urinary calcium and phosphorus, and parathyroid hormone are shown in Table 1. The level of 25-hydroxy vitamin D was 9 pg/mL (normal range: 10-55 pg/mL), while the level of 1, 25-dihydroxy vitamin D was 130 pg/mL (normal range: 15-90 pg/mL). The bone mineral density (BMD) analysis was 0.5% lower than that typical of adolescents of a similar age. Analyses of thyroid, parathyroid, abdominal B ultrasonography, double-lower extremity arteriovenous color Doppler, and echocardiography were all normal.\\nThe clinical presentation was initially controlled by Celebrex, and the differential diagnosis prior to biopsy included hyperparathyroidism, Paget's disease (teenager's type), osteopetrosis, melorheostosis (leri) (variant type), skeletal fluorosis, Erdheim-Chester disease, and osteosarcoma. Serum calcium levels continued to decrease after treating the patient with chewable vitamin D tablets (200 U/day), calcitriol soft capsules (0.75 microg/day), Celebrex (200 mg/day), and intravenous (i.v.) Aclasta (5 mg/day). Since the treatment regimen alleviated the muscle pain, the patient was voluntarily discharged on March 19, 2011, despite persistent hypocalcemia. After discharge, the patient gradually developed numbness and weakness of both lower limbs with subsequent dysuria. On March 30, 2011, he was admitted to the department of orthopedics at our hospital. Physical examination showed that the patient had a positive straight leg raise test in the lower extremities of both appendages, hypopselaphesia below the navel plane, and class III-V muscle strength in both lower limbs. Hypocalcemia was again identified by laboratory tests, while the hemoglobin, white blood cell count, platelet count, blood urea nitrogen, serum creatinine, aspartate aminotransferase (AST), C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), and albumin were all within normal ranges. The magnetic resonance imaging (MRI) revealed a tumor compressing the fifth thoracic spinal cord. An x-ray of the lungs was normal.\\nAn open bone biopsy was performed on the bilateral distal femora and proximal tibiae, and four foci were found that exhibited mid-grade osteoblastic osteosarcoma (Fig. 4). Based on the imaging, pathology findings, and clinical manifestation, a diagnosis of MOS was ultimately established (synchronous MOS). Following administration of neoadjuvant chemotherapy with a first cycle of methotrexate (MTX), pirarubicin (THP), and ifosfamide (IFO), the serum calcium level returned to normal, although the clinical symptoms continued to progress. A CT scan of the lung showed no signs of tumor metastases. In comparison to the previous MRI (Fig. 5B and C), the number of lesions had increased and the tumors in the spinal canal were amplified after the neoadjuvant chemotherapy (Fig. 5A). Due to the progression of clinical symptoms after chemotherapy, the patient's parents made the decision to discharge the patient from hospital. At the 4-month follow-up, which was conducted by telephone, we determined that the patient's symptoms had continued to deteriorate, and the patient died 15 months after diagnosis.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 60,\n",
       "    'case_id': 'PMC7248319_01',\n",
       "    'case_text': 'A 60-year-old man with hyperlipidemia and with no history of hypertension, diabetes, or heart disease boarded the cruise ship 16 days before it went into quarantine. He noticed fever (day 0), RT-PCR positive was observed on day 4, and he was admitted to our hospital on day 7. His family members that had been in close contact with him tested negative. On admission, he had a fever and cough but had no difficulty in breathing. The physical examination showed no abnormalities. The results of blood examination were as follows: white blood cell (WBC) count 6,900/muL, lymphocyte count 1,056/muL, sodium level 131 mmol/L, C-reactive protein (CRP) 4.45 mg/dL.\\nFollowing continuous fever for 7 days, on day 13, oxygen saturation suddenly decreased to 88% at room air without any obvious symptoms such as dyspnea. We started oxygen inhalation, which had to be increased. Chest X-ray demonstrated infiltrative shadows at the bilateral lower lung, and chest computed tomographic (CT) scan revealed bilateral ground-glass opacity (GGO) and a crazy-paving appearance, and we diagnosed him with COVID-19 pneumonia. Blood examination showed a slight elevation of WBC count, with decreased absolute lymphocyte counts, hyponatremia, hiper-ferritinemia, and a high CRP level: WBC 7,900/muL, lymphocyte 711/mL, sodium level 132 mmol/L, Ferritin level 866 ng/mL, CRP 12.21 mg/dL. Due to the abrupt oxygen requirement, which had to be increased, and the results of the CT scan, Lopinavir/Ritonavir was started on day 13. Simvastatin 50 mg once daily for hyperlipidemia was switched to pravastatin due to contraindication of simvastatin during treatment with LPV/r. The body temperature and oxygen requirement decreased and lymphopenia normalized within 2 days, followed by improvements in other measures. Chest-CT images showed that subpleural curvilinear shadow, ground-glass pattern, and consolidation were improved on day 16. He was discharged from the hospital after testing RT-PCR negative twice.',\n",
       "    'gender': 'Male'},\n",
       "   {'age': 88,\n",
       "    'case_id': 'PMC7248319_02',\n",
       "    'case_text': 'An 88-year-old Japanese male with a history of prostate cancer and hypertension boarded the cruise ship with his wife 16 days before the ship was quarantined. He recognized fever (day 0) and underwent RT-PCR testing on day 4, with a positive result, and was admitted on day 6. On admission, he suffered from fever and fatigue without cough or breathing difficulty. Blood results were as follows: WBC 3,100/muL, lymphocyte 704/mL, AST 39 IU/L, ALT 18 IU/L, sodium 127 mmol/L, and CRP 1.52 mg/dL. Fever and fatigue persisted, and other symptoms such as cough and diarrhea were developed on day 11. Despite our efforts to correct sodium abnormality, hyponatremia continued, ranging from 125 to 127 mmol/L, with a mild oxygen requirement (1-2 L/min). Chest X-ray revealed a new appearance of infiltrative shadow in the bilateral lung, and the CT scan image showed GGO in the outer area with or without consolidation. The diagnosis of COVID-19 pneumonia was made, and LPV/r was initiated after achieving consent. He had continued to take telmisartan 40 mg and trichlormethiazide 1 mg for hypertension, tamsulosin hydrochloride 0.2 mg for dysuria, and bicalutamide, an androgen receptor antagonist, 80 mg for prostate cancer. Symptoms gradually decreased in severity, with improvements in hyponatremia and lymphocytopenia. Although diarrhea and appetite loss due to LPV/r were seen, he was able to continue treatment. On day 25, he tested RT-PCR-negative for two samples and was discharged.',\n",
       "    'gender': 'Male'},\n",
       "   {'age': 44,\n",
       "    'case_id': 'PMC7248319_03',\n",
       "    'case_text': 'A 44-year-old female without past medical history who is healthcare personnel and had close contact with COVID-19 pneumonia patients recognized fever without any other symptoms (day 0). An RT-PCR test was positive on day 2, and she was admitted to our hospital on day 3. On admission, she was symptom-free without any abnormality on physical examination. Her laboratory test results were as follow: WBC 3,600/muL, lymphocyte 1,224/mL, sodium level 136 mmol/L, Ferritin 20 ng/mL, and CRP 0.06 mg/dL. She developed a fever and dry cough on day 5 but had no severe respiratory symptoms such as difficulty in breathing, chest pain, or productive sputum. However, infiltrative shadows were observed in the right upper and left lower area on chest X-ray on day 6, and CT scan showed consolidations in the same areas on day 7. After obtaining consent, we started LPV/r on day 8, but she suffered from gastrointestinal adverse events and discontinued LPV/r on day 11. She had no concurrent medication. Improvement of pneumonia was observed on day 15, and she was discharged after two consecutive negative RT-PCR results. Interestingly, following the improvement of pneumonia without any symptoms or abnormality in blood examinations, RT-PCR remained positive during her follow-up RT-PCR testing.\\nPatients 1 and 2 developed a fever over 38 C and required oxygen inhalation, but neither were observed throughout the clinical course in Patient 3 (Figures 1-3). Pneumonia developed 8, 12, and 7 days after the onset of illness in Patients 1, 2, and 3, respectively (Figure 4; P1A, P2A, and P3A). After LPV/r was initiated, body temperature decreased, with improvement of cough, lymphopenia, hyponatremia, hyper-ferritinemia, and infiltrative shadows in Patients 1 and 2 (P1B, P2B). This effect was rapid in Patient 1 and gradual in Patient 2. No abnormal laboratory test results except for increased CRP were observed in Patient 3. The duration of treatment with LPV/r was 10, 12, and 3 days for patients 1, 2, and 3, respectively.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 8,\n",
       "    'case_id': 'PMC3262997_01',\n",
       "    'case_text': 'A previously healthy, 8-year-old, right-handed girl initially presented to the emergency department of another institution with nausea and vomiting followed by a decreased level of consciousness. Upon examination, she was somnolent but arousable with intact brainstem reflexes and no motor deficit. An urgent computerized tomography (CT) scan revealed a right occipital intraparenchymal hematoma with intraventricular extension into the right lateral and fourth ventricle [Figure 1]. There was no overt hydrocephalus. The patient received supportive therapy in this institution and she made an uneventful recovery with residual left homonymous hemianopsia. She was discharged from the hospital after 4 weeks. Three months following the hemorrhage, on November 16, 1995, she underwent a brain Magnetic Resonance Imaging (MRI) that showed an area of encephalomalacia in the right occipital lobe [Figure 2]. A subsequent DSA was performed on December 28, 1995, which revealed a Spetzler-Martin grade III (4 x 3 x 1.5 cm) occipital AVM supplied by the posterior parietal and angular branches of the middle cerebral artery (MCA) and draining through a superficial cortical vein into the right transverse sinus [Figure 3]. There were no feeders from the left internal carotid artery (ICA), external carotid artery (ECA) or posterior cerebral artery (PCA). The patient was then referred to our center for AVM management.\\nOn January 5, 1996, the patient underwent a right occipital craniotomy for AVM resection. Postoperative DSA performed 17 days after surgery demonstrated no residual AVM [Figure 4]. The patient made an uneventful recovery except persistent visual field deficit. Although a Magnetic Resonance Angiography (MRA) was recommended at 8-month follow-up, the family declined this study and the patient was lost to follow-up.\\nSixteen years after surgery, at the age of 24, the patient developed daily headaches associated with nausea and dizziness that progressed over a 2-month period. Upon consultation in another institution, neurological examination revealed left homonymous hemianopsia and mild (4+/5) motor weakness of the left lower extremity. She was otherwise neurologically intact. CT angiography revealed a recurrence of the right occipital AVM fed by MCA branches and draining into the superior sagittal sinus (SSS) [Figure 5]. The patient was referred to our center where, on August 24, 2011, a DSA confirmed the right occipital AVM [Figure 6a and b]. The patient underwent an uneventful second microsurgical resection of the occipital AVM recurrence through a right occipital craniotomy using ultrasonographic guidance. Postoperative DSA performed 7 days after surgery showed no evidence of residual AVM [Figure 6c]. Her preoperative symptoms resolved, but her visual deficit was mildly accentuated postoperatively. The postoperative course was otherwise uneventful and she remains stable at 5-week follow-up.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 34,\n",
       "    'case_id': 'PMC8411882_01',\n",
       "    'case_text': 'Sylvia was a 34 year old woman who was referred to the Helen Dowling Institute, a mental healthcare institute for psycho-oncology. She suffered from severe fatigue (score of 49, which is way above the severe fatigue cut-off of >=35 on Checklist Individual Strength - Fatigue Severity subscale (Vercoulen et al.,)) for over a year by then. Two years prior she was diagnosed with ovarian cancer with bone metastases. The tumor was removed through surgery. Next, she received four rounds of chemotherapy, followed by two surgeries to remove the affected rib and vertebra. After one year of curative treatment, leading to chemotherapy-induced kidney failure, she received medical follow-up consultations every few months by an oncologist. She also suffered from inflammatory bowel disease and inflammatory rheumatism since her teenage years. She lived together with her partner, had a university education, and was fully incapacitated for work since her cancer diagnosis. Previously, she worked fulltime as a project leader.\\nWhile she had always struggled with fatigue due to her comorbidities, throughout her cancer treatment the fatigue worsened dramatically. Sylvia described she had particular trouble concentrating when she felt tired. When she tried to read a newspaper or do her administration, she could get headaches and become nauseous. This severely limited her daily life activities. Her experience of fatigue was rather similar from day to day. Usually, she had trouble starting the day, which usually took her a few hours. Fatigue increased throughout the day, with a dip in the late afternoon. She usually took a nap by then because she was unable to do any of her activities. She did, however, also experience unexpected waves of extreme fatigue that did not seem to be related to previous activities. During those moments, it was difficult to get through the day. Furthermore, when she had a particularly busy activity, for example when she went to a party, she had trouble dealing with all the stimuli and social interactions at once. As a result, she would be extra fatigued for the following two to three days.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 5,\n",
       "    'case_id': 'PMC8655870_01',\n",
       "    'case_text': \"A 5-year-old, intact male Bengal cat weighing 5.2 kg (body condition score: 3/9) suffered a fracture of the right femur following a motor vehicle accident. A referring veterinary hospital performed surgical fixation using a dynamic compression plate, screws, and cerclage wires. Three weeks after surgery, the cat was presented to the Veterinary Medical Teaching Hospital at the National Pingtung University of Science and Technology due to the recurrence of non-weight-bearing right hind limb lameness.\\nInitial physical examination revealed pain and instability upon palpation of the right femur with soft tissue swelling. No other physical abnormalities were observed. Radiographic examination revealed a closed, comminuted, mid-diaphyseal fracture of the right femur with notable bone callus formation and implant failure (Figure 1A).\\nThree surgical revisions were performed before the final revision, along with concurrent activity restriction, analgesic medication administration, and low-level laser therapy. During the first revision surgery, the previous implants were removed and the fracture edges were debrided. The fracture was stabilized with a 2.7-mm non-locking reconstruction plate and a 1.6-mm intramedullary (IM) pin. After 2 months, the cat presented with persistent lameness and muscular atrophy of the affected limb on palpation. Radiographic examination indicated 30% femoral shortening and loosening of the four distal screws (Figure 1B). A second revision surgery was performed; the fracture edges were debrided, and an autologous cancellous bone graft harvested from the proximal ipsilateral humerus was placed around the fracture. The fracture was stabilized using a longer 2.7-mm plate and a 2.0-mm IM pin. However, 4 months later, the lameness remained unimproved, and radiographs showed delayed union with screw loosening (Figure 1C). Treatment options including femur amputation, type IA external skeletal fixation alone or combined with a tie-in technique, and autograft combined with BMP were discussed with the owner. In the meantime, the loosened reconstruction plate and screws were removed to minimize damage to the surrounding soft tissue and bone in a third revision surgery. The IM pin was left in place according to the owner's request although it provided only minimum bone fracture support. At presentation 11 months later, atrophic non-union of the affected femur was noted (Figure 1D). The owner eventually opted for fracture repair using a structural bone autograft and BMP. The surgical events of this case are shown in the timeline (Figure 2).\\nThe preoperative complete blood count and serum biochemistry results were within normal limits. Fentanyl (5 mug/kg) and cefazolin (22 mg/kg) were administered intravenously as a premedication and prophylactic antibiotic, respectively. General anesthesia was induced with intravenous propofol (6 mg/kg) and maintained with 1-2% inhaled isoflurane. Intraoperative analgesia was administered via a constant rate infusion of fentanyl (1.5 mug/kg/h), lidocaine (1.2 mg/kg/h), and ketamine (0.15 mg/kg/h). The cat was positioned in left lateral recumbency, and the previous IM pin was removed from the trochanteric fossa. Subsequently, the fracture site was exposed using a lateral approach in a routine manner. When fully exposed, the fracture edges were surrounded by smooth fibrotic tissue and mild callus formation was noted. The fracture edges were debrided with an ultrasonic surgical device (SonoCure, Tokyo Iken Co., Tokyo, Japan) (Figure 3A). The medullary canal was recanalized by drilling a 2.8-mm pin into the canal from the fracture site (Figure 3B). The fractured edges were maximally distracted using bone-holding forceps, although the original bone length could not be restored due to excessive soft tissue tension. An 8-hole, 66-mm, ball-shape reconstruction locking plate (Lisen Tech., Taoyuan City, Taiwan) with six 2.7-mm locking self-tapping cortical screws was used to stabilize the fracture segments; two holes in the middle were left empty. A bone gap of ~1.8 cm was measured in the defect.\\nThe ipsilateral seventh rib was approached by making an incision through the skin and thoracic muscles. The periosteum of the rib was incised to expose the mid-section of the rib body, and it was elevated carefully. A 2-cm segment of the rib was harvested using an ultrasonic scalpel (SonoCure, Tokyo Iken Co., Tokyo, Japan) (Figure 3C). The intercostal muscles were then apposed over the cut edge of the rib with 3-0 polydioxanone suture in a simple interrupted pattern. The length of the graft was chosen to be the length of the fracture gap plus 0.5 mm. The graft was then positioned at the center of the fracture gap with gentle manual impaction (Figure 3D). No additional fixation was performed. Another skin incision was made over the ipsilateral iliac crest. Several pieces of corticocancellous iliac autograft were obtained with a rongeur (Figure 3E) and placed to fill the residual space around the rib graft. Finally, a 3 x5 cm absorbable collagen sponge (SavPet, Oriental Co., Taipei, Taiwan) was soaked in 100 mug of rhBMP-2 (10426-HNAE, Sino Biological, Beijing, China) reconstituted in 0.5 mL of normal saline and wrapped around the bone defect (Figure 3F). Routine closure of the three surgical sites was performed. As the pleura was left intact, a thoracostomy tube was not required. Although the exact range of motion was not measured by a goniometer during surgery, the range of motion of the right stifle was subjectively judged to be about half that of the contralateral side on physical exam before extubation. Postoperative radiographs were obtained to confirm the position of the graft (Figure 4A). Mild distal femoral varus was also noted (Figure 4A). The radiographically measured length of the right femur was ~8.0 cm, and that of the left femur was 12.1 cm (~34% shortening).\\nAnesthetic recovery was uneventful. Pain was managed with intravenous tramadol (2 mg/kg) twice a day for 2 days, a single dose of intravenous meloxicam (0.1 mg/kg), and low-level laser therapy on the surgical sites. Intraoperative aerobic and anaerobic bacteria cultures were performed on a sample collected from the bone defect before debridement, and no pathogens were identified. No postoperative complications were observed. The cat was discharged on the fourth postoperative day with an instruction of cage rest.\\nOn the seventh postoperative day, occasional weight-bearing lameness during walking was noticed (lameness score: 4/5). After 2 months, the cat was able to trot with mild lameness at home. On physical examination, the cat was consistently bearing weight on the affected limb with a moderate weight-bearing lameness during walking (lameness score: 3/5) characterized by a decreased swing phase. Radiographs showed bridging callus formation with new bone formation and incorporation of the transplanted rib graft (Figure 4B). On radiographs taken 5 months postoperatively, bony union at the fracture gap was evident and the transplanted rib graft was indiscernible (Figure 4C). Moreover, at the last recheck examination 12 months postoperatively, successful bone remodeling and apparent maturity of the generated bone were noted (Figure 4D). To compensate for the discrepancy in hind limb length, the cat stood with the affected hip, stifle, and hock joints at greater angles of extension. Despite mild lameness during walking (lameness score: 2/5) (see Supplementary Video 1), the cat was energetic and had no difficulty jumping at home. The passive range of motion of the right stifle was also increased but was still about 30% less than contralateral side on physical exam without application of anesthesia or sedation. The owner was satisfied with the improved health status and good ambulatory function.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 23,\n",
       "    'case_id': 'PMC5944016_01',\n",
       "    'case_text': 'A 23-year-old healthy female presented with non-progressive right upper eyelid painless swelling for 8 months. It was not associated with other ocular or visual complaint. The patient\\'s medical history and family history were unremarkable particularly for signs and symptoms of neurofibromatosis.\\nOn Examination, a soft, non-tender, compressible, mobile mass was appreciated in the right upper eyelid. The Hertel exophthalmometer (at a base of 105) measured 22 mm on the right eye and 19 mm on the left eye with no changes during Valsalva\\'s maneuvers. The extraocular muscles movement was full. The superior fullness over the right upper eyelid was evident to the patient and disturbing for her cosmetically (Fig. 1A). Systemically, the patient did not also have any signs suggestive of neurofibromatosis.\\nUltrasound B-scan was done on the left side and showed a cystic lesion suggestive of a unilateral dermoid cyst.\\nOrbital computed tomography (CT) showed a cylindrical shaped hypodense mass measuring approximately 4.4 x 1 x 1.3 cm in the superior aspect of the right orbit causing an inferior displacement of the superior rectus muscle as well as the right globe. Incidentally, a similar, smaller, hypodense lesion was noted in an identical location within the superior aspect of the left orbit with similar inferior displacement of the left superior rectus muscle. The remaining extraocular muscles were preserved (Fig. 1B and C).\\nThe lesion was excised through upper eyelid skin crease incision and superior orbitotomy. It appeared intra-operatively to be cystic in nature (Fig. 2A) arising in relation to the supra-orbital nerve and extending deeply along the course of the frontal sensory nerve into the superior orbital fissure (Fig. 2B).\\nGrossly, the tissue consisted of a cystic fusiform mass attached to a slender-like structure representing a nerve. The whole specimen measured 4 x 0.3 x 0.2 cm, was serially sectioned and submitted \"en toto.\"\\nHistopathologically, the unremarkable part of the nerve tissue was evident, however the dilated part observed grossly showed many myelinated axons, and collagen fibers loosely distributed within a myxoid stroma. The tissue was surrounded by a thin layer of perineurium and continues as a thickened unremarkable nerve (Fig. 2C and D).\\nPost operatively, the patient complained of decreased sensation and numbness over the distribution of the frontal nerve and was improving gradually over few months. She had no recurrence 2-years post-surgical treatment and possible excision of the lesion on the left side is being considered.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 27,\n",
       "    'case_id': 'PMC8182299_01',\n",
       "    'case_text': \"A 27-year-old male with no past medical history presented to the emergency department with headache for the past 2 days. He also endorsed photophobia, chills, night sweats, decreased appetite, 10-pound unintentional weight loss, and fevers. The patient reported being sexually active with men only with the last unprotected sexual intercourse 2 weeks ago. He denied any illicit drug use.\\nIn the emergency department, the patient had a temperature of 38.2  C, a heart rate of 103 beats/minutes, respiratory rate of 20 breaths/minutes, blood pressure of 100/60 mm Hg, and O2 saturation of 100% on room air. Physical examination was unremarkable with no meningeal signs. Given his headache and a fever of 38.3  C, the patient was started on empiric meningitis treatment with vancomycin and ceftriaxone. Computed tomography of the head without contrast showed no acute intracranial process. Magnetic resonance imaging of the brain with and without contrast was unremarkable.\\nInitial laboratory findings (Table 1) were significant for leukopenia of 2.2 x 103/microL, thrombocytopenia of 81 x 103/microL, hemoglobin of 12.3 g/dL, transaminitis, elevated C-reactive protein of 3.16 mg/dL, and hypoalbuminemia. Chest X-ray did not reveal any active infection or any other pathology. Blood cultures were negative. Lumbar puncture revealed the following: white blood cells 3 cells/cm2, red blood cells 378 cells/cm2, glucose 54 mg/dL, and elevated protein 51 mg/dL. Cerebrospinal fluid (CSF) was negative for cryptococcal antigen, herpes simplex virus, and CSF VDRL. Accordingly, vancomycin was discontinued. Ceftriaxone was decreased to 1 g every 24 hours for 2 weeks, followed by intramuscular benzathine penicillin G 3 million units to treat presumed neurosyphilis due to elevated protein in the CSF. HIV antigen/antibody test was positive, with an HIV-RNA level over 10 000 000 copies/mL, CD4 T-cell count of 201 cells/microL, and CD8 T-cell count of 93 cells/microL. These results along with fatigue, fever, pancytopenia, and transaminitis supported the diagnosis of acute retroviral syndrome; therefore, ART was initiated consisting of darunavir/cobicistat/emtricitabine/tenofovir alafenamide.\\nAdditional laboratory values (Tables 1 and 2) showed hyperferritinemia >40 000 ng/mL, D-dimer >5000 ng/dL, bi-cytopenia, transaminitis, and hypertriglyceridemia, which raised concern for HLH. H-score showed a 93% to 96% probability of having HLH (Table 3). A collaborative decision was made by the patient and the physicians to defer bone marrow biopsy and we chose to confirm our suspicion by performing noninvasive tests such as interleukin (IL)-2 receptor and natural killer (NK) cell activity.\\nComputed tomography of the abdomen and pelvis with contrast showed borderline prominent right hepatic lobe, slight hypodensity of the liver suggesting fatty hepatocellular changes, and mesenteric adenitis. The patient's symptoms of headache had self-resolved on the third day of admission and he left against medical advice. Following discharge, IL-2R returned >4000 pg/mL. The suspicion of HLH secondary to acute HIV was confirmed as the patient met 4/8 criteria for the diagnosis including fever, bi-cytopenia of thrombocytopenia and neutropenia, elevated ferritin, elevated IL-2R along with the high probability of H-score. The patient followed-up outpatient and he reported complete resolution of his symptoms.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 9,\n",
       "    'case_id': 'PMC10311060_01',\n",
       "    'case_text': 'A 9-year-old previously healthy Syrian boy was admitted with a 1-day history of epistaxis, hematemesis, hematuria, and melena associated with periumbilical abdominal pain. He also has been complaining of pallor, decreased activity and appetite, and weight loss for a month prior to his presentation. A week before his admission, there was a noticeable increase in his pallor. Upon presentation, he was hypoactive, pale, and jaundiced. He was normothermic and hemodynamically stable. System examination revealed hepatosplenomegaly small palpable lymph node in the supraclavicular and inguinal region. The remainder of his physical examination was unremarkable.\\nHis initial Laboratory tests at admission showed a picture of bi-cytopenia in the form of anemia and thrombocytopenia. Platelet 11 x 109/L (normal range: 150-400 x 109/L); hemoglobin 97 mg/L (normal range: 113-150 mg/J); white blood cells 10.2 x 109/L (normal range: 4-12 x 109/L); and reticulocyte counts 2.45% (normal range: 0.5%-1.5%). Peripheral blood smear showed red blood cell fragmentation (Schistocytes) at 1.45%, and white blood cells, mainly neutrophilia, displayed reactive changes in forms of toxic granulation.\\nLactate dehydrogenase was 1,021 U/L (normal range: 125-220 U/L); aspartate aminotransferase 46 IU/L (normal range: 5-34 U/L); alkaline phosphatase 143 IU/L (normal range: 156-369 U/L); total bilirubin 41.3 micromol/L (normal range: ~20.5 micromol/L); and direct bilirubin 12.7 micromol/L (normal range: ~8.6 micromol/L). Blood urea nitrogen and creatinine were within normal limits. Urinalysis showed hematuria and hemoglobinuria. Coagulation screening tests were within the normal range; fibrinogen level was decreased to 1.72 g/L (normal range: 1.5-4.1 g/L); Coombs test was negative.\\nInitially, the patient was diagnosed with atypical idiopathic thrombocytopenic purpura (ITP) and treated with Intravenous Immunoglobulin (IVIG) 1 g/kg. He received two doses of IVIG without response, and his Hgb and platelet counts declined further.\\nIn order to rule out bone marrow infiltration, bone marrow aspirations (BMA) and biopsy were performed. The preliminary report of the BMA did not suggest malignancy; however, it showed megakaryocytes which is suggestive of immune destruction. Therefore the patient was started on a six days trial of pulse steroid therapy (intravenous methylprednisolone 2 mg/kg/day divided twice a day), with no improvement in Hgb or platelet count. The final result of BMA revealed peripheral destruction of blood cells, indicating microangiopathic hemolytic anemia (MAHA), likely TTP, congenital or acquired due to an immune reaction to ADAMTS-13; this diagnosis was supported by repeated peripheral blood smear showing Schistocytes fragments of red blood cells >2.5% (Normal range <1.5%), accordingly a five days trial of fresh frozen plasma transfusion was initiated, in which the patient showed improvement in LDH and platelet levels.\\nIn addition, bone marrow biopsy results showed morphologic evidence of frequent small epithelioid non-necrotizing granuloma. Considering that this is a nonspecific finding that could be attributed to various etiologies, including infections (viral, bacterial, and tuberculosis), infiltrating diseases such as sarcoidosis, and malignancies, further investigation has been pursued. Viral surveillance, including EBV, CMV, and HIV were negative. QuantiFERON-TB Gold was negative. Abdominal ultrasound and computerized chest and abdominal tomography (CT) scan showed splenomegaly with no significant lymph node enlargement. Since Brucella is endemic in Saudi Arabia and the patient had recently consumed a significant amount of unpasteurized goat milk and cheese, brucella titers were sent, and the result showed Brucella abortus 1:5,120 (normal range: <1:160), and Brucella melitensis 1:20,480 (normal range: <1:160).\\nA combination of Doxycycline (5 mg/kg/day orally twice a day) and Rifampin (20 mg/kg/day orally twice a day) antimicrobial therapy was commenced for a total of 6 weeks (42 days) to treat brucellosis. Once starting the anti-brucellosis management, the patient did not require further FFP transfusion. The ADAMTS-13 essay result showed: extremely low ADAMTS-13 activity, which was found at 0.02 IU/ml (normal range: 0.40-1.30 IU/ml), with an antigen assay below the detection level of 0.01 IU/ml (normal range: 0.41-1.41 IU/ml); and anti-ADAMTS-13 antibodies were detected at high concentrations of >95 IU/ml (>15 IU/ml is considered positive). All these findings, along with the presentation of thrombocytopenia and hemolysis, are specific to acquired TTP.\\nSeveral days following the commencement of antibiotic therapy, the platelets count and hemoglobin levels recovered to the normal range (Figure 1), while the lactate dehydrogenase levels decreased substantially to a normal level.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 45,\n",
       "    'case_id': 'PMC8648468_01',\n",
       "    'case_text': \"The patient was a 45-year-old female who was admitted to an acute psychiatric hospital with depressed mood, suicidal ideation, and auditory hallucinations. She was discharged five days prior from a different hospital, and according to previous records, has been repeatedly hospitalized within the last 12 months totaling 18 emergency department visits. Her psychiatric history was significant for benzodiazepine use disorder, opiate use disorder, borderline personality disorder, and major depressive disorder. Her medications on admission included clonazepam, clonidine, buprenorphine and naloxone, fluoxetine, gabapentin, and trazodone. Her social history included unemployment and homelessness without family support.\\nDuring the admission, the patient exhibited a wide range of odd behaviors that will be described in the categories of catatonia-like signs, psychotic signs, and seizure-like signs. Catatonia-like signs included (1) a flat affect with psychomotor retardation and fluctuating mutism, (2) complete lack of social contact with other patients for the entirety of the hospital stay, (3) twitching and eye grimacing with shoulder shrugging, (4) posturing and immobility, and (5) diaphoresis. These severe signs persisted throughout her hospital stay and were so convincing of catatonia that multiple attendings, nurses, and staff held special meetings to specifically review her catatonic status. Additional consultants were recruited to discuss her case at length. Furthermore, these catatonic symptoms resulted in the patient's hospital stay lasting almost two months as the appropriate treatment and disposition were considered. Psychotic signs included (1) mouthing words and seemingly responding to internal stimuli, (2) thought blocking, and (3) reported auditory hallucinations. Seizure-like behavior included episodes of jerking head back and forth with her eyes fluttering without tongue biting. She was conversant during the episodes, and when seen by a consultant, her exam was benign.\\nThe signs described above were complicated by subtle clues pointing towards volitional behavior, as confirmed by multiple staff members and psychiatry attendings involved in her care. Her external goals appeared to be to gain access to benzodiazepines as well as to shelter and food. Evidence for this included repeatedly verbalizing that she was withdrawing and needed clonazepam, and selectively choosing only the benzodiazepines, clonidine, and gabapentin from the cup of medications given to her every day while refusing the other medications. Discussion of her case with a relative revealed that she had been overusing her prescription clonazepam and opioids. Throughout her hospital stay, she ate every meal without prompting or interruption from her other behaviors, unusual of catatonia. Furthermore, she was not eager for discharge and appeared to prolong the hospital stay willingly. In terms of her catatonia-like behaviors, the patient would lapse into psychomotor retardation, mutism, and repetitive movements such as grimacing and eye twitching during uncomfortable or uninteresting topics of conversation. She would then lapse out of these actions abruptly and speak lucidly about urgent issues she wanted to vocalize. This was similar to her psychotic symptoms, such as abruptly lapsing in and out of mumbling, mouthing words, and seemingly responding to internal stimuli. The use of risperidone did not seem to alleviate these psychotic behaviors. As for inconsistencies in her seizure-like activity, the patient would often have dramatic seizure events and then suddenly stand up after her seizure episodes and walk independently back to her room to position herself for an expected lorazepam injection. There was one incidence where staff members saw her purposefully pour water onto her pants to feign urinary incontinence during a seizure episode. In some of her more minor automatisms, she would shake and jerk one arm while the other arm would steadily hold onto food and drink without spillage.\\nThe patient's case was discussed at length with all the attending psychiatrists, case managers, and hospital staff who were involved in her care. A catatonia specialist in the region was also consulted, who confirmed that she was likely to not have catatonia. Repeated administration of lorazepam as challenge tests seemed to have a limited effect on her catatonic and other behaviors and would instead seem to reinforce them. After a protracted hospital stay of two months, the patient was discharged to a shelter with proper social supports and psychiatric follow-up. Two and three months after discharge, the patient represented to two different hospitals at different cities for unusual medical concerns and requests for medications, leaving against medical advice each time, once walking out with a peripheral IV still in hand.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 45,\n",
       "    'case_id': 'PMC9676932_01',\n",
       "    'case_text': \"A 45-year-old non-smoking female patient received a diagnosis of stage IV lung adenocarcinoma on March 2021 with pleural, bilateral lung lesions and the involvement of mediastinal lymph nodes, the sternum and the right pubic symphysis ( Figure 1A ). The magnetic resonance (MR) of the column showed the presence of metastases in the vertebral body of T9, from T6-T7 up to T9-T10, and dural enhancement anteriorly to the spinal cord of T8. The brain MR showed at least 12 lesions at sub and supratentorial sites ( Figure 1B ). To obtain a diagnosis, the patient underwent video-assisted thoracoscopic surgery with the identification of multiple alterations in the parietal, diaphragmatic, mediastinal, and visceral pleura. Histologic diagnosis described multiple localizations of acinar and solid adenocarcinoma (grade 2) of the lung ( Figure 2A ). Targeted next-generation sequencing (NGS) analysis across 161 of the most relevant genes implicated in cancer was performed using the Oncomine  Comprehensive Assay v3 panel (Thermo Fisher Scientific) as previously described. The EML4::NTRK3 gene fusion was identified (EML4 exon2-NTRK3 exon14), and confirmed by both fluorescence in situ hybridization (FISH) analysis, using ZytoLight SPEC NTRK3 Dual Color Break Apart and ZytoLight SPEC EML4 Dual Color Break Apart ( Figures 2B, C , and immunohistochemistry staining with panTRK antibody (Roche) ( Figure 2D ). The same OCAv3 NGS analysis performed on matched normal tissue of the patient did not detect germline alterations.\\nBased on such findings, entrectinib was started.\\nWhole brain radiotherapy was avoided because the patient had no neurological symptoms, there was no evidence of edema in the brain MR, the number of brain lesions did not support the use of stereotactic radiosurgery and data from literature suggested the efficacy of entrectinib to cross the blood-brain barrier.\\nThe PET scan ( Figure 3 ) and the brain MR performed two months following the beginning of treatment showed a partial response. Treatment is currently ongoing. The brain MR and the PET scan performed recently documented a complete radiologic regression. In  Figure 4 , a summary of the patient's clinical history.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 75,\n",
       "    'case_id': 'PMC6356047_01',\n",
       "    'case_text': 'A 75-year-old female patient was admitted with sudden-onset dizziness on April 8, 2017. She had a medical history of hypertension, diabetes mellitus, pulmonary tuberculosis and chronic obstructive pulmonary disease with an FEV1 of 62% of normal predicted (1.39 L). This patient did not report any allergies from the past. Brain magnetic resonance imaging indicated an infarction in the posterior inferior cerebellar artery territory. Atrial fibrillation was also found. Edoxaban and bisoprolol were administered together with amlodipine, gliclazide, metformin, and atorvastatin.\\nThe patient became drowsy and dyspneic on May 4, 2017. Her body temperature was 37.6  C with a white blood cell (WBC) count of 7530/mm3 and D-dimer level of 0.89 mug/ml. Enterobacter cloacae was grown on blood and urine cultures. She received ertapenem for 15 days. However, she continued to experience dyspnea until May 18 and the D-dimer level increased to 5.52 mug/ml. Multiple PTEs were found at the segmental pulmonary arteries of the right lower lobe and left lung with focal deep vein thromboses at the infrarenal inferior vena cava, left popliteal vein and calf vein on three-dimensional angiography computed tomography scans. The activated partial thromboplastin time was 38.4 s (29.0-44.0 s); the prothrombin time, 14.5 s (international normalized ratio, 1.17) and WBC count, 7440/mm3. We stopped edoxaban and started intravenous heparin injection.\\nRivaroxaban 15 mg twice a day was started from May 30. Non-blanching erythematous palpable petechiae and purpura (Fig. 1) were found on both thighs, both arms, and the lower abdomen on June 16. Complete blood count (CBC), erythrocyte sedimentation rate (ESR), and the biochemical profile with liver and renal function, coagulation studies, and urine analysis were within normal limits. Chest X-ray (CXR) showed no active parenchymal lesion. Further studies, including antinuclear antibody (ANA), rheumatoid factor (RF), antineutrophil cytoplasmic antibodies (ANCA) (cytoplasmic and perinuclear), complement levels (C3, C4), serum cryoglobulins, hepatitis B surface antigen, hepatitis C antibody, and human immunodeficiency virus test, yielded normal results. We performed punch biopsies on the abdomen on June 20. The biopsy specimen showed superficial perivascular neutrophilic infiltration with leukocytoclastic debris, and interstitial infiltration of a few eosinophils and melanophages, consistent with LCV. Direct immunofluorescence (DIF) staining demonstrated granular deposition of immunoglobulin A and C3 in dermal blood vessels (Fig. 2).\\nWe stopped rivaroxaban on July 12 and started dabigatran 110 mg twice a day instead. The skin lesions improved within 2-3 days. We administered rivaroxaban 20 mg daily again from July 19 to confirm that the skin lesions were caused by it. Similar skin lesions developed again on July 29, and rivaroxaban was stopped on July 31. We started dabigatran 110 mg daily again from August 1. The skin lesions improved within 2-3 days again but they began to reappear on August 13. Dermatological assessment performed at that time indicated that this was the same disease. Since the patient was not receiving any concomitant medication that could be suspected as the cause of LCV, we stopped dabigatran on August 15, and started edoxaban 15 mg daily from August 16. The skin lesions improved over several days. We did not administer rivaroxaban and dabigatran anymore, and the skin lesions also did not develop again subsequently. However, the patient developed hospital-acquired pneumonia and died of it on September 11, 2017.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 67,\n",
       "    'case_id': 'PMC5680665_01',\n",
       "    'case_text': 'A 67-year-old male presented with nonmechanical axial back pain, neurogenic claudication, and an otherwise normal neurological exam. Established T1 (hypointense), T2 (hyperintense), and T1 enhanced magnetic resonance (MR) studies documented a large tumor centered at the L3 level with marked epidural compression and bilateral retroperitoneal extension [Figure 1].\\nFollowing confirmation of a chordoma by needle biopsy, our patient underwent a three-stage operation for complete resection.\\nFollowing a midline exposure from T12 to L5, the pedicles of L1, L2, L4, and L5 were instrumented bilaterally. Transforaminal interbody grafts were placed at L1/2 and L4/5. A massive en-bloc resection of the tumor required bilateral troughs in the L3 pars extending to the superior lamina, and included L2/3 bilateral facetectomies and transverse process resections. Pedicle screws were then connected with two rods and a crosslink [Figure 2].\\nThe vascular surgery team performed a retroperitoneal approach to the anterolateral lumbar spine on both the right and left sides respectively. The ribs of T11 and T12 were taken, the psoas muscle was mobilized, and the anterolateral disc spaces of L2/3 and L3/4 were exposed allowing retroperitoneal tumor resection utilizing annulotomies and diskectomies [Figure 3]. The defect was reconstructed with an expandable cage and lateral plate, whereas the harvested rib was used to create a strut graft next to the cage for early bone fusion [Figure 4].\\nPostoperatively, the patient only had mild paresthesias and numbness of the right anterior thigh accompanied by a partial 4/5 dorsiflexion deficit; symptoms/signs resolved prior to transfer to a rehabilitation center. The histological examination of the en-bloc specimen confirmed tumor excision along with 1 of 3 lymph nodes that was positive for chordoma. Subsequent plans were made for future proton beam therapy.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 69,\n",
       "    'case_id': 'PMC3420376_01',\n",
       "    'case_text': \"A 69-year-old woman presented to the Rheumatology Clinic in January 2010 for evaluation of generalized morphea/localized scleroderma diagnosed 7 months after receiving local radiation to right breast for treatment of breast cancer. In September 2008, breast cancer was diagnosed by needle biopsy when an abnormal cluster of calcifications was identified by a screening mammography in September 2008. After consultation with her surgeon, oncologist, and radiation therapist, she underwent lumpectomy and sentinel lymph node biopsy. The cancer was estrogen receptor negative, and the sampled lymph nodes were negative. The tumor was estrogen and progesterone receptor positive. She opted not to take tamoxifen or other antiestrogen therapy. To prevent cancer recurrence, external beam radiation to right breast was completed (October 2008). She experienced local radiation side effects of erythema and superficial blister formation that resolved with local wound care.\\nApproximately 7 months after completing radiation therapy, she developed two painful blisters in the inframammary fold of the right breast. On examination she was found to have generalized induration of the right breast and right axilla attributed to postradiation fibrosis. The breast and axilla were warm to touch and painful to palpation. That was with sparing of the areola. Additional lesions distant from the radiation field were also noted. These included hyperpigmentation of the skin at the waistline, induration of the skin in the left upper inner thigh and left groin, and a shiny patch of thickened skin on the anterior left shin. The lesions not involving the breast and axilla were not painful.\\nIn May 2009, a punch biopsy of the left groin lesion diagnosed localized scleroderma (morphea). On microscopy, the skin surface was thin with a slightly keratotic epidermis. The papillary dermis was edematous and homogenous. The reticular dermis had dense collagen in bundles with intervening mild lymphoid and plasma cellular inflammation present around the adnexal structures. Mild chronic inflammation in the subcutaneous fat was noted at the base of the biopsy. For treatment of the right breast and axillary lesions, topical calcipotriol and topical betamethasone dipropionate were prescribed without benefit. Painful ulcers developed in the area of application in the right axilla which healed slowly when the topical medications were discontinued. The area under the right breast remained painful with chronic superficial ulceration. Application of topical silver impregnated dressings was of no benefit.\\nIn addition to the skin lesions, she described fatigue and generalized arthralgias. She denied more specific symptoms of systemic connective tissue disease, that is, no history of Raynaud's, esophageal reflux, shortness of breath, cough, joint swelling, morning stiffness, sicca symptoms, pleuritis, or serositis. Prior to diagnosis of breast cancer, she had no significant past medical or psychiatric history and was on no prescribed medications. Family history was negative for connective tissue disease. Physical examination confirmed circumferential induration of the right breast with sparing of the areola. Induration extended into the right axilla. Superficial erosion of the epidermis was noted in the inframammary fold of the right breast. A band of hyperpigmented, thickened skin was noted along the anterior waistline. A hypopigmented indurated patch was noted in the left groin with a healed punch biopsy site. Thinning of the skin with hypopigmentation and superficial telangiectasias was noted in the upper left medial thigh. A 3 cm patch with central hypopigmentation was present on the left anterior mid tibia. She had no sclerodactyly. Nail fold examination for capillary changes was normal. Examination of the heart, lungs, and abdomen was normal. Laboratory testing was normal, including complete blood count, chemistry panel, thyroid function tests, and urine analysis. Sedimentation rate and C-reactive protein were normal. Lyme titer was negative. Thyroid autoantibody testing was negative. ANA was interpreted as borderline positive, with titer of 1 : 160 in a speckled pattern. Further testing for ANA subtypes was negative for anti-topoisomerase, anti-RNP, anti-Smith, anti-ds DNA, anti-SSA, and anti-SSB.\\nShe was prescribed minocycline 100 mg twice a day, and, after three days of therapy, she reported dramatic improvement in generalized pain and fatigue. The superficial erosions in the inframammary fold healed. However, despite the initial perceived benefit, the right breast remained warm and tender to palpation. New lesions occurred on the right lower extremity. In August 2010, methotrexate 7.5 mg weekly and titrated to 12.5 mg was prescribed. Folic acid 1 mg per day was prescribed to prevent methotrexate side effects. After the addition of methotrexate, no new lesions occurred. Signs of inflammation in the irradiated right breast resolved though skin thickening remained unchanged. The lesions on bilateral lower extremities softened. Minocycline was discontinued in March 2011 when abnormal pigmentation developed as a side effect. She remained without signs or symptoms of a systemic connective tissue disease.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 24,\n",
       "    'case_id': 'PMC4598389_01',\n",
       "    'case_text': \"A 24-year-old man was referred to the Department of Oral & Maxillofacial Pathology for evaluation of an asymptomatic bony hard expansion in relation to the buccal aspect of maxillary right canine & first premolar. Patient's medical history was non-contributory. The lesion was slow growing with one-year duration. It had increased in size slowly for nine months and remained static thereafter. Clinical examination did not show any endodontic or coronal pathologic condition of the neighboring maxillary canine, first premolar, and the maxillary incisors. \\nPanoramic (Fig. 1) and occlusal radiographs (Fig. 2) showed an oval well-defined unilocular expansile radiolucency measuring 2 x 1.7 cm. The lesion had a target-like appearance with a central area of floccular calcification and caused divergence of the roots of the right canine and maxillary first premolar with no root resorption. Based on the clinical and radiographic findings a provisional differential diagnosis was reached. Central ossifying fibroma, focal cemento-ossifying dysplasia and adenomatoid odontogenic tumor were the pathologies considered.\\nSince the lesion was small and appeared well demarcated on radiographs patient was advised to undergo an excisional biopsy. Upon patient's acceptance and medical clearance, the procedure was performed. The lesion was easily separated from the surrounding tissue and enucleated in toto. Gross examination showed an encapsulated lesion with a thick wall, to which multiple irregular gritty pieces of tissue were attached. The overall size of the excised lesion was 3.4x 3x 1.3 cm. The cut- section of the encapsulated lesion showed an intracapsular solid mass with multiple cystic spaces. The overall consistency of the contents was gritty. The entire tissue was prepared for microscopic examination. The tissue blocks were processed for routine paraffin embedding without decalcification. \\nA whole slide digital scan showed the presence of two distinct and yet closely associated contiguous lesions. A larger well-encapsulated lesion with a thick fibrous wall containing multinodular cellular proliferation with scanty connective tissue and multiple empty areas and, small fibrocellular proliferations interspersed with irregular mineralization partly attached to the extra-capsular surface (Fig. 3A & B).\\nThe cellular mass within the encapsulated lesion consisted of multiple nodules of varying sizes. The majority of the nodules consisted of cuboidal or columnar epithelial cells that formed nests, rosette-like patterns and duct- like spaces. Tumor droplets (eosinophilic amorphous material) were seen between the cells and in the rosette- like structures. The spaces between the nodules were occupied by interlacing strands of oval, angular and elongated epithelial cells. Basaloid epithelial cells formed single and double layered trabecular or cribriform configurations between and connecting cell rich nodules (Fig. 4A & B). Few areas showed collections of eosinophilic polyhedral squamous like epithelial cells with well-defined cell borders (Fig. 5A) and intercellular bridges (Fig. 5B). Calcified bodies were found through- out the lesion but were mostly associated with the polygonal cells (Fig. 5B). The mineralization was in the form of globular mineralization that was nearly translucent and, concentric rings (Liesegang pattern). Islands of amyloid- like material that were Congo-red positive and produced characteristic apple green birefringence on polarized microscopy were also found (Fig. 6A-C). The stromal connective tissue was overall scant and loose. The endothelial lining of the blood vessels showed degenerative changes (Fig. 4A).\\nThe extra capsular lesion consisted of multiple small fragments of fibrocellular mesenchymal tissue interspersed with numerous irregular and interconnecting bone and cementum- like material. An artefactual split existed between parts of the lesion and the fibrous capsule. The fibrocellular collections showed few hemorrhagic areas, thick curvilinear ginger root-like trabeculae with few lacunae and ovoid cementicles with prominent resting lines. Cellular areas showed spindle-shaped fibroblasts. (Fig. 7A & B). The maturing areas of the lesion showed a confluence of woven and lamellar bone (Fig. 8A & B).\\nThe resultant diagnosis was two- fold and reported the existence of two concomitant and contiguous lesions. First lesion was diagnosed as extra-follicular AOT with CEOT-like areas based on clinicopathological findings. The second lesion was diagnosed as an FCOD attached to the fibrous wall of the AOT in an extra capsular relation based on the radiological and histological findings that were confirmed by gross findings of the surgical specimen. \\nFollow-up was uneventful and showed normal bone healing and the canine and first premolar, were vital two years postoperative.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 36,\n",
       "    'case_id': 'PMC7591673_01',\n",
       "    'case_text': 'A 36-year-old woman with 21 weeks of pregnancy was admitted to our hospital for a left renal tumor, which was incidentally detected by ultrasonography in a routine pregnancy examination. Ultrasound showed a confounding echo mass in the middle part of the left kidney, 7.9 cm in size, uneven internal echo, and clear blood flow signal inside. Computed tomography (CT) was not performed, as she was pregnant. Abdominal magnetic resonance imaging (MRI) showed a round mass in the middle part of the left kidney with a maximum diameter of 8.3 cm (Figure 1). The signal is heterogeneous, with some fluid visible inside the mass. Since angiomyolipoma usually shows hyperechoic rather than confounding echo in ultrasound, renal cancer was considered. The patient denied lower back pain, hematuria, fever, frequency of urination, urgency, pain, and other discomforts. Past medical history was unremarkable. The patient gave birth to a healthy girl 5 years ago. Personal history and family history were not remarkable. After admission, there were no abnormalities in vital signs, blood pressure was 130/80 mmHg, blood routine and biochemical examinations were within the normal range (hemoglobin was 114 g/L, serum creatinine was 47 mumol/L, and potassium was 3.7 mmol/L). Physical examination: There was no tenderness or muscle tension in the abdomen, and the mass was not touched.',\n",
       "    'gender': 'Female'},\n",
       "   {'age': 36,\n",
       "    'case_id': 'PMC7591673_02',\n",
       "    'case_text': \"A multidisciplinary team including urologists, gynecologists, pediatrists, anesthesiologists, and radiologists was responsible for the decision making to help the patient and her baby. Considering that the patient is only 36 years old, her strong desire to remove the tumor as well as retain the kidney, and the relatively indolent nature of the RCC, retroperitoneal laparoscopic partial nephrectomy was performed by an experienced surgeon after the risk was explained and informed consent was signed.\\nDuring the procedure, the patient was placed in the lateral flank position and underwent general anesthesia with endotracheal intubation. The procedure was performed through a retroperitoneal approach, and the retroperitoneal cavity was formed by blunt dissection and balloon dilation from a small incision located 2 cm above the iliac crest of the midaxillary line. After the establishment of the retroperitoneal space, four trocars were inserted on the left waist between the superior edge of the iliac spine and the inferior border of the rib. The tumor was removed completely, and renal reconstruction was then achieved with a 1/0 self-retaining barbed suture (V-Loc). Although maternal hemodynamic parameters were maintained stable and end-tidal CO2 was monitored below 35 mmHg, pneumoperitoneum pressure was strictly controlled below 12 mmHg to reduce maternal hypercapnia and fetal acidosis throughout the surgery. The operation time was 100 min with a warm ischemia time of 28 min and an estimated blood loss of 150 ml. The patient recovered uneventfully after the operation and was discharged within a week after the surgery. Blood hemoglobin was decreased postoperatively [95 g/L on postoperative day (POD) 1, 99 g/L on POD3] and back to normal on POD7 (121 g/L), while serum creatinine levels were normal throughout the perioperative period (66 mumol/L on POD1, 61 mumol/L on POD3, and 60 mumol/L on POD7). Obstetrics and gynecology consultation monitored the fetus before and throughout the operation.\\nThe pathology report revealed an 8.2-cm clear RCC, Fuhrman grade 2, with negative surgical margins (Figure 2). According to the TNM classification system, it is classified as pT2aN0M0. During the 38th gestational week, a healthy male infant was born. We followed our patient every half year after surgery. Blood hemoglobin, serum creatinine, and thorax-abdominal-pelvic CT scan showed normochromic, normal renal function, and no sign of local recurrence or metastases. After 46 months of follow-up, the patient's baby is in good health and does not have any developmental birth defects. The whole treatment process is shown in Table 1.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 12,\n",
       "    'case_id': 'PMC4227511_01',\n",
       "    'case_text': 'This diminutive structure has been investigated for its potential role in seizure generalization (Fernandez-Miranda et al.,). It is thought that epileptoform propagation from limbic sites may be linked to the motor cortex via the claustrum (Mohapel et al.,). A case study was conducted on a 12-year-old girl who presented with status epilepticus (multiple, repeated complex partial and myoclonic seizures occurred in the upper extremities and face with orofacial automatisms, eye deviation, and nystagmus) displaying psychotic behavior with agitation, severe cognitive impairment and temporary loss of vision, hearing and speech, as well as loss of orientation in time and place. Bilateral, strip-like lesions were discovered in T1 and T2 images of her claustrum and external capsule. The case indicates that lesions of the claustrum function more like gray matter disease than white matter disease. Additionally, the case study implies a functional correlation between seizures, behavioral state, and abnormalities in the claustrum (Sperner et al.,).\\nIn contrast, unilateral removal of the claustrum did not lead to sensorimotor or cognitive impairment in patients receiving surgery for low-grade cerebral glioma (Duffau et al.,). So, perhaps the claustrum operates as part of a network or networks, rather than as the epicenter of a network.\\nThe most common clinical association is the effect of the claustrum on memory. Claustral amyloid plaques accumulation has been implicated in the outcomes of Alzheimer\\'s disease and aging (Morys et al.,; Fernandez-Miranda et al.,). These amyloid deposits seem to cluster in the ventral claustrum, and may disrupt limbic connections (Morys et al.,). These changes in the claustrum associated with aging, however, are subtle, appearing several years after those in the cerebral cortex become apparent. The claustrum has also been examined in cases of memory impairment associated with HIV, AIDS, Parkinson\\'s, and Dementia with Lewy Bodies (DLB) (Kozlowski et al.,; Yamamoto et al.,; Smith et al.,; Kalaitzakis et al.,).\\nOther neurological conditions have been examined in the claustrum as well. Negative correlations between anhedonia and metabolism in the claustrum have been shown in both patients with unipolar depression and bipolar disorder (BD), which may be part of overall enlargement of the basal ganglia and increase in claustral GM volume in BD (Chen et al.,). Such factors may be the result of differences in pruning between diseased and healthy populations. Severity of delusions in schizophrenia is correlated with the reduction in left claustral volume (Cascella et al.,) and schizophrenia patients with hallucinations show signs of white matter excesses (Shapleske et al.,). The claustrum is alternately reported as spared from insular gliomas, or commonly found to be invaded by such tumors (Fernandez-Miranda et al.,).\\nIn Wilson\\'s disease, abnormal brightness of T2-weighted images in the claustrum is considered one of the markers of the disease though its effects may be misattributed in the literature to its close neighbor, the putamen (Sener,; King et al.,). In fact, Wilson himself cited the possible role of the claustrum in his initial description of the disease in 1912 (though he referred to it as \"Progressive Lenticular Degeneration\") (Wilson,; Sener,). The disease, which is invariably fatal without intervention, is caused by high copper levels:and sometimes iron levels:in the brain, particularly in the basal ganglia. Symptoms include bilateral tremors of the extremities, spasticity of the limbs and face, emaciation, dysphagia, dysarthria, emotionalism, and difficulty maintaining equilibrium (Wilson,).\\nBased on the summation of the micro-connectomics information gathered from centuries of histology, structural imaging, functional imaging, and clinical pathology studies, interactions have been proposed between the claustrum and every major sensory network. The extent to which these networks rely on the function of the claustrum, or to which the claustrum relies on information from these networks, remains to be investigated.\\nClaustral neurons are overwhelmingly binocular; 84% respond to stimuli from either eye, while only 40% of overall cortical neurons do (Sherk and LeVay,). Responses in the claustrum to photic stimuli can be abolished by lesioning the lateral geniculate nucleus (LGN) (Edelstein and Denaro,). V1 connections may not be reciprocal, as connections from V1 to the claustrum in macaques have not been reported (Crick and Koch,).\\nCortico-claustral connections from layer VI reach layer IV through the claustrum, creating an alternative route to the direct projection from layer VI to layer IV (LeVay and Sherk,). In the contralateral half of the visual field, the upper fields map to the caudal region of the claustrum, while the lower ones map rostrally. The far periphery can be mapped to the claustral surface, while the vertical meridian lies at the lower limit of the visual region. A single representation of the visual hemi-field exists as a unified map without discontinuities or duplications in the claustrum (LeVay and Sherk,).\\nThe medial ectosylvian gyrus (AII) relays information from the medial geniculate nucleus to the claustrum. In fact, ablation of the entire AII results in a lack of claustral response to MGN stimulation (Edelstein and Denaro,).\\nFunctional localization has not been demonstrated in the claustrum, so it is unlikely that the claustrum can influence specific muscular groups (Salerno et al.,).\\nThe claustral loop to the striate cortex is involved in motion detection, but cannot discriminate the direction of motion (Edelstein and Denaro,). Most (approximately 70%) of movement-related neurons increased discharge regardless of whether the motion was a push, a pull, or a turn, while only 16% were selective to one movement. This differs from the specificity of the motor cortex itself, in which about half of the neurons are responsive to a single motion (Shima et al.,). This may be indicative of a high degree of convergence of inputs. This lack of selectivity, along with the presence of inhibitory efferents, may suggest that the claustrum generally suppresses cortical activity immediately before the initiation of movement.\\nProjections to M1, pre-SMA, SMA-proper, and various subdivisions of PM and area 46 emanate from the entire rostro-caudal extent of the claustrum, with no distinct topographic or somatotopic organization. Along the dorso-ventral axis, however, these projections tend to originate in the dorsal or intermediate claustrum (Tanne-Gariepy et al.,). There is overlap of region of origin in most motor areas, but Pre-SMA and SMA-proper both uniquely show local segregation through inter-digitations. Area 46 also receives projections from the most ventral portion of the caudal claustrum, which sends minor projections to M1, the subareas of PM, pre-SMA, and SMA-proper (Tanne-Gariepy et al.,). M1 projections to the claustrum are then projected to S1, indicating a role in sensorimotor coordination (Smith et al.,).\\nIn terms of oculomotor control, the mid-ventral claustrum receives projections from the frontal eye fields, and is organized topographically according to the size of saccades (Tanne-Gariepy et al.,).\\nWhile there is general agreement on its heterotopic organization, there is no apparent somatotopic organization of the claustrum (Spector et al.,). Some somatic afferents to the claustrum are conveyed via the posterior spinal funiculi fibers. In addition, the anterior ectosylvian gyrus (SII) relays information from the ventral posterolateral nucleus (VPL) to the claustrum. Lesions in the VPL lead to reduced responsivity of the claustrum to skin stimulation. Marked claustral activity was noted in response to stimuli in somatic-vagal-tooth pulp. This may be indicative of trigeminal projections similar to those noted in other structures of the basal ganglia (Edelstein and Denaro,).',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 79,\n",
       "    'case_id': 'PMC8273265_01',\n",
       "    'case_text': 'A 79-year-old female presented with stage 2B T3N1M0 pancreatic cancer. The tumor arose in the pancreatic head but was felt to be unresectable due to neurovascular involvement. During an FDG-PET/CT scan for staging, the patient experienced a significant radiopharmaceutical extravasation and was reimaged the following day. The patient subsequently received chemoradiation since she was not considered a surgical candidate for tumor resection. Procedure parameters and images are compared in Table 3 and Figure 1.',\n",
       "    'gender': 'Female'},\n",
       "   {'age': 69,\n",
       "    'case_id': 'PMC8273265_02',\n",
       "    'case_text': 'A 69-year-old female with a history of a T2N2aM0 breast cancer who subsequently developed metastatic skeletal disease. The patient received their first re-staging 18F-FDG PET/CT and was noted to have oligometastatic skeletal metastases. The patient received radiotherapy and then a second re-staging FDG PET/CT 15 weeks later. This second re-staging study was compromised by a significant radiopharmaceutical extravasation and was repeated 3 days later. Procedure parameters and images are compared in Table 4 and Figure 2. The extravasated image SUVmax values were understated by 53-73%.',\n",
       "    'gender': 'Female'},\n",
       "   {'age': 81,\n",
       "    'case_id': 'PMC8273265_03',\n",
       "    'case_text': 'An 81-year-old male presented with a history of clinical stage T1cN0M0 prostate cancer. Post-prostatectomy, the patient had persistently elevated prostate-specific antigen levels and a 99mTc-MDP bone scan was ordered to look for metastatic disease. The bone scan image was deemed non-diagnostic by the radiologist due to significant extravasation and was not interpreted. The study was repeated 2 days later. Benign degenerative disease was noted, but no metastatic bone lesions were found. Procedure parameters and images are compared in Table 5 and Figure 3.',\n",
       "    'gender': 'Male'},\n",
       "   {'age': 80,\n",
       "    'case_id': 'PMC8273265_04',\n",
       "    'case_text': 'An 80-year-old male presented with a history of bladder carcinoma that had metastasized to the liver. Initial follow-up imaging was determined to be non-diagnostic due to a significant extravasation observed on imaging and TAC data. Repeat 18F-FDG PET/CT imaging of the patient was performed the following day. Repeat imaging confirmed disease progression and identified additional uptake not seen in the prior extravasated scan:including an upper liver lesion, increased hilar node activity, and prostate uptake. Quantitative results showed an average increase in SUVmax calculations of ~25%. Procedure parameters and images are compared in Table 6 and Figure 4.',\n",
       "    'gender': 'Male'},\n",
       "   {'age': 61,\n",
       "    'case_id': 'PMC8273265_05',\n",
       "    'case_text': 'A 61-year-old female presented with a history of breast cancer and malignant right pleural effusion. Follow-up imaging identified possible bone involvement and additional 18F-FDG PET/CT imaging was ordered. The restaging PET/CT images were deemed non-diagnostic due to a significant extravasation. Repeat PET/CT imaging was ordered, and the patient was imaged 5 days later. Repeat imaging showed evidence of a minor extravasation which was supported by TAC data but indicated diffuse metastatic disease with bone involvement:confirming further disease progression. Additionally, the repeated imaging clearly identified a left adrenal lesion that had appeared equivocal on the previous extravasated image and increased SUV values. Procedure parameters and images are compared in Table 7 and Figure 5.\\nDosimetry results for the five extravasations are shown in Table 8. Skin and tissue effects were not observed post-imaging procedure, as expected due to the latent effects of ionizing radiation on skin and tissue.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 35,\n",
       "    'case_id': 'PMC6215577_01',\n",
       "    'case_text': \"A 35-year-old man was admitted at the oculistic emergency room for a right exophthalmos accompanied with severe pain, periorbital swelling, redness, and mucopurulent discharge. The patient, HIV and HCV positive for 11 years, had a history of drug and alcohol addiction, including habitual marijuana smoking. Clinical examination revealed severe nonreducible exophthalmos with bulb dislocated medially and inferiorly, associated with eyelid chemosis and decreased vision in the right eye (1/10). The motility of the globe in all gazes was restricted by mechanical proptosis. Fundus examination revealed optic disc swelling associated with venous congestion. A brain MRI was performed in order to evaluate the involvement of the orbit and the brain. The examination showed an intraorbital mass that was inhomogeneously hypointense on T2-weighted images and hypointense on T1-weighted images and showed intense and inhomogeneous contrast enhancement. The mass was located in the lateral orbit cavity extending to the ethmoid and maxillary sinuses, with bony destruction, encasing and displacing the medial rectus and superior oblique muscles, optic nerve, ocular globe, and vascular structures (Figure 1).\\nOn the basis of these findings and considering patient's history of HIV related diseases and drug addiction, few diagnosis have been hypothesized that included neoplastic diseases, e.g., lymphoma, and infections, in particular mycotic origin, such as aspergillosis, considering the known association with marijuana smoking. Prior to beginning any treatment, the patient was subjected to a biopsy of the orbital mass. At histology H&E stain of the tumor showed a monomorphic proliferation of plasmablastic cells that was suggestive of plasmablastic lymphoma. The patient died within a week following diagnosis for a heart attack, even before further treatment could be initiated.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 58,\n",
       "    'case_id': 'PMC10359673_01',\n",
       "    'case_text': 'A 58-year-old male had a pancreas tail tumor incidentally discovered during a medical checkup and came to our hospital for a detailed examination and treatment. Diagnostic confirmation of PNET grade 2 (G2) was achieved based on endoscopic ultrasound-fine needle aspiration pathological findings. LDH, NSE, and ProGRP in laboratory results were within normal limits. Preoperative contrast-enhanced CT showed a persistently enhanced mass in the pancreas tail that measured 20 x 25 mm (Fig. 1a,b), significantly enlarged #11p (18 x 22 mm) (Fig. 1a) and #18 (10 x 12 mm) lymph nodes (Fig. 2a), and an equivocal #11d node (8 x 10 mm) (Fig. 1a). Whole-body SRS with SPECT/CT scanning demonstrated abnormal uptake in the primary tail tumor (Fig. 1c), as well as the #11p (Fig. 1c) and #18 (Fig. 2b) nodes, while the #11d node showed no uptake in SRS findings (Fig. 1c). Whole-body FDG-PET/CT scanning showed mild FDG uptake with a maximum standardized uptake value of 2.89 in the primary tail tumor (Fig. 1d) and mild FDG uptake with a maximum standardized uptake value of 3.42 in the #11p node (Fig. 1d), with the #11d (Fig. 1d) and #18 (Fig. 2c) nodes showing no FDG uptake. No distant metastatic lesion was indicated by SRS with SPECT/CT or FDG-PET/CT findings, and the clinical stage was determined to be T2N1M0.\\nPhysicians at the Department of Hepato-Biliary-Pancreatic Surgery performed a laparoscopic resection of the pancreatic body and tail (Fig. 3a), plus dissection of abdominal lymph nodes, which included #8 (common hepatic artery nodes), #10 (splenic hilum nodes), #11 (splenic artery nodes), and #18 (inferior pancreatic nodes). A pathologic examination of the tail tumor, sized 20 x 23 mm, revealed a PNET with tumor cells small to intermediate in size, which had formed sheets and nests (G2) (Fig. 3b). Immunohistochemical findings with chromogranin A, synaptophysin, and somatostatin were positive, and the Ki-67 index was 5% (Fig. 3c-e). Pathological analyses of the lymph nodes showed that none of three in #8, none of four in #10, one (13 x 19 mm) of four in #11p, one (7 x 9 mm) of two in #11d, and one (8 x 12 mm) of three in #18 were metastatic. SSTR results of the primary tumor (Fig. 3f) showed positive staining, indicating three metastatic nodes: all of #11p, part (6 x 6 mm) of #11d, and all of #18 (Fig. 4a-c).',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 12,\n",
       "    'case_id': 'PMC7224471_01',\n",
       "    'case_text': 'VI: 3 is a 12-year-old Chinese female. At nine years of age, she presented with impairment of muscle relaxation after voluntary contraction in her lower limbs. Her upper limbs were also affected by age. The myotonia could be alleviated by continued activity (warm-up phenomenon). Her clinical manifestations also include transient weakness upon initiating movements but were not associated with handgrip or lid myotonia. The myotonia symptoms did not severely impact the quality of her life. In addition, VI: 3 showed recurrent flaccid paralysis mainly involving bilateral lower limbs in 11-year-old children. The attacks always lasted for a few hours or for a day, which usually occurred after cold exposure and vigorous exercise. Periodic paralysis was not associated with dyspnea or dysarthria. Her father (V: 7) was definitively diagnosed with hypokalemic periodic paralysis in his twenties. Her mother (V: 6) suffered from myotonia and muscle hypertrophy from childhood. Physical examination revealed normal muscle force without muscle hypertrophy or myodystrophy. The percussion myotonia was negative. The laboratory tests showed no abnormalities in creatine kinase levels. Her previous examinations in another hospital suggested that the serum levels of potassium were below the normal range during paralysis attacks. Electromyography (EMG) examination revealed myotonic potential in her four limbs. Her recurrent flaccid paralysis could be relieved by oral potassium supplementation treatment. Comprehensive analysis of the clinical symptoms, family history, positive physical laboratory findings and therapeutic effects suggested a clinical diagnosis of hypokalemic periodic paralysis in combination with MC. She did not require carbamazepine treatment to alleviate her myotonia symptoms.\\nIn the family, IV: 2, V: 2 (the proband) and V: 6 showed varying degrees of muscle stiffness and hypertrophy. Their EMG examination revealed myotonic potential. They were clinically diagnosed with MC in our hospital. IV: 1, who died a natural death, and V: 3, who died in a car accident, also had muscle stiffness and hypertrophy. We speculated that they were also affected by MC. In addition, V: 2 and V: 6 responded to carbamazepine (200 mg per day) treatment. IV: 2 did not need treatment.',\n",
       "    'gender': 'Female'},\n",
       "   {'age': 52,\n",
       "    'case_id': 'PMC7224471_02',\n",
       "    'case_text': 'Unlike other MC patients in the pedigree, the proband (V: 2), a 52-year-old Chinese male, was born from consanguineous parents (IV: 1 and IV: 2). He came to our hospital in April 2016 for the first time. EMG only identified myotonic potential. In 2019, the proband underwent EMG examination again, which showed not only myotonic potential but also slight muscle damage. Clinical findings are presented in Table 1.\\nThe WES yielded data covering 99.73% of the target region. Three mutations were identified during the first three steps of the filtering strategies (Table 2). Then, the pathogenicity of the mutations was predicted by MutationTaster, PolyPhen-2 and SIFT. Considering the bioinformatics analysis results and ACMG guidance for the interpretation of sequence variants, we chose the F306S CLCN1 mutation and the R222W SCN4A mutation as the potential pathogenic variants.\\nSanger sequencing validated the two candidate variants in the pedigree (Fig 1B). VI: 3 carried both the heterozygous c.917T>C, p.F306S, g.14710T>C CLCN1 mutation and the heterozygous c.664C>T, p.R222W, g.1718C>T SCN4A mutation. Nothing abnormal was detected in the length of DMPK gene CTG and ZNF9 gene CCTG repeats in V: 2.\\nRepresentative current traces from HEK293T cells expressing WT, CLC-1_F306L and CLC-1_F306S are shown in Fig 2A-2C. The current values (pA) determined by the cell capacitance (pF) were used to calculate the instantaneous and steady-state current densities (pA/pF) and thereby establish I-V associations. The I-V curves of instantaneous currents for CLC-1 channels are presented in Fig 2D. At negative test voltages (ranging from -180 to 0 mV), the WT channel displayed large outward currents, while the two mutant channels (CLC-1_F306L and CLC-1_F306S) only produced a small inward rectification. In contrast, at positive test voltages (0-200 mV), the two mutant channels conducted outward currents, while the WT channel conducted inward currents. The average instantaneous current densities of mutant CLC-1_F306L and mutant CLC-1_F306S at -180 mV were 13.0+-1.5 pA/pF (n = 12) and 18.6+-1.6 pA/pF (n = 11), respectively. These current densities were significantly different from that of the WT channel (-288.4+-36.8 pA/pF, n = 9, P<0.001). At the resting potential of normal skeletal muscle fibers (~-85 mV), chloride ions were conducted outward (Cl- efflux) through the WT CLC-1 channel, whereas the mutant channels facilitated a small Cl- influx. Therefore, the p.F306S and p.F306L mutations in the CLCN1 gene disrupted the chloride ion balance across the cell membrane.\\nThe I-V curves of steady-state currents revealed that the reversal potentials of the mutant channels CLC-1_F306L and CLC-1_F306S were +50 and +160 mV, respectively and were markedly shifted in the depolarizing direction compared with the 0-mV reversal potential of the WT channel (Fig 2E).\\nThe voltage-dependent activation curves of the WT and mutant channels, calculated from tail currents at -105 mV, are presented in Fig 2F. The V1/2 of the mutant channels were markedly more depolarized relative to the WT channel (F306L: 91.1+-2.1 mV, n = 12; F306S: 127.0+-5.9 mV, n = 11; WT: -49.2+-1.8 mV, n = 9, P<0.001), with a significant alteration in the slope factors (WT: 17.4+-1.6 mV, n = 9; CLC-1_F306L: 33.6+-1.7 mV, n = 12; CLC-1_ F306S: 49.2+-3.3 mV, n = 11, P<0.001). These results suggested that, compared with the WT CLC-1 channel, the voltage-dependent activation of two mutations at position 306 in the CLC-1 channel markedly shifted toward a positive potential.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 25,\n",
       "    'case_id': 'PMC4602942_01',\n",
       "    'case_text': 'A 25-year-old man was admitted to our hospital with a headache. However, the patient had no vomiting and convulsion of the limbs. General physical examination and neurological examination showed no abnormalities. Magnetic resonance imaging (MRI) revealed a round cystic lesion with solid part in the right cerebellum (Figure 1). The cyst appeared hypointense on T1WI and hyperintense on T2WI (Figure 1A and B). The solid part was enhanced after gadolinium administration (Figure 1C and D). After 4 days, the tumor was resected. A soft, reddish, rich blood supplied mass with integral capsule was found. Histological examination of the tumor specimen exposed a highly vascular tumor containing abundant capillary vessels and stromal cells intermingled with a large number of red blood cells that certified the occurrence of the intratumoral hemorrhage (Figure 2).\\nThe postoperative course was uneventful. A computed tomography (CT) scan without contrast infusion was taken 1 day after the operation and presented a low-density shadow on the operative region (due to tumor resection) and no abnormal density lesions on other regions (Figure 3A). The MRI with contrast infusion revealed no enhanced lesions in the cerebellum (Figure 3B). Seven days later, the final pathological diagnosis was hemangioblastoma. The patient was discharged without discomfort.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 50,\n",
       "    'case_id': 'PMC9632847_01',\n",
       "    'case_text': \"T2 received the same textual information (i.e., identical to T1), along with the additional illustration. The illustration visualized the relationship of how the older generations and one's own generation were benefiting the current generation and future generations via disposable plastics. Owing to the wide range of participant age groups, the illustrations of the participants' own generation and previous generations were changed according to age group (under 50 years or 50 years and older). Because those over 50 years old were less likely to have living parents, we presented older people in the traditional clothing that their parents and grandparents wore. This illustrative framework was based on our previous survey of nudges for increasing positive attitudes toward air pollution caused by industrialization (S2 Appendix in S1 File).\\nThe respondents were again asked the same question as for Qpre before the intervention (Qpost). Both of the questions ascertained the perceived risks of disposable plastics on Future Generations and Yourself before and after receiving the designed messages.\\nThe statistical analyses comprised three parts. The first part was analysis based on descriptive statistics for the initial status of respondents, such as the attitudes toward plastic recycling and COVID-19. The second part was a difference-in-difference (DID) estimation to identify the intervention effects by comparing a control group with treatment groups on how the attitude change differed across the groups. Then, correlation analyses were performed to investigate how perceived support by older generations via recycling disposable plastics and perceived support of future generations that benefit from the recycling were correlated with the message effects. Estimation of the message effects based on descriptive statistics was also conducted by segment, such as sex and age. The third part was a panel analysis based on forced-entry linear regression models to extract the intervention effects more precisely by separating the influence of the respondents' basic attributes and personality traits.\\nTo identify our designed message effects in all the analyses, we set two separate explained variables, which were perceived risks of disposable plastics to future generations (Future Generations) and those to the respondents themselves (Yourself). Although we evaluated both of the explained variables in parallel, our main target variable was Future Generations to determine the effectiveness of the nudging message.\\nStatistical significance of the differences across our segments was calculated using the Wilcoxon signed-rank test. All error bars in graphs were computed as 95% confidence intervals based on t-distributions. All of these analyses were performed using Matlab R2021b with the Statistical and Machine Learning Toolbox.\",\n",
       "    'gender': 'Unknown'}],\n",
       "  [{'age': 50,\n",
       "    'case_id': 'PMC10328123_01',\n",
       "    'case_text': 'A 50-year-old man of unremarkable past health presented with palpitation and dyspnea for 2 days. His blood pressure was 85/60 mmHg, pulse 160 beats/min, and afebrile. He reported no prior febrile episodes. No murmur was detected. Electrocardiogram showed typical atrial flutter. He received amiodarone with no improvement. Transthoracic echocardiogram was limited by poor acoustic window, but showed elevated inflow gradient across the tricuspid valve with the mean pressure of 27 mmHg [Figure 1]. Before direct current cardioversion, transesophageal echocardiogram (TEE) was performed demonstrating a large 3 cm right SVpA causing tricuspid inflow obstruction [Figure 2]. No sign of aneurysm rupture was evident on color Doppler. The aortic valve was trileaflet; the right and left coronary leaflets were mildly thickened with vegetation [Figure 3 and Video 1]. Sinus rhythm and normotension were restored following cardioversion. Serial blood cultures were negative. Vancomycin, ceftriaxone, and rifampicin were given as an empirical treatment for culture-negative infective endocarditis. Cardiac computed tomography (CT) confirmed the echocardiographic findings [Figure 4] demonstrating a narrow-necked pseudoaneurysm arising from the right sinus of Valsalva measuring 3.1 cm (width) x3.5 cm (length) x2 cm (height). While the patient was being prepared for surgery, he suddenly deteriorated into pulseless electrical activity and could not be resuscitated. On autopsy, vegetation was found on the aortic valve consistent with infective endocarditis as well as rupture of the right SVpA.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 25,\n",
       "    'case_id': 'PMC6562175_01',\n",
       "    'case_text': \"A Caucasian female sought care at 22 years of age for evaluation of a mass characterized by progressive growth located laterally in the right breast, measuring 3.3 cm; she underwent surgical excision, with anatomic-pathological examination suggestive of FA. One year later, the patient had a palpable mass of 4.7 cm in the same location, and a lumpectomy was performed, with a repeated diagnosis of FA. At eight and 12 months thereafter, two new tumors, both 4.5 cm, were resected, and benign PTs were diagnosed with compromised resection margins. After another eight months, at the age of 25, three new lesions appeared; all nodules were excised, with borderline PT diagnosis, positive margins for the largest (3 cm) and benign PT for the other two.\\nOver time, a 6-cm scarring lesion was presented, laterally in the right breast, consequent to the previous procedures, and thickening of the underlying tissue, without phlogosis (Fig. 1). On palpation, no new nodules or axillary lymph nodes were identified. The immuno-histochemical examination showed positivity for vimentin, calponin, Ki-67 and estrogen receptor in the epithelial component. Mammography, ultrasonography (US) and magnetic resonance imaging (MRI) showed an anechoic collection measuring 3.0 x 1.0 cm in a surgical site of the right breast, with persistent and slightly irregular late enhancement in the inferolateral margin of the collection, and an area between 0.4-0.7 cm, correlated with the previous pathology. Thoracic CT and abdominal US showed no metastases. Genetic testing revealed uncertain significance variants in BRCA1 and BRCA2, without mutation in PT53.\\nAll lesions occurred in the right breast and were asymptomatic. Because of the history of frequent relapses, a right-sided skin-reducing mastectomy was chosen, followed by reconstruction. The intraoperative frozen section showed a scarring lesion underlying the surgical marking and another nodular hemorrhagic lesion in a super-medial quadrant with resection margins greater than 1.0 cm in relation to the adjacent tissues. On the left, reduction mammaplasty was chosen for symmetry, because of the patient's large breast volume (Fig. 2, Fig. 3). The pathology showed no residual PT. At 8-month follow-up, there was no relapse of the lesions on clinical examination or US (Fig. 4).\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 17,\n",
       "    'case_id': 'PMC7086431_01',\n",
       "    'case_text': 'A 17-year-old lady, nulliparous, was admitted in the gynecological ward with complaint of abdominal swelling and loss of weight. Her menstrual history was unremarkable. On examination, a palpable abdominopelvic mass was detected; the ultrasound scan revealed a left ovarian cyst (15 x 17 cm), no free fluid was seen, the rest of her abdominopelvic sonographic examination was normal, and the initial clinical diagnosis was one of left ovarian cyst. Her Hb was 10.3 g%; the urinalysis, HIV test, hepatitis, and beta hCG were unremarkable. A laparotomy was planned three days later, and perioperatively, the mass resembled a hemorrhagic solid tumor as shown in Figure 1. Grossly, the left ovarian mass measured 15.0 x 20.0 x 8.0 cm and was brownish and hemorrhagic, with solid and cystic areas, irregular surface with adhesions of the colon to the mass, and no ascites. The right tube and ovary appeared normal with a grossly normal uterus, and a left salpingo-oophorectomy was performed and hemostasis achieved. She was given one unit of blood. The specimen was sent to the laboratory for histology and the result came out after 24 days and revealed diffuse lymphoma with largest cells vs. carcinoid tumor with requirements of doing immunohistochemistry (Figure 2). Her postoperative findings were unremarkable, and she was discharged on her 6th postoperative day.\\nShe came for review a month later without any complaint, her hemoglobin was 13.2 g%. Two months later, she came back again with lower limb swelling progressively increased in a week as shown in Figure 3. She has received ibuprofen and cloxacilline as an outpatient unsuccessfully. Her last menstrual period was 21 days back.\\nOn examination, she was in a fair general condition, alert, afebrile on touch, no pallor, no jaundice with general edema, and no palpable lymph nodes. Her weight was 42 kgs. Her blood pressure was 90/60 mmHg.\\nThe abdomen was not distended, but with palpable mass, firm and tender in the hypogastrium.\\nThe vulva was edematous with lower limb swelling.\\nUrea: 60.95 mg/dl, creatinine: 10.5 mg/dl (ten times higher than the normal range)\\nSerum hCG was negative\\nHemoglobin: 10.4 g/dl\\nWBCs: 3,700\\nThe laboratory tests revealed: \\nThe ultrasound scan revealed a mass of 11.6 x 9.6 cm in the hypogastrium with bilateral hydronephrosis.\\nThe diagnosis of metastatic ovarian cancer was made with renal failure.\\nShe was given IV hydrocortisone 200 mg three times a day with 2.5 l of normal saline and IV lasix 80 mg. The urine output was monitored, and oliguria was noticed despite the dose of lasix.\\nShe was given IV ceftriaxone 1 g two times a day and IM diclofenac 75 mg two times a day.\\nThe patient did not improve and had persistent abdominal pain, lower limb swelling, and oliguria despite the kidney challenge and her treatment. On day 8, her relatives requested for her to be discharged for further management in Beni which is close to their home.\\nLater on, we heard that the patient was given some traditional medicine, and the patient improved well and went back to a training center where she was learning hairstyle. For a year, she was doing somehow with progressive weight loss as reported by her relatives.\\nOn a bad note, we heard that she was taken to the general hospital and was managed as an outpatient but passed on two days after the check up in an unrevealed picture.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 76,\n",
       "    'case_id': 'PMC4331673_01',\n",
       "    'case_text': 'A 76-year-old Caucasian woman was found to have implant-associated anaplastic lymphoma with pathologically proven nodal involvement and was successfully treated by implant removal, chemotherapy, and radiotherapy. She had gel breast implantation performed 20 years prior to presentation. These were later replaced by saline implants. One year before presentation the saline implants were leaked and replaced with gel implants. She developed a recurrent fluid collection involving her right breast (Figure 1). A drain was placed and yielded minimal output before being removed 1 week later. Cytology of the fluid demonstrated atypical appearing lymphocytes. The fluid later reaccumulated, and right axillary lymphadenopathy was noted on physical exam (largest node 5.1 cm on ultrasound). Core needle biopsy of the node revealed rare atypical cells.\\nShe underwent capsulectomy and right axillary nodal excisional biopsy with bilateral implant removal in 2011. On histopathologic analysis, anaplastic large-cell lymphoma (ALCL), anaplastic lymphoma kinase (ALK)-negative was demonstrated in the fibrous capsule, cystic fluid, and axillary lymph nodes (Figures 2 and 3). Imaging with CT and PET scans demonstrated residual right axillary lymphadenopathy with FDG avidity, as illustrated in Figure 4. Bone marrow analysis was performed and showed no evidence of lymphoma involvement. The patient was staged as Ann Arbor stage IIE. She was treated with six cycles of cyclophosphamide 750 mg/m2, doxorubicin 50 mg/m2, vincristine 2 mg, and prednisone. Prednisone required a dose reduction from 100 to 75 mg after the first cycle to minimize hyperglycemia secondary to diabetes mellitus type II. Pegfilgrastim 6 mg was injected each cycle for hematopoietic support. Ciprofloxacin 500 mg BID was used daily for bacterial infection prophylaxis. After cycle 2, she began to display adverse effects of nausea grade 2, oral mucositis grade 1, and dysgeusia grade 2 per National Cancer Institute Common Terminology Criteria for Adverse Events grading scale version 4.03. Tetrahydrocannabinol was administered for treatment of nausea and anorexia. Weight loss of grade 1 occurred by the end of therapy. Interval PET and CT imaging were performed after cycle 2, demonstrating metabolic activity of SUV 0.88 in the right axillary lymph nodes, a partial response. Repeat PET imaging was performed after cycle 4 of chemotherapy, confirming complete response to treatment.\\nAdjuvant radiation therapy was then delivered to the right breast, axilla, and right supraclavicular nodes to 30.6 Gy in 1.80 Gy fractions, finishing in January of 2012. A monoisocentric technique was used with breast tangents matched to a field covering the supraclavicular nodes and high axilla. The axilla levels 1-3 were contoured and a lightly weighted posterior axillary field was used to bring the volume up to the prescription dose (Figure 5). With therapy, the patient experienced grade 1 dermatitis manifested as faint erythema within the treatment field. Two-year follow-up with PET imaging and clinical evaluation showed no evidence of disease. The patient wished to have breast augmentation again. She underwent silicone gel implant placement bilaterally and has been followed for an additional year without evidence of disease.\\nPrimary breast lymphomas represent about 0.1-0.5% of total breast tumors, and approximately 3% of non-Hodgkin lymphomas of extranodal sites. Tumors of ALCL histology represent 2% of adult non-Hodgkin lymphomas and are the second most common peripheral T cell lymphoma. The entity of breast implant-associated ALCL was first described by Keech and Creech in 1997, and currently at least 60 cases have been described in the literature. A study in the Netherlands estimated that the incidence of breast implant-associated ALCL is 1 out of 500,000 per woman with prostheses per year, using a case-control model with breast lymphomas other than ALCL as the control. However, there has been controversy regarding the level of risk associated with breast prosthesis implantation. The FDA reports that 5-10 million women have undergone breast implantation, leading to a possible estimation of breast-associated ALCL incidence of 1:80,000 to 1:170,000 given the 60 reported cases thus far.\\nMorphologically, ALCL is composed of large blastic cells with pleomorphic, often horseshoe-shaped or multiple nuclei. Growth is in a cohesive pattern often involving lymph node sinuses with a variable composition of granulocytes and macrophages. In breast-associated and cutaneous ALCL, the cells are CD30 positive on cytogenetic studies and negative for ALK. In contrast, systemic ALCL is characterized by positive ALK. Those who present with a mass rather than an effusion have a higher risk of failure or relapse. Various treatment regimens have been employed including surgery (implant removal) followed by observation, chemotherapy alone, chemotherapy and radiation, and radiation alone. Patients who present with disease limited to an effusion surrounding the fibrous capsule surrounding the implant have been shown to have a favorable outcome with observation; however, there are rare cases of advanced and treatment-resistant disease leading to fatality. The ideal treatment schema is yet to be elucidated.\\nWe report a locally advanced case of breast implant-associated ALCL at our institution. Pathologic axillary nodal involvement by breast implant-associated ALCL is rare: only four cases of pathologically confirmed disease of the axillary nodes have been described. Of the 60 cases reported, workup for axillary nodal involvement was carried out in 29, 10 of which were found to have clinical evidence of axillary lymphadenopathy. Four of these were confirmed pathologically; our patient represents the fifth.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 48,\n",
       "    'case_id': 'PMC2892671_01',\n",
       "    'case_text': 'A 48-year-old woman (weight: 108 kg, height-170 cm) was scheduled for a laparoscopic cholecystectomy because of cholelithiasis. At the preoperative assessment she reported postoperative apnoea following a Caldwell-Luc procedure at the ENT-OR in 1981. A prolonged effect of succinylcholine had been confirmed by a dibucaine number of 10, written on a crumpled warning card. The patient herself was absolutely clear about the condition of her butyrylcholinesterase deficiency. Her medical history showed an appendectomy, hypertension, and a trigeminal neuralgia due to repetitive sinus infections. Current medication was amitriptyline, gabapentin, diclofenac, omeprazole, metoprolol, and acetaminophen combined with codeine. \\nInduction of anaesthesia was carried out with fentanyl and propofol. To facilitate tracheal intubation 100 mg succinylcholine (0.9 mg/kg) had been administered unintentionally. Maintenance was performed with intermittent dosages of fentanyl, morphine and a continuous infusion of propofol. The surgical procedure lasted 90 minutes and was done uneventfully.\\nMonitoring of neuromuscular function was started using acceleromyography (TOF-Watch SX), by performing intermittently a \"train-of-four\". Determination of the supramaximal stimulus could not be performed, as deep neuromuscular blockade was already induced. Anaesthesia, using propofol continuously in combination with intermittent doses of morphine, and neuromuscular monitoring were continued until recovery of the TOF-ratio above 90%; at this value it was assumed that the patient could breathe without help. Recovery of neuromuscular function took more than seven hours. The first twitch was seen 87 minutes after the administration of succinylcholine. The course was uneventful although the patient was emotional and anxious postoperatively we were able to regain her trust after several talks.\\nAfter informing this adverse event to the patient and her partner, she gave permission to take blood samples for quantitative and qualitative analysis and for molecular genetic investigation.\\nThe plasma concentration of cholinesterase was 2520 U/l (ref: 4800-12000 U/l) and the dibucaine number was 8. These results are indicative for a homozygous atypical variant. Because of the very long clinical duration of action we did not limit molecular genetic investigations to known BCHE variants but decided to sequence both strands of the complete BCHE coding sequence. This identified a homozygous A- as well as a homozygous K-variant. The A-variant (209A > T, leading to Asp70Val) is most causative for the clinical feature and the K-variant (1615G > A, leading to Ala539Thr) contributed to the markedly prolonged muscle relaxation and the dibucaine number of 8. The clinical significance of the K-variant as a single mutation has been described by Gatke et al..',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 30,\n",
       "    'case_id': 'PMC3245192_01',\n",
       "    'case_text': \"A 30-year-old female patient first discovered glycosuria 3 years prior to being examined at a medical institution for the condition. The patient initially sought medical treatment for a floating spot in her right eye, and after it was determined that this was due to vitreous hemorrhage, she was referred to our institution. Best corrected visual acuity of her right and left eyes at her initial visit was 10/20 and 20/20, respectively. Similar to her father and grandfather, the patient had white hair. She had dystopia canthorum identified by calculation of the W index (2.01), but did not have sensorineural hearing loss. Although hypochromic iris was observed in the superior iris between the 10 and 2 o'clock positions in her right eye, her entire left eye exhibited hypochromic iris (Figure 1). Mild anterior and posterior subcapsular cataract was found in both eyes, and hypopigmentation of the fundus was seen in the superior part of her right eye. This eye also had a huge neovascularization on the optic disc that was 7 discs in diameter and was surrounded by preretinal hemorrhage. Conversely, her left fundi showed hypopigmentation of the fundus in the entire region of the left eye, and dot hemorrhages were observed all over the left fundi. However, no neovascularization could be seen microscopically (Figure 2). Optical coherence tomography seemed to demonstrate slight outer retinal atrophy in the left eye (Figure 3). Fluorescein angiography showed a huge neovascularization on the optic disc in the right eye. Only a tiny neovascularization was noted on the left eye (Figure 4). Gene analysis revealed the presence of a PAX3 gene homeobox domain mutation which was detailed as mutation in exon 6: F267I (801T changed to A), and led to her being diagnosed as Waardenburg syndrome type 1. Magnetic resonance imaging and magnetic resonance angiography showed that there was no obstructive region at either of the internal carotid arteries or ophthalmic arteries. We performed panretinal photocoagulation in both eyes using a multicolor photocoagulation laser system (Novus Varia , Lumenis Ltd, Yokneam, Israel). Since the yellow light laser (wavelength 561 nm) was invalid for the hypopigmented areas of the fundus, we chose to use the green light laser (wavelength 532 nm) in order to perform panretinal photocoagulation over the entire extramacular area. Due to the diabetic retinopathy, tractional foveal detachment in her right eye and mild vitreous hemorrhage of her left eye occurred at 10 months after panretinal photocoagulation. Because of this, we then carried out pars plana vitrectomy in both eyes. At approximately 2 years after her surgery, her condition normalized, and at the present time, her best corrected visual acuity remains at 20/30 and 20/20 in her right left eyes, respectively.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 51,\n",
       "    'case_id': 'PMC5362702_01',\n",
       "    'case_text': 'A 51-year-old male presented to a private orthodontic practice for initial assessment. His medical history was unremarkable and he was not on any medication at that time. During intraoral examination, a 1 x 1 mm translucent nodule with a smooth round surface was noted. It was located in the attached gingiva between the lower left mandibular canine and first incisor. The nodule was asymptomatic, cystic in appearance, fluctuant, and noncompressible (Figure 1). Pulp testing of his lower left canine and central incisor indicated normal pulp vitality. Radiographically, there was no finding suggestive of osseous involvement. The patient was unaware of the lesion prior to this assessment. Complementing his oral assessment, he also had bilateral agenesis of his lower lateral incisors and first premolars (Figure 2). Based on the clinical and radiographic findings, the provisional diagnoses were salivary gland tumor or cystic lesion of the gingiva.\\nDue to the size of the lesion, an excisional biopsy was performed under local anesthetic infiltration. An incision was made in the overlying mucosa and the lesion was completely dissected from the adjacent tissues. The specimen was fixed in 10% buffered formalin and sent to the Oral Pathology Laboratory of the Sao Leopoldo Mandic Dental Institute and Research Center for histopathologic examination. On macroscopic inspection, the material consisted of a nodular fragment of soft tissue, measuring 5 x 3 x 2 mm, with smooth surface, whitish coloration, and friable consistency. Histological sections revealed a cystic cavity lined by two or three layers of odontogenic epithelium (Figure 3), exhibiting focal epithelial plates containing clear cells (Figure 4). The histopathologic diagnosis was of a gingival cyst of the adult.\\nThe sutures were removed 1 week postoperatively and the patient reported minimal discomfort. After one month, the patient returned for follow-up when complete resolution of the lesion was observed. The patient is currently under regular follow-up with satisfactory healing and no relapse for over 15 months. Written consent was obtained from the patient for publication of the images relating to his case.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 44,\n",
       "    'case_id': 'PMC5791444_01',\n",
       "    'case_text': 'A 44-year-old woman came to our attention for a right simple ureterocele with Grade III hydronephrosis, discovered during gynecological assessment for light stress urinary incontinence (SUI) with Stage I cystocele. A computed tomography (CT) scan confirmed a 7 cm x 4 cm right intravesical ureterocele with Grade III of hydronephrosis [Figure 1]. She underwent an endoscopic incision of the ureterocele on its basis under spinal anesthesia. A bladder catheter was placed and removed after 24 h. At the postoperative visit, she reported a bulging mass protruding in the vagina. A flap of mucosa coming out from her urethra was noted and manually reduced. At the ultrasound, no right hydronephrosis was detected. The following day, the patient returned with the flap protruding into the urethra, such as demonstrated by cystoscopy and CT scan findings [Figure 2]. An endoscopic resection of the redundant part of the ureterocele was programmed. Final histopathological assessment showed normal mucosa. After 24 months, she was asymptomatic with no history of renal colic or urinary tract infection (UTI). At the ultrasound examination, no right hydronephrosis was revealed.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 44,\n",
       "    'case_id': 'PMC5368395_01',\n",
       "    'case_text': 'The patient was a 44-year-old woman with a lifetime history of low VWF and clinically significant bleeding manifestations. Her disease manifested with excessive bleeding including menorrhagia and epistaxis. Laboratory evaluation confirmed type 1 VWD with ristocetin cofactor activity of 38%, von Willebrand antigen level of 41%, factor VIII level of 60%, and a normal von Willebrand factor multimer distribution. The patient had type A blood and abnormal Platelet Function Assay (PFA) markedly prolonged clotting times with both collagen/epinephrine and collagen/ADP stimulation. The patient previously underwent a DDAVP challenge test which more than doubled her ristocetin activity after administration of 20 mcg of intravenous DDAVP. This challenge test was not followed by any complications. She presented to the pain clinic with a long-standing history of low back and bilateral lower extremity pain. Over the years, she had tried a variety of medications, multiple episodes of physical therapy, and other conservative care without significant improvement. MRI imaging of the lumbar spine revealed an annular tear and disc bulge at L5-S1. After discussion of risks versus benefits of the procedure and the need for consideration of DDAVP to reduce the risk of bleeding, the patient underwent an infusion of DDAVP 0.3 mcg/kg receiving a total of 22 mcg over a period of 30 minutes immediately before the procedure. The patient was not given any specific instructions for fluid restriction postoperatively. Bilateral L5-S1 transforaminal epidural steroid injections were carried out. Once needle position and good contrast spread along the nerve roots were confirmed, an injection of 1 mL of 0.25% bupivacaine and 40 mg methylprednisolone was carried out on each side. Although the procedure was performed without incident, the patient experienced persistent dizziness and a nonpositional headache early the next day. Thorough investigation, including serial serum and urine electrolyte evaluations, revealed findings consistent with hyponatremia (serum sodium: 125 mmol/L), which was a decrease from baseline serum sodium of 138 mmol/L. Further investigation also revealed excessive water intake of 80 ounces per day that may have contributed to the acute onset of hyponatremia. The electrolyte disorder was gradually corrected over a period of 24 hours through fluid restriction and administration of sodium with complete resolution of symptoms. Serum sodium went from 125 mmol/L to 128 mmol/L at the 6th hour after diagnosis, to 134 mmol/L at the 10th hour, and then to 139 mmol/L at the 18th hour after diagnosis and remained at 136-139 mmol/L for the next several days to weeks on outpatient follow-up.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 70,\n",
       "    'case_id': 'PMC2738499_01',\n",
       "    'case_text': \"The patient was a 70-year-old woman, who has been diagnosed with intermediate-grade, CD 20-positive, B-cell non-Hodgkin lymphoma, involving a left intraparotid lymph node. Staging workup demonstrated stage 1-A disease. Treatment plans for the patient included three courses of CHOP (cyclophosphamide, hydroxydoxorubicin, vincristine [Oncovin], and predisone) chemotherapy plus rituximab (chimeric CD 20 monoclonal antibody), to be followed by involved field radiation. After the first cycle of chemotherapy in July 2001, neutropenia developed in the patient after both the second and third cycles of chemochemotherapy. The third cycle of chemotherapy was administered on September 11, 2001. Four days later, she was treated with oral levofloxacin for low-grade fever. On day 7 after chemotherapy, she was admitted to the hospital with fever, cough, chills, rhinorrhea, joint aches, decreased appetite, lethargy, and lightheadedness. She had no recollection of any ill contacts or insect bites. She was a resident of southern Nassau County, New York, and did not have a history of travel. Physical examination was within normal limits. The patient was neutropenic; G-CSF was continued, and she was given cefipime and gentamicin. One day after admission, she continued to have fever and experienced mild headaches that responded to acetaminophen. Urine cultures showed penicillin-sensitive enterococci, and blood cultures were negative. Two days after admission, the patient continued to have fever, headaches, and dizziness. A computed tomography (CT) scan of the brain revealed no acute cerebral processes. On the 3rd day after admission, the patient was noted to be confused. Further deterioration of mental status was noted, with incomprehensible speech, but she was able to follow commands. Arterial blood-gas analysis showed an acute respiratory acidosis pattern, and the patient was subsequently intubated and transferred to the intensive care unit. The patient had a hypotensive episode secondary to atrial flutter, which required cardioversion for stabilization. Ceftriaxone and ampicillin were added to the antibiotic coverage, and antifungal treatment was also initiated with lipid complex amphotericin B. After the patient's hematologic parameters improved, G-CSF was discontinued on day 9 of hospitalization, and the patient continued to be afebrile. Because of the clinical picture of encephalitis and because the patient lived in an area where WNV was endemic, lumbar puncture was performed on day 8, and a CSF specimen was sent to the New York State Department of Health laboratories for comprehensive PCR testing. Renal tubular necrosis developed in the patient, leading to acute renal failure by day 10, with further deterioration of her mental status. Dialysis was initiated on day 16, and antibiotic therapy was discontinued on day 17 as the patient remained afebrile and the neutropenia was resolved. The patient remained unresponsive, staphylococcal septicemia developed, and she died on day 35 of hospitalization. Autopsy showed a small focus of perivascular lymphocyte cuffing in the mamillary bodies of the brain, consistent with viral encephalitis. No evidence of residual lymphoma was found.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 38,\n",
       "    'case_id': 'PMC3003993_01',\n",
       "    'case_text': \"A 38-years-old man was diagnosed a IIA stadium IgD-k (MM). He immediately underwent chemotherapy (two DAV cycles and 4 ProMECE-CytaBOM cycles) and, one year later, bone marrow transplant (BMT). One month after BMT he developed a GVHD with skin and articular involvement. When he was 41 years old he developed muscular symptoms (myalgias and hyperCKemia). He underwent a skeletal muscle biopsy which led to a diagnosis of polymyositis: he was treated with steroids for some months and with azathioprine for three years with complete disease remission. \\nAt age of 42-years myeloma relapsed: the patient was treated with thalidomide for six years with good clinical remission, but progressively increasing levels of serum IgD were demonstrated.\\n Six years later (at age of 48 years), the patient came to our observation for a new onset of neuromuscular symptoms: distal lower limb hypopallaesthesia, proximal limb hypotrophy, lower limb girdle weakness, hyperCKemia. Conduction studies examination showed changes suggestive of axonal polyneuropathy associated with a myopathic pattern on needle EMG investigation. \\n He underwent both muscle and peripheral nerve biopsy to discriminate between myositis (paraproteinemia versus GVHD), amyloidosis, and thalidomide toxicity. Conventional histological/histochemical studies along with immunohistochemistry for HLA, membrane attack complex (MAC), and IgD, were performed on both skeletal muscle biopsies and peripheral nerve cryostat sections. CD8, CD4, CD19, and CD68 immunohistochemistry was performed on skeletal muscle only. The first muscle biopsy showed an inflammatory pattern with necrotic fibres, macrophage invasion (CD68 positivity), rare interstitial cellular infiltrates, rare CD8 and absence of CD4 lymphocytes, widespread sarcolemmal HLA positivity, and no MAC detection in capillaries. The second muscle biopsy showed the same inflammatory pattern seen in the previous one plus an involvement of blood vessels (several perivascular cellular infiltrates in muscle with mild MAC positivity) and a slight increase of endomysial connective tissue. Sural nerve biopsy demonstrated both demyelinating and axonal aspects. No inflammatory infiltrates, but positive immunohistochemistry for HLA and MAC and dilated endoneurial capillaries were observed. \\n Congo Red was negative in both skeletal muscle and peripheral nerve.\\nDirect immunofluorescence for IgD was positive in both muscle biopsies: in the first one, IgD mainly accumulated along the sarcolemma; in the second one necrotic fibres and endomorphism connective were also strongly reactive. Conversely, nerve biopsy was IgD negative (see Figure 1). \\nMM is associated with amyloidosis. In our case, no Congo Red positivity was observed in both muscle and nerve tissues. Cryoglobulins were absent in serum and autoimmune diseases were excluded by the absence of the most common antibodies. \\nMyositis during chronic GVHD presents CD8-positive interstitial infiltrates with rare macrophages. Our patient's biopsies showed a predominance of macrophages: these results do not favour GVHD diagnosis even if a systemic involvement was evident when the first myositis episode occured.\\nThalidomide causes a neuropathy without inflammatory signs. In our patient, nerve biopsy showed a mixed pattern with evidence of inflammation at immunohistochemistry. \\nKiprov and Miller demonstrated IgG deposits along basement membrane and myelin sheath in case of myositis or demyelinating neuropathy during MM.\\nGiven the presence of sarcolemmal and cytoplasmic deposits of IgD in both muscle biopsies, we hypothesize that myositis in our patient is paraproteinemia-correlated. The presence of IgD deposits correlates with high blood levels of monoclonal proteins at least in the second episode. \\nConversely, polyneuropathy could be caused by thalidomide, though inflammation cannot be excluded (HLA and MAC positivity) even if we did not observe IgD deposits. \\nThis is the first case of concurrent polyneuropathy and myositis in IgD MM. In our patient neuromuscular symptoms subsided after steroid therapy.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': None,\n",
       "    'case_id': 'PMC5502805_01',\n",
       "    'case_text': 'Human red blood cells express a wide variety of antigens. Three in particular (A, B and Rh) are commonly identified in clinical laboratories for purposes such as cross-matching blood for transfusion. Blood donors and blood recipients are characterized as having A, B, AB or O blood and as being Rh positive or negative. Except in rare instances, an individual\\'s blood type does not change over his or her lifetime.\\nToday, most blood banks report these antigens together as the result of a single test; e.g., A+, B-, AB+, O-, etc. However, in the past, these results were reported across two tests: the ABO test to report types A, B, AB and O, and the Rh test with the possible results \"positive\" and \"negative\". Even earlier, the ABO test results were reported as two separate tests for the A and B antigens. A patient could have a positive results for both of these tests (type AB), one of these tests (type A or B), or neither of these tests (implying type O).\\nThis heterogeneity has been well-documented as a challenge for dealing with pooling data from, or sharing them between, multiple health care sites.(, also: Huff SM, personal communication; inspiring) As a repository of data from multiple sites over 40 years, BTRIS often presents users with this type of challenge. We chose it as a case study for the normalization of heterogeneous data, since proper normalization should result in patients having consistent blood types over time, in effect serving as their own gold standards.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 62,\n",
       "    'case_id': 'PMC7071810_01',\n",
       "    'case_text': \"In October 2016, a male, 62-year-old nonsmoker and nondrinker presented with productive cough that had lasted for a week. He was diagnosed with stage IVA right upper lobe lung adenocarcinoma (cT4N2M1a, ECOG 0), with obstructive pneumonia and right-side malignant pleural effusion. The time course of his disease starting from diagnosis and his treatment is displayed in Figure 1. The patient's lesion was found to be EGFR wild-type and ALK-negative by standard clinical testing. Furthermore, chemotherapy was not considered due to the patient's pneumonia, which was treated by antibiotics. Instead, the patient initially underwent radiotherapy (6400 cGy/30 FX).\\nIn agreement with current guidelines, broad molecular profiling was performed to identify treatment-relevant genomic alterations, and informed consent was obtained for the use of the resulting data. For analysis, a formalin-fixed paraffin-embedded (FFPE) sample biopsied from the right upper lobe was used. Areas with high tumor content were identified by H&E stain, and subsequently, a macrodissection was performed to enhance the tumor cell proportion. The ACTOnco  panel from ACT Genomics, Ltd. was used for comprehensive genetic testing. The assay performs next-generation sequencing of all coding exons of 409 cancer-related genes to detect single nucleotide variants, small insertions and deletions, and copy number variants. Details regarding this panel have been previously published. Sequence variants with a coverage of at least 25 reads and an allele frequency of >=5% for regular variants and >=2% for actionable variants were considered. An additional NGS test able to detect the presence of 72 known fusion transcripts for ALK, ROS1, RET, and NTRK fusion genes was also performed.\\nThere were no fusion genes detected in the patient's sample. However, 27 sequence variants, including TP53 Y220C, were identified (Table 1). The tumor had a stable copy number profile, and no copy number gains or losses were detected, with the exception of amplification of cytoband 17q12. This amplification included CDK12, PGAP3, and the clinically relevant gene ERBB2 (Figure 2). The observed copy numbers for those genes were 11.5, 15, and 15, respectively. However, the observed copy number does not take tumor purity into account, and a copy number of 45 copies for ERBB2 were calculated based on the estimated tumor purity of 30%. These results suggested an ERBB2-driven tumor and a potential benefit from therapies targeting ERBB2, such as trastuzumab.\\nThe patient started trastuzumab treatment in February 2017. Trastuzumab was first administered once as monotherapy without concurrent chemotherapy due to the patient's obstructive pneumonia. After the patient's pneumonia improved, the patient received three more doses of trastuzumab with concurrent docetaxel treatment. CT imaging in June 2017 demonstrated a necrotic regression of the right upper lobe lung lesion after the initiation of trastuzumab treatment (Figure 3). The restaging in July 2017 confirmed the absence of local recurrence. However, the patient had developed brain metastasis. There was no evidence for other systemic metastasis. Since trastuzumab and docetaxel do not effectively pass through the blood-brain barrier, whole brain radiotherapy (WBRT; 3000 cGy/15FX) was initiated in addition to the continuation of trastuzumab and docetaxel. In October 2017, a follow-up was performed. At that time, the patient's ECOG performance status was 0. CT imaging of the lung showed no evidence of local progression or distant metastasis. However, the patient's blood was used for the ACTMonitor  Lung 11 gene NGS circulating tumor DNA (ctDNA) test. This test covers hotspots in the genes ALK, BRAF, CDKN2A, CTNNB1, EGFR, ERBB2, KRAS, MET, PIK3CA, TP53, and U2AF1. The results showed the TP53 Y220C mutation that had previously been detected in the FFPE tumor specimen and an additional TP53 R248W mutation at allelic frequencies of 4.4% and 1.1%, respectively. The detection of tumor-specific variants in plasma upon therapy is associated with less favorable treatment outcomes, and our results indicated the possibility of a future disease progression. The patient was treated with combined bevacizumab and trastuzumab therapy, and the treatment was given three times until January 2018. At that time, CT imaging of the brain indicated a newly progressive brain metastasis. A bronchoscopic exam and serial staging studies did not indicate local tumor recurrence or other metastasis, and the obtained specimen from a bronchoscopic biopsy showed chronic inflammation but no presence of cancer cells. The patient was treated with RT for the brain metastases and atezolizumab in early February 2018. However, he developed pneumonia, followed by septic shock, and died in mid-February.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 54,\n",
       "    'case_id': 'PMC9421220_01',\n",
       "    'case_text': \"A 54-year-old man presented with a history of long-standing persistent atrial fibrillation (PersAF) and has been treated with Beta-blocker and Apixaban for the last 8 years. He also had a history of failed DC cardioversion 2 times since 2018. Preoperative echocardiography demonstrated 5.8 cm dilated LA, no intracardiac thrombus and good left ventricular function (Ejection fraction 50%). Based on the multi-disciplinary team (MDT) decision, the patient has undergone convergent subxiphoid epicardial ablation on the beating heart without cardiopulmonary bypass and AtriClip exclusion of LA appendage plus a single 200 kJ direct current (DC) cardioversion. The MDT rationale for the hybrid programme was that the LA size (5.8 cm) and endocardial ablation outcome in long-standing PersAF with this LA size were poor. The patient's informed written consent was obtained; patient confidentiality and data were protected and encrypted.\\nUnder general anaesthesia, a 2 cm midline subxiphoid incision was made, the xyphoid was preserved and raised to allow entry into the pericardium. A 5 mm pericardioscope was utilised to investigate the pericardium cavity outwardly. The coronary sinus and inferior pulmonary veins were identified, and sequential superior and inferior transmural ablation was performed across the back left atrium. A total of 32 points of ablation were performed utilising the 3 cm ablation catheter and 30 W RF energy for 90 seconds at each point. Moreover, the baseline temperature (36 C) was monitored with an oesophagal probe throughout the procedure. If the temperature increased by 1 C more than baseline, ablation was stopped to allow deaeration and waited until temperatures returned to baseline. Each area had multiple ablations until macroscopically the area was discoloured.\\nFollowing pulmonary vein (PV) isolation, 3 left VATS ports (5 mm port in the second intercostal space (ICS), 5 mm port in the mid-axillary line at fourth ICS, and 12 mm port in the sixth ICS in the posterior axillary) line were performed. A double lumen endotracheal tube was placed prior to the beginning of the case. The left lung was deflated, and the pericardium was opened parallel and below the phrenic nerve. The LA appendage was envisioned and measured, and a 35 mm pro-2 Atriclip device were deployed through the lower 12 mm port around the base of the LA appendage. The patient was in sinus rhythm towards the finish of the hybrid procedure after having a single DC cardioversion shock at 200 kJ. The post-procedural period was uneventful, and the patient was discharged on the first postoperative day with satisfactory biochemical, chest X-ray and echocardiography findings (Figure 1). Postprocedural medication includes Edoxaban, oral Lansoprazole and the patient was advised to come for follow-up in the Electrophysiology clinic after 3 months. The anticoagulant Edoxaban was prescribed as per the Electrophysiology Consultant Cardiologist opinion and on an individual basis dependent upon CHA2DS2VASC score. Though the patient was on a beta-blocker preoperatively, we did not need to restart his beta-blocker postoperatively as the patient was in sinus rhythm and heart rate was 68 beats per minute (regular) till following up at 6 months. Follow-up echocardiography at 6 months was also satisfactory with good biventricular function, and we endeavour to evaluate the patient with a formal Holter monitoring at 1 year postoperatively.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 54,\n",
       "    'case_id': 'PMC6364124_01',\n",
       "    'case_text': \"A 54-year-old male with a history of renal cell carcinoma, pancreatic adenocarcinoma stage II (T2 N1 3/5 lymph nodes positive), having previously received chemotherapy followed by stereotactic body radiation therapy (SBRT) presented 5 months after the Whipple's surgery with failure to thrive, fatigue, and nausea. Exam was unremarkable and laboratory investigations revealed albumin of 1.3 mg /dl, bilirubin of 2.8 mg/dl, mainly conjugated, serum alkaline phosphatase of 825 U/L, and CA 19-9 of 81.4 (normal <37 U/ml). Computed tomography scan (CT) of abdomen showed a perigastric abscess adjacent to the fundus (Figure 1). Endoscopic ultrasound (EUS) was suggestive of 35 mm anechoic, heterogeneous, well-circumscribed fluid collection in the immediate perigastric area surrounding the fundus (Figure 2). Under endosonographic, fluoroscopic, and Doppler guidance, a 10 x 10 mm LAMS was placed from the stomach into the fluid collection with drainage of pus.\\nThe patient improved clinically along with significant improvement in his bilirubin and alkaline phosphatase after the procedure. Repeat CT abdomen after one week of stent placement showed a near-complete resolution of the abscess (Figure 3), although he had developed ascites by this time, likely due to presence of severe hypoalbuminemia. Removal of the stent was planned after 3 weeks of placement. However, the patient was readmitted 3 weeks later with respiratory failure and altered mental status. His family elected to provide supportive care only and he died shortly thereafter.\",\n",
       "    'gender': 'Male'},\n",
       "   {'age': 54,\n",
       "    'case_id': 'PMC6364124_02',\n",
       "    'case_text': '54-year-old male underwent distal pancreatectomy with splenectomy for treatment of pancreatic neuroendocrine tumor. In the immediate postoperative period, patient developed a pancreatic fluid leak from the tail of pancreas and an intra-abdominal drain was placed that was removed after it stopped draining. CT scan showed interval increase in the size of the rim enhancing fluid collection around tail of pancreas 1 month after drain removal (Figure 4). ERCP was performed for suspected pancreatic duct (PD) leak and confirmed a leak from the tail of the pancreas. Endoscopic pancreatic sphincterotomy was done with placement of a 5 Fr x 13 cm pancreatic duct stent with internal barbs. Subsequently, EUS showed a well demarcated, hypoechoic, heterogeneous collection, adjacent to the tail of the pancreas about 6.5 cm in the largest dimension (Figure 5). Under endosonographic guidance, a 15 mm x 10 mm LAMS was placed from the stomach into the fluid collection with drainage of a large amount of pus. CT scan of abdomen after 1 month showed decrease in the size of the previously demonstrated LUQ rim-enhancing fluid collection (Figure 6). Unfortunately, patient later had a neurological event that led to his demise, prior to stent removal.',\n",
       "    'gender': 'Male'},\n",
       "   {'age': 34,\n",
       "    'case_id': 'PMC6364124_03',\n",
       "    'case_text': 'A 34-year-old male presented to hospital after a motor vehicle accident. Patient was hypotensive on arrival and underwent exploratory laparotomy, splenectomy, embolization of hepatic vessels, and right-sided partial hepatectomy due to grade V liver laceration. Postoperatively, the patient developed bilious drainage from an intra-abdominal drain and underwent ERCP for suspected bile leak. ERCP revealed a leak from the right biliary system; therefore a 10 Fr x 5 cm plastic biliary stent was placed. A week later, the patient continued to have high output of amylase-rich fluid from a separate intra-abdominal drain which was suspicious for a pancreatic duct leak. Repeat ERCP with pancreatogram revealed a leak from the pancreatic tail for which a 5 Fr x 13 cm pancreatic duct stent was placed and the biliary stent was upsized to a 10 mm x 4 cm covered self-expanding metallic stent (SEMS) due to a persistent biliary leak.\\nAfter 1 month, the patient became septic and was found to have a peri-pancreatic abscess on CT abdomen. IR performed a percutaneous drainage of the peripancreatic abscess with minimal drainage through the drain, without any clinical improvement. EUS was then performed by one of the authors (JN) that revealed a 55 mm, oval, heterogeneous peri-pancreatic fluid collection which had hyperechoic material consistent with the solid debris. A 10mm x 10mm LAMS was then placed from the stomach into the fluid collection with subsequent drainage of pus and debris. The patient clinically improved and was discharged home with improvement of the fluid collection. A follow-up CT Abdomen 4 weeks later showed interval decrease in the size of the previous small fluid collection. The LAMS was uneventfully removed endoscopically at 8 weeks after the initial placement.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 71,\n",
       "    'case_id': 'PMC6381921_01',\n",
       "    'case_text': \"A 71-year-old female smoker presented with stage IV lung adenocarcinoma harboring the EGFR exon 21 L858R mutation. She had no history of drug allergies or autoimmune disease. She was started on erlotinib at 150 mg/day for the treatment. Although she had been taking medications over many years, including calcium-channel blocker for hypertension and statin for hyperlipidemia, erlotinib was her only new medication. Then, by 28 days after the start of erlotinib therapy, she presented with severe pruritus of grade 3 according to the National Cancer Institute's Common Toxicity Criteria. The pruritus was resistant to local application of steroid ointment and to standard systemic therapies, including oral steroids and antihistamines. Furthermore, the pruritus was also linked to acneiform skin rush, leading to the interruption of erlotinib therapy for a period of 2 weeks.\\nAfter recovering from these skin side-effects, she was restarted on erlotinib at a reduced dose of 100 mg/day. Oral steroids and antihistamines were continued to prevent recurrence of the pruritus and skin rush. However, within 2 weeks after restarting erlotinib, severe pruritus of grade 3 developed again, followed by acneiform skin rush especially on her face (Fig. 1). An evaluation of the pruritus by means of a visual analogue scale (VAS), in which a score of 0 indicates no pruritus and a score of 10 indicates the worst pruritus imaginable, resulted in a score of 8. Therefore, erlotinib was again discontinued, and she was started on aprepitant at 125 mg on day 1 after discontinuation, 80 mg on day 3, and 80 mg on day 5 with the aim of treating the pruritus and skin rush. This treatment schedule for aprepitant administration was decided after studying the various treatment schedules on the basis of the scientific reports of aprepitant administration. Then, the prompt improvement was observed within 5 days after starting the first dose of aprepitant, leading to a score of 2 for the pruritus on the VAS (Fig. 2).\\nAfter this recovery, she was restarted on erlotinib at 100 mg/day. However, the pruritus and skin rush gradually exacerbated thereafter, leading to scores of 4 and 8 for the pruritus on the VAS within 2 and 4 weeks, respectively (Fig. 3). Then, by starting the second dose of aprepitant, the prompt improvement was again observed within 5 days, leading to a score of 2 for the pruritus on the VAS. However, the pruritus and skin rush eventually exacerbated within 4 weeks. At this point, bi-weekly schedule for aprepitant administration (125 mg on day 1, 80 mg on day 3, and 80 mg on day 5, every 2 weeks) was considered and, then, adopted. As the results, throughout the subsequent treatment with erlotinib, the pruritus and skin rush remained well-controlled within the scores of 2 and 4 for the pruritus on the VAS (Fig. 4).\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 65,\n",
       "    'case_id': 'PMC9629861_01',\n",
       "    'case_text': \"We present the case of a 65-year-old Caucasian male, without any significant medical history, admitted to our clinic with bilateral lower limb motor deficit and distal paresthesia in all limbs, with an onset of ~3 weeks prior. The patient also complained of sudden bilateral decreased visual acuity, more severe on the right side, which preceded the motor deficit by approximately 10 days and had a spontaneously favorable evolution and was partially remitted by the time of admission.\\nAn ophthalmologist in another service evaluated the patient approximately 7 days from the onset of the visual symptoms, where he tested positive for SARS-CoV-2. At that moment, he had had mild respiratory symptoms (slight cough and rhinorrhea) for a~2 days. The interval between the onset of the neurological and COVID-19 symptoms was ~5 days.\\nThe ophthalmological examination noted VOS Presbyopia 0.5 sc (0.7 c), VOD PHM, with a regular fundus examination in both eyes. At that time, sight in the left eye was already spontaneously improving, and the diagnosis was right retrobulbar optic neuritis. He was not started on any therapy and received a recommendation for a neurological evaluation and a brain MRI scan. The patient chose to isolate himself at home for 14 days, per the local recommendations at the time.\\nApproximately 3 days into the isolation period, he developed lower limb paresthesia, followed by paraparesis and ataxia, which progressively worsened until he could no longer walk.\\nOur initial clinical examination showed a slight loss of visual acuity in the right eye (he could read a newspaper), asymmetric paraparesis (3/5 MRC on the right, 4/5 MRC on the left), bilateral Babinski sign, distal paresthesia in all limbs, severe bilateral lower limb myoarthrokinetic and vibratory hypoesthesia, with important secondary ataxia, and a T10 sensory level on the left side; walking was impossible.\\nThe full spine MRI revealed a non-enhancing, T2 and STIR hyperintense cervical demyelinating lesion extending from C4 to C7 levels (Figures 1A,B), cervical spondylotic changes, and degenerative lumbar stenosis at L4-L5 levels. The cerebral MRI was unremarkable except for a slight STIR hyperintense signal affecting the right ON, extending posteriorly into the optic chiasm (Figure 2).\\nThe patient was evaluated extensively for autoimmune disorders associated with myelitis, testing negative for ANA, c-ANCA, p-ANCA, anti-Ro, anti-La, and anti-neuronal antibodies. The infectious screening was negative except for the incidental presence of IgG against HCV. Testing for HIV, syphilis, and borreliosis was negative. The B12 serum level was normal. Serum anti-AQP4 antibodies and anti-MOG antibodies were both positive. The AQP4 was tested by indirect immunofluorescence with a titer of 1:1,000 (N < 1:10). The MOG testing was Western Blot.\\nThe CSF had elevated protein levels (albumin 0.44 g%, positive Pandy test) without pleocytosis (6 elements/muL) and no oligoclonal bands. The IgG index was normal (0.63).\\nGiven the patient's history of optic neuritis, longitudinal extensive cervical myelitis, positive tests for anti-AQP4 and anti-MOG antibodies, and the exclusion of other possible causes that could have caused central nervous system demyelination, a diagnosis of neuromyelitis optica was reached.\\nThe patient had been treated with iv Methylprednisolone 1,000 mg daily for 5 days with significant improvement of motor function (4-/5 MRC bilaterally) and partial remission of the paresthesia but with the persistence of the objective sensory deficits. The patient was able to walk using a Zimmer frame. He was discharged with oral prednisone at 1 mg/kg/day.\\nAt the 2-month checkup, the patient had continued to improve, presenting with normal visual acuity, asymmetric paraparesis (4-/5 MRC on the right, 4+/5 MRC on the left), bilateral lower limb paresthesia up to the lower half of the thighs, and crural proprioceptive hypoesthesia, still requiring a frame for walking. The cervical MRI showed a slightly favorable evolution of the cervical lesion (Figures 1C,D). As a corticoid-sparing treatment, he was started on Azathioprine (AZA), gradually reaching a dose of 150 mg per day.\\nHe was seen again at the 1-year mark, being stationary from a neurological point of view, with the persistence of the asymmetric paraparesis and sensory anomalies. The cervical MRI examination was discreetly improved, as the intramedullary pathological signal had continued to decrease in area and intensity (Figure 1F). AZA was continued in the same doses while prednisone tapering was initiated.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 63,\n",
       "    'case_id': 'PMC2958542_01',\n",
       "    'case_text': 'A 63-year-old, HIV-negative woman was referred in June 2000 by a general practitioner to the outpatient pulmonary service because she had exhibited a fever and night sweats for 3 months. The patient\\'s medical history included a mild hypertensive cardiovascular disease and a pulmonary tuberculosis episode when she was 16 years old. Her father and brother had pulmonary tuberculosis. She lived in an urban area and had no history of acoholism, smoking, or use of steroids or immunosuppressive drugs. No other pulmonary diseases that could potentially lead to bronchiectasis and further mycobacterial colonization were reported. Physical examination revealed no pathologic findings except a strong positive reaction (24 mm of induration) with tuberculin skin test (5 U of purified protein derivative-standard [PPD-S]). Results of clinical laboratory tests were unremarkable, apart from an elevated erythrocyte sedimentation rate (77 mm/h). A computed tomographic (CT) scan of the chest showed multifocal bronchiectases in the middle right lobe, multiple small nodules in the lower right lobe, and a cavitary lesion in the upper right lobe, which appeared to have thin walls and was surrounded by a scant or absent inflammatory reaction. Bronchoscopy showed no inflammatory mucosal changes on the right side. Smears of bronchial washings were negative for acid-fast bacilli (AFB), and smears of two sputum specimens were positive, while all specimens gave negative results when tested by a ligase chain reaction commercial assay specific for MTB. A reactivation of tuberculosis was assumed, and chemotherapy with isoniazid, rifampin, and ethambutol was begun. Cultures of bronchial washing and sputum specimens produced a slow-growing Mycobacterium, which was identified as M. celatum in July 2000. The isolate was not considered clinically important, and chemotherapy was unchanged.\\nIn December 2000, although the general condition of the patient had slightly improved after 6 months of treatment, a control CT scan showed a worsening (enlargement) of the nodular lesions. Smears of two sputum specimens and one bronchial washing specimen were positive for AFB, whereas all specimens were negative when tested by the MTB ligase chain reaction assay. All of these specimens yielded M. celatum. On the basis of susceptibility data obtained from the first M. celatum isolate, chemotherapy was changed to a schedule that included isoniazid, ethambutol, and clarithromycin, which lasted until November 2001. This regimen proved to be well tolerated by the patient. The bacteriologic results (specimens from two additional bronchial washings were negative for AFB by smear and culture) and clinical response were good. In December 2001, chest x-ray examinations and a CT scan showed a considerable reduction of nodular lesions as well as improvement of lung cavitation (Figure). The patient was considered cured after taking medication for approximately 18 months.\\nClinical, microbiologic, and radiologic data as well, as information on response to treatment and follow-up, were obtained from the patient\\'s records. All material was carefully reviewed to evaluate the clinical significance of the findings according to the criteria proposed by the American Thoracic Society.\\nWe examined sputum and bronchoaspirate specimens for acid-fast organisms. They were stained with routine Ziehl-Neelsen stain and cultured by standard procedures by using a combination of radiometric Bactec system (Becton Dickinson Biosciences, Sparks, MD) and Lowenstein-Jensen medium. Amplification for MTB was performed by the LCx-MTB assay (Abbott, Diagnostics Division, Chicago, IL). Conventional identification and growth tests were performed according to standard methods. We tested recovered strains with the Accuprobe system using specific probes for MAC and MTB. Assays were run from liquid culture setting the unbound probe hydrolysis incubation time at 5 and 10 min and temperature at 60  +- 1 C. The amount of chemiluminescence emitted was estimated with a Leader 50 luminometer (Gen-Probe Inc., San Diego, CA, USA) and quantified as relative light units (RLUs). Definitive identification was achieved by mycolic acids high-performance liquid chromatography (HPLC) analysis. Drug susceptibility pattern was determined in 12B liquid medium (Becton Dickinson Biosciences) by using the radiometric macrodilution method developed for MAC.\\nSix isolates were recovered in a 6-month period. M. celatum was isolated from different specimens: two isolates were from bronchial washing and four from sputum. Acid-fast smears were positive in five of the six specimens. Cultures on Lowenstein-Jensen medium yielded multiple colonies, ranging from 100-150 CFU to a confluent growth. No additional microorganisms were isolated during the admission and follow-up period. Amplification tests performed on all respiratory specimens were repeatedly negative for MTB on smear samples positive and negative for M. celatum. M. celatum strains were isolated on both currently used media, radiometric liquid medium (Bactec 12B) and conventional Lowenstein-Jensen solid medium. We used an extended panel of biochemical and cultural tests for conventional identification. On the basis of these test results, the most likely identification, estimated by a program for the computerized identification of mycobacteria, appeared to be M. avium-intracellulare (Table). All strains isolated from this patient produced a weak yellow pigment in the dark, which grew at 45 C and were negative for arylsulfatase activity when tested after 3 days by the method of Kubica and Rigdon. The Bactec NAP test (Becton Dickinson Biosciences) did not demonstrate, as expected, any inhibition by para-nitro-alpha-acetilamino-beta-hydroxypropiophenone (NAP). The hybridization test performed with Accuprobe specific for MAC gave negative results. Weak positive or slightly below the cutoff (30,000 RLUs) results were observed with Accuprobe MTB (mean RLU value 51,170; range 28,219-111,365). When selection reagent (unbound probe hydrolysis) incubation time was set at 10 min, M. celatum strains clearly showed negative results (range 5,721-9,574; mean RLU value 7,210). A reference strain (M. tuberculosis ATCC 25177), run in the hybridization assay as a positive control, gave RLUs of 580,321, about 20 times the cut-off value. Finally, the strains were sent to the Mycobacteria Reference Centre in Florence, Italy (Dr. E. Tortoli), and studied by HPLC analysis of mycolic acids. They showed the same profile that allowed all of our strains to be attributed to M. celatum.\\nMICs (mug/mL) determined for the first isolate were the following: streptomycin, 2.0; isoniazid, 0.5; rifampin, >64.0; ethambutol, 2.5; ciprofloxacin, 1.0; ofloxacin, 1.0; clarithromycin, 1.0; ethionamide, 2.5; and rifabutin, 0.5. Drug susceptibility testing was completed after 6 days.\\nWe searched the English-language literature from 1993 to 2001 for all previously reported cases of pulmonary infections with M. celatum in immunocompetent patients. The search yielded two published reports. Descriptions of the clinical signs, radiologic findings, and treatment were not always available, however.\\nClinical and radiographic features of M. celatum pulmonary infection resemble those of tuberculosis and other nontuberculous mycobacterial infections. Cough and weight loss are the main symptoms, while pulmonary infiltrates and extensive cavitations have been described in all published reports. Patients did not suffer from any underlying diseases when pulmonary infection with M. celatum was diagnosed and had a strongly positive tuberculin skin test, suggesting immunocompetence. Published data and our findings indicate that M. celatum caused pulmonary disease, and not merely colonization, in the affected patients. Indeed, all of these cases met the American Thoracic Society criteria for the diagnosis of nontuberculous mycobacterial disease. The patients displayed radiographic evidence of pulmonary disease that could not be attributed to other causes and that was associated in two of three cases with the repeated isolation of the same mycobacterial strain. By contrast, clinical presentation in immunocompromised patients differs greatly, being characterized by interstitial pulmonary infiltrates or by clinical and micobiologic evidence of disseminated disease.\\nM. celatum strains were isolated on currently used liquid media in all reported cases (radiometric Bactec 12B and MB/BacT [Organon Teknika B.V., Boxtel, the Netherlands]), while samples from one of the published case-patients did not grow on conventional Lowenstein-Jensen solid medium, and growth has not been reported for samples from the second case-patient. Data from an extended panel of biochemical and cultural tests for conventional identification have not been reported; however, the appearance of a scotochromogenic pale yellow pigment with growth at 45 C and a negative 3-day arylsulfatase test are in full agreement with our present and previous findings. All strains showed a partial hybridization with Accuprobe MTB, which disappeared after 10 min of incubation with selection reagent. From a practical standpoint, setting the selection time at 10 min is advisable when the Accuprobe identification is performed on a mycobacterial culture grown in a liquid medium. In this situation, the characteristics of mycobacterial colonies cannot be observed and false-positive reactions may lead to misidentification. However, if the Accuprobe assay is carried out on a mycobacterial culture grown on a solid medium, a 5-min selection time is recommended. In this case, the appearance of mycobacterial colonies and their characteristics of growth may help to evaluate Accuprobe results. Thus, a weak positive reaction when testing nontuberculous mycobacteria with the M. tuberculosis complex Accuprobe strongly suggests that the organism is likely to be M. celatum.\\nIn one case, a misleading positive reaction occurred when a clinical sample containing M. celatum was tested for MTB by the Amplified M. tuberculosis direct test (AMTD, Gen-Probe, Inc.). The test amplifies 16S rRNA of Mycobacterium species by transcription-mediated amplification. The resulting amplicons are then detected by a hybridization protection assay by using a probe that targets the same genomic region as the probe of the Accuprobe kit. In our case, when we tested clinical samples by a different amplification system, no false-positive results potentially leading to a delay of appropriate treatment were reported. Patients (including our case-patient) were given different treatment regimens, with three or four antibiotics, mainly ethambutol, rifabutin, clarithromycin, and ciprofloxacin. Clinical improvement, as defined by resolution of symptoms and improved radiographic findings (infiltrates and cavitary lesions), was obtained within 6 months after initiation of therapy in two of three patients. One patient who received antimycobacterial therapy died 10 weeks after admission from complications apparently related to the M. celatum infection. Data from necropsy were not reported. Both cured patients showed a marked improvement when clarithromycin was added the chemotherapy regimen; the patient who later died felt better for 3 weeks when his chemotherapy was changed to a new schedule that included clarithromycin. Despite evidence of clinical and radiologic improvement, one patient was still sputum-positive 1 year after the initiation of therapy. In-vitro susceptibility data (when available) seemed to correlate with patients\\' clinical improvement as the MICs of tested drugs were below the serum concentrations achievable during therapy.\\nOur findings show that M. celatum is an infrequent cause of potentially treatable pulmonary disease in immunocompetent subjects. Clinical picture and repeated isolation from respiratory specimens enabled us to consider M. celatum strains as clinically relevant in all the patients reported. Treatment with a three- or four-drug combination, including clarithromycin and ethambutol, should result in considerable reduction in the illness associated with this disease. Although at present only 16S rDNA sequencing or mycolic acid HPLC analysis can confirm M. celatum identification, the most practical way to get a preliminary identification relies on a positive DNA hybridization signal for MTB at 5 min but negative hybridization at 10 min with the Accuprobe test. Finally, although no major immunologic disorder could be detected in these patients, the host\\'s defense failure associated with M. celatum infection suggests a possible \"hidden immunodeficiency\" rather than a true immunocompetence. Recent data on the immunology of nontuberculous mycobacterial infections seem to support this hypothesis.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 54,\n",
       "    'case_id': 'PMC8626178_01',\n",
       "    'case_text': 'A 54-year-old man presented with progressive shortness of breath, cough, and recurrent pneumonia. Chest examination was notable for reduced bilateral lung excursion, coarse breath sounds diffusely, and paradoxical breathing in the supine position. Pulmonary function testing suggested severe restriction with FVC of 27% predicted, FEV 1 28% predicted, normal FEV1/FVC ratio, and respiratory muscle strength < 10% predicted.\\nComputed tomography (CT) of the chest revealed basilar bronchiectasis and bilateral diaphragmatic elevation with associated atelectasis. Dynamic CT showed anterior displacement of the posterior tracheal wall at the distal trachea, bilateral main stem bronchi, and bronchus intermedius. Electromyogram demonstrated bilateral phrenic neuropathy and left brachial plexus neuropathy. Ultrasound confirmed the absence of diaphragm movement bilaterally. He had progressive clinical decline requiring near constant noninvasive positive pressure ventilation (NPPV). Dynamic bronchoscopy showed severe expiratory central airway collapse (ECAC) with >90% collapse of the trachea, main stem bronchi, and bronchus intermedius (Figure 1(a)). A stent trial (Figure 1(b)) was performed with placement of three uncovered self-expandable metallic stents in the left mainstem bronchus, distal and mid trachea and right mainstem bronchus and bronchus intermedius. This resulted in measurable improvements in the quality of life by validated questionnaires at two weeks and the stents were removed. He was recommended to undergo combined tracheobronchoplasty and right diaphragmatic plication.\\nThe initial surgery was aborted due to the inability to maintain adequate oxygenation during single lung ventilation. One week later, the procedure was successfully completed through right thoracotomy under venous-venous extra-corporeal membrane oxygenation (VV ECMO) support. Central airway stabilization was achieved by suturing a knitted polypropylene mesh to the posterior membrane of the trachea and bilateral main bronchi. Due to persistent ventilator dependency, left diaphragm plication through a left thoracotomy was performed 5 days postoperatively. He was discharged home on postoperative day #23.\\nAt follow-up evaluation, he no longer required NPPV and regained independence in activities of daily living. Pulmonary function testing showed improvement with FVC of 53% predicted, FEV1 42% predicted, and respiratory muscle strength 13% predicted. CT of the chest demonstrated improved lung volumes (Figure 2). Dynamic bronchoscopy showed improvement in the degree of ECAC (Figure 1(c)).',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 81,\n",
       "    'case_id': 'PMC6008880_01',\n",
       "    'case_text': \"An 81-year-old man presented with abdominal discomfort and distention. His medical history was remarkable for hypertension and type 2 diabetes mellitus. He and his family denied alcohol abuse. Physical examination revealed hepatomegaly without jaundice, ascites, or hepatic encephalopathy. Laboratory data included platelet count 101,000/mm3, total bilirubin 0.9 mg/dl, AST 33 IU/L, ALT IU/L, and PT-INR 1.15. The serum AFP and PIVKA-II levels were 1081.0 ng/ml and 43 mAU/ml. Serologic tests for hepatitis B and C virus were negative. The diagnosis of nonalcoholic steatohepatitis with Child-Pugh A liver cirrhosis was made and four HCC lesions were found in segments II, VI, and VIII on the imaging. The largest one was located near the liver capsule in segment II measuring 6.5 cm in diameter. The other three lesions were less than 2 cm with one in segment VI and two in segment VIII. Segmental TACE with epirubicin and iodized oil was performed and he was discharged uneventfully.\\nHe was doing well until he developed abdominal pain 15 days after TACE which was gradually getting worse emergency transport to the hospital. His temperature was 37.7 C, blood pressure 102/41 mmHg, and pulse rate 79/minute. On physical examination, the abdomen was distended and hard to palpation without rebound tenderness. His hemoglobin was 12.6 g/dl. A contrast enhanced computed tomography (CT) scan of the abdomen showed iodized oil and intraperitoneal free air with a rupture of the HCC in segment II into the peritoneal cavity adjacent to the gastric wall (Figure 1). Extravasation of contrast medium was not seen. Emergent upper gastrointestinal endoscopy confirmed no gastric mucosal lesions or a site of perforation. Without evidence of septic shock or hemorrhage, surgical drainage and transcatheter arterial embolization (TAE) are considered less effective. He was treated nonoperatively with piperacillin and tazobactam. Although an abdominal abscess formed, he was discharged on hospital day 18 with continued antimicrobial therapy.\\nFive weeks after undergoing TACE, he was readmitted with hematochezia and hemorrhagic shock. The hemoglobin level was dropped to 6.6 g/dl. A contrast enhanced CT scan demonstrated gastric extraluminal compression by an HCC lesion with extravasation of contrast medium into the stomach (Figure 2). Emergent upper gastrointestinal endoscopy showed a submucosal tumor with central ulceration located on the anterior wall of the gastric body, corresponding to extraluminal compression by a HCC (Figure 3). The hemorrhage from the ulcer was successfully controlled by hypertonic saline-epinephrine injection. Another submucosal tumor was found in the gastric fundus without ulcer formation (Figure 4). The patient's condition stabilized and he was discharged for palliative care and died six weeks after undergoing TACE.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 40,\n",
       "    'case_id': 'PMC5070353_01',\n",
       "    'case_text': 'A 40-year-old Tunisian female, without any past history of dysimmune disorder or arthralgia, developed progressive unsteadiness of gait worsening over 4 years. She had no familial history of gait disturbance. She complains also about tremor of limbs and head appearing since 1 year. On initial neurological examination, she was unable to walk, with a severe cerebellar syndrome including dysarthria and ataxia of four limbs and trunk. Motor power and sensory examinations were normal. Her deep-tendon reflexes were normoactive, and her plantar responses were flexor bilaterally. Bilateral rest and intention tremor of the four limbs and head was also noticed. She had no nystagmus, no bladder dysfunction, no parkinsonism and no cognitive impairment. General examination was otherwise normal. During her hospitalization, she complained about dry eyes and mouth.\\nComplete blood count, serum electrolytes, creatinine, glucose, coagulation tests, liver functional tests, lacticodeshydrogenase, blood sedimentation rate, lipids, and creatine kinase were normal.\\nBrain magnetic resonance imaging (MRI) showed bilateral hyperintensities on T2 and FLAIR sequences, affecting periventricular white matter, predominantly in the subcortical white matter. No gadolinium enhancement was found (Fig. 1). Marked cerebellar atrophy without signal abnormalities was notified (Fig. 2). Spinal MRI was normal. Visual evoked potential and electromyography were both normal. Toxic causes of cerebellar ataxia were ruled out by the interrogatory.  \\nThe cerebrospinal fluid contained 01 cell/ mm3 and 70 mg/dl of protein, and the glucose level was not decreased. There was no oligoclonal bands. Laboratory tests were positive for anti-Ro-SSA antibodies. Anti-nuclear antibodies were slightly positive (1/100) and speckled on immunofluorescence, DNA antibodies were negative. Assays for ss-B (anti-La), anti-phospholipids (cardiolipin and beta2 glycoprotein), anti-nuclear ribonucleoprotein (RNP), anti-Smith (Sm), anti-histone, anti PM-Scl, anti-PCNA, anti-Scl70, anti-centromere, anti-Jo1, anti-ribosomal and anti-nucleosome antibodies were all negative. Rheumatoid factor was also negative. HIV and hepatitis tests were negative. Paraneoplasic antibodies (anti-Hu, anti-Ri, anti-Yo, anti-PNMa2 and anti-CRMP5), anti-GAD, anti-gliadin, anti-transglutaminase, anti-thyroglobulin and anti-thyroid peroxidase antibodies were not detected. Anti-VGCC antibodies were not tested. The break up time test confirms the xerophtalmia. Salivary glands biopsy was not performed because of the important head tremor. The diagnosis of pSS with neurological complications was retained according to the 2002 American European classification criteria.\\nGenetic tests for Friedreich ataxia and ataxia with vitamin E deficiency were negative.\\nThe patient was treated by intravenous methylprednisolone (1 g/day), administered for 5 days followed by maintenance therapy with oral methylprednisolone (1 mg/kg/day) continued for 3 months, and then progressively decreased. She received Cyclophosphamid once per month for 6 months. Normocardil (60 mg/day) and Meprobamate (600 mg/day) were also administered for tremor. There was no significant clinical improvement, but her state did not worsened after 2 years of follow up. A second brain MRI, made 3 months after she received sixth dose of Cyclophosphamid, showed the same stable lesions.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 31,\n",
       "    'case_id': 'PMC4068338_01',\n",
       "    'case_text': 'This male patient was initially referred to the genetics clinic at 10 years of age for short stature, first noticed at the age of 2 years, and a rib cage deformity. He was born to a 31-year-old mother and a 45-year-old father. The parents denied consanguinity and there was no family history of skeletal dysplasia on either side. The patient had normal weight and length at birth; he met all developmental milestones appropriately and psychomotor development was normal. At the age of 10 years, the pertinent findings noted on physical examination included a height of 117.6 cm (-3.5SD) and an upper to lower segment ratio of 1.12 (+2SD). The chest examination was significant for a marked symmetrical deformity of the anterior thorax with normal sternum, \"hollowing\" of the ribs in the mid-parasternal region, and flaring of the lower costal margins. He was not dysmorphic and neurologic examination was normal. Color blindness and nystagmus with amblyopia were noted on ophthalmologic examination at the age of 10 years and endocrinology investigation was normal. A brain magnetic resonance imaging (MRI) scan, performed for headaches, was normal. The patient was seen again in the skeletal dysplasia clinic at the age of 14 years. At this visit, his height was 144 cm (-3SD), psychomotor and sexual development were normal, and no dysmorphic facial features were noted. On physical examination, scoliosis of the thoracic spine and rhizomesomelic shortening of the extremities were noted, with full range of motion in all joints. The chest deformity was unchanged. A follow up examination at the age of 16 years revealed that his height remained the same since the age of 14 years and no new physical findings were noted (Fig. 1). He continues to perform well in regular classes and reported gastrointestinal bleeding and microcytic anemia, leading to a diagnosis of ulcerative colitis.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 17,\n",
       "    'case_id': 'PMC9649972_01',\n",
       "    'case_text': 'A 17-year-old boy was admitted to the eye hospital in September 2007 due to sequential visual acuity (VA) loss, first on the right eye (RE) and 3 weeks later on the left eye (LE). Interestingly, the VA loss on the RE was accompanied by painful eye movements (timeline of the disease is presented in Table 1). In the spring of the same year, he reported an episode of vomiting and dizziness, with vertigo and weight loss. At that time, head computerized tomography (CT) was normal, so he was prescribed antidepressant drugs. Upon admission, VA on the right eye was counting fingers at 3 m, and 0.6 (Snellen) on the LE. Color vision on the RE was poor (1/15) although it was still relatively preserved on his LE 13/15 (Ishihara). Fundoscopy revealed hyperemic optic disks (papilla nervi optici/PNO) without vessel tortuosity and intraretinal hemorrhage at RE superior arcade (Figure 1a). The patient had no early leakage, but some staining of the PNO in the late phases of fluorescein angiography (Supplementary Figure 1A). There was central scotoma in his visual field which increased, with visual acuity decrease and delayed and decreased VEP P100 wave. Pattern ERG N95 wave at that time was still in the normal range, although of lower amplitudes in the worse eye (Figure 1a). The patient was treated with intravenous corticosteroid therapy Solumedrol i.v. (1g/day) for 3 days. Over the next 7 days, his LE visual acuity dropped to 0.3 and was followed by continuous visual function degradation for the next 2.5 months, when it reached the nadir of RLE 0.03 with color vision decreasing to 0/15 and 1/15. 7 years after the onset, visual function started improving with the appearance of the small fenestrations in the central scotoma of both eyes and the patient reached stable 0.1 Snellen bilaterally 14 years after the onset (Figures 1b, 2 and Supplementary Figure 2).',\n",
       "    'gender': 'Male'},\n",
       "   {'age': 18,\n",
       "    'case_id': 'PMC9649972_02',\n",
       "    'case_text': 'An 18-year-old boy was admitted to our hospital in September 2009 due to bilateral painless visual acuity loss which lasted for 3 weeks (timeline of the disease is presented in Table 2). Upon admission, his RE VA was 0.2 and LE 0.15 on the Snellen chart, whilst color vision was still, surprisingly, 15/15 (Ishihara) on both eyes.\\nFundoscopy was pathognomonic for LHON with circumpapillary telangiectatic microangiopathy, swelling of the retinal nerve fiber layer (RNFL) - pseudo edema, and vessel tortuosity without leakage on fluorescein angiography (Figure 1c and Supplementary Figure 1B). The electrophysiology showed decreased N95 wave and delayed and decreased VEP P100 (Figure 1c). The patient was treated with intravenous corticosteroid therapy Solumedrol i.v. (1 g/day) for 3 days without improvement. Over the next 5 months, his visual acuity further deteriorated to counting fingers at 1 m and his visual field scotoma enlarged. At 14 months, after 9 months of legal blindness, numerous fenestrations in central scotoma appeared and the patient VA improved to 0.2. During the next 3 years, the patient experienced continuous VA improvement. Visual acuity improved to 0.7 (Figure 1d), whilst the visual field has been continuously improving during the follow-up period (Supplementary Figure 3). It is also of interest to note excellent late improvement of color vision.\\nBoth of our patients had genetic testing for LHON after the presentation. They were first tested for three common mutations. Then, next-generation sequencing (NGS) of the mtDNA and NGS of the clinical exome (panel for the optic atrophy mutations known at that time) were carried out, followed by whole exome sequencing, which were all negative. For 14 and 12 years, respectively the patients were without a confirmed diagnosis up until recently when they were retested and DNAJC30:c.152G>A pathogenic homozygous variant c.152A>G (p.Tyr51Cys) in DNAJC30:c.152G>A gene was confirmed.\\nA short phenotype description of both patients was included in the article by Jarc Vidmar et al. due to some changes in mtDNA which later were not identified as pathogenic.\\nBoth of our patients had visual acuity improvement which was modest in case 1 (started at year 7 and improved from NADIR off chart to 0.1 during the next 7 years), and significant in case 2 (started at month 14 and continued for the next 2 years to reach stable 0.7 bilaterally). The visual acuity improvement in case 2 was accompanied by an almost complete recovery of the color vision, whilst there was no improvement of color vision in Case 1 (Figure 2). The visual recovery in Case 2 corresponded well to the VA change. During the period of VA deterioration, there was an enlargement of the central scotoma in the visual field. At 14 months, first fenestrations in the visual field appeared and VA started improving (Supplementary Figure 3).\\nThe peripapillary RNFL thickness decreased during the chronic phase in both patients, even with improved and stable visual acuity, and corresponded with the progression of the optic disc atrophy (Supplementary Figures 4, 5). In comparison to the controls, there was significant thinning of 360-degree retinal thickness in both patients (Supplementary Table 2). The greatest thinning was present in superior temporal, temporal, and inferior temporal parts both at 3.5 and 12 years (Supplementary Table 2). When we compared the RNFL thickness between the 3.5 and 12y check-up, Case 1 had an average decrease of the peripapillary RNFL thickness from 47.43 to 44.86 mum RE and from 42.71 to 40.14 mum on the LE. The greatest thinning between 3.5 and 12 y check-ups was noticed in the inferior temporal part of the optic disc (8.77% RE and 13.33 % LE). In Case 2, peripapillary RNFL thickness decreased from an average of 49.14 to 44 mum RE and 51.86 to 43.57 mum LE for all sectors. The greatest thinning was present in the inferior temporal quadrant of the right eye (14.29 %) and the superior temporal quadrant of the left eye (27.87%).\\nCase 2 had significant improvement in visual function which was also confirmed on microperimetry (Supplementary Figure 6). The first microperimetry was performed at month 14, when visual acuity started to improve. As can be seen, at onset, there was abnormal retinal sensitivity (0 dB) at all spots. The second recording was made 3.5 years after the onset, with the visual acuity bilaterally 0.7 when the mean sensitivity (MS) significantly improved (RE 6.3 dB +- 4.6 dB; range, 0-14 dB; LE 6.5dB +- 6.1dB; range 0-18 dB). The biggest MS improvement was noticed in temporal and nasal macular areas. At the last follow-up, MS somewhat decreased (RE 4.3 dB +- 4.7 dB, range 0-18 dB; LE 4.8 dB +- 5.03 dB, range 0-14 dB). The MS decreased on average RE 2 dB +- 3.9 dB and LE 1.75 dB +- 6.3 dB. Spatially, the most functional were the peripheral regions, especially the nasal and temporal macular area, while the lowest function was detected in the superior and inferior parafoveal region and in the area corresponding to the foveal center (Supplementary Figure 6). Fixation was relatively stable and almost central on all three visits (Supplementary Figure 6).\\nBoth of our patients had thinning of the overall retina, RNFL, GCL, and IPL in all ETDRS quadrants in comparison to healthy controls, whilst the outer retinal layers were well-preserved in comparison (Supplementary Figures 7-9).\\nThe delayed and decreased VEP P100 wave in the acute phase of the disease were present in both patients (Figures 1a,c). Case 1 had normal PERG at the first visit, while the N95/P50 ratio became abnormal 3 months later. At the last visit 4 years later, the quality of PERG recording was poor (probably due to problems with fixation caused by low visual acuity), however, an abnormal N95/P50 ratio was seen at least on the left eye, whilst the VEP P100 wave became undetectable. In Case 2, the amplitude of the N95 wave improved, but it remained abnormally shaped and at the level of the isoelectric line; the N95/P50 ratio remained abnormal (under 1), indicating dysfunction of retinal ganglion cells. The amplitude of the P 100 wave improved, but the latency remained delayed (Supplementary Figure 10).',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 81,\n",
       "    'case_id': 'PMC5019914_01',\n",
       "    'case_text': 'An 81-year-old grand-multiparous woman (G10 P8) presented to our clinic complaining of a vaginally protruding mass and urinary incontinence. The urinary incontinence was mixed (urgency and stress incontinence); however, the SUI component was dominant. Her past medical history was unremarkable. The general systemic physical examination was normal. On pelvic examination, total pelvic organ prolapse with anterior-posterior and apical prolapse (grade IV) was noted (Figure 1). A surgical approach including vaginal hysterectomy, anterior four-arm mesh implant, posterior large segment vaginal enterocele repair, and perineoplasty with levator ani fixation was planned.\\nOn the operation day, the patient was placed in dorsal lithotomy position under spinal anesthesia. A pericervical circular incision was performed on the vaginal mucosa. The vesicovaginal cleavage plane was found, and the bladder was retracted anteriorly. From the posterior of the cervix, peritoneal entry into posterior cul-de-sac was accomplished. Bilateral cardinal ligaments and sacrouterine ligaments were clamped with Heaney clamps, cut, and suture ligated. Bilateral uterine arteries were clamped, cut, and suture ligated. The anterior cul-de-sac peritoneum was opened. The uterine fundus was held with clamp and pulled out from the vagina by tumbling it backwards. Bilateral round ligaments, uteroovarian ligaments, and bilateral fallopian tubes were clamped, cut, and doubly ligated. McCall culdoplasty was performed with high peritonization. The vaginal cuff was closed in a continuous fashion with 2/0 polyglactin suture. The vaginal hysterectomy was thereby completed. A linear incision was performed on the anterior vaginal mucosa, on about 2.5 cm below the external urethral opening, and the space was dissected until reaching the bladder base. Vesicovaginal ligaments were retracted laterally. Proximal part of the mesh was passed over arcus tendineus fascia pelvis (ATFP) with an obturator fossa guide. The posterior part of the four-arm mesh was passed through the obturator foramen (Figure 2). The anterior arms were placed as a midurethral sling as in the intravaginal slingplasty (IVS) procedure, supporting the midurethra and bladder (Figure 3). Posterior fringes of the mesh were fixed on sacrouterine and cardinal ligaments. About an 8-10 cm piece of monofilament, inelastic polypropylene tape is attached to the underside of the vaginal apex. Polypropylene sutures are placed into both of the sacrospinous and cardinal ligaments and threaded through the lateral edges of the apical sling and tied down, restoring apical support. Posterior mesh arms were fixed at the skin level by performing traction, but anterior part was not fixed at the midurethra and skin level, and tension free placement was performed.\\nVagina mucosa was sutured in a continuous locking fashion with 2/0 polyglactin suture. In the same session, rectocele repair was performed. Rectovaginal fascial dissection was performed from posterior vagina and grade IV posterior prolapse was dissected broadly up to the apical region. Fascial defect was repaired with 2/0 polyglactin suture and a purse suture was placed. Excess vaginal mucosa was excised. A horizontal incision was made on the perineum, and perineoplasty was performed by enhancing puborectalis muscle medial region fixation. The vaginal mucosa and perineum were repaired using 2/0 polyglactin suture. Hemostasis was confirmed and the operation was concluded by placing a gauze tampon in the vagina. There were no intraoperative or immediate postoperative complications.\\nThe patient was discharged home at the second postoperative day. Follow-up visits at the first, 3rd, and 6th months were normal. There was complete symptomatic relief and objective cure of the POP and urinary incontinence symptoms.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 53,\n",
       "    'case_id': 'PMC3742348_01',\n",
       "    'case_text': 'A 53-year-old Caucasian woman was referred to our Psychiatry Unit for hospitalization by her general practitioner. Anamnestic data collection revealed that the patient had had a difficult adolescence, due to the fact that her father had had a mistress and suffered from pathologic gambling. Notwithstanding, she had not experienced any previous psychopathologic problems in the past. She was a housewife with two daughters, and the eldest daughter had always been in conflict with her mother. On the day of her admission to hospital, the patient had a fatuous expression, seemed apathetic, and was suffering from considerable psychomotor retardation. She was distrustful of other patients because they were \"too intrusive\". However, when approaching other patients, she showed a childish attitude and was disrespectful of conventional interpersonal distances. The patient had the delusional belief that her eldest daughter, whom she thought had disappeared for 12 months, had been replaced by an impostor. In fact, the previous year the patient\\'s daughter had left her house without telling her mother. The patient tried to get in touch with her, and the girl answered the phone saying that she was at work. Because her workplace was quite far off from her house, the patient thought that it was not possible for her daughter to arrive at work in such a short time. Hence, she believed that the person she had spoken to over the phone was an impostor who was replacing the daughter whom she thought had disappeared.\\nHer delusional belief was characterized by incorrigibility and unwarranted subjective conviction. The patient had two \"proofs\" to justify her belief: the distance of the workplace and the impostor\\'s makeup, which was heavier than that worn by her daughter.\\nThe patient was experiencing not only the tragedy of a mother who had lost her daughter, but also the frustration of continuous deception by the \"double\"/impostor. Indeed, the patient thought that the \"double\" was imitating her daughter\\'s way of speaking so as to convince her (the patient) that she (the \"double\") was her daughter. The patient had no idea where her daughter could be. However, she did nothing to find out where she was. In addition, even though she considered the impostor to be a menacing presence, the patient had a passive attitude towards the impostor, and treated her with indifference. Her mood was deflected owing to her daughter\\'s disappearance. Obviously, the patient had no insight into her illness. The Capgras delusion was the only unusual belief presented by this patient, who did not show any other psychotic symptoms. The clinical picture of this patient was peculiar: she was tormented by the thought of the \"double\" who, in addition, provoked a feeling of disgust. This feeling was caused by the fact that the \"double\" treated the patient in a confidential way in order to deceive her without feeling any real affection. This thought, which was particularly intrusive, caused her considerable distress and even disturbed her sleep; almost every night, she had difficulty in falling asleep at the thought of the painful condition of deception that she had to endure. In addition, this delusional belief was presented to the medical interviewers in an obsessive way, with perseveration regarding the subject (she constantly repeated that the woman was not her daughter), and the thought content restricted to it. The story about her daughter was the answer to simple questions that had nothing to do with the topic. The intrusive thoughts pertaining to her daughter\\'s disappearance and to the impostor were always present and did not fluctuate much over time.\\nGeneral physical examination was within normal limits. She did not drink alcohol or coffee, and did not use any illicit or recreational drugs. The Mini-Mental State Examination (MMSE) was 27/30, indicating normal cognition. Items of the MMSE that the patient was less able to complete pertained to calculation and to short-term and long-term memory. The Structured Clinical Interview for DSM-IV Axis II Personality Disorders indicated an unspecified personality disorder, with a preponderance of paranoid and obsessive-compulsive personality traits. The electroencephalogram was characterized by background alpha activity and rapid rhythms in the frontocentral regions, bilaterally, as shown in Figure 1. Magnetic resonance imaging (images obtained through fluid-attenuated inversion recovery, spin echo, and turbo field echo techniques, diffusion weighted in axial, sagittal, and coronal planes) showed moderate lesions in the frontal subcortical white matter and in the semioval centers on both sides. In particular, in long repetition time sequences, these cerebral areas showed hyperintensities compatible with a picture of gliosis, as shown in Figure 2.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 24,\n",
       "    'case_id': 'PMC4217363_01',\n",
       "    'case_text': 'A 24-year-old unmarried female presented to the outpatient clinic with painful swelling of the right sternoclavicular joint of 2-month duration without any discharging sinus (Figure 1). The swelling was gradually increasing in size and was accompanied with mild pain. The pain was dull, continuous, and limited to the site of the lesion. She also complained of neck stiffness and pain on neck movements. There was no history of any injury. History of cough, weight loss, night cries (severe pain at night), and low grade fever was present for the past 4 months. There was no history of previous tuberculosis or contact with an open case of tuberculosis. She had been prescribed several antibiotics and analgesics at another centre but had no symptomatic improvement. On physical examination the swelling (2 x 3 cm) was present over right sternoclavicular joint and was associated with presence of mild tenderness, erythema, and local rise of temperature. Laboratory tests revealed haemoglobin of 10.4 gm%; total leukocyte count was 10.300/mm3. Her ESR was 34 mm in first hour. She was negative for HIV based on ELISA method. On radiographic evaluation there was destruction with sclerosis on the medial end of the right clavicle along with features of diffuse pulmonary infiltrate (Figure 2). MRI revealed bilateral upper lung lobe infiltrate with arthritis of right sternoclavicular joint, with regional fluid collection. A destruction of the atlanto-axial junction, D7-8 intervertebral disc space along with a pus collection from D5 to D8 region could also be appreciated (Figures 3(a), 3(b), and 3(c)). An early morning sputum sample was sent for Ziehl-Neelsen (ZN) staining and it came out positive suggesting the diagnosis of pulmonary tuberculosis. Fine needle aspiration of the right sternoclavicular lesion was done using a 22-gauge needle and sent for Gram staining, staining for acid-fast bacilli (AFB), histopathology, and cultures including a tubercular culture. The histologic picture was that of chronic inflammation with a caseating granuloma compatible with tuberculosis. The Ziehl-Neelsen stained smear also showed the presence of acid-fast bacilli (AFB), confirming the diagnosis of tuberculosis. The culture for Mycobacterium tuberculosis came out as negative. Antitubercular chemotherapy with four first line antitubercular drugs (rifampicin, isoniazid, ethambutol, and pyrazinamide) was started. The patient had a good clinical response within 6 weeks and was switched to three drugs (rifampicin, isoniazid, and ethambutol) after 3 months of therapy with four drugs. The clinical, haematological, and radiological parameters showed complete healing of the lesion after 1 year of treatment with ATT, which was further continued for a total duration of 18 months. After successfully completing the therapy for 18 months, the patient was followed up for 2 years and showed no recurrence of symptoms.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 48,\n",
       "    'case_id': 'PMC7318809_01',\n",
       "    'case_text': 'In 2006, a 48-year-old male presented to an outpatient dermatology clinic with an enlarging cutaneous lesion on the right scapula. Histologic examination showed invasive BSCC. He underwent wide local excision, with the closest peripheral margin reported at 1 mm. He then received adjuvant external beam radiotherapy (45 Gray (Gy) in 15 fractions) due to the narrow margins. Two years later, he developed cutaneous recurrence at the periphery of the radiation field with clinical right axillary lymphadenopathy. A biopsy of the cutaneous lesion and fine needle aspiration of the right axillary lymph node confirmed a locally metastatic BSCC. He subsequently underwent a right axillary complete lymph node dissection with 3/18 positive nodes. He was treated with adjuvant chemoradiotherapy with weekly cisplatin and 54 Gy of external beam radiation in 30 daily fractions to the right axilla and supraclavicular lymph nodes.\\nHe had stable disease without recurrence until 9 years later, when he developed new onset neurological symptoms including headaches and photopsia. A subsequent brain magnetic resonance imaging (MRI) showed a 4.2 cm, large, irregular tumor in the right occipital lobe (Figure 1). He underwent parieto-occipital craniotomy for gross total resection of the tumor, with histological examination demonstrating BSCC. He then received adjuvant fractionated stereotactic radiotherapy (30 Gy in 5 fractions over 1 week). A staging computed tomographic (CT) scan of the chest, abdomen, and pelvis did not show any other evidence of metastasis. Post-craniotomy, his neurologic symptoms returned; however, repeat biopsy revealed necrotic brain tissue without malignancy. He is routinely seen in follow-up and is currently stable, without evidence of relapse. Immunotherapy will be trialed if there is evidence of disease progression.\\nAll the biopsies were retrospectively reviewed. Identical features of BSCC were present in all samples (Figure 2(a)). P16 immunohistochemistry was performed on samples from the brain lesions, which showed strong and diffuse cytoplasmic and nuclear positivity (Figure 2(b)). HPV DNA detection by genotyping demonstrated HPV16 positivity.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 36,\n",
       "    'case_id': 'PMC4659706_01',\n",
       "    'case_text': 'A G2P2 36-year-old female presented to her primary care physician for enlarged cervical and axillary lymph nodes in December 2010. She had no relevant family history nor known comorbidities apart from obesity (BMI: 33.9 kg/m2). The two previous pregnancies and deliveries had been uneventful. A routine blood test showed leucocytosis and lymphocytosis (55.340/mcl and 35.417/mcl, respectively), with mild anaemia (haemoglobin 11.5 g/dl). The immunophenotype of the peripheral blood revealed monoclonal B-lymphocytes (CD5+, CD23+) compatible with B-CLL. A fluorescence in situ hybridisation (FISH) test showed a chromosome 13 deletion (13DS319). A whole-body computerised tomography (CT) scan confirmed multiple pathological lymph nodes at cervical, mediastinal, axillary, coeliac, hepatic, and retroperitoneal stations. She received rituximab/cladribine combination for 4 cycles followed by maintenance rituximab every 2 months for a total of eight administrations. No significant toxicities were reported and the patient achieved a clinical and radiological complete response, with minimal circulating residual disease. Seventeen months after the end of rituximab, the patient got unintentionally pregnant. Her white blood cell count was 15.350/mcl with 9.970 lymphocytes/mcl, and all the other haematological parameters were within the norm. A cervical, axillary, and inguinal ultrasound was normal and the embryo was well implanted. At 28 weeks gestation, a glucose curve demonstrated gestational diabetes that was treated with diet and subcutaneous insulin. The foetal parameters were normal, without intrauterine growth restriction (IUGR) or macrosomia. At 32 weeks gestation, the patient presented with high fever, shivering, and cough. A thoracic ultrasound performed demonstrated left lobar pneumonia that was successfully treated with intravenous ceftriaxone and clarithromycin. At 34 weeks, the patient developed cholestasis with elevated liver enzymes, hyperbilirubinaemia and pruritus treated with ursodesossicholic acid; at 36+ weeks gestation, steroids were administered in order to increase the foetal pulmonary surfactant, as an amniocentesis performed showed that full foetal maturity was not yet reached. Because of the concomitant presence of cholestasis and suspicion of maternal disease progression (progressive leucocytosis, lymphocytosis, and thrombocytopenia) an increased risk of endouterine death was recognised and anticipation of labour was decided. Therefore, at 37 + 4/7 weeks, labour was induced with cervical prostaglandins and the patient delivered a healthy 3,580 g female baby, with an Apgar score of 10/10 at 1 and 5 min, respectively. There were no obstetric or neonatal postpartum complications. Four months after delivery, her lymphocyte count started to increase and an ultrasound assessment showed several pathological lymph nodes (cervical, axillary, hepatic). She remained under close observation with monthly haematological and clinical examinations. At the time of this report, she is still under surveillance without any treatment.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 63,\n",
       "    'case_id': 'PMC7566087_01',\n",
       "    'case_text': 'A 63-year old woman with a medical history of combined liver and kidney transplantation due to autosomal dominant polycystic kidney disease in 2016 was referred because of iron deficiency anemia and a persistent cough.\\nApproximately one year prior to admission, the patient had a colonoscopy because of a positive fecal occult blood test, which showed the presence of diverticulosis and internal hemorrhoids. Approximately 6 months later a control colonoscopy and a gastroscopy were planned because of worsening anemia with iron deficiency. In addition, a few weeks before presentation, the patient developed a non-productive cough and a low-grade fever. A chest X-ray revealed multiple bilateral patchy lung infiltrates. This was confirmed by computed tomography (CT), raising the suspicion of an underlying opportunistic infection or lymphoproliferative disorder (Fig. 1).',\n",
       "    'gender': 'Female'},\n",
       "   {'age': 7,\n",
       "    'case_id': 'PMC7566087_02',\n",
       "    'case_text': \"Upon admission, the patient reported an ongoing dry cough, fatigue, intermittent fever and night sweats. She had noticed a weight loss of 3 kg in the last 3 months. On examination, body temperature was 37.9  C, oxygen saturation was 98 % while breathing ambient air, other vital signs were normal. She looked pale but was comfortable. The lungs were clear on auscultation, with no crackles nor rhonchi. There were no lymphadenopathies noted, further clinical examination was unremarkable. Laboratory findings (Table 1) showed a decreased hemoglobin level of 8.1 g/dl (normal value, >12 g/dl), an elevated C-reactive protein level of 32 mg/L (normal value, <5 mg/l), a normal total white blood count with neutrophilic predominance. Electrolytes and liver function were normal. Creatinine level was in line with previous values. Additional medical history included nephrectomy of the right native kidney in 2016 at the time of transplantation and cytomegalovirus reactivation early after transplantation for which a 3 months course of valganciclovir was administered. Maintenance medication consisted of mycophenolate mofetil 1000 mg daily, tacrolimus 4,5 mg/day and a calcium/vitamin D supplement. The patient was born in Suriname. She lived there until she was 7 years old and then moved to the Netherlands. She moved to Belgium at the age of 11, where she currently resides. There was no history of recent travels outside Europe. She had never smoked. The donor was a 50 year old male originally from Flanders, Belgium who died from a head trauma in a traffic accident. He had no medical history, took no maintenance medication and had a negative infectious screening at the time of donation except for a positive CMV serology. There were no post-transplant diseases reported in the other organ recipients.\\nOn admission a bronchoscopy was first performed, which was macroscopically normal. Cultures and a respiratory PCR panel of the lavage fluid were obtained. Colonoscopy showed a bulging mass arising from the ileocecal valve, suspicious for a tumoral process from which biopsies were taken (Fig. 2).\\nHence, a tentative diagnosis of a colorectal tumor was made. However, given the patient's immunocompromised state and the bilateral patchy lung infiltrates, the suspicion of a concomitant opportunistic lung infection remained.\\nConsidering the hypothesis of colon cancer, additional abdominal imaging was warranted. A positron emission tomography-CT (PET/CT) with 18F-fluorodexyglucose (18F-FDG) was performed to evaluate the lung lesions, and as a staging tool for the putative colon cancer. PET/CT showed multiple mesenteric lymph nodes and a tumoral mass in the terminal ileum at the ileocecal valve and one in the descending colon (Fig. 3). These radiographic findings were highly suspicious for an underlying post-transplant lymphoproliferative disorder (PTLD). In contrast, the diffuse pulmonary nodules and opacities throughout both lungs were rather suspected to be of infectious origin. There were hypermetabolic lymphadenopathies in the right lung hilum and at the right-sided pretracheal level (4R).\\nDuring the patient's hospital stay, she developed intermittent high-grade fever (40  C) together with increasing C-reactive protein level (100 mg/L). Otherwise she remained in general good condition, without oxygen need. Repetitive blood cultures were all sterile.\\nIn addition, cultures of the bronchoalveolar lavage came back negative, including auramine staining and culture for acid-fast bacilli, as was aspergillus antigen (galactomannan). The respiratory panel (polymerase-chain-reaction, PCR) showed only the presence of respiratory syncytial virus (RSV), which was being considered clinically irrelevant. PCR for cytomegalovirus and pneumocystis pneumonia were also negative.\\nAdditional blood tests were negative for Epstein-Barr virus DNA but revealed an increased blood level of 1,3- beta-d-glucan (90 pg/mL; <60 pg/mL: negative; >80 pg/mL: positive) and negative galactomannan (index 0.3).\\nSince there was still no clear diagnosis, the patient was referred to the abdominal surgery department for an exploratory laparoscopy with lymph node excision for pathological examination, culture, panbacterial PCR and panfungal PCR.\\nWhile awaiting the results of the lymph node specimen, the pathological examination of the ileocecal mass became available. It showed inflammation with lymphocytes and histocytes without signs of malignancy. In the cytoplasm of the histocytes rounded organisms were identified (Fig. 4). Grocott's methenamine silver stain revealed organisms morphologically consistent with Histoplasma capsulatum, these results were later reproduced on the lymph node biopsy. Eventually, culture and panfungal PCR of the lymph node confirmed the presence of Histoplasma capsulatum.\\nA diagnosis of disseminated histoplasmosis with pulmonary and intestinal involvement was convincingly made and the patient was started on high dose itraconazole (loading dose of 200 mg three times daily for three days, subsequently twice daily). At that time, we took a thorough lifelong travel history which revealed travels to North America (New York City and Washington D.C.), Suriname and Indonesia more than 20 years prior to transplantation.\\nThe patient remained febrile throughout the first two weeks of antifungal therapy. Itraconzole blood concentrations were within the therapeutic range (1-2 mg/L). Tacrolimus oral dose had to be reduced from 4.5 mg daily to 0.5 mg/day as a result of the known drug-drug interaction between itraconazole and tacrolimus in order to maintain target concentrations. Approximately after one month of treatment, the patient was discharged from the hospital while continuing to have a cough and fatigue, whereas the fever resolved, and her C-reactive protein level decreased to near normal.\\nTen days after discharge the patient was readmitted with diffuse abdominal pain, nausea and vomiting. She reported absence of stool for 5 days. On clinical examination the abdomen was distended, no muscle resistance observed, and bowel sounds were reduced. CT revealed a small bowel obstruction secondary to thickening of an ileal intestinal segment. The patient was conservatively managed with intravenous fluid, a nasogastric tube in suction and she was put on IV posaconazole as IV itraconazole is not available in Belgium. While this strategy initially seemed successful, one-week later symptoms recurred and a decision for surgery was made. Laparoscopic resection of two small bowel segments was performed. Histological examination of both specimens confirmed active histoplasmosis infection as the underlying cause of obstruction. Six out of 10 resected lymph nodes also showed signs of active infection. After regaining intestinal transit, oral itraconazole was restarted with a 3-day loading dose and continued at a maintenance dose of 2 x 200 mg/day for a planned duration of 12 months. Five weeks after discharge from the hospital the patient started to have improved appetite and regained weight. Fever and cough had disappeared. A plain chest x-ray demonstrated partial regression of the lung lesions. Itraconazole blood concentration remained within the therapeutic range.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 73,\n",
       "    'case_id': 'PMC8226359_01',\n",
       "    'case_text': 'A 73-year-old man noticed that he could not chase a golf ball 2 months previously, and also became aware of narrow field of vision and metamorphopsia in the right eye. At the visit to an ophthalmologist, he was found to have a large nonpigmented dome-shaped choroidal mass in the superotemporal quadrant of the midperipheral fundus of the right eye, associated with serous subretinal fluid, which extended to the macular area and inferior to the choroidal mass (Figure 1A and B). The vitreous and anterior chamber in the right eye had no pigments or cells. The left eye had nothing particular. The best-corrected visual acuity in decimals was 0.4 in the right eye and 1.2 in the left eye. The intraocular pressure was 15 mm Hg in the right eye and 17 mm Hg in the left eye. He had been undergoing hemodialysis 3 times a week for 3 years due to chronic renal failure from glomerulonephritis. He had no systemic symptoms and was well with daily medications of amlodipine 10 mg, benidipine 4 mg, clopidogrel 75 mg, lansoprazole 15 mg, precipitated calcium carbonate 1000 mg, calcium polystyrene sulfonate 1000 mg, cinacalcet hydrochloride 25 mg, and pantethine 300 mg. He also took intravenous injection of maxacalcitol 5 microg 3 times a week at the time of hemodialysis and subcutaneous injection of darbepoetin alfa 40 microg once a week.\\nWith the diagnosis of metastatic choroidal tumor, primary and other metastatic sites were searched for by whole-body 2-[18F]fluoro-2-deoxy-D-glucose PET (FDG-PET). Abnormal uptake was found in the prostate (standardized uptake value [SUVmax] = 4.75; Figure 2C), vertebral bones (SUVmax = 8.01; Figure 2D), bilateral hilar and mediastinal lymph nodes (SUVmax = 5.77; Figure 2E), and bilateral lung fields, in addition to the right eye (SUVmax = 3.31; Figure 2B). The combined computed tomography (CT) scan showed multiple lung-field nodular lesions on both sides (Figure 2F), indicative of metastatic lesions in the lung. Head magnetic resonance imaging showed an intraocular mass with mildly high T1-weighted signal, mildly low T2-weighted signal, and high diffusion-weighted signal in the right eye (Figure 2A), but no intracranial abnormalities. He was referred to a urologist for prostate cancer as the primary site. Serum PSA was extremely elevated to 541 ng/mL, which supported prostate cancer as the primary site. He began to receive subcutaneous injection of degarelix acetate at the initial dose of 240 mg, followed by 80 mg every 4 weeks. One month after the initial visit, the choroidal tumor resolved rapidly and became flat degeneration in response to the initial dose of hormonal therapy (Figure 1C). Two months after the initial visit, needle biopsy of the prostate showed poorly differentiated adenocarcinoma with Gleason score of 4 + 4 = 8 (Figure 3A and B), which was indeed a presumed value as he was under hormonal therapy. He immediately underwent surgical castration, and degarelix was discontinued.\\nOne year after the initial visit, the serum PSA in the patient with no medication remained at the low level of 0.48 ng/mL. The serum PSA was gradually elevated to 2.34 ng/mL 2 years after the initial visit, further elevated to 3.56 ng/mL 3 years after the initial visit, and to 6.05 ng/mL in the following 3 months. CT scan demonstrated multiple bony osteosclerotic metastases in thoracic and lumbar vertebrae but no metastasis in the liver or lymph nodes. At this time point, therefore, he began to take oral bicalutamide 8 mg daily, and in 1 month, the serum PSA decreased to 0.61 ng/mL. The serum PSA was elevated again to 1.22 ng/mL 5 years after the initial visit, and thus, bicalutamide was replaced with enzalutamide at a full dose, 160 mg daily, leading to the decrease of serum PSA to 0.38 ng/mL in 2 weeks. In a month, however, because of hypertension, the administration of enzalutamide was reduced to half a dose 80 mg daily, and in another month, was replaced with abiraterone acetate at half a dose, 500 mg daily in combination with prednisolone 10 mg daily. The serum PSA became an undetectable level (<0.009 ng/mL) in 2 weeks. The patient was well with hemodialysis and maintained the undetectable PSA level with continuous abiraterone until the latest follow-up 6.8 years after the initial visit. Throughout the course, the right eye showed flat retinal regeneration corresponding to the area of the previous choroidal tumor (Figure 1D). The best-corrected visual acuity was 1.0 in both eyes.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 12,\n",
       "    'case_id': 'PMC4768458_01',\n",
       "    'case_text': 'A 12-year-old male child with a 3-month history of bilateral, constant, radiating lower limb, and back pain was brought to Institute Rotary Cancer Hospital (IRCH) by his father. The patient described the pain as an aching, throbbing, stabbing pain, and rated it a 9/10 on the Verbal Analogue Scale (VAS). He stated that he had not been able to walk or do any of his regular physical activities for a month. He had associated weakness and paresthesias in his legs bilaterally. He was unable to sleep at night for the past 2 weeks, due to back pain that was elicited by lying down. The patient also had associated constipation and urinary retention for which he had to be catheterized.\\nWhen the patient came to the pain clinic, he was held in his father\\'s arms, as the patient was paralyzed from the waist down. On physical examination, the patient appeared to be in severe pain. Deep tendon reflexes were not present in bilateral lower limbs. Muscle strength was 2/5 on the Oxford Scale (muscle strength grading scale) in bilateral limbs (hip/knee/ankle). Sensation to pinprick and soft touch were diminished over the gluteal regions and legs. Upon palpation of the patient\\'s legs, he felt electricity running through his legs. The patient denied any other symptoms.\\nIn March 2015, the patient had sudden onset of excruciating left lower quadrant abdominal pain. In April 2015, he underwent an exploratory laparotomy and excision of a growth between the spleen and renal space. Pathology reports suggested the growth was a CD99 and vimentin-positive YST. Further tests were conducted such as an ultrasound to see if there was any involvement of the testes. Results showed no gonadal involvement.\\nThe patient\\'s father stated that the patient was attending school, running, and was pain-free until 15 days postoperatively. The doctors at his local hospital were unable to find the etiology of his postoperative pain. The patient was referred to a different hospital for consultation. A CT scan was done that showed a heterogeneous mass in the left suprarenal region, suggestive of a residual mass that was infiltrating the posterior abdominal wall and muscle. A whole abdomen contrast-enhanced computed tomography (nonionic CECT) revealed a devascularized left kidney possibly due to left renal artery injury. After various inconclusive testing, the patient was referred to IRCH (AIIMS.)\\nAt the time of the patient\\'s presentation at IRCH his condition had progressively worsened. He had developed bilateral paralysis, severe lower lumbar back pain, and bilateral leg pain. Many investigations were initiated which included complete blood count (CBC), liver function tests, complete metabolic panel, blood test checking for thyroid-stimulating hormone (TSH), beta-human chorionic gonadotropin (beta-HCG), and alpha-fetoprotein (AFP) levels, comparison CECT scan, ultrasound of neck to check for lymph node involvement.\\nCBC showed hemoglobin was 10.4 (normal range: 13.5-17.5 g/dl for males), thin layer chromatography was 24.8 (normal range: 4000-11,000). Liver function tests showed that bilirubin levels were below the normal range at 0.2 mg% (normal range: 0.8-1 mg%), TSH and beta-HCG were within normal limits, but AFP 3 was 0.52 ng/ml (normal range: 0.89-8.78 ng/ml). Ultrasound of the neck showed no sign of metastasis to lymph nodes or glands. The CECT scan was unchanged compared to the previous scan. The mass seen previously was causing erosion of the left 12th rib with extension into neural foramina with suspicious intraspinal extension. No metastatic lung nodules were visible.\\nBased on the patient\\'s history, physical exam and investigations, the diagnosis of primary retroperitoneal extragonadal YST extending into the neural foramina of the spinal cord at L1/L2 was made. The metastasis was causing compression of the spinal cord producing his paralysis. For management of this patient the medical oncologist, surgical oncologist, and radiologist were consulted. Due to the extent of cancer, further surgery was no longer an option. Although the paralysis was not reversible, the pain, with the help of proper pain management, and palliative care team was treatable.\\nWhile interacting with the patient and his father, I could see that the patient\\'s father was distraught about his son\\'s condition. Medical treatments for the patient had taken a financial toll on the family. The patient\\'s father had to sell off his land where he was farming in Patna, Bihar in order to pay for proper treatments. He expressed to me that he was willing to sell his house too if it meant we could make his son walk again. The patient\\'s mother became severely depressed and threatened to commit suicide if her son\\'s health did not improve. Despite explaining that at this stage only the pain of the patient could be managed and that the paralysis was permanent, the father was in denial. He kept saying, \"Please make my son walk again, that is, all I want.\" Family bonds are reasonably vulnerable during the time of distress, and the entire palliative care team provided a positive and supportive environment so that they could communicate their needs most effectively.\\nThe patient was initially started on infusion morphine, which was dose titrated appropriately and later converted to tablet morphine. Dexamethasone was prescribed to reduce the swelling caused by the compression of the spinal cord. He was given gabapentin for the neuropathic pain, which was converted, to tablet pregabalin. Studies suggest pregabalin provides equivalent efficacy to gabapentin, however, at much lower doses. Because lower dosages can be used to treat neuropathic pain, it is likely that pregabalin will be associated with fewer dose-related adverse events such as dizziness, chest pain, difficulty breathing, and constipation. Pregabalin requires lower dosages, has a much higher bioavailability (90% vs. 33-66% of gabapentin) and is rapidly absorbed (peak: 1 h).\\nMorphine reduced the pain from 9/10 to 4/10 on the VAS. To further relieve the patient\\'s pain, we discussed chemotherapy and attempting a nerve block. The father cited apprehensions for both of these treatment options. The patient\\'s father was explained the positive impact the procedure would have on relieving his son\\'s pain, and that his son would be able to sleep peacefully and be pain-free. He was told giving chemotherapy would not have reversed the neurological deficit but would have definitely reduced the pain by treating the cause. The father had seen many unfortunate situations about what can happen after chemotherapy is given and explained to us how he knew some people that had died in his village after chemotherapy was given. He was further explained all the benefits chemotherapy would have on not only the pain the patient was experiencing but also in slowing down the progression of metastasis. All his questions were addressed, and he was told that the situation in which other people might have received chemotherapy might be different than his son\\'s. When explained how attempting a nerve block could be beneficial, the father again refused and said he heard it would permanently damage his son\\'s nerves. The whole palliative care team made many efforts to make the patient\\'s father understand exactly how these treatments would be given as well as how all the side effects would be managed for both the nerve block and chemotherapy, but the father was convinced that these will only cause harm to his son based on what he had seen and what people told him about these medical advances in his village. Even after multiple attempts of ensuring the father that this would be the next best option for his son\\'s pain, consent was not given, so these treatments were not given. One of the major components of palliative care is respect for patient\\'s autonomy. Due to lack of health literacy there are many proven, working treatments that are simply not done.\\nThe patient\\'s pain was managed based on the World health Organizations Cancer pain protocol (WHO ladder). This included the analgesics tablet Morphine (P) 10 mg three tablets 4 hourly, tablet paracetamol (acetaminophen) 500 mg one tablet QID and tablet pregabalin 75 mg HS x 6 weeks. Anti-emetics were given to avoid nausea and vomiting, the patient was experiencing. For GI ulcer prophylaxis tablet pantoprazole 40 mg once daily was prescribed. Tablet dexamethasone 4 mg TDS x 7 days was also given and later changed to 2 mg TDS x 7 days. After monitoring the patient\\'s pain and bringing it down to a 3/10 on the VAS, the patient was counseled and sent to a nonprofit organization called Cankids (Cankids is a registered charitable national society working to make a change for childhood cancer in India.) There, he would receive further pain management treatments and psychosocial support through counseling for him and his family.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 24,\n",
       "    'case_id': 'PMC4942733_01',\n",
       "    'case_text': \"The patient was a healthy 24-year-old woman with an anterior open bite (3 mm overbite, 4 mm overjet, 2 mm Angle class II anterior occlusion, and 2 mm Angle class III posterior occlusion) who had been undergoing orthodontic treatment for 2 years (Fig. 1A-C). She presented to the Oral and Maxillofacial Surgery Center of Pontificia Universidade Catolica do Rio Grande do Sul for treatment of her dentofacial deformity, with a chief complaint of difficulty chewing with the front teeth. Written informed consent was obtained from the patient for publication of this case report, including accompanying images, and the manuscript was written in accordance with the CARE criteria.\\nA cone-beam computed tomography (CBCT) scan was performed using an i-CAT system (Image Sciences International, Hatfield, PA, USA). Three-dimensional (3D) images were constructed using Dolphin Software (Dolphin Imaging and Management Solutions, Chatsworth, CA, USA). Surgical planning was based on the patient's chief complaint, facial analysis, and 3D cephalometric analysis. Based on these factors, monomaxillary surgery with Le Fort I osteotomy was chosen for 2 mm advancement of the posterior maxilla and a V-shaped segmental maxillary osteotomy between teeth UR3/4 and UL3/4 for 8  clockwise rotation and 5-mm down repositioning of the premaxilla, thereby modifying occlusion to Angle class I and closing the anterior open bite (Fig. 1D-F). Reconstructions of the segmented osteotomies showed a gap of approximately 4.1 mm in the area between teeth UR3/4 and UL3/4 and approximately 4.8 mm on the floor of the nasal fossa (Fig. 2). As such, the decision was made to place a bone graft.\\nThe patient was placed under hypotensive general anesthesia. The maxillary vestibular approach was used for surgical access and detachment of the nasal fossa mucosa. Next, a Le Fort I osteotomy was performed and, after down fracture, a V-shaped segmental maxillary osteotomy was made between teeth UR3/4 and UL3/4 and behind the incisive foramen to correct the anterior open bite and over-projection of the anterior teeth. Osteotomies were performed using NSK VarioSurg piezoelectric instruments (NSK America Latina Ltda, Joinville, Santa Catarina, Brazil).\\nThe splint was attached to the orthodontic appliance with a steel wire. Once the maxilla and mandible were stabilized in occlusion, the surgery was considered to be in accordance with the virtual plan. Then, as previously established, bone grafting was performed by placing 2 g of small Bio-oss  granules (Geistlich Pharma AG, Wolhusen, Switzerland) into the surgical gaps. These areas were then covered with a Bio-Gide  collagen membrane (Geistlich Pharma AG, Wolhusen, Switzerland).\\nThe maxilla was positioned for rigid internal fixation with bilateral L-shaped miniplates in the zygomatic buttress and bilateral L-shaped microplates around the piriform aperture, to ensure stability of the collagen membranes for bone graft protection (Fig. 3).\\nThe surgical splint remained in place for 30 days with maxillomandibular fixation, after which time the patient was instructed to follow a liquid/semisolid diet and avoids chewing. The overbite improved from -3 mm to 2 mm and overjet from 4 mm to 2 mm, ensuring closure of the anterior open bite and maintaining coordination between the posterior and anterior segments of dental occlusion at Angle class I (Fig. 1G-I) Repeat CBCT performed 6 months after surgery revealed bone formation with density greater than that of the tissue surrounding the segmental maxillary osteotomy, providing stable occlusion (Fig. 4).\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 86,\n",
       "    'case_id': 'PMC9614080_01',\n",
       "    'case_text': 'The patient, female, 86 years old, felt that her left eye was red and secretions increased in May 2020. She went to the local clinic and was given drug treatment (the specific medication is unknown). But the curative effect was poor. She went to the local hospital seven months later and was diagnosed as \"left eye tumor\". Then, she was recommended to go to the superior hospital for diagnosis and treatment.\\nOn 27 January 2021, the patient went to the Lanzhou University Second Hospital and was diagnosed as \"left eyelid tumor\". On 1 February 2021, histopathological diagnosis was: (left eyelid conjunctiva) squamous epithelial papilloma, mild to moderate atypical hyperplasia of epithelium, accompanied by suppurative inflammation. Therefore, \"left eye conjunctival cryosurgery\" was performed under local anesthesia on 22 February 2021 and 16 March 2021.\\nThe patient felt that the tumor in his left eye increased rapidly, accompanied by obvious swelling and pain, loss of vision and difficulty in opening her eyes. She was treated in the first people\\'s hospital of Lanzhou city on 7 April 2021. The diagnosis was: space occupying in the left eye orbit, and surgical treatment was recommended.\\nThe patient was admitted to Lanzhou Huaxia ophthalmic hospital for surgical treatment on 20 April 2021.\\nEye examination: The upper eyelid of the left eye is red and swollen, the dermatoglyphs disappear, and it is difficult to open the eyes. The upper eyelid can touch a size of about 30 mm  x  20 mm mass with unclear boundary, hard texture, poor activity, obvious tenderness, bulbar conjunctival congestion and edema, corneal conjunctivalization, and other structures cannot be seen clearly; the international standard visual acuity chart was used to check the visual acuity: the naked visual acuity was 0.2 in the right eye and no light perception in the left eye; the intraocular pressure was measured by non-contact tonometer: 11.5 mmHg (1 mmHg = 0.133 kpa) in the right eye and 46.5 mmHg (1 mmHg = 0.133 kpa) in the left eye (Figures 1A-C).\\nOcular ultrasonography: the upper part of the left eyeball is about 30 mm x 19 mm heterogeneous hypoechoic mass with unclear boundary, pressed close to the eyeball wall and sunken into the ball.\\nColor Doppler flow imaging (CDFI): point and strip blood flow signals can be seen in eyeball.\\nEnhanced MRI examination of orbit and orbit: irregular soft tissue signal shadow can be seen in the left orbital diaphragm, inside and outside the muscle cone and lacrimal gland area, which is filled in the orbit as frozen and extends backward into the optic nerve canal. T1W1 shows equal signal, T2W1 and DW1 show slightly high signal, the internal signal is uneven, and the space occupying effect is obvious. The left eyeball is compressed, deformed and moved forward, the eyeball wall collapses, and the left optic nerve is compressed, the external rectus muscle of lacrimal gland was not clearly displayed. The left orbit and optic canal are enlarged, and no abnormality is found in the bone. The enhancement scan was performed immediately after 15 ml gadolinium diamine contrast agent was injected through elbow vein. It showed that the signal shadow of soft tissue in left diaphragm, inside and outside muscle cone and lacrimal gland area was significantly enhanced, and there was spotted low signal shadow inside, and there were no abnormal enhancement changes in the rest (Figures 2A,B).\\nExclude cancer metastasis diagnosis: In order to exclude metastatic cancer, the patient underwent systemic examination, and no abnormality was found in gynecological examination; No space occupying lesions were found in brain MRI, chest x-ray examination, neck and abdominal ultrasonography (liver, gallbladder, pancreas, spleen and double kidneys); No obvious abnormality was found in liver and kidney function and blood routine. Metastatic cancer and systemic lesions can be excluded.\\nLeft eye orbital tumor resection: Due to the patient\\'s old age and the request of her family to retain the patient\\'s eyeball, the \"left eye orbital tumor resection\" was performed under general anesthesia on 22 April 2021. The postoperative histopathological diagnosis was: (left eye) malignant tumor, consistent with squamous cell carcinoma, with extensive infiltration of cancer tissue into stroma and multifocal necrosis (Figures 2C,D).\\nApoptosis detection: The cell apoptosis in patient tumor tissues was detected by mIHC(mutiplex immunohistochemistry). The expression of CASPASE3,8,9 and BCL2, BAX were determined by mIHC. It was showed that all of the apoptosis markers were extensively expressed in the tumor tissues, which infer to there was ubiquitous apoptosis in tumor tissues (Figure 3).\\nThe immune cells infiltration detection: The immune cells infiltration in tumor tissues were detected by mIHC. CD3 is the total T lymphocyte marker, CD4 is the helper T lymphocyte marker, CD8 is the cytotoxic T lymphocyte marker, CD11C is the natural killer cell, and F480 is the macrophage marker. It was showed that there were lots of CD3, CD4, CD8 and F480 expression in tumor tissues, except for CD11C (Figure 4).',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 72,\n",
       "    'case_id': 'PMC1236954_01',\n",
       "    'case_text': 'A 72-year-old Caucasian woman was complaining of bloody stools and constipation for three months. There was a palpable mass 3-4 cm from the anal verge. A colonoscopy showed a tumor 3 cm from the anal margin with no other indication of multiple synchronous tumors in the colon. Biopsies of the tumor were positive for adenocarcinoma. An investigation with upper gastrointestinal endoscopy, computed tomography of chest and abdomen showed cholelithiasis with thickening of gallbladder anterior wall (arrow in the figure 1). No evidence of metastatic disease documented. Blood examinations showed anemia (Ht: 28,5% and Hb: 9,5 g/dL) and the rest laboratory evaluation was normal. The carcinoembryonic antigen (CEA) was: 15,9 ng/ml (range 0,0-10,0). She had a cholecystectomy and abdominoperineal resection of the rectum. The histopathological diagnosis was a moderately differentiated adenocarcinoma of the gallbladder (T2, N0, M0; stage II) and differentiated moderately adenocarcinoma of the rectum (pT2, N0, M0 in TNM/UICC, stage A of the Dukes staging system and stage B1 of the modified Astler - Coller classification). No adjuvant chemotherapy was required post-operatively. The patient joined a five-year follow up programme and is doing well six months after surgery.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 79,\n",
       "    'case_id': 'PMC6700242_01',\n",
       "    'case_text': \"A 79-year-old man was admitted to our emergency room complaining fatigue, generalized weakness, nausea, and worsening of usual diplopia, following an episode of bronchitis treated with cephalosporins. Moreover, he received flu vaccination a few weeks before the onset.\\nMG was diagnosed 8 years earlier after the onset of lid ptosis and head drop (class IIA according to the MGFA classification). Antibodies against acetylcholine receptor (AChR) and ryanodine receptor (RyR) were detected, but chest CT scan was negative for thymoma. So far, clinical symptoms had always been well-controlled by pyridostigmine, azathioprine, and low doses of steroids. Last neurological examination, performed 2 months earlier, revealed only mild diplopia on left lateral gaze after prolonged fixation.\\nThe patient also suffered from a mild iatrogenic chronic sensorimotor axonal polyneuropathy due to chemotherapy administered after surgical resection of colon cancer; he also underwent ablation of two metastatic lesions in the liver, but the subsequent oncological follow-up was reported negative.\\nOn admission, neurological examination revealed diplopia on lateral gaze, limitation in upward gaze, mild ptosis of the left eye after prolonged fixation, uncertainties at finger-to-nose test, mild proximal limb muscles fatigability, and absence of knee and Achilles reflexes. Brain CT scan and chest X-rays were negative.\\nA putative diagnosis of worsening of myasthenia gravis was made and the patient was hospitalized due to concerns of respiratory failure, considering the age and the recent infection. Absence of lower limbs deep tendon reflexes was initially ascribed to the polyneuropathy. On admission, taking into account the mild presenting symptoms and the absence of respiratory involvement, Prednisone and Azathioprine dosages were increased (respectively from 7.5 to 12.5 and from 50 to 75 mg), withholding standard treatments for MG exacerbation, such as intravenous immunoglobulin or plasmapheresis.\\nIn the first days of hospitalization, the patient developed progressive worsening of ocular movement abnormalities with horizontal and vertical gaze limitation, mild fluctuating diplopia in primary and lateral gaze, nystagmus on left lateral gaze, limb ataxia, and wide-based gait with multi-directional sways during Romberg maneuver. Additional findings included partial ptosis of the left eye, hands tingling, mild proximal weakness in lower limb, dysarthria, and facial asymmetry; nausea and episodes of vomiting persisted. While ophthalmoparesis could be compatible with MG, other clinical features suggested a different etiology.\\nDespite the fact that one of the most common presentations of MG is represented by ocular symptoms, acute bilateral ophthalmoparesis can be also attributed to various etiologies (Table 1).\\nBlood tests were unremarkable, except for mild hypercholesterolemia and increase of inflammatory indexes (C-reactive protein 0.71 mg/dl:normal value <0.5 mg/dl; erythrocyte sedimentation rate 35:normal value <20). Thyroid function, serum folic acid, and vitamin B12 dosages were normal. Antibodies against AChR and GQ1b were dosed.\\nElectromyography, performed after 5 days from the symptom onset, revealed mildly increased latency of the compound muscle action potential (CMAP) of the right facial nerve and moderate chronic neurogenic abnormalities in the muscles innervated by the right L5 and the right C5-C6 nerve roots; right tibial and right ulnar nerve F-wave latency was normal. Repetitive nerve stimulation did not show a decremental response.\\nBrain MRI revealed only mild chronic cerebrovascular disease and mild cortical and subcortical atrophy, without signs of acute cerebral lesions or Wernicke's encephalopathy (Figures 1A,B).\\nClinical symptoms worsened up to complete external ophthalmoplegia and inability to walk unsupported with almost complete disappearance of upper limb reflexes. Another electromyography was repeated 3 days later, displaying a predominantly sensory polyradiculoneuropathy, characterized by increased facial nerve latency and absence of sural, ulnar, and radial sensory nerve action potentials (SNAP) (Figure 1C); ulnar nerve F-wave seemed not clearly detectable.\\nCerebrospinal fluid (CSF) analysis, including virological investigations, was performed 6 days after symptom onset and resulted unremarkable, without albuminocytological dissociation (cells <1/mmc, proteins 24 mg/dl). Serum and CSF oligoclonal banding were absent.\\nOncological screening, including neoplastic markers and full-body CT scan with contrast, performed due to the medical history of the subject, was negative for malignancies.\\nThe workup suggested a diagnosis of acute polyradiculoneuropathy; thus, the patient was treated with five sessions of plasmapheresis, leading to stabilization of the clinical features and subsequent slow mild clinical improvement, especially of limb ataxia and, at a lesser extent, of gait ataxia and diplopia. Nausea and episodes of vomiting decreased too.\\nAntibodies against ganglioside GQ1b turned out to be positive at high titer on serum (IgM 1/2560 and IgG 1/5120; cut-off <1/640), confirming the diagnosis of Miller-Fisher syndrome (MFS). Antibodies against AChR were positive but lower compared to the last known titer (36.3 pmol/ml   7.2 pmol/ml; normal values < 0.5 pmol/ml).\\nAt discharge, the patient still presented severe ophthalmoparesis (only minimal ocular movements were possible), exhaustible left palpebral ptosis, facial asymmetry, gait ataxia (need for external support, maintenance of Romberg with multi-directional swinging with closed eyes), and slight weakness in proximal lower limb muscles, and brachioradialis reflex reappeared, though greatly reduced.\\nThe patient underwent a cycle of physiotherapy and rehabilitation. After 2 months, without further therapy modifications, he was able to walk independently and the ophthalmoparesis markedly improved. Clinical evaluation showed mild convergence strabismus in primary position, mild limitation in horizontal and upward gaze, diplopia after 15 s on left lateral gaze, mild ptosis in the left eye after exercise, presence of the biceps and patellar reflexes, absence of limb or gait ataxia. Last electromyography showed a slightly prolonged ulnar F wave and persistence of the axonal sensory polyneuropathy.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 38,\n",
       "    'case_id': 'PMC8560288_01',\n",
       "    'case_text': 'A 2600 g female infant was born to a gravida 3, para 2, 38 year-old HIV-positive female under highly active antiretroviral therapy (HAART) for two years. There was no history of exposure to alcohol, tobacco, teratogens, or ionizing radiation during pregnancy or of any other diseases. An ultrasound scan (USS) performed at 34 weeks of pregnancy reported a single intrauterine fetus in a vertex presentation with a single horseshoe-shaped ventricle, a considerable cortical mantle, and a fused thalamus without septum pellucidum (Figure 1). The other major organs were reported to be of normal appearance.\\nAt 37 weeks, a caesarian section was done due to premature labor and fetal distress, and a female neonate was delivered. She was initially viable with APGAR scores of 6/6/8, at 1/5/10 minutes. Clinically, the neonate had microcephaly (28 cm), hypotelorism, and a single nostril giving a clear picture of a monkey-like head, known as cebocephaly (Figures 2 and 3). There were no other associated external abnormalities such as cleft palate, spina bifida, omphalocele, imperforate anus, or genital abnormalities (Figures 2, 4, and 5). Alobar HPE with cebocephaly diagnosis was made related to the above clinical presentation associated with USS findings showing a single dilated ventricle with a considerable cortical mantle and a fused thalamus with completely fused hemispheres but without septum pellucidum. The neonate was given supplemental oxygen (2 l/minute) due to distress, and 30 minutes later, she passed away due to severe respiratory failure. Any genetic exam or postmortem was not performed.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 40,\n",
       "    'case_id': 'PMC5622815_01',\n",
       "    'case_text': 'Renal Cell Carcinoma (RCC) has also been called the \"Internist\\'s tumour\" due to the myriad of ways it may present. Bellini duct carcinoma (BDC) is a rare type of RCC accounting for less than 3% of Renal Carcinomas. In Nigeria, BDC has been reported as a slightly higher fraction of RCC (4%)by Tijani et al. A 7-year retrospective review of RCC in our center between 2007 and 2014 during which a total of 51 cases of RCC were managed showed no case of BDC. Forty percent (40%) of BDC are known to present with metastatic disease with 66% succumbing to the disease within 2 years of presentation,. It has been found to be more common in men of African descent when compared with Caucasians. The typical clinical presentation is similar to that of clear cell RCC though symptoms from metastatic disease or paraneoplastic syndromes at presentation have been described. These features include gross hematuria, loin pain, loin mass and general weakness. Unusual presentations reported in literature include acute renal failure and cervical lymphadenopathy (Kru Lin et al), multiple osteoblastic bone lesions (Nakamura et al) and meningeal carcinomatosis (Ohnishi et al). The diagnoses in these cases were not made till autopsy due to the bizzare presentations. We present in this report a 40 year old man with a rare metastatic BDC to the iliac bone managed by the Urology and Orthopaedic Units, Obafemi Awolowo University Teaching Hospital, Ile-Ife, Osun state, Nigeria.',\n",
       "    'gender': 'Male'},\n",
       "   {'age': 40,\n",
       "    'case_id': 'PMC5622815_02',\n",
       "    'case_text': \"A 40-year-old man presented to the Orthopaedic out-patient clinic on account of a month history of right sided pelvic pain and a limp following a trivial fall at home. There was no preceding history of similar symptoms, haematuria, loin pain or loin mass. There was no weight loss. Initial clinical evaluation was unremarkable. An Abdominopelvic Contrast Computerized Tomography Scan (CT scan) revealed an expansile lytic mass in the right iliac bone, eroding it and invading the contiguous iliacus and gluteal muscles (Figure 1 A). It also showed a large hypodense mass in the central portion of the right kidney, adjacent to the renal hilum with peri-hilar lymph node enlargement (Figure 1 B). The renal vein and inferior vena cava were however not involved.There were no other areas of metastasis. Based on the above findings, a diagnosis of Right RCC (Clinical Stage T3, N1, M1 (Stage 4) was made. He was subsequently scheduled for right radical nephrectomy via a right subcoastal transperitoneal approach. Intra-operatively, we found a solid right renal mass which had invaded the Gerota's fascia in some areas measuring 7 by 8 centimeters. It was resected en bloc with adjoining peri-hilar lymph nodes (Figure 2). Following recuperation, he had wide local excision of the right pelvic mass along with the diseased iliac bone and iliacus muscle through a right Ilio-inguinal approach. Both specimen had negative resection margins. Histopathologic evaluation of the resected kidney specimen revealed proliferation of malignant epithelial cells forming tubules which are cystically dilated. The renal stroma was desmoblastic and infiltrated by some of these malignant cells. Tumour was confined to the gerota's fascia. The findings were consistent with a tubulocystic variant of BDC. Evaluation of the iliac bone specimen was in keeping with a metastasis from BDC of the kidney. The patient made a smooth post-operative recovery and is being planned for commencement of immunotherapy with Sunitinib (Figure 1, Figure 2, Figure 3, Figure 4).\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 75,\n",
       "    'case_id': 'PMC4322812_01',\n",
       "    'case_text': \"A 75-year-old Chinese Singaporean lady with multiple comorbidities including Type 2 diabetes mellitus on insulin, hypertension, dyslipidemia, ischaemic heart disease, end-stage renal failure on hemodialysis, degenerative spondylosis and osteoarthritis, was admitted for fever, chills and rigors of one-day duration. There was also discharge of pus over her right femoral dialysis catheter.\\nShe was diagnosed to have disseminated Methicillin-sensitive Staphylococcus aureus (MSSA) bacteraemia secondary to infected right femoral non-tunnelled dialysis catheter. Her first nine blood cultures grew MSSA, so did her wound culture. Her femoral line was removed and she was treated in medical intensive care unit (MICU) for her septic shock. She was referred to the infectious diseases (ID) team and she received systemic vancomycin, clindamycin and then cloxacillin over the course of several weeks as culture results became known. The patient subsequently improved clinically with resolution of fever and improvement of haemodynamic parameters. Her inflammatory markers including procalcitonin and white blood cell count showed decreasing trends. Approximately six weeks after admission, there was documented clearance of MSSA from her blood. The plan by ID was to continue intravenous cloxacillin for a total of six weeks from her last negative blood culture for the presumed endovascular infection although she had a normal two dimensional echocardiograph.\\nUnfortunately her stay in hospital was delayed as she developed extensive right lower limb deep vein thrombosis, for which she was treated with heparin infusion, inferior vena cava (IVC) filter and subsequently warfarin. Approximately two months into her stay in hospital, she developed an episode of sepsis with desaturation, drop in Glasgow coma scale (GCS) and low grade fever. Urgent neuroimaging revealed no intracranial infarct or hemorrhage. However her subsequent four blood cultures, taken two days apart, all grew Elizabethkingia meningoseptica, which was susceptible to cotrimoxazole, levofloxacin, and minocycline, but resistant to amikacin. She was treated with intravenous antibiotics, comprising courses of cotrimoxazole, cefazolin and meropenem, after consultation with the ID team. Three days after her first positive blood culture for Elizabethkingia meningoseptica, she developed a red and painful left eye with blurring of vision.\\nA referral to Ophthalmology was promptly made. On examination her right pupil was noted to be sluggish, and left pupil fixed. There was a reverse relative afferent pupillary defect (RAPD). Visual acuity in her right eye was 6/120 (without reading glasses) with no perception of light (NPL) in her left eye. Examination of her left eye showed an injected conjunctiva, hazy cornea with Descemet's membrane (DM) folds, and a deep anterior chamber filled with a hypopyon and fibrin. A glint of an intraocular lens could be seen. There was no view of the fundus but B-scan ultrasonography showed multiple vitreous opacities. The impression was that of left eye endogenous endophthalmitis, for which she underwent an intravitreal tap for vitreous culture, as well as injection of intravitreal vancomycin and amikacin. She was also started on hourly fortified gentamicin and cefazolin eyedrops. In view of the absence of perception of light, as well as her systemic status, vitrectomy was not resorted to. There was also no immediate indication for evisceration.\\nThe patient's vitreous cultures came back positive for Elizabethkingia meningoseptica, which was sensitive to ciprofloxacin, levofloxacin, cotrimoxazole, and minocycline, but resistant to ceftazidine, gentamicin and amikacin. In consideration of the sensitivity results, the intravitreal antibiotics were switched to ciprofloxacin (100 micrograms/0.05 ml). The injection was repeated five times before it was felt that the infection was under reasonable control. The fibrin clot in her anterior chamber progressively resolved and the inflammatory material in the vitreous cavity became organised. The eye was quiet with no pain. While vision was not expected to recover, the need for evisceration was successfully averted.\\nPotential environmental source links were investigated. Workflows for ward staff were reviewed. Environmental screening was performed by swab cultures of surfaces and equipment within patient rooms, taps and aerators, water sampling and sampling of chlorhexidine solution. While no clear source of the bacteria was identified, it was presumably from aerators and hand hygiene sinks, as was found in a previous investigation of the same bacteria in the hospital.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 29,\n",
       "    'case_id': 'PMC9922053_01',\n",
       "    'case_text': \"A 29-year-old Caucasian female patient presented to the surgery out-patient clinic requesting for foreign body removal. The patient was diagnosed with EDS and MCAS when she was a child. During her lifetime, the patient has suffered from endless anaphylactic reactions due to immunological hypersensitivity of MCAS. According to the patient, her clinical symptoms include nausea, vomiting, constipation, intestinal swelling, migraines, facial edema, hives, acne, fatigue, bloating, fever, chills, night sweats, and acute pulmonary inflammatory reactions. The patient stated that she has had subclinical symptoms of MCAS since childhood that became more problematic when she reached puberty. The patient's past medical history is remarkable for EDS, MCAS, postural orthostatic hypotension, mitral valve regurgitation, tricuspid valve regurgitation, atrial fibrillation, brain fenestration (frontal lobe), pineal gland cyst, migraines, cystinuria, hypothyroidism, anemia, hypokalemia, vitamin B-12 deficiency, menorrhagia, celiac disease, osteopenia in the right hip, bowel hypomotility, post-traumatic stress disorder (PTSD), mild urinary bladder prolapse, and MCAS-induced asthma. The patient's past surgical history includes tonsillectomy, lithotripsy, plica shelf removal of right knee, medial patella-femoral ligament (MPFL) reconstruction and lateral patella-femoral ligament (LPFL) reconstruction cadaver graft and stabilization of right knee, peroneal tendon cadaver graft and deltoid debridement of left ankle, peroneal tendon cadaver graft of right ankle, hardware removal and replacement of right ankle, labrum repair of right hip, labrum hardware removal of right hip, 360 degree labrum repair of right shoulder, hardware repair and replacement of right shoulder, 360 degree labrum repair of left shoulder, cholecystectomy, and gallbladder clip removal.\\nAccording to the patient, allergies include plastic and synthetic surgical materials, latex, plastic medical tape, soy, lecithin, gluten, wheat dextrin and wheat derived maltodextrin, seafood, mold, nickel, butter, sea salt, beef, tomatoes, watermelon, kiwis, banana, yellow #5, eggs, cheese, and phytoestrogens. She also reports hypersensitivity reactions to the flu vaccine, amoxicillin, Augmentin, Bactrim, Betadine, Bystolic, Cefaclor, Corlanor/ivabradine, duloxetine, gabapentin, iodine, ketotifen fumarate, Marcaine HCl/bupivacaine, methylprednisolone, midodrine, Motegrity, Norco, propranolol, pyridostigmine bromide, ranitidine, and tramadol. Currently, the patient's medications include acetaminophen/butalbital, Allegra-D, Ativan, Benadryl, Bisoprolol, buffered salt tablets, calamine, cromolyn sodium, desonide cream, topical drysol, Epi-pen, Errin, fludrocortisone, glucose tabs, Linzess, loratadine, montelukast, mupirocin, naproxen, olopatadine, Pennsaid, Pepcid, Percocet, Plaquenil, potassium chloride, quercetin, Robaxin, triamcinolone cream, Ubrelvy, IM B12, Xolair injections, Xyzal, Zofran, Zyrtec, and toradol injections. Family medical history includes maternal EDS. She has no history of smoking or alcohol use. \\nDue to the pathological progression of EDS, the patient underwent multiple orthopedic procedures for her hip, knee, shoulders, and ankles. After the procedures, she started having worsening symptoms such as increased joint pain and facial swelling. After looking through the patient's past medical and surgical history, her immunologist concluded that the aggravation of symptoms was strongly associated with medical implants placed during the procedures that triggered mast cells to initiate an immune response. The patient was advised to remove the foreign bodies which were implanted. This report highlights the removal of three Weck clips that were placed during her cholecystectomy. \\nOn the day of the operation, she was taken to the operating room, and prepped under general anesthesia. At this time, pneumoperitoneum was obtained periumbilically, and the abdomen was explored. Epigastric, midepigastric, and right mid quadrant ports were placed percutaneously under direct vision. During the procedure, fluoroscopy was utilized and there was no evidence of metal clips in the right upper quadrant. Next, the gallbladder fossa was examined where three separate Weck clips were found. Two clips were located on the cystic duct and one on the cystic artery. All clips were removed and sent to pathology (Figure 1). No bleeding or bile spill was encountered. The patient tolerated the procedure well and was taken to the recovery room in stable condition. A few hours after the procedure, the patient was discharged without any postoperative complications. After one week, the patient returned to the out-patient clinic for a follow-up and stated that she had felt great relief of her hypersensitivity reactions since the procedure.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 13,\n",
       "    'case_id': 'PMC8645473_01',\n",
       "    'case_text': 'A 13-year-old boy, previously assisted by an external team, presented with a hemorrhagic stroke secondary to an AVM rupture in 2013. A 2013 angiography revealed a left occipital lobe AVM, fed by the calcarine and the posterior inferior temporal artery branches, with superficial venous drainage through the medial occipital vein into the posterior third of the superior sagittal sinus, and deep drainage through the occipital vein into the vein of Galen, thus classifying it as a Spetzler-Martin grade III AVM [Figure 1].\\nThe patient underwent partial resection of the malformation in 2014. We complemented the treatment with embolization in August 2017, with the intraluminal permanence of the endovenous catheter evolving as a complication after gluing to the vein. We performed cervicotomy to remove the catheter but could not remove the intracranial part. The patient was subsequently diagnosed with a brain abscess (2018) after a physical examination revealed purulent exudate through the cervical surgical wound. He presented neurologically with contralateral homonymous hemianopsia, without any other symptoms.\\nThe patient was admitted to our hospital in February 2019. He was reinvestigated using cerebral angiography, which demonstrated residual AVM with the embolization material and the presence of an endovenous catheter in the posterior third of the superior sagittal sinus up to the right jugular vein [Figure 2]. He also underwent magnetic resonance imaging (MRI) in May 2019 (T1-weighted with gadolinium and T2). We observed the presence of an intra-axial, rounded lesion, with well-defined edges, heterogeneous at the expense of a hyperintense halo with a hypointense center in T2, located in the convexity of the left pre-cuneus, surrounded by significant perilesional edema. The lesion showed significant ring enhancement with the passage of the contrast medium [Figure 3].\\nThereafter, he underwent microsurgery, with reopening of planes, complete resection of the AVM transulcal route, removal of residual granuloma.\\nThe catheter remained in the posterior third of the superior sagittal sinus extending up to the cervical region of the right jugular vein. Antibiotics were administered (linezolid and ceftriaxone) in the postoperative period and the patient started to show a good response, without new febrile episodes.\\nIn February 2020, the patient presented with thrombosis of the right jugular vein and purulent exudate through the cervical wound. We started anticoagulation therapy with warfarin and performed a right cervicotomy. We opened the jugular vein to remove the catheter and subsequently ligated the vein [Figure 4].\\nThe patient is currently asymptomatic, without neurological deficits or new febrile episodes. Postoperative MRI scans of the brain showed expected changes without the presence of residual lesions, including edema in the surgical location. Cerebral angiography revealed the absence of residual AVMs [Figure 5].\\n[Table 1] lists the main variables that were analysed. There were seven cases of abscesses resulting from endovascular procedures for AVM [Table 1]. The symptoms for AVM diagnosis mainly were: headache, nausea, hemiparesis, and seizures. All the patients underwent embolization, most often with N-butyl-cyanoacrylate. The most frequently detected microorganism in culture was Escherichia coli.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 32,\n",
       "    'case_id': 'PMC3881385_01',\n",
       "    'case_text': \"A 32-year-old female patient reported for the filling of her lower 1st molar. On clinical examination tooth number 36 was root canal treated one month back (Figure 1). It was asymptomatic and the occlusogingival height of the remaining crown structure was approximately 4 mm. The radiographic findings revealed well obturated canals with no periapical changes.\\nA conservative approach of restoring the tooth with an endocrown was decided as the treatment option, as more than half the residual tooth structure was remaining and there were no occlusal wear facets. On additional request by the patient for an advanced and a prompt restoration, CAD/CAM ceramic was chosen.\\nAfter removal of the provisional restoration, preparation for endocrown was initiated. Resin modified glass ionomer cement (Fuji II LC GC Corporation, Tokyo, Japan) was used to achieve a flat pulpal floor and to block the undercuts. The preparation consisted of a circular equigingival butt-joint margin and central retention cavity into the entire pulp chamber constructing both the crown and the core as a single unit. The appropriate reduction of the buccal and lingual walls was done (Figure 2).\\nInterocclusal space was carefully evaluated and occlusal reduction done to achieve a clearance of 2 mm. Shade-B1 was selected (VITAPAN Zahnfabrik, Germany). Retraction cord was placed and impressions made with polyvinyl siloxane impression material (Aquasil LV, Putty/Light Body, Dentsply DeTrey, Germany) using putty wash technique. Die stone model was fabricated.\\n CAD/CAM Processing. The three-dimensional reconstruction of the preparation was done using the Yenadent D40 milling machine (Yenadent, Istanbul, Turkey) and DWOS scanner (Dental Wings Inc., Montreal, Canada). The 3D scanning of the individual die and the antagonist arch for occlusal function (virtual articulation) were done. The milling was then initiated on a monolithic solid zirconia block (Metoxit AG, Thayngen, Switzerland) (Figures 3 and 4).\\nThe finished endocrown was checked for shade, fit, and occlusion in the patient's mouth and then cemented using dual cure resin luting agent (Variolink, Ivoclar/Vivadent, Schaan/Liechtenstein).\\nClinical and radiographic evaluation was done and follow up after 28 months showed no secondary caries, fracture, discoloration or loosening/decementation of the crown (Figures 5 and 6).\",\n",
       "    'gender': 'Female'},\n",
       "   {'age': 26,\n",
       "    'case_id': 'PMC3881385_02',\n",
       "    'case_text': 'A 26-year-old female patient reported with a chief complaint of pain since 2 days. On radiographic examination radiolucency involving pulp of tooth 36 was seen. Based on the clinical and radiographic examination tooth 36 was diagnosed with acute irreversible pulpitis. Root canal treatment was performed. Based on the remaining tooth structure, that is, approximately 4-5 mm, occlusal evaluation, and patients esthetic demands, IPS E.max Press endocrown was decided as the treatment option. The endocrown preparation and the impression technique were performed as described in the previous case. IPS E.max Press HO Lithium-disilicate glass ceramic ingots (Ivoclar/Vivadent, Schaan/Liechtenstein) were used for the press technology. The restoration was fabricated according to the lost wax technique of investing and wax pattern burnout followed by pressing of the ceramic ingot in the pressable furnace at a press temperature of 915-920 C. It was then finished and polished with Proxyt pink polishing paste (Ivoclar/Vivadent, Schaan/Liechtenstein). The endocrown was cemented using a dual cure resin luting agent (Variolink, Ivoclar/Vivadent, Schaan/Liechtenstein). Clinical and radiographic evaluation was done and a 28-month followup showed no secondary caries, fracture, discoloration or loosening/decementation of the crown (Figures 7, 8, 9, 10, 11, and 12).',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 29,\n",
       "    'case_id': 'PMC10328728_01',\n",
       "    'case_text': 'The patient is a 29-year-old woman, referred to our Hepato-Bilio-Pancreatic and Splenic Unit, with a history of continuous abdominal pain in the right upper quadrants with periods of sharpening, abdominal distension, perception of a mass in the right inferior quadrant, and constipation, for the last 3 months.\\nShe had a past history of polycystic ovary syndrome and gastritis. The patient had no children, had menarche at 14 years with regular menstrual cycles and had a history of oral contraceptive intake for 13 years. She had no history of hepatic disease, diabetes, hypertension, or dyslipidemia, and denied smoking or recreational drug usage. Presented an IMC of 16 kg/m2.\\nHer regular medication was chlordiazepoxide + clidinium bromide and the oral contraceptive estradiol valerate 1-3 mg + dienogest 2-3 mg for the last 5 years.\\nAn abdominal ultrasound showed the presence of a solid nodular lesion with origin in the right hepatic lobe. A computerized tomography scan confirmed the presence of a solid pediculate nodular lesion in segment 5. An MRI with administration of paramagnetic hepatospecific contrast product, showed an exophytic nodular lesion with 56 mm x 83 mm heterogeneous signal in the different weightings, heterogeneously capturing the contrast product in a mainly peripheral way, maintaining areas of central hyposignal probably with a more fibrosis/hyalinization component (Figure 1), in an otherwise normal liver.\\nLiver function tests were normal, with a slight increase in total bilirubin (BT 2.05 mg/dl). Other parameters, including leukocytes, hemoglobin, platelet counts, and renal function tests, were normal. Serum tumor markers (alphafeto-protein, CEA, and CA19-9) were normal. Serum virus markers (HBV, HCV, and HIV) were negative.\\nThe case was discussed in our Hepato-Bilio-Pancreatic Multidisciplinary Tumor Board and it was decided surgical resection was appropriate.\\nA laparoscopic approach showed a pedunculated hepatic lesion arising from segment 5, not adherent to adjacent structures, without ascites, with no evidence of peritoneal carcinomatosis, or other hepatic lesions confirmed by an intraoperatively ultrasound. The resection was carried out, and the patient was discharged at day 2.\\nThe surgical specimen revealed a well-defined tumor with 7.9 cm in largest dimension (Figure 2). On the cut surface the tumor had a central fibronecrotic core and two distinct peripheral areas were apparent. The surgical margin had no neoplasia. The tumor was confined to the liver parenchyma without invasion of the hepatic capsule (Figures 3 and 4).\\nHistological examination showed a hepatocellular tumor with a peripheral area with a predominant trabecular pattern with steatosis, cholestasis, and fibrovascular septa with a lymphocytic inflammatory infiltrate (Figure 5). In the central area, there were foci of atypical cells and necrosis (Figure 6). There was no vascular or perineural invasion.\\nImmunohistochemical study showed expression of HEP-PAR-1, liver fatty acid-binding protein (LFABP), C-reactive protein (CRP), and glutamine synthetase (GS) in the neoplastic cells (Table 1) The beta-catenin expression was membranous only (Figure 7). The tumoral cells had no expression of glypican-3 (GPC-3) and heat-shock protein 70 (HSP-70) (Table 1).\\nThis tumor was diagnosed as a well-differentiated hepatocellular neoplasm with morphologic characteristics of an inflammatory adenoma, probably with a beta-catenin mutation (the diffuse, but heterogeneous expression of GS and nuclear negativity for beta-catenin pointed to mutation in the exon 3 S45) with a central area with atypia, absence of biliary ducts, loss of reticulin fibers, and sinusoidal capillarization (Figures 6 and 7).\\nInvestigation for mutations in the CTNNB1 gene (NM_001904.3; beta-catenin, the entire coding sequence including exon-intron transitions), was made through the polymerase chain reaction (PCR) technique, with direct sequencing of PCR products obtained from tumoral DNA. However, no mutations were found.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 58,\n",
       "    'case_id': 'PMC6417323_01',\n",
       "    'case_text': \"A 58-year-old female with a history of chronic rheumatic heart disease and atrial fibrillation was admitted for cranioplasty. She previously underwent a decompressive craniectomy for the management of her massive right middle and anterior cerebral artery infarction 6 months before. The ischemic stroke rendered the patient severely disabled with left hemiplegia and hemisensory loss. The patient also experienced chronic headache and nonspecific dull aching pain over the left side of the body that required gabapentin for partial relief. There was a large right fronto-parietal-temporal scalp concavity coinciding with a craniectomy skull defect of 25 cm x 20 cm [Figure 1a-c].\\nCranioplasty using the patient's autologous bone flap was performed uneventfully and there was no intraoperative breach of the dura. Blood loss was 150 ml and the operation lasted for 100 minutes. During scalp wound closure, a single subgaleal suction drain was placed with vacuum applied as a routine measure. The drain was a negative pressure closed system with an inner diameter of 3.33 mm (Fr 10) and according to the manufacturer supplied medical device specifications, exerted a negative pressure 75 mmHg (10kPa). Within 1 hour after extubation the patient developed status epilepticus with bilateral eye deviation to the left. Pupil size was 3 mm bilaterally and reactive to light. There was fast atrial fibrillation (160 beats/min) and hypotension of 85/40 mmHg. At that juncture, the subgaleal drain output was <20 ml. The patient was mechanically ventilated and her seizures were controlled after administrating intravenous midazolam and phenytoin. A computed tomography (CT) brain scan showed an interhemispheric acute subdural hematoma, intraventricular hemorrhage within the left occipital horn of the lateral ventricle with obliteration of the quadrigeminal and superior cerebellar cisterns. There was also upward displacement of the vermis at the level of the incisura and flattening of the posterior third ventricle [Figure 1d-f]. The patient was diagnosed with ATH and the subgaleal drain was immediately removed. She was sedated for 24 hours and a CT brain performed the next day showed resolution of the ATH [Figure 1g, h]. The patient eventually recovered to her preoperative functional performance level with no further headaches and resolution of her limb numbness. There were no seizures and her phenytoin was weaned off a month after the cranioplasty.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 40,\n",
       "    'case_id': 'PMC5803942_01',\n",
       "    'case_text': 'A 40-year-old man presented with progressive flaccidity of skin, mainly on his face, neck, and trunk since two years. He gave a history of developing anasarca, breathlessness, anemia, and fatigue 1 year back. At the time of presentation to our institute, he had bilateral pedal edema with pallor and prematurely aged appearance. There was no family history of cutis laxa. He was diagnosed with hypertension 2 months back, and had a history of heavy drinking and smoking for the past 20 years, which he stopped 2 months back. Cutaneous examination revealed loose hanging ear lobes, blepharochalasis, lax nasolabial folds, and increased folds over the neck, axilla, and trunk [Figures 1-3].\\nFurther investigations revealed nephrotic range proteinuria (24-hour urine protein - 9.1 g), hematuria, raised urine beta2 microglobulin levels, presence of urine Bence-Jones proteins, raised levels of blood urea (98 mg%) and serum creatinine (1.61 mg%), reduced total protein (4.8 gm/dl) and albumin (2.3 gm/dl), low hemoglobin (7.7 g/dl), normal calcium, high LDH, and uric acid levels. Serum electrophoresis revealed \"M-band\" - 0.3 g% in gamma region. Immunofixation electrophoresis showed IgG-kappa, with elevation of free kappa, normal lambda chain levels (kappa = 100 mg/L, lambda = 24 mg/L), and raised kappa/lambda ratio of 4.2. Bone marrow examination revealed 9% plasma cells with occasional immature forms. Radiological evaluation was negative for lytic lesions. Two-dimensional echo showed a large pericardial effusion with no valvular prolapse. Ultrasonography of the abdomen pelvis was normal. Renal biopsy showed nodular glomerulosclerosis with positive staining on immunohistochemistry for monoclonal kappa and IgG. Skin biopsy showed markedly reduced elastic fibers [Figures 4 and 5]. Staining for amyloid in both renal and skin biopsy was negative.\\nBased on the above investigations, he was diagnosed to have ACL with LHCDD.\\nHe was started on chemotherapy with Cy-BorD protocol (weekly doses of inj. dexamethasone 20 mg, tab. cyclophosphamide 300 mg/m2, inj bortezomib 2 mg). He was suggested facelift surgery, but he did not consent for the same.\\nDuring the 6th cycle of therapy, he showed significant improvement clinically as well as in laboratory parameters with an elevation in Hb (8.9 g%), total protein (6.9 g/dL), albumin (4.4 g/dL), and reduction in serum creatinine (1.25 mg%), blood urea (92 mg%), 24-hour urine protein (2.5 gm), and urine Bence-Jones proteins were negative. Serum electrophoresis showed faint band in gamma region. Immunofixation electrophoresis showed IgG kappa - end of gamma. Unfortunately, we lost the patient to follow-up after the 6th cycle.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': None,\n",
       "    'case_id': 'PMC6166281_01',\n",
       "    'case_text': 'At referral, the patient weighed 111 k (kg), and had a body mass index (BMI) of 41. A medical examination showed no organic illnesses or dysfunctions which could contraindicate surgery.',\n",
       "    'gender': 'Unknown'},\n",
       "   {'age': None,\n",
       "    'case_id': 'PMC6166281_02',\n",
       "    'case_text': 'After the patient was accepted as a candidate for BS, she lost 8% of her excess weight by traditional dieting, in line with the local pre-surgical requirements, before a sleeve gastrectomy procedure was performed. At the time of surgery, the patient weighed 101 kg and had a BMI of 37. The pre-surgical weight loss, as well as the surgery and recovery period, had proceeded without medical or behavioural complications. At the 18 months follow-up, the weight-loss was 27 kg, corresponding to a new BMI of 31, and as a result the surgery and outcome could be deemed satisfactory.',\n",
       "    'gender': 'Female'},\n",
       "   {'age': None,\n",
       "    'case_id': 'PMC6166281_03',\n",
       "    'case_text': 'The pre-surgical psychosocial assessment had revealed a severe history of both AN and BED. AN was of the restrictive type, with onset at age 16, minimum weight 45 kg and BMI 16.5. At age 18, the eating disorder migrated to BED, and the BMI rose accordingly, with the maximum weight being 110 kg and a BMI of 41. The patient was characterised by a high degree of body dissatisfaction, which had been present since childhood. As a consequence, the patient avoided scales as well as mirrors and public display. The patient reported she still had eating binges, but the frequency was low, with the most recent episode occurring three months prior to the psychosocial assessment interview. Within the past four years, she had not met the full diagnostic criteria for BED. Her existing eating binges were provoked when experiencing difficulty with emotion regulation, for example after a quarrel with her partner. Alongside the eating disorder symptoms, the patient suffered from depression. The symptoms were active at referral to BS but the patient was in treatment with antidepressants, which was described as helpful. Although the clinical impression was of depression in remission, the patient scored 36 on the Beck Depression Inventory (BDI-ii), corresponding to severe depression. Family history revealed serious parental neglect, and childhood memories were considered \"painful\", and as roots to the depressive inclination. Binge eating was described as something that could provide a feeling of security and comfort in a world of pain and chaos. Her current life situation was assessed as stable: the patient lived with her partner, with whom she planned to raise a family. The partner was characterised as a person who offered emotional support and had helped the patient gain healthier eating habits. The psychosocial assessment evaluated the patient as \\'at risk\\' and in need for close monitoring, but did not recommend rejection of surgery. In addition, the pre-surgical psychosocial assessment concluded that since the patient was socially withdrawn and seemed very dependent on her partner, the continuation of the relationship was essential for a satisfactory surgery outcome. This vulnerable impression was supported by the following measures: the Experience in Close Relationships (ECR-r) questionnaire showing an anxious-avoidant attachment pattern; the Difficulty with Emotion Regulation Scale (DERS) which placed her at the 80th percentile (when using a median cut within the GO bypass study sample), and an alarming amount of psychiatric symptoms, measured with SCL-90-R. See Table 1 for psychometric test-results.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 41,\n",
       "    'case_id': 'PMC7531809_01',\n",
       "    'case_text': 'We report the case of a 41-year-old with no relevant underlying medical conditions who was admitted to our hospital on June 15 due to a 10-day history of gait ataxia, dizziness, headache, and vomiting. On admission, he was screened for COVID-19 as a standard procedure for hospitalized patients (BD MAX  System: negative SARS-CoV-2 RT-PCR). Thorough diagnostic workup raised the suspicion of a secondary demyelinating disease, and the patient was started on high-dose steroids (methylprednisolone 1 g/day for 3 days followed by prednisolone 1 mg/Kg/day) (Fig. 1).\\nOn June 21, a patient who had been admitted for a bilateral pneumonia (with two negative tests for SARS-CoV-2) and was sharing the same room was intubated as an emergency in the context of a cardiopulmonary arrest, with a subsequent post-mortem nasopharyngeal and oropharyngeal swab revealing SARS-CoV-2 RNA. Hence, our patient collected a swab on the 23rd of June as screening, which proved to be positive (QuantStudio  7 Flex RT PCR system: N1 Ct 35.8, N2 Ct 37.3, RP Ct 29). He was moved to a COVID-19 isolation area, and during his hospital stay reported no fever, respiratory, or gastrointestinal symptoms. He subsequently presented two negative SARS-CoV-2 tests on June 29 and 30 (Aptima  SARS-CoV-2 assay, which uses target capture and transcription-mediated amplification), so he was considered cured from asymptomatic COVID-19. He was discharged on July 3 on prednisolone 80 mg/day. While at home (July 6), he had chest computed tomography (CT), which had been ordered to exclude signs of sarcoidosis as part of the secondary demyelinating disease workup and which revealed a peripheral ground-glass opacity compatible with early COVID-19 (Fig. 2).\\nOn July 9, he represented with fever, headache, myalgias, and cough, and on July 13, he was tested as an outpatient for SARS-CoV-2 with a positive result. His family (mother, father, and wife) also developed respiratory symptoms and all tested positive for SARS-CoV-2. Importantly, they were shielding and reported no other risk contact besides the one with our patient.\\nOn July 15, he was admitted to our hospital, reporting worsening of the symptoms, with dyspnea and thoracalgia. On admission, he was tachypneic and presented with severe respiratory failure, rapidly requiring intubation and transfer to our intensive care unit (ICU). Chest CT showed diffuse bilateral ground-glass opacification and extensive subpleural consolidation of the lower lobes (Fig. 3), and SARS-CoV-2 swab was positive (Xpert  Xpress SARS-CoV-2: E Ct 15.9; N2 Ct 17.8; SPC Ct 0.0). Serologic tests were performed on July 16 (negative IgM and IgG) and on July 20 (positive IgG (8.00 UA/mL); positive IgA (9.18 ICO); negative IgM (4.5 UA/mL)). The patient clinically improved on methylprednisolone 80 mg/day (for 7 days followed by tapering), piperacillin/tazobactam, and remdesivir and was extubated after 7 days. At the time of the writing of this report, he has been discharged from the ICU and is progressing favorably in the COVID ward.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 24,\n",
       "    'case_id': 'PMC2796233_01',\n",
       "    'case_text': 'A 24-year-old previously healthy woman fell from standing height directly on her left elbow and sustained an isolated comminuted olecranon fracture with axial impaction and depression of the articular joint surface (Figure 1(a)). The radial head was intact. She was treated in an outside hospital with a figure-of-eight tension band construct despite the presence of intraarticular comminution. Intraoperative views with an image intensifier reveal marginal reduction of the fragments and incongruency of the ulnohumeral joint (Figure 1(b)). She was immobilized in a cast for 10 days and was not allowed passive nor active range of motion exercises. Ten days after the injury the patient was evaluated for routine postoperative follow-up. Radiographic evaluation at that time revealed ulnar shortening and poor ulnohumeral congruency. After 13 weeks she underwent a second procedure for removal of prominent hardware.\\nFive months after the injury, the patient presented to the senior author with a poor functional result. She had 65 degrees of ulnohumeral motion with 90 degrees of flexion and a 25 flexion contracture with full forearm rotation. She had a stable elbow with pain in active and passive range of motion. Computed tomographic evaluation revealed depression of the articular surface of the trochlear notch and shortening of the proximal ulna. She had an incongruent ulnohumeral joint leading to impingement and loss of function. The articular surfaces of the radiocapitellar joint remained opposed (Figure 2). \\nAn osteotomy was planned to restore congruency of the trochlear notch to achieve a functional arc of motion. After induction of general anesthesia, the patient was placed in lateral decubitus and the left arm was placed over a bolster. A midline posterior incision was used to expose the proximal ulna. An osteotomy was performed at the level of the depressed articular surface to mobilize and elevate the depressed fragments in an attempt to realign the articular surfaces of the ulnohumeral joint. Reduction of the malunited intra-articular fragments was not possible because the fracture fragments were sclerotic. Shortening of the olecranon due to axial impaction:which was worsened by the tension-band construct:prohibited good alignment. An iliac-crest bone graft, 6 mm by 15 mm in size, was interposed to widen and reconstruct the trochlear notch. After lengthening of the proximal olecranon, the humerus could be easily reduced to restore ulnohumeral congruency. Stable fixation was achieved with 2 lag screws secured with a 4-hole LCP plate (Figure 3). It was noted that the posterior capsule was contracted. However, at this point it was chosen not to perform a posterior capsular release to preserve the surrounding soft tissues of the olecranon tip to protect vascular blood supply. Postoperatively, the patient was immobilized in a long arm cast and continuous passive motion was initiated 24 hours after surgery and therapy was started. Careful active motion also began immediately under the supervision of a physical therapist.\\nOne year after the index surgery, the patient had a functional arc of motion. She had 95 degrees of ulnohumeral motion with 115 degrees of flexion and a flexion contracture of 20 degrees. Her elbow was rendered stable and she has no pain. Posterior contracture release was performed at this point combined with hardware removal. Postoperative radiographs suggested posterior impingement of the olecranon tip hindering extension. This was not found on Intraoperative passive range of motion.\\nTwo years after the index surgery, and one year after removal of hardware and contracture release, she had a functional elbow with 105 degrees of ulnohumeral motion (115 degrees of flexion and a 10-degree flexion contracture), 87 points according to American Shoulder and Elbow Surgeon evaluation and 7 points on the Disability of Arm Shoulder and Hand score (see Figure 4).',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 56,\n",
       "    'case_id': 'PMC5220406_01',\n",
       "    'case_text': 'A 56-year-old male with history of AF, status after ablation, eight years ago at an outside hospital, presented with recurrent AF. Five years after his initial ablation, the patient developed symptomatic palpitations due to atrial fibrillation and he was prescribed flecainide and metoprolol. Despite antiarrhythmic therapy, the patient continued to have symptomatic atrial fibrillation with palpitations but no shortness of breath. The patient was taken for AF ablation. The preablation echocardiogram demonstrated normal ventricular function and pulmonary pressures. The preprocedural computed tomography (CT) scan along with the three-dimensional (3D) reconstruction was done on the procedural table prior to the transeptal puncture but did not pick up the pulmonary vein stenosis. Pulmonary vein potential mapping noted that there was a potential at the ostium of the left superior pulmonary vein. There was also difficulty advancing the catheter into the left superior pulmonary vein due to a possible obstruction. Direct angiography of the left superior pulmonary vein (LSPV) confirmed complete PV stenosis. The procedure was aborted in lieu of further diagnostic work up. A higher resolution cardiac CT angiogram (Figure 1(a)) and left atrium 3D reconstruction (Figure 1(b)) was used to confirm subtotal occlusion of the left superior pulmonary venous trunk. A lung perfusion scan revealed significantly decreased left upper lung perfusion (Figure 2) with the left lung contributing approximately 18% of the lung function and the right lung contributing 82% of the total lung function. A levophase angiogram of the right middle lobe pulmonary arterial system demonstrated venous return confined to the area of the lung supplied by the arterial vasculature. The levophase pulmonary angiogram demonstrated well developed collateral circulation from the left upper lobe to the mid segment of the left lung (Figures 3(a) and 3(b), resp.). After cardiac workup, it was concluded that this pulmonary vein stenosis is chronically totally occluded and less amenable to percutaneous intervention for reestablishment of flow. Ultimately, the decision to intervene to relieve the stenosis and to repeat AF ablation on the remaining pulmonary veins was left to the patient. The patient initially opted for continuance of antiarrhythmic drug therapy. However, due to persistence of breakthrough atrial fibrillation despite antiarrhythmic therapy, the patient ultimately underwent repeat atrial fibrillation ablation procedure two years after his initial presentation to our institution.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 23,\n",
       "    'case_id': 'PMC2836895_01',\n",
       "    'case_text': \"A 23-year-old woman with a 4-month history of doxycycline treatment and a subsequent 3-month history of minocycline treatment for acne developed tinnitus, vomiting, phonophobia, and photophobia along with severe headaches and progressive horizontal binocular diplopia. She was otherwise healthy and took no other medications.Visual acuity was 20/15 in the right eye and 20/20 in the left eye with a left relative afferent pupillary defect.Humphrey visual fields revealed a triangular scotoma in her left eye (Figure 1). \\nSevere bilateral papilledema was present, greater on the left than the right. Lumbar puncture demonstrated an opening pressure of 41 cm H2O with normal cerebrospinal fluid. Minocycline use was discontinued. Head CT and contrast-enhanced MRI were both normal and an MRV showed no venous thrombosis or stasis. The patient's symptoms of diplopia improved 3 weeks later, but papilledema and headache persisted with worsening of visual fields. Repeat MRV was normal. The intracranial pressure remained elevated at 33 cm H2O despite treatment with 2 g acetazolamide/day. Ventriculoperitoneal shunting was performed for intracranial pressure control.\",\n",
       "    'gender': 'Female'},\n",
       "   {'age': 15,\n",
       "    'case_id': 'PMC2836895_02',\n",
       "    'case_text': 'A 15-year-old girl with a 6-week history of minocycline treatment for acne vulgaris developed progressive bifrontal headache with pain around the right eye, vertical binocular diplopia, nausea, neck pain, and muscle spasm. Visual acuity was 20/20-2 in the right eye and 20/15-1 in the left eye. Threshold visual fields revealed enlarged blind spots in both eyes, but otherwise normal findings. Dilated ophthalmoscopy disclosed florid papilledema in both eyes with peripapillary hemorrhages and choroidal folds (Figure 2). Head CT and enhanced MRI were both normal, and an MRV showed no evidence of venous thrombosis. The opening pressure was 55 cm H2O  with normal CSF formula. Minocycline was discontinued. Acetazolamide treatment was prescribed, then discontinued 5 months later after resolution of the papilledema, headaches, visual field defects, and diplopia.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 37,\n",
       "    'case_id': 'PMC5282427_01',\n",
       "    'case_text': 'A 37-year-old woman sought neurological assistance after an episode of TIA manifesting predominantly as left hemiparesis of 5-minute duration. At that time, she had no abnormalities on examination of the cranial nerves, and brain computed tomography (CT) scan findings were normal. She was referred to a cardiologist to be evaluated for TIA. The physical examination and routine blood laboratory investigations results were normal. Her past medical history showed hypertension (HTN) and hyperlipidemia (HLP) which both were under control. During further clinical assessments, transesophageal echocardiography (TEE) was performed, which revealed an echogenic, round, and mobile mass measuring 5 x 5 mm in diameter attached by a short pedicle on the atrial surface of the anterior mitral valve leaflet (Figure 1). There was mild to moderate regurgitation of the mitral valve. The other valves and cardiac structures were normal. Left ventricular ejection fraction (EF) was 60%. The patient was given anticoagulant therapy and referred for surgery with clinical suspicion of a papillary fibroblastoma or other primary cardiac tumors. At operation, after a median sternotomy, cardiopulmonary bypass via aortobicaval cannulation was established. An incision was made in the left atrium, and a soft, firm, and friable mass was founded on the atrial surface of the anterior leaflet of the mitral valve which was easily removed (Figure 2). The anterior leaflet was repaired with an autologous pericardium patch. The patient was warmed and weaned from cardiopulmonary without difficulty.\\nHistopathological evaluation of the resected tumor showed a dense calcification (shredded due to no decalcification) in a background of amorphous degenerating fibrinous material (Figure 3) and according to the clinical and histological features, a diagnosis of cardiac CAT was provided. The postoperative course was uneventful, and the patient was discharged from the hospital 4 days after the surgery without any complications.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 48,\n",
       "    'case_id': 'PMC3442446_01',\n",
       "    'case_text': \"A 48-year-old woman was referred to the Department of Oral Medicine, Faculty of Dentistry, Tabriz University of Medical Sciences, for diagnosis and management of a non-painful oral ulceration which had been present for the past six months. The past medical history revealed a diagnosis of RA established five years before, and prednisolone 2.5 mg/d, azathioprine, and methotrexate medications since then. \\n Intraorally, along the occlusal line on the buccal mucosa of the left side, there was an ulcerated area measuring approximately 3x3 cm, the margins of which were hyperkeratotic and irregular in outline and the base was covered with a pale yellow-colored slough. The clinical appearance of the intraoral ulcer was more typical of squamous cell carcinoma or a traumatic ulcer because of the lesion's presence on the line of occlusion (Figure 1). \\n Under local anesthesia, an elliptical incisional biopsy was taken from the lesion, which included part of the ulcer and normal mucosa. The biopsy specimen was fixed in 10% formalin for conventional histologic examination. Light microscopic examination of sections stained with hematoxylin and eosin showed hyperplastic squamous epithelium and suprabasal bullae with acantholytic cells. There was moderate chronic inflammation in the stroma. Based on these results, a diagnosis of pemphigus was established. Regarding the pathologic diagnosis, the patient was examined for Nikolsky's sign, which proved negative (Figure 2). \\n In order to confirm histopathologic diagnosis, the patient was examined for Direct Immunoflurocent (DIF) and Indirect Immunoflurocent (IIF). A biopsy specimen that was obtained from clinically normal appearing peri-lesional mucosa was placed in normal saline solution and was sent for immunofluorescence evaluation for in vivo deposits of IgG, IgM, IgA, IgD, IgE, and complement components of C3 and C4. The patient's serum was examined by a routine indirect immunofluorescence technique for autoantibodies such as anti-epithelial intercellular and basement membrane antibodies. The findings of DIF and IIF were negative. \\n The patient in the present case report was scheduled a recall visit after three months, at which the clinical examination did not reveal any changes in the lesion size with no involvement of new locations in the oral mucosa. In addition, no skin involvement was observed and Nikolsky's sign was negative. Another recall visit was scheduled for the next three months. The patient was asked to return to the clinic before the 3-month follow-up period in case of any oral ulcer or blisters. \\n In case of the absence of any signs or changes in the variables mentioned above further recall visit will be scheduled for the next 6-month and 1-year periods. The patient has been instructed to pay a recall visit whenever new oral mucous membrane or skill lesions appear, regardless of the visits scheduled for her.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 45,\n",
       "    'case_id': 'PMC5320816_01',\n",
       "    'case_text': 'A 45-year-old male patient presented with a history of intermittent claudication pain for the last 3 months and blackish discoloration of the right toe for 15 days. The patient is a known case of peripheral arterial disease, previously underwent right transfemoral iliac angioplasty with femoropopliteal bypass 1 year ago for similar complaints. He is also a smoker and diabetic, no family history of ischemic heart disease and peripheral vascular disease. Coronary angiogram revealed normal coronaries. On examination, blackish discoloration of the right middle toe, absent pulse in bilateral lower limbs. Computed tomography (CT) peripheral angiogram was revealed diffuse internal thickening with wall calcification noted in aorta causing 40% diameter stenosis, right common iliac artery (CIA) in-stent restenosis of 90% at proximal and distal edges of the stent [Figure 1a], right femoropopliteal graft is thrombosed and left CIA shows multifocal areas of narrowing and occlusion of 90% [Figure 1b]. The patient was subjected for PTA, left CIA approached from the left brachial artery with 0.035 Terumo wire and exteriorized through left femoral artery [Figure 2a]. The right femoral arterial approach was used for deploying CIA stent. Serial predilatation was done using 8 mm x 55 mm peripheral balloon [Figure 2b]. A 8 mm x 120 mm medtronic self-expanding stent was deployed in the right CIA and 7 mm x 150 mm medtronic self-expanding stent deployed in left CIA. A postdilatation with simultaneous kissing at aortoiliac junction was done using 8 mm x 55 mm balloon in right CIA and 7 mm x 40 mm balloon in left CIA. Postprocedure showed good distal flow [Figure 3]. CT peripheral angiogram was done after 1 week which showed patent stent seen in relation to distal aorta, left CIA, external, right CIA [Figure 4].',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 77,\n",
       "    'case_id': 'PMC5313436_01',\n",
       "    'case_text': 'A 77-year-old man was diagnosed with diffuse large B cell lymphoma stage IIA at low-intermediate risk according to the international prognostic index in July of Year X. A routine examination before treatment revealed positive HBsAb and HBcAb and negative HBsAg and HBV-DNA; we therefore concluded that this patient had previously had an HBV infection and started periodical monitoring of HBV-DNA according to the recommended management scheme in Japan. Six courses of R-CHOP therapy successfully induced complete remission.\\nSince the patient remained negative for HBV-DNA for 20 months after R-CHOP therapy, we suspended further monitoring in November of Year X+2. We continued measuring ALT/AST as a routine laboratory test at outpatient visits. Nineteen months later (June of Year X+4; 33 months after the last session of R-CHOP therapy), this patient presented with increased levels of liver enzymes (ALT 104 IU/L, AST 97 IU/L) that had been within normal ranges one month prior. A further examination revealed reverse seroconversion of HBs (HBsAg 111 IU/mL, HBsAb <10 mIU/mL), and given that the patient had no history of blood transfusions and was sexually inactive, we diagnosed him with de novo hepatitis. The lymphocyte counts in the peripheral blood and serum IgG level were within normal limits. Entecavir was started, and the hepatitis resolved promptly leading to rapid suppression of HBV-DNA and HBsAg and recovery of HBsAb (32.1 mIU/mL) within two months. The clinical course of HBV-related markers is shown in Table 1. A further examination revealed that the patient had HBV-DNA genotype B, with a mixed precore mutation (nt1894, 10% mutated and 90% wild) and a wild type core promotor region (nt1972 and nt1974).',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 46,\n",
       "    'case_id': 'PMC4378320_01',\n",
       "    'case_text': \"A 46-year-old Caucasian male presented to the Department of Implant Dentistry, Faculty of Dentistry, University of Sao Leopoldo Mandic, Campinas, Sao Paulo, Brazil, in August 2012, requesting implants for aesthetic and functional purposes. Titamax Ex external hexagon implants (Neodent, Brazil) were placed in the regions of the upper left premolar and the lower left first molar, with their respective healing abutments. In June 2013, the patient presented with a lesion associated with and covering the lower left first molar implant site. Intraoral examination showed a well-circumscribed, pedunculated, painless, purple mass measuring approximately 1 cm, rubbery in consistency. Radiographically, in the lower left molar region, the presence of an implant was observed without evidence of radiographic features that would be compatible with bone involvement (Figure 2). The clinical differential diagnosis was pyogenic granuloma and peripheral giant cell granuloma (PGCG) (Figure 1). The patient underwent an excisional biopsy, which was sent to the Department of Oral Pathology, Faculty of Dentistry, University of Sao Leopoldo Mandic, Campinas, Sao Paulo, Brazil. The biopsy was fixed in 10% buffered formalin for 24 hours. Macroscopic examination revealed two fragments of brown-colored soft tissue, with a fibrous consistency, the larger fragment measuring 10 x 8 x 4 mm and the smaller fragment 7 x 6 x 3 mm. Histopathological examination revealed a fragment of mucosa lined by a parakeratinized stratified squamous epithelium. The lamina propria was composed of connective tissue containing various multinucleated giant cells surrounded by ovoid and spindle-shaped mesenchymal cells with multiple interspersed small blood vessels (Figure 3). The histopathological diagnosis was peripheral giant cell granuloma.\\nIn October 2013, the patient was referred to the Oral Medicine Clinic, Faculty of Dentistry, University of Sao Leopoldo Mandic, Campinas, Sao Paulo, Brazil, with a recurrence of the lesion. A deeper and wider excisional biopsy, curettage of the adjacent bone, and application of surgical cement were performed. The biopsy was once again forwarded to the Department of Oral Pathology, Faculty of Dentistry, University of Sao Leopoldo Mandic, Campinas, Sao Paulo, Brazil. The histopathological diagnosis was peripheral giant cell granuloma. The patient remains lesion-free following one year of follow-up.\\nThe paraffin-embedded blocks from each biopsy were selected for immunohistochemical staining using the antibody CD68. Five mum sections were deparaffinized, hydrated, and subsequently immersed in 3% hydrogen peroxide for 30 minutes (Dinamica, Diadema, SP, Brazil). For antigen retrieval, the slides were put into a steamer immersed in a citrate buffer (pH 6.0) for one hour at 95 C (Sigma, St. Louis, MO, USA). The sections were then incubated with the primary antibody overnight at 4 C at a dilution of 1 : 1200 (Dako, Carpinteria, CA, USA). The sections were then incubated with Labeled Streptavidin Biotin (LSAB, Dako, Carpinteria, CA, USA) for 30 minutes, stained for 5 minutes at 37 C with 3.3'-diaminobenzidine tetrachloride (Dako, Carpinteria, CA, USA), and counterstained with haematoxylin (Dinamica, Diadema, SP, Brazil). Macrophages were used as the positive control.\\nImmunohistochemical staining with CD68 was strongly positive for multinucleated giant cells, as shown in Figure 4, suggesting a histiocyte/macrophage or osteocyte origin.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 0,\n",
       "    'case_id': 'PMC6260389_01',\n",
       "    'case_text': \"Patient one, a 3-month-old female patient, presented in March 2015. Her parents had noticed a rapidly growing maxillary swelling during the previous month. The patient's medical history was insignificant. On examination, a firm swelling measuring 3 x 4 cm was detected on the anterior maxilla. The overlying mucosa was ulcerated in the middle, with a deciduous incisor exfoliating through the lesion (Fig. 1).\\nMultislice Computed Tomography (CT) revealed a well-defined osteolytic lesion encroaching on the right anterior maxillary wall. Incisional biopsy, performed by a team led by author FAM, confirmed a diagnosis of melanotic neuroectodermal tumour of infancy. Subsequently, a second surgery was performed in April 2015, with tumour excision via a transoral approach (Fig. 2, Fig. 3).\\nPossibly due to the conservative nature of the surgical excision and/or tumour seeding, a recurrence of the lesion occurred four months later in August 2015. Via a Weber Ferguson approach, a right subtotal maxillectomy was performed to resect the recurrent tumour with a safety margin of 1 cm. Histopathology affirmed the diagnosis of MNTI. The patient's subsequent recovery was uneventful; she has been followed up for over three years, with no incidence of recurrence clinically or radiographically (Fig. 4, Fig. 5).\",\n",
       "    'gender': 'Female'},\n",
       "   {'age': 0,\n",
       "    'case_id': 'PMC6260389_02',\n",
       "    'case_text': \"The second patient was a 4-month-old female infant, who presented to our unit in December 2015 after her parents noticed a progressively growing left maxillary mass of gradual onset.\\nOn examination, a well-defined firm mass of the left maxilla was detected. The lesion was roughly 4 x 5 cm in size and smooth in texture, with an ulcer measuring 1 x 1 cm located at the lesion's surface. Computed Tomography revealed an expansile lesion of the left maxilla with poorly-defined margins (Fig. 6, Fig. 7).\\nAn incisional biopsy revealed a diagnosis of Melanotic Neuroectodermal Tumour of Infancy. Histologically, the specimen showed groups of round cells with abundant cytoplasm and pale nuclei, surrounding nests of neuroblast-like cells possessing scant or fibrillar cytoplasm. Immunohistochemistry confirmed the specimen was positive for both HMB45 and Synaptophysin.\\nA thorough work-up was subsequently performed, including Computed Tomography of the chest, abdomen and pelvis to rule out any metastasis; this was negative for any tumor spread.\\nVia a Weber Ferguson approach, a surgical team headed by author ME performed a left subtotal maxillectomy and the tumour was excised with a safety margin of 1 cm. The surgical defect was closed primarily with the use of a buccal fat pad and no reconstructive procedure was taken (Fig. 8, Fig. 9).\\nA follow-up CT was taken 18 months postoperatively, with no recurrence detected. Accordingly, a minor residual soft tissue defect in the left premaxilla was closed via a local flap in July 2017. The patient has been followed up for over two years following the MNTI excision, with no signs of recurrence clinically or radiographically (Fig. 10).\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 27,\n",
       "    'case_id': 'PMC3555002_01',\n",
       "    'case_text': 'A 27-year-old male present with a slow growing painless mass in right upper lid since past 6 months duration. The mass was 1.5 cm x 1.5 cm firm, non-tender, sub-cutaneous and not fixed to underlying tissues [Fig. 1]. This was a recurrence of a lesion that had been removed by lamellar excision in the same site 2 years back. The recurrent mass was removed this time by pentagonal full thickness lid excision with re-construction by advancement eyelid flap. Histopathological examination showed tumor with variegated appearance. The epithelial component composed of round to oval cells with large nucleoli with scanty cytoplasm and the cells were arranged in nests and acinar pattern. The coating for epithelium of the glandular elements was two layered. The intervening stroma showed fibrosis and myxoid areas. No evidence of lacrimal gland tissue was noted in multiple sections [Fig. 2].\\nChondroid syringoma is a tumor arising from the sweat glands which can be apocrine (found throughout the surface of lid) or eccrine (glands of Moll in association with eyelash follicles) with a mean age of 50 years (22-73 years). Ozdal et al. in a study of 228 benign ocular adnexal tumors reported apocrine/eccrine hydrocystoma as very common and no case of Chondroid Syringoma was found in that series. Tyagi et al. in their study of 207 eyelid tumors had one case of Chondroid syringoma with an incidence of 0.48% in their series.\\nThis tumor was first described by Billroth and the term chondroid syringoma was coined by Hirsh and Helwig to characterize the origin from sweat glands though the appearance is like pleomorphic adenoma of lacrimal gland. A proper histopathological examination to rule out presence of normal lacrimal gland tissue external to the tumor capsule helps to differentiate chondroid syringoma. The case being reported had tubular and cystic branching lumina with 2 layered epithelium showing an apocrine origin.\\nChondroid syringoma is a benign tumor but incomplete excision can undergo malignant transformation. Hence complete excision is advised.\\nThis case is being reported for its rarity (this is the 28th case in literature involving ocular adnexa), its occurrence in a young patient and the need to keep this rare entity as a differential diagnosis of eyelid tumors.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 20,\n",
       "    'case_id': 'PMC4900127_01',\n",
       "    'case_text': 'A 20-year-old female presented with classic symptoms of Cushing\\'s syndrome. The patient first noticed symptoms one year earlier. During that year, she complained of a 60-pound weight gain, amenorrhea, hirsutism, acne, bruising, and diffuse striae. Physical examination demonstrated moon facies, \"buffalo hump,\" and diffuse striae (abdomen, hip, buttock, breast, and lower extremity), as well as acne, bruising, and significant hirsutism (Figs. 1A-C).\\nBiochemical evaluation revealed elevation of both cortisol (serum 26.0 microg/dL, normal range 5-23 microg/dL) and adrenocorticotropin hormone (ACTH) (32 pg/mL, normal range 5-27 pg/mL). Neither cortisol nor ACTH was suppressed by a high- or low-dose dexamethasone suppression test. MRI of the head with and without contrast (performed to evaluate for a potential pituitary adenoma, given the elevated ACTH) revealed a possible microadenoma, although this was felt to be an unlikely source of excess ACTH. Subsequently, a contrast-enhanced computed tomography (CT) scan of the chest, abdomen, and pelvis was performed to search for an ectopic source of ACTH production. The CT revealed a 7x4cm, heterogeneous, lobulated, left adrenal mass. Portions of the mass showed poorly defined margins, raising suspicion for local invasion into the retroperitoneal fat (Figs. 2A-C). Contrast enhancement kinetics could not confirm an adrenal adenoma (relative percentage washout [RPW] of 24%), although this examination was not performed for dedicated adrenal mass evaluation (images were obtained at 75 seconds and 3 minutes per a standard abdominal CT protocol versus at 60 seconds and 15 minutes per a dedicated adrenal mass protocol). Given the size of the mass and clinical findings of hormonal hypersecretion, adrenal cortical carcinoma was the favored diagnosis. The right adrenal gland was normal, and there was no imaging evidence for distant metastasis within the chest, abdomen, or pelvis.\\nGiven the presence of an adrenal mass, additional biochemical evaluation was ordered; it revealed elevation of dehydroepiandrosterone sulfate (DHEA-S) (697 ug/dL, normal range 145-395 ug/dL). Elevation of multiple adrenal products, especially the sex hormone precursors DHEA-S and testosterone, also raised suspicion for carcinoma. Metanephrines, prolactin, growth hormone, luteinizing hormone, and follicle-stimulating hormone were normal.\\nThe patient underwent open surgery with en bloc resection of the tumor. An elongated, lobulated, left adrenal mass weighing 136g was removed (Fig. 3). Afterward, the patient\\'s cortisol, DHEA, and ACTH levels returned to normal. Histopathological evaluation of the specimen demonstrated an adrenal neoplasm with two large nodular foci of extension into the surrounding fat. Grossly, the tumor was friable, beige-tan, with areas of pale yellow necrosis. On light microscopy, the vast majority of the tumor showed a lobular-to-solid growth pattern with deeply eosinophilic cytoplasm (Fig. 4a). A few vacuolated foci were present (Fig. 4b). The adrenocortical carcinoma (ACC) showed extensive infiltration into the adjacent fat (Fig. 4c). Marked cytologic atypia was noted, with nuclear enlargement and pleomorphism. Lipofuchsin pigment, typical for hormonally active tumors, was easily discernible. Pathologically, a tumor is defined as ACC when three of the following histologic criteria are met: 1) high nuclear grade, 2) mitotic rate > 5 per 50 high-power fields, 3) atypical mitoses, 4) clear cells < 25%, 5) diffuse architectural pattern in more than one-third of the tumor, 6) confluent necrosis, 7) venous invasion, 8) sinusoidal invasion, and 9) capsular invasion. This tumor fulfilled five of the criteria. Curiously, despite the aggressive pattern of invasion, mitotic figures were less than 5/50 hpf, and no atypical mitoses were noted.\\nThe invasion into surrounding tissue, in addition to the size of the tumor, indicated a stage III ACC. After surgery, the patient underwent 45 days of adjuvant external-beam radiation. The etiology of the elevated ACTH levels in the setting of ACC remains unclear. Furthermore, the tumor did not stain for ACTH (Fig. 5).\\nOne year following surgery, the patient has returned to her baseline weight with near-complete resolution of her Cushingoid habitus and hirsutism, and a return of menstruation. Followup abdominal and pelvic CT 11 months after surgery revealed no evidence of local recurrence or distant metastasis.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 60,\n",
       "    'case_id': 'PMC4178356_01',\n",
       "    'case_text': 'A 60-year-old lady reported to the Department of Oral and Maxillofacial Surgery (OMFS) with chief complaint of swelling at anterior region of mandible since 6 months. Patient gave history of trauma at chin region due to Road Traffic Accident (RTA) 3 years back. At that time, patient was conservatively managed by some private clinician. After 6 months of trauma, patient noticed an extra oral swelling over anterior mandible with pus discharge intraorally. After 1 year of time, patient noticed loosening of mandibular anterior teeth. Patient again went to a private clinician where she was again conservatively managed with medication. Since past 2 years pus used to appear intermittently from same place, which used to stop on use of antibiotics. But since last 6 months, there is gradual increase in swelling of anterior mandible for which patient reported to OMFS department where patient was examined, evaluated and incisional biopsy of lesion was done which was suggestive of ameloblastoma. Then patient was admitted to OMFS ward for further management.\\nExtra-oral inspection showed a large swelling in anterior region of mandible over chin area crossing midline, measuring approximately 8 x 7 cm in size. Face was asymmetrical, deviated towards left. Scar mark was present over right side of chin. Color of the overlying skin was normal. On palpation, the swelling was bony hard. It was non-compressible, non-fluctuant, and slightly tender. Temperature of overlying skin was normal. Swelling extends to involve bilateral body of mandible [Figure 1].\\nIntra-oral inspection showed a large swelling seen involving buccal vestibule, floor of the mouth, and lower alveolus region. Mouth opening was adequate. On palpation, intraoral swelling was hard and mild tender. Sinus opening with respect to lower right and left canine (may be socket of teeth). There was bleeding from lower left canine region on palpation [Figure 2].\\nIncisional biopsy revealed epithelial islands admixed with fibrocollagenous tissue. Outermost layer of epithelial island was composed of tall columnar cells with polarization of the nuclei away from the basement membrane. The central portion of the island was composed of loose network of cells showing squamous metaplasia [Figure 3].\\nOrthopantomogram (OPG) of mandible showed multilocular expansile lytic lesion involving the symphysis and bilateral body of mandible. All mandibular teeth were lost except one molar tooth on either side [Figure 4].\\nComputed tomography (CT) scan revealed: Plain and contrast axial and coronal CT scans of face region revealed large multiloculated cystic expansile lesions arising from symphysis menti and bilateral body of mandible, and extending up to bilateral angle of mandible. Margins of the lesions were sclerotic and scalloped. Overlying all mandibular teeth was lost except one molar tooth on either side. Bilateral masseter muscles and tongue was normal in CT attenuation and dimensions. No obvious cervical lymphadenopathy [Figures 5 and 6].\\nOn the basis of above findings, resection of mandible and reconstruction with reconstruction plate was planned, under general anesthesia. The mandible was resected bilaterally at the body. The specimen was taken out and the defect was reconstructed using reconstruction plate. The genioglosus and the geniohyoid muscles were tied to the reconstruction plate and the incision was closed [Figures 7-9].\\nHistopathological findings of excised specimen confirmed the diagnosis of ameloblastoma.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 36,\n",
       "    'case_id': 'PMC9135378_01',\n",
       "    'case_text': \"A 36-year-old male with a medical history of advanced atherosclerosis of the aorta with aneurysm of the right and left sinus of Valsalva, abdominal aortic aneurysm, and renal artery stenosis (post stenting) was admitted with chief complaints of acute-onset high-grade fever and pedal edema. The patient had undergone aortic root replacement and coronary artery bypass graft (CABG) two months prior. His medical history included the headache workup and Grade-IV hypertensive retinopathy, right renal artery stenosis at 11 mm from the origin for which he underwent renal artery stenting 11 years prior. The patient also had a 12.5 cm abdominal aortic aneurysm in the suprarenal abdominal aorta, for which endovascular aneurysm repair (EVAR) with visceral debranching and polytetrafluoroethyelene (PTFE) graft was done eight years back. He also underwent Bentall's procedure four months prior to current admission for sinus of Valsalva with a massive aneurysm with thrombosis, which was detected on imaging on follow-up.\\nOn admission, his blood pressure was 120/88 mmHg, heart rate was 142/min, the temperature was 38,3  C, pallor. He was pale and pedal edema was present. The patient was diagnosed with acute left ventricular failure with suspected infective endocarditis in view of prior surgeries, fever, and edema. He was started on ceftriaxone, vancomycin, and gentamycin. Fever persisted, and he developed oliguria, unresponsive to diuretics, progressive breathlessness, hypotension; and had a sudden cardiac arrest on the 7th day of admission and died.\\nThe laboratory work-up showed hemoglobin of 7.8 g/dL (reference value [RV]: 12-14 g/dL), leukocytes of 9,670/ mm3 (RV; 4.4-11.3 x 103/mm3) without a shift to the left, and platelets of 156,000/mm3 (RV; 150-400 x 103/mm3), creatinine of 1.3 mg/dL (RV: 0.4-1.3 mg/dL), and normal electrolytes. Bedside 2D echocardiogram showed left ventricular function of 15-20% with moderate aortic regurgitation. Paired blood culture revealed growth of Acinetobacter species.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 20,\n",
       "    'case_id': 'PMC1192821_01',\n",
       "    'case_text': 'A 20-year-old Tunisian man with a three weeks history of dyspnoea, cough and haemoptysis was admitted. At the age of 18, he had suffered from painful oral and genital ulcerations and polyarthralgias. At that time, examination revealed bilateral papillary oedema and brain magnetic resonance imaging showed superior sagittal and left lateral thromboses. The patient was given oral prednisone at the dose of 1 mg/kg/day that was tapered gradually and colchicine 1 mg/day in addition to acenocoumarol to maintain International Normalized Ratio between 2 and 3. These medications were discontinued per the patient 7 months later which resulted in the recurrence of aphtous ulcerations and papulopustular eruptions episodes.\\nOn physical examination the patient had fever, face and neck oedema, prominent superficial thoracic venous collaterals, and pseudofolliculitis lesions. There was evidence of penile and scrotal scarring and minor aphthae on the buccal mucosa. Blood pressure was 110/80 mm Hg and pulse rate 100/min.\\nAs to laboratory tests, haemoglobin concentration was of 9 g/dl, erythrocyte sedimentation rate of 60 mm/hr and C reactive protein concentration of 19 mg/l (normal < 2 mg/l). Renal and liver function tests were normal. Levels of serum IgG and IgM anticardiolipin, protein C, protein S, antithrombine III and total homocysteine were within the normal range. Electrocardiogram showed sinus rhythm tachycardia with no other abnormalities. Chest X-ray demonstrated hilar enlargement. Transthoracic and transoesophageal echocardiography showed multiple cardiac masses, one in the right atrium protruding through the tricuspid valve and two in the right ventricle (Figure 1 - see Additional file 1). Helical computed tomography (CT) showed multiple thrombi in both right atrium and ventricle extending into the superior vena cava. There was innominate and brachiocephalic vein occlusion, it also showed bilateral pulmonary embolism and multiple pulmonary infarcts in the lower lobe of the lungs. A large (14 mm in diameter) aneurysm located in the right basal segmental arteries (Figure 2 - see Additional file 2). We opted for a treatment based on low molecular weight heparin twice daily then oral anticoagulant, 1 gr of methyl prednisolone per day for 3 days, 1 mg/kg/day of oral, then tapered over 3 weeks and 1 g pulse cyslophosphamide monthly associated with colchicine 1 mg/day.\\nTwo weeks later, oedema of the chest and neck has completely resolved. Thrombus size has substantially decreased. Nine months after discharge, no cardiac masses were detected by echocardiography and CT scan showed no evidence of previously mentioned thromboses with a complete disappearance of pulmonary aneurysm.',\n",
       "    'gender': 'Male'},\n",
       "   {'age': 29,\n",
       "    'case_id': 'PMC1192821_02',\n",
       "    'case_text': 'A 29-year-old Tunisian man with a two-month history of fever of unknown origin, weight loss and inspiratory thoracic pain was admitted. He had suffered from both genital and oral ulcers over five months. The initial physical examination revealed a temperature of 38 C, multiple pseudofolliculitis, oral and scrotal ulcerations. Laboratory tests on admission revealed: haemoglobin of 13 g/dl, erythrocyte sedimentation of 105 mm/hr and C reactive protein concentration of 204 mg/l. The tests looking for antiphospholipid antibodies, protein C, protein S and antithrombine III deficiencies were negative. The plasma total homocysteine level was 27 mumol/l (normal < 10 mumol/l). HLAB5 and pathergy tests were positive. Electrocardiogram showed sinus rhythm tachycardia, and chest X-ray was normal. Transoesophageal echocardiography revealed a cardiac mass in the right atrium of 20/23 mm size attached into atrial septum protruding through the tricuspid valve into the right ventricle (Figure 3 - see Additional file 3). These findings were confirmed by CT scan that also showed a partial obstruction of the terminal portion of the inferior vena cava and thrombosis of the left lobar pulmonary artery with multiple pulmonary infarcts. We started treatment with intravenous heparin then oral anticoagulant, 1 gr of methyl prednisolone per day for 3 days, 1 mg/kg/day of oral, which was tapered gradually and 1 g pulse of cycslophosphamide monthly associated with colchicine 1 mg/day. Consequently, the thrombus in the right atrium has substantially decreased in size. At five months follow-up, a complete resolution of the thrombi in the right atrium, vena cava and pulmonary artery tree was observed.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 71,\n",
       "    'case_id': 'PMC2797594_01',\n",
       "    'case_text': 'Case 1: A 71-year-old man entered our emergency department presenting with abdominal pain that had lasted for six months and had worsened in the last week. His past medical history revealed hypertension, tabagism, dyslipidemia and epilepsy. His left lower leg was amputated 11 years earlier, after an accident with chemicals; the right lower leg of the patient was also amputated after an episode of acute ischemia six years before that date. His physical examination revealed a painful, palpable pulsatile mass extending from the mesogastrium to the infraumbilical area. There was no femoral pulse, but the stumps and buttocks had a normal temperature. An abdominal computed tomography (CT) scan revealed a thrombosed infra-renal aneurysm with a maximum transverse diameter of 10.5 cm (Pictures 1 and 2).\\nAfter cardiac evaluation, an elective laparotomy was performed. The surgery revealed an inflammatory aortic aneurysm with clearly visible local wall necrosis (Picture 3). After clamping the aorta, the aneurysm sac was incised, releasing a great volume of thrombosed and liquefied clots under significant pressure. The aorta and both iliac common arteries were sutured, and no bypass was performed. The postoperative course was unremarkable, and the patient was sent home on the sixth postoperative day. He continued with ambulatory consultations. On the 40th postoperative day, the patient returned to the emergency room in a septic state with abdominal pain, ascites and circulatory shock. The patient expired in the emergency room before surgery could be performed, despite aggressive attempts to resuscitate him. The post mortem examination revealed diffused peritonitis as a consequence of mesenteric ischemia and perforation of the small intestine, associated with pancreatitis. There was neither an aortic stump blow-out nor a colon ischemia.',\n",
       "    'gender': 'Male'},\n",
       "   {'age': 57,\n",
       "    'case_id': 'PMC2797594_02',\n",
       "    'case_text': 'Case 2: A 57-year-old man sought medical attention for evaluation of spontaneous ischemic necrosis of the fifth toe of the right foot. He denied symptoms of abdominal pain, but his general condition was extremely poor. Notable parts of his past medical history included hypertension, tabagism, coronary heart disease and stroke. His physical examination indicated a 4-cm palpable pulsatile mass in megogastrium. There were no femoral or distal pulses. A CT scan of the abdomen and lower extremities revealed a thrombosed 3.5-cm infra-renal AAA with occlusive arterial disease of the iliac and femoral arteries (Picture 4). Deep femoral arteries were patent. A duplex scan of the carotid arteries showed an occlusion of the right internal carotid artery and no significant stenosis in the left internal carotid artery.\\nCardiac evaluation had deemed him as high risk for open repair. An axillobifemoral bypass using an 8-mm Dacron graft was performed under general anesthesia. The patient was sent home on postoperative day 8. The patient is still been attentively observed to check the aneurysm.',\n",
       "    'gender': 'Male'},\n",
       "   {'age': 58,\n",
       "    'case_id': 'PMC2797594_03',\n",
       "    'case_text': 'Case 3: A 58-year-old man sought medical attention for evaluation of an infected ulcer in the calcaneous and the dorsal aspect of the left foot. He denied any symptoms of abdominal pain. His past medical history was significant for diabetes, hypertension and 38 years of smoking. Clinical examination revealed the absence of femoral pulses. A CT scan of the abdomen and lower extremities detected a 3.0-cm infra-renal AAA and a thrombosed 2.5-cm right common iliac artery aneurysm with occlusive arterial disease of the external bilateral iliacs (Picture 5). Common femoral arteries were evident.\\nAn aortic-iliac-femoral bypass was successfully performed. Following a prolonged recovery, due to an uncontrolled infection of the left foot, a transtibial amputation was performed. The patient was discharged and sent home on postoperative day 25.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 40,\n",
       "    'case_id': 'PMC8214893_01',\n",
       "    'case_text': 'A 40-year-old man presented to the gastroenterology outpatient department complaining of pain after defecation for 3 months. There was no history of bleeding or mucoid discharge per rectum. Rectal examination showed unremarkable perianal skin, but growth at the fingertip was palpable. Subsequent endoscopic examination of the large intestine showed friable polypoidal growth in the anal canal. The remaining parts of the colon up to the terminal ileum were normal. Abdominal contrast-enhanced computed tomography (CECT) showed a well-defined polyp measuring 18x13x12 mm in the anterior wall of the anorectal junction. There was no definite muscular layer and serosa involvement noted on the pelvic MRI, neither locoregional lymphadenopathy was identified. Perirectal and perianal fat were normal. Serum CEA level was 2.7 ng/ml (Reference Range; RR; 0-4.0 ng/ml). Anti-HIV was negative. Polypectomy was done, and tissue was submitted for histopathological examination.\\nOn microscopy, it showed fragmented polypoidal tissue with papillary folds lined by variably thickened truly stratified epithelial cell layers with a maximum of 20 cell thickness (Figure 1A, B). The stratified layers of epithelial cells exhibited full thickness dysplasia with marked nuclear atypia, hyperchromasia, and increase number of mitotic figures, resembling a high-grade squamous intraepithelial lesion (Figure 1C). However, the epithelial cells in the stratified layers had also shown intracytoplasmic mucin vacuoles. Due to the abundance of intracytoplasmic mucin in a few cells, the nucleus was displaced to the periphery and gave a signet ring-like morphology. PAS-AB highlighted intracytoplasmic mucin in the stratified epithelial cell layers (Figure 1 D). There was no gland formation within these stratified layers. Also, adjacent fragments showed invasive components with tumor cells arranged in solid nests with central comedonecrosis, tubules, and trabecular patterns (Figure 22B).\\nOn the immunohistochemistry, these stratified cells showed strong immunoreactivity for CK7 and negative expression for p63, excluding the possibility of a high-grade squamous intraepithelial lesion. Furthermore, these cells showed strong nuclear expression for p16, and Ki 67 index was 80% (Figure 3AD).\\nThough the usual type adenocarcinoma component was noted in a few fragments in the invasive areas, the observation of truly stratified layers with intracytoplasmic mucin is unusual in the anal canal and not documented in the literature. Unfortunately, due to insufficient material in the formalin-fixed paraffin-embedded block, we could not perform the HPV-ISH or genetic sequencing for the human papillomavirus.\\nAfter the polypectomy, whole-body FDG PET CT was performed, which showed mild diffuse FDG uptake in the anorectal region. The patient further received 16 cycles of chemotherapy for the residual tumor. Furthermore, now he is on the 8-month follow-up without symptoms.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 6,\n",
       "    'case_id': 'PMC3350299_01',\n",
       "    'case_text': 'Six-year-old female child, first product of nonconsanguineous marriage resident of New Delhi, presented with fever for four days, yellowish discoloration of eyes, and urine for two days, progressive swelling of whole body starting from feet for one day. Fever was moderate to high grade, intermittent in type associated with chills and rigor subsided with medication and profuse sweating. She was having high coloured urine for two days. Progressive swelling of whole body for last one day starting from feet then involved the whole body. Stools were normal in colour. There was no history of black coloured stools, vomiting, bleeding from any site, and any change in conscious level, jaundice in the past, any history of blood transfusion, and intravenous medication in the past or any history of drug intake. There was no history suggestive of respiratory tract infections, skin infection, decreased micturition, and reddish coloured urine. There was no significant past, antenatal, perinatal, or family history. The child was fully immunized and was receiving adequate calories and proteins for her age.\\nOn examination, the child was conscious, cooperative, and orientated. At admission her pulse was 78 per minute, respiratory rate 26 per minute, and blood pressure 98/68 mm of mercury. There were severe pallor, and icterus. Lymph nodes were not palpable. On abdominal examination liver was palpable 4 cms below costal margin with span of 10 cm the spleen was palpable 1 cms below costal margin. Her respiratory, cardiovascular (CVS), and central nervous system (CNS) examination was unremarkable.\\nOn investigation haemoglobin was 4.9 g/dL, total leucocyte count 10.6 x 103 per muL with polymorphs 54%, lymphocytes 42%, monocyte 4%, platelet count 11x103 per muL and erythrocyte sedimentation rate 8 mm/1st hour by Westergren method. Blood sugar was 84 mg/dL. Total serum bilirubin was 27.5 mg/dL, indirect fraction of 18 mg/dL. SGOT was 495 and SGPT 210. Serum total protein was 2.8 gram (gm) and albumin 1 gm per 100 mL of blood. Blood urea nitrogen was 189 mg/dL, creatinine 0.6 mg/dL, sodium 136 meq/L, potassium 4.1 meq/L. Prothrombin time was 17.3/12 with INR of 1.44. Viral markers (HBsAg, IgM hepatitis C, A and E) were negative. Chest X-ray was normal and ultrasonography abdomen showed hepatosplenomegaly. On peripheral smear trophozoites and schizonts of P. vivax and trophozoites and gametocytes of P. falciparum were seen. Rapid malarial antigen test was positive. Arterial blood gas analysis showed pH 7.45, partial pressure (PP) of oxygen 104, PP of carbon dioxide 45, and standard bicarbonate 28 meq/L. Urine routine and microscopy were normal. She was given injection of Artesunate 2.4 gm per kilogram body weight, along with cefotaxime and vitamin K. She received fresh frozen plasma, packed red cell, platelets along with inotropes. Within five hours of admission she developed profuse upper gastrointestinal bleeding, along with deterioration of consciousness. She went into shock, then cardiorespiratory arrest from which she could not be revived.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 70,\n",
       "    'case_id': 'PMC5872664_01',\n",
       "    'case_text': 'The patient was a 70-year-old Caucasian male with coronary artery disease, sick sinus syndrome with pacemaker dependence, chronic kidney disease, type 2 diabetes mellitus, dementia, and schizoaffective disorder, who was found to have spontaneous unilateral epistaxis and left-sided facial asymmetry. He lived at a board and care facility, and medical decisions were made in conjunction with the patient and his sister who was his power of attorney. Prior to these symptoms, the patient was Eastern Cooperative Oncology Group functional status (ECOG) of 2. Upon admission to the hospital, he was found to have a large nasal mass, palpable large left cervical lymphadenopathy. Timeline of events is outlined in Table 1.\\nCT imaging demonstrated a large infiltrative enhancing mass centered in the left side of the nasal cavity and left maxillary sinus as well as an enlarged left submandibular lymph node. Left submandibular lymph node fine-needle biopsy demonstrated sheets of lymphocytes with effacement of the normal lymph node architecture, with medium to large lymphocytes with nucleoli and vesicular chromatin. By immunohistochemistry, the atypical cells were Pax-5, CD20, MUM1, BCL2, and BCL6 positive and CD56, TdT, CD10, and cyclin D1 negative, with a Ki-67 of about 95%, consistent with diffuse large B-cell lymphoma, NGCB type (Figure 1). PET/CT was performed after the biopsy to complete staging, which demonstrated multifocal hypermetabolic tumor foci including bilateral nasopharynx, bilateral nasal cavity, left maxillary sinus with extension to the left parapharyngeal space, soft palate, lingual tonsil, palatine tonsil, left face, bilateral neck nodes including jugulodigastric, posterior cervical, and the largest of which was a left submandibular node with central necrosis of 4 centimeters (Figure 2(a)). In addition, the liver and bone were diffusely increased in avidity suggestive of involvement by lymphoma (Figure 2(b)). The initial standardized uptake value (SUV) of the left submandibular node was 6.4, the liver was 3.2 SUV, and the bone marrow was 3.7 SUV. The patient and his sister refused biopsy of these sites to confirm the presence of disease pathologically. Based on these findings and a normal initial LDH level of 159 units per liter, he was considered stage IV, with International Prognostic Index (IPI) of 4 (high risk), as well as high risk for CNS involvement. After discussion with the patient and his sister, decision was made to pursue only \"nonchemotherapy\" treatments. As such, monoclonal antibodies, targeted therapies, and corticosteroids were all considered; however, intrathecal chemotherapy was declined.\\nThe patient started treatment with ibrutinib, and the dose was escalated over several weeks to 420 mg daily by mouth. At the same time, 21-day cycles of rituximab 375 mg/m2 IV on day 1 along with prednisone 1 mg/kg PO for days 1 through 5 were also initiated. Supportive care was initiated simultaneously with allopurinol for tumor lysis prophylaxis. In addition, since the patient was wheelchair bound and at risk for thromboembolism, he was started on prophylactic dose of enoxaparin at 40 mg subcutaneously daily. Baseline hepatitis B, C, and HIV testing was negative. The patient tolerated the treatment well with no hematologic toxicities, minimal tumor lysis, no effect on renal or liver function, and no significant infection. The patient had an excellent response to treatment, and after the first cycle of chemotherapy, his epistaxis had resolved and his pain and swelling had also subsided. After five cycles of treatment, the patient had repeat PET/CT imaging that demonstrated near-complete response (Figure 2(a)). The dominant submandibular lymph node decreased in size from more than 4 cm to less than 1.5 cm, there were only residual erosive changes in the maxilla with mild residual FDG avidity (SUV max 3.6), the FDG activity in the liver resolved to SUV 2.7, and however the bone marrow remained PET avid with SUV 3.8. After 4 additional cycles, the patient achieved a complete response on repeat PET imaging including resolution of the bone marrow avidity (Figure 2(a)). This response was durable, and even after cessation of therapy, he had no signs of recurrence.\\nAfter a total of 9 cycles of rituximab, prednisone, and ibrutinib, the patient had a complete response (Figure 2). At that time, however, ECG demonstrated that he was in atrial fibrillation with rapid ventricular response. He was referred to cardiology, and his dose of enoxaparin was increased to a therapeutic level at 1 mg/kg subcutaneously twice per day. He was started on beta blockade with control of his heart rate. At that point, the plan was to transition to rituximab maintenance every 2 months. Ibrutinib was continued as his atrial fibrillation seemed to be rate controlled. Repeat PET/CT showed the disease was still in remission one month later; however, prior to his first dose of maintenance rituximab, he presented to an outside hospital with fever, cough, shortness of breath, and atrial fibrillation with rapid ventricular response. He was diagnosed simultaneously with sepsis from pneumonia and respiratory failure from both pneumonia and an acute exacerbation of heart failure. During the hospital course, the patient and his sister decided to stop all interventions and he was made comfort care. He died a few weeks later on hospice care. Despite being off of treatment for several weeks, however, there was no sign of recurrent disease at that time.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 2,\n",
       "    'case_id': 'PMC4789394_01',\n",
       "    'case_text': \"A fifty-two-year-old, nonsmoker female presented with right-sided severe dull aching chest pain, dry cough, and exertional dyspnoea for four months. Severity of chest pain was gradually increasing and disturbs her sleep at night. Shortness of breath was initially of mMRC grading 2; later it was increased to grade 3. There was no history of hemoptysis, fever, weight loss, and loss of appetite. There was no past history of pulmonary tuberculosis.\\nOn examination, general survey revealed no abnormality. Her temperature was 97.2 F, pulse rate, 84 beats/minute, respiratory rate, 24 beats/minute, and blood pressure, 124/80 mmHg. Examination of respiratory system revealed diminished movement of chest wall on right side, tracheal shifting to left, apical impulse in left fifth intercostal space, 1.5 cm lateral to the left midclavicular line, stony dull percussion note over right chest wall, absent vesicular breath sound, and diminished vocal resonance on right side, suggestive of right-sided pleural effusion. Examination of other systems revealed no abnormality.\\nComplete hemogram and blood biochemistry (including serotonin, gastrin, somatostatin, and glucagon) were within normal limit. Chest X-ray posteroanterior view (CXR, PA view) revealed right-sided pleural effusion (Figure 1). Ultrasound of abdomen revealed no abnormality. Pleural fluid was aspirated from right hemithorax and its analysis showed haemorrhagic, exudative, and lymphocyte predominant pleural effusion with adenosine deaminase level 16 U/L. No malignant cell or acid fast bacilli were seen in pleural fluid. Contrast enhanced computed tomography (CECT) of thorax showed only right-sided pleural effusion (Figure 2). No mass lesion or mediastinal lymphadenopathy was detected on CECT thorax. Closed pleural biopsy was done with Abram's needle and histopathological examination of biopsy tissue taken from right parietal pleura showed diffuse sheets of round to oval cells with hyperchromatic nuclei and scant to moderate amount of cytoplasm. Few scattered large cells with abundant eosinophilic cytoplasm were present. Focally spindle cells with hyperchromatic nuclei were seen. Focal micropapillae formation was also noted; features were suggestive of a poorly differentiated malignant tumour (Figure 3). Immunohistochemistry of pleural tissue showed that majority of tumour cells were positive for synaptophysin and a few cells were positive for Ki-67 (2%) and negative for pan-cytokeratin, calretinin, Wilm's tumour protein 1 (WT1), desmin, vimentin, carcinoembryonic antigen (CEA), thyroid transcription factor 1 (TTF1), and CD 56 (Figure 4). Hence, tissue diagnosis was well-differentiated malignant neuroendocrine tumour of pleura. Histopathology and IHC findings were reviewed by another pathologist of different centre, and the diagnosis was confirmed. Fibreoptic bronchoscopy (FOB) was normal. CECT of abdomen and brain revealed no abnormality. No abnormality was detected on endoscopic examination of upper gastrointestinal tract and on colonoscopy. Radionuclide bone scan did not show any metastatic deposit in bones. So, final diagnosis was primary, well-differentiated, malignant neuroendocrine tumour of pleura, presenting as isolated right-sided pleural effusion.\\nSix cycles of cytotoxic chemotherapy comprising of intravenous infusion of carboplatin (at an area under the concentration-time curve 6.0 on day 1, 450 mg in this case) and etoposide (100 mg/m2/day, 130 mg in this case on days 1, 2, and 3) were given. Along with chemotherapy, intercostal tube drainage under water seal was given in right hemithorax through fifth intercostal space at right midaxillary line, as recurrent and rapid collection of massive amount of pleural fluid occurred and repeated aspiration of pleural fluid failed to reduce the volume of pleural fluid. When there was clinicoradiological evidence of complete expansion of right lung parenchyma, chemical pleurodesis with 20 mL of 10% povidone-iodine was done. On one-year follow-up, progressive regression of pleural effusion with alleviation of chest pain was documented.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 57,\n",
       "    'case_id': 'PMC4900105_01',\n",
       "    'case_text': \"A 57-year-old Caucasian female with a known history of a 20-year, stable midline cerebellar mass presented with severe gait ataxia. Conventional brain MRI scans included diffusion tensor imaging (DTI). MRI data was processed to obtain tractography and fractional anisotropy (FA) maps using GE FuncTools software. MR images were examined for extent and location of tumor as well as invasion, destruction, or displacement of brain parenchyma and white-matter tracts. A 4.0 x 3.9-cm solid cystic lesion with lobulated margins in the cerebellar vermis was observed on T2-weighted MRI (Figs. 1A, 1B), which had increased in size from prior studies. There was also herniation of the vermis with effacement of the quadrigeminal plate cistern, mild herniation of cerebellar tonsils below the level of foramen magnum, and partial obstruction of CSF outflow at the level of the 4th ventricle. Tractography (Figs. 2A, 2B) and FA maps (Fig. 3) suggested on the basis of imaging that fiber tracts surrounding the lesion were displaced, but fiber integrity (as represented by fractional anisotropy) was maintained. This suggested a less aggressive type of neoplastic lesion.\\nThe patient underwent tumor-debulking surgery via a suboccipital craniotomy, with good outcome. The histopathology showed a largely circumscribed astrocytoma with associated macrocysts, microcalcifications, eosinophilic granular bodies, and rare Rosenthal fibers, consistent with a benign entity such as a pilocytic astrocytoma (PA) (Fig. 4). However, focally localized atypical features were also present, including a hypercellular focus with increased mitotic activity and pseudopalisading necrosis, and vascular proliferation, consistent with PA with anaplastic features (Fig. 5). Immunohistochemistry demonstrated GFAP positivity, p53 negativity, and focally positive MIB1 labeling. In light of this patient's longstanding history of a midline cerebellar mass, it is likely that this mass may have been a stable nonanaplastic PA that eventually developed anaplastic features around the time of symptom progression.\\nA followup MRI performed three months after resection demonstrated expected postoperative changes without evidence to suggest recurrence.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 46,\n",
       "    'case_id': 'PMC3604869_01',\n",
       "    'case_text': \"While driving her car, a 46-year-old woman with long-standing idiopathic hypertension developed a sudden tingling sensation in the right side of her face and arm, heaviness of the right arm, double vision and nausea. Notably, her hypertension was diagnosed at the age of 16 years, and her blood pressure had been difficult to control. At the time of presentation, she was taking three anti-hypertensive drugs. She had never experienced neurological symptoms before.\\nShe drove to an emergency department where mild weakness of the right arm was found, and she was immediately referred to the stroke department. An MRI scan revealed no acute ischemia on the diffusion-weighted scan, but on T2*-weighted imaging, a dark focus of increased susceptibility ('microbleed') was visible in the left pons, in the area of her described symptoms (fig. 1). The symptoms fit well with the location because of the proximity to the corticospinal tract (lesion of which causes contralateral weakness) and the medial longitudinal fasciculus (lesion of which causes double vision due to internuclear ophthalmoplegia.) Dizziness is a rather unspecific symptom but often seen with lesions in the vertebrobasilar circulation. On the B-zero diffusion series, the microbleed revealed a rim of T2 hyperintensity consistent with edema and an acute timing of the lesion (fig. 2).\\nOn the following day, the patient complained of subjective dizziness, but the neurological exam was normal. She was referred to the nephrology service for better antihypertensive control and was subsequently discharged.\\nTransient ischemic attack (TIA) is defined as a focal neurological deficit that normalizes within 24 h and is attributable to ischemia. Microbleeds have been associated with transient deficits, but only in patients with cerebral amyloid angiopathy. This is, to our knowledge, the first report of a presumed hypertensive microbleed presenting with TIA-like symptoms. The case emphasizes the usefulness of MRI in the workup of TIA patients.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 48,\n",
       "    'case_id': 'PMC4296998_01',\n",
       "    'case_text': 'A 48-year-old man presented to our clinic with an 8-year history of persistent tinnitus in his right ear, combined with ipsilateral progressive hearing loss and aural fullness. He did not report vertigo, ototoxic exposure, a history of otitis media or trauma, or a similar familial history.\\nUpon physical examination, there were no otologic findings, facial palsy, or any other affected cranial nerves. Audiological examination revealed normal hearing in the left ear and moderate to severe sensorineural hearing loss in the right ear, with a speech reception threshold (SRT) of 80 dB and a word recognition score (WRS) of 58%. An audiogram obtained 7 years previously showed mild to moderate hearing loss in the right ear, and the patient had an SRT of 55 dB and a normal WRS of 92%.\\nMRI demonstrated a small intracochlear nodular lesion (diameter, 3.0 mm) in the modiolus, with a diffuse contrast in the apical turn, isointense on T1 (Fig. 1) with a high contrast enhancement on T1 postgadolinium images (Fig. 2). The lesion showed sharply delineated edges on enhanced T1-weighted images and sharply delineated signal intensity loss in the high-intensity intralabyrinthine fluid on heavily T2-weighted images (Fig. 3). After 22 months, there were no symptomatic or audiologic changes and MRI presented the same images.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 9,\n",
       "    'case_id': 'PMC2778135_01',\n",
       "    'case_text': \"A previously healthy 9-year-old boy (whose mother was recently found to be HIV-positive) presented to the hospital with 1 week of right-sided hemiplegia and right-sided facial palsy. Past medical history included psoriasis, diagnosed 4 years prior. His only HIV exposure was perinatal. On exam the patient weighed 22 kilograms, and vitals signs were within normal limits. He was alert and oriented with a normal level of consciousness and responded appropriately to questions. His speech was slowed and slurred, but this was his baseline according to his mother. He had right-sided facial palsy and right-sided tongue deviation; otherwise cranial nerves were intact. The boy had 3/5 strength in the right upper extremity and 4/5 strength in the right lower extremity. Left-sided strength was 5/5. The patient was able to walk with limited difficulty. Deep tendon reflexes were 2+ and 3+ throughout. Babinski's sign showed dorsiflexion of the right 1st toe. Sensation was intact throughout. The patient also had clusters of 1-2 mm skin colored papules on his forehead and left cheek in addition to diffuse mild psoriatic scaling. Immunizations were up to date. The patient was admitted for a workup of these symptoms.\\nLaboratory studies showed complete blood count: hematocrit 31.6%, hemoglobin 10.5 g/dL, white blood cell count 5000 cells/muL (N 41%, L 35%, E 12%, M 6%, B 1%, atypical L 1%), and 157 000 platelets/muL. HIV-antibody test was positive with a CD4 T-cell 0.21% (4 cells/muL) and plasma HIV RNA virus of 185 976 copies/mL (log 5.27). Tests for Cryptococcus antigen, Toxoplasmosis antigen, Ebstein Barr virus IgG and IgM, Cytomegalovirus IgG and IgM, Hepes Simplex virus polymerase chain reaction (PCR), Japanese encephalitis as well as cultures for tuberculosis and fungi (plasma and cerebrospinal fluid, CSF) were all negative. Plasma and CSF samples were positive for JCV by real time PCR with a plasma RNA level of 226 copies/mL.\\nThree days after admission a brain computerized tomography (CT) scan was performed and showed frond-like hypodense lesion at the left frontal lobe with mild effacement of the left frontal horn of the lateral ventricle. Highly active antiretroviral therapy (HAART) regimen was subsequently started 10 days after admission, consisting of GPOvir-Z (coformulated zidovudine 250 mg, lamivudine 150 mg, and nevirapine 200 mg). Clinically, the patient deteriorated during the 1st and 2nd weeks of HAART with fever and increased right leg weakness, but immunologic and virologic improvement was seen (CD4 T-cell count 0.8%, 10 cells/muL, and a plasma HIV RNA viral level of 26 532 copies/mL, log 4.42). CT (Figure 1) and brain magnetic resonance imaging (MRI; Figure 2) scans were subsequently performed. The scans showed progressive of white matter lesions with asymmetrical deep and subcortical white matter lesions over the left frontotemporoparietal region and the right frontal lobe. The lesion on the left hemisphere involved internal capsule, lentiform nucleus, thalamus, and genu of corpus callosum and anterior cerebellar hemisphere. There were no enhanced areas after the contrast study.\\nThe patient was discharged 7 weeks after the first admission. Upon discharge he was able to walk with assistance, but was unable to speak.\\nThe patient was readmitted one day after discharge due to autonomic nervous system dysfunction (nausea, vomiting, and loss of bowel and bladder tone). Deep tendon reflexes were 4+ throughout, and Babinski was positive bilaterally. Continued improvement of immunologic (CD4 T-cell count 2.0%, 30 cells/muL) and virologic (HIV RNA level 3220 copies/mL, log 3.51) measures were seen. Due to progressive neurologic symptoms HAART was ceased. The second MRI (Figure 3) scan was performed and showed a progressive lesion in the same regions as described in the previous MRI, but also found new lesions over the midbrain, pons, and medulla predominantly on the left. The patient was discharged approximately 3 weeks after admission.\\nThe patient was readmitted 1 month later (100 days after onset of symptoms). Immune Reconstitution Inflammatory Syndrome (IRIS) was suspected, and the boy was treated with methylprednisolone (2 mg/kg/day) for 5 days. Despite HAART suspension and administration of steroids, his clinical symptoms worsened. The third MRI (Figure 4) scan showed new lesions in the regions of the right brainstem and right hemisphere with gyral enhancement. The patient's mother refused further treatment, he was discharged home, and he subsequently died 1 year later.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 2,\n",
       "    'case_id': 'PMC7263430_01',\n",
       "    'case_text': 'The phenotypes associated with C12orf65 variants may be classified into three groups: mild, intermediate and severe, distinguished by disease severity, mortality, and the lack or presence intellectual disability. Here we describe a 2-year-old female patient with Leigh syndrome and a novel frameshift deletion pathogenic variant of the C12orf65 gene. We also review clinical and molecular aspects of the clinical phenotype caused by C12orf65 variants.',\n",
       "    'gender': 'Female'},\n",
       "   {'age': 2,\n",
       "    'case_id': 'PMC7263430_02',\n",
       "    'case_text': \"The 2-year-old girl was admitted to our hospital presenting with respiratory failure and sleepiness. Physical examination showed global hypotonia, developmental delay, and no dysmorphisms. She was the first child of healthy consanguineous parents, without pathological familiar history. Delivery was preterm via caesarean section because of foetal distress. Her weight was 1.720 kg, height of 41.5 cm, and an occipitofrontal circumference of 29 cm. The Apgar scores immediately after delivery and at 5 minutes were 3 and 8, so she was given neonatal resuscitation. She was observed in the neonatal care unit for the first three months of life because of respiratory distress episodes. Chromosome analysis showed a normal karyotype, abdominal and ophtamological exams were unremarkable. The patient was then referred to the paediatric unit after the respiratory distress episodes were treated. Her developmental milestones were incompletely informed: social smile and holding head at 3 months, sitting without support at 10 months, crawling at 11 months, and standing up with support and first words at 12 months of age. After the first year of life, the patient presented with failure to thrive and neurological regression was reported as she stopped grabbing toys and pointing objects and persons. At 2 years of age, she started episodes of diarrhoea and sleepiness evolving with respiratory failure at home and was taken to the emergency room for support and management. Her respiratory failure could not be resolved, so she was referred to the paediatric intensive care unit for better support. Her laboratory findings showed consecutive high levels of serum lactate (21 mg/dL when admitted to our critical time intervention programme, 19 mg/dL at day 7, 54 mg/dL at day 14, 69 mg/dL at day 19, and 30 mg/dL at day 24 after admission; the reference lactic acid level is 4.5 - 14.4 mg/dL). Metabolic investigations included tandem mass and urinary organic acid analyses, which were normal. Ophthalmological examination showed optic atrophy and echocardiography, abdominal and doppler sonography were normal. The electroencephalography suggested parieto-occipital epileptiform discharges, and brain magnetic resonance imaging (MRI) showed bilateral high intensity T2/Flair foci in the periventricular and peritrigonal white matter, internal capsule of the posterior limb and thalamus periphery; additionally, hyperintensities were observed in the cerebral peduncle, midbrain tegmentum, dorsal pons, and medulla oblongata, with a few areas of restricted diffusion, which is typical for mitochondrial disorders (Figure 1).\\nEmpirical mitochondrial vitamin cocktail therapy, including thiamine, riboflavin, coenzyme Q10, biotin and L-carnitine, was initiated without clinically detectable improvement. Her treatment outcome was poor, with oxygen dependence, spastic tetraplegy, and severe developmental delay.\\nClinical exome sequencing was then performed. Informed consent was obtained from the patient's parents, according to the ethical principles of the Declaration of Helsinki. Genomic DNA was isolated from peripheral blood samples (QIAamp DNA Blood Mini Kit; Qiagen, Hilden, Germany), and was quantified by using the Qubit dsDNA HS Assay kit for the Qubit 2.0 Fluorometer (Life Technologies, Carlsbad, CA). We used the TruSighta One Sequencing Panel (Illumina, Inc., San Diego, CA, USA) for paired-end sequencing with a v3 600 cycles kit on a MiSeq System platform (Illumina), according to the manufacturer's guidelines. The FASTQ files were aligned to the Human Genome Reference Consortium build 37 (hg19) by using the Burroughs Wheeler Alignment algorithm as implemented in the BWA software package. After genome alignment, Variant Calling was performed by using the Genome Analysis Toolkit (GATK). Variants were annotated by using ANNOVAR, and selected read alignments were visualised by using the Integrative Genomics Viewer. All regions with a sequencing depth < 20 were considered unsuitable for analysis. Furthermore, we established a minimum threshold Phred-like quality score of 30 (base call accuracy of 99.9%). Common variants (3 1% in the general population) were discarded by comparison with the 1000 Genomes, the Exome Variant Server, and the Exome Aggregation Consortium database. Synonymous variants were filtered and only exonic and splice site variants were prioritized. Initially, we evaluated the variants in the homozygous state, because the parents of the proband were consanguineous, and prioritized genes based on phenotypic databases, such as the Online Mendelian Inheritance in Man. The variant identified as pathogenic was confirmed by Sanger sequencing.\\nWe identified a novel homozygous 14 bp frameshift deletion in exon 2 of the C12orf65 gene: c.207_220del; p.Pro70Asnfs*28 (NM_152269), which was validated by Sanger sequencing, the sequence, being aligned with CRISP-ID (). This variant is not present in population control databases (Exome Aggregation Consortium, 1000 genomes and Exome Variant Server). The truncated protein is predicted to have 96 aa as opposed to the original length of 166 aa, lacking the GCQ domain (residues 57-121) and the coiled-coil region (residues 127-160) (UniProt databank); this likely results in loss of function. Based on these features and according to the American College of Medical Genetics and Genomics guidelines, this variant is considered to be pathogenic.\\nTo our knowledge, 27 patients were described with pathogenic variants in the C12orf65 gene with different clinical diagnoses (). The phenotype can vary from spastic paraparesis - type 55 - to Leigh syndrome. It has been thought that the main clinical features caused by C12orf65 variants correspond to a triad of optic atrophy, peripheral neuropathy, and spastic paraparesis, associated or not with Leigh syndrome. The information available from 27 patients showed that 92.3% presented with optic atrophy, 80% with peripheral neuropathy, 60% with spasticity, 52.1% with cognitive impairment, 42.8% with nystagmus, 38.4% with ophthalmoplegia, and 20% with bulbar disfunction. Our patient had optic atrophy, bulbar dysfunction (manifested as dysphagia and respiratory failure), and neurodevelopmental delay. We could not evaluate nystagmus and ophthalmoplegia, and spasticity was not present at the time of examination; the MRI findings were typical for Leigh syndrome. Our patient could be included in the COXPD7 severe phenotype, as she had a dramatically deteriorating course as described by. This phenotype consists of significant cognitive and motor impairment and results in wheelchair dependence and typically abnormal Leigh syndrome brain MRI. Moreover, our patient showed a more severe phenotype when compared to patients described previously. The severity of this phenotype can be explained by the variant found, which affects an important functional protein domain (Figure 2).\\nRegarding the molecular status, the 27 described patients had 11 different pathogenic variants in the C12orf65 gene (). These variants were predominantly nonsense, splicing site and frameshift, and considered to be null variants. Only one of them, c.282G > A (p.Lys94Lys), was synonymous, but it was predicted to create a loss of splicing site with retention of intron 2, thus acting as a frameshift variant. The variant found in our patient was also a null variant, and we suggest that truncated C12orf65 proteins were generated after the deletion of 14 base pairs, which reinforces the idea that a loss-of-function mechanism is a fundamental part of the pathogenesis.\\nWe classified the phenotype of the reviewed patients as severe when there was bulbar dysfunction, or typical MRI findings of Leigh syndrome, or intellectual disability/neurodevelopmental delay, or absence of ambulation. The variants linked to severe phenotypes were more likely to affect the GCQ domain of the protein, although they could impact other protein domains (Figure 2).\\nThe reviewing of clinical features and variants of 27 already described patients and the patient herein shows that the phenotype associated with C12orf65 variants is heterogeneous and that variants impacting the GGQ protein domain tend to be associated with more severe phenotypes. This is in agreement with, who concluded that a clear genotype-phenotype correlation is anticipated, with deleterious mutations that disrupt the GGQ-containing domain being expected to result in a more severe phenotype, whereas downstream C-terminal alterations might result in a more favourable phenotype, typically lacking cognitive impairment.\\nOur review also showed that the median age for the onset of symptoms was 4 years and the median age for diagnosis was 17 years, so there was a 13-year diagnostic delay. Our patient presented the first symptoms immediately after birth, and the diagnosis was made two years later. A diagnostic delay may occur because of a variable phenotypic expression, despite the same aetiology (pathogenic variants in the C12orf65 gene), the rarity of the disease, the lack of knowledge about its existence and because of difficult access to molecular confirmation. Compared with literature data, our diagnostic delay was shorter, probably due to our patient having classical MRI signals of Leigh syndrome and elevated serum biomarkers (e.g., lactate), as well as a severe phenotype that contributed to active search for the aetiology. The prompt access to exome sequencing allowed a molecular diagnosis of the disorder.\\nIn conclusion, the present study allowed the identification of a C12orf65 gene variant associated with a severe phenotype of Leigh syndrome caused by COXPD7 and reinforces the importance of the GGQ protein domain for the conserved peptidyl-hydrolase function. Furthermore, this study highlights that the mechanism of loss of function has an important role in the pathogenesis of the disease. Additional reports could help to better understand genotype-phenotype correlations.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 56,\n",
       "    'case_id': 'PMC3529871_01',\n",
       "    'case_text': 'A 56-year-old woman (body mass index, 29.8 kg/m2), a former smoker, with a history of chronic venous insufficiency who suffered from recent-onset schizophrenia was admitted to our institution for PE after a 48 h treatment with unfractionated heparin in a regional hospital. Two months prior to admission she was hospitalized in a psychiatric ward and received no thromboprophylaxis. On admission, the patient presented with progressing dyspnea, cyanosis and chest discomfort with elevated D-dimer (>16,000 mug/l). Contrast-enhanced computed tomography revealed large emboli at the right pulmonary artery (PA) trifurcation and in the left PA (Fig. 1a). Extensive proximal DVT in both legs was observed. Transthoracic echocardiogram demonstrated right ventricular (RV) overload with RV systolic pressure exceeding 50 mmHg, and a right atrial mass originating in the inferior vena cava. Within 2 h she developed cardiogenic shock requiring inotropic support. Due to rapid clinical deterioration despite anticoagulant therapy, she underwent urgent embolectomy with extracorporeal circulation in deep hypothermia. Pulmonary trunk was opened, and fresh and organized thrombi were removed from right and left lobar and segmental branches. After opening of the right atrium, a 7 cm long fresh thrombus coming from the inferior vena cava was removed. The patient required prolonged ventilatory support and management of pulmonary hypertension during the post-operative period. Three-month follow-up was uneventful. She was treated with warfarin. Thrombophilia screening and family history of thrombosis were negative. Cancer as a cause of thrombosis was excluded. \\nThe thromboemboli were evaluated using SEM, as previously described. After washing, the thrombus was fixed with 2.5 % glutaraldehyde phosphate buffered saline solution. Specimens were dehydrated, gold coated, and photographed digitally with a JEOL JSM 5410 (JEOL, Tokyo, Japan).\\nThe microscopic analysis revealed that the atrial thrombus was mainly composed of erythrocytes with few platelet aggregates, and some white cells (Fig. 1b, e). The fibrin network of the atrial thrombus was rather randomly arranged. In the thrombi removed from lobar (Fig. 1c, f) and segmental pulmonary arteries (Fig. 1d, g), a stepwise increase in relatively dense fibrin and platelet aggregates was observed. There was a noticeable decrease in the count of erythrocytes and increase in the count of white cells in the thrombotic material removed from lobar and segmental arteries, as compared with the atrial thrombus (Fig. 1). Thrombi removed from lobar and segmental arteries were characterized by fibrin fibers alignment along the longitudinal axis of the respective vessel, which was absent in the atrial thrombus.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 74,\n",
       "    'case_id': 'PMC6123837_01',\n",
       "    'case_text': \"A 74-year-old female with a history of hypothyroidism, treated with levothyroxine, presented to the clinic with a 2-month history of involuntary movements. The movements developed slowly over a couple of days. They involved her trunk and thighs, and then spread to her neck and lower extremities over the following weeks. The movements were associated with neck, shoulder, and thigh pain. The movements were functionally and socially impairing with no aggravating or relieving factors reported. Movement did not relieve the associated pain and there was no sense of urgency reported with the movements. She noted the ability to suppress the movements at times. She also reported the presence of dry eyes and mouth over the previous 6-8 weeks. Her physical examination exhibited globally decreased reflexes. Her movements were described as slow, undulating movements of the trunk and legs, which moved and rotated from one side to the other in a non-specific pattern. The movements were only present during rest, either when sitting or lying down and were more intense when lying down. They did not interfere with walking and were absent during sleep (Video 1). The remainder of the neurological examination was unremarkable.\\nToxic/metabolic and infectious causes were ruled out. A magnetic resonance imaging (MRI) brain scan, electroencephalogram, nerve conduction studies (NCS), and electromyography of all four extremities revealed no abnormalities.\\nA contrasted thoracic-abdominal-pelvic computed tomography scan was normal. Her proinflammatory markers showed highly abnormal acute-phase markers. In addition, her autoimmune profile was positive for antinuclear antibodies (1:640 mottled/spiculated), anti-Ro/SS-A (22.9 U/mL, negative <12 U/mL), rheumatoid factor (immunoglobulin M >200.0 U/mL, negative <6 U/mL), anti-topoisomerase I (29.67 U/mL, negative <32 U/mL), and anticentromere (141.48 U/mL, negative <50 U/mL). A paraneoplastic panel was negative. A Schirmer's test revealed <3 mm and <4 mm of moisture in the left and right eye, respectively. Her salivary gland biopsy showed sialadenitis with a Focus score >2. Lumbar puncture revealed no cells, normal glucose and protein, with positive oligoclonal bands. A diagnosis of pSS was made according to the 2016 American College of Rheumatology/European League Against Rheumatism (ACR/EULAR) criteria. Treatment was started with hydroxychloroquine, 200 mg per day; pilocarpine, 5 mg per day; gabapentin, 300 mg per day; and clonazepam, 0.5 mg per day. At the 6-month follow-up, the patient reported 90% improvement of symptoms. The frequency of athetoid movements decreased substantially to a frequency of one or two events per month.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 8,\n",
       "    'case_id': 'PMC6332758_01',\n",
       "    'case_text': 'Thirty-eight years old, G0P0, recurrent implantation failure of 11 failed embryo transfers with unknown reason. Her first endometrial microbial analysis by sequencing resulted in NLDM, with dominant Streptococcus spp (Figure 2A, B-1). LF 300 mg/d per os was started after administration of amoxicillin 750 mg/d per os for 7 days. Nineteen days after the initiation of prebiotics (56 days from her first endometrial microbial analysis), second endometrial microbial analysis was performed, resulting in LDM (Figure 2B, B-2 and 5).',\n",
       "    'gender': 'Female'},\n",
       "   {'age': 3,\n",
       "    'case_id': 'PMC6332758_02',\n",
       "    'case_text': 'Thirty-three years old, G1P1, male factor, hoping for a second child. She had two failed FBT cycles prior to her initial endometrial microbiome analysis. Her first endometrial microbial analysis by sequencing resulted in NLDM, with dominant Bifidobacterium (Figure 2A, A-1). Although we explained to her that even though the result was classified as NLDM, Bifidobacterium dominancy may not have an adverse effect for implantation, the patient selected to have intervention for her endometrial microbes before her next FBT attempt. After administration of levofloxacin 500 mg/d for 7 days per os, LF 300 mg/d per os and probiotic vaginal suppositories (1 capsule/d) were started. The reason why levofloxacin was selected was that it was one of the broad-spectrum antibiotics available at our clinic as in-house prescriptions, and this patient had not been prescribed it before. Twenty-four days after the initiation of prebiotics and probiotics, second endometrial microbial analysis was performed, resulting in LDM (Figure 2B, A-2). She had a successful ongoing pregnancy in her next FBT (Figure 6). The probiotic vaginal suppositories were discontinued after her pregnancy was confirmed by positive serum beta-hCG. We recommended that she continue LF through her pregnancy.',\n",
       "    'gender': 'Male'},\n",
       "   {'age': 1,\n",
       "    'case_id': 'PMC6332758_03',\n",
       "    'case_text': 'Thirty-one years old, G2P0, primary infertility with a male factor. She had four FBT cycles prior to her initial endometrial microbiome analysis and had early miscarriage 7 months before. Her first endometrial microbial analysis by sequencing resulted in NLDM, with dominant Atopobium and Gardnerella (Figure 2A, D-1A). LF 300 mg/d was started after administration of levofloxacin 500 mg/d per os for 7 days. The reason why levofloxacin was selected was the same as in Case 2. Twenty days after the initiation of prebiotics (60 days from her first endometrial microbial analysis), a second endometrial microbial analysis was performed, still presenting NLDM, with changes in dominant microbiota (Figure 2A, D-1B). The patient then underwent oocyte pickup (OPU) with GnRH antagonist protocol. Twelve oocytes were retrieved, seven were fertilized by ICSI, and four blastocysts were vitrified. In our clinic, we make it a rule to administer doxycycline to patients prior to OPU and cefdinir after OPU for the purpose of preventing infection, so she was administered 100 mg/d doxycycline for 7 days per os prior to OPU and 300 mg/d cefdinir for 3 days per os after OPU. Just after her OPU cycle, she used probiotic tampons during her menstruation. Sixty-four days after the initiation of Lf and 16 days from the usage of probiotic tampons (104 days from her first endometrial microbial analysis), a third endometrial microbial analysis was performed, finally resulting in LDM (Figure 2B, D-2). She had a successful ongoing pregnancy in her next FBT (Figure 7). We recommended that she continue LF through her pregnancy.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 60,\n",
       "    'case_id': 'PMC9893367_01',\n",
       "    'case_text': 'Through final follow-up, the incidences of postoperative complications after acetabular labral tear treatment via puncture capsulotomy are shown in Table 4. There were no complications in 144 (88.3%) patients. Two patients underwent total hip arthroplasty during their respective follow-up periods: A 60-year-old woman (Outerbridge grade 3) underwent labral repair and subsequent total hip arthroplasty 24 months later because of cartilage degeneration, and a 47-year-old woman (Outerbridge grade 4) underwent labral repair with acetabuloplasty and subsequent total hip arthroplasty 21 months later because of cartilage degeneration. There were no incidences of infection, avascular necrosis of the femoral head, dislocation/instability, or femoral neck fracture.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 5,\n",
       "    'case_id': 'PMC9479501_01',\n",
       "    'case_text': \"A 5-year-old male patient was admitted to the National Children's Hospital with the complaint of abdominal pain and distention. Approximately 3 years ago, he presented with unexplained abdominal distention and intermittent abdominal pain accompanied by a sign of bowel loops floating in pain without vomiting. He had alternating episodes of constipation and diarrhea. He has been diagnosed with many different diseases such as prolonged digestive disorder, colitis, or chronic intestinal pseudo-obstruction in several hospitals. Last year, he underwent gastroscopy and colonoscopy with images of total colitis, congestive gastritis with H. Pylori positive, and pyloric regurgitation. The patient then was taken internal medicine with inconsiderable improvement in symptoms. This time, the patient was admitted to the hospital because of more severe abdominal pain and distention. A clinical examination showed his height to be 116 cm (+1SD), and weight 17 kg (-1SD). There was a cafe au lait spot found on the neck, about 2 x 1.8 cm in size. The abdomen was much distended with the sign of bowel loops floating, no response of the abdominal wall, and no peritoneal reaction. On anorectal examination, the rectal balloon was empty.\\nHis abdominal X-ray image showed a lot of air-fluid levels, >2.5 cm in width [Figure 1]. On the abdominal ultrasound, the bowel was dilated and distended with air. On the enhanced CT images, there were diffuse lesions of small bowel mesentery and transverse mesocolon, encasing the mesenteric vessels without invasion or causing vessel stenosis/obstruction [Figure 2]. In addition, there were similar lesions surrounding the rectum. The lesions decreased in density on noncontrast CT images (~25HU), and slightly enhanced on portal venous phase CT images (~40HU). The small bowel loops were dilated with the largest transverse diameter of 45 mm. Some loops had wall thickening about 11 mm. There was free abdominal fluid accumulating predominantly in the pelvis cavity.\\nThe stool test showed pH = 7 and did not contain blood, mucus, pus, undigested meat fibers, and fungi. The blood test including complete blood count, coagulation tests, and blood chemistry tests (liver and kidney function tests, pancreatic enzymes) were normal.\\nThe patient underwent an exploratory laparotomy. Intraoperative observation showed that the bowel loops were dilated about 4 cm in diameter, and the colon was soft in palpation without dilation. The entire small bowel mesentery and the right haft of the transverse mesocolon were thickened with yellow nodular cord-like structures along the vessels [Figure 3].\\nThe patient performed biopsies on the lesions of the mesentery and four bowel segments including dilated ileum, collapsed ileum, ascending colon, and transverse colon. The H&E staining specimens on the mesenteric lesions showed tumor tissue structure consisting of clusters of long slender spindle cells with wavy cytoplasm and slightly mucoid basal substances. There was blood vessel proliferation, interspersed with adipose tissue. No evidence of malignant transformation was seen. The immunohistochemical staining results showed S100 (++), SOX10 (-), CD117 (-) [Figure 4]. The final pathologic diagnosis was benign neurofibromatosis. On the specimens of dilated ileum, collapsed ileum, and ascending colon, no enteric ganglia were seen. On the specimens of the transverse colon, there were muscle tissue, enteric nerve plexus, and ganglion cells. Calretininx4 immunohistochemical staining result showed a loss of calretinin expression that indicated a decrease and loss of intestinal muscle function. The Synaptophysin stain result was positive. The pathologic diagnosis was enteric neuromuscular dysfunction.\\nWhen performing exploratory laparotomy, the surgeon found that the lesions were diffuse, encased in superior and inferior mesenteric vessels, and unable to completely resect. In addition, the pathologic result was benign. Therefore, the patient was treated with conservative therapy to relieve the symptoms and careful observation to detect malignant transformation early.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 59,\n",
       "    'case_id': 'PMC10313132_01',\n",
       "    'case_text': 'A 59-year-old female patient with a 17-year history of DM was transferred to our Diabetic Foot Center due to a non-healing heel ulcer after 2 months of scalding. In the early stage of the disease, a large blister burst with much light-yellow exudation on the skin of the lesion site. Further, the amount of exudate decreased gradually, and the ulcer became black and failed to heal even with some conventional treatments such as dressing change and using antibiotics prescribed by another hospital.\\nOn both of her feet, the skin temperature was low, and the pulse of the dorsalis pedis artery and posterior tibial artery could not be palpated. There was a large, round ulcer of approximately 5 cm x 5 cm in diameter and unclear in depth. Its surface was covered with large black scabs with a little yellowish exudation visible around it. The tissue around it was cool, dark red, and swollen (Figure 1A). Laboratory tests showed her peripheral blood white blood cell (WBC) was 9.1 * 109/L, of which neutrophils accounted for 79.9% and lymphocytes for 12.2%. Meanwhile, the erythrocyte sedimentation rate (ESR) was 79 mm/h, C-reactive protein (CRP) was 12 mg/dl, and procalcitonin (PCT) was 0.41 ng/ml. MRI of the diseased foot revealed local osteomyelitis on the calcaneal surface. B-scan ultrasound of her lower limb vessels showed diffuse moderate-to-severe stenosis in the middle and lower segments of the bilateral femoral artery. Computed tomography angiography (CTA) examination further indicated mild-to-severe stenosis in multiple segments of her bilateral femoral and popliteal arteries, as well as complete occlusion of her right femoral artery and posterior tibial artery (Figure 1B).\\nThere are more than 10 classification methods for diabetic foot, such as Meggitt-Wagner, Texas, PEDIS, SINBAD, and WIfI. The contents and indications of these classification methods are different, and each of them has its own advantages and disadvantages. Among them, the WIfI classification has been proposed for the threatened lower limb, based on the three main factors that have an impact on limb amputation risk: wound (W), ischemia (I), and foot infection (\"fI\"). This classification is commonly used in patients with ischemic diabetic foot, with the advantage of clear evaluation indicators that can help guide the diagnosis and treatment of DFUs, but with the disadvantage of lacking evaluation of diabetic neuropathy. The patient in this case report was evaluated and diagnosed using the WIfI classification. The person in this case report was found to have a large ulcer on the heel with approximately 25 cm2 in area, accompanied by severe limb ischemia and heel osteomyelitis by MRI but no systemic inflammatory response syndrome (SIRS). Therefore, the DFUs of this patient were rated as diabetic foot W3 I3 fI2.\\nFirst, the surgery of balloon dilation under local anesthesia was planned for this patient to revascularize her right superficial femoral artery and peroneal artery. Preoperative angiography confirmed long segment occlusion of the inferior segment of her right superficial femoral artery with segmentary severe stenosis (Figure 1B). Intraoperatively, the superficial femoral artery, popliteal artery, anterior tibial artery, and peroneal artery were successfully revascularized, but the posterior tibial artery was not successfully re-opened. Postoperative angiography showed that the vascular lumen of the superficial femoral artery, popliteal artery, anterior tibial artery, peroneal artery, and some arterial arches of the foot were unobstructed in the affected limb (Figure 1C). Subsequently, the patient was then allowed several weeks for the recovery of local blood supply to the wound, while the wound was periodically debrided and dressed in a small range. In the fourth week after surgery, the peroneal perforator flap was transferred and repaired under general anesthesia. Postoperative nursing was also very important. For postoperative nursing, we took the following measures: psychological counseling, keeping the non-weight-bearing state of the limb, keeping the limb warm, raising the limb, and closely observing the blood transport and the color change of the flap. In the 7th week, stitches were removed, and the flap was alive (Figure 2G). At the 12th week, the affected limb could be loaded with moderate weight bearing. In the 24th week, the patient was able to walk freely with this limb in which the flap appearance and texture were perfect.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 63,\n",
       "    'case_id': 'PMC7007016_01',\n",
       "    'case_text': \"A 63-year-old female patient reported blisters on the face, neck, upper, and lower limbs, which exuded and evolved as hypochromias and sclerotic areas one year ago, with no therapeutic response to topical corticosteroid therapy and phototherapy (NBUVB).\\nThere were exulcerations and hypochromic sclerotic plaques on the face, cervical region, upper, and lower limbs, as well as areas of frontal, temporal, and occipital alopecia (Figures 1 and 2). There was restriction on wrist movement and oral opening. She did not report Raynauld's phenomenon or dysphagia, and nailfold capillaroscopy was normal.\\nThere was increase in hepatic enzymes (TGO 74 U/L - reference < 36 U/L, TGP 93 U/L - reference < 52 U/L), anemia (hemoglobin 10.8g/dL), and anti-HCV was positive. The other biochemical tests were normal, and anti-HIV was negative. The histopathological examination revealed upper dermis edema and thickened collagen bundles. The urinary porphyrin analysis was positive and there was reddish fluorescence in urine exposed to Wood's light (Figure 3).\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 56,\n",
       "    'case_id': 'PMC5471581_01',\n",
       "    'case_text': 'A 56-year-old Japanese man was referred to our hospital for investigation of tarry stool. The patient had been consuming lansoprazole, irsogladine, metoprolol, flutoprazepam, and ethyl loflazepate for gastritis, hypertension, and anxiety disorder but had no history of dyslipidemia or diabetes mellitus. A physical examination revealed no abnormalities in his abdomen or xanthomas on his skin, and laboratory findings showed no abnormalities. The levels of cholesterol, triglyceride, and plasma glucose were within normal range. Esophagogastroduodenoscopy showed erosive and atrophic gastritis.\\nDuring colonoscopy, multiple yellowish spots measuring approximately 3 to 5 mm were observed in the rectum, in addition to hemorrhoids (Figure 1(a)). Magnifying observation with narrow-band imaging revealed that the pits of the rectal mucosa were intact (Figure 1(b)). Indigo-carmine spraying emphasized the whitish to yellowish color of the lesions (Figures 1(c) and 1(d)). Histological analysis of the biopsied samples revealed accumulation of xanthoma cells within the mucosal layer. Consequently, a diagnosis of rectal xanthoma was made.',\n",
       "    'gender': 'Male'},\n",
       "   {'age': 78,\n",
       "    'case_id': 'PMC5471581_02',\n",
       "    'case_text': 'A 78-year-old Japanese man had been treated for remitting seronegative symmetrical synovitis with pitting edema. The patient underwent colonoscopy for screening purposes. He had been taking 2 mg/day of prednisone but had no history of dyslipidemia or diabetes mellitus. A physical examination revealed no xanthomas on his eyelid or extremities and a blood test revealed that his levels of cholesterol, triglyceride, and plasma glucose were within normal range.\\nColonoscopy showed a whitish plaque of 4 mm in diameter in the rectum (Figure 2). Biopsy examination revealed massive deposition of xanthoma cells within the rectal mucosa (Figure 3), leading to the diagnosis of rectal xanthoma.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 26,\n",
       "    'case_id': 'PMC3761953_01',\n",
       "    'case_text': 'A 26-years-old second gravida female reported at 37th week with antenatal ultrasound of the fetus showing well-defined and hyperechoic solid mass of size of 5.5 x 6 centimeters in the anterior aspect of neck [Figure 1]. Associated findings included mild polyhydromnios and vertical lie. Guarded prognosis with conservative management till the birth of the fetus was advised. Mode of the delivery was to be decided by obstetric indications. Finally, the baby was born by cesarean section and had huge cervical mass. Baby cried immediately after birth and had respiratory distress of mild nature apparent only in supine position when the compression effect was maximum. The distress was relieved in lateral position, and baby was maintaining saturation with minimal oxygen support.\\nOn initial assessment, the vitals of the baby were stable. Examination of respiratory system revealed equal air entry on both the side with mild conducted sounds and inspiratory stridor. Rests of the systemic examinations were within normal limits. On local examination, there was a neck mass which was solitary, oval, of size about 9 x 5 x 6 cms in midline anteriorly having firm consistency with moderate mobility in all the directions [Figure 2]. Swelling was non-pulsatile, and there were no skin changes.\\nInitial imaging was done by X-ray neck and ultrasound. These were stipulated calcifications within the mass as shown by X-ray. Ultrasound showed the mass to be consisting of solid matrix with occasional cystic areas filled with hemorrhagic fluid having freckles of calcifications and well-defined capsules all around with neck vessels pushed laterally and some degree of tracheal displacement suggestive of the teratoma with mass effect. Computed tomographic scan was obtained to further rule out the organ of origin, vascular involvement, and thoracic extension of the mass lesion. CT showed the mass to be of size 8 x 6 x 5 cms and heterogeneous with scattered, nodular calcification extending superiorly into sub-mandibular and inferiorly up to supraclavicular region [Figure 3]. Invasive investigations like fine needle biopsy were not attempted due to the fear of hemorrhage within the tumor leading to further aggravation of respiratory distress and complicating the pre-operative clinical scenario. Corroborative evidences of the mass to be teratoma were obtained by means of tumor marker studies like estimation of alpha-fetoprotein and beta human chorionic gonadotropins. Alpha-fetoprotein level was significantly high in the range of 83,000 ng/ml though there was no rise in beta HCG. As the neck teratomas mostly arise from and completely replace the thyroid tissue, thyroid function test was also obtained, but T3, T4, and thyroid-stimulating hormone levels were within normal range.\\nAfter pre-operative stabilization and investigations, patient was taken up for the surgical excision of the mass. General anesthesia with endotracheal intubation was done though securing the airway was difficult. Transverse incision directly over the mass was given. Below the platysma muscles, the well-encapsulated mass was lying above the strap muscles of the neck, attached only with the fibrous bands and few small caliber vessels feeding the mass. Complete enucleation of the mass without capsule rupture was attained, and specimen was sent for histopathological examinations. No ventilatory support was needed in post-operative period. Feeds were allowed in 2nd post-operative day, and patient was discharged on 4th day. Repeat alpha-fetoprotein and beta HCG at the end of 1 month, 3 months, and 1 year were within normal range.\\nHistopathology report came out as lobulated grey-white mass predominantly solid with areas of cystic changes. Cysts were ranging from 1 mm to 1 cm and filled with mucinous material. The solid parts consisted of cartilages and bony spicules. Multiple sections studied from tumor showed mature as well as immature elements derived from all 3 germ layers. Mature elements comprised of nests of squamous cells, glands, mature cartilage, occasional bony tissue, neural tissue, and smooth muscle tissue. Immature elements included neuroepithelial elements, occasional group of blastemal cells, and immature cartilage in myxoid stroma. Mitosis was in the range of 2/10 HPF. Normal thyroid tissue was not seen in the section studied. Final diagnosis was immature cervical teratoma; grade II.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 23,\n",
       "    'case_id': 'PMC10321783_01',\n",
       "    'case_text': 'A 23-year-old man attended a private clinic complaining of an uncomfortable, slowly progressing mass on his tongue that impaired speech and swallowing and had been present for two weeks. During anamnesis, he mentioned that he used to smoke Cannabis sativa. He did not indicate comorbidities. He denied having a cough, runny nose, nasal congestion, or fever. The intraoral examination revealed a painless exophytic irregular dark red-violaceous nodular lesion in the tongue\\'s right ventral and lateral border and a similar papule in the ipsilateral dorsal region surrounded by white plaques (Figure 1A).\\nUnder the clinical hypotheses of Kaposi\\'s sarcoma (KS) and COVID-19-related lesions, an incisional biopsy was performed. And a complete blood count and serology for Human Immunodeficiency Virus (HIV) 1 and 2, as well as a SARS-CoV-2 reverse-transcriptase-polymerase-chain-reaction test (RT-PCR test for COVID-19) were requested. Nasopharyngeal and oropharyngeal swabs were taken for RT-PCR test. None of the examinations showed abnormalities.\\nMicroscopically, hyperparakeratosis, acanthosis, and papillomatosis in close association with large, dilated vessels lined by normal-appearing endothelial cells and containing inside erythrocytes and proteinaceous eosinophilic material were observed (Figure 1C-D).\\nAn immunohistochemical panel was performed. Most vessels were CD34 positive; some were highlighted by alpha-SMA, whereas D2-40 was focal (Figure 2A-C). Human Herpes Virus 8 (HHV-8) was negative.\\nBased on the clinical, microscopical, and immunohistochemical features, a definitive diagnosis of hemangiolymphangioma was obtained. The patient underwent minimally invasive surgical excision. After 18 months of follow-up, there were no signs of relapse (Figure 1B).\\nAn electronic search was conducted in PubMed, Scopus, and Web of Science for studies published up to August 2022, with the following keywords: (\"hemangiolymphangioma\" OR \"lymphangiohemangioma\") AND (\"oral lesions\" OR \"mucosal lesions\"). Related articles were also searched in the reference lists of the found full-text articles. 16 full-text articles were evaluated, of which two were excluded because the lesions were in the parotid gland and neck, respectively. Table 1 summarizes cases reported in scientific journals. Eight were located on the tongue, being 3 cases reported by Jian.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 29,\n",
       "    'case_id': 'PMC10159324_01',\n",
       "    'case_text': 'A 29-year-old man was referred to our hospital for MMD treatment. The patient had experienced transient left-sided hemiparesis when he was 11-years-old, and he was eventually diagnosed with MMD at 12 years of age. He was prescribed aspirin at a previous hospital. Sixteen years had passed uneventfully; however, at 28 years of age, he presented with a sudden headache. Computed tomography revealed right thalamic hemorrhage with ventricular hemorrhage [Figures 1a and b]. Digital subtraction angiography (DSA) showed MMD (Suzuki grade 4) development of the thalamic channel with hemorrhage in the ipsilateral hemisphere [Figures 1c-f]. We performed superficial temporal artery-to-middle cerebral artery (STA-MCA) bypass and encephalo-duromyo-arterio-pericranial synangiosis (EDMAPS) in the right hemisphere for the prevention of rebleeding. The postoperative course was uneventful. After 3 months, STA-MCA bypass and EDMAPS were performed in the left hemisphere. DSA performed 3 months after the last surgery showed patency of the direct bypass and development of transdural anastomosis due to the indirect bypass. In addition, a pseudoaneurysm was observed in the right posterior branch of the MMA [Figures 2a and b]. The pseudoaneurysm was located immediately under the edge of the craniotomy site [Figure 2c].\\nFigure 2d demonstrated the intraoperative photo of STAMCA bypass and EDMAPS on ipsilateral hemisphere of pseudoaneurysm development. The arrow showed the location of pseudoaneurysm hereafter. The damage to MMA by craniotomy or dura cut may be a cause of aneurysm development.\\nWe planned to perform the internal trapping under general anesthesia. After intravenous administration of 4000 U of heparin, the right external carotid artery was catheterized with a 4-Fr guiding sheath (ASAHI FUZBUKI, Asahi Intech, Japan). Subsequently, a distal access catheter (Guidepost, Tokai Medical Products, Japan) and microcatheter (Echelon-10, Medtronic, USA) were navigated into the right MMA. Microangiography of the posterior trunk of MMA revealed transdural anastomosis by indirect bypass [Figure 3a]. The aneurysm size was 4.2 mm x 3.9 mm and neck length was 1.1 mm [Figure 3b]. Fortunately, aneurysm neck was small against our expectations; as a result, we could embolized aneurysm tightly without MMA occlusion.\\nThe microcatheter was navigated into the pseudoaneurysm, and the pseudoaneurysm was embolized using five platinum coils (Optima Coil System , BALT, USA) [Figure 3c]. Angiography after embolization showed complete occlusion of the pseudoaneurysm, patency of the MMA, and transdural anastomosis [Figure 3d]. The postoperative course was uneventful, and the patient was discharged without neurological deficits. Follow-up DSA performed 1 month after the endovascular treatment showed no recanalization of the pseudoaneurysm [Figures 3e and f].',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 80,\n",
       "    'case_id': 'PMC9243420_01',\n",
       "    'case_text': 'An 80-year-old, right-handed woman was referred to our hospital for a 3 year history of moderate amnesia and progressive difficulties in finding words and understanding conversations. She was a college graduate and had worked as a nurse until her mid-50 s. She was healthy except for bladder cancer surgery at the age of 60. At age 77, she demonstrated difficulty in finding words and diminished ability to recognize spoken words, which progressed in subsequent years. At age 78, in addition to the prominent aphasia, she demonstrated amnesia and slight behavioral change, such as compulsive washing of hands and dishes; however, they did not have a significant effect on her daily activities.\\nOn admission to our hospital, she was alert and cooperative to the examination, but she was occasionally a little reluctant to, particularly memory tests. Sometimes, we had to repeat instructions because she could not understand the first time. However, she understood what should be done following repetitive instructions or written commands.\\nFrontal signs such as disinhibition were occasionally observed, but they were relatively mild. Neurological examination did not reveal motor or sensory disturbance and parkinsonian symptoms. She exhibited bilateral palmomental reflexes but no grasp reflex. Her autonomic functions were well preserved.\\nNeuropsychological assessments were performed between the second and 18th days of hospitalization. Some of her performance seemed to be affected by her impaired listening comprehension or non-serious attitude. For her best performance, clear and plain instructions were repeated until she could understand them. The results of the neuropsychological tests are presented in Table 1.\\nTest scores on WAIS-III and Raven\\'s Colored Progressive Matrices were nearly at the lower limit of normal performance. The Wechsler Memory Scale-Revised and Rey-Osterrieth Complex Figure Test indicated severely impaired visual memory. Apraxia, visual agnosia, and prosopagnosia were not observed.\\nHer speech was fluent without distortion or agrammatism. She demonstrated difficulty in finding words and visual confrontation naming. Although auditory comprehension of sentences and words was impaired, they were due to the difficulty in phonological word processing. Written word comprehension was much better than spoken word comprehension. Results of the Western Aphasia Battery Japanese version revealed anomia, poor spoken word comprehension, and poor writing, but speech production was relatively well preserved. The scores on the repetition task were good, but phonological errors in words were observed. She could read kana (phonogram) and regular kanji (morphogram) words, but she frequently made mistakes when reading irregular kanji words, indicating surface dyslexia. In addition, she demonstrated difficulty writing kanji but not kana. These features in Japanese suggested impairment of semantic memory for words and were often observed in semantic dementia. On the standard tests in Japanese to examine naming and auditory comprehension of 100 high-frequency and 100 low-frequency words, she scored 31/200 on the naming task and 137/200 on the auditory comprehension task. We examined written comprehension for 61 of the 63 words that could not be understood on the auditory comprehension task. We excluded two words because we selected the word that she presented a two-way anomia. Accordingly, her written word comprehension was correct for 31 words (50%).\\nTo evaluate her non-verbal semantic memory, we used the object decision task of the Birmingham Object Recognition Battery and an original semantic memory task, similar to the Pyramid and Palm Trees test. We used the original semantic task because some items in the Pyramid and Palm Trees test are unfamiliar to Japanese people. The results of these tests revealed that the patient also had non-verbal semantic memory impairment. Thus, the patient experienced prominent language deficits throughout the clinical course with verbal and non-verbal semantic memory impairment, which fulfilled the diagnostic criteria for svPPA.\\nBy contrast, the patient demonstrated difficulty in repeating and dictating spoken words, which is not a common feature in svPPA. Listening errors were improved by the repetition of target words, and the ability to repeat long sentences was relatively preserved. Therefore, we hypothesized that impaired detection of each phoneme may affect her ability to comprehend and repeat spoken words. The context could also help estimate the words in long sentences.\\nAccordingly, we performed a comprehensive examination of the higher auditory functions of the patient and conducted neuroradiological analyses to reveal the areas associated with the auditory symptoms.\\nAuditory brainstem responses that were elicited with the standard protocol demonstrated normal waves. We used an adapted form of a standard clinical audiometry protocol in assessing frequencies of 500, 1,000, 2,000, and 4,000 Hz. The patient\\'s pure-tone audiometry threshold was within the normal range for her age, with mean threshold values of 36.3 and 36.3 dB on the right and left, respectively.\\nTo examine the higher auditory functions, we performed: (1) temporal auditory acuity and; (2) verbal sound discrimination and recognition. The results are presented in Table 2. Her ability to identify non-verbal sounds and nursery songs was also examined (Supplementary Table 1). We did not analyze these data in detail because several factors including word-finding impairment and semantic memory loss made further analyses difficult.\\nClick counting and click fusion tests were also performed. In the click counting test, the patient was asked to count the number of clicks per second. She was able to count five clicks per second in each ear, which was lower than the 9-11 clicks per second detected by normal controls. In the click fusion test, click sounds were delivered to each ear at various intervals between binaural pulses. The patient was requested to report whether one or two clicks were made. She exhibited binaural fusion at an interval of 8 ms, which was worse than the several milliseconds detected by normal controls.\\nIn Japanese, the ultimate minimum unit of a verbal phoneme sound is expressed as a \"mora.\" A mora was defined as one vowel or a unit of a consonant and a vowel, which corresponded to one kana letter. When measuring the speech recognition score in Japanese, the participants are requested to listen to a mora, a monosyllabic sound, produced verbally and to answer the corresponding kana letter by dictation. Because she was unable to write well enough, the test was performed by recitation. She recognizes 15/20 moras (75%) at 65 dB with the right ear and 16/20 moras (80%) at 65 dB with the left ear. The speech audiogram revealed significantly impaired speech recognition relative to the normal range advocated by the Japanese Audiological Society (Figure 1). Her maximum recognition score in a phonetically balanced word list of the right ear was 75% (15/20 moras) at 65 dB and that of the left ear was 80% (16/20 moras) at 65 dB. Thus, a higher volume was needed to increase the accuracy, and speech recognition accuracy did not exceed 80% in either ear even at the suprathreshold level. The two-mora discrimination tasks using 36 words and 36 non-words were performed. She discriminated 31 of 36 words (normal range; 35.82 +- 0.50) and 28 of 36 non-words (normal range; 35.14 +- 1.06), which was worse than normal controls. These results support the hypothesis that the patient\\'s ability to recognize phonemes was impaired, and she used the context of sentences to estimate the words.\\nThe MRI scans and 123I-iodoamphetamine single-photon emission computed tomography (123I-IMP-SPECT) were performed.\\nEight days after admission, we performed an MRI of the brain using a 3-Tesla MAGNETOM Trio (Siemens Medical Solutions United States, Inc., PA, United States). Three-dimensional magnetization-prepared rapid acquisition with gradient echo (3D-MPRAGE) images demonstrated diffuse cerebral atrophy, which was especially marked in the anterior and medial parts of the left temporal lobe (Figure 2A).\\nTo identify brain regions of the patient in which gray matter volumes were smaller than those in patients with typical svPPA, we performed VBM using statistical parametric mapping software (SPM), version 12 (http://www.fil.ion.ucl.ac.uk/spm/). Three-dimensional spoiled gradient echo or 3D-MPRAGE image data of 10 patients with typical svPPA as disease controls (mean age, 64 +- 8.0 years; 7 women and 3 men) were used for the analysis. The imaging parameters used for the acquisition of structural imaging data are presented in Supplementary Table 2. The disease controls were retrospectively recruited from the database for the study of dementing illnesses from June 2009 to April 2021 in Tohoku University Hospital and were diagnosed by board-certified neurologists based on the PPA criteria.\\nThe protocol of the study was approved by the Ethics Committee of Tohoku University Hospital (approval nos. 2006-19, 2014-1-278, 2018-1-024, 2019-1-156, and 2020-1-285).\\nA Z-score map of the present patient was created using the mean and standard deviation of the gray matter volume (normalized by the total intracranial volume) of each voxel in the disease controls and the following equation: Z-score = [(Control mean) - (Present patient\\'s value)]/(control standard deviation). Significance was defined as a Z-score above 3.29 (alpha < 0.0005). The Z-score map is exhibited in Figure 2B. Compared with that of disease controls, in the present patient, gray matter volume was significantly smaller in the bilateral perisylvian areas, including the bilateral superior temporal gyri (STG), bilateral plana temporale (PT), bilateral Rolandic area and frontal inferior opercula, and left SMG.\\nWe performed ROI-based analyses for gray matter volumes using the computational anatomy toolbox (CAT12, http://www.neuro.uni-jena.de/cat/) for SPM. The ROIs were defined based on the previous studies that have reported lesions that were associated with the manifestation of word deafness or auditory agnosia. These ROIs were as follows: (i) left and right STG; (ii) left and right PT; (iii) left and right Heschl\\'s gyri; (iv) left and right angular gyri; and (v) left and right SMG. A Z-score of each ROI was calculated by the same equation as that used for creating the Z-score map. Significance was defined as a Z-score above 2.81 (alpha < 0.025/10). The results of the ROI-based analyses are presented in Supplementary Table 3. Compared with those of the disease controls, in the present patient, gray matter volumes were significantly smaller in the left STG (Z-score = 4.28), left PT (Z-score = 3.88), and bilateral SMG (left: Z-score = 4.21; right: Z-score = 3.35).\\nTo assess the patterns of hypoperfusion, 123I-IMP-SPECT data were analyzed with three-dimensional stereotactic surface projections using the normal perfusion database for a Siemens e-cam. There was hypoperfusion from the temporal to the parietal lobes of the left hemisphere, with a more intense reduction from the anterior temporal lobe to the middle and inferior temporal gyri (Figure 2C).\\nBeta-amyloid 1-42 (Abeta42) and phosphorylated tau protein (p-tau) in the patient\\'s cerebrospinal fluid (CSF) were quantified on days 11 after admission. The patient\\'s CSF Abeta42 level (1,023 pg/ml) was within the normal range, whereas the CSF p-tau level (68.3 pg/mL) was slightly elevated (reference value of <50 pg/ml).\\nAt her last visit to the hospital (3 years after hospitalization scrutiny), she had developed marked aphasia with phonological mishearing and sentence comprehension disorder. She still understood the written word better than the spoken word, but her understanding of the written word was also greatly declined, due in part to her progressive semantic comprehension disorder. The effort of speech production was not increased, and prosodic articulation was intact. Although she could produce a meaningful speech, she talked about the same content with similar phrasing and only superficial. Behavioral disorders did not worsen, except for obsession with handwashing. She continued to do well physically, and her neurological examinations were unchanged.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 47,\n",
       "    'case_id': 'PMC4438634_01',\n",
       "    'case_text': \"Gender and age: Male, 47 years old\\nChief complaint: Left chest pain\\nThe patient started working for a Korean-style barbecue restaurant from January 5, 2013. His primary duty was to ignite and manage the charcoal used for barbecuing meat at the restaurant. He worked 10 hours a day six days a week. On January 19, 2013, 14 days after he had started working, he suddenly collapsed and lost consciousness while on duty. The length of period for which he lost of consciousness is unknown; however, he was observed as alert and working approximately 30 to 40 minutes prior to the syncope. He regained consciousness without any medical treatment, and no medical attention was provided. However, he complained of a squeezing pain in his left chest for one hour after the initial episode; thereafter, he was brought to hospital via ambulance. Within one hour of arriving at the emergency room, he received cardiac angiography and was admitted to the hospital. Diagnosis at the time of admission was unstable angina and carbon monoxide poisoning. In the emergency room, his electrocardiogram was normal, and his systolic and diastolic blood pressures were 125 mmHg and 74 mmHg, respectively. He was discharged without any complications. On January 31, 2013, he filed a claim with the Korea Worker's Compensation and Welfare Service seeking compensation for the cardiac incidence that was believed to have been related to his work managing the charcoal at the restaurant. Before a decision regarding his claim could be made, the service requested an occupational epidemiological study from the Occupational Safety and Health Research Institute, and our hospital's occupational and environmental medicine department was given the task of creating the epidemiological report. After further investigation by our department, it was concluded that the patient had carbon monoxide induced cardiomyopathy after exposure to hazardous materials in his work place. The informed consent for epidemiologic investigation and case report is performed.\\nIn August 2012, he had been diagnosed with nonspecific hypertension (Korean standard classification of diseases code I10.9) at Gangdong district health center, but we were unable to find his exact blood pressure measurement at the time of this diagnosis. The patient testified that he was not taking hypertension medication. His medical history was otherwise insignificant. Prior to January 2013, he had visited a local clinic intermittently seeking treatment for shoulder and back pain. According to his medical records until January 19, 2013, the patient had no remarkable family or social history and had never been exposed to any radiologic treatment. However, we were not able to confirm any of these records using the patient's annual medical check-up, which is managed by the National Health Insurance Service. He told the medical personnel at our hospital that he smokes 10-20 cigarettes per day, but his medical record from Samsung Medical Center showed a record of 20 pack-years. He also reported rarely consuming alcohol.\\nAt the emergency room, his systolic and diastolic blood pressures were 125 mmHg and 74 mmHg, respectively, with a pulse rate of 65 beats per minute, a respiratory rate of 18 breaths per minute, and a body temperature of 36 C. Upon auscultation, a rale was heard in both lung fields. Otherwise, no abnormal findings were reported.\\nThe results of the electrocardiogram taken at admission were normal. Table 1 lists the initial and follow-up concentrations of carboxyhemoglobin, methemoglobin, and hemoglobin oxygen saturation. The carboxyhemoglobin concentration at the emergency room was 35.8%, which is significantly higher than the normal level. In addition, the results of the cardiac enzyme tests are shown in Table 2. Troponin I, which typically indicates cardiac injury, was considerably elevated.\\nA cardiac angiogram was performed within one hour of admission to the emergency room. In the right coronary artery, a 40% obstruction and thrombotic plaque were found, but the other three branches of the coronary artery appeared normal.\\nA cardiac contrast ventriculography was performed, and the myocardium and cardiac output were found to be functioning normally.\\nInitially, the patient's systolic and diastolic blood pressures were 125 mmHg and 74 mmHg, respectively. His pulse and respiratory rates were 65 beats per minute and 18 breaths per minute, respectively, and he had an oxygen saturation of 98% at room temperature. He was given emergency therapy with a sublingual nitroglycerine. After taking the medication, the only response was a sudden drop in his systolic and diastolic blood pressures to 83 mmHg and 53 mmHg, respectively. To counter this low blood pressure, 500 mL of normal saline was infused intravenously, and after confirming the stabilization of his vital signs, the patient underwent an emergency angiocardiogram. He was admitted to the intensive care unit for close observation immediately after the procedure. An angiotensin converting enzyme inhibitor (Losartan ) and aspirin were prescribed, and his systolic and diastolic blood pressures remained level at approximately 135 mmHg and 80 mmHg, respectively. He was discharged from the hospital on January 22, 2013, four days after his first visit to the emergency department.\\nAfter discharge, he did not return to his previous vocation. He visited our outpatient clinic on January 31, 2013, 14 days after the initial attack. At that time, his systolic and diastolic blood pressures were 116 mmHg and 79 mmHg, respectively, and he reported no longer suffering from chest pain or other cardiac symptoms. The angiotensin converting enzyme inhibitor and aspirin were prescribed for continuous use. His last visit was on February 21, 2013 to obtain a copy of his medical record. At the last visit, no chest pain was present, and his systolic and diastolic blood pressures were 143 mmHg and 100 mmHg, respectively.\",\n",
       "    'gender': 'Male'},\n",
       "   {'age': 46,\n",
       "    'case_id': 'PMC4438634_02',\n",
       "    'case_text': \"According to this patient's insurance employment records, his first full-time recorded job was at a Korean barbecue grill restaurant. He started working there on January 5, 2013 (at 46 years old), and prior to this full-time employment, he worked as a part time employee from June 2, 2012 to August 1, 2012 cleaning tables and washing dishes.\\nAt Korean barbecue grill restaurant, he worked at the charcoal recycler (Figure 1), which was located outside of the restaurant, and his job was to ignite fresh charcoal or revive the flames of burning charcoal to be placed on customers' tables in the restaurant. His informal duties included washing charred material from gridirons and moving stacks of charcoal for storage. He washed used gridirons once or twice a day, usually in the morning or late at night. His job was also to remove large deposits of soot, first using a device called a 'grand', and then using a metallic brush to scrape off any charred materials and minor soot from the gridiron. He performed these tasks outside of the restaurant. It is unknown whether the patient also used chemical agents while cleaning. An exhaust duct is fitted above the recycler. Smoke from the fire at the charcoal recycler is cleared by natural air ventilation, and no additional circulation is provided to ventilate the unwanted smoke.\\nHe worked for six days a week, from 10 AM to 10 PM. He was given an hour and a half lunch break. The quantity of charcoal he managed each day and the amount of his daily workload depended on the number of patrons who visited the restaurant that day. When the restaurant was not busy, he had anywhere between several minutes to one hour of break time throughout his day, and he usually rested next to the charcoal recycler. The estimated amount of charcoal used per day was three to four boxes (6-10 kg). We requested an estimate of the number of customers and daily sales figures from the business owner in an attempt to estimate the quantity of charcoal used per day. However, even with this information, the amount of charcoal handled by the patient or used at a table in this restaurant is difficult to estimate because it can vary greatly for each table. Charcoal is provided at customer's request or after a further order of meat.\\nThe steps to operating the charcoal recycler, which was used by the patient, are as follows. There is on and off button on the bottom of the recycler. After turning on the recycler, the appropriate amount of fresh charcoal for single use is loaded into the charcoal bowl and moved from the bowl to the grid pan. Then, the pan is placed below the ventilation duct in the center of the recycler. With aeration, a flame is applied to start a fire in the charcoal. The flaming charcoal is then placed in a bowl, and the bowl is then placed just under the duct for more aeration. When the charcoal becomes hot enough for grilling, the burning charcoal is moved to another metal container for the use at a customer's table. The whole procedure takes 30 to 40 seconds.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 46,\n",
       "    'case_id': 'PMC5771871_01',\n",
       "    'case_text': 'A 46-year-old male farmer, presented with a history of multiple, recurrent discharging scrotal ulcers over a period of three (3) years. He had had multiple wound debridements and dressings done, but the ulcers had recurred a few months after complete healing. The discharging wounds occurred after the formation and subsequent rupture of pustules.\\nHe was otherwise healthy with no constitutional symptoms, significant comorbidities, and no previous history or contact history of TB. He had received the BCG vaccination during infancy. He was an averagely built male with normal general and systemic examination. Genitourinary examination revealed bilateral craggy, hard epididymes, an enlarged and tender right testis, and multiple, superficial, noninfected scrotal ulcers (Fig. 1A and B).\\nUltrasonography showed bilateral normal-sized testes. The right epididymis was enlarged and thickened with a 1.4 x 1 cm sized hypoechoic lesion in relation to the head of the right epididymis and a 2 cm x 1.8 cm sized hypoechoic lesion in relation to the lower pole of the right testis. Internal vascularity was noted. The right testis was not identified separately from the lesion. Furthermore, there was a 1.3 x 0.8 cm sized hypoechoic lesion in the left testis and a 0.7 x 0.6 cm sized hypoechoic lesion in relation to the left epididymis.\\nHis complete blood count and chest radiograph were normal. Erythrocyte sedimentation rate (ESR) was 90 mm/h, and the Mantoux was strongly positive with a diameter of 20 mm after 72 h. The urine full report (UFR) showed a field full of pus cells, and routine bacterial cultures were negative.\\nHe underwent surgical exploration where the right epididymis was noted to be enlarged, irregular, and thickened with mild enlargement of the right testis with an irregular surface lesion, favoring chronic epididymo-orchitis (Fig. 2A and B). A right epididymal and testicular biopsy was performed, and histology revealed evidence of granulomatous inflammation with central caseous necrosis favoring mycobacterial TB infection. There was no evidence of intratubular germ cell neoplasia or malignancy. The Ziehl-Neelsen stain was negative for acid-fast bacilli. Pus from the scrotal discharge, the biopsy specimen, and the urine sent for TB culture returned negative.\\nHe was started on category 1 antituberculosis therapy, that is, quadruple antimicrobial therapy for 2 months followed by dual therapy with rifampicin and isoniazid for 4 months, for which there was a good response with healing of the scrotal ulcers. He was compliant, and no significant adverse effects of treatment were noted. However, three (3) months into therapy, he presented with worsening lower urinary tract symptoms, strangury, and acute urinary retention. He required suprapubic catheterization, and subsequent retrograde urethrography revealed a bulbar urethral stricture for which he is under urological care.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 16,\n",
       "    'case_id': 'PMC4475344_01',\n",
       "    'case_text': 'A 16-year-old female volleyball player was diving for a ball when she hit the right side of her head on the floor. There were no transient neurological symptoms or cervical or occipital pain. The next morning, she awoke with severe headache at the back of her head. A Sports Concussion Assessment Test (SCAT) only revealed one symptom (headache). Neuropsychological computerized testing demonstrated excellent performance in all categories; however immediately thereafter, the patient developed severe headache and nausea. At 12 d after the injury, the patient was reassessed and reported a headache with severity of 1 out of 6 localized at the right posterior aspect of her head as her only symptom. Physical examination demonstrated decreased range of motion and tenderness throughout the cervical spine, most prominently at the right greater than left occiput with reproduction of her headache upon palpation. Trigger point injections with 1% lidocaine were performed at eight locations over the bilateral superior trapezius and achieved 50% reduction of her headache for 2 h. This prompted a referral to an interventional anesthesiologist for a diagnostic block of the right greater occipital nerve (GON) and lesser occipital nerve (LON), after which the patient expressed complete relief of all symptoms for 6 h. The patient then was prescribed a multimodal approach to symptom management, including massage therapy, myofascial release, and a right-sided pulsed radiofrequency stimulation of the GON and LON. The patient achieved temporary resolution of her headaches shortly following this last procedure at 166 d after the concussion. While her headaches significantly improved at rest and without rotational movement, any rotational movement during exertion creates headaches that impede participation in sports. Thus the patient has decided to voluntarily retire from volleyball.',\n",
       "    'gender': 'Female'},\n",
       "   {'age': 28,\n",
       "    'case_id': 'PMC4475344_02',\n",
       "    'case_text': 'A 28-year-old professional baseball player sustained a concussion from a collision at home plate. The patient complained of anterograde amnesia and feeling significantmental fogginess. After essentially maintaining bed rest for 2 d, he experienced severe cervical pain and a bout of emesis during ambulation. Subsequent computed tomography (CT) imaging of the cervical spine was normal. On examination, his cervical range of motion was limited to the left more than the right and his neck pain and limited range of motion gradually resolved over 2 months. Despite this, he was unable to resume any physical activity due to the development of a severe sharp, stabbing, and throbbing headache located in the left occiput. Triggers included the resumption of any athletic activity, but he found that he could avoid triggering headaches by looking straight ahead. A follow-up physical examination was significant for tenderness in the left occiput at the craniocervical junction. He was diagnosed with ON and was referred to interventional pain management for a left cervical medial branch block of C2 to C3 and third occipital nerve (TON) blocks. These procedures provided 100% pain relief and greatly increased cervical range of motion. He was then able to complete a graded return to play protocol successfully and resumed baseball.',\n",
       "    'gender': 'Male'},\n",
       "   {'age': 17,\n",
       "    'case_id': 'PMC4475344_03',\n",
       "    'case_text': 'A 17-year-old female soccer player was hit in her forehead during a challenged header and experienced immediate symptoms, most prominently including headache, fogginess, dizziness, and photophobia. No neck pain was noted on the initial physical examination. Her initial SCAT2 symptom number was 17 (which included headache) with a symptom severity score of 67. Several trials of medications including acetaminophen, ibuprofen, amitriptyline, and zonisamide failed to reduce her headache symptoms. Five weeks after the concussion, she developed neck pain, and on repeat examination, she had a positive Tinel sign at the left craniocervical junction with significant worsening of her headache. She was referred to interventional pain management for a GON and LON block. During a phone follow-up, she reported 100% relief of her headache and neck pain for 3 d and noted significant improvement of her other concussion symptoms as well. She then received a pulsed radiofrequency stimulation of the left GON and LON, which resulted in 50% relief from her headache and neck pain for 3 wk. Due to the partial and short duration of the effect, a nerve block was then performed on the C2 and C3 medial branches and TON. The patient received 100% relief of her headache and neck pain for 5 d, again with concomitant improvement of her other symptoms. Given this response, a radiofrequency denervation of these same nerves was performed. She received complete relief of her headache and neck pain with a SCAT2 symptom number of 3 with a symptom severity score of 10. After return of her symptoms in 4 months, the procedure was repeated with the same results. She continues to work with physical therapy and speech and language pathology to address her remaining lingering symptoms.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 69,\n",
       "    'case_id': 'PMC6679641_01',\n",
       "    'case_text': 'A 69-year-old woman was admitted to hospital in November 9, 2007 with acute exacerbation of chronic cough and dysphagia with solids and liquids for 2 weeks. She did not have hemoptysis, fever, chills, chest pain, or weight loss. When she was 9 years old, she had worked as a stone crusher for 3 years and was exposed to a large amount of quartz dust for not using any respiratory protective equipment. In 1969, she was diagnosed with silicosis and tuberculosis. She was treated for tuberculosis and was stable. She had no further exposure to dust or other toxic substances, thereafter. On follow-up, her condition had no change. The patient was a life-long nonsmoker and consumed no alcohol. Nor did she receive any medications. \\n On physical examination, the patient looked well, with no palpable peripheral lymph nodes. Occasional wheezing was heard on both lung fields. Laboratory data, including blood tests and serum electrolytes, liver enzymes, and bilirubin, as well as renal function were normal. Skin test for tuberculosis was negative. Three consecutive samples of sputum were negative for acid-fast bacilli by staining and culture. Chest x-ray and computed tomography (CT) of the chest demonstrated eggshell calcification of the hilar and mediastinal lymph nodes in the paratracheal, subcarinal, and aorticopulmonary window regions. Bilateral multiple pulmonary nodules were also visible. The lower lobe of the left lung showed a ground-glass, dense shadow. Barium esophagography revealed two fistulas between the middle esophagus and the left main bronchus, immediately tracking into the left bronchial tree (Fig 1). The diagnosis was silicosis with esophagobronchial fistula and aspiration pneumonitis. The patient received antibiotics. An esophageal stent was placed on December 14, 2007. The symptoms improved. \\n The symptoms however recurred within three days. Gastroesophageal endoscopy demonstrated a small ulcerated lesion above the metallic stent, with a small diverticulum 18 cm from the upper incisor; the esophageal mucosa was inflamed and friable. Biopsy revealed chronic inflammation and an ulcer without granulomas, malignancy, or organisms (Fig 2). Another esophageal stent was placed on December 20, 2007. The symptoms improved and the patient was discharged from hospital. \\n After two months, the patient was admitted to another hospital because of severe cough exacerbated by swallowing liquids and solid foods. Gastroesophageal endoscopy revealed a new small mid-esophageal ulcer. Other examinations, including tests for tumor markers, were normal. A tuberculin skin test gave negative results. Over the next few days, the patient reported expectoration of small grayish coral-like calculi with a stony consistency, measuring 5-10 mm in diameter, as well as episodes of coughing. Bronchoscopic examination showed a free broncholithiasis in the left main bronchus, mucosal thickening, and stenosis with no significant airway obstruction of the main bronchus. The broncholithiasis was extracted with no bleeding. Biopsy of the bronchus revealed chronic inflammation, with no evidence of malignant tumor cells or granulomas. Sputum and bronchoalveolar lavage analyses did not reveal Mycobacterium tuberculosis, fungi, or malignant cells. The diagnosis was silicosis with broncholithiasis and esophagobronchial fistula. \\n The patient continued to have frequent complications and persistent fistula probably related to stasis in the esophagus. Because of her frail condition, we decided to initiate a conservative operative approach and inserted a gastrostomy tube. \\n Two samples of the expectorated materials were analyzed by electron microscopy and energy-dispersive spectrometry (EDS), with a Phenom ProX system (Phenom-world Co, the Netherlands), operating at 15 kV. Without any coating on the sample, with SDD high resolution and a high-sensitivity EDS detector, semiquantitative chemical analyses were performed. Mineralogy analysis revealed the broncholithiasis was composed of calcium and phosphate, with no crystals of silica or silicate (Fig 3). \\n After 16 months, in June 2009, the patient was readmitted because of cough, sputum, dyspnea, fever, and night sweating for 10 days. The admission laboratory data included a white blood cell count of 6.65x103/muL (reference range 4.0-10.0x103/muL), hemoglobin level of 11.4 g/dL (11.0-15.0 g/dL), high-sensitivity C-reactive protein level of 26.38 mg/L (0-3 mg/L), serum albumin level of 4.32 g/dL (35-55 g/dL), serum protein level 7.0 g/dL, erythrocyte sedimentation rate 34.9 mm/h (0-20 mm/h). A skin test for purified protein derivative (5 TU) was strongly positive, with an induration of 25 mm with ulceration. The concentrated sputum test result was positive. The diagnosis was silicotuberculosis relapse. CT revealed an esophageal stent shadow, esophageal wall thickening, multiple small nodule spots, patchy shadows, and mediastinal and lung door multiple calcified lymph nodes (Fig 4). Antituberculous treatment with 450 mg rifapentine, twice a week, 300 mg inhaled isoniazid, once a day, and 750 mg pyrazinamide, once a day, was started. After nine months of antituberculous treatment, the patient did well. We continued to follow the patient until the time we wrote this report; she had no change (Fig 4).',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 0,\n",
       "    'case_id': 'PMC7336922_01',\n",
       "    'case_text': \"The patient was an 18-days-old Iranian neonate girl with current weight of 3600 g referred to the Bahar hospital with symptoms of respiratory distress, cyanosis, fever and cough. The neonate was born by cesarean delivery on February 10, 2020 in Khatam hospital with birth weight of 3020g. The newborn had no medical history, except for neonatal icterus and two-day phototherapy in the Khatam hospital (10-12 February, 2020).\\nThe neonate had nasal congestion, cough and wheezing on February 26, 2020 and was admitted to the isolated room of the NICU ward at Bahar hospital due to the progression of symptoms towards worse cough, lethargy, respiratory distress, fever, cyanosis, respiratory rate more than 65 times per minute and impaired breastfeeding; The initial diagnosis of pneumonia was made on February 28. The results of the patient's initial tests are shown in Table 1. In addition, blood type and O2 saturation were O + and 74 % respectively.\\nThe chest x-ray (Fig. 1A) and HRCT-Scan without contrast (Fig. 1B) were performed from the infant's chest on 29 February 2020. Consolidation with air bronchograms were seen in medial segments of the upper and middle lobes of the right lung and the lingula region. There was no evidence of pleural effusion or mediastinal lymphadenopathy. Due to the patient's chest X-ray and CT scan and the ongoing epidemic of COVID-19, the infant was referred to the ICU of the specialized COVID-19 hospital of Shahroud on 01-March and was admitted to an isolation room. Careful monitoring of vital signs, blood oxygen saturation, blood glucose and necessary supportive measures were performed. According to the pediatrician sub-specialist's prescription and considering the possibility of late bacterial pneumonia, the intravenous vancomycin 36 mg (q8 hr) (30 mg/kg/day) and cefotaxime 180 mg (q12 hr) (100 mg/kg/day) were prescribed from the first day until discharge, also the soluble Oseltamivir capsule and Hydroxychloroquine tablet were prescribed 20 mg (daily) (5.5 mg/kg/day); Cardiac monitoring was performed in the ICU while taking Hydroxychloroquine, and no significant signs were noted like Q-T prolongation. Furthermore, the oxygen therapy was performed by the oxy-hood. The RT-PCR for SARS CoV-2 of throat swab specimen was negative on 29 February 2020.\\nLaboratory tests of the fourth day (2 March, 2020) showed in Table 1. The blood culture was negative after 48 h of bacterial growth (Staphylococcus aureus and Streptococcus pneumonia and other common microorganisms), but no tests were performed to detect the flu and other viruses.\\nAfter admission and starting the treatment, the neonate's fever was abated and repeat chest CT-Scan show there was a lower alveolar consolidation on the sixth day of hospitalization (March 4, 2020), but there was still consolidation in the middle lobe of the right lung (Fig. 1C). The neonate was without fever for more than 4 days; and clinical symptoms and chest radiographic findings indicated the improved respiratory and vital status. On day 7th of hospitalization, the newborn was discharged from hospital with prescription of oral azithromycin syrup 100 mg (1.5cc daily) and oral ranitidine syrup 75 mg (0.5 cc twice a day). The patient was hospitalized with an initial diagnosis of pneumonia. Due to the patient's condition, along with the viral causes of pneumonia such as coronavirus and typical bacterial causes, atypical factors were also considered. Therefore, azithromycin was added to the treatment.\",\n",
       "    'gender': 'Female'},\n",
       "   {'age': 3,\n",
       "    'case_id': 'PMC7336922_02',\n",
       "    'case_text': \"The result of a second pharyngeal swab on March 12 was positive for SARS CoV-2. According to the medical history, the 3-years- old sister and 34-years-old father had mild cold symptoms with fever, cough and lethargy on February 23, 2020 and were under outpatient treatment without hospitalization. They had close contact with a person with symptoms of fever, cough and lethargy 1 week after the birth of the baby (17/02/20) and then have not had any contact with other person except their family. The nasopharynx swab test was performed on neonate's sister, and the nasopharynx and nasal swab test on parents on March 18 and the results of all family tests were negative.\\nIn our study, the identified case or cases of the disease in contact with this patient and even his family were not identified. We know that many patients are asymptomatic, and the strong hypothesis is that the patient also received the disease from asymptomatic individuals.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 35,\n",
       "    'case_id': 'PMC10272408_01',\n",
       "    'case_text': \"We conducted a retrospective analysis of the medical records of a 35-year-old Caucasian woman who presented with severe AFVI-induced bleeding and subsequent immunosuppressive therapy. The publication of this report was approved by the ethics committee of the South Pest Central Hospital/National Institute of Hematology and Infectious Diseases, and the patient provided written informed consent.\\nData were collected from the patient's medical records, including laboratory test results, imaging studies, surgical reports, and medication administration records. The patient's clinical course was tracked from the initial admission to our department on 21st February 2014, to the present day. Descriptive statistics were used to analyze the patient's clinical data, including laboratory test results and medication regimens. The time course of changes in coagulation parameters, including FV activity, was depicted graphically. The response to therapy was assessed by monitoring the patient's bleeding symptoms, laboratory test results, and adverse events.\\nLimitations of this retrospective analysis include the potential for missing or incomplete data and the inability to establish causality between the patient's clinical course and the treatments administered. Furthermore, this case report describes the experience of a single patient and may not be generalizable to other patients with similar conditions.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 0,\n",
       "    'case_id': 'PMC3012841_01',\n",
       "    'case_text': \"A 32-month-old boy was admitted to our hospital with two days of irritability and fever. He was born with a birth weight of 2.9 kg by normal spontaneous vaginal delivery at 40 weeks gestation to a healthy 28-yr-old G3P2 mother. His delivery was non-eventful, but there was flexion deformity of both his middle fingers, so he was transferred to our hospital and underwent many diagnostic tests and physical therapies in January, 2002. He showed mild general hypotonia in that his cry was weak, and he sucked poorly during early infancy. He had epileptic seizures 6 times since the age of 15 months despite taking anti-epileptic medications. A diagnosis of mental retardation complicated by epilepsy was made, and his development was noted to be markedly delayed. He raised his head at age 7 months, sat up at 26 months, and had not yet acquired the ability to stand. He had a flat and mid-hypoplastic face with prognathism, narrow and upward slanting palpebral fissures with hypertelorism, low-set ears, a small crashed nose, widely spaced incisors, carp-like mouth, and round back (Fig. 1). He demonstrated repeated stereotyped behavior like hitting his chin with his palm; this behavior was often associated with emotional outbursts.\\nSoon after admission, a generalized tonic-clonic type seizure was started and lasted approximately one hour; at that time his vital signs were as follows: blood pressure 100/60 mmHg, pulse rate 138 bpm, respiration rate 32 bpm, and body temperature 38.5C. Mild throat injection was seen, but other systemic examinations were normal. On neurologic exam, mental status was alert, all cranial nerve exams were normal, and muscle tone in both extremities were decreased to grade IV/IV bilaterally but all deep tendon reflexes were physiologic. There was no spasticity or pathologic reflex. Sensory functions were normal and meningeal irritation signs were absent.\\nInitial laboratory investigations revealed: hemoglobin 12.7g/dL, platelet count 374,000/microL and white blood cell count 11,780/microL. The C-reactive protein was slightly elevated at 19.0 mg/dL on the day of admission and returned to normal 3 days later. Urinalysis was normal. All microbiologic studies were negative. A sleep electroencephalogram revealed intermittent high-amplitude slow wave discharges from the temporo-occipital area, representing mild cerebral dysfunction. On radiologic evaluation, spine radiography revealed mild scoliosis. An echocardiogram was normal.\\nThe characteristic facial features and mental retardation of the patient led us to consider ATR-X syndrome; thus, peripheral RBCs were screened for hemoglobin H (HbH) inclusion bodies. HbH inclusions were detected under the microscope in 1.1% of brilliant cresyl blue stained RBCs, consistent with the diagnosis of ATR-X syndrome (Fig. 2). The patient's father, mother and two sisters were all given the same test; only his mother and eldest sister had the same findings. We performed gene analysis to confirm the diagnosis of ATR-X syndrome. Genomic DNA from the peripheral blood of our patient and his 4 family members was extracted with the Wizard  Genomic DNA Purification Kit (Promega, Madison, WI, USA) and used as a template for amplification of the ATRX gene. Polymerase chain reaction (PCR) was separated into three parts and carried out with sequence-specific oligonucleotide primers containing 20 known major mutation sites (Table 1, Figs. 3, 4). PCR amplification using each primer was conducted with premixture kit (PreMix -Top, Bioneer Inc., Seoul, Korea). Cycling conditions were one cycle at 95C for 5 min, followed by 35 cycles of 95C for 30 sec, at an annealing temperature adjusted to each primer's (Tm) for 30 sec, 72C for 30 sec, followed by one cycle at 72C for 7 min. For direct sequencing, the PCR products were purified using a PCR clean-up system offered by Promega. DNA sequencing was performed using the purified PCR products as template, the same primers as those used for template generation, the BigDye terminator cycle sequencing ready reaction kit (Applied Biosystems, Foster City, CA, USA), and automatic sequencer ABI Prism 3730 XL DNA Analyzer (Applied Biosystems, Foster City, CA, USA). Sequence data were assembled and compared to that of a previously reported ATRX sequence from accession number Z84487 using the DNAstar software (DNASTAR Inc., Madison, WI, USA).\\nMutation analysis for our patient showed a point mutation on the 9th exon in the ATRX gene of thymine to cytosine so that Trp(C), the 220th amino acid, was replaced by Ser(R) (Fig. 5). This missense mutation was reported by Gibbons in 1997. We investigated the same mutation in his 4 family members, and his mother and two sisters were found to be carriers.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 20,\n",
       "    'case_id': 'PMC8076759_01',\n",
       "    'case_text': \"A 20-year-old female with a prior history of mild intermittent asthma and atopic dermatitis was admitted to the hospital following rapidly progressing acute psychosis. She had been diagnosed with COVID-19 infection by polymerase chain reaction (PCR) testing one month prior after exposure to a roommate who tested positive after developing respiratory symptoms. Her only symptom at time of diagnosis was fatigue which resolved by hospital presentation. At baseline, the patient was a high functioning college student with no history of mental illness. Approximately 2 weeks after her COVID-19 diagnosis, she developed insomnia and panic attacks, which progressed over a span of two weeks to acute psychosis manifested by anxiety, agitation, forgetfulness, disorganized thoughts, paranoia, flight of ideas, insomnia and visual hallucinations of her recently decreased grandmother. She was initially prescribed quetiapine, but due to progression of psychosis, she was admitted for further diagnostic workup.\\nBased on the hospital policy regarding admission testing for COVID-19, a nasopharyngeal swab was obtained and tested by PCR, and was noted to be positive. Computed tomography of the head without contrast and magnetic resonance imaging of brain did not demonstrate any abnormalities. Continuous electroencephalogram was normal, and both urine drug screen and blood alcohol test were negative. Acetaminophen, salicylate and heavy metals toxicities were excluded. Cerebrospinal fluid (CSF) protein, glucose and cellular counts were normal. A meningitis/encephalitis panel (Biofire), which included numerous bacterial and viral targets, was negative. Additional workup including serum human immunodeficiency virus (HIV) antigen/antibody and treponema pallidum antibody was also negative. Routine laboratory tests including complete blood count (CBC), erythrocyte sedimentation rate, C-reactive protein, creatinine kinase, thyroid stimulating hormone, folic acid and vitamin B12 were within normal ranges. CSF encephalopathy panels were completed, and the results did not suggest autoimmune encephalopathy as an underlying cause for this patient's acute psychosis.\\nAfter discussion with the microbiology lab, COVID-19 PCR testing was performed on the patient's CSF sample. Though this test is non-FDA approved, multiple reports in the literature showed that the COVID-19 PCR testing on CSF samples has been performed and was positive in some cases. Our patient's CSF sample was negative for COVID-19.\\nThe psychiatry team were consulted, and after assessing the patient's past medical history, clinical manifestations and laboratory findings, the patient was diagnosed with hyperactive catatonia. She was started on high-dose lorazepam, with the intention to taper off the dose in the outpatient settings.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 28,\n",
       "    'case_id': 'PMC6344176_01',\n",
       "    'case_text': \"A 28-year-old female, with history of 2 cesarean sections 8 years ago and 2 years ago, was admitted into the emergency department for a 7-day ongoing gross hematuria with clots. Full blood count analysis on admission revealed a hemoglobin of 62.0 g/L. Then two units of red blood cells 200 ml plasma were infused to observe the condition continually while defining diagnoses and determining the treatment plan. A brief cystoscopy reported from the previous hospital showed a tumor approximately 2*3*4 cm in size near the bladder neck at 11 o'clock (lithotomy position). A computed tomography (CT) scan of the abdomen and pelvis showed a mass near the bladder neck and massive blood clots in the bladder (Fig. 1). Aiming to wait for hematuria to be controlled and then re-cystoscopy before we can perform the treatment, we consulted the interventional department for bladder tumor vascular embolization (Surgery related images shown in Fig. 2) in the hope of controlling bleeding. Nevertheless, her hemoglobin reduced to 39 g/L due to continuous hematuria prompting transfusion of 3 units of packed red blood cells and 400 ml plasma urgently the next morning. Consequently, the patient underwent an emergency transurethral resection of the bladder tumor (TURBT), demonstrating a lot of clots and a solid tumor of about 4 cm near the bladder neck. Once again, 2 units of red blood cells were injected and we gave other symptomatic supportive treatment after surgery to improve the general condition of the patient. To elaborate the change of hemoglobin in patient more intuitively, we specially created a line chart (Fig. 3). Finally, the patient's condition improved and she was discharged smoothly.\\nPostoperative pathological results show that it is bladder myofibroblastic tumor with muscle layer infiltration, finding tumors in the basement (Fig. 4). The results of immunohistochemistry examination showed: SMA (+), ALK (+), Demsin (-); CK (-), with about 20% the tumor cells as Ki-67 positive (Fig.5). Three months after surgery, computed tomography and cystoscopy were reviewed without signs of recurrence and no symptoms such as dysuria appeared in patient.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 50,\n",
       "    'case_id': 'PMC6313968_01',\n",
       "    'case_text': \"We report a case of a 50-year-old woman, normal weight and length (49 kg, 164 cm), known to have HIV for the previous 6 years and who was recently started on ART (2 weeks ago). No report was found of the patient taking any HIV therapy in the past. The ART started was abacavir-lamivudine, respectively, 600mg and 300 mg once daily in combination with darunavir 400mg twice daily. Further medical history consists of depression and anxiety, migraines, gastroesophageal reflux disease, and no known use of illicit drugs. She was admitted in the Intensive Care Unit (ICU) after being apathetic, lethargic, and having a painful cold cyanotic right hand for 4 days. The day of hospitalization she was found very drowsy on the floor by her partner who called the health emergency services immediately. Earlier that week a general practitioner was consulted concerning the painful hand. He suggested this was due to lateral epicondylitis and treated her with NSAID's.\\nIn hospital on admission physical examination revealed a woman with a Glasgow Coma Scale of 13/15, conscious but sleepy, oriented, slow speech, and grossly intact cranial nerves. On examination she had cyanotic cold toes on the right foot and a cyanotic right hand extending to the wrist and no pulsations were felt on all 4 limbs (no sign of edema). The patient had a blood pressure of 140/70 mmHg on the left arm and heart rate of 80 beats/min. On auscultation no irregularities were found and the SpO2 indicated 99%. Examination revealed no abdominal abnormalities, but auscultation showed hyperactive bowel sounds. There were no signs of a fever and the urine output was normal. On admission the SAPS score was 40, APACHE-II score 12, MODScore 6, and SOFA score 4; thus the mortality prediction by the SAPS-II score was 24.7%.\\nA central venous catheter was inserted at the Emergency Department due to failed attempts of placing a peripheral canula. Complete blood cell count showed a white blood count of 11.5 x 109/L and no further abnormalities (see supplementary information nr 1). The serum biochemistry showed a CRP of 24 mg/dl, CK 2285U/L, normal renal function with a of sodium of 121 mEq/L and chloride 87 mEq/L. Lactate was 0.7 mmol/L and troponins were negative with two consecutive blood samples. Toxicology screening, including ethanol, were also negative. Coagulation showed normal PT and APTT but D-dimers were raised to 2.2 mg/L (reference normally < 0.5). HIV viral load showed 42 copies/mL and CD4 count was 380 cells per cubic millimeter of blood.\\nBecause of the altered consciousness and lethargy a CT scan of the head was done. This showed no acute intracranial abnormality. During the following days the patient deteriorated and showed increasing unconsciousness and ischemic limbs. Platelet and coagulation disorders were excluded and the lumbar puncture showed no abnormalities. On the 3th day of admission, due to quickly lowering Glasgow coma scale, the patient needed intubation. At the same day a CT angiography of the aorta and lower limbs was done to find a cause for the increasingly cyanotic limbs. Findings included (i) multiple renal infarctions, (ii) narrowing of the external iliac arteries, and (iii) bilateral narrowed femoral-popliteal arteries with multitudinous stenosis or occlusions. The radiologists had difficulties to differentiate between thrombogenic pathology, medically induced arterial spasms, hypovolemia, or congenital hypotrophic arteries.\\nTwo days after intubation, when sedation was stopped, clinical examination showed no improvement of consciousness and fixed pupils were noticed. A CT angiography of the head (Figure 1(a)) showed important supratentorial hydrocephalus with narrowing of cortical sulci and cerebral edema. A normal intracranial perfusion, caliber, and patency of the vertebral arteries and the carotid arteries were seen.\\nOn the 6th day, a head MRI (Figure 1(b)) showed extensive recent ischemia in the cerebellum and hemispheres, more pronounced on the right side than the left side. An obstructive dilatation of the third and fourth ventricle with clear signs of edema in the posterior fossa and pontocerebellar cisterna could be noticed. In addition, beginning herniation of the cerebral tonsils in the foramen magnum was visible. The MRI showed flow void in the basilar arteria and internal carotid arteria. Blood results had shown a slow decline in red blood cell count to 2.74 x 1012/L with a hemoglobin of 8.2 g/dl and a rise in white blood cell count up to 17.8 x 109/L with CRP of 27 mg/dl on the day she passed away. Liver function tests and renal function were slightly elevated.\\nAfter seeing the evolving ischemia with several CT's that could not clearly differentiate between nonocclusive vasospasms or multitudinous stenosis and no sign of underlying peripheral artery disease, the medical history of the patient was re-examined. This revealed a document 10 years prior to the current hospitalisation suggesting former use of ergotamine containing medication (Cafergot ). Current use of ergotamine prior to hospitalization for a severe migraine attack was also confirmed by the partner. All this information in combination with the clinical presentation led to the diagnosis of ET.\\nTreatment was promptly started (3 days after admission), with IV nimodipine, intra-arterial sodium nitroprusside, and nitroglycerin transdermal patches on affected limbs (both legs and right arm). In addition, an epidural catheter was placed for infusion of bupivacaine. The HIV medication was discontinued and to prevent secondary thrombosis anticoagulation with low-molecular-weight heparin was started. However, no improvement was noticeable.\\nTwo days after stopping sedation, the patient did not wake up and pupils were fixed. MRI of the head (Figure 1(b)) showed beginning herniation of the cerebral tonsils in the foramen magnum. Neurosurgeons believed that the brain damage due to hydrocephalus was irreversible and that there would be no improvement with external ventricular drainage. Due to the evolving symptomatology and poor prognosis, in agreement with family futile life sustaining therapies were limited and supportive therapy for comfort was started. Patient died 7 days after being admitted at the ICU.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 10,\n",
       "    'case_id': 'PMC7417938_01',\n",
       "    'case_text': 'A 10-year-old girl (height 140 cm, weight 50.4 kg) was admitted to our emergency center for intensive care. The patient\\'s mother had a history of Graves\\' disease. The patient had a medical history of Kawasaki disease at two years old; however, she had been healthy and had steadily grown without further management since then. School teachers noticed her attention deficit and hyperactivity in school; however, no treatment was required. One day prior to admission to our department, the patient visited a local clinic with fever, sore throat, and rhinorrhea. As a rapid influenza test conducted using a nasopharyngeal swab was positive for the influenza A virus, baloxavir was administered. A few hours later, the patient presented tachypnea, restlessness, hypoxia (oxygen saturation 86%, ambient air) and drowsiness. The patient presented tachypnea with stridor, paradoxical abdominal breathing, and \"barking\" cough. Arterial blood gas analysis indicated carbon dioxide narcosis: pH; 7.11, pCO2; 84 mmHg, pO2;110 mmHg, HCO3-; 21.1 mmol/L.\\nThe patient was diagnosed with croup and influenza infection and was given nebulized racemic epinephrine and dexamethasone 8 mg intravenously. Since the patient\\'s breathing remained difficult with stridor and her work of breathing was followed by clonic convulsion, intravenous thiamylal (40 mg) was administered and intratracheal intubation using a 5 mm tracheal tube for mechanical ventilation was required. As influenza encephalopathy and airway compromise due to croup with influenza infection was suspected, the patient was transferred to our department for intensive care. In our emergency department, physical examination revealed a body temperature of 40.0  C, blood pressure of 115/68 mmHg, heart rate of 150 bpm, respiratory rate of 12 breaths/min, oxygen saturation of 97% (FIO2 0.8), and Glasgow Coma Scale score of E4VTM4. Her clinical examination revealed a diffuse elastic goiter with bilateral exophthalmoses (Fig. 1A). The patient had normal heart sounds without murmur or gallop. Her lungs were clear when auscultated. Her abdomen was soft and non-tender. Her skin was warm and wet. She had no lower extremity edema. A chest radiograph was normal. The electrocardiogram showed marked arterial tachycardia. Neurological examination showed normal reactive pupils without lateralization signs or neck stiffness.\\nLaboratory results were as follows: white blood cell count 14.66 x 109/L; hemoglobin, 11.5 g/dL; serum aspartate aminotransferase 66 U/L (normal range [NR], 10-35 U/L); serum alanine aminotransferase 39 U/L (NR, 0-40 U/L); blood urea nitrogen, 11.3 mg/dL (NR, 8-20 mg/dL); creatinine, 0.37 mg/dL (NR, 0.46-0.79 mg/dL); blood sugar, 142 mg/dL (NR, 73-109 mg/dL); and serum sodium 125 mEq/L (NR, 138-145 mEq/L). Blood lactate level was 0.8 mg/dL. Sputum culture grew oral organisms, but blood culture did not grow any organisms.\\nShe had nasal flaring, inspiratory stridor, accessory respiratory muscle use, and paradoxical abdominal breathing. As there was no swelling on the epiglottis and glottis, the 5 mm diameter tracheal tube was exchanged for one 6 mm in diameter. While slight difficulty in intubation was noted due to subglottic stenosis, airway management was successfully performed, and the patient was sedated with midazolam and fentanyl. Computed tomography showed the trachea was narrowed by the nodular goiter (Fig. 1B). Reconstructed computed tomography of the chest revealed a narrowing of the trachea (Fig. 1C). Electroencephalography (EEG) revealed no slow waves or paroxysmal waves. Brain computed tomography was unremarkable. Brain magnetic resonance imaging (MRI) was performed on the second hospital day; a splenium of the corpus callosum lesion appeared with high intensity on diffusion weighted image (Fig. 2). Initial thyroid function tests revealed hyperthyroidism; free-T4; 6.46 ng/dL (normal range NR 0.9-1.4 ng/dL), free T3; 7.51 pg/mL, thyroid-stimulating hormone under the threshold of sensitivity (0.3-5.0 muIU/mL), thyroglobulin under the threshold of sensitivity (NR < 33.70 mg/mL), and TRAb (thyroid stimulating hormone receptor antibody) 39.30 IU/L (NR <= 2).\\nEchocardiogram revealed tachycardia >150/min and deteriorated left ventricle ejection fraction (40%), although the patient had no congenital heart disease. As the diagnosis of thyroid storm associated with concomitant high-output cardiac failure was considered, administration of a short-acting beta-blocker (landiolol 1 mug/kg/min), hydrocortisone (300mg/day), thiamazole (30 mg/day), and saturated solution of potassium iodide (170 mg/day) was initiated. Tachycardia and hemodynamics significantly improved after these interventions. Her level of consciousness and thyroid gland swelling causing airway obstruction improved. Thyroid function tests on day 5 demonstrated significantly improved thyroid hormones, free T3 of 3.91 pg/mL and free T4 of 2.84 ng/dL. On day 8, the patient was extubated and transferred to a local hospital on day 11.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 36,\n",
       "    'case_id': 'PMC3406614_01',\n",
       "    'case_text': 'A 36-year-old woman presented with a cystic lesion located on the right popliteal fossa, which grew slowly for 7 years and became remarkably larger in the last few months. The lesion was dark red in color (Fig 1) and elastic hard in consistency. When punctured by her primary care physician, darkish blood was aspirated.\\nWhat is the differential diagnosis of a subcutaneous cyst around the knee?\\nWhich diagnostic imaging studies are appropriate to help reach diagnosis?\\nWhat are the therapeutic options for this lesion?',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 81,\n",
       "    'case_id': 'PMC8012864_01',\n",
       "    'case_text': 'An 81-year-old female was admitted to the Emergency Department of Khorshid Hospital in Isfahan, Iran, with a loss of consciousness and a history of fever, dry cough, and dyspnea over the past few days. The patient had attended the ophthalmology department 5 days before with a red eye and had received treatment for conjunctivitis. Over the following days, she had experienced anorexia, vomiting, and progressive loss of consciousness. She had been tested for COVID-19 before admission to the hospital, and a positive polymerase chain reaction (PCR) test was reported.\\nShe had a history of hypertension and was using losartan/hydrochlorothiazide (50/12.5 mg daily), chlordiazepoxide tablets (2.5 mg daily), and Vitamin B6.\\nThe initial physical examination revealed a body temperature of 37 C, oxygen saturation of 93% on air, respiratory rate of 22 breaths/min, blood pressure of 166/110 mmHg, and the pulse was 96 bpm. The laboratory results were as below: white blood cell = 145,000/mm 3, red blood cell = 2.47 x 106/muL, hemoglobin = 7.2 mg/dl, hematocrit = 23.5%, lactate dehydrogenase = 2237 unit/L, platelet = 52,000/mm 3, and creatinine (Cr) levels = 8.9-9.1 mg/dL.\\nAfter admission to Khorshid Hospital, another PCR test was performed to confirm the previous findings, and it was positive again for COVID-19. A ground-glass pattern was reported in the high-resolution computed tomography (CT) of the lung. Spiral multislices showed diffuse bilateral ground-glass opacity and crazy paving opacity with peripheral and peribronchovascular distribution, a pattern highly suggestive of COVID-19-associated pneumonia [Figure 1]. In a spiral multislice brain CT scan, irregular hypodensities in the deep white matter and centrum semiovale were detected that suggested small vessel disease. Cortical sulci and Sylvian fissures appeared prominent and indicated brain atrophy.\\nUpon admission, the patient was immediately treated with nasal oxygen (3-5 L/min) and amlodipine 5 mg oral. Based on the hospital protocol, treatment for COVID-19 infection was initiated: hydroxychloroquine 200 mg tablet twice a day, azithromycin 500 mg daily, and ceftriaxone 1 g intravenous daily. The peripheral blood smear showed schistocytes 3% [Figure 2] without platelet aggregation, suggesting TTP. An infusion of 500 mg methylprednisolone and ISO group fresh frozen plasma was commenced and electrocardiogram monitoring in the emergency department. Unfortunately, 45 min later, the patient developed ventricular tachycardia and subsequently suffered a cardiac arrest. Cardiopulmonary resuscitation was performed immediately, and cardiac shock was given. The cardiac rhythm returned to normal after approximately 30 min of effort. As the patient was being prepared for transfer to another hospital for plasmapheresis treatment, cardiac arrest occurred again, and the patient passed away.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 0,\n",
       "    'case_id': 'PMC7585050_01',\n",
       "    'case_text': \"A 22-month-old boy with the chief complaint of an abdominal mass was referred to our hospital. An elastic, hard mass was palpable in his right abdomen on physical examination (Fig. 1). Ultrasonography revealed a nonuniform, hyperechoic mass in the right lobe of the liver. Abdominal magnetic resonance imaging revealed a large solid tumor, with a heterogeneous interior on T2-weighted images, approximately 100 mm in diameter, protruding into the abdominal cavity from the right hepatic lobe (Fig. 2). Chest computed tomography (CT) revealed parenchymal nodules considered to be metastases in both lobes of the lungs (Fig. 3). Although liver function test results were within normal ranges, serum alpha-fetoprotein (AFP) concentration was 248,443 ng/mL. A mixed embryonal/fetal hepatoblastoma was diagnosed via liver tumor biopsy.\\nWe planned chemotherapy to treat the hepatoblastoma and lung metastases. However, the day before the scheduled start of chemotherapy, the patient became lethargic and tachycardic, with unstable vital signs that led to shock that was unresponsive to conservative measures. His hemoglobin level was 6.8 g/L. We performed an emergency laparotomy because the patient's small size precluded TAE. During the surgery, the left margin of the tumor ruptured and the tumor contents leaked into the abdominal cavity (Fig. 4). The patient's respiratory and circulatory statuses stabilized after blood transfusion and hemostatic compression of the tumor rupture site. The tumor protruded from the liver, and the capsule had also thinned in other areas that appeared to be in a state of imminent rupture. Therefore, we performed a partial resection of the liver (segments 5 and 6) along the boundary between the tumor and the healthy liver (Fig. 5). In addition, all visible tumor contents in the abdominal cavity were removed. The total operation time was 2 h 54 min, and the intraoperative blood loss volume was 1,190 mL. The postoperative course was uneventful. The histological results for the resected tumor were the same as those from the biopsies.\\nThe patient received six courses of chemotherapy (modified SIOPEL-4 regimen) in the pediatric department (Fig. 6). Chest CT performed after chemotherapy showed a barely detectable metastatic lesion in the right lung, which was resected after the fifth chemotherapy treatment, as a reference to the protocol of the SIOPEL-4 regimen. Serum AFP level had decreased logarithmically and remained <10 ng/mL after the completion of chemotherapy. The patient remained in remission 2 years after the emergency surgery despite the poor prognosis indicated by distant metastases at the time of initial diagnosis.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 60,\n",
       "    'case_id': 'PMC3730474_01',\n",
       "    'case_text': 'A 60-year-old unmarried male, presented with a history of multiple ulcers over his right groin of 4 months duration. It started as a painless swelling over the right groin, which evolved into multiple ulcers with foul swelling discharge. One month later, he developed a similar swelling in the left groin. There was no history of trauma at the site. Patient denied history of sexual exposure and there was no history of genital ulcer. He does not give history of arthralgia, loss of weight, or loss of appetite. Bowel and bladder habits were normal.\\nThe patient also gave history of multiple blisters over the trunk and extremities of 1 month duration. There was no history of oral erosions or drug intake prior to the onset of lesions.\\nOn general examination, the patient was moderately built and nourished, there was no pallor, icterus, pedal edema, or generalized lymphadenopathy. His systemic examination was normal.\\nExamination of the right inguinal region showed three tender excavating ulcers of sizes 6 x 8, 5 x 7, and 3 x 5 cm, respectively, located adjacent to each other with rolled out, everted edges, and foul smelling purulent, blood-stained discharge. Enlarged, grouped, and matted tender inguinal lymphnodes of sizes 5 x 7 cm were felt below the ulcer. Examination of the left inguinal region also revealed enlarged, grouped, tender inguinal nodes of size 8 x 6 cm present both above and below the inguinal ligament giving the appearance of \"Groove sign of Greenblatt\" [Figure 1]. External iliac lymph nodes were not palpable.\\nGenital examination revealed phimosis. A firm, indurated, non tender mass of size 3 x 2 cm was felt through the prepucial skin on the glans penis, located on the 11\\'o-clock to 2\\' o-clock position. There was no lymph edema of penis. Per-rectal examination was normal.\\nMultiple tense bullae filled with clear fluid and erosions were present over upper limbs, lower limbs [Figure 1], and trunk. A tense bulla was present over the shaft of penis, which eroded later. Nikolsky\\'s sign and bulla spreading sign were negative. There were no oral erosions.\\nWith the above clinical findings, a differential diagnosis of lymphogranuloma venereum (LGV) or SCC of penis with regional metastasis associated with bullous pemphigoid (BP) occurring as a para neoplastic phenomenon were considered.\\nDark field smear was negative for Treponema pallidum. Tissue smear was negative for Donovan bodies. Gram\\'s stain was negative for gonococci. IgG antibody for Chlamydia trachomatis (serovars L1, L2, L3) was negative. VDRL for syphilis and ELISA for human immunodeficiency virus (HIV) 1 and 2 were nonreactive. Mantoux was also negative. No abnormality was seen in his urine microscopy and pus culture reports. His laboratory investigations revealed anemia. Other blood counts, liver and renal function tests were normal. Tzanck smear taken from the bulla did not show acantholytic cells. His chest x-ray and ultra sound of the abdomen were normal.\\nWedge biopsy of the ulcer in the right groin and from the penile growth showed ulcerated hyperplastic epidermis with severe dysplasia. The dysplastic epithelial cells invade the basement membrane forming nests with keratin pearls, consistent with keratinizing SCC of penis [Figure 2]. Skin biopsy taken from a tense bulla over the trunk, showed a sub epidermal bulla with mild lymphocytic infiltrate in the upper dermis consistent with BP.\\nHence, a diagnosis of keratinizing SCC of penis with regional lymphnode metastasis and BP was confirmed. Patient was referred for surgical opinion and management.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 11,\n",
       "    'case_id': 'PMC7308213_01',\n",
       "    'case_text': 'The proband, a Sudanese male born following normal pregnancy and delivery presented at the age of three months with abdominal distension and constipation, in the absence of a goiter or umbilical hernia. Growth was normal for height and weight at the 50th percentile. Written informed consent was obtained from the parents for blood and serum draws and analyses. Serum TSH and free thyroxine (FT4) were initially measured in Khartoum. Serum thyroid function tests (TFTs) after starting treatment including TSH, total thyroxine (TT4), total triiodothyronine (TT3), FT4, thyroxine-binding globulin (TBG), thyroglobulin (TG), thyroid peroxidase antibody (TPOAb), and thyroglobulin antibody (TGAb) were completed (Immulite 1000; Siemens, Munich, Germany and by Elecsys; Roche, Switzerland). Reverse triiodothyronine (TrT3) was measured by radioimmunoassay (Adaltis Italia S.p.A, Bologna, Italy). DNA for sequencing was extracted from peripheral white blood cells using a Qiagen DNA Blood Mini Kit (Hilden, Germany). DNA from the mother and proband were sent for whole exome sequencing (Novogene, Agilent SureSelect Human All Exon V6 Kit). Whole exome sequencing (WES) results were first scanned for mutations in genes known to be related to TH synthesis or function (Supplemental Table 1). Functional prediction scores Sorting Intolerant from Tolerant (SIFT), Polyphen2 HumanDiv (HDIV) MutationTaster and Combined Annotation Dependent Depletion (CADD) were tested in silico, allele frequency, and zygosity were all considered in determining the likely cause of the CCH phenotype. The mutation was confirmed by sanger sequencing of DNA from all available family members in order to determine the mode of inheritance.\\nTFTs at 3 months of age revealed a TSH reported as 0.01 mIU/L (reference range 0.4-4.3 mIU/L) and low FT4 of 1.0 pmol/L (reference range 4-10.6 pmol/L). The proband had no family history of thyroid disease, however, both parents reported being first-degree cousins. The proband was diagnosed with CCH and started on levothyroxine (L-T4) treatment. Now, at eleven-year-old on subtherapeutic L-T4 replacement the TFTs demonstrated undetectable TSH on the Elecsys (<0.01) and on Immulite (<0.03) with Low FT4 (Individual II-1, Figure 1). The proband had normal neurological and psychological development on physical examination. WES found a novel missense mutation located on exon 2 of the TSHbeta, c.T141G p.C47W (numbering includes the 20 amino acid signal peptide). Sanger sequencing confirmed that both parents were heterozygous for the C47W mutation, while the proband was homozygous. The mutation was predicted by several in silico methods to have a deleterious effect (SIFT 0.0, Damaging; Polyphen2_HDIV 0.973, probably damaging; MutationTaster 1, disease causing; and CADD 3.17, 16.62). Analysis of the allele frequency in the African and general populations was not available as this is a novel mutation not located in the Genome Aggregation Database.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 71,\n",
       "    'case_id': 'PMC9726922_01',\n",
       "    'case_text': 'A 71-year-old woman with diagnosis of ESS 30 months ago. After receiving treatment with radiotherapy and chemotherapy, the patient remained asymptomatic during the follow-up until 2 years later, when she complained of dyspnea.\\n 18F-FDG PET/CT was performed to identify if there was a potential malignancy tumor. The maximum intensity projection image ( Figure 1A ) revealed hypermetabolic lesions in the right thorax ((long arrow) and the right upper abdomen (short arrow). On the axial CT ( Figure 1B ), PET ( Figure 1C ), and fused PET/CT ( Figure 1D ) showed a large irregular lesion in the right lung upper lobe, measuring 8.4 cmx10.2 cmx8.1 cm showing intense 18F-FDG uptake with SUVmax of 13.4. The axial CT ( Figure 1E ), PET ( Figure 1F ), and fused PET/CT ( Figure 1G ) revealed the increased activity corresponded to a slight hypodense right adrenal gland soft tissue mass, measuring 5.1 cmx6.3 cmx6.5 cm showing intense 18F-FDG uptake with SUVmax of 13.4. The patient underwent thoracoscopic resection of the right upper lobe at an outside hospital, and postoperative pathology diagnosed high-grade ESS metastasis to the right side of the lung. The patient had follow-up outside the hospital. After 2 months, the ultrasound revealed a right adrenal mass that was 9.1 x 6.5 cm. After 5 months, the 18F-FDG PET/CT revealed a right adrenal mass that was 11.4 cm x 11.0 cm x 10.8 cm. After a period of recuperation at home, she was came to our hospital for further treatment.\\nThe past medical history was significant for hypertension and coronary artery disease. Coronary stenting was performed, and she was usually treated with oral aspirin anticoagulation and avastatin lipid regulation. Physical examination revealed a palpable and hard mass, in the right area of her kidney. The levels of CA-125 were normal (17.49 U/mL, normal reference values: 0-35 U/mL). The levels of CA-199 were abnormal (36.74 U/mL, normal reference values: 0-35 U/mL). Plasma ACTH, angiotensin and renin concentrations were within the normal range. Other laboratory tests showed no significant abnormalities.\\nWith adequate preoperative preparation, an open right adrenal tumor resection was performed. The intraoperative exploration revealed a cystic solid mass with a size of about 11.0 cmx10.5 cm. In a pathological view, the lesion was a round, dark red in color, and surrounded by a thick membrane and adhered to the surrounding tissues. On histopathological examination, the tumor cells were seen arranged in a swirling flow structure ( Figures 2A, B ). Immunohistochemistry showed: ER (-), PR (-), CD10 (+) ( Figure 2C ), P16 (+), Ki-67 (50%). The postoperative pathological diagnosis confirmed the high-grade ESS with right adrenal gland metastases. After 4 months of postoperative follow-up, metastasis was detected again during a 18F-FDG PET/CT examination at an outside hospital. The PET/CT of the outside hospital showed thickening of the left adrenal gland union with increased metabolism.\\nTimeline: Diagnosed ESS for 30 months:Pulmonary and Adrenal Glands Metastases were detected by 18F-FDG PET/CT before 6 months:She had undergone thoracoscopic right upper lobe resection 5 months ago, and postoperative pathology diagnosed high-grade ESS metastasis in the right lung:Right adrenal tumor resection was performed:After 4 months of postoperative follow-up, metastasis was detected again during a 18F-FDG PET/CT examination at an outside hospital ( Figure 3 ).',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 62,\n",
       "    'case_id': 'PMC5620405_01',\n",
       "    'case_text': \"A 62-year-old female presented with a left RNP. At first presentation in our hospital, the patient reported progressive palsy starting with painless weakness only of her left wrist and long fingers extension 2 years ago. There was no history of any trauma or surgical procedure at her left upper extremity. Within these 2 years, the patient had a checkup by her family doctor and a neurologist. The diagnostic management included magnetic resonance imaging (MRI) of the cerebrum and cervical spine, electromyography, electroencephalography, and diagnostic analysis of blood and cerebrospinal fluid samples to exclude systemic specific or non-specific infectious or inflammatory or autoimmune diseases. No causes could be found that declared her RNP. So the diagnosis of a radial nerve mononeuropathy with unclear genesis was made, and the patient was treated by oral medication of glucocorticoids and vitamin B12. Additionally, the patient received a prefabricated wrist splint which immobilized only her left wrist in neutral position. Fortunately, stiffness or contractures in the wrist and all finger joints did not appear.\\nOn the first clinical examination in our hospital, an incomplete but severe RNP was present. The strength of extension of the wrist and thumb's extension and abduction was completely lost according to grade 0 in Medical Research Council (MRC) scale (0-5), and the extension in the metacarpophalangeal (MP) joints II-V showed palsy grade 3 in MRC scale (Fig. 1A). The sensibility in the peripheral radial nerve area was completely lost. Electromyography revealed an advanced demyelinating radial nerve palsy, but not a complete neurotmesis. On physical examination, there was a painless and non-tender mass around the proximal radius. MRI revealed a submuscular, clearly demarcated and encapsulated tumor with a homogeneous and high-intensity signal similar to subcutaneous fat which surrounds the proximal radius shaft approximately a half part of its total circumference, and without visible septae inside the tumor after gadolinium injection (Fig. 1B). According to these findings, the diagnosis of a benign GL was made by the radiologist, and surgical removal of the tumor with exploration of the radial nerve was detected by us. The tumor was exposed typically through a volar approach. The radial nerve was carefully dissected, it was fixed to the capsule of the GL (Fig. 1C). The encapsulated GL with the size of 11x7x5 cm was completely removed in a monobloc manner. After that, an overstretching-related partial disruption of the nerve with a gap of 1 cm involving a half part of its overall circumference was visible (Fig. 1D). At this time (i.e. 2 years after first neurological symptoms) a sural nerve graft would be inappropriate, and a tendon transfer procedure was detected by us. This could not go beyond the scope of this first surgical procedure because the time of tourniquet already lasted 80 minutes. Additionally, a complete neurotmesis of the radial nerve was not found by electromyography, and so the patient was not cleared up by us on specificities of a tendon transfer procedure preoperatively. Furthermore, the potential risk of problems with wound healing would have been too high due to the necessity of another large surgical incision at this time. The diagnosis of a benign GL was confirmed by histological examination.\\nSix weeks after removal of the GL, a triple tendon transfer procedure that included the transfer of the pronator teres (PT) to the extensor carpi radialis longus/brevis (ECRL/B), the transfer of the flexor carpi ulnaris (FCU) to the extensor digitorum communis (EDC), and the transfer of the rerouted extensor pollicis longus (EPL) to the palmaris longus (PL) was performed (Figs. 2A, B). All tendon sutures were done in the Pulvertaft technique (end-to-side: PT to ECRL/B and FCU to EDC; end-to-end: EPL to PL). The wound healing was uneventful. The left upper extremity was immobilized in a plaster splint for 2 weeks. After that, the movement of elbow joint was freed, whereas the wrist was immobilized in the neutral position with a cast which additionally allowed the active flexion of all finger joints accompanied with its feather-related passive extension for another four weeks. Then, active strengthening of the wrist and all finger joints was started. Four months after surgery, the patient was completely able to perform her daily life activities again.\\nAt the 10-months follow-up, strength of wrist extension, thumb's extension and abduction, and long fingers II-V extension had all improved to grade 4 in MRC scale that was accompanied with a sufficient circumduction of the thumb (Figs. 3A-C). The patient reported that she would undergo the same motion- restoring triple tendon transfer procedure again if it would be necessary.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 3,\n",
       "    'case_id': 'PMC4724101_01',\n",
       "    'case_text': \"A three year old, second lactation Holstein dairy cow presented to the Scottish Centre for Production Animal Health and Food Safety (SCPAHFS), School of Veterinary Medicine, University of Glasgow in November 2014 with a history of post-calving vulval/vaginal bleeding nine days prior to presentation followed by a sudden cessation in milk production. The animal was referred from a 230 cow, year round calving, closed dairy herd in Dumfries and Galloway, south-west Scotland. Cattle are housed all year round and fed a total mixed ration ad libitum. Animals receive leptospirosis, salmonella, infectious bovine rhinotracheitis (IBR) and bovine viral diarrhoea (BVD) vaccinations and the herd is a BVD negative herd in accordance with the Scottish government BVD eradication scheme. All cows are treated in the summer with a deltamethrin pour-on product (Butox Swish, MSD Animal Health, Milton Keynes, UK). This cow was homebred and had not left the farm during its lifetime until it was referred into the veterinary school.\\nOn admission the animal was bright, alert and responsive and had a normal appetite and thirst. Tachycardia (100 beats/min) was evident on clinical examination but temperature and respiratory rate were within normal limits. Pallor of oral, conjunctival and vaginal mucous membranes was evident, raising a clinical suspicion of anaemia. There was no vaginal discharge. The remainder of the clinical examination was unremarkable.\\nHistory and initial clinical examination enabled significant calving trauma, ongoing haemorrhage and toxicities to be ruled out as potential differential diagnoses for the suspected anaemia in this animal prior to further investigation.\\nAn EDTA-anticoagulated blood sample taken on admission revealed a markedly regenerative, severe (haematocrit 9.9 %; ref: 24-46 %) macrocytic anaemia with spherocytes and basophilic stippling present on the blood smear (Figs. 1 and 2) (Table 1). Serum biochemistry revealed hyperbilirubinaemia and elevated alkaline phosphatase (ALKP), aspartate aminotransferase (AST), gamma-glutamyl transferase (GGT) and glutamate dehydrogenase (GLDH) (Table 2), remaining serum biochemical parameters were all within the reference range. These biochemical abnormalities, together with the presence of a regenerative anaemia raised the suspicion of a haemolytic anaemia.    \\nHaemolytic anaemias commonly result in elevated liver enzymes and increased total bilirubin. Pathologic haemolysis increases haemoglobin degradation and consequent bilirubin formation exceeds the hepatic capacity for uptake and conjugation of bilirubin and excretion into bile, resulting in bilirubinaemia. Upregulation of hepatic function in response to increased need for bilirubin excretion results in increases in liver enzymes seen on serum biochemistry in cases of haemolytic anaemia.\\nThere was no evidence of haemoglobinuria or haematuria on either urine dipstick analysis or laboratory urinalysis.\\nThe presence of inclusion bodies on the blood smear coupled with a positive direct Coombs' test meant a diagnosis of immune-mediated haemolytic anaemia could be made with suspected underlying infectious aetiology. The inclusion bodies seen on the blood smear were confirmed to be Mycoplasma wenyonii parasites by polymerase chain reaction (PCR).\\nGenus-specific Mycoplasma primers generated a specific 270 bp product from whole blood DNA. The Sanger-sequenced product (Source BioScience, Lanarkshire, UK) showed high sequence similarity to Mycoplasma wenyonii str. Massachusetts (NCBI GenBank accession number CP003703 with 97.8 % (forward primer) and 98.7 % (reverse primer) probability.\\nThere is a paucity of information available regarding the treatment of either haemotropic mycoplasmas or immune mediated haemolytic anaemia in cattle. Tetracyclines have been reported to be effective in treating both M.haemofelis and M.suis infections and there are reports of M.wenyonii in cattle being treated with oxytetracycline, however response to treatment has been variable. In light of this, oxytetracycline was the treatment of choice in this case. Corticosteroids were considered, as part of this clinical presentation was immune-mediated; however, previous work has shown that Coombs' positive cats infected with M.haemofelis respond to antibiotic treatment alone. In addition to this, there are some cases where concurrent corticosteroid therapy has been shown to delay the clearance of haemotropic Mycoplasma from the blood. It was decided to treat with oxytetracycline alone initially and only use concurrent corticosteroid if warranted by deteriorating clinical status of the animal in spite of appropriate antibiotic therapy. In light of the degree of anaemia exhibited by this animal blood transfusion was considered, however due to the clinical stability of the cow and concerns regarding the possibility of adverse transfusion reactions it was elected not to perform a blood transfusion on this occasion.\\nThe cow was treated with 20 mg/kg long-acting oxytetracycline (Alamycin LA 300; Norbrook, Newry, Northern Ireland, UK) every three days by deep intramuscular injection. A blood sample was repeated 48 h following the commencement of treatment which showed a good initial response; haematocrit increased from 9.9 % to 15.2 % (Table 1), and total bilirubin reduced from 23 mumol/l to 6 mumol/l (Table 2). In addition, all elevated liver enzymes were reduced (Table 2). The cow initially improved in demeanour and the mucous membrane pallor resolved as the haematocrit improved, which was to be expected.\\nBlood samples for haematology and biochemistry were repeated regularly for the duration of treatment. The haematological improvement continued for the first week following treatment, from which point no further improvement in haematological parameters occurred despite continued treatment (Table 1). Liver enzymes and total bilirubin showed rapid initial improvement then remained within the reference range for the duration of treatment (Table 2). Blood taken on the 8th of December 2014 was PCR negative for Mycoplasma species however there were still a few inclusion bodies seen in small numbers of erythrocytes, which were suggestive of continued Mycoplasma species infection in spite of a negative PCR result. A direct Coomb's test was now negative.\\nAfter an initial improvement in demeanour and haematological and biochemical parameters, the cow failed to improve further and approximately three weeks after admission started to deteriorate in demeanour with the development of a soft cough and a persistent tachycardia (heart rate persistently greater than 90 beats per minute). The decision was made to euthanase the cow on the 19th of December 2014, one month after presentation to the SCPAHFS due to limited further improvement and because the prognosis was considered to ultimately be poor.\\nA blood sample was taken immediately prior to euthanasia and submitted for repeat PCR testing. This blood sample was positive on PCR for Mycoplasma species however, this could not be confirmed to be M.wenyonii on sequence analysis.\\nPost mortem examination showed mild hepatomegaly, mild enlargement of the spleen with prominent lymphoid follicles within the white pulp (Fig. 3) and mild lymphadenomegaly of the right pre-scapular lymph node. Samples of spleen, lymph node, liver and bone marrow were collected in fixative (10 % neutral buffered formalin) and processed for paraffin embedding and sectioning for histological examination. Sections were stained with Haematoxylin and Eosin (H & E). An additional section of liver was stained with Perl's Prussian Blue. \\nHistological examination of the spleen confirmed expansion of the lymphoid follicles with prominent germinal centres within the white pulp. The red pulp was moderately congested with an increase in haemosiderin-laden macrophages. In the right pre-scapular lymph node, there was an increase in size and number of lymphoid follicles with expanded germinal centres, along with congestion of the paratrabecular and medullary sinuses. Numerous aggregates of nucleated erythroid precursors and variable numbers of megakaryocytes were noted in the medullary cords (Fig. 4). Hemosiderin-laden macrophages were also prominent in the lymph node. Large numbers of erythroid precursors and megakaryocytes were noted in a section from a bone marrow sample. Increased intracytoplasmic accumulation of haemosiderin (confirmed by Perl's Prussian Blue staining) was also noted in Kupffer cells in hepatic sinusoids (Figs. 5 and 6).   \\nIncreased haemosiderin accumulation in the spleen, lymph node and liver is consistent with increased erythrocyte turnover as a result of extravascular haemolysis in the context of haemolytic anaemia. The occurrence of extramedullary haematopoiesis (EMH) in the lymph node, characterised by a predominance of erythroid and megakaryocytic elements and the apparent increase in erythroid precursors and megakaryocytes in the bone marrow are both consistent with a regenerative response secondary to anaemia.\",\n",
       "    'gender': 'Unknown'}],\n",
       "  [{'age': 71,\n",
       "    'case_id': 'PMC6458882_01',\n",
       "    'case_text': 'A 71-year-old man with a 25 pack-year history of tobacco use presented for continuing care, and physical examination revealed a painless right parotid gland mass previously unnoted by the patient. It was palpable as a soft 0.5 cm mass. Cranial nerve examination was without deficits, and no cervical lymphadenopathy was detected. He had a history of left parotidectomy for Warthin tumor three months prior and Mohs surgery of the right cheek for nonmelanoma skin cancer five years prior. CT scan revealed a 1.4 x 1.3 cm right superficial parotid mass. For diagnostic and therapeutic purposes, a right superficial parotidectomy was performed. Intraoperative frozen section examination revealed mucoepidermoid carcinoma, intermediate grade. Thus, the decision was made to perform a right deep lobe parotidectomy with preservation of facial nerve and right neck dissection. The patient underwent definitive IMRT 60Gy radiation therapy following recovery from the surgery and has been followed up for four months.\\nOn gross examination of the resected right superficial parotidectomy specimen, serial sections revealed a 1.3 x 1.1 cm firm, tan-white intraparenchymal tumor nodule with ill-defined borders. In addition, a cyst measuring 0.6 cm was present 1.1 cm away from this tumor, with grossly unremarkable intervening parenchyma. Histologic examination of the nodule showed two distinct lesional components that were well-demarcated from each other with no transition zone (Figure 1(a)). One portion showed well-circumscribed multinodular proliferation composed of dark blue, basaloid tumor cells arranged in nests with frequent peripheral palisading. Cytologically, the tumor cells demonstrated ovoid, basophilic nuclei and scant cytoplasm. Distinct, dense ribbons of eosinophilic hyaline material were noted surrounding the islands of tumor cells (Figure 1(b)). These histologic findings were those of basal cell adenoma, membranous type. Immunohistochemical stains for p63 and CK5/6 highlighted a prominent abluminal population, and CK7 highlighted patchy cells throughout, with a subset of luminal cells staining intensely (Figure 2). The other portion of the tumor was characterized by a multinodular proliferation of multiple distinct cell populations arranged in frequent mucin-containing glandular spaces and as solid tumor cell nests. The lesional cells consisted of an admixture of mucous cells (mucocytes), polygonal epidermoid cells, and intermediate cells (Figure 1(c)). A special stain for mucicarmine highlighted intracellular mucin within the mucocytes as well as the extracellular mucin (Figure 1(d)). Cytologic atypia was moderate to focally marked. Necrosis was not seen and the mitotic activity was scant. Immunohistochemical stains for p63 and CK5/6 highlighted a predominant abluminal epidermoid/squamoid cell population, and CK7 highlighted mucocytes and cells adjacent to extracellular mucin of the glandular lumens. The Ki-67 proliferation index was approximately 3-4% (Figure 2). The histologic findings were consistent with intermediate-grade mucoepidermoid carcinoma. Microscopically, the grossly noted 0.6 cm cyst consisted of a simple cyst composed of cytologically bland cuboidal lining cells with focal mucinous metaplasia, consistent with a salivary duct cyst. The parenchyma between this region and the tumor was histologically unremarkable as was the deep lobe of the parotid. Eighteen sampled lymph nodes were negative for tumor.\\nTo further investigate the association between the two tumor components, molecular profiles of both were analyzed by next-generation sequencing (NGS) (FoundationOne , Cambridge, MA). Among the 315 genes tested, the MEC and BCA components shared five genomic variants in common, all characterized as variants of unknown significance (VUS). Additionally, each showed one or two distinct likely driver genomic alterations (Table 1). Interphase fluorescence in situ hybridization (FISH) for MAML2 rearrangement, a genetic alteration commonly found in MEC, was attempted, but testing was uninformative as no interpretable hybridization signals were present to complete the analysis.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 82,\n",
       "    'case_id': 'PMC5741137_01',\n",
       "    'case_text': 'An 82-year-old man with multiple comorbidities was initially evaluated for coffee-ground emesis associated with a 3-g/dL drop in hemoglobin. Upper endoscopy demonstrated a subepithelial mass with an overlying ulceration and an adherent clot in the duodenal bulb, with no histological evidence of a malignancy (Figure 1). Computed tomography (CT) obtained during the initial hospitalization demonstrated air within an inflamed gallbladder that contained stones and sludge, as well as a rounded, well-circumscribed mass in the duodenum (Figure 2). Liver enzymes at the time were notable for aspartate aminotransferase 182 IU/L, alanine aminotransferase 167 IU/L, alkaline phosphatase 176 IU/L, and total bilirubin 1.4 mg/dL. The lesion, which was the source of the bleeding, was presumed to be a gastrointestinal (GI) stromal tumor, and he was referred for an endoscopic ultrasound (EUS).\\nEUS revealed a 21-mm hypoechoic ulcerated subepithelial mass with a duct-like structure in the duodenal bulb. During suction to appose the lesion against the tip of the echoendoscope, the mass decompressed, and the areas of ulceration morphed into 2 small orifices draining bile and small stones (Video 1; Figure 3). Subsequent magnetic resonance imaging demonstrated resolution of the mass-like density in the duodenum (Figure 4). A small bile duct stone and subtle contrast opacification of the cholecystoduodenal fistula was also identified (Figure 4). The patient had multiple comorbid conditions including metastatic prostate cancer, chronic liver disease due to hepatitis C infection, congestive heart failure, ischemic stroke, and atrial fibrillation. He did not have a known history of biliary disorders. Therefore, the patient was managed conservatively because the bleeding had ceased and biliary drainage had been established through the fistula. The patient remained clinically stable without any bleeding, abdominal pain, or jaundice on follow-up. Subsequent endoscopy to assess healing demonstrated the persistence of the fistula orifice and clear decompression of the mass lesion (Figure 5).',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 43,\n",
       "    'case_id': 'PMC9479505_01',\n",
       "    'case_text': 'A 43-year-old woman presented with severe headaches and generalized malaise for 5 days. Endocrine investigation revealed hypopituitarism with markedly decreased levels of early morning cortisol, thyroid hormone with low thyroid-stimulating hormone, growth hormone, and insulin-like growth factor 1. Physical examination was unremarkable. There were no visual deficits on ophthalmological examination. MRI and magnetic resonance angiography showed a significant mass effect on the pituitary gland, with a giant right cavernous ICA thrombotic aneurysm measuring 26.4 mm at the largest diameter [Figures 1a and b]. Digital subtraction angiography revealed a right cavernous ICA aneurysm [Figures 1c and d]. Considering the possibility of pituitary apoplexy, hormone replacement therapy with hydrocortisone (40 mg/day) and levothyroxine (25 mg/day) was initiated without a hormone loading test. Bayaspirin tablets (100 mg/day) and clopidogrel tablets (75 mg/day) were also administered for 2 weeks before the treatment. One month after the beginning of hormone replacement therapy, the aneurysm was treated using a pipeline Flex device (size: 5.0 mm x 16 mm; Medtronic). Immediately after pipeline placement, the flow-diverting effect and good patency of the stent were confirmed [Figures 2a-c]. The patient tolerated the procedure well, without any complications. MRI at 1 week, 9 months, 16 months, and 24 months after endovascular surgery showed that the cerebral aneurysm thrombosed and shrank accordingly [Figures 3a-d]. One week after endovascular surgery, loading tests of the hypothalamic hormones (corticotropin-releasing hormone, thyrotropin-releasing hormone, and luteinizing hormone-releasing hormone) and growth hormone-releasing peptide-2 demonstrated panhypopituitarism. Although complete functional recovery of the pituitary gland was not achieved at 6 months postoperatively, the hormone loading test confirmed functional improvement of the pituitary gland [Figure 4]. The patient was clinically stable but still required hormone replacement therapy (Cortil tablets [15 mg/day], Thyradin-s tablets [25 mg/day], Minirin melt OD tablets [120 mg/day], Duphaston tablets [10 mg/day], and estradiol tape [0.72 mg once a day]).',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 34,\n",
       "    'case_id': 'PMC8093374_01',\n",
       "    'case_text': \"Our patient is a 34-year-old male with history of D-TGA who underwent Mustard operation at 14 months of age. Surveillance monitoring showed stable pulmonary pressures, but slowly decreasing RV ejection fraction (RVEF 55% in 2007 to 42% in 2013) and increasing RV end diastolic volume (RVEDV 221 ml in 2007 to 423 ml in 2013) (Table 1). Cardiac magnetic resonance imaging (MRI) in 2013 showed severely dilated and hypertrophied RV (Figure 1A). In June 2014, the patient was admitted with worsening heart failure. He was hypotensive (blood pressure: 86/57 mmHg), lactate was 2.8 mmol/L. He also had evidence of multiorgan failure requiring inotropic support. Catheterization revealed significantly increased mean pulmonary artery pressure (MPAP) at 52 mmHg and PVR at 5.5 wood units (WU), as well as decreased cardiac index (CI) at 1.7 L/min/m2. Due to the patient's inotrope dependence and prohibitive elevation in PVR (> 4 WU), he underwent implantation of a Heart Ware HVAD  for systemic RV support. He tolerated the procedure very well. VAD flows were titrated with echocardiographic monitoring, RV chamber size decreased from 6.2 cm at low VAD speed [2,740 revolutions per minute (rpms)] to 5.3 cm at high VAD speed (2,780 rpms) (Figures 1B,C). He was successfully discharged on post-operative day 22.\\nB-type natriuretic peptide decreased markedly post VAD implantation. Cardiac MRI could not be repeated due to the presence of the VAD, but chest x-ray showed significant decrease in RV size between post-operative day 1 and 10 months postoperatively (Figures 1D,E). The patient has not had any unplanned hospital readmissions and was able to walk more than one mile daily without symptoms after that. Repeat catheterization in 4 months showed complete normalization of PVR at 1.5 WU, and a CI of 3 L/min/m2. MPAP was 27 mmHg at that time, it continued to decrease to 14 mmHg in 2016.\\nBecause of normalization of pulmonary resistance, he was ultimately listed for cardiac transplantation (UNOS status 1B). A suitable donor was identified in February 2017. He underwent VAD extraction and orthotopic heart transplantation (OHT) at that time. Surgical course was complicated by significant blood loss, requiring multiple units of blood products. Otherwise, he tolerated the transplantation very well. Immune suppression was induced with anti-thymocyte globulin, then transitioned to a regimen consisting of tacrolimus, mycophenolate mofetil, and prednisone. Symptoms continued to improve at 3 years post-transplant (New York Heart Association class I) and the patient's quality of life improved given that he is more active. Myocardial biopsies showed no signs of rejection and prednisone was weaned successfully.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 18,\n",
       "    'case_id': 'PMC9619325_01',\n",
       "    'case_text': \"An 18-year-old female with no significant past medical history presented with a 3-week history of abdominal pain. The patient was a collegiate cheerleader and the pain started suddenly when performing a stunt at cheerleading practice. Immediately after the injury, she was treated conservatively with Meloxicam and rehabilitation with her team's athletic trainer. After the initial assessment and treatment, she was referred to a formal physical therapist to work on her core and hip strength. A rectus abdominus muscle tear was suspected, and an abdominal musculature ultrasound was performed demonstrating a 2.7 x 1.7 x 3.6 cm full-thickness, grade 3 tear of her distal right rectus abdominus muscle (Fig. 1). Up to the time of the ultrasound, the patient continued to practice with the team, however, she had been removed from some stunts that were becoming too difficult for her to perform. After the diagnosis of the tear by ultrasound, the patient decided the pain was too severe to allow her to continue competing as a division 1 athlete and was causing her significant distress. She was counseled that this injury could take several weeks to months to fully resolve and that her pain was to be expected at that time. She ultimately decided to end her cheerleading career because of the injury to focus on her education.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': None,\n",
       "    'case_id': 'PMC6161692_01',\n",
       "    'case_text': 'Our patient with CF (homozygous for DeltaF508 genotype) was diagnosed following newborn screening. He was from a rural Queensland family who lived some distance from tertiary CF services. Despite HRCT evidence of progressive bronchiectasis (see Figures 1, 2), growth and development was excellent (Weight and height 64th centile) with baseline FEV1 3.8 l (93.9%). He had previously cultured Staphylococcus aureus (SA) and PsA (non-mucoid) and had one admission in the previous 12 months, requiring a pulmonary optimization with intravenous Piptazobactam and Tobramycin following a period of wet cough and decline in lung function.\\nHe presented to his family doctor with a 3-month history of a progressively painful swollen right ankle. He was referred to an orthopedic specialist in a near-by provincial center where an MRI identified a suspected tumor in his distal tibia (see Figure 3). A biopsy confirmed the diagnosis to be a malignant fibrous histiocytoma type osteosarcoma. No systemic metastases were detected.',\n",
       "    'gender': 'Male'},\n",
       "   {'age': None,\n",
       "    'case_id': 'PMC6161692_02',\n",
       "    'case_text': 'Treatment was initiated using protocol AOST0331 consisting of two 5-week cycles of neoadjuvant induction chemotherapy of cisplatin, doxorubicin and high dose methotrexate followed by surgery and consolidation therapy consisting of 4 monthly cycles. Our patient was supported with GSCF after each cycle to minimize duration of myelosuppression to ameliorate the risk of neutropenia and transfusion burden. In-view of impending immunosuppression he was commenced on prophylactic cotrimoxazole and voriconazole.',\n",
       "    'gender': 'Male'},\n",
       "   {'age': None,\n",
       "    'case_id': 'PMC6161692_03',\n",
       "    'case_text': 'Two sputum cultures were sent immediately prior to starting chemotherapy, given the patient was asymptomatic he was not commenced on targeted anti-microbial whilst the culture results were awaited. Two days after initiation of chemotherapy he developed wet cough and was productive of green sputum with an associated significant reduction in FEV1 to 2.96 l (69% predicted). Sputum culture grew PsA (non-mucoid) and SA. He was started on twice daily hypertonic saline nebulisers and completed 2 weeks of treatment using intravenous Piptazobactam and Tobramycin.\\nSeven days after commencing chemotherapy repeat sputum was PCR positive for NTM with culture growing Mycobacterium intracellulare and Mycobacterium abscessus subspecies abscessus. Given the risk of disseminated disease in patients who are immunosuppressed he was commenced on a 6-month course of oral azithromycin, ethambutol, and moxifloxacin along with a 1-month course of inhaled amikacin.\\nFour months after diagnosis he underwent distal tibial resection and free fibula flap reconstruction (see Figure 4) which he recovered well from, requiring repeat bone graft to the right tibia 6 months later. Post-surgery consolidation chemotherapy consisted of cisplatin and doxorubicin, which was well-tolerated. Pulmonary function improved during his treatment from baseline (see Figure 5) with FEV1 4.15 l (102.3% predicted) whilst nutritional status remained stable with weight 64.1 kg (62nd centile).',\n",
       "    'gender': 'Male'},\n",
       "   {'age': None,\n",
       "    'case_id': 'PMC6161692_04',\n",
       "    'case_text': 'Twelve months post completion of consolidation chemotherapy and NTM eradication our patient is physically active and is in the process of begin transitioned to adult care. His lung function was reduced with FEV1 3.49 l (81.3% predicted) in the context of a short duration wet cough that was treated with 2 weeks of Tobramycin nebulisers and oral ciprofloxacin. He has normal hepatic function, renal function, audiometry, and echocardiography. There has been no further mycobacterium obtained on repeated sputum culture.',\n",
       "    'gender': 'Male'},\n",
       "   {'age': None,\n",
       "    'case_id': 'PMC6161692_05',\n",
       "    'case_text': 'His treatment was planned conjointly by the oncology and respiratory teams. There was an obvious concern that immunosuppression from chemotherapy in the presence of PsA and NTM might lead to significant pulmonary complications. What might have otherwise been complex decisions were simplified by the knowledge that without best-practice treatment for his sarcoma, eventual death was the expected outcome for our patient. The role of the Respiratory team then became that of supporting the oncology team and monitoring our patient through the planned cycle of treatment and surgery.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 31,\n",
       "    'case_id': 'PMC8574110_01',\n",
       "    'case_text': 'A 31-year-old woman was admitted to the hospital for the treatment of newly diagnosed drug-resistant (pre-extensively drug resistant) pulmonary tuberculosis (chest X-ray at time of diagnosis - Fig. 1). She was treated with second-line antituberculosis drugs: moxifloxacin, kanamycin, cycloserine, prothionamide, para-aminosalicylic acid. After 3 weeks of therapy she developed high fever (> 39 C), lymphadenopathy in the cervical and axillary regions and pruritic maculopapular eruption all over the body (Fig. 2). Hematologic abnormalities such as leukocytosis with eosinophilia (1.81 x 109/l) and monocytosis (1.85 x 109/l) were detected in peripheral blood of the patient. Hepatitis was asymptomatic and detected by the evaluation of liver function: serum aspartate aminotransferase (AST) 1379 IU/l and alanine aminotransferase (ALT) 1221 IU/l; levels of liver enzymes were increased by approximately 30-40-fold above the normal limits. The positive diagnosis of Epstein-Barr infection was based on the onset of increase in the anti-Epstein-Barr immunoglobulin (Ig) G titer (> 200 U/ml), implicating Epstein-Barr virus re-activation. Based on the clinic and laboratory findings diagnosis of DiHS/DRESS was suspected, and all the drugs were discontinued. Symptoms and laboratory abnormalities gradually resolved over 4 weeks without additional treatment.\\nA patch test was performed and analyzed according to the recommendations. The results of the patch test are presented in Table 1 and Figure 3. Treatment was adjusted to ethambutol, kanamycin, cycloserine, pyrazinamide, and linezolid, and no new symptoms were observed.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 47,\n",
       "    'case_id': 'PMC10164996_01',\n",
       "    'case_text': 'A 47-year-old man presented to the emergency department with a two-week history of pain in the right flank and new-onset painless haematuria. His medical history was notable for 30 pack-years of smoking. Physical examination revealed tenderness in the right flank. The results of the complete blood count and metabolic panel were normal. Creatinine and urea nitrogen were 0.87 mg/dl and 4.30 mmol/L, respectively. Urinalysis showed more than 15977 red cells per high-power field and more than 62 white cells per high-power field. The serum carcinoembryonic antigen result was 5.05 nanograms per millilitre (normal range, 0 to 5.0 nanograms per millilitre). A urine culture revealed Streptococcus agalactiae, and the results of urine cytologic testing suggested that the transitional cell carcinoma was arranged in a papillary structure with mild-moderate heterogeneity of cells, and urothelial carcinoma was considered ( Figure 1A ). CTU showed a filling defect in the lower right ureter with right hydronephrosis ( Figures 1B, C , arrow). Preoperative examination of the bladder with a rigid cystoscope was unremarkable. After the treatment options were discussed, the patient chose to undergo 3D totally intracorporeal laparoscopic kidney autotransplantation, bladder cuff excision, and segmental resection of the proximal two-thirds of the ureter based on the concept of membrane dissection.\\nAfter general anaesthesia, a cystoscope was used to examine the bladder, and it showed normal mucosa and no tumour invasion at the bilateral ureteral outlet. The patient was placed in a 70  oblique position on the left side and treated with epirubicin 40 mg bladder irrigation chemotherapy for 30 minutes, and a 10 mm trocar and laparoscopic lens were placed through an incision at the right edge of the rectus abdominis muscle next to the umbilicus. A 12 mm and 5 mm trocar was placed under the costal margin in the midclavicular line and under the glabella, respectively, and a 5 mm trocar was placed at the intersection of the umbilical level and the right anterior axillary line and at the umbilicus and the right anterior superior iliac spine, respectively. The membrane was separated from the right kidney, right ureter, vena cava, and digestive system. The method used for membrane dissection in our study has been previously described in the literature.\\nFirst, the right Toldt\\'s line was incised, and the digestive system was separated along the level between the posterior lobe of the right colonic mesentery and the anterior layer of Gorota\\'s fascia as follows: superiorly to the base of the liver, inferiorly to the iliac vessels, and medially to the left side of the vena cava. Then, the right renal artery and vein were freed as well as the right ureter. The right middle ureter was clamped using a hem-o-lock clip ( Figures 2A, B ), the right ureter-bladder was cuffed and resected, and the cystotomy incision was sutured ( Figure 2C ). Then, the following lymph nodes were cleared sequentially: right hilar lymph nodes, right perirenal fat, paraventricular lymph nodes, right internal and closed foramen lymph nodes, and right external iliac lymph nodes. The right renal artery and vein were fully clamped and disconnected, respectively, and the right vena cava was sutured ( Figures 2D, E ). The right kidney and right ureter were quickly removed through an incision of approximately 7 cm in length in the right iliac fossa. We used a flexible ureteroscope in the intraoperative management of the kidney with the aim of confirming the presence of metastatic tumours in the renal pelvis and ureter. The right kidney and right renal vessels were trimmed under cold ischaemic hypothermia supplemented with small ice cubes, and a ureteral stent was placed in the right ureter. The right internal iliac vein was clamped at both ends by bulldog clips, and the right vein was reconstructed end-to-end with the right internal iliac vein ( Figure 2F ). Similarly, the right artery was reconstructed end-to-end with the right internal iliac artery ( Figure 2G ). Then, the right ureter was reconstructed end-to-end with the right posterior wall of the bladder ( Figure 2H ), and finally, the right internal iliac vein and arterial hobgoblin were released to restore blood flow to the right kidney, which was rich in vitality ( Figure 2I ). The right perirenal and pelvic drains were left in place, and each incision was sutured. The patient\\'s operative time was 534 minutes, and the estimated intraoperative blood loss was 100 ml. The patient was discharged from the hospital on the 8th day after surgery.\\nFinal pathological analysis revealed high-grade papillary ureteric carcinoma, with negative surgical margins, no invasion of the vasculature and nerves, and no metastasis in the lymph nodes (including right renal hilar, inferior vena cava parietal, right external iliac, right internal iliac, and closed hole). The pathological stage of the tumour was pT2N0Mx. The patient was discharged from the hospital and instructed to take oral aspirin for anticoagulation therapy, and on the 5th day, painless haematuria appeared. Then, we performed \"transurethral cystoscopy\", and no significant bleeding was found in the bladder intraoperatively. We considered bleeding from the right uretero-vesical anastomosis due to postoperative oral aspirin. A regimen of 3 courses of gemcitabine 1.7 g in combination with cisplatin 120 mg chemotherapy was initiated on 23 January, 2022. The glomerular filtration rate (GFR) is a parameter representing kidney function. The GFR of the patient\\'s transplanted kidney was 48.6 ml/min at 4 months after surgery.\\nOn 18 April, 2022, the CTU examination was repeated and showed a right ascending colon tumour with a size of approximately 5*4 cm, so laparoscopic radical surgery was performed for a right hemicolectomy. The postoperative pathology suggested intermediately differentiated adenocarcinoma of the ascending colon, and the patient\\'s postoperative genetic test results suggested microsatellite instability (MSI) status of high microsatellite instability (MSI-H), and the immunohistochemistry (IHC) results showed mismatch repair deficiency (dMMR), indicating a diagnosis of Lynch syndrome (LS). Immunotherapy with 120 mg of BCG bladder instillation was started on 12 May, 2022. One year after the procedure, renal function was normal, with a creatinine level of 0.93 mg/dl. The patient was in good health and showed no sign of haematuria. Surveillance cystoscopy and CTU examination showed no evidence of disease recurrence ( Figures 3A, B ). The postoperative cosmetic results were satisfactory ( Figure 3C ), and the patient is still undergoing close follow-up ( Figure 4 ).',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 80,\n",
       "    'case_id': 'PMC4204450_01',\n",
       "    'case_text': 'All patients underwent IMRT followed by SBRT boost. Figures 1 and 2 show representative cumulative dose distribution and dose volume histograms (DVHs) of critical structures for an 80-year-old patient with SCC histology who underwent definitive RT with concurrent cetuximab for a Stage T4bN2b squamous cell carcinoma of the parotid. The median IMRT dose was 64.8 Gy (range 50-75.6) given in 1.8 Gy fractions in the majority of cases except one (patient no. 6), who received 2 Gy fractions. The median SBRT boost dosage per fraction was 4.5 Gy (range 2-7 Gy) given in a median of five fractions (range 3-6 fractions) for a total SBRT boost dose of 17.5 Gy (range 10-30 Gy) and a total median cumulative dose of 81.2 Gy (range 73.2-95.6 Gy). The median cumulative BED10 was 97.25 Gy (range 88.10-117.20 Gy) and the median cumulative BED3 was 143.8 Gy (range 120.5-167.6 Gy). The median interval between IMRT and initiation of SBRT boost was 1 week (range 0-2 weeks). The majority of the patients received concurrent chemotherapy with their radiation (Table 1). Carboplatin was the most administered chemotherapy, although cisplatin was used in one patient and Cetuximab in another.\\nA summary of survival outcomes is shown in Table 2 and Figure 3. At a median follow-up of 29 months (range 12-120 months) for all patients and 43 months for surviving patients (range 12-120 months), actuarial LRC, distant control (DC), PFS, and OS were 88, 81, 68, and 79%, respectively (Table 2, Figure 2). Median values were not reached for any of the survival outcomes. Only one patient (no. 8 in Table 1) failed locally 15 months after the end of his radiation. He enrolled in phase I targeted biologic trials with local progression of his disease and died 8 months later. Two patients (no. 9 and 10 in Table 1) developed distant metastases. One died of disease progression and the other continues to receive palliative radiation therapy and systemic chemotherapy/biologics.\\nAcute toxicities included mucositis, dysguesia, skin toxicity, and odynophagia. Generally, the acute symptoms were managed with palliative treatments such as skin creams, mouth wash, narcotics, and nutritional support. There were no grade IV or V toxicities or unexpected acute toxicities. None of the patient required feeding tube placement, and there were no treatment related deaths. Long-term toxicity included hypothyroidism in two patients (no. 1 and 3 in Table 1), sensorineural hearing loss on the affected side in four patients (no. 2, 3, 5, and 6 in Table 1), overnight xerostomia in three patients (no. 3, 4, and 5 in Table 1), and fibrosis in six patients (no. 3, 4, 5, 7, 8, and 9 in Table 1), which was managed with physical therapy in all patients. One patient developed osteoradionecrosis (no. 4 in Table 1), which was managed with hyperbaric oxygen and surgical reconstruction. One patient (no. 3 in Table 1) developed graft ulceration that was surgically reconstructed. Both remain without evidence of disease at their last follow-up. There were no patients with facial nerve injuries.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 45,\n",
       "    'case_id': 'PMC7363694_01',\n",
       "    'case_text': 'A 45-Year-old male presented to the Emergency Department following a syncopal episode whilst being at the wheel of a vehicle involved in a road traffic collision. He was driving and accompanied with his partner in the passenger seat, when suddenly started to violently cough after inhaling cigarette smoke. He subsequently lost consciousness at speeds of 30mph causing the vehicle to skid into metal railings. He and his partner escaped from the incident unhurt. Although a long-term smoker with no history of a chronic cough, this was his first episode of paroxysmal violent coughing after inhaling cigarette smoke.\\nHis medical history includes many years of wheezing and persistent breathlessness which was investigated and diagnosed six years ago by his General Practioner as Chronic Obstructive Pulmonary Disease. He admits that he has been non-compliant with his prescribed inhaler therapy. Clinically he remained well and there was no evidence of head, neck, hard or soft tissue injuries. His observations, laboratory investigations and Electrocardiogram (ECG) were all within normal limits. The implications of this event on his day to day life became apparent when he was informed of the Driving Vehicle Licensing Agency (DVLA) requirements to notify the incident together with a driving ban for 6 months.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 10,\n",
       "    'case_id': 'PMC3607913_01',\n",
       "    'case_text': \"The patient first developed tics when he was 10 years old. The first tic consisted of brief movements of his head to the left. The tics evolved to include sniffing, throat clearing, and blinking. The patient also developed significant attentional disturbances and subsequent difficulties in school. At the age of 12 years, he was diagnosed with Tourette's syndrome. Multiple medications were tried. Typically, his tics would initially respond well to the various medication trials, but he would always relapse within 5-6 weeks. His medication history includes guanfacine (1 mg twice a day), clonidine patch (0.1 mg patch daily), clonazepam (up to 1 mg at bedtime), risperidone (up to 0.5 mg three times a day), propranolol (up to 10 mg three times a day), and levetiracetam (up to 750 mg twice a day) for tics, as well as atomoxetine (up to 60 mg) for attentional deficits. From the ages of 12 to 18 years, he did very poorly in school, which was likely due to a combination of attention deficit disorder and the sedating side effects of his various medications. He had very mild compulsive tendencies, such as excessive counting, but this did not interfere with functioning. Towards the end of high school, he weaned himself off all his medications as none were particularly effective, and currently he is not taking any medications.\\nDuring high school, the neck-turning tic began to be pervasive. He discovered that if he applied gentle pressure to anywhere along his head circumference, the tics, and the accompanying urge to perform them, would be completely quelled. Touching his lower face was also effective, although less so. His sensory tricks included resting the back of his head against a wall, resting his chin on his hand, and wearing a bandana or hat. Unfortunately, his school did not allow headgear and this limited his ability to control his neck tic. Now that he is at university, he wears a baseball cap every day with much success in tic control. His other tics, such as sniffing and blinking, which are significantly less bothersome than his neck tics, are not responsive to sensory tricks. Video 1 demonstrates this phenomenon.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 73,\n",
       "    'case_id': 'PMC5457932_01',\n",
       "    'case_text': 'A 73-year-old man with disturbance of consciousness, headache and high fever was admitted to the cardiology department of our hospital, and was transferred to the neurological department on day 4. Significant past medical history included an episode of pneumonia 4 months prior and meningitis 2 months prior to this admission. Pneumonia resolved with 7 days of levofloxacin (LVFX), and meropenem (MPEM) was administered for meningitis for 14 days. In both instances, no etiology was detected. The patient was addicted to alcohol, consuming approximately 150 mL of ethanol each day. Physical examination on admission revealed high fever of 38.5C and arrhythmia. Neurological examination identified nuchal rigidity and mild disorientation, but no paresis or numbness. The patient was severely emaciated (height, 163 cm; weight, 43 kg). Although activities of daily life had been sufficient for independence before admission, he was unable to walk without assistance due to severe emaciation; a wheelchair was required for mobility.\\nPeripheral blood analysis on day 4 revealed mild pancytopenia (white blood cell count, 6,200 /muL; neutrophil count, 5,208 /muL; lymphocyte count, 682 /muL; hemoglobin, 10.2 g/dL; platelets, 88,000 /muL); and CRP, 1.44 mg/dL, representing a mild increase. The CD4 T-cell count was 23 /muL, but negative results were obtained for human immunodeficiency virus (HIV) antibody and polymerase chain reaction for HIV. Serum testing for beta-D-glucan, Aspergillus antigen and cryptococcal antigen were all negative. Tests to detect soluble interleukin 2 receptor, myeloperoxidase anti-neutrophil cytoplasmic antibody, proteinase 3 anti-neutrophil cytoplasmic antibody, and antinuclear antibody markers for collagen disease were also all negative. The first cerebrospinal fluid (CSF) analysis, on day 4, revealed: cell count, 1,244 /muL (polymorphonuclear cells, 90%; monomorphonuclear cells, 10%); protein, 273 mg/dL; and glucose, 47 mg/dL (simultaneous blood glucose, 135 mg/dL) (Table 1 and Fig. 1). Gram staining and smear for acid-fast bacilli yielded negative results. Adenosine deaminase and cryptoccocal antigen were likewise negative. Although CSF cultures were incubated for 2 weeks for bacteria and 8 weeks for mycobacteria, both appeared to yield negative results. At the same time, two sets of blood cultures were ordered and incubated for 4 weeks, and were still negative. Computed tomography (CT) of the head on admission showed a low-density area in the left uncal region and parietal cortex (figure not shown).\\nOn magnetic resonance imaging (MRI) performed on day 14, diffusion-weighted imaging (DWI) revealed a high-intensity spot in the posterior horn of the left lateral ventricle of the brain (Fig. 2A), implying ventriculitis. However, this region appeared iso-intense on apparent diffusion coefficient (ADC) mapping (Fig. 2B). DWI also showed a high-intensity lesion with ADC iso-intensity in the left parietal cortex, judged as representing some kind of inactive lesion (figure not shown). On fluid-attenuated inversion recovery (FLAIR) imaging, a high-intensity lesion was detected in the white matter adjacent to the posterior horn of the left lateral ventricle (Fig. 2C). The parietal cortex lesion was also signal hyperintense on FLAIR (figure not shown). Pneumonia was not detected on chest roentgenography or CT (figure not shown).\\nOn day 4, bacterial meningitis was suspected and treatment with vancomycin (VCM), ceftriaxone (CTRX) and piperacillin (PIPC) was initiated (Fig. 1). Rifampicin (RFP), isoniazid (INH) and ethambutol (EB) were concomitantly administered for possible tuberculous meningitis. On day 10, a second analysis of CSF revealed non-significant changes compared with the first analysis: cell count, 802 /muL (polymorphonuclear cells, 90%; monomorphonuclear cells, 10%); protein, 196 mg/dL; and glucose, 34 mg/dL (simultaneous blood glucose, not determined) (Table 1). High fever had not resolved (Fig. 1). Because fungal meningitis was not able to be ruled out, liposomal amphotericin-B (L-AMB) was started. The regimen of VCM, CTRX, and PIPC regimen was switched to panipenem/betamipron (PAMP/BP) and minocycline (MINO). RFP, INH and EB were terminated due to low adenosine deaminase levels in the first CSF analysis. Although negative results were obtained for the CSF culture for fungi, fever resolved several days after beginning L-AMB (Fig. 1) and findings from the third CSF analysis on day 18 had improved: cell count, 128 /muL (polymorphonuclear cells, 83%; monomorphonuclear cells, 17%); protein, 117 mg/dL; and glucose, 38 mg/dL (simultaneous blood glucose, not determined) (Table 1, Fig. 1). Due to bone marrow suppression, L-AMB (100 mg once a day) was terminated on day 21.\\nFindings from the fourth CSF analysis, on day 29, showed further improvement: cell count, 40 /muL (polymorphonuclear cells, 65%; monomorphonuclear cells, 17%); protein, 152 mg/dL; and glucose, 41 mg/dL (simultaneous blood glucose, 101 mg/dL) (Table 1 and Fig. 1).\\nThese improvements in CSF findings suggested that an undetected fungi was the causative microorganism and that L-AMB had been effective. Fever of 37-38C reappeared around day 35 (Fig. 1), and oral fluconazole (FCZ) was started on day 36. MINO and PAPM were continued until days 28 and 35, respectively. Fever did not resolve and loxoprofen was started on day 46. Fever reduced initially, but relapsed at 37-38C around day 60. A fifth CSF analysis on day 50 revealed worsened findings: cell count, 1,311 /muL (polymorphonuclear cells, 85%; monomorphonuclear cells, 15%); protein, 732 mg/dL; and glucose, 44 mg/dL (simultaneous blood glucose, not determined) (Table 1 and Fig. 1). DWI on days 50 and 71 revealed exacerbation of the ventriculitis (Fig. 2D and G) and partial ADC hypointensity (Fig. 2E and H). Spread of a hyperintense region was evident in the white matter adjacent to both lateral ventricles on FLAIR imaging (Fig. 2F and I). The area of high intensity may have represented brain edema due to ventriculitis. Direct paracentesis of the ventricle was considered, but the family of the patient declined to consent. Although CSF and MRI findings worsened, we persisted in suspecting fungal infection and continued with FCZ.\\nDisturbance of consciousness slowly worsened (Fig. 1), and aphasia and left hemispatial neglect gradually appeared around day 60. MRI on day 71 showed the ventriculitis and hyperintense lesion in the white matter adjacent to both lateral ventricles on FLAIR imaging had become more severe (Fig. 2D-F). Neither swelling of the brain nor encephalocele was seen. On days 71 and 84, pneumonia complicated the hospital course, resulting in administration of CTM for 9 days and MEPM for 11 days, respectively (Fig. 1). In both episodes of pneumonia, no causative bacteria were detected. Although the sixth CSF analysis on day 80 revealed improvements in cell count (268 /muL; polymorphonuclear cells, 86%; monomorphonuclear cells, 14%), no improvements were seen in protein (753 mg/dL) or glucose (34 mg/dL; simultaneous blood glucose, 104 mg/dL) (Table 1 and Fig. 1). FCZ was continued because of improvements in cell counts. The general condition of the patient did not improve and he died on day 99 due to transtentorial hernia, as confirmed on head CT (figures not shown). The transtentorial hernia was attributed to brain edema ventriculitis and meningitis. Repeated cultures of CSF and blood until death had consistently yielded negative results for bacteria, fungi and mycobacteria.\\nAutopsy was performed 2 hours after death. On opening the cranium, yellowish pus flowed from the left ventricle (Fig. 3A). This pus was not malodorous, and Gram staining revealed a delicate, branching, filamentous organism (Fig. 3B). Although acid-fast staining was not performed, the organism was determined to be a Nocardia species from the colony appearance, and was identified as N. araoensis by 16s rRNA gene sequencing. Pus was observed throughout the basal cistern and pontomedullary cistern (Fig. 3C). In formalin-fixed sections of brain, both lateral ventricles were filled with pus (Fig. 3D) and some small abscesses that had remained undetectable on MRI were seen in the cerebral white matter (Fig. 3E). No infectious lesions were identified in other organs, including the lungs and skin. No evidence of pancytopenia, such as hematological disease or liver cirrhosis, was found. Minimal inhibitory concentration (MIC) testing showed that only doxycycline (DOXY), ciprofloxacin (CPFX) and MINO seemed ineffective (Table 2). The final diagnosis was meningitis, ventriculitis and brain abscess due to N. araoensis.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 39,\n",
       "    'case_id': 'PMC3662738_01',\n",
       "    'case_text': \"A 39-year-old woman, gravida 4 para 2022, presented to the gynecologic oncology clinic complaining of persistent vaginal spotting for the prior 5 months. She had a cesarean delivery 3 months before the onset of symptoms. Three months before her presentation, the patient resumed normal menses, which was associated with persistent spotting. She denied abdominal or vaginal pain, dyspareunia, fever, nausea, vomiting, or vaginal discharge. During these months, she also complained of progressive fatigue and exercise-induced shortness of breath.\\nHer obstetric history was significant for 2 cesarean deliveries, the first in 2006 and the last 3 months before the onset of her symptoms. The indication for both surgeries was failure to progress. During the last cesarean delivery, the obstetrician reported that the subcutaneous tissue was very thin but densely adherent to the fascia, with significant scarring. Also, the bladder was densely adhered to the uterus. The uterine incision was low transverse, just above the lower uterine segment. Uterine closure was performed in 3 layers. The postoperative period was uncomplicated. The patient had a laparoscopic ovarian cystectomy in 2008. Her last Pap smear, 6 months earlier, had normal findings.\\nHer past medical history was positive for iron deficiency anemia and migraine headaches. She reported being allergic to nabumetone. She was taking 325 mg of ferrous sulfate twice per day.\\nOn physical examination, the patient had stable vital signs. Her weight was 63.9 kg, height was 1.7 m, and body mass index was 22.1. The pelvic examination revealed normal external female genitalia and some dark blood in the vagina vault, but no visible cervical or vaginal lesions. The uterus was mobile without any masses or nodularity.\\nAs part of the patient's work-up, a magnetic resonance imaging (MRI) scan and an ultrasonogram were obtained and showed dehiscence at the lower uterine segment, with a collection of blood in the area of the dehiscence and hematocolpos (Figure 1). These findings led to the diagnosis of abnormal uterine bleeding secondary to uterine scar dehiscence. Treatment options with associated risks and benefits were discussed with the patient, and she opted for a da Vinci-assisted laparoscopic repair of the lesion.\\nAfter general anesthesia, the patient was placed in a low lithotomy position, and an 8-mm skin incision was made in the umbilical area. A pneumoperitoneum was created, and three 5-mm incisions were made:2 pediatric da Vinci ports and 1 assistant port were placed. The uterus was densely adhered to the abdominal wall, so adhesiolysis was performed using sharp dissection and electrocautery. The bladder flap was developed using sharp dissection, mobilizing the bladder from the lower uterine segment. The defect in the lower uterine segment was identified. At this point, hysteroscopy was initiated, and the hysteroscopic view showed an approximately 3-cm defect in the lower uterine segment and a thin scarlike membrane covering it; however, during the hysteroscopy, the laparoscopic view showed a bulging lower uterine segment (Figure 2). The intrauterine cavity appeared to be normal. A uterine incision was made using electrocautery and the blood was removed. The edges of the defect were freshened using unipolar electrocautery. The uterus was closed using 0-Vicryl sutures in 2 layers. The sutures were inspected hysteroscopically. After copious irrigation and evacuating the pneumoperitoneum, the trocars were removed and the skin was closed using 4-0 Caprosyn sutures. Blood loss was <50 mL. The patient was discharged home on postoperative day 1.\\nThree months later, she had her first follow-up examination and was asymptomatic. She had spotting for about 2 weeks after surgery but has since had no problems. Menses were adequate with no intermenstrual spotting.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 50,\n",
       "    'case_id': 'PMC7229232_01',\n",
       "    'case_text': 'A 50-year-old male was referred to the emergency department by his dentist with a perimandibular swelling. In the physical examination there was an indolent, fluid-filled swelling intraorally in the left mandible region with signs of infection. In his medical history an adenocarcinoma of the lung (pT3 pN2b L1 V1 Pn1 R1 M0) was treated operatively with the resection of the right superior lobe and radiotherapy 16 months ago. The patient is a former smoker, not taking regular medication. The common radiological diagnostics, including computed tomography (CT), showed a mandible fracture (Fig. 1) and abnormal perimandibular soft tissue as well as accentuated cervical lymph nodes (level IIa, left). Immunohistochemical analyses of a subsequent intraoral biopsy of the mandible identified a metastasis of the primary adenocarcinoma of the lung (strong expression of cytokeratin 7 (CK7) and thyroid transcription factor 1 (TTF-1)). Using a positron emission tomography-computed tomography (PET-CT) further peripheral metastases could be excluded (Fig. 2). The interdisciplinary tumor board recommended a tumor resection and neck dissection. After a left hemimandibulectomy and left sided-selective functional neck dissection (level I-III) a CAD/CAM microvascular fibula transplant was used for reconstruction. The postoperative histopathological analysis revealed lymph node metastases in levels Ia, Ib and IIa. Postoperatively, the patient received adjuvant chemotherapy with carboplatin and pemetrexed.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 74,\n",
       "    'case_id': 'PMC5498208_01',\n",
       "    'case_text': \"A 74-year-old woman was referred to our hospital due to steroid-resistant bilateral uveitis persisting for more than 3 years. The patient had no significant medical history and was seronegative for human immunodeficiency virus (HIV). She had undergone vitrectomy of the right eye that was negative for malignant cells. DNA extracted from the vitreous fluid was negative for immunoglobulin heavy locus (IgH) rearrangements, as determined by polymerase chain reaction (PCR). The levels of interleukin (IL)-10 and IL-6 in the vitreous fluid were 51 pg/mL and 712 pg/mL, respectively. The IL-10/IL-6 ratio was <1.0, which was atypical for a diagnosis of vitreoretinal lymphoma.\\nOn admission to our hospital, the visual acuity of the right eye was almost lost. The fundoscopic image of the left eye obtained on admission is shown in Fig. 1A. An analysis after diagnostic pars plana vitrectomy of the left eye did not detect any malignant cells. DNA extracted from the vitreous fluid was negative for both IgH and T-cell receptor (TCR) rearrangements, as determined by PCR. These findings did not support that the uveitis occurred because of lymphoma. The concentrations of IL-10 and IL-6 were 53 pg/mL and 430 pg/mL, respectively. The ratio of IL10/IL6 of the left vitreous fluid was <1.0, similar to that in the right vitreous fluid, as indicated above. Screening for infectious diseases by quantitative multiplex PCR of the vitreous fluid DNA was performed for the detection of herpes simplex virus types 1 and 2, varicella-zoster virus, EBV, cytomegalovirus, human herpes viruses 6-8, Toxoplasma gondii, bacterial 16S, fungal 18S/28S, and mycobacterium tuberculosis, according to our previously described method. The PCR results were negative for all tested pathogens, except for EBV DNA, which was detected at 5.47x105 copies/mL. Her anti-EBV antibody titers were 1:80 for anti-viral capsid antigen (VCA)-IgG and 1:10 for anti-EB nuclear antigen (EBNA). Anti-VCA-IgM antibody was undetectable. An otolaryngological examination was negative for nasal lymphoma. EBV DNA was negative in the peripheral blood, and a systemic examination including the nasal cavity with 2-Deoxy-2-[18F] fluoro-D-glucose positron emission tomography (PET)/CT (FDG-PET/CT) did not detect any lesions. We could not determine the diagnosis of lymphoma and injected subtenon triamcinolone acetonide into the left ocular lesion. However, this failed to improve her symptoms. In order to preserve her visual acuity, 400 mug methotrexate (MTX) weekly for 6 weeks, based on the treatment protocol for vitreoretinal lymphoma, was administered into the left vitreous following the approval of the Institutional Review Board. The treatment resulted in a dramatic improvement, and the patient achieved complete response (CR; Fig. 1B).\\nHowever, two years after the MTX treatment and four years after the onset of symptoms, the uveitis of the right eye rapidly progressed. Because of severe ocular pain and loss of visual acuity that was considered irreversible, the patient underwent enucleation of the right eye. A pathological examination revealed massive necrosis and the absence of lymphoma cells (data not sown). While the symptoms were resolved, the patient subsequently underwent both an ophthalmological examination and magnetic resonance imaging (MRI) for the head and neck.\\nTwo years and two months after enucleation, multiple hyperintense lesions were detected on T2-weighted fluid-attenuated inversion recovery (FLAIR) imaging MRI in the right occipital and parietal lobes and the precentral gyrus, and a left visual field defect was detected on an ophthalmological evaluation (Fig. 2). The tumor was suspected to be high-grade glioma and was removed by craniotomy; however, the pathological diagnosis was ENKL. As shown in Fig. 3, the infiltrating cells in the pathological specimen were positive for CD3, CD56, and TIA1. The tumor cells were positive for EBV. EBV DNA was negative in the peripheral blood. The DNA extracted from the right vitreous and brain lesions was amplified for the sequence analysis of LMP1, an EBV gene, to determine homology. The forward and reverse primers were 5'-GCT GTC GAC GCC ACC ATG GAA CAC GAC CTT GAG AGG-3' and 5'-GCT GGA TCC TTA GTC ATA GTA GCT TAG CTG AAC-3', respectively, and their nucleotide positions in EBV variant B95.8 (Genbank No. V01555) were 169474-169454 and 168160-168183, respectively. This lesion had sequence variations in each EBV. The conditions for the PCR reactions were as follows: 94 C for 2 minutes, 98 C for 10 seconds, 62 C for 30 seconds, and 68 C for 90 seconds for 40 cycles. The LMP1 sequence was confirmed after TA cloning with PCR products. As shown in Fig. 4, the repeat regions of LMP1 detected in the vitreous and brain lesion were identical. Based on the clinical, pathological, and genetic findings, the CNS lesion was confirmed to be closely associated with and most likely originated from the uveitis. The patient was treated with intravenous high-dose MTX at 3.5 g/m2, administered 3 times, and has since maintained CR for 24 months without recurrence.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 3,\n",
       "    'case_id': 'PMC5485299_01',\n",
       "    'case_text': \"A 3-year-old male presented with a left-sided headache localized over the occipital bone, with progressive torticollis over the last year, as well as vomiting and ataxia over the last week. Examination of the patient was unremarkable with the exception of bilateral lower limb weakness. Computed tomography (CT) without contrast showed a large lobulated heterogeneous hyperdense lesion in the left posterior fossa. The lesion exerted a mass effect compressing the 4th ventricle and brainstem structures, with supratentorial triventricular hydrocephalus (Figure 1) accompanied by permeative bone reaction in the left occipital bone (Figure 2).\\nMagnetic resonance imaging (MRI) of the brain showed evidence of an infratentorial posterior fossa extra-axial mass that appeared to be dural. There was invasion of the marrow space of the left occipital bone (Figure 3(a)). In addition, heterogeneous signal intensity in T2-weighted images with multiple areas of central higher signal intensities representing necrosis was observed (Figure 3(b)). MRI with contrast enhancement showed the mass invading the inner skull table and intradiploic space (Figure 4).\\nDue to the primary malignancy, there was a significant mass effect over the left cerebellar hemisphere. The plane of cleavage between the tumor and the cerebellum was lost, indicating invasion. Furthermore, the tumor was noted to protrude through the foramen magnum, causing compression and displacement over the brainstem, especially over the upper medulla. Additional diagnostic testing with blood and imaging were found to be normal. The patient's tumor had destroyed the involved occipital bone, with minimal invasion of the dura and obvious calcification.\\nThe patient underwent a left parietooccipital craniotomy for tumor resection, with samples collected for histopathological evaluation. The gross specimen had a size of 5 x 4 x 2 cm3, grey color, irregular, firm consistency, without obvious necrosis or hemorrhage, and confirmed cerebellar invasion. From histopathology, the tumor sheets showed a compactly arranged round cell tumor with cells having clear cytoplasm. Small spicules of bone were also seen in the tumor tissue, suggestive of occipital bone destruction. It was noted that the cells were large with irregular nuclear membranes and prominent nucleoli. The pleomorphic cells with few pseudorosettes were positive for EWS-FLI1 translocation in 98% of the cells. On immunohistochemistry, cells were immunoreactive for surface antigen CD99/MIC2 and positive for neuron-specific enolase and Leu 7.\\nPostoperative CT confirmed total tumor resection. The patient then received adjuvant chemotherapy with focal radiation. The patient was given vincristine, doxorubicin, and cyclophosphamide followed by ifosfamide and etoposide plus radiation to the left cerebellopontine angle. After three cycles of chemotherapy, a subsequent MRI showed marginal response. The patient was then switched to another chemotherapy regimen consisting of vincristine, temozolomide, and irinotecan. The patient was lost to follow-up examination for eight-month duration after confirmation of remission. The patient then presented with severe constant lower back pain and urinary incontinence during the day. A whole-spine MRI showed intraspinal enhancing lesions representing cerebrospinal fluid (CSF) seeding, extending from the level L5-S4 (Figure 5). Palliative treatment including spinal radiation and ICE (ifosfamide, carboplatin, and etoposide) chemotherapy protocol was administered. The patient has been followed for six months to date, with disease stability from the palliative treatment.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 30,\n",
       "    'case_id': 'PMC5569634_01',\n",
       "    'case_text': \"A 30-year-old Caucasian female presented to the emergency department with complaints of increasing lethargy and fatigue over the course of several weeks, along with a one-day history of shortness of breath, hematemesis, and palpitations. Past medical history was significant for HIV, anemia, and septoplasty. She was intubated on admission for airway protection due to concern for impending respiratory failure. On exam she was found to be febrile with Tmax of 39.9C, heart rate of 122 beats per minute, respiratory rate of 30 breaths per minute, and blood pressure of 91/57 mmHg, saturating at 97% on 35% FiO2. Complete blood count revealed white blood cells of 3 x 103 cells/mL with 73% segs and 15% bands, hemoglobin of 4.5 g/dL, hematocrit of 17.7%, and platelets of 4,000 cells/mL. Ferritin was significantly elevated at 19,406 ng/mL and triglycerides were 412 mg/dL. HIV viral load was 1,842,730 copies/mL and CD4 count was 4 cells/mL. Physical exam revealed hepatosplenomegaly which was confirmed by abdominal ultrasound. The patient was diagnosed with HLH based on meeting the required five of eight criteria set forth in HLH-2004 guidelines (fever > 38.5C, splenomegaly, bicytopenia with hemoglobin < 9 g/dL and platelets < 100,000 cells/mL, triglycerides > 265 mg/dL, and ferritin > 500 ng/mL). The other three criteria (NK cell activity, CD25 level, and pathological evidence of hemophagocytosis) were not evaluated due to unavailability of labs and thrombocytopenia precluding bone marrow biopsy.\\nThe patient was placed on empirical antibiotics (levofloxacin and vancomycin) for sepsis while investigation for infectious source was conducted. She was also started on methylprednisolone for respiratory failure at admission, which was continued for three days. Blood and urine cultures were negative. Sputum culture grew normal flora. Tests were negative for Pneumocystis jirovecii, acid fast bacilli, cytomegalovirus, parvovirus, Epstein-Barr virus, cryptococcus, histoplasmosis, syphilis, and influenza A. The only positive finding was antibody for influenza B, which was attributed to a mild upper respiratory infection that had resolved on its own with supportive measures two weeks prior to admission.\\nDespite aggressive transfusions, significant anemia and thrombocytopenia persisted. At this point, the most likely trigger of the HLH was determined to be an uncontrolled HIV infection. Given the patient's clinical instability and unresponsiveness to supportive treatment, ART was empirically initiated with tenofovir/emtricitabine, darunavir, and ritonavir. Within one week of initiation of ART, the patient improved clinically and was able to be extubated, and her laboratory parameters began to normalize (Figure 1). By the time the patient was discharged three weeks after ART initiation, hemoglobin had risen to 10.5 g/dL and platelets to 169,000 cells/mL.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 40,\n",
       "    'case_id': 'PMC7265835_01',\n",
       "    'case_text': 'A 40-year-old woman, married, working as a school housekeeper, presented to the emergency department with a one-day history of abdominal pain. This pain started as a vague, mild generalized pain, then localized to the right iliac fossa and became severe and constant. She denied any change in her bowel motions. It was associated with nausea and recurrent episodes of nonprojectile food content vomiting for 3 days.\\nShe had a febrile sensation, has not been recorded, and a lack of appetite for the last 3 days, but there was no history of nasal congestion, runny nose, sore throat, cough, or chest pain. The patient did not report any contact with sick patients or recent travel to epidemic areas. The patient was previously healthy with no history of chronic medical conditions of relevance. She was afebrile and vitally stable. She had a peripheral oxygen saturation (SpO2) of 100 % on ambient air, a respiratory rate (RR) 17 breath per minute, a heart rate (HR) 72 beats per minute, and blood pressure 123/85 mmHg. The abdomen was not distended and soft, but there was tenderness and rebound tenderness at the right iliac fossa. There was no organomegaly. The examination of the chest and the other systems were normal. Her routine blood examination showed leukopenia with WBC 3000/muL, lymphopenia 800/muL, a microcytic hypochromic anemia with hemoglobin 9.6 g/dl (normal range 12-15), a mean corpuscular volume (MCV) 62.6 fl (normal range 83-101), and platelet level was normal.\\nKidney and liver functions were normal, C-reactive protein 14.4 mg/l (normal range 0-5), and procalcitonin was normal. Pregnancy test was negative. Chest x ray was completely normal initially and after 3 days (Fig. 1).\\nBased on the history, physical examination and laboratory results, Alvarado score assessment for acute appendicitis was done (5/10) which supported the diagnosis of appendicitis. CT abdomen was ordered to rule out acute appendicitis. The image revealed that the appendix is normal, but there are bilateral patchy peripheral lung basal consolidations and ground-glass attenuations (Figs. 2 and 3 ). Given the current pandemic of COVID-19, the CT scan findings suggested the possibility of COVID-19. Therefore, nasal and throat swabs from the patients were tested for COVID-19. The results of the reverse transcription polymerase chain reaction (RT-PCR) came back positive for SARS-CoV-2.\\nShe was admitted to communicable diseases center (CDC) under airborne isolation and started on a COVID-19 pneumonia treatment local protocol; azithromycin 500 mg IV daily for 10 days, ceftriaxone 2 g IV daily for 10 days, oseltamivir 150 mg q 12 h for 10 days and darunavir/cobicistat (800/150 mg) for 14 days. She has improved and her symptoms have resolved. The CT chest (image 4 and 5) was repeated after 2 weeks of management to confirm the improvement and it showed almost complete resolution of the previously noted patchy lower lung zones consolidation and ground glass opacities without obvious residual significant ground glass opacity or consolidation could currently be appreciated, however, minimal dependent possible congestive changes still noticed. PCR test was repeated after 2 weeks and still positive (Figs. 4 and 5 ).',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 56,\n",
       "    'case_id': 'PMC5396431_01',\n",
       "    'case_text': 'A 56-year-old female with a history of pulmonary embolism, myotonic dystrophy, and complete heart block on pacemaker presented to the emergency department (ED) with sudden onset shortness of breath and substernal chest pain radiating to the back. There was no history of fever, chills, cough, sore throat, or chest trauma. Her history was negative for any gastrointestinal, musculoskeletal, or neurological symptoms. She was taking rivaroxaban 20 mg once daily for deep vein thrombosis of the left axillary vein diagnosed 7 weeks ago. There was no prior history of tuberculosis, chest irradiation, or chemotherapy. She had a history of pulmonary embolism in 2007 for which she was on coumadin for a year. She had a biventricular pacemaker placed in 2008 for complete heart block induced nonischemic cardiomyopathy. Complete heart block was diagnosed at the same time and was believed to be secondary to myotonic dystrophy. The pacemaker device reached elective replacement indicator and was replaced with a Medtronic Protecta D314TRG device in 3/2012. She was on Tylenol 500 mg as needed for back pain, levocetirizine 5 mg twice daily for seasonal allergies, and rivaroxaban and zolpidem 5 mg nightly as needed. The above-listed medications do not have p-glycoprotein altering activity or CYP3A4/5 or CYP2J2 inhibiting activity. The past surgical history and family history were unremarkable.\\nIn the ED, her blood pressure was 78/48 mm Hg, pulse 106/minute, temperature 36.5 F, and respiratory rate 18/min with saturation of 87%. Her height and weight were 1.7 m and 180 lbs, respectively. Cardiac examination was normal. Chest examination was significant for bibasilar rales. Electrocardiogram revealed ventricular paced rhythm. There was no associated electrical alternans. Lab tests revealed negative troponin, INR of 1.3, and PTT of 28 s. Complete blood count and basic metabolic profile were unremarkable. Computed tomography (CT) on chest showed no pulmonary embolism but revealed a large hyperdense pericardial effusion (Figure 1). Echocardiogram showed moderate-sized circumferential effusion with a swinging heart consistent with pericardial effusion (prior echo 4 years ago showed no pericardial effusion) (Figure 2). Inferior vena cava was dilated with no respiratory collapse and right ventricle outflow tract collapsed in diastole. With the diagnosis of cardiac tamponade, emergency subxiphoid pericardial window was performed and a total of 300 mL of bloody pericardial fluid was drained. Hemostasis was achieved and was satisfactory. Transesophageal echocardiogram confirmed emptying of the collection as well as improved cardiac function. There was immediate improvement in her hemodynamic status. Postprocedure images showed complete resolution of the effusion. Further etiologic workup was unrevealing. Pericardial fluid culture was negative with normal cytology. Pericardial tissue biopsy was negative for malignancy. Thyroid and liver function tests were normal. ANA, rheumatoid factor, anti-saccharomyces cerevisae antibody, anti-mitochondrial antibody, C3, C4, and anti-liver-kidney-muscle antibody were negative making the autoimmune cause unlikely. Myotonic dystrophy was considered to be an unlikely cause of her hemopericardium as pericardial involvement has not been reported with it. In addition, her previous echo was negative for pericardial effusion. There was no temporal relation to the axillary vein DVT and the pacemaker lead implantation as CT scan done in 2013 and echocardiogram done in 2015 mentioned a normal pericardium with appropriately implanted leads. Intraoperatively, there was no mention of pacemaker lead induced pericardial perforation. Further hospital course, unfortunately, was complicated by healthcare associated pneumonia with septic shock and multiorgan failure. The autopsy was not done.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 8,\n",
       "    'case_id': 'PMC9159873_01',\n",
       "    'case_text': 'An eight-year-old female of Iraqi descent presented to the Department of Clinical Genetics with a history of global developmental delay, regression, microcephaly, spastic diplegia, and leukodystrophy confirmed on brain magnetic resonance imaging (MRI).\\nThe patient was the fourth child born to double first cousins. She had two older healthy siblings and a brother who died at 12 days of age following an infection. The patient had an unremarkable perinatal course and was slowly meeting her developmental milestones. At four years, she developed fever, following which she lost the ability to walk independently and showed signs of developmental regression. At that time, she had her first episode of myoclonic seizures.\\nAt age six, the family emigrated to Canada. Within a year, the patient was wheelchair bound and had lost spontaneous speech. Ophthalmologic and hearing exams were normal. A neurological assessment identified microcephaly (<1 percentile), poor growth parameters (weight and height were at 5th percentile), and a pattern of spastic tetraparesis. MRI scan of the head showed generalized cerebral atrophy and ventriculomegaly with periventricular white matter volume loss (Figures 1 and 2). Electroencephalogram (EEG) confirmed frequent bitemporal epileptiform discharges.\\nChromosomal microarray analysis identified greater than 21% absence of heterozygosity (AOH) and no copy number variants (CNV). Rett gene (MECP2) testing was normal. Metabolic screening including plasma amino acids, acylcarnitine profile, total and free carnitine, plasma lactate, ammonia, urine organic acids, and urine mucopolysaccharide screen were negative. Negative results were received from genetic testing with a 201 leukodystrophy genes panel and mitochondrial DNA panel.\\nAt age nine, she was diagnosed with precocious puberty in addition to nonclassic, late-onset congenital adrenal hyperplasia. Cortical blindness was confirmed by an ophthalmological assessment. There were difficult to control seizures and her symptoms worsened. A request for funding of whole exome sequencing (WES) was declined on the administrative basis of the previous negative panels ordered less than three years prior.\\nAt 12 years of age, approval for a clinical WES was granted and the results identified two diagnoses. There was a homozygous pathogenic partial HERC2 gene deletion of exons 43-45 responsible for autosomal recessive HERC2-related disorder, which is characterized by intellectual disability, gait disturbance, seizures, hypotonia, and brain anomalies. This was recently described as a cause of pediatric lethality in a consanguineous population.\\nIn addition, a homozygous ACMG class 1 mutation (c.836 C> T, p.A279 V) in the SUMF1 gene was identified, which is responsible for autosomal recessive multiple sulfatase deficiency (MSD). MSD is a lysosomal storage disorder that presents with developmental delay, regression, leukodystrophy, and coarse facial features. SUMF1 was not included in the initial leukodystrophy panel (Supplementary Material 1). The diagnosis of MSD was further confirmed biochemically by very low leukocyte arylsulfatase A activity (0.05 nmole/h/mg protein and low leukocyte arylsulfatase B activity 3 nmol//mg protein (same-day control 101 and 133). We were able to correlate the above changes to 21% AOH identified on her chromosomal microarray analysis. The AOH included 15q13.1, which harbors the HERC2 gene as well as the region 3p26.1 which carries the SUMF1 gene (Supplementary Material 2).\\nHer parents were identified to be carriers for those two conditions. Both parents and caregivers now have a better understanding of the cause and overall prognosis. The parents have presently accepted a referral to the palliative care team. The older siblings have also been made aware of the genetic findings and advised to seek prenatal counseling.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 40,\n",
       "    'case_id': 'PMC9320325_01',\n",
       "    'case_text': 'In 2021, a 40-year-old male patient came for consultation. He had chronically recurrent gastrointestinal bleeding for 15 years, developed malignant lesions of the descending part of the duodenum, and then underwent pancreaticoduodenectomy in our hospital. The patient has lost 15 kg of weight since the onset in September 2020. Moreover, he had no notable family medical history.\\nThe patient was admitted to the local hospital on March 8, 2019, and operated on a partial enterectomy with a 150 cm intestine because the enteroscopy found bleeding in a part of the intestine. However, the patient was still under anemia after the operation (Figure 1). After then, the patient suffered from jaundice and incomplete ileus with the feeling of ventosity and nausea in October 2020. The local hospital implemented PTCD to improve jaundice and treat fasting, nasogastric drainage, and total parenteral nutrition for incomplete ileus. However, they did not find a solution to handle the bleeding event. Therefore, the patient came to our hospital for further medical consultation. Tracing the history, we found that the patient had anemia before he was 16 and was given blood transfusion therapy. This situation recurred 3-4 times before.\\nWe did regular pre-operation examinations after the patient was admitted to our hospital. Enhanced computer tomography showed dilatation of the duodenum and stomach, and there was a space-occupying lesion that tended to be malignant. Magnetic resonance imaging revealed duodenal malignancy, slight dilatation of the bile duct, and fatty liver (Figure 2). Obviously, the gastrointestinal obstruction was caused by the occupying lesion of the descending part of the duodenum.\\nUpper gastrointestinal endoscopy revealed multiple diffused polyps located in the stomach and the duodenum, and colonoscopy showed the same extent polyps of varying sizes localized in the rectosigmoid region. The onset of small intestinal malignant tumors combined with upper and lower gastrointestinal tract polyps might suggest MUTYH-associated polyposis syndrome (MAP) or Lynch syndrome. Nevertheless, further physical examination revealed that the patient had macrocephaly, and dermatologic examination was remarkable (Figure 3). Miliary papules were scattered on the face, especially on the forehead. Also, there was papilloma of the tongue, hyperkeratosis of soles, and melanosis spots on the glans of the penis. Therefore, we considered the possibility of other diseases such as Cowden syndrome and P-J syndrome and performed a radical pancreaticoduodenectomy (classic Whipple) to remove the malignant lesion in the duodenum on March 23, 2021.\\nThe gross pathology showed a 6 x 5 x 4 cm cauliflower-like protrusion lesion (Figure 2). The cut surface of the tumor was pale, soft, and fragile and visually infiltrated the muscular layer of the duodenum. Diffuse hyperplastic grayish-brown polyps could be seen in the entire intestinal wall, ranging from 1 to 4 mm. The common bile duct was dilated, and the pancreas was undisturbed. Microscopic pathology (Figure 4) reported that the cauliflower-like elevated tumor of the duodenum was considered a hamartomatous polyp, with malignancy in some areas (80% non-mucinous adenocarcinoma, 20% mucinous adenocarcinoma). Also, the carcinoma tissue had infiltrated into the subserous layer. Other polyps were described as polypoid hyperplasia of mucosal glands. No metastasis was observed in perigastric lymph nodes and peripancreatic lymph nodes. In addition, it is suggested that the mesentery nodules were hemangioma. Immunohistochemical results showed Ki-67(40% positive), CDX2(+), MSH2(+), MSH6(+), PMS2(+), CK20(+), STK11(+/-), PTEN(expression deletion), Her-2(weak +), SATB2(little +), D2-40(no apparent lymphatic tumor thrombus was found), and p52(DO7) (70%+); special staining showed no definite venous invasion of elastic fibers. Immunohistochemical results showed that PTEN protein expression was lost in the tumor and surrounding mucosal tissues, which may be an important factor in tumorigenesis. However, MLH1 and STK11 proteins were normally expressed. Therefore, we believed Cowden syndrome was the most likely diagnosis. At the suggestion of the pathologist, further NGS gene testing was carried out.\\nGene testing of the tissue samples suggested multiple germline gene mutations. A frameshift mutation was detected in the PTEN gene, leading to amino acid p.E242fs alternation. We refined the localization to position 89717695 of chr10, which might lead to a premature terminator in the new reading frame, resulting in protein dysfunction and having pathogenic significance. According to the large population databases (gnomAD, ExAC, 1,000 genome, ESP6500, etc.), this was a rare mutation that has never been discovered before. Partial genetic mutations of the PTEN gene are related to PTEN hamartoma tumor syndrome/Cowden syndrome. This autosomal dominant genetic disease is associated with an increased risk of breast cancer and thyroid disease and may increase the risk of endometrial cancer and central nervous system tumors. On chr13, missense mutation occurred in two-locus:32906558 and 142274875, causing P.C315S of the BRCA2 gene and p.T729A of ATR change. Missense mutations occurred in PALB2 and MC1R gene on chr16, causing p.Q1114R and p.A166G changes. All mutations of these germline genes were heterozygous mutants, and their clinical significance for CS has not been clarified except for PTEN. Four critical tumor driver gene mutations were detected in the patient. Tumor mutational burden was 2.20 muts/Mb, and microsatellite instability was detected as microsatellite stable. The mutation in exon 2 of KRAS changed P.G12A inactivated GTPase, leading to the accumulation of tumor-associated KRAS in the active GTP-bound conformation. That possibly promoted the development of malignant tumors. Currently, there are drugs targeting KRAS gene mutations in the market. Nevertheless, the detection of KRAS mutation also suggested that patients with colorectal cancer may be resistant to Cetuximab(A) and Panitumumab(A). These discoveries can be expected to guide the follow-up treatment. The other three mutations, resulting in p.R714H, p.A4083P, and p.D351G alternations, were detected in exon 11 of CREBBP, exon 48 of KMT2C, and exon 9 of SMAD4. However, the clinical significance of these mutant genes is unknown. PD-L1 immunohistochemical staining score is as follows: TC >= 1% and IC+:2%; the result was positive.\\nBased on that evidence, the diagnosis of Cowden syndrome is confirmed. Since there were no indications such as regional lymph node metastasis, postoperative adjuvant chemotherapy was not performed. The patient was followed up for 1 year, and there was no postoperative obstruction of bilioenteric anastomotic stenosis. Gastrointestinal bleeding did not recur, and the anemia had been corrected. Repeated reexamination of tumor markers did not suggest recurrence. All these suggest a good prognosis.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 0,\n",
       "    'case_id': 'PMC3015617_01',\n",
       "    'case_text': 'A fifty-year-old man was initially treated by ERCP for suppurative cholangitis. During the ERCP session, the patient became agitated, and the procedure was aborted after a simple sphincterotomy. A repeat session with the patient under general anesthesia was unsuccessful in removing the distal CBD stone (approximately 1 cm in size) because of the inability to manipulate and crash the stone. The following day, the patient underwent a laparoscopic exploration that had to be converted to open cholecystectomy due to the unclear anatomy. During the open procedure, the CBD was explored and 1 stone was extracted. The intraoperative cholangiogram revealed a retained stone in the distal CBD but flow of contrast in the duodenum (Figure 1). The patient was discharged with a T-tube in place. Seven weeks later, the patient presented with mild acute pancreatitis. The T-tube cholangiogram showed at least 1 stone impacted in the distal CBD (Figure 2). A percutaneous approach under fluoroscopy was at this point attempted, but it failed due to the inability to grasp the stone. A 16 Fr drain was left in the T-tube tract.\\nAt this point, the patient was taken to the operating room with the intention to perform EHL via the T-tube tract.\\nWith the patient under conscious sedation, 2 wires were inserted through the T-tube tract under fluoroscopic guidance. The retained stone was confirmed to be approximally 2 cm above the ampulla. A flexible cholangioscope was introduced over the guidewire. Basket extraction was again attempted under direct vision. With some manipulation, the stone was freed from the bile duct wall. Subsequently, a 3 Fr EHL probe was passed through the working channel of the choledochoscope. Utilizing 80 W current, adequate fragmentation of the stone was obtained. During the process of stone fragment extraction, the patient became agitated and hypoxic with signs of pulmonary edema and hence endotracheally intubated. A few more fragments were removed, and a cholangiogram revealed contrast flowing into the duodenum (Figure 3).\\nThe patient was kept intubated overnight. At a 3-year follow-up, the patient was asymptomatic without evidence of recurrence.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 83,\n",
       "    'case_id': 'PMC4681885_01',\n",
       "    'case_text': \"In 06/2008, an 83-year-old, Caucasian female with a past medical history of Alzheimer's disease, coronary artery disease, hypertension, and hyperlipidemia presented with acute shortness of breath to the University of Texas Medical Branch emergency department. Computed tomography (CT) of the chest with intravenous (IV) contrast showed a saddle embolus with multiple bilateral, central, and peripheral pulmonary emboli. She was diagnosed with acute, unprovoked PE. Hypotension requiring monitoring by the intensive care unit complicated her hospital course. Transthoracic echocardiogram showed moderately reduced left ventricular systolic function with an ejection fraction of 30-35%, moderately dilated right ventricle (RV), and mildly reduced RV function. Right ventricular systolic pressure was 40-45 mm Hg. Bilateral doppler ultrasound of lower limbs revealed bilateral DVTs. She received anticoagulation therapy and, due to the high risk of further PEs in the future, an interventional radiologist deployed an infrarenal vena cava filter (G-2 recovery retrievable filter). Six months later, a repeated CT scan of the chest with IV contrast showed an almost complete resolution of the PE. However, the patient remained on chronic oral anticoagulation and there was no discussion of retrieving the IVC filter.\\nIn 9/2010, the patient presented to the internal medicine clinic with left sided pleuritic chest pain. Unchanged electrocardiogram and negative cardiac biomarkers ruled out acute coronary syndrome. Chest CT scan with IV contrast showed a high-density linear structure extending into the superior segmental and superior lingular segmental pulmonary artery branches and the left lower lobe (Fig. 1). This most likely represented a broken IVC filter strut. A chest x-ray shows the same finding (Fig. 2). Abdominal CT scan with IV contrast revealed the infrarenal IVC filter with missing struts. Fig. 3 shows a comparison between two abdominal CTs. The CT scan taken in 12/2008 shows the IVC filter with 12 struts while the CT taken in 9/2010 shows only 11 struts. The patient was diagnosed with stable chronic angina pectoris and her chest pain improved with nitroglycerine. As the displacement was asymptomatic and the removal procedure holds risk of complications, a multidisciplinary team chose a conservative approach and left the IVC filter strut and the original IVC filter in place. The patient was managed with chronic oral anticoagulation. Over the next 4 years the patient's symptoms were monitored through regular clinic follow ups and serial chest CT scans. As of 2/2014, the patient remained asymptomatic and there was no evidence of any complications, including changes in the position of the fractured and migratory strut.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 70,\n",
       "    'case_id': 'PMC5340951_01',\n",
       "    'case_text': 'A 70-year-old female patient consulted medical doctor for recurrent moderate abdominal pain in the last few months. She had had a cholecystectomy 30 years ago; later on, without significant illness in medical history, she was a teetotaler and she smoked 2 cigarettes per day during 10 years but stopped completely during the 6 last months. Routine blood tests were in the normal range. Abdominal ultrasound did not visualize the pancreas well due to bloating. A CAT scan was performed, finding multiple calcifications and irregularly dilated main pancreatic duct, predominantly in the pancreatic head (Figures 1(a) and 1(b)), where the dilatation had some cystic aspect and was disproportionally more pronounced than in the pancreatic body and tail. The same alterations were confirmed by MRI (Figures 1(c) and 1(d)), without intramural nodules in the dilated main duct. Based on the two imaging methods, we could not distinguish between chronic calcifying pancreatitis and mucin-producing neoplasia, that is, main duct IPMN. ERCP was performed, and contrast injection revealed a cystic dilation of main pancreatic duct in the head (Figure 2(a)). The duct of Wirsung was less dilated in the body. Through pancreatic papillotomy, typical whitish pancreatic stone passed into the duodenal lumen (Figure 2(b)). However, after having continued the contrast injection, mucin passage was seen producing the typical fish eye appearance in the major and also the minor papilla (Figures 2(c) and 2(d)). Simultaneous existence of CP with pancreatic stones and main duct IPMN was our final diagnosis. Given the high probability of malignancy in the dominant cystic lesion, surgery was decided and performed. Surgery revealed a cystic tumor that was found in a fibrotic pancreas. Pancreatoduodenectomy was performed with preservation of pylorus and pancreaticogastrostomy. Some whitish pancreatic stones were extracted. No lymph node metastasis was seen. Histological (Figure 3) findings confirmed the existence of a mucinous tumor emerging from the main pancreatic duct, with multiple foci of high grade dysplasia and even with evident transformation into an infiltrative malignant lesion (Figure 3). No lymph node metastasis or vascular involvement was found. Fibrosis, acinar cell degeneration, and tubular complexes were seen in the surrounding tumor-free pancreatic tissue. The patient is still doing well 4 years after the intervention, without suspicion of any tumor recurrence.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 52,\n",
       "    'case_id': 'PMC4272654_01',\n",
       "    'case_text': \"A 52-year-old woman presented with a history of progressive nyctalopia and visual acuity (VA) loss over the last two decades. On ophthalmic examination, her best-corrected visual acuity (BCVA) was of 20/200 in both eyes (with a correction of +12,75 diopter sphere OU). Biomicoscopy showed symmetric shallow anterior chambers, with corneal diameters of 12,5mm, and moderate nuclear lens opacity.\\nGonioscopy was performed and showed open angles, and IOP was 10mmHg OU. Fundoscopic examination disclosed large optic disc drusen, cystic macular changes, and retinal pigment epithelium (RPE) clumping and atrophy at the macular region and mid periphery in both eyes, as well as vascular sheathing (Figure 1).\\nBiometric scans showed short axial length (16.79 mm in the right eye and 15.40 mm in the left eye). Electroretinogram (ERG) showed abolished photopic and scotopic light response in both eyes, compatible with RP. OCT macular scans demonstrated a diffuse increase in retinal thickness and hyporeflective cystic changes at the inner and outer plexiform layers, as well as a small pocket of subfoveal fluid in the right eye. Central foveal thickness was of 694 +- 12 microns in the right eye and 483 +- 14 microns in the left eye. Central retinal volume was of 13.65mm3 in the right eye and 10.49mm3 in the left eye (Figures 2A and B).\\nThe molecular analysis was performed and the patient was a compound heterozygote for two frameshift mutations in exons 5 (492delC) and 10 (1149dupC).\\nThe patient was submitted to phacoemulsification in both eyes in a week interval, and a +40 dioptries intraocular lens (IOL) was implanted in both eyes. After cataract surgery and IOL implantation, vision was stable at 20/100. The patient was then treated with topical dorzolamide 2% 4 times a day as an attempt to reduce the cystoid macular edema.\\nTopical CAI was applied for two months. During that interval, the patient's BCVA improved to 20/50 OU. A progressive decrease of macular thickness and of cystic changes, more pronounced at the right eye, was observed during the course of topical CAI treatment, and the central macular thickness improved to 355 +- 12 microns in the right eye (central volume of 10.31mm3) and 361 +- 22 microns in the left eye (central volume of 10.00mm3) (Figure 2C and D). Macular thickness remained stable after six months of follow up (four months after discontinuation of the treatment).\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 19,\n",
       "    'case_id': 'PMC5061310_01',\n",
       "    'case_text': 'A 19 year-old male who jumped off a bridge and was subsequently hit by a passing car presented as a polytrauma call to our hospital. His Glasgow Coma Scale (GCS) was 3 - E1V1M1 at the scene and he had a tension pneumothorax which was decompressed at the roadside.\\nHe was intubated before arriving in the emergency department. His CT Head showed a fracture to the right pterion with an associated underlying fracture haematoma. There was no intracranial haemorrhage or contusions to note. His cervical spine was radiologically normal. Additionally he had associated lumbar, pelvic and coccygeal fractures.\\nInitially he was managed for his low GCS and head injury with an intracranial pressure bolt monitor. His repeat CT Head the next day revealed radiological features of diffuse axonal injury. A week later he was difficult to wean off sedation and a repeat CT Head was undertaken which revealed evidence of new left sided hypodensity of the brain, suggestive of an infarction in an area which did not previously show contusion/pathology.\\nThis made us investigate further and a CT Angiogram of the neck was undertaken (Fig. 1) and subsequently an MRI Head with contrast (Fig. 2, Fig. 3).',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 0,\n",
       "    'case_id': 'PMC7817230_01',\n",
       "    'case_text': 'Subsequently, the infant developed unrelated renal vein thrombosis complications and renal atrophy, which were managed accordingly. The infant developed cutaneous HSV lesions whenever valacyclovir was discontinued, even for a few days. The vesicles were mostly present over the lower abdomen, back, and lower extremities. Breakout lesions occurred at least 3 times over the last 6 months. When writing this report, the child was 20 months old, on valacyclovir, and had normal developmental milestones for corrected age. The growth pattern of the child is illustrated in Figure 3.',\n",
       "    'gender': 'Unknown'}],\n",
       "  [{'age': 51,\n",
       "    'case_id': 'PMC4080668_01',\n",
       "    'case_text': 'A 51-year-old female patient non-smoker was diagnosed with carcinoma lung in September 2010. Work-up revealed: Staging positron emission tomography computed tomography (PET CT)-Mass lesion in left upper lobe (T1) with N2 lymph node. The biopsy revealed adenocarcinoma. She received 3 cycles of neoadjuvant chemotherapy with pemetrexed and cisplatin. She had near complete morphologic and metabolic response to chemotherapy on PET CT after 3 cycles of chemotherapy. She underwent left upper lobectomy on 24-12-2010. Histopathology revealed residual foci of adenocarcinoma 0.1 cm (yPT1N0M0). She was on regular follow-up since then. She developed a headache after 16 months of surgery. She presented with headache and occasional vomiting in august 2012. Clinical examination including neurologic examination was normal. Magnetic resonance imaging (MRI) brain revealed extensive leptomeningeal enhancement in the right parietal and occipital lobes though there was no parenchymal metastasis. CT scan thorax and abdomen was normal. Cerebrospinal fluid (CSF) cytology was negative once. Repeat CSF cytology was positive for metastatic carcinoma.\\nOmmaya reservoir was placed followed by weekly intraventricular methotrexate (MTX) injections. Patient was also started on gefitinib 250 mg once a day. Her tumor sample was analyzed for epidermal growth factor receptor (EGFR) mutation, which was positive. After 3 months of weekly MTX her symptoms improved remarkably. Her headache subsided and vomiting resolved. She received 10-12 mg twice a week for 4 weeks. Consolidation: 10-12 mg every week for 1 month and then every 2 weeks for 1 month. MRI brain repeated at the end of 3 months showed early features of leukoencephalopathy (due to MTX) although the leptomeningeal enhancement resolved completely. Repeat CSF analysis was normal. Hence further doses of intrathecal MTX withheld and she was continued on gefitinib alone. She is asymptomatic after 6 months of relapse.',\n",
       "    'gender': 'Female'},\n",
       "   {'age': 71,\n",
       "    'case_id': 'PMC4080668_02',\n",
       "    'case_text': 'A 71-year-old male patient presented with us stage IV lung cancer due to pleural fluid cytology positivity. Initially, started on gefitinib empirically on which he had stable disease for 11 months. However, gefitinib was stopped due to altered liver function test. He progressed after stopping gefitinib hence started on gemcitabine and carboplatin. After six cycles, he had stable disease after which he was started on switch maintenance with pemetrexed. After three cycles of single agent pemetrexed patient developed excessive fatigue.\\nOn clinical examination, he had bilateral ptosis, with normal third nerve function. He underwent CSF examination, which was positive for adenocarcinoma cells. Even this patient did not have brain parenchymal metastasis. He was started on erlotinib and weekly intrathecal MTX. He received 10-12 mg twice a week for 4 weeks. Consolidation: 10-12 mg every week for 1 month. His symptoms of drowsiness, altered behavior and ptosis and performance status gradually improved after that. However after 2 months, patient was lost to follow-up.\\nBoth these cases highlight the way isolated CSF metastasis can occur in patients with lung cancer. Though brain parenchyma does not show parenchymal disease on imaging one should have a high index of suspicion and perform at least three CSF analyses if the clinical setting is appropriate. Furthermore, in patients with EGFR mutation positive lung cancer with isolated CSF metastasis, addition of tyrosine kinase inhibitor may lead to much improved outcomes. Importantly patients with CSF disease derive significant palliation in symptoms after intrathecal therapy as demonstrated in above cases.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 42,\n",
       "    'case_id': 'PMC8047179_01',\n",
       "    'case_text': \"A 42-year-old male with no previous significant medical history presented to the emergency department with fever, excessive sweating, myalgia, malaise, headache, photophobia, neck stiffness and low back pain. The patient had been on camping trips in Vermont and western Massachusetts, most recently 3 weeks prior to his presentation. Symptoms later manifested as he developed profound weakness in his lower extremities, right side greater than left. He first noted slight difficulty in ambulation, which progressed to lower extremity weakness which prompted him to seek care.\\nOn initial presentation he had a temperature of 101.1 F. Physical examination was notable for normal cognition. He had an unremarkable heart, chest and abdomen exam. On neurologic exam: speech was fluent, cranial nerves II through XII were intact. Bilateral upper extremity strength was 5 out of 5. Right lower extremity strength was 2 out of 5 and left lower extremity strength was 4 out of 5. Sensation was grossly intact. Achilles reflexes were 0-1 + bilaterally, patellar reflex 0 right, left patella 1 + . Gait testing showed him patient to be unstable, having trouble walking. Finger-nose-finger showed no signs of dysmetria or ataxia.\\nInitial lab work showed normal leukocyte count, mild transaminitis, and lactic acidosis. His inflammatory markers including C-reactive protein and erythrocyte sedimentation rate were normal. Lumbar puncture revealed a lymphocytic pleocytosis with WBC of 155 per mm (0-5) (90 % lymphocytes (<65 %), 8% PMN (0-5 %)), RBC 13 per mm (0-5), protein 56 mg/dL (12-60), glucose 55 mg/dL (40-70). Infectious workup confirmed infection with WNV CSF PCR positive, CSF IGM positive (4.89, reference range < 0.90), positive serum IgM (3.03, <0.90) and, negative serum IgG (within the reference range <1.3). Additional work up was negative for HIV, Herpes simplex viruses, syphilis and Lyme.\\nMRI of the lumbar spine demonstrated long segment increased intramedullary T2 signal extending from the conus medullaris to T10 with cord expansion but without enhancement, suggestive of longitudinally extensive transverse myelitis (LETM), a subset of ATM (Fig. 1).\\nOnce a diagnosis of ATM secondary to the WNV had been confirmed the patient was managed symptomatically. A urinary catheter was required for our patient's acute urinary retention which resolved prior to discharge. He was discharged to an acute rehab facility where his symptoms continued to improve although some degree of weakness was still present at follow-up approximately 1 month later.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 62,\n",
       "    'case_id': 'PMC4836125_01',\n",
       "    'case_text': \"This study involved a 62-year-old male who had undergone scleral buckling surgery 40 or more years ago for rhegmatogenous retinal detachment, as well as trabeculectomy 20 years ago for primary open-angle glaucoma in his left eye at another hospital. He presented to our hospital complaining of blurred vision in that eye. The patient reported that although the previous retinal reattachment surgery had resulted in a favorable outcome, he had experienced persistent conjunctival hyperemia, conjunctival edema, and low levels of ptosis during the subsequent recovery period. He reported that he had recently become aware of blurred vision in his left eye and subsequently consulted a local doctor. Upon examination at that facility, iritis and proliferating changes in the fundus had been identified in that eye, and he had been referred to our hospital.\\nUpon examination, his visual acuity was 1.0 x S-3.5D C-1.5D A x 30  OD and 0.5p x S + 2.0D C-2.25D A x 160  OS, and his intraocular pressure was 20 mm Hg OD and 11 mm Hg OS. Iritis was observed in the anterior chamber of the left eye, as well as a great number of pigment cell keratoprecipitates on the posterior surface of the cornea (fig. 1). Minor cataracts were observed beneath the posterior capsule, and mydriasis was somewhat poor. In the ocular fundus of the left eye, extensive atrophy of the retinal pigment epithelium and partial hyperpigmentation were observed, accompanied by subretinal strands, yet the retina remained reattached. Around the entire peripheral area of the retina we observed a high, ring-shaped protrusion, but we also saw a shiny, filamentous material in the vitreous cavity that penetrated the sclera and choroid, completely extending from the 4- to 8-o'clock position of the protrusion (fig. 2). During a B-mode ultrasound scan, we observed a high-luminance image on the edge of the buckle protrusion with an acoustic shadow (fig. 3). We also observed slight opacity and inflammatory cells in the vitreous cavity. Thus, we diagnosed this patient as a case of intraocular erosion and intrusion by an Arruga suture, and for the iritis in the left eye we began to administrate low-concentration steroid eye drops, after which the inflammation disappeared. A previous doctor had performed a trabeculectomy on the left eye 20 years previously to treat primary open-angle glaucoma, and we recognized a filtration bleb in the upper part of the corneal limbus, but we saw no particular abnormalities in the middle optic media or fundus in the right eye.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 40,\n",
       "    'case_id': 'PMC9617715_01',\n",
       "    'case_text': 'A 40-year-old female patient was involuntarily brought by the husband and mother with chief complaints of meditating for 14-18 hours a day, neglecting food, sleep, and self-care. She had stopped doing household chores and instead used to sit for hours together with her eyes closed while mumbling to self, since last 4 years. The patient was interviewed in an empathetic and nonjudgmental way to make her comfortable and share her story. She was introduced to a meditation guru who teaches transcendental meditation by one of her family friends. After that, the patient never met the guru. Though the guru instructed her to practice meditation in her free time for a limited duration (20 minutes twice per day), she gradually increased time spent on meditation from initial one hour to 14-18 hours. Later, she would watch videos related to meditation on television and Internet for the rest of her day. When asked, she told that she felt very much relaxed and felt a sense of detachment from her body and a great sense of pleasure when she meditated. Hence, she increased her time spent on meditation. When enquired about her mumbling behaviour, she told that she was talking to her guru whose voice she could only hear. The voice of her guru ordered her to practice the meditation throughout the day to activate inner chakras and get special powers. She would sit in her room and talk to the guru through \"telepathy\" according to the patient. She also reported that she got the power to see the future of others with her third eye, and she reported that meditation gave her these superpowers. On inquiry, she told that she can travel through time and space and can communicate with the aliens while meditating. She started speaking in gibberish manner saying that she was replying to aliens in their language. She also told that few aliens were following her in the form of humans from the last few years. On further probing, she stated that those were bad aliens who came to kidnap and harm her.\\nWhen questioned about her reduced sleep, food intake, and her poor self-care, she told that meditation itself keeps her healthy, fit, and clean. She was refusing to have sex with her husband and was demanding for divorce. When questioned about this, she answered that she had a special bonding with her guru and she considers her guru as her \"soul mate.\" She could perceive \"the signals\" from her guru who stays away from her, as her soul meets with the soul of her guru in universal space and she equated this to sex between their souls. She was physically aggressive towards her family members if they asked her to stop meditating. She stopped attending any social gatherings saying people will steal her powers if she goes out of the house. The course of the illness was insidious in onset and continuous and progressive in nature. The patient was reluctant to consult any mental health professional, so she was brought forcefully.\\nShe had no past history of significant psychological or medical illness. Her mother and maternal uncle were diagnosed with unspecified psychoses and received treatment in the past. Premorbidly, the patient was well adjusted. She was a graduate and used to work as a primary school teacher till 4 years back. She got married at the age of 25 years and has 2 kids. She used to take care of the family and kids before the onset of the illness. Her husband works as a government employee, and their relationship was cordial before the onset of the illness as per the husband.\\nOn examination, the patient was malnourished and unkempt. She was continuously muttering to herself throughout the interview. Her speech was disorganized sometimes. She reported perceptual experiences like auditory hallucinations, telepathy, and clairvoyance. In thought content persecution, grandiosity and magical thinking were found. Her test and personal judgment were impaired. She had no insight into her illness. Provisionally, she was diagnosed with schizophrenia as per Diagnostic and Statistical Manual of Mental Disorders 5th edition (DSM5). She scored 78 on Brief Psychiatric Rating Scale (BPRS) and 6 (severely ill) on the Clinical Global Impression-Severity (CGI-S) Scale. Her responses on the Rorschach inkblot test were suggestive of schizophrenia. Her blood investigations were unremarkable except for low hemoglobin. She refused using any psychotropic substances, and her urine drug screen was negative for any drugs. Computerized tomography (CT) of the brain revealed no abnormality.\\nShe was admitted to the hospital and started on tablets olanzapine, lorazepam, and iron supplementation. As the patient was very much symptomatic, she refused to take medication and food. Six sessions of modified electroconvulsive therapy (M-ECT) were given. The patient showed improvement and started to accept food and tablets. She was discharged after 20 days from the hospital. The patient was stabilized on 15 mg of oral olanzapine. Her BPRS score came down to 32 and CGI-S score to 3 at the time of discharge. She was advised to refrain from any kind of unguided meditation. Family members of the patient were doubtful about the compliance with treatment at home. She was shifted to olanzapine depot injection and currently receiving 405 mg of olanzapine palmitate on monthly basis and maintaining well with regular follow-ups.\\nOn Naranjo\\'s scale, the patient had scored 5 indicating \"probable role\" of meditation in causing psychosis.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 45,\n",
       "    'case_id': 'PMC8502108_01',\n",
       "    'case_text': 'Our study included 10 patients, including 5 women and 5 men, aged 1 to 45 years old. The course of the disease ranged from 3 days to 30 days (Table 1). Patients 3, 4 and 7 did not receive any treatment before the initial visit. The effect of external antibiotic ointments on the other patients before their first visit was not satisfactory. \\nPatients 1 and 2 achieved PR 2 days after one fire needle therapy and achieved SR 1 week later due to their smaller skin lesion and early onset. Patients 4 and 8 received fire needle therapy twice because of more pus, achieving SR and CR at 1 and 2 weeks, respectively, after treatment. Except for patient 4, who achieved SR 1 week after treatment due to a longer medical history, other patients with abscesses measuring less than 4 cm in diameter all achieved CR 1 week after treatment (Tables 2 and 3). Representative images are shown in Figure 1A, B, D-F. All patients had no recurrence within the 12 weeks after treatment. There was no reported recurrence in patient 4 after a 1-year follow-up post-fire needling.  \\nAll treatments were well tolerated, with patients complaining of moderate pain at most that quickly subsided after a fire needle intervention.',\n",
       "    'gender': 'Unknown'}],\n",
       "  [{'age': 41,\n",
       "    'case_id': 'PMC10010872_01',\n",
       "    'case_text': 'A 41-year-old male presented to the emergency department of a regional Australian hospital with sudden onset severe chest and abdominal pain. On arrival, the patient was haemodynamically stable, but became rapidly unresponsive with oxygen saturations of 85%, tachycardia to 140 beats per minute, unrecordable blood pressure, and a Glasgow Coma Scale of 8 (eyes 3 points, voice 1 point, and motor 4 points). Bedside, ultrasound scan yielded intra-abdominal free fluid in the left upper quadrant. The patient was resuscitated sufficiently to allow prompt computerized tomography (CT) angiogram. He had no history of trauma, falls, pancreatitis, or known hypertensive crisis, and no knowledge of any previous aneurysms.\\nCT angiogram demonstrated a large left upper quadrant intraperitoneal and retroperitoneal haematoma with dense peritoneal free fluid consistent with hemoperitoneum (Figure 1). A splenic artery aneurysm at least 28 mm x 16 mm was seen with active contrast extravasation (Figure 2).\\nIn our regional centre, there are no interventional radiology or endovascular services available; hence, the patient underwent emergency laparotomy where a 2 L hemoperitoneum was evacuated. The bleeding splenic artery aneurysm was approached via division of the gastro colic omentum and reflection of the stomach superiorly to allow exposure of the lesser sac. This allowed adequate visualisation of the length of the splenic artery and the ruptured aneurysm mid-way along the artery was easily seen. Following this exposure, control of the splenic artery vessel at two points was achieved via suture ligation: the splenic artery proximal to the aneurysmal sac and distal to the aneurysmal sac were both secured, resulting in ligation of the artery at these two points. This was sufficient to achieve haemostasis. Due to the exposure technique via division of the gastro colic omentum, the short gastric and left gastro epiploic arteries were undisturbed and left intact allowing collateral circulation to the spleen to persist despite ligation of the splenic artery. Perfusion to the spleen appeared preserved and splenectomy was not required to be performed.\\nThe patient was admitted to the intensive care unit postoperatively for monitoring and made an unremarkable recovery. A surgical drain placed into the left upper quadrant of the abdomen at the time of operation had minimal output with no evidence of ongoing bleeding and was able to be removed day 2 postoperatively. On post-operative day 3, the patient remained very well and was fit for discharge home after an ultrasound scan confirmed continuing splenic perfusion and organ viability, though noted some surrounding residual haematoma. Three weeks postoperatively, the patient remained well and underwent surveillance CT angiogram, which confirmed ongoing sufficient collateral perfusion of the spleen and viability of the organ, with a resolving peri-splenic haematoma also seen (Figure 3). The differential diagnosis for the cause of the peri-splenic haematoma includes inadequate evacuation of haematoma at time of operation, iatrogenic damage to collateral vessels resulting in minor bleeding postoperatively, or inadequate control of the splenic artery. The post-operative drain had minimal output and the haematoma was reduced in size on repeat imaging; therefore, inadequate evacuation of an already formed clot from the time of operation is the most likely cause. At review 6 months post-procedure, the patient remained well with no latent complications.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 56,\n",
       "    'case_id': 'PMC6350572_01',\n",
       "    'case_text': \"A 56-year-old man with a history of dyslipidemia, multiple transient ischemic attacks (TIAs), and a 40 pack-year smoking history presented to the local hospital with sudden left-sided weakness, slurred speech, and left facial droop. His family history was significant for stroke and diabetes in multiple family members. He was on atorvastatin for dyslipidemia. He had no history of connective tissue or autoimmune disease. He was diagnosed with acute ischemic cerebrovascular accident and was given tissue plasminogen activator (tPA). The patient received a single dose of atorvastatin 80 mg and aspirin 325 mg orally during the admission; he never received clopidogrel or ticlopidine therapy. The symptoms improved gradually, but he developed thrombocytopenia that worsened over the next few days. The team discontinued statin and aspirin therapy once they observed low platelets. The patient was managed conservatively, but his platelet counts reached a nadir at 16,000 per cubic mm. His peripheral blood smear showed no schistocytes in high-power fields. He was given a platelet transfusion with no improvement. He was then transferred to our hospital, and the inpatient hematology team was consulted. At the time of presentation, the patient complained of clumsiness in his left arm, although he was able to carry out daily activities with minimal difficulty. He was stable, the facial droop had resolved and speech slightly improved with residual dysarthria and expressive aphasia, and his motor power was better. A review of outside laboratory results revealed that 2 days before his transfer, his platelet count was 115,000 per cubic mm, BUN was 16, and his creatinine was 1.3. His initial lab values on arrival at our hospital were as follows: platelets 26,000 cells per cubic mm, hemoglobin (Hb) 10.7 g/dl, hematocrit (Hct) 31.2/L, leucocytes 16,300 cells per cubic mm, blood urea nitrogen 35, blood urea nitrogen/creatinine 27, lactic acid dehydrogenase of 794 (98-192), bilirubin 0.9, and reticulocyte count 2.8. During admission, B12 and folic acid levels, antiphospholipid panel, disseminated intravascular coagulation panel, coagulation panel, antinuclear antibodies, and rheumatoid factor were measured and found to be within normal limits. HIV, hepatitis B, and direct Coombs tests were negative. However, his peripheral blood smear showed 5-6 schistocytes/high-power field. Neither the patient nor his family members underwent any screening for connective tissue or autoimmune disorders.\\nThe patient was immediately started on a daily total plasma exchange (TPE). On day 3, his neurological symptoms improved significantly, and his platelet count normalized to 167,000 per cubic mm. Despite the improved platelet count, TPE was continued for 2 more days. By day 5, his speech was clear and his expressive aphasia resolved. He recovered full strength in his right extremities and TPE was stopped. Blood samples were sent to the Blood Center of Wisconsin, Milwaukee, for measurement of ADAMTS13 levels, and we got the results 5 days later. ADAMTS13 activity measured using FRETS-VWF73 substrate was <5% (reference range >=67%). ADAMTS13 inhibitor was measured using mixing studies with standard pooled plasma, and residual ADAMTS13 activity measured using FRETS-VWF73 substrate was <0.4 inhibitor units (reference range <=0.4). Platelet count remained stable throughout the patient's stay. At the time of discharge, his counts and Hb/Hct remained stable, lactate dehydrogenase (LDH) was 249, and no schistocytes were present in peripheral blood smears. Because of his atypical presentation of TTP, he was advised to seek medical attention immediately if his neurological symptoms worsen to evaluate TTP relapse. After discharge, he was evaluated twice weekly with a CBC and LDH measurements after discharge for 2 weeks and once a week afterward. Higher levels of LDH were noticed subsequently normalized in 2 months. He complained of intermittent left facial numbness and tingling of the left hand during follow-up visits. The patient remained in remission without a relapse for 2 years after his initial presentation.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 86,\n",
       "    'case_id': 'PMC10020938_01',\n",
       "    'case_text': 'An 86-year-old woman was referred to us for a tumor on the right upper eyelid that had increased in size over a period of 4 weeks. A 12 x 10 x 7 mm nodule with good mobility to the lower bed was recognized (Fig. 1a). A skin biopsy from the tumor showed papillary proliferation of squamous epithelium and nucleoli enlargement; however, there were no findings of malignancy, making a definitive diagnosis difficult. Although the tumor showed a shrinking trend after skin biopsy, the tumor remained (Fig. 1b); therefore, total resection with a 1-mm margin was performed. The clinical findings and course were typical of keratoacanthoma; however, the histological findings of the excised tumor showed a seborrheic keratosis-like appearance with hyperplasia of the epithelium with a high nuclear/cytoplasmic (N/C) ratio accompanied by the formation of pseudokeratocysts (Fig. 1c).',\n",
       "    'gender': 'Female'},\n",
       "   {'age': 79,\n",
       "    'case_id': 'PMC10020938_02',\n",
       "    'case_text': 'A 79-year-old woman was referred to us for a tumor on the right lower eyelid that had increased in size over a period of 4 weeks. An 8-mm-sized dark purple nodule with central keratinization was detected (Fig. 1d). The clinical findings showed suspected keratoacanthoma. The histology of the biopsy showed pseudokeratinocyst formation in the epidermis and inflammatory cells consisting mainly of mononuclear cells in the upper dermis, which was suspicious of seborrheic keratosis (Fig. 1e).',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 44,\n",
       "    'case_id': 'PMC3356992_01',\n",
       "    'case_text': \"A 44-year-old woman was referred to an orthopedic clinic in a city hospital, complaining of low back pain (LBP) of several years duration. Her severe sciatalgia had exacerbated since 6 months before admission. The diagnosis of L5/S1 disc herniation compressing S1 root on the left side was made and she underwent operation. It was a no-contrast standard lumbosacral magnetic resonance imaging (MRI). At operation, L5 and partial S1 laminectomy followed by bilateral S1 foraminotomy, and bilateral L5/S1 discectomy was performed. Two weeks after the operation, the patient's symptoms exacerbated and paresthesia appeared in the left buttock. Paresthesia of the perineal region and urinary incontinency were also added to her previous complaints. On admission to our department, the muscle forces of the lower limb were intact both proximally and distally, but pin prick sensation was disturbed in S1, S2, and S3 dermatomes, and Achilles tendon reflex was absent in the left side. However, anal sphincter tone was intact. Re-evaluation of the previous preoperative lumbosacral MRI revealed that in addition to the L5/S1 bulged disc, there was an extradural dorsally located mass at S1, S2, and S3 levels. The new contrast-enhanced MRI revealed a 3 x 2 x 2 cm extradurally located tumor, extending from lower edge of S1 down to S2/S3 interspace. The tumor was hypointense in both T1 and T2 images and enhanced homogenously after contrast material injection. Scalloping of the posterior aspect of the S2 vertebra was also detectable [Figure 1a-d]. In the second operation, the previous laminectomy was extended from lower edge of L5 down to S3. A reddish gray tumor located in the extradural space, extending from S1 root axilla down to the S3 root, could be excised totally. There was neither tumor invasion to the dura or intradural space, nor any bone involvement detectable under microscopic observation. Histopathologic examination revealed a highly cellular neoplasm composed of diffuse sheets of tumor cells having monomorphic, round to oval, finely vesicular nuclei and occasional nucleoli with indistinct cytoplasmic border. Delicate fibrovascular septae surrounded the tumor mass along with intra tumoral extensions. In some foci, tumor cells gathered in groups around small vessels (pseudo-rosette appearance). There were nerve bundle entrapments within the tumor nests. Several groups of mitotic figures were noted, but no necrosis was detected [Figure 2a and b].\\nImmunohistochemical (IHC) staining showed that the tumor cells stained positively for neuron-specific enolase, synaptophysin, and chromogranin, suggestive of neuronal differentiation of the tumor. Tumor cells also expressed CD99, consistent with the diagnosis of ES/PNET [Figure 2c]. Ki-67 proliferative index showed about 10-15% proliferative activity. Other markers such as leukocyte common antigen (LCA), epithelial membrane antigen (EMA), cytokeratin (CK), desmin, smooth muscle actin (SMA), and myogenin were negative. Fluorescence in situ hybridization and chromosomal study were not performed.\\nThe postoperative course was uneventful and all her symptoms including radicular pain and sphincter problems improved rapidly. The patient was referred for radiotherapy as the adjuvant therapy. In the last re-evaluation of the patient after 18 months, there was no sign of tumor recurrence in MRI.\\nAfter our wide search using Tehran University of Medical Sciences electronic resources (www.tums.ac.ir) and motor searches of Pubmed, Ovid, and EBSCO using the key words, spinal primitive neuroectodermal tumor and spinal extraskeletal Ewing sarcoma, 106 abstracts were found in the form of case series and case reports, which reported 141 cases of primary intraspinal EES/pPNET. Full texts of all the articles were collected from different electronic and paper archives including English, French, Spanish, and Italian articles. The earliest articles were published by Smith et al. and Tefft et al. in 1969 and the latest by Gollard et al. in Feb 2011. Patients' information including age, sex, clinical signs and symptoms, duration of symptoms, family history, location of the tumor, metastasis, recurrences, therapeutic methods, duration of follow-up, and eventual outcome were all extracted from resources. As the articles were reported from various clinical departments (e.g. Neurosurgery, Orthopedics, Radiology, Oncology, Pathology, Pediatrics), different aspects of the disease were reviewed in each, and this led to neglecting some other aspects resulting in missed values regarding some subjects. In some of them with missing data about the mode of therapy, final outcome, or follow-up of the patients, the authors were contacted via e-mail directly for the required information. In spite of sending e-mail to 20 authors, only one reply was received.\\nAfter collecting and classifying the information, the data were analyzed utilizing SPSS version 13.0.\\nFor analysis of the numeric variables such as age, Kolmogorov-Smirnov test was used to evaluate normal distribution of the data upon which we could decide to utilize parametric versus non-parametric tests to compare the data. Chi-square test (chi2) was used when comparing two nominal or ordinal variables such as 1-year survival in patients receiving different therapies. Independent sample t-test was used to evaluate numerical variable among two populations (e.g. age in different subgroups). P-values less than 0.05 were considered statistically significant.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 63,\n",
       "    'case_id': 'PMC5477857_01',\n",
       "    'case_text': \"The donor was a 63-year-old female patient with end-stage bilateral heart failure due to ischaemic heart disease, considered for listing for heart transplantation. The patient met all indication criteria, apart from an exceedingly high fixed pulmonary hypertension. A biventricular pulsatile assist device (Thoratec PVAD, Thoratec Corporation, Pleasanton, CA) was implanted in a biventricular fashion in order to reduce the pulmonary resistance to measures matching the criteria for subsequent heart transplantation. Anticoagulation therapy, required due to the implanted mechanical circulatory support (MCS), was established with warfarin (INR 2.0-2.5). The patient's previously deteriorated renal function improved after biventricular assist device implantation (serum creatinine 1.87 mg/dL   0.97 mg/dL and GFR 29 mL/min   62 mL/min). Thirty-five days after surgery, the patient complained of a sudden onset of severe headache and coma rapidly developed. Despite a moderate level of anticoagulation at the time of the event (INR 2.1), CT scan verified a vast haemorrhagic stroke in the left cerebral hemisphere with propagation to the cerebral ventricular system and malignant brain oedema. In view of the lethal neurological prognosis, organ donation was taken into consideration, as the patient had a relatively well-preserved function of other organs because of adequate circulatory perfusion. Having received negative brain perfusion at the angiography, after laparatomy and perfusion with 2000 mL of UW solution, a bilateral transabdominal nephrectomy was performed and the kidneys were shown to be suitable for transplantation. The MCS was maintained for the duration of the kidney procurement and thus the procedure was performed under the same conditions as a normal beating heart. At that time, the patient's kidney function was satisfactory (Cr 0.97 mg/dL, GFR 62 mL/min). The backtable wedge kidney biopsy showed acute tubular necrosis along with mild benign nephrosclerosis with focal interstitial fibrosis and tubular atrophy of both kidneys (Figure 1). The allocation of these kidneys to recipients over 60 years old was suggested. Prior to surgery, both kidney transplant recipients were informed about the possible limitations and signed informed consent.\",\n",
       "    'gender': 'Female'},\n",
       "   {'age': 62,\n",
       "    'case_id': 'PMC5477857_02',\n",
       "    'case_text': \"The recipient of the left kidney was a 62-year-old female with end-stage renal failure due to tubulointerstitial nephritis, who had undergone chronic haemodialysis therapy for 2 years. The surgery was complicated with the external iliac endarterectomy. Since acute tubular necrosis was suspected, a polyclonal antithymocyte globuline single shot (ATG-Fresenius S, Fresenius Biotech GmbH, Grafelfing, Germany, 9 mg/kg) prior to reperfusion was given, followed by mycophenolate mofetil and steroids. Cyclosporine A was delayed until Day 6. On Day 14, a renal biopsy was performed (Figure 1) that confirmed mild regenerating acute tubular necrosis and transfer of mild benign nephrosclerosis without any evidence of acute rejection. The patient was discharged on Day 16 with stable renal function (Cr 2.17 mg/dL, GFR 24 mL/min).\\nThree months after transplantation, a routine protocol biopsy was performed. Light microscopy demonstrated normal histological findings (Figure 1). Twelve months after transplantation, the patient's kidney function remains stable (Cr 1.88 mg/dL, GFR 29 mL/min).\",\n",
       "    'gender': 'Female'},\n",
       "   {'age': 63,\n",
       "    'case_id': 'PMC5477857_03',\n",
       "    'case_text': 'The recipient of the right donor kidney was a 63-year-old female with end-stage renal failure due to chronic glomerulonephritis, who had undergone haemodialysis for the previous 8 months. An ATG-Fresenius single shot (9 mg/kg) prior to reperfusion was administered and followed by tacrolimus (0.2 mg/kg/day), mycophenolate mofetil (2 g b.i.d.) and prednisone (20 mg) since the peristaltic was noted. Despite the immediate use of tacrolimus due to higher frequency of PRA (48%), a kidney graft function was observed from the first postoperative day.\\nA biopsy performed on Day 14 revealed regenerating acute tubular necrosis and a transfer of mild benign nephrosclerosis without any evidence of acute rejection (Figure 1). The patient was discharged on Day 18 with a satisfactory renal function (Cr 1.79 mg/dL, GFR 30 mL/min) and having received lower tacrolimus exposure (trough blood level 6.7 ng/mL). At 3 months after renal transplantation, the graft had an excellent graft function (Cr 1.51 mg/dL, GFR 37 mL/min) and a routine protocol biopsy was performed. Light microscopy revealed only a transfer of benign nephrosclerosis (Figure 1). At 12 months after transplantation, an excellent kidney graft function was observed (Cr 1.41 mg/dL, GFR 40 mL/min).\\nOver the last decade, MCS has become a relevant and effective option in the treatment of end-stage heart failure patients as bridge-to-transplantation, or as a permanent solution known as destination therapy. In the long term, this method diminishes the adverse processes connected with low cardiac output syndrome, by restoring adequate systemic and organ perfusion and reducing pulmonary vascular resistance.\\nRecently, an extended donor criteria pool program has been widely used in both the United States and Europe to solve the progressive disparity between the increasing number of patients waiting for kidney transplantation and a limited donor pool. The use of more and more marginal donors for kidney transplantation and transplantation from donors after cardiac death has often failed to give optimal results in the long term. An MCS device which mediates well-perfused organs in deceased donors might be considered as acceptable for transplantation in the context of an organ shortage. In contrast to successful kidney recovery in a donor after cardiac death, treated previously with a left ventricular assist device, we here present a satisfactory 1-year follow-up of kidneys transplanted from a brain-dead heart transplant candidate, treated during the kidney removal with a biventricular assist device. Because of the increasing usage of mechanical circulatory support in the treatment of terminal heart failure with the risk of fatal complications, we encourage transplant professionals to consider such donors to be suitable for kidney donation.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 3,\n",
       "    'case_id': 'PMC10141254_01',\n",
       "    'case_text': 'A 3-year-old neutered domestic shorthair cat was referred for a nodular dermatitis that had appeared 2 months previously. The cat lived in southwest France but had spent several months in the Central African Republic when it was 1 year old. The cat had access to the outdoors, and its owner reported regular fights with other cats. About 18 months previously, the cat had been diagnosed with idiopathic immune-mediated haemolytic anaemia and thrombocytopenia (IMHA/IMT) but had been relatively stable for the past 10 months on oral ciclosporin (Atopica chat 100 mg/ml; Elanco) at a dosage of 7.4 mg/kg q24h and oral prednisolone (Prednicortone 20 mg; Dechra) at a dosage of 2.5 mg/kg q48h. The cat had recently developed one nodule on the lateral carpal of the right foreleg. The lesion was 7 mm in diameter, cutaneous to subcutaneous, pigmented, soft, haired, non-painful and non-productive (Figure 1). This lesion was reported to have grown slowly, without disturbing the cat. No other dermatological or clinical abnormalities were observed.\\nThe history (immunocompromised cat with access to the outdoors) and clinical features were most consistent with the hypotheses of a cutaneous/subcutaneous infection (pseudomycetoma, leprosy syndrome, other opportunistic mycobacteria, phaeohyphomycosis, hyalohyphomycosis, eumycotic mycetoma, cryptococcosis, sporotrichosis, poxvirus infection, leishmaniosis), neoplasms (melanoma, haemangioma, feline progressive histiocytosis, mastocytoma) and, less likely, sterile granuloma.\\nFine-needle aspirates were taken from the nodule, and smears were May-Grunwald-Giemsa stained. Cytological examination revealed damaged inflammatory cells suggestive of neutrophils and the presence of multiple pigmented fungal elements, leading to a diagnosis of phaeohyphomycosis without precise identification of the fungal species involved (Figure 2).\\nSurgical excision was proposed as part of the therapeutic regimen, and also to provide material for histological examination and mycological culture, and was accepted by the owner. On the day of the surgery, 1 month after the initial presentation, the nodule was slightly larger (approximately 1 cm in diameter), and a pigmented plaque-like lesion had appeared between the eyes (Figure 3). Complete excision of the limb nodule and a 4 mm punch biopsy of the plaque were performed under general anaesthesia. Oral itraconazole (Itrafungol; Virbac) at a dosage of 10 mg/kg q24h was started on the same day.\\nMicroscopic appearance was similar for both lesions and was characterised by diffuse, superficial and deep dermal (Figure 4a,b) histiocytic, lymphocytic and, to a lesser extent, neutrophilic infiltrate, with numerous spherical elements, measuring 3-20 microm in diameter, often isolated or with narrow-based buds, surrounded by a basophilic capsule (Figure 4c). Periodic acid-Schiff staining revealed that the elements were positive (Figure 4d). The margins of the nodule appeared to be free of fungal elements.\\nThe fungus was cultured on Sabouraud dextrose agar plates complemented with 0.5 g/l chloramphenicol for 11 days at 27 C and 37 C and yielded colonies of a black yeast-like fungus (Figure 5). The fungus was identified through macroscopic and microscopic observations, confirmed by mass spectrometry (matrix-assisted laser desorption/ionisation-time of flight mass spectrometry) and molecular biology. Mass spectra were acquired after complete protein extraction using a Microflex LT/HS (Bruker Daltonik) and matched against the online application MSI-2 (https://msi.happy-dev.fr). The species E spinifera was identified by mass spectrometry. Confirmation was obtained using Sanger DNA sequencing of internal transcribed spacer regions. The DNA sequence was compared with sequences in the NCBI GenBank database using the Basic Local Alignment Search Tool. The best match (99.8% identity) was with E spinifera, strain CNRMA6.306 (GenBank accession number KP132129.1). The sequences have been deposited in Genbank (accession number OQ466703).\\nTo investigate the antifungal susceptibility of the isolate, minimal inhibitory concentrations (MICs) were identified using the concentration gradient band (E-test; Biomerieux). The tests showed sensitivity to voriconazole, posaconazole, itraconazole and amphotericin B (MIC 0.023 microg/ml, 0.008 microg/ml, 0.006 microg/ml and 0.19 microg/ml, respectively) and resistance to fluconazole (MIC 24 microg/ml). Based on these results, itraconazole was maintained.\\nAt the 8-week follow-up evaluation, the excisional wound had completely healed and no relapse was visible. Clinical resolution of the non-excised facial lesion was observed. Itraconazole was continued for six more weeks and stopped. Immunosuppressive therapy (ciclosporin and prednisolone) was continued to prevent relapse of IMHA/IMT.',\n",
       "    'gender': 'Unknown'}],\n",
       "  [{'age': 25,\n",
       "    'case_id': 'PMC3279504_01',\n",
       "    'case_text': 'A previously healthy 25-year-old-Asian woman was referred for evaluation of an enlarging, painless, subcutaneous mass located intergluteal fold. It was clinically diagnosed as a pilonidal cyst by previous examiner. She could remember that a mass had been present in this region for 2 years. During the 2-year period the mass had slowly increased in size from less than 0.5 cm to over 2.5 cm in diameter. During the past few months, the mass had become tender and sometimes making it uncomfortable to sit down. There was no history of urinary or faecal problems. Physical examination revealed a 2 x 3 cm sized, solid, mildly tender, mobile mass over the coccyx. It was well circumscribed proximally but not in distally on palpation. Neurological examination was normal.\\nMagnetic resonance imaging (MRI) revealed a 6 x3 cm well-circumscribed subcutaneous mass located over the coccyx. This tumor was comprised of two ovoid mass and there was no direct invasion to the coccyx (Fig. 1). Ultrasonography (USG)-guided needle biopsy was performed and microscopic examination showed a myxopapillary ependymoma. Computed tomography (CT) scanning of the thorax and abdomen demonstrated no evidence of lung or liver metastases. Isotope bone scanning revealed no evidence of skeletal metastases.\\nThe mass was completely excised. Intraoperatively, the lesion was seen near the tip of the coccyx and well-circumscribed. It was composed of two ovoid but contiguous masses, the larger 3.0 x 2.5 x 1.5 cm, and the smaller 1.2 x1.0 x0.8 cm (Fig. 2). The histology of the specimens again confirmed a myxopapillary ependymoma (Fig. 3). Her postoperative course was uneventful and no adjuvant therapy was offered.\\nDuring 2 years of follow-up no local recurrence or metastasis were detected, with chest radiography and abdomino-pelvic MRI (Fig. 4).',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': None,\n",
       "    'case_id': 'PMC5894322_01',\n",
       "    'case_text': 'Our institutional review board does not require approval publishing case reports. Written informed consent was obtained from the patients for all the procedures. A 24-year male who was a prospective liver donor for his mother was referred to us for percutaneous LB. The indication of LB was a suspicion of parenchymal liver disease, as suggested by the widening of inter-lobar fissure of liver on contrast-enhanced computed tomography (CT) examination [Figure 1A and B], which also showed normal portal veins [Figure 2A and B]. Ultrasound-guided plugged liver biopsy was planned under local anesthesia. Baseline platelet count was 389 x 109/L, hemoglobin level was 14.3 mg/dl, and prothrombin time and INR were 13.0 s and 1.01, respectively. Local anesthesia was administered by infiltration of 10 ml of 2% xylocaine hydrochloride. A Quick-core biopsy needle set (Cook, Bloomington, IN, USA) containing coaxial needle (16 Gauge, 12 cm long) and core biopsy needle (18 Gauge, 15 cm long with 2 cm specimen notch) was used to obtain tissue core. The coaxial needle was inserted from the right intercostal approach. Through the coaxial needle, the biopsy needle was inserted and a single tissue core was obtained. The biopsy needle was removed while the coaxial needle was left in place. This was followed by the injection of gelfoam (Spongostan standard, Ferrosan, Denmark) slurry through the coaxial needle to plug the parenchymal track under real-time ultrasound guidance. Post biopsy, the patient was asked to lie on his right side for approximately 4 h. Later, the patient was discharged after a routine screening ultrasonography, which was unremarkable. Two weeks later, the patient presented with mild right upper quadrant pain. Ultrasound of the abdomen revealed echogenic thrombus completely occluding the right portal vein [Figure 3A]. Contrast-enhanced CT scan of upper abdomen confirmed right portal vein occlusion [Figure 3B and C]. The patient was started on oral antiplatelets and anticoagulants for 1 week, however, there was no resolution of the thrombus on repeat ultrasound and Doppler scan. Because the donor was symptomatic with thrombus in subacute stage, percutaneous endovascular intervention appeared to be the best option for his treatment.\\nUnder ultrasound guidance, percutaneous puncture of the left portal vein was done using a 22-gauge micropuncture needle. Using NEFF set (Cook, Bloomington, IN, USA), a 0.035\" J tip guide wire was introduced into the portal vein and exchanged for a 5F KMP catheter (Cook, Bloomington, IN, USA). Digital subtraction angiogram (DSA) of the portal system was obtained which also confirmed the right portal vein occlusion [Figure 3D]. Using multi-sideport catheter infusion set (Cook, Bloomington, IN, USA), urokinase bolus (50,000 units) were given in a pulse spray method. A check angiogram revealed unsatisfactory results. A continuous infusion of urokinase (30,000 units/h) was started for the next 24 h. Repeat angiogram next day showed restoration of the blood flow in the right portal vein [Figure 4A and B]. The procedure ended with coil embolization of the liver parenchymal track to reduce the chances of hemorrhage.\\nA through work-up of coagulation disorders [Table 1] revealed a raised homocysteine level (32.2 mumol/l (normal range, 5-15 mumol/L). The biopsy report revealed a normal liver histology which ruled out any parenchymal liver disease.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 72,\n",
       "    'case_id': 'PMC10083011_01',\n",
       "    'case_text': \"In December 2004, a 72-year-old female was diagnosed with a stage IIIC (pT2bN3), BRAF V600E mutant, cutaneous melanoma of the left thigh, and was treated with a wide local excision and a left inguinal-iliac-obturator lymph node dissection, after a positive sentinel node biopsy. She entered a follow-up program that was negative until September 2007, when a restaging computed tomography (CT) scan identified disease recurrence at the left popliteal and iliac metastatic lymph nodes, with normal Lactate Dehydrogenase levels. In October 2007, the patient was evaluated at our Center for Immuno-Oncology at the University Hospital of Siena, Italy, for enrollment in a randomized, double-blind, Phase III trial (BMS CA184024), comparing ipilimumab 10 mgs i.v. combined with dacarbazine (DTIC) 850 mg/mq i.v. versus DTIC alone, in untreated MM patients. Due to evidence of autoimmune thyroiditis, the patient did not meet the study protocol eligibility criteria and received DTIC 800 mg/mq i.v. every 3 weeks in combination with Thymosin-alpha (4 cycles), within an Expanded Access Program (EAP).\\nIn April 2008, due to evidence of progressive disease (PD) of the pre-existing metastatic lesions, the patient was enrolled in the randomized, open-label, Phase II, BMS CA186-006 (NCT00612664) clinical trial and received the CD137 agonist mAb, urelumab, at 1 mg/kg i.v. every 3 weeks (10 cycles) until November 2008, without treatment-related side effects. Nevertheless, treatment had to be discontinued for the premature study closure due to two fatal cases of drug-related hepatic toxicity. Despite early treatment discontinuation, the patient achieved complete response (CR) in May 2009, 6 months after the last dose of urelumab, as shown by a CT scan (Figure 1). Importantly, she remained in CR for more than 4 years.\\nIn December 2013, a control [18F] fluorodeoxy-glucose positron emission tomography (FDG-PET) scan revealed a right inguinal metastatic lymph node and a left thigh subcutaneous metastatic lesion; thus, the patient received standard third-line therapy with ipilimumab (3 mgs) i.v. every 3 weeks (4 doses). Therapy was well tolerated, except for a treatment-related (TR)-grade (G) 2 skin toxicity and TRG2 diarrhea, treated with symptomatic therapy and low dose steroids (ie, prednisone 25 mg/die) for 3 weeks, slowly tapered with rapid improvement of side effects. Tumor assessment (TA) performed by FDG-PET scan at week 12 showed a mixed response consisting of a partial regression of the right inguinal node and a progression of the left thigh subcutaneous lesion. Thus, the patient had achieved stable disease (SD) as per immune-related Response Criteria (irRC) and PD as per Response Evaluation Criteria in Solid Tumors (RECIST) v. 1.1 (Figure 2). However, the subsequent TA at week 24, confirmed PD according to RECIST v. 1.1 and irRC criteria (data not shown).\\nBased on the confirmed PD, in October 2014 the patient received fourth-line therapy with the anti-PD-1 pembrolizumab (2 mgs) i.v. every 3 weeks within an EAP, achieving a new CR at week 24 of therapy (Figure 3). Treatment was well tolerated with evidence of TRG1 arthralgia and TRG1 fatigue after the 4th cycle and TRG1 diarrhea after the 10th cycle, which resolved with symptomatic therapy.\\nIn August 2017, due to the durable CR and to the patient's desire, treatment with pembrolizumab was permanently discontinued. The last FDG-PET scan performed in December 2022 confirmed CR lasting 91+ months.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 73,\n",
       "    'case_id': 'PMC8326275_01',\n",
       "    'case_text': 'A 73-year-old man with a history of chronic obstructive pulmonary disease (COPD) for more than 10 years, he regularly inhaled salmeterol/fluticasone propionate (50microg/500microg) twice a day. He had 30 pack-years of smoking history and quit smoking for more than 10 years. He was a farmer by profession. He was admitted to hospital with cough and hemoptysis for more than five months.\\nAdmission blood tests showed a white cell count of 5.8 x 109/L, C-reactive protein 3.1 mg/L and interleukin-6 16.32pg/mL. All of sputum smear acid-fast staining, tuberculin test and tuberculosis antibody test were negative. Serum biomarkers of lung cancer, such as carcinoembryonic antigen (CEA), Cytokeratin-19-fragment (CYFRA21-1), squamous cell carcinoma antigen (SCC), and neuron-specific enolase (NSE) were negative.\\nThe images of computed tomography (CT) scan of the chest revealed large dense shadows and cavity formation in the inferior lobe of the left lung (Figure 1A). The electronic bronchoscopy showed a big and white neoplasm in the lower left lung, with a narrow opening and a lot of white necrotic material in the subsegment (Figure 2). Biopsy revealed chronic inflammation of endobronchial membrane with lymphoid follicular hyperplasia, but without any definite tumor cells (Figure 3). Acid-fast staining and Periodic Acid-Schiff (PAS) staining were both negative. Not only the traditional culture (including aerobic and anaerobic) but also the galactomannan (GM) test of bronchoalveolar lavage fluid were negative. Surprisingly, the mNGS of bronchoalveolar lavage fluid revealed 4415 sequences of Campylobacter rectus and 1091 sequences of Parvimonas micra.\\nEmpirical antimicrobial therapy commenced immediately with intravenous tazobactam/piperacillin (4.5g three times daily) and ornidazole (500 mg twice daily) from the first day in the hospital. One week later when we got the result of mNGS, etimicin (300mg one time daily) was used in combination to enhance treatment against Gram-negative bacteria. Another two weeks later, the symptom of diarrhea in the patient was considered to be due to the imbalance of intestinal flora induced by long-term extensive use of broad-spectrum antibiotics. Therefore, the anti-infective treatment regimen was reduced to etimicin only. The patient was hospitalized for one month. The results of CT re-examination suggested that the area of infection in the inferior lobe of the left lung was significantly reduced, and the cavity was smaller (Figure 1B). After he was discharged from hospital, he was treated with oral levofloxacin (0.5g once daily) for four months. The condition of the lung was further improved than before (Figure 1C).',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 4,\n",
       "    'case_id': 'PMC7378605_01',\n",
       "    'case_text': 'The child is now 4 years old and has had an excellent outcome. She has a very slight language learning disability and no signs of cardiomyopathy. Anthropometrical measurements are normal according to the WHO standards: p50-75 for length and weight and p25 for head circumference.\\nSo far, she has had only two mild metabolic decompensations coinciding with respiratory infections. Discrete elevations of hepatic transaminases and creatine kinase (maximum 1200 U/L) were detected during these episodes, but no acidosis or hyperammonemia. As a preventive measure, the dose of NCG was doubled during these episodes.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 27,\n",
       "    'case_id': 'PMC9894875_01',\n",
       "    'case_text': \"A 27-year-old man came for treatment complaining of a progressively enlarging mass on his left upper arm over 4 months with occasional slight discomfort. He reported no history of trauma, infection, or prior surgery of the lesion. Magnetic resonance imaging (MRI) confirmed the presence of a well-defined mass located deeply in the outer edge of the middle humerus muscle, but at the focal border, it had protruded into the surrounding muscle. The signal intensity was slightly enhanced on T1-weighted imaging (Figure 1A) and marked heterogeneous enhancement on T2-weighted imaging (Figure 1B). The MRI findings suggested the possibility of fibromatosis. The patient underwent surgery for mass excision. On gross examination, it was an irregular, solitary mass measuring 5.0 cm x 4.0 cm x 4.0 cm, in the muscle with a grayish-white cut surface.\\nMicroscopic examination showed that the tumor was relatively well demarcated, but in the focal, it was infiltrating the adherent muscle (Figure 2A). It was highly cellular and composed of fibroblasts and myofibroblasts arranged in bundles with an interlaced pattern (Figure 2B). Part of the lesion was discohesive and myxoid with a microcystic appearance (Figure 2C). Some tumor cells had mild atypia with active mitotic counts (the average mitotic counts up to 8 per 10 high-power fields, Figure 2D) and mingled conspicuous multinuclear or atypical giant cells (Figure 2E). Erythrocyte extravasation was easily seen on a background of collagenous stroma (Figure 2F), with some hemosiderin deposition and scattered lymphoplasmacytic cells infiltration.\\nImunohistochemical detection, The tumor cells were only positive for smooth muscle actin (SMA) (Figure 3A), negative for cytokeratin, desmin, H-Caldesmon (see supplement data), CD34, S100, ALK, and beta-catenin. The multinuclear giant cells were positive for CD68 (Figure 3B)). The average rate of ki67 positivity was 10% (Figure 3C). According to histopathological and immunohistochemical studies, fibromatosis was first excluded for the tumor's growth pattern and beta-catenin negative. Leiomyosarcoma was ruled out as well for H-Caldesmon and desmin negative. However, it was still difficult to distinguish the tumor from a (myo) fibroblastic sarcoma.\\nMolecular detection was performed on 4 mum paraffin-embedded tumor section by Fluorescence in Situ Hybridization (FISH) using a USP6 dual-color break-apart probe (Guangzhou LBP Medicine Science and Technology Co., Ltd., Guangzhou, China). The FISH results revealed evidence of USP6 gene rearrangement given the division of green and red signals (Figure 3D). The average percentage of USP6 split signals was 40%. Molecular findings confirmed the diagnosis of intramuscular NF. At 56 months after surgery, the patient recovered well with no evidence of recurrence or metastasis by the imaging examination.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 41,\n",
       "    'case_id': 'PMC5890374_01',\n",
       "    'case_text': 'A 41-year old obese (Body mass index: BMI of 31), type II insulin-dependent diabetic female diagnosed with stage II carcinoma of the right breast underwent treatment with neoadjuvant chemotherapy followed by bilateral total skin sparing mastectomies with immediate reconstruction using tissue expanders and acellular dermal matrix (ADM). The ADM employed was ready-to-use AlloDerm (Life Cell Corporation, Branchburg, New Jersey). \\nOn post-operative day 18, the patient developed bilateral breast seromas, requiring needle aspiration using an 18-gauge IV catheter. Mild erythema was noted at this time and a ten-day course of oral levaquin was started. Aspiration was performed again on the right side two days later. Both seroma cultures grew Mucor (zygomycetes) colonies (few colonies). Oral voriconazole 200 mg every 12 hours was started per infectious disease recommendations. Tight glycemic control (<180) was maintained with close follow-up by her endocrinoloist.\\nOn post-operative day 23, dehiscence was noted at the apex of her vertical incision abutting the areola with an area of skin necrosis from mastectomy skin flap ischemia (Figure 1 and 2). The patient was afebrile and exhibited no signs of sepsis. Debridement of the skin and closure of the wound was performed, preserving the tissue expander and ADM. The ADM was intact without expander exposure. There was no purulence or necrosis of tissue deep to the dermis at the site of dehiscence. Subcutaneous tissue and fluid cultures were positive for Mucor (moderate count). Antifungal therapy was switched to posaconazole 800 mg per oral per day. \\nAt the time of her drain removal from this second surgery, biofilm strands from the drain site also grew two colonies of Mucor. She required repeat seroma aspiration one week later, and this time the culture was negative. On week later, repeat seroma aspiration grew out skin flora, and this aspiration was followed one day later with abrupt onset of right breast cellulitis which was successfully treated with two weeks of IV ertapenem and vancomycin. She required additional right breast seroma aspirations, two more times over the next 3 weeks. \\nThe first culture was no growth and second one was positive for skin flora. All aspirations revealed cloudy seroansguinous seroma content, never frankly purulent. Her recurrent seromas resolved, but three months later, her right breast cellulitis recurred, which again responded to IV antibiotics, this time with vancomycin and piperacillin/tazobactam. Thereafter, her healing became uneventful and her tissue expansion was competed to 700 mL bilaterally. \\nShe completed a one-year course of antifungal under the surveillance of infectious disease consultants, which included close monitoring of liver function tests. Seven weeks after completion of posaconazole, bilateral tissue expander exchange to 750 mL high profile smooth silicone round implants was performed. Capsular tissue appeared normal. Post-operatively two years later, the patient has had no recurrent infections (Figure 3). The patient is currently 3 years after her second-stage breast reconstruction doing well.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': None,\n",
       "    'case_id': 'PMC7649943_01',\n",
       "    'case_text': 'A 24-year female, resident of Odisha, presented with complaints of chest pain, fever, cough with yellowish sputum, breathlessness at rest, pain in all limbs more in upper limb compared with lower limb. She also complaint of headache, pain in abdomen often at right hypochondrium associated with vomiting. Patient had similar episodes in the past with frequent history of easy fatigue, anaemia, jaundice, skin ulcerations, upper respiratory infections and gall bladder stones. She had received only 1 unit of blood transfusion in her childhood.',\n",
       "    'gender': 'Female'},\n",
       "   {'age': None,\n",
       "    'case_id': 'PMC7649943_02',\n",
       "    'case_text': 'On examination patient was dyspnoeic with severe pallor, yellowish discoloration of eyes and a small ulcer on the lateral side of her right thigh. She had sinus tachycardia with pulse rate of 131 beats/minute, SPO2 of 78% on room air and blood pressure (BP) of 100/60 mmHg. On auscultation crepitations were present on the right infrascapular and infraaxillary region. Abdominal palpation revealed an enlarged liver measuring 7 cm below the right costal margin and an enlarged spleen measuring 12 cm in its largest dimension. Chest X ray at mid inspiration revealed right anterior rotation with ill-defined radio opacity, and right lower zone consolidation. Abdominal ultrasound revealed splenomegaly of 13.5 cm with obliteration of medullary pyramids.',\n",
       "    'gender': 'Female'},\n",
       "   {'age': None,\n",
       "    'case_id': 'PMC7649943_03',\n",
       "    'case_text': 'Laboratory findings as in Table 1, showed severe anaemia, increase in total leucocyte count predominant with neutrophils, with sickle cells on peripheral smear. Additional test showed positive sickling test and total bilirubin of 5.90 mg/dl. High performance liquid chromatography (HPLC) showed Hb-S = 76 area%, Hb-F = 19 area%, Hb-A1 = 1.7 area%, Hb-A2 = 2 area%. A provisional diagnosis of sickle cell anaemia with hereditary persistence of foetal haemoglobin (Hb-F) or compound heterozygous thalassaemia was made. Patient was second order female child with no similar complaint in other family members. Her father and mother were screened for sickle cell disease by HPLC and were found to be sickle cell trait with Hb-S, 36.2 area% and 33.9 area%, respectively.',\n",
       "    'gender': 'Female'},\n",
       "   {'age': None,\n",
       "    'case_id': 'PMC7649943_04',\n",
       "    'case_text': \"In view of persisting symptoms and discussion with clinician, automated red cell exchange was planned. On day 3 of admission, an internal jugular line was secured and red cell exchange was started on automated cell separator (RCEx). Before the start of procedure, patient's condition deteriorated with sudden fall in SPO2, severe breathlessness, chest pain, fall in blood pressure, feeble pulse and bradycardia. Procedure was postponed and the patient was shifted to intensive care unit (ICU) where she was immediately intubated and given normal saline as bolus with adrenaline in 1 in 10 000 dilution intravenously. Her chest X ray was repeated which showed new pulmonary opacities, and bilateral pulmonary effusion (Figure 1), suggestive of deterioration in condition. Electrocardiography (ECG) was within normal limits and 2D-ECHO shows left ventricular ejection fraction (LVEF) of 60%, normal cardiac dimensions, and valves with no features of pulmonary embolism. Non-contrast CT scan (NCCT) head was normal. On day 8 of admission, in view of persisting and severe symptoms, clinical team requested for RCEx. RCEx was done on patient on ventilator support with blood pressure of 96/58 mmHg on noradrenaline and pulse 122 beats/minutes. Target haematocrit was kept at 30% and fraction of cell remaining (FCR) at 30%, cell separator processed a total of 3178 ml of the whole blood and removed 1929 ml of red cell volume. The blood volume was replaced with 1696 ml (8 units of packed red cell) of leucoreduced Rh and Kell matched and cross match compatible packed red cell having a haematocrit of 55%. During the procedure, patient received 122 ml of acid citrate dextrose as anticoagulant and 40 ml of 0.93% of calcium gluconate in 400 ml normal saline at 1 ml/min to prevent calcium chelation. Whole procedure was completed in 193 minutes and patient was comfortable and did not show any signs of further deterioration. Complete blood count, liver function test, renal function test, ionised calcium and HPLC were repeated after 12 hours as shown in Table 1, showing dramatic improvement in laboratory values. Patient was relieved of chest pain and bone pain immediately after the procedure. Oxygen saturation improved to above 90% on room air. On day 13, patient was asymptomatic, comfortable and was discharged on hydroxyurea 500 mg twice daily, folic acid supplement and advised for influenza and pneumococcal vaccinations. She was followed up monthly for next 3 months with Hb-S load and planned for prophylactic RCEx if Hb-S greater than 50% or if she becomes symptomatic, that is in crisis.\",\n",
       "    'gender': 'Female'},\n",
       "   {'age': None,\n",
       "    'case_id': 'PMC7649943_05',\n",
       "    'case_text': 'She was given instructions to seek medical help in case of fever, new ulcers on limbs, bone pain that does not get away with treatment, abnormal speech, weakness and to prevent herself from infection and dehydration. During her stay in the hospital, genetic analysis of the patient and her parents could not be done but were advised for the confirmation and characterisation of compound heterozygous thalassaemic state with sickle cell disease.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 60,\n",
       "    'case_id': 'PMC3567412_01',\n",
       "    'case_text': 'A 60-year-old woman with no history of tuberculosis, pyothorax or artificial pneumothorax therapy, presented 4 months before her admission an asthenia, fever, chills, and night sweats. Physical examination revealed a mass of 10 cm localised in lateral chest wall (Figure 1). ignificant laboratory findings were as follows: haemoglobin: 9,3g/dL, erythrocyte sedimentation rate: 60 mm/h, LDH rate: 620 UI/ml. Computed tomographic scan confirmed the localisation in chest wall with invasion of the ribs (Figure 2).\\nA biopsy of the chest tumor was performed and revealed a non-Hodgkin lymphoma with null phenotype. Immunohistochemical staining of the specimen was positive for leukocyte common antigen, CD20, and Ki67 and negative for CD3, vimentin, desmin, chromogranin, neuron specific enolase, CD99, and actin.\\nThe patient received four cycles of chemotherapy CHOP 21 (Cyclophosphamide 750 mg/m2 Intraveinously (IV) at day1, doxorubicin 50 mg/m2 IV at day1, vincristine 1, 4 mg/m2 with a maximum total dose of 2 mg IV at day1 and prednisone 40 mg/m2/day per os from day 1 to 5) followed by local radiotherapy, total dose was 40 Gy delivered as 2Gy daily fractions, 5 day per week. She had a complete response maintained for more than 7 months.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 73,\n",
       "    'case_id': 'PMC6536776_01',\n",
       "    'case_text': \"A 73 year old man underwent successful EVAR with a bifurcated aortic stent graft (Excluder; W. L. Gore and Associates Inc., Newark, DE) for a 5.5 cm infrarenal abdominal aortic aneurysm (AAA) following the manufacturer's instruction for use. He had a previous medical history of hypertension. The post-operative course was uneventful and enhanced CT showed no migration or endoleak one week after EVAR. Follow up with enhanced CT revealed no change in the aneurysm sac with a diameter of 5.5 cm for the first three years, no endoleak and no stent graft migration. After three years, the aneurysm sac started shrinking rapidly to 4.0 cm at four years and 3.5 cm at five years.\\nAfter five years and eight months, the patient suffered from fever and back pain with C reactive protein elevated to 20.7 mg/dL and the white blood cell count 19.2x109/L. Blood culture revealed no organisms. Enhanced CT demonstrated enlargement of the aneurysm sac to 4.5 cm and type II endoleak from the third and fourth right lumbar arteries (Fig. 1A and B). Air was seen around the stent graft inside the aneurysm sac, and the margin between the duodenum and AAA was ill defined.\\nDiagnosis of stent graft infection was made, and intravenous antibiotic therapy with meropenem and vancomycin was started. However, as CT showed ventral protrusion of the aneurysm sac two days later (Fig. 2), an emergency operation was indicated.\\nThrough a median laparotomy, the AAA was exposed, and grey malodorous pus was encountered when the aneurysm sac was dissected from the adhesive duodenum. The infrarenal abdominal aorta was clamped above the stent graft, and the common iliac arteries were clamped below the limbs of the stent graft. The stent graft was then wholly removed after opening the aortic sac, and the proximal hooks were removed from the wall of the aorta by pushing the stent graft upwards. Backflow from the third and fourth right lumbar arteries was confirmed. The aneurysm sac was radically debrided together with the surrounding tissue. In the third part of the duodenum there was a small fistula resembling the mouth of a fish measuring 1x1 cm (Fig. 3). The fistula was located away from the anchors at the proximal edge of the Excluder.\\nThe duodenal fistula was closed by direct suture and in situ reconstruction was performed with an 18x9 mm standard polyethylene terephthalate graft (J-graft, Japan Lifeline Co. Ltd., Tokyo, Japan). After vigorous lavage the laparotomy was closed temporarily. The next day, omentopexy was performed, which consisted of wrapping the synthetic prosthesis and covering the suture line on the duodenum with the omental pedicle. The culture of the explanted stent graft revealed only gram negative enterobacter. A fungal test was negative. Intravenous antibiotic therapy with sulbactam/ampicillin and levofloxacin was continued for six weeks. Antibiotic therapy was stopped after confirming no recurrence of infection on computed tomography and laboratory testing. Two years later there has been no recurrence of infection. Informed consent for research was obtained at the outpatient clinic.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 30,\n",
       "    'case_id': 'PMC10313112_01',\n",
       "    'case_text': \"Case 1 (P1) was of a 30-year-old female patient with PV, who exhibited increased haemoglobin level 4 years ago and then underwent bone marrow aspiration and biopsy in a local hospital. The usual MPN-related gene mutations (Table 1) were not detected using qPCR and the bone marrow biopsy result at the initial diagnosis was lost. She was diagnosed with JAK2 unmutated PV at the same hospital and underwent phlebotomy and oral aspirin therapy. The patient visited our hospital in October 2020, and her haemoglobin level was 198.0 g/L. Bone marrow biopsy was conducted again, and the results confirmed diagnosis of MPN (Table 2; Figure 1). Targeted NGS revealed the presence of JAK2 exon12 mutation (p.H538_K539delinsQL) (Figure 2) with a VAF of 20.9%. This mutation is very rare, and was reported only few times in the COSMIC database before May 2023. COSMIC is the catalogue of somatic mutations in cancer, and is the world's largest and most comprehensive resource for exploring the impact of somatic mutations in human cancer (https://cancer.sanger.ac.uk/cosmic?genome=37). It was omitted from initial diagnosis because qPCR did not include this locus.\",\n",
       "    'gender': 'Female'},\n",
       "   {'age': 56,\n",
       "    'case_id': 'PMC10313112_02',\n",
       "    'case_text': 'Case 2 (P2) was of a 56-year-old female patient with ET. The patient presented with dizziness when she first visited the hospital, after which an increased platelet count was noted. She underwent routine blood tests regularly, and the platelet count increased progressively to 812.0 x 10^9/L. Conditions involving increasing number of reactive platelets, such as in infection, bleeding, or tumours, were excluded. The patient then underwent bone marrow aspiration and biopsy. Aspirated bone marrow films showed clues of MPN (Table 2; Figure 1). MPN-related gene mutations were found to be negative using Sanger sequencing. After 6 months of close monitoring, the platelet count did not decrease. Therefore, targeted NGS was conducted, and CALR p.E380Rfs*51 was detected with a VAF of 12.3% (Figure 2). NFE2 p.R284C with a VAF of 14.9%, and TET2 p.Q622* with a VAF of 9.6% were also detected. CALR p.E380Rfs*51 is a novel driver variant; therefore, any relevant report was not retrieved from the COSMIC. Because of the relatively low sensitivity of Sanger sequencing (15%-20%), the mutation was eliminated at initial diagnosis. Subsequently, the patient was administered interferon therapy. After 2 months of treatment, the platelet count decreased to 761 x 10^9/L. The patient then switched to oral hydroxyurea therapy and maintained a stable platelet count that varied in the range of 560-630 x 10^9/L.',\n",
       "    'gender': 'Female'},\n",
       "   {'age': 36,\n",
       "    'case_id': 'PMC10313112_03',\n",
       "    'case_text': 'Case 3 (P3) was of a 36-year-old patient with PMF. She was admitted to our hospital because of pleomorphic adenoma, splenomegaly (with a thickness of 6.3 cm), anaemia, increased leukocyte count, platelet count, and lactate dehydrogenase (LDH) level (954 U/L). Additionally, the patient had constitutional symptoms of night sweats and weight loss. She underwent bone marrow aspiration and biopsy. Peripheral blood films and bone marrow tissues confirmed the diagnosis of MPN (Table 2; Figure 1). Common MPN-related mutations were confirmed to be negative using qPCR. Targeted NGS was performed, and the MPL p.W515_Q516del (Figure 2) mutation with a VAF of 68.9% was identified. ASXL1 p.G996Sfs*3 with a VAF of 46.7%, and EZH2 p.C590Y with a VAF of 48.3% were also identified. MPL p.W515_Q516del is a novel driver variant, and has not been reported in the COSMIC. qPCR did not cover this locus; therefore, this mutation was omitted. After 3 months of treatment with JAK2 inhibitor, the platelet count decreased to normal, constitutional symptoms disappeared, and the spleen shrank by more than 50%.',\n",
       "    'gender': 'Female'},\n",
       "   {'age': 65,\n",
       "    'case_id': 'PMC10313112_04',\n",
       "    'case_text': 'Case 4 (P4) was of a 65-year-old patient with PMF who was diagnosed with triple-negative MPN 3 years ago. He presented to the hospital with fatigue and dyspnoea lasting 8 months. The patient exhibited constitutional symptoms including significant weight loss of 7.5 kg in 20 days. After admission to the hospital, anaemia, increased LDH level (998 U/L), and splenomegaly (with a thickness of 4.7 cm) were observed. Peripheral blood smears and bone marrow tissues revealed the diagnosis the MPN (Table 2; Figure 1). Both qPCR and targeted NGS did not detect JAK2, CALR, or MPL mutations; however, the SH2B3 p.S337Ffs*3 with a VAF of 37.3%, which is associated with JAK/STAT signal transduction pathway, was detected by NGS. The mutation is novel; therefore, any relevant report was not retrieved from the COSMIC. After receiving stimulus to erythrocytes and support treatment, the patient voluntarily left the hospital.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 63,\n",
       "    'case_id': 'PMC4802324_01',\n",
       "    'case_text': 'A 63 years-old woman was admitted in emergency for a pain of the right hypochondria combined with a pneumoperitoneum, after a 3rd episode of high digestive hemorrhages.\\nNine months earlier, the patient had a CPD on a normal pancreas for pancreatic head adenocarcinoma with good evolution. The anatomo-pathological examination concluded of an adenocarcinoma of the head of pancreas pT2N+. An adjuvant chemotherapy by Gemsar and 5-FU is introduced but stopped precociously (3 courses) due to a bad tolerance.\\nThe patient showed a first episode of hematemesis with hemorrhagic shock requiring a hospitalization for 48 h in surgery intensive care (transfusion of three corpuscular caps). Oeso-gastro-duodenal fibroscopy shows three ulcerations on the set-in ileac efferent loop without any hemorrhagic sign, treated by endoscopy. Ten days later a 2nd episode of high digestive haemorrhage, with a state of shock, occurred. The patient was hospitalized for etiological research and monitoring. Two oesogastro-duodenal fiberscopies, followed by a colonoscopy and a video capsule endoscopy did not help to identify the origin of the bleeding. An abdominal computed tomography (CT) angiography with high opacification did not find any active arterial bleeding, neither any pseudo-aneurism of the different branches coming from the celiac trunk (particularly from the gastroduodenal artery stump). It was not found apparent leaks of the pancreatico-jejunal anastomosis.\\nThe occurrence 33 days later after the 1st episode, of a 3rd episode of high digestive hemorrhage combined with faintness and a melena required the carrying out in emergency of an abdominal CT angiography. This showed a pneumoperitoneum of average abundance without any apparent sign of leak. With a stable clinical state, an abdomen tenderness, and because of a surgery made complex by the CPD previous history, without possible detecting of the perforation on abdominal CT scan, a medical treatment with nasogastric tube, proton-pump-inhibitor (PPI) intravenous and antibiotherapy was introduced. After 24 h, the patient was transferred to digestive surgery due to the aggravation of the abdominal pain combined with a light muscular defense. Abdominal CT scan with ingestion of contrast product did not show any leaking of the contrast product. The patient was conscious without any sign of hemodynamic choc, the abdomen was painful with a severe pain on the right hypochondrium combined with a light muscular defense. Biology did not show any signs of cardiovascular decompensation (level of hemoglobin = 8,8 g/dl), nor of hemostasis disorder. An exploratory laparotomy was done due this clinical condition. Surgical exploration showed a chronic sinus between the pancreatico-jejunal anastomosis and the left hemi-liver. The sinus was 1 cm of length; We noted there, an active bleeding of the gastroduodenal artery stump covered by the left hemi-liver (Fig. 1). A perfect hemostasis of the gastro-duodenal artery stump is carried out by a double ligation with Prolen 5/0. A pancreatic cutting is carried out at the level of the fistula, followed by a repairing of the pancreatico-jejunal anastomosis on a solid pancreas and, of a Wirsung canal of moderate caliber. Two TACOSIL compresses are placed on the vessels. A drain is placed on the Wirsung, as well as a multi-tubulated blade ahead of the great omentum and draining the posterior face of the pancreatico-jejunal anastomosis. The pancreatic cutting was not invaded during the extemporaneous anatomo-pathological examination. The operating effects were simple with an authorized exit of fifteen days after the operation. No hemorrhagic recurrence was noted up to this date after eight months of passed time.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 29,\n",
       "    'case_id': 'PMC9830020_01',\n",
       "    'case_text': 'Our patient is a 29-year-old female (height 164 cm, body weight 103 kg, body mass index 38 kg/m2) with GD1. GD1 was diagnosed 10 years ago by molecular testing of the GBA1 gene revealing two pathogenic mutations (c.475C>T [p.Arg159Trp] in exon 5; c.1226A>G [p.Asn409Ser] in exon 9). On examination and investigation at the emergency department, she showed the following signs of GD1: splenomegaly, anemia (hemoglobin level 11.3 g/dl, red blood cell count 4.01 million cells/mul, and hematocrit level 34.4%), and thrombocytopenia (148 000/nl). The patient was on long-term substrate reduction monotherapy with oral eliglustat (daily dose 84 mg) for 2 years. This dosage regimen is based on her cytochrome P450 2D6 genotype (poor metabolizer, PM). The patient did not take any concomitant medication. In February 2021, in a suicidal attempt, she ingested all at once 94 capsules of eliglustat (84 mg of eliglustat per capsule) which is a total of almost 8 g of eliglustat. The patient herself called the ambulance within the first hour after ingestion of the medication. Upon arrival of the emergency physician, she was already somnolent and hemodynamically unstable. The patient showed severe bradycardia (37 bpm) and hypotension (70/50 mmHg). The emergency physician promptly administered atropine (1 mg) and also cafedrine/theoadrenaline (100 mg/5 mg) into a forearm vein. When she was in a stable condition, the patient was transferred to the nearby emergency unit. Upon arrival at hospital, heart rate and blood pressure were no more below normal (heart rate 80 bpm and blood pressure 100/75 mmHg), and the patient remained in a stable condition. No respiratory insufficiency was detected (oxygen saturation 94% and respiratory rate 10/min). Neurological examination revealed mild somnolence with lack of concentration. A complete blood analysis showed normal serum electrolyte levels, normal liver and kidney function, and normal blood glucose levels. A broad toxicology screening in urine (methamphetamine, cocaine, tetrahydrocannabinol, ecstasy, methadone, morphine/heroine, benzodiazepines, tricyclic antidepressants, barbiturate, amphetamines, and buprenorphine) was negative. During 24 h of continuous electrocardiographic monitoring at the intensive care unit an increased frequency of supraventricular ectopic activity and mild first-degree atrioventricular block (PR interval: 206 ms) were observed. The patient improved gradually by supportive care (fluid therapy). After 24 h, the reactions had resolved completely and the patient was transferred to a psychiatric facility for follow-up (suspected undiagnosed schizophrenia). She has reported to a clinician on auditory hallucinations as cause of her suicidal attempt: commanding voices had told her to take the drugs.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 52,\n",
       "    'case_id': 'PMC4499615_01',\n",
       "    'case_text': \"The proband (II-1) is a 52-year-old male who was admitted to our department complaining of abdominal pulsatile mass. Computed tomography angiography (CTA) scan revealed a bilateral common iliac artery aneurysm and abdominal aorta tortuosity (Figure 1(b)). The right common iliac artery aneurysm was estimated to be 5.0 cm in diameter accompanied by mural thrombosis (Figure 1(c)). He also reported a ten-year history of back pain. He was subsequently referred to magnetic resonance image (MRI) evaluation, which showed marked degenerative changes of lumbar spine and narrowing of the spinal cord (Figure 1(d)). He underwent an endovascular repair of the aneurysm and the procedure was uneventful. Family history was positive for sudden death in the proband's father (I-1) at the age of 48, for which the underlying cause remained unknown. Subsequent screening of his children revealed prominent dilation of the ascending aorta in the 22-year-old son (III-1). Neither of his mother (I-2) and daughter (III-2) presented vascular anomalies at the time of evaluation.\\n SMAD3 screening identified a heterozygous substitution of guanine to adenine at nucleotide 266 in the coding sequence of exon 2 (c.266G>A), in individuals II-1 and III-1 (Figure 2(a)). This variant resulted in a transformation of Cysteine into Tyrosine at amino acid position 89 (p.Cys89Tyr). It was not present in the unaffected individuals of the pedigree or in the 100 controls. Furthermore, this variant was not annotated in major databases, such as the Exome Sequencing Project, 1000 Genome, and dbSNP139. The altered amino acid is highly conserved across species (Figure 2(b)). Three programs for analyzing protein functions, PolyPhen2, SIFT, and MutationTaster, predicted that the p.C89Y variants are possibly damaging and disease causing, respectively. All three different algorithm based bioinformatics programs yield a consistent result of detrimental effect of the variant, suggesting that the site (C89) plays pivotal roles in the function of SMAD3.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 53,\n",
       "    'case_id': 'PMC6109579_01',\n",
       "    'case_text': \"A 53-year-old white female presented to outpatient orthopedics with a chief complaint of sharp lumbar back pain radiating down her right leg for 2 weeks. The pain was a 7/10 on the visual analogue scale. Review of symptoms was positive for fatigue and negative for bowel or bladder dysfunction. Pertinent physical exam findings included the following: no tension signs, right antalgic gait, right paraspinal tenderness, and normal lumbar spine range of motion. The neurologic exam was normal except for an absent right patellar reflex. The patient had previously underwent multiple lumbar spine surgeries related to a work injury, including L4-L5 right endoscopic discectomy, L3-S1 laminectomies and posterolateral instrumental fusion, L2-L3 lateral left interbody fusion with posterior instrumentation, and correction of L1-L2 segmental kyphosis with extension of fusion to T10 with T10-L5 posterior segmental instrumentation. X-rays and MRIs were obtained at this time, showing instability and spinal stenosis at L1-2. This was above her prior fusion level.\\nThe patient elected to have a L1-2 laminectomy with removal of all prior posterior spinal instrumentation and extension of the posterior fusion from L2-T10 with instrumentation placed posterior from T10-L5. She had no acute complications following surgery and was discharged on postoperative day 5.\\nAt the patient's 2-week postoperative visit, she reported a 2-day history of acute onset excruciating pain over her lower thoracic region with radiation throughout her ribs and lower back. She also had difficulty walking due to diffuse, ascending weakness, pain, numbness, and tingling in her legs bilaterally, without bowel or bladder dysfunction. The patient reported that she was doing well until the onset of these symptoms and denied any preceding fevers or signs of infection. On physical exam, she was afebrile and her wound was healing well. Neurologic exam revealed varying degrees of muscle weakness in all lower extremity groups with diffuse hyposensitivity to touch over dermatomes L3-S1. There was trace patellar reflexes and absent Achilles reflex bilaterally. She received an immediate thoracic and lumbar MRI with and without contrast. MRI showed no significant cord compression or epidural hematoma or abscess, although there was difficulty interpreting the studies due to extensive spinal hardware. Further imaging was obscured due to her extensive spinal instrumentation from prior surgeries (Figure 1).\\nThe patient returned to the operating room 1 week later for exploration of the spine due to the inconclusive imaging and worrisome symptoms and physical exam findings. Cross-link instrumentation was removed at this time, and her laminectomy at L1 was revised. There was no evidence of postoperative hematoma or spinal compression noted intraoperatively. Neurology was consulted, and postoperative nerve conduction testing and electromyography (EMG) were performed in order to further elucidate the cause of her symptoms (Figure 2). EMG and nerve conduction studies showed generalized nonlength-dependent sensory greater than motor polyneuropathy with mostly axonal features. Given the acute onset of her symptoms and lack of significant demyelinating features on nerve conduction studies, the findings were indicative of AMSAN, which is an axonal variant of GBS.\\nThe patient was started on intravenous immunoglobulin (IVIG) therapy as well as antiganglioside antibodies. During her first month of treatment, she experienced partial neurologic recovery and then relapsed back to her baseline symptoms at 6-week postoperative. She is currently in in-patient rehabilitation being treated with physical therapy, IVIG, and antiganglioside antibodies with minimal neurologic recovery at this time.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 62,\n",
       "    'case_id': 'PMC6739703_01',\n",
       "    'case_text': 'A 62-year-old patient presented with increasing frontal headaches over the preceding 10 days, not relieved by ibuprofen. By the time of presentation, he had developed double vision and drooping of the right eyelid. He reported no other complaints, in particular no fever, rhinitis, or meningeal symptoms. His past medical history was unremarkable, especially with no acute or chronic sinusitis.\\nEndoscopy showed mild edema of the mucosa of the ethmoid cells without any signs of purulent nasal discharge. Ptosis and miosis of the right eye (Fig. 1a) were found, consistent with Horner syndrome. Signs of paralysis of the oculomotor nerve included palsy of right eye movement when looking upwards (Fig. 1b), during adduction (Fig. 1c), and looking downwards. No further neurological deficits were found, and the visual acuity was normal.\\nMagnetic resonance imaging (MRI) of the brain revealed acute right sphenoidal sinusitis with subtle irregularities of the internal carotid artery in the cavernous segment in the 3D TOF MRA and TWIST. Furthermore, thrombosis of the cavernous sinus, ophthalmic vein, superior petrosal sinus, sigmoid sinus, internal jugular vein, and sphenoparietal sinus on the right side (Fig. 2) was seen in post-contrast acquired images. The additional computed tomography scan showed a permeative osseous erosion of the posterior and lateral walls of the right sphenoid sinus, while the carotid artery remained covered by bone (Fig. 2d).\\nGiven the above-mentioned intracranial complications, surgical drainage of the right sphenoidal sinus was indicated. Endoscopic sinus surgery with neuronavigation, including endoscopic septoplasty, middle meatotomy, and drainage of the sphenoidal sinus was performed. Surgical access to the sphenoidal sinuses was exclusively paraseptal with consecutive enlargement of the natural ostium with drainage of purulent discharge of the right sphenoid sinus; the cavity was otherwise intact.\\nPenicillin-resistant Staphylococcus aureus was cultured from the intraoperative nasal swab; the histology showed chronic inflammatory changes of the tissue, with no signs of malignancy. Because of intracranial septic thrombosis the patient was treated empirically with intravenous ceftriaxone and metronidazole, followed by administration of oral sulfamethoxazole and trimethoprim for 39 days as advocated by the consultant for infectious diseases. Additionally, anticoagulation was started at the first postoperative day for a total duration of 6 months. All initial signs of ptosis, miosis, palsy of the oculomotor nerve, and double vision improved progressively postoperatively. Four weeks after surgery, the patient was symptom free apart from a mild headache (Fig. 1d-f). Upon endoscopic examination, the sphenoid sinuses were well accessible, with healed mucosa.\\nOur institutional review board (Kantonale Ethikkommission Bern) does not require formal approval for case reports. The patient granted written permission to publish the case and images.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 44,\n",
       "    'case_id': 'PMC10035645_01',\n",
       "    'case_text': 'A married couple, a 44-year-old male and a 43-year-old female, were evaluated at our facility for OUD. They were previously on methadone for the treatment of OUD and were transitioned successfully to buprenorphine via rapid micro-induction. The rapid micro-induction procedure was performed in an outpatient setting with ancillary medications administered for withdrawal symptom relief. Both patients were assessed and followed on-site by a team composed of an addiction psychiatrist, nursing staff, and an addiction fellow.',\n",
       "    'gender': 'Female'},\n",
       "   {'age': 44,\n",
       "    'case_id': 'PMC10035645_02',\n",
       "    'case_text': 'Patient A was a 44-year-old male patient with a past psychiatric history (PPH) of OUD and attention-deficit/hyperactivity disorder (ADHD) on treatment with methadone 50 milligrams (mg) for the past nine years. He had been stable on that regiment without any complications, but sought a change in treatment due to transportation difficulties and the driving distance to the clinic. Additional past medical history included melanoma and renal cell carcinoma status post left nephrectomy. He was started on hydromorphone and various prescription opioids following his left nephrectomy. The patient had chronic bilateral knee pain in addition to his post-surgical pain which was managed with opioid therapy. He then developed tolerance to the opioids, started to increase the dosage and frequency of opiates, and obtained them illicitly from the streets. He was diagnosed with OUD, started on methadone, and nine years later he decided to switch therapies.',\n",
       "    'gender': 'Male'},\n",
       "   {'age': 43,\n",
       "    'case_id': 'PMC10035645_03',\n",
       "    'case_text': \"Patient B was a 43-year-old female patient with a past medical history of hypothyroidism, PPH of OUD, and ADHD and was on treatment with methadone 67 mg. There were no reported issues or side effects with methadone, but she wanted to make the change to buprenorphine for reasons similar to her husband, including her job, transportation, and children at home.\\nRapid micro-dosing of buprenorphine technique was explained to the patients, and they expressed interest in this method. For patient A, the micro-induction procedure began with a 2 mg sublingual film of buprenorphine. The film was divided into four parts of 0.5 mg buprenorphine that was administered in intervals of one-half to one hour under direct supervision in the clinic. Following complete dosing, 50 mg of methadone was administered.\\nThe Clinical Opiate Withdrawal Score (COWS) scale was used to quantify the severity of opiate withdrawal. The COWS scale establishes severity ranges based on patients' signs or symptoms in the following manner: Scores 5-12 = mild; 13-24 = moderate; 25-36 = moderately severe; more than 36 = severe withdrawal. COWS was obtained at the start of micro-dosing and thirty minutes after completion (Table 1). Mild withdrawal symptoms of sweating, chills, fatigue, and nausea were observed on the first day with a COWS score of 9.\\nThe dose of buprenorphine was increased to 3 mg on day two, followed by the administration of 50 mg of methadone. On day three, patient A was scheduled to take 6 mg of buprenorphine, but decided to take 4 mg to align his treatment course with his wife. On this day, he reported feeling anxious and had a COWS of 0. On day 4, he was administered 8 mg buprenorphine with methadone dosing. On day 5, he started on 12 mg of buprenorphine at home and discontinued methadone. He returned to the clinic the following week dosed at 16 mg buprenorphine, but reported cravings and mild withdrawal symptoms. He expressed interest in increasing the dosage greater than 16 mg. At that time, he was switched to 20 mg daily and entered the stabilization phase of buprenorphine treatment.\\nPatient B followed a similar treatment course, but needed an additional day of micro-induction to achieve the complete transition from methadone to buprenorphine. Micro-dosing of buprenorphine was followed by administration of 67 mg of methadone. She stopped her levothyroxine for hypothyroidism several days prior to starting microinduction due to concern about medication interaction. On day one, she was started on 1 mg buprenorphine, but began to display withdrawal symptoms (chills, fatigue, nausea, myalgias, and anxiety) and had a COWS of 12. At that point, micro-induction was stopped, and methadone was dosed at 67 mg. The patient was administered hydroxyzine 25 mg and clonidine on day one and continued to receive them on days two and three (Table 2).\\nOn day two, she was administered 2 mg buprenorphine and had a COWS of 8, reporting chills, fatigue, abdominal pain, diarrhea, nausea, itching, tremors, and headaches. On the third and fourth days, the patient was dosed with 4 mg and 8 mg of buprenorphine, respectively. On both days, the patient denied having withdrawal symptoms. The following days occurred over the weekend and her dose was increased to 16 mg. She reported having headaches, low energy, and insomnia over both days. She stated that she felt more comfortable at 12 mg and did not want to increase the dose.\\nBoth the patients transitioned successfully to buprenorphine. Four days were required for patient A and five days for patient B to complete the transition, including a day for initial assessment and half days dedicated to clinical care. On follow-up in four weeks, both the patients were stable on buprenorphine and did not report relapse.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 52,\n",
       "    'case_id': 'PMC9772969_01',\n",
       "    'case_text': \"The patient was a morbidly obese 52-year-old female with a past medical history of hypertension, diabetes mellitus, peripheral vascular disease, and coronary artery disease with a smoking history of three packs per day for over 10 years. She was 5'3'', 210 lbs, and had a body mass index (BMI) of 37.2 kg/m2. She first presented to a different hospital's emergency department with chest pain in addition to intermittent claudication. Electrocardiogram (EKG) and cardiac work-up at that time showed unstable angina requiring percutaneous coronary intervention. Femoral artery catheterization was attempted and unsuccessful, so radial artery catheterization had to be performed. After the coronary stent was placed her chest, pain resolved but she continued to have lower extremity rest pain. Computed tomography (CT) performed at that time showed infrarenal occlusion of the aorta with positive collateral flow. She was told to follow-up with her vascular surgeon but was lost to follow-up. One month following her hospital admission, the patient presented to our emergency department for the first time with acutely worsening symptoms of bilateral lower extremity paresthesia and pain at rest. The patient had weak posterior tibial and dorsalis pedis pulses as well as monophasic signals bilaterally on doppler exam. She had intact lower extremity motor function, and appropriate skin color. Further evaluation through computed tomography angiogram at that time revealed infrarenal occlusion of the abdominal aorta and bilateral common iliac arteries with reconstitution of the external iliac arteries (Figure 1). Additional work-up was performed to rule out causes of limb ischemia. EKG showed no signs of acute cardiac ischemia or infarction. Echocardiogram showed normal ejection fraction and no cardiac wall abnormalities. Coagulation studies including D-dimer testing, COVID testing, antiphospholipid antibody syndrome enzyme studies, and Factor 5 Leiden deficiency were all negative. Troponins were not elevated, and neither myoglobin nor creatinine kinase levels were assessed. Renal function testing showed a creatinine level increased to 1.4 from 1.1 at baseline.\\nIntraoperatively, proximal control of the aorta was obtained using a supra-renal cross clamp with control of the renal arteries to prevent renal artery embolization. The common femoral arteries were found to be soft and were cross clamped for distal control. Following control, the proximal aorta was transected inferior to the renal arteries as indicated by our CTa showing total infrarenal aortic occlusion. At the level of transaction, there was dense atherosclerosis with overlying organized thrombus formation. Interestingly, there were no gross signs of ruptured plaque or transmural inflammation identified. An aorto-femoral bypass with a bifurcated 28 mm Terumo (Ann Arbor, MI) Gelsoft plus graft was promptly performed in the traditional fashion (Figure 2). Postoperatively, the patient experienced immediate resolution of her lower extremity symptoms.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 31,\n",
       "    'case_id': 'PMC6642751_01',\n",
       "    'case_text': \"A 31-year-old primigravida was referred to our Maternal Fetal Medicine practice after a routine first-trimester ultrasound at 11 weeks' gestation that revealed a nuchal translucency (NT) of 3.2 mm (Figure 1). The crown rump length measured 11 weeks two days, which was consistent with the patient's last menstrual period which placed her gestational age at 11 weeks. A chorionic villi sample (CVS) was performed at that time. Cytogenetic analysis from the chorionic villi showed a normal male karyotype of 46,XY. The results of the fluorescent in situ hybridization (FISH analysis), Noonan's panel, and microarray for aneuploidy testing were normal. Due to the elevated NT, the patient was referred for a fetal echocardiogram at 15 weeks and 5 days' gestation which revealed a regular atrial rhythm with no structural cardiac abnormalities. An early anatomy ultrasound at 16 weeks and 0 days' gestation was normal, with fetal size appropriate for gestational age and no evidence fetal anomalies.\\nA comprehensive anatomy scan at 20 weeks' and 1-day gestation revealed fetal ascites and a small pleural effusion (Figures 2, 3, and 4). No pericardial effusion was observed. The middle cerebral artery peak systolic velocity (MCA PSV) was elevated (1.95 multiples of the median (MoM)), which was suggestive of fetal anemia. At this time, routine serologic testing for herpes simplex virus (HSV), parvovirus, toxoplasmosis, and cytomegalovirus was performed. The patient underwent amniocentesis with polymerase chain reaction (PCR) testing for parvovirus, toxoplasmosis, cytomegalovirus (CMV), and adenovirus.\\nA follow-up fetal echocardiogram showed no structural cardiac abnormalities or rhythm abnormalities seen as a cause of hydrops. However, the fetus was noted to have scalp edema, worsening pleural effusion and ascites, and, now, a pericardial effusion. Fetal hemodynamics was normal, including Doppler flow patterns in the umbilical artery and vein, ductus venosus and arteriosus, and middle cerebral artery. Fetal ascites was still present at 20 weeks and 2 days' gestation. The MCA PSV was elevated at 75 cm/second. Maternal parvovirus B19 IgG and IgM were elevated, with values of 5.3 and 2.4 (negative or equivocal <1.1), respectively. At this time, the patient recalled an upper respiratory illness at approximately 9 to 10 weeks' gestation. She denied rash, arthralgias, or knowledge of exposure to a child or an adult with symptoms consistent with a parvovirus infection. Given the above findings, the decision was made that day to perform an amniocentesis, a cordocentesis, and an intrauterine transfusion based on the presumptive diagnosis of fetal anemia secondary to an acute parvovirus infection. The fetal hematocrit was 10%, indicating anemia, and 12 cc of blood was transfused, raising the fetal hematocrit to 25%. At the end of the procedure, the MCA PSV was 45 cm/sec, with decreased systolic/diastolic (S/D) ratio of approximately 2.0.\\nAt 20 weeks and 5 days' gestation, the results of the amniocentesis demonstrated elevated parvovirus B19 DNA, quantitative PCR (2,589,801 copies/mL, reference range <100 copies/mL). Fetal ascites persisted the following day at 20 weeks and 6 days' gestation. The MCA PSV was 42 cm/min. A cordocentesis revealed a fetal hematocrit of 24%, and an additional intrauterine transfusion was given for a total volume of 15 cc. The following week, there was no evidence of fetal ascites and the MCA PSV was normal. Subsequent maternal serologic testing for herpes simplex, cytomegalic, and toxoplasmosis virus was negative.\\nFor the remainder of the second trimester, ultrasounds were performed every other week to assess fetal growth and MCA Doppler flow. Weekly antenatal surveillance was performed in the third trimester and was consistently reassuring.\\nAt 37 weeks and 5 days' gestation, the patient was induced for gestational hypertension. She delivered a viable male fetus weighing 2880g at 37 weeks and 6 days. The neonatal Apgar scores were 8 and 9 at 1 and 5 minutes, respectively. At the time of this report, the infant is doing well and developing appropriately for 5 months of age.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 55,\n",
       "    'case_id': 'PMC4628715_01',\n",
       "    'case_text': \"A 55-year-old female applied to our clinic (Department of Oral Implantology, Faculty of Dentistry, Istanbul University) seeking for full prosthetic oral rehabilitation. Patient had already been a wearer of complete dentures in both arches and she wanted them to be replaced by fixed prostheses. After clinical and radiological assessments (Figure 1), considering the loss of the bone and labial support, two treatment options had been presented for the patient: implant supported overdentures or implant supported hybrid dentures. The former was refused by the patient. Considering her financial status, lower arch was preferred to be treated with an implant supported overdenture, considering the insufficient bone height and width.\\nAfter clinical and radiological assessments including computerized tomography, it was decided that the patient was a candidate to receive implant supported rehabilitation. Maxillary and mandibular restorations were planned to restore both hard and soft tissues. Thus, seven internal hexed titanium implants (WIS, Merate, Italy) were inserted according to manufacturer's recommendations. Implant locations were 15, 13, 11, 16, 26, 23, and 21 (Figures 2 and 3). Two-staged approach was employed and implants were left to submerged healing. After four months of an osseointegration period, healing abutments were placed by a palatal crestal incision. A coronally repositioned flap from the palatal soft tissue was achieved in order to facilitate a gain of attached tissue and tension-free closure of the flap around the healing abutments (Figure 4).\\nSoft tissue around the healing abutments was left to mature for 3 weeks after the second-stage surgery. Impressions were taken using the pick-up technique and a try-in for the quantitative assessment of occlusal vertical dimension and aesthetic appearance evaluation was performed on the wax-up. To determine the position of the future teeth, a complete denture try-in with plastic teeth was made. This setup is considered as the facial border of the future planned wax-up and it also helps the technician to construct a computerized design for this hybrid prosthesis which stimulates the final restoration (Figure 5).\\nA porcelain metal substructure was fabricated by CAD-CAM technology, and this structure was sintered by laser to create retention grooves that increase the mechanical retention between the metal and the composite material. In addition to the mechanical retention, chemical retention was provided by a proprietary bonding agent (GC Metalprimer II) (Figures 6, 7, and 8).\\nHybrid prosthesis was fixed to the implant abutments at sites 15, 11, 16, 26, 23, and 21 by occlusal screws. Implant at site 13 was found to be placed, tilted to the vestibular aspect during the first surgery, so this abutment at site 13 was cemented to the framework to provide a parallel path of insertion to the framework and to improve this implant's emergence profile (Figure 9).\\nHybrid denture teeth and the artificial soft tissue were made by 75% Nanofilled Composite and 25% acryl in composition (NFC; UDMA with inorganic nanofillers, Condulor). The lower overdenture was made by acrylic teeth and metal supported acrylic flange. The abutments were screwed to the implants. Hybrid denture was cemented to number 13 and screwed to the other abutments though a torque wrench to generate the preload that keeps the prosthetic components together. After that occlusion was adjusted, the end result provided adequate contour to facilitate maintenance and healthy gingival tissues (Figures 10, 11, and 12).\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 66,\n",
       "    'case_id': 'PMC9674928_01',\n",
       "    'case_text': 'A 66-year-old woman with a history of multiple myeloma presented to our hospital referred from outpatient clinic with dyspnea on exertion which gradually worsening for the last one month. Physical examination was significant for decrease breathing sound and dull percussion on the left hemithorax.\\nThe patient was initially diagnosed with immunoglobulin A (IgA) lambda multiple myeloma in 2011, when she developed back pain and was found to have a lytic lesion involving the T7 vertebra. A bone marrow biopsy revealed borderline hypocellular bone marrow (30%) with 10% plasma cells expressing CD38, CD56, and CD136 with cytoplasmic lambda light chain. The patient received palliative radiation therapy to the lower thoracic vertebrae for 14 days, and subsequently, was started on bortezomib. She received maintenance therapy with bortezomib for 7 years, after which she was taken off the drug with regular surveillance with serum protein electrophoresis (SPEP), urine protein electrophoresis (UPEP), immunofixation, serum free light chain measurement, urine kappa/lambda light chain measurement, and whole-body positron emission tomography/computed tomography (PET/CT) performed every 6 months.\\nThe patient remained in remission for almost 9 years. However, 18 months ago, a PET/CT scan revealed a new PET-avid soft tissue mass along the posterior pleural surface of the right lower lobe with an erosion of the adjacent right ninth rib as well as the right-sided cortex and transverse process of the T9 vertebra. Bilateral PET-avid pulmonary lymphadenopathy was also present. T9 bone biopsy showed infiltration of monoclonal plasma cells and the bone marrow biopsy showed only 8% plasma cells, thus confirming the diagnosis of solitary plasmacytoma of bone (SPB) with minimal marrow involvement. Laboratory result showed normal level of free kappa light chains, free lambda light chains, with normal free kappa/lambda ratio. Local therapy was elected and palliative radiotherapy for the lower thoracic vertebrae was performed.\\n1 month ago, the patient started complaining of significant shortness of breath on exertion. A PET scan was performed and revealed multiple lytic lesions and PET-avid foci in the skeleton, including the occipital and parietal bones of the skull, left maxilla, thoracic and lumbar spine, sacrum, both femurs, sacrococcygeal joint, and the right anterior iliac crest. She was also found to have multiple pleural-based, PET-avid soft tissue lesions in both hemithoraces and a soft tissue nodule in the right lateral chest wall with moderate size right sided pleural effusion (Fig. 1). Laboratory result showed that free kappa light chains 1.38 mg/dl, free lambda light chains 12.13 mg/dl, free kappa/lambda ratio 0.11, IgG 607 mg/dl, IgA 2770 mg/dl, IgM 14 mg/dl, total protein 7.8 g/dl.\\nDuring the current hospitalization, Thoracoscopy with pleural mass biopsy was done and right-side chest tube was inserted (Fig. 2).\\nBiopsy confirmed the diagnosis of extramedullary plasmacytomas in the setting of multiple myeloma relapse (Fig. 3A and B).\\nThe patient was started on pomalidomide, bortezomib, and dexamethasone with regimen of pomalidomide 4 mg by mouth (days 1-14), bortezomib 1.3 mg/m2 (days 1 and 8), and dexamethasone 20 mg by mouth (days 1, 8, and 15) every 21 days of a chemotherapy cycle. Current cycle: 14 day 8. Last received: 9/6/22. -William Scheer, PharmD.\\nOn the fourth day, she was discharged home to be followed up in the outpatient clinic. A repeat PET scan after 6 months and after about 7 cycles of VPD therapy showed Interval diminution in PET activity in multiple bony foci, pleural based areas, left lung, cervical lymph node and right lateral chest wall consistent with a positive response to therapy (Fig. 4A and B). Then the patient maintained on the therapy.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 22,\n",
       "    'case_id': 'PMC7204860_01',\n",
       "    'case_text': 'A 22-year-old woman came to our attention when she was sent to us by the sinologist for the appearance, during breastfeeding, of a right breast lump. She underwent biopsy, which was positive for infiltrating ductal carcinoma with estrogen 5%, progesterone 70%, GATA3, GCDFP15 (focal), E-cadherin, basal markers 8CK5/6, EGFR, and focally p63, negative for Her2, chromogranin, and synaptophysin. The proliferation rate (ki67 was 95%.\\nA positron emission tomography (PET) scan was performed and showed intense accumulation of the metabolic tracer by the known lesion occupying the right mammary gland, multiple lymphadenopathies in the right axillary site (the largest having a maximum diameter of about 21 mm), and, of lesser intensity, a lymphadenopathy along the right internal breast chain. Furthermore, metabolic accumulation was detected at a pulmonary nodule located in the basal segment of the right lower lobe, 16 x 12 mm in size, strongly suspected of being a malignancy.\\nThe patient had no comorbidity and was in excellent condition, according to her young age. She had a term pregnancy 2 years before and she was still breastfeeding her child at the time of the diagnosis. No other causes for hospitalization and no family history of cancer were reported. She had normal body mass index, no history of smoking, nor alcohol habits. She had a good blood exam and a normal cardiac ultrasound; so, she was started on a regimen with docetaxel 75 mg/m2, doxorubicin 50 mg/m2, and cyclophosphamide 600 mg/m2 (TAC regimen) with GCSF support (pegfilgrastim 24 h after chemotherapy).\\nOn the seventh day, the patient came to the oncology ward for abdominal pain that she scored as 8 (VAS scale), obstinate constipation since the day of therapy, and fever. She was found to be neutropenic (neutrophil count 500/mm3) despite the use of GCSF support after chemotherapy. A CT scan showed severe thickening of the ascending colon, part of the caecum and of the proximal transverse colon; the distal transverse colon was normal. The pathological thickness was measured as 15 mm with diffuse hyperemia of the mucosa and marked hypodensity of the submucosa (Fig. 1).\\nNeutropenic enterocolitis (typhlitis) was diagnosed, and we aimed to manage the case with medical treatment which consisted of empiric broad-spectrum antibiotic therapy (piperacillin/tazobactam and amikacin), GCSF (filgrastim 30 one administration per day that was continued for 2 days until neutrophil count was >1,000/mm3), hydration, bowel rest, and parenteral nutrition.\\nAfter 2 days from hospitalization and antibiotic therapy, the neutrophilic count was normal, the fever was gone, but the abdominal pain was getting worse. So, she underwent a second CT scan which reported an increased circumferential thickness of the transverse colon (16 vs. 14 mm) involving almost the entire transverse colon. A surgical evaluation indicated the need for surgery; so, the patient underwent a right hemicolectomy with resection of the caecum and right and transverse colon till the splenic flexure with lateral ileostomy (Fig. 2).\\nThe histological examination showed widespread full-thickness necrotic phenomena with the presence of granulocytic infiltrate involving all the colic wall with extension to the pericolic adipose tissue and to the visceral peritoneum (Fig. 3).',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 41,\n",
       "    'case_id': 'PMC3617894_01',\n",
       "    'case_text': \"The present study was approved by the Ethical Committee of Kanazawa University Graduate School of Medical Science and followed the tenets of the Declaration of Helsinki. In January 2010, a corneal opacity OU was detected in a healthy 41-year-old male by his primary ophthalmologist when the patient was treated for hordeolum in the left eyelid. He was referred to Kanazawa University hospital for corneal opacity OU in May 2010. At the initial visit, his best-corrected visual acuity was 20/16 OD and 20/16 OS. Intraocular pressure was 17 mm Hg OD and 16 mm Hg OS. Central corneal thickness was 633 mum OD and 648 mum OS. Endothelial cell density was 2,336/mm2 OD and 2,352/mm2 OS. Slit-lamp biomicroscopy revealed a subepithelial opacity in the mid-peripheral to peripheral cornea OU and numerous opacities located at the level of Descemet's membrane OU; however, it was difficult to distinguish precisely the location of the opacity (i.e. deep stroma or Descemet's membrane) (fig. 1). No abnormal findings were noted upon fundus examination. In vivo laser confocal microscopy (Heidelberg Retina Tomograph 2 Rostock Cornea Module, Heidelberg Engineering GmbH, Dossenheim, Germany) showed numerous hyperreflective particles in the subepithelium to superficial stroma OU (fig. 2c, d) and hyperreflectivity of Descemet's membrane OU (fig. 2h). No abnormal findings were noted in the epithelial cell layer, midstroma, deep stroma, and endothelial cell layer (fig. 2a, b, e-g, i). The patient had been a soft contact lens user for 16 years. Although his used soft contact lens OU showed a brown discoloration, metal deposition was not detected with differential interference contrast microscope (fig. 3b). The patient had no skin disorders, no history of metal exposure, and no family history of corneal diseases. He had taken an alpha lipoic acid-containing dietary supplement for a 1-year period in 2005. No abnormal findings were noted on blood testing including serum copper, liver and renal function. Based on the clinical appearance and in vivo laser confocal microscopy findings, a differential diagnosis of pre-Descemet's membrane corneal dystrophy and corneal argyrosis was excluded, but the clinical diagnosis was unclear. Visual acuity, clinical symptoms, and degree of corneal opacity did not change in the 1-year follow-up period in this case of Descemet's membrane and subepithelial opacity OU with unknown origin.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 9,\n",
       "    'case_id': 'PMC3864908_01',\n",
       "    'case_text': 'The proband is an Italian 9-years-old boy, offspring to first cousins, with an older and healthy sister. We followed this patient since the age of 2 years. He was born at 40 weeks after an uneventful pregnancy and delivery. During the first months of life, the child presented hypertonus and eye rolling movements. Afterwards, a severe delay of psychomotor development became apparent, characterized by legs hypertonia, axial hypotonia, dyskinetic movements and myoclonic jerks of the arms and the head, no eye contact, and uncoordinated eye movements. The first epileptic seizure occurred at 5 months without fever, characterized by salivation, loss of contact and clonic jerks on the left side of the body. The first seizure lasted 20 minutes and the interictal EEG showed slow waves on the left occipital regions. Over time, several seizure types occurred, characterized by: a) left eye and head deviation with clonic jerks on the left side of the body; b) generalized hypertonia, loss of contact, uncoordinated movements of eye and limbs, cyanosis, and facial and arms twitching; or c) loss of contact, generalized hypotonia and clonic jerks, and tachycardia or bradychardia. Occasionally, at the end of the ictal event, dyskinetic (particularly choreiform) movements of the limbs appeared, without recovery of consciousness. The seizures, with or without fever, could be prolonged (20-30 minutes) and were frequently followed by sleep. Between seizures, the child always showed head tonic extension, erratic limb movements and tremor. The interictal EEG showed multifocal spikes over the right centro-temporal and the left parieto-occipital regions.\\nAt three years of age, absences with eye up deviation and eyelid myoclonus appeared ( Figure 1 ). The other seizure types persisted, although reduced in frequency. Seizures were resistant to many drugs (phenobarbital, benzodiazepine, valproic acid, levetiracetam, lamotrigine); absences frequency was improved by ethosuximide. The EEG recordings showed slowing background activity, multifocal, diffuse paroxysmal abnormalities, and a transitory photosensitivity.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 34,\n",
       "    'case_id': 'PMC8378491_01',\n",
       "    'case_text': \"A 34-year-old Indian male patient reported with a chief complaint of sensitivity to hot and cold and pain while biting concerning the upper right side last two teeth for 2 weeks. The patient gave a history of pain that persisted for about a few minutes even after removing the stimulus, and sometimes, it occurred spontaneously. The patient had good general health without any significant medical history. The patient gave an account of root canal treatment and crown placement in his upper right first molar tooth 2 years ago. On clinical examination, tooth 17 had mesial caries, and tooth 16 had a crown. There was no extraoral or intraoral swelling or sinus tract associated with the concerned teeth. The attached gingiva was normal in appearance and palpation. Both the teeth were nontender to percussion. Cold testing (Roeko Endo Frost, Coltene/Whaledent Inc., OH, USA) showed an immediate and prolonged response in tooth 17. Pre-operative periapical radiographs revealed caries almost approaching mesial pulp horns concerning tooth 16 and a typical periradicular architecture. Radiograph also revealed inadequately obturated tooth 16 and full coverage extra coronal restoration [Figure 1A and B]. Tooth 17 was diagnosed with symptomatic irreversible pulpitis with normal periapical tissues. Tooth 16 was diagnosed with previously endodontically treated. We planned for a root canal treatment in tooth 17 and a nonsurgical retreatment for tooth 16. For the sake of convenience, we have limited the description to the treatment performed only on the maxillary second molar.\\nAfter taking informed consent, local anesthesia was administered using lidocaine hydrochloride 2% with adrenaline 1:80,000 (Lignospan Special; Septodont, Saint-Maur-Des-Fosse, France). Access opening was made under rubber dam isolation and magnification (OPMI Pico Carl Zeiss Meditec AG, Jena, Germany). Three mesial canals, one distobuccal (DB), and one palatal canal were detected on exploration. Coronal flaring was done (Hyflex 25/08) after negotiation with a no. 10 and 15 k file. A soft, sticky catch between the MB 3 and MB2 created doubt for the presence of the fourth mesial canal as well [Figure 1D]. The access was temporized, and a limited Field of View (FOV 5 cm x 5 cm) CBCT scan (Carestream CS9300 imaging system; Carestream Health, Inc., New York) was advised to confirm the findings.\\nImage volume was reconstructed with isotropic isometric 90 mum x 90 mum x 90 mum voxels. The workstation comprised the dual monitors (Dell 24-inch nonglossy monitor (1920 x 1200 resolution) with a Dell Precision Workstation using CS 3D software (v3.5.7). CBCT revealed four canals in the mesiobuccal root, two canals in the DB root, and one palatal canal. The configuration of mesial canals was (4-1). What we had located were MB1, MB2, and MB4. A small opening for MB3 was present between MB2 and MB4, merging with MB4 in the middle third. MB1, MB2, and MB4 all joined together as one canal in the apical one third [Figure 2A-F]. There was one canal orifice at the floor for the DB canal, dividing into two and then reuniting again in the middle third and continuing as a single canal till the apex exhibiting Vertucci's Type III (1-2-1) pattern [Figure 2A-F].\\nIn the next visit, working length was established using an electronic apex locator (Canal Pro, Coltene/Whaledent, GmbH + Co. KG, Germany) and reconfirmed by periapical radiographs from different angulations [Figure 1C and F]. Canals were shaped using Hyflex CM (Coltene/Whaledent Inc., OH, USA) files up to the following sizes: MB1-25/06, MB2-25/04, MB3-25/04, MB4-25/04 [Figure 1E]. The DB was shaped till 30/04, and the palatal canal up to size 40/04. After taking a master cone radiograph [Figure 1G], the final irrigation protocol was employed. Sodium hypochlorite was activated using Endoactivator (Dentsply Maillefer, Ballaigues Switzerland) followed by 17% ethylenediaminetetraacetic acid for 1 min per canal. Normal saline was used as the final flush. The canals were dried using paper points and obturated using AH Plus sealer (Dentsply, DeTrey, GmbH, Germany) employing warm vertical compaction (Elements, Sybron Endo, Glendora, CA) technique. The access cavity was restored with composite resin (Filtek P 60,3M ESPE, USA) [Figure 1H and I]. A post obturation CBCT investigation confirmed satisfactory obturation in all the canals [Figure 2G-J]. Photographs were taken directly through the microscope's eyepiece by smartphone (Moto G3, Motorola Mobility, Lenovo, China) as a beam splitter, and camera accessories were not available for documentation.\\nMetal ceramic crowns were given for both the teeth. A 1, 2, and 4-year follow-up radiographs [Figure 1J-L] showed normal periradicular findings.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 52,\n",
       "    'case_id': 'PMC6051121_01',\n",
       "    'case_text': 'A 52-year-old farmer was referred to us 7 hours after he had met with a high-velocity road traffic accident. He was resuscitated as per the ATLS protocol at the hospital where he was initially treated and when he arrived at the casualty department of our hospital, he was conscious and all his vital parameters were within normal limits. He also gave the history that he was under treatment for segmental myoclonus which was characterised by semirhythmic involuntary muscle contractions.\\nHis radiographs showed a left-sided posterior acetabular wall fracture (AO type 6 2 A1). He also had an ipsilateral femoral neck fracture with the femoral head displaced anteriorly (Figures 1(a) and 1(b)) and also an associated middle-third fracture of the shaft of the femur (Figure 1(c)). He also had an extra-articular distal femur fracture on the opposite side (AO type 3 3 A1). On arrival, his serum lactate level was 1.9 mmol/l indicating that he had been adequately resuscitated.\\nHe was taken for definitive surgery 9 hours after arrival. The patient was positioned in the lateral position and a posterolateral approach was planned to address the acetabular and femoral head fractures. Upon dissection, the femoral head (Figure 2(a)) was found to have buttonholed and displaced anteriorly through the capsule which was found to be torn. The posterior wall of the acetabulum was addressed using two contoured reconstruction plates (Figure 2(b)). Using the trochanteric flip osteotomy, better access to the femoral neck was achieved and the femoral head was reduced anatomically and secured with K-wires. Then the femoral shaft fracture was reduced by opening the fracture site and held with a clamp. The femoral head fracture and the shaft fracture were fixed with an antegrade femoral nail with two screws securing the femoral head (Figures 2(c) and 2(d)). The flip osteotomy was fixed using a tension band wire and the joint was reduced. The torn capsule was sutured. Closure was done in layers. The operating time was 4 hours and the intraoperative blood loss was 600 ml. Three days following this surgery, the contralateral distal femur fracture was addressed using a titanium locking plate. The postoperative period was uneventful.\\nThree weeks after the initial surgeries, the patient experienced an episode of rhythmic contractions of the lower limbs at his home. He presented to us with an anterior dislocation of the left hip joint (Figures 3(a) and 3(b)). An open surgery was done to reduce the left hip joint (Figure 3(c)). Considering the displacement of the femoral head at the time of initial presentation, the chances of avascular necrosis of the femoral head was explained to the patient. The patient was also on follow-up treatment with a neurologist to manage the myoclonus problem.\\nFour weeks after the surgery to relocate the femoral head, non-weight-bearing mobilization was initiated. As expected, avascular necrosis of the femoral head occurred (Figure 4(a)) and we waited for union of the femoral shaft to occur as any procedure to address the femoral head would require removal of the intramedullary nail.\\nEight months after the initial surgery and after union of the femoral shaft fracture, the patient was planned for total hip replacement surgery. Through a posterior approach, the antegrade femoral nail was removed. The acetabulum was reconstructed using a cage, and an uncemented hydroxyapatite-coated stem was used for the femur (Figure 4(b)). A ceramic on a polybearing surface was used. Postoperatively, there was no shortening of the limb. Immediate full weight-bearing mobilization was started using walker support. One year following the hip replacement surgery and 22 months following the initial trauma, the patient was ambulatory without any support and able to do all activities with an LEFS (lower extremity functional score) of 72. The radiographs showed complete union of all the fractures and there was no loosening of the femoral prosthesis.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 81,\n",
       "    'case_id': 'PMC9116235_01',\n",
       "    'case_text': 'An 81-year-old male patient presented with diagnosis of severe aortic stenosis and a history of chronic ischemic cardiopathy with previous percutaneous transluminal coronary angioplasty (PTCA) and a coronary artery bypass grafting; recent vein graft PTCA for the posterolateral branch of the circumflex artery; carotidopathy and abdominal aortic aneurism with thrombotic stratification. There were symptoms of heart failure (NYHA II), and the Heart Team opted for TA-TAVI.\\nOn November 2016, the patient underwent TAVI to implant a 3-29 mm Edwards Sapien valve (Edwards Lifesciences, Irvine, CA, USA) via left anterior mini-thoracotomy. Both the operation and the immediate post-operative course were devoid of significant complications, allowing rapid weaning off pharmacological support, and extubation after 6 h. After 6 days, the patient was discharged in good general clinical and cardiocirculatory condition. The surgical site was as expected at discharge and early post-operative check-ups.\\nHowever, roughly 18 months after surgery, and despite appearing in good health and totally asymptomatic, the patient was once more seen by the heart surgeon due to a previously unnoticed apex beat suggestive of left ventricular pseudoaneurism. Thoracic CT revealed a 40 x 54 x 39 mm plurilocular accumulation with density greater than fluid from the anterior wall of the left ventricle to the subcutaneous soft tissues, through the intercostal space between ribs 5 and 6; its walls were significantly enhanced after contrast. Cardiac MRI was indicative of siero-haematic accumulation with no evidence of communication with the left ventricular cavity or signs of active bleeding.\\nSurgery was performed to drain the accumulation, exposing the cardiac apex and removing the sutures and foreign matter from the previous operation (sent for culture, this was negative for bacterial growth). Curettage was performed, leaving the thoracotomy open until the wound was clean. Antibiotic therapy with Daptomycin was administered in the post-op and for 2 weeks. After three weeks there was a wide, full-thickness defect in the thoracic wall exposing left ventricle movement.\\nThe Plastic Surgery proposed via perforator flap repair. A portable Doppler probe was used to identify an intercostal artery perforator in the 6th intercostal space; a tear-shape flap was centred on this vessel, with the upper margin of the flap coinciding with the lower margin of the defect (Figure 1). After debridement, the flap was raised and the pedicle directly examinated. We found that the flap could be sufficiently mobilised without using the island technique, thereby sparing the inferior and medial extensions of the surgical incision. The portion of tissue distal to the perforator was de-epithelialized and used to fill the defect; fibrin sealant Tisseel (Baxter Healthcare Corp., Deerfield, IL) was applied to promote flap adhesion to the surrounding tissue and further reduce dead space (Figure 2(A-C)). The wound was closed by bringing the upper margin of the flap to the upper margin of the defect (Figure 3). Surgery time for wound cleaning and reconstruction was 100 min. At the last clinical and CT control (June 2019) the flap was completely consolidated with the thoracic tissues, scars were well healed and no distortion of the thoracic surface was noted (Figure 4(A,B)).',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 23,\n",
       "    'case_id': 'PMC3956971_01',\n",
       "    'case_text': \"A 23-year-old female presented with a 1-year history of pain in the left hip. The pain was located in the groin region and her symptom had gradually increased. At her initial visit, a physical examination of the hip revealed limited range of motion, particularly in flexion and internal rotation. Additionally, the anterior impingement test was positive with pain induced on flexion combined with internal rotation. The routine radiological examination (anterior-posterior radiograph) showed findings of DDH with a Sharp angle and centre-edge (CE) angle of 50  and 7 , respectively. The crossover sign and posterior wall sign were identified by radiography and computed tomography indicating the presence of acetabular retroversion (Fig. 1). Based on the clinical and radiological findings, a diagnosis of DDH combined with acetabular retroversion was made for this patient. Considering the persistent nature of pain and disability for the preceding year, surgical intervention was indicated. \\nAt surgery, hip arthroscopy was performed prior to CPO. The surgical set-up for hip arthroscopy followed the technique reported by Philippon et al.. Under general anaesthesia, the patient was positioned supine on the fracture table that allowed independent lower extremity traction. Two portals (lateral and anterolateral) were established for the scope and the instruments. The arthroscopic examination revealed a full thickness labral tear at the anterior-superior region (Fig. 2). A labral tear was identified at the anterosuperior edge of the acetabulum, and the tear was fixed back to the rim using two suture anchors (Fig. 3). Additionally, a motorized burr and shaver were used to remove the osteochondral surface and synovium at and around the head-neck junction to avoid impingement on the repaired site. Subsequently, CPO was carried out following the technique described by Naito et al. with the patient repositioned on the operative table in supine position. Three poly-l-lactic acid screws were used to fix the reoriented acetabular fragment, while two double-threaded metal screws were used for the fixation of the osteotomized anterior superior iliac supine. The post-operative radiograph showed improved acetabular coverage of the femoral head with a resultant Sharp angle of 36  and CE angle of 50 , while the crossover sign as well as the posterior wall sign was no longer evident (Fig. 4). Post-operatively, passive motion of the operative hip was initiated on the first post-operative day. Weight-bearing was not allowed for 2 weeks. Thereafter, partial weight-bearing began with progression to full weight-bearing at 8 weeks.   \\nHealing of the osteotomy site and functional recovery were accomplished uneventfully during the subsequent period. Six months after the surgery, the patient returned to her original job as a nurse without left hip pain. The D'Aubigne and Postel hip score improved from 10/18 preoperatively to 17/18 at the 18-month follow-up.\\nThe Review Board of the Hyogo College of Medicine approved this study (No. 1215), and the appropriate written informed consent was obtained from the patient.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 25,\n",
       "    'case_id': 'PMC8448584_01',\n",
       "    'case_text': \"Case 1 was a 25-year-old woman receiving oral contraceptives for treating dysmenorrhea. The patient was injured in a motorcycle accident and was admitted to our hospital because of abdominal pain. Her vital signs were as follows: Glasgow Coma Scale score, 15; arterial blood pressure, 106/82 mmHg; heart rate, 88 b.p.m.; and oxygen saturation, 97%. The initial blood test results were as follows: hemoglobin level, 16.7 g/dL; platelet count, 221,000/mm3; prothrombin time, 11.7 s; activated partial thromboplastin time (APTT), 21.4 s; aspartate transaminase level, 398 IU/L; and alanine transaminase level, 349 IU/L. The contrast-enhanced computed tomography (CT) findings revealed hepatic contusion of the sixth segment based on Couinaud's classification, and classified as grade 1 according to the AAST classification. No other traumas were detected. The patient was treated conservatively and started walking the day after the injury to prevent thrombosis. Anticoagulants were not provided because of concerns regarding bleeding complications after trauma. During hospitalization, the patient was followed-up with coagulation tests, which showed an upward trend. The contrast-enhanced CT findings at 1 week after the injury revealed thrombus formation with a maximum diameter of 0.6 cm and a length of 0.2 cm (Fig. 1). During this time, the blood coagulation factor was on the rise. Unfractionated heparin treatment was initiated, and APTT was controlled at 50-60 s. At 2 weeks after the accident, the contrast-enhanced CT findings showed that the thrombus had shrunk, and the patient was discharged after replacing the anticoagulant with oral medication.\",\n",
       "    'gender': 'Female'},\n",
       "   {'age': 58,\n",
       "    'case_id': 'PMC8448584_02',\n",
       "    'case_text': \"Case 2 was a 58-year-old man who was injured when he was hit from behind by a motorcycle. His vital signs were as follows: Glasgow Coma Scale score, 14; arterial blood pressure, 118/99 mmHg; heart rate, 88 b.p.m.; and oxygen saturation, 94%. The initial blood test results were as follows: hemoglobin level, 15.4 g/dL; platelet count, 218,000/mm3; prothrombin time, 11.5 s; APTT, 24.3 s; aspartate transaminase level, 526 IU/L; and alanine transaminase level, 545 IU/L. The contrast-enhanced CT findings revealed hepatic contusion of the sixth segment based on Couinaud's classification, and classified as grade 1 according to the AAST classification. The patient also presented traumatic subarachnoid hemorrhage, facial bone fracture, right hemothorax, and multiple rib fractures. We treated the liver injury conservatively and followed up with contrast-enhanced CT at 1 week after the accident. The findings showed a false aneurysm of the hepatic artery at the liver injury site and a thrombus (maximum diameter, 1.5 cm; length, 6.5 cm) in the IVC (Fig. 2). As in Case 1, the patient started walking early, but was not treated with anticoagulants. The hepatic false aneurysm was treated with arterial embolization after implanting an IVC filter. At 1 week after unfractionated heparin treatment, the contrast-enhanced CT findings showed that the thrombus had shrunk. The patient was discharged after replacing the anticoagulant with oral medication.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 50,\n",
       "    'case_id': 'PMC8675622_01',\n",
       "    'case_text': \"A 50-year-old male presented to a nephrology clinic for evaluation of persistent proteinuria. His medical history was only pertinent for seasonal allergy and a mild COVID-19 infection that did not require hospital admission 4 months prior to evaluation. He was taking no medications. Six weeks prior to presentation, the patient had developed a skin rash on his lower legs that erupted 2 weeks after he received the first dose of a SARS-CoV-2 mRNA vaccine (BNT162b2 (mRNA), Pfizer, Inc) (Figure 1). His primary care provider treated the rash with fluocinonide 0.05% cream, applied to the affected area twice daily for 1 to 2 weeks. Three weeks after the first vaccine injection, the patient received his scheduled second vaccine injection. Within 2 days, the skin rash reappeared. This time, the lesions were more severe in nature, with violaceous nonblanching papules and blisters involving the same area on his lower legs but also affecting his thighs, the dorsal aspect of his forearms, lower abdomen, upper back, and buttocks. He reported concomitant myalgias. He denied gross hematuria or dark or foamy urine. Skin biopsy revealed IgA-dominant leukocytoclastic vasculitis. The patient was treated with prednisone for 3 weeks: 60 mg daily for the first week, 40 mg daily for the second week, and 20 mg daily for the third week.\\nAfter completion of 2 weeks of oral corticosteroids, urinalysis revealed proteinuria, and a nephrology consultation was requested. On examination in the nephrology clinic, the patient's vital signs were normal with blood pressure of 122/81 mmHg. Healing papules were noted on his lower extremities, but otherwise the physical examination was normal. Laboratory data are shown in Table 1. Two weeks after the second dose of vaccine, serum creatinine was normal at 0.9 mg/dL. Microscopic examination of the urinary sediment revealed acanthocytes (Figure 1). Three weeks after the second dose of vaccine, urine protein to creatinine ratio (UPCR) was 1.1 g/day. Serum complements were normal, and all pertinent serology was negative. A second UPCR repeated 1 week later (4 weeks after the second dose of vaccine) was still elevated at 0.8 g/day. Microscopic examination of the urinary sediment was repeated, and acanthocytes were again identified.\\nUpon discussion of risks and benefits of establishing a diagnosis, the patient agreed to a kidney biopsy. The biopsy was performed without complications and consisted of 16 glomeruli by light and immunofluorescence microscopy with 2 globally sclerosed with diagnostic changes of an IgA nephropathy with dominant polyclonal, lambda slightly more than kappa, mesangial staining by immunofluorescence microscopy, and corresponding scattered mesangial deposits by electron microscopy. Mild mesangial hypercellularity was present in only 1 of the 16 glomeruli in the light microscopy sample, with no endocapillary hypercellularity, no segmental sclerosis, minimal (approximately 5%) interstitial fibrosis and tubular atrophy, and no crescents or necrosis (Figure 2). The findings were diagnosed as IgA nephropathy, which in the context of the skin lesions was consistent with IgA vasculitis. Although the MEST-C score has not been validated in IgA vasculitis, these lesions correspond to M0E0S0T0C0 (M=mesangial proliferation, E=endocapillary proliferation, S=segmental sclerosis, T=tubulointerstitial fibrosis, C=crescents).\\nAfter the kidney biopsy, the patient began treatment with lisinopril 10 mg orally daily. No further immunosuppression was given. At a follow-up visit 1 week after the kidney biopsy, the rash had subsided completely. The UPCR 4 weeks after starting the lisinopril was 0.5 g/day. Figure 3 presents a timeline of the case.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 44,\n",
       "    'case_id': 'PMC4319252_01',\n",
       "    'case_text': 'A 44 year old single male, presented to our outpatient department with complaints of day time excessive sleepiness, lethargy, low mood and disturbed sleep at night for the past 3 months. History revealed that these symptoms were triggered by the death of his father. On detailed evaluation, it was found that he had been on treatment for his mental illness from 2005. The course of illness was continuous characterized by withdrawn behavior, preoccupation, fear, auditory hallucinations, referential delusions and decline in social and occupational functioning. He was evaluated by a psychiatrist and started on psychotropics. During follow-up, the patient complained of episodes of depressed mood, anxiety and sleep disturbance, lethargy and sleepiness that affected his shift work, for which he was prescribed modafinil 200 mg, along with the antipsychotics Risperidone 4 mg and Amisulpride 400 mg. The patient himself gradually increased the dose to overcome the drowsiness that interrupted his shift work. He started with 100 mg every 3-4 h over a shift work of 12 h. For the last 6 months he was unable to overcome his sleepiness during work without modafinil 100 mg/h thus making a total of 1200 mg/day of modafinil which he used to obtain over the counter. He claimed to have symptoms of worsening of lethargy, tremors of hands, anxiety and erratic sleep hours when he skipped modafinil, patient reported a sense of well-being only with the drug and with the above dose.\\nThere was no family history of mental illness. Physical examination was within normal limits except for fine tremors. His blood investigations gave the following values hemoglobin - 12.4 gm%;, WBC count - 6300 cells/mm3; platelet count - 2.4 lakhs/mm3;, random blood sugar - 122 mg/dl. His metabolic parameters including renal function, liver function, lipid profile were within normal limits. Electrocardiogram showed sinus rhythm and echocardiogram showed normal left ventricular function.\\nThe provisional diagnosis made was schizoaffective disorder currently in partial remission. An additional diagnosis of modafinil dependence syndrome (dependence criteria as per DSM V) was made in view of the tolerance, withdrawal, inability to cut down, progressive increase in the amount of drug over a longer period of time and craving.\\nThe dose was tapered slowly over a period of 1 month with 100 mg every 2-3 days and started on bupropion. He reported sleep disturbance, increased sense of body warmth, lethargy and low mood during the process of tapering the drug. Low dose of clonazepam was added to reduce the withdrawal symptoms. Patient reported significant improvement in his sleep pattern. His dysphoric mood and lethargy improved and his level of anhedonia and amotivation decreased.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 27,\n",
       "    'case_id': 'PMC6324112_01',\n",
       "    'case_text': 'A 27-year-old Asian-Indian lady, systemically normal, with diffuse iris hypopigmentation, telecanthus, mild synophrys with a congenital white forelock treated with hair color and 20/20 vision in both eyes presented for treatment of the heterogeneous iris color [Fig. 1a]. Fundus examination revealed a sectoral superonasal hypopigmented choroid in the left eye [Fig. 1b]. Fundus autofluorescence revealed hyperautofluorescence through the hypopigmented choroidal region in the left eye [Fig. 1c], indicating unmasking of scleral autofluorescence. The patient was diagnosed as a case of Waardenburg syndrome Type 1 and was offered a cosmetic contact lens. Audiometry on both sides and gastrointestinal examination was normal.\\nWaardenburg syndrome has four subtypes distinguished by their physical characteristics and sometimes by their genetic cause. Iris and choroidal hypopigmentation are central to all the subtypes [Fig. 1]. Telecanthus is more frequent in type 1, and hearing loss is more frequent in Type II. Type III includes limb anomalies predominantly of upper limb. Type IV is associated with Hirschsprung disease, an intestinal disorder that causes severe constipation or blockage of the intestine. According to the phenotypic presentation, the systemic work-up to classify the patient into one of the subtypes is crucial.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 22,\n",
       "    'case_id': 'PMC6409012_01',\n",
       "    'case_text': 'A healthy 22-year-old male presented with a two-week history of hemoptysis, weight loss of 10 pounds, generalized fatigue, and persistent night sweats. On physical examination, he had scattered rhonchi in both lungs. There was no palpable peripheral lymphadenopathy or organomegaly in the abdomen. The testes were normal to exam without palpable masses. The CT of the chest revealed innumerable pulmonary nodules concerning for metastatic disease (Figure 1). CT abdomen showed a 6.9 x 8.0 x 7.6 cm retroperitoneal mass. An US of the testicles was done showing an ill-defined hypoechoic structure measuring 8 mm within the right testicle. He underwent a CT-guided lung nodule biopsy, which revealed metastatic choriocarcinoma. The serum B-hCG level was 274,465 IU/L. The patient underwent right orchiectomy consistent with choriocarcinoma. A diagnosis of stage IIIC choriocarcinoma of the right testis with metastasis to the retroperitoneum and lungs was made. He delayed the treatment to seek another opinion and elected to proceed with sperm banking. 16 days after diagnosis, the patient returned to the emergency department with worsened hemoptysis, melena, tachycardia, tachypnea, and hypoxia. His serum B-hCG level had increased to 1,629,195 IU/L. The patient was transferred to the medical intensive care unit, and chemotherapy was started on an urgent basis with etoposide, ifosfamide, and cisplatin (VIP) with mesna support.\\nOver the next few days, his respiratory status declined as he developed severe acute respiratory distress syndrome and, therefore, was intubated. Due to the high tumor burden and worsening of his clinical status after the initiation of chemotherapy, a diagnosis of choriocarcinoma syndrome was made. He completed 5 days of planned chemotherapy but remained in critical condition needing increased ventilator support. In spite of maximal respiratory support, the patient remained hypoxic. Extracorporeal membrane oxygenation was considered, but due to gastrointestinal bleeding, he was not a candidate. He eventually passed away due to hypoxic cardiac arrest.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 60,\n",
       "    'case_id': 'PMC5366790_01',\n",
       "    'case_text': 'A 60-year-old man from a rural area of Saltillo, northern Mexico, came to our institution presenting an ulcerated lesion on the left lateral border of the tongue of 1.5 cm of diameter. According to the patient the lesion has been growing for the last 5 months (Figure 1). He is a nonsmoker, with no evidences of any systemic disease. Considering the clinical aspects, age of the patient, and poor oral health, epidermoid carcinoma was considered as diagnosis. After an excisional biopsy the diagnosis was of coccidioidomycosis (Figure 2).\\nHistology demonstrated a granulomatous lesion with abundant lymphoplasmacytic chronic inflammatory infiltrate and multinucleated giant cells with spherical cytoplasmic inclusions of different size which correspond to the infectious agent C. immitis (Figures 3-6).',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 79,\n",
       "    'case_id': 'PMC6899263_01',\n",
       "    'case_text': 'A 79-year-old male was diagnosed with prostate cancer in 2003 after a screening prostate-specific antigen (PSA) level of 7 ng/mL, alongside a firm prostate upon digital rectal examination. A transrectal ultrasound (TRUS) guided biopsy at the time revealed a Gleason score of 7 (4 + 3) adenocarcinoma of the prostate. He underwent an open retropubic radical prostatectomy with bilateral pelvic lymph node dissection. The final pathology result revealed a Gleason score of 7 (4 + 3) adenocarcinoma with prostatic capsule and seminal vesicle involvement as well as perineural invasion. Studies were consistent with a pT3bN0M0R0 disease; surgical margins were negative. Postsurgical PSA dropped to a nadir of less than 0.02 ng/mL.\\nThree years after his surgery, his PSA level gradually rose to 0.5 ng/mL for which he was started on adjuvant external beam radiation therapy (EBRT) and intermittent androgen deprivation therapy (ADT) using Goserelin acetate. Consequently, his PSA dropped down to less than 0.02 ng/mL yet rose back up to a level of 1.06 ng/mL in November 2010, i.e., seven years post operation (Figure 1). During that time, the patient was maintained on continuous ADT.\\nThroughout the years, his PSA levels were steadily increasing; an abrupt rise in PSA to 3.9 ng/mL was noted in January 2019, sixteen years post operation (Figure 1). Physical exam at the time revealed a normal genitourinary examination along with a flat prostatic fossa upon digital rectal examination. Urine culture at the time was also negative. Upon that, a PET/CT 68Gallium-PSMA (prostate-specific membrane antigen) scan was performed for adequate restaging of his primary disease. A single focal radiotracer uptake was noted in the left testicle with a maximal SUV of 9.3 mSv (Figures 2(a) and 2(b)). There was no other uptake neither in the surgical bed, in the pelvic lymph nodes, nor in the bones.\\nA dedicated pelvic magnetic resonance imaging (MRI) was done to further characterize the testicular findings. Several poorly defined hypointense left testicular lesions were found, the largest one measuring 1.8 cm, at the level of the rete testis (Figures 2(c) and 2(d)).\\nFollowing a multidisciplinary tumor board meeting, consensus was to proceed with bilateral simple orchiectomy for the purpose of surgical castration as well as pathologic examination of this left testicular lesion (Figure 3(a)). Pathology studies revealed a metastatic adenocarcinoma of prostatic origin (Figures 3(b) and 3(c)). Postorchiectomy, his PSA level dropped back to 0.02 ng/mL.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 66,\n",
       "    'case_id': 'PMC9253533_01',\n",
       "    'case_text': 'After obtaining the approval of the local ethics committee (Section Giovanni Paolo II- IRCCS Casa Sollievo della Sofferenza) and written informed consent, we report the case of a 66-year-old man with a history of hypertension and ocular MG. This disorder was diagnosed 2 years before the pandemic onset by electromyography (EMG) and frontal muscle jitter study at the neurology unit of our hospital (Figure 1). AChR antibodies were detected, and and the thymoma ascertainment results were negative. He undertook pharmacology therapy consisting of pyridostigmine at a dosage of 30 mg three times daily, which was efficacious in treating myasthenic symptoms. The strength quantification performed by the Medical Research Council (MRC) was normal before the pandemic. At the beginning of December 2020, he developed fever, cough, myalgia, and dyspnea with progressive severe respiratory failure, which required ICU admission. He underwent chest computer tomography (CT) and nasopharyngeal swab that were positive for COVID-19 and was treated with remdesivir and corticosteroids. The patient underwent mechanical ventilation and tracheotomy. Laboratory tests did not detect an increase in the serum CK level. He also developed infections caused by multi-drug resistant germs, including Klebsiella pneumonia, Acinetobacter baumannii, and Pseudomonas aeruginosa, and underwent multiple antibiotic therapies. The Simplified Acute Physiology Score was 35. During the ICU stay, 15 days after admission, he complained of muscle weakness that evolved into the manifestation of tetraparesis without ocular involvement. Despite this development, pyridostigmine was increased to 60 mg three times daily; the strength remained unchanged. The length of stay (LOS) in ICU was 35 days. After improvement of the clinical conditions, the patient was transferred to our neuro-rehabilitation (NR) unit. At admission, the patient breathed spontaneously but needed 3 L/m oxygen by mask. Capillary oximetry was 97%; he had a central venous catheter, a tracheal tube, and a nasal-gastric tube for nutrition. The neurological picture showed severe tetraparesis that involved predominantly the lower limbs, and he had absent tendinous reflexes. No deficit in ocular or facial muscles was detected, and superficial and deep sensibilities were normal. Given the neurological feature, on day 2 of admission, the patient underwent electroneurography (ENG), electromyography (EMG), and frontal muscle jitter study that confirmed MG and showed overlapping ICUAW. In this respect, the electrophysiological exam revealed signs characteristic of CIP (Table 1). However, a lumbar puncture was performed, and cerebrospinal fluid (CSF) was collected and processed for standard analysis to exclude Guillain-Barre syndrome and polyneuropathies of different etiology. Pressure, cell count, and protein levels (<45 mg/dl) of the CSF were normal without albumin-cytologic disassociation. CSF/serum glucose ratio was normal. The CSF culture results for possible organisms, such as human immunodeficiency virus, hepatitis B virus, hepatitis C virus, bacteria, Mycobacterium tuberculosis, fungi, Borrelia, enteroviruses, Herpes viruses, and CMV, were negative. Similarly, the laboratory test for autoimmune disorders, including lupus anticoagulant, anticardiolipin antibodies, a panel of antiganglioside antibodies, including anti-GM1, -GM2, -GM3, -GD1a, -GD1b, -GT1b, and -GQ1b, and a panel for paraneoplastic syndrome, were negative.\\nStrength and functional evaluation were quantified through the MRC scale sum-score, the Disability Rating scale (DRS), the Barthel scale (BS), and the functional independence measure (FIM) at admission, discharge, and 6 months of follow-up. During NR stay, the patient underwent a personalized and tailored rehabilitation treatment for 3 h daily, 6 days a week. Furthermore, he performed 2 h of daily electrical muscular stimulation on the lower limbs by placing surface electrodes on the quadriceps and anterior tibial muscles bilaterally. The muscular strength improved progressively, and the MRC sum score was 50 at discharge. The anticholinesterase therapy with pyridostigmine at the dosage of 30 mg three times daily, the same that the patient was taking before he had COVID-19, was resumed. His motor abilities recovered and, at discharge, he was able to walk without support but remained with left foot drop, which required the application of an ankle-foot orthosis (AFO). Furthermore, he complained of mild fatigue with reduced endurance, which improved over time. At follow-up, the MRC scale sum score and all functional scale scores resulted to be normal (Table 2). The LOS in neuro-rehabilitation was 42 days.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 56,\n",
       "    'case_id': 'PMC6417290_01',\n",
       "    'case_text': \"A 56-year-old HIV-positive male was admitted to our institution for knee arthralgia and submitted to knee prosthesis. The patient's pharmacological treatment at entry consisted in antiplatelet, antiviral, and analgesic medication. His full blood count and clotting were within normal range. Electrocardiography and chest X-ray were normal.\\nSA was performed in sitting position at L3-L4 level on the midline, using a 27-gauge SPROTTE needle BROWN (only one puncture) with 20-gauge epidural catheter; 12.5 mg of Chirocaina 0.5% was administered for analgesia with an optimal efficacy. He underwent knee prosthesis surgery that lasted 114 min. The surgical procedure was uneventful. On the 2nd day, the patient complained of headache with the typical features of postural headache without other neurological symptoms or signs, in particular, there was no nuchal rigidity. PDPH was diagnosed and treatment with paracetamol and ketorolac, bed rest therapy, and hydration started. On the 4th postoperative day, the patient was pain free and he could be discharged 4 days later with anticoagulant therapy.\\nTwo days after discharge, the patient complained of severe headache and presented at our emergency department. Neurological examination was normal. The patient was discharged after hydration, corticosteroid (Soldesam 8 mg/die) was prescribed, and bed rest ordered.\\nDue to the persistence of headache and the change in the headache's characteristic, even being present in clinostatism, the patient visited again the emergency room; neurological examination was once again normal. In consideration of the persistence of headache in clinostatism, we decided to perform a brain computed tomography (CT) scan, which showed a bilateral subdural hematoma, larger on the right side (12 mm) causing a left-sided brain shift of about 5.3 mm [Figure 1]. The patient was hospitalized at the neurosurgical unit. Antiplatelet medication was suspended. Initially, given the absence of neurological deficit and in light of the dimensions of the bleed, which were borderline for surgical intervention, we adopted for a conservative treatment which consisted in bed rest, hydration, and analgesia. Four days later, the patient complained again of worsening headache, so we performed a brain CT scan which showed an increase in density of the subdural collection with an increase in brain shift [Figure 2]. Considering that the conservative treatment was not sufficient, we considered and proposed a subdural hematoma evacuation, which the patient accepted. Surgical procedure was performed under general anesthesia and was uneventful. The postoperative CT scan showed the evacuation of the blood collection with reduction of the midline brain shift [Figure 3]. The patient reported a significant reduction of his headache. At this point, deambulation was commenced. On the 3rd postoperative day, the patient again complained of worsening of headache with accompanying photophobia. A brain CT scan was performed demonstrating a reformation of the subdural hematoma on the right side larger than that one before surgery; hydration, analgesia, and bed rest were again implemented [Figure 4a and b]. Nine days after the intervention, a cranial CT showed a further increase of the subdural blood collection with brain shift [Figure 4c]. At this point, as the only hematoma evacuation was not sufficient, we decided performing a lumbar blood patch and a surgical re-evacuation of the subdural hematoma. Lumbar blood patch was performed at L3-L4 level with midline approach, and 15 cc of a solution composed by the patient's blood, iopamiro, and fibrin glue was introduced through a Tuohy needle under fluoroscopic control. The surgical procedure was uneventful. Intraoperative fluoroscopy control showed a good extension from L2-L5 level. Surgical procedure of hematoma evacuation was regular. Radiological control showed a complete evacuation of subdural hematoma with decrease of the intracranial structure shift of the midline. The patient reported a complete resolution of headache. Three months after surgical procedure, the patient was symptom free, and CT scan showed a complete resolution of the subdural hematoma without brain shift [Figure 5].\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 74,\n",
       "    'case_id': 'PMC4854227_01',\n",
       "    'case_text': \"A 74-year-old man with a history of dyslipidaemia, impaired glucose tolerance, and cholelithiasis, came to our attention because of dyspepsia and dorsal pain lasting for two months. He underwent an upper gastrointestinal (GI) endoscopy showing a submucosal nodule in the gastric antrum, and an abdomen ultrasonography (US) showing multiple gallstones and a 3 cm pancreatic body lesion.\\nA chest-abdomen contrast medium Computed Tomography (CT)-scan detected a pancreatic body lesion of 26 mm axial diameter (O) with pancreatic duct dilation and perilesional lymphadenopathy with 15 mm O. Endoscopic US (EUS) with fine-needle aspiration (FNA) showed a 37 mm O hypoechoic and inhomogeneous lesion comprising mesenteric-portal axis without a clear infiltration (uT3uN0, AJCC 2010). Cytology was conclusive for anaplastic/undifferentiated pancreatic carcinoma. Immunohistochemical (IHC) analysis was positive for cytokeratin AE1-AE2, negative for S-100 protein, Melan-A, chromogranin-A (CgA), synaptophysin (Syn), and CD-56.\\nOn this basis after discussion within the gastrointestinal multidisciplinary team (GI-MDT), a diagnostic laparoscopy plus intraoperative US were performed showing no evidence of peritoneal carcinomatosis but infiltration of splenic artery and upper mesenteric vein were seen. A peritoneal washing cytology (PWC) revealed the presence of neoplastic cells (Figure 1). Following a further multidisciplinary discussion, systemic chemotherapy was therefore proposed. The patient was asymptomatic; his performance status (PS) was 0 Eastern Cooperative Oncology Group (ECOG). Because of the particular histotype, he was not eligible for first-line chemotherapy trials, therefore a regimen with cisplatin (60 mg/mq day 1 every 21) and gemcitabine (1000 mg/mq days 1, 8, every 21) was decided on an individual scale and administered outside clinical trials (Figure 2). After day one of the second cycle, treatment was delayed because of thrombocytopaenia, and definitively discontinued because of unstable clinical status for acute lower limb peripheral neuropathy and appearance of upper abdominal pain. In the meantime, given the time from the start of chemotherapy, a restaging C-scan was performed, showing an increased pancreatic lesion (46 mm O) with dilatation of the Wirsung duct, and multiple pathological lymph nodes in the retroperitoneal region. As a result, we assumed that the patient had a metastatic disease, based on the radiological features (morphology, dimension, rapid growth, and contrast enhancement of paraaortic lymph nodes) and clinical evaluation (increased level of Ca 19.9, deterioration of the patient's clinical condition and the previously positive peritoneal cytology). On this basis a third GI-MDT discussion indicated a second-line systemic chemotherapy with modified FOLFIRI (folinic acid 200 mg/mq; irinotecan 180 mg/mq; bolus fluorouracil (5-FU) 400 mg/mq; continuous infusion 5-FU 2400 mg/mq) at 70% of the conventional dose.\\nFurthermore, because of the particular pattern of progression (expansive rather than infiltrating primary tumour growth) and its local symptomaticity, a locoregional palliative procedure was discussed.\\nTherefore, after the fourth cycle of chemotherapy the patient underwent high-intensity focused ultrasound (HIFU) ablation on the pancreatic lesion. The treatment was performed with computerised axial scanning and power Doppler to evaluate the effect of ablation on the artery engaged. The patient was placed in a prone position on the HIFU table, and then we verified that the abdomen skin was in very close contact with degassed water. The treatment was performed with vertical scanning mode separated by 5mm-distance between each slice. HIFU ablation was performed using the JC-HIFU system (Chongquing Haifu-HIFU-Tech, Chongquing, China). The procedure was supervised by real time US; the diameter of transducer that issues US energy was 20 cm with a focal length of 15 cm and a frequency of 0.8 MHz. The software used for the real time imaging unit was MyLab70 imaging device (Esaote, Genova, Italy). This 1.0 to 8.0 MHz imaging probe is located in the centre of the HIFU transducer. Treatment was carefully monitored with US guide and finished when the lesion showed a large part of coagulation necrosis in the centre. The duration of HIFU ablation was about 90'. At the end, US revealed an extended necrosis area on the pancreatic lesion. A CT-scan performed the day after revealed a 56 mm O pancreatic lesion and paraaortic lymphadenopathies. After HIFU the patient received five more cycles of modified FOLFIRI. A CT-scan performed six weeks after HIFU revealed a reduction of the pancreatic head lesion (45 mm versus 56 mm O) and of the left paraaortic lymph nodes (15 mm versus 33 mm O). A restaging CT-scan after four months from the HIFU treatment revealed a further reduction of the pancreatic lesion (38 mm versus 45 mm O) and left paraaortic lymph nodes (8.4 mm versus 15 mm O).\\nThe patient became totally asymptomatic after HIFU. Chemotherapy was well tolerated and is still ongoing.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 14,\n",
       "    'case_id': 'PMC5406521_01',\n",
       "    'case_text': 'A previously healthy 14-year-old girl with no medical, social or surgical history complained of a gradually enlarging mass on her left shoulder over the period of two months, with no pain or constitutional symptoms. On examination, there was a 5 x 6 cm cystic mass at the upper border of her left scapula, with soft and intact overlying skin. The cyst was freely mobile with no signs of localized inflammation. Clinical examination also revealed markedly decreased breath sounds over the lower right lung field. The serological tests were within normal limits. chest x-ray showed a rounded regular density in the right lower lobe (Fig. 1). Computed tomography confirmed the presence of a 10 x 8 cm cystic mass within the lower lobe of the right lung (Fig. 2A), a 5.5 x 4.5 cm cystic mass within the muscular components over the left scapula, and a 2 x 1.5 cm cystic mass within the right lobe of the liver (Fig. 2B). T1-weighted MRI images of the left shoulder cyst revealed a low signal intensity cystic mass with a low intensity rim and high signal intensity on T2-weighted images within the thickness of left trapezius muscle (Fig. 3C and D).\\nDecision was made to manage both lung and shoulder cysts surgically with one operation following 2 weeks of medical treatment with albendazole because of the extraheptic involvement of the former and the superficial location prone to trauma of the latter. The right lung lesion was approached firstly through a right thoracotomy in the 5th inter-costal space, and the 10 x 6 cm cystic mass in the right lower lobe (Fig. 4) was excised by means of aspiration, injection of 20% hypertonic saline and re-aspiration and then the germinal membrane then was enbloc excised. Bronchial fistulas and the remainder cavity were closed with 2.0 vicryl (absorbable) suture. A second incision was made over the left shoulder cyst. A 5 x 4 cystic mass was found within the thickness of the left trapezius muscle, and was enucleated taking care not to induce any leak (Fig. 5) and the remainder cavity was closed with 2.0 vicryl stuture. Complementary medical therapy with albendazole was continued for 3 months. The patient had been followed up for the next three months after surgery there were no signs of recurrence at the lung and trapezius cysts sites. The liver cyst reduced in size.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 61,\n",
       "    'case_id': 'PMC3420418_01',\n",
       "    'case_text': 'This paper discusses the sexual homicides of four victims, of both genders and different ethnicities, by a male 61-year-old African-American ordained Baptist Minister, in Los Angeles and San Diego Counties, over an 11-month time period, during the years 2000 and 2001. (The subject has given his full informed consent for the author to disclose all information pertaining to this case and his personal life.) The above brief review on the topics of serial murder, sexual homicide, and necrophilia will be compared with the particulars of this case. The actual acts of the perpetrator and his subjective viewpoint during the murders, in combination with crime scene information and psychological test data, will be utilized to create a comprehensive depiction of the factors that precipitated the decision to murder four human beings. Each homicide will be examined according to three distinct stages: the period during which Mr. D. met the victim and engaged in consensual activity, the period of coercive sexual activity, and Mr. D.\\'s postmortem sexual activity with his victims. A fourth stage, the disposal of the body, will be covered only briefly. The quotes included are Mr. D.\\'s verbatim statements regarding his subjective experience. (Clinical interview of the subject lasted 19 hours and was videotaped. The entire interview was transcribed verbatim.)\\nIn late May of the year 2000, when he was 59 years of age, Samuel D. met an apparently homeless African-American female, a casual acquaintance of his in her early 20\\'s, on a street near his apartment in Los Angeles. (\"Alicia\\'s\" body was never found. Mr. D. was convicted of this crime based on his admission to this homicide and three others, forensic details of which corroborated his report.) He \"became curious\" as to whether he could engage the woman in sexual activity and explicitly denied during interviews subsequent to the murder the existence of coercive or homicidal fantasies at this juncture. The two walked back to Mr. D.\\'s apartment, showered together, and engaged in consensual fondling. Mr. D. supplied Alicia with alcohol, crack cocaine, and marijuana. He did not use any substance. The two engaged in multiple vaginal intercourse for a period of between 24 and 48 hours, by Mr. D.\\'s estimate: \"there was a period of at least a day or so that she would have been there nude the whole while. And having sex with me ... like constantly.\"\\nConsensual sexual activity was brought to an end when Alicia expressed a desire to leave Mr. D.\\'s apartment. When asked if her refusal to continue to have sex with him was frustrating, he stated, \"I didn\\'t like it. If I got mad I wouldn\\'t know that I got mad.\" In sequence, Mr. D. reported that the following occurred: he prevented Alicia from exiting his bedroom by blocking the doorway with his body; he \"struck her a few times in the face,\" to incapacitate her and quiet her struggling; he used stereo speaker wire as ligature to bind the victim\\'s hands and feet behind her back, legs bent at the knee with feet in the air: \"I tied her so that her buttock area, her vaginal area would be exposed.\" He was questioned on his conscious motivations for binding Alicia. He reported \"I don\\'t want her to leave, I want to keep her. All I wanted was to fuck, I kept telling her that.\" He was also asked whether the act of binding the victim was sexually arousing to him: \"I don\\'t remember feeling sexual at all during that time, aroused or anything. The [ligature] was just to like make her still in the position I wanted her in.\"\\nIn contrast to his claim, evidence on each victim for which information is available suggests that Mr. D.\\'s use of either ligature or violence was extreme, and more than adequate than that which would be used only for restraint. For example, Mr. D. gagged Alicia with a blouse, sweater or washcloth (He was unable to remember precisely). When she would not quiet, he threatened her with a butcher knife approximately 12 inches long by 1.5 inches wide, by holding it above her chest in a stabbing gesture. He verbally threatened to kill her. Mr. D. was asked if he thought the victim was frightened (at this point she was bound, gagged, and was being threatened with a butcher knife). He replied \"I don\\'t think so.\" It is possible that the deficit in affect from which Mr. D. suffered, which facilitated both the lack of empathy for others and his use of predatory violence, rendered him unable to recognize the extreme nature of his behavior. It is also possible, however, that his denial of sadistic sexual pleasure is related to his knowledge that the level of violence used in his crimes would lead to a harsher penalty during the sentencing phase of his legal case.\\nMr. D. stated that he felt \"something akin to anger or frustration\" at Alicia\\'s constant struggling. He reported that, for the first time, he thought of drugging Alicia with the sedating tricyclic antidepressant amitriptyline. The medication was in 25 mg tablet form, which he placed in the victim\\'s vagina and rectum. Mr. D. also fed the victim through a straw, into which he had placed medication. When sedation took effect, the victim\\'s struggles quieted. She remained bound and gagged. He now began to anally rape the victim, and when questioned on her emotional state at this point, he reported \"she reacted as if it was ... extremely painful ... [but] I don\\'t know what her reactions mean, I can only guess. They don\\'t give me a clue even now.\" \\nMr. D. was asked to report on his subjective state, at the point in time at which he had immobilized his victim and her anus and vagina were exposed for his use. He reported \"I could do what I want now. This girl is under my control. There are no barriers, there\\'s no resistance. Unlimited sex is here.\" Mr. D. then anally and vaginally raped this victim for a period of approximately 24 hours. He was asked what he felt for Alicia during this time: \"nothing, except here\\'s a body.\"\\nSexual activity ended after approximately 48 hours of consensual sex and 24 hours of coercive sex, when the victim died while being raped. Mr. D. denied any acute action by him that led to the victim\\'s death. In each homicide for which information is available, however, strangulation has been listed as one possible cause. \\nMr. D. continued to have anal and vaginal sex with the corpse, without pause from pre- to postmortem, for a period of roughly 48 hours. The corpse remained on his bed, bound and gagged. He covered the victim\\'s head with a cloth he found in his room, secondary to revulsion at the sight of her face, which was bloated and swollen from his blows. He was asked what was specifically arousing to him regarding sexual intercourse with a corpse. He responded \"It was just here\\'s a hole, basically.\" For the first time since her arrival, Mr. D. climaxed and ejaculated inside the victim\\'s vagina. \\nAfter roughly two days of nearly continuous sex with the corpse, Mr. D. \"couldn\\'t stand the smell or sight\" of the body anymore, and carried it from the bed to the bathtub. He reported that he had read a book on Jeffrey Dahmer and developed the idea to dispose of the body by pouring onto it bleach, liquid Plumr. lye, drano, and other solvents, in attempts at \"dissolving it.\" The body remained in the tub during the events of the second homicide.',\n",
       "    'gender': 'Male'},\n",
       "   {'age': 37,\n",
       "    'case_id': 'PMC3420418_02',\n",
       "    'case_text': 'Approximately one week after he had murdered Alicia, Robyn W., a 37-year-old, African-American female acquaintance of Mr. D. appeared alone and unannounced at his door. Mr. D. quickly engaged Robyn in sexual conversation, and she agreed to enter his apartment. \\nConsensual sexual activity consisted of multiple vaginal and anal intercourse, for a period of between 24 and 48 hours. As he had done with Alicia, Mr. D. bought the victim crack cocaine, which she smoked at his apartment, and Cisco wine; once again, he did not use substances. Robyn\\'s statement to Mr. D. regarding her desire to leave the apartment to care for her children, signaled the onset of coercive activity. He \"pinned\" Robyn to the bed by sitting on her chest, and then bound her in a fetal position, so that he could \"get at ... either her pussy or her butt ...where I could stand up on the bed and fuck her with her facing up, on her back, with her feet and knees in the air. (The defendant placed pillows underneath Robyn so that he could have easier access to her vagina and anus as he stood on the bed.)\" When asked of his subjective experience at this point, Mr. D. stated \"I have control of them now. All the tying and drugging had achieved was to let me have sex like uninterrupted without ... fighting, because ... that detracted from it for me.\" Once again, Mr. D. denied sadistic arousal from the victim\\'s pain. The specifics of the behavioral evidence, however, suggest otherwise. \\nRobyn began to plead with Mr. D. and mentioned that she had children. Mr. D. reported that he \"ignored it,\" though may have said to her \"I told you what I wanted.\" He threatened her with the same knife he had used with Alicia. After he had restrained her with ligature, he gagged Robyn with a sweater he found on his bed, which was fastened into place with wire. He pulled another sweater over her head, covering her entire head and mouth. (This action was likely motivated by twin desires: to denigrate the victim and to heighten his own sense of control.) In contrast to his actions with Alicia, perhaps because he remembered the struggle which had ensued, Mr. D. immediately drugged Robyn with amitriptyline by inserting two to three tablets into her vagina. He then anally raped this victim:who remained bound, gagged, and drugged:for a period of between 36 and 48 hours, by his estimate. He denied any conversation: \"there was no reason for conversation ... there was no way she could stop it.\" After carrying Robyn to a corner of his bedroom and covering her with clothes and linens, Mr. D. left the bedroom for his kitchen, where he remained for between 15 and 60 minutes. He returned to the bedroom intent on continuing to have sex with Robyn, but reported that she was dead upon his entrance to the room.\\nThe coroner\\'s report of this death stated that death occurred from \"apparent multiple ligature strangulation,\" and \"possible blunt force trauma to the head and face.\" Mr. D. stated to two investigators and to myself that Robyn died while he was away from the room. He stated during a separate psychological evaluation that Robyn died during the act of being anally raped. Although he denies it, medical evidence suggests that Robyn died secondary to a volitional act from Mr. D.: either manual strangulation or blunt force trauma to the head.\\nMr. D. reported that \"the fact that [Robyn] wasn\\'t physically responding was not a problem.\" He did not remove the ligature from Robyn postmortem and stated that as he continued to have sex with the body he did not want to ejaculate because \"climaxing ended the sex. I [would have] had to stop. It was just sex, just sex, just sex and I didn\\'t want it to end.\" Mr. D. remains uncertain whether he ejaculated inside the corpse of Robyn. After roughly two days of nearly continuous vaginal and anal sex with Robyn\\'s corpse, Mr. D. \"pushed\" the body of his second victim into the bathtub, on top of his first victim. Like in the first homicide, the odor of the decomposing body, and the lividity change, precipitated his decision to discontinue sex.\\nMr. D. stated that during the time period between the death of Robyn and the death of his next victim, he began to consider abducting a person to keep as his \"sexual slave.\" He considered keeping the person either in a \"hiding place\" outside his apartment, and then transporting the victim to his home for sex, or inside the organ he had at his apartment. Around this time, he wrote a short narrative which makes clear that, while the death of Alicia may have been \"accidental,\" as he claimed during investigation after his confession, his subsequent behavior was planned, purposeful, and predatory. Mr. D. wrote: \"tools of the trade:cable wire, clothes, necktie (regarding his use of ligature, Mr. D. stated to me that he would use \"anything that was nearby ... like a necktie.\" This statement appears to belie that suggestion; it appears that ligature was chosen before the crimes, for specific purposes), gag-rope (and the search for more), better gag, then stocking cap and later, wire mask to keep in on. c*r got them off several times. (Why didn\\'t they scream?-fear of drugs. Need hand and leg cuffs:too many escapes. (learning the ropes) getting them on (g kept gedding loose and r same flysr kept waking up and moving things as if she knew what was coming ...\"\\nEither accidentally or deliberately, Mr. D. found an activity that suited his sexual appetites. He had no internal prohibitions in the form of conscience or fear of punishment which would preclude drugging, bondage, and rape. During our interview, Mr. D. took exception to my use of the term \"serial killer\" to describe him self. In responding to me that although he did not \"see\" himself as a serial killer, he stated that he might have \"killed more had the opportunity or circumstances been different.\" After he had committed his first murder, Mr. D. decided to kill again by using similar methods.\\nApproximately 7 to 14 days after he had killed Robyn, Mr. D. met his next victim, Salvador, a mentally disabled Hispanic male approximately 36 years of age. Mr. Reyes, according to Mr. D., approached him and offered sex in exchange for $15. Mr. D. accepted and the two walked from the street to Mr. D.\\'s apartment.\\nConsensual sexual activity consisted of multiple anal intercourse for a period of roughly four hours. Mr. D. assumed the dominant \"top\" position and did not allow Mr. Reyes to penetrate his anus. They did not kiss. (Kissing is perhaps the most affectionate sexual activity. Mr. D. either kissed his victims before they were bound or drugged, as a predatory \"grooming\" behavior, or did not kiss them at all.) During this intercourse, Mr. D. decided that Salvador \"was not ever going to leave ... I wanted to keep him there with me.\" He equated Salvador to a \"sex toy\" and to a \"sexual slave.\"\\nMr. D. drugged Salvador by giving him a beer into which he had placed amitriptyline. He also inserted tablets into Salvador\\'s anus. He then gagged him and put a nylon stocking over his head. Salvador\\'s struggles irritated Mr. D., and the two \"began fighting.\" Mr. D. again denied being sexually aroused by the act of binding the victim, by his pleas, or by the obvious pain the victim was in. He anally raped Salvador for approximately two days and one night, by his estimate. During times when Mr. D. left the apartment when Salvador was still alive, he carried him by the ligature to a closet. Upon his return, he transported Salvador back to his bed, to continue to rape him. \\nSalvador died while being anally raped. Mr. D. was asked what he had done to precipitate Salvador\\'s death. He responded \"nothing I knew except just fucking him.\" Mr. D. did not pause at the time of death, but \"went on\" anally raping Salvador, and continued to do so for between 24 and 48 hours, by his estimate. He was asked if it was more arousing to have sex with a live person or with a corpse. He stated \"it didn\\'t make any difference. I don\\'t remember it being any different.\" Mr. D. continued to engage in sexual activity with the corpse of Salvador until the body began to smell, at which point he put the still-bound body into a plastic bag, carried it down the stairs and placed it into a shopping cart, which he used to transport the body to a local park.\\nOn Saturday, 28 April 2001, approximately 11 months after he had committed his first homicide, Mr. D. traveled to San Diego to take part in a poetry reading at a local book store. He and his male companion arrived too late for the reading and were rescheduled; Mr. D. chose to spend the rest of his night in San Diego at a bath house frequented by gay males, for the purpose of engaging in anonymous sexual activity.',\n",
       "    'gender': 'Male'},\n",
       "   {'age': 46,\n",
       "    'case_id': 'PMC3420418_03',\n",
       "    'case_text': 'Soon after his arrival at the bath house, he attempted to place several amitriptyline tablets he had brought with him from Los Angeles in the anus of a sleeping Black male; this man awoke briefly and pulled the sheet on which he was laying tighter around his body, which precluded Mr. D. from drugging him. He next engaged in simultaneous sexual activity with three men. During this, Gary B., a 46-year-old gay Caucasian male stranger approached him and expressed a desire for sex with the defendant, alone. Mr. D. refused, though after he had completed the sexual act with the other males left to find Gary. \\nThe two engaged in consensual anal intercourse at the bath house, after which Gary invited Mr. D. to his apartment in San Diego. They arrived at the apartment in the early morning hours of Sunday 29 April. Although Mr. D. had planned to drug Gary\\'s food early during this time, he did not because Gary did not eat with him. They again engaged in multiple consensual anal intercourse for a duration of several hours. They parted company during the day of Sunday and met that evening at Gary\\'s apartment, where Mr. D. watched pornographic videos. \\nAt approximately 5 P.M. the two engaged in multiple anal intercourse for a period of several hours, during which Mr. D. drugged Gary with amitriptyline and diphenhydramine. The method of drugging, in contrast to his activity with previous victims, was to insert the tablets into the foreskin of his penis, then insert his penis into Gary\\'s rectum. After a long period of sexual activity, Gary informed Mr. D. that he wished to discontinue the sexual activity and wanted to sleep so that he could go to work that morning. Mr. D. unplugged the clock in Gary\\'s room to prevent him from knowing the time. He later told investigators that the victim\\'s statement regarding his desire to stop having sex \"irritated\" him. He got up from the bed and, in a sullen gesture, went into the living room. Gary appealed to Mr. D. to either come back to bed and sleep or leave his apartment.\\nMr. D. was angry at Gary for not giving him what he wanted, and felt rejected and insulted by his suggestion that he leave. He stated to investigators that Gary\\'s statement, \"set [him] off ... I was upset he didn\\'t let me do what I wanted to do.\" Gary, said Mr. D., \"should have let me do what I needed to do. (Mr. D.\\'s statement to investigators is similar to his statement to Robyn, during the time she was bound, gagged, and fighting him: \"why you fighting me? I told you what I wanted.\" The absence of empathy, and presence of entitlement, leave Mr. D. irritated and perplexed by his victim\\'s actions.)\" Mr. D. next returned to the bed and attempted to insert his penis into the sleeping Gary\\'s rectum. He recognized that Gary was \"trying to let [him] know\" that he wanted to sleep, which further angered him. Mr. D. successfully inserted his penis, however, and the two had anal intercourse for between 30 and 35 minutes.\\nAs Gary\\'s resistance weakened, Mr. D. \"took over and did what [he] wanted to do,\" which was to anally rape him. Gary again began to struggle, and Mr. D. attempted to bind him with ligature. He used a plastic coated wire cord to tie one of Gary\\'s ankles to the bed. He used shoestrings and attempted to tie his hands together, but Gary was able to struggle free. At this point, Gary began to scream, whereupon Mr. D. attempted to gag him with a dark blue towel. He then left the bedroom and went to the kitchen, where he found an electric \"bread dough mixer,\" similar to a rolling pin. He returned to the bedroom and struck Mr. B. twice in the head with this instrument, intending to \"knock him out.\" From behind, Mr. D. grabbed Gary around his neck, with his right arm, and shoved large amounts of petroleum jelly into his nose and mouth to quiet his screams.\\nMr. D. reported to police investigators that Gary died during this struggle, after he had \"pulled up\" on his mouth with his left hand. The coroner\\'s report stated cause of death as asphyxia, either from \"forcible covering of the mouth\" or from \"pressure on the neck.\"\\nRegarding Gary\\'s death, Mr. D. stated \"he just slumped over and stopped moving. I ... decided he must be dead. Then I went back and tried to put him on the bed so I could have more sex with him.\"\\nMr. D. used ligature to bind the body in a fetal position postmortem, to aid his attempt at placing Gary\\'s body back on the bed, so that he could have anal intercourse with the corpse. However, he soon discontinued his attempt, after coworkers called Gary\\'s house to check on his whereabouts, and instead dragged the body into a bedroom closet. He filled four plastic trash bags with the victim\\'s belongings, unplugged the telephone, and attempted to carry the bags from the apartment. The bags broke; Mr. D. then took \"what [he] thought might have [his] name on it,\" and Gary\\'s checkbook and apartment and car keys and exited the apartment.\\nSeveral days after killing Gary, Mr. D. returned to San Diego by bus, intent on \"taking off\":robbing:the apartment. He saw police tape across the door frame of the apartment and thought better of entering. He did, however, use the victim\\'s car keys to steal his vehicle and drove back to Los Angeles.\\nOn 17 May 2001, Mr. D. was arrested in Los Angeles for the theft of Gary\\'s vehicle. On 01 August, while in custody in San Diego after being charged with auto theft (Mr. D. was originally charged with auto theft and murder; the latter charge had been dropped at the time of his confession), Mr. D. approached a correctional counselor and stated \"you\\'re going to go down in history. God is telling me to tell you [of the four murders]\" he had committed.\\nMr. D. also left several living victims, whom he either attempted to drug, rape, or kill. Several days after killing his second victim, in June 2000, Mr. D. resumed sexual encounters with a \"light skinned\" Black male in his early 20\\'s. The two had engaged in sexual intercourse on several occasions in the recent weeks, either at Mr. D.\\'s apartment or at a local park in Los Angeles. After Robyn\\'s death, Mr. D. attempted to drug this man by encouraging him to drink beer into which he had dissolved amitriptyline and by attempting to insert tablets of the medication into his rectum. He reported that although the man drank the beer, he did not become sedated to the point that he could do as he hoped, which was to bind and rape him. When asked whether he would have killed him, Mr. D. reported that he \"probably\" would have tried to \"keep him.\"\\nDuring the same time period, between the time of Robyn\\'s death and the death of Salvador, Mr. D. also drugged a longtime friend of his, Michael T., with whom he had often engaged in consensual anal intercourse, by giving him drug-tainted beer. However, Michael may have been using crack cocaine at the time and sedation did not take effect. If it had, Mr. D. reported that he would have bound and raped Michael.\\nMr. D. had originally met Robyn through a young Black male named Tyrone B., who, according to Mr. D., was either her boyfriend or pimp. During the summer of 2000, prior to Robyn\\'s death, Tyrone broke into Mr. D.\\'s apartment while he was sleeping. It soon became clear to Mr. D. that Tyrone was going to use his apartment as a \"crash pad,\" and had no intention of leaving. In response to this, for a period of one week Mr. D. put amitriptyline in Tyrone\\'s Kool Aid and into the food he gave him. He did not have either consensual or coercive intercourse with Tyrone.\\nIn June or July 2000, in the weeks after he had disposed of Salvador\\'s body, Mr. D. had sex with two Black females, one of whom came to his apartment on several occasions, whom he did not attempt to drug or bind. A third Black female, who refused to have sex with him, also visited his home during this time period. While she was sleeping in his bedroom, Mr. D. dressed in overalls and a woman\\'s white fur coat. He pulled \"greenish\" colored netting over his face and fastened it around his neck. He snuck into the bedroom, intent on binding her with the ligature he had recently begun to collect. Mr. D. accidentally caused a television set to fall over, which caused the woman to stir in bed. Mr. D. \"raced\" out of the room, removed the disguise (\"I [could] say to her, someone was in here, someone tied you up.\") and then reentered the bedroom. He reported that he did not speak to the women and she did not question him regarding who had been in the bedroom. Mr. D. denied ever successfully binding this woman and stated that she simply \"walked away.\"\\nIn the days before the murder of Salvador, in June 2000, and continuing for a period of several months, Mr. D. drugged his lover of four years, Tom B. He reported that \"things about [Tom] were constantly perturbing\" him, including his belief that Tom continued to grieve the death of his former lover (\"face reality, he\\'s dead. What\\'s wrong with me? I\\'m alive\"), that he controlled the amount of time the two spent together, and that he controlled the type of sexual activity the two engaged in. All of these were felt by Mr. D. as humiliating and gave rise to deep resentment. Mr. D. reported that he had reached a point at which he was \"not only trying to be dominant over [Tom], but run his life.\" He told Tom that what God wanted was for him (Tom) to be his lover.\\nAfter the murder of Salvador, Mr. D. began to drug Tom\\'s food, by crushing medication in a small bowl and putting it in food he gave him, then by putting it in boxes of cereal, in milk, ice cream and cream for the coffee, and in the ice Tom used in his drinks. He reported that his goal was to keep Tom constantly drugged, so that he could have sex with him whenever he came to the house. During an argument between the two over the telephone, Mr. D. told Tom that he had killed three people, something which was motivated by a desire to \"make [Tom] obey\" him by frightening him into submission. Mr. D. told Tom that he was continuing to kill and at one point told him that he had murdered 30 people. Regarding this strategy, Mr. D. stated, \"this makes him listen to me.\"\\nMr. D. also considered killing Tom while he slept. He stood above him and thought of twisting a stereo wire around his neck, of striking him in the head with a hammer, and of using ligature to tie him to the bed and killing him there. He denied ever actually attempting any of these. After roughly two months of drugging Tom, Mr. D. told him of his actions. He stated to him \"I didn\\'t want to kill you. I didn\\'t want to drug you, but you\\'re making me do it. If you listen to me and do what I ask and don\\'t make me mad ... I try to tell you how to get along with me, and you won\\'t do it. I don\\'t want to hurt you. I care for you.\" After this, the two apparently reconciled. Soon thereafter, Mr. D. became embittered by a perceived slight from Tom and again began drugging him. This time, Tom recognized what was being done and confronted Mr. D., who again told Tom that if he would simply do as he was asked, he would not have to resort to such measures.\\nMr. D. was born and raised in Wilmington, NC, USA, in 1940, one of six children born to a Baptist Minister father and a homemaker mother. He denied any history of known developmental problems or delays, denied a history of physical or sexual abuse, and denied any juvenile history of arrest or involvement with social services. He described excellent academic achievement and ultimately graduated from a small liberal arts college in Ohio, in 1962.\\nHis psychiatric history is positive for episodes of both depression and mania, during which he would go without sleep, suffer delusions, hallucinations, racing thoughts, grandiosity, and massive agitation. For example, after he had committed his first three murders, Mr. D. traveled to Little Rock, Ark, USA, where he heard the voice of God telling him to \"herald the end of the world.\" He was taken to a psychiatric hospital for a brief period and released without antipsychotic medications. Mr. D. denied, however, active symptoms of either mania or psychosis during the time period of the murders.\\nMr. D. freely reported that he had \"conned and hustled\" all his life, beginning with thefts as a child. His first arrest occurred in 1962, at age 22, when, apparently by accident, he struck another vehicle with his own and killed its occupant. He was charged with second-degree manslaughter and sentenced to six months in jail. In 1963, Mr. D. was arrested for burglary and breaking and entering, which involved thefts from a local high school. In 1968, he was arrested for manslaughter, second-degree burglary, and larceny, in 1976 for grand theft, in 1985 for alien smuggling, in 1990, twice, for disorderly conduct and soliciting a lewd act, and in 1997 for assault with a deadly weapon.\\nMr. D. also reported a prolific and deviant sexual history, with an onset beginning prior to his adolescence. Specific behaviors included exposing himself, public masturbation, fetishism (involving the insertion of objects into his rectum, such as broom handles, carrots, zucchini, water hose, stool leg), and frottage of children and adults of both sexes, as well as staring at the genitals of various animals, including horses. He additionally reported extensive sexual activity with the following animals: chickens, mules, goats, pigs, dogs, cows, and cats. (I was somewhat incredulous regarding Mr. D.\\'s report of sex with animals. However, the specifics of his report appear to lay to rest any doubt. For example, he reported that he disliked penetrating goats because, unlike other animals, the fecal matter inside the anus was hard and crusty and chafed his penis.) He admitted to six previous victims of child molestation, all adolescent males, and to professional sexual misconduct, which involved sexual intercourse with parishioners. He additionally reported massive use of prostitutes, sexual affairs, and anonymous sexual activity with strangers.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 54,\n",
       "    'case_id': 'PMC9062931_01',\n",
       "    'case_text': \"A 54-year-old female presented to hospital with status epilepticus. She had a previous history of subarachnoid hemorrhage (World Federation of Neurological Surgeons' Grade II) due to a ruptured aneurysm at the bifurcation of the right middle cerebral artery that was treated by open clipping surgery when the patient was 44 years old. The initial computed tomography (CT) revealed a low-density area around the right central sulcus, apparently involving the primary motor area. Magnetic resonance imaging (MRI) demonstrated an intracerebral mass lesion that showed diffusion restriction, hypointensity on T1-weighted images, and hyperintensity on T2-weighted images [Figures 1a-c]. The epilepsy was controlled with medication, but the patient became increasingly drowsy in the days that followed. Repeat CT examinations revealed a hematoma and associated edematous change around the lesion and progressive expansion of the hematoma despite efforts to control blood pressure and treatment by hemostatic agents [Figures 2a and b]. The patient showed considerable neurological decline and semi-emergently underwent hematoma evacuation and decompressive frontotemporal craniectomy.\\nHistopathological sections revealed numerous red blood cells with fibrin and debris and massive infiltration of atypical round blue cells [Figure 3a]. Atypical cells demonstrated clumped nuclear chromatin pattern and eccentric eosinophilic cytoplasm [Figure 3b] suggesting plasma cell origin. Immunohistochemistry study showed CD138 positivity [Figure 3b; inset] and in situ hybridization demonstrated uniform lambda light chain positivity and negative kappa signal, reinforcing the diagnosis of plasma cell neoplasm [Figures 3c and d].\\nFurther imaging studies performed following the diagnosis, including F-18 fluorodeoxyglucose positron emission tomography and bone scintigraphy, revealed no involvement of other organs. Serum and urine electrophoresis showed no increase in monoclonal protein. Bone marrow biopsy showed plasma cell infiltration of 5%-10%, but without light chain restriction. A final diagnosis of PISP was confirmed. Although the patient was obtunded and showed severe left hemiparesis soon after the surgery, correlating with the focus of the lesion in the right central sulcus, postoperative CT revealed apparent brain decompression [Figure 4a]. She showed a dramatic recovery over time, finally becoming alert and conscious. Postoperative MRI demonstrated extensive near-total resection of the lesion with small residual tumor at the periphery of the cavity [Figures 4b and c]. She underwent intensity-modulated radiation therapy (IMRT) with a total dose of 50 Gy in 25 fractions. The lesion showed an excellent response to IMRT, showing a complete disappearance on MRI [Figures 4d and e]. There were no signs of tumor relapse at the 3 years follow-up visit. After intensive rehabilitation, the patient has resumed her daily life as a housekeeper.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 14,\n",
       "    'case_id': 'PMC4735083_01',\n",
       "    'case_text': \"A 14-year-old girl living in Hebei, China presented with a 2-week history of progressive ulcers in her right preauricular skin. These lesions initiated as swelling and nodules with severe itching after a precursor of facial palsy, which was treated topically with herbal plaster. The nodules soon developed to progressive ulcers and kept enlarging. She had a medication history with cephalexin and topical dexamethasone in local clinic after suspected with cellulitis and vasculitis, however, without improvement. The girl had no history of immune disorders and diabetes mellitus. There is no family history of lymphoma, vasculitis or metabolic disorders.\\nOn examination, the patient was afebrile. Her blood investigations and liver and renal function tests were within normal limits. Nodules and ulcers with marked boundary were seen on her right preotic skin (Fig. 1A). Little pus was seen within the ulcers. Biopsy was sampled on the ulcer for bacteriological and fungal culture and for histopathological examination (Fig. 1B).\\nHistopathology revealed vasculitis with thromboses, granulomatous inflammatory infiltration with lymphocytes, macrophages and a few multinucleate giant cells (Fig. 2A). Grocott's methenamine silver (GMS) staining showed actinomycetes-like mycelia within vessel walls and thrombi (Fig. 2B) while they could be seen as clusters or chains from the epidermis to the subcutaneous tissues (Fig. 2C and D). Mycological culture was negative for fungi while bacterial culture was positive with creamish white colonies, later identified as bacterium. The bacterium was identified using VITEK II automatic bacteria identification system and the drug susceptibility done by the Kirby-Bauer method. Antimicrobial susceptibility testing results were determined in accordance to the United States performance standards for antimicrobial susceptibility testing CLSI-M100.S21. The organism was sensitive to minocycline, meropenem, levofloxacin and ceftazidime, intermediate to ceftriaxone and resistant to cefaclor, cephalexin and aztreonam.\\nThe patient was treated with minocycline at the dosage of 50 mg twice daily and topical mupirocin cream. Ulcers and swelling began to shrink soon after treatment administration and healed within 3 weeks (Fig. 1B and C). She remains well two year after and the facial palsy has never relapsed.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 78,\n",
       "    'case_id': 'PMC9139337_01',\n",
       "    'case_text': \"A 78-year-old man was admitted due to recurrent fever and fatigue for past one year. Two weeks prior to admission, his fatigue intensified, and the highest temperature reached 39.5C. He had lost 5kg over the past year and had a history of cerebral infarction and hypertension. On examination, the patient was febrile at 38C. His C-reactive protein (CRP) (62.49 mg/dl), procalcitonin (0.213ng/mL) and erythrocyte sedimentation rate (84 mm/h) were elevated. Computed tomography (CT) of the chest revealed diffusely distributed nodules in both lungs, bilateral bronchiolitis, and tuberculosis could not be excluded. The aortic arch was thickened and the local calcified plaque moved inward, which indicated further aortic computed tomography angiography (CTA) examination (Figure 1). Echocardiography revealed no vegetation in the mitral and aortic valve areas. The chest CTA confirmed multiple atherosclerosis and ulcers, and intermural hematoma in the aortic arch and thoracic aorta. Combined with the medical history, the involvement of tuberculosis in the aorta should be highly suspected (Figure 2). Re-examination of lung CT revealed bronchiole lesions and multiple miliary foci in both lungs, which were larger than one week prior, with pleural effusion, and slightly thickened pleura, suggestive of miliary tuberculosis (Figure 3). The T cell spot test, sputum culture, and sputum GeneXpert test were positive for Mycobacterium tuberculosis and GeneXpert indicated sensitivity to rifampicin. Since disseminated tuberculosis was definite and the patient's disease potentially involved the major thoracic vessels, anti-tuberculosis and steroids were initiated immediately. Methylprednisolone was administered at 40mg/day for 3 days, 20mg/day for 3 days, 8mg/day for 3 days, 4mg/day for 7 days, and then discontinued. Due to liver dysfunction, with alanine aminotransferase of 161U/L and aspartate aminotransferase of 203U/L, a regimen consisting of meropenem 1 g every 8 h, linezolid 0.6 g once daily, amikacin 0.4 g once daily, and levofloxacin 0.5 g once daily was administered. Surgical consultation concluded that no immediate surgical intervention was needed because the aortic wall was not ruptured. On normalisation of liver function, the anti-tuberculosis regimen was changed to isoniazid 0.3 g once daily, rifapentine 0.45 g twice a week, linezolid 0.6 g once daily, ethambutol 0.75 g once daily, levofloxacin 0.5 g once daily. After two weeks of treatment, the patient's body temperature returned to normal, and a re-examination of the lung CT indicated that the lesion was partially absorbed (Figure 4). The patient was discharged and continued to receive oral medications. We planned the follow-up to be weekly initially, gradually transitioning to every two weeks, and then monthly after stabilisation. Routine blood, liver and kidney functions were examined at each follow-up visit. Sputum smears and cultures were performed monthly. Pulmonary CT was re-examined two months later, and aortic CTA was re-examined four months later. The patient tolerated and was compliant with anti-tuberculosis drugs.\",\n",
       "    'gender': 'Male'},\n",
       "   {'age': 61,\n",
       "    'case_id': 'PMC9139337_02',\n",
       "    'case_text': \"A 61-year-old woman presented with intermittent low back pain that persisted for past one month. The pain worsened within one week and became unbearable. Three months previously, the patient was admitted to a local hospital for productive cough. Lung CT showed suspicious TB lesions, and T-SPOT was positive. After excluding other diseases, the local hospital started diagnostic anti-tuberculosis treatment consisting of HRZE. The patient took the medication irregularly because of gastrointestinal reaction. A physical examination revealed no abnormalities. Laboratory results were white blood cells, 7.22x109/L; hemoglobin, 122 g/L; platelets, 216 x109/L; CRP, 32.97 mg/dl; and procalcitonin, 0.213ng/mL. The sputum GeneXpert test result was positive and sensitive to rifampicin. Multiple infections and diffuse miliary nodules in both lungs suggested tuberculosis. Thoracic and abdominal aortic CTA examination showed a 51x28 mm2 pseudoaneurysm arising from the lower abdominal aorta, surrounded by a patchy shadow and lymphadenopathy (Figure 5). Combined with the patient's medical history, tuberculous aortic pseudoaneurysm was considered. Emergency digital subtraction angiography was performed after admission, and two coated stents were implanted in the abdominal aorta and iliac artery. Angiography showed that the stents were well- positioned, blood flow was smooth, and a pseudoaneurysm did not develop. The patient was discharged from the hospital 2 days post-operation and received anti-tuberculosis drug treatment, including isoniazid 0.6 g once daily, rifapentine 0.45 g twice a week, ethambutol 0.75 g once daily, pyrazinamide 0.5 g three times daily, and moxifloxacin 0.4 g once daily. Abdominal aortic CTA performed two weeks later revealed that the aneurysm did not recur (Figure 6). Our follow-up plan was consistent with that of the patient in case 1. The patient tolerated the anti-tuberculosis drugs well.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 51,\n",
       "    'case_id': 'PMC8285566_01',\n",
       "    'case_text': 'A 51-year-old diabetic (HbA1c: 7.1%, National Glycohemoglobin Standardization Program (NGSP)) male patient developed severe M. abscessus pneumonia, although he had been treated with clarithromycin (CAM) 800 mg/day, minocycline (MINO) 100 mg/day and levofloxacin (LVFX) 500 mg /day orally for three years before the bacterium was isolated (Figure 1A). His initial white blood cell (WBC) count was 11,700/L, C-reactive protein (CRP) was 18.5 mg/dL, and HbA1c was 7.8 (NGSP). P. aeruginosa was also isolated from his sputum.\\nAfter admission, he received CAM 800 mg/day, intravenous imipenem/cilastatin (IPM/CS) 3 g/day and amikacin (AMK) 10 mg/kg/day, with improvement in his chest radiograph findings and inflammatory markers, such as WBC count (5400/L) and CRP level (0.86 mg/dL). His clinical parameters, such as inflammation, chest X-ray, and nutritional status have since been well controlled with outpatient administration of CAM 800 mg/day and SFTX 100 mg/day for a year, and M. abscessus has not been further isolated. Liver dysfunction and diarrhea, as side effects of SFTX, have also not occurred.',\n",
       "    'gender': 'Male'},\n",
       "   {'age': 78,\n",
       "    'case_id': 'PMC8285566_02',\n",
       "    'case_text': 'A 78- year-old diabetic female (HbA1c: 6.6%, NGSP) was admitted due to exacerbation of Mycobacterium pulmonary infection (Figure 1B). She weighed less than 40 kg and was initially suspected to have MAC infection, although M. abscessus was isolated by bronchoscopic analysis after three weeks. S. aureus was also isolated from her sputum although she had been receiving erythromycin (EM) 200 mg/day as an immune-modulatory agent, along with the anti-diabetic agent, sitagliptin phosphate hydrate 50 mg/day. Subsequently, relatively low doses of CAM 600 mg/day and SFTX 50 mg/day were started as outpatient treatment, with no further recurrences of pneumonia or M. abscessus isolation from sputum. Liver dysfunction and severe diarrhea did not occur and her weight increased above 40 kg.',\n",
       "    'gender': 'Female'},\n",
       "   {'age': 63,\n",
       "    'case_id': 'PMC8285566_03',\n",
       "    'case_text': 'A 63-year-old male with heart failure and DM (HbA1c: 6.1%, under observation without anti-diabetics), who had been receiving voriconazole 300 mg/day orally for chronic pulmonary aspergillosis, was admitted for follow-up because of exacerbation of pulmonary symptoms. He received oral LVFX 500 mg/day as outpatient therapy for pneumonia, but with no improvement. His chest x-ray worsened and M. abscessus was isolated from his sputum, although A. fumigatus was not isolated (Figure 1C). Combination therapy with CAM 800 mg/day, IPM/CS 3 g/day and AMK 10 mg/kg/day were started after admission, with significant improvement in his condition. He was effectively treated and has been maintained with CAM 800 mg/day and SFTX 100 mg/day, respectively for 6 months, with no liver dysfunction or diarrhea, and no further isolation of M. abscessus after SFTX commencement.',\n",
       "    'gender': 'Male'},\n",
       "   {'age': 54,\n",
       "    'case_id': 'PMC8285566_04',\n",
       "    'case_text': 'A 54-year-old male patient with chronic heart failure with pacemaker implantation and DM was admitted because of suspected pneumonia (Figure 1D). His initial WBC count was 6400/L, C-reactive protein (CRP) was 6.8 mg/dL, and HbA1c was 6.4% (NGSP) on sitagliptin phosphate hydrate 50 mg/day. He received LVFX 500 mg/day intravenously, with no improvement. Subsequently, M. abscessus and P. aeruginosa were isolated from his sputum twice.\\nWe changed the antibiotic regimen to CAM 800 mg/day, intravenous IPM/CS 3 g/day and AMK 10 mg/kg/day, which resulted in improvement in his chest radiograph findings and inflammatory markers: WBC (3400/L) and CRP (1.02 mg/dL). His condition has since been well controlled with CAM 800 mg/day and SFTX 100 mg/day as outpatient treatment. Although M. abscessus was subsequently isolated, recurrent pneumonia and side effects were not observed.',\n",
       "    'gender': 'Male'},\n",
       "   {'age': 74,\n",
       "    'case_id': 'PMC8285566_05',\n",
       "    'case_text': 'A 74-year-old female patient under treatment for DM (HbA1c: 5.8%, NGSP) that was well controlled with sitagliptin phosphate hydrate 50 mg/day was admitted for sudden hemosputum, and underwent emergency bronchial artery embolization. Her chest X-ray showed infiltrative shadows with cavity formation (Figure 1E), and M. abscessus was isolated from her sputum. Her serum was strongly positive for MAC antibodies (6.8 U/mL), although MAC was not isolated from sputum. We started CAM 600 mg/day and SFTX 50 mg/day therapy, and her condition has been stable since then and hemosputum has not recurred, and with no further M. abscessus isolation. Her liver and gastrointestinal functions remained stable.\\nThe M. abscessus isolated from all five patients had relatively high susceptibility/low minimum inhibitory concentration (MIC) to CAM, but lower susceptibility/higher MIC to IPM/CS and AMK in vitro, although all these agents were clinically effective (Table 1). For drug susceptibility analysis, the broth microdilution method was performed according to Clinical and Laboratory Standards Institute (CLSI) guidelines, using a 96-well round bottom microtiter plates kit (Kyokuto Co. Ltd. Tokyo, Japan). Briefly, the prepared MIC plates were incubated aerobically at 30 C. MICs were measured on day 3 or 4 and compared with control wells without antibiotics, showing sufficient bacterial growth. MIC was defined as the lowest drug concentration at which bacterial growth was not visualized. The isolated organisms were resistant to most of the other antibiotics, including levofloxacin and moxifloxacin. Clofazimine and SFTX were found to be effective against the isolated M. abscessus strains in all five cases.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 40,\n",
       "    'case_id': 'PMC3350215_01',\n",
       "    'case_text': \"A 40-year-old African-American female with a history of idiopathic familial cardiomyopathy was being evaluated for heart transplantation. Eleven months earlier, she had a CT abdomen performed as part of a cardiac transplant workup which revealed a 1.5 cm enhancing left upper pole renal mass (Figure 1). Given her age, it was possible that this lesion was a benign tumor such as angiomyolipoma or oncocytoma. Therefore, she underwent a CT-guided biopsy of this mass to reconcile the issue prior to heart transplant. This biopsy proved inconclusive due to insufficient tissue, and a second attempt was made under conscious sedation six months prior to LVAD placement. This attempt had to be aborted when she developed severe chest pain and dyspnea preventing adequate sampling. As her ejection fraction worsened, she became progressively dyspneic at rest and received a Heartmate II LVAD (Thoratec Corp., Pleasanton, CA). After much discussion of options, she underwent a CT-guided biopsy under general anesthesia which revealed oncocytic-type cells with fine needle aspiration but again was nondiagnostic. By the time the patient developed severe decompensated heart failure necessitating LVAD placement, the mass had grown to 2.7 cm (Figure 1). \\nThe patient had a past medical history of a nonischemic cardiomyopathy and resultant heart failure manifested by orthopnea, dyspnea on exertion, paroxysmal nocturnal dyspnea, palpitations, and angina. Transthoracic echocardiogram revealed a dilated and hypertrophic left ventricle with a left ventricular ejection fraction of 10-15% with no significant valvular pathology. Cardiac catheterization revealed the absence of coronary artery disease. She had undergone an implantable cardiac defibrillator due to her diminished ejection fraction, but the device had never discharged. \\nPreoperatively, physical examination revealed a well-nourished, well-developed woman (70 kg, BMI 23.4) who was an active participant in decision making. She carried the LVAD in a satchel and had the expected vital signs for a patient with an LVAD. She had a well-healed scar over her sternum and upper abdomen. Trace pedal edema was present. Laboratory examination revealed hemoglobin of 9.2 g/dL, serum creatinine 0.9 mg/dL (estimated glomerular filtration rate 92 mL/min), international normalized ratio (INR) 2.6, and negative urine culture.\\nThe decision was made to perform partial nephrectomy due to the imaging characteristics and growth rate of the mass and the imperative to clear her of a potential renal cell carcinoma in the setting of cardiac transplant listing. Given the need for future immunosuppression, the cardiologist, urologist, and cardiac surgeon felt that maximization of nephrons outweighed the risk of transient bleeding that may have been avoided by performing a radical nephrectomy. Percutaneous ablative approaches were not considered due to tumor location. The cardiology team assisted in medically maximizing the patient preoperatively. The patient was preadmitted to the urology service to facilitate the coordination of care. She was given a gentle bowel preparation of magnesium citrate along with one day of clear liquids. She was maintained off warfarin for 3 days preoperatively with therapeutic-dose enoxaparin which was discontinued the morning of surgery. Her INR on admission was 1.5. Anesthesiology was consulted, and the case was coordinated to ensure that a cardiac anesthesiologist administered general anesthesia. Additionally, the cardiac surgeon was available in the operating room the morning of the surgery. \\nGeneral anesthesia was initiated, and an arterial line was placed with the cardiac surgeon standing by. Extensive padding was utilized with respect to the LVAD as the patient was positioned in the left modified flank position. To avoid excessive pressure points, the kidney rest was not utilized. From a retroperitoneal approach just off the eleventh rib, the kidney was freed and the hilum dissected. At no point did the LVAD present any difficulties. The lesion was not readily identified on gross inspection. Intraoperative ultrasound revealed the mass in the superior pole abutting the collecting system. After injection of 6 mg of mannitol, the renal artery was clamped and then iced. After fifteen minutes of cooling, the capsule was scored with argon plasma coagulation and resection of the mass was performed with the blunt edge of a knife handle. Inferior and deep margins were sent for frozen examination and found to be negative for tumor. The collecting system was closed with 4-0 poliglecaprone suture. Argon plasma coagulation was performed to the resection bed. A Surgicel (Ethicon, Inc., Somerville, NJ) bolster and Avitene powder (Alcon, Inc., Humacao, Puerto Rico) were placed in the defect. The defect was closed with a 0-chromic suture on a liver needle bolstered with a strip of polytetrafluoroethylene (PTFE) pledget both anteriorly and posteriorly. Unclamping was performed for a total clamp time of 59 minutes, and the kidney was observed for 15 minutes. FloSeal (Baxter International Inc., Deerfield, IL) coagulation matrix was applied to the defect and hilum and argon plasma coagulation was performed on some oozing portions of Gerota's fascia. Gerota's fascia was then used to cover the kidney again. A 1.5 cm defect in the pleura was closed with 2-0 polyglactin, and the air was evacuated with a red rubber catheter. A Jackson-Pratt drain was left in the retroperitoneum to bulb suction, and the wound was closed. The patient was extubated and transferred to the cardiac care unit for postoperative care. The patient received at total of 3 units of packed red blood cells and one unit of fresh frozen plasma. Estimated blood loss was 500 mL.\\nPostoperative chest radiograph revealed no pneumothorax. Warfarin and enoxaparin were resumed on postoperative days two and four, respectively. Furosemide was restarted on postoperative day number one. The patient had her diet quickly advanced, and pain was controlled on oral narcotics. She was up and ambulatory, tolerating a low-sodium diet and had all of her heart failure medications restarted. Her Jackson-Pratt drain was removed on postoperative day number 4, and she went home on postoperative day number 6. Final pathology revealed clear cell RCC 2.6 x 2.0 x 1.5 cm with negative margins, Fuhrman grade 3 (high grade). The serum creatinine upon discharge was 0.8 mg/dL (eGFR 103 mL/min).\\nHer managed care consortium mandated postdischarge urologic care be performed at an outside institution. Her postoperative check was unremarkable, but at her 6 month followup she was experiencing worsening left flank pain. CT scan of the abdomen revealed a radiodense material over the superolateral aspect of the left kidney (Figure 2). The final impression stated that there was a retained laparotomy sponge, and the patient was informed that she would require further surgery. This distressed the patient, and she immediately wanted to return to the original surgeon, but the managed care consortium required prior approval which caused a 2-month delay in return to our clinic for evaluation. Upon reevaluation, plain abdominal radiographs were obtained in both the posterior-anterior and oblique orientations. This did not reveal ribbon-like radiopaque material which would be consistent with a retained laparotomy sponge (Figure 3). Reassurance was provided.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 7,\n",
       "    'case_id': 'PMC4226570_01',\n",
       "    'case_text': \"This study was reviewed by the Department of Ophthalmology, Wuhan General Hospital of Guangzhou Military Command on Clinical Investigation and it conformed to the tenets of the Declaration of Helsinki. The seven-year-old girl and her family were referred to the Department of Ophthalmology, Wuhan General Hospital of Guangzhou Military Command on Clinical Investigation. After informed consent was obtained, all participants underwent six ophthalmologic examinations, including best-corrected visual acuity, slit-lamp, and fundus examination with dilated pupils to exclude infection or other diseases. Ophthamoscopic findings were recorded by color fundus photography. Optical coherence tomography (OCT, Topcon 3D-1000 Mark II, Tokyo Japan) was used to examine the retinal structure. Spectral-domain OCT (SD-OCT) recording with 3D macular protocol was performed with 6-mm single line scans over the fovea. In detail, the 3D macular protocol consists of a radial-scanning composed of 512x128 scan resolution covering an area of 6x6 mm in the macular region. The patient underwent fundus fluorescein angiography (FFA) and visual field examination. Clinical diagnosis was based on the results of the above-mentioned ophthalmologic examinations.\\nBlood samples were obtained by venipuncture and genomic DNA was extracted according to the manufacturer's protocol (TIANamp Blood DNA Kit, Tiangen) as described in our previous report. For sequencing, the entire coding region and adjacent intronic sequences of 14 coding regions of the RPE65 gene were amplified by PCR, using the primers in Table 1. PCR products were purified with the AxyPrep DNA Gel Extraction Kit (Axygen, CA, USA). All PCR products were bi-directionally sequenced with the dideoxy nucleotide chain terminator technique. Sequencing was performed on an automated sequencer - ABI 3730XL DNA Analyzer (ABI, USA). The results were assembled and analyzed using the Applied Biosystems Sequencing Analysis 5.2 software. Sequences were aligned with the published cDNA sequences of RPE65 gene (GenBank accession no. NM_000329). We also assessed the potential functional consequences of nucleotide changes using multiple web servers for mutation analysis such as PolyPhen-2 (Polymorphism Phenotyping, http://genetics.bwh.harvard.edu/pph-2/), SIFT (Sorting Intolerant From Tolerant, http://sift.jcvi.org/), and Automated Splice Site and Exon Definition Analyses (http://splice.uwo.ca/) with default parameters.\\nThe 293T cell line was purchased from the Type Culture Collection of the Chinese Academy of Sciences (Wuhan, China) and cultured in Dulbecco's modified Eagle's medium (DMEM, GIBCO) supplemented with 2 mM glutamine, 10% fetal calf serum (FBS, GIBCO), 100 UI/ml penicillin, and 100 microg/ml streptomycin sulfate. The Cells were maintained at 37 C in a 5% CO2 incubator until confluent, then sub-cultured at 1:3 to 1:10 dilutions using trypsin-EDTA.\\n RPE65 mutated minigenes (pCIneo-m65) were constructed by subcloning the c.1243+2T>A mutation from the patient into pCI-neo vector (Promega, Madison, WI). The wild-type minigene (pCIneo-65), without the c.1243+2T>A mutation, was generated by subcloning the genomic DNA of her father. PCR-amplified exons (11, 12, and 13) of the RPE65 gene were inserted at the EcoRI/SalI restriction enzyme site in pCI-neo vector. Primers and conditions used in the PCR amplification of the inserts were listed in Table 1. The corresponding DNA inserts were confirmed by sequencing.\\nTo analyze the effects of the c.1243+2T>A mutation on splicing in vitro, 293T cells were transfected with RPE65 minigenes. Prior to transfection, cells were seeded with a density of 4.0x105 cells per well in a six-well plate and grown to approximately 80% confluence. RPE65 minigene used in this study was transfected into cells with Lipofectamine 2000 reagent (Invitrogen) by using 2 microg of DNA per well. After 24 h transfection, cells were serum starved for another 24 h before harvest. Total RNA was extracted from cells using TRIzol reagent (Invitrogen) according to the manufacturer's instructions. DNase I (Promega) was used to treat the RNA extract to eliminate DNA contamination. 1.0 microg of treated RNA was used as a template for reverse transcription using the First Strand cDNA Synthesis Kit (TOYOBO). The exogenous RPE65 minigene transcript was amplified using F1 and R1 primers (Table 1) and the fragment sizes of the wild and mutant PCR products were detected by 2% agarose gels electrophoresis and stained with ethidium bromide. To confirm the nucleotide sequences, the wild and mutant PCR products were purified from the gel and sent for sequencing.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 28,\n",
       "    'case_id': 'PMC3785357_01',\n",
       "    'case_text': 'A 28-year-old man, presented with a history of pleuritic right chest pain and haemoptysis for 2 days. The pain was intermittent and worse when he lies down and improved in standing position. It did not radiate, and was no reproducible with palpation. He also noticed a small amount of blood in the sputum but denied any traumatic injury, and he did not have other symptoms such as dyspnoea, fever, chills, night sweats of weight loss.\\nSix years earlier a sclerosing mesenteritis with retroperitoneal lymphadenopathy, hypoplasia of the inferior vena cava, and thrombosis with cavernomatous transformation of the portal vein have been diagnosed, and he was treated with prednisone and acenocoumarol. Moreover, a diagnosis of common variable immunodeficiency had been made four years before, and the patient was started on monthly regimen of intravenous immunoglobulin.\\nHe was an ex-smoker of 15 pack-years since one month before admission, and consumed 2-3 alcoholic drinks on occasional weekends. His current medications included prednisone (10 mg/day), colchicine, enalapril, weekly risedronate, and acenocoumarol. He had neither recent travel history, nor noticed environmental exposures, and his family history was unremarkable.\\nThe patient was in good health status with normal body weight and had normal vital signs. Chest examination showed no abnormalities. Neither lymphadenopathy nor organomegaly were detected. The reminder of physical examination was unremarkable except for the presence of collateral circulation in the anterior abdominal wall and both legs.\\nHemogram, blood chemistry profile and urinalysis were within normal limits. The international normalized ratio was 1.97. Sputum and blood cultures were sterile. He tested negative for human immunodeficiency virus (HIV). An electrocardiogram showed a normal sinus rhythm. As plain chest radiography showed no abnormalities, an iodine-based contrast enhanced thoracic multidetector computed tomography (CT) was performed. A rounded peripheral well-defined nodule, 1.23 cm in diameter, was detected in the right lung basis (Fig. 1). There was no evidence of lymphadenopathy. To rule out malignancy he underwent a 18-fluorodesoxiglucose positron emission tomography (FDG-PET) scan which showed intense focal uptake in the nodule with a degree of activity highly suspicious of neoplastic origin (Fig. 2A and 2B). There were no other metabolically active lesions in the lungs. Although a fine needle aspiration biopsy was considered, it was thought prudent to confirm the diagnosis with complete excision of the nodule by video-assisted thoracoscopy. The procedure was performed without complications and resection specimen was collected and sent for pathologic analysis (Fig. 3) and a diagnosis of pulmonary cryptococcosis was made.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': None,\n",
       "    'case_id': 'PMC5484609_01',\n",
       "    'case_text': \"A baby born at 37 weeks, one of twins, was admitted to the intensive care unit with tachypnea and hypothermia with an increased hamatocrit (70%). He had a single umbilical artery detected on fetal ultrasound examinations, but no other accompanying anomalies were identified.\\nAbdominal ultrasound findings were as follows: dilatations of the right-left portal vein, a thin hypoechoic tract between the right portal vein and inferior vena cava (IVC) (Figure 1A). Color Doppler US confirmed blood flow in these vessels (Figure 1B, 1C). The DV was not detected in the normal anatomical location. It became clear that the tract was an alternative intrahepatic porto-caval shunt that was carrying oxygenated blood from the right portal vein to the IVC during fetal life. Blood flow through the shunt gradually decreased on follow-up Doppler ultrasound examinations which closed on the 33rd day since birth and became a thin, hyperechoic ligamentous structure equivalent to the 'ligamentum venosum' (Figure 1D).\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 81,\n",
       "    'case_id': 'PMC9792275_01',\n",
       "    'case_text': \"An 81-year-old woman was admitted to our institution due to prominent bilateral leg oedema and orthopnoea concomitant with 8 kg of weight gain in 3 months after four courses of trastuzumab therapy to treat HER-2 overexpressing breast cancer. She was prescribed with irbesartan 100 mg/day, amlodipine 10 mg/day, febuxostat 10 mg/day, and ibandronate 100 mg/month for hypertension, hyperuricaemia, and osteoporosis, respectively. In September 2021, she underwent mammectomy for Stage IIb breast cancer with high proliferative activity (Ki 67, 63%), negative hormone receptors, and HER-2 overexpression. After surgery, she received adjuvant therapy with trastuzumab (loading dose of 8 mg/kg followed by a maintenance dose of 6 mg/kg) at one dose every 3 weeks. She noted bilateral leg oedema and diarrhoea, 9 weeks after the initiation of anti-HER-2 targeted therapy, which progressively worsened after four courses of treatment. Although she was referred to a general cardiologist, the patient was not diagnosed with CTRCD due to the absence of LV systolic dysfunction [LV ejection fraction (LVEF) of 70%] paired with a nonspecific elevation of brain natriuretic peptide (BNP) level of 57.3 pg/mL. After 15 weeks of treatment with trastuzumab, dyspnoea, general fatigue, orthopnoea, and anorexia developed, and the patient was eventually diagnosed with heart failure.\\nOn admission, her blood pressure was 176/68 mmHg, heart rate was 69 beats/min, and oxygen saturation was 93% (room air). Physical examination revealed hepatomegaly, jugular vein distension, and prominent bilateral leg oedema. On auscultation, a SIII gallop with no cardiac murmur was observed. On admission, the NT-proBNP concentration was 1525 pg/mL (normal value <125 pg/mL) and the Troponin I level was 32.6 pg/mL (normal value <26.2 pg/mL). Electrocardiography indicated a normal sinus rhythm with first-degree atrioventricular block and a nonspecific T-wave inversion on precordial leads. Chest radiography and computed tomography revealed bilateral pleural effusion with significant cardiomegaly (Figure 1AandB), in comparison with the patient's preoperative images which did not show any pleural effusion (Figure 1CandD). Transthoracic echocardiography revealed that LV contraction was preserved without any ventricular remodelling (Figure 2), and the LVEF was calculated at 62% using the bi-plane Simpson's method (see Supplementary material online, Videos S1-S3). Moreover, no significant reduction in GLS was observed compared with results obtained before anti-HER-2 targeted therapy (from -16.5 to -14.6%; relative reduction of 11.5%, Figure 3). In contrast, the left atrial volume index (LAVI) and tricuspid valve regurgitant jet velocity increased from 48.8 to 85.1 mL/m2 and 2.5 to 3.2 m/s, respectively. Doppler echocardiography showed that the transmitral flow pseudonormalized (E/A ratio; from 0.70 to 1.30), e' velocity was reduced (e' septal 5.1 cm/s and e' lateral 6.0 cm/s), E/e' ratio was elevated from 14.3 to 19.1, and pulmonary venous flow changed from a systolic component dominant to a diastolic component dominant pattern (Figure 4), all of which indicated elevated ventricular filling pressure as a result of the development of LV diastolic dysfunction. The patient was consequently diagnosed with decompensated heart failure, and combined treatment with diuretics (torasemide 8 mg/day, spironolactone 25 mg/day, and trichlormethiazide 2 mg/day for 14 days), arteriodilators (amlodipine 5 mg/day and olmesartan 20 mg/day), and venodilators (carperitide 0.125 mug/kg/min for 7 days) was introduced, resulting in the complete disappearance of pleural effusion and peripheral oedema concurrent with a reduction in body weight of 8 kg in over 3 weeks. After successfully achieving volume reduction, the patient underwent cardiac catheter examination to further assess her haemodynamic status (Table 1). Notably, the mean pulmonary artery wedge pressure was elevated to 18 mmHg without any systolic dysfunction or LV dilation, indicating LV diastolic dysfunction.\\nAfter a thorough discussion with her breast surgeon, trastuzumab was discontinued. At discharge, the patient was treated with 3.75 mg of tolvaptan, 200 mg of sacubitril valsartan, 5 mg of amlodipine, 25 mg of spironolactone, and 30 mg of azosemide. At 12 weeks after the interruption of trastuzumab administration, her heart failure symptoms significantly improved to New York Heart Association functional Class I; thus, maintenance medication was reduced to 5 mg of amlodipine and 200 mg of sacubitril valsartan. As shown in Figure 4, Doppler echocardiographic parameters of diastolic function, including E/A of 0.60, E/e' of 14.3, and LAVI of 57.1 mL/m2, significantly improved.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 38,\n",
       "    'case_id': 'PMC2799640_01',\n",
       "    'case_text': \"A 38-year-old woman with a history of pulmonary thromboemboli of seven months' duration was referred to our hospital for further evaluation. The patient had suffered from cough, dyspnea and transient hemoptysis. The patient had also undergone resection for a pelvic lymphangioma two months previously. At that time, pelvic MRI had demonstrated the presence of a large cystic mass with many septations and no involvement of the adjacent organs in the pelvis (Fig. 1A).\\nA physical examination revealed no vital sign abnormalities. Levels of pro-BNP (B-type natriuretic peptide) and D-dimer were mildly elevated to 196.2 pg/ml (normal range, 0-97.3 pg/ml) and 486 microg/L (normal range, 0-324 microg/L), respectively. However, peak serum levels of creatine kinase-MB fraction (CK-MB), troponin T, other blood chemistry findings and blood counts were within normal ranges. An initial plain chest radiograph demonstrated reduced volume of the right hemithorax and a paucity of pulmonary vascular markings on the right side (not shown). Perfusion lung scanning using Tc-99m macro-aggregated albumin identified the absence of perfusion throughout the right lung, indicating occlusion of the right main pulmonary artery (Fig. 1B). Transthoracic echocardiography (TTE) performed for the evaluation of persistent dyspnea demonstrated the presence of a mobile echogenic tumor adhering to chordae and papillary muscles of the tricuspid valve at the right atrium and right ventricle chordae. The tumor extended from the IVC into the right heart and caused tricuspid regurgitation (Fig. 1C, D). Chest CT confirmed the presence of an elongated non-enhanced mass in the right chambers of the heart and in the IVC, with extension to the right distal pulmonary artery (Fig. 1E, F). A median sternotomy was performed and the tumor was resected. Despite the presence of a neoplastic thrombus in the IVC, excision was straightforward except for resections of an adhesive chordal portion and a web-like tumor, which occluded the right distal pulmonary artery (Fig. 1G). Postoperative recovery was excellent, and the patient was extubated the day after surgery and was discharged to the general ward on day-2 postoperatively. At seven days postoperatively, the patient underwent follow-up TTE that demonstrated the absence of any residual mass inside the cardiac chambers (data not shown). The postoperative period was uneventful and the patient was discharged at day-15 postoperatively.\\nSpecimens from the IVC, right heart and right pulmonary artery were all diagnosed as cavernous lymphangiomas without features of malignancy. Grossly, the contiguous 29 cm long mass was a well-circumscribed, gray-white tumor with a soft, rubbery consistency (Fig. 1G). Based on the histology, the tumor consisted of dilated lymphatic channels with variable wall thicknesses (Fig. 1H). Lumina were lined with attenuated, bland endothelial cells. A few lymphocytes and rare lymphoid follicles were observed in the surrounding stroma, and a small number of disorganized bundles of smooth muscle were present in the walls of larger channels. Atypical features, such as, endothelial tufting, atypia and mitotic activity of lymphatic endothelium were absent, and based on immunohistochemical staining, tumor cells were positive for lymphatic vessel marker D2-40 (Fig. 1H, insert) and CD31.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 73,\n",
       "    'case_id': 'PMC10250735_01',\n",
       "    'case_text': 'A 73-year-old European woman presented with abnormal vaginal discharge. On clinical vaginal examination, a brown pigmented flat lesion of 2 x 2 cm was seen on the posterior vaginal wall just beyond the vaginal introitus. The lateral and anterior walls of the vagina did not show any abnormalities. No inguinal lymphadenopathy was found. Her medical history included only hypertension. She was a non-smoking female, gravida 4:para 4, with four vaginal deliveries. Her surgical history included a bilateral salpingo-oophorectomy and an appendectomy. Her family history showed her mother died of metastatic breast cancer.\\nA primary excisional biopsy was performed, and pathology reports showed a malignant melanoma with a minimal diameter of 20 mm and a thickness of 8 mm. There was no lympho-vascular or perineural invasion. The margins were positive on the lateral and distal sides. The patient was subsequently referred to our tertiary cancer center for robotic oncological surgery. Preoperative imaging involved magnetic resonance imaging (MRI), ultrasound scan of the groins, and FDG-positron emission tomography/computed tomography (PET-CT) scan. All of these investigations did not reveal any lymphadenopathy nor distant metastases. To exclude primary melanoma from other sides such as ocular melanoma, an ophthalmologic investigation was performed, which did not reveal any pathology. On the basis of these investigations, a primary melanoma from another side was excluded. The patient was clinically staged according to the 2009 International Federation of Gynaecology and Obstetrics (FIGO) staging for vaginal cancer as FIGO-stage I (cT1bN0M0) and according to the American Joint Committee on Cancer (AJCC; eighth edition) for (cutaneous) Melanoma Staging as clinical stage IB (T4bN0M0, with T4: >4 mm thickness and b: with ulceration). The patient was planned for a combined vaginal and robotic en bloc resection of the total vagina and uterus, in order to achieve a complete resection of the vaginal melanoma, together with a pelvic sentinel lymph node dissection.\\nThe robot da Vinci Xi platform (Intuitive Surgical Inc., Sunnyvale, CA, USA) with near-infrared fluorescence imaging (Firefly  technology) was used. As a fluorescent agent, indocyanine green (ICG: Verdye 25 mg, Diagnostic Green GmbH  , 85609 Aschheim-Dornach, Germany) was used at a concentration of 1.9 mg/mL H2O. A total of 2 mL ICG was used for the patient and 0.5 mL was injected, just beyond the vaginal introitus, in the submucosa of the anterior, posterior, and lateral vaginal walls.\\nA robotic pelvic bilateral sentinel lymph node dissection was performed prior to the en bloc resection of the uterus and total vagina (Figure 1).\\nVaginal approach: circular incision, with diathermy, of the vaginal mucosa just inside the vaginal introitus.\\nSubsequent dissection of the distal 3 cm of vagina, with releasing the vagina anteriorly from the urethra, posteriorly from the rectum, and laterally on both sides from the bulbocavernosus muscle.\\nRobotic approach: sealing/cutting of the round ligaments with an opening of the retroperitoneal space at the pelvic side walls.\\nUreterolysis: traction medially on the peritoneum of the broad ligament with subsequent ureterolysis, while keeping the mesoureter intact, down to the level of the crossing with the uterine arteries.\\nSealing of the uterine arteries at its origin, close to the internal iliac artery, and lateral from the ureters.\\nTraction of the bladder peritoneum toward the anterior abdominal wall (with robotic Cadiere forceps) and sealing/cutting of the uterine arteries on the uterus, both ascending and descending branch down to the vaginal edges.\\nPreparation for the robotic vaginal dissection: with fenestrated grasper, via the assistant trocar, traction of the uterus cranially, and with the robotic Cadiere foceps traction of the bladder peritoneum toward the anterior abdominal wall.\\nAnterior/lateral robotic vaginal dissection: dissection and dividing of the vagina from the bladder anteriorly and paravaginal tissues laterally, with robotic bipolar forceps and unipolar scissor, down to the level of the vaginal dissection.\\nPosterior robotic vaginal dissection: with the robotic Cadiere forceps elevation of the uterus against the pubis; opening of the posterior peritoneum with unipolar scissor and sealing/cutting of the sacro-uterine ligaments; dissecting the rectovaginal septum with releasing the total vagina from the rectum down to the level of the initial vaginal dissection; removal of the total vagina and uterus vaginally.\\nClosure of the vaginal introitus: approximation of the bulbocavernosus muscle on both sides toward the midline with Vicryl 1 sutures, below the level of the urethral orifice. Closure of the skin above the bulbocavernosus muscle with Ethilon 2/0 Donati stitches.\\nThe 10 surgical steps of the combined vaginal and robotic en bloc total vaginectomy and hysterectomy were as follows, with the patient placed in the lithotomy position (Figure 1): The methylene blue test showed a small bladder lesion at the top of the bladder, which was closed with two single sutures Monocryl 3/0. The estimated blood loss was approximately 300 cc. The rectal serosa was intact. The total combined vaginal and robotic operation time was 195 min. Postoperative recovery was uneventful. Hemoglobin levels did not drop below 9.8 g/dL. C-reactive protein levels remained low postoperatively (maximum of 13 mg/L). The patient was discharged on day 5. The bladder catheter was removed during an outpatient visit on day 10. She had no complaints. The pathology report showed a residual malignant melanoma of 6.23 mm in width with an invasion thickness of 0.8 mm; the combined dimensions of the residual melanoma and the initial excision biopsy (20 x 8mm, with ulceration) provide a final TNM stage as pT4bN0 (AJCC Stage IB) or FIGO stage I. There was no ulceration in the residual melanoma, perineural and lympho-vascular invasion were absent, and there was no invasion in the cervix. The surgical margins were free. All bilateral sentinel lymph nodes showed negative results. Immunohistochemical staining showed that the tumor cells were positive for Sox10, PRAME, and MIB1. P53 showed a wild-type expression. PHH3 did not show a clear mitosis. ATRX showed a weak but preserved expression in tumor cells. No BRAF mutation was found; however, a mutation was found in the KIT gene (exon 11). The suggested multidisciplinary advice was adjuvant treatment with immunotherapy and an intravenous administration of Pembrolizumab (PD-1 receptor blocker) for 1 year. During follow-up, there was no evidence of recurrent disease clinically or on imaging 4 months after surgery.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 24,\n",
       "    'case_id': 'PMC3426826_01',\n",
       "    'case_text': 'A 24-year old patient with secondary osteoarthritis of the hips due to Legg-Calve-Perthes disease underwent primary hybrid THA of the left hip seven years before trauma, followed by primary cementless THA of the right hip one year later at our institution (Fig. 1) Six years after the right THA, he was involved in a motorcycle accident, in which he suffered direct trauma to this hip, as well as a complex ankle fracture which was treated in a smaller regional hospital on admission. Although initial anteroposterior radiographs of the pelvis and right hip axial views were performed, no signs of fractures, aseptic loosening or implant damage were diagnosed by the attending trauma surgeons (Fig. 2). Two weeks after surgical treatment of the ankle fracture, the patient noticed a sudden \"cracking\" sound in his right hip, as well as shortening of the right lower limb. Interestingly, the patient had no relevant pain.\\nDespite this sign, he had no further medical observation or secondary radiographic evaluation over the next month. In the following months he was increasingly troubled by back pain and an unpleasant cracking \"phenomenon\" with movement of his right hip; no severe hip pain or associated direct thigh pain was mentioned at any time. Further conventional radiographs, in two planes, more than a year after the initial radiographs, revealed a completely destroyed multifragmented ceramic head (Fig. 3). A thorough clinical examination revealed a shortening of 2 cm of the right lower limb, yet the patient was able to walk without relevant pain.\\nIntraoperatively, extensive damage of the ceramic head and correlating taper junction of the femoral neck was found (Figs. 4, 6, 7). Concomitantly, there was severe debris-related metallosis throughout the entire joint (Fig. 5). The intervention consisted of conversion of the short cementless CFP stem to a cementless revision stem and an acetabular cup revision to a ceramic-ceramic bearing surface (Alloclassic stem and Allofit-IT acetabulum with Delta Ceramic Inlay, Zimmer, Warsaw, Indiana, USA and Ceramtec, Plochingen, Germany). Meticulous debridement of all affected soft tissues and extensive lavage was additionally performed.\\nThe postoperative course was uneventful, with radiographs revealing a correct position and articulation of the cementless implant (Fig. 8). A 12 month postoperative inquiry was performed and the Oxford Hip Score obtained, with both indicating satisfactory joint function. The patient had no pain and was able to perform his daily activities.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 13,\n",
       "    'case_id': 'PMC4159397_01',\n",
       "    'case_text': 'A 13-year-old Caucasian male previously diagnosed at 7 years of age with choroideremia presented with subacute loss of central acuity in his left eye. The patient has been followed routinely with the Ophthalmic Genetics Service at Casey Eye Institute and has maintained 20/20 visual acuity bilaterally, until now. The visual acuity was 20/20 and 20/100 in his right and left eye, respectively. An afferent pupillary defect was absent. Tonometry and anterior segment examination were within normal limits. Dilated fundus examination revealed diffuse peripheral chorioretinal atrophy in both eyes with sparing of the central fovea on the right side. In the left macula, there was a subfoveal elevated gray-white membrane with an adjacent punctate area of subretinal hemorrhage (Figure 1). Spectral domain optical coherence tomography (SD-OCT) (Figure 2) and fluorescein angiography (FA) (Figure 3) revealed a subretinal membrane with late staining and mild leakage. The findings were consistent with a subretinal neovascular membrane with mild activity. Outside the central macula, the choriocapillaris and RPE were diffusely absent in both eyes. Given his significant decrease in visual acuity and associated neovascular lesion, treatment with anti-vascular endothelial growth factor (VEGF) therapy was recommended. A total of ten intravitreal injections of 1.25 mg bevacizumab (Avastin ; Genentech, San Francisco, CA, USA) were administered over a 12 month period. Visual acuity at last follow-up was 20/150. Clinical exam appeared stable and SD-OCT revealed mild anatomical improvement (Figure 2). The images are unchanged.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 17,\n",
       "    'case_id': 'PMC3173925_01',\n",
       "    'case_text': 'A 17-year-old adolescent male patient presented to Ear, Nose and Throat Out-Patient Department (ENT OPD) with complaints of right eye proptosis and loss of vision for last 20 days [Figure 1]. There was no history of nasal obstruction or epistaxis. Patient also complained of bilateral non-tender neck swelling for last 7 days. On examination, nose was normal on anterior rhinoscopy, but perception of light in right eye was absent. The right globe was fixed in all directions and relative afferent papillary defect (RAPD) was also present. Left eye vision was normal. Coronal [Figure 2] and axial [Figure 3] cuts of contrast enhanced computerized tomography (CECT) scan of nose, paranasal sinus and orbit showed heterogeneously enhancing soft tissue density involving right nasal cavity, anterior and posterior ethmoids with erosion of cribriform plate and with right intraorbital extension. MRI of brain and orbit was done which showed Kadish stage C extension. Both T1 and T2 showed heterogenous signal intensity with dural enhancement along with involvement of right orbital apex and intraconal part of right eye. Patient underwent a nasal biopsy which was sent for histopathological examination (HPE). HPE report revealed small, round cell tumor forming Holmer-Wright rosettes suggestive of olfactory neuroblastoma. Fine needle aspiration cytology (FNAC) was also done from bilateral cervical level II lymph nodes which showed them as metastatic. In view of bilateral lymph nodes, radiotherapy consultation was sought and patient was put on external radiotherapy. The tumor responded very well to radiotherapy and both the metastatic lymph nodes and proptosis of right eye subsided within one month of starting radiotherapy. The patient received 66 gray radiation (Gy) in 33 fractions of 2 Gy a day for 5 fractions per week. Total treatment lasted for 7 weeks. At 1 month follow-up post radiotherapy, patient is clinically normal without palpable cervical lymph nodes and his proptosis has also decreased. He is on regular follow-up and according to the patient, his appetite and his weight has also improved after treatment.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 13,\n",
       "    'case_id': 'PMC3606735_01',\n",
       "    'case_text': 'A 13-year-old previously healthy Iraqi-born unvaccinated immigrant boy presented with a one-year history of worsening vision loss. Over the course of 2 months, he developed myoclonic jerks involving all extremities that increased in frequency over the next few months, occurring every 10 seconds. In addition, he had atonic episodes resulting in him falling to the floor. He had difficulty with fine motor movements, including writing and putting on clothes. Over several months, he progressed to being unable to ambulate independently. He had frequent urinary incontinence. His memory and performance in school began to decline, first gradually and then more rapidly after 6 months. He started to have aggressive outbursts towards his family with behaviors such as hitting and biting. His mother reported a febrile illness associated with a rash as a toddler without confirmation of measles.\\nInitial exam demonstrated decreased visual acuity in the right eye (20/200) and left eye (20/40) and frequent myoclonic jerks. He had evidence of macular retinopathy on fundoscopic evaluation. On mental status examination, he showed progressive impairment with simple multiplication and difficulty with recall and comprehension. He had difficulty with orientation questions. On cranial nerve examination, he had sluggish poorly reactive pupils to direct light bilaterally with normal reactivity on convergence and an oculomotor apraxia. He had diffuse spasticity of both upper and lower extremities with diffuse hyperreflexia. Coordination exam revealed a progressive resting and action tremor bilaterally and an unsteady, wide-based gait.\\nEEG showed significant frontal slowing during the awake state as well as recurrent periodic generalized periodic epileptiform discharges with preservation of his posterior basic rhythm (Figure 1) that raised suspicion for a diagnosis of a progressive myoclonic epilepsy included in the differential diagnosis: baltic myoclonic epilepsy, Lafora body disease, Unverricht-Lundborg disease, neuronal ceroid lipofuscinosis, sialidosis, myoclonic epilepsy with ragged red fibers, and SSPE.\\nFollowing an extensive negative metabolic and infectious workup of serum and CSF samples, the diagnosis of subacute sclerosing panencephalitis was confirmed by elevated serum measles IgG (22.4) and CSF measles IgG (12.0) titers.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 59,\n",
       "    'case_id': 'PMC4311031_01',\n",
       "    'case_text': 'A 59-year-old Korean man had a medical examination for healthy check-up in December of 2012. An abnormal mass-like lesion in the right hilum was incidentally detected on chest X-ray without any symptom. He was referred to our center for further evaluation.\\nThe patient has hypertension, diabetes mellitus and a history of angina. He visited the division of cardiology of our hospital in March of 2010, and was diagnosed with angina and hypertension. A cardiac angio computed tomography (CT) scan performed at that time detected a 2.5-cm diameter, minimally enhanced mass in the right hilar area (Figure 1A). Since then, he failed to return and was lost to follow up. The patient had a 40 pack-year cigarette smoking history and a family history of stomach cancer. On this admission, the physical examination was unremarkable. The blood examination showed eosinophilia (eosinophil 18.5%, 1,750/microL) and the rest of the laboratory tests including serum tumor markers (carcinoembryonic antigen, cancer antigen 19-9, alpha-fetoprotein, and prostate specific antigen), viral markers (hepatitis virus and human immunodeficiency virus), and autoimmune antibody titers were all within normal range. Examination for parasites was also negative.\\nA chest CT scan showed a 2.5-cm diameter mass in the right hilum that changed little in terms of size since 2010 (Figure 1B). A primary lesion was not found in the lung parenchyma. The torso fluorodeoxyglucose (FDG) positron emission tomography identified an abnormal FDG uptake in this right hilar mass, but no other pathologic hypermetabolic lesion was seen that may indicate a primary site. Bronchoscopy revealed mild bronchial wall thickening at the right upper lobe and right middle lobe opening but no endobronchial lesion was present. A biopsy of the bronchial wall thickening was done and histologic examination showed chronic nonspecific inflammation with squamous metaplasia. No abnormal finding was seen on the cytologic exam in the bronchial washing specimen. Endobronchial ultrasound guided transbronchial needle aspiration from the right hilar mass was performed. Atypical cells, favor malignancy, was seen in the aspiration cytology. Endoscopy for gastrointestinal tract and head and neck examination also failed to disclose a primary site of cancer.\\nRight pneumonectomy and mediastinal lymph node dissection were done. Grossly, several enlarged lymph nodes were found in the hilar and interlobar areas (Figure 2). On serial gross section of the lung, there was no abnormal lesion at bronchial tree and lung parenchyma except multiple lymph nodes enlargement. Entire bronchus and peribronchial tissue were embedded and evaluated. Microscopically, metastatic squamous cell carcinoma was found at several lymph nodes (8/45) and there was no tumor in the lung parenchyma and bronchial tree (Figure 3). Although the tumor was very close to the main bronchus, there was no evidence of bronchial invasion microscopically by tumor. The patient was diagnosed with T0N1M0 lung cancer and has received four cycles of adjuvant chemotherapy with cisplatin and vinorelbine. He has been observed at outpatient clinic after treatment without any evidence of recurrence so far.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 36,\n",
       "    'case_id': 'PMC6883338_01',\n",
       "    'case_text': 'We present a 36-year-old man, smoker with no known chronic medical illnesses, who had a history of idiopathic priapism for which he underwent a distal (Al-Ghorab) shunt surgery 3 years ago. Consequently, the patient presented to our clinic complaining of ED. As a result, he was started on Tadalafil and Alprostadil intracorporeal injections for 3 years but without satisfying erections. Thus, the choice of inserting a 3-piece penile prosthesis was discussed with the patient and he agreed. In June 2018, the patient underwent penile prosthesis insertion (Coloplast Titan ). Intraoperatively, severe corporal fibrosis was noted and dilated successfully. The procedure went uneventfully without complications. The patient was admitted for pain control and a 4-day course of intravenous Vancomycin and Gentamycin. During the hospital stay, no scrotal swelling or tenderness were noted, and the patient was discharged on Ciprofloxacin plus Cephalexin for 14 days. A month later, the patient presented with a painless scrotal swelling. However, no signs of systematic infection were detected. Local examination revealed an intact surgical scar with no overlying skin changes or discharge. Additionally, a small left scrotal confined collection was felt. Scrotal ultrasonography revealed 5.6 x 3.3 x 3.9 cm scrotal hematoma surrounding the prosthesis pump (Fig. 1). As there were no signs of infection and the device was functioning properly, the patient was managed conservatively with scrotal support and he was instructed not to use the device until the resolution of the hematoma. On the following visit, hematoma decreased in size, prosthesis recycling was performed successfully, and the patient was allowed to resume sexual intercourse. Two months later, the patient presented with a painless large scrotal swelling with the inability to use the pump due to the surrounding collection. On examination, there were no signs of local or systemic infection. A large, painless and firm scrotal swelling at the site of the pump was palpated. A pelvic MRI showed a 6.4 x 3.6 x 3.9 cm scrotal collection with findings suggestive of an underlying infectious process (Fig. 2, Fig. 3). The choice of elective scrotal exploration with a possible exchange of the implant was discussed with the patient, and he agreed after all risks and benefits were explained.\\nUnder general anesthesia, a penoscrotal incision was made. The pump was covered by a fibrous layer which was incised sharply. Upon opening the capsule surrounding the pump, blood poured out and a sample was taken for culture (Fig. 4). Complete hematoma evacuation and excision of the cavity was done, and the device was recycled successfully multiple times with no evidence of malfunction (Fig. 5). Accordingly, the decision was made not to replace the device. Vigorous scrotal washout was done using 1-liter of antimicrobial solution (Vancomycin and Gentamycin), povidone and hydrogen peroxide. Then, a new space was created for the pump in the right scrotal side. Eventually, size 10 French Jackson-Pratt drain was inserted, and the scrotal layers were closed using vicryl suture.\\nThe intraoperative culture came back positive for Staphylococcus Lugdunensis, so the patient was shifted from intravenous Vancomycin and Gentamycin to oral Clindamycin 600 mg three times a day for 3 weeks. The patient was discharged on day 7 postoperatively in a good condition. The patient is being followed up postoperatively for 2 months now with no evidence of hematoma recurrence or prosthesis malfunction.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 10,\n",
       "    'case_id': 'PMC10308279_01',\n",
       "    'case_text': \"A previously-healthy 10-year-old white-British girl of non-consanguineous parentage was referred to our tertiary pediatric rheumatology service with a 6-month history of worsening skin rash that was suspected to be vasculitic in nature by the local paediatrician. An initial 4 x 2 cm lesion on the right lower leg had gradually increased in size, followed by scattered 1 cm lesions developing across the left leg and buttocks (Figures 1A,B). The macular lesions were asymmetrical with irregular borders and a violaceous color (purpura- like), and there was associated atrophy and subtle telangiectasia with visible vessels. The surrounding skin also had a mottled appearance with mild livedo reticularis-like appearance but was warm to touch with normal capillary refill time. On assessment at our centre, she was systemically well, thriving, with no evidence of systemic vasculitis, specifically: no evidence of granulomatous inflammation in the nasal mucosa; normal blood pressure (93/65) with normal peripheral pulses and no thrills or bruits; normal respiratory and abdominal examination; normal musculoskeletal examination; no evidence of inflammatory eye disease clinically and normal fundi. Dip test of the urine revealed absence of blood or protein.\\nIn the year prior to referral, only limited blood tests were available, revealing no evidence of an inflammatory process with C-reactive protein (CRP) <1 mg/L (reference range 0-20 mg/L) and erythrocyte sedimentation rate (ESR) 2 mm/h (reference range 0-10 mm/h); normal complement C3 and C4 levels; and negative lupus anticoagulant and rheumatoid factor. Her full blood count, renal function, liver function, creatine kinase and lactate dehydrogenase were all within normal limits, as was her urine protein:creatine ratio. There were, however, no recent blood tests available due to severe needle phobia. This significantly affected our ability to assess the patient fully to exclude vasculitis as the cause of the unusual skin rash and for any serological evidence of an ongoing inflammatory or autoimmune process driving vasculitis. However, our clinical assessment was that these findings could also be part of an inherited vasculopathy. Based on that, the pre-test probability of systemic vasculitis was low, and gave us confidence that we had time to work with the child and family to initially avoid invasive investigations in the context of her extreme procedural anxiety.\\nOn further scrutiny of the past medical history, we noted an antenatal history of mitral regurgitation (which had resolved by 30 weeks' gestation). This had prompted an echocardiogram three months prior to her first clinic appointment, which unexpectedly showed aortic root dilatation, with aortic annulus 18.8 mm (z-score +0.44), sinus of Valsalva 32.2 mm (z-score +3.99), ST junction of 22.9 mm (z-score +2.45) and proximal ascending aorta 23 mm (z-score 2.14). The patient had also previously been investigated for mild hypermobility but had a normal skeletal survey, with no evidence of skeletal dysplasia or other skeletal abnormality, and she had normal arm span/height ratio, with height on the 70th percentile and weight on the 40th percentile.\\nSpecific clinical screening for MFS revealed a systemic score of 0/20, while the median systemic score in patients with MFS is 7/20. However, in recognition of the limitations of the systemic score, especially in childhood, the revised Ghent-2 criteria from 2010 place more emphasis on the cardinal features of ectopia lentis and aortic root dilatation, alongside molecular genetic testing. It is also of note that while skin striae are the only cutaneous manifestation listed in the revised Ghent-2 systemic criteria, other unusual skin rashes like those seen in our case have been reported. A skin biopsy or further investigation under general anesthesia was offered but not performed due to the patient's severe procedural anxiety.\\nWith the severe needle-phobia hampering our ability to repeat any blood tests or biopsy the skin lesions, we focused on DNA analysis via a salivary sample using a targeted gene panel of 214 genes, designed to screen for monogenic forms of vasculitis, and genetic vasculopathies that are known to mimic vasculitis of the young, as described previously by our group. The full list of genes in this panel are provided as Supplementary Material (Supplementary Table S1). This targeted gene panel revealed a frameshift variant in the fibrillin 1 gene: FBN1, NM_000138, c.1211delC, p.P404Hfs*44 het. Sanger sequencing results of parental samples were consistent with the variant having arisen de novo in the proband (Figure 1D). This variant is not listed in the Genome Aggregation Database (gnomAD), there are two entries in ClinVar where submitting laboratories have classified this variant as either pathogenic or likely pathogenic, and the same frameshift caused by a different nucleotide deletion has been previously described in MFS. The variant is expected to result in either an abnormal truncated protein product or loss of protein from this allele through nonsense-mediated mRNA decay. This allowed us to conclude that this genotype is pathogenic (Class 5) despite lack of experimental functional data directly probing the molecular mechanism of pathogenicity. Loss-of-function variants are a known mechanism in MFS and haploinsufficiency has been associated with a more severe aortic phenotype, although both haploinsufficiency and dominant negative effects have been implicated in pathogenesis of MFS.\\nThe patient was first seen in our clinic in June 2019 and received the genetic diagnosis in December 2019. During close clinical follow-up until May 2023, no features of systemic vasculitis emerged. In January 2020, due to aortic root dilatation in context of MFS with aortic annulus 19.9 mm (z-score +1.84) and sinus of Valsalva 32.2 mm (z-score +3.75), ST junction 21.83 mm (z-score +1.79) and ascending aorta 22.4 mm (z-score +1.59), she was commenced on treatment with losartan and atenolol at standard doses; the mother reported that this was associated with complete resolution of the cutaneous lesions within three weeks. The patient remained clinically well until February 2022, when she developed recurrent spontaneous pneumothoraces. These were managed with bilateral bullectomy and pleurodesis and to date (May 2023), no other features of MFS have emerged.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 83,\n",
       "    'case_id': 'PMC9149410_01',\n",
       "    'case_text': \"Case 1 An 83-year-old man with dilated cardiomyopathy and a complete left bundle branch block underwent implantation of a cardiac resynchronization therapy defibrillator (CRTD, Quadra Assura MPTM 3371-40, St. Jude Medical, USA) in May 2019. In September 2021, he was diagnosed with Dukes D stage rectal cancer and accepted expectant treatment. Beginning in October 2021, he suffered from recurrent paroxysms of palpitation, accompanied by occasional shocks. In November 2021, he was admitted to a small hospital due to syncope. At arrival to the hospital, the patient was hemodynamically stable (arterial blood pressure of 100/47 mmHg). A physical examination and an electrocardiogram (baseline rhythm: sinus rhythm/DDD pacing mode, 74 beats/min) did not provide evidence of acute decompensation of heart failure or acute coronary syndrome. Laboratory examinations found the level of hemoglobin was decreased (110 g/L) and the brain natriuretic peptide level was slightly increased (1,786.58 pg/ml). Electrolyte abnormalities and hyperthyroidism were excluded. Because of the lack of qualification to reprogram a CRTD, the local medical staff contacted the device specialist from the author's hospital for emergent technical assistance.\\nRemote device interrogation demonstrated a total of 64 episodes of ventricular fibrillation (VF), 31 episodes of non-persistent events, and 1 episode of supraventricular tachycardia. The maximum frequency of VF episodes was 45 times within 26 h. Antitachycardia pacing (ATP) terminated 54 of the 64 episodes of VF. Ten episodes of VF were unaffected by ATP and required a shock for termination. The shocks were ineffective in 2 episodes of VF, with successful termination by a subsequent shock.\\nThe device was remotely reprogrammed as follows without the loss of connectivity or programmability: VF shock energy output 2, 30 J to 36 J; value of the VF R-R interval, 12 to 18; VT-2, therapy 2 shock energy output, 15 J to 30 J; VT-2, therapy 3 shock energy output, 30 J to 36 J; left ventricular pulse width 2, 2.5 V to 1.75 V.\",\n",
       "    'gender': 'Male'},\n",
       "   {'age': 77,\n",
       "    'case_id': 'PMC9149410_02',\n",
       "    'case_text': 'Case 2 A 77-year-old woman with sick sinus syndrome and paroxysmal atrial fibrillation underwent implantation of a single chamber pacemaker (AccentTM SR RF 1,210, St. Jude Medical, USA) in VVIR pacing in July 2019. In December 2021, she presented to the emergency department due to palpitations and general debility. At hospital arrival, the patient was hemodynamically stable (arterial blood pressure 146/84 of mmHg). An electrocardiogram examination detected atrial fibrillation with rapid ventricular rates (130 beats/min). The emergency room physician applied for emergent device evaluation. To minimize personnel exposure to COVID-19 infection, we remotely interrogated and tested the device from the cloud follow up center. The result of remote interrogation found the device was in VVIR pacing mode and the maximum sensor-based rate was 130 beats/min. The ventricular lead parameters were in normal ranges. Before receiving further medication treatment, the atrial fibrillation was autoterminated.',\n",
       "    'gender': 'Female'},\n",
       "   {'age': 69,\n",
       "    'case_id': 'PMC9149410_03',\n",
       "    'case_text': \"Case 3 A 69-year-old woman with sick sinus syndrome underwent implantation of a dual-chamber pacemaker (AccentTM DR 2112, St. Jude Medical, USA) in DDD pacing in 2019. In November 2021, she presented to the author's follow-up clinic due to pacemaker syndrome. Device evaluation results showed that her device was in backup VVI mode: the base rate was 67 beats/min, and the ventricular pulse amplitude was 5.0 V. To address this emergent situation, we contacted the manufacturer's representative in Abbott China (Shanghai) for technical support. After obtaining written informed consent from the patient, we began the realtime remote programming session by contacting the remote manufacturer's representative via video call. Once getting the specific password from St. Jude Medical (Sweden), the remote manufacturer's representative successfully reset the device and reprogrammed it to DDD pacing of 60 bpm. We checked with patient's activities, there was no evidence of exposure to strong electro-magnetic field. Since the device have restored successfully, we monitored the patient. At follow-up after realtime reprogramming, the palpitation was completely remitted, and there were no signs of recurrence.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 62,\n",
       "    'case_id': 'PMC8326104_01',\n",
       "    'case_text': 'A 62-year-old female who had undergone prior subtotal resection of a schwannoma of the cauda equina (5 years ago) newly presented with a 3-month history of low-back pain/dysesthesias radiating into her right lower extremity, anesthesia in her perineal region, and urinary retention. Her lower extremity examination revealed a partial paresis (4/5), hyporeflexia, and hypoesthesia of the lower limbs and perineal region.\\nA gadolinium-enhanced MR imaging (MRI) documented an intradural extramedullary solid lesion with marked gadolinium enhancement extending from L1 to L2, resulting in anterior compression/displacement of the cauda equina/ conus medullaris [Figure 1]. Due to the prior history, this was determined to likely be a recurrent schwannoma of the cauda equina.\\nShe underwent bilateral laminectomies of L1-L2; following the durotomy, a well-defined (14 x 20 x 22 mm) solid yellowish lesion was visualized adjacent to the filum terminale; it was completely resected. Neuromonitoring potentials and electromyography remained unchanged. Next, a T11-L3 transpedicular screw-rod system was used to prevent mechanical instability in the thoracolumbar junction because of the multiple laminectomies performed at this level.\\nShe was discharged three days postoperatively, having regained full neurological function except for residual hypoesthesia in the perineal region. In addition, the postoperative MRI scans confirmed complete tumor removal [Figure 2].\\nPathology revealed a fusocellular tumor that was compatible with the diagnosis of a schwannoma of the cauda equina [Figure 3]. It had a Ki67 <1%, positivity for S100 protein and smooth muscle actin, and negativity for desmin, DC34, and CD117.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 24,\n",
       "    'case_id': 'PMC4232202_01',\n",
       "    'case_text': \"We report an unusual case of Behcet disease presenting with retinal vasculitis and unilateral exudative retinal detachment. A 24 years old man presented with 1 week history of acute vision loss of both eyes. He reported a 3 years history of recurrent oral and genital ulcerations, with arthralgia of wrists and ankles. The best correct visual acuity was 6/30 in the right eye and 6/24 in the left eye. Slit lamp examination showed bilateral mild inflammation in the anterior chamber and vitreous. Funduscopy revealed bilateral extensive perivascular sheathing with scattered yellowish retinal infiltrates and hemorrhages. In the right eye there was, in addition, a bullous exudative retinal detachment involving the superior and inferior quadrants of the temporal retina (a, white arrows). Fluoresce in angiography (b) showed late staining of the retinal vasculature with diffuse dye leakage in both eyes. In the right eye, late frames showed an evident fluorescein pooling in the subretinal space (black arrows). The patient received intravenous bolus of methylprednisolone (1 g daily / 3days) leading to prompt clinical improvement. Azathioprine was also started at a dose of 150 mg daily. Exudative retinal detachment is an uncommon finding in Behcet's disease, and only few cases were reported in the medical literature. This entity could reflect the severity of the underlying disease. In addition the early set of the disease and male gender are usually associated with poor long term prognosis. This justifies our choice of giving azathioprine as an immunosuppressive therapy.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 28,\n",
       "    'case_id': 'PMC4367056_01',\n",
       "    'case_text': \"A 28-year-old male patient reported [Figure 1] with the chief complaint of a painless swelling in the right upper back tooth region since 3 years. History revealed swelling was of insidious in onset, which increased to attain the present size. Family history revealed the patient's father [Figure 3] also had multiple swellings all over the body and face. On general examination, multiple swellings all over the trunk region and arms were observed [Figure 2]. Solitary well-defined oval shaped swelling [firm in consistency and nontender on palpation Figure 4] approximately 4 cm x 3 cm was present in the right maxillary posterior region extending from distal aspect of maxillary first premolar to mesial aspect of third molar. Radiographic screening was normal. However, multiple, discrete, sessile cutaneous masses which had started appearing since childhood were observed. Histopathological examination of incisional biopsy of the oral lesion showed spindle cells with elongated wavy nuclei. The lesional area was separated from the overlying epithelium by mature fibrous connective tissue [Figure 5].\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 45,\n",
       "    'case_id': 'PMC5180436_01',\n",
       "    'case_text': 'A 45-year-old Caucasian male patient presented at our emergency department with headache, visual deficiencies, and moderate disorientation. On the day of the admission, he experienced a convulsive seizure. His medical history was free of any severe infections, immunomodulatory diseases, severe traumas, malignancies, and recent surgical interventions. In the past years, he had not visited any tropical or subtropical areas.\\nLaboratory parameters on admission were not deranged and physical examination showed normothermia without meningeal irritation. In addition to the visual deficiencies and the mild mnestic impairment, no neurological deficits could be identified.\\nImmediate computed tomography (CT) scan showed a hypodense lesion in the right parietal region. On contrast-enhanced magnetic resonance imaging (MRI), a ring-shaped lesion in the right parietal lobe was noted [Figure 1a-c]. The diffusion-weighted images showed an intensive hyperintense signal, which was strongly suspicious for a brain abscess [Figure 1d].\\nCalculated antibiotic treatment was initiated with amoxicillin/clavulanic acid and metronidazole. The patient was prepared for surgical intervention. The patient was informed regarding the off-label use of FL, and he provided written consent.\\nApproximately 30-45 minutes prior to skin incision, 5 mg/kg bodyweight of FL (Natrium Fluoreszein  10%, ALCON, Germany) was administered via the central venous line during induction of anesthesia.\\nCraniotomy was planned with neuronavigation. After durotomy, the PENTERO 900 surgical microscope was applied. The lesion could not be detected under white light, however, showed intensive fluorescent staining under the YE560 nm filter [Figure 2a and b]. After opening of the capsule, viscous pus poured out [Figure 3a] that was not fluorescing under filtered light [Figure 3b]. The pus and the capsule were microsurgically removed and sent to the neuropathology and microbiology department.\\nThe postoperative course was uneventful. Because no microbiological specimen could be identified, calculated antibiotic treatment was continued. The visual deficiencies and the mnestic impairment completely resolved, and the patient was discharged after 5 weeks.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 56,\n",
       "    'case_id': 'PMC10157198_01',\n",
       "    'case_text': 'A 56-year-old male with an unremarkable medical history presented with an acute onset of headache. The patient was of Chinese Han nationality and had no history of drug abuse or surgical treatment of craniocerebral diseases. The computed tomography (CT) obtained at the local hospital showed a grade 1 subarachnoid hemorrhage (SAH) on the modified Fisher scale (Figure 1A). After 6 days of conservative treatment, the patient was admitted to our hospital. CT was repeated and showed that the SAH had been absorbed (Figure 1B). CT angiography showed the arterial network of the right proximal MCA and an aneurysm on the A1 segment of the ACA (Figures 1C, D). The patient could correctly obey commands during the physical examination, and his condition was classified as grade I on the Hunt-Hess scale. The limb muscle strength was grade V, and the Babinski sign was positive in both lower limbs.\\nThen, endovascular coil embolization for the aneurysm was planned. During the treatment, digital subtraction angiography (DSA) confirmed that the right MCA was twig-like, an aneurysm with a diameter of 4 mm was located at the origin of the AccMCA from the A1 segment of the ACA, and the AccMCA was a collateral artery for the MCA twig (Figure 2). After the three-dimensional reconstruction of the DSA data, the best projection degree showed the aneurysm sac and its neck. An Echemon-10 microcatheter (Medtronic, Irvine, CA, USA) was used to perform the coiling [Axium Prime coils: 3.5 mm x 10 cm, 2 mm x 6 cm, 1.5 mm x 3 cm (Medtronic, Irvine, CA, USA)], and the aneurysm was completely embolized (Figures 3A, B).\\nPostoperatively, the patient recovered uneventfully. One month later, the patient returned to his job without any neurological deficits. A postoperative CT at the 3-month follow-up showed that the brain tissue was normal (Figures 3C, D).',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 42,\n",
       "    'case_id': 'PMC9199574_01',\n",
       "    'case_text': \"This is a case study of a 42-year-old woman (who will be called Emma). She had secondary education, was divorced, and raised by herself her 10-year-old daughter and 9-year-old son with autism spectrum disorder. She remained unemployed and used care allowance. Emma came from a very religious family and was raised by mother and grandparents. No one used psychiatric treatment in her mother's family and there was no information about that from the father's side. Her father was born in a Nazi concentration camp and after the war he relied on financial compensation. He was much older than Emma's mother, aggressive, and abused alcohol. He left the family before Emma's first birthday, and reappeared every 6 or 12 months thereafter. According to Emma, her mother was controlling and turned her against her father. Emma also perceived herself as a solution for her mother's pain after miscarrying a child shortly before Emma had been conceived.\\nEmma had a good relationship with her maternal grandfather, who was supportive and a model of morality and piety. He led her to develop her interest in religion when she was in primary school, but he died when she was 15. Around that time her problems with aggressive or auto-aggressive behavior started, as well as attention seeking by unlawful behavior and breaking school regulations. She became rebellious, and frequently quarreled with her mother who tried to control her social life and sexuality, before running away from home for a year to live in squats, abusing alcohol and drugs, and engaging in risky sexual behavior for money. She was sexually abused under the influence of substance a few times. In adulthood, she lived abroad for almost 10 years, earning money by providing sexual services. During that time she also experienced rape and threats. As she never had close friends, she only used support from priests who, based on her life history, believed she was possessed. She was first exorcized a few times in charismatic groups at age 16. In adulthood, she regularly used deliverance ministries and individual exorcisms according to Roman Catholic ritual for a few years, but her problems and symptoms persisted.\\nShe had elevated levels of somatoform and psychoform dissociation (respectively, measured with SDQ-20 and DESR-PL). More information about her symptoms reported during the clinical interview and mental state examination is provided in Table 3.\\nRecordings of all the interviews were transcribed verbatim and analyzed together with researchers' notes using qualitative data-analysis software (MaxQDA 2020 ver. 20.4.0). Consecutive IPA procedures were employed in the study. Researchers watched each interview and read the transcripts carefully. They individually made notes about body language, facial expressions, the content and language use, reported symptoms, and wrote down their interpretative comments using the annotation feature in MaxQDA 2020. Next, they categorized their notes into emergent themes by allocating descriptive labels. They then compared and discussed their diagnostic insights, coding and interpretations. They analyzed connections between themes and grouped them according to conceptual similarities into main themes.\\nDuring each interview, the participant was encouraged to illustrate reported symptoms or experiences with specific examples. Interviewers asked clarification questions to negotiate the meaning the participant wanted to convey. At the end of the interview, she was also asked questions to check that her responses were thorough. The researchers discussed her case thoroughly, including the diagnosis and interpretative notes to compare their understanding of the content and its meaning (the second hermeneutics).\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 35,\n",
       "    'case_id': 'PMC6787949_01',\n",
       "    'case_text': \"The patient provided informed consent for inclusion in this case report, and Peking University First Hospital committee approved the study. A 35-year-old female patient of Han ethnicity was admitted to our hospital with a 5-year history of painful intercourse accompanied by oral mucosal lesions and a 3-year history of difficulty with intercourse. The patient began a normal sex life in 2005 and in the same year had a medical abortion. In 2006, the patient experienced partial hair loss over an area ~1 cm in diameter on the head (Figure 1). The patient considered the hair loss to be alopecia areata and did not consult a doctor. In January 2007, a medical abortion at 16 weeks of pregnancy was performed, and the fetus and placenta were successfully delivered; uterine curettage was not performed. The patient recovered her menstrual cycle after one month and resumed normal sexual activity after 2 months.\\nIn 2009, the patient started experiencing symptoms of vaginal dryness and deep dyspareunia. In June 2009, the patient experienced gingival pain after eating spicy food and subsequently developed bilateral oral mucosal peeling, but she did not consult a doctor. In 2010, the patient was admitted to another hospital due to aggravation of the symptoms of vaginal dryness during sexual intercourse and the development of pain. A vaginal mucosal ulcer with a diameter of about 8 mm was found. The patient was admitted to Union Medical College Hospital, where tests for anti-nuclear antibody spectrum and lupus antibody were normal, as were the results of other examinations. Behcet's disease was excluded, and she did not receive a formal diagnosis or any treatment.\\nIn 2011, the patient developed difficulty having sexual intercourse, and the main manifestation was pain at the vaginal orifice that prevented penetration. The patient had no sex life after 2013. In January 2014, the patient was admitted to the Stomatological Hospital, and physical examination showed that the oral lesions (Figure 2) resembled LP. Other than the oral ulcers and hyperemia, there was no symptoms in other parts of the oral cavity (gingiva or throat). She was treated with oral prednisone (4 mg qd), Tripterygium wilfordii, mouthwash (containing 5 mg/mL dexamethasone sodium phosphate 1 mL twice a day), and thalidomide. The patient reported increased nocturia and vivid dreams during the treatment period, and she refused to continue the therapy. She had a history of trichomonas vaginitis twice in 2013.\",\n",
       "    'gender': 'Female'},\n",
       "   {'age': 34,\n",
       "    'case_id': 'PMC6787949_02',\n",
       "    'case_text': \"A vaginal microecological examination in August 2014 showed an abnormal flora, and a lactobacillus capsule was administered to the upper vagina once daily for 10 days. The patient was previously healthy (before the onset of symptoms) and denied a history of surgery. The menstrual cycle was 4/25-28 days, and menstrual volume had decreased during the previous year, but there was no dysmenorrhea. The last menstrual period had occurred on September 12, 2014. The patient was gravida 2 (one medical abortion and one induction of labor in the second trimester), para 0. She had an allergy to penicillin. There was no relevant family history of note. The patient's husband was 34 years old and had normal erectile function.\\nIn September 2014, the patient was admitted to the Department of Obstetrics and Gynecology, Peking University First Hospital, due to inability to have sexual intercourse. She had a height of 155 cm and a weight of 46.5 kg. Examination of the vulva revealed an extremely thin mucous membrane, hyperemia, a slight lowering of the pubic arch, and a small, bright-red, defect-like lesion on the mucosal surface of the medial labia minora. The vaginal orifice was stenosed with a diameter of 1 cm. There was vaginal stenosis with disappearance of the mucosal folds. The urethral orifice was less than 1 mm in diameter. Ring-like stenosis was present at the 9 o'clock position of the upper two-thirds of the vagina. A small speculum was unable to expose the cervix (Figure 3A). The pH of the vaginal secretions was 5.4. Hormone levels were normal (luteinizing hormone, 4.92 mIU/mL; follicle stimulating hormone, 8.12 mIU/mL; estradiol, 43.0 pg/mL; prolactin, 26.3 ng/mL; and testosterone, 0.48 ng/mL). Tests for autoimmune antibodies (anti-nuclear antibody, anti-double-stranded DNA antibody, and anti-extractable nuclear antigen) were negative, and tests for anti-thyroid antibodies were also normal (anti-thyroperoxidase antibody, 16.06 IU/mL; anti-thyroglobulin antibody, 23.05 IU/mL). Examination of the eyes showed no abnormalities.\\nAn oral mucosal biopsy (performed due to the history of oral mucosal ulceration) revealed the following results for the right cheek: squamous epithelial mucosa, squamous epithelial parakeratosis, scattered lymphocytes in the epithelium, lymphoid and plasma cells distributed in a strip-like pattern in the superficial lamina propria, and small vessel hyperplasia (Figure 4A and B).\\nA vaginal wall biopsy was performed on November 17, 2014 after preoperative tests. The pathological sections were considered to have squamous epithelial mucosal tissue, partial epithelial atrophy, partial simple hyperplasia, hyperkeratosis and incomplete keratosis, scattered focal infiltration of lymphocytes and plasma cells in the superficial dermis with formation of lymphoid follicles, and small vessel hyperplasia (Figure 5A and B). These results were consistent with an inflammatory lesion.\\nIn view of the symptoms of urinary difficulty and the discovery of a pinpoint urethral orifice on examination, urine flow rate was measured at the Urology Department and found to be 5.2 mL/s (normal value: >18 mL/s) (Figure 6A).\\nAfter multidisciplinary discussion of the case between the Departments of Dermatology, Obstetrics and Gynecology, and Urology at our hospital, the patient was diagnosed as having LP with multiple system involvement including the scalp, mouth, vagina, and urethra. Since the patient had not tolerated the adverse side effects of corticosteroid therapy during previous treatment and had fertility requirements, she was treated with oral cyclosporine A (125 mg/day) combined with physical dilatation of the urethra, and this resulted in an increase in urine flow rate to 11.5 mL/s (Figure 6B).\\nAfter one month of drug therapy (January 8, 2015), the patient resumed her sex life and had sexual intercourse for 10 min without serious dyspareunia. In addition, the oral ulcer had improved, and urination was less problematic than before treatment but more difficult than just after urethral dilatation. Physical examination revealed that the mucosa of the labia minora was smooth, the frenulum labiorum pudendi was lightly chapped and the vaginal elasticity had improved, although the upper vagina still had a ring-like narrowing and no folds (Figure 3B).\\nAt the 3-month follow-up, the patient reported only mild pain during sexual activity, but a feeling of dryness persisted. There was no change in urination, and no oral mucosal lesions were present. The patient was treated with cyclosporine A for a total of 6 months, and this resulted in the vulvar lesions essentially disappearing (as assessed by gynecological examination), although the symptoms did not notably improve during the latter 3 months. The patient discontinued the medication due to economic pressures.\\nThe patient was followed-up annually with gynecological examinations for a further 4 years. During the 4-year follow-up period, the patient reported that her psychological stress had been relieved and that symptom aggravation had not occurred. In July 2018 (the last outpatient follow-up), the patient reported a satisfactory sex life and a slight decrease in urine flow rate, but no treatment was needed. Oral mucosal lesions had not re-appeared. Gynecological examination showed that the mucosa of the medial labia minora was slightly reddened, smooth, and without defects, the elasticity of the vaginal mucosa was good, and two fingers could be accommodated (see Figure 3C). There was no discomfort during the physical examinations. At present, the patient is not pregnant and continues to be followed-up.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 16,\n",
       "    'case_id': 'PMC5259602_01',\n",
       "    'case_text': 'A 16-year-old boy was referred to our hospital for symptoms of hepatosplenomegaly and pancytopenia with suspicion of metabolic diseases like Gaucher disease especially. Past medical history revealed cervical abscess in infantile period, an axillary abscess at the age of 10, and necrotizing pneumonia at the age of 14 years. He was the 6th child of nonconsanguineous parents with 10 live births. One brother deceased because of recurrent pulmonary infections.\\nHepatosplenomegaly (spleen 10-12 cm, liver 8 cm below the costal margin), petechia on skin and mucous membranes, and decreased lung sounds were recorded on physical examination. Anemia, thrombocytopenia, neutropenia, hypergammaglobulinemia, and elevated ALP (alkaline phosphatase) (884 U/L) and GGT (gamma-glutamyl transferase) (356 U/L) levels were recorded as abnormal laboratory results. Chronic lung findings as bronchiectasis and atelectasis were observed in chest X-ray (CXR). Portal hypertension via portal Doppler US and biopsy proven perivenular fibrosis and congestion of liver were detected. Investigations revealed no significant results confirming any metabolic diseases including the early suspicion of Gaucher\\'s disease. Pancytopenia was considered to be associated with splenomegaly related to portal hypertension and improved in follow-up. The quantitative oxidative burst activity (\"Phagoburst\" kit, Glycotope, Biotechnology) was abnormal (FMLP 0.94%, PMA 4.10%, and opsonized E. Coli 4.89%; normal values 1-10%, 98-100%, and 97-100%, resp.). He was diagnosed as CGD which was later confirmed with molecular analysis revealing a \"hemizygous X-linked c.1609T>C mutation\" in CYBB gene-gp91phox.\\nProphylactic antifungal and antibacterial medications and interferon gamma-1b were started although patient adherence to the treatment and follow-up visits was very poor. He was admitted with the complaints of fever, cough, respiratory distress, and stomachache, two years after the diagnosis. He had bilateral fine crackles with decreased lung sounds in the left basal region, hepatosplenomegaly (spleen 2 cm, liver 3 cm palpable), and a swelling inferior to sternum with dimensions of 4 x 5 cm in abdomen. He had iron deficiency and chronic disease anemia, high acute-phase reactants (C-reactive protein (CRP) 11.2 mg/dL, erythrocyte sedimentation rate (ESR) 90 mm/hour), and minimally elevated ALP (133 U/L) and GGT (36 U/L) levels in laboratory evaluation. CXR revealed an expanded pneumothorax within left hemithorax. There were chronic lung findings relevant to recurrent infections in addition to pneumothorax in thorax CT (Figure 1). Ciprofloxacin, teicoplanin, and fluconazole were started empirically. There was a 7 x 4 cm heterogenous mass lesion in liver with cystic areas in center which was a multiloculated abscess in abdominal US that was subsequently confirmed with abdominal CT (Figure 2). There were multiple lymph nodes in periportal, peripancreatic, and para-aortic regions. Interventional radiology department inserted a drainage catheter to the abscess and a pigtail catheter to the left hemithorax. Staphylococcus aureus (methicillin sensitive) grew in the culture from abscess material. Antibiotics were replaced with cephazolin and rifampicin and a transient response was achieved. However, control CT 5 days after catheter placement showed no significant change in the dimensions of abscess (Figure 2). Surgical treatment was considered due to the multiloculated nature of the abscess and ongoing fever. Irregular abscess wall on anterior liver surface was dissected, and granulomatous changes in peripheral tissues were noted during the operation. Intraoperative US showed multiple small granulomas in liver. Fever did not recur followed by decreases in CRP to 1.4 mg/dL and in ESR to 22 mm/hr, after the operation. Pathologic findings were consistent with necrotizing granuloma and abscess in liver. He was discharged with supportive treatment and appropriate antibiotics two weeks after the operation. Hematopoietic stem cell transplantation (HSCT) was planned as the disease progressed despite the supportive measures. He had a full match donor but the family did not accept HSCT as a treatment option.',\n",
       "    'gender': 'Male'},\n",
       "   {'age': 0,\n",
       "    'case_id': 'PMC5259602_02',\n",
       "    'case_text': 'A 3-month-old girl was referred to our hospital with a suspicion of Langerhans cell histiocytosis. She was hospitalized for pneumonia at the fifteenth day of birth followed by recurrent and treatment resistant cervical lymphadenopathies with high CRP levels. She was the first child of a consanguineous family. She had bilateral cervical lymphadenopathies and maculopapular skin eruptions over body and legs on admission. Laboratory investigations revealed anemia, leukocytosis, high CRP level (12 mg/dL), and hypergammaglobulinemia. Histological findings of the skin biopsy and lymph node excision were reported as granulomatous inflammation and necrotizing granulomatous lymphadenitis, respectively. Meanwhile, oxidative burst activity (\"Phagoburst\" kit, Glycotope, Biotechnology) was insufficient (FMLP 9%, PMA 9%, and opsonized E. Coli 4%; normal values 1-10%, 98-100%, and 97-100%, resp.) leading to a probable diagnosis of CGD later confirmed with mutation analysis disclosing a \"homozygous autosomal recessive c.369 + 1G>A mutation\" in CYBA gene-  p22phox.\\nShe was admitted again with tachypnea with coarse lung sounds relevant to acute pneumonia at 30 months of age. She had anemia (Hb: 8.9 g/dL), leukocytosis (16800/mm3), and high CRP (3 mg/dL) and ESR (60 mm/hr) levels. CXR showed bilateral extensive infiltrations especially prominent in left upper lobe (Figure 3). Thorax CT revealed pneumonic consolidations with calcifications (Figure 3). These findings were interpreted in favor of tuberculosis (TB) although objective mycobacterial evidence was absent (PPD 9 mm, gastric fluid acid-fast bacilli and PCR negative). Three-drug combination therapy (isoniazid, rifampicin, and pyrazinamide) was initiated. Echocardiography showed pericardial thickening which was also evaluated as TB sequela.\\nDespite treatment, her clinical condition worsened in a two-month period. Extensive lymph node enlargements in mediastinum and around pericardium reaching to 3 cm in diameter, some showing central necrosis, were recorded in the new thorax CT (Figure 3). During hospitalization, she developed right congestive heart failure signs, fine crackles in lungs, and increased oxygen need. Echocardiography showed findings compatible with pulmonary hypertension, diastolic dysfunction, and constrictive pericarditis (Figure 4). Emergency pericardiectomy was performed. Aspergillus fumigatus was cultured in pericardial fluid and blood Aspergillus antigen was positive for the first time. Parenteral caspofungin and voriconazole infusions were initiated in combination for antifungal therapy. Histological interpretation of the pericardial sample was reported as granulomatous pericarditis.\\nFever and respiratory distress continued and thorax CT revealed an abscess of 4.5 x 1.7 cm diameter in left lung inferior lobe, two weeks after the pericardiectomy (Figure 5). The abscess was drained and drainage material culture was positive for Aspergillus fumigatus (Figure 5). Granulocyte transfusions were applied for the subsequent days and fever subsided gradually in a few days. She was discharged with oral voriconazole after her condition stabilized with parenteral antifungal therapy for one month. Blood Aspergillus antigen was still positive in low titers.\\nTwo weeks later, she was brought to emergency department with left hemiparesis, left central facial paralysis, and fever. Glasgow Coma Scale was 12, motor strength was 2/5 in left upper and lower extremities, and left plantar response was abnormal in neurological examination. A hypodense lesion at the level of right basal ganglia was interpreted as acute ischemic infarction in cranial CT (Figure 6). Diffusional restriction consistent with acute ischemia in right basal ganglia and cerebral, cerebellar millimetric enhancing foci consistent with aspergillosis were reported in cranial and diffusion magnetic resonance imaging (MRI) (Figure 6). In MR angiography, right middle cerebral artery was occluded from M2 segment to end which was also associated with Aspergillus infection (Figure 6). Voriconazole, amphotericin B, vancomycin, and meropenem were started. Intravenous immunoglobulin, 1 gr/kg/day, was given for two days. Fever was controlled and her general condition improved. Acetylsalicylic acid treatment was commenced to prevent further infarction.\\nNeurological findings regressed with decreased facial asymmetry and increased motor strength in the follow-up. Parenteral antifungal treatment was continued for two months and she was discharged with oral voriconazole and negative blood Aspergillus antigen. The ischemic lesion in the right basal ganglia showed chronicity and appeared as cystic encephalomalacia; most of the cerebral/cerebellar foci were smaller than before and some disappeared in the control MRI five months after the initial evaluation (Figure 7). Due to the severe course of her disease, HSCT was planned and due to the lack of full matched relative, an unrelated donor search is initiated.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 73,\n",
       "    'case_id': 'PMC4993919_01',\n",
       "    'case_text': 'A 73-year-old male from a remote village presented with complaints of intense itching and crawling sensation with maggots wriggling and falling from the wound of left orbit since 1 week. This was associated with pain and foul-smelling purulent discharge from the wound. He had a history of surgical removal of the pigmented nonhealing ulcerated lesion in left lower eyelid 9 years ago, reported as basal cell carcinoma.\\nAt presentation, the unaided visual acuity was 6/18 and best corrected visual acuity was 6/9 in right eye. The rest of the findings in the right eye was normal. In left orbit examination, there was a large fungating, foul-smelling, ulcerated mass with wound extension up to eyebrow superiorly and malar region inferiorly and up to lateral canthus and medial canthus. Necrotic tissues along with crusts and scabs were present within and at the wound edges along with granulation tissues. There was intense foul smell and purulent discharge with multiple maggots crawling over the wound. The left eyeball was not seen.\\nInitially, around 100 maggots were manually removed and debridement of necrotic tissues was done under local anesthesia (Figure 1). Exposed bone edges of lateral wall of the orbit were noticed after sterile dressing. The patient was started on oral antibiotics and analgesics. He also received single dose of oral Ivermectin (9 mg, 200 mcg/kg) following which the patient had significant relief from pain and discomfort. Dead maggots were easily removed from the wound and the rapid wound healing ensued. The left socket was covered with healthy granulation tissues and was maggot-free within few days.\\nThe CT scan of orbit and paranasal sinuses revealed left anophthalmic socket with soft tissue lesion in left orbit and maxillary sinus along with erosion of orbital floor and lateral wall of the orbit (Figure 2). However, orbital apex and cranial fossa were not involved. Nasal endoscopy revealed only streaks of mucopurulent discharge in maxillary sinus. Punch biopsy was done from the wound margins and central region and sent for histopathological evaluation. The biopsy report revealed basal cell carcinoma invasive into the left orbit.\\nHence, the patient underwent uneventful extended exenteration of the left orbit and the socket was covered by transposition of myocutaneous flap from forehead and temporal region (Figure 3). The postoperative period was also uneventful and patient recovered well. The patient was reassessed 7, 14, 30, and 60 days after the discharge from the hospital with complete healing of the wound.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 8,\n",
       "    'case_id': 'PMC4524006_01',\n",
       "    'case_text': \"This 8-year-old boy presented with complaints of progressively worsening headaches along with vomiting and intermittent fever since 20 days. There were no significant findings on general physical and neurological examination. The patient's routine laboratory investigations were normal. A magnetic resonance imaging (MRI) brain was performed which showed multiple intracranial cysts predominantly in the right frontal region with significant mass effect [Figure 1]. The patient's chest X-ray, ultrasound abdomen, and eosinophil counts were normal. The patient was started on dexamethasone, leviteracetem, and albendazole and scheduled for surgery.\\nA frontoparietal craniotomy was performed. There was significant dural tension, and a c-shaped durotomy was done which revealed a huge hydatid cyst extending toward the lateral ventricle [Figure 2a]. A soft rubber catheter was inserted between the brain parenchyma and the cyst capsule (Dowling's technique); a cleavage plane was established using warm hypertonic saline and the cyst was delivered unruptured [Figure 2d]. Numerous daughter cysts were then identified which were carefully delivered unruptured using the same technique [Figure 2b and c]. We were able to remove all of the 19 cysts without rupturing the cyst capsule this way. An endoscope was used after removing all the cysts to make sure that none of the daughter cysts was left behind. The cavity was copiously irrigated with hypertonic saline and hydrogen peroxide. Histopathological examination confirmed hydatid cyst and no bacterial agent was isolated.\\nThe patient continued taking albendazole (200 mg, BID), dexamethasone, cefazolin, and levetiracetam postoperatively and had an uneventful postoperative course. The patient was seen in clinic on 3 months postoperative visit and his complaints of headache and vomiting had completely resolved. His neurological examination was completely normal and considering financial constraints a follow-up computed tomography (CT) scan was thus not performed.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 49,\n",
       "    'case_id': 'PMC5839875_01',\n",
       "    'case_text': 'A 49-year-old female patient, who suffered from an iliofemoral deep vein thrombosis (DVT) due to the presence of chronic obstruction of the iliac vein system, underwent venous stenting using a venous stent for recanalization (Boston Scientific, EPIC Stent, size 12 mm/40 mm). One hour postprocedural echocardiography and computed tomography scan ( Fig. 1 ) revealed stent migration into the subvalvular chordal structures of the right ventricle causing significant tricuspid regurgitation. The patient became hemodynamically unstable due to severe cardiac arrhythmias with heart rates up to 180 per minute and was scheduled for emergency surgery. \\nMedian sternotomy and bicaval cannulation for cardiopulmonary bypass was performed. Transesophageal echocardiography showed further migration of the stent toward the right ventricular outflow tract. To prevent further migration into the pulmonary vasculature, manual compression was applied. The right atrium was opened in beating heart technique to locate the stent.\\n Despite the fact, that the stent was entrapped by subvalvular chordal structures of the tricuspid valve due to the stent design with wire brackets, it was possible to recover it without harming the tricuspid valve and adjacent structures ( Fig. 2 ). The postoperative course was uneventful and the patient was discharged on postoperative day 7. Postoperatively, the patient received warfarin. No reocclusion of the iliac vein occurred and the patient underwent no redo stenting. The patient is in a good condition 1 year after the procedure.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 9,\n",
       "    'case_id': 'PMC6296693_01',\n",
       "    'case_text': 'In Apr 2008, a 9-yr-old girl with initials A.S. (born in 1999, in Maglaj, Bosnia and Herzegovina) was admitted into the General Hospital Tesanj (Tesanj, Bosnia and Herzegovina) with a severe headache, mental confusion, high fever, and a cough. Neither the patient\\'s own medical history nor that of her family contained details of any specific disorder. Both her birth weight (3850 gr) and her birth length (58 cm) were considered normal. Prior to that admission to the hospital, she manifested no cognitive disabilities. She was diagnosed with having epilepsy with mental disorientation and she was treated with phenobarbitone, sodium valproate, and lamotrigine. Then, in 2010, she started having seizures: they would begin with nausea, impaired vision, and a loss of consciousness. During the seizures, her eyes were tightly closed and she exhibited no twitching of her legs nor her arms. After ten to thirty min, the patient would regain consciousness and would complain of feeling cold at the terminal part of extremities. Additionally, she would feel pain in her ankles, with bruising joints, after which the pain would progress towards her toes, followed by swelling and reddening. Magnetic resonance imaging (MRI) of the patient\\'s head showed no apparent changes in the structure of the patient\\'s brain. \\nDuring the third year following the onset of her symptoms and her first seizure, the patient experienced a different type of \"seizure\" during her sports class: she began to walk aimlessly and insecurely, with tottering, she had a fixed gaze, pale face, and was rambling (calling a friend by her name over and over again). However, she did not lose her balance and did not fall. In addition, she manifested no twitching of extremities. That particular \"seizure\" lasted for about ten minutes, after which she regained consciousness. However, following that particular seizure the patient failed to re-establish her previous state: she had absent gaze, difficulty using cutlery, she lost her sense in space and time, and she did not recognize her parents and people she previously knew around her. On one occasion, she had a generalized epileptic seizure.\\nIn July 2011, the patient experienced a sudden loss of consciousness, and she lost her balance and fell, her body becoming rigid and cyanotic, without twitching of the extremities, while her eyes were closed. At the time, the patient\\'s pupils were round, symmetrical, with proper response to light. Following recovery from this seizure, the patient had difficulty walking independently; she walked aided and her walk was atactic (suggesting a lack of muscle coordination), with significant deviation to the left. She also had difficulty in performing a walk on heels and toes and could not walk in a straight line. Dystonia of torso and extremities was present. Romberg was unstable, with a deviation to the left. Finger to nose test was abnormal (suggesting dysmetria). Gross motor abilities test was in order. Muscle tendon reflex (MTR) was symmetrical, live. Right, Babinski sign was positive. Lumbar puncture test, as well as findings of ophthalmologists and cardiologists, were without noticeable pathologies. Hormonal status of the patient was within the normal range. An electroencephalogram test (EEG) showed continuously discharging of the high voltage Delta Theta activity with interposed sharp and steep waves of high voltage and paroxysmal high voltage spikes, as well as multiple spike-and-wave discharges. During the stay at the hospital, the EEG registration did not change. The patient was subjected to additional MRI scans which revealed no apparent changes in the brain structure. Seizures were classified as visually partial twitches, eventually becoming myoclonic, and generalized tonic-clonic twitching. At this time, the patient exhibited evident cognitive deterioration. No cranial nerve deficits were present, but rapid irregular myoclonic twitches that were palpable at rest were present and were increased by voluntary movements of the upper limbs. There was no sign of Babinski. The patient was able to cooperate with the doctor during the examination. In addition, the patient was decelerated with a little verbal and motor activity.\\nGenetic testing was carried out in Genoa, Italy, on Mar 2013, from the DNA that was extracted from leukocytes of peripheral blood. Analysis of exons 1-4 of the EPM2A gene (NM_005670) and the single exon, exon 1, of the NHLRC1 gene (NM_198586), using direct sequencing, was performed. Multiplex Ligation-dependent Probe Amplification (MLPA) method was used to examine the genes and the genomic region that includes the region from exons 1 and 4 of the EPM2A gene and exon 1 of the NHLRC1 gene. The genetic testing identified that the patient is the carrier of the homozygous 1-bp deletion, 990G, within the NHLRC1 gene. Following the result of the genetic testing, clonazepam was included in the patient\\'s therapy. \\nIn July 2015, levetiracetam was added to the therapy. In May 2015, treacheostoma was placed, as well as percutaneous endoscopic gastrostomy. Currently, (Apr 2017), the patient is bedridden, in a continuous horizontal position, with the rapid irregular myoclonic twitches noticeable at rest, and increased by voluntary movements of the upper limbs. Furthermore, the patient also experiences frequent episodes of fever, which is insensitive to antipyretics.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 39,\n",
       "    'case_id': 'PMC10265348_01',\n",
       "    'case_text': 'A 39-year-old female physician visited the Occupational Health and Safety Office (OH&S) at the Faculty of Medicine Khon Kaen University (KKU) for counseling on her latex allergy problem. She had a history of two episodes of severe anaphylaxis due to latex exposure. In addition, she suffered from atopic dermatitis and controlled hypothyroidism since her childhood.\\nIn 2001, in a surgical rotation, she was routinely assigned to assist the surgeon in the surgical field for 4 h a day. She regularly wore powdered latex gloves five pairs per day. As a result, she developed on-and-off vesiculopapular rashes, mainly on the dorsal side of both hands. She then applied a topical corticosteroid to control the disease.\\nIn 2004, she worked as a physician and suffered from glove-related contact urticaria. Her skin manifestation was mostly wheal and flare on both hands and arms, with severe pruritic symptoms. She, therefore, decided to put on plastic gloves underneath the powdered latex gloves. However, the symptoms were commonly recurrent. As a result, she frequently used topical steroids to reduce her symptoms. In addition to the latex allergy, she developed allergic symptoms, including urticaria, itching, and flushing after contact with Kiwi, Jackfruit, Durian, Passion fruit, Mango, and Nam Wah Banana. However, she denied any skin prick test to confirm latex-fruit syndrome due to her previous anaphylaxis experience. In addition, as this patient is an internal medicine specialist, she confirmed her allergic reaction was caused by those fruits previously mentioned.\\nIn 2013, she underwent a pelvic examination and suddenly developed flushing, syncope, and facial angioedema. She was diagnosed with anaphylaxis and was administered intramuscular epinephrine, intravenous dexamethasone, and chlorpheniramine. Her symptoms resolved, and she had no complications after 24 h. Following this anaphylaxis episode, she opted for neoprene gloves to replace the latex gloves, albeit her employer did not have any occupational health procedures to support the replacement cost.\\nIn 2019, she underwent a computed tomographic (CT) colonography due to chronic constipation. Unfortunately, she developed a second anaphylaxis episode during the imaging immediately after rubber catheter insertion and prior to contrast media administration. She received emergency management for anaphylaxis and recovered without complications.\\nIn 2020, she was admitted to the clinical fellowship program at KKU. She sought counseling at OH&S for evaluation and specific occupational health management of her latex allergy. According to ImmunoCAP (Phadia, Uppsala):fluorimetric enzyme-linked immunoassay tests:her latex-specific IgE was 10.20 kUA/L with negative results on other atopic allergens. She has been diagnosed with latex allergy with a history of two episodes of latex anaphylaxis.\\nIn addition, OH&S has provided her with personalized occupational health programs, including personal synthetic glove replacements (i.e. nitrile and sterile neoprene gloves), preparation or prevention of possible recurrences (i.e. latex allergy labeling bracelets), and encouraging the use of non-powdered latex gloves among peer healthcare professionals to reduce airborne latex allergens. After these interventions, she has rarely experienced any allergic symptoms in the last 2 years.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 52,\n",
       "    'case_id': 'PMC6348196_01',\n",
       "    'case_text': 'A 52-year-old Lebanese woman presented to the emergency department of the American University of Beirut Medical Center (AUBMC) complaining of redness, pain and swelling at her pacemaker site on the upper left chest wall. The symptoms started one week earlier and had worsened over few days. She had no fever or chills that day. She was previously healthy except for an unclear history of an arrhythmia that occurred in 2005 necessitating the insertion of the cardiac pacemaker. The patient also complained of right breast pain, swelling and erythema of 3 days duration. Her primary care physician had prescribed amoxicillin-clavulanate for suspected mastitis. The patient also reported episodes of fever (temperature reaching 38.5  C) and chills especially at nighttime for about three months prior to this current illness. She denied localizing signs or symptoms at the time.\\nOn physical examination, the patient was hemodynamically stable and afebrile. Left chest wall erythema, induration and tenderness were observed. Erosion was noted at the skin overlying the pacemaker impulse generator and wires. The right breast was swollen, diffusely erythematous, and tender. No palpable masses were appreciated. The laboratory examination revealed a normal white Blood Cell count of 5400 per cu mm, (reference range: 4000-11000), polymorphonuclear cells were 50% (reference range: 40-65), and lymphocytes were 40% (reference range: 25-40). Her creatinine was 0.6 mg/dL (reference range: 0.5-1) but her C-reactive protein was elevated at 12.5 mg/dL (reference range: 0.0-2.5). A computed tomography scan of the chest wall with intravenous contrast revealed three well-circumscribed rim enhancing fluid collections in the right breast the largest measuring 1.9 x 2 cm. There was overlying skin thickening and associated subcentimetric right axillary lymph nodes. A collection on the left side of the chest wall over the site of the pacemaker was also noted.\\nOn the second day of admission, the pacemaker impulse generator and wires were removed. Purulent drainage was noticed in the pacemaker bed and sent for culture. The Gram stain showed numerous WBCs but no microorganisms. The patient received intravenous teicoplanin and amoxicillin-clavulanate empirically awaiting the culture results. An ultrasound-guided aspiration of the right breast abscess was also performed. The content was sent for microbiologic culture as well and cytologic evaluation to rule out an underlying malignancy. On the 5th day of admission, cultures from both the pacemaker bed and the right breast grew Brucella species. The titers for the direct serum tube agglutination (STA) as well as the indirect test (Brucella Capt., Vircell, Spain) were both >= 1:1280. Two sets of blood cultures done on VIRTUO Biomerieux blood culture automated system were negative.\\nUpon further questioning, the patient remembered eating unpasteurized cheese several months before. She also remembered an episode of breast tenderness, swelling and warmth after that. The symptoms resolved spontaneously but were followed by a period of night sweats and low-grade fever.\\nThe patient received intravenous gentamicin (240 mg intramuscularly daily) for two weeks along with rifampin (600 mg orally daily) and doxycycline (100 mg orally twice daily) for three months. At the end of her treatment, the patient reported marked improvement in her condition and complete resolution of the fever and chills. Four months later, the patient was asymptomatic, with normal physical examination. Repeat Brucella serology showed a decrease in the direct STA titer (1:320) and indirect Brucella titer (1:640). The repeated blood cultures were negative at 14 days of incubation and the breast ultrasound did not reveal a residual abscess.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 70,\n",
       "    'case_id': 'PMC10369060_01',\n",
       "    'case_text': 'A 70-year-old female with metastatic lung adenocarcinoma presented to the Emergency Department with new-onset headaches and retrosternal chest pain radiating to the right arm.\\nThe patient had stage IV lung adenocarcinoma with metastases to the pleura, pericardium, and mediastinal lymph nodes. She was on maintenance therapy with pembrolizumab and pemetrexed. She also had a history of atrial fibrillation on apixaban and had undergone pericardiocentesis earlier that same year after presenting with cardiac tamponade with a malignant pericardial effusion.\\nA CT scan of the head done in the ED disclosed new brain hypodensities concerning for brain metastasis. A subsequent MRI showed changes consistent with new multifocal embolic infarcts throughout the cerebral and cerebellar hemispheres, largest in the left cerebellar hemisphere and right temporal lobe.\\nDue to the presence of new multiple embolic infarcts, a transthoracic echocardiography (TTE) was then obtained and showed the presence of a small 7-8 mm soft mobile echodensity attached to the atrial surface of the mitral leaflet tips (Supplementary Video S1). Because of the underlying malignancy, NBTE was suspected but a diagnosis of subacute bacterial endocarditis could not be ruled out in the setting of immunosuppression. Blood cultures came back negative, and a workup for antiphospholipid syndrome was negative as well. A transesophageal echocardiogram (TEE) was done at our institution redemonstrating the soft mobile echodensity at the tip of both leaflets in a \"kissing-lesion\" appearance and measuring up to 1.1 cm in width. Moderate mitral valve regurgitation was noted (Supplementary Video S2).\\nLaboratory tests revealed an elevated high-sensitivity troponin level of 364 (up from a baseline of 44 previously) alongside new lateral ST depression at V4-V6 and new T-wave inversions on ECG. To further investigate the presentation of atypical chest pain with elevated troponins, a cardiac MRI demonstrated signs of myopericarditis.\\nBrain Metastasis, NBTE, Subacute bacterial endocarditis, Myxoma, Papillary fibroelastoma, NSTEMI, Myocarditis.\\nThe diagnosis of NBTE in the setting of a multifocal stroke with peri-infarct edema complicated the management plan of the patient due to the risk of hemorrhagic transformation of the ischemic stroke. The NBTE and subsequent strokes occurred despite adequate dosing and adherence to anticoagulation with apixaban. This was considered an apixaban failure.\\nAfter careful review and consideration by the multidisciplinary team and shared-decision making with the patient, a decision was made to transition the patient to parenteral anticoagulation immediately due to the high risk of recurrent embolization in the setting of apixaban failure. The patient was started on a lower dose of enoxaparin initially (40 mg BID subcutaneous) due to the concern of hemorrhagic transformation. The dose was titrated up to 1 mg/Kg twice daily (70 mg). Anti-Xa levels were checked 4 h after the 4th dose and demonstrated therapeutic levels of 1.01. A repeat CT of the head was performed after 2 therapeutic doses (70 mg) of enoxaparin to assess for hemorrhagic conversion of infarcts. She was discharged on therapeutic low molecular weight heparin (LMWH) therapy, and a TEE repeated after 4 weeks of therapy showed complete resolution of the NBTE (Figure 1, Supplementary Video S3).',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 3,\n",
       "    'case_id': 'PMC8268003_01',\n",
       "    'case_text': 'Sixty-three years old woman, suffering from Recurrent Depressive Disorder (F33). Patient is married with three children and does not suffer from psychiatric comorbidity including substance abuse. Physically, recurrent urinary tract infections were recorded on outpatient follow-ups by an urologist, no active infection was present during our research recruitment or follow-up. The patient does not take daily medications, other than the psychopharmacological treatment. The patient experienced her first MDD episode at the age of 39, and suffered from seven recurrent episodes since then. Each episode lasted between 4 weeks and several months, in two of the episodes she was severely depressed and required hospitalization and electroconvulsive (ECT) treatment. Between episodes as well as at the time of recruitment, she was in remission. Her psychopharmacological treatment at time of recruitment included PO TAB Sertraline 100 mg X 2/d, Mirtazapine 30 mg X 1/, Clonazepam 1 mg X 2/d, and P.O TAB Quetiapine XR 100 mg X 1/d. No recent changes in her medications was made.\\nShe was recruited as part of a long-term follow up study, including weekly WatchPAT device recording (which the investigators were blinded from), and a monthly clinical evaluation. WatchPAT is a wrist-worn device, designed for ambulatory Sleep Apnea tests, capable of detecting REM sleep through analysis of Heart Rate and Peripheral Arterial Tone. During our study, the patient placed the device on her wrist before going to bed, as well as placing a probe on her finger. During the night she slept with the device, and in the morning returned it to the box.\\nHer baseline MADRS score (used as inclusion criteria) was four, compatible with state of depression in remission. She was also evaluated for BDI-II score (used for follow up), with a result of six [cutoff score used to identify potentially clinically significant depression is 0-13 to indicate minimal or no depression; 14-19, mild depression; 20-28, moderate depression; and 29-63, severe depression ].\\nAfter signing the informed consent forms for participation in the study, she received a WatchPAT device, and began follow up.\\nHer first sleep study showed the following results, indicating normal sleep variables:REM Latency (min): 117, Sleep Latency (min): 15, Proportion of REM sleep 19.1%, Total Sleep Time 6 h 36 min (examples of data obtained from sleep tests in are presented in Figures 1, 2).\\nAs shown in Figures 3, 4, Rem Latency was gradually reduced over the following weeks, followed by a significant reduction to 53 min. At the same time, the BDI-II data obtained showed no significant change in self-report. She later complained of lack of energy and asked to stop using the monitoring watch. After a month of subsequent BDI-II follow-up, significant depressive recurrence was discovered and the study was discontinued. Of notice, in several consecutive follow-ups, the patient refused to change her medications, reporting only subjective feeling of anxiety, relating them to the Covid-19 crisis. She agreed to change her psychopharmacological treatment only a month later, and begun reporting subjective improvement. Interestingly during the Covid-19 crisis, she did not leave her house, therefore ambulatory sessions were done using telemedicine platform.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 3,\n",
       "    'case_id': 'PMC6350110_01',\n",
       "    'case_text': 'A 3-year-old boy was referred to our clinic for further investigation of a mass in the right hemithorax. Present illness started 5 days ago with fever, cough and wheeze that complicated with and signs of respiratory distress (tachypnea, intercostal retractions) two days later. A chest X-ray was performed showing a giant soft tissue, well-demarcated, well - demarked mass in the right hemithorax expanding and splaying the adjacent ribs, Fig. 1. The mass was an incidental finding in the chest X-ray, as the mass was not visible, nor palpable on examination. Complete Blood Count examination was within normal limits. Signs of respiratory distress gradually resolved after the administration of inhaled bronchodilators and systemic steroids (methylprednisolone). Contrast enhanced CT images revealed a large lobulated, well defined, predominantly fatty mass originating from the chest wall. The lesion was seen to be invading between the ribs with extension into the thorax and into the overlying muscles of the thoracic wall. Inside the fatty mass there where thick enhancing septations with some nodularity. There were no calcifications. Fig. 2.\\nAbdominal ultrasound was performed with normal findings. Magnetic Resonance Imaging (MRI) showed a large heterogeneous, lobulated mass in the right posterolateral thoracic wall, measuring 7,1 x 6,3 x 6,8cm. The mass contained mainly high-signal; material identical to that of subcutaneous adipose tissue in all sequences. Inside the mass there were low-signal, non-enhancing streaks probably representing fibrous tissue. There was also a mild enhancing area with high signal on T2 images probably representing myxoid cystic changes. Fig. 3. I n this patient age group the imaging findings were highly suggestive of thoracic wall lipoblastoma. Biopsy of the extrathoracic part of the tumor confirmed the diagnosis of also revealed lipoblastoma. A week later, excision of the tumor through a right posterolateral incision at the level of the fifth rib took place. The arch of the 5th rib was removed and the extrapleural part of the mass was excised. The pleura was opened and the intrapleural part of the tumor was exposed extending from the apex of the right lung to the level of the 7th rib and to the midline. The upper and the medial lobe of the lung were compressed towards the midline. Gradual removal of the tumor due to its friability took place. Finally, full excision of the tumor was managed, the lung was decompressed and a thoracic drain was left at the area of the removed mass.\\nPostoperatively, the patient was stable and had an uncomplicated course. He was discharged on the 7th postoperative day with instructions. Three and six months later, on the follow up visit the boy was asymptomatic.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 25,\n",
       "    'case_id': 'PMC5111013_01',\n",
       "    'case_text': \"A 25-year-old male student presented with pain and swelling of the right index finger following catching it in another player's T-shirt while playing rugby. On examination, he was unable to flex his distal interphalangeal joint (DIPJ). Plain radiographs revealed an avulsion fracture of the distal phalanx retracted back to the level of proximal interphalangeal joint (PIPJ).\\nDescribe a classification system for zone I flexor tendon injuries.\\nWhat are the options for repair of zone I flexor tendon injuries?\\nWhat are the possible complications of zone I flexor tendon repairs?\\nWhat is the importance of postoperative hand therapy?\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 75,\n",
       "    'case_id': 'PMC9719080_01',\n",
       "    'case_text': 'A 75-year-old male presented with six weeks of colicky abdominal pain associated with constipation. He has hypertension, hypercholesterolaemia, asthma and is an ex-smoker. He had a previous open cholecystectomy, and his last gastroscopy and colonoscopy were normal.\\nHe has not had any previous presentations with abdominal pain. He has had multiple gastroscopies and colonoscopies in the past as part of the national bowel cancer screening program but however none of these showed any evidence of colitis, malignancy or any other concerning lesions.\\nThe patient did not have aggravated pain, it was similar to what he was experiencing for the last 6 weeks. He had clinical signs of a partial small bowel obstruction at that stage such as not passing bowel motions, only passing flatus and being symptomatic for nausea.\\nHe was afebrile, tachycardic and normotensive on arrival at the hospital. His abdomen was soft and tender centrally but had nil peritonism. He had normal white cell count, C-reactive protein, and lactate. The abdominal CT scan (diagnosed by a board certified consultant radiologist) showed dilated jejunal loops with an abrupt transition in the mid-abdomen caused by a short intussusception. The leading edge of the intussuscepted bowel had an irregular outline, which was suspicious for a small mucosal mass of approximately 2.5 cm, acting as a lead point. Distal to the intussusception, the small bowel loops and colon were collapsed (Fig. 1A, B, C and D).\\nHe was resuscitated with intravenous fluids, and a nasogastric tube was inserted given the evidence of dilated small bowel loops on CT and signs of a partial bowel obstruction. About 60 ml of gastric content was aspirated initially. He was given adequate analgesia and antiemetics. The decision was made to perform surgery due to the suspicion of presence of a small bowel mass on CT leading to transient intussusception along with clinical signs of a partial small bowel obstruction.\\nThe case was commenced laparoscopically, however due to nil visualisation of the suspected mass noted on CT, a mini-laparotomy was performed. There were omental adhesions to the RUQ from a previous laparoscopic cholecystectomy. The small bowel loops were not dilated. A small bowel run was performed from Ligament of Treitz (duodenojejunal flexure) to terminal ileum and it was completely normal. There was no significant dilatation, masses or intussusception. There was also no evidence of Meckels diverticulum. Other intraoperative findings included diverticulosis of sigmoid colon.\\nThere were no immediate post-operative complications. He tolerated his diet and was discharged home after two days.\\nA follow up was organised with his GP on discharge. Upon my conversation with the patient recently, his pain had improved since the procedure and has been taking laxatives regularly as advised. He has had no such similar episodes of pain post operatively.\\nHis most recent gastroscopy and colonoscopy were normal. Given he has been asymptomatic on discharge, a plan was made to perform a MR Enterography if he does become symptomatic in the future.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 39,\n",
       "    'case_id': 'PMC7728115_01',\n",
       "    'case_text': \"A 39-year-old man presented to the Neurology Clinic for paralysis of the left arm and half of the left face of a transient nature. A diagnostic of transient ischemic accident and antiphospholipid syndrome was established and treated with acetylsalicylic acid and folic acid. During the physical examination, a thyroid nodule was detected in the right lobe. It showed good mobility on palpation. The ultrasound (US) study revealed a single solid hypoechoic nodule with well-defined limits and peripheral vascularization, in the lower pole of the right lobe, the major axis of which was 1 cm. This nodule was classified as Thyroid Imaging Reporting and Data System (TI-RADS) 4a. In addition, a slightly hypoechogenic polylobed lesion with no well-defined limits was detected in the middle third of the left lobe, 1.15 cm in maximum diameter. The lesion was also classified as TI-RADS 4a. No cervical enlarged lymph nodes were observed. Fine-needle aspiration cytology (FNAC) diagnoses were follicular neoplasia in the right lobe and follicular lesion of undetermined significance in the left lobe. The analytical study showed that the lesions in both lobes were non-functional.\\nAfter two years, the neurological symptoms had not recurred and antiphospholipid antibodies had normalized. Three years later, he presented with a sleep disorder that was classified as moderate supine apnea-hypopnea syndrome treated with automatic positive pressure in the airway. A year later, he consulted for a Bennett fracture of the left hand without displacement that was treated with immobilization. A new US study of the thyroid revealed that the lesions had slightly increased in size. The nodule of the right lobe measured 1.5 cm of maximum axis and that of the left lobe 2 cm. The TI-RADS rating scale remained the same for both lobe lesions. The new cytological diagnoses were similar to the previous ones. An otorhinolaryngological study showed no abnormalities. The patient underwent total thyroidectomy six years after the first consultation. Postoperatively, there were no complications. Blood calcium and parathyroid hormone (PTH) levels were normal. Both thoracoabdominal and abdominopelvic computed tomography scans with contrast showed no significant changes. The patient was doing well three months after the intervention.\\nCytopathological findings\\nFNACs were performed on the patient with US control. The cytological smears were fixed in an ethanol solution or air dried and stained with the Papanicolaou (Pap) and Diff-Quik methods. FNAC of the right lower lobe revealed moderate cellularity. There were groups of clear cells or microfollicular structures with a diffusely vacuolated cytoplasm (Figure 1A). The cell borders were moderately defined. The nuclei were round, hyperchromatic, with homogenous chromatin, and visible single nucleoli. Modest nuclear anisokaryosis was identified. Nuclear pseudoinclusions or grooves were no present. Colloid was very scant. Based on these findings the successive diagnoses in two samples were follicular neoplasia (Figure 1, B and C). FNAC of the left lobe showed moderate cellularity with follicular cells in plates and little colloid. Some cells showed irregular nuclei with grooves. Lymphocytes were seen in the background of the smears. The cytological diagnoses in two samples were follicular lesion of undetermined significance.\\nHistopathological findings\\nThe thyroid weighed 20 g and measured 7x5x3 cm. The right lower lobe contained a 2 cm diameter encapsulated, solid, pale tan, fleshy, nodular lesion (Figure 2). The left lobe showed two brown, non-encapsulated, poorly circumscribed nodules measuring 2 cm and 0.3 cm located in the middle zone.\\nThe entire surgical specimen was fixed in 10% neutral buffered formalin. Representative tissue samples were embedded in paraffin. For routine microscopy, 4-mum-thick sections were stained with Hematoxylin and Eosin (HE), Alcian Blue (pH 2.5), Periodic Acid-Schiff (PAS), PAS-Diastase digestion method, and Mayer's Mucicarmine method. Immunohistochemical (IHC) staining was performed using the EnVision FLEX+ Visualization System (Dako, Agilent Technologies, SL, Las Rozas, Madrid, Spain). The IHC reaction was performed using appropriate tissue controls for the antibodies utilized. Automatic staining was accomplished on a Dako Omnis stainer (Agilent Technologies, SL). Antibodies used are detailed in Table 1.\\nThe nodular lesion of the right lobe was well circumscribed, with a thin smooth capsule of fibrous connective tissue (Figure 3A). The cells were grouped in solid areas showing a diffuse, trabecular, or nesting pattern of growth (Figure 3B) with occasional formation of microfollicular structures with central lumen surrounded by clear cells (Figure 4A). The lumens contained PAS-positive colloid (Figure 4B). These cells were large, round to polyhedral, with an abundant clear cytoplasm showing an extremely fine granularity due to fine vesicles. Negative Alcian Blue and Mucicarmine stainings in these cells excluded the presence of mucin. The PAS staining accentuated the cytoplasmic granularity (Figure 4B) and this reaction was diastase resistant indicating the absence of glycogen. The nuclei were central, regular, often with visible nucleoli. The vascularity within the lesion was not prominent. After multiple sections, there was no evidence of multi-nucleated giant balloon cells, spindle cell component, necrosis, mitoses, and extracapsular growth or vascular invasion.\\nThe IHC panel revealed the tumor cells positive for pan-cytokeratin (CK) AE1/AE3 (Figure 5A), thyroglobulin (TGB) (Figure 5B), paired box gene 8 protein (PAX8) (Figure 5C), and thyroid transcription factor-1 (TTF-1) (Figure 5D), whereas no immunoreactivity was seen for renal cell carcinoma marker (RCCM), cluster of differentiation 10 (CD10), carbonic anhydrase IX (CAIX), anti-mitochondrial antibody (AMA), PTH, p53 protein, anti-human melanosome [human melanoma black 45 (HMB45)], S100 protein, and smooth muscle actin (SMA). The Ki67 index was around 1%. A diagnosis of complete clear cell change in follicular adenoma of the thyroid was made. Besides, intrathyroidal ectopic parathyroid without histological abnormalities was also found in the right lower lobe. The nodules of the left lobe corresponded to conventional hyperplasic nodules.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 46,\n",
       "    'case_id': 'PMC8554224_01',\n",
       "    'case_text': \"The patient was a 46-year-old man with a history of recurrent cough, expectoration, and a 3-year history of progressive dyspnea. Before admission to our hospital, he was diagnosed with chronic bronchitis and bronchiectasis at other hospitals and had received antibiotic treatment numerous times. Despite antibiotic treatment, his symptoms progressively worsened such that he required oxygen therapy and ECOG performance status of him was 4. A physical examination revealed that his respiratory rate was 25 cycles per minute. Moreover, diffuse wheezing could be heard in both the lung fields. Laboratory findings included leukocytosis (11.52 x 109/L) and significantly reduced partial pressure of oxygen (63 mmHg). Arterial blood gas analysis revealed an oxygen uptake of 3 L/min. We also have conducted related inspections to rule out systemic involvement. Results of tests for liver and kidney function, myocardial enzyme levels, NT-proBNP, and troponin levels were unremarkable, and no proteinuria was found on 24-h urine analysis. Color Doppler echocardiography showed normal cardiac structure. No abnormalities were found in gastrointestinal endoscopy. The results of the PPD test were negative, as were all sputum samples for bacteria, acid-fast bacilli, and fungi. The patient's lung function test revealed obstructive dysfunction of pulmonary ventilation with a severe reduction in small airway function, and his bronchodilator test result was negative.\\nChest computed tomography (CT) revealed that the tracheal walls and bronchi were extensively uneven to different degrees and exhibited luminal stenosis (Figures 1A,B). Electronic bronchoscopy revealed completely irregular and thickened bronchial mucosal surface with prominent nodes accompanied by a small amount of white secretion (Figure 1C). The lumen of the right middle bronchus exhibited extreme narrowing, and pathological examination of the tracheal mucosal biopsy specimen at the site of narrowing revealed mucosal calcification and fibrous hyperplasia with deposition of kappa light chain, as well as the following: PAS stain (-), acid-fast staining (-), and Congo red stain (+) (Figure 1F).\\nSerum electrophoresis showed a monoclonal spike, although immunofixation electrophoresis (IFE) revealed a double monoclonal component: IgA kappa and IgG kappa (Figures 1D,E). Serum immunoglobulin A (IgA), IgM, and IgG levels were 1.48 g/L (0.7-4.0 g/L), 0.62 g/L (0.4-2.3 g/L), and 5.23 g/L (7.0-16.0 g/L), respectively. The free kappa and lambda light chain levels were 15.8 mg/L (normal, 6.7-22.4 mg/L) and 17.8 mg/L (normal, 8.3-27.0 mg/L), respectively, with a normal kappa/lambda ratio of 0.888 (normal, 0.31-1.56). Bone marrow cytology revealed an irregular monoclonal plasma cell population (CD45+, CD38+, CD138+, CD200+, and ckappa+), representing 0.86% of the total leukocytes.\\nThe patient underwent further examinations to determine the extent of systemic involvement. Echocardiography revealed no signs of myocardial involvement. Skeletal osteolytic lesions, organomegaly, and neuropathy were absent. Blood biochemistry revealed normal levels of creatinine, liver enzymes, and alkaline phosphatase. Based on the comprehensive evaluation described thus far, the patient was diagnosed with localized amyloidosis given the observed lack of extrapulmonary organ involvement.\\nThe broad endobronchial manifestations enabled the performance of endoscopic resection of the amyloid masses under combined rigid and soft bronchoscopy guidance. The patient underwent rigid bronchoscopy with argon plasma coagulation (APC) and Nd:YAG laser debridement for the treatment of his endobronchial obstruction. However, this did not improve the patient's dyspnea with massive expectoration. Therefore, we attempted to relieve his persistent endobronchial obstruction by initiating external beam radiation therapy (EBRT) at a dose of 20 Gy in 10 fractions of 2 Gy each. However, the patient's dyspnea showed no significant improvement at 3 months after the EBRT. Another bronchoscopy revealed progression of the tracheobronchial lesions due to the endobronchial situation. Subsequently, he experienced an aggravation of dyspnea, developed an inability to move, and reported poor quality of life.\\nThe patient then consulted with our hematology department. Although he had not previously received systemic treatment for local amyloidosis, we noticed that local treatment could not alleviate his symptoms or delay the disease progression. Therefore, given his strong desire for treatment, we administered systematic chemotherapy. He was treated with one cycle of CyBorD [subcutaneous (SC) bortezomib: 1.3 mg/m2 on days 1, 4, 8, and 11; intravenous (IV) cyclophosphamide: 300 mg/m2 on days 1-4; IV dexamethasone: 20 mg on days 1-4 and 8-11]. Interestingly, the patient's symptoms of dyspnea improved significantly after treatment. In addition to a decrease in sputum volume, he began to perform simple daily activities, and evidence suggested functional improvements in oxygenation and spirometry findings (Table 1). However, follow-up bronchoscopy and chest CT performed 1 month later revealed no improvements in the obstruction. After one cycle of treatment, there was minimal secretion, the patient did not require inhaled oxygen, and he could walk independently. The patient has completed three cycles of treatment, and the ECOG performance status is 0. The patient exhibits good tolerance to CyBorD regimen, and no treatment-related adverse reactions such as peripheral neuritis, infectious disease and bone marrow suppression have occurred. The patient's ECOG score is reduced from 4 to 0 which shows an improvement of life quality, and the pulmonary function test results show that obstructive ventilatory disorder is improved. The patient is evaluated a validated organ response.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 61,\n",
       "    'case_id': 'PMC10202565_01',\n",
       "    'case_text': 'A 61-year-old man with a 20-year smoking history and peripheral arterial disease presented to his regional hospital with left lower extremity weakness, aphasia, and worsening dyspnea. Magnetic resonance imaging (MRI) confirmed right middle artery cerebral stroke as well as 85% stenosis of the right internal carotid artery (ICA). An uptrending troponin-I to 3.510 ng/mL prompted the diagnosis of non-ST elevation myocardial infarction and immediate cardiac catheterization followed. Cardiac catheterization revealed 70% left main coronary artery stenosis and complete occlusion of the distal right coronary artery. Two days after catheterization, the patient went for right ICA endarterectomy and two-vessel CABG with left internal mammary artery (LIMA) to left anterior descending artery and saphenous vein graft to obtuse marginal along with mitral valve repair with a 28-mm annuloplasty Physio II Ring (Edwards Lifesciences, Irvine, California, United States). The patient was supported with inotropes, vasopressors, and intra-aortic balloon pump postoperatively.\\n On postoperative day 6, a chest computed tomography scan performed due to respiratory distress revealed a potential LVPA. Subsequent transesophageal echocardiography (TEE) identified an outpouching of the basal inferolateral left ventricular wall as well as a supra-annular and posterolaterally dehisced mitral annuloplasty ring. The patient was subsequently transferred to our institution, where noncontrast cardiac MRI confirmed the finding and identified a significant amount of layered thrombus. A repeat TEE at our institution further characterized the dehisced mitral ring as well as the LVPA contained by the posterolateral pericardium ( Fig. 1 ). The patient subsequently underwent redo sternotomy for repair of the LVPA repair along with MVR ( Fig. 2 ). \\n During surgery, the right ventricle was found to be densely adhered to the sternum likely from severe pericarditis due to residual intrapericardial blood. The LIMA was identified and prepared for temporary occlusion during the cardioplegic arrest. After standard bicaval cardiopulmonary bypass was established and cardioplegic arrest, the left atrium was opened, and the mitral valve was inspected. The dehisced annuloplasty ring was removed, and the whole posterior leaflet was detached from the annulus. The LVPA neck measuring 8 x 6 cm was identified under the P3 area of the annulus and extending toward the lateral commissure. The anterior leaflet was detached from the annulus, and while preserving all chords, the A2 segment was divided in the middle separating it into medial and lateral portions in preparation for total chordal-sparing MVR. Given that the pseudoaneurysm defect was much larger than the orifice of the mitral valve, it was apparent that bovine patch repair via intracardiac approach would not be feasible even if all mitral leaflets were detached. We therefore decided it was necessary to patch the pseudoaneurysm via an external approach. The 12 x 10 x 9 cm pseudoaneurysm was first exposed and incised. Subsequently, a large amount of thrombus was removed with great care to avoid any fragmentation. The pseudoaneurysm wall was then carefully cleaned of all thrombi with high power suction with an open-ended tip ( Fig. 3A ). The neck of the pseudoaneurysm was patched on the posterior aspect of the heart using a bovine pericardium patch and sewn to the underside of the mitral annulus extending to the anterior and medial aspects of the ventricle ( Fig. 3C ). The remaining flaps of the pseudoaneurysm were excised and closed by suture. \\n In repairing the mitral annulus, chordae tendineae were spared to support the posterior annulus with parts of the anterior and posterior leaflets and to maintain left ventricular structure. Pledgeted sutures in a noneverting manner were placed from the ventricular side to the atrial side at the level of the A3-P3 commissure ( Fig. 3D ). Sutures were placed through the patch and the annulus was sized to accommodate a new 29-mm pericardial Magna Valve (Edwards Lifesciences). The sutures were secured, and the atrium was closed. The cross-clamp time was 180 minutes, and total cardiopulmonary bypass time was 267 minutes. Final postoperative TEEs confirmed successful closure of the LVPA, normally functioning mitral valve prosthesis, and an ejection fraction of 50%.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 49,\n",
       "    'case_id': 'PMC4898297_01',\n",
       "    'case_text': \"A 49 year-old woman presented with severe, sudden, sharp pain in her right elbow after performing triceps exercises. The pain decreased from a 7/10 to 3/10 severity over the course of one week. However, the patient noted increasing bony prominence over her right lateral elbow. On physical examination, there was a tender bony prominence over the lateral epicondyle. Bilateral elbow radiographs demonstrated hyperostosis, especially involving the proximal ulnas, bilateral triceps tendon insertions, and the right lateral humeral condyle (Figure 1, Figure 2, Figure 3). No fracture, dislocation, joint effusion, or radiographic evidence of triceps tendon tear was evident in the right elbow (Fig. 3).\\nAlthough no prior elbow radiographs were available for comparison, radiographs of the thoracic spine from two years prior also showed flowing ossification of the anterior longitudinal ligament with relatively maintained disc spaces (Fig. 4). An AP radiograph of the pelvis from one year prior showed multiple sites of hyperostosis, including at the iliac crests (Fig. 5).\\nInitial differential-diagnostic considerations included diffuse idiopathic skeletal hyperostosis (DISH) or sports activity requiring bilateral overhead throwing. Investigation of recent clinical notes revealed a history of autosomal recessive congenital icthyosis (lamellar icthyosis) requiring long-standing treatment with 13-cis-retinoic acid. Although the patient's radiographic findings are in keeping with DISH, her young age and long history of retinoic acid therapy strongly suggest retinoic acid arthropathy as the correct diagnosis.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 52,\n",
       "    'case_id': 'PMC4309504_01',\n",
       "    'case_text': 'A 52-year-old woman with a history of multiple episodes of paroxysmal supraventricular tachycardia underwent electrophysiologic studies and a catheter ablation procedure. The 12-lead electrocardiogram during tachycardia showed a long RP tachycardia with negative P waves in leads II, III, and aVF. At baseline, dual atrioventricular (AV) and ventriculoatrial (VA) nodal conduction was elicited by atrial and ventricular premature stimulation. During intravenous administration of isoproterenol, the earliest site of atrial activation during ventricular pacing was observed near the His bundle, and a previously recorded narrow QRS tachycardia was reproducibly induced by premature or rapid ventricular apical pacing, with an initial V-A-A-V activation sequence (Fig.1). During tachycardia, the HA and AH intervals measured 71 and 342 milliseconds, respectively, and the earliest atrial activation was recorded at the ostium of the coronary sinus (CS). The earliest first \"A\" of the initial \"V-A-A-V\" activation sequence was recorded in the His bundle region, reflecting conduction over a fast pathway (FP), as was observed during ventricular pacing, while the second \"A\" was recorded near the CS ostium, as was observed during the tachycardia. The interval between the first and second \"A\" was often shorter than the subsequent tachycardia cycle length. Premature ventricular stimuli delivered during tachycardia while the His bundle was refractory did not reset the atrial cycle. From these observations, what is the mechanism of tachycardia?',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 0,\n",
       "    'case_id': 'PMC8493334_01',\n",
       "    'case_text': \"A 7-month-old boy was referred to the Second Affiliated Hospital (also known as Yuying Children's Hospital) of Wenzhou Medical University after identification of an intracranial lesion by magnetic resonance imaging (MRI) scans that had been performed 12 days postnatally at a local hospital. He was born at full-term after an uneventful pregnancy by normal spontaneous vaginal delivery. At birth, he weighed 3.8 kg and was 50 cm in length. Physical examination on admission to our hospital revealed faltering growth (6.0 kg and 58 cm) [WHO criteria at this age is 6.7-10.3, 8.3 kg (+- 2 standard deviation, 50th percentile) and 64.8-73.5, 69.2 cm (+- 2 standard deviation, 50th percentile)]. There were also dysmorphic features including left-hand polydactyly, syndactyly (Figure 1a) and a reducible omental hernia (1.5 x 1.5 cm). Flexible bronchoscopy showed bifid epiglottis, tracheal diverticulum, and laryngomalacia (Figures 1b,c). Neurological examination showed a normal muscle tone, strength, and reflexes. Endocrinology evaluations of pituitary, thyroid and cortisol hormones were within normal range. However, his parents reported that patient experienced frequent attacks of inappropriate laughter which suggested features of gelastic seizures. Unfortunately, electroencephalography was not available for such a small child to provide more objective evidence of seizure activities.\",\n",
       "    'gender': 'Male'},\n",
       "   {'age': 0,\n",
       "    'case_id': 'PMC8493334_02',\n",
       "    'case_text': \"Computed tomography (CT) and MRI scans showed a suprasellar hypothalamic lesion suggestive of a hamartoma (Figures 1d-f). Surgery was performed because of parents' concerns over the faltering growth. The intracranial lesion was partially resected via transcallosal anterior interforniceal approach through the space between the internal carotid artery and optic nerve, and part of the tumor was left to avoid injuring the hypothalamus. The intraoperative diagnosis was hamartoma, and tumor samples were sent for histopathological and molecular testings. Postoperative course was uneventful, and repeated CT and MRI confirmed some residual tumor (Figures 1g,h). Patient was discharged 2 weeks later, and follow-up MRI 1 year later showed subtotal removal of the tumor (Figure 1i). Since the operation, he experienced normal growth without signs of gelastic seizures. At the clinical follow-up when he was 20-months-old, patient showed recovery of growth velocity (12 kg weight and 70 cm height). MRI at this time showed the residual tumor to be of a stable size and to be located in the tuber cinereum.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 53,\n",
       "    'case_id': 'PMC7533312_01',\n",
       "    'case_text': 'A 53 year-old Caucasian female with history of sleep apnea and acid reflux presented with gradual swelling of her forehead for 3 months. She denied having any history of chronic sinusitis or illicit drug use. She did smoke tobacco, 1 pack per day for 30 years. About 6 months prior to presentation, the patient had undergone a tooth extraction; shortly thereafter that she developed symptoms of sinus pressure and congestion. She was initially treated with multiple courses of antimicrobials and steroids for presumed sinusitis without improvement. About three weeks prior to presenting, the patient underwent sinus surgery and was placed on oral levofloxacin for five days. No cultures were obtained at that time.\\nAbout a week after surgery, the patient started to develop fevers, chills and worsening headache. She reported that while she did have forehead swelling prior to surgery on her sinuses, it became much more pronounced post-operatively. Three weeks after surgery the patient had a CT head that revealed a peripherally enhancing fluid collection measuring 3.1 cm x 5.9 cm along the right frontal scalp in close proximity to the frontal sinuses and enhancement of the frontal subdural space. MRI head confirmed the findings (Fig. 1). The patient underwent surgical debridement of the abscess with frontal sinus trephination. Cultures were obtained, which grew Actinomyces naeslundi. Due to history of being allergic to penicillin the patient was treated with intravenous (IV) ceftriaxone for 9 weeks and then transitioned to oral doxycycline for a total of 6 months of therapy. At 6 month follow up, her symptoms and radiological abnormalities had resolved.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 72,\n",
       "    'case_id': 'PMC8077640_01',\n",
       "    'case_text': 'Candidiasis can be found throughout the world. The incidence of the disease is the same in men and women. This disease can affect all ages increases in infants and elderly. Cutaneous candidiasis is divided into two types namely intertriginous and granulomatous candidiasis. In intertriginous candidiasis, lesions occur on the skin folds of the armpits, groin, intergluteal, breast fold, between fingers or toes, glans penis, and umbilicus in the form of streaks that are demarcated, scaly, wet and erythematous. Lesions are surrounded by dots in the form of small vesicles and pustules or bullae that leave erosive areas. On the other hand, granulomatous candidiasis is more common in children and presents as reddish papules covered in thick brownish yellow crusts and are firmly attached to the base. This lesion may appear like a 2cm long horn and can often be found on the face, head, nails, body, and legs. We report a case of cutaneous candidiasis caused by Candida kefyr in a 72-year-old woman who responded well to topical antifungal therapy.',\n",
       "    'gender': 'Female'},\n",
       "   {'age': 72,\n",
       "    'case_id': 'PMC8077640_02',\n",
       "    'case_text': 'A 72-year-old woman was consulted to the Wahidin Sudirohusodo Hospital, Makassar, South Sulawesi, Indonesia, with a chief complaint of blackish red spots on the posterior trunk since one day before admission. The initial lesion was unknown. Complaints of itching is unknown due to patient s decreased of consciousness state. The patient had a long history of immobilize for 14 days. History of similar complaint from the family was denied. History of diabetes mellitus was absent. Patient had a history of syphilis with HIV infection and got therapy of intramuscular injection 2.4 million unit of benzathine penicillin G for three consecutive weeks. He was also treated with antiretroviral therapy (ART) with tenofovir 300mg, lamivudine 300mg, and efavirenz 600mg.\\nPhysical examination showed blood pressure of 100/80 mmHg, heart rate of 80 beats per minute, respiratory rate of 18 beats per minute, and temperature 36.5 C. Laboratory blood tests were within normal limits. Neurologic examination showed decreased awareness and lateralization of both sides. Dermatological examination of the posterior trunk region found hyperpigmented macules accompanied by crust, squama and erythematous macules (Figure 1). Based on the history taking and physical examination, the patient was diagnosed with sepsis, suspected meningoencephalitis, hypoalbuminemia, community-acquired pneumonia, and cutaneous candidiasis. The patient was given citicoline 500mg/12 hours/IV, omeprazole 40mg/12 hours/IV, ceftriaxone 2gr/12 hours/IV, vancomycin 1gr/12 hours/IV, vitamin B complex 1gr/24 hours/intravenously, acetazolamide 250mg/12 hours/nasogastric tube, and paracetamol 1gr/8 hours/intravenously. Topical fusidic acid cream was also applied on ulcerative lesions to avoid bacterial superinfection. For the cutaneous candidiasis, patient was treated with miconazole cream twice daily in the morning and evening and fusidic acid cream for 14 days. Direct microscopic examination using 10% potassium hydroxide (KOH) and culture were done to for further investigation on the causative agent. Direct microscopic of the skin scrapings on the back using 10% KOH showed clustered spores and pseudohyphae (Figure 2). Culture in Sabouraud Dextrose Agar (SDA) media added with chloramphenicol incubated at 25 -30 C showed mucoid brownish white colonies with smooth surfaces on the third day (Figure 3), typical of the fungus Candida sp. One week later, gram staining was carried out and positive purple color mildews were obtained (Figure 4). There were yeast cells and budding spores which were consistent with candida species. Further examination was carried out using carbohydrate fermentation to determine the type of candida which showed a change in color from purple to orange in glucose, sucrose, and lactose and gas formed in each of the reagents (Figure 5). The findings from carbohydrate fermentation test supported Candida kefyr as the causative agent (Table 1).\\nData from the history taking, physical examination, and supporting examinations concluded a diagnosis of cutaneous candidiasis caused by Candida kefyr. On the fifth day of treatment the lesion showed marked improvement (Figure 6). Fusidic acid was dropped and only miconazole was continued. The patient was eventually discharged from the neurology department on the sixth day.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 23,\n",
       "    'case_id': 'PMC5778723_01',\n",
       "    'case_text': 'A 23-year-old male presented to his primary care provider (PCP) in March 2006 with headaches, blurred vision, and diplopia. A computed tomography (CT) scan indicated mild ventricular dilation and a possible mass lesion in the region of the upper, anterior, third ventricle which was approximately 11 mm in size. A follow-up MRI revealed a hyperintense mass in the region of the foramen of Monro without significant obstructive hydrocephalus suggestive of a colloid cyst of the third ventricle measuring 11.2 mm in diameter. There was additional evidence of a pineal cyst measuring 6.34 mm. The patient was referred to our clinic in regards to operative treatment of the colloid cyst. Stereotactic aspiration of the cyst, followed by radiosurgery a week later was recommended and scheduled.\\nAccordingly, utilizing the Leksell frame and transaxial MRI scan of the brain without contrast [Figure 1, Left], the X-Y-Z coordinates for the target were calculated. Aspiration of the colloid cyst was performed with a 2.1-mm Sudan needle. Point of entry in the skull was just anterior to the right coronal suture and 2 cm to the right of the midline. A whitish mucoid material was then aspirated from the colloid cyst and sent to pathology. A postoperative CT scan did not reveal any residual proteinaceous material within the anterior third ventricle. The patient was discharged home the following day in excellent condition.\\nThe patient initially declined postoperative radiosurgery. Approximately 6 weeks following stereotactic aspiration of the colloid cyst the patient returned for a follow-up MRI. The MRI indicated a colloid cyst in the region of the foramen of Monro now measuring 5.5 mm in greatest diameter. The patient was again consulted by the radiation oncologist for the possibility of undergoing stereotactic radiosurgery for the recurrent cyst, however, he again elected to go home and discuss it with his friends and family before making a final decision.\\nApproximately 10 weeks following stereotactic aspiration of the colloid cyst the patient elected to undergo stereotactic radiosurgery of the colloid cyst. The patient was subsequently scheduled to undergo stereotactic radiosurgery 14 weeks after the initial aspiration. Previous MRI scans were used for three-dimensional (3D) treatment planning. Treatment was carried out uneventfully with the Novalis LINAC system (Westchester, IL). The head was mobilized by the stereotactic frame. The total prescribed single dose was 18 Gy delivered with a 6-mm collimator and six arcs.\\nSix months following stereotactic radiosurgery the patient underwent a follow-up MRI [Figure 1, Right] which revealed a lesion consistent with of a colloid cyst of the third ventricle measuring 7.3 mm in greatest dimension. The patient declined follow-up MRI but has reportedly remained asymptomatic since treatment for the last 10 years.',\n",
       "    'gender': 'Male'},\n",
       "   {'age': 50,\n",
       "    'case_id': 'PMC5778723_02',\n",
       "    'case_text': 'The second patient was a 50-year-old woman who presented in October 2006 with numbness in her feet and a history of depression. Previous nerve conduction studies were normal. Due to a familial history of multiple sclerosis, an MRI was recommended. The MRI [Figure 2, Left] was significant for a 12-mm lesion at the anterosuperior aspect of the third ventricle in the region of the foramen of Monro suggestive of a colloid cyst. In January 2007, the patient presented again with severe headaches, dizziness, and memory loss associated with name recall difficulty for the past 5 days. At this point stereotactic aspiration of the colloid cyst was discussed and it was decided that the patient would be admitted to undergo this procedure. Stereotactic aspiration of the colloid cyst was performed, as described in case #1. Postoperatively, the patient indicated that her headache had improved and the dizziness appeared resolved. Five days after stereotactic aspiration of the colloid cyst, the patient underwent stereotactic radiosurgery of the residual lesion of the colloid cyst. The stereotactic radiosurgery was again performed similar to the procedure for patient #1. Following a detailed planning (unable to be recovered) of the procedure the total prescribed dose of 16 Gy was delivered by 5 dynamic conformal arcs utilizing the Novalis micro multileaf collimator for field shaping and blocking to a single isocenter. Treatment was carried out uneventfully and the patient was discharged home with follow-ups scheduled. The most recent MRI [Figure 2, Right] taken in January 2013 showed no evidence of recurrence of the colloid cyst. The patient has remained asymptomatic.',\n",
       "    'gender': 'Female'},\n",
       "   {'age': 42,\n",
       "    'case_id': 'PMC5778723_03',\n",
       "    'case_text': 'A 42-year-old female with a significant history of depression with bipolar disorder initially presented to her family physician with complaints of headache, nausea, and vomiting over 2 weeks in January of 2009. An MRI [Figure 3, Left] revealed a mass measuring 7.7 mm x 7.2 mm within the anterior third ventricle at the foramen of Monro indicative of a colloid cyst. Stereotactic aspiration was carried out in a similar procedure as described above. Postoperatively, the patient stated that her headaches had markedly improved. The patient was then scheduled to undergo stereotactic radiosurgery for treatment of the residual cyst to prevent possible regrowth. A planning MRI [Figure 3, Right] revealed a reduction in ventricle size and no identifiable residual lesion of the colloid cyst. Based on the previous MRI, the stereotactic radiosurgical procedure was carried out in a fashion similar to that described above. A custom 5-arc radiosurgery plan with a 12.5-mm collimator using 16 Gy in a single fraction was developed and delivered to the isocenter utilizing the Novalis linear accelerator. Treatment was uneventful and the patient was discharged in excellent condition. The patient has remained asymptomatic since treatment. The patient has declined follow-up MRIs.',\n",
       "    'gender': 'Female'},\n",
       "   {'age': 29,\n",
       "    'case_id': 'PMC5778723_04',\n",
       "    'case_text': 'In June 2009, a 29-year-old female patient presented to her local clinic with complaints of headache, nausea, and vomiting. The patient had experienced migraine headaches since the age of 13. CT scan of the brain [Figure 4, Left] revealed that there was evidence of a hyperdense colloid cyst within the right third ventricle at the junction of the foramen of Monro with mild dilation of the right lateral ventricle. The patient was scheduled for stereotactic aspiration of the colloid cyst to be followed by stereotactic radiosurgery.\\nTwo weeks after aspiration, stereotactic radiosurgery was performed. The planning MRI revealed a small somewhat ovoid area of mixed signal intensity seen along the posterior-inferior margin of the septum pellucida in the expected area of the anterior roof of the third ventricle at a level corresponding to the foramen of Monro. These changes correspond with the area of increased attenuation on prior CTs with the size of residual lesion/cavity measuring 8.6 mm cephalo-caudad x 4.7 mm anterior-posterior x 5.7 mm transverse. The target was outlined, the isocenter was identified, and the total prescribed dose of 16 Gy was delivered by means of 7 dynamic arcs in a single fraction utilizing the Novalis micro multileaf collimator for field shape and field blocking. Treatment was uneventful and the patient was discharged in excellent condition. Three months following stereotactic radiosurgery of the colloid cyst lesion, the patient returned for a follow-up MRI (with and without gadolinium) which showed an area of approximately 6 mm of mixed signal at the anterosuperior aspect of the third ventricle in the region of the foramen of Monro. The appearance was not significantly changed from previous exams and there was no increase in fluid content. The most recent axial CT without contrast [Figure 4, Right] from October 2015 demonstrates that the previously noted hyperdense presumed colloid cyst is no longer present. Though it is well demonstrated the patient has been cleared of the colloid cyst she still experiences migraine headaches.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 22,\n",
       "    'case_id': 'PMC7034944_01',\n",
       "    'case_text': \"A 22-year-old male presented to the Emergency Department of a community medical center with abdominal pain for 1-2 weeks. He denied any hematuria, dysuria, flank pain, fevers, bone pain, anorexia, nausea, vomiting, or weight loss. His past medical history was negative for renal calculi or any chronic illnesses. He endorsed occasional smoking, but denied any hazardous or environmental exposures through his work in construction. An initial evaluation with a non-contrast CT of the abdomen and pelvis revealed a 19cm diffusely heterogeneous right renal mass. Further evaluation with an abdominal MRI confirmed the presence of a right renal mass, measuring 20.3 x 12.6 x 10.6cm, with both solid and cystic components (Figure 1). A chest CT identified multiple sub-centimeter lung nodules. Initial laboratory testing was unremarkable with the exception of a mild leukocytosis and 2+ blood on urine dipstick.\\nGiven this presentation and high suspicion for renal carcinoma, the patient was referred to a NCI-designated comprehensive cancer center for further evaluation and management of his large right renal mass. The patient was reviewed at our multidisciplinary tumor board and Pediatric Hematology/Oncology was asked to participate given the possibility of a Wilms tumor. He subsequently underwent a right open radical nephrectomy and was discharged on post-operative day 2.\\nTumor pathology demonstrated an extraosseous Ewing sarcoma/primitive neuroectodermal tumor with evidence of lymphovascular invasion and microscopic positive tumor at the soft tissue surrounding the vascular margin (R1 resection). Immunohistochemical staining revealed the neoplastic cells positive for CD99 and FLI-1. Cytogenetics showed EWSR1 gene translocation involving the chromosome 22q12. The morphology, immunoprofile and chromosomal aberration support the diagnosis of PNET. (Figure 2)\\nA PET/CT scan performed 2 weeks post-operatively showed residual FDG uptake in the area of the right kidney, but did not demonstrate any other significant hypermetabolic areas. The patient's subcentimeter lung nodules were considered metastatic disease based on clinical staging. A bone marrow biopsy was negative for metastatic disease. The patient enrolled in a clinical trial (NCT02306161) evaluating adjuvant chemotherapy consisting of vincristine/adriamycin/cyclophosphamide alternated with ifosfamide/etoposide in combination with ganitumab for patients with metastatic Ewing sarcoma. He also received 50.4 Gy radiation therapy to the right flank in addition to whole lung irradiation (WLI) to 15 Gy in 10 fractions. In efforts to minimize any overlap between the flank radiation and WLI, as well as minimizing secondary effects of radiotherapy, he was treated with proton beam therapy (PBT) to the flank (Figure 3).\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 65,\n",
       "    'case_id': 'PMC4073032_01',\n",
       "    'case_text': 'A 65-year-old man with a two-year history of a perianal fistula and recent worsening of symptoms underwent fistulectomy with the track completely excised. Histopathology revealed an unexpected diagnosis of moderately differentiated adenocarcinoma. A contrast-enhanced computed tomography of the abdomen and pelvis was performed which revealed a sigmoid tumor (Fig. 1). Colonoscopy revealed a normal rectum, but a circumferential ulcerating lesion 18 cm from the anal verge, confirmed by histology to be a moderately differentiated adenocarcinoma. He was referred to us for further management. The perianal scar was soft with no palpable mass. A complete staging work-up found no other evidence of metastatic spread. A day before the surgery he developed another perianal abscess (Fig. 2). Surgery consisted of abdominoperineal resection (APR) with excision of the sigmoid mass, perianal mass and the scar site of excised fistula (Fig. 3). Pathological results of the sigmoid tumor revealed moderately differentiated adenocarcinoma with focal signet ring cell morphology up to subserosal fat without lymph node involvement of 12 lymph nodes dissected (T3N0M0) with MSI-H histology (Fig. 4 A). The perianal fistula tract (Fig. 4 B,C) also revealed moderately differentiated adenocarcinoma with extracellular mucin amidst acute inflammation. Tumor was seen infiltrating the perianal skeletal muscle; however lateral and distal resection margin were free of tumor. The site of perianal abscess showed dense acute organizing inflammation with no evidence of tumor. The histologic appearances of the two malignancies were similar (Fig. 4 A,D). Immunohistochemistry for cytokeratin (CK) 7 and CK20 was performed to distinguish colorectal adenocarcinoma from anal gland carcinoma. Both the sigmoid cancer and the perianal tumor were CK7- and CK20+ and showed a similar pattern (Fig. 5A-D). The patient recovered uneventfully from surgery and no adjuvant chemotherapy or radiotherapy was planned. The patient remains well at 3 months of follow up, with no local recurrence or distant metastases identified.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 58,\n",
       "    'case_id': 'PMC3654631_01',\n",
       "    'case_text': 'We report the case of a 58-year-old female, with a known history of multiple sclerosis that was at the time asymptomatic and under no specific therapy. She was otherwise healthy, not taking any medication. Her family history was unremarkable. The patient was referred to the hematology department with the diagnosis of T-cell lymphoblastic lymphoma. She had been observed in her local hospital two months earlier, after the incidental discovery of leukocytosis with eosinophilia, bicytopenia, and elevated lactate dehydrogenase (LDH) (Table 1). At the time, a bone marrow aspirate was performed and revealed a hypercellular bone marrow (BM) with marked hypereosinophilia, no increase in the number of blasts, and no specific morphologic alterations. Immunophenotyping and cytogenetic studies were not conducted at this point. The patient was kept under observation and remained asymptomatic, with spontaneous normalization of the hematological parameters and LDH. Two months later a cervical enlarged lymph node appeared. The excisional biopsy showed lymphoblastic lymphoma of T-cell lineage, and she was referred to our hospital for further management.\\nAt admission, the patient presented with fatigue but was otherwise asymptomatic. Specifically, she denied respiratory, gastrointestinal, or other symptoms suggestive of a reactive eosinophilia. She was not a smoker and had no history of allergies. Physical examination revealed enlarged bilateral cervical, supraclavicular, and axillary lymph nodes and an enlarged spleen.\\nLaboratory abnormalities included anemia, a slight leukocytosis with eosinophilia, and a normal LDH (Table 1). \\nThe cervical lymph node biopsy was reviewed, and the diagnosis of T-cell lymphoblastic lymphoma was confirmed. A fine needle aspirate was conducted and flow cytometry studies showed infiltration by 92% aberrant immature T-cells that were Tdt/CD99/cCD3/CD5/CD2/CD1a/CD4 positive. The fluorescent in situ hybridization (FISH) analysis for BCR-ABL gene fusion in the lymph node aspirate was negative.\\nThe BM aspirate revealed a normocellular BM with 45.8% eosinophils, relative granulocytic hyperplasia, and no lymphoblastic or myeloblastic infiltration. No dysplastic changes were found. Flow cytometric analysis did not identify an aberrant lymphoid or myeloid population; 0.3% CD34+ precursors were present. BM biopsy findings were interpreted as reactive. \\nThe investigation of PDGFRA rearrangements by FISH and polymerase chain reaction (PCR) in the bone marrow was negative at this time point. Cytogenetic studies showed a normal karyotype in the 20 metaphases analyzed. \\nAs part of the lymphoma staging procedures, a computed tomography (CT) scan was performed showing multiple enlarged lymph nodes (cervical, supraclavicular, axillary, mediastinal, abdominal, iliopelvic, and inguinal) as well as splenomegaly. The PET scan revealed some adenopathies with an increased metabolism. Neoplastic cells were not found in the spinal tap.\\nTreatment was started according to the CALGB 9111 protocol for lymphoblastic lymphoma/leukemia, with complete remission documented after induction. The patient proceeded with the early intensifications, according to schedule, without significant toxicities, except for an allergic reaction to the E.Coli asparaginase requiring a switch to Erwinase. Central nervous system prophylaxis was performed with high dose methotrexate (MTX), and radiotherapy was not administered due to the known history of multiple sclerosis.\\nSixteen days after MTX administration, the patient was admitted with fever without an obvious infectious cause. A progressive increase in the leukocytosis, with neutrophilia, eosinophilia (Table 1), monocytosis, and the appearance of immature myeloid precursors in the peripheral blood (myeloblasts 8%, promyelocytes 3%, myelocytes 3%, and metamyelocytes 4%) followed, as well as a raise in LDH levels. This picture resembled the alterations that occurred two months prior to diagnosis.\\nAt this time, a repeated BM aspirate showed a hypercellular marrow, with myeloid hyperplasia, and infiltration by 11% of myeloblasts (Figure 1). This finding was confirmed by flow cytometry that identified 10% myeloblasts expressing CD34, CD117, HLA-DR, CD33, and CD13. Prominent eosinophilia was also present, and phenotypic aberrations in the granulocytic maturation were evident. There was no evidence of lymphoblastic infiltration either in morphology or in flow cytometry. Conventional cytogenetic analysis showed 10 metaphases with t(7;12)(q22;p13) as well as the addition of unknown genetic material to the short arm of chromosome 16 (Figure 2(a)). FISH studies using a dual color break-apart probe were positive for the ETV6 (12p13) rearrangement (Figure 2(b)). To further characterize these alterations, whole chromosome painting of chromosomes 7 and 12 was conducted (Figure 2(c)) and revealed a complex pattern of rearrangements involving chromosomes 7, 12, and 16: 46,XX,del(7)(q22),der(12)t(7;12)(q22;p13)t(12;16)(p13;p13),der(16)t(12;16).\\nThe BM samples were also retested for PDGFRA, PDGFRB, and BCR-ABL rearrangements by FISH, with repeated negative results.\\nA PET scan was repeated at this time point and showed only splenic caption (SUV 4.55). An abdominal ultrasound showed a heterogeneous splenomegaly without nodular lesions, suggesting a spleen infiltrative process.\\nDespite the introduction of high dose of steroid therapy, there was a progressive increase of leukocytosis with 19% circulating myeloblasts, thrombocytopenia, and anemia, possibly reflecting progression to acute myeloid leukemia, although this finding was not confirmed by bone marrow evaluation. Cytoreduction with hydroxyurea was attempted with a slow but steady decrease in the leukocyte counts.\\nEight days later, the patient developed sudden dyspnea with severe respiratory failure. Bilateral pulmonary infiltrates present on chest X-ray and high resolution pulmonary CT scan raised the hypothesis of an infectious process. In spite of antimicrobial therapy, the patient progressed to acute respiratory distress syndrome requiring invasive mechanical ventilation and eventually died in the ICU, about 4 weeks after the febrile episode and 6 months after the diagnosis of lymphoblastic lymphoma. Autopsy was not conducted, so the exact cause of death (infection/disease progression) was not determined.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 65,\n",
       "    'case_id': 'PMC8264843_01',\n",
       "    'case_text': \"A 65-year-old male patient with history of keratoconus and penetrating keratoplasty (PK) over 30 years ago developed corneal oedema subsequent to the graft failure in his left eye with best corrected visual acuity (BCVA) of counting fingers. He had an eccentric 7.5 mm penetrating keratoplasty, which made repeat full thickness keratoplasty with a larger donor graft a high risk for rejection. He also had a mild cataract. Therefore, he was offered Descemet membrane endothelial keratoplasty (DMEK) on failed PK combined with cataract surgery using standard keratometry of 43.5D and a hydrophobic acrylic intraocular lens. After inserting the intraocular lens, while the anterior chamber was filled with a cohesive viscoelastic device, we performed a Descematorhexis within the graft-host junction. Care was taken not to expose posterior stromal strands during Descematorhexis. After a thorough washout of the viscoelastic device a 7.25 mm Descemet membrane graft was delivered and secured on the stroma within the old penetrating keratoplasty, using an intracameral injection of 50% Sodium Hexafluoride (SF6) gas. Cyclopentolate 1% eye drops were used immediately after the injection of gas to prevent pupillary block, since he has had no peripheral iridotomies. The patient was advised to comply with supine posture for a minimum of 2 days and was given antibiotic-steroid combination drops qds for a month, G. Cyclopentolate 1% tds for a week and Tb. Acetazolamide 250 mg sustained release for 3 days post-surgery. One week post-operatively the cornea appeared oedematous with inferior detachment of DMEK graft (Figure 1(a)). Re-bubbling with air was performed at the slit lamp via 5 o'clock paracentesis,   the patient was started on Acetazolamide 250 mg slow release tablets for 3 days and advised to maintain a supine posture for a minimum of 2 days and ideally as long as the air was present in the anterior chamber. One week later, he was noticed to have persistent inferior graft detachment and corresponding corneal oedema (Figure 1(a)); therefore, the second re-bubbling was performed at the slit lamp in the same fashion. His cornea remained oedematous inferiorly at 4 weeks due to persistent inferior Descemet membrane detachment (Figure 1(a)) despite two subsequent re-bubblings. Careful inspection of his anterior segment OCT (AS-OCT) revealed a ridge on the posterior surface of the graft-host junction infero-nasally (Figure 1(a)), which was the probable cause of his recurrent inferior Descemet membrane detachment. To manage this complication, he underwent DMEK suturing in the theatre under subtenon anaesthesia. The detached graft was repositioned, using intracameral injection of air. Based on the extent of the DMEK detachment three radial full thickness 10-0 nylon interrupted sutures were placed in the inferior cornea to hold the graft in place. The needle passed through the host cornea and exited from the graft cornea. Care was taken not to tear the detached Descemet with unnecessary needle movement in the anterior chamber (Supplemental Video 1) (Figure 1(b)). One week post-operatively, his AS-OCT confirmed complete attachment of the DMEK graft with clear appearance of posterior protuberance (Figure 1(c)). Four weeks later, the corneal sutures were removed at the slit lamp and no further sutures were needed. Following this, his medications switched to G. Dexamethasone 0.1% qds for 2 months followed by bd for long-term. His corneal oedema resolved (Figure 2(a) and (b)) and his visual acuity gradually improved. Eight months from DMEK, his cornea was clear, and his unaided visual acuity was 20/63 with BCVA of 20/32 using rigid gas permeable contact lens (best spectacle corrected vision was 20/60 and best contact lens corrected vision was 20/32 before PK graft failure).\\nThe patient provided written informed consent to publish all related medical data, images and videos.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 60,\n",
       "    'case_id': 'PMC3909696_01',\n",
       "    'case_text': 'A 60-year-old man, known diabetic, was admitted in emergency for disorders of consciousness. The medical history with the family revealed a notion of diabetes for 1 year and transurethral resection of the prostate for 5 years. A disorder of micturition for one year with burning urination. The examination found a feverish patient (38 C), a tympanic globe bladder and a prostate estimated to be 30g.\\nThe biological balance sheet revealed an infectious syndrome with renal insufficiency (creatininemia = 57 mg/dl, CRP = 322 mg/dl, urea = 2.22 g/dl and a hyperglycemia = 6g/dl). Abdominal X-ray without preparation shows the presence of air (sight) at the pelvic area (Figure 1). Ultra-sonography (US) of the bladder was realized but was not contributive. An abdominal pelvic computed tomography (CT) without injection of intravenous contrast showed a vesical globe containing air (Figure 2, Figure 3) and the presence of the sight at the level of the left pyelon (Figure 4) confirming the diagnosis of cystitis and pyelonephritis emphysematous.\\nAfter a failure of urethral catheterization, the patient underwent a pubic catheterization returning gases and shady urines, drainage of the upper urinary tract was not done because of the lack of the expansion. Antibiotic treatment with ceftriaxone associated to metronidazole was started with an adapted insulotherapy. The bacterial culture of urines isolated an infection due to Escherichia coli. Apyrexy was obtained in 48 hours and a normalization of the renal function in 4 days. Urethrocystography retrograde micturition was realized after 3 weeks showing a stenosis of the urethra and the patient underwent an endoscopic uretrotomy.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 55,\n",
       "    'case_id': 'PMC5015792_01',\n",
       "    'case_text': 'A 55-year-old man presented with acute visual loss in the left eye (LE). The patient denied other ocular or systemic symptoms. He was not taking any medications and his medical, social and family history was unremarkable. Visual acuity (VA) was 20/20 in the right eye (RE) and hand movements in the LE. Slit-lamp examination findings of the anterior segment were normal in both eyes (OU) and intra-ocular pressure was 12 mmHg bilaterally. Dilated fundoscopy of the LE revealed a few vitreous cells and a large yellow macular placoid lesion with a curvilinear edge (Figure 1A (Fig. 1)). Fluorescein angiography (FA) showed early hypofluorescence with late staining in the affected area (Figure 2 (Fig. 2)). Optical coherence tomography (OCT) in the LE demonstrated subretinal fluid overlying the macular lesion (Figure 3 (Fig. 3)). No abnormalities were detected in the RE. Screening blood tests, including syphilis serology, were requested and the patient was monitored without treatment.\\nThree days after the placoid lesion had extended (Figure 1B (Fig. 1)). The patient did not follow our recommendation for serologic work-up and the tests were ordered again. One week after the initial presentation, VA remained stable but the placoid lesion had increased outside the temporal retinal vascular arcades (Figure 1C (Fig. 1)). New multiple yellow lesions and hemorrhages were observed in the retinal superior nasal area. Indocyanine green angiography (ICGA) revealed persistent leakage of the choriocapillaris and hypofluorescence areas in the early and late phases (Figure 4 (Fig. 4)). The patient continued not to follow our recommendation for the blood tests and they were ordered for the third time. He was informed again about his clinical situation and the importance of the work-up was underlined. \\nThe patient abandoned the clinic for two weeks and when observed again, VA had improved to 20/20 in the LE and the lesions showed complete spontaneous resolution (Figure 1D (Fig. 1)). RE examination remained normal. Finally, we had access to the serologic tests results that revealed a positive VDRL (1/128) and FTA-ABS. HIV titers were negative. All other tests were normal. The diagnosis of acute syphilitic posterior placoid chorioretinitis in the LE was made. The patient was referred to the Infectious Disease Department. He had no other syphilitic manifestations and no abnormalities were detected after computed tomography of the cranium and orbits. A lumbar puncture revealed a positive VDRL and CSF-TPHA in the cerebrospinal fluid (CSF). The patient accepted to start treatment only 45 days after the initial presentation. During this period no relapse of the ocular lesions occurred and no systemic manifestation was observed. The patient was treated with intravenous aqueous penicillin G (four million units given every 4 h for 2 weeks). Three months after treatment, VA was 20/20 and fundoscopy remained normal both eyes. Follow-up serologic testing revealed a decrease of VDRL to 1/32.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 53,\n",
       "    'case_id': 'PMC6500649_01',\n",
       "    'case_text': 'A 53-year-old female presented with gradually progressive diminution of vision in her left eye for 2 months. She had a history of diabetes mellitus for 20 years for which she is taking insulin. Her most recent HbA1C was 7.5%. She had no history of hypertension or renal problems. She had no past ocular history. Examination revealed a corrected distance visual acuity (CDVA) of 20/40 in her right eye and 20/100 in the left. Anterior segment examination showed nuclear sclerosis in both eyes. Posterior segment examination revealed intraretinal hemorrhages in all 4 quadrants indicating severe nonproliferative diabetic retinopathy in both eyes with clinically significant macular edema in the left eye confirmed by fluorescein angiography (Figure 1). Spectral domain optical coherence tomography (OCT) of the macula was done and revealed multiple cystic spaces, mild subfoveal neurosensory detachment, and diffuse retinal thickening with a central subfield macular thickness of 332 mum in the left eye (Figure 2(a)). The right eye showed only few cystic spaces with minimal thickening. OCTA (Optovue, Inc., Fremont, CA, USA) was done in both eyes and showed areas of capillary nonperfusion in the superficial capillary plexus (SCP) of the maculae of both eyes (Figures 3(a) and 3(e)). Three monthly intravitreal bevacizumab injections were done to treat the macular edema in the left eye. One month following the last intravitreal injection, CDVA improved to 20/60 in the left eye and was stable in the right eye. OCT showed improvement of the macular edema in the left eye (Figure 2(b)). OCTA was performed in both eyes and showed decreased vascular density of the SCP of the left eye compared to pretreatment OCTA while a mild increase was noted in the vascular density of the SCP of the untreated right eye (Figures 3(b) and 3(f)). The patient was then followed up without requiring further intravitreal injections and 4 months following the last intravitreal injection OCTA was repeated in both eyes and showed improvement of the vascular density of the SCP of the left eye with unchanged SCP in the right eye (Figures 3(c) and 3(g)). CDVA was 20/60 in the right eye and 20/100 in the left. Clinical examination revealed retinal neovascularization in the right eye with clinically significant macular edema in both eyes. OCT showed increased center-involving macular edema in both eyes with recurrent neurosensory detachment in the left eye (Figure 2(c)). Three monthly intravitreal bevacizumab injections were then done for treatment of proliferative diabetic retinopathy in the right eye and the macular edema in both eyes. One month following the last intravitreal injection, CDVA was 20/40 in the right eye and 20/60 in the left, OCT showed decreased macular thickness in both eyes (Figure 2(d)), and OCTA revealed decreased vascular density of the SCP of both eyes (Figures 3(d) and 3(h)). Changes in the deep capillary plexus closely followed those in the SCP at all stages.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 60,\n",
       "    'case_id': 'PMC5259666_01',\n",
       "    'case_text': \"A 60-year-old woman had been aware of a mass in her left lower neck for 5 months. She underwent an open biopsy of the left neck by a previous physician. The findings of the histopathological examination indicated spindle cell sarcoma. On physical examination, an extremely soft mass was palpated in the left lower neck. Computed tomography (CT) scans (Figure 1(a)) revealed a 60 x 26 x 42 mm well-marginated soft tissue mass in the left lower anterior neck. The sternocleidomastoid muscle was markedly displaced anteriorly. The mass presented with heterogeneous enhancement and low-density areas, suggesting the presence of intralesional fat. On magnetic resonance imaging (MRI), the tumor exhibited soft tissue intensity with scattered high intensity that was suggestive of fat in T1-weighted images (WI) (Figure 1(b)) and T2WI (Figure 1(c)). In fat-suppressed gadolinium-enhanced T1WI (Figure 1(d)), the mass showed marked enhancement, and high-intensity areas were suppressed. On 18fluorodeoxyglucose positron emission tomography/CT (FDG-PET/CT) imaging, the maximum standard uptake volume in the tumor was 2.1. Histopathological examination of the previous open biopsy revealed spindle cells with epithelioid differentiation. On immunohistochemical examination, the spindle cells and epithelial cells were cytokeratin (CK) AE1/3 (+). The spindle cells were alpha-smooth muscle actin (alpha-SMA) (+), S100 (-), desmin (-), Bcl2 (+), and terminal deoxynucleotidyl transferase (TdT) (-). SS and spindle cell carcinoma were suspected.\\nThe tumor was resected from the left neck under general anesthesia. The scar created by the previous open biopsy was also resected. The sternocleidomastoid muscle around the tumor was also resected. Resection progressed along the deep cervical fascia with attaching adipose tissue surrounding the tumor. A phrenic nerve running to the deep portions of the tumor was resected. The tumor was detached from the surrounding tissue. Intraoperative frozen section examination results indicated the presence of a spindle cell tumor.\\nWe used frozen samples to assess SYT-SSX fusion gene expression by PCR. cDNA was prepared from total RNA extracted from the excised specimen. We used the SYT51 (5'-cagggaccacctccacaacag-3') and SSX124-31 (5'-cctctgctggcttcttgggc-3') primers, which recognize SSX1/2/4, to perform the 35-cycle PCR. The SYT-SSX fusion gene was not expressed, and thus SS was eliminated from the differential diagnosis. On histopathological examination of the resected tumor, the tumor consisted of plump to thin spindle cells growing in a bundle shape (Figure 2(a)), epithelial cells that formed anastomosing cords (Figure 2(b)), and epithelial islands with solid or microcystic extension areas. In addition, mature adipose cells (Figure 2(c)) and lymphocytes were observed between spindle cells and epithelial cells. Upon evaluation of the overall lesion, we diagnosed the tumor as EHT. The patient has had no recurrence for 56 months after surgery. The patient provided written informed consent for all medical procedures and for the publication of this case report.\",\n",
       "    'gender': 'Female'},\n",
       "   {'age': 24,\n",
       "    'case_id': 'PMC5259666_02',\n",
       "    'case_text': 'A 24-year-old woman had been aware of a lower left neck swelling for several days. She underwent an open biopsy of the left neck by a previous physician. The histopathological examination suggested SS. The previous physician planned to perform surgery after chemotherapy or chemoradiotherapy. The patient was referred to our department to obtain more detailed examinations before surgery. On physical examination, a soft mass was palpated in the lower left neck. CT scans (Figure 3(a)) revealed a 42 x 35 x 48 mm well-circumscribed mass with nonhomogeneous enhancement between the sternocleidomastoid muscle and internal jugular vein. The mass had low signal intensity similar to muscle on T1WI (Figure 3(b)) and higher intensity than muscle on T2WI (Figure 3(c)). Densities and intensities resembling those of intralesional and marginal fat were observed. On FDG-PET/CT, there was no accumulation in the tumor. Upon histopathological examination of the open biopsy performed by the previous physician, the tumor consisted of comparatively even spindle cells and adipose-like cells. According to the immunohistochemical examination, the spindle cells were CK AE1/3 (+), alpha-SMA (+), S100 (-), desmin (-), Bcl2 (+), and TdT (-). The tumor was suspected of being SS. We used the Vysis SS18 Break-Apart FISH Probe Kit (Abbott Laboratories, Abbott Park, Illinois, USA). The gene was not disrupted in the sample, and SS was excluded from the differential diagnosis.\\nOn the basis of the findings in Case 1, we suspected EHT, but a definitive diagnosis could not be obtained from the biopsy. Tumor resection from the left neck was performed under general anesthesia. The scar created by the previous open biopsy was also resected. Part of the sternocleidomastoid muscle between the skin scar and the tumor was also resected. The tumor (Figure 3(d)) was encapsulated with a smooth surface, and there was no adhesion to the surroundings. The surrounding organs were preserved, aside from the partial resection of the sternocleidomastoid muscle between the tumor and the scar, which was performed because the possibility of malignancy could not be excluded.\\nOn intraoperative frozen section examination, spindle cells with no pleomorphism and adipose tissue were seen inside the lesion. Necrosis and mitotic figures were absent. These findings were compatible with a diagnosis of EHT. On histopathological examination of the resected tumor, the tumor consisted of plump to thin spindle cells growing in a bundle shape (Figure 4(a)) and adipose cells (Figure 4(b)). Based on immunohistochemical examination and fusion gene examination, we diagnosed the tumor as EHT. The patient has had no recurrence for 29 months after surgery. The patient provided written informed consent for all medical procedures and for the publication of this case report.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 62,\n",
       "    'case_id': 'PMC10035883_01',\n",
       "    'case_text': \"A 62-year-old man was admitted for treatment of progressive limb weakness over 4 months. He suddenly felt weakness in the right lower limb during farming over 4 months ago, accompanied by pain and cramps in the calf. He received treatment in the community for 4 days, and the above symptoms disappeared. One week after the initial onset of the weakness, the patient began to have left-sided angle of mouth, salivation, chewing difficulties, difficulty in closing the right eye, slurred speech, transient diplopia, ataxia, weakened tendon reflex of the right limb, and the MRC grade of the right limb muscle was 4 (Table 1), with CT examination showing low-density lesions in the bilateral basal ganglia area. The patient's symptoms progressed after antithrombotic treatment, with recurrence of transient diplopia. He was discharged after 2 weeks of hospitalization. At 9 weeks after the initial onset, after suffering from upper respiratory tract infection, pain occurred in the lower parts of both lower limbs, and the distal knuckles and toes of both lower limbs continued to have numbness. The distal numbness of the limbs gradually spread to the proximal end, accompanied by weakness of both feet, followed by weakness of the limbs, mainly the distal limbs. At 13 weeks after initial onset, he had difficulty in passing stool and needed enema to help, and 15 weeks after initial onset, he had difficulty in passing urine. He was in good health in the past and had a history of COVID-19 vaccination 10 days before the onset of symptoms. He did not have a family history of genetic disease or history of exposure to poisons.\\nUpon admission, the following were observed: normal cognitive function, the speech was unclear, bilateral forehead lines disappeared, could not wrinkle forehead, bilateral eye closure was weak and right side was obvious, the right nasolabial groove was shallow, the bilateral drum gills were weak, the strength of the right side teeth was weak, the angle of mouth was left, the tongue body was thin, the tongue muscle strength was weak, with right tongue muscle tremor. The masticatory muscle was slightly weak, the pharyngeal reflex disappeared, shoulder shrug and neck were powerful, the neck flexion was weak. Limb muscle strength (MRC) grades: proximal left upper limb: V, distal: II+; left lower limb proximal extensor: IV+, flexor: III, distal: II; proximal right upper limb: V, distal: II+; proximal extensor of right lower limb: IV-, flexor: II+, distal: 0. The muscle tension of both lower limbs decreased, the tendon reflex and abdominal wall reflex of the limbs disappeared. The ataxia of both upper limbs was unstable and both lower limbs cannot be completed. Stocking glove hypoesthesia was observed for vibratory and cold stimuli.\\nUpon auxiliary examination, the following were observed: blood test examination: blood routine, blood coagulation routine; blood glucose, liver and kidney function, thyroid function, tumor markers, serum protein electrophoresis, and vitamin B12 were not significantly abnormal. Cerebrospinal fluid (CSF) protein level: 618.91 mg/dL (normal value 15-45 mg/dL), white blood cell count: 6/muL (normal value 0-8/muL). The neuroelectrophysiology is shown in Table 2. An MRI of the cervical plexus is shown in Figure 1A, an MRI of the lumbosacral plexus in Figure 1B, and musculoskeletal ultrasounds are shown in Figure 2.\\nThe diagnosis upon admission was as follows: acute inflammatory demyelinating polyradiculoneuropathy (AIDP)?/ACIDP?/Autoimmune nodopathies? After IVIG treatment, the limb weakness of the patients improved. Blood antibody report: anti-CNTN1 antibody IgG4 positive 1:100, CSF corresponding antibody 1:32. Diagnosis: Autoimmune nodopathies. The treatment was 500 mg methylprednisolone intravenous shock therapy and hormone reduction 5 days after surgery with 48 mg methylprednisolone orally administered. The patient's fatigue symptoms gradually improved, but he was still unable to walk, and improvement of numbness was not obvious.\\nAfter discharge, the patient's condition was stable and he was readmitted to the hospital for rituximab treatment because of his inability to walk. Upon follow-up 1 year after onset of disease, he was able to walk normally and felt numbness only in the fingertips. The changes in muscle strength during the three admissions are shown in Table 3. EMG comparisons for the three admissions are shown in Table 2.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 68,\n",
       "    'case_id': 'PMC8329363_01',\n",
       "    'case_text': 'A 68-year-old Chinese man complained of gradual visual loss that occurred in both eyes over a period longer than 9 months. Approximately 6 months before he came to our clinic, he underwent a subtotal pneumonectomy to treat a pulmonary tumor, for which the pathological diagnosis was benign. Two months before he came to our clinic, assessments at another medical center revealed increased intraocular pressure (IOP) (around 30 mmHg in both eyes), a whole circle thickened ciliary body according to ultrasonic biomicroscopy (UBM), and decreased anterior chamber depth. He was able to count fingers in an assessment of best corrected visual acuity (BCVA) for both eyes. The IOP was 19 mmHg for the right eye and 20 mmHg for the left eye. A slit-lamp examination of the anterior segment of the eyes showed obviously tortuous and dilated episcleral vessels (Supplementary Figure 1), significantly decreased depth of anterior chamber, iris bombe, slight eversion of iris pigment at the pupillary margin and prominent cortical opacity of the lens (Figure 1). There were no signs of synechia, neovascular membranes in the iris, or active inflammation (Figure 1). Open angles with pigmentation within the trabecular meshwork were revealed by gonioscopy. Color fundus retinal photography revealed typical exudative retinal detachment in both eyes (Figure 1), accompanied by naevus-like multifocal reddish patches under RPE in the superior part of the fundus. Ocular coherence tomography (OCT) showed exudative retinal detachment of the macula with multiple hyperreflective elevated lesions under RPE. Lensectomy, peripheral iridectomy, diagnostic pars plana vitrectomy (PPV), and silicon oil tamponade were performed on the right eye to deepen the anterior chamber, restore the transparency of the refractive media, reattach the retina, and take a choroid sample for biopsy. Vitreous fluid and subretinal fluid were collected during the surgery, but immunological analyses revealed no specific positive results. Haematoxylin-eosin (HE) staining for biopsies from the choroid suggested predominantly spindle-shaped melanocytic cell masses, while immunohistochemistry showed that the samples were positive for antibodies against S-100, and negative for antibodies against Ki67, LCA, PAX-5, and SOX-10 (Figure 2). The histopathological examination showed that the choroid lesion was a benign proliferation of melanocytes.\\nOne month after surgery in the right eye, the patient underwent surgery in the left eye. This had a similar procedure but no biopsy, and subretinal fluid was drained through the sclera. At a 1-week follow-up assessment, the BCVA of the patient had recovered to 20/100 for the right eye and 20/80 for the left eye, and the IOP was 21 mmHg for both eyes. The depth of the anterior chamber had increased and the iris bombe had disappeared (Figure 3). The retina was basically reattached with only a small amount of subretinal fluid. A mass of multifocal reddish patches (Figure 3) was found all around the retina, especially in the mid-peripheral sections. These patches were consistent with the elevated hyper-reflective mass under RPE (Figure 3) in the OCT data, and also with the hyperfluorescence in the autofluorescence images and hypofluorescence in the early FA data.\\nA small amount of subretinal fluid persisted during the early postoperative follow-up period, and this was accompanied by thickening of the choroid. Three months after the operation, the patient underwent a rectectomy to treat a rectal tumor, and postoperative pathology revealed a rectal adenocarcinoma. Six months after the rectectomy, the subretinal fluid had completely disappeared and the thickness of the ciliary body and choroid had significantly decreased (Figure 4). The BCVA had improved to 20/60 for both eyes at the last follow-up.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 10,\n",
       "    'case_id': 'PMC9626241_01',\n",
       "    'case_text': \"The patient was a 10-year-old girl at the time of her visit to the Department of Genetic Medicine, King Saud Medical City, Riyadh. She is the first child of the first healthy Saudi cousin. She was born at full term of pregnancy via spontaneous vaginal delivery. The family history was unremarkable, and the other four siblings were healthy, with a history of one abortion. She had early motor development delay (sat at 2 years and walked at 3 years), speech delay, and subnormal mentality. Skeletal changes with a waddling gait, difficulty rising after sitting down. During the clinical examination, she had good eye contact, obeyed simple commands, and could pronounce a few unclear words. She could walk with assistance. Stairs are difficult. She looks like a dysmorphic triangular face with a prominent check, a forehead, retromicrognathia, large ears, and skeletal deformities with mild pectus carinatum, short and broad hands with brachydactyly, kyphosis, knock knees, valgus tibial bowing, and pes cavus foot (Figures 1(a)-1(d)), and her height was 102 cm (2.9 SDs), weight was 16 kg, and head circumference was 48 cm below the third percentile. The radiological findings (Figures 2(a)-2(d)) coincided with the clinical findings. The radiological analysis revealed diffuse osteopenia. Tubular bones are short. Metaphyseal sclerosis and irregularities are more pronounced in the lower limbs. Right humerus bowing deformity; small, fragmented, and sclerotic femoral heads; right hip dislocation with external rotation of the right lower limb; bilateral coxa varus; and left genu valgus bowing deformity of the left tibia were identified. Metacarpals and metatarsals are short. The echocardiogram and abdominal ultrasound were unremarkable. She had an intellectual disability (IQ = 60) and lived alone. No corneal cataract, hearing deficit, or involvement of other systems was identified.\\nInvestigations included complete blood count; coagulation profile; GAG (glycosaminoglycans) in the urine, urea, and electrolytes; thyroid function tests; parathyroid hormone; serum calcium; phosphorus; and alkaline phosphatase.\\nMagnesium, vitamin D, and liver enzymes were normal. Unremarkable Tandom MS was found, and urine organic acid analysis was performed. Lysosomal enzyme activities were analyzed and showed elevated enzyme activity levels for alpha-glucosidase, beta-glucuronidase, beta-mannosidase, alpha-mannosidase, and beta-hexosaminidase.\\nWeS was performed on the proband and her parents utilizing genomic DNA extract from blood. Genomic DNA is enzymatically fragmented, and target regions are enriched using DNA capture probes. These regions include approximately 41 Mb of the human coding exome (targeting >98% of the coding RefSeq from the human genome build GRCh37/hg19), as well as the mitochondrial genome. The generated library is sequenced on an Illumina platform to obtain at least 20x coverage depth for >98% of the targeted bases. An in-house bioinformatics pipeline, including read alignment to the GRCh37/hg19 genome assembly and revised Cambridge Reference Sequence (rCRS) of the Human Mitochondrial DNA (NC_012920), variant calling, annotation, and comprehensive variant filtering, is applied. All variants with a minor allele frequency (MAF) of less than 1% in the gnomAD database, as well as disease-causing variants reported in HGMD , ClinVar, or CentoMD  are considered. The investigation for relevant variants is focused on coding exons and flanking +-10 intronic nucleotides of genes with clear gene-phenotype evidence (based on OMIM  information). All potential patterns for the mode of inheritance are considered. In addition, provided family history and clinical information are used to evaluate identified variants with respect to their pathogenicity and causality. Variants are categorized into five classes (pathogenic, likely pathogenic, VUS, likely benign, and benign) according to ACMG guidelines for classification of variants. All relevant variants related to the phenotype of the patient are reported. CENTOGENE has established stringent quality criteria and validation processes for variants detected by NGS. Variants with low quality and/or unclear zygosity are confirmed by orthogonal methods. Consequently, a specificity of >99.9% for all reported variants is warranted. Mitochondrial variants are reported to have heteroplasmy levels of 15% or higher.\\nThe copy number variation (CNV) detection software has a sensitivity of more than 95% for all homozygous/hemizygous and mitochondrial deletions, as well as heterozygous deletions/duplications and homozygous/hemizygous duplications spanning at least three consecutive exons. For uniparental disomy (UPD) screening, a specific algorithm is used to assess the well-known clinically relevant chromosomal regions (6q24, 7, 11p15.5, 14q32, 15q11q13, 20q13, and 20).\\nThe patient's entire exome sequence was discovered to be a homozygous (c.2634C > A) p. (Ser878Arg) variant of the MBTPS1 gene (Figure 3). An amino acid change from Ser to Arg at position 878. It is classified as a variant of uncertain significance (class 3) according to the recommendations of CENTOGENE and ACMG, and further Sanger sequencing indicated that the parents carried a single heterozygous mutation each. The missense c.2634C > A variant in the MBTPS1 gene has not been previously reported in clinical cases and was classified as a Variant of Uncertain Significance (class 3) according to the CENTOGENE and ACMG. The Kondo-Fu type of spondyloepiphyseal dysplasia (SEDKF) is caused by a homozygous mutation in the MBTPS1 gene. The autosomal recessive Kondo-Fu type of spondyloepiphyseal dysplasia (SEDKF) is consistent with the genetic diagnosis of the autosomal recessive Kondo-Fu type of spondyloepiphyseal dysplasia (SEDKF). Variable clinical phenotypes include short stature, developmental delay, eye abnormalities, and skeletal dysplasia. We are aware of the paper published by Kondo et al.. They report cases of MBTPS1 variants identified by compound heterozygosity for mutations in the MBTPS1 gene: a 1-bp duplication and a missense mutation. The gene variant mentioned here has never been described in the literature before.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 20,\n",
       "    'case_id': 'PMC7369465_01',\n",
       "    'case_text': \"We present the clinical case of patient M.S. 20 years old, with MEN 2A syndrome, which has been manifested by bilateral pheochromocytoma and medullary thyroid carcinoma.\\nIn 2015, after a check-up, suspicion of an adrenal gland tumor was raised. The patient presented the following symptoms: hypertension with often crises, episodic headaches, palpitations, irritability, sweating, pallor.\\nThe diagnosis was confirmed by biochemical tests (increased plasma and urinary metanephrines levels) and MRI, where an ovoid tumor (46 x 37 x 43 mm with regular contour, homogeneous structure) has been visualized.\\nAccording to the patient, her mother suffered from hypertension, episodic headache and palpitations during pregnancy. The diagnosis of eclampsia has been established. During birth she had a hypertonic crisis again and died within hours of the birth of profuse uterine bleeding. Necropsy revealed adrenal tumor on her left and histopathological examination confirmed multicentric, predominantly alveolar pheochromocytoma.\\nIn 2015 our patient underwent laparoscopic adrenalectomy on her left. Histopathological examination revealed multicentric, predominantly alveolar pheochromocytoma.\\nDuring the years 2015-2018, after the intervention, her well-being improved, with hypertonic crises only once a month. In July 2018 more intense, frequent hypertensive crises appeared with characteristic signs.\\nThus, on 11.07.2018 a CT of the abdomen was performed, where a tumor (27 x 32 mm) of the right adrenal has been detected (benign origin according to the character of contrasting).\\n15.12.2018 PET-CT: Increased metabolic activity of FDG (mean SUV = 11.5) at the level of a tumor of the right adrenal gland (36 x 29 mm), possibly pheochromocytoma increased diffuse accumulation of radiopharmaceutical in the bone marrow, more evident in the thoracic segment of the spine and pelvic bones (Fig. 1).\\nAll laboratory tests for the years 2014-2020 are presented in Table 1.\\nIn April 2019, the patient underwent laparoscopic total adrenalectomy on the right. This intervention was done by head surgeon with thirty years' experience. Macroscopic examination revealed multinodular solid adrenal tumor, the biggest nodule being 41 x 32 mm. Histopathological examination described multicentric, predominantly alveolar pheochromocytoma (Fig. 2A, B).\\nIn February 2020, the patient is hospitalized for scheduled total thyroidectomy, showing symptoms of a permanent lump in the throat, difficulty swallowing, feeling of suffocation in a supine position, general weakness, fatigue.\\nTotal thyroidectomy is the recommended treatment for all medullary thyroid carcinoma in MEN 2A syndrome, confirmed by elevated calcitonin levels and imaging data.\\nUSG of the thyroid gland 11.12.2014: right lobe - 19 x 12 x 32 mm, left lobe - 19 x 12 x 36 mm. Isthmus 3,3 mm, heterogeneous nodules 3 x 4 mm and 7 x 4 mm.\\nUSG of the thyroid gland 15.01.2020: right lobe - 14 x 14 x 31 mm, one heterogeneous node 7 mm with multiple calcinates, left lobe - 13 x 14 x 29 mm one heterogeneous node 8 x 6 mm with single calcined and irregular borders, pronounced peri- and intranodular vascularity), isthmus - 0.3 cm (Fig. 3).\\nCT of the thyroid gland with contrast 11.21.2018: areas with nodular lesions in both thyroid lobes with dimensions of 5 mm on the right and 12 x 9 mm on the left.\\nTotal thyroidectomy was performed, macroscopic examination revealed multinodular thyroid gland with dimensions 8 x 3 cm (Fig. 4). This intervention was done by head surgeon with twenty years' experience. Given that regional lymphadenopathy was determined neither preoperatively nor intraoperatively, and thyroid gland with small nodules without invasion into a capsule, it was decided not to perform neck lymph nodes dissection.\\nHistopathological examination of the thyroid tissue revealed non-encapsulated medullary carcinoma with trabecular pattern, amyloidosis of the tumor stroma, low degree of pleomorphism and minimal mitotic activity, without LVI-0 and 0 lymphovascular invasion, surgical resection margins negative to tumor (R0), no invasion into thyroid capsule, pT1aNxMx LVI-0 Pn-0 R0. Histochemical investigation with Congo red for detecting amyloid deposits in the tumor stroma was positive (Fig. 5A, B).\\nThe postoperative evolution of this patient is favorable. She is satisfied with the received treatment and is being supervised by an endocrinologist, undergoing hormone replacement therapy. Currently the patient receives 25 mg of cortisone in the morning and the fourth part at noon, prednisolone tablets 2.5 mg in the morning, under the monitoring of the arterial pressure, and L-thyroxin tablets 50 mg.\\nRecent laboratory tests (25.05.20): PTH - 19,3 pg/mL, calcitonin - 18,7 pg/mL, TSH- 0,2ul/mL, ionic calcium - 1,09 mmol/l. The decrease in calcitonin from 121 to 18.7 pg/mL reflects the effectiveness and radicality of the surgical treatment applied.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 56,\n",
       "    'case_id': 'PMC5356200_01',\n",
       "    'case_text': \"A 56-year-old man initially presented for evaluation of iron deficiency anemia. Further evaluation with esophagogastroduodenoscopy (EGD) and colonoscopy revealed a large, benign-appearing mass in the duodenum (Figure 1). Subsequent endoscopic ultrasound (EUS) revealed a 3 x 4-cm subepithelial mass arising from the submucosa with numerous cystic spaces and mixed echogenicity (Figure 2).\\nTransduodenal resection per hepatobiliary surgery revealed a 3 x 12-cm polyp (Figure 3). Surgical evaluation also revealed ulcerations of the mucosa surrounding the polyp, which were thought to be the cause of his iron deficiency anemia. Pathology revealed Brunner's gland hyperplasia with secondary polyp formation that extended to the margin. The interface between normal small intestine and the polyp was visible. Both showed an intact unremarkable mucosal surface without inflammation. The transition from small nests of Brunner's glands and other submucosal elements to a multinodular proliferation composed entirely of closely spaced Brunner's glands was also noted (Figure 4). On follow-up one month after resection, the patient's hemoglobin level normalized and he no longer required iron supplementation.\\nWhile Brunner's gland hamartomas are rare, with an incidence of 0.008%, they also account for 5-10% of all benign duodenal tumors. These lesions usually present in the fifth or sixth decade of life and have low malignant potential. Brunner's gland hamartomas are usually 1-3 cm in size, so our case was unusual with a large 12-cm Brunner's gland, which was successfully removed by means of transduodenal resection. Interestingly, although the patient's gastric biopsies did not show evidence of Helicobacter pylori, there has been an association of Brunner's gland hamartomas with concurrent H. pylori infections. In one study, dysplastic changes were noted in 2.1% of cases, with only 0.3% of those being invasive carcinoma. Treatment for Brunner's gland hamartomas is usually conservative in asymptomatic patients, while surgical or endoscopic resection is indicated for symptomatic patients.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 73,\n",
       "    'case_id': 'PMC3358721_01',\n",
       "    'case_text': 'The 73 year old female patient was admitted to our orthopaedic department on the basis of intermittent pain in her left lower limb. She reported of gait disturbance, weakness and recurring sciatica in the left lower limb since about 24 hours. At the time of her hospitalisation, she wasn`t able to walk anymore.\\nIntermittent pain in the left leg with incomplete paresis and paresthesia since 24 hours. The onset of symptoms was spontaneous; there was no history of trauma. No history of lumbago, no fever or weight loss. The symptoms were reported for the first time. The current medication comprised antihypertensive drugs, diuretics and an anticoagulans (cumarine). The patient reported a biologic aortal valve implantation from 6 months ago and an atrial fibrillation as a reason for the anticoagulation.\\nOn physical examination, we had an adipose female patient with a height of 165cm and weight of 95kg (BMI= 34.9). The mental status was normal. During the examination, the patient was asked to stand up for the purpose of inspection. While trying to get into a prone position, the patient lost control of her left lower limb. At this moment she also suffered urine incontinence the first time. Further examination presented an incomplete paraplegia of the lower limb, while the right limb had a normal motor and sensible function. On the left side, there was a loss of power for the hip flexion, knee extension and foot elevation, varying from 4/5 MRC (medical research council) grade to full plegia (Asia Impairment Scale AIS D to AIS C) and inability to move the limb during a second examination, which was performed 15 minutes later in the radiology department by the same examiner. Lasegue and Bragard sign was positive on the left side. Babinski sign was bilaterally negative. There was no saddle block anaesthesia present and the anal sphincter tonus was normal. Peripheral pulse status was also normal. Crural varicosis was inspected, but there was no change in limb circumference, color, temperature, pain on palpation of the calves nor near the great saphenous vein.\\nThere was no tenderness on the examination of the spine. Abdomen was smooth and also presented no tenderness to palpation.\\nDuring the radiographic examination (changing position), the patient presented a rapid worsening of the paresis, not being able to move the affected limb. Because of undulating neurologic deficits in the lower limb, the patient was admitted to cranial computer tomography and magnetic resonance tomography examination of the spine.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': None,\n",
       "    'case_id': 'PMC6803738_01',\n",
       "    'case_text': 'A male Italian patient of 66 years presented with a history of kidney transplantation in treatment with cyclosporine, intestinal resection for lymphoma, and arterial hypertension and heart failure; in July 2018, he visited an ENT clinic and was diagnosed as chronic left purulent otitis media and began at-home antibiotic therapy with poor benefit. On 13/09, he was admitted to the hospital \"S. Maria\" of Terni for persistence of left ear pain and complete hearing loss in the absence of fever or other symptoms. A computerized tomography (CT) of the left ear without contrast medium documented \"thickening of the walls of the external auditive canal, marked thickening of the tympanic membrane, and the ossicular chain conglobated by inflammatory material\" (Figure 1).\\nThereafter, antibiotic therapy with ertapenem was administered once daily in the day-ospital regimen, and it continued for eight days with no benefit because of persistent pain and hearing loss of the left ear. The blood exams showed nonsignificant values of C-reactive protein and white blood cells (WBC) because the patient took immunosuppressive therapy. Then, on 28/09, the patient was hospitalized at our department, and a brain MRI without and with contrast medium showed \"in correspondence of the petrous rock and the mastoid on the left, a nonhomogeneous hyperintensity in the long TR sequences, compatible with the presence of flogistic tissue\" (Figure 2).\\nDuring admission, he was initially treated with empiric intravenous antibiotic therapy with imipenem 500 mg/8 h and linezolid 600 mg/12 h. Blood and urine cultures were negative. Auricular swabs and later surgical drainage of the purulent material present in the left ear were performed and both were positive for XDR Pseudomonas aeruginosa, sensitive only to colistin in absence of synergism with rifampicin. On the isolated strain, E- test was performed for ceftolozane-tazobactam and ceftazidime-avibactam with MIC 8 and 2, respectively (Figure 3). \\nThe blood cultures were negative for Pseudomonas aeruginosa. From 17/10 to 02/11, the day of discharge, the patient underwent antibiotic therapy with ceftolozane-tazobactam at a dosage of 0.75 g/8 h for the first 4 days and, after abundant hydration and improvement in renal functionality at the dosage of 1.5 g/8 h. The patient presented a progressive clinical improvement with the disappearance of the ear pain and slow resumption of auditory function. The CT scan of the ear without contrast, performed on 10/29/2018, confirmed a \"significant reduction of inflammatory material occupying the middle ear and reduction of thickening of the tissues of the external auditive canal.\" (Figure 4).',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 18,\n",
       "    'case_id': 'PMC7399133_01',\n",
       "    'case_text': 'We retrospectively reviewed the medical records of patients diagnosed with CJD between March 2018 and December 2019 at Xiangya Hospital and the Second Xiangya Hospital of Central South University. Only patients aged 18-90 years with CJD who met the proposed diagnostic criteria were included. The information collected and analyzed from patients included: sex, age at onset of CJD, age of death, disease duration, symptoms at onset, and examination findings.\\nThe clinical features of the patients are summarized in Table 1. Ages at onset of CJD ranged from 60 to 66 years (mean age was 61.75 years), and the group included two women and two men. They did not have any history of contacting a source of infection or related CJD family history. All patients experienced characteristics of a progressive dementia within <2 years; for example, patients 1, 3, and 4 did not recognize their family members and could not recall their home address. Moreover, all patients had myoclonus, ataxia, and extrapyramidal or pyramidal signs during disease progression, and either visual disturbances or akinetic mutism developed in the other two patients. All patients were admitted to hospital with obvious symptoms of dementia.\\nAfter admission, cerebral CT as well as T1- and T2-weighted cerebral MRI were performed in all patients, and no apparent abnormalities were identified. Lumbar puncture was also performed, and there were no positive results in the routine laboratory tests, biochemical indicators, complete viral testing, histologic staining, oligoclonal bands (OB) testing, or autoimmune encephalitis antibodies in CSF. However, abnormal high signal in two or more cerebral cortex regions, referred to as \"cortical ribboning\" (Figure 1), and/or the basal ganglia, was incidentally found in the DWI of all four patients, which alerted physicians to suspect a diagnosis of CJD. These patients were all subsequently recommended to undergo the following tests: DWI, EEG, and laboratory CSF analysis; two of them also underwent a brain biopsy. Testing performed by China DCD (Center for Disease Control and Prevention) for CSF 14-3-3 protein were positive in all patients. However, tests for other CSF biomarkers such as total tau protein, S100B, neuronal specific enolase and amyloid-beta (Abeta)1-42 were not performed because these assays were not widely used in Chinese hospitals at the time. Patients 1 and 3 had characteristic period sharp wave complexes (PSWCs; Figure 2) recorded by EEG. And atypical little sharp waves, instead of PSWCs, were identified in the EEG trace of patient 4. Additionally, upon consideration of the risk of brain surgery, only two patients (#1 and #4) underwent a brain biopsy, which in both cased demonstrated prominent spongiform changes and neuronal loss in the gray matter of the brain. PrPSc protein was also detected in the living brain tissue by western blotting. Moreover, prion protein (PRNP) genetic testing in the four patients did not reveal any pathogenic mutation. In light of the typical clinical features, the presence of \"cortical ribboning\" on DWI, 14-3-3 protein in CSF, PSWCs on the EEG, and the results of brain biopsy, all four patients were diagnosed with sCJD; two (#1, #4) were confirmed cases and the other two (#2, #3) were probable cases. There were no specific treatments available for CJD. The average time interval between the onset of CJD symptoms and death ranged from 4 to 12 months (average: 7.5 months).',\n",
       "    'gender': 'Unknown'}],\n",
       "  [{'age': None,\n",
       "    'case_id': 'PMC8804283_01',\n",
       "    'case_text': 'Cox\\'s Bazar, in Bangladesh, comprises a large refugee population spread across 34 highly congested subcamps along the Bangladesh/Myanmar border. The international response coordination in Cox\\'s Bazar is managed under a situation specific mechanism led by a Strategic Executive Group at the national level and through the Inter Sector Coordination Group (ISCG) in Cox\\'s Bazar. The ISCG comprised ten sectors and six inter sector working groups that provide humanitarian assistance to close to 900,000 Rohingya refugees. The WHO Emergency Sub-office in Cox\\'s Bazar, in collaboration the district level health administration, chairs the Health Sector of the ISCG.\\nGuided by the WHO Emergency Response Framework, WHO Bangladesh established an incident management system soon after the largest influx of refugees from Myanmar in 2017 that effectively managed many outbreaks and natural disasters prior to COVID-19. Both the WHO incident management system and the ISCG were leveraged for COVID-19, highlighting the benefit of having existing mechanisms using a whole-of society response for emergencies. The COVID-19 response was also extended to the entire population of Cox\\'s Bazar district.\\nPrior to the first COVID-19 cases in the district, a COVID-19 response plan was developed that outlined key activities across 11 identified thematic pillars of the national COVID-19 response plan. A dedicated COVID-19 related Crisis Management Team for Cox\\'s Bazar was established, initially comprised of the UN Resident Coordinator and Heads of Agencies of WHO, International Organization for Migration (IOM), UN High Commissioner for Refugees (UNHCR), UNICEF, and WFP as well as the Head of Sub-office of WHO and the senior coordinator of ISCG. This forum enabled frequent and direct interagency decision making and was a key facilitator of operational decision-making between the field and national decision makers.\\nThe response to COVID-19 in Cox\\'s Bazar provides many examples of how WHO supported whole-of-society COVID-19 activities. World Health Organization provided technical updates to the Heads of UN agencies and the ISCG, and between UN agencies, local community groups, donors/partners, and embassies to facilitate decision making, allocate resources, and mobilize funds. In collaboration with the technical working groups, the health sector developed an orientation package and online awareness training sessions for healthcare workers to ensure mainstreaming of cross-cutting themes including gender, protection from sexual exploitation and abuse, gender-based violence, protection, and child protection in the response. Prior to the reopening of the destination for domestic tourism, in collaboration with local government, WHO provided technical advice, training, and information materials on operating safely within the COVID-19 context to various sectors, including the tourism, agriculture, and livelihood sectors.\\nOne unique example of the role of WHO in the whole-of-society response to COVID-19 in Cox\\'s Bazar was the provision of technical advice and coordination for repurposing Rohingya volunteers involved in garment manufacturing and tailoring as livelihoods activities to produce cloth face masks. World Health Organization\\'s role in this initiative was to provide the specifications for the fabric masks, the quality standards for local production, and in collaboration with the livelihood sector partners including UNHCR, IOM, and WFP, the government counterparts including the district\\'s Civil Surgeon and regulatory authority, support the system for UN agencies that normally work with the production sector. More than one million masks were made and distributed in the camps and nearby community. This initiative contributed to the health response and improved the refugees\\' micro economy.\\nRestriction to the camps was another challenge for the whole-of-society response as many volunteers from non-health sectors such as protection, education, and nutrition were unable to continue their work. To overcome this challenge, WHO utilized these volunteer networks in partnership with the other UN agencies for health activities, which also enabled their usual volunteer roles. The volunteers contributed to the community surveillance system established prior to COVID-19, referred cases for testing and treatment, assisted with vaccination programs, and provided the backbone of RCCE. With partners, WHO provided training for 3,600 humanitarian workers and over 2,000 volunteers involved in the COVID-19 response on how to protect themselves from COVID-19 while working. By June 2020, every household was visited once a week by these community volunteers.\\nThe training provided to the volunteer networks enabled RCCE efforts as the volunteers disseminated these messages whilst completing their usual work. This intersectoral involvement in RCCE successfully alleviated the infodemic within the camp, as evidenced by improved outpatient attendance and health seeking behavior of the population. The RCCE feedback loop was also supported by WHO, as it enabled structured feedback to the government, UN agencies, and non-government partners at national and local level to improve the response. In collaboration with partners, messages were also delivered by WHO staff through weekly audio podcast program on local radios.\\nUzbekistan is a middle-income country in central Asia that has a UN interagency presence with a UNCT that comprises 24 UN agencies. World Health Organization works closely with the Ministry of Health (MOH), and prior to COVID-19, established Health Development Partnership meetings to facilitate communication between the UNCT, non-UN development partners, and the government.\\nA UN Crisis Management Team for COVID-19 was established and was co-chaired by WHO. The Crisis Management Team operated according to the national SPRP and the UN framework for the socio-economic response to COVID-19 in Uzbekistan. World Health Organization led the SPRP, contributed to the combined UN/WHO sitreps, was a co-chair of most COVID-19 related meetings, and a vital part of the UN decision making process. This further increase the visibility and added value of WHO within the UN system in Uzbekistan.\\nThere were six COVID-19 taskforces led by the UN and the government: capacity building, procurement, human rights and vulnerable groups, economic and social impact, education, and risk communication. World Health Organization led the capacity building taskforce and had a presence in all others. By MOH request, WHO was the liaison between the MOH and other UN agencies and the conduit between the COVID-19 taskforces. The Health Development Partnership meetings continued as the intersectoral communication and collaboration mechanism between the UN, non-UN partners, and government. World Health Organization presented technical information to each taskforce as needed and reviewed taskforce documents prior to distribution to the government:a \"translator.\" The COVID-19 response cemented that intersectoral collaboration is crucial for advancing the health agenda with WHO as a key contributor.\\nOne example of WHO working across the whole-of-society response in Uzbekistan was in the education taskforce. Working closely with UNICEF and the UN Educational, Scientific, and Cultural Organization (UNESCO), WHO contributed to technical guidance on school closures, required school infrastructure, such as building ventilation and the safe reopening of schools. Information, education, and communication materials were developed in collaboration with the MOH, Ministry of Education, and Ministry of Pre-School Education with more than 6 million children in schools, 1.4 million children in pre-schools, 2 million parents received information, and 14,000 preschool institutions receiving materials.\\nOnline training mechanisms developed by WHO, in conjunction with the MOH Post Graduate Medical Institute, allowed experts to train large groups of healthcare workers in the public and private sector from across Uzbekistan (500 people per session) on COVID-19 related issues and topics, with the training materials made available to partners outside of the health sector.',\n",
       "    'gender': 'Unknown'}],\n",
       "  [{'age': 9,\n",
       "    'case_id': 'PMC6296698_01',\n",
       "    'case_text': \"The patient was a 9-yr-old Iranian girl presenting to the Pediatric Emergency Room of Moosavi Hospital, Zanjan, Iran in January 2017, with sudden onset of headache and recurrent vomiting, ataxia and history of 3 consecutive days of fever and malaise. There were left eye ptosis and decrement of left nasolabial fold in patient's face. The patient had tremor and truncal ataxia. The force of the extremities and deep tendon reflexes were normal in physical examination. Her heart rate was 110 min, blood pressure 90/60 mm Hg and temperature 38.2  C. The patient's weight was 21 kg and had 133 cm height and head circumference was 52 cm. The patient had no history of head trauma. \\nAn informed consent was obtained from her parents in order to publish data as a case report without publishing her name. Ethics Committee of the university approved the study.\\n Diagnostic focus and assessment: \\nThe patient underwent a brain CT scan without contrast in first day of admission preceded by CBC, diff, BUN, Cr, Na, K, Arterial blood gas sampling (ABG) and Urine analysis. On the second day, brain magnetic resonance venography (MRV) and magnetic resonance imaging (MRI) with flair, T1, T2 and DWI sequences and also EEG were ordered, then lumbar puncture with 3 samples was carried out. About 48 h after the MRI the patient became aggressive and had severe headache, nausea and vomiting plus ataxia and delirium, then the patient transferred to PICU and we decided to order the second CT scan and after the results, we asked for urgent neurosurgery consultation and the patient was prepared for brain surgery. The day after surgery the patient underwent brain CT scan without contrast again and laboratory tests were repeated. The patient underwent the last brain CT scan without contrast on thirteenth day and also had an EEG on the same day. We also did a portable echocardiography plus electrocardiography to determine presence of any PFO or ASD or any cardiac problems.\\n Therapeutic focus and assessment: The patient presented with sudden onset of headache and recurrent vomiting, ataxia, and history of 3 consecutive days of fever and malaise. Our first clinical suspicion was cerebellitis or post infectious ataxia (Figure 1) so we ordered intravenous ceftriaxone, intravenous pantoprazole, and ondansetron for two days. We also ordered acyclovir ampule plus dexamethasone ampule for the patient and after the brain MRI results that were consistent with cerebellar infarction aspirin tablet was prescribed for the patient. On the fourth day (48 h after) because of the patient's severe headache, intravenous acetaminophen was administered and dexamethasone was held and the patient was transferred to pediatric intensive care unit (PICU) and intravenous phenytoin ampule plus vancomycin ampule were prescribed. After the brain CT, because of obstructive hydrocephaly arising from cytotoxic edema mannitol and dexamethasone ampule were ordered for the patient and the patient became ready for the brain surgery. The next day after the surgery and inserting a drain in the left lateral ventricle, mannitol was discontinued. The day after, phenytoin ampule was held and Diamox tablet (acetazolamide) was ordered. Physiotherapy and occupational therapy of the left extremities begun for the patient and because of constipation lactulose syrup were ordered. \\n Follow-up and outcomes \\nThe first EEG report was mildly abnormal due to some spike and wave discharges (Figure 2 Left) and in the last EEG report, there were some background attenuations without epileptiform activity (Figure 2 Right). The patient had a lumbar puncture with normal result. The first and the last laboratory data are as follows (Table-1)\\nThe urine analysis result was normal. The HPLC Amino Acid profile was normal except lower than normal range of arginine (26.8) and higher than normal range of alanine (148.0). We also obtained an Arterial Blood Gas sample from the patient that was normal (Table 1). The echocardiography and electrocardiography results both were normal. Findings on the first brain CT scan were a dim hypodensity in the left cerebellar hemisphere accompanied by a mild generalized ventriculomegaly (Figure 3 Left). The MRV's result was also normal (Figure 4 Right). In the MRI report, there were abnormal low T1 and high T2 signal intensity in left cerebellar hemisphere involving superior and middle cerebellar peduncles in the same side as well (Figure 3 Right , Figure 4 Middle), restriction was noted in this region. DWI findings were consistent with cerebellar infarction in this region (Figure 4 Left). On the second brain CT scan that was 48 h after the MRI, there was an intense hypodensity arising from cytotoxic edema in the left cerebellar hemisphere with concomitant cortical entanglement exerted pressure on fourth ventricle and had resulted in hydrocephaly, severe ventriculomegaly was also seen in the CT scan (Figure 5 Left) . On the third brain CT which was after the patient's surgery, there were evidence of craniotomy in occipital bone on the left side and hemispherectomy of the left hemisphere of the cerebellum, the drain in the left lateral ventricle was in its appropriate position (Figure 5 Middle). The last brain CT scan had no new findings and the drain was extracted from the brain (Figure 5 Right). Pathology result of surgical biopsy of brain tissue was cerebellar tissue with small foci of hemorrhage accompanied by presence of vascular malformation, most probably venous angioma.\\nAfter 5 months the force of the extremities was normal and the ataxia was completely disappeared. The patient now goes to school and has no problems in daily life activities. The patient is now under treatment with an aspirin 80 mg tablet daily.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 47,\n",
       "    'case_id': 'PMC4302971_01',\n",
       "    'case_text': \"A 47-year-old Caucasian woman with a nonsignificant medical history presented with generalized chronic severe periodontitis with secondary occlusal trauma (Figure 1).\\nPrimary etiologic factors included heavy accumulation of plaque and calculus, with secondary factors including defective restorations and occlusal trauma. She presented with cyanotic edematous gingiva, severe clinical attachment loss, and mucogingival defects and recession. Upon occlusal evaluation, it was revealed that the maxillary midline coincided with the facial midline, with horizontal overlap of 1 mm and vertical overlap of 2 mm. Smile analysis revealed that the patient had an average smile line and maxillary incisal edges did not follow the curvature of the lower lip (Figure 2). Centric occlusion to maximum intercuspation discrepancy was found to be 1 mm forward.\\nThe patients' final treatment plan included full mouth rehabilitation through a staged approach with guided implant surgery. The final implant abutments were selected on the guided software in areas # 3, 5, 7, 10, 12, and 14 for the maxilla and 19, 21, 23, 26, 28, and 30 for the mandible. The case was treatment-planned to be staged using selected maxillary teeth # 6, 11, and 13 and the mandibular teeth # 20, 22, 27, and 29 to be retained as abutments for a fixed temporary prosthesis with a transitional removable prosthesis (Figure 3).\\nThe first phase of the periodontal treatment plan included oral hygiene instruction and full mouth supragingival debridement, followed by root planning with subgingival irrigation with chlorhexidine gluconate on the temporary abutment teeth. The criteria for the retention of these teeth included decreased mobility and probing depths and a favorable prognosis compared to the remaining hopeless teeth. Selected teeth were prepared and single unit provisional crowns were fabricated using temporary acrylic material (Alike, GC America Inc., Alsip, IL) and cemented with temporary cement (Tempbond NE, Kerr Manufacturing Co., Romulus, MI). At the re-evaluation visit, the patient presented with significantly improved oral hygiene and a reduced plaque index.\\nUpon phase 1 re-evaluation, the first surgical phase of the treatment included extraction of hopeless maxillary and mandibular teeth, utilizing GBR with mineralized crushed cortical bone (RegenerOss Allograft, Biomet 3i) and a resorbable collagen membrane (OsseoGuard Flex, Biomet 3i) for the deficient extraction socket areas, # 3, 7 to 10, 23 to 26, 21, and 28. Tooth # 5 was selected for extraction and GBR with tenting screw technology as part of the maxillary grafting procedures (Figure 4).\\nPeriosteal releasing incisions were followed by horizontal mattress and single interrupted Vicryl 4.0 sutures, stabilizing the flap and achieving primary closure. The patient was prescribed amoxicillin 500 mg every eight hours for 7 days, chlorhexidine gluconate rinse twice a day for 2 weeks, nonsteroidal anti-inflammatory medication (ibuprofen 600 mg, q4-6 h) for 7 days postoperatively, and 2 grams of amoxicillin premedication. Preparation for full coverage restoration was finalized and preliminary alginate impressions (Jeltrate Plus, Dentsply Caulk, York, PA) were made to create diagnostic casts. Record bases with occlusal rims were fabricated on the diagnostic casts, which were mounted on semiadjustable articulator (Hanau Wide Vue, Whip Mix, Fort Collins, CO) using facebow transfer and centric relation records. Intraoral protrusive record was made to program the horizontal condylar inclination. The lateral condylar inclination was calculated based on Hanau formula (L = H/8 + 12). The result of the formula was used to program the lateral condylar inclination on the articulator. Full mouth diagnostic setup using denture teeth was completed on the mounted casts. The casts with diagnostic setup were duplicated and provisional fixed prostheses were then fabricated and cemented on abutments teeth # 6, 11, and 13 with a cantilever pontic # 5 for the maxillary arch. The initial set of temporary prostheses was delivered immediately after extraction of the hopeless maxillary and mandibular teeth. It was used as a template for adjustments in order to arrive at optimized esthetics, phonetics, and function before fabrication of metal-reinforced laboratory processed provisional prosthesis. Bilateral internal sinus lifts in the areas # 3 and 14 and implant placement were scheduled in 3 months. Abutment teeth # 20, 22, 27, and 29 were used to retain a mandibular fixed provisional prosthesis (Figure 5).\\nAfter 3 months of uneventful healing, another set of provisional fixed prostheses for improved esthetics, phonetics, function, and strength were fabricated. Alginate impressions were made for the previously optimized provisional prostheses and prepared teeth. Alginate impressions were poured in dental stone. The casts of the maxillary and mandibular prepared teeth were cross-mounted to the casts of the optimized provisional prosthesis. Denture teeth were set on the casts of prepared teeth, which were hollowed out from the palatal/lingual aspect to accommodate the prepared teeth and create space for the metal frames that were cast with beads to retain denture teeth and temporary acrylic material (Alike, GC America Inc., Alsip, IL). The metal-reinforced provisional prostheses were relined with acrylic material and cemented over abutment teeth using temporary cement (Tempbond NE, Kerr Manufacturing Co., Romulus, MI). Interim removable partial dentures were delivered to replace the missing posterior teeth for better esthetics and function.\\nThe provisional fixed prostheses were evaluated and adjusted periodically, if needed, to enhance esthetics and phonetics. Alginate impressions were made from the provisional fixed prostheses, which were then removed, and another set of alginate impressions were made of the prepared abutment teeth. The casts were then cross-mounted on a semiadjustable articulator. Mucosa-tooth supported radiographic guides were fabricated over the prepared teeth using orthodontic resin (Dentsply International Inc., Milford, DE) mixed with barium sulfate for the teeth and orthodontic resin only for the denture base. Straumann templiX reference plates, containing three titanium reference pins, were attached to the radiographic guides where Straumann gonyX was used to record reference pins orientation.\\nThe second surgical phase initiated with CBCT evaluation and treatment planning of restoratively dictated implant positions. The reference pins were detected on the coDiagnostiX software. The match between the software planning and the reference pins on the radiographic guides was ensured. The radiographic guides were fitted back on the casts of prepared teeth. The casts were remounted on Straumann gonyX using previous reference pins orientation. The radiographic guides were then converted to surgical guides with addition of metal sleeves based on spatial position and depth information provided by coDiagnostiX software. A flapless approach and CBCT guided surgery with tooth-stabilized mucosa-supported surgical guides for minimally invasive intervention were the treatment of choice. Two-staged bone level SLActive titanium implants were placed at # 3, 5, 7, 10, and 14 sites in the maxilla and at # 19, 21, 23, 26, 28, and 30 positions in the mandible. The canine positions in the mandible were not considered as potential implant sites because there was enough bone quantity at the lateral incisors position, which provided proper implant distribution in the arch. Additionally, six implants were enough to support mandibular implant fixed prosthesis due to favorable bone quality in mandible (types I-II) as apposed to maxilla (types III-IV). The mandibular definitive prosthesis was planned to be splinted using precision attachments. At this stage preventive maintenance of the abutment teeth for the temporary prosthesis was, also, performed.\\nStaging the case allowed for a novel technique for sinus lift procedures through a surgical guide using Salvin/Drew osteotomes (Figure 6).\\nThe CBCT evaluation revealed 7.0 mm of residual bone in areas 3 and 14. Ideal implant placement indicated bilateral sinus lifts at the areas of 3 and 14 and simultaneous ridge expansion through the surgical guide, utilizing the Salvin osteotomes # 2.6, 3.1, and 3.8 mm and the intermediary Salvin/Drew osteotomes 2.6 and 3.1 mm. The intermediary osteotomes were tapped through cortical crestal bone to ensure that the Salvin osteotomes engaged the site. It should be noted that as soon as Salvin/Drew osteotomes reach the initial hub, the next Salvin osteotome can be engaged. The Salvin osteotome # 3.8 mm was then tapped to the final length of 1 mm from the sinus floor. To ensure the final length is accurate, the operator needs to consider the height of the soft tissue and the height of the sleeve in the surgical guide, through which the osteotome is inserted. For site 14, planning on the software revealed 7.0 mm of residual ridge, 5.0 mm in height of the guide sleeve, and the 6.0 mm in soft tissue height. The final length on the last osteotome of 17.0 mm was marked with a stop cylinder, when used through the surgical guide. The guide could now be easily removed. The osteotomy was filled with bone graft material (Bio-Oss, Osteohealth) and osteotome # 3.8 mm was pushed 1.0 mm from the floor of the sinus. The authors recommend using the osteotome with particulate graft material, when the concave tip of the osteotome is 1 mm coronal to the sinus floor. Using this protocol, the graft material, and not the osteotome, is elevating the sinus. The addition of bone graft material was repeated 4 times until the desired length of 17.0 mm was achieved, resulting in a 4 mm internal lift.\\nFor the prepared osteotomy at site # 14 an SLActive 4.8 x 10 mm was planned to be placed, but due to lack of initial stability a 6 x 10 mm MTX microtextured surface implant was eventually placed. Utilizing the same technique for site # 3 we achieved an increase of 5.0 mm in height which allowed us to place as planned a 4.1 mm x 12.0 mm SLActive implant. Utilizing a tooth-borne surgical guide enabled an easy removal of the guide and radiographic evaluation with 2 periapical X-rays to confirm adequate sinus elevation at sites # 3 and 14. The provisional fixed prostheses were then cemented back, which was an advantage of staging the treatment. The provisional pontic areas above the implants were relieved slightly to allow for minor swelling (Figure 7).\\nPre-operative medications for the guided surgery and the simultaneous sinus lifts were prescribed 1 hour before the appointment included 2 grams of amoxicillin and 2 tablets of an Medrol dose pack. Postoperative medications that included amoxicillin 500 mg every 8 hours for 7 days, chlorhexidine gluconate rinse twice a day for 2 weeks, Tylenol # 3 every 4 hours as needed for 7 days, and Medrol dose pack (methylprednisolone 4 mg) were prescribed.\\nAfter 3 months, all the implants were uncovered and periodontal plastic surgery, with partial thickness flaps, 2 vertical releasing incisions, and an apically positioned flap, was performed for site 3 and the mandibular molar areas due to lack of attached gingiva (Figure 8). This inadequate attached gingiva is common postextraction/GBR, where the mucogingival junction is advanced coronally to achieve closure. Implant level impressions were made for maxillary and mandibular implants which were then poured and mounted against the previous mounted casts of provisional prostheses. Screw-retained provisional prostheses were fabricated with apical pink acrylic to avoid excessively long nonesthetic prostheses. The abutment teeth # 13, 20, 22, 27, and 29 were extracted and augmented with mineralized crushed cortical bone (RegenerOss Allograft, Biomet 3i) and a resorbable collagen membrane (OsseoGuard Flex, Biomet 3i). The screw-retained provisional prostheses were delivered at this point (Figure 9).\\nAdditionally, flapless immediate one-stage bone level SLActive implants were placed at # 6 and # 11 extraction sockets, through the surgical guide. Peri-implant augmentation with mineralized crushed cortical bone, prior to healing abutment placement, was performed. The sites were stabilized with Vicryl 4-0 sutures after easy removal of the mucosal-tooth-borne guide (Figure 10).\\nScrew-retained prostheses were hollowed in positions # 6 and 11 and temporary cylinders were attached to the immediately placed one-stage implants # 6 and 11. The cylinders were picked up intraorally using temporary acrylic material (Alike, GC America Inc., Alsip, IL). The provisional fixed prostheses were finished and polished around newly added temporary cylinders and delivered back to the patient (Figures 11 and 12).\\nSix weeks allowed for healing around immediately placed implants # 6 and 11. Fixture level impressions were taken for maxillary and mandibular implants and poured in dental stone (Silky Rock, Whip mix) for master casts. The master casts were then cross-mounted against the duplicate cast of corrected implant retained provisional prostheses. The design of the definitive prostheses involved screw-retained porcelain fused to metal for ease of retrievability when needed on follow-up visits. The use of cast metal frame, which is an integral part of the definitive prosthesis, allows predictable sectioning and soldering in case of misfit upon try-in stage and provides high strength while giving enough space for porcelain to get an excellent esthetic outcome. The maxillary and mandibular definitive prostheses were designed in 3 separate sections in each arch. The provisional and the definitive prostheses were fabricated with even posterior teeth contacts in centric jaw position, anterior guidance in protrusion, and canine guidance with immediate posterior disocclusion on lateral eccentric movements. Since 6 implants were placed for the mandible, the definitive prostheses had precision attachments on the distal aspects of the mandibular canines. Designing the prostheses with multiple sections allows for easier maintenance and management of future prosthetic complications. Post-insertion management includes delivery of night guard and follow-up visits every 3-4 months for the first year and then every 6 months thereafter.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 50,\n",
       "    'case_id': 'PMC7750755_01',\n",
       "    'case_text': 'A 50-year-old man presented with a 1-month history of an enlarging, painless chest wall mass. The patient has been a smoker for 30 years (two packets per day). The mass was excised, and gross examination revealed a hard, whitish, subcutaneous lesion with infiltrative borders. The lesion measured 3.8 cm in maximum dimension. Microscopic examination revealed a highly cellular neoplasm composed of closely packed, atypical spindle cells with scant cytoplasm, nuclear hyperchromasia, and brisk mitotic and apoptotic activity. A prominent hemangiopericytoma-like vascular pattern was observed (Figure 1). Moreover, a fibrosarcoma-like fascicular pattern was focally identified. Lymphovascular invasion was also observed. The tumor cells were immunohistochemically positive for TTF1, synaptophysin, and chromogranin, but were negative for S100 and BCL2. The Ki67 proliferative index was approximately 80% (Figure 2). Small cell carcinoma was the preferred diagnosis. Further evaluation by positron emission tomography-computed tomography (PET/CT) whole-body scan revealed an irregular spiculated right hilar lung mass with widespread metastases to the brain, liver, and adrenal glands. The cervical, supraclavicular, mediastinal, and retroperitoneal lymph nodes were also involved. The patient was scheduled for radio- and chemotherapy.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 64,\n",
       "    'case_id': 'PMC9428849_01',\n",
       "    'case_text': \"A 64-year-old Caucasian woman with a past medical history of chronic alcohol abuse disorder and recent poor oral intake presented for altered mental status. Initial labs were notable for a sodium 107 and a white blood cell count of 17.7. She was admitted for severe symptomatic hypovolemic hyponatremia which improved with one bolus of hypertonic saline and tube feeds. Initial chest x-ray (Fig. 1) showed no signs of consolidation. However, over the next 36 hours, she developed acute hypoxemic and hypercapnic respiratory failure, requiring intubation. Left subclavian central venous line was attempted and was complicated by left sided pneumothorax (Fig. 2). Considering this image and patient's clinical presentation, aspiration pneumonitis was considered. Her interval chest x-ray later showed a worsening right middle and lower lobe consolidation (Fig. 3), concerning for pneumonia. She treated with Ceftriaxone and Azithromycin and later escalated to Vancomycin and Cefepime for empiric treatment of community and hospital associated pneumonia, respectively. She failed to improve clinically on both courses. Over the next 5 days, she developed a large loculated right sided pleural effusion demonstrated on chest CT and x-ray (Fig. 4). Pulmonology obtained a bronchoalveolar lavage that grew >100,000 CFU of Bordetella bronchiseptica, and she was placed on droplet precautions. Due to high coinfection rates in the literature, she was tested for HIV and COVID-19 which were both negative. Of note, the patient endorsed having two dogs and a cat that lives indoors. The patient underwent ultrasound guided thoracentesis with thoracostomy tube placement for drainage. The pleural fluid's LDH was 1,389, total protein was 3.5, and fluid culture grew B. bronchiseptica, confirming the diagnosis of empyema based on Light's criteria . Her hospitalization course improved with a 10-day course of piperacillin-tazobactam, thoracostomy tube drainage, and alteplase/dornase alfa infusions for fibrinolysis of the loculations (Fig. 5, Fig. 6). She was discharged on a 4-week course of Augmentin with follow up with the Infectious Disease clinic. At the follow up visit, the patient's respiratory symptoms were completely resolved, and her repeat chest x-ray (Fig. 7) showed complete resolution of pulmonary consolidations and empyema.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 50,\n",
       "    'case_id': 'PMC9536313_01',\n",
       "    'case_text': \"A 50-year-old male with a previous history of chronic pancreatitis came to the hospital with three episodes of melena and epigastric fullness. On clinical examination, he had anemia and his blood pressure was 90/60 mmHg. After resuscitation, he underwent upper gastrointestinal endoscopy which was normal. He also had a history of hematemesis for which he was evaluated with triphasic abdominal contrast-enhanced computed tomography (CECT) (Figure 1). His abdominal CECT showed an 8x6 cm pseudocyst in the lesser sac with a 4x3 cm hyperdense area and multiple calcifications were observed in the pancreas. For the SAP, he underwent digital subtraction angiography embolization and celiac trunk angiography was performed during the procedure by puncturing the femoral artery using the Seldinger method. The splenic artery pseudoaneurysm was identified and a total of three coils were used for embolization (2 coils proximally and 1 coil distally) and no stents were used (Figure 2). Three weeks after embolization, the patient presented with hematemesis and hypovolemic shock. His abdominal CECT showed a giant splenic artery pseudoaneurysm with calcifications in the pancreatic parenchyma (Figure 3). The patient was resuscitated and prepared for exploratory laparotomy, given his clinical condition.\\nOn exploration, the patient's abdomen was filled with blood and clots, which were suctioned out. Opening the gastrocolic omentum revealed a thrombosed sac with diffuse bleeding visible from the outer wall of the sac, but no arterial spurt was identified from the sac. After opening the lesser sac, control of the supraceliac aorta was taken, but we were unable to reach the celiac axis and splenic artery proximally or distally because of dense adhesions. After obtaining supraceliac aorta control, we directly opened the sac and an arterial spurt was identified and ligated (Figure 4). Since the splenic vein was thrombosed, it was identified and ligated (Figure 5), followed by splenectomy. Pathology of the pancreas was suggestive of chronic pancreatitis. Postoperatively, the patient had a grade A pancreatic fistula which was managed conservatively and he was discharged on day 7. Anticoagulation medications were not used postoperatively. Six months post-surgery he was asymptomatic.\\nThis manuscript is in accordance with the Helsinki declaration and with local ethical guidelines. Informed consent was obtained from the patient. Written informed consent was obtained from the patient's husband for publication of this case report and any accompanying images.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 2,\n",
       "    'case_id': 'PMC5702414_01',\n",
       "    'case_text': \"Five patients were treated at the N.N. Blokhin Russian Cancer Research Center (Moscow, Russia) and the Children's Hospital of Michigan (Detroit, MI). We obtained informed consents for chemotherapy and PBSC collection from all patients included in this analysis. The patients received repeated cycles of ICE (ifosfamide 9000 mg/m2, carboplatin 500 mg/m2, and etoposide 500 mg/m2) chemotherapy supported by autologous PBSC. Three patients had a single leukapheresis procedure following 2nd to 4th cycle of chemotherapy and G-CSF stimulation, and the product was split into four equal doses. In two patients (patients 2 and 4, Table 1), we used PBSCs obtained after leukapheresis procedures that did not collect required numbers of CD34+ cells to support myeloablative chemotherapy and otherwise would be discarded. The PBSCs were reinfused 24 hours after completion of consolidation chemotherapy cycles followed by G-CSF or GM-CSF stimulation. We used the number of days from the start of chemotherapy to ANC recovery to > 1000/mm3 to evaluate hematopoietic toxicity. We compared these data to induction chemotherapy cycles administered without PBSC support in the same patients. We used the Student's t-test to determine the significance of differences.\\nThe following is a short description of each patient's case:\\nPatient 1 was a 2-year-old male with stage 4 anaplastic Wilms' tumor whose metastatic lung disease was refractory to the first line of chemotherapy, and he was switched to ICE. He subsequently received 4 cycles of ICE chemotherapy with PBSC support after cycles 3 and 4. He had partial radiological response (PR) to chemotherapy and subsequently received high-dose melphalan with PBSC support; however, he developed a second disease recurrence 3 months after transplant.\\nPatient 2 was a 17-year-old female with stage 4 favorable histology Wilms' tumor who developed both pulmonary and abdominal recurrence 10 months after initial therapy. She was treated with abdominal tumor resection and 4 cycles of ICE chemotherapy with PBSC support after cycle 3 (an infusion of 0.3 x 106 CD34+ cells/kg from apheresis that did not collect required dose for myeloablative therapy was given). She had PR to chemotherapy. She then received high-dose thiotepa and melphalan with autologous bone marrow transplant. She developed recurrent disease 4 months after transplant.\\nPatient 3 was a 9-year-old male with stage 3 favorable histology Wilms' tumor who had pulmonary recurrence 13 months after his initial therapy and was treated with 6 cycles of ICE chemotherapy with PBSC support after cycles 3 through 6. He had PR to chemotherapy and was alive without signs of disease more than 10 years off therapy at the time of this report.\\nPatient 4 was a 1.5-year-old male with stage 3 Wilms' tumor abdominal recurrence. He underwent complete abdominal tumor resection and then received ICE chemotherapy as a consolidation with PBSC support after cycle 3 (an infusion of 1.8 x 106 CD34+ cells/kg from apheresis that did not collect required dose for myeloablative therapy was given). The patient was still under therapy at the time of this report.\\nPatient 5 was a 20-year-old female with metastatic PNET with primary abdominal tumor and multiple metastases to the lungs, lymph nodes, and vagina. She underwent abdominal surgeries and received ICE chemotherapy. She had very good partial response after the first two cycles but developed significant hematological toxicities after cycles 3 and 4 even with 30% chemotherapy dose reductions. She received her ICE cycles 5 and 6 at full dose followed by 0.82 x 106/kg CD34+ cells support per cycle and tolerated them well with significant reduction of hematological toxicity. The ANC recovery to > 1000/mm3 was on day 26 after cycle 4 and on day 17 after cycles 5 and 6. Platelet count recovery to > 50,000/mm3 was on day 29 after cycle 4 and on day 26 after cycles 5 and 6. She subsequently remained in remission for 7 months but developed metastatic recurrence thereafter and died of disease.\\nSevere myelosuppression was the main toxicity observed in all patients receiving ICE chemotherapy. The doses of infused CD34+ cells ranged 0.3 to 1.8 x 106/kg (mean 0.76 x 106/kg), and in 9 out of 10 PBSC infusions, the dose of CD34+ cells was below 1 x 106/kg (Table 1). In patients who started to receive PBSC support after their 3rd and subsequent cycles, there were no significant differences in ANC recovery between the first 2 induction cycles and the subsequent cycles given with PBSC support (17.6 days after cycles 1 and 2 versus 17.1 days after cycle 3 and subsequent cycles, p=0.28). All PBSC-supported cycles were given at the full planned doses.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 57,\n",
       "    'case_id': 'PMC4997775_01',\n",
       "    'case_text': \"A 57-year old man presented to the emergency department for right wrist pain following a motorcycle crash. Physical examination revealed right wrist edema, pain with passive and active range of motion, and tenderness to palpation over the dorsal and volar wrist. Sensation was mildly diminished in the right thumb and the index and long fingers. X-rays of the right wrist were done (Figs 1a and 1b).\\nWhat are the basic kinematic forces that act on the lunate?\\nWhat is the Mayfield classification, and what stage is this patient's wrist injury?\\nWhat are the immediate- and long-term concerns following lunate dislocation?\\nWhat treatment options exist for the long-term sequelae of lunate dislocations?\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 79,\n",
       "    'case_id': 'PMC9643303_01',\n",
       "    'case_text': \"A 79-year-old female with CTCL was referred to our facility with symptoms of widespread plaque lesions, intense pruritis, and scattered ulcerated tumors on her extremities. After careful assessment of the patient's skin involvement, the modified severity weighted assessment tool (mSWAT) score was determined to be roughly 40 %. Prior to seeking treatment from our facility, she tried topical steroid treatment, systemic therapy (romidepsin), and had received 3 courses of focal radiation treatments to doses of 44 Gy in 22 fractions with complete response in those fields. Upon initial discussion of TSEBT the patient expressed hesitation, as she did not want to lose her hair. She had no past or current clinical evidence of scalp involvement, and we assured her that accommodations were possible. We created a customized helmet using high-quality blue wax polyethylene material manufactured by .decimal (dotdecimal.com) to create a bolus type structure that would attenuate the majority of dose, and spare the underlying scalp.\\nOur beam is commissioned using 6 MeV electrons, and the expected energy at the patient's surface is roughly 4 MeV. Using commissioning data and percent depth dose curves, we estimated a 1.5 cm thick bolus helmet would be adequate to reduce the dose to the scalp to less than 10 percent.\\nOur patient underwent computerized tomography (CT) simulation to obtain the exact contour of her head. Her hairline was wired during the simulation. The CT scan was imported into our treatment planning system; and a standard body contour was created, with a 1.5 cm uniform expansion. From this, a 1.5 cm thick false structure was formed using the previously wired hairline for reference (Image 1). This false structure contour was then transferred to .decimal for manufacturing. Within five business days, we received the milled polyethylene helmet in two pieces. These pieces were combined using adhesive and tape to form the final helmet (Image 2). The patient presented the day before treatment for a dry run and the helmet fit snugly. We use the modified Stanford technique with 6 standing positions and eye shields, so we added a chin strap to ensure the helmet did not fall or move when the patient changed positions during treatment.\\nOn the first day of treatment, two nanoDot optically stimulated luminescence dosimeters (OSLDs) were placed on top of the bolus helmet and two OSLDs under the bolus helmet. The readings from these were 84-86 % for the two OSLDS placed on top of the helmet versus 3.9-4.1 % for the two OSLDs placed immediately under the helmet. Using these measurements, the estimated total dose to her scalp was less than 0.5 Gy over the six fractions of treatment.\\nThe patient completed radiation treatment with good tolerance. She returned to the clinic one month and 6 months later with nearly a complete response of her skin disease (MSWAT 5 %) and no alopecia (Image 3).\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': None,\n",
       "    'case_id': 'PMC7591958_01',\n",
       "    'case_text': 'A 59-year female presented to our outpatient clinic with recurrent episodes of right upper quadrant pain and nausea. Her medical history included morbid obesity (a body mass index (BMI) of 40.2), type II diabetes mellitus, hypertension, and right knee osteoarthritis. Her prescribed medications were metformin, atenolol, and buprenorphine patches. She was not on antiplatelets or anticoagulants. Previous surgical history included only an uneventful lumbar disc laminectomy. Ultrasound scan revealed fatty liver, multiple gallbladder stones without signs of cholecystitis, and a normal common bile duct (CBD) diameter. Preoperative work-up including full blood count, coagulation profile, and liver function tests was normal. An elective laparoscopic cholecystectomy was planned after discussing benefits and risks.',\n",
       "    'gender': 'Female'},\n",
       "   {'age': None,\n",
       "    'case_id': 'PMC7591958_02',\n",
       "    'case_text': \"A prophylactic dose of enoxaparin (40 mg) was administered four hours preoperatively as per local protocol. An infraumbilical blunt port was inserted via Hasson' open technique. Following establishment of pneumoperitoneum, a further 10 mm epigastric operating port and two 5 mm right subcostal assisting ports were inserted under direct vision. The gallbladder was retracted, Calot's triangle anatomy was clearly displayed, and an adequate safety window was achieved before clipping and dividing the cystic artery and the cystic duct, respectively. The gallbladder dissection from the liver bed was accomplished without concerns by using an electric-coagulating hook. No blood loss or biliary leak was noted throughout the dissection. The gallbladder was extracted in an endobag through the infraumbilical port. All ports were removed under direct vision with no bleeding noticed from trocar sites. However, the patient had refractory hypotension within one hour postoperatively as her blood pressure dropped to 94/74 mmHg (compared to 140/90 mmHg one hour preoperatively) despite intravenous fluid resuscitation. She was saturating 97% on 100% oxygen therapy, with a pulse rate of 80 beats per minute and a respiratory rate of 20 breaths per minute. She was responsive and did not complain of abdominal pain. Abdominal examination revealed no signs of peritonitis. The haemoglobin level dropped from 13.5 g/dl preoperatively to 10.5 g/dl. Two units of red blood cells (RBCs) were transfused. Platelet count and coagulation profile were normal. An ECG showed T-wave inversion in leads II, III, and V1-V5; however, serial data (ECG and troponin levels) were negative for an acute coronary event. She was transferred to the intensive care unit for haemodynamic monitoring.\",\n",
       "    'gender': 'Female'},\n",
       "   {'age': None,\n",
       "    'case_id': 'PMC7591958_03',\n",
       "    'case_text': 'Following haemodynamic stabilization, an urgent triphasic CT scan demonstrated a large (21 cm x 3.1 cm x 17 cm) acute subcapsular haematoma surrounding the lateral surface of the right lobe of the liver and extending to the anterior surface of the left lobe (Figures 1(a) and 1(b)), with fresh blood along the paracolic gutters bilaterally. No contrast extravasation was visualized, and the hepatic artery, portal vein, and hepatic veins opacified normally. She was transfused two more units of RBCs and required a pressor support to maintain haemodynamic stability overnight. Broad-spectrum intravenous antibiotics were commenced as per microbiology advice. A plan of laparoscopic exploration in the event of further haemodynamic instability was discussed with the patient and her family. A national hepatobiliary unit was consulted, and they advised to continue with the conservative management. The patient was transferred the following day to specialized hepatobiliary services for close observation and possible surgical or radiological intervention if deemed necessary.',\n",
       "    'gender': 'Female'},\n",
       "   {'age': None,\n",
       "    'case_id': 'PMC7591958_04',\n",
       "    'case_text': 'She was continued on the conservative management in the tertiary care centre. The patient was discharged on day 7 upon stabilization of haemoglobin level and a partial resolution of the haematoma. A follow-up ultrasound scan eight weeks postoperatively demonstrated a complete resolution of the subcapsular haematoma.',\n",
       "    'gender': 'Unknown'}],\n",
       "  [{'age': 3,\n",
       "    'case_id': 'PMC4156985_01',\n",
       "    'case_text': 'A twenty-three-year-old African-American female with sickle cell trait presented to the emergency room with periumbilical and right-sided back pain associated with poor appetite and ten-pound weight loss over 4 months. She denied gross hematuria, dysuria, or additional urinary symptoms. She was a previously healthy nonsmoker with paternal family history of sickle cell trait. Physical examination was pertinent for fullness in the right flank and left supraclavicular lymphadenopathy. Laboratory findings revealed hemoglobin of 11.3 g/dL, platelet count of 269,000 per mm3, and normal LDH of 147 IU/L. Computed tomography (CT) scan of the neck, chest, abdomen, and pelvis demonstrated a 12 cm heterogeneous right renal mass (Figure 1(a)) with retrocaval, aortocaval, and paraaortic lymphadenopathy. In addition, there were bilateral pulmonary nodules (largest in right upper lobe measuring 1.8 x 1.4 cm), left pleural-based nodules (largest at the level of diaphragmatic pleura measuring 2.6 x 1.9 cm), and right hilar (2.5 x 2.2 cm), left supraclavicular, and bilateral cervical lymphadenopathy. MRI of the brain showed no evidence for intracranial metastasis.\\nBiopsy of left supraclavicular lymph node revealed high-grade renal medullary carcinoma with prominent lymphovascular tumor emboli. The tumor cells were eosinophilic, containing large nuclei and focally prominent nucleoli with brisk mitotic activity. The neoplastic cells stained positive for AE1/AE3, cytokeratin CAM 5.2, epithelial membrane antigen (EMA), E-cadherin, cytokeratin 7, and cytokeratin 19 on immunohistochemical analyses (Figure 2). The cells stained weakly positive for c-Kit and negative for cytokeratin 20, S100 protein, carbonic anhydrase IX, mucicarmine, and CD10. Cytogenetic studies performed on the lymph node isolated a clone of cells with duplication of the long arm of chromosome 1 (resulting in partial trisomy 1q) and a derivative chromosome 22 with chromatin material of unknown origin attached to the long arm (resulting in partial monosomy 22q). Fluorescence in situ hybridization (FISH) for transcription factor E3 (TFE) gene translocation was negative.\\nTreatment was initiated with dose-dense (dd) MVAC consisting of methotrexate 30 mg/m2 on day 1 followed by vinblastine 3 mg/m2, doxorubicin 30 mg/m2, and cisplatin 70 mg/m2 on day 2 of a 14-day cycle as described for metastatic urothelial carcinomas. She received growth factor support with pegfilgastrim on day 3 to reduce the risk of neutropenic fevers. Treatment with four cycles of dd-MVAC was associated with a significant reduction in size of renal mass from 9.3 cm to 5.9 cm with areas of necrosis on a CT scan of chest, abdomen, and pelvis (Figure 1(b)). There was near-complete resolution of right upper lobe and left lower lobe parenchymal lung nodules and retroperitoneal lymphadenopathy. Multiple pleural-based nodules in the left hemithorax and right hilar lymph node decreased. Two additional cycles of dd-MVAC were administered and a follow-up CT scan showed continued improvement in size of renal mass to 4.4 cm, improvement in retroperitoneal, hilar lymphadenopathy, and parenchymal lung lesions. The subject developed grade I renal insufficiency and grade II chemotherapy-induced nausea and vomiting (CINV) for which the cisplatin dose was reduced by 25% after the initial two cycles. Overall, she tolerated six cycles of dd-MVAC extremely well, with no hospitalizations.\\nAfter achieving an excellent partial response to neoadjuvant chemotherapy, the patient underwent right radical nephrectomy with complete, bilateral retroperitoneal lymph node dissection without complications. Pathology revealed a gross tumor resection size of 6.2 cm. Viable carcinoma comprised approximately 2-4% of the tumor volume showing neoplastic cells with rhabdoid features in a background of extensive fibrosis and chronic interstitial inflammation. All surgical margins were negative for tumor. Two of 11 lymph nodes (one paracaval and one preaortic from the level of the aortic bifurcation) were involved with carcinoma (0.7 cm in greatest dimension) with no extracapsular extension. Pathologic TNM stage was assessed as pT1b N1 M1. Immunohistochemistry revealed a complete loss of SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily B member 1 (SMARCB1) expression. Subsequently, she underwent video assisted thoracoscopy and wedge resection of right lower lung lobe. Pathology showed inflammatory changes with no evidence of residual malignancy.\\nFollow-up imaging in the form of CT chest, abdomen, and pelvis was obtained every four months and at one year from diagnosis she showed no recurrence of disease. At 16 months from initial diagnosis, she developed shortness of breath and restaging scans showed disease recurrence with hepatic, pulmonary lesions and bilateral pleural effusions. She had a rapidly progressive decline after relapse and died without receiving any further therapy.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': None,\n",
       "    'case_id': 'PMC3184519_01',\n",
       "    'case_text': 'A 20-minute-old newborn, whose mother used 64 mg methylprednisolone per day during her pregnancy due to ITP, was hospitalized for follow-up. Pregnancy duration was 39 weeks. The neonate was 2680 grams (3-10th percentile) at birth with head circumference of 36 cm (75-90th percentile) and height of 50 cm (25-30th percentile). Whole blood examination showed hemoglobin level of 19.1 g/dL, leukocyte count of 10 530/mm3, and platelet count of 10 000/mm3. Biochemistry  profile revealed the following: blood glucose 29 mg/dL,  sodium level 138 mEq/L, potassium 4.5 mEq/L, ALT 18 U/L, AST 62 U/L, calcium 9.5 mg/dL, phosphorus 4.8 mg/L, alkaline phosphatase 100 U/L, parathormone 13.91 pg/mL. On adrenal ultrasonographic examination, the adrenal glands were small measuring 10x2 mm in size for the right and 12x2 mm for the left one. Since the patient was thrombocytopenic, 0.8 g/kg IVIG infusion was given and repeated platelet count was 30 000 mm3. On the third day of follow-up, sodium level became 123 mEq/L, potassium 3.9 mEq/L, and urinary sodium level was 26 mEq/L. On the fourth day, cortisol level was 16.22 mug/dL, ACTH was 44.4 pg/mL, 17-OH progesterone was 2.58 ng/mL. On the 10th day, rechecking the adrenal functions,  cortisol level was found to be 0.194 mug/dL and ACTH 20.9 pg/mL. After administration of 1 mug of ACTH i.v. (low-dose ACTH test), the cortisol level increased to 9.69 mug/dL at 30 minute. Then, the patient was given 3 mg/m2/day p.o.  methylprednisolone as physiological replacement. The result of low-dose ACTH test on the 40th day postpartum was as  follows: basal cortisol level of 4.29 mug/dL and 30th minute  cortisol level of 11.29 mug/dL. Therefore, methylprednisolone therapy was continued  and stopped by slowly tapering at the end of the 3rd month (Table 1). Low-dose ACTH test was repeated in the 4th posnatal month  and the results were as follows: basal cortisol 4.75 mug/dL, ACTH 19.5 pg/dL. After 30 minutes, cortisol level was 19.9 mug/dL. Hormone tests and their results are summarized in Table 1. These results showed that the patient was relived from adrenal suppression.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 2,\n",
       "    'case_id': 'PMC8013530_01',\n",
       "    'case_text': 'A 2-year-old boy was referred to the Otolaryngology department from the Neurology department with persistent and involuntary episodic chin trembling, which became more pronounced when he was upset or tired. The main concern was tongue biting during the night due to his chin trembling, which caused considerable bleeding and was beginning to cause scarring of the tongue. He was otherwise well with no significant past medical history and took no regular medications.',\n",
       "    'gender': 'Male'},\n",
       "   {'age': 40,\n",
       "    'case_id': 'PMC8013530_02',\n",
       "    'case_text': 'His 40-year-old mother suffered with the same symptoms of chin trembling which had been present since early childhood, although had improved slightly over time. Her symptoms were worse with activities that required concentration, such as reading on the computer. It was also noticeable when the patient was stressed. She also suffered with occasional tongue-biting when asleep. She had no other medical problems and took no regular medications.\\nThe diagnosis was made clinically by the neurology team based on the isolated symptoms and family correlation. They were both referred to the Otolaryngology department for treatment with botulinum. Other differentials include bruxism, tics, sleep disorders, and seizures. All patients should have a neurology consultation before coming to this diagnosis. Genetic testing was not available at our centre.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 44,\n",
       "    'case_id': 'PMC6735193_01',\n",
       "    'case_text': 'A 44-year-old woman visited a nearby hospital with microscopic hematuria in June 2009. Her past medical history is tetralogy of Fallot. She had no medications at the time of the visit. There was no abnormality on physical examination. Computed tomography (CT) showed urachal remnant (urachal diverticulum at the dome of the bladder) and a large bladder diverticulum at the right lateral wall (Figures 1(a)-1(e)). Urine cytology was negative. Since she did not have any symptoms, she was followed up without therapeutic intervention. However, the residual urine had been increasing gradually, and she was referred to our hospital for continuous follow-up in February 2016. The postvoid residual urine was 150 ml at the time. After six months, she complained of severe dysuria and repeated urinary tract infection possibly caused by bladder diverticulitis. Cystoscopic examination showed a large diverticulum at the right wall, and diverticular mucosa was reddish and erosive (Figures 2(a) and 2(c)). Urachal diverticulum was small and without inflammation (Figure 2(b)). Antibiotic therapy with Levofloxacin was effective for UTI. She was started treatment with Urapidil of 30 mg/day simultaneously; however, the postvoid residual urine and dysuria did not improve.\\nWe performed bladder diverticulectomy and excision of urachal remnant simultaneously with the laparoscopic approach in August 2017. We cut out the umbilicus circumferentially with the umbilical ligament connected and then dropped into the abdominal cavity. The 12-mm camera port was placed in the umbilical hole. We prepared the five working ports (Figure 3(a)). Two were inserted at the height of the umbilicus on the bilateral middle clavicular line, and the other three were inserted at the inside of the right upper abdomen and outside of the bilateral lower abdomen. First, we inserted a camera into the right side working port of the umbilicus height and dissected the urachal ligament and adjacent tissues toward the bladder using the remaining right working port (Figure 3(b)). We transferred the camera to the central camera port and dissected the umbilical ligament until just above the bladder dome. We could confirm the bulging of the bladder diverticulum just to the right side of the bladder dome (Figure 3(c)). We used the cystoscopy to visualize the diverticular neck. The cystoscopic light could be observed from the abdominal cavity, and the bladder diverticulum was circumferentially resected at its neck. The resection line was extended to the bladder dome, and the urachal diverticulum was also resected (Figure 3(d)). The specimens were placed in an organ retrieval bag and removed through the 12-mm camera port site. The bladder defect was closed in 2 layers with a running 3-0 V-loc suture. The total operative time was 216 min with minimal blood loss.\\nThe Foley catheter was removed on the seventh postoperative day, and she was discharged home on the same day. For 18 months after the operation, she was able to void without residual urine, urinary tract infection ceased to develop, and had no recurrence of the diverticula (Figure 1(f)). Microscopic hematuria also disappeared.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 70,\n",
       "    'case_id': 'PMC3959373_01',\n",
       "    'case_text': 'A 70-year-old, housewife, living in a small village, presented with a six-month history of more than 10 watery diarrheas per day and loss of 18 kilos of body weight. Laboratory data were normal, including hemoglobin, white cell count and differential, CRP, serum albumin and immunoglobulin, iron, feritin, vitamin B12, and folate. Chest x-ray was normal. ESR was 40 mm/h. Stool examination for hemoglobin, leukocytes, parasites and cultures for pathogens was negative (twice). Colonoscopy with biopsies was normal. Duodenal biopsies showed mild, non-diagnostic changes of mucosa villi. Antibodies to tissue transglutaminase, endomysial antibodies and serum chromogranin-A were negative, including HIV infection. A small bowel videocapsule endoscopy (SBVCE) study showed mucosal areas of denuded villi and prominent small bowel submucosal vessels in the jejunum, multiple linear whitish lesions surrounded by reddish mucosa (Fig. 1), and parasites within the ileal fluid, entering the ileal mucosa (Fig. 2). These SBVCE findings favored the diagnosis of Strongyloides stercoralis infection. Review of previous histology of small bowel and colon, two more stool examinations for parasites and serum IgG antibodies against Strongyloides stercoralis (ELISA) were negative. She also tested negative for the HTLV-1 co-infection. The patient was treated with two cycles of albendazole 400 mg/d for 7 days. At 6-month follow up, she had no diarrhea and gained 4 kg of body weight.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 39,\n",
       "    'case_id': 'PMC2939437_01',\n",
       "    'case_text': \"We report a case of 39-year-old man without familial history of thyroid dysfunction, autoimmune disease, or thrombosis. \\nHe presented with an acute right hemiplegia for which he was hospitalized in neurology department. Computed tomography (CT) scan had confirmed the presence of lacunar infarction in the internal capsule of the left cerebral hemisphere. \\nHe was referred to our endocrinology unit because of signs of thyrotoxicosis including palpitation, polydipsia, and significant weight loss (6 kilograms).\\nPhysical examination revealed a body mass index of 25 kg/m2, a blood pressure within normal range of 130/80 mm Hg, heart rate of 96 beats/min, bilateral exophthalmos, homogeneous goitre, and right hemiparesis. \\nThe electrocardiogram showed regular sinus rhythm without atrial fibrillation.\\nThyroid function studies revealed undetectable serum thyroid-stimulating hormone (TSH) (below 0.05 mUI/L) and positive antithyroid-stimulating hormone receptor antibodies confirming the diagnosis of Graves' disease (Table 1).\\nThyroid scan with technetium 99 m (Tc-99 m) showed an enlarged thyroid gland with diffuse increased uptake.\\nFasting blood glucose was 14.3 mmol/L and remained high in the subsequent assessment confirming the presence of diabetes, according to World Health Organization. The antibodies to glutamic acid decarboxylase (GAD) were negative. \\nFor the assessment of his cerebrovascular accident, other investigations were performed showing positive antiphospholipid (APL) antibodies with IgG anti-beta2-Glycoprotien-I positive (beta2GP-I) and IgM anticardiolipin antibody positive which remains positive 3 months later (Table 1).\\nThrombophilic factors including protein C activity, antithrombin III, protein S, and prothrombin time were within normal range. Antinuclear antibodies were negative.\\nThe diagnosis of Graves' disease associated with a primary antiphospholipid syndrome (APS) was confirmed. The patient was treated with Aspirin (250 mg/day) and benzyl thiouracil (25 mg) at the dose of 12 tablets/day, with progressive regression. Improvement was shown in clinical symptoms and laboratory studies; Glycaemia levels and glycated haemoglobin returned to normal without any antidiabetic treatment.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 68,\n",
       "    'case_id': 'PMC10331202_01',\n",
       "    'case_text': 'A 68-year-old female with a past medical history of well-controlled hypertension presented with a 10-day clinical course of paranoid delusions, anorexia, mutism, dysphagia, constipation, and disorganized behavior and speech.\\nThe patient had no personal or family history of psychiatric illness; however, 2 months prior to the index presentation, she was evaluated due to anhedonia, non-specific gait abnormalities, and a 5-kg weight loss. The onset of these symptoms was related to a traumatic event in which she and her husband were simultaneously hospitalized for severe COVID-19, requiring critical care. Although the patient made a full recovery, her husband died, and due to her critical condition, she did not find out until several weeks later. In that previous consultation, she was diagnosed with a mixed anxiety-depressive disorder with psychotic symptoms for which treatment with antidepressants (sertraline 50 mg/day) and atypical antipsychotics (levomepromazine 5 drops/day) was started without an adequate response. The symptoms persisted after 6 weeks, even after the addition of a second antipsychotic (risperidone 2 mg/day). She reported being adherent to treatment and denied recreational drug use or other remarkable personal or familial psychiatric history.\\nAt the index admission, the mental examination revealed diminished language production, altered introspection, and paranoid delusions. The rest of the physical and neurological examinations were unremarkable. The initial working diagnosis was probable schizoaffective features associated with the newly diagnosed psychiatric condition. However, the age and abruptness of onset, as well as the suboptimal response to medications, raised the suspicion of underlying organic pathology.\\nComputed tomography (CT) and magnetic resonance imaging (MRI) of the brain showed no abnormal findings. Laboratory workup ruled out infections and ingestions. Moreover, an upper gastric endoscopy was performed due to dysphagia and weight loss, ruling out malignancies and other anatomical defects. The metabolic panel was remarkable for an elevated corrected total calcium (13.21 mg/dL, normal: 8.6-10.3 mg/dL), confirmed with ionized calcium (1.8 mmol/L, normal: 1.15-1.30 mmol/L). A workup for hypercalcemia ruled out malignancies with a negative serum protein electrophoresis and a normal thoracoabdominal CT. pHPT was diagnosed based on an elevated PTH (396 pg/mL, normal: 14-55 pg/mL), a normal 24-h urinary calcium (224 mg/day, normal: 100-300 mg/day), and the incidental finding of nephrolithiasis in the abdominal CT (laboratory results are presented in Table 1). Scintigraphy was performed and revealed a retropharyngeal ectopic parathyroid adenoma.\\nIntravenous fluids were used as first-line treatment of hypercalcemia, without improvement. Consequently, a single 4 mg dose of intravenous zoledronic acid was administered, achieving a decline in ionized calcium to 1.11 mmol/L in the following week. With the resolution of hypercalcemia, psychiatric symptoms subsided, delusions ceased, and dysphagia resolved.\\nUpon discharge, the antipsychotics were discontinued, and cinacalcet (30 mg daily) was started. She was referred to the head and neck surgery department for parathyroidectomy. However, in the context of the COVID-19 pandemic, surgery had to be deferred, and the patient was lost to follow-up.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 16,\n",
       "    'case_id': 'PMC10119779_01',\n",
       "    'case_text': \"A previously healthy 16-year-old Hispanic girl presented with abdominal pain and jaundice. She reported a 4-week history of intermittent, sharp, right upper quadrant pain that was worse after eating. When she developed scleral icterus, acholic stools, and dark urine, she presented for evaluation. Blood work revealed transaminitis (AST 322 U/L [normal 17-33 U/L], ALT 360 U/L [normal 8-24 U/L]) with a direct hyperbilirubinemia (total bilirubin 7.2 mg/dL [normal 0.2-1 mg/dL], direct bilirubin 5.2 mg/dL [normal <0.3 mg/dL]), and elevated GGT (1,346 U/L [normal 10-21 U/L]). Computed tomography of the abdomen and pelvis revealed a large, infiltrative central liver mass. Magnetic resonance imaging (MRI) confirmed a poorly defined, T1 hypointense, T2 hyperintense mass at the porta hepatis measuring 6 cm x 6.7 cm x 6.9 cm with distal biliary ductal dilatation. The left portal vein was not visualized in its course through the mass; the right portal vein demonstrated normal enhancement (shown in Fig. 1a, b). A chest computed tomography scan was notable only for a left lower lobe calcified granuloma, and a positron emission tomography scan revealed fluorodeoxyglucose avidity solely in the known hepatic mass. The patient underwent percutaneous biliary decompression and drain placement along with biopsy of the mass by interventional radiology. Pathologic evaluation of the biopsied tissue demonstrated immunohistochemical staining positive for CK7 (strong, diffuse), mucicarmine, CK19 (focal), CK56 (focal), and galectin-3 (focal) and staining negative for CK20, S100P, TTF-1, and CDX-2, which, in conjunction with morphologic features, confirmed the diagnosis of cholangiocarcinoma (shown in Fig. 1c, d). The liver tumor was deemed unresectable due to its locally advanced nature. The patient therefore received standard cytotoxic chemotherapy treatment for unresectable cholangiocarcinoma with eight cycles of cisplatin-gemcitabine (cisplatin 25 mg/m2 followed by gemcitabine 1,000 mg/m2 on days 1 and 8 every 3 weeks). A partial response to chemotherapy was documented. She then underwent hypofractionated proton beam radiation therapy for definitive treatment (58.05 Gy [RBE] in 3.87 Gy [RBE] per fraction for a total of 15 fractions (shown in Fig. 1e, f)). The patient tolerated the treatment well with only grade 1 nausea and fatigue that was transient. On follow-up imaging, her primary tumor remained stable.\\nThe patient enrolled in our institution's precision medicine study. Tumor tissue from the diagnostic biopsy was sent for comprehensive genomic sequencing (whole exome/paired normal and transcriptome sequencing) utilizing the GEM ExTra  assay (Ashion Analytics, Phoenix, AZ, USA). Details of the test methodology and clinical reporting have been published previously. Tumor tissue sequencing identified a novel, presumed oncogenic AGRN-NRG1 fusion between chromosome 1 (AGRN) and chromosome 8 (NRG1) with breakpoints within exon 2 of AGRN and intron 1 of NRG1 (shown in Fig. 2a). Based on our institution's molecular tumor board discussion, the patient was started on the oral pan-ERBB family inhibitor, afatinib, as a form of maintenance therapy. She continued on afatinib 40 mg daily with stable disease for 17 months with the main side effect being acneiform rash. The patient then experienced disease progression with development of three new, subcentimeter, satellite liver lesions. Biopsy of the largest lesion confirmed cholangiocarcinoma, and sequencing identified persistence of the AGRN-NRG1 fusion along with the development of a MCL1 amplification. Despite detection of 66 new genomic alterations, none were classified as driver events (shown in Fig. 2b). The patient subsequently chose to enroll in a clinical trial utilizing an anti-ERBB3 monoclonal antibody for NRG1-altered tumors.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 64,\n",
       "    'case_id': 'PMC4987474_01',\n",
       "    'case_text': 'A 64-year-old female patient with an otherwise normal medical history presented with abdominal pain over the previous four months. An upper gastrointestinal (GI) endoscopy showed an ulcerative lesion on the cardia of the stomach, and the pathological findings revealed a signet-ring cell adenocarcinoma of the stomach. The patient underwent a total gastrectomy, and the postoperative histological findings were consistent with medullary carcinoma with a lymphoid stroma. The surgical margins and extracted lymph nodes were negative. The pathological specimens, which were reexamined in our institute in order to confirm the diagnosis, were compatible with prominent lymphoid cell infiltration without evidence of signet-ring cells (Figure 1). The disease was staged as a T2N0M0 GMC and adjuvant capecitabine chemotherapy was planned. This patient had no relapse through 25 months of follow-up.\\nThe tumour tissue specimens were also examined to investigate any possible associations with MSI and EBV. Positive staining for MLH1, MSH2, PMS2, and MSH6 was observed in the immunohistochemical analyses of the neoplastic cells; however, no significant loss of nuclear expression was present. The in situ hybridization studies using the EBV-encoded small RNA (EBER) test showed diffuse positive staining in the tumour cells (Figure 2).',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 88,\n",
       "    'case_id': 'PMC6175750_01',\n",
       "    'case_text': 'The first patient was an 88-year-old male that was referred to our center for a 1 mm neuroendocrine tumor in the upper rectum at 14 cm from the anal verge. This lesion was first diagnosed and biopsied during a routine colonoscopy. This was staged as yT1N0M0 rectal lesion. The patient had no symptoms. Additional histological findings demonstrated a 1 mm lesion without mitoses, a ki67 index at 1.1% and most importantly, positive margins. On follow-up rigid proctosigmoidoscopy, the residual stellate scar, which was less than 1 cm, was confirmed to be at 14 cm from the anal verge in the left lateral position (Fig. 5).\\nAll treatment options were discussed with the patient including laparoscopic low anterior resection versus the less invasive trans-anal minimally invasive surgery. TAMIS procedure was selected for this patient. Given that the lesion was at 14 cm from the anal verge and therefore likely above the peritoneal reflection, a simple local excision could result in entering into the peritoneal cavity. Intraoperatively, the remaining scar was found to be mobile. It was therefore decided to proceed with the residual scar removal using a stapled technique. Echelon 60 and Endopath Flex 45 laparoscopic staplers were used, each with two reloads. The final pathology demonstrated only scar with no residual neuroendocrine tumour. The specimen was reported as full-thickness by the pathologist.\\nThe second patient was a slim 56 years old female with an endoscopically non-resectable tubular adenoma at 12 cm from the anal verge in the anterior position. Stapled TAMIS surgery was proposed for this patient. The Endopath Flex stapler with 2 blue cartridges was used. Due to the anterior position of the lesion, in addition to abdominal entry at 12 cm, another potential complications could be vaginal trauma. A mandatory maneuver in this situation therefore was to include identification of the recto-vaginal septum using digital manual inspection. Prior to firing the stapler, a finger was kept in the vagina to make sure that it was not pulled into the resection. An additional helpful maneuver is to develop a plane between the vagina and rectum by injecting 5-10cc of saline into the recto-vaginal septum. At the end of the excision in this case, the vagina was intact. Final pathology demonstrated a full-thickness excision, no malignancy and negative margins.\\nThe third patient was a 65-year-old female who had a recurrent serrated adenoma at 8 cm from the anal verge. Multiple attempts for removal under colonoscopy were unsuccessful. A pelvic MRI was performed. The MRI results featured an anterior 1.2 cm rectal lesion with concerns of invasion into the anterior mesorectal fascia (possible stage T4 lesion). However, there was no obvious pelvic lymphadenopathy or evidence of vascular involvement. Furthermore, there was no invasion or malignancy demonstrated on extensive biopsy. On digital rectal examination, the lesion appeared very mobile and smooth. It was therefore believed that the MRI findings could have been secondary to scarring due to prior endoscopic resections and biopsies rather than due to the presence of an advanced cancer. The diagnostic dilemma was discussed in a multidisciplinary meeting and reviewed with the patient. A decision was made to proceed with excision using the TAMIS platform. This was to serve as an excisional biopsy to be followed by further treatment if the lesion was confirmed to be an advanced cancer. This could also be a curative procedure if the final pathology was consistent with an adenoma or a T1 cancer with good prognostic factors.\\nTAMIS using six laparoscopic stapler firings was performed in order to achieve macroscopically negative margins. The final pathology showed a tubulovillous adenoma with no high-grade dysplasia or malignancy with clear microscopic margins. Pathology confirmed the specimen was removed full thickness so a second procedure was spared.\\nThe fourth patient was a 60 year old male who had a rectal lesion identified on colonoscopy after a positive FIT test. The lesion was located at 12 cm from the anal verge posteriorly and was attached to a relatively narrow pedicle. It was a large lesion which extended an additional 7 cm proximally. It was removed in a piecemeal fashion using 19 firings of the ETS Endo-GIA stapler and 3 firings of the Echelon blue powered stapler. Residual mass was left as the team had used multiple cartridges and felt that removing the distally remaining portion increased the chances of entering into the abdominal cavity. The residual mass appeared to be villous adenoma, which was felt would best be removed at an interval colonoscopy. The final pathology confirmed the specimen as villous adenoma with low-grade dysplasia. The residual lesion will be removed via colonoscopy two months post-operatively.\\nThe fifth patient was an 81 year old, slim female who presented to hospital with hematochezia. She had a colonoscopy which showed a rectal polyp at 9 cm. Biopsy demonstrated severely dysplastic colonic epithelium suspicious for adenocarcinoma. She had a follow up endoscopic ultrasound which identified no obvious mass lesions or perirectal lymph nodes. CT imaging showed no metastatic disease. Interestingly, a pelvic MRI did not identify the lesion nor any lymph nodes of concern. Intraoperative assessment identified the lesion at 9 cm from the anal verge, in the anterolateral position. It was felt to be mobile intraoperatively and that a stapler would be beneficial to simultaneously remove and close the defect to reduce any chance of entering into the peritoneum. Three shots of the Endo-GIA stapler were fired. Final pathology identified multiple foci of well-differentiated invasive colonic adenocarcinoma within the submucosa: this lesion is pT1N0 SM3. At the follow up appointment management options going forward were discussed: full excision (via low anterior resection), which was recommended given the SM3 status, versus close surveillance. The patient wished to pursue close surveillance given her age and comorbidities. As is our standard she will undergo a flexible sigmoidoscopy at 3months and a colonoscopy at 1 year post-operatively. She will have a repeat MRI in 6 months time and if any findings, another repeat scope at that time. Her CEA levels will be repeated every 6 months.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 17,\n",
       "    'case_id': 'PMC4766290_01',\n",
       "    'case_text': 'The CVI patient (and age/gender matched control subject) and parents provided written informed consent prior to participating in the study. The protocol was approved by the investigative review board of the Massachusetts Eye and Ear Infirmary (Boston, MA, USA) and the study was carried out according to the tenants of the Declaration of Helsinki and conformed to the requirements of the United States Health Insurance Portability and Privacy Act (HIPPA). Ophthalmological examination of the patient was conducted by an experienced pediatric neuro-ophthalmologist. At the time of study, the CVI patient was a 17-year-old girl, born prematurely at 32 weeks gestational age. In the perinatal period, she developed a grade III intra-ventricular hemorrhage with subsequent post-hemorrhagic hydrocephalus, periventricular leukomalacia (PVL), and spastic diplegia. She underwent bilateral strabismus surgery at 11 months to correct an esotropia. Best corrected visual acuity (Snellen) at the time of testing was 20/50 (right eye) and 20/40 (left eye). Her sensorimotor exam was notable for latent nystagmus and a residual microtropia. Funduscopic examination revealed evidence of optic atrophy in each eye, but was otherwise unremarkable. Visual field assessment was performed with automated visual field testing on a Humphrey Field Analyzer using a SITA-Fast 24-2 protocol (Humphrey Field Analyzer 750i, Zeiss Humphrey Systems; Dublin, CA).',\n",
       "    'gender': 'Female'},\n",
       "   {'age': 17,\n",
       "    'case_id': 'PMC4766290_02',\n",
       "    'case_text': 'As a control, an age and gender matched subject (female, 17 years old) with normal visual acuities and no history of prematurity or neurological/ophthalmic disorders was also recruited for comparison.\\nAutomated perimetry using the Humphrey Field Analyzer revealed a stable, bilateral visual field defect involving the inferior visual fields (Figure 1A). Inspection of the pattern deviation plot confirmed the presence of an inferior visual field defect with an apparent greater impairment on the left side. Record review confirmed that the bilateral, inferior visual field loss was non-progressive and identified as early as age 5; when the patient was first able to participate in formal visual field testing.\\nAll imaging was carried out using a 3 Tesla Philips Achieva system and an eight-channel head coil. Conventional T1 weighted structural images were acquired using an MP-RAGE pulse sequence (TE 3.1 ms, TR 6.8 ms, flip angle 9 degree, 1 x 1x 1.2 mm voxel size). For white matter tract reconstruction, high angular resolution diffusion imaging (HARDI) was chosen given its superior ability in revealing intravoxel white matter fiber heterogeneity and delineation of multiple fiber orientations within an individual voxel (Tuch et al.,). HARDI images were acquired using a single shot EPI sequence (TE 73 ms, TR 17844 ms, 64 directions, Bmax 3000, Bmin 0, 2 mm isotropic voxel size). White matter fiber tracking and reconstruction were performed using DSI Studio software (http://dsi-studio.labsolver.org/) with diffusion decomposition and sparse solution of the fiber orientation distribution function (ODF). HARDI images were aligned to the anatomical data using boundary based registration (Greve and Fischl,). The optic radiations were defined using a two-seed approach. For each hemisphere, the thalamus (composed of the thalamus proper and the ventral diencephalon containing the lateral geniculate nucleus; Desikan et al.,) was used as the start seed, while the white matter adjacent to the pericalcarine cortex was used as the second seed. Termination criteria were based on a subject-specific threshold of quantitative anisotropy and an angle change of 75 degree, enabling the capture of the full extent of the optic radiations. Both T1-weighted and HARDI images were acquired in the same scanning session. HARDI images were acquired within a 22 min scan period.\\nStandard T1-weighted MRI imaging of the CVI patient revealed markedly enlarged ventricles characteristic of PVL as compared to the age/gender matched control (Figure 1B). However, no details regarding the structural integrity of the optic radiations could be ascertained by standard MRI alone. By comparison, white matter reconstruction of the optic radiations obtained by HARDI revealed a generalized reduction in geniculo-striate projections in the CVI patient compared to the normal developed control (sagittal view; Figure 1C). Furthermore, the optic radiations along the superior bank qualitatively appeared to be markedly reduced than in the ventral bank, consistent with the inferior visual field deficit characterized on clinical examination. Finally, the marked reduction of optic radiations in the right hemisphere (compared to left) was also consistent with the laterality of the visual deficit suggested by perimetry findings.\\nThe functional organization of occipital visual cortex was characterized using static retinotopic mapping techniques allowing for rapid and robust identification of early visual area borders (Rajimehr and Tootell,; Nasr et al.,). Boundaries between primary (area V1), secondary (area V2), and tertiary (area V3) visual areas were functionally identified in both hemispheres. Flashing high-contrast colored checkboard stimuli (8 Hz) were presented in sub regions of the visual field and two spatially complementary stimuli were contrasted: (1) a horizontal meridian wedge (8.6  radius and 30  angle) vs. a vertical meridian wedge (8.6  radius and 60  angle) to identify early visual area borders and (2) an upper-field wedge (8.6  radius, 15  angle) vs. a lower-field wedge (8.6  radius, 15  angle) to differentiate activation between the upper and lower visual field. Each pair of stimuli (i.e., meridians as well as upper and lower wedges) were presented in two runs of 16, 16-s blocks comprised of six blocks of each stimulus and four blocks of fixation per run. Retinotopy was acquired with a single-shot EPI sequence (TE 28 ms, TR 2000 ms, flip angle 90 degree, 3 mm isotropic resolution with no slice gap). Each run of the scan was 256 s in duration. For all retinotopic runs, the subjects were instructed to maintain fixation on a central 0.9  fixation stimulus throughout the run and respond using a button box when the central target changed its luminance (TR-wise probability of a luminance change = 30%). Fixation performance (detection accuracy and reaction time) was scored after the scanning session. Stimuli were viewed under binocular viewing conditions.\\nAll structural and functional data were analyzed with FreeSurfer and FS-FAST packages (http://surfer.nmr.mgh.harvard.edu/). Using standard FreeSurfer methods (Fischl et al.,; Greve and Fischl,), the surface of each cerebral cortical hemisphere was extracted via image processing based on the anatomical gray-white matter boundary and computationally reconstructed as a 3D mesh of vertices. In order to permit visualization of multiple visual cortical areas, each cortical hemisphere was computationally inflated to reveal buried sulcal regions and an occipital lobe \"flat patch\" was created for each subject hemisphere by making cuts in the vertex mesh (along the calcarine sulcus and the anterior extent of the occipital lobe) and unfurling this mesh into a 2D representation (see Figure 2A for further details). Each functional run was rigidly registered to the anatomical data using gray-white matter boundary based registration (Greve and Fischl,). Functional data was motion corrected and spatially smoothed using a 3D Gaussian kernel (fwhm = 3.0), separately by run and by hemisphere. Voxel-wise statistical tests were based on a univariate general linear model (GLM), and the significance levels (inverse log p-value) were visualized on the inflated and flattened cortical surfaces.\\nDorsal (d) and ventral (v) regions of interest (ROI) were identified in each hemisphere and in each participant using block-design retinotopic fMRI analysis (e.g., Nasr et al.,). Briefly, the V1/V2 border lies along the center of the vertical meridian response, as it runs both dorsally and ventrally, and the center of the horizontal meridian representation in the calcarine sulcus was used to define dorsal and ventral subdivisions in each cerebral hemisphere. Each ROI represents the diametrically opposed region of the visual field (e.g., dorsal V1 of the right hemisphere represents the lower-left quadrant of the visual field). It is important to note that identifying the boundaries between early visual areas permits us to define ROIs for V1 and V2, but leaves the anterior border of V3 undefined. Since the visual cortical areas just anterior to V3d and V3v (V3A and hV4) contain hemifield representations rather than quadrant representations, the quadrant analysis could be seriously contaminated if the anterior borders are not well localized. For this reason, we quantitatively examined the quadrant results only in areas V1 and V2.\\nWe then determined the BOLD percent signal change to the upper visual field wedge (relative to passive fixation) and to the lower visual field wedge, within each ROI for each subject for each run. Since the dorsal parts of V1 and V2 are responsive to lower visual field stimulation and ventral parts are responsive to the upper visual field stimulation, this allowed us to create an in-field vs. out-of-field metric for each ROI and for each subject, normalized by the standard deviations of the blood oxygen level dependent (BOLD) signals. This in vs. out metric was computed as follows: \\nWhere \"preferred\" is the BOLD percent signal change evoked by the preferred stimulus for each ROI (i.e., the upper visual field wedge in ventral areas and the lower field wedge in dorsal areas) and \"nonpreferred\" is the BOLD percent signal change evoked in the ROI by the other, nonpreferred wedge. Standard deviations in BOLD percent signal change were computed within subjects and across runs. The in vs. out metric was contrasted between the CVI and control subject for each visual quadrant ROI as a ratio. A ratio of 100 indicates that the CVI patient and the control demonstrate similar responsivity profiles, while a ratio less than 100 indicates that the representation of the upper/lower visual field is less strongly segregated in the CVI patient than in the control subject.\\nBoth the CVI patient and the control subject were able to maintain adequate central fixation during the fMRI scans allowing for the identification of retinotopically specific cortical activation patterns (CVI patient fixation accuracy: 80%, mean reaction time 640 ms; control subject fixation accuracy: 58%, mean reaction time 729 ms). Functional MRI assessments resulting from the stimulation of horizontal and vertical visual field meridians were used to reveal the boundaries between visual cortical areas and the boundaries of early visual areas (i.e., V1-V3, see Figure 2A). These areas were robustly identified in each hemisphere in both the CVI and control participants suggesting that the overall organization of early visual areas is largely intact in the CVI patient despite the maldevelopment of geniculo-striate projections (compare upper and lower panels of Figure 2B). However, the upper and lower visual field responses showed the most marked difference in the CVI patient mirroring the visual field deficit identified by automated perimetry (described above). Specifically, activation within primary visual cortical representations of the lower visual field (V1d) in the right and left hemisphere of the CVI patient exhibited respectively only 21.5 and 22.2% of the activation observed in the same lower visual field representations in the control participant (Figure 2C). In contrast to those strongly attenuated for the lower visual field, cortical representations of the upper visual field (V1v) exhibited minimal differences in activation between participants (right hemisphere: 91.9% activation of control, left hemisphere: 89.1% activation of control). Again, this pattern is consistent with the inferior visual field deficit characterized by perimetry and the observed reduction in optic radiation tracts along the dorsal branch corresponding to the inferior visual field representation. Finally, in terms of laterality, a greater reduction in activation in the right lower visual field (V1d) compared to the left lover field (V1d) was also observed. This is further consistent with the lateralized visual field deficit in the left side as well as marked reduction in optic radiations observed in the right hemisphere. For comparison, we also examined regional activations in V2 and found a similar pattern to that of V1. Specifically, dorsal areas (lower field representations) exhibited much lower activations in the CVI subject as compared to control (right hemisphere: 33.1% activation of control, left hemisphere: 35.3% activation of control), while the ventral (upper field representations) were similar between CVI and control subjects (right hemisphere: 147.4% activation of control, left hemisphere: 93.7% activation of control). We further noted that the activation ratios between the CVI and control subjects were somewhat smaller in V1 than in V2 (approximately 22% compared to 34%, respectively). This result is consistent with the fact that V2 neurons have larger receptive fields than V1 neurons and thus V2d receives more upper field visual stimulation than does V1d (Zeki,; Smith et al.,).',\n",
       "    'gender': 'Unknown'}],\n",
       "  [{'age': 56,\n",
       "    'case_id': 'PMC2259370_01',\n",
       "    'case_text': \"A 56-year-old man presented to our unit 6 days after he had a channeling TURP and bilateral orchidectomy performed at another centre. He presented with generalized colicky abdominal pain, abdominal distension and constipation. Though the symptoms started on the first day after the operation, they were not severe and he was discharged from the hospital three days postoperatively. There were associated vomiting, anorexia and hiccoughs, which all started on the fifth day after surgery. The urethral catheter was removed on the third postoperative day and he experienced a significant improvement in his urinary symptoms. He had no known history of hypertension or diabetes patient and there was no previous history of intra-abdominal operations\\nClinical examination at presentation revealed mild pallor, fever (T-37.8 C), and bilateral peri-orbital and pedal swellings. The pulses were normal but blood pressure was 170/100 mmHg. The abdomen was distended but soft with no areas of tenderness. Percussion notes were tympanitic and the bowel sounds were hyperactive. Digital rectal examination revealed an enlarged nodular prostate and the rectum contained soft brownish stool. The absent testes and the healing scrotal wound were noted. There was no neuromuscular abnormality.\\nHis hemoglobin was 11.2 g/dL; the white cell count was 10.8 x 109/L, (neutrophilia of 73%) and platelet count of 258 x 109/L. He had evidence of renal impairment: serum urea was 28.2 mMol/L (normal range: 2.5-6.5 mMol/L) and serum creatinine level was 744 mumol/L (53-106 muMol/l). He was hyponatraemic (Sodium 126 mMol/L) (135-145 mMol/L) and slightly hyperkalaemic (Potassium, 5.1 mMol/L) (2.9-5.0 mMol/L), Urinary specific gravity was normal. Abdominal radiographs revealed features of intestinal obstruction, with gaseous distension of the bowel especially of the small bowel with multiple air fluid levels and paucity of gas in the pelvis (see Figures 1 and 2). Abdomino-pelvic ultrasound scanning revealed bilateral moderate hydronephrosis, a thickened urinary bladder wall with irregularity in its lower segment and remnants of the prostate gland. Urine microbiology culture yielded growth of klebsiella pneumoniae, which was sensitive to ceftazidime and amoxicillin-clavulanic acid combination.\\nIt was apparent that the patient had intestinal obstruction occurring after the Channel TURP with obstructive nephropathy. Initially, conservative management was instituted vis a vis nothing by mouth, intravenous fluids (normal saline alternating with 5% dextrose-saline), and intravenous antibiotics using a combination of ceftazidime and metronidazole. The gastro-intestinal tract was decompressed by passing a naso-gastric tube for continuous drainage. A size 18 Fr Foley urethral catheter was passed to monitor the patient's urine output and to decompress the upper urinary tract.\\nThe patient's renal function improved significantly with the conservative management but the abdominal pain and distension persisted and got worse. On the tenth day of admission, he had an exploratory laparotomy. Findings at laparotomy were distended small bowel loops and multiple adhesions involving the dome of the bladder, the small intestine and the large omentum. Adhesiolysis was done and the intestinal loops were released. The postoperative period was uneventful and he was commenced on graded oral diet on the third postoperative day after which he moved his bowel on the same day. The renal status of the patient continued to improve and urethral catheter was removed on the tenth postoperative day, and the patient voided satisfactorily. The serum electrolyte and urea levels at discharge were all within normal ranges (Sodium, 135 mMol/L; Potassium, 4.4 mMol/L; Urea-4.8 mMol/L and creatinine - 88 muMol/L). The patient was discharged from the hospital on antihypertensive medications 22 days after admission. He was seen in the out patient department six months after discharge and his condition had remained satisfactory.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 45,\n",
       "    'case_id': 'PMC4501463_01',\n",
       "    'case_text': 'This patient suffered from a high cervical spinal injury (C1/C2 fracture, traffic accident) resulting in flaccid quadriplegia and full ventilator dependency in May 2000, aged 45. Diagnostic phrenic nerve stimulation demonstrated bilateral diaphragm responses, allowing diaphragm pacing. In May 2001, the patient was implanted with intrathoracic phrenic stimulators (Atrostim , Atrotech, Finland). After 4 weeks of diaphragm reconditioning, complete ventilator weaning was obtained, the patient rapidly using diaphragm pacing 24 h a day and then doing so for several years. Decreased pacing efficiency was first noted in 2007, with the need to increase stimulation intensities to maintain tidal volume at the level needed to keep alveolar ventilation adequate (650-700 mL). The situation slowly deteriorated over the following years, with the appearance of dyspnoea in the sitting position, decreased tidal volumes, and partial followed by total loss of ventilatory autonomy leading to nocturnal, and then permanent ventilator dependency in 2012 (tidal volume 200-250 mL). Phrenic nerve function was verified several times, always with normal phrenic nerve conduction times and ample, and symmetrical diaphragm action potentials. A progressive decrease in tracheal pressure and abdominal movements following phrenic stimulation was noted. During this course, device replacement, aggressive correction of malnutrition and aggressive urologic management of chronic urinary tract infection (both liable to be responsible of muscle weakness and/or neuromuscular transmission impairment) were conducted without modifying the course of diaphragm pacing deterioration. In May 2011, high-resolution chest computed tomography revealed widespread vertebral fusion suggestive of ankylosing spondylitis (Fig. 1). This diagnostic had indeed been established prior to the accident having led to quadriplegia (HLA B-27 positive), the patient reporting the occasional use of non-steroidal anti-inflammatory drugs to control intermittent back pain before he became quadriplegic. It was concluded that the disease had evolved over years, the patient not perceiving pain because of the spinal lesion, and diaphragm pacing failure was attributed to thoracic ankylosis preventing diaphragm contractions to adequately inflate the rib cage. The patient died in May 2012 of severe pneumonia.',\n",
       "    'gender': 'Male'},\n",
       "   {'age': None,\n",
       "    'case_id': 'PMC4501463_02',\n",
       "    'case_text': 'At age 15, this patient suffered from meningococcal meningitis complicated by acute cerebral oedema leading to compressive spinal cord ischaemia. Magnetic resonance imaging did not show spinal cord lesions below C3. Diagnostic phrenic nerve stimulation demonstrated bilateral diaphragm response, allowing diaphragm pacing. In September 2009, the patient was implanted with intradiaphragmatic phrenic stimulators (NeuRXDPS , Synapse Biomedical, Oberlin, OH, USA). After nine months (July 2010), diaphragm pacing was considered efficient, producing tidal volumes of 500 mL on average and achieving normocapnia (PaCO2 39 mmHg). One year later, tidal volumes had fallen to less than 250 mL and the patient was hypercapnic (PaCO2 51 mmHg) in spite of maximal stimulation intensities (25 mA). Phrenic stimulation induced-thoracic expansion had become almost undetectable. No device dysfunction was identified. Phrenic nerve conduction was normal, as was tracheal twitch pressure in response to bilateral phrenic stimulation. Over the same time frame, complex hormonal disorders led to massive weight gain (from 67 to 104 kg, body mass index 22.6-35.1 kg/m2), with an ulterior diagnostic of Klinefelter syndrome. Diaphragm pacing failure was attributed to excessive chest wall and abdominal weight preventing diaphragm contractions to adequately inflate the rib cage.',\n",
       "    'gender': 'Unknown'}],\n",
       "  [{'age': 65,\n",
       "    'case_id': 'PMC4352736_01',\n",
       "    'case_text': \"A 65-year-old female patient presented to our emergency room with abdominal pain, nausea, vomiting, and pain radiating towards the back. The patient history included nothing specific other than diabetes mellitus (DM) for 20 years and cholecystectomy a year ago. She did not have a history of alcohol consumption and she was on subcutaneous insulin treatment twice a day. During the physical examination, the patient was observed to be in a confused state and her general state was poor; her blood pressure was 90/55 mmHg, heart rate was 132/min, body temperature was 38.3 C, and the respiratory rate was 28/min. Her abdomen was slightly distended and epigastric tenderness was detected. No rebound or guarding was observed. The laboratory parameters were as follows: Hb: 17.1 g/dL, Hct: 45.7%, WBC: 8.9 K/uL, PLT: 505 K/uL, sedimentation: 37/hour, CRP: 24 mg/dL, glucose: 255 mg/dL, urea: 28 mg/dL, creatinine: 1.6 mg/dL, AST: 57 U/L, ALT: 34 U/L, LDH: 1995 U/L, amylase: 212 U/L, lipase: 349 U/L, triglycerides: 2148 mg/dL, albumin: 2.3 g/dL, calcium: 6.5 mg/dL, and HbA1c: 9.6%. The blood gas analyses gave the following results: pH: 7.32 mm/Hg, pCO2: 44 mm/Hg, PO2: 72 mm/Hg, HCO3: 19.6 mmol/L, and lactate: 0.9 mmol/L. The other laboratory parameters were normal. The abdominal ultrasonography was interpreted in favour of AP. In the abdominopelvic contrast-enhanced computed tomography (CT), the gall bladder could not be observed (excised) and the pancreas was diffusely enlarged (Figure 1), while widespread increases of density and fluid retention were observed in the peripancreatic bilateral anterior renal fascia, splenic hilum, mesenteric adipose tissue, and the pelvic region. There was 19 x 18 mm necrosis area in the head of pancreas. Filling defects (thromboses) were observed in the splenic vein at the level of the tail of the pancreas. The patient's CT image shows the AP and splenic vein thrombosis (Figure 2). A central venous catheter was placed and the patient was prescribed blood glucose tests every six hours and insulin treatment for the regulation of her blood glucose levels. After the consultation with the infectious diseases department, the patient was started on 4 x 500 mg/day of imipenem. She was administered 4 x 5000 units of low molecular weight heparin through the subcutaneous route and infused intravenously 5 units of regular insulin along with each 1000 mL 5% dextrose fluid and lipid apheresis was performed once a day for three days. After the three times lipid apheresis, the triglyceride values declined to 829 mg/dL. In addition to the low molecular weight heparin, the patient was started on warfarin treatment and the dose was adjusted to keep the patient's INR value over 2. When the patient's general condition was observed to improve after the treatment, she was discharged with the recommendation of a low-fat diet and fenofibrate and warfarin treatment.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 60,\n",
       "    'case_id': 'PMC6136482_01',\n",
       "    'case_text': 'A 60-year-old woman with arthralgia and back pain lasting for several months and recent metatarsophalangeal luxation of the left toe presented to the ambulatory unit of rehabilitation clinics. She was referred to the clinics as a patient with chronic pain syndrome. The patient had joint hypermobility since childhood, diagnosed as ligament laxity. In adolescence, she is remembered to be called \"a clumsy freak\" due to joint mobility.\\nAt physical evaluation, marfanoid habitus with waxy, sagging skin and varicose veins in the feet was observed. Sclerae were bluish and eyelids dropping. In fingers and toes, spontaneous subluxation in all joints could be elicited. Elbows, knees, and all fingers were overextended. She had flat feet with a bilateral hallux valgus (Figure 1). She had scoliosis with prominent kyphosis. Lungs auscultation was characteristic of chronic obstructive pulmonary disease (COPD); the murmur of mitral valve prolapse was heard over the chest.\\nOn the Beighton score, she received all (9) scores: passive apposition of the thumb to forearm and passive dorsal hyperextension of the metacarpophalangeal joint >90  on both sides were done with no strain (Figure 2); she was able to actively hyperextend both elbows and knees on both sides over >10  and flex her spine to the ground with palms placed on the ground without knee flexing. On Five-point Hypermobility Questionnaire, she answered \"yes\" to all questions. She remembered vividly contorting her body into strange shapes and being called names by other children. Genetic analysis showed a typical mutation consistent with the classical Ehlers-Danlos syndrome.\\nIn the ambulatory unit, she received systematic, light, nonweightbearing, and proprioception exercises; she was referred to the occupational therapist for lower limb orthosis; she was taught relaxation techniques including mindfulness-based stress reduction and counselling support, though she was already familiar with cognitive behavioural therapy. She used regular anti-inflammatory drugs. She was referred to the plastic surgeon due to the wound on her foot, since sutures should be applied generously, without tension, in layers, and left in place twice as long as usual. She was already regularly followed by her cardiologist due to mitral valve prolapse.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 30,\n",
       "    'case_id': 'PMC9036379_01',\n",
       "    'case_text': 'A 30-year-old man with a history of hypertrophic cardiomyopathy and chronic uncontrolled hypertension presented with chest pain and sudden onset of blurring of vision of the right eye with left hemiparesis approximately 16 hours after snorting cocaine. His blood pressure upon arrival to the emergency room was 185/115 mm Hg.\\nThere was no history of trauma. Results of laboratory testing are displayed in Table 1, showing significant elevation in troponin T. Electrocardiography showed normal sinus rhythm. Cardiac angiography and echocardiogram showed an ejection fraction of 70% without significant abnormalities(Figure 1). The dissection was a non-flow limiting and was in a distal location. Magnetic resonance imaging of the brain revealed an ischemic stroke (restricted diffusion) in the right temporal-parietal junction and insula in the middle cerebral artery distribution (Figure 2). Computerized tomography angiography (CTA) of the head and neck (Figure 3) showed right internal carotid artery (ICA) occlusion.\\nThe patient underwent left heart catheterization which revealed dissection of the distal right coronary artery involving the origin of posterior descending artery with thrombolysis in myocardial infarction (TIMI)-II flow (Figure 4). This was felt to be the causative lesion for the patient\\'s chest pain and troponin abnormality. As the patient had already been started on aspirin and clopidogrel, intervention was undertaken with aspiration thrombectomy, balloon angioplasty, and subsequent stent placement in the distal right coronary artery into the posterior descending artery with restoration of TIMI-3 flow (Figure 5). He subsequently underwent cerebral angiogram showing complete occlusion of the right ICA. The occlusion had a tapering, \"flame-shaped\" appearance, approximately 1 cm distal to the origin of the ICA:consistent with dissection (Figure 6).\\nThe patient underwent physical therapy and occupational therapy while in the hospital with resolution of his left hemiparesis. He was discharged home on day 5 of hospitalization. He underwent repeat CTA of the head and neck in 6 months which revealed persistent occlusion of the right internal carotid artery. He has not had any further signs or symptoms of coronary ischemia.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 86,\n",
       "    'case_id': 'PMC4531034_01',\n",
       "    'case_text': 'An 86-year-old Filipino man presented to the emergency room for dyspnea at rest. His shortness of breath had worsened over the previous 2 days, and was associated with substernal dull chest pain and hemoptysis. Patient also reported a decrease in urine output and bilateral ankle swelling that had been worsening over the past 2 weeks. He had no history of recent travel, sick contacts or blood transfusion. Past medical history is significant for hypertension, chronic kidney disease stage III, gout, and COPD. He had no allergies. He had quit smoking 9 years ago, did not drink alcohol or use illicit drugs.\\nThe patient was hospitalized for pneumonia 3 weeks before presentation, and was treated with intravenous cefazolin for 2 weeks for methicillin-sensitive Staphylococcus aureus bacteremia. On examination, the patient was tachypneic (respiratory rate 25/min), temperature 97.6 F, blood pressure 155/71, pulse 109 bpm, with a saturation of 99% on 3 liters via nasal cannula. The skin and conjunctiva were pale. There were bibasilar rales in the lungs and bilateral lower extremity pitting edema 2+; the remainder of the examination was normal.\\nElectrocardiogram showed sinus tachycardia and nonspecific ST segment and T wave abnormalities. Chest radiograph showed bibasilar opacifications and bilateral pleural effusions. Furosemide was administered intravenously, sublingual nitroglycerin, and oral aspirin were given. Blood work was significant for hemoglobin of 8.3 g/dL (baseline 10), creatinine of 9.2 mg/dL (baseline of 1.67 GFR 39 mL/min/1.73m2), troponin of 0.6 and albumin 2.6 g/dL. Lower extremity duplex study showed right peroneal deep vein thrombosis and heparin infusion was initiated for possible pulmonary embolism and non-ST elevation myocardial infarction (NSTEMI). In addition, broad-spectrum antibiotics (vancomycin and meropenem) were initiated empirically. Urinalysis showed large blood, and red blood cell (RBC) casts were seen on light microscopy. Sputum staining showed epithelial cells and few white blood cells.\\nTransthoracic echocardiogram revealed a left ventricular ejection fraction of 55%, with moderate mitral regurgitation and a small pericardial effusion. Ultrasonography of the abdomen revealed bilateral renal echogenicity, compatible with renal disease. The right kidney was measured to be 10 cm in length by 4.4 cm in width by 4.4 cm anteroposterior diameter. The left kidney measured 9.3 cm by 4.6 cm by 4.9 cm. Vascular flow was demonstrated within each kidney. Serology workup for rapidly progressive glomerulonephritis (RPGN) was sent.\\nOn day 2 of the hospitalization, the patient became more tachypneic and fatigued necessitating oxygen supplementation with bi-level positive airway pressure. He was anuric (urine output 100 cc/24 hours) and was started on hemodialysis for hypervolemia; blood and urine cultures were negative. The patient had acute drop in hemoglobin (7 g/dL); heparin was stopped and he remained on acetylsalicylic acid and clopidogrel. On day 4, the patient was started on pulse steroids Solu-Medrol 1 g daily for 3 days. Patient\\'s condition and thrombocytopenia had precluded kidney biopsy up to this point. On day 6, sputum culture showed heavy growth of Klebsiella oxytoca.\\nRapidly progressive GN workup: hepatitis viral panel was negative. Hematological and immunological workup was normal including antinuclear antibody, anti-DNA, anti-glomerular basement membrane antibody, anticardiolipin IgG and IgM, cryoglobulin, anti-neutrophil cytoplasmic antibody (proteinase-3 AB <1.0, myeloperox AB <1.0), C3 and C4. Serum protein electrophoresis showed polyclonal gammopathy (gamma fraction 2.2 g). Rheumatoid factor titers were elevated 45 H (<14); elevated free kappa and lambda serum with normal ratio (1) (free kappa serum 205.8 mg/L [3.3-19.4], free lambda serum 205.0 mg/L [5.7-26.3]).\\nOn day 7, the patient was intubated for impending respiratory failure and put on mechanical ventilation. Bronchoscopic examination revealed blood in both bronchial trees and alveolar hemorrhage and the patient was started on total plasma exchange with fresh frozen plasma on a daily basis (total of seven sessions); bronchoalveolar lavage cultures grew Streptococcus bovis and Aspergillus fumigatus and antifungal were added to meropenem.\\nOn day 13, renal biopsy and staining with hematoxylin and eosin stain, Periodic acid Schiff stain, and Jones methionine silver stain revealed core of renal cortex contains 19 glomeruli, 18 of which are globally sclerotic and one of which has ischemic tuft retraction associated with tubular atrophy, interstitial fibrosis and a moderate chronic inflammatory infiltrate. There is moderate narrowing of small arteries and arterioles by intimal and medial sclerosis. The glomeruli appear enlarged with diffuse and global mild to moderate mesangial sclerosis forming segmental nodules. The glomerular basement membranes appear diffusely thickened with focal duplications. (Figure 1A) Superimposed on this nodular sclerosis, there is mild to moderate mesangial hypercellularity and segmental to global endocapillary proliferation (Figure 1B) including infiltrating neutrophils. (Figure 1C) There is endocapillary and focal extracapillary proliferative and exudative features: cellular/fibrocellular crescents; arteries and arterioles are narrowed by moderately severe intimal sclerosis; (Figure 1D) RBC casts (Figure 1E) and focal acute tubular injury. Figure 1F; the immunofluorescence (IF) findings of granular global mesangial and \"starry-sky\" pattern of glomerular capillary wall positivity for IgA and C3 (Figure 1G and H) support IgA-dominant post-infectious glomerulonephritis (IgA-PIGN) with endocapillary and focal extracapillary proliferative and exudative features associated with staphylococcal infection. Smoking-related moderate nodular glomerulosclerosis, (associated with longstanding smoking and COPD), focal subcapsular cortical scar with ischemic glomerulosclerosis, consistent with hypertensive arterionephrosclerosis, and moderately severe arteriosclerosis were also noted. On electronic microscopy, there was evidence of \"hump-shaped\" subepithelial deposits.\\nThe hospital course was complicated by pneumonia, pulmonary edema, and hemorrhage. The patient remained anuric requiring hemodialysis. The patient expired on day 18 secondary to respiratory failure, hypoxia, and cardiac arrest.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 22,\n",
       "    'case_id': 'PMC7268156_01',\n",
       "    'case_text': 'A 22-year-old female of Malay ethnicity presented to the haematology department with fever and left axillary swelling for a week. She has no past medical or family history. She is a non-smoker and does not consume alcohol. She works as a bank clerk.\\nOn examination, she was pale. She had a left axillary swelling of 5 x 5 cm (Figure 1(a)) which was firm, non-tender with no discharge. Other systemic examinations were unremarkable with no presence of palpable lymph nodes or organomegaly.\\nHer complete blood count revealed normochromic normocytic anaemia of 5.5 g/dL with leucocytosis at 22 x 109/L and thrombocytopenia at 30 x 109/L. She had no coagulopathy.\\nThe peripheral blood smear (Figure 2(a)) and bone marrow aspirate (Figure 2(b)) showed presence of blasts, abnormal promyelocytes and faggot cells. The trephine biopsy microscopy (Figure 2(c)) showed a hypercellular marrow which comprised almost entirely of blast population expressing myeloperoxidase (MPO) but lacking CD34 and CD3 on immunohistochemistry (Figure 2(d)-(f)). Marrow flow cytometry revealed 69% cluster of aberrant myeloid cells expressing CD117, cMPO, CD13, CD33, CD38 but lacking CD34 and HL-DR. Marrow for molecular PML-RAR-alpha fusion gene t(15;17) (q22; q12) was detected by polymerase chain reaction (PCR). The left axillary swelling histology showed diffuse monomorphic infiltrates with neoplastic cells exhibiting fine nuclear chromatin and moderate rim of basophilic cytoplasm. On immunohistochemistry, the cells were positive for MPO (diffuse positivity), CD13, CD33, CD68 and CD117. The cells were negative for CD34 and HLA-DR. These findings were consistent with granulocytic sarcoma.\\nShe was diagnosed as high-risk APML (Modified Sanz score 2017) with granulocytic sarcoma (GS). She was treated with dexamethasone prophylaxis for differentiation syndrome (DS) of 10 mg twice daily and triple therapy induction comprising of daily oral all-trans-retinoic-acid (ATRA) 45 mg/m2, intravenous arsenic trioxide (ATO) 0.15 mg/kg for a total of 25 doses and 3 doses of intravenous idarubicin. On day 14 of induction, she developed culture-negative neutropenic sepsis. She was in Type 1 respiratory failure. She was intubated and nursed at the intensive care unit. There was no evidence of alveolar haemorrhage. The chest radiograph (Figure 1(b)) revealed diffuse nodular pulmonary infiltrations. The computed tomography of the pulmonary arteries (Figure 1(c)) showed no features of pulmonary embolism. Serum galactomannan was not detected.\\nShe was treated with antimicrobials in which she responded completely. She has completed her induction, consolidation and maintenance therapy. She has been in complete molecular remission for the past 2 years.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 45,\n",
       "    'case_id': 'PMC4246683_01',\n",
       "    'case_text': \"In September 2006, a 45-year-old male underwent extraction of the upper left, first and second premolars at a dental clinic (Takamatsu, Japan). In March 2012, the patient identified a gingival swelling in the upper left premolar region and was referred to another general dental practitioner (Takamatsu, Japan). At that clinic, the patient underwent incision and drainage of the lesion following clinical diagnosis of a dental infection. However, there was no improvement following the treatment and thus repeat curettage of the lesion was performed. Following these treatments, the lesion continued to grow gradually. In July 2012, the patient was referred to Kagawa Prefectural Central Hospital (Takamatsu, Japan) with swelling and mild pain in the upper maxilla. The patient had no medical or surgical history. The patient smoked 20 cigarettes a day and has consumed two alcoholic beverages per week for the past 15 years. The patient's family history was noncontributory.\\nExtraoral examination revealed marginal left-sided facial asymmetry and tenderness (Fig. 1A); however, the patient experienced no abnormal sensation in the left buccal area. The left submandibular and upper jugular lymph nodes were palpable and tender. The intraoral examination revealed a mass, 25x35-mm in diameter, located in the buccal and palatal aspect of the edentulous alveolus of the left maxilla, in the area between the second premolar and the first molar (Fig. 1B and C). The mucosal surface of the mass was rough and covered with small and protruding hemorrhagic papules, which were pink-red in color. On palpation, the mucosa surrounding the mass appeared to be normal and was not indurated. However, tenderness and bleeding were identified.\\nA panoramic radiograph revealed a dome-shaped radiopaque mass with well-defined margins extending from the left maxilla to the maxillary sinus. The lesion caused the floor of the antrum to be elevated (Fig. 2). CT revealed a round cystic lesion, 30x40 mm in dimateter, which extended from the left maxillary alveolar region to the maxillary sinus (Fig. 3A and B). The floor of antrum was elevated by the cystic lesion and its margins were thickened (Fig. 3B and C). A section of the elevated sinus floor had been destroyed (Fig. 3C). 18F-fluorodeoxyglucose-positron emission tomography (FDG-PET) detected FDG uptake in the left maxilla [maximum standardized uptake value, (SUVmax), 12.4; Fig. 4A] and in two submandibular lymph nodes (SUVmax, 2.2). No abnormal FDG uptake that would have been indicative of another primary tumor or distant metastasis was detected on the FDG-PET images (Fig. 4B).\\nFrom these imaging results, the lesion was diagnosed as a primary malignant tumor arising from the left maxilla. The tumor was clinically staged as T4aN2bM0 in accordance with the 2009 Union for International Cancer Control system. An incisional biopsy was performed and indicated that the lesion was a PIOSSC. The patient underwent a subtotal maxillectomy of the left maxilla, and left radical neck dissection under general anesthesia and the diagnosis was histopathologically determined following surgery.\\nThe histopathological examination of the excised specimen revealed tumor cells consisting of atypical squamous epithelial cells with enlarged nuclei, which had invaded the submucosal connective tissue and bone (Fig. 5A-C). The tumor was accompanied by necrosis inside the tumor nests and scattered mitotic figures (Fig. 5D and E). These features indicated a poorly differentiated SCC. Inside the lesion, there was no clear evidence of the presence of cysts. However, the tumor had progressed to the surface from deep within the tissue, no atypical cells were observed in the epithelium at the boundary of the ulcer, and there was no contiguity between the oral mucosal epithelium and the maxillary sinus mucosa. No histological metastasis to the lymph nodes was identified. Based on these findings, the lesion was finally diagnosed as PIOSCC.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 34,\n",
       "    'case_id': 'PMC6721507_01',\n",
       "    'case_text': \"A 34-year-old previously healthy male presented with high grade fever associated with constitutional symptoms of five days' duration. He was complaining of right hypochondrium pain and tea-coloured urine for two days associated with yellowish discolouration of the eyes. He had severe loss of appetite to food and water, but his bowel habits had been normal throughout the illness. On admission, he was afebrile with normal vital signs but was deeply icteric. His abdominal examination revealed a tender, mild hepatomegaly while his cardiovascular, respiratory, and nervous system examination was normal.\\nHis full blood count revealed a white cell count of 3 x 103 muL with a platelet count of 116 x 103 muL. His aspartate aminotransferase (AST) and alanine aminotransferase (ALT) were 5162 U/L and 3964 U/L, respectively. Initial total bilirubin was found to be 61.7 mumol/L with an increased direct fraction. His prothrombin time/international normalized ratio (PT/INR) and serum protein were normal throughout the illness. His dengue IgM antibody done by chromatographic immunoassay was positive on the 6th day of the illness. Hepatitis A IgM antibody done by the ELISA technique was positive on day 6 of the illness, while hepatitis A IgG antibody was negative. Other investigations done during the hospital stay are summarized in Table 1.\\nDuring the course of the illness, the patient was closely monitored for features of development of liver failure while continuing with the precritical monitoring of the dengue fever. The patient's hospital stay was uneventful, and he did not develop features of acute liver failure or features of plasma leakage as in DHF. He was discharged on day 10 of the illness. On follow-up, his AST, ALT, and bilirubin have become normal.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 25,\n",
       "    'case_id': 'PMC4352650_01',\n",
       "    'case_text': 'A 25-year-old male presented with progressive weakness of both lower limbs since 3 months. He had headaches and vomiting 1-week prior to admission. On neurological examination, the patient had spastic paraparesis. Both fundi revealed papilledema. Magnetic resonance imaging demonstrated a well-defined lobulated intraventricular mass lesion occupying lateral ventricles, third ventricle, fourth ventricle and extending into cisterna magna through foramen of magendi [Figure 1 and 2]. The tumor literally formed a cast of the entire ventricular system. The tumor was isointense on T1-weighted images, hyperintense on T2-weighted images and significant flow voids were noted. On contrast administration, heterogeneous enhancement was seen. The patient underwent right fronto-parietal parasagittal craniotomy with transcallosal radical excision of the tumor within the lateral ventricles. The tumor was soft, easily suckable and extremely vascular. Haemostasis was achieved with great difficulty. The patient deteriorated in sensorium within a few hours after surgery and had to be put on ventilatory support. Postoperative computed tomography scan demonstrated postoperative changes with residual tumor in third and fourth ventricle. There was no hydrocephalus. The patient was treated conservatively with decongestants and anticonvulsants. The patient succumbed on second postoperative day. Histological examination confirmed the lesion to be a central neurocytoma.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 33,\n",
       "    'case_id': 'PMC10310325_01',\n",
       "    'case_text': \"A woman, 33 years old, married, merchant, 8 years of schooling, Jehovah's witness, from the countryside of the state of Para/Brazil, attended the Gaspar Vianna Clinical Hospital Foundation in May/2015 complaining of difficulty to walk, dyspnoea at rest, cough with hemoptoics sputum and syncope.\\nSince the age of 16, she had dyspnoea and fatigue, with worsening of symptoms after the first pregnancy, at 17 years. In the same period, she started to experience frequent episodes of headache, palpitations and hypertension, a condition that was treated as anxiety attacks. At the age of 32, she reported loss of motor strength, drowsiness, fatigue and indisposition to daily activities.\\nAfter worsening the condition, in 2015, at the age of 33, she sought specialised care in Belem, the capital of the state of Para, being referred to the reference institution in cardiology of the public network of the region with a clinical picture of acute pulmonary oedema with aetiology yet to be determined.\\nOn physical examination, she demonstrated tachypnoea, skin pallor (++/+++), fine basal rales and moderate mitral systolic murmur. She had no diagnosis of primary heart disease and denied exposure to chemicals and toxic materials.\\nShe underwent transthoracic echocardiography (Figure 1), which showed cavitary enlargement of the left atrium, moderate to important mitral stenosis with mass adhered to the anterior leaflet, a systolic function of the left ventricle preserved at rest and mild aortic and tricuspid insufficiencies. Based on these findings and epidemiology, the hypothesis that it was a benign tumour called myxoma was raised.\\nShe underwent urgent cardiac surgery at the institution for complete removal of the lesion or R0 resection of an adipose nodule encapsulated in the wall of the left atrium measuring 6.0 cm, in its largest diameter, which obstructed the mitral valve.\\nAnatomopathological analysis revealed negative microscopic margins for tumour. The morphology described was myxoid fusocellular tumour with cellular anaplasia, and the immunohistochemical study with desmin (Figure 2) showed that the neoplastic cells were positive for D33 and smooth muscle actin 1-4; and negative for CD34, AE1/AE3, FSD and protein S100; findings compatible with undifferentiated high-grade LMS in the left atrium.\\nThe young woman was subsequently referred to the oncology centre in the state of Para/Brazil, where the initial proposal was to perform five cycles of adjuvant chemotherapy, therapy administered every 21 days, with Gemcitabine (900 mg/m2/day) - 1,620 mg (days 1 and 8) and Docetaxel (75 mg/m2/day) - 135 mg (day 8), in addition to receiving the granulocytic colony-stimulating factor (days 9-13). However, before the third cycle, she presented adverse effects, such as myalgia (grade 1), asthenia (grade 1), mucositis (grade 1), nausea (grade 1), diarrhoea (grade 2) and arthralgia (grade 2). It was necessary, from the third cycle, to increase the chemotherapy interval to 28 days and reduce the initial dose of Docetaxel by 15%, remaining 63 mg/m2/day or 114 mg, until the fifth cycle.\\nConcomitant to chemotherapy, she performed three-dimensional conformal radiation therapy, 25 sessions, in the cardiac area, with a total of 50 Gr in 25 phases of 2 Gr/day or PTV 200 cGy/day and a total of 5,000 cGy, in the period from January 4 to 2 March 2016.\\nAfter these sequences of treatments with post-surgical radiotherapy and chemotherapy, no evidence of local or systemic oncological disease was detected, proven by staging tests. However, the patient presented cardiac sequelae, with moderate symptoms of arrhythmia and heart failure, well controlled with the use of medication: Enalapril, Carvedilol and Ancoron.\\nIn 2018, she performed a diagnostic investigation of breast and lung nodules, excluding malignant neoplastic processes.\\nIn 2020, 5 years after diagnosis and treatment, the patient remained in complete remission, in follow-up with the multiprofessional oncology team. She used medications for systemic arterial hypertension, diabetes mellitus, heart failure and arrhythmia.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 0,\n",
       "    'case_id': 'PMC5143702_01',\n",
       "    'case_text': 'An eleven-month-old boy came to our genetic clinic with the complaints of difficulty in breathing. He was second in birth order of second degree consanguineous couple at term after normal vaginal delivery with birth weight of 3 kg. Baby was hospitalized for 5 days for delayed cry at birth. His mother has history of epilepsy and was on sodium valproate since last 10 years. She had taken 1000 mg of valproate in two divided doses throughout pregnancy. Baby has global developmental delay as there is no neck holding and no speech or interaction with parents at 11 months of age. His weight, length, and head circumference were 5 kg (less than 3rd centile), 67 cm (less than 3rd centile), and 40.2 cm (less than 3rd centile), respectively. Facial examination revealed bifrontal prominence, high forehead, left epicanthal fold, depressed and broad nasal bridge, upturned nares, prominent philtrum, thin upper lip, posterior cleft palate, and bilateral low set ears (Figure 1). Limb examination detected shortening of left forearm, absent thumb, ulnar deviation at wrist and contracture of 1st, 2nd, and 3rd fingers at PIP joints of left hand (Figure 2), and rudimentary thumb with contracture at proximal phalangeal joint of fingers of right hand. Overriding of toes was present on right foot. There was no hepatosplenomegaly nor were there any neurocutaneous stigmata. Genital examination showed absent testis on left side. His body tone was normal with normal reflexes. X-ray hands were detected with absent radius and with absent thumb bone on left side (Figure 3). Complete blood counts, renal function tests, liver function test, and hearing evaluation were normal. Ultrasonography abdomen showed presence of left testis in inguinal canal. 2D echocardiography was suggestive of ostium secundum atrial septal defects of 1.6 mm size. A diagnosis of fetal valproate syndrome was made on the basis of antenatal history of valproate intake, facial dysmorphism, radial ray defect, cardiac defect, and associated genital anomaly.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 22,\n",
       "    'case_id': 'PMC8287412_01',\n",
       "    'case_text': 'A 22-year-old female is not known to have chronic medical illnesses. Presented to the emergency department with epigastric pain and vomiting for a couple of days with no similar presentation before. Thoroughly investigated by gastroenterologist and labeled as dyspepsia after gastroscopy. Found to have persistently high platelet count ranging between 600 and 900 x 10%uL level for 4 years duration. Referral to hematology service was done for further investigation.\\nPatient had thrombocytosis since 2015, had no history of thrombosis or bleeding, and no history of significant weight loss. She has no risk factors for Coronary Vascular Disease. Has positive family history of myeloproliferative disease in her aunt who was diagnosed recently to have high-risk ET with positive CALR gene mutation.\\nOn examination, the patient looks well, not pale, jaundiced, or cyanosed. Blood pressure was 113/53 mm Hg, temperature was 36.6 C, pulse was 85 beats per minute, respiratory rate was 19 per minute, and oxygen saturation was 100% on room air. There was no lymphadenopathy. Respiratory system and cardiovascular system examination was unremarkable. Abdominal examination was negative for any masses or organomegaly. Grossly intact neurological examination was carried out. In lower limbs, there is no edema or evidence of deep veins thrombosis clinically.\\nInitial investigations showed hemoglobin of 12.7 g/L, white blood cell (WBC) of 6.08 x 10/uL, platelets of 680 x 10%uL with normal mean corpuscular volume (MCV) and mean corpuscular hemoglobin (MCH). Reticulocytes count was 1.39%. Liver panel and renal panel were within normal, lactate dehydrogenase (LDH) was 163 U/L, aspartate aminotransferase (AST) was 15.2 U/L, total bilirubin was 6 umol/L, and direct bilirubin was 2 umol/L. Partial thromboplastin time (PTT) was 31.9 and international normalized ratio (INR) was 1.13. Ferritin was 20.8, iron was 10 which is the borderline level, as per our reference range, and total iron binding capacity (TIBC) was 66. Peripheral Blood Film showed normochromic normocytic red blood cells picture with normal weight blood cells count and morphology, platelets were increased in distribution, and no blast or abnormal cell was seen. Ultrasound abdomen showed no organomegaly, spleen measures were 9.5 cm, and liver measures were 12.6 cm, otherwise unremarkable scan.\\nBone marrow examination showed increased megakaryocytes with no increased in blast cells or dysmorphic cell and no fibrosis (Figure 1). Flow cytometry showed normal study with no signaling that indicated the presence of any active hematological malignancy. Cytogenetic study for BCR/ABL gene mutation showed negative test for any mutation, and no mutation was detected in JAK2 gene, Exon 12 and 14, as well as CALR and MPL genes. Extended cytogenetic and molecular study showed TET2 (c.3813C>T) mutational burden 45%. Other genes such as ASXL1, CBL, DNMT3A, EZH2, IDH1, RUNX1, SF3B1, SRSF, TP53, UAF1, and ZRSR2 were not mutated.\\nHence, the patient was labeled as very low-risk triple negative:TET2 positive:ET and she was advised to increase fluid intake, her iron deficiency was treated, and to maintain on prophylaxis, aspirin 81 mg was given per oral once daily. Since then, she is on follow-up with hematologist for any progress in her condition. She had no further admissions for any reason since then.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 83,\n",
       "    'case_id': 'PMC6369501_01',\n",
       "    'case_text': 'A 83-year-old woman presented with a visual acuity of light perception in the left eye for four years. The patient underwent detailed ophthalmological examinations including slit-lamp biomicroscopy, intraocular pressure measurement (applanation tonometry), dilated fundus examination (+90 D), and B-scan ocular ultrasonography. On initial examination, visual acuity was 0.2 (Snellen equivalent) in the right eye and light perception was in the left eye. Slit-lamp biomicroscopy revealed left hard brown cataract and right pseudophakia. Specular microscopy was within acceptable limits (cell density >2000 cells/mm2, hexagonality >50%) in the left eye. Intraocular pressure measurements were normal bilaterally. Right fundus examination showed macular atrophic changes. However, dense cataract did not allow a detailed fundoscopic evaluation in the left eye. B-scan ocular ultrasonography revealed no retinal detachment or intraocular mass.\\nPhaco surgery was performed under retrobulbar anesthesia due to poor patient compliance. A 2.75 mm superior clear corneal incision was created, and anterior lens capsule was stained with trypan blue dye. Central part of the anterior lens capsule was punctured with a cystotome following OVD injection into the anterior chamber (AC). A continuous curvilinear capsulorhexis was created. Two corneal side port incisions were made using a 20-gauge blade two clock hours away from the superior corneal incision. After hydrodissection, central vertical groove was formed, and nucleus was cracked into two halves (Figures 1(a) and 1(g)). Using the phaco needle, core nucleus (which is the rock-hard part of the lens) of the two halves was hollowed sideward in the capsular bag (using low vacuum (linear increment with an upper limit of 80 mmHg) and power (linear increment with an upper limit of 80% torsional amplitude) settings) (Figures 1(b) and 1(h)). A dispersive OVD was injected into the AC to protect corneal endothelium. The nuclear halves were removed from the capsular bag using the phaco tip, and each half was pushed to one side on the iris plane with assistance of OVD (Figures 1(c) and 1(i)). Capsular bag was inflated with OVD, and a foldable IOL was implanted (Figures 1(d) and 1(j)). Thus, posterior capsule moved backwards and got fully secured. Then, nuclear halves were chopped into small pieces and removed as far as possible from the corneal endothelium, which is also protected by dispersive viscoelastic (Figures 1(e), 1(f), 1(k), and 1(l)). After nucleus removal, the remaining cortical material and OVD were aspirated with bimanual irrigation/aspiration (I/A). Corneal incisions were hydrated, and intraocular antibiotic injection was performed.\\n Video 1 demonstrates the steps of the phaco surgery.\\nAt first day postoperatively, biomicroscopic examination revealed normal findings except grade 2 corneal edema in the left eye. At 1-week control visit, corrected visual acuity was 0.7 (Snellen equivalent), cornea was clear, and minimal macular atrophic changes were present in her left eye. Postoperative control specular microscopy was planned at 1-month visit, whereas the patient was out of follow-up.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 68,\n",
       "    'case_id': 'PMC8728800_01',\n",
       "    'case_text': 'Ectopic adrenal gland tissue is induced by small fragments of the adrenal cortex originating from the ectoderm during the course of invasion into the central vein during adrenal gland development, and was first reported by Morgani in 1740. According to the embryological process of this tissue, it is mainly observed in the spermatogenic cord region and the retroperitoneum, but it is rarely observed in the ovary, broad ligament, testis, stomach, and liver. The incidence rates according to the location of the ectopic adrenal gland tissue reported in other papers are presented as follows: celiac axis area (32%), broad ligament (23%), kidney (0.1%-6%), and adnexa of the testis (7.5%). This tissue is mainly observed in male children with a probability of approximately 50%, and it is rarely observed in adults, especially in women, because it becomes atrophied by the normal function of the adrenal glands in adulthood. It is usually asymptomatic, and most cases are diagnosed incidentally as a result of groin surgical exploration in children and other surgical treatments for other purposes in adults. Furthermore, an ectopic adrenal gland tissue tends to be observed more on the right side than on the left, and it is rare on both sides. We report a rare case of ectopic adrenal gland tissue observed in the left ovary of a 68-year-old female.',\n",
       "    'gender': 'Female'},\n",
       "   {'age': 68,\n",
       "    'case_id': 'PMC8728800_02',\n",
       "    'case_text': 'Patient information: a 68-year-old multiparous (gravida 2, para 2) woman presented with a bearing down sensation due to uterine prolapse grade III that lasted for 5 years. At the time the patient was first diagnosed with uterine prolapse, she had a follow-up observation at a local hospital after a pessary was inserted, but she visited this hospital for surgical treatment. Past medical history of hypertension was reported. She was taking medications due to hypertension, and her blood pressure was well controlled.\\nClinical findings: as a result of physical examination, there was no palpable mass in the lower abdomen area, and there was no tenderness at all. As a result of gynecology examination, there were no specific findings other than grade III uterine prolapse.\\nDiagnostic assessment: a transvaginal sonographic evaluation revealed a 0.69 cm intramural-type uterine myoma, and no other lesions were observed on both adnexa.\\nTherapeutic intervention: the symptoms of the patient s uterine prolapse were causing discomfort in her daily life. As she was post-menopausal, her ovaries were no longer producing female hormones. For these reasons, the patient agreed to a prophylactic bilateral salpingo-oophorectomy during hysterectomy. Although no ovarian lesions were present, neither of the ovaries were functional and there was a risk that lesions such as ovarian malignant masses may develop later. Therefore, the patient underwent laparoscopic hysterectomy with prophylactic bilateral salpingo-oophorectomy as well as anterior and posterior repairs. The surgically removed uterus, bilateral ovaries, and fallopian tubes were sent to the pathology department for histological analysis.\\nOn section, the cut surface showed intramural leiomyoma and both adnexa were unremarkable, grossly. Microscopic examination revealed 0.3x0.2x0.2 cm sized ectopic adrenal tissue in the left ovary. The tissue consisted of pale cells with spongy-appearing cytoplasm and polygonal cells with acidophilic granular cytoplasm, which is reminiscent of zona fasciculata and zona reticularis of the adrenal cortex (Figure 1A, Figure 1B). The ectopic tissue was reactive for inhibin-A and Melan-A, which favored the diagnosis of ectopic adrenal tissue (Figure 1C, Figure 1D). The final pathological diagnosis was leiomyoma and ectopic adrenal tissue on the left ovary. She was discharged on the seventh day after the surgery.\\nFollow-up and outcome of interventions: the patient presented with no complications six months after surgery.\\nInformed consent: the patient consented to the publication of a case report containing her clinical data; because her case was rare, and she wanted to be helpful in the treatment of such a case in the future.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 60,\n",
       "    'case_id': 'PMC5985244_01',\n",
       "    'case_text': 'Our patient was a 60-year-old woman with a previous medical history of primary hyperparathyroidism. She was studied in another hospital, where three years before she had hypercalcemia detected in routine laboratory and underwent a left parathyroidectomy (one gland). Histopathological examination of the gland showed \"benign parathyroid tissue\".\\nIn a routine control by her family doctor, hypercalcemia with persistent hyperparathyroidism was detected and she was referred to our hospital two years after surgery. She complained of bone disease (osteoporosis), hypertension, constipation, and neuropsychiatric symptoms (irritability and depression). She had no family history of hypercalcemia or metabolic diseases. Physical examination did not reveal any palpable neck masses.\\nLaboratory data showed increased serum concentrations of parathyroid hormone (PTH; 301 pg/mL [normal range, 15-65 pg/mL]) and calcium (2,8 mmol/L [normal range, 2.09-2.42 mmol/L]), phosphorous 0.88 mmol/L (normal range, 0.87-1.45 mmol/L), albumin 5.12 g/dL (normal range, 3.5-5.0 g/dL), magnesium 0.9 mmol/L (normal range, 0.6-1.1 mmol/L). Serum levels of 25-hydroxyvitamin D, creatinine and urea were within normal range.\\nA neck ultrasonography had been performed, which revealed a thyroid nodule on right lobe with 22 mm and an enlarged nodule (35 mm) on the posterior face of the left thyroid lobe.\\nThe computed tomography (CT) scan of the neck revealed a heterogeneous mass with approximately 5 cm in diameter, located posterior to the left inferior pole of thyroid gland and extending to the mediastinum - adenoma versus PTC. A 99mSestamibi-CT scan confirmed increased uptake in the topography of left inferior PT, corresponding to CT scan findings. Therefore, the patient was referred for formal cervical exploration with parathyroidectomy. At surgery, the inferior left PT was a polycystic gland of about 5 cm, adherent to the posterior face of left thyroid and close to the esophagus. The gland was easily dissected from esophagus and en bloc removal of the gland with the left thyroid lobe and all involved tissue was performed. The left recurrent nerve was free of disease. There was no gross involvement of regional lymph nodes. A decrease of serum levels of intact PTH of 81% was observed 10 min after removal of the PT (final value of 53 pg/mL). Both superior and inferior right PT had normal size and shape and were preserved.\\nPathological examination of the PT revealed, on gross inspection, a hard mass measuring 6.5 x 4 x 2.5 cm and weighting 26 g. The cut surface was mostly occupied by a heterogeneous whitish nodule, with hemorrhagic and cystic areas. Microscopically, the PT was occupied by a partially encapsulated nodular tumor, with trabecular and pseudo follicular solid pattern. It was composed of uniform cells which variated in size and shape, and areas of thick fibrous bands. It had a low mitotic index (less than 2 mitoses per 10 high-power fields). There was partial capsular invasion with extension to the thyroid and cervical soft tissues. There were also some images that suggested neural and vascular invasion. Based on these findings the diagnosis was a PTC. Free margins (less than 1 mm) were found.\\nPostoperatively, the patient did well, without complication. In the first day after the surgery, PTH and serum calcium had returned to normal levels, 40 pg/mL and 2.28 mmol/L, respectively. She was discharged home uneventful at the 7th postoperative day.\\nAt 12-month follow-up, the patient is asymptomatic with normal serum calcium.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 0,\n",
       "    'case_id': 'PMC7652926_01',\n",
       "    'case_text': \"As detailed above, the amino acid sequence of ACE-2 is a determining factor of the host species range affected by SARS-CoV-2. During the search for an animal model of COVID-19, bioinformatic predictions and previous studies with SARS-CoV-1 indicated that non-human primates, ferrets, hamsters, and domestic cats were possible animal candidates to be explored. Accordingly, experimental SARS-CoV-2 infection and clinical sign development have been successfully accomplished in non-human primates, ferrets, and golden Syrian hamsters (Mesocricetus auratus). Experimental infection was also successful in cats, but the animals developed no clinical signs. In dogs, the intranasal inoculation of SARS-CoV-2 in 3-month-old beagles resulted in only two out of four experimentally infected animals developing neutralizing antibodies and no detectable viral RNA in organ tissues of one euthanized animal 4 days postinfection. Viral RNA was sporadically detected in the feces of these dogs a few days postinfection. This same study shows that experimental infection of SARS-CoV-2 was not successful in pigs, ducks, and chickens. Taken together, these results raise the possibility that companion animals, particularly cats and hamsters, may get infected with SARS-CoV-2 outside experimental laboratory conditions. As previously shown in a review on cell, tissue, and animal models for SARS-CoV-2 infection, non-human primates may be used for human clinical tests, while primary cell culture, primary tissue explants, and organoids may be applied for other human and animal approaches.\\nWith millions of people detected with SARS-CoV-2 worldwide, reports of companion animals possibly infected with the virus started to emerge. These animals were frequently owned by individuals with confirmed or suspected SARS-CoV-2 infection, raising concerns that an anthropozoonotic transmission occurred. Therefore, our aim is to review reported cases of animals naturally infected with SARS-CoV-2, particularly companion pets, shedding light on the role of these animals in the epidemiology of COVID-19.\\nMembers of the Coronaviridae family have a positive-sense single-stranded RNA genome varying from 26 to 32 kilobases, the largest viral RNA genomes ever described. CoVs are enveloped viruses and identified in several species of birds and mammals, including humans. The Coronaviridae family is composed of two subfamilies (Letovirinae and Orthocoronavirinae) and four genera (Alphacoronavirus, Betacoronavirus, Gammacoronavirus, and Deltacoronavirus) found in the subfamily Orthocoronavirinae. The organization and expression of their genome are very similar, with 15 to 16 non-structural proteins (nsp1 to nsp16, with nsp1 being absent in Gammacoronavirus), codified by ORF1ab at the 5' end, and four to six structural proteins, hemagglutinin-esterase (HE, found in some betacoronaviruses) spike (S), envelope (E), membrane (M), and nucleoprotein (N), which are codified by ORFs at the 3' end of the genome.\\nIn humans, CoVs primarily cause infections of the upper respiratory and gastrointestinal tracts, with clinical manifestations ranging from asymptomatic to severe or lethal. Seven CoV strains are able to infect humans: HCoV-NL63, HCoV-229E (Alphacoronavirus), HCoV-OC43, HCoV-HKU1, SARS-CoV-1, MERS-CoV, and more recently, SARS-CoV-2 (all these in the Betacoronavirus genus). HCoV-NL63, HCoV-229E, HCoV-OC43, and HCoV-HKU1 are distributed globally, with seasonal and geographic variations. These are low-pathogenic CoVs associated with a variety of mild upper respiratory tract infections, occasionally affecting the lower respiratory tract, leading to pneumonia, bronchiolitis, or both. Nonetheless, in the last two decades, highly pathogenic, zoonotic CoVs emerged. These are SARS-CoV-1, which emerged in China in 2002; MERS-CoV, which was first detected in Saudi Arabia in 2012; and SARS-CoV-2 identified in China in 2019. These CoVs are highly pathogenic and may cause lethal disease, with variable mortality rates of about 10% for SARS-CoV-1, 34% for MERS-CoV, and from 1 to 7% for SARS-CoV-2. The epidemic of SARS-CoV-1 affected 26 countries, and more than 8,000 cases were reported, while MERS-CoV was identified in 27 countries, with more than 80% of the 2,494 cases reported in Saudi Arabia. Currently, SARS-CoV-1 is not detected in any region of the world, and MERS-CoV cases are sporadically reported in Saudi Arabia. SARS-CoV-2, on the other hand, is currently at epidemic peaks in many regions, with exponential growth of case numbers and fatalities globally.\\nCoronaviridae species affecting host species other than humans have been reported, causing respiratory, gastrointestinal, liver, kidney, or neurological diseases in a variety of domestic and wild animals, with no human infection by these coronaviruses ever reported. Among companion animals, canine coronavirus (CCoV) and feline coronavirus (FCoV) belong to the species Alphacoronavirus 1 with two serotypes (I and II), each occurring as either a low-virulence biotype that causes mild to silent enteric infectious and high-virulence, pantropic biotypes in dogs (a CCoV-IIa lineage) and cats (feline infectious peritonitis virus). In addition, a betacoronavirus named canine respiratory coronavirus has been associated with respiratory disease in dogs.\\nAmong large animals, calves and adult cattle are susceptible to enteric and respiratory disease after infection by bovine coronavirus (a Betacoronavirus), while another betacoronavirus, equine coronavirus, has been associated with enteric disease in horses. Avian coronavirus (a Gammacoronavirus) has chickens as a natural host, infecting the trachea, lungs, kidneys, reproductive tract, and intestines in broilers, layers, and breeders with a wide range of serotypes. Moreover, swine acute diarrhea syndrome coronavirus (SADS-CoV), first reported in 2017, together with porcine epidemic diarrhea virus (PEDV) and transmissible gastroenteritis virus (TGEV) are alphacoronaviruses that cause highly lethal enteric disease in pigs. Porcine deltacoronavirus (PDCoV) and the betacoronavirus porcine hemagglutinating encephalomyelitis virus (PHEV) also use pigs as hosts.\\nTo understand how certain domestic animal species may be infected with SARS-CoV-2, it is crucial to investigate the underlying reason for the ability of the virus to enter host cells and establish infection. Current knowledge of the SARS-CoV-2 pathogenesis indicates that such event is made possible by the interaction between SARS-CoV-2 and the host ACE-2 protein, which acts as a receptor for viral adherence and membrane fusion. Supplementary Data and Table 1 show a multiple protein sequence alignment of ACE-2 of human, main domestic, and laboratory animal species and cross-species identity of the 22 amino acids of ACE-2 that physically interact with SARS-CoV-2, respectively. Among putative pet animals, golden Syrian hamsters, cats, and rabbits diverge in only 3 of the 22 amino acids of ACE-2 responsible for the interaction with SARS-CoV-2, while dogs diverge in five amino acids (Supplementary Data and Table 1). However, the whole-protein sequence of ACE-2 of golden Syrian hamsters showed higher sequence similarity and phylogenetic relatedness to human ACE-2 than the rabbit and cat ACE-2 (Supplementary Figure 1). Whether at the whole-protein level or at the 22 interaction-defining amino acids, this sequence may be determinant of a successful infection, along with the expression of ACE-2 protein in different tissues and yet to be unraveled alternative receptors of SARS-CoV-2 in host cells. The link between structural properties of ACE-2 orthologs to SARS-CoV-2 spike protein has been already investigated. In this study, non-conservative mutations in several ACE-2 amino acid residues have been associated with interrupted key polar and charged viral spike protein contacts, which may decrease the susceptibility to SARS-CoV-2 infection across different animal species. In addition, structural analysis of amino acid residues has suggested that changes in amino acid positions 30 and 83 may affect structural interaction of ACE-2 and SARS-CoV-2 RBD, differentiating non-susceptible from susceptible species.\",\n",
       "    'gender': 'Unknown'},\n",
       "   {'age': 17,\n",
       "    'case_id': 'PMC7652926_02',\n",
       "    'case_text': \"The first report of SARS-CoV-2 infection in dogs occurred in Hong Kong, China, by the Hong Kong Agriculture, Fisheries, and Conservation Department (AFCD) (Table 2). A 17-year-old male Pomeranian with several comorbidities was asymptomatic and quarantined on February 26, 2020, after its owner was diagnosed with COVID-19. On March 18, an asymptomatic 2.5-year-old male German shepherd dog tested positive for SARS-CoV-2 by RT-qPCR in nasal and oral swabs; the two dogs had detectable antibodies against SARS-CoV-2. In addition, viral sequences were identical to the virus identified in the respective owner cases, suggesting human-to-animal transmission. On June 1, in the Netherlands, neutralizing antibodies against SARS-CoV-2 were detected in an 8-year-old American bulldog with breathing distress, with a COVID-19-positive owner. The animal was euthanized due to clinical worsening. In New York State, Richmond County, USA, two dogs tested positive to anti-SARS-CoV-2 antibodies. One dog showed signs of respiratory illness and severe lethargy associated with hemolytic anemia. The other dog was asymptomatic. The owner of the two dogs tested positive for COVID-19. Both dogs are recovering. In May 2020, a 7-year-old male German Shepherd tested positive for SARS-CoV-2 by RT-qPCR, after 6 weeks with breathing distress. On July 11, 2020, the animal died with a diagnosis of lymphoma, which may have been a confounding cause for the respiratory signs.\\nAlso, in Hong Kong, nasal and oral swab and fecal samples from a clinically healthy cat tested positive for SARS-CoV-2 by RT-qPCR. The owner had been hospitalized with COVID-19. Until April 15, 2020, the Hong Kong Agriculture, Fisheries, and Conservation Department tested 17 cats from guardians positive for COVID-19, and only the cat mentioned above was positive. In mid-March 2020, in Belgium, viral RNA from SARS-CoV-2 was detected in samples of vomit and feces of a cat with diarrhea, vomiting, and dyspnea, using RT-qPCR. Despite the animal's guardian being infected with COVID-19, it was not possible to establish the level of identity between the genomic sequences of SARS-CoV-2 present in the cat and human. This cat showed clinical improvement 9 days after the onset of symptoms.\",\n",
       "    'gender': 'Male'},\n",
       "   {'age': 5,\n",
       "    'case_id': 'PMC7652926_03',\n",
       "    'case_text': 'On April 22, the OIE, the Centers for Disease Control and Prevention (CDC), and the United States Department of Agriculture (USDA) reported that two cats from the New York I State in the USA, both presenting sneezing and nasal discharge, tested positive for SARS-CoV-2 by RT-qPCR. One cat is a 5-year-old Devon Rex, from Orange County, and the owner was positive for COVID-19. The clinical signs in the cat appeared after the owner showed COVID-19-compatible symptoms. Another cat in the same household remained asymptomatic but was not tested for the presence of the virus. The second positive 4-year-old cat was from Long Island (Nassau County) with outdoor access. The animal has presented respiratory signs and lethargy and tested positive to SARS-CoV-2 RNA by quantitative RT-PCR. Three of five households have shown clinical signs related to COVID-19 but were not tested, and the cat is presumed to have been infected by someone at home or by a virus carrier. The latest laboratory tests on the two cats have shown that they are clearing the infection and will likely have full recovery.',\n",
       "    'gender': 'Unknown'},\n",
       "   {'age': 9,\n",
       "    'case_id': 'PMC7652926_04',\n",
       "    'case_text': \"On March 18, a case of a Belgian cat with a breathing problem, vomiting, and diarrhea was reported, with SARS-CoV-2 detected by RT-qPCR in vomit and feces samples. On April 17, a 9-year-old female cat of European breed from France was tested positive to SARS-CoV-2 RNA by RT-qPCR on a rectal swab. The animal showed clinical signs, such as anorexia, vomiting, and cough, 17 days after its owner has tested positive to COVID-19. Antibodies against SARS-CoV-2 have been detected in two serum samples taken 10 days separately. In addition, sequence analysis of cat SARS-CoV-2 has shown that it belongs to the phylogenetic clade A2a, similar to the French human SARS-CoV-2. In June, one cat from Minnesota and another one from Illinois, USA, tested positive for SAR-CoV-2, confirmed by USDA's National Veterinary Services Laboratories.\\nIt is not surprising that cats develop clinical signs; SARS-CoV-2 penetrates the cell by binding to the ACE-2 receptor, and the ACE-2 receptor in cats has high homology with the human receptor, as shown above. The coronavirus that caused the SARS epidemic (SARS-CoV-1) in 2003 also uses the ACE-2 receptor to enter cells. Cats are susceptible to experimental infection with the SARS-CoV-1 and also became naturally infected during the SARS epidemic in 2003. Recently, cats were experimentally inoculated intranasally with high doses of SARS-CoV-2. The animals showed no clinical signs, developed neutralizing antibodies, and eliminated viral RNA in the feces. At necropsy, infectious virus was found in the nasal turbinates, soft palate, tonsils, trachea, and lungs. Experimentally infected cats transmitted the disease by air particles to susceptible cats. Moreover, an experimental study has shown that SARS-CoV-2 was transmitted by virus-inoculated cats to cats with no previous infection, after cohoused contact. After 24 days of inoculation, all the cats showed IgG antibody titers ranging from 5,120 to 20,480. Since no clinical signs were reported in this study, the authors speculate that cats may be a silent intermediate host of SARS-CoV-2.\\nExperimental infection with SARS-CoV-2 is also possible in hamsters, ferrets, rhesus macaques (Macaca mulatta), cynomolgus monkeys (Macaca fascicularis), and African green monkeys (Chlorocebus sabaeus). Callithrix jacchus monkeys have been resistant to SARS-CoV-2 experimental infection, when compared with M. fascicularis and M. mulatta. Experimental studies with rhesus macaques have shown mild disease as frequently observed in human cases and suggest that primary SARS-CoV-2 infection protects against reinfection throughout early recovery days.\\nIn hamsters and ferrets, transmission occurred to other susceptible animals by air. To date, there are no reports of natural cases of SARS-CoV-2 infection in hamsters or ferrets. The Hong Kong Agriculture, Fisheries, and Conservation Department tested two hamsters from guardians positive for SARS-CoV-2, and both were negative. Under experimental conditions, Syrian hamsters (M. auratus) have been successfully infected by SARS-CoV-2, and transmission between cohoused animals was observed by direct or indirect contact with blood, feces, saliva, and tears.\",\n",
       "    'gender': 'Female'},\n",
       "   {'age': 4,\n",
       "    'case_id': 'PMC7652926_05',\n",
       "    'case_text': 'On April 4, 2020, the US Department of Agriculture (USDA) announced that samples from a 4-year-old female Malayan tiger at the Bronx Zoo in New York City tested positive for SARS-CoV-2 by RT-qPCR. The swab samples were collected and tested after two Malayan tigers, three Siberian tigers, and three African lions showed respiratory signs for a week. On April 17, the OIE confirmed that one of the African lions tested positive for SARS-CoV-2 by RT-qPCR. Later on, all these animals and one asymptomatic Siberian tiger tested positive for SARS-CoV-2 by RT-qPCR of stool samples. The five positive tigers live separately in the same enclosure. The three lions live in an enclosure in another zoo area, and they occasionally interacted. The Bronx Zoo also has one Malayan tiger and two Siberian tigers living in a distant enclosure. These three tigers showed no clinical signs. SARS-CoV-2 was identified and characterized in a Malayan tiger. The seven symptomatic animals have improved and are expected to fully recover. In addition, SARS-CoV-2 characterization has shown distinct viral sources for tigers and lions, with similarities between tiger and zookeeper viruses suggesting human-animal transmission, but no identified viral source was found for the infection in lions.\\nOn April 26, 2020, the Dutch Ministry of Agriculture, Nature, and Food Quality communicated SARS-CoV-2 outbreak in two mink (Neovison vison) farms, after respiratory disease and increased mortality. Infection by SARS-CoV-2 has been reported in minks on a farm with 13,000 minks. Additional infections were identified on a second farm with 7,500 adult minks. Three minks with gastrointestinal and respiratory signs were euthanized. Samples of manure, air, and dust collected from the vicinity of the farm are being tested for the presence of the virus. Cats from the farms will also be tested. At least one worker tested positive for SARS-CoV-2 in both farms. It is not surprising that minks are susceptible because they are from the same family (Mustelidae) as ferrets (Mustela putorius furo), and ferrets can be experimentally infected with SARS-CoV-2 and transmit the disease to other ferrets by direct or indirect contact. The infection in minks appears to be a case of human-to-animal infection, once viral sequences of two farms were related to human being sequences, but in separate introductions. In addition, since March 2020, rabbit farms near infected visons have been investigated by the Dutch Ministry of Agriculture, Nature, and Food Quality due to possible susceptibility to SARS-CoV-2.\\nExperimental transmission study has shown that pigs (Sus scrofa) and chickens (Gallus gallus) were not susceptible to SARS-CoV-2, since none of the animals seroconverted and all samples were negative for viral RNA after intranasal inoculation. On the other hand, fruit bats (Rousettus aegyptiacus) have presented virus replication detected by RT-PCR, in situ hybridization (ISH), and immunohistochemistry (IHC) associated with mild rhinitis.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 46,\n",
       "    'case_id': 'PMC3085326_01',\n",
       "    'case_text': \"A 46-year-old man with HIV and a history of cutaneous Kaposi's sarcoma presented with left eyelid droop and left-sided facial numbness five days after restarting antiretroviral therapy following a long hiatus. He was diagnosed with HIV 21 years prior and had a nadir CD4 cell count of 107. His CD4 cell count when he restarted his antiretroviral regimen was 159 cells/mm3, viral load 511,000 c/mL. He had been intermittently compliant with antiretroviral therapy in the past and since resumption of therapy. In 2005, he had a recurrence of Kaposi's sarcoma and received five cycles of paclitaxel with clinical remission by 2006. Physical examination was otherwise unremarkable at the time and magnetic resonance imaging (MRI) of the brain was read as having no significant abnormalities. His symptoms initially were stable, but in the subsequent two months, they worsened, with hypoesthesia and paresthesia over all three branches of the trigeminal nerve on the left, severe headaches, ataxia, dysarthria, and dysphagia. He also began to experience fatigue, weight loss, and night sweats. A repeat MRI revealed enhancing leptomeningeal masses with associated mass effect involving the trigeminal nerve, middle cerebellar peduncle, pons, and upper spinal cord. Review of his prior MRI showed a suggestion of enhancement of the left trigeminal nerve intradurally. \\nA lumbar puncture revealed elevated protein (205 g/dL), slightly depressed glucose (45 g/dL), with 106 leukocytes (32% lymphocytes, 26% monocytes, and 42% unclassified cells), and no erythrocytes. Cerebral spinal fluid (CSF) cytology was notable for atypical appearing cells, which were suspicious for, but not sufficient for a primary diagnosis of malignancy (see Figure 2(a)). CSF flow cytometry demonstrated no clonal B- or T-cell populations, and IGH gene rearrangement was not detected by PCR. CSF PCR for EBV was negative.\\nA bone marrow biopsy was unremarkable and core needle biopsy of a modestly enlarged retroperitoneal lymph node showed no evidence of lymphoproliferative disease. There was no evidence of pleural, peritoneal, or pericardial effusions on computed tomography and ultrasound studies. A positron emission tomography with computed tomography (PET/CT) was then performed and demonstrated increased uptake at the known cerebellopontine lesion, as well as in the posterior inferior wall and papillary muscle of the left ventricle of the heart (Figure 1). An endomyocardial biopsy of the left ventricle was performed via left heart catheterization. Pathology revealed large atypical discohesive cells infiltrating the myocardium. Immunostains of the atypical lymphoid cells were strongly KSHV+ (Figure 2), MUM1/IRF4+, CD79a rare+, CD20-. In situ hybridization for Epstein-Barr virus (EBV) using a probe for EBER showed no staining. Comparison with the CSF specimens showed that these atypical cells were morphologically similar to the suspicious cells in the CSF (Figure 2(a)).\\nA preliminary diagnosis of large B-cell lymphoma was made based on morphologic appearance, and the patient was initiated on treatment with R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone) along with intrathecal methotrexate, cytarabine, and hydrocortisone for the leptomeningeal disease. He was observed on telemetry for one week without cardiac ectopy and was discharged home. One day following discharge, he had syncope and was found to be in ventricular tachycardia with preserved blood pressure, for which he was treated with lidocaine and amiodarone with successful conversion to sinus rhythm. CD20 staining on his pathology returned negative and so treatment with cycle 2 was changed to EPOCH (etoposide, prednisone, vincristine, cyclophosphamide, and doxorubicin) without rituximab. High-dose systemic methotrexate was included to treat the CNS disease. Six weeks into treatment, restaging PET CT imaging showed no persistent FDG-avid disease of the heart, and MRI showing significant resolution of his intracranial tumor. Spinal fluid examination demonstrated no persistent circulating disease in the CSF. Clinically, his headaches, dysarthria, and dysphagia improved, but he still had numbness of his left face along the V1 and V2 distribution of the trigeminal nerve along with an upper motor facial nerve palsy on the left. Some residual gait ataxia was notable on examination.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 14,\n",
       "    'case_id': 'PMC5437796_01',\n",
       "    'case_text': \"A 14-year-old boy presented with neck pain, progressive neck tilt, and spastic quadriparesis of 1 year duration. He had difficulty in swallowing and was bed ridden for 4 months. Examination revealed low hairline, torticollis, and severe spasticity with grade 3/5 power. The modified Japanese Orthopaedic Association score was 9/17 and breath hold time was 8 s.\\nDynamic X-ray of cervical spine revealed AAD, absent spinous process of axis, and fused lower cervical spine. Computed tomography (CT) with three-dimensional reconstruction done showed occipitalization of atlas. Posterior arch of axis and transverse foramen were absent, C3 body was split into halves (butterfly vertebrae), and the posterior elements of C3 were not connected to the bifid body (floating). They were connected to the C4 facet alone. C4-C6 vertebral bodies were fused. C1-C2 joints were oblique [Figure 1]. CT angiography revealed anomalous course of vertebral artery. VAs were skirting along lateral surface of C2 body and turned posteromedially just short of superior facets of C2.\\nThe patient was put on Crutchfield's tong traction starting with 7%-8% of body weight increased over a period of 24 h. Lateral cervical radiographs showed distraction with partial reduction. The patient was operated through midline posterior incision. Inferior surface of C1 arch traced and dissected to identify C1-C2 joints. Bilateral C2 root ganglia were transected to obtain a panoramic view of the C1-C2 joints. The anomalous VA was addressed appropriately, by dissecting and safeguarding it. C1-C2 joints were opened and drilled comprehensively to make them flat in sagittal and coronal plane. Spacers were inserted with bony chips taken from rib graft. C1 screws were inserted into lateral masses and C2 screws were directly inserted into C2 body just below C2 facets. Further manipulation of C1-C2 joints were manipulated using rod holder and loosely fastened rod to realign facets. The arteries were protected while drilling the C1-C2 joints and inserting the screws.\\nPostoperatively, the patient improved neurologically with immediate relief from spasticity. Immediate postoperative scan revealed good reduction of the dislocation and was discharged after a week [Figure 2]. In the 2nd postoperative week, the patient came back with high-grade fever and tachypnea. Although his improved neurological status was maintained, the chest X-ray showed right lower lung showing pneumatic patch [Figure 3]. Repeat CT scan was obtained showing no construct failure. Unfortunately, the patient succumbed to Type 1 respiratory failure.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 43,\n",
       "    'case_id': 'PMC4267161_01',\n",
       "    'case_text': 'B. L., a 43-year-old Caucasian female, was referred in 2007 to our service for thrombocytosis (1,000 x 109/L), discovered during a routine blood checkup. The patient was asymptomatic and there was no personal or familial history of thrombosis or hemorrhage. The full blood counts also revealed a mild leukocytosis (12 x 109/L), with a normal differential count, except for mild basophilia (0.24 x 109/L). The hemoglobin and the hematocrit were within normal range (140 g/L and 42%, resp.). The physical examination revealed no pathologic modifications. A bone marrow biopsy was also performed, revealing megakaryocyte hyperplasia. Thus, the diagnosis of ET was established. In 2008 the detection of the JAK2 V617F mutation became available in our institution, and a mutant allele burden around 25% was found in the patient. The patient was given initially acetylsalicylic acid (ASA) 150 mg/day. However, because the platelets continued to increase to values of around 1,500 x 109/L, the patient was subsequently started on anagrelide, 2 mg/day. Thereafter, the platelets dropped to normal values, with the patient remaining asymptomatic.',\n",
       "    'gender': 'Female'},\n",
       "   {'age': 72,\n",
       "    'case_id': 'PMC4267161_02',\n",
       "    'case_text': 'Four years later, the father of the patient, P. T., a 72-year-old man, was referred to our service for thrombocytosis (1,100 x 109/L), discovered during a routine blood checkup. The blood counts and the peripheral smear revealed no other modifications. The physical examination was normal. The JAK2 V617F mutation tested negative at diagnosis, but other causes of thrombocytosis were ruled out. Thus, the diagnosis of ET was established. The patient was given 150 mg ASA and 1 g hydroxyurea/day. The platelets dropped to near normal values, with the patient remaining asymptomatic. Later, the diagnosis of MPL exon 10 and CALR exon 9 mutations became available in our institution. The patient lacked the CALR mutations, but he was found to harbor the MPL W515L mutation.\\nWe genotyped in both patients also the rs10974944 SNP, which tags the JAK2 46/1 haplotype. Both of them were homozygous for the \"nonrisk\" C allele of the rs10974944 SNP. Thus, none of them carried the JAK2 46/1 haplotype.\\nAll the genotyping procedures were performed on DNA obtained from peripheral blood, using a commercially available kit (Quick-gDNA MiniPrep Kit, ZymoResearch, Irvine, CA, USA). The JAK2 V617F and MPL mutations were genotyped by tetraprimer PCR and multiplex PCR assays, as previously described. The rs10974944 SNP, tagging the JAK2 46/1 haplotype, was genotyped by a PCR-RFLP assay, as we described previously. In order to analyze the common mutations within the exon 9 of the CALR gene (type 1 and type 2 mutations), which account for almost 90% of all CALR mutations, we developed a simplex PCR assay. We analyzed the sequence of CALR gene and developed primers encompassing the two common mutations, using the online program Primer3 v.0.4.0. The primers chosen have the following sequences: forward 5\\'-GCAGCAGAGAAACAAATGAAGG-3\\' and reverse 5\\'-CTTCCTCCTTGTCCTCCTCA-3\\'. The reactions were set up in 20 muL volumes, with the following composition: 10 muL 2xPCR MasterMix (Fermentas MBI, Vilnius, Lithuania), 10 pmoles of each Fw and Rev primers, 1 muL of 2 mg/mL BSA solution (Fermentas MBI, Vilnius, Lithuania), and 50 ng of genomic DNA. The amplifications were run in Applied Biosystems 2720 and Eppendorf Mastercycler thermal cyclers (Applied Biosystems, USA and Eppendorf, Germany), under the following conditions: initial denaturation at 95 C for 10 min, followed by 35 cycles, each comprising denaturation at 95 C for 40 s, annealing at 55 C for 45 s, and extension at 72 C for 40 s, followed by a final extension at 72 C for 5 min. The amplicons were resolved in a 4% MetaPhor agarose gel (Lonza, Rockland, USA), stained with RedSafe (Chembio, UK). In order to validate our PCR assay, we randomly selected 24 samples and sequenced them bidirectionally, using the same primers as described above. There was a 100% concordance between the results obtained by sequencing and those obtained by the PCR assay.\\nThe study was carried out according to the guidelines of the Declaration of Helsinki and informed consent was obtained from both patients.\\nWe also performed a routine clinical and hematological examination on Ms. B. L.\\'s two daughters and on Mr. P. T.\\'s sister, but there were no pathological aspects that would suggest the presence of MPN. In order to search for a possible latent MPN, we also genotyped JAK2 V617F, CALR, and MPL mutations in these three relatives of the patients, but none of them harbored any of these mutations.\\nDuring follow-up, both patients had a favorable evolution, and to date none of them had any of the ET-associated complications (thrombosis or progression to myelofibrosis).',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 48,\n",
       "    'case_id': 'PMC5422736_01',\n",
       "    'case_text': 'A 48-year-old woman was brought to our emergency department because of confusion and incoherent speech. A striking abdominal distention was noted. The patient was not known to have any underlying medical or psychological illnesses and previously had not had any symptoms or complaints. On physical examination, she was alert but disoriented, with no focal neurological deficit. Results of the cardiopulmonary examination were normal. Shifting dullness was elicited on abdominal examination, but the abdomen was soft and nontender. Results of the initial laboratory parameters revealed anemia with hemoglobin of 8.4 g/dL (normocytic/normochromic anemia), white blood cell count 10.3 x 103/muL with left shift, and platelet count 181 x 103/muL. She had renal dysfunction with a serum creatinine level of 3.5 mg/dL. Liver chemistry revealed an albumin level of 2 g/dL, total protein 8.8 g/dL, total bilirubin 1.7 mg/dL, and aspartate aminotransferase 71 IU/mL; otherwise, she had normal liver enzymes. The ammonia level was 28 mol/L. The patient was positive for HIV-1 RNA, but <20 copies/mL were detected, with a CD4 count of 335 cells/mm3, and she had negative viral hepatitis markers. Computed tomography and magnetic resonance imaging of the head showed multiple, bilateral, acute lacunar infarcts with a distribution suggesting an embolic origin. The echocardiography showed no abnormalities, and normal results from the cerebrospinal fluid examination ruled out acute bacterial meningitis. To investigate the abdominal distension, computed tomography and ultrasound imaging of the abdomen were performed, which showed hepatomegaly with mild surface nodularity, massive ascites, and normal spleen size. Abdominal paracentesis was performed, and the fluid analysis results were as follows: white blood cell count 443 cells/mm3, absolute neutrophil count 389 cells/mm3, lactic dehydrogenase 221 IU/L, glucose 72 mg/dL, amylase 45 IU/L, albumin 1.7 g/dL, serum ascites albumin gradient (SAAG) 0.1, protein 6.8 g/dL, and adenosine deaminase activity level 15.8 IU/L (normal = 7.6). Ascitic bacterial and mycobacterial cultures were negative.\\nBecause of the anemia, kidney failure, and albumin protein dissociation, serum protein electrophoresis was performed, which showed an M spike in the beta1-globulin region (see Table 1 for detailed analysis). Serum immunoglobulin levels were as follows: IgM 20 mg/dL, IgG 4.3 mg/dL, IgE 27 kU/L, and IgA 6,033 mg/dL. Protein electrophoresis of the ascitic fluid showed an M spike in the beta-globulin region (Fig. 1). Serum, urine and peritoneal fluid immunofixation showed IgA lambda monoclonal proteins, which confirmed peritoneal infiltration of myelomatous cells. Bone marrow biopsy presented diffuse infiltration by well-differentiated plasma cells, which comprised 49-52% of the nucleated hematopoietic cells. Results of flow cytometry showed lambda light chain restriction consistent with MM. The serum beta2-microglobulin level was 12.5 mg/L, and the skeletal survey was negative, indicating stage III MM according to both the Durie-Salmon staging system and the International Staging System. The patient was discharged to a nursing home and planned to receive follow-up care in the hematology clinic to begin treatment with bortezomib and dexamethasone.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 27,\n",
       "    'case_id': 'PMC3616049_01',\n",
       "    'case_text': 'A 27 year-old African-American male was brought in by his family for altered mental status and possible seizure activity. The family stated that the patient had been complaining of a headache for one to two months. The family noted some mild behavioral and cognitive changes that had progressed over the last month. The week prior to presentation to our facility, the patient had an episode of slurred speech, facial droop, drooling, and seizure-like activity in the left upper extremity. The patient was taken to outlying emergency department (ED) but on arrival to the outside facility his symptoms had resolved. He was evaluated with basic labs and a non-contrasted computed tomography (CT) of the brain. He was discharged from the outside ED with a prescription for naprosyn and doxycycline. Over the next week, he had further behavior changes and became very lethargic. The family brought the patient to our facility for further evaluation at this time. The patient had no known past medical history and no prior surgeries. Current medications included naprosyn and doxycycline that he had received one week prior, no other home medications. Social history was significant for alcohol misuse for 10 years, tobacco use of 1 pack per day for 10 years and occasional marijuana use. The patient had just recently moved back to Tennessee to seek help from his family in quitting alcohol, after living in Texas and working as a bank teller for 7 years. No known travel outside of the country and no known contact with persons with communicable diseases. On physical exam he was well developed, well nourished, profoundly encephalopathic and diaphoretic. Temperature was 103 F, heart rate 87 beats/min, blood pressure 154/84 mmHg, respiratory rate 16 /min, and oxygen saturation 99% RA. His cardiovascular, pulmonary, and abdominal exams where unremarkable, skin was notable for significant diaphoresis without rash. He was unable to follow commands for a full neurologic exam but was confused and combative, moved all extremities spontaneously and with equal strength, and did exhibit significant photophobia or nuchal rigidity.\\nInitial laboratory data revealed leukocytosis of 11.7 th/mm3 with 92% neutrophils otherwise hemoglobin, hematocrit, and complete metabolic panel where within normal limits. Cerebral spinal fluid evaluation revealed WBC count of 302/mm3 with 98% lymphocytes, glucose 14 mg/dl, protein 144 mg/dl, and was clear in character. Chest x-ray and non-contrast CT of head where without significant pathology. After blood cultures had been obtained and initial CSF studies sent, the patient was place in the neurologic intensive care unit and started on broad spectrum antibiotics with vancomycin and piperacillin/tazobactam. Over the next twelve hours the patient was closely monitored and supportive care was continued as initial results began to return. Gram staining of CSF and blood was negative for bacteria and HIV, RPR, Cryptococcal antigen, HSV PCR where negative. The patient showed minimal mental status improvement within the first 24 hours and an MRI of the brain and Neurologic consult where obtained. MRI with and without contrast revealed right basilar meningeal enhancement with an acute right basil ganglia infarction (Figures 1,2). Given the characteristic finding of the CSF and MRI a PPD was placed and Infectious disease was consulted. PPD was read as negative at 48 hours by nursing staff and re-read as positive at 72 hours by an infectious disease physician. Initial direct smears of two separate samples of CSF where negative for acid fast bacilli, and PCR of the CSF was negative for TB on two different occasions. CT of the chest was obtained to look for possible source of infection and revealed right upper lobe nodules with central cavitations (Figures 3,4). Biopsy of the lung was performed and pathology revealed necrotizing granulomatous inflammation with acid fast bacilli (Figures 5,6). Initial concentrated direct smears for acid fast bacilli from the lung biopsy where negative, but Mycobacterium tuberculosis was isolated and identified by DNA probe with High Performance Liquid Chromatography at 32 days.\\nTreatment should be initiated on the basis of strong clinical suspicion. As mentioned previously it may take several repeated studies before obtaining positive proof of tuberculous infection and delay in treatment often leads to irreversible deficits or death. Recommended treatment is for 9-12 months and is divided into two phases. The intensive phase is four drug therapy with isoniazid (INH), rifampin (RIF), pyrazinamine (PZA), and either ethambutol (EMB) or streptomycin (STM) for two months followed by a continuation phase of INH and RIF for 7-10 months depending on clinical response and sensitivity of the specimen.\\nOnce empiric TB coverage was started the patient showed significant clinical response with improvement of his mental status, but at the time of discharge still had prominent personality, memory, and functional impairment.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 32,\n",
       "    'case_id': 'PMC4231314_01',\n",
       "    'case_text': 'This 32-year-old-man was admitted to the emergency department because of S1 left acute sciatica. An emergency CT-scan showed a highly probable appearance of herniated disc in L5-S1 level (A). The patient was operated without finding disc herniation, but an aspect of anterior and posterior epidural abscess compressing the dural sheath at L5-S1. Medullary MRI showed after the up and the down extention of disease process (B). Histological examination of samples found a B lymphoblastic leukemia (C). The patient died 3 weeks after because of systemic infection. After review of literature, it was never been described that the sciatic pain can be a mode of revelation of B acute lymphoblastic leukemia. Only two cases reported this mode of revelation but for lymphoma requiring a surgical intervention -as our case- firstly to relieve the patient by a radicular decompression and secondly for histological diagnosis.',\n",
       "    'gender': 'Unknown'}],\n",
       "  [{'age': 41,\n",
       "    'case_id': 'PMC4821335_01',\n",
       "    'case_text': 'A 41 year old lady presented with dry cough and progressive breathlessness for a year. She was evaluated in another centre with a CT thorax and VATS biopsy 3 months into illness. This showed fibrosing interstitial pneumonia (the slides reviewed in our centre was reported as organizing pneumonia). Post biopsy, she developed a left sided loculated pneumothorax, and this remained even after intercostal drainage. She was treated with oral corticosteroids. After a brief period of stability, her symptoms continued to progress. Azathioprine was added on for another 3 months with no response and hence stopped. She was then briefly initiated on Pirfenidone, which was stopped due to intolerance. When she presented to us, she was only on oral steroids. In the mean time, she developed a spontaneous pneumothorax on right side which completely resolved with intercostal tube drainage. There was no history suggestive of a connective tissue disorder. Her co-morbidities were type 2 diabetes mellitus, hypothyroidism and primary infertility. On examination, she was not clubbed. She had reduced air entry in the left infraclavicular region and bilateral diffuse crackles and squeaks. Her room air saturation was 95% but she quickly desaturated to 82% on exertion. Her ABG revealed chronic type 2 respiratory failure with hypoxia. Her CT scan (Fig. 1) revealed loculated pneumothorax in left upper zone, pleural and subpleural parenchymal fibrosis with upper lobe predominance. The fibrotic changes have significantly worsened compare to previous CT picture.\\nThe differentials considered were idiopathic pulmonary fibrosis, idiopathic pleuroparenchymal fibroelastosis and chronic hypersensitivity pneumonitis. Absence of response to steroids and absence of triggering factors dissuaded a diganosis of chronic hypersensitivity pneumonitis. She was started on the maximum tolerable dose of Pirfenidone(400 mg thrice a day) and the oral steroids were gradually tapered. She underwent pulmonary rehabilitation. She was also initiated on nocturnal Non-invasive Ventilation (NIV) at IPAP (Inspiratory Positive Airway Pressure) of 15 cm of H2O and EPAP (Expiratory Positive Airway Pressure) of 6 cm of H2O and long term oxygen therapy was initiated at 1 L/min. She re-presented with increasing shortness of breath, cough with purulent expectoration and pleuritic right sided chest pain. A CTPA was done to rule out a pulmonary embolism and revealed new areas of bilateral ground glass opacities. She was initiated on intravenous antibiotics. After an improvement for few days, she deteriorated with reduced sensorium secondary to worsening type 2 respiratory failure. Her supports on the NIV were increased. She succumbed to her illness in the next couple of days.\\nAn autopsy was performed. The pleura appeared fibrotic and adherent to the underlying lungs. The right and left lungs were contracted and weighed 250 g and 335 g, respectively. Serial sectioning revealed areas of consolidation and fibrosis. On histopathological examination (Fig. 2), there was marked pleural fibrosis and elastosis with involvement of the underlying lung parenchyma. There was interstitial fibrosis and elastosis with some of the alveoli displaying type 2 pneumocyte hyperplasia. Overall, the features were in keeping with pleuroparenchymal fibroelastosis. As there were no precipitating factors, we concluded her to have had Idiopathic Pleuroparenchymal Fibroelastosis (IPPFE).\\nThe various differentials considered were discussed with the patient and her husband. A few uncoventional treatments were given with good intentions (Pirfenidone for possible idiopathic pulmonary fibrosis and NIV for type 2 respiratory failure in the presence of a loculated pneumothorax), and these were discussed with the family prior to initiation.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 29,\n",
       "    'case_id': 'PMC4643352_01',\n",
       "    'case_text': 'A 29-year old male chronic smoker (10 pack years) with a negative vasculitis screen presented with a three-week history of poor healing of a right third toe ulcer. An arterial duplex ultrasound and CT Angiogram (Fig. 1) found that the anterior tibial artery (ATA), which was the target angiosome vessel, was occluded. Segments of the plantar artery were also occluded. The angiographic images of the distal posterior tibial artery (PTA) (Fig. 2) were suggestive of underlying Buerger\\'s disease.\\nThe patient underwent a tibial angioplasty. An attempt to reopen the ATA antegradely resulted in the guidewire traversing subintimally in the mid ATA and was unable to re-enter the true lumen distally. Retrograde attempt with fluoroscopy was technically difficult as the visible target dorsalis pedis artery (DPA) was too small. An ultrasound guided approach could not find a sufficient patent lumen. In view of poor imaging quality from both techniques but with a potential target distal DPA, a decision was made for an open approach.\\nAs the patient had preoperatively undergone a popliteal nerve block, the skin overlying the DPA was cut longitudinally for 3 cm (Fig. 2b). The artery was identified but not dissected out and looped as traditionally performed. The surrounding tissue around the vessel provides a stable platform for direct puncture. Using the transpedal/micropuncture 4 Fr needle kit (Angiodynamics Inc., NY) the DPA was punctured and back bleeding was obtained. A V18 (0.018\") (Boston Scientific, MA, USA) wire (Fig. 2c) was used to traverse the occluded point of the distal ATA supported with a 2.6 Fr angled CXI (Cook, Bloomington, USA) catheter. The wire was retrieved via an antegradely passed Berenstein 2 catheter (Angiodynamics Inc., NY) at the proximal ATA (transluminally). Subsequently an antegradely passed CXI catheter was passed just proximal to the puncture point of the DPA and the V18 wire was retrieved. The puncture point was closed with a 7/0 prolene stitch. A PT2 0.014\" (Boston Scientific, MA, USA) wire was passed antegradely and passed beyond the puncture point and into the tarsal branch of the DPA. A 0.014\" 2 mm x 80 mm Nanocross (EV3, Covidien, Plymouth, USA) balloon angioplasty was performed across the puncture followed by 0.014\" 2.5/3.0 mm tapered balloon (EV3, Covidien, Plymouth, USA) to the ATA (Fig. 3). Check angiogram revealed good run off to the DPA and the metatarsal artery and a palpable DPA was present. He underwent a third toe ray amputation with good bleeding from the raw edges of the wound. Patient was subsequently placed on double antiplatelet therapy, a statin and was advised to stop smoking. During his routine follow up in the clinic (8 weeks post angioplasty) the wound had healed and he still had a palpable DPA.',\n",
       "    'gender': 'Male'},\n",
       "   {'age': 62,\n",
       "    'case_id': 'PMC4643352_02',\n",
       "    'case_text': 'A 62-year old female with end stage renal failure on haemodialysis, diabetes, hypertension and hyperlipidaemia, presented with a 3-week history of left fourth toe wet gangrene. Duplex imaging and on table angiogram (Fig. 4) revealed PTA and ATA occlusions but ATA reconstituted distally by the peroneal artery (main run off). Plantar arch was also incomplete. Vein mapping showed no suitable conduit for bypass.\\nAn antegrade angioplasty of the ATA was attempted with multiple wires and supporting catheters and balloons, which proved unsuccessful. The vessel wall was moderately calcified and an attempt at retrograde percutaneous technique using an ultrasound also failed. As the patient was already under regional anaesthesia (popliteal nerve block), DPA was exposed by surgical cutdown and directly punctured with a 4F micropuncture set (Angiodynamics Inc., NY). A 2.6 Fr angled CXI (Cook, Bloomington, USA) crossing catheter over a V18 (Boston Scientific, USA) wire was used to guide the wire transluminally towards the proximal ATA, where it was snared with 4 Fr Berenstein 2 (Angiodynamics Inc., NY) catheter. The angled 2.6 Fr CXI (Cook, Bloomington USA) catheter was then inserted antegrade up to the retrograde puncture point at which point the v18 wire was exchanged with an antegrade PT2 (0.014\" Boston Scientific) guidewire to traverse into the DPA. The puncture point was closed with 7/0 prolene stitch (Ethicon, USA). Post dilatation with a 0.014\" balloon angioplasty showed significant recoil (>50%) at the DPA. A Maris deep (Medtronic MN, USA) nitinol self-expanding stent 3 mm x 80 mm was deployed across the ATA to proximal DPA. However the distal DPA still showed significant stenosis with poor outflow therefore a 3mm x 28 mm Xience Prime (Abbott, Santa Clara, USA) drug eluting stent was deployed across the distal DPA (covering the puncture point). Subsequent angiogram showed rapid outflow to the digital vessels (Fig. 5). The third, fourth and fifth toes were amputated, which showed brisk back-bleeding.\\nOne month post intervention the wound showed poor healing and a surveillance duplex scan showed the ATA and DPA stents were thrombosed. Patient underwent a successful antegrade passage of guidewire across the blocked stent and into the metatarsal artery. On angiogram it was discovered the proximal ATA stenosis was the cause of early occlusion and this was treated with a proximal stent. The wound had healed completely at two months follow-up.',\n",
       "    'gender': 'Female'},\n",
       "   {'age': 64,\n",
       "    'case_id': 'PMC4643352_03',\n",
       "    'case_text': 'A 64-year old male with diabetes and hypertension was admitted with a 3-weeks history of left heel gangrene. He had absent popliteal and pedal pulses. Duplex imaging revealed multi-level peripheral artery disease with left superficial femoral, tibioperoneal trunk (TPT) stenosis and PTA occlusion. He underwent an antegrade femoral angiogram and successful balloon angioplasty of his SFA, popliteal and TPT. However, the guide wire was not able to re-enter the true lumen of the distal PTA, despite using a supporting catheter and a multitude of wires (Fig. 6a and b). As the PTA vessel was calcified, attempt via retrograde ultrasound guided puncture was unsuccessful due to a poor ultrasonic window. Fluoroscopic guided puncture was also attempted but failed. The PTA was dissected out and punctured under direct vision with a micopuncture set (4 Fr Angiodynamics Inc., NY). A V18 (0.018\" Boston Scientific, MA, USA) wire on a supporting catheter was used and the wire stayed intraluminally and was retrieved at the distal end of the proximal PTA with an antegradely passed 4F Berenstein Catheter (Angiodynamics Inc., NY). After crossing the distal puncture site with a lower profile wire, balloon angioplasty of the whole length of the PTA was performed. There was good flow into the medial plantar artery on completion (Fig. 6c and d). The heel looked well perfused by the PTA and it was debrided. The patient was started on dual antiplatelet and the wound healed completely 10 weeks after revascularization.\\nThe open surgical cutdown wounds in all three cases healed without any complications.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': None,\n",
       "    'case_id': 'PMC8668381_01',\n",
       "    'case_text': 'A term female neonate, weighing 2.63 kg, was delivered in our hospital and was diagnosed with EA/TOF at birth. The antenatal investigations were normal. It appeared as a routine EA/TOF case. She was stabilized, investigated, and underwent primary repair of the EA/TOF on day 3. An extrapleural approach through a right-sided thoracotomy was used. Following ligation of the TOF, the two esophageal ends were mobilized and anastomosed end-to-end with interrupted sutures. Abnormal large arterial vessels were seen coursing across the surgical fields; however, this abnormal anatomy did not interfere with the surgery.',\n",
       "    'gender': 'Female'},\n",
       "   {'age': None,\n",
       "    'case_id': 'PMC8668381_02',\n",
       "    'case_text': \"The patient developed bilious aspirates on day 8. We did an upper gastrointestinal (GI) contrast series that suggested a duodenal obstruction. In the same series, a communication between the right lung lower lobe and esophagus was identified at T8-T9 level ( Fig. 1A ). The patient underwent an exploratory laparotomy on day 9. Intraoperatively, she was found to have DA/AP and intestinal malrotation. She subsequently underwent a Ladd's procedure and a gastrojejunostomy to bypass the duodenal obstruction. A typical duodenoduodenostomy could not be performed as the two atretic ends of the duodenum were far apart. A repeat contrast swallow performed 5 days later confirmed the patency of the esophageal and gastrojejunal anastomosis but also identified a second communication from the esophagus into the right lower lobe at T5-T6 level ( Fig. 1B ). This created a diagnostic dilemma in the form of a recurrent TOF.\",\n",
       "    'gender': 'Female'},\n",
       "   {'age': None,\n",
       "    'case_id': 'PMC8668381_03',\n",
       "    'case_text': 'The postoperative course in the neonatal unit was also difficult, the infant did not tolerate nasogastric feeds secondary to severe gastroesophageal reflux, and therefore she was given nasojejunal feeds instead. She was initially ventilator dependent and on high flow oxygen in the latter period. The child also underwent esophagoscopy and bronchoscopy during the 5th and 7th week of life. The bronchoscopy findings were normal demonstrating no recurrent TOF, but the esophagoscopy showed an opening, discharging purulent material corresponding to the second communication from the esophagus into the right lower lobe at T5-T6 level ( Fig. 1B and C ) and a patent esophageal anastomosis. Subsequently computed tomography (CT) thorax confirmed two separate communications between the esophagus and right lung tissue, with an accompanying anomalous blood supply ( Fig. 1D ).',\n",
       "    'gender': 'Female'},\n",
       "   {'age': None,\n",
       "    'case_id': 'PMC8668381_04',\n",
       "    'case_text': 'At exploratory thoracotomy at 4 months of age, a three-lobed right lung was seen; however, the lower lobe was enlarged and connected in two separate locations to the esophagus. The right lower lobe was separated from the esophagus, by ligating and dividing these two fistulous connections, which bore more resemblance to bronchial type tissue, followed by a partial lobectomy ( Fig. 2A ). A postoperative upper GI contrast series identified a patent esophageal anastomosis, no leakage, and no fistulous connections ( Fig. 2B ). The child required postoperative ventilation for 12 days. The chest drain was inserted intraoperatively. It was removed on 20th postoperative day as there was chest infection with suspicion of collection. She was also given a prolonged course of antibiotics according to culture and sensitivity reports of chest drain fluid and stopped after removal of chest drain. The child was discharged on postoperative day 41 with full oral feeds at 5 months of age. She is currently feeding well and gaining weight as per the last follow-up that was done at 6 months postoperatively.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 23,\n",
       "    'case_id': 'PMC10046697_01',\n",
       "    'case_text': 'A 23-year-old female initially presented with a 2-month history of severe frontal sinus headaches and upward gaze diplopia. She had no other significant medical issues and denied nasal symptoms. An outside magnetic resonance imaging scan of her brain was obtained that showed a left ethmoid mass measuring 2.4 x 2.3 x 2.5 cm extending into the left frontal sinus. A computed tomography sinus was then done in the office that revealed an expansile mass destroying the left lamina papyracea and fiberoptic laryngoscopy demonstrated a mass in the posterior nasopharynx adjacent to the left orbit and posterior to the left middle turbinate (Figure 1).\\nShe was taken emergently to the operating room for functional endoscopic sinus surgery (ESS) under COVID restrictions and the frontal ethmoid mucocele was completely decompressed. A culture of the left frontal sinus was taken and did not show any fungal organisms. The patient then performed daily nasal saline irrigations and presented to postoperative appointments with mild orbital pain that decreased in intensity with each subsequent visit. Monthly nasal endoscopies consistently revealed an open, wide area at the site of the decompressed mucocele for three consecutive months. Three weeks later, she called the surgeon (N.L.S.) one Saturday night complaining of sudden onset, sharp pain that felt like she had a \"knife in her left eye.\" She was treated conservatively over the weekend with nasal irrigations and a nasal corticosteroid spray. A video endoscopy in the office revealed a sharp object penetrating the left orbital tissue (Figure 2). Attempted removal under video endoscopy failed and was painful as the spicule was impacted into the periorbital tissue that was now unprotected because the bony lamina papyracea had been resorbed by pressure from the mucocele. The object was finally irrigated under general anesthesia in the operating room. Spicule fragments were cultured and sent to pathology. Both reports were consistent with Aspergillus fumigatus. The patient\\'s \"knife-like\" pain was relieved after the procedure, but orbital pressure persisted until the fungal infection was brought under control.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 32,\n",
       "    'case_id': 'PMC6884723_01',\n",
       "    'case_text': 'A 32-year-old man with no antecedent comorbidities presented to the emergency department of a tertiary hospital in South Western Nigeria with an acute onset high-grade intermittent fever with chills and rigors, headache, myalgia, abdominal pain, and vomiting. There was no reported diarrhea or yellowness of the eyes. Prior to presentation, he had used oral anti-malaria medications, oral ciprofloxacin and antipyretics with no improvement. He worked as an agricultural research fellow and routinely spent a fair amount of time at work outdoors in farms and fields. Physical examination showed an acutely ill looking febrile patient with a temperature of 38.9 C, blood pressure of 120/70mmHg, a pulse of 92 beats per minute, and a respiratory rate of 24 cycles per minute. The rest of his physical examination was normal. His initial laboratory evaluation showed a leukocyte count of 7,090/mul of which 84.7% were neutrophils, a hemoglobin of 14.5g/dl, and platelet count of 89,000/mul. Activated Partial Thromboplastin Time (APTT) and prothrombin time were prolonged by 15.2 and 5.3 seconds, respectively. A slightly elevated INR of 1.35, but a markedly elevated D-dimer of 224.6mug/ml (ref 0-0.5mug/ml) were observed. The renal biochemical parameters were normal except for creatinine of 1.5mg/dl. Apart from an AST of 223 IU/l and an ALT of 70IU/l, all other liver function tests were normal. Urinalysis revealed microscopic hematuria. Other investigations are detailed in Table 1. Intravenous ciprofloxacin, metronidazole, and parenteral artesunate were commenced.\\nOn subsequent review, the temperature was 39.2 C, pulse was 102 beats per minute, and there was tenderness on the right iliac fossa and suprapubic areas. Ciprofloxacin was changed to ceftriaxone, and parenteral metoclopramide was added to control the vomiting which had persisted since admission. On the fourth day of admission, he complained of rhinorrhea. Further physical examination revealed a mildly inflamed pharynx with no significant regional lymph node enlargement. Pulse was 82 beats per minute, blood pressure 110/70mmHg, respiratory rate of 32 cycles per minute, and reduced breath sounds in the middle and lower zones. Chest X-ray showed perihilar patchy opacities worse on the right with few patchy opacities on the right upper and lower zones. With concern for a sub-optimally treated community-acquired pneumonia, azithromycin was added for atypical pathogens. The following day, the temperature was noticed to be 40.5 C despite regular antibiotics. Pulse was 100 per minute, blood pressure was 130-170/60-100mmHg. The respiratory rate was 62 cycles per minute, and SpO2 was 79-81% while breathing ambient air. Percussion notes were dull on the right lower zone, and breath sounds were vesicular with a mix of coarse crackles and rhonchi on the right lower zone.\\nA repeat laboratory evaluation showed worsening microscopic hematuria, thrombocytopenia, and a leukocytosis of 11,720/mul. Blood film for malaria parasite detection was repeatedly negative. Supplemental intranasal oxygen at 4L per minute was administered. Loratadine and amlodipine were added, and the patient was transferred to the Intensive Care Unit (ICU) for respiratory support. In the ICU, the dyspnea improved with oxygen therapy by face mask. SpO2 on oxygen therapy ranged between 93% and 97%. Respiratory rate was 26 cycles per minute, pulse was 88 beats per minute, and blood pressure was 135/76mmHg. However, he continued to have high-grade fever, tachypnea and developed diarrhea with dark-colored stools over the next 3 days while in the ICU. On the 10th day of admission, a positive result for viral hemorrhagic fever screening using real-time RNA polymerase chain reaction panel detecting the dengue virus was obtained. Supportive management was continued. After 16 days of conservative management, the patient had an uneventful recovery and was discharged home from the hospital. He was established to have a normal blood pressure with no medication after a year of follow up.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 47,\n",
       "    'case_id': 'PMC3921775_01',\n",
       "    'case_text': 'A 47-year-old man presented with dysuria. Digital rectal examination revealed a nodule in the left lobe of the prostate. The prostate-specific antigen (PSA) level was 65.5 ng/mL. Transrectal biopsy of the prostate revealed adenocarcinoma. A computed tomography (CT) scan, magnetic resonance imaging, and bone scan showed no metastasis. After two months of neoadjuvant hormonal therapy (leuproreline and bicalutamide), retropubic radical prostatectomy and obturator lymph node dissection were performed. The pathological finding was a moderately differentiated adenocarcinoma (Gleason score 3 + 4 = 7) (Fig. 1A). The surgical margins and obturator lymph nodes were negative.\\nHe was young and was a high-risk patient for recurrence; hence, postoperative adjuvant hormonal therapy (leuproreline and bicalutamide) was started immediately. Three years later, hormonal therapy was changed to monotherapy (bicalutamide). Monotherapy was discontinued because the PSA level was maintained below 0.04 ng/mL for eight years. Two years after the discontinuation, the PSA level increased gradually to 0.73 ng/ml. A CT scan showed no metastasis. He was diagnosed with biochemical recurrence and refused to receive salvage radiotherapy. Complete androgen blockade (leuproreline and bicalutamide) was restarted, and an intensive follow-up was performed every 1 to 1.5 months. Twenty-one months after the biochemical recurrence, the PSA level increased to 10.4 ng/mL and a CT scan showed left inguinal lymphadenopathy (Fig. 2A). The maximum size of the lymph nodes was 2 cm in diameter. To determine whether the lymphadenopathy was caused by metastatic prostate cancer, one of the swollen inguinal lymph nodes was obtained by open biopsy. Pathological findings revealed metastatic prostate cancer (Fig. 1B). The patient was then treated with estramustine phosphate sodium and dexamethasone for 1 year. The size of the lymph node decreased to 8 mm in diameter, and no other metastatic lesions were found (Fig. 2B). The PSA level decreased to 0.2 ng/mL.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 0,\n",
       "    'case_id': 'PMC5827702_01',\n",
       "    'case_text': \"Growing up, father and son had relatively little to do with one another. Nine siblings were formidable competition, and the eldest - a girl - was already twenty years old when Heisaku came along, by which time fatherhood for Takataro may have lost much of its charm. To make matters worse, under Japan's ie (household) system, the first son mattered by far the most in terms of family name and inheritance. Heisaku's existence was, at least in this social sense, neither here nor there. His eldest brother's name -   : Soei - meant religious glory or honour. Heisaku -    - meant 'normal crop'.\\nOther than Kosawa's early wish to become Prime Minister, which he attributed to the influence of his father's politics, there is little evidence that Takataro attended to or shaped the young boy directly in any meaningful way. Kosawa later recalled Takataro reserving most of his attention instead for the third son of the family, Saburo, who appears to have suffered with behavioural problems. Kosawa resolved to become a psychiatrist one day partly so that he could better understand people like Saburo - how they came to be the way they were, and what might be done about it.\\nTakataro's influence on Kosawa was largely indirect, but formidable nonetheless. He plainly scared his son, who found him overbearing, unpredictable, stubborn and fundamentally selfish (Kosawa, yume bunseki). He recalled his father once complaining to him about the cost of Heisaku's lengthy hospital treatment for a detached retina while in his mid-20s. Despite this being a serious condition, and doubtless a frightening experience, the only fatherly comments that stayed with Kosawa were that one family member shouldn't be allowed (financially) to destroy the rest. Even as Takataro lay dying, there was no let up. Kosawa was by this point a fully qualified medical doctor, pursuing a specialism at one of the country's most prestigious universities. His father simply asked him how long he intended to keep messing around 'at school' (Kosawa, Satogaeri no ki). Kosawa, for his part, tried to bring what he could of his medical know-how to prolonging his father's life. He was unsuccessful, and may even have blamed himself for his father's early death in 1931.\\nTwo things now happened. First, Kosawa started to identify himself with Prince Ajase, who in a famous Buddhist legend set during the lifetime of the historical Buddha imprisons and then kills his father, King Bimbisara. By the summer of 1931, Kosawa had published a mixed psychoanalytic and religious theory of guilt based on this legend, including in it his parable of the smashed plate. Second, Kosawa left Japan in late 1931 to seek out Sigmund Freud. He wrote to his brother Ichiro - the fourth son, who having inherited the family's money agreed to help finance Kosawa's trip - that his aim was to get Freud's approval for his new 'Ajase Complex' idea and then return to lay his completed thesis at their father's grave (Kosawa,).\",\n",
       "    'gender': 'Female'},\n",
       "   {'age': 10,\n",
       "    'case_id': 'PMC5827702_02',\n",
       "    'case_text': \"In Kosawa's parable, the child's mother appears by contrast as a saintly figure: capable of great patience and gentleness but also possessing a spiritual gift of sorts, able to see into the depths of the child, meet him there, and nurture a 'truly religious state of mind'. Kosawa's own mother, Kon, was a rather more complex figure, and in any case as was common for a family of the Kosawas' standing, the young Heisaku was mostly looked after as a child not by his mother but by a local girl serving as his nanny. 'Ichi' was around ten years old when she began looking after Heisaku, and as one might expect from someone of that age was not entirely committed to the idea of responsible childcare. Missing her friends, she once tied Heisaku to a tree so that he couldn't wander off while she went out to play. Much later in life, Kosawa's thoughts used to return frequently to that moment - a sign, thought one of his students, that his idealization of the maternal possessed deep roots not in satisfaction but in longing and loss (Takeda,). 1  \\nKosawa was by no means out of the ordinary here. He grew up in a society many of whose men rhapsodized rather than really knew their mothers (Napier,), and who sought to fix the womanly and the maternal as comforting social, emotional and even spiritual categories. She was, nevertheless, a strong presence in his life, ensuring that 'home' offered a reassuring resonance and embrace for Heisaku - powerful enough to surface years later in his free associations. He remembered her joy when he used to return home from boarding at his Higher School in Sendai, in the north of Japan. Mother would make amazake - a sweet rice drink - to welcome him back. She would smile at him as he licked his cup - 'like a baby', he wrote, 'just moving onto solid food'. Heisaku remembered too the vivid sensation of being in the bath with her (Kosawa, yume bunseki).\\nKosawa's early relationships with his father and mother seem to have shaped his attitudes towards both Buddhism and mental health, and to have inspired his interest in seeing the two placed together in a single, salvific system - albeit with Buddhism and psychoanalysis still retaining separate goals and languages and institutions of their own. Helping to set this emerging conversation in train was a Buddhist monk of the Jodo Shinshu (Shin) sect by the name of Chikazumi Jokan. Kosawa met Chikazumi while he was at Higher School in northern Japan, encountering via him a highly devotional, emotional form of Buddhism in which intra-familial relationships were understood as furnishing the individual with transpersonal salvific opportunity. Chikazumi came to this realization while lying in bed one day, critically ill, and hearing his father by his bedside quietly wishing his son's troubles upon himself. It became a moment of conversion: an encounter with compassion so strong and pure that all at once it broke him out of the small, citadel mentality of a young university intellectual, showing him instead a truer, more vital vision of himself - as weak, vulnerable and loved (Iwata,).\\nThe proximate source of this love and compassion was his father. Their ultimate source, for human beings, was the quasi-monotheistic figure of the cosmic Buddha 'Amida' - the Buddha of Infinite Light. The thirteenth-century founder of Shin Buddhism, a man by the name of Shinran, had insisted that the limits of human nature and the boundless compassion of Amida were such that a person needed only to recite a short prayer - Namu-Amida-Butsu: 'Hail to Amida Buddha' - in order to be saved. This wasn't some magical formula. Rather, it was an honest and profoundly generative recognition of weakness, such that the very term 'weakness' lost its typical, negative connotations.\\nThe voice with which I call Amida Buddha\\nIs the voice with which Amida Buddha calls to me.\\nShinran went as far as to say that this prayer could only be truly spoken by Amida Buddha himself, working at the deepest level of a person's subjectivity. As Kai Wariko, a modern Shin poet, put it:For Chikazumi, and soon for Kosawa, the full force of his home life coming into play alongside a new-found devotionalism, modern Japanese family relationships were the means by which Amida's mercy broke into mundane, linear time, and into mundane, human lives (Iwata,).\\nTo twenty-first century ears, much of this must already sound like psychotherapy of a sort (Ross,). But for Kosawa, the connection only really came when he encountered the writings of Sigmund Freud while at university. He found in Freud a modern-day Shinran: someone who understood human frailty, and appeared to be on a quest to tease out and treat them, bringing all the tools of modern science to the task.\\nA few months spent in Vienna, with Freud and his circle, failed to change Kosawa's mind about Freud and the purpose of psychoanalysis, although he did write home to his brother to say that he was a little disappointed with the general level of psychoanalytic practice in Vienna - and was looking forward to getting home to start his own clinic in Tokyo (Harding,). 2  This he accomplished in 1933, seeing hundreds of clients from all walks of life over the next few years - students, farmers, civil servants, company employees, even a sushi chef, a politician, and a Buddhist monk. From his client records, and from the testimony of those still alive who were treated by Kosawa, we get a sense of the therapeutic fruits of Kosawa's inner religion-psy dialogue across his early life.\\n  Kosawa's impeccably neutral consulting room - Buddhist conversation with interested clients would instead be held next door, once the session had ended.\\nPerhaps most revealing are the records of what Kosawa called 'psychoanalysis by mail'. This involved asking clients who couldn't make it for face-to-face sessions in Tokyo to send him, at regular intervals, two documents. The first was a covering letter, addressed to Kosawa. The second was a written record of a period of solo free association - all that had flashed through their heads when they obeyed the standard psychoanalytic command to allow their thoughts and feelings to go where they will. The first document told Kosawa about the client's own self-understanding. The second was the really interesting one: it revealed something of what lurked in the client's unconscious. As therapy went on, Kosawa would hope to see material move from this second document into the first: unconscious elements making their way into conscious awareness.\\nCovering up the ears symbolizes castration, which in turn suggests your desire to become a girl as a means of securing affection from your father. What's more, your recollection and sharing of that memory now may well be a sign of homosexual feelings towards me ...\\nOne client confided in Kosawa that he recalled being embarrassed, as a child, when his parents forced him to wear a girl's rubber swimming cap at the seaside. Kosawa responded that he hadn't been embarrassed at all: he had liked it. \\nPerhaps the client spilled his morning tea as he read this. Maybe he glanced nervously over the top of the letter at his father sitting across the table. Whatever happened, this was part analysis, part carefully calibrated attempt to nudge a client who was beginning to over-intellectualize the process of therapy into precisely the kind of gentle, helpless humiliation that Kosawa believed Shinran and Freud were agreed was central to the success of religious practice and psychotherapy alike. One day, a client of Kosawa's reported to him a vivid experience of being momentarily outside of himself, or at least not quite 'in' himself in the usual way. Kosawa was overjoyed. That, he said, is the real aim of psychoanalysis. Without it, psychoanalysis as a technique can never survive (Harding,).\\nAwareness in the West of the Shin Buddhist sect to which Kosawa belonged has generally been low, despite its considerable size and power in Japan. 3  Buddhism, and especially Japanese Buddhism, has tended to be associated more with Zen. One of the reasons put forward for this is that in Zen, mid-twentieth-century Westerners found a combination they felt Christianity failed any longer to provide: vivid experience, real inner change, minimal theological baggage. Shin Buddhism's emphasis on faith and fundamental human inadequacy, by contrast, was too close for comfort to Protestant, particularly Calvinist Christianity. Why travel thousands of miles to a brand new culture - whether literally or in one's reading - only to find the very thing you were trying to escape?\\nAnd yet for all the past and on-going interest in how Zen and psychoanalysis might work together, pioneered in the late 1950s and early 1960s by Erich Fromm and Japan's famous Buddhist evangelist D.T. Suzuki (Fromm, Suzuki, & De Martino,), Shin Buddhism and psychotherapy - as Kosawa's experience shows - possess promising commonalities. So it is all the more interesting to see that just five years after Fromm and Suzuki's work was published, Protestant Christianity and psychotherapy were entering into dialogue via a radio and television studio conversation between the German-American theologian Paul Tillich and Carl Rogers - the latter once having spent time in training for the Christian ministry.\\n Carl Rogers in conversation with Paul Tillich, filmed for television in 1965.\\nWe may identify four key themes arising in and from Kosawa's inner religion-psy dialogue and the more literal 'dialogue' between Tillich and Rogers: a concern with the damaging social and psychological impact of modernity; a conviction that a profound experience of acceptance lies at the heart of the remedy; a sense that, almost by definition, this cannot be effected by the individual acting alone for his or her own benefit; and a danger - pointed out by critics - that such a remedy, especially where it takes hybrid religion-psy form, risks fostering subjectivities more suited to the totalitarian societies of the recent past in Europe and Japan than their postwar counterparts. It is worth briefly addressing each of these themes in turn.\\nKosawa Heisaku was a great critic both of what he saw as pathological individualism in early 1930s Japan and the false community and comfort offered by Marxism and by Japan's 'new religions', the latter striking Kosawa as shallow and manipulative. Kosawa was hardly alone in these concerns: commentators from the novelist Natsume Soseki through to journalists and philosophers like Watsuji Tetsuro worried about Japan's social and cultural fabric coming apart under the pressure of successive waves of Western fads and fashions from the late nineteenth century onwards. In the United States, both Paul Tillich and Carl Rogers worried, as Terry Cooper has shown (Cooper,), in similar ways. Tillich wrote about 'estrangement': from the ground of our being (a phrase Tillich used frequently for what other theologians called God), from others, and from ourselves. Rogers coined the term 'incongruence': the result of steadily concealing parts of ourselves from others as we grow up, in the hope of making ourselves more acceptable, the end-point of which is the partial concealment of ourselves from ourselves (Cooper,, pp. 17-21).\\nIn all three schemes - Kosawa, Tillich, Rogers - we find that acceptance plays a crucial role in countering all this. Not 'acceptance' in the everyday sense for which 'tolerance' may be the more accurate term, but rather the kind of acceptance that relies on deep knowledge of the person who is being accepted, along with that person's willingness and ability to, as it were, accept the acceptance. One of the reasons why Kosawa chose a little boy, as opposed to an adult, for his parable may be that a little boy, or girl, might still be at the stage where they have not lost their natural ability to accept acceptance. What Rogers called 'conditions of worth', all too clearly communicated in the father's outburst in the parable, have not yet become completely entrenched.\\nBut here is an important point of complication: where does this acceptance come from? For Rogers, the human realm is the source. For Tillich, the human realm - including family and therapist - mediates an acceptance that comes from somewhere well beyond us. Though there are obvious perils in seeking to compare Kosawa's with Tillich's cosmologies, the two share something important in common here. They are convinced that anxiety or other forms of distress stem, in part at least, from our very nature, which in turn is a 'given' of existence rather than something we are capable of shaping. Because of this there is always need of what Tillich called grace and what Kosawa understood as the working of Amida's compassion: some salvific force from without, operating in and through the human.\\nThis places important limits on religion-psy dialogue, in at least two ways. First, though in entirely secular counselling settings one could talk of moments of 'grace' (where something powerful and unintended arises), and on that basis much fruitful conversation can happen between the religion and psy spheres, Tillich's and Kosawa's cosmologies nevertheless understand the human as something else, or more. So for all their usefulness as bridging concepts between the religious and the psy, ideas like 'grace' should not have distinct meanings folded into them as though such things do not matter. Second, in Kosawa's and Tillich's cosmologies human limitations extend to our ability to formulate any adequate concepts - suggesting an even more fundamental hermeneutic problem for religion-psy dialogue (Hirota,). 4  \\nCritics of particular instances of religion-psy dialogue have been quick to offer related cautions. We need some way of distinguishing in meditation, argues one, between psychological insights (about us, in the past and present) and spiritual insights (relating to the 'divine', for wont of a more appropriately inter-religious term, and our place in it, or relationship with it). We need to avoid religion-psy 'dialogue' devolving into the former simply serving the latter - as a provider of high-sounding, inspirational alternative terminologies for what is basically psychology, effectively masking a slide into agnosticism. 5  Still others wonder how forms of Buddhism and Christianity that resist the idea of ultimate reality having a personal dimension can meaningfully talk about 'acceptance'. Surely acceptance is a process with a person at either end (Cooper,; Harding,).\\nLastly, there is a concern about what kinds of people some forms of religion-psy dialogue helps to create. Kosawa, in his own day, was accused of literally 'drinking' his clients: thriving on their tales of distress and even playing the saviour to some extent - unable, despite his theorizing to the contrary, to imagine himself rather than Amida Buddha as the source of a person's felt acceptance. An American critic, though not especially well informed about Japan, offered the provocative criticism that whereas psychoanalysis in the United States sought to free the individual from the fetters of society, people like Kosawa actively sought to tighten them. If one stands back and seeks to read, at a purely social level, Kosawa's therapy, then reliant as it was on encouraging an individual to really experience their frailty, inadequacy, and deep need of others it might indeed fit such concerns. Read, however, at a religious or philosophical level, there might seem to have rather more going on: on this reading, everyone is heir to the very same constitutional weaknesses, so there can - or at least should - be no tyranny of 'strong' over 'weak'. In practice, of course, there was the serious risk of a religious reading glossing, even enabling, the harmful effects described in a social reading. Kosawa was criticized on precisely these grounds by some of his young psychoanalytic trainees.\\nFor Kosawa Heisaku, the fruits of religion-psy dialogue emerged in two simple questions: what is insight, and what does it cost? Good questions, which seem likely to remain with us for some time yet. And there is much to welcome, from this point of view, in the increasing interaction between the religion and psy professions, institutions, ideas and practices - even orientations within individuals. Finding ways to hold such interaction to account, by understanding its sources, claims, motivations and possible implications, is an important task, in which a range of academic and non-academic specialisms have roles to play. This article has sought to sketch out a social-historical and transcultural approach, as just one of many potential angles on this complex modern and contemporary phenomenon.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 82,\n",
       "    'case_id': 'PMC4382053_01',\n",
       "    'case_text': 'An 82 years old patient was admitted to the emergency department complaining since 15 days of fatigue, dizziness and lipothymia. He had a history of hypertension and diabetes; and had undergone a coronary bypass in 2005. His physical examination showed a blood pressure at 160/50mmHg, a heart rate at 26cycles/min, and he was afebrile. On admission the ECG showed a third degree atrioventricular bloc with a regular rhythm at 26 cycles/min, P wave was absent, QRS complex was not wide (<0.10ms) and the T wave was not \"tente like\", tall, peaked and symmetric, it was negative in the inferior territory and the ST segment was underlined in the laterobasal derivations. The laboratory findings included a serum potassium level of 6.9mEq/l (normal 3.6-5.5), sodium 132mEq/l (normal 135-140), creatinine 30mg/l (6-14) and urea nitrogen 0.82g/l (0.17-0.43), MDRD clearance was at 20ml/min (normal > 80). The arterial blood gas analysis revealed a pH of 7.32, pO2=115mmHg, and pCO2=34mmHg. The patient was treated immediately with furosemide, bicarbonate serum, calcium gluconate, glucose solution, and insulin, after three hours, the ECG showed normal sinus rhythm with visible P waves, a heart rate at 60cycles/min and a shortening of the QT interval in comparison with the first ECG. Blood potassium at this moment was at 5.60mEq/l. Hyperkalemia is known to cause a depression of the conduction velocity and excitability of the pacemaker cells and conduction tissues, resulting generaly in an advanced atrioventricular bloc with wide QRS complex. In this case the QRS remained normal.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 8,\n",
       "    'case_id': 'PMC7165356_01',\n",
       "    'case_text': 'The patient, an 8-month-old female, was born to a nonconsanguineous couple from a healthy 37-year-old mother of Native American descent and a healthy 30-year-old father of German and Irish descent. Family history is notable for an older sibling with cleft palate, paternal uncle with autism, paternal second cousin with congenital heart defect, and distant paternal great-great uncle with Down syndrome and webbed/fused 4th and 5th digits of one hand. A normal pregnancy was noted until the second trimester when an omphalocele was detected on ultrasound. A subsequent ultrasound revealed possible syndactyly of the hands. The patient was born at 39 weeks by vaginal delivery with induction. The birth weight was 3.552 kg (75th percentile), birth length was 50 cm (68th percentile), and birth head circumference was 34.5 cm (70th percentile). Apgar scores were 9 at both one minute and five minutes.\\nMultiple congenital anomalies noted at birth included an omphalocele that measured 4 cm at base and 3.5 cm across with intestines present in the sac, but no liver. The patient had a normocephalic head with sparse wispy hair, a small nose with hypoplastic alae, a prominent columella, small-appearing palpebral fissures, a small cornea, microphthalmia, a wide anterior fontanelle, and retrognathia (Figure 1). Syndactyly of digits 4 and 5 and webbing of digits 3 and 4 of the right (Figure 2) and left hands were present. Cardiac echocardiogram on the day of birth showed the presence of a mild patent ductus arteriosus, mild patent foramen ovale, and a normal aorta. Feeding difficulties were exacerbated by the presence of the omphalocele; surgical correction was performed on day 2 of life.\\nAn ophthalmologic assessment at 4 months of age was notable for deep anterior chambers, bilateral nasolacrimal duct obstruction, microphthalmia, small 8 mm corneas, a blonde fundus, and moderate hyperopia in both eyes.\\nAt her last examination at 8 months of age, the patient continues to have poor feeding with self-limiting volumes but has improved weight gain. The patient is at the 9th percentile for weight and 12th percentile for length. Cognitive and motor developments are delayed.\\nSequencing of the GJA1 gene (transcript number: NM_000165.3) from patient genomic DNA revealed a heterozygous missense mutation in the GJA1 gene: c.65G>A (p.G22E). Deletion/duplication analysis of the GJA1 gene using the aCGH test was negative.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 20,\n",
       "    'case_id': 'PMC4031092_01',\n",
       "    'case_text': 'Exostoses are the most frequent benign bone tumors. They account from 10 to 15% of both benign and malignant bone tumors. Osteochondroma may be present as a solitary lesion or in exostoses multiple hereditary form. Usually, they are asymptomatic. However, they may cause various complications such as arterial pseudo-anevrysm. This pseudo anevrysm is most often located on the popliteal artery. Pseudo-anevrysm results from an arterial injury due to exostose. Its mechanism development is still unknown because it is usually asymptomatic. Our case involved a 20 year-old boy with multiple hereditary exostoses. A large pseudo-anevrysm was observed and broken during surgery. Then, He was admitted for care in our Hospital. Although arterial pseudo-anevrysms rarely develop, we must always pay attention to patients who present multiple exostoses.',\n",
       "    'gender': 'Male'},\n",
       "   {'age': 22,\n",
       "    'case_id': 'PMC4031092_02',\n",
       "    'case_text': 'A 22-year old man with hereditary multiple exostoses was scheduled for a surgical excision of distal right femur osteochondroma. The preoperative evaluation was unremarkable, distal pulses were presents and the leg was well perfused. Knee X-rays showed bilateral distal femoral exostosis (Figure 1)\\nDuring intervention a massive bleeding occurred, and for hemostasis, the surgeon was forced to lie the popliteal artery. Three hours later, the patient was admitted to our emergency department with a relative ischemia of the right lower limb, with normal vital signs. On physical examination, sensation was present but reduced to the foot, the popliteal and distal pulses were absents. Laboratory tests were normal except for haemoglobin; it was at 9 g/dl. An arteriography was performed and clearly showed a popliteal artery occlusion opposite the incision (Figure 2). The patient underwent surgery. The popliteal artery was exposed through a medial supra-geniculate and infrageniculate approach. The artery was found ligated near the prior surgical site. The popliteal artery wall was repaired by veinous graft after vascular clamps were applied (Figure 3). The postoperative course was uneventful and the patient regained his normal activity. There was no sign of malignant transformation on histopathological examination of bone',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 34,\n",
       "    'case_id': 'PMC4612613_01',\n",
       "    'case_text': 'A 34-year-old right-handed female with a history of pseudotumor cerebri presented to our clinic with several months of headaches, vertigo, and diminished hearing on the left with gait imbalance. Pre-operative MRI demonstrated 3 cmx2.5x3.3 cm homogenously contrast enhancing mass in the cerebellar-pontine angle with extension medial to the seventh/eighth nerve complex and slight extension into the internal auditory canal (Fig. 3a). MR venography demonstrated patent transverse/sigmoid sinuses bilaterally. The patient underwent an uneventful left-sided extended retrosigmoid craniotomy with lumbar drain placement and intra-operative neuro-monitoring. Postoperatively the patient was discharged home postoperative day 3 neurologically intact with post-resection imaging that demonstrated complete resection (Fig. 3b). Final pathology was WHO grade I meningioma.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 11,\n",
       "    'case_id': 'PMC7182763_01',\n",
       "    'case_text': 'An 11-year-old boy presented with cough persisted for about 3 months. He had recurrent bronchitis many times previously and without relevant surgical history. His cough was worse at night and post-exercise. Physical checkup revealed decreased breath sounds on the left lung. Laboratory results showed elevated inflammatory biomarkers. Imaging study included a computed tomography examination of the chest.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 44,\n",
       "    'case_id': 'PMC4559873_01',\n",
       "    'case_text': 'In August 2008, a 44-year-old female had undergone surgery for resection of a malignant melanoma in the right lower leg and a right inguinal metastatic lymph node (Fig. 1), followed by chemotherapy with doxorubicin, adriamycin, vincristine, and interferon beta (DAV-feron). In March 2012, computed tomography (CT) revealed brain and lung metastases, so the patient began radiation therapy to treat these lesions.\\nIn September 2012, the patient was admitted to our hospital for back pain. Abdominal CT and magnetic resonance imaging detected new multiple hepatic metastases of melanoma. A transcatheter arterial infusion of cisplatin was administered, and transcatheter arterial embolization (TAE) was performed. In October 2012, she began treatment with vemurafenib, based on the finding of a positive BRAF V600E mutation in the resected primary site of the skin, which was analyzed by direct sequencing analysis using DNA from the paraffin-embedded primary cutaneous melanoma. She tolerated the treatment remarkably well, and the size of the multiple hepatic and lung metastases decreased, while the size of the brain metastases did not. In addition, the serum concentration of 5-S-cysteinyldopa (5-S-CD), a biological marker of melanoma progression, was also decreased from 40.1 ng/mL to 5.2 ng/mL.\\nIn December 2012, she suddenly developed severe abdominal pain. Abdominal CT revealed ruptured hepatic metastases accompanied by massive intra-peritoneal hemorrhage. A retrospective and sequential analysis of the CT images suggested that a part of the liver metastases had enlarged rapidly and then ruptured with intratumoral hemorrhage during vemurafenib treatment (Fig. 2). An emergency TAE was performed by selective occlusion of the right hepatic artery using gelatin sponge particles. The postoperative course was uneventful for several days. However, on the 26th postoperative day, she developed hemorrhagic shock and died of renewed intra-abdominal bleeding.\\nAn autopsy examination revealed hemoperitoneum due to rupture of the liver metastases. Metastases were also discovered in the brain and lungs as well as in the kidneys, adrenal gland, and lymph nodes, although these had not been detected on imaging while she was alive. There was also massive bloody ascites (1700 mL). The background liver was completely normal, whereas exposed necrotic tissue and intratumoral hemorrhage were observed at the site of tumor rupture (Fig. 3). We concluded that the cause of death was hemorrhagic shock from ruptured hepatic metastases of malignant melanoma. Finally, for improved understanding of the mechanism of refractory metastasis, we conducted an immunohistochemical analysis of the signal transduction molecules, phosphorylated extracellular signal-regulated kinase (p-ERK), and phosphorylated Akt (p-Akt), as well as the melanocyte marker Melan-A and Ki-67 in tumor cells of the primary malignant melanoma obtained from the right lower leg and in hepatic and lymph node metastases obtained on autopsy (Fig. 4). Our findings showed that hepatic and lymph node metastases were positive for p-ERK and negative for p-AKT, even though the primary tumor was negative for both.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 8,\n",
       "    'case_id': 'PMC9815528_01',\n",
       "    'case_text': 'The patient is an eight-year-old male born to non-consanguineous parents of Arab origin. He has three healthy siblings, and his pregnancy and delivery were normal. In January 2014, at the age of 5 months he presented to the Emergency Department of our hospital with acrofacial ulceronecrotic plaques which appeared initially at the age of 1 month over the cheeks and nose with subsequent development of similar lesions over the hands and feet. The parents reported exacerbations upon exposure to cold temperatures. At his arrival, he was hemodynamically stable and alert with no fever.\\nPhysical examination on admission showed erythematous violaceous indurated plaques with central necrotic ulceration located over the tip of the nose, bilateral cheeks and ear helices. Similar lesions were seen on the knees and extensor surfaces of the arms (Figures 1A-C). There were no cardiopulmonary, gastrointestinal, genitourinary or ophthalmological abnormalities.\\nThe patient was admitted for further investigation and treatment. During his hospitalization he showed signs of poor feeding, weight loss and failure to thrive. A nasogastric tube was inserted that facilitated his feeding, improving his weight. Despite topical wound care and systemic antibiotics including cephalosporins and vancomycin, systemic corticosteroids and antifungals, no improvement was observed, with new lesions appearing on the right hand and right elbow after exposure to cold. In addition, the patient developed unexplained febrile episodes with concurrent deterioration of the ulcers. Extensive laboratory workup was performed, as follows: skin and blood cultures showed no evidence of microbial growth (bacteria, mycobacteria and fungi). Cutaneous leishmaniasis was also excluded by smear and polymerase chain reaction. Blood work showed normal kidney and liver function tests moderate leukocytosis and thrombocytosis, normal hemoglobin level and no marked elevation of C-reactive protein or erythrocyte sedimentation rate. Anti-nuclear antibodies, rheumatoid factor, anti-Ro, anti-La, immunoglobulins, cryoglobulins and cryofibrinogens, C3, C4, C-ANCA and P-ANCA were all within normal limit. A biochemical assay for prolidase deficiency was negative, chest x-ray, abdominal ultrasound, were normal. Serology for human immunodeficiency virus was negative as well.\\nTwo skin biopsies were performed, demonstrating epidermal necrosis, mild parakeratosis, mild focal vacuolar degeneration and apoptosis of basal cell keratinocytes., mononuclear lymphohistiocytic infiltrate surrounding blood vessels, eccrine glands and hair follicles together with fat necrosis and hyalinization suggestive of lipodystrophy. No thickening of the basement membrane was observed (Figures 2A,B).\\nGiven the history of transient sterile pyrexias with pernio-like skin lesions, ulcerations and lipodystrophy, a disorder of type I interferonopathy was suspected. Trio exome sequencing obtained from peripheral blood of the patient and his parents was negative for mutations in genes responsible for different type-1 interferonopathies that were included in our differential diagnosis. Mutations in candidate genes which may explain the phenotype of our patient were not identified as well.',\n",
       "    'gender': 'Male'},\n",
       "   {'age': 7,\n",
       "    'case_id': 'PMC9815528_02',\n",
       "    'case_text': \"Following prolonged admission and inconclusive investigations, the patient's diagnosis remained unclear. Severe scarring and deformity became noticeable with time. The patient was eventually transferred to a hospital in his hometown to continue follow up and rehabilitation. He returned for follow-up for the first time after his discharge in November 2021, 7 years later at the age of 8-years-old. Then, physical examination showed numerous dyspigmented atrophic scars on the face and ulcers covered with crusts and thick yellow scales on the extremities. Saddle nose, muscle wasting, lipodystrophy and joint contractures were noted. Sadly, on his recent follow up in our clinic in November 2022 he presented a similar but more strikingly debilitating picture (Figures 3A-C). There was no involvement of the trunk or the genital area. During winter months the patient continues to suffer from febrile episodes with worsening of his skin lesions.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 59,\n",
       "    'case_id': 'PMC4119434_01',\n",
       "    'case_text': 'A 59-year-old man with a history of chronic ankylosing spondylitis for many years, developed neck pain and left cervico-brachial neuralgia following a road traffic accident sustained one week before. Plain radiographs of cervical spine were initially misinterpreted. On examination, he had severe neck pain on mobilization without any neurological deficits. Delayed cervical computed tomography scan showed ossification of the anterior longitudinal ligament, calcification of the intervertebral discs and complete vertebral fusion (so called bamboo spine) with transversal fracture at C5-C6 disc level (so called carrot-stick fracture) causing a luxation of the cervical spine with significant compromise in canal space (A and B). A transcranial spinal traction was performed followed by anterior decompression and stabilization via an anterolateral cervical approach. The outcome was favourable. Transverse fractures of the spine are rare in patients with ankylosing spondylitis and diagnosis should be considered following even minor trauma. These atypical unstable fractures occur because of the loss of flexibility and fragility of the osteoporotic spine. Early diagnosis for possible intervention is important because of the high mortality rate.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 31,\n",
       "    'case_id': 'PMC6594286_01',\n",
       "    'case_text': 'In our three patients:(I) a 31-year-old man, (II) a 67-year-old woman, and (III) a 40-year-old man:the mechanism of injury consisted of an ankle sprain. In patient I, the sprain occurred during a soccer match and in patients II and III it occurred while walking in the sidewalk. They went to the outpatient clinic complaining of lateral pain at the hindfoot for 24, 18, and 16 months, respectively. Previous treatments elsewhere were based only on anti-inflammatory drugs, ice, and rest. On a physical exam, there were pain and swelling over the course of the PT. In patients I and II, there were no clinical signs of ankle instability or varus of the hindfoot. In patient III, a bilateral cavovarus deformity was observed. No restriction of the range of motion of the subtalar joint was observed in any of them. Radiographic images were normal. In all MRI images, there were irreparable tears of the PB tendon and anatomical conditions were noted in patients I and II, such as low-lying muscle belly of the PB tendon and a peroneus quartus tendon, respectively. Initially, we conducted a conservative treatment for six months with physiotherapy, rest, analgesics, and ankle stabilizer to restrict inversion-eversion movements, but it was proved unsuccessful.\\nThe illustrative case (patient II) was presented for the demonstration of the surgical technique (Figures 2-9). The surgery was performed with the patient placed in an oblique lateral decubitus under regional anesthesia with a nonsterile thigh tourniquet on a radiolucent operating table. The STA was harvested through a medial longitudinal incision of 3 cm at the region of the proximal lower leg with the hip externally rotated to provide a frontal view of the knee. The graft was prepared by resection of the muscle belly; then its two stumps were tubularized with a 1-0 Vicryl whip stitch. We kept the STA in its full length to ensure that the entire defect was filled after the resection of the unhealthy PB tendon (Figure 2).\\nA lateral curved incision over the course of the PT was performed along the posterior border of the lateral malleolus, from 3 to 4 cm proximal to the tip of the fibula extending to the fifth metatarsal base (Figure 3). During dissection, care was taken to avoid damage to the sural nerve branches inferior to the lateral malleolus. The peroneal tendon sheath and the superior peroneal retinaculum (SPR) were opened, and PB and peroneal longus (PL) tendons were exposed. Dissection was performed proximally and extended distally to isolate the compromised portion of the tendon (Figure 4). The PB was assessed, and the nonviable portion was resected. The distal stump was debrided and totally removed to prevent local pain due to a bulky suture of the STA to the remaining distal stump, under a thin skin. The STA was sutured to the proximal stump of the native PB tendon using a Pulvertaft suture with a 1-0 Vicryl (Figure 5). The suture was performed 3 cm above the tip of the lateral malleolus to prevent the volume effect of increased pressure within the retromalleolar groove. This distance was based on previous studies which recommend to place peroneal brevis tendon tenodesis to the peroneus longus to avoid pain due to the entrapment of the suture. The distal fixation of the STA was carried out through a bone tunnel at the fifth metatarsal base to provide a bone-to-tendon fixation. Since we kept the full length of the STA, there was an adequate distal stump length remaining to fix it distally (Figure 6). The bone tunnel was drilled with a 3.2 mm drill (Figure 7) perpendicular to the long axis of the fifth metatarsal, from plantar to dorsal. The distal stump was pulled from plantar to dorsal through the tunnel and sutured back to itself with a 1-0 Vicryl (Figure 8). Alternatively, it can be fixed with a biotenodesis screw or an anchor. During the suture, the foot is positioned in neutral inversion/eversion and dorsiflexion/plantarflexion, and the tendon graft was tensioned at 50% of the maximum excursion of the PB muscle belly. The length of the reconstruction was determined at this point. The deep tissues, SPR, and skin were closed in layers. The closure of the SPR was made carefully to prevent PT subluxation. Finally, a sterile dressing and a short leg cast were applied.\\nPatients remain non-weight-bearing for two weeks with the cast. At 2 weeks, sutures are removed and they are placed in a walking boot (WB) with full weight-bearing as tolerated. At this period, physical therapy is initiated focusing in the dorsiflexion/plantarflexion range of motion to prevent adhesions in the tendon graft. Inversion-eversion movements are prohibited to prevent stretching of the healing tendon graft and the subsequent development of an elongated tendon with the loss of strength. Patients are instructed to always maintain the WB except for hygiene purposes and dorsiflexion/plantarflexion exercises. The patient who underwent the calcaneal osteotomy followed the same postoperative protocol as the others. At 8 weeks postoperatively, the WB is removed and the patient is transitioned into an ankle-stabilizing orthosis. A physical therapy program is oriented to start inversion-eversion movements and to progressively restore proprioception and strengthening. The ankle-stabilizing orthosis is used progressively less accordingly to the patient rehabilitation.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 67,\n",
       "    'case_id': 'PMC6159251_01',\n",
       "    'case_text': 'A 67-year-old male initially underwent contrast-enhanced multidetector CT of the abdomen in Sept 2014 at another hospital, which showed an incidental 4.2 x 3.9 cm mass in the upper abdomen. This was interpreted as a head of pancreas mass causing portal vein compression. The patient was asymptomatic; physical and laboratory examinations were all unremarkable.\\nThe patient was lost to follow-up and did not receive any further investigation or treatment. Although still asymptomatic, he re-presented 12 months later for a repeat MDCT, which showed that the mass had increased in size to 4.8 x 5.0 cm. Cavernous transformation of the portal vein was also observed. The patient underwent exploratory laparotomy, which showed a tumour at the upper border of the pancreas and duodenum compressing the portal vein. A 1-cm lesion in the subcapsular aspect of segment II of the liver was also seen. The presumed pancreatic tumour was deemed unresectable and multiple biopsies were taken. The liver lesion was resected and the histology of both samples showed spindle cell tumour. The patient also underwent a positron emission tomography-CT, which showed the lesion to be hypermetabolic with SUVmax of 7.3. No metastatic disease was identified.\\nThe patient was then referred to the hepatobiliary team in Queen Mary Hospital in Hong Kong for further assessment. The patient remained asymptomatic clinically with normal laboratory results including liver biochemistry (bilirubin 4 mumol l-1, alkaline phosphatase 54 U l-1, alanine aminotransferase 29 U l-1 and aspartate aminotransferase 23 U l-1). A repeat MDCT 2 months later showed that the lesion had a soft tissue density on non-contrast scans. The mass now measured 5.3 x 5.9 x 6.4 cm, extending from the superior mesenteric vein/splenic vein confluence to the porta hepatis. It exhibited heterogeneous enhancement with feeding vessels seen on the arterial phase, both within and around the mass. On the portal venous phase, numerous collaterals were seen surrounding the mass with a sharp interface between the mass and opacified portion of the main portal vein at the porta hepatis giving the appearance of a \"beak\" (Figure 1). The pancreatic duct was mildly dilated and measures 3 mm. The biliary tree was not dilated. There was splenomegaly measuring 13.5 cm craniocaudally. No gastroesophageal varices or ascites was appreciated. Based on these MDCT and histological findings, a preoperative diagnosis of primary leiomyosarcoma of the main portal vein was made.\\nThe patient underwent Whipple\\'s procedure and portal vein reconstruction using cadaveric graft. Intraoperative findings confirmed the tumour arising from inside the portal vein and confined to the lumen with no macroscopic evidence of disease spread. Histological examination of the tumour showed spindle cells with enlarged, pleomorphic, hyperchromatic nuclei and abundant eosinophilic cytoplasm. Patchy coagulative necrosis was also seen. Mitotic figures were at 8 per 50 high power fields, and atypical mitotic figures were found. There was focal infiltration into adjacent pancreatic parenchyma. Immunohistochemical stains showed the tumour was positive for actin, h-caldesmon and desmin but negative for myogenin, c-kit and S100 protein. The final histological diagnosis was of a primary LMS of the portal vein (Figure 2). The patient made an uneventful recovery and no adjuvant radiotherapy or chemotherapy was given. He was followed up for 4 months in our institute with no complications.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 43,\n",
       "    'case_id': 'PMC10183579_01',\n",
       "    'case_text': 'A 43-year-old man was admitted to the intensive care unit in our hospital due to multiple open traumas caused by a traffic accident. The patient had a history of hypertension. At admission, the patient presented a constant body temperature of 36.5 C. Physical examination showed no obvious abnormality in the heart, lungs, or abdomen. He suffered multiple lacerations and fractures of the right acetabulum and inferior ramus of the pubis, accompanied by pelvic extraperitoneal hematoma. On the first day of hospitalization, he underwent surgery for multiple injuries. Based on empirical therapy, cefuroxime (1.5 g, every 8 h) was administrated for infection prevention, and anti-infective therapy with cefoperazone-sulbactam (3 g, every 8 h) and levofloxacin (500 mg, daily) was conducted for common bacteria and traumatic wet lung. On day 2, the patient developed a fever (38.4 C), with an increase of procalcitonin (PCT; 31.47 ng/ml) and lactic acid (8.58 mmol/L) after the operation. The antibiotic treatment was changed to meropenem (1.0 g, every 8 h) plus teicoplanin (0.4 g daily). On day 14, P. aeruginosa was positive in the bacterial culture of wound tissues ( Figure 1A ) and was identified as a multiple-resistant strain with antibiotic susceptibility testing (AST; Kirby-Bauer method), thus amikacin (0.4 g/day) was added to the anti-infective regimen. Despite antimicrobial therapies, a P. aeruginosa-positive blood culture was still identified as bloodstream infection on day 16; the dose of amikacin was therefore adjusted. On day 21, the patient underwent thigh amputation, surgical debridement, and drainage due to recurrent vascular rupture and aggravated cyanosis. Five days later, due to the less effective anti-infective therapy, P. aeruginosa-positive blood culture along with fever still existed; therefore, the patient received moxifloxacin to replace the teicoplanin and amikacin. Despite this management, fevers continued, and infection was still under suspicion. Ceftazidime-avibactam (2.5 g/day) was then administrated to replace the meropenem. The culture was P. aeruginosa negative for the 26th-day blood sample but still positive for wound tissues.\\nDue to the uncontrolled infection, other pathogens were suspected. On day 26, tiny, nonhemolytic, and transparent colonies grew on the Columbia blood agar plate of four blood sample cultures ( Figure 1B ), possibly representing M. hominis. Gram staining of the blood smear showed no bacteria. A subculture of blood and wound tissue samples on mycoplasma medium presents as fried-egg-type colonies after 5 days of incubation ( Figure 1C ). Colonies were then identified to be M. hominis by the matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS) and further confirmed by 16S rRNA sequencing (primers: 27F, AGAGTTTGATCMTGGCTCAG; 1492R, GGTTACCTTGTTACGACTT) and phylogenetic tree analysis ( Figure 2 ; GenBank Accession No. OQ642125 for a strain isolated from a wound tissue sample and OQ642126 for a strain isolated from a blood sample). On day 31, therapy with polymyxin B in a dose of 5 x 105 U/day was initiated instead of ceftazidime-avibactam due to its shortage. In addition to the initial isolates of M hominis, two subsequent cultures obtained in the following week were also positive. The AST with a commercial kit (broth dilution method, Zhongaisheng, Hebei, China) showed that M. hominis was susceptible to doxycycline, minocycline, and josamycin but resistant to azithromycin, clarithromycin, norfloxacin, ciprofloxacin, roxithromycin, sparfloxacin, spectinomycin, and levofloxacin ( Figure 1D ). Based on the results of AST, minocycline (100 mg, twice/day), meropenem plus teicoplanin were started instead of moxifloxacin on the 33rd day of hospitalization. On the 37th hospital day, the hematology data and PCT level returned to normal, and infection was controlled. After starting minocycline-based therapy for 6 days, repeated cultures from the blood were M. hominis negative. Details regarding the diagnosis and treatment are shown in  Figure 3 .',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 36,\n",
       "    'case_id': 'PMC7395541_01',\n",
       "    'case_text': \"A 36-year-old otherwise healthy male presented to an outside hospital with blurred vision for few days and acute onset of aggressive behavior and agitation. While in the emergency department, he deteriorated rapidly to a Glasgow Coma Scale of 8 requiring intubation. A head computed tomography (CT) revealed a large, bifrontal extra-axial mass of the anterior skull base, measuring 52 mm x 37 mm. The lesion also involved the ethmoid cells and frontal sinuses as well as the right orbit. It was infiltrating the dura. Extended peritumoral brain edema with significant mass effect was also noted [Figure 1]. The patient was emergently transferred to our hospital. On arrival, he had fixed mid-dilated pupils, with minimal flexion movement to pain and intact corneal and gag reflexes. Laboratory tests were within normal limits. He was treated with intravenous push of high- dose dexamethasone (20 mg) and mannitol (70 g) and was immediately transferred to the operating room for a bifrontal decompressive craniectomy and tumor debulking.\\nAt surgery, the tumor was found to be very vascular. On opening the dura, the brain was swollen and of firm consistency with no pulsations. A debulking operation was performed along with bifrontal decompressive craniectomy. An intracranial pressure (ICP) monitor was inserted to the parenchyma. The ICP levels were <25 mmHg on average during the postoperative course, the patient was in Glasgow Come Scale 3, with no brain stem reflexes. Postoperative head CT demonstrated persistent, bilateral, massive edema, the patient's condition remained critical and he passed away 1 week later.\\nHistological examination for hematoxylin and eosin stain showed a tumor comprised small to medium size cells, some of them with clear cytoplasm. Rhabdoid cells were not noted. The tumor shows areas of necrosis and high levels of mitotic and apoptotic activity [Figure 2a and b]. The stain for INI1 was negative (loss of expression) [Figure 2c]. Immunohistochemical stains were diffusely and strong positive for epithelial membrane antigen (EMA) [Figure 2d] and P63, partially positive for smooth muscle antigen (SMA) [Figure 2e], glial fibrillary acidic protein (GFAP) [Figure 2f], B-cell lymphoma 2, and vimentin (VIM), focally positive for pan-KER and KER 8, and negative for OLIG2, S100, desmin, synaptophysin, NEU-N, and chromogranin. The proliferative index Ki-67 was 25-30%. The initial diagnosis was ATRT. Later, the possibility of SMARCB1-deficient sinonasal carcinoma was added as a differential diagnosis.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 42,\n",
       "    'case_id': 'PMC3558351_01',\n",
       "    'case_text': \"A 42-year-old man was hospitalized with sudden-onset weakness in both lower extremities. The patient had been treated with isoniazid 300 mg, rifampin 450 mg, and ethambutol 800 mg daily for pulmonary tuberculosis during the past two months. He had no history of exposure to antituberculosis antibiotics before beginning therapy. His compliance to antibiotics was excellent after the treatment for pulmonary tuberculosis and he denied the interruption on these regimens. He reported no constitutional symptoms, history of hyperthyroidism or paralysis.\\nA physical examination indicated that the muscle strength of the lower extremities was 2/5 of normal. The rest of the physical examination was unremarkable. A chest radiograph revealed reticular opacities on the bilateral upper lung fields, consistent with pulmonary tuberculosis. His laboratory data included hemoglobin 13.0 mg/dL, leukocyte count 9900/muL, and platelet count 290,000/muL. His biochemical data for serum and urine on admission are shown in Table 1. Profound hypokalemia, hypophosphatemia, and hypouricemia were present. Serum pH, bicarbonate level and anion gap indicated hyperchloremic metabolic acidosis with normal anion gap. The urinary anion gap was positive (10.2 mEq/L), suggesting the presence of renal tubular acidosis. Urinalysis showed normoglycemic glucosuria, beta2-microglobulinuria, pH 5.5, 2.5 g/day proteinuria and microscopic hematuria. The fractional excretion of potassium was 29.3% (normal range, 4%-16%); the calculated ratio of the maximal tubular transport of phosphate reabsorption to the glomerular filtration rate (TmP/GFR) was 0.24 mg/dL (normal range, 2.3-4.3 mg/dL); and the fractional excretion of uric acid was 77.4% (normal range, 6%-20%). Generalized hyperaminoaciduria was detected with liquid chromatography-tandem mass spectrometry. These findings suggest generalized proximal tubular dysfunction with wasting of bicarbonate, glucose, protein, potassium, phosphate, and uric acid.\\nAdditional blood tests were performed to determine other possible causes of the patient's hypokalemia. His plasma renin activity and serum level of aldosterone were 21.6 ng/mL/h and 30.5 ng/dL, respectively. His thyroid-stimulating hormone and free thyroxine levels were within the normal ranges. Serum and urinary protein immunoelectrophoresis showed no evidence of monoclonal gammopathy, and immunological surveys of autoantibodies were negative. The patient's reticulocyte count, serum lactate dehydrogenase, and liver enzymes levels were within the normal ranges.\\nAn ultrasonographic examination showed a normal-sized kidney, with slightly increased echogenicity in the bilateral renal parenchyma. A renal biopsy showed extensive mononuclear cell infiltrates, including epithelioid histiocytes and eosinophils, mild interstitial fibrosis, and tubular atrophy (Figure 1A and B). Ziehl-Neelsen staining for acid-fast bacilli and PCR detection of Mycobacterium tuberculosis in the renal biopsy specimen were negative. Focal granular deposits of immunoglobulin A (IgA) and complement 3 (C3) were demonstrated in the tubules (Figure 1C and D). The same immunofluorescent positivity was also shown in glomerular mesangium, and electron microscopy showed electron-dense deposits in the subendothelial and mesangial spaces (Figure 1E and F). These findings were consistent with IgA nephropathy accompanied by focal immune deposits along the tubules. Half the epithelial foot processes were effaced, and there were no pathological findings in the mitochondria.\\nPotassium chloride supplementation was given to treat the patient's hypokalemic paralysis. His muscle strength increased one day after potassium chloride supplementation. We substituted rifampin with levofloxacin, but his other antituberculosis antibiotics remained the same. Supplementation with potassium chloride and sodium bicarbonate was continued, and the patient was discharged on hospital day 14. The biochemical markers associated with Fanconi syndrome were significantly resolved, and he experienced no paralytic symptoms after discharge. His proteinuria and microscopic hematuria was also improved, and we discontinued supplementation with potassium chloride and sodium bicarbonate at the three-month follow-up. The patient's renal function and proximal tubular function remained stable at the last follow-up.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 53,\n",
       "    'case_id': 'PMC5377292_01',\n",
       "    'case_text': 'A 53-year-old man presented with a one year history of postprandial abdominal discomfort. Past medical history was positive for diabetes mellitus treated with linagliptin. His body mass index was 27.4 kg/m2. The physical examination was unremarkable. His serum CEA and CA19-9 levels were within normal limits. Total colonoscopy showed a 14 mm sessile polyp in the sigmoid colon and polypectomy was performed. Pathological evaluation showed a well-differentiated adenocarcinoma invading more than 1000 mum in the submucosa with both vertical and horizontal resection margins positive.\\nLaparoscopic sigmoid resection was planned and a contrast enhanced computed tomography scan was obtained preoperatively which showed the small bowel and colon on the right and left sides of the abdominal cavity, respectively. The ileocolic artery (ICA) and the inferior mesenteric artery (IMA) originated from a common channel which branched directly from the abdominal aorta (Fig. 1, Fig. 2). Laparoscopic sigmoid resection with a D2 dissection was performed using typical trocar placement (Fig. 3). Non-rotation of the intestine was confirmed at surgery. The ascending colon was free from the retroperitoneum but the descending colon was attached to the retroperitoneum and the sigmoid colon and rectum seemed anatomically normal. The IMA was divided after exposure of the common arterial channel and its branches, the ICA and the IMA. There were no technical difficulties due to intestinal malrotation. The patient did well postoperatively and was discharged on seventh postoperative day.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 29,\n",
       "    'case_id': 'PMC7566195_01',\n",
       "    'case_text': \"A 29-year-old female was referred to our hospital with the suspicion of mucinous cystic neoplasm of the liver. The patient had no previous medical history including drug history, family history, and psychosocial history. The tumor was located at the segment III in the form of compressing the root of the Glissonean pedicle of segment III (Fig. 1). In addition, the computed tomography and magnetic resonance imaging revealed the potential risk of malignancy, therefore we decided to perform laparoscopic left hepatecomy instead of left lateral sectionectomy. Hepatic functional reserve was normal with indocyanine green (ICG) retention rate at 15 min of 5.9% and the Child-Pugh grade A (score 5).\\nThe patient was placed in the supine position with the operator between the legs and the assistant and scopist at the left side. Four trocars technique was introduced at the umbilical portion for the camera and the both subcostal areas for the operator and assistant (Fig. 2). Firstly the left lateral lobe was mobilized with transection of the Falciform ligament and left triangular ligament. After cutting off the Arantius's ligament, the left extrahepatic Glissonean pedicle was encircled. Secondly the liver dissection line was marked on the ischemic demarcation line after clamping the left Glissonean pedicle. Intermittent Pringle's maneuver was applied for inflow control using a tourniquet system at the right subcostal area (Fig. 2). The liver parenchyma was dissected using the Cavitron Ultrasonic Surgical Aspirator (CUSA) and Ultrasonic shears (Ligasure).\\nThe overview of our novel modified hanging maneuver is represented in Fig. 3. For this hanging technique, the upper edge of the hanging tape was placed on the lateral side of the LHV, and fixed with the Falciform ligament using clips (Fig. 4a). The hanging tape was positioned along the left side of the middle hepatic vein, and the lower edge of the hanging tape was extracted along the tourniquet for the Pringle's maneuver (Fig. 4b). This hanging technique does not require assistance by an assistant for hanging the tape up. Moreover, the hanging tape can be controlled extraperitoneally. During the liver parenchyma dissection, the hanging tape was pulled out not only to control the bleeding from the outflow, but also to expose a better surgical field. In addition, the hanging tape was used as a guide toward the root of the LHV.\\nFinally the left Glissonean pedicle and LHV were divided with the stapler, and the specimen was extracted through the Pfannenstiel incision. The total operative time was 280 min, including the Pringle's maneuver for 45 min, and the estimated blood loss was 35 mL.\\nThe patient was discharged on postoperative day 7 without any complications. The final pathological examination of the liver specimen was diagnosed as mucinous cystic neoplasm of the liver without malignancy.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 0,\n",
       "    'case_id': 'PMC4809441_01',\n",
       "    'case_text': 'A purplish reticulated vascular network, phlebectasia, and telangiectasia were observed at birth of a female of 39+3 gestational weeks, suggesting a diagnosis of CMTC. The lesions were located on the entire back, most of the buttocks, right half of the front of the trunk (with a clear demarcation from the unchanged skin right in the midline), right thigh, and left knee (Fig 1). The lesion was made more distinct when the baby was crying, during vigorous activity, and when cold. Additionally, the hyperpigmented patches, which were considered Mongolian spots, partly intermingled with the lesions of CMTC, were located on the right upper back, the mid-spine, and the lumbosacral region (Fig 2). Extremities were symmetrical, with no atrophy or hypertrophy of soft tissue. The infant showed normal mental and physical development. Her parents were not consanguineous. The first child of the family is a healthy boy, who was 20 months old at the time of writing.\\nRegularly monitored laboratory, hematologic, biochemical analysis and chromosomal microarray detection were unremarkable. Histopathologic examination on the right side of the thigh found numerous dilated capillaries and venules in the dermis (Fig 3).\\nGiven the constellation of clinical findings, PPV type V or phacomatosis cesiomarmorata was diagnosed. There are few cases reported in the literature of this kind of PPV.',\n",
       "    'gender': 'Female'},\n",
       "   {'age': 0,\n",
       "    'case_id': 'PMC4809441_02',\n",
       "    'case_text': \"In a follow-up examination when the infant was 2 months old, her mother reported that the child's legs trembled occasionally with no obvious cause. However, magnetic resonance imaging of the brain was unremarkable. The skin changes of CMTC had almost disappeared, while the Mongolian spots were persistent (Fig 4).\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 59,\n",
       "    'case_id': 'PMC6938193_01',\n",
       "    'case_text': 'A 59-year-old lady presented with a large full-thickness MH in her left eye. The minimum size of the MH was 553 microm, and the basal diameter was 1100 microm (Figure 4A). Her initial visual acuity was 20/100. Pars plana vitrectomy with hemicircular ILM peeling with nasally hinged flap (the technique used for group A) was performed, and the MH was closed 1 week postoperatively. One month after surgery, visual acuity improved to 20/50. An area of hyperreflective tissue on the inner retinal surface and nasal to fovea was seen on OCT, which corresponded to the location of the inverted ILM flap (Figure 4B). At 3 months, visual acuity improved to 20/40 with improvement in EZ irregularities. Besides outer retinal regeneration, some degree of inner retinal dimpling at the temporal side was observed at 3 months after surgery (Figure 4C). After 6 months of follow up, visual acuity improved to 20/30.',\n",
       "    'gender': 'Female'},\n",
       "   {'age': 65,\n",
       "    'case_id': 'PMC6938193_02',\n",
       "    'case_text': 'A 65-year-old man presented with a large full-thickness MH with a minimal diameter of 744 microm and basal diameter of 1337 microm (Figure 5A). The initial visual acuity was 20/400. Pars plana vitrectomy with circular ILM peeling and superior inverted flap (the technique used for group C) was performed. The MH was closed 1 week after surgery. Visual acuity improved to 20/200 at 1 month postoperatively. OCT showed closed MH with two hyporeflective spaces, created by the inverted flap (Figure 5B). At 3 months after surgery, these spaces were filled with regenerated tissue with improved foveal contour (Figure 5C). Visual acuity was 20/63. Six months after surgery, visual acuity improved to 20/40, and a small defect in the ellipsoid zone with atrophic inner retinal changes was seen on OCT. Although the peeling was circular and involved both the temporal and nasal sides of fovea, inner retinal dimpling was most prominent at the temporal side (Figure 5D).',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 12,\n",
       "    'case_id': 'PMC9873479_01',\n",
       "    'case_text': 'A 12-year-old boy was a belted backseat passenger in a high-speed frontal car collision, a multitrauma with injury to abdomen with intestine involvement requiring surgery, a Chance fracture of L3, and AOD. The patient was neurologically intact with severe neck pain apart from his other injuries. The initial CT showed no fractures in the cervical spine, but hematoma posterior to the clivus, BDI 10 mm, CCI 5.5 mm, and subluxation C0-C1 suggesting a ligamentous injury of the CCJ ( Fig. 2 ). MRI revealed rupture of the tectorial membrane, and rupture and elongation of the alar ligaments ( Fig. 2 ). The patient was operated with temporary C0-C2 fixation via muscle-preserving approach and navigation ( Fig. 3 ). The implants were removed at 10 months, and after that MRI confirmed normal appearance of the soft tissues of the CCJ. Follow-up was at 3 and 11 months after implant removal. The patient was free of symptoms, had no neck pain, and is fully active. To assess stability and motion, CT in rotation, flexion-extension radiographs, and MRI were obtained. CT showed normal CCI and BDI, and 44 degrees of C1-C2 rotation (22 degrees dexter, 22 degrees sinister) at follow-up at 3 months. At 11-month follow-up, CT in rotation showed 39 degrees of C1-C2 rotation (21 degrees dexter, 18 degrees sinister). MRI showed good visualization of alar ligaments, assessed as radiologically intact, and the tectorial membrane was at normal position. Flexion-extension radiographs showed no excess C0-C1 movement.',\n",
       "    'gender': 'Male'},\n",
       "   {'age': 7,\n",
       "    'case_id': 'PMC9873479_02',\n",
       "    'case_text': 'A 7-year-old girl was hit by a car as she got off a bus. Apart from AOD she sustained a head concussion, an undisplaced acetabular fracture, and a liver contusion. She was initially a little lethargic, but awake and neurologically intact. CT revealed increase in BDI and CCI, an asymmetrical widening of the neurocentral synostosis of C2, displacement of the tip of the odontoid, and a retroclival hematoma. MRI showed a rupture of the tectorial membrane. A temporary C0-C2 fixation was performed with implant removal after 4 months. A long-term follow-up, including MRI in rotation, was made after 8 years. At this time the patient had no cervical symptoms and had a clinically normal range of cervical motion. An MRI of C1-C2 showed that the alar ligaments and tectorial membrane were normal and rotation MRI of the CCJ showed 30 degrees of motion in C1-C2 segment (9 degrees dexter, 21 degrees sinister), shown in Fig. 4 . \\nSurgical technique : Navigated C0-C2 muscle-preserving fixation. \\nThe main goal is to achieve a temporary rigid fixation from the occiput to the C2-vertebra without major injury of the C2 muscles.\\nThe following six steps are made during the procedure: 1st step: To access the deep muscles of the neck with midline approach. 2nd step: To make space for C0 plates and screws with partial muscle removal. 3rd step: Make space for attachment of navigation reference on C2 spinal process without injury of muscles. 4th step: C2 pedicle screws placement using navigated probe or drill. 5th step: Tunneling of the rods under the muscles. 6th and final step: Attachment of C0 plates.\\n1st step : A midline posterior skin incision is made from the occiput to the C3 spinal process to provide access from the occipital protuberancia all the way to the C3 vertebra. Then, splitting of the nuche ligament is performed from occiput to C3 spinal process. Once the nuche ligament is split, one can easily dissect the connective tissue between nuche and the C2 spinal process without injury of the superficial muscles of the neck. The muscles are then moved laterally as shown in Supplementary Fig. S1 (online only). \\n2nd step : Access to the occipital protuberancia is made by exposing the midline portion of occiput and approximately 1.5 to 2 cm laterally. This means removal of the insertion of the rectus capitis posterior minor muscle and partial removal of semispinalis capitis muscle. The goal is to make enough space for occipital plates and rods as shown in Supplementary Fig. S2 (online only); then, one continues dissection deep toward the C1 arch and the posterior tubercle of atlas to remove the origin of rectus capitis posterior minor muscle approximately 1 cm laterally from midline. Once C1 arch is exposed, one can easily access the space between C1 arch and the C2 spinal process and exposure of the epidural membrane C1-C2 as shown in Supplementary Fig. S2 , (online only). \\n3rd step : Attachment of navigation reference to C2 is made by access of the interspinal space of C2-C3 and free cranial margin of C2. A midline dissection of C2-C3 will make space for the navigation reference which is attached to C2 spinal process as shown in Supplementary Fig. S3 (online only). \\n4th step : O-arm scan is now performed with reference on C2 spinal process. Correct entry point of C2 pedicles are now located by using navigation and exposing the bony entry point on C2 with sharp neural dissector. Navigated pedicle probe is helpful due to the small pedicles of pediatric C2 pedicles. Screws are then placed without too much injury of muscle tissue and attachments. The rectus capitis major, obliquus inferior, and the cervicis spinalis muscles are attached to the C2 spinal process, in some cases they can be split without too much injury of the muscle. \\n5th step : Rod placement is made by first making a tunnel under the rectus capitis posterior major muscle and the obliquus capitis inferior muscle. This is done by a sharp neural dissector from the screws in following the lamina of C2 in direction of C1 midline. This needs to be done with care, shown in Supplementary Fig. S4 (online only) by the blue rubber bands. Once rods are measured they can be inserted in craniocaudal direction under the muscles and attached to C2 screws. \\n6th step : Final step is adding the occipital plate to the rods and fixations of plates in midline of the occiput as shown in Supplementary Fig. S4 (online only).',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 11,\n",
       "    'case_id': 'PMC7074520_01',\n",
       "    'case_text': \"An 11-year-old castrated male domestic shorthair cat was presented to the emergency service of the University of Missouri Veterinary Health Center (MU-VHC) for anorexia, lethargy and an apparent seizure in May 2019. Approximately 1 week prior to presentation, the cat had a suspected altercation with an unidentified animal. The owners cleaned a puncture wound to the neck and applied antibiotic ointment; the cat seemed relatively normal until 3 days prior to presentation.\\nHyporexia prompted a visit to the primary care veterinarian, where there were no abnormalities on examination other than a temperature of 104oF (40oC). Point-of-care retroviral tests were negative, hematocrit was 40% and no parasites were identified on peripheral blood smear examination. The cat was discharged with pradofloxacin but re-presented the following day for complete anorexia and worsened lethargy. Fever was unchanged and mild icterus was now identified. A complete blood count (CBC) demonstrated a hematocrit of 31% with mild neutropenia (2.11 x 103/mul; reference interval [RI] 2.5-12.5 x 103/mul) and platelet aggregates; no parasites were identified. Subcutaneous crystalloid fluids were administered, but the cat was not hospitalized. The following morning, the cat experienced what the owners described as a seizure, prompting the emergency visit to MU-VHC. The cat, which had survived cytauxzoonosis 7 years prior, lived on several wooded acres adjacent to Mark Twain National Forest in Cherryville, MO, USA, and was treated regularly with a combination product containing fipronil, etofenprox and (S)-methoprene (Frontline Tritak; Merial).\\nOn presentation at MU-VHC, the cat's temperature was 104oF (40oC), pulse 180 beats per min, respiratory rate 24 breaths per min and was judged to be 6% dehydrated. There were no obvious wounds. Mucus membranes were pale and mildly icteric. Complete neurologic examination findings were not recorded, but the cat was reported to be dull and lethargic. Abnormalities on plasma chemistry profile included hyperglycemia (179 mg/dl; RI 80-155 mg/dl), hyponatremia (140 mEq/l; RI 148-154 mEq/l), hypochloremia (108 mEq/l; RI 112-123 mEq/l), hypokalemia (3.0 mEq/l; RI 3.1-4.6 mEq/l), hypocalcemia (8.4 mg/dl; RI 8.6-10.4 mg/dl) and hyperbilirubinemia (2.6 mg/dl; RI 0.1-0.2 mg/dl). Abnormalities on CBC included marked thrombocytopenia with few platelet clumps identified (10 x 103/mul; RI 166-466 x 103/mul), neutropenia (1.82 x 103/mul; RI 2.2.7-9.82 x 103/mul) and moderate numbers of intraerythrocytic signet ring-shaped inclusions compatible with C felis (Figure 1). Hematocrit was again 31%.\\nBased on a suspected diagnosis of cytauxzoonosis and the associated costs for treatment, the owners opted against specific therapy and took the cat home. After their cat experienced several additional seizures later that same day, they arranged for an at-home euthanasia. Based on our discussions about the unique nature of repeat cytauxzoonosis, the owners requested that the veterinarian performing euthanasia harvest a small sample of liver and spleen to be shipped in formalin to the MU Veterinary Medical Diagnostic Laboratory for confirmation of the suspected diagnosis.\\nOn hematoxylin and eosin stain of prepared tissues, portal tracts were infiltrated by small numbers of lymphocytes, macrophages and plasma cells. Marked lymphoid depletion of the splenic white pulp was noted. Mild extramedullary hematopoiesis was identified in the parenchyma of both the spleen and liver. Although modest in numbers, schizont structures typical of the protozoan C felis were recognized in hepatic arterioles and sinusoids, as well as in splenic sinusoids (Figures 2 and 3). Formalin-fixed paraffin-embedded tissues (from this case and a non-infected cat as a negative control) were sent to North Carolina State University for the molecular detection of C felis. Slides were heated to remove paraffin and total DNA was extracted. Partial C felis cytochrome oxidase C1, 18S rRNA and mitochondrial large ribosomal subunit-4 genes were amplified from the infected cat but not the control (see supplementary material for methodologic detail).\\nIn May of 2012, the same cat had been hospitalized at MU-VHC for treatment of acute cytauxzoonosis. Diagnosis was based on a typical presentation, including acute onset of anorexia and lethargy, high fever, pancytopenia, hyperbilirubinemia, hyperglycemia, panhypoproteinemia and multiple electrolyte abnormalities, as well as cytologic identification of numerous typical red blood cell (RBC) piroplasms. Engorged ticks were found on the cat at the time of diagnosis. Treatment included atovaquone and azithromycin, as well as intensive in-hospital supportive care, including multiple blood transfusions, thoracocentesis to relieve pleural effusion, and placement of an esophagostomy tube to facilitate feeding and medication administration. Despite a complicated clinical course, the cat was discharged after 9 days. It recovered completely, and a single CBC performed 2 weeks after hospital discharge failed to identify any parasites.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 54,\n",
       "    'case_id': 'PMC5591568_01',\n",
       "    'case_text': 'A 54-year old athletic male was a helmeted cyclist on a street race bicycle, when he fell over the handlebars and struck his head directly on cemented ground, sustaining a hyperflexion injury to his neck. He was able to get up at the accident scene and pushed his bicycle to the closest meeting point. Due to severe neck pain, he asked a friend to call an ambulance. He was initially brought to a local hospital in the Rocky Mountain region, where a CT of the head and cervical spine was obtained. The patient was placed in a C-collar and transported by ambulance to our level 1 trauma center for definitive management of his cervical spine fracture. Upon arrival, the patient was awake and alert with a GCS of 15. He stated to have felt some tingling sensation in his right hand after the accident, which apparently subsided by the time of his presentation to our hospital. His clinical exam demonstrated full symmetric motor strength (M5/5) in all four extremities, a normal rectal tone and bulbocavernosus reflex, and minimal hypoesthesia in the small finger on the right hand, related to the C8 dermatome. The review of his CT scan from the outside facility revealed a complex multi-level fracture-dislocation of the cervical spine from C6 to T1, with rotational instability (AO/OTA classification 51-C2.1). The injury pattern included a C7/T1 fracture-dislocation (Fig. 1a) with a left-side locked/perched facet at C6/C7 (Fig. 1b,c), a right side facet fracture-dislocation at C7/T1 (Fig. 1d), and a \"saving\" traumatic laminotomy at C6 and C7 on right side (Fig. 1e,f). A CT-angiogram was obtained which demonstrated a grade 1 intimal tear to the left vertebral artery at the C6 level. In light of the highly unstable fracture pattern, we decided to apply a Halo fixator for temporary external fixation. The Halo application was performed under local anesthesia without any closed reduction attempts, in order to mitigate the risk of an iatrogenic compression of the spinal cord. The patient was kept awake throughout and reported no change in symptoms. Thereafter, an MRI of the cervical spine was obtained for advanced imaging and preoperative planning. The MRI demonstrated a complete disruption of the annulus fibrosus of the C7/T1 intervertebral disc, a disruption of the anterior longitudinal ligament (ALL) and posterior longitudinal ligament (PLL) at the same level, and a complete extrusion of the C7/T1 disc into the spinal canal, positioned behind the C7 vertebral body (Fig. 1g,h). The interspinous ligament was disrupted at C6/C7, and there was mild spinal canal stenosis at C6/C7 without signs of cord compression or contusion. \\nThe posterior perched facet requiring posterior approach and open reduction to restore anatomic sagittal alignment of the spine;\\nThe extruded disc at C7/T1 requiring a C7 corpectomy and decompression through an anterior approach;\\nThe sequence of surgery being dictated by the intraspinal disc which requires (1) anterior decompression, followed by (2) posterior fracture reduction, and ultimately (3) an anterior completion fusion after posterior reduction and instrumentation.\\nA surgical plan was designed based on the following considerations: \\nAs part of the preoperative shared decision-making process for surgery, the patient understood the detailed plan and the risks of intra- and postoperative complications. He agreed to proceed with surgery and provided a written informed consent. We took him to the operating room the next day for the 3-stage procedure under continuous neurophysiological monitoring. In supine position, the cervical spine was exposed from C6-T1 through a standard left side anterior Smith-Robinson approach. The dislocation at C7/T1 was visualized and the intervertebral disc at this level was obliterated, as expected from the preoperative MRI findings. A C7 corpectomy was performed which allowed decompression of the spinal canal by removal of the extruded intervertebral disc. The anterior wound was then closed temporarily. Under strict log-roll precautions, using the Halo ring for axial traction, the patient was carefully moved into prone position, for the 2nd stage of the procedure. We then performed a standard posterior approach from C4-T2. A completion laminectomy was performed through the laminar fractures at C6 and C7, for posterior spinal canal decompression. The perched facet at C6/C7 on the left and the facet fracture-dislocation at C7/T1 on the right were anatomically reduced, and a left side C6/C7 facetectomy was performed, which resulted in adequate rotational and sagittal alignment of the cervical spine. Spinal fixation was performed by posterior instrumentation with placement of lateral mass screws at C4, C5, C6, and pedicle screws at T1 and T2. The posterior wound was closed, and the patient was log-rolled back into supine position for the 3rd stage of the procedure. The previous anterior cervical wound was re-opened. The exposed dura was visualized through the preceding C7 corpectomy, and a 2-level anterior fusion from C6-T1 was performed with a PEEK cage filled with autograft bone from the resected C7 vertebra, and placement of a 2-level anterior locking plate (Fig. 2). The anterior wound was then closed, the Halo was removed, and the patient was transitioned into a cervical collar. He tolerated the procedure well and was extubated in the operating room. His neurological exam was normal and the hypoesthesia in the right C8 dermatoma resolved postoperatively (Fig. 3). The grade 1 vertebral artery intimal injury was managed conservatively with 325 mg acetylsalicylic acid (Aspirin) for three months. The patient was mobilized with physical therapy and discharged home on the 2nd postoperative day. He remained in a cervical collar for 6 weeks and was allowed to remove the collar for showering only during that period of time. The patient resumed full activity at three months. He was back riding his bicycle at 7 months, and by 10 months after surgery he had returned to competitive street bicycle racing in the 100 mile \"Elephant Rock Century Ride\" in Castle Rock, Colorado (Fig. 4). The patient remained asymptomatic and continued his work as a financial consultant as well as unrestricted physical activity and exercises, including regular participation in competitive bicycle races, at follow up 7 years after the accident.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 32,\n",
       "    'case_id': 'PMC4898005_01',\n",
       "    'case_text': \"A 32-year-old male presented with new-onset slurred speech of three weeks' duration. The patient had a known case of Wilson's disease on znc therapy (50 mg TDS). The ceruloplasmin level was very low, at 4 mg/dl. No features of jaundice or cirrhosis were seen to suggest marked hepatic involvement. No evidence of significant abnormalities were seen on liver function tests. No features of tremors, dystonia, or dysphagia were seen. No prior CT or MRI studies were available for comparison.\\nAn MRI study revealed marked T2 and FLAIR hyperintense lesions involving bilateral thalami, midbrain, and pons (Figure 1A, Figure 1B, Figure 1C, Fig 1D, Fig 1E). The lesions were hypointense on T1-weighted sequence and showed no evidence of restricted diffusion or postcontrast enhancement. Minimal involvement of the lentiform nuclei was seen. No significant involvement of the caudate nuclei, cerebellar white matter, centrum semiovale, or subcortical white matter was seen.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 54,\n",
       "    'case_id': 'PMC4821337_01',\n",
       "    'case_text': \"A 54 year old female with a history of celiac disease was on treatment with proton pump inhibitors (PPI) for her new onset of reflux symptoms. Upper gastrointestinal endoscopy was unremarkable. Esophageal manometry and motility studies revealed a hypertensive lower esophageal sphincter with mild esophageal dysmotility, suggestive of achalasia. PPIs were continued on a twice daily basis. She also received endoscopic injections of botulinum toxin in the lower esophageal sphincter (LES) with partial and transient relief of symptoms. Six months following the onset of her reflux symptoms, she developed slowly progressive shortness of breath and cough. A chest radiograph showed bilateral interstitial thickening. A high-resolution computed tomography (CT) of the chest revealed a bilateral prominent interstitial reticular pattern predominantly in the lower lobes and subpleural regions with mild honeycombing (Fig. 1), consistent with IPF. Pulmonary function tests (PFTs) showed an FVC of 61%, FEV1 of 64% and FEV1/FVC of 106% suggestive of a restrictive pattern. Total lung capacity and vital capacity were diminished, the residual volume to total lung capacity ratio was elevated at 122% and the diffusion capacity for carbon monoxide was diminished at 39%. Video assisted thoracoscopic lung biopsy showed chronic active interstitial pneumonitis and fibrosis with maximal changes beneath the pleura. Histopathology demonstrated a usual interstitial pneumonia (UIP) pattern, corresponding to the clinical diagnosis of IPF (Fig. 2). PPIs were continued and she also followed the lifestyle changes advised for GER. She was placed on a trial of N-acetyl cysteine without obvious benefit.\\nOver the next year, while stable symptomatically, PFTs showed a gradual decline in lung volumes, forced vital capacity and diffusion capacity. In the next few months, she developed progressive worsening shortness of breath. A repeat CT of the chest demonstrated bilaterally increasing interstitial fibrosis and traction bronchiectasis (Fig. 3). Since she also had progressive reflux symptoms despite medical treatment, she underwent a laparoscopic Heller's myotomy (LHM) with Dor fundoplication. In the next three months her reflux symptoms worsened, and she deteriorated with severe shortness of breath and hypoxia, requiring continuous nasal oxygen. A double contrast barium swallow revealed no evidence of a leak and persistent dilatation at the region of fundoplication (Fig. 4). Gastric emptying studies showed no delay. Repeat imaging revealed severe extensive honey combing and air trapping with superimposed ground glassing (Fig. 5). Her respiratory status continued to decline and she died of respiratory failure.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 50,\n",
       "    'case_id': 'PMC3785351_01',\n",
       "    'case_text': \"We describe the case of a 50-year-old white male with small bowel Crohn's disease initially admitted with nausea and abdominal distention secondary to a small bowel obstruction. The patient has a 30 year history of Crohn's disease involving the jejunum and terminal ileum with multiple proximal small bowel strictures. He has had an appendectomy and back surgery in the past but was never treated surgically for his Crohn's disease. He was on maintenance therapy with Azulfidine and Azathioprine. The patient was started on Infliximab in November 2005 after multiple admissions for small bowel obstruction. The patient was changed to Adalimumab in May 2007 for patient convenience and difficulty related to obtaining regular intravenous access. He denied any recent antibiotic use.\\nComputerized tomography scanning on admission demonstrated a small bowel obstruction with thickened and edematous small bowel in the right lower quadrant 8-10 cm from the ileocecal valve with a small amount of ascites and no evidence of abscess. A nasogastric tube was placed for decompression and the patient was placed on solumedrol 20 mg intravenous (iv) every eight hours along with aggressive iv hydration and pain management with hydromorphone. The patient initially improved on hospital day number one. On the morning of hospital day number 2, the patient was reported to be febrile to 39.4 oC and tachycardic. The patient was complaining of increased pain and on exam had significantly increased tenderness with absent bowel sounds. At that time, the blood culture drawn on admission was reported as growing Escherichia coli, Enterococcus fecalis and Klebsiella oxytoca. The patient was started on intravenous antibiotics (ampicillin/sulbactam and gentamicin) and taken for an emergent laparotomy. He was found to have a perforation with a free abdominal abscess and a partial small bowel obstruction of the jejunum. The patient underwent a small bowel resection with jejunojejunal anastamosis and a right hemicolectomy with ileocolonic anastamosis and ileostomy. The pathology revealed a T4N1 poorly differentiated adenocarcinoma of the jejunum. The patient did well clinically post-op however a routine blood culture drawn for fever on post-op day number one grew Clostridium difficile. The patient denied significant diarrhea. Subsequent stool studies sent for Clostridium difficile toxins A/B were negative. At that time, the patient had received four days of antibiotics. The patient was maintained on pipercillin-tazobactam. All other follow-op blood cultures were unremarkable. The patient received a total of 21 days of intravenous antibiotics (6 days of ampicillin/sulbactam and gentamicin followed by 15 days of pipercillin-tazobactam). The remainder of his post-op course was unremarkable and he made a full recovery.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 70,\n",
       "    'case_id': 'PMC4899547_01',\n",
       "    'case_text': \"In September of 2012, a 70-year-old female presented with erythema and induration in the left arm that she presumed was caused by a recent mosquito bite. The patient's past medical history revealed left-sided breast cancer that was treated with mastectomy and lymph-node dissection, chemotherapy, and radiation therapy six years earlier. The new presenting lesion appeared on the ipsilateral side as her left mastectomy. The patient's initial assessment was thought to be cellulitis of the left arm, and she was treated with multiple courses of antibiotic therapy for two months with no significant improvement. An incision and drainage at that point did not demonstrate any purulent drainage. Approximately one month later, multiple blue satellite lesions developed within the area of erythema and induration. The mass also advanced in size at a rapid rate, to 20 centimeters in circumferential length extending from the proximal arm down to the elbow. The enlarging plaque of coalescing purple papules appeared necrotic, with multiple small satellite lesions that had erupted within the plaque (Fig. 1).\\nAfter biopsy of the lesion, histology results confirmed an angiosarcoma. The patient was consequently treated with multiple doses of chemotherapy. Since the diagnosis and treatment of the left-arm angiosarcoma, both the size of the mass and metabolic activity on CT/PET imaging showed significant improvement without evidence of metastatic disease.\\nMagnetic resonance imaging (MRI) performed after the initial incision and drainage revealed marked edema-like signal with decreased signal on the T1-weighted sequence and increased signal on the T2-weighted images involving the subcutaneous soft tissues of the arm, without muscle or osseous involvement (Fig. 2).\\nA subsequent PET/CT scan after the biopsy confirmed an angiosarcoma for staging purposes that demonstrated marked hypermetabolism. It was associated with severe subcutaneous edema confined to the left arm without evidence of adenopathy or distant metastasis (Fig. 3).\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 70,\n",
       "    'case_id': 'PMC5838830_01',\n",
       "    'case_text': 'A 70-year-old male presented with bilateral upper thigh pain of 20 years duration that progressed over the last 3 years. Although neurologically intact, the MRI documented an L1/conus medullaris intradural, nonenhancing, thin-walled, cystic lesion resulting in significant cauda equina compression. He underwent an L1-L2 laminectomy with intradural resection of two lesions that were adherent to the conus. Following careful resection/dissection, he remained neurologically intact, and was still asymptomatic 1 year later [Figures 1 and 2]. Pathologically, the lesions proved to be NECs typified by simple ciliated columnar epithelium [Figure 3].',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 46,\n",
       "    'case_id': 'PMC9353025_01',\n",
       "    'case_text': 'Mr. A was a 46-year-old single, male.\\nChronic pain in the left maxillary and right mandibular molar regions (according to him, due to gingival recession caused by periodontal treatment), occlusal discomfort (specific teeth unidentified), extracted teeth, teeth sticking to the lips, occlusal instability, difficulty in opening the mouth, eating, and speaking.\\nNone.\\nHe began visiting a nearby dental clinic in 2018. On May 7, 2019, he was referred to the clinic of periodontics at the Tokyo Medical and Dental University dental hospital by the nearby dentist due to problems with oral hygiene instructions owing to complaints such as \"gingival damage due to tooth brushing\" and many other complaints (e.g., occlusal instability, difficulty eating, difficulty speaking). At the clinic, he mentioned that his teeth were sensitive to cold water and did not understand the explanation of the lack of identifiable causes requiring treatment. Thereafter, he had repeated unscheduled visits and phone consultations with the clinic to present with complaints such as \"I feel some teeth are missing,\" \"I can no longer chew with the left teeth.\" In July, periodontal scaling was initiated. However, his complaints increased and worsened (e.g., \"gingival recession,\" a tingling sensation and numbness,\" and \"the lower teeth are damaged by the upper teeth\"). He began visiting the clinic approximately once or twice a week. During 3 months after August, he lost 20 kgs due to \"hip pain\" and \"difficulty walking.\" From October, he was unable to work and took leave. The Department of Psychiatry, to which he was recommended by his younger sister, suspected he had somatic symptom disorder after excluding psychotic disorders, depression, and bipolar disorder. However, the psychiatric treatment was discontinued because he remained highly dissatisfied with the dental treatment.\\nOn November 26, 2019, he visited our clinic (Department of Psychosomatic Dentistry) for the first time. However, the examination did not reveal any findings correlated with his complaints (Figure 1). Mr. A was diagnosed with AO, regarding that his pain was limited around his teeth (however, moving beyond nerve distribution), not provoked by jaw movement and failed to respond to every conventional dental treatment. However, based on the previous treatment process and his attitude, underlying developmental disorders were suspected. Hence, effects of amitriptyline and so on were not anticipated. He was referred to the outpatient department of SK, who is familiar with the treatment of developmental disorders in the Department of Anesthesiology, The University of Tokyo Hospital; at this point, the patient declined the referral.\\nHowever, given his continued complaint calls and letters regarding \"incidents at the periodontics clinic\" to the chief of periodontics clinic, our dental hospital director issued a treatment refusal document and send it to the patient in April. In response to our letter, the patient made repeated visits and phone consultations with our department, asking \"What should I do with my teeth?\" Therefore, he was advised to seek treatment at the University of Tokyo Hospital. Despite reluctance, on March 6, he eventually agreed to the referral. He was referred to Dr. SK a psychiatrist at the Department of Anesthesiology and Pain Relief Center, on April 24, 2020 (day 0). The timeline for this patient is shown in Figure 2. During the examination, he was suspicious of the treatment in the primary referral hospital and made unsolicited complaints without listening to the advice of Dr. SK. A structured interview, the Mini-International Neuropsychiatric Interview, was conducted to differentiate comorbid psychiatric disorders. He did not have a major depressive episode with hypochondriac delusions or other melancholy-type features, a manic episode, or psychotic disorder. He displayed gender-atypical gestures and abnormal eye contact and ritualized patterns of verbal or non-verbal behavior (his speech was excessively formal and polite). He was overly particular about Dr. SK\\'s wording and frequently corrected his expressions. He had highly restricted and fixated interests in gingival pain and was hyperreactive to sensory input. Hence, he was diagnosed with ASD according to the diagnostic criteria of the DSM-5. He was highly educated and employed in a highly structured, professional occupation, and did not have severe impairment in social functioning due to ASD prior to the onset of AO.\\nBased on hyperactivity and impulsivity symptoms observed (fidgeting with hands and squirms in seat, blurting out answers, interrupts others), the long version of the Conners\\' Adult ADHD Rating Scale (CAARS-S) and the observer-rated (CAARS-O) questionnaire were administered to examine the suspected comorbidity of ADHD. Mr A\\'s percentiles of the subscale of the CAARS-S were: E. DSM-IV Inattentive Symptoms, 90; F. DSM-IV Hyperactive-Impulsive Symptoms, 98; G. DSM-IV ADHD Symptoms Total, 96; H. ADHD Index, 88. According to ADHD symptoms in the CAARS, Mr. A\\'s ADHD symptoms were at the clinical level of psychiatry (Table 1). In addition, according to the CAARS-O completed by his younger sister, the percentile of the subscale D. Problems with Self Concept was 99, indicating low self-esteem related to ADHD symptoms. His developmental and life history was obtained and evaluated with the CAARS using the Diagnostic Interview for Adult ADHD. The results indicated inattention: poor listening to others since childhood; avoiding tasks requiring sustained mental effort, poor logical thinking; easily distracted by ambient noise; forgetful in daily activities. Accordingly, he was diagnosed with ADHD, predominantly inattentive type in the DSM-5 (day 26).\\nDuring each examination, the pain numerical rating scale (NRS), the Hospital Anxiety and Depression Scale (HADS), and Pain Catastrophizing Scale (PCS) were administered. Subjective pain intensity was assessed using the numerical rating scale (NRS). Regarding the changes in NRS scores, the minimum clinically important difference is called MCID, decreases of-2 points (or-33.0%) or more in NRS is considered to be substantial or optimal. The average pain NRS score of Mr. A was high (7 points).\\nSymptoms of anxiety and depression were assessed using the Hospital Anxiety and Depression Scale (HADS). Based on previous studies, the MCID of HADS is set at 1.5. Mr. A\\'s HADS results revealed clinical anxiety and depression symptoms (HADS-A, 15 points; HADS-D, 12 points).\\nCatastrophic thinking related to pain was evaluated using the Pain Catastrophizing Scale (PCS). It has been reported that strong catastrophizing thoughts leads to increased pain and disability possibility, resulting in chronic pain. The MCID of PCS can be improved by 38-44%. Mr. A\\'s PCS results (PCS score 30 points) indicated clinically catastrophic thinking. Changes in pain NRS, HADS, and PCS during treatment course are shown in Figure 2.\\nMr. A exhibited strong anger and suspicion at the periodontist who performed scaling. Dr. SK identified the uncontrollable temper outbursts and aggression as ASD irritability and prescribed risperidone (1 mg/day) (day 39). In addition, atomoxetine was initiated at 10 mg to treat severe anxiety and fear due to hyperarousal of ADHD that may contribute to irritability. At the subsequent examination (day 69), the patient responded to medication and stated that \"pain was reduced.\" Temper outbursts and frequent suspicions and complaints of scaling in the primary referral hospital were reduced and Mr A was more polite and considerate. To prevent discontinuation of medication due to side effects, atomoxetine was carefully increased to 20 mg.\\nDuring the examination 2 weeks later (day 83), he was calmer, and his facial expression was less grim, and the amount complaints regarding the symptoms he faced had reduced. Therefore, atomoxetine was increased to 30 mg. During the examination 2 weeks later (day 97) he did not mention anger or suspicion of previous treatments except one mention of oral discomfort. He requested consultation on more practical topics such as the preparation of the document for sickness and injury allowance. Therefore, atomoxetine was increased to 40 mg. During the examination 2 weeks later (day 110), pain and numbness were almost resolved. He stated, \"Lately, I have been very stable mentally.\" Additionally, he wanted to discuss with his boss when he would return to work, so the doctor created a medical certificate permitting him to return to work. Thereafter, atomoxetine was increased by 10 mg at ~2-week intervals, leading to reduced pain and numbness and improved mental health status. He returned to work after the administration of the maximum dose of atomoxetine (120 mg/day) (day 226) with no side effects indicating discontinuation. He stated, \"I am able to set up my work better than before because of the medication I have been taking.\" Re-administration of the CAARS-S at day 324 showed the following percentiles for the subscale of the CAARS-S and improved ADHD symptoms: E. DSM-IV Inattentive Symptoms, 60; F. DSM-IV Hyperactive Impulsive Symptoms, 21; G. DSM-IV ADHD Symptoms Total, 36; and H. ADHD Index, 26 (Table 1). Pain NRS (4 points) improved by 3 points, HADS-A (7 points) improved by 8 points, HADS-D (8 points) improved by 4 points, and PCS (16 points) improved by 14 points (46.7%) from the first visit. Clinically significant improvement was observed exceeding MCID on all scales. Thereafter, he continued to visit the clinic once a month to receive medication. Regardless of the presence of mild pain, he continued his work and achieved social integration. He stated that \"the pain has improved, and I am now able to do my hobby of reading, which I had to interrupt because of the pain.\"',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 76,\n",
       "    'case_id': 'PMC3362849_01',\n",
       "    'case_text': \"A 76-year-old Caucasian female was referred to our department due to a 6-month history of constant aching pain over her left hip region. Imaging features were very typical of a primary bone tumor and thus, as tentative diagnosis chondrosarcoma was made by the reporting radiologist (Figure 1). Subsequently performed tumor staging revealed the tumor as being a primary with an otherwise clear bone scan, CT chest, and abdomen. There was no evidence of metastatic disease. However, imaging of the kidneys suggested possible renal cell carcinoma involving the right kidney.\\nBiopsy specimen of the proximal left femur revealed a biphasic tumor composed of a cartilaginous component with abrupt transition into a noncartilaginous malignant mesenchymal component (Figure 2). The diagnosis of a dedifferentiated chondrosarcoma was made. The dedifferentiated part was consistent with an osteosarcoma.\\nThe patient underwent limb salvage surgery, performed according to standardized local protocol by surgeons specialized in oncologic surgery, followed by endoprosthetic replacement. Wide surgical margins were achieved. Although the patient was reasonably fit, adjuvant chemotherapy was not given due to the patient's age.\\nDuring the further course of treatment, the suspicious condition in the right kidney, that had already been present during initial tumor staging prior to limb salvage surgery, was diagnosed as clear-cell renal cell carcinoma (Figure 2) and immediately subjected to nephrectomy. There was no evidence of metastatic disease. After more than 5 years of followup the patient is still free of disease.\",\n",
       "    'gender': 'Female'},\n",
       "   {'age': 67,\n",
       "    'case_id': 'PMC3362849_02',\n",
       "    'case_text': 'Besides the current complaints described above, the patient underwent hysterectomy and cholecystectomy years ago. She could not remember the reason and there is no documentation discussing why those operations were performed. However, her medical family history (Figure 3) revealed that her youngest brother started suffering from invasive medium- to-low differentiated urothelial carcinoma (Figure 4) of the bladder when he was 67-year-old. He died at age 69 of a fibroblastic osteosarcoma (Figure 4) located in his left femur. Their mother presented with renal cell carcinoma as well when she was 65-year-old (specimen not available).\\nTo assess the hypothesized diagnosis of LFS, DNA was isolated from blood samples of the female index patient, and we analyzed the tumor suppressor gene p53 using semiquantitative, multiplex ligation-dependent probe amplification (MLPA, MRC-Holland) to rule out alterations of the TP53 gene. Moreover, the entire coding (exons 2-11) region and flanking intron regions of TP53 were sequenced. Since both MLPA and sequenciation did not reveal pathologic changes of the TP53 gene, the GAG-banding pattern derived from cell division was analyzed as well. However, chromosomal aberrations were not detected in the cytogenetic analysis neither for structural or numerical reasons. Taking into account all the results obtained, the diagnosis of LFS could not be confirmed, but there is still uncertainty regarding a definitive diagnosis in terms of a possible new genetic syndrome.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 70,\n",
       "    'case_id': 'PMC6292857_01',\n",
       "    'case_text': 'The AED for which most of studies and interactions with DOACs have been reported is phenytoin, which bears relevant clinical interactions with dabigatran, rivaroxaban, and apixaban. In 2017, Chang et al. found that in a large cohort of 91.330 patients suffering from non-valvular AF and treated with dabigatran, rivaroxaban or apixaban, there was a higher risk of major bleeding when the patients were taking phenytoin (N-7158) for concomitant epilepsy, as compared with patients not assuming this drug with an adjusted incidence rate difference (99% CI) per 1,000 person-years of 52.31 (32.18-72.44; p < 0.01). However, this study bears the strong limitations of a Health Insurance database system analysis (including the lack of detailed clinical/radiological information on the single patients). In the same year, Hager et al. described the occurrence of a left atrial thrombus in a 70-years-old patient whit a clinical history of hypertension, persistent AF, heterozygous factor V Leiden, recurrent deep venous thrombosis (DVT), and a pulmonary embolus, in co-treatment with atenolol, betahistine, diltiazem, valsartan, phenytoin 300 mg orally QD, and dabigatran etexilate 150 mg BID.',\n",
       "    'gender': 'Unknown'},\n",
       "   {'age': 45,\n",
       "    'case_id': 'PMC6292857_02',\n",
       "    'case_text': \"Phenytoin can affect both the absorption and metabolism of dabigatran, suggesting that could have led to a decreased anticoagulant effect and the development of atrial thrombus. Clinical relevance of this drug interaction has not been well described; anyway, the co-administration should be avoided. In 2016, Wiggins et al. had hypothesized the same type of interaction. They showed undetectable serum levels of dabigatran in a 45-years-old Afro-American male patient with AF treated also with phenytoin indicating that this drug could have a significant influence on dabigatran's metabolism and that this patient was at high risk for stroke.\",\n",
       "    'gender': 'Male'},\n",
       "   {'age': 48,\n",
       "    'case_id': 'PMC6292857_03',\n",
       "    'case_text': 'Similarly, Becerra et al. observed, in the first case documenting laboratory interaction between rivaroxaban and phenytoin, that DOAC levels were considerably low in a 48-years-old woman with cerebral vein thrombosis receiving also phenytoin, a combined CYP3A4 and P- glycoprotein inducer, which might reduce rivaroxaban levels.',\n",
       "    'gender': 'Female'},\n",
       "   {'age': 77,\n",
       "    'case_id': 'PMC6292857_04',\n",
       "    'case_text': 'Phenobarbital may bear relevant interactions, too. In 2014, Chin et al. evaluated median dose- corrected steady-state plasma dabigatran concentration (60 lg/L; range 9-279) in 52 patients (38-94 years). The dose-corrected concentration in a patient with co-administration of phenobarbital and dabigatran etixilate 110 mg BID was found 3 standard deviations below the cohort mean (concentration of 9 lg/L; dabigatran = 0.04l g/L per mg/day, z-score of the log-transformed dabigatran = -3.25). Authors hypothesized that this could occur via P-gp induction. In 2018, King et al. reported the case of a 77-years-old patient on low-dose phenobarbital treatment for essential tremor, who was diagnosed with AF and, after dabigatran (150 mg BID) failure, she was switched to apixaban 5 mg BID.\\nIn the following year, she suffered from two distinct episodes of cardioembolic stroke, and apixaban serum levels were lower (89 ng/mL approximately 11 h post-dose) than the expected therapeutic concentration. Furthermore, after phenobarbital discontinuation, the DOAC concentration rose to normal levels (361 ng/mL; unknown time post-dose) confirming a direct effect.',\n",
       "    'gender': 'Female'},\n",
       "   {'age': 53,\n",
       "    'case_id': 'PMC6292857_05',\n",
       "    'case_text': 'Carbamazepine may affect the anticoagulant efficacy of dabigatran and rivaroxaban. In 2016, Laureano et al. described 2 patients, a 53-years-old man with epilepsy and AF (CHADS2 score of 2) and a 66-years-old woman with bipolar disorder, previous pulmonary embolism, and right leg deep vein thrombosis, receiving carbamazepine and dabigatran 150 mg BID. In both patients, dabigatran serum concentrations were reduced (steady state 24 ng/mL and 20 ng/mL, respectively), effect probably due to induction of P-gp by carbamazepine. In 2017, Stollberger and Finsterer, described the case of a 55-years-old Caucasian male, suffering from recurrent venous thrombosis in treatment with rivaroxaban (10 mg BID) and carbamazepine (900 mg/die) for structural epilepsy with complex partial seizures and secondary generalization. He was hospitalized because of increasing pain and swelling of his right leg starting spontaneously. Sonography showed a thrombosis of the right popliteal and femoral vein and analysis of drug concentrations showed a serum-carbamazepine level in the therapeutic range while anti-Xa activity was low (< 20 ng/ml). Independently, in 2018, Burden et al. reported the case of a 71-years-old woman with clinical history of pulmonary embolism, subjected to the same therapy as the previous case. Presented to the Emergency department with acute onset shortness of breath, chest pain and palpitations, computed tomographic pulmonary angiography (CTPA) revealed multiple bilateral pulmonary emboli. Carbamazepine was hypothesized to be responsible of the DOAC inefficacy as the anti Xa activity was reduced in both cases.',\n",
       "    'gender': 'Female'},\n",
       "   {'age': 53,\n",
       "    'case_id': 'PMC6292857_06',\n",
       "    'case_text': 'Finally, Risselada et al. reported in 2013, only in Dutch language, a case of a 53-years-old man who underwent a partial knee arthroplasty and 4 days before developing a pulmonary embolism, whose symptoms started 1 day after he was switched from prophylactic dalteparin 5000 IE QD to rivaroxaban 10 mg one a day. Being the patient also in therapy with carbamazepine 600 mg BID for epilepsy, the authors of the case report hypothesized that pulmonary embolism was caused by a decrease in serum rivaroxaban levels due to the enzymatic induction of CYP3A4 by carbamazepine.',\n",
       "    'gender': 'Male'},\n",
       "   {'age': 88,\n",
       "    'case_id': 'PMC6292857_07',\n",
       "    'case_text': 'Rivaroxaban efficacy may also be affected by valproate and oxcarbazepine. In 2014, Stollberger and Finsterer described the case of an 88-years-old female patient, taking valproate and rivaroxaban 15 mg/die together, and whose anti-Xa activity was higher than expected. Indeed, coagulation tests after 28 h rivaroxaban-intake showed INR 2.26, PT 35%, aPTT 38.3 s and anti-Factor Xa-activity 2.00 U/m.',\n",
       "    'gender': 'Female'},\n",
       "   {'age': 68,\n",
       "    'case_id': 'PMC6292857_08',\n",
       "    'case_text': \"Even after the DOAC withdrawal, it took several days before coagulation was normalized, despite the short half-life of rivaroxaban (5-9 h). The authors themselves acknowledged a potential key role of the patient's poor renal function and low body-mass-index (eGFR 34-42 ml/min/1.73 m2 and BMI = 19.95), but they could not exclude a drug interaction between rivaroxaban and valproate. The potential role of oxcarbazepine as a rivaroxaban inhibitor was suggested by Serra et al., which described the case of a 68 years old man, suffering from permanent AF who had been put on rivaroxaban treatment, before undergoing external electrical cardioversion. He eventually did not undergo cardioversion because he developed a left atrial thrombosis despite DOAC treatment. The authors supposed that the thrombotic event was due to the interaction between rivaroxaban and oxcarbazepine, which the patient was taking for epilepsy, and which, as a strong CYP3A4 inducer, could have reduced rivaroxaban efficacy.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 81,\n",
       "    'case_id': 'PMC4719911_01',\n",
       "    'case_text': 'An 81-year old presented to our clinic with a chief complaint of \"my bladder is hanging out of my anus.\" His pertinent past medical history began with urinary retention leading to a transurethral resection of prostate for benign prostatic hypertrophy. He subsequently developed anterior urethral stricture disease which required multiple endoscopic procedures, including urethral dilations, direct visualization internal urethrotomy, and transurethral resection of urethral stricture and bladder neck contracture. Eventually, he began to void per rectum and was diagnosed with a large recto-urethral fistula. He was referred to a tertiary center and underwent diverting colostomy and ileal conduit. At the time of diversion, the bladder and rectum were left in situ due to a \\'hostile pelvis.\\' After surgery, he developed rectal prolapse and underwent a Thiersch procedure. Unfortunately, the pelvic organ prolapse worsened and he was advised that no further operative options were available. He and his wife began to manage the prolapse of his bladder and rectum by manual reduction, packing the rectum with Kerlix gauze, and applying dressings and tape to his buttock. He sought out further surgical opinions and presented to our center for management of this extremely complex and rare scenario. After meeting with a team of urologic, plastic, and colorectal surgeons, he elected for repair.\\nUsing a transanal approach, the posterior bladder wall was seen adjoined to the anterior rectal wall, consistent with a recto-urethral fistula. The anterior rectal wall was dissected from the posterior bladder wall, preserving all rectal tissue. The posterior bladder was then dissected laterally into the perivesical space. Bladder was mobilized off the peritoneal lining and the posterolateral pedicles were controlled with the LigaSure device. The anterior bladder was then dissected off the pubic symphysis using the transanal approach with slight vertical extension to gain access and exposure of urethra and Foley. Resection of residual prostate with closure of the urethra was performed.\\nAfter cystoprostatectomy, completion proctectomy was judged to be impractical due to the presence of parastomal hernias of the anterior abdominal wall. Bilateral gracilis muscle flaps were harvested from medial thighs and transposed into the pelvic defect. Left gracilis muscle was wrapped around the rectum and sutured to ischium in order to restore some muscular support to the sphincter. The right gracilis myocutaneous flap was used to fill dead space within the pelvis, bridging the gap between the anterior rectal margin and anal verge. Postoperatively, he developed venous congestion of the myocutaneous flap which was treated with medical leaches and eventually necessitated a return to the operating room 7 days post-op. After debridement of skin and subcutaneous tissue, the anterior margin of rectum was inset to muscle and anal verge in place of the skin paddle. By 4 weeks after surgery, thigh donor sites healed well and anterior rectum and anal verge were re-epithelialized. No evident prolapse of viscera was seen or palpated with digital rectal exam. Patient (and spouse) quality-of-life are now much improved, more than 6 months after surgery (Fig. 1).',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 48,\n",
       "    'case_id': 'PMC8683450_01',\n",
       "    'case_text': 'Sister Mary-Joseph nodule (NSMJ) is an umbilical skin metastasis that manifests as a firm, ulcerated and painful mass. Rare in intra-abdominal cancers of digestive or gynecological origin, associated with the poor prognosis, with a survival time average of two months without treatment, and poses a therapeutic problem because it has long been considered an outdated stage of the disease and requires palliative treatment. Here, we report the observation of a 48-year-old man who referred to our training for surgical management of an umbilical budding that changed character by becoming aggressive, he has received a surgical treatment that carries the umbilical mass, the sigmoid, and resection of bladder flange with end-to-end anastomosis of the colon, and suture of the slice of the bladder section, the histological assessment revealed the NSMJ originated from sigmoid adenocarcinoma. Through a review of recent literature, we will discuss the usefulness of aggressive surgery associated with adjuvant chemotherapy to treat this disease, we also specify its epidemiological, diagnostic, and therapeutic aspects.',\n",
       "    'gender': 'Male'},\n",
       "   {'age': 48,\n",
       "    'case_id': 'PMC8683450_02',\n",
       "    'case_text': \"A 48-year-old man from Moroccan East presented to the outpatient department with a six-month history of an umbilical mass, generalized body weakness, and abdominal pain. He was operated on (one year and six months ago) appendicular peritonitis with a suppurated appendix in the local hospital of Taourirt. He also was on oral anti-diabetic medication (metformin 1000 mg 1cp3*/day) for two months at the time of presentation.\\nClinical findings: on admission, we found on physical examination, an ulcero-budding mass (Figure 1), which appeared ten months after the treatment of peritonitis is which manifested in the beginning as a hard mass of 3 cm without inflammatory signs insight and which changed character after three months becoming fixed to the deep planes and measuring six cm, with inflammatory signs. Examination of the other systems was unremarkable, the patient had no Bowel obstruction, or rectal syndrome, drug history or family history of tumor, or any symptoms suggestive of colic manifestations.\\nDiagnostic assessment: laboratory parameters were normal, two computed tomography were performed out at six months intervals, the first at the beginning of the symptomatology objectified the presence of a urachal cyst, while the second revealed the existence of an infiltrating process of the sea urchin. A skin biopsy was performed, returning in favor of the granulation tissue. An abdominal-pelvic computed tomography (Figure 2) was performed, objectifying the presence of: a urachal-cyst that manifested like an oblong structure, extending from the umbilicus to the dome of the urinary bladder measuring 68 * 18 mm. Two incisional-hernias, with mixed intestinal and mesenteric content: the first, median, measuring 61 mm, and the seconds, right lateral with a collar measuring 32 mm.\\nTherapeutic intervention: the patient was hospitalized, diagnosis and management were discussed with the patient. He benefited from an exploratory laparotomy under general anesthesia. We found that it infiltrated the sigmoid colon (it was perforated), the umbilical wall, and the bladder. This finding justified the resection of the umbilical mass, segmental resection of the sigmoid, resection of bladder flange with end-to-end anastomosis of the colon, and suture of the slice of the bladder section.\\nThe histological assessments (Figure 3, Figure 4, Figure 5) of the resectioned parts retained the diagnosis of NSMJ with: for the bladder: no tumor proliferation, chronic inflammatory reshaping of the bladder mucosa; for segmental colectomy of the sigmoid: a well-differentiated and infiltrating adenocarcinoma of 2 * 2.5 * 4 cm, exceeding the sub-serous with a perforated wall, the limits of peripheral surgical resection are healthy (>4 cm), absence of vascular emboli or peri-nerve infiltration, lymph node curage 13 N-/13 N, tumor classified Pt4N0Mx; for the umbilical resection: skin localization of a well-differentiated adenocarcinoma. The tumor was located 6 mm from the deep resection boundary 4 mm from the nearest lateral resection boundary. Other lateral resection limits are healthy (more than 1 cm from it).\\nFollow-up and outcomes: postoperative follow-up was simple. During a staff of a multidisciplinary consultation meeting, the size of the tumor, the negativity of the extension assessments indicate adjuvant chemotherapy based on XELOX (oxaliplatin and capecitabine) for six months. The patient is regularly followed in our training (we opted for clinical, biological, and radiological monitoring by three months after a decline of 18 months, no recurrence detected).\\nPatient perspective: during the time he was hospitalized and after the treatment, the patient was delighted with the care she received and was optimistic about the outcome of her condition.\\nInformed consent: the patient was informed about the case report, why her case was peculiar and the author's interest in publishing her case. She willingly gave informed consent to allow the authors to use her photos for this case report.\\nPatient's consent: informed consent was obtained from the patient for us to use the pictures.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 64,\n",
       "    'case_id': 'PMC6510510_01',\n",
       "    'case_text': \"The patient was a 64-year-old, virologically stable HIV-positive male enrolled at the Grady Health System Infectious Disease Program (IDP) at the Ponce de Leon Center, a multidisciplinary HIV clinic in Atlanta, Georgia, USA. The patient was diagnosed with HIV in 2005, 12 years prior to this report. At the time of this study, the patient was on the anti-retroviral (ART) regimen of Prestiza , Norvir  and Epivir . The patient's viral load remained undetectable throughout the intervention period, and his CD4 count ranged from 369 cells/mm3 to 313 cells/mm3. Aside from HIV, the patient's medical history was significant for controlled hypertension, controlled Diabetes Mellitus, and a history of fungal sinusitis, which requires him to be on long-term antibiotics. The patient had stable food and housing, and lived alone in an apartment. He reported positive social support from a sibling and 2 close friends, however reported periods of loneliness and depression. He was followed by a mental health counselor at the Ponce Center for intermittent depression and psychological support.\\nThe patient was referred to PT for chronic pain secondary to a 15-year history of bilateral lower extremity distal sensory polyneuropathy, as well as 5-year history of chronic lower back pain. The patient had a lumbar spine MRI on the same week as the initial evaluation, which revealed L3/L4 disc bulge without spinal canal narrowing, L3/L4 left neural foraminal narrowing, and multilevel mild degenerative joint disease.\\nThe patient signed an informed consent form to voluntarily be the subject of this case report after guided ethical information was provided. The CARE checklist was closely adhered to in the writing of this case report. The patient expressed readiness to decrease opioid use, and understood that the goal of the intervention was to both decrease pain and wean opioids.\\nThe patient received all medical care - including PT - at the Ponce Center, which is the largest, most comprehensive ambulatory outpatient HIV/AIDS facilities in the nation with an enrollment nearly 6,000 individuals, all with a history of AIDS. Nearly 90% of enrolled patients pertain to ethnic or racial minority groups, 42% are uninsured, and 64% are below 100% of Federal Poverty Level. The clinic is located an identified HIV cluster in Atlanta, and more than 70% of HIV-positive individuals residing in Atlanta live within two miles of the clinic. Physical therapy has been available on a weekly basis at the IDP since 2014. The physical therapy treatment room has an adjustable treatment table, blood pressure monitor, pulse oximeter, and PT equipment such as varying levels of resistive exercise band, therapeutic tape, and pre-fabricated orthoses.\\nThe patient's PT goals were as follows: 1) to be able to perform functional activities such as walking and housecleaning for >30 minutes without needing to rest; 2) to be able to stand long enough to cook himself nutritional meals; 3) to sleep through the night (>= 7 hours) without awakening from pain; 4) To gain independent pain management skills for home.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 69,\n",
       "    'case_id': 'PMC3884727_01',\n",
       "    'case_text': \"A 69-year-old woman was hospitalized in India for subarachnoid hemorrhage in January 2013. Her hospitalization was complicated by unsuccessful coil embolization and subsequent hydrocephalus. A ventriculoperitoneal shunt was inserted, and she was transferred to an acute care hospital in Pittsburgh, Pennsylvania, USA, for further management in February 2013. She underwent reinsertion of the shunt and was discharged to a long-term care facility (LTCF 1). She was readmitted to the same hospital because of fever in March 2013.\\nA urine culture collected at the time of readmission grew carbapenem-resistant K. pneumoniae and extended-spectrum beta-lactamase-producing E. coli. Although production of KPC-type beta-lactamase was initially suspected in K. pneumoniae, the unusually high level of resistance to amikacin (MIC >32 mug/mL) and gentamicin (MIC >8 mug/mL) increased concern for presence of an NDM-1 producer, which is frequently highly resistant to aminoglycosides because of production of 16S rRNA methyltransferase. A modified Hodge test showed a positive result for carbapenemase production, and a metallo-beta-lactamase Etest (bioMerieux, Marcy l'Etoile, France) showed a positive result for metallo-beta-lactamase production.\\nPCR and sequencing identified NDM-1 and OXA-232, a 5-aa variant of OXA-48 recently reported in K. pneumoniae isolates from India. Presence of the gene for 16S rRNA methyltransferase (armA) was also confirmed by PCR and sequencing and accounted for the high-level aminoglycoside resistance. The isolate belonged to sequence type (ST) 14, as determined by multilocus sequence typing, and has been reported to be common among NDM-1-producing K. pneumoniae in Europe.\\nThe patient was discharged to LTCF 1 but was readmitted because of recurrent fever. A urine culture collected at this admission grew carbapenem-resistant K. pneumoniae and carbapenem-resistant E. coli. This E. coli isolate belonged to ST95 and was positive for the NDM-1 gene but negative for the OXA-48 group and armA genes. The original extended-spectrum beta-lactamase-producing E. coli isolate belonged to ST3865, which is distinct from ST95. Therefore, it is likely that the patient was already colonized by NDM-1-producing E. coli ST95 at the time of the first admission, but this colonization was not detected in a clinical culture at that time. All K. pneumoniae and E. coli isolates remained susceptible to fosfomycin and colistin.\\nThe patient did not receive any antimicrobial drug therapy specific for these isolates because she was deemed to be only colonized with them in the urine. Enhanced contact precautions were also implemented at the time of PCR confirmation of the NDM-1 gene. These precautions included all components of contact precautions (handwashing, gowns, gloves, disinfected/dedicated equipment), and dedicated personnel monitored compliance with these measures around the clock.\\nThe patient was eventually discharged to another long-term care facility (LTCF 2) in April 2013. A point surveillance testing for NDM-1-producing Enterobacteriaceae by using rectal swab specimens was conducted for all inpatients at the acute-care hospital and for all residents of the unit at LTCF 2. Testing did not identify any other patients colonized with NDM-1-producing Enterobacteriaceae.\\nIn transformation and conjugation experiments, transformants carrying the OXA-232 gene were obtained from K. pneumoniae, but those carrying the NDM-1 gene could not be obtained by either method, suggesting that the 2 genes were not located on the same plasmid. For E. coli, transformants and transconjugants carrying the NDM-1 gene were obtained, which indicated that this gene was located on a self-conjugative plasmid.\\nDetection of NDM-1- or OXA-48-group-producing Enterobacteriaceae, in particular K. pneumoniae, poses a diagnostic challenge in regions to which KPC-producing K. pneumoniae is endemic. In our case, recognition of resistance to multiple aminoglycosides by an automated instrument, which was confirmed to be high level by the disk diffusion method (i.e., no inhibition zone), prompted early detection and implementation of appropriate infection prevention measures. Production of 16S rRNA methyltransferase by KPC-producing K. pneumoniae is extremely rare, and no cases have been identified in the United States. Therefore, we propose that high-level resistance to amikacin and gentamicin can serve as a clue for suspecting potential NDM-1-producing isolates in clinical diagnostic laboratories.\\nConversely, Enterobacteriaceae producing OXA-48-group carbapenemase, including variants such as OXA-232, do not have characteristic susceptibility patterns and may easily not be recognized in areas with a high background prevalence of KPC-producing organisms. Therefore, organisms producing OXA-48 or their variants might have already spread in the United States.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 59,\n",
       "    'case_id': 'PMC5851018_01',\n",
       "    'case_text': 'On May 2016, a 59-year-old Bulgarian male referred from the office of cardiologist to our hospital complaining of worsening shortness of breath, weight gain of 6 pounds, leg swelling, and low blood pressures (BP) down to 80/60 mmHg for a few weeks. Medical history was significant for hypertension, coronary artery disease, diabetes, atrial fibrillation, polycystic kidney disease, and a recent tamponade diagnosed 4 months prior to this hospitalization. Dizziness was his initial complaint in March. A large serosanguinous pericardial effusion was drained at that time with inconclusive fluid analysis including a negative culture and cytology. His medications included amlodipine, lisinopril, and atorvastatin. He used to work as a truck driver. After 45 packs per year smoking history, he quit in 2015. Positive findings on exam were a BP of 85/60 mmHg, mild respiratory distress on room air, increased jugular vein pressure, muffled irregular heart sounds, and pitting edema of the shins. Echocardiography showed normal left ventricular ejection fraction of 59% and a moderate sized posterior pericardial effusion with borderline signs of tamponade. The echo also revealed a fibrinous material and stranding suggestive of adhesions in the collection (Figure 1). Attempt to drain the pericardial effusion with subxiphoid pericardial window was terminated due to fusion of pericardium to the anterior surface of right ventricle. Partial pericardiectomy was then attempted through median sternotomy with frozen section, which revealed a neoplastic process. Hence, a subtotal pericardiectomy was performed. There were adhesions of the pericardium to the right ventricular wall and diaphragmatic surface and nodularity on pericardium. Repeat echocardiogram showed no further effusion. Pericardium and epicardium tissue slides revealed predominantly solid sheets of high-grade epithelioid to spindle cells with focal areas of vasoformation. Tumor cells predominantly epithelioid show prominent atypia with abundant amophilic to eosinophilic cytoplasm, large vesicular nucleoli, and prominent nucleoli with atypical mitotic figures. On immunostaining, tumor cells were positive for CD31, CD34, WT1, vimentin, keratins AE1/AE3, and focal CK7 and negative for CK20, PSA, PSAP, AFP, TTF1, CDX2, BerEp4, calretinin, podoplanin D2, CD45, and S100 (Figures 2-2). These findings led to the diagnosis of epithelioid angiosarcoma of the pericardium. Chest computed tomography scan showed nodular opacifications within both lungs with concern for metastasis. His condition stabilized with Lasix and oxygen. He was then referred to the university hospital for a second opinion regarding his management. Cardiac MRI showed extensive vascular malignant mass in the pericardium encircling and infiltrating the right heart chambers. He received paclitaxel weekly for 6 doses with palliative intents. Later he developed malignant pleural effusions and intracranial metastatic lesions. He was admitted again in our hospital for weakness and encephalopathy. Patient preferred comfort care. Hence, he passed away 9 months after his initial presentation.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 32,\n",
       "    'case_id': 'PMC4314886_01',\n",
       "    'case_text': \"A 32-year-old man presented with a linear skin lesion of segmental distribution over his left arm, shoulder and upper back. The epidermal nevus was not of the common hyperkeratotic pigmented type, but resembled a linear organoid nevus by its softer texture and light color. However, the patient refused additional biopsy and further workup to determine histologic subtype of the nevus. The lesion had been present since birth and was asymptomatic until approximately 1 year ago, when a slowly enlarging ulcer appeared on the upper arm. The ulcer was biopsied and histological investigation revealed basal cell carcinoma (BCC) with deep invasion into the dermis [Figure 1]. The patient was offered appropriate therapy by an oncologist, but he sought the second opinion and was referred to the Dermatology Department. On clinical examination, it was noted that besides the large crusted ulcer of confirmed BCC on the arm [Figure 2], there were several other loci of evolving tumors on the patient's back [Figures 3 and 4]. Dermoscopy revealed diagnostic features of a BCC. The patient declared no other problems with his health and was advised to follow treatment recommendation of the consultant oncologist.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 30,\n",
       "    'case_id': 'PMC4376922_01',\n",
       "    'case_text': 'We examined a 30-year-old male with a sudden, painless visual loss in his right eye that lasted for 3 h. Nine years ago, he had been treated with scatter laser photocoagulation for an ischemic type of upper branch retinal vein occlusion (BRVO) in the left eye. At that time, he was diagnosed with homocysteinemia with the homozygous C677T mutation in the methylenetetrahydrofolate reductase gene. After a detailed systemic workup, he was put on warfarin sodium. On examination, his best-corrected visual acuity (BCVA) was hand motions in the right eye and 20/30 in the left eye. A slit-lamp examination was unremarkable in each eye. The intraocular pressure was 15 mm Hg in both eyes. Dilated fundoscopy revealed tortuous and dilated retinal veins with 360  scattered retinal hemorrhages as well as a clearly demarcated pale retina in the distribution of the upper temporal artery in the right eye and scattered laser spots with macular retinal pigment epithelium changes in the left eye (fig. 1). Our fundus autofluorescent image clearly depicted the extent of the infarcted area (fig. 2a), and fluorescein angiography demonstrated that the peripheral retina was well perfused in the right eye (fig. 2b). Optic coherence tomography (OCT) showed the presence of subretinal fluid and the ganglion cell layer infarct in the right eye (fig. 2c). The diagnosis was simultaneous CRVO and upper BRAO in the right eye. After a prompt digital ocular massage and a 20% mannitol infusion, an anterior chamber paracentesis was immediately performed. However, no visual improvement was noted following the procedure. Two weeks later, a dexamethasone intravitreal implant (Ozurdex, Allergan Inc., Irvine, Calif., USA) was injected into the right vitreous cavity to at least alleviate the CRVO-related concomitant macular edema, as the patient still had a visual acuity of hand motions in the right eye. Visual acuity gradually improved in the following weeks with a remarkable decrease in the central macular thickness, and no postoperative injection-related complication was observed. Six months after the operation, the retinal anatomy appeared to be dramatically improving (fig. 3a, b), and his BCVA was found to be 20/25. His visual field defect contracted with time in the right eye (fig. 4a, b).',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 39,\n",
       "    'case_id': 'PMC9858885_01',\n",
       "    'case_text': \"This patient is a 39-year-old African American male with a past medical history of tobacco and cannabinoid use, fentanyl abuse, and asthma who presented to the emergency department with an abrupt onset of shortness of breath and palpitations. The patient's symptoms began the evening prior. The patient was experiencing chest pain on the left side, which is accompanied by neck pain. The chest pain and dyspnea (shortness of breath) appeared to be worse when the patient was walking upstairs. It is not specified whether the pain is radiating or not. His last fentanyl use was one month prior. At the time of admission, he had been in a rehabilitation facility for one month.\\nHe denied fever, chills, recent weight loss, change in vision, nausea, vomiting, headache, diarrhea, recent sick contacts, or previous episodes of his presenting symptoms.\\nThe physical examination revealed an afebrile patient, with a blood pressure of 131/85 mmHg, tachycardic (110 bpm), and tachypneic (22 breaths/minute), with an oxygen saturation of 100% on room air. Findings included shortness of breath with lung fields clear to auscultation bilaterally and hand tremors on outstretched extremities bilaterally. The remaining physical examination results were unremarkable.\\nSignificant initial laboratory results include the following: cross-linked dimeric degradation product (D-dimer), N-terminal pro-B-type natriuretic peptide (NT-proBNP), high sensitive cardiac troponin I, and creatine kinase-myocardial band (CK-MB) (Table 1). An elevated D-dimer prompted chest computed tomography pulmonary angiogram (CTPA) (Figure 1), which revealed no signs of pulmonary embolism, patchy ground glass opacities within the lingula and left lower lobe, mild dependent changes with subsegmental atelectasis within the bilateral lower lobes, and mildly enlarged main pulmonary artery, suggestive of underlying pulmonary artery hypertension, with an upright X-ray showing signs of cardiomegaly (Figure 2). Electrocardiography (ECG) revealed sinus tachycardia and left ventricular hypertrophy (LVH) (Figure 3). A two-dimensional (2D) echocardiogram showed an ejection fraction (EF) of 36%, with diffuse mild dilation of the atria and ventricles and trace mitral and tricuspid regurgitation (Video 1).\\nOn the second day of admission, the patient was placed in droplet isolation according to hospital policy due to COVID-19. It is important to note that the initial rapid at-home SARS-CoV-2 test was positive, but on hospital reassessment using PCR testing, the patient was found to be negative. Together with the lack of overt symptoms on physical examination, we suspect that this was likely a false-positive result. While SARS-CoV-2 has been associated with dilated cardiomyopathy in rare cases, we did not believe that there was sufficient evidence in this patient to include it as a likely differential diagnosis. His free T4 was 6.58 ug/dL and total T3 was 459.37 ng/dL, with a suppressed thyroid-stimulating hormone (TSH), indicating a hyperthyroid state. A thyroid ultrasound indicated an enlarged and relative hypervascular thyroid. However, due to the prior CTPA use of iodine, the radioactive iodine uptake study could not be completed. Nuclear medicine myocardial perfusion single-photon emission computed tomography (SPECT) at rest and stress indicated no evidence of a fixed defect or stress-induced ischemia (Figure 4).\\nThe third day of admission resulted in serology studies, with thyroid-stimulating immunoglobulin of 127 IU/L, thyroglobulin antibody < 1.0 IU/mL, thyroid peroxidase antibody of 281 IU/mLco, and thyroid-stimulating hormone receptor antibody of 39.60 IU/L, indicating Grave's disease. The treatments provided were as follows: methimazole dosing titrated to 20 mg tablet, orally, twice daily; metoprolol 50 mg tablet, orally, daily; and Entresto 1 tablet (49/51 mg), orally, twice daily. A summary of the patient's notable laboratory values throughout the hospital stay is provided in Table 1.\\nThe patient significantly improved. Six weeks later, he was clinically and biochemically euthyroid. His heart failure medication was discontinued, A repeat echocardiogram showed normal left ventricular (LV) and right ventricular (RV) systolic function with an ejection fraction of 56%.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 35,\n",
       "    'case_id': 'PMC7666633_01',\n",
       "    'case_text': 'A 35-year-old white female presented to the emergency room for severe midsternal chest pain and left shoulder pain that started the previous day. She had a recent vaginal delivery at home approximately ten weeks before this presentation and had ongoing intravenous drug use. Since the birth at home, she had lower abdominal pain but failed to seek medical attention. She also reported two to four weeks of generalized malaise, fever, and chills. She was febrile at the emergency room, with tachycardia of 105 beats per minute, normal blood pressure, and oxygen saturation >90% on room air. Based on her clinical history and physical examination findings such as tachycardia and severe lower abdominal tenderness, acute pulmonary embolism was a concern. She underwent a computed tomography (CT) scan of the chest, abdomen, and pelvis for further evaluation. Imaging revealed multiple small pulmonary emboli and findings concerning septic arthritis of the pubic symphysis and edema of the left clavicle. Based on her clinical presentation and risk factors, IE was suspected. Therefore, she was transferred to our hospital for further management.\\nOn arrival at our facility, the patient had a fever of 38.8ocelsius, tachycardia of 125 beats per minute, blood pressure of129/79 mmHg, and oxygen saturation of 93% on room air. Labs revealed leukocytosis of 19,000/mL with neutrophil predominance and normal renal and hepatic functions. Labs were significant for hypoalbuminemia and elevated inflammatory markers, including ESR (Erythrocyte sedimentation rate) of 100 mm/Hr and CRP (C-reactive protein) of 27 mg/dL. Her urine drug screen was positive for amphetamines and opiates, and she admitted to the daily use of heroin and methamphetamine. On physical examination, she was alert and oriented but appeared to be in painful distress, expressing significant abdominal and left shoulder pain. Lungs were clear on auscultation, whereas on the cardiac exam, a diastolic murmur in the pulmonary area was heard. She had severe suprapubic area tenderness on palpation. The left shoulder limited range of motion with no spine tenderness was appreciated on musculoskeletal examination. Left antecubital and buttock areas showed the presence of multiple needle marks with no signs of infection. A portable chest X-ray disclosed diffuse lung opacities suspicious of septic emboli (Figure 1). Empirically intravenous (IV) vancomycin and ceftriaxone were initiated for suspected IE treatment. The transthoracic echocardiogram (TTE) demonstrated an extensive mobile 3.7 x 0.5 cm vegetation on the pulmonary valve with moderate to severe pulmonic regurgitation (Figure 2). The patient refused a transesophageal echocardiogram (TEE) despite multiple requests. The cardiothoracic surgery team review of the TTE was negative for any left-sided IE stigmata.\\nMagnetic resonance imaging (MRI) of the left shoulder revealed acromioclavicular joint septic arthritis and abnormal marrow edema in the distal clavicle concerning for osteomyelitis (Figure 3). A subcentimeter abscess in the region of subacromial bursa was also seen (Figure 3). Pelvis MRI showed peripherally enhancing fluid collection from pubic symphysis compatible with septic arthritis and erosion in the left pubic body without confluent marrow replacement to indicate osteomyelitis and bilateral hip joint effusions (Figure 4). Blood cultures returned positive for MRSA within 12 hours, and they remained positive from the first day of hospitalization until day 7. The mean inhibitory concentration of vancomycin for MRSA was 1. The positive blood cultures resulted in the de-escalation of antibiotics to vancomycin alone.\\nThe patient underwent irrigation and debridement of the pelvic abscess and left shoulder joint. The cultures from the fluid aspiration of the left acromioclavicular joint and pubic symphysis grew MRSA confirming septic arthritis. On the 13th day of hospitalization, she underwent bioprosthetic pulmonic valve replacement and pulmonary artery reconstruction with autologous pericardial patch placement. Intraoperative echocardiogram did not reveal any left-sided IE stigmata. The special stain for fungal organisms was negative. Cultures from the valve were not sent due to positive blood and tissue cultures from the joint aspirations. Histopathology of the pulmonic valve vegetation revealed a partially necrotic cardiac valve with septic vegetations, numerous Gram-positive cocci in clusters, and pairs. After one week following cardiac valve surgery, she had dental extraction of the remaining upper teeth to optimize dental hygiene. After valve replacement, she was started on warfarin with an international normalized ratio goal of 2-3.\\nDue to the history of active ongoing intravenous drug abuse, outpatient parenteral antibiotics were deferred. Instead, the patient received intravenous antibiotics, inpatient, until completion of her antibiotic course. She completed the IE treatment with six weeks of vancomycin. Inpatient pharmacy managed the vancomycin dosing based on the trough levels. Vancomycin dosing was three times a day, and the average dose ranged from 750 mg to 1250 mg over six weeks. Her mean vancomycin trough levels ranged from 15 mcg/mL to 18 mcg/mL. Upon completing antibiotic therapy, the ESR had decreased to 32 mm/Hr and CRP decreased to 1.32 mg/dL. Before being discharged home, she underwent an evaluation by psychiatry for suboxone treatment. She was discharged home in a stable condition. Unfortunately, she was lost to the outpatient clinic follow-up and repeat imaging to ensure that the infection resolution could not be obtained.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 27,\n",
       "    'case_id': 'PMC6864125_01',\n",
       "    'case_text': 'A 27-year-old female with no significant past medical history and no previous surgeries presented to the emergency department with one day of abdominal pain. The pain was initially located in the periumbilical region but migrated to the right lower quadrant with associated nausea and vomiting. On examination, she was afebrile with focal tenderness in the right lower quadrant and voluntary guarding. Labs were notable for a white blood cell count of 18.8. CT of the abdomen and pelvis performed showed acute, simple appendicitis. The patient received intravenous piperacillin-tazobactam. She was then taken to the operating room for a laparoscopic appendectomy. Three trocars were used. The appendix was inflamed primarily at its base but there was no evidence of perforation. The mesoappendix was divided using a LigaSure device (Covidien, Mansfield, MA). The base of the appendix was divided using an endo-GIA purple 45 mm load (Covidien, Mansfield, MA). There were no free or malformed staples seen after the stapler was fired. The patient had an uneventful postoperative course and was discharged the following day.\\nEight days later, the patient presented to the emergency department with six hours of severe epigastric abdominal pain. The pain was worse than when she had appendicitis and had spread more diffusely since onset. She was mildly tachycardic but otherwise hemodynamically normal. However, she was peritoneal on exam. Labs were unremarkable. CT of the abdomen and pelvis showed a large amount of free air, some air tracking along the staple line, and small bowel mesenteric edema. She was taken to the operating room for an exploratory laparotomy. Upon entry, there was murky fluid and a clearly necrotic small bowel segment. Closer examination revealed a single loose malformed staple that had hooked onto the small bowel mesentery, causing a volvulus (Fig. 1, Fig. 2). The staple was removed and the bowel was detorsed 360 degrees counterclockwise, but was not viable and was resected using purple GIA cartridges. The bowel was run in its entirety -there was no evidence of small bowel perforation and the appendectomy staple line was intact. A stapled side to side anastomosis was created using a purple GIA cartridge with a blue transverse anastomosis (TA) stapler load to close the common channel. The mesenteric defect was closed using 3-0 vicryl sutures. A nasogastric tube was left postoperatively and removed on the second postoperative day. The postoperative course was uneventful and the patient was discharged on postoperative day four after gradual diet advancement. The patient has subsequently been seen in clinic on postoperative day 11 and has been doing well. This complication was reported to the surgical device company.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 1,\n",
       "    'case_id': 'PMC6396587_01',\n",
       "    'case_text': 'A 1-year-old female child born to nonconsanguineous parents was admitted with delayed milestones and one episode of seizures. There was no history of birth asphyxia. Pregnancy and delivery were uneventful. The head circumference was normal. There was delay in speech and language development. Abdominal ultrasound was normal. Magnetic resonance imaging (MRI) brain was advised and sent to MRI department for the same. Axial T2-weighted images at the level of mid-brain shows median cleft, which is seen separating the cerebellar hemispheres and communicating with fourth ventricle, producing the typical bat wing (open umbrella) (solid arrow) appearance [Figure 1a].\\nMRI revealed enlargement of posterior fossa with absence of cerebellar vermis [Figure 1c] and elongated bilateral superior cerebellar peduncle giving molar tooth appearance [Figure 1b]. There was mild colpocephaly seen. Joubert syndrome was hence diagnosed.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 66,\n",
       "    'case_id': 'PMC9287348_01',\n",
       "    'case_text': 'We present a 66-year-old patient with a medical past history relevant for hypertension, type 2 diabetes mellitus, dyslipidemia, sleep apnea, and obesity. He was diagnosed with Parkinson\\'s disease at age 51, being the initial symptom tremor involving his left upper extremity. Initially, he was treated with levodopa and dopaminergic agonists (pramipexole) with a good clinical response. After five years, he developed motor fluctuations, and generalized dyskinesias. Other complications of therapy included binge eating and hallucinations related to the use of dopamine agonists. Mild cognitive impairment was also observed. At this moment, he received adaily equivalent levodopa dose of 1600 mg. Besides, he also suffered mental depression and anxiety requiring specific treatment with duloxetine and clonazepam.\\nThe progressive clinical worsening due to motor complications and side effects of medications, led us to consider the use of intestinal levodopa intraduodenal infusion.\\nThe patient scored III at the Hoen&Yahr scale in the \"on\" period and IV in the \"off\" period. He had mild cognitive impairment scoring on Montreal Cognitive Assessment (MoCA) 23/30 at hospital admission. Initial UPDRS III scored 55. Blood tests before the procedure did not disclose any significant abnormalities.\\nThe nasojejunal test improved postural stability, motor fluctuations, and gait. PEG placement was performed two days after. It took one attempt without success to perform the procedure because of great solid content in the stomach, requiring fasting for more than 24 h, and the use of laxatives. The next day, the operation for PEG catheter placement took place without complications; he received antibiotic prophylaxis with meropenem and linezolid, an anesthetic plan with desflurane, fentanyl, and rocuronium, and postoperative pain management with methadone.\\nOn the first postoperative day, the patient developed mild abdominal pain surrounding the PEG incision area. Initially, he presented diminished hydro-air noises with no inflammatory or peritoneal irritation signs. An abdominal X-ray showed a fecal mass; he received intestinal enemas with an improvement in symptoms. Three days later, the patient developed an acute right-sided abdominal pain that required analgesia with methadone and tramadol. Blood examinations showed severe inflammatory response and elevation of liver enzymes. An abdominal CT was indicated. It showed acute cholecystitis signs with inflammatory changes in adjacent fat and the transverse colon. Thus, an urgent cholecystectomy was performed; areas of gallbladder necrosis were observed in the absence of gallstones.\\nThe patient restarted levodopa infusion the next morning. Ten days after admission, cholecystitis symptoms resolved, motor fluctuations improved; dyskinesias and psychiatric symptoms disappeared; l gait and stability improved leading to a partially recovered independence for daily living activities.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 36,\n",
       "    'case_id': 'PMC4525444_01',\n",
       "    'case_text': 'A Hindu male aged 36 years, an auto driver by profession was addicted to alcohol since last 20 years was admitted in the hospital (Indoor of Psychiatry, Mental Health Institute, SCB Medical College, Cuttack, Odisha, India) with complaints of confusion in daily routine activities, irritability, aphasia, ataxia, urinating in the bed most of the time at night, unsteady gait, memory impairment (immediate and recent), forgetfulness, and difficulty in the initiation of sleep and loss of appetite. On examination, there is dysfunction in the Lever function test ( AST,  ALT,  GGT,  Alkaline phosphatase with fatty changes in the liver). After improvement in the physical conditions, thiamine injection was administered in the doses of 200 mg/day around 1 month. After that, in order to assess the neurocognitive functioning of the patient, PGI-BBD was tried. However, due to the presence of aphasia, visuo-motor incoordination, unsteady gait, the patient did not cooperate for the test.\\nHe was treated for 1 year with donepezil, thiamine, and benzodiazepines with follow-up in every month at the OPD. Neuropsychological evaluation was done after 1 year by the administration of PGI-BBD.\\nThe findings of PGI-BBD are as follows: Impairment in recent and remote memory, immediate recall, delayed recall, attention and concentration, visual retention, recognition, retention for similar and dissimilar pairs. Impairment in memory scale indicates the involvement of temporal lobe, impaired performance IQ revealed the involvement of frontal lobe, which suggests the patient has difficulty in abstract reasoning and practical ability. Dysfunction in NBT suggested difficulty in visual acuity and depth perception. Visuo-motor in coordination and organicity were confirmed from Bender Gestalt Test. VAIS was not administered because of persistent motor aphasia of the patient, while there was no indication of sensory aphasia. Even after the adequate treatment of the patient, the improvement in the neurocognitive function was very slow. Computed tomoth graph y (CT) scan findings revealed lesion in the frontotemporal region.',\n",
       "    'gender': 'Male'},\n",
       "   {'age': 40,\n",
       "    'case_id': 'PMC4525444_02',\n",
       "    'case_text': 'A Hindu male, aged 40 years, an industrial worker in a steel plant, belongs to a tribal community of the state, where alcohol (Handia) was regularly consumed by almost all adult males and females in the evening time after returning from the work as their sociocultural customs. The person after returning from the work started consuming alcohol from his adolescent age, at the age of 16, before admitted to a tertiary care hospital (Mental Health Institute, SCB Medical College, Cuttack, Odisha, India). He had complaints of confusion in daily routine activities in social and occupational sphere (the confusion is such an extent that at times he was unable to reach at home in the evening after returning from the plant work). He had ataxic gait, diminished vision, forgetfulness, confabulation, neuropathic pain all over the body, agitated, episodic seizure once. For all the above symptoms, he was admitted in the hospital. On investigation, there was liver dysfunction ( ALT,  GGT,  Serum alkaline phosphatase, and fatty changes in the liver), neuropathic pain in all four limbs. The neuropsychological assessment was tried after the improvement of his physical conditions (around 1 month). However, the patient did not cooperate at that time. After 2 months of discharge, neuropsychological assessment was done. PGI-BBD findings revealed impairment in memory, verbal and performance intelligence quotient, disturbances in visual acuity and depth perception, as well as disturbances in visuo-motor coordination, which indicates there may be the involvement of all the four lobes of the brain. On ophthalmological investigation, there was dysfunction of refractive error. However, there was no optic atrophy or cranial nerve palsy as examined by the ophthalmologist. CT scan findings are suggestive of cortical atrophy.',\n",
       "    'gender': 'Female'},\n",
       "   {'age': 55,\n",
       "    'case_id': 'PMC4525444_03',\n",
       "    'case_text': 'A Hindu male, aged 55 years, educated up to third standard belonging to lower socioeconomic status, who was working as a mechanic in a motor garage. He was addicted to alcohol from his adolescence age of 13 years. He was abdicated to beer (Local name-Aska 40), Whisky-40% of alcohol, and Rum-45% of alcohol and was taking very often with his friends. In the initial years of addiction, the frequency of consuming alcohol was 3-4 times/week. However, after 5 years his frequency had been increased to almost every day. He was admitted in the hospital with complaints of grandiose ideas, aggressive behavior, paranoid ideas, confusion, and ataxia. On examination, he had liver dysfunction ( ALT,  AST,  ALK. Phos. and   GGT). On CT scan, a hypodense lesion was seen in the left temporal lobe which was a small infarct and diffuse hypodensity in bilateral periventricular area suggesting ischemic changes was found, whereas lateral and third ventricle was normal. After improvement of his physical conditions, he was discharged from the hospital and reported after 2 months. After 2 months, there were complaints of forgetfulness in his daily routine and occupational activities, persistent paranoid ideas, and minor mistakes in his occupational work. There was no ataxia, but diminished vision was there which is because of refractive error, but not due to optic nerve atrophy (as examined by the ophthalmologist).\\nTo assess the neurocognitive status, PGI-BBD was administered. The findings were as follows:\\nThere were dysfunctions in the immediate, recent, remote memory, and recognition, whereas minimal impairment in attention and concentration, retention for dissimilar pairs, and visual retention. In verbal intelligence scale, there were minimal impairment in information, digit span, and arithmetic. Slight deviation in dysfunction rating score on NBT suggested the disturbances in visual acuity and depth perception. Organicity and disturbances in visuo-motor coordination were confirmed by Bender Gestalt test.',\n",
       "    'gender': 'Male'},\n",
       "   {'age': 48,\n",
       "    'case_id': 'PMC4525444_04',\n",
       "    'case_text': 'A Hindu male, aged 48 years, educated up to graduation, worked as a store keeper in Indian Army, was addicted to alcohol from his age 33. He was taking around 180-200 ml alcohol (Rum: Containing 45% of alcohol). Being the store keeper in the army, he had easily accessible to alcohol and was consumed very often almost every day at evening time. He was admitted in the drug de addiction center with complaints of global confusion, gait disturbance (ataxia), forgetfulness in daily activities, doing minor mistakes in daily routine activities, highly irritable, and restless. On examination, there was liver dysfunction ( ALT,  AST,  ALK. Phos. and   GGT and there was a fatty change in the liver). There was no abnormality detected on CT scan.\\nAfter treatment in the drug de addiction center, he was discharged. After 2 months to assess the Neurocognitive functions, PGI-BBD was administered and results are as follows:\\nThere were great deviations in delayed recall, attention and concentration retention for dissimilar pairs, whereas little deviations in remote memory, mental balance, immediate recall, visual retention, and recognition. However, there was no impairment in recent memory. His intelligence was found to be decreased from the previous level. The results in NBT also revealed the disturbances in visual acuity and depth perception. No abnormality was detected in CT scan findings.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 10,\n",
       "    'case_id': 'PMC6041995_01',\n",
       "    'case_text': \"A 10-year-old Caucasian girl with history of vesicoureteral reflux grade 3 bilaterally, was transferred from an outside hospital with abdominal pain. The patient was complaining of right upper quadrant (RUQ) abdominal pain 5 days prior to admission with worsening into the evening. The pain continued despite Tylenol and Motrin. It was described as achy, 7/10 in intensity, and was in the RUQ without radiation. There were no aggravating factors, and the pain had no association with food intake. She felt better when she was resting. She had an episode of diarrhea on the same day of pain onset and one episode of nonbilious/non-bloody vomiting 2 days prior to admission. Associated symptoms included a fever with a temperature of 100.4 F from 4 days prior to admission; she was responsive to treatment with Tylenol and Motrin. She developed a rash on the same day of fever onset. The rash first appeared on her neck and later spread to her face, upper, and lower extremities. The rash was not itchy or painful.\\nHer mother took her to urgent care 4 days prior to admission. She was sent home with reassurance and with a diagnosis of viral illness. She had poor appetite and decreased oral intake for 5 days before the admission. Her mother was concerned that she was still having abdominal pain, poor appetite, and rash. She took the patient to her pediatrician; who performed a rapid streptococcal antigen test (negative), and streptococcal throat culture was sent and was subsequently negative. She was provisionally diagnosed with scarlet fever and was started on amoxicillin therapy. Of note, there were no known sick contacts at home or school. She completed 2 days of amoxicillin, did not show any improvement, and so her mother took her to an outside hospital.\\nVitals at the outside hospital were temperature 37.4 C, heart rate 149/minute, blood pressure 106/57 mm Hg, respiratory rate 22/minute, and SpO2 96% on room air. Complete blood count showed white blood cells 12.2 k/mm3 (with 70% neutrophils, 14% lymphocytes, and 9% monocytes), hemoglobin 13.3 g/dL, hematocrit 38.9%, platelets 439,000/mm3, serum sodium 138 mmol/L, potassium 3.5 mmol/L, chloride 102 mmol/L, carbon dioxide 27 mmol/L, blood urea nitrogen 6 mg/dL, creatinine 0.45 mg/dL, serum glucose 106 mg/dL, calcium 10 mg/dL, total protein 7.2 g/dL, and albumin 3.7 g/dL. Alkaline phosphatase was high at 402 U/L, aspartate aminotransferase (AST) 37 U/L, alanine aminotransferase (ALT) was high at 111 U/L, Total bilirubin was high with total 2.2 mg/dL, and direct bilirubin was not available. Lipase was mildly elevated at 284 U/L. Urinalysis with microscopy showed specific gravity 1.014, bilirubin 1+, ketones +, urobilinogen 1, glucose -, nitrite -, LE trace, red blood cells 3 to 10/high-power field (HPF), white blood cells 3 to 10/HPF, and epithelial cells 6 to 30/HPF.\\nAbdominal ultrasound showed a prominent gallbladder that was distended measuring up to 4.6 cm in short axis. No gallstones, gallbladder wall thickening, or pericholecystic fluid were noted. She received intravenous (IV) famotidine 10 mg, normal saline bolus at 20 cc/kg once, IV Zofran 4 mg, and was transferred to our tertiary care emergency department for further management.\\nIn our emergency department, vitals were temperature 36.9 C, heart rate 96/minute, respiratory rate 22/minute, blood pressure 101/68 mm Hg. Abdominal X-ray showed moderate retained stool on the right and left colon with a nonobstructive bowel gas pattern. C-reactive protein was mildly elevated at 16.39 mg/L, erythrocyte sedimentation rate was mildly high at 36 mm/h, and direct bilirubin was 1.3 mg/dL.\\nAbdominal ultrasound (Figure 1) was repeated, which showed distention of the gallbladder measuring 4.3 cm in maximum transverse dimension that was stable when compared with the earlier study. Gallbladder wall hyperemia was noted on Doppler, and gallbladder wall thickness was at the upper limits of normal measuring 3 mm without evidence of biliary stone. There was mild pericholecystic fluid. A small amount of free fluid in the right lower quadrant was noted. The appendix was not visualized.\\nShe was started on maintenance IV fluids and was sent to 23 hours observation unit.\\nIn the observation unit, the patient was hemodynamically stable and remained afebrile. She was noted to have an erythematous macular rash all over the body (Figure 2). She had conjunctival injection in both eyes with clear discharge. Symmetric tonsillar enlargement with mild erythema (2+) was noted. There were no tonsillar exudates. She had tenderness over the RUQ with a positive Murphy's sign on admission. There were no organomegaly or palpable masses. The rest of the examination was normal. She was kept NPO (nil per os) initially, started on IV ceftriaxone, and was continued on IV fluids\\nLaboratory tests were repeated on the day of discharge and showed the following: lipase 310 U/L, bilirubin 0.9 mg/dL, AST 44 U/L, ALT 89 U/L, C-reactive protein 9 mg/L, and erythrocyte sedimentation rate 27 mm/h.\\nInfectious Diseases consultation recommended evaluating for possible infectious causes of acalculous cholecystitis. Cytomegalovirus immunoglobulin Ig G and IgM (negative), anti-streptolysin O titer (negative), hepatitis panel (negative), infectious mononucleosis screen (negative), EBV serology panel (negative). Parvovirus B19 IgM was negative. Respiratory virus polymerase chain reaction panel was negative. Liver enzymes were retested, with the results AST 53 U/L and ALT 98 U/L. Diet was advanced slowly and the patient tolerated well without vomiting, diarrhea, or return of abdominal pain. Infectious Diseases consultation also recommended Mycoplasma IgG and IgM antibody testing. Mycoplasma pneumoniae IgM was positive. M pneumoniae IgG was negative. The patient was discharged home with oral azithromycin therapy. She followed-up in gastroenterology clinic a few weeks after discharge, where she was completely asymptomatic. ALT, AST, bilirubin, and lipase were repeated and were within normal limits. Her repeat ultrasound was normal with no signs of cholecystitis.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 16,\n",
       "    'case_id': 'PMC3350101_01',\n",
       "    'case_text': 'A 16-year-old Moroccan male presented with a four-month history of LUTS and micturition pain. The digital rectal examination revealed a large, soft, fluctuant mass arising from the prostate. TRUS revealed a cystic mass measuring 5 x 4 x 3.5 cm arising from the prostate and no left kidney was seen. On MRI, a tube-like structure meandering along the rear wall of the bladder was recognized as the lower portion of the left ureter. The mass showed low T1- and high T2-weighted signal intensity compatible with a cyst in the left seminal vesicle area (Figures 1 and 2). Enhanced CT revealed left renal agenesis and a retroperitoneal cystic lesion. The urine culture showed that E. coli was sensitive to all antibiotics tested and Q  max at uroflow was greater than 15 mL/second. As surgery is very demanding and features many complications, we decided to manage this disease conservatively with alpha-blockers and antibiotics. After 6-month followup, the patient did not report any complain and the uroflow test was similar to a normal urination.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 23,\n",
       "    'case_id': 'PMC10242137_01',\n",
       "    'case_text': \"A premature male was born at 28 weeks and five days gestation with a birth weight of 1,200 grams due to preterm labor. This was a dichorionic-diamniotic twin pregnancy. The co-twin was selectively terminated at an outside hospital at 21 weeks' gestation for multiple congenital anomalies secondary to amniotic band syndrome. The mother, a 23-year-old Hispanic with no reported history of serious disease tested positive for SARS-CoV-2 by polymerase chain reaction (PCR) tests 13 days before delivery and upon admission to the hospital. The mother was asymptomatic at presentation and reported no previous symptoms of COVID-19. She received antenatal steroids 29 days prior to delivery after she presented to the hospital with suspected rupture of membranes. Placental pathology of the co-twin showed acute chorioamnionitis with areas of fibrin deposition characteristic of intra-amniotic infection of an unidentified source.\\nAPGAR scores were 6 at 1 min and 9 at 5 min of life and initial resuscitation included positive pressure ventilation for one minute, followed by continuous positive airway pressure (CPAP) of 5cmH2O. The infant was admitted to the neonatal intensive care unit (NICU) on CPAP and FiO2 0.21. Chest x-ray showed mild diffuse hazy granular opacities consistent with respiratory distress syndrome (Figure 1A). A nasopharyngeal SARS-CoV-2 PCR at 24 h postnatal age was positive and remained positive until day of life (DOL) 26. Inflammatory markers showed elevation of C-reactive protein (CRP) to 3 mg/dl (normal is <1 mg/dl) and interleukin-6 (IL-6) to 36.2 pg/ml (10x normal), which normalized by DOL 7. Serum antibodies (IgG, IgM) for SARS CoV-2 were undetectable on DOL 4, but present on DOL 19.\\nOn DOL 5, increasing oxygen requirement (FiO2 0.5) prompted treatment with dexamethasone (0.1 mg/kg every 12 h for 3 days, 0.05 mg/kg every 12 h for 2 days) and remdesivir (5 mg/kg loading dose, followed by 2.5 mg/kg/dose daily for 4 days). Chest x-ray at this point showed diffuse bilateral hazy opacities with increased perihilar markings (Figure 1B). Echocardiography was normal. By DOL 10, progressive respiratory failure required intubation, mechanical ventilation and FiO2 1.00. Chest x-ray now showed bilateral interstitial infiltrates (Figure 1C). Due to deteriorating respiratory status, the dexamethasone dose was increased to 0.1 mg/kg every 6 h for 2 days with subsequent tapering. Anakinra (a synthetic IL-1 receptor antagonist) was started on DOL 11 at 1 mg/kg/dose every 12 h. FiO2 requirements improved to 0.6, whereupon dexamethasone and anakinra were discontinued by DOL 30.\\nOn DOL 25, antibiotics were started for ventilator-associated pneumonia, presumedly due to respiratory cultures positive for Klebsiella pneumoniae and methicillin-resistant Staphylococcus aureus. On DOL 40, another course of dexamethasone was started at a dose of 0.15 mg/kg/day for 10 days, with some improvement in oxygen requirement, which worsened with dexamethasone taper. His FiO2 requirements increased further to 0.80-1.00, and a tracheostomy was performed on DOL 104. The infant continued to have severe respiratory failure requiring mechanical ventilation and high oxygen requirements despite multiple courses of empiric antibiotic treatment for presumed pneumonia. Echoencephalography was normal on DOL 5, 7, 14, 40, and 124. At 5 months of age, the infant's respiratory status progressively deteriorated and ventilatory support was withdrawn because of the extremely poor prognosis, and the infant soon expired.\\nLung pathology showed severe bronchopneumonia. To investigate the plausible role of hyperinflammation in the etiology of the severe progressive respiratory failure and potential systemic effects in this infant, we performed additional stains in the lung and heart for proteins potentially involved in macrophage and platelet activation and neutrophil extracellular trap formation indicative of SARS CoV-2 hyperinflammation. We found, specifically, increased low-density lipoprotein receptor (LDLR) and phospo-NF-kB-p65 expression in lung macrophages and cardiomyocytes, increased osteopontin (OPN) and intracellular adhesion molecule 1 (ICAM-1) in blood vessels in the lung and heart (Figure 2), and increased citrullinated histone H3 (citH3) in the lung and blood vessels in the heart (Figure 2), indicating hyperinflammation with formation of NETs.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 0,\n",
       "    'case_id': 'PMC8822334_01',\n",
       "    'case_text': \"A 4-month-old male entire indoor-only domestic shorthair cat was referred to the Royal (Dick) School of Veterinary Studies' Neurology Service for acute onset of right thoracic monoparesis following a fall from a chair. Clinical signs progressed rapidly and within 18 h the cat was unable to walk, with right hemiplegia, left hemiparesis and right Horner's syndrome. At this stage the patient was referred. On presentation the cat was quiet, alert and responsive; vitals were within normal limits; and a large, firm bladder was evident on abdominal palpation. Neurological examination revealed anisocoria with a miotic right pupil, cervical hyperaesthesia, right hemiplegia, left hemiparesis, thoracic limb hypotonia, pelvic limb hypertonia, right thoracic limb areflexia, absent deep pain in the right thoracic limb below the elbow and pelvic limb hyperreflexia. Neurolocalisation was to the C6-T2 spinal segments, with lateralisation to the right. Differential diagnoses were trauma, vascular event and infectious/inflammatory disease (feline infectious peritonitis/toxoplasmosis).\\nAn emergency CT scan (64-row multi-slice CT scanner; Somatom Definition AS) of the head and spine was performed shortly after admission; no structural abnormalities were identified to explain the clinical signs. Serum biochemistry and haematology identified no significant findings. An echocardiogram revealed trivial tricuspid regurgitation, no left atrial enlargement, no thrombus formation and good contractility. Activated partial thromboplastin time (APTT) and prothrombin time (PT) were within their respective reference intervals (RIs), and serum fibrinogen concentration was not increased: APTT 13.4 s (RI 10-20 s); PT 10.2 s (RI 5-12 s); and fibrinogen 3.2 g/l (RI 2-4 g/l). Testing for serum feline leukaemia virus antigen and feline immunodeficiency virus antibody was negative (SNAP FIV/FeLV Combo Test; IDEXX). Serum IgG and IgM antibody titre testing for Toxoplasma gondii was negative (<50 [Biobest Laboratories, Edinburgh]). Serum analysis for feline coronavirus antibody titre by immunofluorescence assay (<10) and alpha1-acid glycoprotein by radial immunodiffusion assay (0.5 g/l; RI 0.124-0.878 g/l) were both negative (Biobest Laboratories). Analysis of the cerebrospinal fluid (CSF) showed a total cell count of 39.6/microl (RI <5/microl) and a total protein concentration of 1.28 g/l (RI <0.45 g/l). Cytology of the CSF fluid revealed increased red blood cells (RBCs) and scattered platelets. The nucleated cells were approximately 8/1000 RBCs and they comprised 30% non-degenerate neutrophils, 46% small and a few medium lymphocytes, 23% large mononuclear cells (monocytes and macrophages) and 1% eosinophils. One macrophage showed erythrophagocytosis; otherwise, cell morphology was unremarkable. No aetiological agents were seen. These findings were consistent with either local haemorrhage or blood contamination.\\nBased on history, neurological examination and investigations, a presumptive diagnosis of spinal cord trauma was made. Daily physiotherapy was initiated included passive range of motion (PROM) exercises. The patient was managed symptomatically with buprenorphine (20 mug/kg IV q8h), dexamethasone (0.1 mg/kg IV q24h, increased to 0.2 mg/kg on result of negative T gondii), clindamycin (25 mg/kg PO q8h, withdrawn on result of negative toxoplasma), ranitidine (2 mg/kg IV q12h) and prazocin (250 mug/kg PO q8h) to aid frequent bladder expressions. Lactulose and enemas containing sodium citrate (450 mg) and sodium alkylsulfoacetate (45 mg [Micralax; RPH Pharmaceuticals]) were used to manage faecal retention. Seven days after the initial trauma the patient failed to show significant signs of improvement and appeared to have persistent cervical hyperaesthesia, despite analgesia and physiotherapy. Pre- and post-contrast MRI (3Philips Intera 1.5-T Pulsar System; Philips Medical Systems) study of the cervical and thoracic spine and brain was performed. All visible intervertebral discs showed normal T2 fluid intensity (Figure 1a). At C6-C7 the intervertebral disc was protruding into the mid-ventral vertebral canal, causing thinning of the subarachnoid space circumferentially and mild dorsal cord deviation (Figure 1b,c). Extending from C5-C6 to cranial C7, the spinal cord contained a large area of T1, T2 and T2* hyperintensity, with only the left dorsolateral aspect of the cord unaffected. In the same area, there was marked contrast enhancement of the right lateral aspect of the spinal cord (Figure 1d). MRI findings were therefore consistent with a C6-C7 acute non-compressive nucleus pulposus extrusion with secondary C5-C7 spinal cord chronic haemorrhage. The contrast enhancement was considered to be most likely due to vascular damage, inflammation secondary to the trauma and chronic haemorrhage. CSF analysis was repeated 7 days post-trauma and was consistent with normal CSF: total cell count 0 (RI <5/microl) and total protein concentration 0.35 g/l (RI <0.45 g/l), suggesting resolution of the previously suspected subarachnoid haemorrhage.\\nFollowing MRI, a splint was applied to the right thoracic limb to prevent knuckling and abrasion of the dorsal paw, and to assist ambulation. By 10 days post-trauma the anisocoria, cervical hyperaesthesia, left-sided paresis and postural deficits, pelvic limb hypertonus, and faecal and urinary retention had resolved. The kitten was able to run, jump and climb. However, the distal right thoracic limb was still paralysed, and over the preceding 10 days progressive contracture of the right carpus developed. PROM exercises elicited pain on extension of the carpus and flexion of the elbow, preventing the physiotherapy from being performed effectively. Splints were trialled, but they also elicited discomfort. Radiographs of the thoracic limbs were taken. No soft tissue abnormalities were detected. An 18  lateral deviation of the right carpus was evident, causing narrowing of the radiocarpal joint space affecting primarily the intermedioradial carpal bone. This was consistent with suspected contracture of the triceps and flexor muscles of the carpus and digits.\\nThe contracture resulted in the development of a non-weightbearing carpal hyperflexion (Figure 2). Amputation of the limb or a therapeutic trial with BTX were discussed; the owners elected for the latter. Under general anaesthesia, 90 units of BTX type A (BTX-A [Botox Cosmetic; Allergan]) were injected into the flexor muscles of carpus and digits, and 10 units into the triceps. The dose was similar to what has previously been shown to be safe in cats in an experimental study.   The aim of the treatment was to alleviate discomfort and reduce the muscle spasticity, allowing the use of a brace and physiotherapy to be performed. The patient was monitored in hospital for 48 h after the treatment; there were no adverse clinical reactions. The cat was discharged with a splint to aid ambulation; the owners were instructed to change the splint daily and perform daily physiotherapy.\\nAt a re-check 8 days post-BTX-A treatment the owners perceived the cat to be pain-free and ambulating well with support from the splint. The owners were managing well with the daily splint changes and rehabilitation exercises, although they reported that the cat resented the removal of the tape that kept the splint in place. Examination showed erythema where the tape was applied. The tape was replaced with a custom-made brace made with a spoon splint and Velcro straps. Repeat neurological examination showed that in the right thoracic limb postural reactions were still absent, sensation was decreased but now present at the second and fifth digit, and the muscle contractions had resolved but muscle tone was decreased. The postural reactions and tone in the other limbs were now normal. Mild hyperaesthesia of the cervical, epaxial and shoulder muscles was present, but there was a greatly improved level of comfort on manipulation of neck, right shoulder, elbow and carpus vs before BTX-A treatment. The owners reported that the cat was very active; we suspected that the neck and shoulder muscles were subjected to an increased load secondary to the reduced tone and function of the injected muscles of the right thoracic limb.\\nThe cat continued to make a clinical improvement. At 6 months post-BTX-A treatment, sensation was present but still decreased on the distal right thoracic limb. The right triceps brachii muscle was atrophied and a mild increase in muscle tone had returned. However, normal mobility was not impeded and the cat was pain free and able to place its right thoracic paw in a normal position when ambulating, only requiring support from the splint after prolonged periods of exercise (see the video in the supplementary material). The residual clinical signs did not appear to be affecting its quality of life.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 0,\n",
       "    'case_id': 'PMC10203705_01',\n",
       "    'case_text': \"This 8-month-old female infant was admitted to the hospital with a severe lung infection, presenting with a recurrent cough and shortness of breath. Additionally, the infant demonstrated a significant difficulty in feeding and had a body length and weight below the 3rd percentile for her age, indicating developmental retardation. Her parents reported poor performance in motor function and a significant neurodevelopmental delay, with acute critical illness, malnutrition, and thin subcutaneous fat. The infant's head circumference measured 39 cm and she had a square skull with a large anterior fontanel measuring 3 x 3 cm. Her visual and hearing evaluations were normal. The infant also exhibited high levels of muscle tension and a rupture and scab on the top of the head. Two lower incisors had erupted, and the pharynx was red with hoarseness in her voice. Respiratory movements were symmetrical in both lungs with rough breath sounds, significant wet rales heard bilaterally, and occasional wheezing sounds. The apex beat was located in the lower left, and there was a sense of lift in the precordial area, with an enlarged heart boundary and increasing heart rate, though the heart sound was dull, and a level II-III systolic murmur was recorded. The abdomen was soft with a medium-textured liver located 6 cm below the subcostal margin and 4-5 cm below the xiphoid process, and a non-palpable spleen. The first and second toes on the left foot were dry and black, with clear boundaries between them and surrounding healthy tissue. The muscle strength was reduced to grade 3 in the upper limbs and grade 2 in the lower limbs, indicating global muscle weakness. She was unable to sit independently and failed to handle grasp building blocks by 12 months of age. Moreover, she failed to produce pronunciation clearly. A Gesell evaluation conducted at 12 months revealed a significant delay in gross and fine motor development. No pathological or meningeal irritation signs were present. The parents reported no positive family history of cardiac attack or cardiovascular disease and declined genetic sequencing analysis and third-generation in vitro fertilization in the next pregnancy. The mother's first pregnancy was terminated at 28 weeks due to awareness of fetal tetralogy of Fallot.\\nThe results of a blood gas analysis indicated the presence of metabolic acidosis, with a pH of 7.278, a BE of -11.8 mmol/L, and an  level of 13.3 mmol/L. The results of blood biochemical tests showed elevated levels of B-type natriuretic peptide (1526.27 pg/mL, normal range <146 pg/mL). No significant findings were identified in the results of hepatic and renal function tests. Elevated levels of blood ammonia (108 umol/L) were noted. An electrocardiogram (ECG) revealed abnormal signals in the right atrium and suspected right ventricular hypertrophy, as well as sinus tachycardia and ST segment changes (depression in lead I, II, III, aVF, and V3-V6 of 0.1-0.5 mV and an increase in aVR and V1 of 0.1-0.2 mV), as illustrated in Figure 1A. Heart failure and cardiac malformation were suspected, leading to the immediate performance of an echocardiogram. The echocardiogram identified a severe type of CHD, type I truncus arteriosus, with ventricular septal defect (VSD) and patent foramen ovale (PFO) (Figure 1B). The aorta was found to be in the right position, with mild semilunar valve regurgitation. The neurological system was assessed through cranial computed tomography (CT) scanning, which showed the presence of bilateral apical, occipital, and temporal subdural effusions; slightly wider bilateral lateral ventricles and annular cisterns; and bilateral cerebral hemispheric parenchyma atrophy (Figure 1C). Chest CT scanning also identified the presence of pulmonary infection and enlargement of the left atrium and left ventricle, while CT scanning did not show any abnormalities in the kidneys.\\nIn the analysis of the proband, a novel homozygous mutation in the TMEM260 gene was identified. The c.1336_1339DEL homozygous variant was found to result in a frameshift mutation in the amino acid sequence (p.L447Vfs*9). The parents of the proband were found to be carriers of the variant by WES analysis and did not exhibit any clinical manifestations (Figure 2A). No other cardiovascular-related variants were identified in the proband or her parents. The frequency of this mutation in the general population is not recorded in any database (Figure 2B). The identified frameshift mutation resulted in the deletion of a few bases (TCTC) from positions 1336 to 1339 in the TMEM260 gene. This led to a change in amino acid 447 from leucine to valine and the creation of a stop codon after the ninth amino acid, causing a structural deletion in the TMEM260 protein and resulting in the loss of gene function (Figure 2C). According to MutationTaster analysis, the variant was determined to be a disease-causing mutation with a probability value of 1.00. The frameshift deletion caused a complete disruption in the structure of the TMEM260 protein, particularly in the transmembranous part, which impaired its normal molecular function. As the structure and function of the TMEM260 protein are not well understood, the discovery of this pathogenic site is of great significance for advancing the understanding of this protein. A summary of all reported variants of TMEM260 is presented in Figure 2D and Table 1.\\nThe infant was diagnosed with a severe and complex CHD of type I persistent truncus arteriosus, VSD, and a right aortic arch. The infant also displayed critical neurodevelopmental delay and neurological dysfunction. Despite undergoing a multi-phase surgical correction and receiving treatment with anti-infection measures, myocardial protection, inotropic agents, and mechanical ventilation, the patient suffered several cardiac arrests during hospitalization in the cardiac care unit. These were managed with prompt cardiopulmonary resuscitation.\\nPost-surgery, the patient developed severe antibiotic-resistant infections, including carbapenem-resistant Acinetobacter baumannii and Elizabethkingia meningitidis, and was treated with tigacycline, polymyxin, and sulperazon.\\nDuring follow-up, the patient presented with recurrent heart failure and pulmonary infections. Echocardiography showed dilation of the aorta, a small shunt through the interventricular septum, slightly accelerated forward blood flow through the artificial pulmonary valve with slightly strong ultrasound signals, moderate tricuspid regurgitation, and a slightly reduced left ventricular contractile function. The patient also experienced regression in motor performance, and a follow-up cranial CT scan revealed aggressive progression of cerebral atrophy (Figure 1D).\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 12,\n",
       "    'case_id': 'PMC3184518_01',\n",
       "    'case_text': 'A 62/12-year-old boy was referred to our endocrine  clinic for marked short stature. Following an uncomplicated pregnancy, the patient was born at term by Caesarean section because of breech presentation (Table 1). His anthropometric measurements at birth and at admission are given in Table 2. The patient was the first child of healthy first-cousin parents. His motor and mental development were normal. Physical examination findings were compatible with 3M syndrome and are presented in Table 1 and in Figures 1A and 2A. \\n Complete blood count and biochemical analysis were  unremarkable. Thyroid function tests were in the normal range. The patient was negative for anti-endomysial antibodies (EMA) IgA. He had a normal response to growth hormone (GH)  stimulation test with clonidine (peak GH level was 19.6 ng/mL). Physiological GH profile during sleep was within normal limits (mean GH: 7.6 ng/mL). Insulin-like growth factor-1 (IGF-1) \\ngeneration test for excluding GH insensitivity syndrome (GHIS) was normal (Table 3). Due to phenotypic findings in this boy and his sister (Case 2), the family was referred for genetic counseling. Radiographic bone survey showed slender long bones with  diaphyseal constriction and flared metaphyses, slender ribs, thick cortex of the tibia and femur, tall lumbar vertebrae, a small pelvis, short femoral neck and short iliac wings ([tif:Figure 3. Lateral radiography of the vertebrae showing tall vertebral bodies with reduced anterior-posterior diameters (Patient 1)|9-3.tif]Figures 3[/tif] and [tif:Figure 4. Radiography of the upper and lower extremities showing slender long bones (Patient 1)|9-4.tif]4[/tif]). Abdominal ultrasonographic examination was normal. \\nPatient 2\\nThis patient was the younger sister of Patient  1. She was born at term after an uncomplicated pregnancy and Caesarean section because of breech presentation (Table1). Her birth weight and length are given in Table 2. Her developmental milestones were achieved within normal time frames.  Anthropometric measurements at  age 411/12 years are given in Table 2. The findings in her physical examination were very similar to those of her brother (Figure 1B). Results of complete blood count and biochemical analysis were unremarkable. Thyroid function tests were in the normal range. EMA IgA was negative.   The patient had a normal response to GH stimulation  test with clonidine (peak GH level was 40 ng/mL). GHIS was  excluded with IGF-1 generation test (Table 3). Skeletal  survey showed slender long bones with diaphyseal  constriction and flared metaphyses, slender ribs, tall lumbar vertebrae, small pelvis and short iliac wings (Figure 5). Abdominal ultrasonographic examination was normal. The phenotypic findings in these sibs in combination with skeletal radiography and consanguinity in the family led us to a diagnosis of 3M syndrome. Unfortunately the parents refused molecular genetic analysis. \\nFamily 2 (Patients 3 and 4)\\nPatient 3',\n",
       "    'gender': 'Male'},\n",
       "   {'age': 12,\n",
       "    'case_id': 'PMC3184518_02',\n",
       "    'case_text': \"This 1011/12 -year-old boy was referred to our clinic for severe short stature. He was the first child of first-cousin  parents. He was born small for gestational age (Table 1). His developmental milestones were achieved within normal  limits. He had incomplete response to GH stimulation as well as to exogenous GH therapy given for two years in another pediatric endocrinology department and the treatment had been stopped. His physical and skeletal findings were not compatible with GH deficiency. The skeletal dysplasia was not considered at genetic evaluation at age 9 and GH  therapy was recommended.  GHIS was excluded with IGF-1 generation test (Table 3).   The patient's anthropometric and physical examination findings are given in Table 1 and in Figures 1C, 2B and 6. His biochemical and hormonal results were within normal limits. Skeletal survey of the patient showed slender long bones with diaphyseal constriction and flared metaphyses, slender ribs, thick cortex in the tibia and femur, short femoral neck, tall lumbar vertebrae, small pelvis and short iliac wings (Figure 7). \\nPatient 4\",\n",
       "    'gender': 'Male'},\n",
       "   {'age': 12,\n",
       "    'case_id': 'PMC3184518_03',\n",
       "    'case_text': 'This boy was the younger brother of Patient 3 (Figure 1D).  At admission, the patient was 74/12 years old. He suffered from short stature, as his brother.  His weight and length at birth and at admission are given in Tables 1 and 2. His developmental  milestones were achieved within normal limits. The boy had testicles small for his age. He had a normal response to GH stimulation test with clonidine (peak GH level was 18.2 ng/mL). GHIS was excluded with IGF-1 generation test (Table 3).  Skeletal survey showed slender long bones with diaphyseal constriction and flared metaphyses, slender ribs, hypoplasia of the 12th ribs, tall lumbar vertebrae, short femoral neck, a small pelvis, and short iliac wings (Figure 8). Abdominal  ultrasonography was normal. The diagnosis of 3M syndrome was established. Genetic analysis could not be performed because the family moved to a different city.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 68,\n",
       "    'case_id': 'PMC3234154_01',\n",
       "    'case_text': 'A 68-year-old female, with end-stage renal disease secondary to diabetic nephropathy had been receiving hemodialysis for 4 years. Her past medical history comprised: peripheral arterial disease with resultant bilateral above the knee amputation and iliac artery endovascular stenting; essential hypertension; lifelong tobacco consumption. She had no candidate vessels for venous catheter placement, other than small caliber femoral veins.\\nA decision was made to insert two smaller, more flexible 10 French catheters into bilateral femoral veins to allow better venous reception and more secure tunneling. This takes into account our experience with the use of larger, less supple catheters and the acute angles involved with typically tunneling upwards through the lower abdominal fascia. The patient was keen to continue dialysis and accepted the enhanced risk (two tunnels) of bilateral lower limb venous thrombosis and bacteremia. We present this interesting image Figure 1 (abdominal X-ray), demonstrating bilateral cuffed tunneled femoral dialysis access; concurrent vascular ectopic calcification and the presence of a left iliac stent. We understand this to be, the first medical image in the world literature of bilateral cuffed femoral dialysis catheters in situ - an unlikely clinical situation.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 69,\n",
       "    'case_id': 'PMC2883827_01',\n",
       "    'case_text': 'A 69-year-old man underwent successful laparoscopic inguinal hernia (TAPP) repair for a right indirect inguinal hernia. Apart from complaining of mild chronic right iliac fossa discomfort, persisting for some time after the repair, the patient made an uneventful recovery from his primary procedure. He presented to the Emergency Department 18 months later with signs and symptoms suggestive of acute appendicitis. He was prepared for the theatre and consented for diagnostic laparoscopy and appendicectomy. Following administration of antibiotics, an emergency diagnostic laparoscopy was performed and digitally recorded utilising the Karl Stortz AIDA II Video-endoscope System.\\nDuring diagnostic laparoscopy the greater omentum was found to be attached to the anterior abdominal wall, along a line corresponding to the peritoneal closure from the TAPP repair [Figure 1]. The omentum was carefully divided with bipolar diathermy taking care not to expose the underlying mesh. The omental adhesiolysis in the right iliac fossa revealed a small amount of free fluid and a turgid appendix overlying and adherent to the peritonealised Mesh from the previous right laparoscopic inguinal herniorraphy [Figures 2 and 3]. The turgid appendix was carefully dissected off the peritonealised Mesh using sharp and blunt dissection; again taking care not to expose the underlying Mesh. An uncomplicated laparoscopic appendicectomy was performed, and a local washout with normal saline completed the procedure. As no Mesh was found to be exposed during the procedure the decision was made to leave the Mesh in situ and a short course of antibiotics prescribed postoperatively. The patient made an uneventful recovery, and was discharged home the following day without subsequent complication. Histology revealed severe acute suppurative appendicitis with early microscopic mucosal ulceration and perforation.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 12,\n",
       "    'case_id': 'PMC3195389_01',\n",
       "    'case_text': 'A 12-year-old male presented with complaints of poor urinary stream and a swelling on the ventral aspect of penile urethra (Figure 1). Swelling was a soft cystic, fluctuant, and compressible, and it collapsed completely on manual pressure with urine coming out per urethra. Urine analysis, routine blood counts and blood urea, and serum creatinine were normal. Ultrasonography showed both kidneys normal in size and shape and with normal urinary bladder. Micturating urethrogram was done, and it showed the presence of a wide-mouthed diverticulum in distal penile urethra and the proximal lip of diverticulum forming an acute angle with normal caliber proximal urethra and normal urinary bladder without any vesicoureteric reflux (Figure 2). Patient was managed by open procedure. The diverticulum was opened by incision on the ventral aspect of penile shaft, and its distal lip was widened by abutting a triangular flap taken from one half of the diverticular wall, and the double breasting of urethral suture line was also done using the other half of diverticular wall after scraping its mucosa. Postoperative recovery was uneventful.\\nA six-month-male child presented with poor urinary stream and a cystic swelling at the penoscrotal junction (Figure 3). On investigations, USG abdomen revealed normal both kidneys as well as urinary bladder. Micturating urethrogram showed anterior urethral diverticulum in midpenile urethra. The patient was managed by open diverticulectomy along with the double breasting of urethral suture line. In the postoperative period, the patient had normal urination without any swelling in the penile urethra and is on regular followup.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 60,\n",
       "    'case_id': 'PMC9403065_01',\n",
       "    'case_text': 'On 16 January 2017, a 60-year-old man was diagnosed with cT2N3M1b IVB stage NSCLC. The results of positron emission tomography (PET) showed that the patient had tumor metastasis in the right cervical lymph node, in addition to primary lesion in the upper lobe of the right lung. Thus, the right lymph node was removed surgically for pathologic diagnosis. Next-generation sequencing (NGS) analysis revealed the presence of echinoderm microtubule-associated protein-like 4 (EML4)-ALK fusion. The patient subsequently received crizotinib as first-line treatment for 11 months and alectinib as second-line treatment for 24 months.\\nDue to the development of drug resistance, after onset of severe backache, oligoprogression involving third to fifth lumbar vertebrae was found by computed tomography (CT) and validated with magnetic resonance imaging (MRI). Therefore, the patient received stereotactic body radiotherapy (SBRT) with the dose of 30 Gy/5f for the lumbar lesion from 10 January 2020 to 16 January 2020. Pain relief of the patient was persistently observed after SBRT. Follow-up MRI on March 2, 2020, showed that the soft tissue of metastasis lesions around the lumbar spine reduced significantly, while CT showed that the primary lung lesion was slightly enlarged ( Figure 1 ).\\nA 23-valent pneumococcal polysaccharide vaccine (PCV) (Pneumovax, MSD) was given 3 months later after radiotherapy, on 6 April 2020, as a precautionary measure to prevent pneumonia. Strikingly, a routine CT on 21 April 2020 showed a significant enlargement of the primary focus after the injection of PCV ( Figure 1 ). In order to avoid further possible progress, resection was conducted on 28 April 2020. Impressively, an abscopal complete response (CR) of primary lesion in the right lung was pathologically confirmed after the resection. Hematoxylin-eosin (HE) and immunohistochemistry (IHC) staining showed that the primary lung lesion was mainly composed of map-like necrosis ( Figure 2A ), while there was a small amount of ALK-positive tumor cells that remained in the lumbar bone marrow of metastasis lesion ( Figure 2B ). Pathologically, multifocal granulomas were formed in the primary pulmonary lesion, with thin-walled capillaries and proliferative fibroblasts on the edge of the tumor bed and peripherally infiltrating immune cells around the central necrosis ( Figure 2A ). There were multinucleated giant cells accumulating and a reactive proliferating vasculum in the tumor bed. In addition, early tertiary lymphoid structures (TLSs) were formed in the primary lesion ( Figure 2A ). Tissue scan by imaging mass cytometry (Fluidigm company) showed primary lesion infiltrated by tumor-infiltrating lymphocytes (TILs), which include CD4+/CD8+ memory T cells, CD68+ tissue macrophage cells, and CD16+ natural killer (NK) cells ( Figures 3A-C ). These results indicated that the primary lesion experienced a robust immune response. After radiotherapy, the patient kept taking the second-generation ALK TKI regularly (alectinib tablets, 600 mg twice a day). To date, the patient is in healthy status and the progression-free survival of the patient has been sustained for more than 26 months after the abscopal response.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 54,\n",
       "    'case_id': 'PMC8457354_01',\n",
       "    'case_text': 'A 54-year-old man was admitted with a 2-month history of pain and weakness in both shoulders. The patient was an office worker with no past medical history except for well-controlled hypertension and diabetes for 10 years. Two months prior, he complained of sudden onset of pain in both shoulders and developed the weakness of both shoulder girdles 2 days later. The weakness in the left shoulder girdle progressed, and weakness in the left wrist and finger extensors newly developed over the next 4 weeks. There were no preceding trauma, immunization, or fever, but he reported weight loss (7 kg) over the 1 month before pain onset. The patient had never regularly exercised other than walking for glycemic control. The symptoms did not change for the next 1 month before admitting to our hospital. A neurological examination showed paresis of shoulder abduction [right: medical research council grade (MRC) 4/5, left: MRC 3/5], elbow flexion (right: MRC 4/5, left: MRC 3/5), elbow extension (right: MRC 4/5, left: MRC 3/5), wrist flexion (right: MRC 4/5, left: MRC 4/5), wrist extension (right: MRC 4/5, left: MRC 2/5), and extension of fingers (right: MRC 4/5, left: MRC 2/5). The muscle power of bilateral finger flexion and lower limbs was normal. A hypesthesia area was identified in the lateral sides of bilateral shoulders and arms, and deep tendon reflexes were reduced in the upper limbs. Atrophy of both shoulder girdles was observed (Figure 1). A complete blood cell count and routine biochemical analysis were normal except for fasting glucose (151 mg/dl) and HbA1c (7.3%). Other serological tests for human immunodeficiency virus, hepatitis B, C, and E, syphilis, and autoimmune diseases including angiotensin-converting enzyme, anti-nuclear antibody, double-stranded DNA, anti-Ro, anti-La, and anti-neutrophil cytoplasmic antibody were negative. An initial nerve conduction study (NCS), performed 2 months after symptom onset, showed a decrease of compound muscle action potential amplitude in the left musculocutaneous nerve (Figure 2A, recording of the biceps brachii muscle) and axillary nerve (Figure 2B, recording of the deltoid muscle) and a significant asymmetry of sensory nerve action potentials of the left lateral antebrachial cutaneous nerve (2.0 muV) compared to the right side (5.0 muV). NCS findings of the bilateral median, ulnar, peroneal, tibial, and sural nerves were normal. Needle electromyography (EMG) showed various degrees of denervation potentials in bilateral infraspinatus, supraspinatus, left deltoid, left triceps, left extensor digitorum, and left flexor carpi radialis muscles. There was reduced recruitment of motor unit in bilateral serratus anterior and right deltoid muscles. The results of initial electrophysiological studies suggested the involvement of bilateral upper and middle trunks (C5-C7) of the brachial plexus, particularly a more severe involvement of the left brachial plexus. Ultrasound with a 18-6-MHz linear transducer was performed on the same day as NCS/EMG and showed no swelling in the brachial plexus, median, radial, ulnar nerves. Magnetic resonance imaging of the brachial plexus was carried out 3 days after NCS/EMG, showing mild swelling without enhancement at the cord level of the left brachial plexus. Based on the clinical history of the acute intense pain of shoulders and weakness of upper limbs with preceding weight loss, considering the involvement of bilateral upper and middle branches of brachial plexus in the electrophysiological studies and having excluded other causes by imaging and serological studies, a diagnosis of diabetic NA was made. Oral steroid (1 mg/kg) was administered 9 weeks after symptom onset and tapered over 4 weeks. Bilateral shoulder pain and weakness, except for weakness of the left wrist and finger extensors, improved. In the follow-up study of the left axillary (Figure 2C) and musculocutaneous (Figure 2D) nerves 4 weeks after the initial study, the amplitude of compound muscle action potential was improved. However, on the conduction study of the left radial nerve that was not included in the initial study, we detected a conduction block between the spiral groove and the elbow (Figure 2E, recording of the extensor indicis muscle). The nerve action potentials of bilateral superficial radial sensory nerves were symmetric. A 4-week follow-up ultrasound revealed constriction of the left posterior interosseous fascicle within the left radial nerve at 1.5 cm proximal to the lateral epicondyle (Figures 3A-D). Surgical exploration for nerve constriction was considered but refused by the patient. Therefore, low-dose oral steroids and a rehabilitation program were continued for another 2 months. A 5-month follow-up NCS revealed a persistent conduction block of the left radial nerve (Figure 2F). The weakness of the left wrist and finger extensors was unchanged (MRC 2/5), but other remaining upper limb muscles were normal, except for the left shoulder abduction (MRC 4/5), left elbow flexion (MRC 4/5), and extension (MRC 4/5). Surgical exploration was performed 6 months after symptom onset and confirmed fascicular constriction at the area identified by ultrasound, for which interfascicular neurolysis was performed (Figures 3E,F). During the 16-month follow-up, the weakness in the wrist and finger extensors did not improve (MRC 2/5). We considered a tendon transfer to improve hand function a year after neurolysis, but the patient did not want secondary surgery.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 8,\n",
       "    'case_id': 'PMC5965336_01',\n",
       "    'case_text': \"The patient chosen was an 8-year-old boy involved in a road traffic accident. Figure 1a-c illustrates scar tissue on the right thigh and peri-patellar areas 18 months after a severe de-gloving injury. The patient did receive acute local treatment (debridement and split thickness graft [SSG]) but following partial loss of the graft, most of the wound had healed by secondary intention. Despite the application of pressure garments, the resultant area demonstrated hypertrophic scarring with some areas being painful and extending beyond the site of injury consistent with keloid scaring. The child had a history of repeated episodes of purulent discharge from crypts within the scar tissue and reports of local hospital admission for drainage of crypt abscesses and antibiotic therapy. The patient presented to our clinic with open, unstable areas within the scar that were contaminated with swab-proven staphylococcus aureus, sensitive to co-amoxiclav. The rationale for the application of Integra in this case was to remove unstable scar and crypts that were causing ongoing issues, minimise further donor site morbidity, improve cosmesis and provide a reconstruction with superior elasticity to accommodate growth.\\nThe first surgical goal was to create a clean surgical field in preparation for Integra application. Visible crypts were excised and open areas debrided, removing potential foci of contamination/infection (Figure 2a, b). Once the area was clean, and bacterial swab negative, the remaining unstable, unaesthetic scar would be excised and resurfaced with a two-stage, standard, Integra application. This would be done as an outpatient with regular review.\\nDespite our careful planning to decrease the risk of Integra loss, one factor not bargained for was the weather! Gaza had the warmest summer on record for 80 years with temperatures topping 45 C during the day. Manufacturer instructions state that the dermal regeneration template must be kept between 2 C and 30 C. During this period in Gaza, electricity was rationed with households receiving a supply of 4 hours per day. Fortunately, our pharmacy had air-conditioning with a 24 hours back-up generator supply. Although this allowed us to store the product, the ambient temperature during transfer of the product and application would have been well above the recommended storage temperature. For this reason, the surgical plan was changed to cleaning up the boy's open areas within the scar tissue at one mission and two months later, on the following mission, a second surgeon (first author), would attempt application of the dermal regeneration matrix.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 12,\n",
       "    'case_id': 'PMC9137965_01',\n",
       "    'case_text': \"By March 2022, several countries, including Saudi Arabia, have simplified COVID-19 rules by relaxing some safe management measures such as social distancing and mask wearing. However, the Saudi ministry of health kept the condition of three vaccine doses. This decision is part of a public health strategy that continues to monitor virus variants, mainly Omicron and its sublineages BA.1 and BA.2. WHO's Technical Advisory Group requests countries to continue to be vigilant because of potential significant rise in the number of infections. Although these variants might resist neutralizing antibodies in the blood, the vaccine allows preventing severe illness and death. Unlike several countries, Saudi Arabia was spared from the lack of oxygen generators, the most important medical equipment for hospitalized patients. The main concern is, however, regulations regarding vaccination. The vaccine was made mandatory for individuals over 12 years old. The open question is the need for vaccine for children aged from 5 to 11 years. Therefore, managers need to simulate the effect of vaccination and make predictions of the virus spread. This work tries to provide them with an efficient tool that captures the specificity of the Saudi case.\",\n",
       "    'gender': 'Unknown'}],\n",
       "  [{'age': 73,\n",
       "    'case_id': 'PMC9125062_01',\n",
       "    'case_text': 'A 73-year-old man presented with chest pain while playing golf. His medical history was significant for prostate cancer treated with radical prostatectomy 7 years ago, hypertension, and hyperlipidemia. Initial workup revealed isolated anemia with a hemoglobin of 7.4 g/dL. Myocardial infarction was ruled out and his angina was attributed to cardiac demand ischemia in the setting of anemia. His other blood counts including white blood cells and platelets were normal. Anemia workup revealed normal iron studies but revealed significant reticulocytopenia with a reticulocyte of 0.07% (normal values 0.5%-2.5%).\\nA thorough and detailed medication history failed to implicate any attributable medications. Nutritional causes of anemia such as iron, vitamin B12, folate, and copper deficiencies were ruled out. Infectious etiologies for common infections such as HIV, hepatitis, and Epstein-Barr virus (EBV) were negative. Parvovirus B-19, which is known to have a strong association with PRCA, was also checked for by polymerase chain reaction (PCR) and was negative. Hemolysis workup was insignificant as lactate dehydrogenase, haptoglobin, and indirect bilirubin were all within normal ranges. Coombs test was also negative. Hemoccult testing negative for any potential gastrointestinal bleeding. Autoimmune workup including an anti-nuclear antibody screen was also unremarkable.\\nThis led us to undergo a bone marrow biopsy. Pathological review showed less than 1% erythroblasts with a mildly hypocellular bone marrow with no signs of dysplasia or neoplastic changes (Picture 1-4). Fluorescent in situ hybridization (FISH) and PCR-gene rearrangement for malignant etiologies were negative. Computerized tomography of the chest was performed to evaluate for any evidence of a thymoma and was negative. Ultimately, an extended cytogenetic testing of the bone marrow revealed DNMT3A mutation.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 15,\n",
       "    'case_id': 'PMC3752856_01',\n",
       "    'case_text': 'A 15-year-old male known to have the CAH salt-wasting type diagnosed earlier in childhood. He presented with synchronous and progressive enlargement of bilateral testicular masses during substitutive medical therapy.\\nOn examination, he had normal stature (body mass index: 21.2 kg/m2). Genital examination demonstrated firm painless 8 cm mass involving the right testis and 10 cm mass involving the left testis.\\nSemen analyses revealed azoospermia. Serum hormonal screening showed high 17-OH progesterone; 24.1 nmol/L (1.5-6.4 nmol/L).\\nSerum tumor markers were low; alpha-fetoprotein was 1 ng/mL (0-44 ng/mL); beta-human chorionic gonadotrophin was <12 IU/L (<5 IU/L).\\nTesticular ultrasound examination confirmed the presence of bilateral hyperechogenic hypervascularized lesion; right: 8.6 cm x 3.5 cm; left: 8.4 cm x 5.5 cm [Figure 1]. These features although non-specific, raised the possibility of a testicular neoplasm.\\nConsidering the possibility of malignant testicular neoplasms, a surgical intervention was scheduled.\\nAt surgery, bilateral large firm, lobulated masses were replacing the testicular tissue. The patient underwent bilateral testicular incisional biopsies and the specimens were sent to our department for intra-operative consultation.\\nMacroscopically, both specimens (2.5 cm from the right testis and 1.8 cm from the left testis) appeared light brown with lobular rubbery cut surface. Frozen sections from each were examined. Microscopic examination showed a complete replacement of the normal testicular tissue by sheets and nests of large round and polygonal cells with defined cell borders, abundant eosinophilic cytoplasm and round central nuclei. Nests of cells were separated by dense fibrous tissue [Figure 2]. The morphological features were of \"LCT-like\" lesion! Nevertheless, Reinke crystals were not seen. At this point, the differential diagnosis was either LCT or mass-forming TART.\\nThe clinical picture of CAH and the bilaterality of the lesions were more compatible with the TART. However, rapid enlargement and the destruction of the testicular parenchyma implying irreversible damage together with worrisome atypical ultrasound features were in keeping with LCT. Two known TART characteristic features if present could strengthen its probability: Hilar location and evidence of response to suppressive therapy. In our case, the lesions occupied the entire testis without definitive hilar location. In addition, no suppressive therapy was tried; the patient was on substitutive therapy when operated.\\nBeing indistinguishable from TART on H and E sections, LCT was difficult to exclude. The pathologic frozen section diagnosis was of benign neoplasm.\\nA decision of bilateral orchiectomy was made and the specimen was sent to our department for permanent examination.\\nMacroscopically, the lesions were bilateral involving almost the entire testes separated into lobules with prominent fibrous bands [Figure 3].\\nMicroscopically, no normal testicular tissue was identified. The lesions were composed of sheets, nests and cords of polygonal cells with abundant eosinophilic cytoplasm. Few of these cells contained lipochrome pigments, but Reinke\\'s crystals were absent. There was mild nuclear pleomorphism without mitotic activity. Some lymphoid aggregates were seen [Figure 4]. Immunohistochemical analyses were performed [Figure 4]. The polygonal cells showed positivity to four markers known to be shared between LCT and TART namely inhibin alpha, melan A, vimentin, and calretinin. However, the cells showed a distinguishing immuno-profile of TART: Intense and widespread staining for CD56, patchy yet strong staining for synaptophysin and non-reactivity to CD10.\\nThese immunohistochemical features with the absence of Reinke crystals leaded to the final diagnosis of TART and implied a better prognosis.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 0,\n",
       "    'case_id': 'PMC10311010_01',\n",
       "    'case_text': \"A 20-month-old girl presented to our pulmonology department with chief complaints of cough for 1 month and fever for 2 weeks. She had a temperature of 38.0 C for 2 weeks. After experiencing cough for 3 weeks, she was taken to a local hospital. The patient's guardian denied any evidence of foreign body-associated choking or inhalation. Routine blood tests showed a white blood cell (WBC) count of 22.68 x 109/L, neutrophil ratio of 69.2%, and C-reactive protein level of 75.88 mg/L. Chest plane CT showed consolidation of most of the left lung with insufficiency and a small amount of pleural effusion (Figure 1). Consequently, the patient received sodium cefotaxime for 5 days for the treatment of lung infection. Nonetheless, her symptoms did not diminish. Therefore, she was transferred to our hospital for further evaluation and treatment. Our treatment team works at a tertiary children's hospital, which is also a national regional medical center. Our department is also a training base for respiratory specialists, with more than 2,000 cases of children's flexible bronchoscopy performed every year.\\nWhen the patient was admitted to the hospital, she was in poor spirits and had shortness of breath and diminished breath sounds in her left lung. Her infection-related markers were significantly elevated. We treated her with intravenous antibiotics and performed an x-ray of her lung, which revealed opacification in the left lung indicative of pneumonia and left atelectasis (Figure 2A). Based on examination and imaging, she underwent flexible bronchoscopy and broncho-alveolar lavage. During the bronchial examination, an abnormal reflective object was found in the left main bronchus, which was removed using a foreign body retrieval basket (Boston Scientific Corporation M00513200), revealing a nutshell fragment (Figures 2B,C). Additional granulation tissue was observed around the original foreign body, with swollen mucosa that easily bled when touched. A large purulent discharge was released after removing the foreign body from the left main bronchus, and more granulation tissue formation around the original foreign body was observed. The broncho-alveolar lavage fluid (BALF) samples were assessed using metagenomic next-generation sequencing, which revealed 695 sequence reads associated with Streptococcus pneumoniae. Her BALF culture and blood culture results were negative. Mycoplasma Pneumoniae immunoglobulin M and immunoglobulin G and nucleic acid tests were negative.\\nEnhanced CT for the lung on the seventh day of hospitalization showed infectious lesions in the left lung with consolidation, atelectasis, and multiple cystic changes in the lower lobe of the left lung, suggesting necrotizing pneumonia (Figure 3). She was treated with intravenous antibiotics of vancomycin (Day1-Day6) in combination with cefoperazone sulbactam sodium (Day1-Day14) and piperacillin tazobactam sodium (Day15-Day27) as anti-infective therapy.\\nHer temperature dropped to normal on the fourth day of hospitalization, but fever recurred between days 12 and 17 (peaking at 38.5 C) post-admission. No fever was observed from day 18 onward. She had less difficulty breathing and coughed less frequently. On her 18th day of hospitalization, a second flexible bronchoscopy was performed. Compared to the previous examination, there was a reduction in her left lumen secretions and the proliferative granulation tissue was clearly absorbed she was discharged on the 27th day of hospitalization and continued oral antibiotics for 2 weeks after discharge. A repeat CT performed after 2 weeks of discharge showed improvement in infectious changes in the left lung with pulmonary consolidation, atelectasis, bronchiectasis of the left lung, and cystic changes (Figure 4). She had no cough, fever, or any other clinical manifestations. We will continue to follow-up the patient for monitoring of cough, body temperature, dyspnea, exercise intolerance, chest CT changes, permissible lung function, and growth and development. The follow-up period will be further adjusted to ensure lung imaging recovery, lung function, and growth and development.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 14,\n",
       "    'case_id': 'PMC10267872_01',\n",
       "    'case_text': 'The patient was a 14-year-old female Chinese semi-professional tennis athlete. She first developed mild right shoulder pain after a forehand tennis stroke with left trunk rotation in practice which disappeared after two days of resting. The second injury occurred five days later with the same mechanism of injury and resulted in 8/10 pain with immediate loss of upper extremity function. An x-ray and Magnetic Resonance Images (MRI) of the patient\\'s shoulder were ordered by her primary care physician. The imagines ruled out epiphyseal plate, ligamentous, or labral damage, but showed a supraspinatus muscle strain. The patient self-referred to our team for TH due to the limited access to local sports-medicine resources. Oral consent was obtained from her guardian. During TH history taking, the patient complained of weakness with shoulder flexion, abduction, and external rotation (ER), as well as kinesiophobia. These combined physical and psychological limitations negatively impacted the patient\\'s activities of daily living (ADL) and tennis. (Details in Table 1).\\nAfter collecting patient history, the clinicians conducted a 30-minute virtual training session with the patient\\'s guardian to teach hand placements, resistance strength, force angle for manual muscle testing (MMT), and special tests. For range of motion (ROM) measurements, the clinicians screenshot the patient\\'s shoulder active ROM (AROM), then measured the angles through a smartphone 2-Dimensional application (Angle Meter 360) after the assessment (Figure 1). For strength tests, modified MMT (partner-assisted MMT) was used. Instead of having the tester grade on a 0 to 5 scale, the patient reported a percentage of effort by answering the question: \"Compared to your uninvolved side, how many percent were you able to resist on the last repetition?\" Special tests cluster (Painful Arc, Drop-arm test, Infraspinatus test, and Hawkins-Kennedy) were performed by the guardian and showed positive signs. (Detailed testing results can be found in Table 1).',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 0,\n",
       "    'case_id': 'PMC3245497_01',\n",
       "    'case_text': \"A 3-day-old female newborn was transferred to our hospital due to suspected neonatal sepsis and presence of a small omphalocele. She was born at term by spontaneous vaginal delivery. We learned that she had undergone transient tachypnea as well as upper gastrointestinal bleeding and hypotension after birth. On admission, physical examination revealed mild tachypnea, an omphalocele, and multiple erythematous skin lesions. Her skin lesions were located on the back, shoulders, the lateral surfaces of the arms, and on the anterior medial side of the right thigh. Laboratory investigations, including complete blood count, serum calcium (Ca), phosphorus (P), alkaline phosphatase (ALP), blood urea nitrogen, creatinine, electrolytes, blood sugar, aspartate transaminase, alanine transaminase, acid-base values, and C-reactive protein levels as well as urinalysis were all normal. Antibiotic therapy was initiated because infection could not be ruled out and terminated after three days  when blood cultures were reported to be sterile. The patient's tachypnea resolved on oxygen therapy within 24 hours and the omphalocele was corrected surgically on the fifth day of admission. On the first week of admission, the skin lesions transformed into red-purple, firm and painful subcutaneous nodules (Figure 1).  These findings were consistent with the early lesions of fat necrosis of the newborn, and a skin biopsy was performed. Pathological examination of the biopsy material obtained from the lesion border revealed a small number of lymphocytes and focal inflammatory areas consisting of histiocytes (Figure 2a). Additionally, there were radial eosinophilic crystals in the fat cells (Figure 2b). Based on these findings, the patient was diagnosed as ScFN. Spontaneous improvement was observed in the lesions during the first  two weeks following the diagnosis. The baby's parents were informed about the risk of hypercalcemia and its signs and symptoms. The patient was discharged on the 15th day of admission. Vitamin-D prophylaxis was not initiated. The lesions progressively disappeared over the following four weeks without any complication.  Serum Ca and P levels were monitored twice per month after discharge. Serum Ca, P, ALP, and parathyroid hormone (PTH) levels during admission and follow-up were all within normal ranges and are given in Table 1. A slight increase was noted in  serum Ca levels during the follow-up period. The patient was breast-fed throughout the follow-up period.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 15,\n",
       "    'case_id': 'PMC4322405_01',\n",
       "    'case_text': 'A 15-year-old girl weighing 32 kg presented to us with effort intolerance and significant central cyanosis. Her oxygen saturations were 78%. There was pulmonary oligemia and normal-sized heart on the chest X-ray. Electrocardiogram showed sinus rhythm, right axis deviation, and RV hypertrophy. Her echocardiogram showed a 11-mm anterior muscular VSD shunting right to left, with severe valvar pulmonic stenosis (PS). On cardiac catheterization, the RV systolic pressures were 40 mmHg more than aortic pressures. The pulmonary artery (PA) pressures were normal and the valvar gradient across the pulmonary valve was 120 mmHg. Right ventriculogram showed thickened and doming pulmonary valve; infundibulum showed dynamic systolic infundibular clamping, but opened well in diastole [Figure 1 and Video 1]. Left ventriculogram revealed a moderate sized mid muscular VSD.\\nAfter ensuring adequate intravascular volume status as shown by right atrial mean pressures of 12 mmHg, an initial BPV with 20-mm Tyshak II balloon (Numed Inc, Hopkinton, NY) resulted in excessive pulmonary flows, mild pulmonary hypertension, reduction of RV systolic pressures to 20 mmHg below the systemic pressures, and normalization of oxygen saturations to 100%. The subvalvar gradient was 60 mmHg and infundibulum opened well in diastole. The VSD was closed with a 14-12 Amplatzer Duct Occluder (StJude Medical, St Paul, MN) from the right ventricle after establishing an arteriovenous circuit [Figure 2 and Video 2]. After release, the RV pressure increased transiently due to dynamic infundibular hyper-contractility and the retention skirt of the device partially protruded into the left ventricle [Figure 3 and Video 3]. The device was snared out from the left ventricle before embolization. The device was replaced with an 18-mm muscular VSD occluder (HeartR, Lifetech Scientific, Shenzhen, PRC) [Figure 4 and Video 4]. Even though device appeared tilted towards the left ventricle on left ventriculogram, right ventriculogram showed correct device orientation [Figure 5 and Video 5]. On the following day, few ventricular ectopics were noted on routine examination and echocardiogram showed embolization of the device to the left ventricular outflow tract (LVOT). The large size of the device did not permit movement of the device beyond the aortic annulus. A snare catheter advanced into the LVOT to retrieve the device. There was transient heart block needing temporary RV pacing [Figure 6 and Video 6]. The device was subsequently snared into the abdominal aorta, but the screw end was facing superiorly. The profile of the device could be made smaller if the device could be slenderized by re-screwing the delivery cable to the device. It is important to slenderize the device to its smallest profile so that it could be removed through the smallest feasible arterial sheath. Through a 6 French left brachial artery access, a 6 French multipurpose guiding catheter was advanced into the abdominal aorta. This catheter allowed passage of a delivery cable of Amplatzer duct occluder I device. The large device was slenderized by re-screwing this cable [Figure 7 and Video 7]. The non-screw end of the left ventricular retention skirt of the device was snared with a small 5-mm Amplatz GooseNeck Snare (ev3 Inc, Plymouth, MN) and the device successfully withdrawn through a 9F femoral arterial sheath. She developed progressive hypotension in the intensive care unit in the subsequent few hours, which warranted initiation of inotropic support with dopamine, dobutamine, and adrenaline. Intravenous fluids were not given despite hypotension due to the concern of excessive pulmonary blood flows through the VSD. The hypotension progressively worsened inspite of escalating inotropes; there was progressive severe hypoxia due to right to left shunt across the VSD despite ventilation with 100% oxygen, metabolic acidosis, and progressive anemia. While examining for causes of low hemoglobin levels of 6 g/dl, a large right iliac retroperitoneal hematoma was recognized. The dangerous combination of inotrope-induced hypercontractile RV infundibulum, severe intravascular volume depletion, and poor oxygen carrying capacity due to anemia triggered a severe \"hypercyanotic spell\". This was recognized on echocardiogram by under-filled hypercontractile ventricles and collapsed inferior vena cava. Blood transfusion, intensive hydration, infusions of phenylephrine, and complete withdrawal of other sympathomimetics aided immediate recovery within few minutes. The retroperitoneal contained bleed was managed conservatively. One month later, transjugular device closure of the VSD was done with a 20-mm muscular VSD device (HeartR, Lifetech Scientific, Shenzhen, PRC) after establishing arterio-venous circuit. During the previous attempts of device delivery through femoral access, the alignment of the device was never proper in relation to the plane of the ventricular septum. Inspite of a better alignment of the sheath with the septum through the jugular route compared with the previous femoral attempts, the device developed cobra deformity and slipped repeatedly into the RV. The VSD device was reintroduced and the tip of left ventricular disk was protruded out and the delivery sheath placed in the ascending aorta. The tip of the left ventricular retention skirt was caught with a 5-mm Gooseneck Snare (ev3 Inc, Plymouth, MN) passed from femoral arterial access. This maneuver allowed holding the RV end of the device with the screw to the cable and left ventricular end of the device with the snare. This stabilization of the device from both ends permitted successful deployment [Figure 8 and Video 8]. At her last follow-up after 14 months, she is asymptomatic with no residual VSD and infundibular gradient of 20 mmHg.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 36,\n",
       "    'case_id': 'PMC2738533_01',\n",
       "    'case_text': \"In September 1998, a 36-year-old male soldier in the French Foreign Legion with hemoptysis was sent back to France from Djibouti. He expectorated bloody sputum after running and on a few other occasions. His medical history was not unusual. When the patient was hospitalized, 2 weeks after the initial symptoms, he began to experience progressive fatigue. He did not experience fever, weight loss, night sweats, anorexia, cough, dyspnea, or chest pain, and did not produce sputum.\\nResults of the clinical examination were normal. The Mantoux test, performed with 10 IU of purified tuberculin (Aventis-Pasteur-MSD, Lyon, France), yielded a maximum transverse diameter of induration of 15 mm. Laboratory values were normal (Table). The chest X-ray showed a triangular consolidation of the left upper lobe with blurred limits and small cavitary lesions. No other contiguous mediastinohilar anomalies were visible. A computed tomographic scan confirmed the cavitary syndrome: three excavated nodular images showed radiating spicules within a micronodular infiltrate. Bronchoscopy showed a moderate inflammation of airway mucosa, especially in the left upper lobe. Biopsy specimens exhibited nonspecific inflammation.\\nA bronchial washing smear from the left upper lobe was positive for acid-fast bacilli. Serologic tests for HIV-1 and HIV-2 were negative. No evidence of disease was found elsewhere; the patient did not experience bone pain. Results of neurologic and ophthalmologic examinations were normal; no lymphadenopathy or hepatosplenomegaly were found and the genitalia were normal. Auscultation revealed no pericardial fremitus; no ascitic fluid was detected. The urinary sediment contained <1,000 red blood cells/L and <5,000 leukocytes/L. Antituberculosis chemotherapy was begun with four drugs: rifampicin, isoniazid, ethambutol, and pyrazinamide. Cultures revealed a strain identified as M. tuberculosis subsp. canetti that was susceptible to all primary antituberculous drugs. Therefore, rifampicin and isoniazid were continued for 3 more months for a total treatment period of 6 months. The patient's response to treatment was favorable, and he remained asymptomatic.\",\n",
       "    'gender': 'Male'},\n",
       "   {'age': 55,\n",
       "    'case_id': 'PMC2738533_02',\n",
       "    'case_text': \"A 55-year-old male soldier in the French Foreign Legion, who returned from Djibouti, was hospitalized in September 1999 after his chest x-ray showed abnormal findings. He was a nurse and had been occasionally in charge at the Djibouti Hospital for 2 years. His medical history was unremarkable. Eight months before he returned to France, he experienced asthenia, anorexia, and a weight loss of 3 kg. The symptoms resolved spontaneously after 2 months, and he had been asymptomatic since then. He had no history of cough, sputum production, hemoptysis, dyspnea, fever, or night sweats.\\nResults of a clinical examination and of laboratory studies were normal (Table), except for hypereosinophilia. Serologic tests for schistosomiasis, hydatidosis, distomiasis, amebiasis, toxocariasis, and trichinosis were negative, and parasites were not found in stool samples. Thoracic radiographs performed when he came back from Djibouti showed parenchymal consolidation of the right upper lobe with small cavities. Sputum was not produced. A gastric aspirate smear was negative for acid-fast bacilli, and a bronchial aspiration smear was positive for acid-fast bacilli. HIV serology was negative, and no other site of the infection was found. Drug therapy was initiated with rifampicin, isoniazid, ethambutol, and pyrazinamide for 2 months. Cultures of bronchial aspirates were positive within 14 days; later, cultures of two gastric aspirates were positive for acid-fast bacilli. An M. tuberculosis subsp. canetti isolate was identified, which was susceptible to all primary antituberculous drugs. The treatment was then extended for 4 months with rifampicin and isoniazid. The patient's response to treatment was favorable.\\nThe following methods were used to identify the etiologic agent. First, the samples were decontaminated with N-acetyl-L-cysteine/NaOH. Acid-fast bacilli were detected by auramine staining, the positive smears also were stained with Ziehl-Nielsen stain. The samples were then seeded onto Lowenstein-Jensen and Coletsos slants and also into a liquid system, the BBL Mycobacterial Growth Indicator Tube (MGIT, BD Diagnostic Systems, Sparks, MD).\\nThe mycobacteria were identified by using a specific DNA probe (Gen-Probe, Gen-Probe Incorporated, San Diego, CA) and by performing the usual biochemical tests (nitrate reduction, 68 C catalase resistance, niacin production).\\nThe Pasteur Institute of Paris used two methods for typing: restriction fragment length polymorphism (RFLP) analysis and spoligotyping. In RFLP analysis, after digestion of the M. tuberculosis strain's genomic DNA with PvuII restriction enzyme and agarose gel migration, the DNA was transferred on a membrane, according to the Southern method, and then hybridized with an insertion sequence IS6110 probe. In the spoligotyping method, after DNA direct repeat amplification, the labeled polymerase chain reaction product was used as a probe to hybridize with 43 synthetic spacer oligonucleotides (DNA sequences derived from the direct repeat [DR] region of M. tuberculosis, H37Rv and M. bovis BCG P3), which were attached to a carrier membrane. The sensitivity to antituberculous drugs was determined by the indirect proportion method.\\nMGIT results were positive for the two cultures in 9 and 12 days, respectively. On Lowenstein-Jensen slants, the cultures were positive in 12 and 14 days, respectively. The white, smooth, and glossy colonies were characteristic of M. tuberculosis subsp. canetti (Figure 1). The two strains had the same phenotypic and genotypic pattern; 68 C catalase was negative, and they reduced nitrate, as do other M. tuberculosis species, but they did not produce niacin. The DNA probe, Gen-Probe, confirmed that these strains belonged to the M. tuberculosis complex.\\nThese strains contained two copies of IS6110. Spoligotyping showed that they shared only 2 of the 43 oligonucleotides reproducing the spacer DNA sequences of M. tuberculosis, H37Rv and M. bovis BCG P3. This profile is characteristic of M. tuberculosis subsp. canetti (Figure 2).\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': None,\n",
       "    'case_id': 'PMC7332718_01',\n",
       "    'case_text': 'All patients included in this review (Table 1 (Tab. 1)) had suffered ocular trauma with globe rupture, iris disinsertion, and traumatic cataract (Figure 1 (Fig. 1)). Mean age was 54.5 years (min. 45, max. 63), with three men and one woman included in this case series. There were no known previous ophthalmological problems. Visual acuity in the preoperative period was hand motion or less in all patients.',\n",
       "    'gender': 'Female'},\n",
       "   {'age': None,\n",
       "    'case_id': 'PMC7332718_02',\n",
       "    'case_text': '25-gauge pars plana vitrectomy was done in all patients. Patient 2 also had phacoemulsification done for partial spontaneous cataract resorption. In all cases, a previously measured and cut CustomFlex  ArtificialIris prosthesis (Human Optics) and an Akreos  IOL (Bausch&Lomb) was folded and dialed into place in the ciliary sulcus, through the superior 3.75 mm limbal-based corneal wound. The IOL was sutured to the mesh on the posterior face of the artificial iris with 10-0 polypropylene sutures, first anteriorly to posteriorly and then posteriorly to anteriorly through the IOL eyelets (Figure 2 (Fig. 2), Figure 3 (Fig. 3)). \\nThe Akreos  IOL-ArtificialIris complex was fixed and centered to que sclera, using two equidistant 7-0 CV-8 Gore-Tex  sutures. The sutures were trimmed, rotated, and buried, only covered by conjunctiva.\\nThe corneal wound was then closed using a 10-0 nylon suture,,,.',\n",
       "    'gender': 'Unknown'}],\n",
       "  [{'age': 16,\n",
       "    'case_id': 'PMC4664626_01',\n",
       "    'case_text': \"Sixteen-year-old male patient from Burkina Faso presented to emergency department of Al-Noor Specialist Hospital, which is a Joint Commission International (JCI) accredited, tertiary care hospital in the Holy city of Makkah, Saudi Arabia. The patient presented with a history of fever; and recurrent convulsions, followed by a decreased level of consciousness.\\nA week before the presentation the patient had nasal polypectomy and sinus surgery in a private hospital. Two days post-surgery the patient developed headache with high-grade fever that did not respond to antibiotics. Headache became progressively worse and the patient started experiencing episodes of fits and loss of consciousness.\\nAssessment of vital signs on presentation revealed a temperature of 37 C, pulse of 112 beats per minute, and blood pressure of 121/97 mmHg. The physical examination revealed no meningeal signs, pupils were normal and reactive, and there was normal muscles tone. Glasgow Coma Scale was 6 (E1 M4 V1), so the patient was intubated and mechanical ventilation was initiated.\\nLaboratory testing revealed a leukocyte count of 10,380 cells per cubic millimeter, with 76.5% polymorphonuclear cells. ESR was 42 mm/h and CRP 7.97 mg/dl. The comprehensive metabolic panel; including liver-function tests, was within normal limits (Table 1). Analysis of the cerebrospinal fluid revealed an elevated protein level of 120 mg/dl (reference range, 15-45), low glucose concentration of 38 mg/dl (reference range of 40-70 mg/dl). Gram stain of CSF showed no bacteria, but white blood cells were increased at 4200 white cells/mul; 90% polymorphonuclear cells.\\nComputed tomography (CT) of the head showed dilatation of supra and infratentorial ventricular system with hydrocephalic changes. CT scan also suggested possible fungal sinusitis of ethmoid, sphenoid, and maxillary sinuses. Other findings were not remarkable and showed normal attenuation of cerebral cortex and white matter, no intra or extra-axial hemorrhage and normal posterior fossa structures (Figure 1). CT of the chest showed left lower lobe consolidation with right upper lobe linear atelectasis and mild ground glass density patches. Mediastinal vascular structures were normal with no lymph node enlargement, no pleural effusion, and normal chest wall.\\nThe patient was started on intravenous vancomycin, ceftriaxone, acyclovir, metronidazole, clindamycin, and glucocorticoids.\\nRoutine bacterial cultures of the blood and cerebrospinal fluid were negative, and microscopic examination of CSF revealed acute inflammatory cells (neutrophil leucocytes) and few admixed histocytes with conclusion of pyogenic meningitis.\\nOn hospital day 3 the patient had signs of brain stem death in the form of dilated fixed unreactive pupils, loss of corneal and conjunctival reflexes and loss of gag reflexes. Brain death was confirmed twice clinically by neurology department with an interval of 24 h. Electroencephalography (EEG) was advised as proof of brain stem death by electrophysiological studies.\\nOn hospital day 4, the patient showed abrupt elevation of blood glucose, urea, creatinine, and liver enzymes. EEG was done using brain death standard technique for 30 min and revealed severe cerebral dysfunction. Patient was continued on mechanical ventilation, but his blood pressure started to decrease. The patient immediately received Alpha/Beta agonists in an attempt to maintain his blood pressure at acceptable levels.\\nOn hospital day 5, the microbiology laboratory reported a filamentous fungus growth in the CSF specimen, which was initially negative for bacteria. This positive CSF specimen was collected on the first day of admission. The filamentous fungus was later identified as Aspergillus species and the culture was sent to a reference mycology laboratory for species identification. Liposomal Amphotericin B and voriconazole were started on the same day, but patient continued to deteriorate. The patient died on hospital day 7 due to sudden cardiac arrest associated with severe meningioencephalitis, renal impairment, and septic shock.\\nThe CSF specimen was cultured in BACTEC FX blood culture bottles and incubated using BACTEC FX system. Three days after initial incubation, a positive culture signal was noted and fungal ball was noted inside the culture bottle. The fungal ball was directly inoculated onto blood, chocolate and Sabouraud's dextrose agar plates and incubated at 30 C. Filamentous fungal growth was obtained within 48 h and identification attempts were made by means of macroscopic and microscopic examination of the culture. Parallel CSF culture was performed according to standard procedure and all results were negative.\\nThe CSF filamentous fungus isolate was identified as Aspergillus species by microscopic examination showing characteristic Aspergillus fruiting heads. For species determination Sabouraud's dextrose agar plate was sent to the Microbiology Research Laboratory, Department of Microbiology, College of Medicine, Umm Al-Qura University.\\nWashed fungal mycelium was used to isolate genomic DNA. A library for ITS metagenomics DNA sequencing was prepared using the Illumina Metagenomics Protocol and sequenced in Illumina MiSeq using version-2 500 cycles Nano kit. Species identification was determined using the Pairwise Sequence Alignment tool, (ISHAM ITS database http://its.mycologylab.org/). Sequence similarity equal to or greater than 97% was used as cutoff for species identification. Alignment of assembled ITS sequences showed high degree of similarity (above 99.7%) to A. terreus ITS reference sequences.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 61,\n",
       "    'case_id': 'PMC6554484_01',\n",
       "    'case_text': 'A 61-year-old woman visited the Hino Municipal Hospital complaining of palpitation, which disappeared soon after her visit. Incidentally, on an X-ray examination, a lung nodule on the right side was pointed out to her, although there were not any related symptoms. A contrast-enhanced chest CT scan revealed a solitary and well-circumscribed nodule (36 x 37 x 40 mm in diameter) in the peripheral region of the right lower lobe (Fig. 1A). While a solid part of the tumor was homogeneously enhanced, the tumor included an irregular-shaped low-density area (19 mm in maximum diameter) that was free from contrast-enhancement (Fig. 1B). Lymph node enlargement or pleural effusion was absent. Her medical record showed that a small lung nodule was previously recognized on a CT scan in our hospital when she was 54 years old (Fig. 1C). A further CT scan had been scheduled, but she missed her follow-up. The initial CT scan when her was 54 years old showed a small nodule (7.5 x 7.9 x 8.7 mm in diameter) in the right lower lobe (Fig. 1C, an arrow mark), which corresponded with the grown tumor in the present study. The tumor doubling time was estimated to be 374 days. She had never smoked and was taking medicines for hypertension.\\nThe patient was suspected of having a stage IB primary lung cancer after an evaluation of her whole body via contrast-enhanced CT and magnetic response imaging scans. A fluorodeoxyglucose (FDG)-positron emission tomography (PET) scan revealed a high maximum standardized uptake value (SUVmax) of 5.2 on the solid part of the lung nodule while a portion of intratumoral radiolucency did not show significant FDG uptake (Fig. 1D). Following this, a diagnostic CT-guided transcutaneous core needle biopsy was scheduled. The biopsy specimen obtained from the solid part of the tumor was composed of two major pathological patterns, a solid proliferation of round cells and papillary growth of type II pneumocyte-like cuboidal cells overlying a core comprised of round cells (Fig. 2A and B). Sclerotic and hemorrhagic patterns were also evident in minor regions (Fig. 2C and D). All of the four characteristic components necessary for a diagnosis of PSP were pathologically proven in a biopsy specimen.\\nSince the tumor doubling time was relatively short in this case, she received a right lower lobectomy and a lymphadenectomy at the Federation of National Public Service Personnel Mutual Aid Associations, Tachikawa Hospital. An examination of the gross features of the fixed lung revealed an encapsulated tumor (30 x 35 x 35 mm in size) underneath the visceral pleura in the right lower lobe accompanying a cavitary space filled with bloody content (Fig. 3A and B). The cavity formation was pathologically attributed to a gross hematoma but not to the hemorrhagic cyst nor to tumor necrosis. The microscopic examination of a solid part of the resected tumor confirmed a diagnosis of PSP, predominantly showing a papillary growth pattern with a portion of solid and sclerotic patterns (Fig. 3C). Immune-staining was positive for cytokeratin 7 (Fig. 3D), thyroid transcription factor-1 (TTF-1) (Fig. 3E), and napsin A (Fig. 3F) on the papillary-growing type II pneumocyte-like cuboidal cells whereas solid-growing round cells were positive only for TTF-1 (Fig. 3E). Together, the immune staining patterns were consistent with those related to PSP. Lymph node metastasis was pathologically absent in the surgical specimens.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 53,\n",
       "    'case_id': 'PMC9241052_01',\n",
       "    'case_text': 'A 53-year-old male with a clinical history of nephrolithiasis came to the outside hospital emergency room (ER) with severe pain in the low back, right hip, and thigh, intermittent fever with chills and night sweats, minimally productive intermittent cough spells with whitish phlegm, exertional dyspnea, generalized fatigue for three weeks along with weight loss of 20 pounds in one month. Six days prior, he was seen at the ER for back pain radiating to the right leg for the last two weeks, and x-rays of the right knee and hip with pelvis were within normal limits. He was discharged home with oral prednisone 40 mg daily for five days and as needed diazepam. He was a farmworker, had quit smoking a month back with 30 pack-years of smoking, and was negative for substance and alcohol abuse. He was sexually active with his girlfriend and resided in a trailer. Clinical examination revealed stable vital signs, lack of sensation over the right anterolateral thigh with no point tenderness, painful hip movements with limited motion, and difficulty walking. Labs revealed leukocytosis, thrombocytosis, hypoalbuminemia, and elevated inflammatory markers (Table 1). He received intravenous (IV) ketorolac 30 milligrams (mg) followed by hydromorphone 0.5 mg 1 dose IV, ondansetron 4 mg IV, and oral diazepam 2 mg. Contrasted computed tomography (CT) of the chest, abdomen, and pelvis revealed right upper lobe (RUL) heterogeneous enhancing mass and scattered bilateral nodules < 6 millimeters (Fig. 1), right iliac diffuse permeative appearance, extensive complex septated acute collections within the right iliopsoas region, deep right gluteal region and the right paraspinal musculature from the L4 - S2 levels. Magnetic resonance imaging (MRI) of the pelvis and lumbar spine with and without contrast revealed a large multilobulated cystic mass centered around the right iliac bone with extension medially into portions of the iliopsoas muscle, laterally into the adjacent gluteal musculature, and posterosuperiorly into the posterior paraspinal musculature (Fig. 2). He was admitted and initiated on pain control, IV fluids, and evaluated by the oncology and orthopedics team, who recommended a biopsy or transfer to a tertiary center. On day two, he was febrile at 39.2 Celsius (C) and ordered blood cultures returned negative, whereas procalcitonin and lactic acid were elevated (Table 1). Empirical IV ceftriaxone and azithromycin were started for suspected right upper lobe pneumonia, and his lactic acid improved. Over the next three days, antibiotics were continued, and on day six, he was transferred to our institution for suspected primary bone malignancy with metastasis.\\nOn arrival, clinical examination revealed fever (39 C), mild improvement of the right hip movements, and poor oral hygiene. Labs revealed leukocytosis, thrombocytosis, and two sets of blood cultures returned negative (Table 2). IV antibiotics were changed to vancomycin and piperacillin-tazobactam. He then underwent an interventional radiology-guided biopsy of the right ilium and aspiration of 20 mL purulent fluid from the right gluteal mass as recommended by the orthopedic oncology team. He remained intermittently febrile over the next two days, which gradually subsided with his right hip pain improvement. The bone biopsy revealed extensive acute and chronic inflammation with focal granulomatous change and no malignancy. The aspirated purulent fluid showed extensive necroinflammation, bacterial colonies most consistent with Actinomyces (Fig. 3) and no malignant cells. Right pelvic fluid histopath revealed the Splendore-Hoeppli phenomenon (sulfur granules and associated inflammation) (Fig. 4). The infectious disease (ID) team recommended continuing the piperacillin-tazobactam and stopping the vancomycin. Inflammatory markers were still elevated, whereas Quantiferon Gold Tuberculosis testing and serology for human immunodeficiency virus were negative (Table 2). A repeat contrasted CT scan of the chest, abdomen, and pelvis confirmed the prior pulmonary findings, whereas, in the pelvis, there was an interval increase in the size of the complex cystic mass indicative of abscess formation. He then underwent irrigation and debridement of the right hemipelvis and an open right ilium biopsy. Right ilium biopsy returned positive for acute and chronic osteomyelitis and negative for cancer. The right pelvic mass biopsy revealed fibrovascular tissue with acute and chronic inflammation, necrosis, hemorrhage, fibrosis, and negative for malignancy. Intraoperative tissue bacterial, mycobacterial and fungal cultures were negative. The pulmonary team performed the bronchoscopy and obtained an RUL protective specimen brush culture sample, bronchioalveolar lavage (BAL) for analysis, culture, and endemic fungal workup. Endobronchial ultrasound (EBUS) guided fine-needle aspiration on enlarged lymph nodes (stations 11 L,7, and 4 R) returned negative for infection and malignancy. BAL fluid analysis did not suggest any infection; however, the cultures returned positive for A. odontolyticus (Table 2). A. odontolyticus was sensitive to penicillin and resistant to clindamycin. Piperacillin-tazobactam was changed to ceftriaxone 2 g (gm) daily.\\nAn oral dental surgeon evaluated his bad oral hygiene (Fig. 4). A transthoracic echocardiogram displayed an ejection fraction of 60% with normal cardiac valves and normal left and right ventricular systolic function. An X-ray Panorex revealed several missing teeth, multilevel caries, significant maxillary and mandibular lamina propria resorption, periapical lucency involving the remaining right maxillary molar, and possible retention cyst/opacification of the left maxillary sinus. He was recommended outpatient follow-up in three weeks to fix his bad teeth. A repeat MRI pelvis with contrast revealed a marked interval decrease in size of the complex multiloculated abscess involving the right retroperitoneum, gluteal muscles, and right paraspinal muscles, abnormal marrow signal, and osseous erosion of the right ilium. He was discharged home on IV ceftriaxone 2 gm daily to complete six weeks of antimicrobial therapy. Four weeks later, he followed up at the ID clinic with a decline in inflammatory markers (Table 2), and he was transitioned to oral amoxicillin 875 mg thrice a day for the next 12 months. Repeat CT chest with contrast at eight weeks post-discharge revealed resolving right upper lobe consolidation with residual linear opacities. A repeat MRI pelvis with and without contrast 12 weeks after discharge revealed markedly improved osteitis of the right innominate bone, surrounding soft tissue infection, and minimal persistent marrow changes within the right iliac bone. At the ninth-month ID clinic follow-up, he had his teeth fixed, recovered weight loss, and resumed daily activities. He completed 12 months of oral amoxicillin with complete recovery. (Fig. 5).',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 7,\n",
       "    'case_id': 'PMC5437802_01',\n",
       "    'case_text': 'A 7-year-old boy with a history of autism presented to a peripheral hospital complaining of headache and neck pain followed by visual disturbance. The ophthalmic examination documented a bilateral loss of visual acuity (2/10), fixed bilateral mydriasis and a Grade IV bilateral papilledema. The noncontrast-enhanced computed tomography (CT) scan of the head was unremarkable. The patient was transferred to the pediatric ward of our hospital with a provisional diagnosis of pseudotumor cerebri.\\nThe patient underwent a magnetic resonance imaging (MRI) scan of the brain with Gadolinium which showed signs in keeping with longstanding raised ICP, including bilateral kinking of the optic nerves within the orbit, enlargement of subarachnoid spaces, flattening of the posterior sclera, and the empty sella sign [Figure 1b]. The same investigation documented a single, 16 mm, oval, T1 and T2 isointense, contrast-enhancing lesion arising in the right mastoid region, and narrowing the transverse-sigmoid sinus junction [Figure 2b].\\nA cerebral angiography digital subtraction angiography documented the compression of the right transverse-sigmoid junction distal to the vein of Labbe, within a picture of mild right side dominance of the venous sinuses circulation in the posterior fossa [Figure 2a]. A diagnosis of raised ICP related to impaired cerebrospinal fluid (CSF) absorption was supposed, considering the intracranial venous hypertension due to the lesion compressing the sinus. We decided to proceed with the surgical removal of the lesion.\\nThe tumor was approached through a right retrosigmoid incision. Intraoperatively, an osteolytic lesion was found on the asterion with a moderately bleeding core underneath, extending in the right mastoid. The lesion did not involve the dura and was indenting and stretching the right transverse sinus. We also considered the possibility to measure intraoperatively the hydrostatic pressure in the transverse sinus proximally to the lesion, but the potential risks related to a maneuver involving a puncture of the sinus outweighed the benefits. However, noticeably the previous proximal turgid sinus collapsed after the tumor excision.\\nThe removal was macroscopically complete, with immediate evidence of sinus decompression. The histological examination was in keeping with a diagnosis of osteoblastoma [Figure 3].\\nOn the postoperative time, a right mastoiditis occurred, which was successfully treated.\\nThe postoperative course was characterized by a prompt resolution of a headache and a progressive improvement of the visual acuity over the following weeks. Indeed, a 4-week follow-up ophthalmic exam documented a visual acuity of 7/10 in the right eye and 4/10 in the left, associated with a complete resolution of the papilledema and some degree of residual left optic atrophy.\\nA follow-up MRI after 4 months showed the normalization of the diameter of the right transverse-sigmoid junction [Figure 1a], and a significant regression of the signs of increased ICP [Figure 1c].',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': None,\n",
       "    'case_id': 'PMC5219627_01',\n",
       "    'case_text': 'The patient was born by repeat Cesarean section at 37 weeks and 2 days, weighing 2960 g. There were no complications during the pregnancy or labor. Apgars were 7 and 9 at 1 and 5 minutes respectively. On day of life 1, the patient began having apneic episodes, which required intubation. By 12 days of life she continued experiencing episodes of apnea and hypercapnia and was diagnosed as having PHOX2B expansion of polyalanine repeats 20/27. Patient underwent tracheostomy at 13 weeks of life. In addition, she was diagnosed with Hirschsprungs disease and underwent a Soave pull through at 15 days of life as well as gastrostomy placement. After discharge from the NICU at 4 months of age, the patient was readmitted at 5 months of age for episodes of hypersomnolence followed by seizure-like episodes. Those episodes involved choking, desaturation to 80%, as well as staring off with arms and legs outstretched. The patient was found to have Enterococcus UTI and MDR Serratia macescens and Stenotrophomon tracheitis, both of which were treated with a 10 day course of levofloxacin. Six days into admission, the patient continued experiencing multiple episodes of hypersomnolence and she had another seizure-like episode with eye deviation to the left. Patient was on an EEG at that time and was found to have no epileptiform activity. It was discovered that the patient was consistently hypoglycemic with blood glucose as low as 30 mg/dl. Patient was started on continuous feeds and D10 1/4 NS at 5 cc/hr. In addition, patient was given diazoxide 10mg/kg times two doses for concern of hyperinsulinemia. While receiving diazoxide, the patient experienced another episode of hypoglycemia of 41 mg/dl, which was noted after holding feeds for only 10 minutes. At that time, diazoxide was discontinued. On abdominal US, the pancreas was found to be normal, and insulin levels, drawn during hypoglycemic episodes while on diazoxide and after its discontinuation, were found to be within normal limits at 0.6 uIU/ml and <0.5 uIU/ml. Patient was discharged home on continuous feeds with q6h glucose checks and glucagon to be used as needed. At home the hypoglycemia symptoms have been well controlled with continues feeds; however, if the feeds are interrupted for more than 15 minutes the serum glucose level decreases to less 30 mg/dl.',\n",
       "    'gender': 'Female'},\n",
       "   {'age': None,\n",
       "    'case_id': 'PMC5219627_02',\n",
       "    'case_text': \"Several authors have reported cases of hypoglycemia in patients with known CCHS (Table 1). One case report noted a patient who was found to have episodes of hypoglycemia at 6 weeks of life. In addition, that patient was found to have hyperinsulinemia as a root cause of the hypoglycemia. At the time of their publication, there had only been one other report of hyperinsulinemia associated with CCHS. In that case report, a patient with severe CCHS was found to have hyperinsulinemia, which was controlled with diazoxide. Since the case report put forth by Hennewig et al., two subsequent publications have reported cases of hypoglycemia associated with hyperinsulinemia. In one case series, three patient presentations with first time seizures with associated hypoglycemia were noted. In one case, the patient's insulin level was normal. In one final case report put forward by Marics et al., another case of hyperinsulinemia was reported. However, that time the patient was noted to have hypoglycemia in routine screening at 14 days of life and avoided any seizure activity due to sustained hypoglycemia. Also of note, none of the previous case presentations reported associated Hirschsprungs disease.\",\n",
       "    'gender': 'Unknown'}],\n",
       "  [{'age': 58,\n",
       "    'case_id': 'PMC3864171_01',\n",
       "    'case_text': 'A 58-year-old Asian female patient was admitted due to neck pain, which occurred occasionally over the previous 2 years, with increasing severity in recent weeks. Moreover, the patient was experiencing difficulty swallowing. During physical examination, a significant mass could not be palpated in the upper left part of the neck, despite sensitivity during palpation. Atrophy and left deviation of the left half of the tongue was observed. Results of complete blood count and biochemical tests were within normal limits. In the neck MRI, a mildly hyperintense lesion was found, located superior to the carotid bifurcation between the left internal carotid artery (ICA) and external carotid artery (ECA) by T2-weighted images. This lesion was hypointense on T1-weighted images. Significant enhancement was present on post-contrast T1-weighted images. Moreover, there was atrophy in the left half of the tongue (Figure 1). The neck mass displaced the left ICA anteriorly and medially (Figure 2).\\nThe operation was performed with left lateral cervical access. The cranial nerves were identified by isolating the upper neck arteries and veins. A mass lesion was found. The hypoglossal nerve was extending towards and entering the expanding mass. This lesion, derived from the hypoglossal nerve, was excised. Results of examination of the other cranial nerves were normal in the early postoperative period. Following histopathological evaluation, the lesion was diagnosed as paraganglioma (Figure 3). Six month postoperative follow up, left sided-tongue atrophy persisted, but the patient did not have difficulty in swallowing.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 69,\n",
       "    'case_id': 'PMC9503891_01',\n",
       "    'case_text': \"A 69-year-old man with a history of heart failure and hypertension presented to the hospital with pulseless electrical activity cardiac arrest while undergoing a routine root canal dental procedure. The patient had a past medical history of congestive heart failure with reduced ejection fraction, hypertension, diabetes mellitus type 2, and hyperlipidemia. In addition, he had a past surgical history of intracardiac defibrillator along with no significant social history. He had no known drug allergies and takes losartan, carvedilol, furosemide, and atorvastatin on a daily basis. He was undergoing a root canal procedure at an outpatient dental office under local anesthesia. During the procedure, he was found to be unresponsive, which prompted the office to call emergency medical services. Subsequently, he was found to be in pulseless electrical activity, and cardiopulmonary resuscitation was initiated. He was resuscitated, and return of spontaneous circulation was achieved upon arrival to the emergency department. His total downtime was 25 minutes.\\nElectrocardiogram showed sinus tachycardia with right bundle branch block (Figure 1). Computed tomography (CT) of the head demonstrated extensive free air within the maxillary bone, facial tissues, and neck veins, and a thoracic CT showed large amounts of air within the RV and portal venous system (Figures 2, 3, 4, 5). Echocardiogram revealed a left ventricular ejection fraction of 20% to 25%, with right ventricular dilation and reduced function. There were artifacts due to the presence of air in the RV. Initial blood work revealed a leukocyte count of 8,400 cells/muL, hemoglobin of 13.1 g/dL, and a platelet count of 78,000 cells/muL. Moreover, sodium level was 140 mmol/L, potassium 3.6/ mmol/L, magnesium 2.2/ mmol/L, and creatinine 1.23 mg/dL. Patient's troponin at point of arrival was 0.017 ng/mL (reference range 0.000-0.039) and N-terminal pro-brain natriuretic peptide was 107 pg/mL.\\nThe patient was admitted to the ICU, and supportive care was initiated along with targeted temperature management and VAE-specific interventions, including left lateral decubitus head-down positioning, and high-FiO2 mechanical ventilation. Although VAE significantly improved, he did not have meaningful neurologic recovery and the decision was made to withdraw care.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 28,\n",
       "    'case_id': 'PMC2698061_01',\n",
       "    'case_text': 'The patient was a 28-year-old woman who was admitted to hospital because of a hepatic mass found incidentally on screening sonography. She had no previous surgical and medical problems. A physical examination and the laboratory findings on admission revealed no abnormalities. The serum alpha-fetoprotein level was 1.2 ng/mL and the carcinoembryonic antigen level was 1.3 ng/mL. Test for the hepatitis-B antigen was negative and the test for hepatitis-B antibodies was positive.\\nCT of the abdomen showed a mass in the segment 6 measuring approximately 4.0x3.8-cm with a capsular retraction. The hepatic helical CT scan during the hepatic arterial phase showed a heterogeneously enhancing mass with a lobulated margin. A central scar was shown as a stellate hypoattenuation. The hepatic helical CT scan during the portal phase showed an isodense mass with a hypodense central scar (Fig. 1A). These findings were compatible with the focal nodular hyperplasia except for a central scar extension to the hepatic capsule causing a retraction. The T1-weighted axial MR image of the liver demonstrated a slightly hypointense mass demarcated by a thin hypointense rim with a central hypointense scar. The T2-weighted axial MR image showed a slightly hyperintense mass with a hypointense central scar. The contrast-enhanced T1-weighted axial MR image revealed a marked enhancement of the tumor with a nonenhancing central scar (Fig. 1B).\\nSegment 6 of the liver was resected. The gross specimen showed a nodular configuration with a dense fibrotic central scar. On the cut surface, a central dense fibrotic scar with radiating fibrous septa dividing the lesion into smaller nodules was noted (Fig. 1C). The central scar extended to the surface, and the surface of the liver parenchyma adjacent to the mass was retracted. The capsular retraction of the liver surface was attributed to the collagenous scar. The resected specimen showed a depressed thickened stellate scar, slightly eccentrically positioned, with tapering fibrous septa, which radiated through the mass, dividing it into multiple lobules. The patient took an uneventful postoperative course and was discharged.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 4,\n",
       "    'case_id': 'PMC7534522_01',\n",
       "    'case_text': \"A four-year-old female patient was admitted to our outpatient clinic due to short stature. She was born to non-consanguineous parents via elective cesarean section at 38 wk of gestation following an uncomplicated pregnancy, with a birth weight of 3,390 g. In early infancy, she suffered from feeding difficulties, hypotonia, gastrointestinal reflux, and failure to thrive with no history of hypoglycemia. A gastrostomy tube was required for feeding. At 10 mo of age, a molecular test was performed due to developmental delay and dysmorphic facial features such as epicanthal folds, a short nose with a flat-depressed nasal bridge and anteverted nares, and posteriorly rotated low-set ears with large lobes. A whole exome sequence analysis was performed at the Center for Human Genetics (Centrum Menselijke Erfelijkheid, CME) at the Gasthuisberg campus of UZ Leuven in Belgium. A heterozygous mutation, c.34G> A (p.Gly12Ser), in exon 2 of the HRAS gene was revealed, which is the most common mutation responsible for CS. A definitive diagnosis of CS was hence achieved.\\nAt first evaluation at 4.2 yr of age, the patient's height was 88.7 cm (-3.49 SD) and her weight was 12.38 kg (-2.29 SD). The mid-parental height was 164 cm, corresponding to 0.15 SD (her mother's height was 159 cm, and her father was 182 cm). On physical examination, characteristic phenotypic features of CS were noted: coarse face, prominent forehead, epicanthal folds, down-slanting palpebral fissures, curly hair, broad and short nose, posteriorly rotated ears with thickened lobes and helices, full cheeks, high arched palate, full lips with large mouth, short neck, as well as dark, loose and soft skinned hands and feet with wrinkling-hypoplastic nails. A gastrostomy scar was noticed. Laboratory tests showed normal hemogram and biochemical parameters, including liver and kidney function, blood glucose, thyroid function, tissue transglutaminase autoantibody Ig A, and serum total Ig A level. Her urine analysis was normal. GH stimulation tests with L-dopa and glucagon revealed low basal GH levels and reduced GH response (peak GH of 1.51 ng/ml and 0.95 ng/ml, respectively) with low IGF1 levels (11.3 ng/ml, -2.39 SD). Her bone age was 2 yr and 6 mo. Magnetic resonance imaging of the cranium and hypophysis was normal. These findings were compatible with GH deficiency. Long term risks and benefits of medical treatment were discussed with the parents, and initiation of medical treatment was decided upon.\",\n",
       "    'gender': 'Female'},\n",
       "   {'age': 58,\n",
       "    'case_id': 'PMC7534522_02',\n",
       "    'case_text': 'rhGH treatment was initiated at 0.2 mg/kg/wk, which was the standard dose at the age of 4.2 yr. The patient responded with significantly improved linear growth, growing 9.5 cm/yr in the first year of treatment. She continued to grow at 6.8 cm/yr, 6 cm/yr, and 7 cm/yr in the next three years, respectively. In the fifth year of the treatment, her growth velocity slowed down to 5.52 cm/yr, and rhGH treatment was increased to 0.23 mg/kg/wk at the age of 9.58 yr. Bone age was 8 yr and 10 mo. Onset of left breast development was realized at 9.58 yr old with no signs of pubarche (Table 1).\\nThe patient was followed-up every three months of treatment for evaluation of growth velocity, response to the treatment, and side effects. Her bone age progression was evaluated annually. Her IGF-1 levels were maintained in the normal range for the age, gender, and pubertal stage. No pathological laboratory results were obtained. Due to concerns of potential cardiac and neoplastic effects of CS, regular monitoring with electrocardiogram, echocardiography, and abdominal and pelvic ultrasonography was done. The plasma concentrations of metanephrine and normetanephrine were assessed every 3-6 mo. No pathological ultrasonographic findings were observed. The repeated echocardiogram was normal with no evidence of hypertrophic cardiomyopathy. At the age of 9.5 yr, mild tricuspid and mitral regurgitation with normal cardiac function were documented (Table 1).\\nOver five years of rhGH treatment, no adverse effects have been observed. While total height gain was 36.3 cm; total change in height SD (DeltaHSD) was +1.86 at the end of the five-year treatment course, with significantly increased linear growth of +1.02 DeltaHSD during the first year of rhGH therapy, and +0.31 DeltaHSD, +0.09 DeltaHSD, +0.45 DeltaHSD, and -0.01 DeltaHSD in the next four years, respectively. Her current height has reached above the 3rd percentile. In growth monitoring, height and weight of the patient are plotted on charts for both CS and healthy national children (Figs. 1 and 2). She is still on daily rhGH injections. She has attended kindergarten and primary school and receives moderate grades.\\nInformed consent was obtained from all individuals included in this case presentation.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 71,\n",
       "    'case_id': 'PMC3420684_01',\n",
       "    'case_text': 'A 71-year-old African American woman presented with a one-week history of lower extremity and facial swelling, nausea, vomiting, and diarrhea. On admission, she was noted to have hypotension (systolic blood pressure 70 mmHg), acute renal failure (blood urea nitrogen 51 mg/dL and serum creatinine 4.99 mg/dL), and hypoalbuminemia (albumin 3 mg/dL). She required fluid and vasopressor resuscitation. Empiric treatment with broad-spectrum antibiotics was started. By hospital day 14, she developed anasarca, 60 pound weight gain, and required additional vasopressor support and continuous veno-venous hemodialysis (CVVH). Evaluations revealed negative or normal blood and urine cultures, quantitative immunoglobulins; serum protein electrophoresis and immunofixation studies, antinuclear antibody, antineutrophil cytoplasmic antibody, anti-double-stranded DNA levels; erythrocyte sedimentation rate. Urine sodium was less than 25 mmol/L, and urine creatinine was 205 mg/dL. She demonstrated adequate response to cosyntropin. Transthoracic echocardiography and right heart catheterization revealed normal left ventricular ejection fraction, normal pulmonary artery wedge pressure, and no pulmonary hypertension. Computed tomography (CT) revealed left inguinal and retroperitoneal lymphadenopathy (largest node measuring 2.2 cm). Positron emission tomography showed hypermetabolic activity of left pelvic lymph nodes.\\n Histopathology from core-needle biopsy of the left inguinal lymphadenopathy showed an abnormal infiltrate of relatively cohesive clusters of large pleomorphic cells with morphologic features summarized in Figure 1. Limited flow cytometric analysis was performed and demonstrated the presence of an abnormal population of large T cells with slightly dimmed expression of surface CD3 and CD2 in comparison to the normal small T lymphocytes. These cells showed bright expression of CD45, CD4, CD5 with no expression of CD7, CD8, CD19, CD20, CD10, kappa or lambda surface light chain. DNA analysis by DRAQ5 showed a relatively high tumor-specific S-phase fraction (12.7%).\\n Immunohistochemical studies showed strong membranous and perinuclear \"Golgi\" expression of CD30 in nearly all neoplastic cells, which were also ALK (-), CD4 (+), CD8 (-), UCHL1 (+), CD43 (+), EMA (-), TdT (-), cytokeratin AE1/AE3 (-), and S-100 (-). There was frequent labeling of nuclei by Ki-67 (in some areas >90%). The overall findings were consistent with ALK-negative anaplastic large cell lymphoma (ALK-ALCL). Bone marrow evaluation was not performed due to rapidly declining performance status.\\nShe was treated with methylprednisolone 90 mg intravenous twice-daily beginning on day 17. Over the next 10 days, she had spontaneous diuresis, resolution of hypotension, and normalization of renal function, and CVVH was discontinued. On hospital day 24, she received cycle one of cyclophosphamide, vincristine, doxorubicin, and prednisone (CHOP). She was discharged home on day 29.\\nThe patient competed six cycles of CHOP chemotherapy and attained a complete response by CT imaging. Five weeks after completion of chemotherapy, she developed blurry vision. She was found to have central nervous system (CNS) relapse of ALCL with involvement of the cerebrospinal fluid. Despite intrathecal and intravenous methotrexate therapy for one month, she had progressive disease and died two months after CNS relapse. SCLS never recurred after her initial presentation.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 43,\n",
       "    'case_id': 'PMC7229345_01',\n",
       "    'case_text': \"The mother is 43 years old and the father is 49 years old, both healthy non consanguineous parents who live in a village. No known teratogenic exposure during pregnancy. They have eight healthy children, six boys and two girls except our case who is the last child for the family. The child is 6 years old medically free, product of normal spontaneous vaginal delivery at full term without any intensive care unit admission. No reports available for his status during delivery and no ultrasound report. According to the mother his weight at delivery was 1.9 kg.\\nFirst time seen in our clinic at 23 months of age where he was referred to our genetic department in the hospital. They found that he has SNP (single nucleotide polymorphism) positive duplication in chromosome y or x. Same mutation was found in the father. The child started to sit at 9 months and walk at 18 months. The parents still didn't enroll him in any school in the village. Upon examination, no dysmorphic features where noted aside from bilateral absent upper limbs from the shoulder (Fig. 1). He has a right limb leg length discrepancy of 2 cm with pelvic tilt with a positive Adams forward bending test with right rib hump. Normal distal neurovascular examination. He has about 90 degrees of flexion and 20-30 degree of extension and lateral bending upon range of motion examination for the back. Abdominal Ultrasound done in our hospital showed no abnormalities. Right thoracolumbar curve of 45 degrees was identified in imaging without any other vertebral or cord abnormalities in MRI (Fig. 2). Bone mineral density exam was normal. The family was counseled about the child's condition and the options for treatment. They agreed for growing rod method. In March 2019 he underwent VEPTR application.\\nOur aim was to keep it as the definitive fixation with periodic lengthening, as well as to preserve spine range of motion as much as possible to maintain his independence in daily living activities by the use of his lower limbs. Rib to ilium VEPTR applied from the 5th and 6th rib to iliac bone with cradle and ala hook and multiple anchor connections. Reduction of 18 degrees was achieved for the thoracolumbar curve (Fig. 3).\\nPost-surgical intervention the child was seen in the clinic. Maintaining preoperative range of motion for the spine and able to use his lower limbs for feeding, drawing and combing his hair (Figs. 4 and 5). Patient followed up for 1 years and will be followed up until the skeletal maturity.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 41,\n",
       "    'case_id': 'PMC5161787_01',\n",
       "    'case_text': 'Two men, aged 22 and 41 years old, presented to the same emergency department within 2 weeks of each other, with decompensating schizophrenia and bipolar disorder refractory to multiple psychopharmacologic interventions (olanzapine, aripiprazole, and fluphenazine). Symptoms included paranoia and grandiose delusions. Both patients were clozapine-naive; neither patient had any history of structural heart defects at the time of admission to the hospital. The patients were thus started on clozapine. Dosages of 300 and 200 mg/day were administered on the 22-year-old and 41-year-old patient, respectively. Paranoia and delusions were observed to be well controlled following clozapine initiation. Both patients continued to be monitored in the psychiatry department following admission to the hospital.\\nBetween the 9th and 13th day of clozapine treatment, both patients started developing cardiac dysfunction as infectious gastroenteritis was propagating throughout the entire hospital population. Initially, the clinical presentation of these psychiatric patients was similar to that of the general medicine ward patients. Both had the abrupt onset of constitutional symptoms, including fever, myalgias, arthralgias, and fulminant, voluminous, explosive diarrhea.',\n",
       "    'gender': 'Unknown'},\n",
       "   {'age': 22,\n",
       "    'case_id': 'PMC5161787_02',\n",
       "    'case_text': 'However, these two patients rapidly worsened and were thus transferred to the medical intensive care unit. Elevated white blood cells (WBCs) levels with a left shift were observed in both patients. The 22-year-old patient acquired a respiratory tract infection while the other did not. Clozapine was stopped in both patients as cardiovascular complications occurred. Both patients showed progression to heart failure with extreme decline in ejection fraction and shock, prompting diagnoses of myocarditis requiring ventricular assist devices.',\n",
       "    'gender': 'Unknown'},\n",
       "   {'age': 22,\n",
       "    'case_id': 'PMC5161787_03',\n",
       "    'case_text': 'Polymerase chain reaction (PCR) tests for the presence of viral nucleic acids were negative in both patients. Cardiac biopsy in the 22-year-old patient showed lymphocyte infiltration of the myocardium (Fig. 1). Cardiac biopsy in the 41-year-old patient showed eosinophilic infiltration of the myocardium (Fig. 2). No echocardiogram was performed. The younger patient expired 2 weeks following clozapine termination, while the other stabilized and was eventually discharged.',\n",
       "    'gender': 'Unknown'}],\n",
       "  [{'age': 57,\n",
       "    'case_id': 'PMC3992216_01',\n",
       "    'case_text': 'A 57-year-old white male had type 2 diabetes complicated by macular edema, cataracts, distal symmetrical polyneuropathy, autonomic neuropathy, hypertension, and ischemic heart disease for at least 17 years. Nine years after diagnosis, because of poor glycemic control (partially due to an inability to tolerate metformin), he was started on twice daily premixed 70/30 insulin aspart in combination with a sulfonylurea, which was later replaced by the DPP4 inhibitor (sitagliptin). Prior to commencing insulin therapy, he weighed 210 lbs (BMI 29 Kg/m2) and with insulin his weight increased to 247 lbs (BMI 34 Kg/m2).\\nAfter an initial assessment, sitagliptin was replaced by the more powerful liraglutide, which was given subcutaneously and slowly increased from 0.6 to 1.8 mg per day. He was also started on canagliflozin 100 mg daily for 1 week, after which the canagliflozin was increased to 300 mg daily. His total insulin dose, which was initially 0.6 units per Kg, was initially decreased to 0.4 units/Kg, and after 2 weeks was changed to 0.2 units/Kg twice daily in divided doses. Four weeks after starting the combination of canagliflozin and liraglutide, he was able to discontinue insulin.\\nWith maximization of liraglutide and canagliflozin therapy over the following 3 months, his HbA1c, in spite of the removal of exogenous insulin, dropped from 7.0% to 6.8%, and he had reductions in body (weight from 247 to 218 lbs), BMI (from 34 to 29.5 Kg/m2), waist circumference (from 47 to 44 1/2 inches), and neck circumference (from 19 1/2 to 18 1/4 inches).',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 0,\n",
       "    'case_id': 'PMC5917864_01',\n",
       "    'case_text': 'Forty-five day old male infant, presented with features of congestive cardiac failure. Echocardiography showed critical coarctation of the aorta (peak gradient across aortic arch 35 mmHg with pandiastolic spilling), severe left ventricular dysfunction (LVEF-25-30%), fossa ovalis ASD (5mm) with left to right shunt, mild TR with peak gradient of 70mmHg, normal connecting pulmonary veins and confluent and dilated pulmonary arteries. There was a bicuspid aortic valve and mild aortic stenosis (peak/mean gradient across aortic valve=23/15 mmHg). The child underwent balloon dilatation of coarctation of aorta successfully.\\nPost balloon dilatation of coarctation, catheterization data and echocardiography showed high right ventricular pressure despite the absence of significant gradient across the aortic valve and aortic arch (table 1), with improvement in left ventricular ejection fraction (LVEF 45%).\\nEchocardiography was reviewed again in detail and showed confluent and dilated central pulmonary arteries and stenosis of the lower branch of the right pulmonary artery (gradient 40mmHg with pandiastolic spilling - figure 1a,1b).\\nIsolated branch pulmonary artery stenosis in isolation might not be responsible for severe PAH but was definitely contributing to high pulmonary artery pressures. The causes of persistence of PAH after relief of LVOTO could be a combination of pulmonary venous hypertension and branch pulmonary artery stenosis. As the child was clinically stable, he was discharged on a once on daily dose of diuretic (frusemide). Follow up after three months showed severe aortic valve stenosis and restenosis of a dilated coarctation segment. The child underwent balloon dilatation of the aortic valve, the coarctation and the lower branch of right pulmonary artery, with success. Post procedure echocardiography showed normalization of RV pressure (TR gradient 25 mmHg) with laminar flow in the right pulmonary artery branch (figure 2a,b). The child has been well since.',\n",
       "    'gender': 'Male'},\n",
       "   {'age': 0,\n",
       "    'case_id': 'PMC5917864_02',\n",
       "    'case_text': 'Fifteen days old male neonate, birth weight of 2.8 Kg, was brought to emergency with severe respiratory distress and features of congestive cardiac failure. Echocardiography showed critical aortic stenosis, left ventricular hypertrophy, severe left ventricular dysfunction (EF 15%), and severe PAH (TR gradient 80 mmHg). The left ventricle was apex forming but the mitral valve annulus had a Z score of minus 2.34 (absolute value 8 mm).\\nBalloon dilatation of the aortic valve was done successfully. Post balloon dilatation echocardiography showed no significant gradient across the aortic valve (mean gradient 10mmHg), mild aortic regurgitation, normal LV systolic function (EF 58%), but persistence of PAH (TR gradient 75 mmHg). The baby was clinically stable and was discharged with regular cardiology follow up. In view of persistence of PAH, cardiac catheterization was done 6 months post balloon dilatation and this showed high LV end-diastolic pressure (LVEDP 18-20mmHg), high pulmonary capillary wedge pressure with no transmitral gradient (table 2).',\n",
       "    'gender': 'Male'},\n",
       "   {'age': 4,\n",
       "    'case_id': 'PMC5917864_03',\n",
       "    'case_text': 'The child was started on oral diuretics and a pulmonary vasodilator (sildenafil). He is now 4 years old but failing to thrive (weight 15 kg, minus 2-3 standard deviation). On echocardiography, the right ventricle is dilated and apex forming, mitral annulus 13 mm (Z score minus 1.5) along with persistence of severe PAH and LV diastolic dysfunction.',\n",
       "    'gender': 'Male'},\n",
       "   {'age': 1,\n",
       "    'case_id': 'PMC5917864_04',\n",
       "    'case_text': 'A one year old female child, weighing 6 kg, was brought to emergency with wheezing and respiratory distress. There was a history of multiple such episodes in the past. The child had undergone balloon dilatation of coarctation of the aorta in the neonatal period in another hospital and was on a pulmonary vasodilator (sildenafil) in view of persistence of PAH. After stabilization, echocardiography evaluation at our centre revealed a well opened dilated coarctation segment (gradient 12 mmHg, no diastolic spilling), tiny patent ductus arteriosus (PDA) with left to right shunt, normal left ventricular function and dimensions, dilated right atrium and ventricle, mild TR (gradient 73 mmHg), and turbulent flow in right and left pulmonary veins suggestive of stenosis. On continuous wave Doppler interrogation, there was continuous pattern with a mean gradient of 6 mmHg. CT pulmonary angiography was done to define the pulmonary veins. There was severe, long segment stenosis of the left lower pulmonary vein with hypoplasia, along with severe stenosis of the right upper pulmonary vein (figure 3a, b). Pulmonary veins stenosis was the factor responsible for persistence of PAH.\\nThis stenosis of the pulmonary veins may be missed at the time of initial evaluation due to high LVEDP and venous hypertension with critical coarctation of aorta. The family was given the option of cardiac catheterization with high risk balloon dilatation/stenting of the pulmonary veins. The parents opted for medical management.',\n",
       "    'gender': 'Female'},\n",
       "   {'age': 0,\n",
       "    'case_id': 'PMC5917864_05',\n",
       "    'case_text': 'A 25 day old male baby born at full term gestation, with uneventful antenatal and perinatal period, birth weight of 3.1 kg, was brought to emergency with complaints of poor feeding and respiratory distress for one week. Chest radiograph showed cardiomegaly. Echocardiography revealed bicuspid aortic valve, critical aortic stenosis, small PDA (right to left shunt) and severe left ventricular dysfunction (LVEF 20%). The baby underwent balloon dilatation of the aortic valve successfully. Two days post balloon dilatation, repeat echocardiography while still on oxygen showed a mean gradient across the aortic valve of 18 mmHg, trivial aortic regurgitation, no flow across the PDA and mild tricuspid regurgitation (gradient 28 mmHg) with a left ventricular ejection fraction of 50%.\\nAfter 3 months, he was readmitted with features of congestive cardiac failure. Echocardiography showed a well opened aortic valve (mean gradient 20 mmHg), trivial aortic regurgitation, normal mitral valve, normal flow in the pulmonary veins and normal LV function. There was right ventricular dysfunction with severe PAH (TR peak gradient 86 mmHg). CT pulmonary angiography was done to profile pulmonary vein anatomy and to rule out any lung malformation contributing to PAH. The child was stabilized with diuretics and oxygen. Repeat echocardiography showed a TR gradient of 50 mmHg (on oxygen by nasal prongs 5 l /minute).\\nCardiac catheterization was done for hemodynamic assessment. Hemodynamic data (taken on oxygen) is given in table 3. The data showed moderate pulmonary arterial hypertension, normal left ventricular filling pressure (5 mmHg) and no significant gradient across the aortic valve. The baby was stabilized on a pulmonary vasodilator (sildenafil) and oral diuretics (frusemide and aldactone). He was discharged in a clinically stable condition.\\nAfter two months the child returned with acute deterioration. Echocardiography showed severe pulmonary arterial hypertension with severe RV dysfunction. Despite all resuscitative measures, child could not be revived.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 28,\n",
       "    'case_id': 'PMC4891467_01',\n",
       "    'case_text': 'We report the case of a 28 year old man who sustained a rotary injury to his wrist. Eight months later at an outside institution, he underwent an ulnar shortening osteotomy. One year later, due to continuing symptoms, a second surgery was performed, with hardware removal and distal right ulna resection. He presented to our institution 16 months later with constant, worsening pain in his right upper extremity which increased with activity, despite treatment. Physical examination showed limited range-of-motion of flexion and extension in the right wrist, decreased range of supination at the elbow, decreased right grip strength, and instability of the distal ulnar stump. Initial radiographs demonstrated distal ulnar resection (Figure 1). The patient next underwent placement of a Scheker prosthesis (Aptis Medical) at the DRUJ. A post-operative image is shown in Figure 2.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 33,\n",
       "    'case_id': 'PMC5340088_01',\n",
       "    'case_text': \"A 33-year-old female patient of Latvian descent reported with a history of decreased bilateral visual acuity. Initially the patient's history was unremarkable, but during her second visit she acknowledged that for spiritual purposes she had been observing the sun with the naked eye regularly for many minutes over the past 8 years. Her uncorrected distance visual acuity (UCVA) was 0,9 in both eyes. A color fundus image disclosed a small round whitish discoloration in the fovea of both eyes (Figure 1 (Fig. 1)). A discrete discontinuity in the inner and outer segment junction (IS/OS), cone outer segment layer (COST), and retinal pigment epithelium layer (RPE) in the fovea of both eyes was noted on SD-OCT along with a streak of increased reflectivity in the choroid and sclera corresponding in size and location to the whitish discoloration on the color fundus image probably caused by focal RPE atrophy (Figure 2 (Fig. 2)). No changes were found on short-wavelength fundus autofluorescence (SW-FAF) (Figure 3 (Fig. 3)). However, on near-infrared fundus autofluorescence (NIA) small spots of hypoautofluorescence in both maculae corresponding in location to the white discoloration in the color fundus image and the IS/OS to RPE layer retinal layer disruption on SD-OCT were found (Figure 4 (Fig. 4)). The hypoautofluorescent spots were also similar in size to the white discoloration in the color fundus image. The anterior segment examination was normal in both eyes. Based on these results we diagnosed the patient with solar retinopathy and advised her to discontinue looking at the sun with the naked eye.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 23,\n",
       "    'case_id': 'PMC6438861_01',\n",
       "    'case_text': 'A 23-year-old woman was admitted to the Neuroradiology Division to participate in an experimental fMRI study as part of the \"normal\" control group. Inclusion criteria were the following: (1) no past or current mental illness assessed using the Mini-International Neuropsychiatric Interview (MINI) Plus: in particular, no major depression, dysthymia, mania or disinhibition based on DSM-V criteria; (2) no family history of mental illness or psychiatric hospitalization; (3) no history of head injury with loss of consciousness; (4) a Mini Mental State Examination (MMSE) ( ) score of >=27; (5) no current pharmacological treatment, substance abuse or dependence that could substantially affect cognitive functioning.\\nAt the pre-scan evaluation, the young woman was alert, conscious and oriented in time and space. Production and comprehension of language were preserved. The neurological examination was negative. The psychological interview for inclusion in the normal control group highlighted normal mental status and psychological adjustment, intellectual and problem-solving ability, processing speed and executive functioning.\\nThe young woman1 had a normal postnatal developmental history and complete functional independence of long-living. She has reached the main milestones of young adulthood. Moreover, she denied any functional or social dysfunction in everyday life.\\nNeuroimaging data was acquired using a 3T Philips Ingenia scanner. Structural images were collected using T1-weighted (TR = 8.1 ms, TI = 900 ms, TE = 3.7 ms, voxel size = 1 x 1 x 1 mm3) and axial T2-weighted FSE (TR = 3200 ms, TE = 100 ms, FOV = 432 x 432 mm, section thickness = 4 mm, acceleration factor = 2) sequences. The MRI showed no alterations of the brain parenchyma in the supra and infratentorial sites. Ventricles and sulci were of normal size and aligned. However, unexpected appreciable agenesis of the splenium of the corpus callosum was found ( Figure 1) with no alterations in the brain parenchyma signal in the supra and infratentorial sites.\\nIn view of such neuroimaging findings, YW was referred to the Neuroradiology Division in order to undergo a thorough neuropsychological evaluation ( ). The neurologist conducted a standardized interview with the patient on her health history before formalizing the diagnostic question to the neuropsychologist. The format of the health history is structured in order to organize patient information by following a written report for other health professionals. Subsequently, the neuropsychologist carried out a psychological anamnesis: it has the purpose of investigating aspects that serve to provide useful indications for the more possible precise psychological diagnosis. The complete interview is divided into the following topics: demographic data and marital status; physiological anamnesis; recent, near and remote anamnesis; functional anamnesis; psychological and psychopathological anamnesis; family history.\\nThe Brief Psychiatric Rating Scale 4.0 (BPRS 4.0) was used to measure neuropsychiatric symptomatology ( ). Specific scales were employed to assess behavioral mood changes: the Apathy Evaluation Scale-Clinician version (AES-C) ( ); the Hamilton Depression Rating Scale (HDR-S) ( ); the Young Mania Rating Scale (YMRS) ( ). The Self-Regulation Skills Interview (SRSI) ( ,  ), a clinical tool developed to measure higher levels of self-awareness and self-regulation skills that imply insight, motivation and compensation was also administered ( ).\\nThe Toronto Alexithymia Scale (TAS-20) ( ) is one of the most widely used tools for measuring alexithymia. Alexithymia refers to individuals who are unable to identify and describe their emotions or have a tendency to minimize their emotional experience and to focus their attention externally. Items are rated on a 5-point Likert scale. The TAS-20 uses cut-off scoring: <=51 = non-alexithymia, >=61 = alexithymia.\\nThe Difficulties in Emotion Regulation Scale (DERS) ( ) was administered to assess multiple aspects of emotion dysregulation. DERS is a 36-item, self-report questionnaire comprising six subscales developed to detect multiple aspects of emotion dysregulation: (1) Non-acceptance of emotional responses (Non-acceptance); (2) Difficulties engaging in goal directed behavior (Goals); (3) Impulse control difficulties (Impulse); (4) Lack of emotional awareness (Awareness); (5) Limited access to emotion regulation strategies (Strategies); (6) Lack of emotional clarity (Clarity) ( ). Recently,   provided equations to calculate age- and gender-adjusted T-scores, so that clinicians would easily interpret the resultant T-transformed DERS scores, which have a mean of 50 and standard deviation of 10. DERS scores between 65 and 70 T should indicate the presence of difficulties in emotion regulation, whereas scores higher than 70 T indicate important problems in emotion regulation. DERS reported high alpha coefficients ranging from 0.80 to 0.89 for the different scales. Exploratory factor analysis was used to provide data on the factor structure of the DERS and identify the underlying dimensions of emotion regulation as assessed by this tool. We obtained T-transformed DERS scores. As mentioned before, DERS scores between 65 and 70 T indicate the presence of problems in emotion regulation and scores higher than 70 T indicate significant problems in emotion regulation.\\nIntelligence was assessed using the Wechsler Adult Intelligence Scale - IV edition (WAIS-IV) ( ). The pre-morbid intelligence quotient was estimated using the Brief Intelligence Test (TIB) ( ;  ) that is the Italian version of Nelson\\'s National Adult Reading Test ( ). Cognitive abilities were analyzed through a comprehensive battery of tests to measure ( ): attention through Attentional Matrices ( ); executive functions by means of Trial Making Test parts A, B ( ); memory through Wechsler Memory Scale -Subtests 4 and 7 ( ); language oral production by means of verbal fluency ( ). The absence of unilateral visual-attentional neglect was assessed by menas of the Bells Test ( ). Dysexecutive syndrome was assessed using ecological neuropsychological tasks created to simulate daily life situations: the Behavioral Assessment of the Dysexecutive Syndrome test battery (BADS) ( ). Theory of Mind visual stories (ToM1 and ToM2) were used to test perspective-taking skills ( ), while the Reading the Mind in the Eyes task (RME) was used to measure social cognition and emotion recognition abilities ( ). Metacognition was assessed with the metacognitive version of the Wisconsin Card Sorting Test (m-WCST) ( ).',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 14,\n",
       "    'case_id': 'PMC4795147_01',\n",
       "    'case_text': \"A 14-year-old female patient reported to our department with complaint of swelling in the gums of the upper and lower right hand side quadrants of the mouth since a year. The patient first noticed the swelling 4 years before in the upper right side of the mouth - gradually and slowly increasing swelling.\\nThe patient had delayed tooth eruption of the upper and lower right premolar teeth associated with gingival swelling. She underwent excisional surgery for the same 2 years before at a private dental clinic. Postsurgery within 6 months, the patient again noticed the swelling which gradually increased in size. The patient gave history of rapid increase in size since the preceding 6 months and spread toward the teeth of the left hand side of the mouth. Swelling was painless, but the patient complained that it interfered with chewing.\\nThere was no history of epilepsy or major illness. She was undergoing treatment for anemia with iron supplement. Developmental milestones and other systems of the child were normal. Family and menstrual history was noncontributary. The patient has unilateral mastication habit with left side since childhood. The right hand used for brushing.\\nGeneral physical evaluation was done. The patient had normal physical appearance and psychomotor skills. Normal bone development seen on the chest and extremity radiographs. The patient showed slight facial asymmetry with fullness of the right upper lip. The lips were competent [Figure 1].\\nGingival enlargement was more predominant on the right hand side of the mouth, but mild involvement was present extending to the incisors as well as the lingual aspect of the left mandibular molar region [Figures 2 and 3]. Only the maxillary left posterior teeth were completely uninvolved. Both facial and palatal/lingual aspects were involved in the maxillary and mandibular right hand side quadrants covering almost the entire clinical crown. There was diffuse involvement of marginal, papillary, and attached gingiva. The swelling was irregular, largely pale pink, and firm devoid of stippling along with softened reddish pink areas toward the occlusal surface associated with calculus deposits.\\nBleeding on probing was present with 14-16 regions. Several teeth were clinically submerged including the maxillary canines (13, 23) and mandibular left canine (33) and both the mandibular second premolars (35, 45). Even, the maxillary and mandibular second molar of the right hand side (17, 47) were clinically submerged. Deep pseudopockets along with attachment loss of up to 13-15 mm were present with 14, 15, 16, and 46 which showed Grade II mobility. Grade I mobility was present with 11, 12, 21, 22, 31, 32, 41-44.\\nOrthopantomogram (OPG) and three dimensional cone beam computed tomography evaluation was done. The radiographs revealed that the submerged teeth had bony impaction except for the maxillary and mandibular right second molars which appeared to be still erupting. Severe bone loss was present with 14, 15, and 16 teeth [Figure 4]. In this region, there was evidence of increased spacing and further bone loss compared to an OPG taken 3 years prior and the current radiograph. In addition, generalized crestal bone loss was present except with the left maxillary posterior teeth.\\nBlood investigations revealed the normal blood profile and hormonal levels. Hemoglobin level was low 10.3 mg%.\\nAfter obtaining written consent, thorough scaling, root planing, and curettage were done and anti-microbial rinse chlorhexidine gluconate 0.2% prescribed and in addition used for irrigation of the pockets. This regime was repeated weekly for 3 weeks as it was difficult for the patient to maintain adequate plaque control. An incisional biopsy was done and 8 mm x 10 mm tissue specimen was sent for histopathological evaluation.\\nPostphase I appearance of the tissues showed overall superficial reduction in inflammation. Following this phase, electrosurgical gingivectomy was performed. First, the maxillary surgery was performed. After administering nerve block anesthesia to the patient, the area of tissue to be excised was demarcated with a probe. The electrosurgical unit (megasurg - high frequency radiosurgery unit) was set up and the passive electrode - the patient plate tied to the patient's calf. The needle electrode (active electrode) at 8 MHz was used to outline the external bevel incision. The tissues were further undermined with a bar electrode and removed in bulk. The bar electrode was then used to plane the tissues and achieve a favorable tissue contour. Following excision, thorough irrigation of the site was done. In some sites, additional curettage was done along and closure of the area with sutures. The operative procedures for Maxilla are shown in Figure 5. Periodontal dressing was placed, and the patient was prescribed anti-biotic and analgesic medication.\\nThe mandibular surgery was performed 2 weeks later similarly [Figure 6]. Postoperative healing a week later was satisfactory. The case was followed-up for 8 weeks postoperatively, and then every 3 months for 2 years. Favorable healing of the sites were seen postoperatively at 1 week, 1 month, and 3 months intervals. The mobility of teeth had significantly decreased from Grade II mobility to physiologic by 3 months postoperatively. The patient was able to maintain good oral hygiene. The patient has visited for recall follow-up since the past 2 years with minimal evidence of recurrence [Figure 7].\\nEvaluation was performed using routine H and E staining as well as polarized microscopy with specific connective tissue staining to verify the nature of the fibrosis. Abundant collagen with hyalinization of the collagen fibers was seen. Congested blood vessels with mixed inflammatory infiltrate focally transgressing the overlying epithelium were observed. There was no evidence of dysplasia or malignancy [Figure 8].\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 72,\n",
       "    'case_id': 'PMC8168694_01',\n",
       "    'case_text': 'A 72-year-old female presented with sciatica and neurogenic claudication. The lumbar MRI demonstrated significant L4-L5 central/bilateral neuroforaminal stenosis with Grade 1 spondylolisthesis [Figure 1a]. She underwent a L4-5 laminectomy with fusion. No DT occurred during the operation. On postoperative day 2, she reported nausea, emesis, and fatigue, but was neurologically intact. However, on postoperative day 3, after an unwitnessed fall, she became disoriented and development left eye ptosis. A brain CT demonstrated a large left temporal ICH and a large left cerebellar hemorrhage with accompanying obstructive hydrocephalus [Figure 1b]. She underwent a suboccipital craniectomy for cerebellar clot evacuation, a left-sided decompressive hemicraniectomy for temporal clot evacuation, and eventual ventriculoperitoneal shunt placement. The postoperative lumbar MRI never showed a CSF leak. At 4-month follow-up, the patient was awake, alert, and following commands symmetrically, but remains aphasic.',\n",
       "    'gender': 'Female'},\n",
       "   {'age': 61,\n",
       "    'case_id': 'PMC8168694_02',\n",
       "    'case_text': 'A 61-year-old female presented with recurrent bilateral leg pain 1 year following an initial L3-5 laminectomy. The lumbar MRI now showed new right L3-4 foraminal stenosis with Grade I spondylolisthesis at the L4-L5 level [Figure 2a]. She underwent a secondary L4-5 decompression/posterior fusion. An intraoperative DT was observed, which was repaired with a braided nylon suture, muscle patch graft, and hydrogel dural sealant, followed by placement of lumbar subarachnoid drain. Postoperatively, the patient awakened with a new left hemiparesis. A postoperative brain CT demonstrated a 17 cc right frontal ICH [Figure 2b], which was managed conservatively. Nine months later, the patient exhibited a residual left-sided hemiparesis and left facial droop with mild dysarthria which were improving.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 54,\n",
       "    'case_id': 'PMC7656049_01',\n",
       "    'case_text': 'A 54-year-old man presented with a history of a left frontal cutaneous cell carcinoma. The patient had surgical removal of the tumor followed by radiation therapy in 2000. He had no metastasis at that time. He was then lost to follow-up for more than a decade. He presented with a painful and ulcerated extensive left frontal cutaneous lesion which occasionally bled. The progressive growth of the lesion was neglected by the patient for years. Because of a rapid progression in the past 3 months, he consulted. No other symptoms were reported. Physical examination showed a 12 x 15 x 14 cm left frontal cauliflower-like mass with a necrotic center and peripheral subcutaneous induration with erythema [Figure 1]. There was no neurological impairment. CT scan showed destruction of the left frontal skull [Figure 2a]. MRI revealed extensive frontal dural induration with a cystic invasion of the left frontal lobe [Figure 2b and c]. The patient underwent surgical removal of the tumor. The invaded skin, bone, and dura were excised with a safety margin of 1 cm [Figure 3a]. The tumor that invaded the cortex was then removed. Fascia lata muscle was used for dural reconstruction and cement for frontal bone reconstruction. Cutaneous reconstruction was performed using a scalp graft and free thigh flap transfer [Figure 3b and c]. Pathological examination revealed invasive SCC with negative margins. Three months after surgery, the grafts had completely healed [Figure 3d]. Local radiation therapy was then performed. Clinical follow-up showed no evidence of recurrence 2 years after surgery.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 10,\n",
       "    'case_id': 'PMC4359789_01',\n",
       "    'case_text': 'The male patient was referred for the first time at the age of 10 years for evaluation of autistic features, learning difficulties, speech and cognitive delays. No information are available on family history since he was adopted. Physical examination at 13 years of age revealed auxological parameters above the average (weight >97th centile; height between the 90th and 97th centile) and dysmorphic features including high forehead with frontal bossing, small palpebral fissures, epicanthal folds, hypertelorism (>2 SD), dental abnormalities, high arched palate, micrognathia, short neck (Figure 1). In addition, hyperopia and skeletal anomalies (scoliosis), gynecomastia and bilateral pes planus were reported.',\n",
       "    'gender': 'Male'},\n",
       "   {'age': None,\n",
       "    'case_id': 'PMC4359789_02',\n",
       "    'case_text': 'Neuropsychiatric evaluation showed speech delay, mild cognitive impairment (QI 68), attention deficit hyperactivity disorder (ADHD). Also, the patient showed walking abnormalities (uncertain gait), clumsiness.\\nAbdominal ultrasound examination and brain magnetic resonance imaging (MRI) were normal. Genetic evaluation revealed a normal 46,XY karyotype while DNA analysis for FMR-1 gene excluded the diagnosis of fragile X (FRAXA) syndrome.',\n",
       "    'gender': 'Unknown'}],\n",
       "  [{'age': 14,\n",
       "    'case_id': 'PMC4516357_01',\n",
       "    'case_text': \"Two fourteen-year-old male siblings (twins) TG90.001 and TG90.002, were initially referred to the Montefiore Pediatric Genetics clinic for evaluation of multiple congenital anomalies. At age four, both boys were diagnosed with focal segmental glomerulosclerosis (FSGS) by renal biopsy and were also noted to have tics, which were felt by their neurologist to be due to a forme fruste of Tourette syndrome. Developmentally, motor and cognitive milestones were slightly delayed, and both had dolichostenomelia with arm spans significantly greater than height. In addition, each had a high arched palate, joint laxity, pectus excavatum, mild scoliosis, and pes planus (flat feet). All of these physical findings suggested a diagnosis of Marfan syndrome (MS) (OMIM#154700). However, since the urologic, renal and developmental problems affecting the siblings are not typically seen in MS, and cardiac evaluations were normal, it was unclear which testing should be performed. At the time of this evaluation, Fibrillin 1 (FBN1) testing was not clinically available. Testing through our panel revealed that both patients carried one previously-reported missense variant in the coding region of the FBN1 gene (c.G4001A; p.G1334D; rs191989961), which produces a guanine-aspartate change and it is predicted as probably-pathogenic by our in silico analysis. This variant was previously reported in one other subject by the Laboratory for Molecular Medicine (Cambridge, MA) and deemed likely pathogenic based on their systematic approach for variant classification, which considers disease association from existing data, mechanism of gene function, and the use of several bioinformatic tools to predict the possible impact of the variant on the gene. MS is inherited in an autosomal dominant manner and since variants in FBN1 are also commonly associated with MS, we believe our findings may help explaining the boys' MS-like features. There were no variants identified in the FSGS-associated genes present in our panel, suggesting that additional testing is needed in these patients to determine the underlying molecular cause for their renal and urologic phenotype. Of note, if testing for these patients were to be performed clinically by Sanger sequencing or using a disease-specific gene panel, the costs associated would have been greater given that two separate testing for each phenotype would have been required.\",\n",
       "    'gender': 'Male'},\n",
       "   {'age': 29,\n",
       "    'case_id': 'PMC4516357_02',\n",
       "    'case_text': \"A 29-year-old woman, RB1, was referred to the Montefiore Center for CardioGenetics for evaluation. She had experienced episodes of palpitations and syncope related to exercise since 11 years of age. Due to intermittent prolongation of her QT interval on electrocardiography (ECG), she was given a provisional diagnosis of either Long QT syndrome (LQTS) or CPVT. These disorders have some overlapping features and both, if left untreated, may result in sudden death. However, because the treatment for various forms of LQTS and CPVT differ, determining the exact genetic variants is extremely helpful in managing patients. In addition, identifying the genetic variant can be life-saving for first degree relatives. Commercial testing is available for this specific phenotype but requires two separate sequencing panels (one for LQTS and one for CPVT) to differentiate the diagnosis. Because of lack of insurance and high cost, commercial testing was never performed. Based on the custom multi-disease gene panel that we designed, this patient was identified to be a compound heterozygote for variants in the calsequestrin 2 (CASQ2) gene, identifying one novel stop variant (c.C199T, p.Gln67*) and one novel splice site variant (c.532+1G>A). Sanger sequencing confirmed the variants and in addition detected the presence of the p.Gln67* variant in the patient's child. The splice site variant was absent in the child, indicating that the mother's variants were in trans. Variants in CASQ2 account for 5-7% of all cases of CPVT, suggesting the most likely mode of inheritance to be autosomal recessive. Although the c.532+1G>A variant has not yet been demonstrated to alter mRNA splicing, we are conducting further functional work to determine how this variant affects splicing.\\nThe DNA from two sisters, TG471.001, TG471.002, presented to the Center for CardioGenetics with overlapping phenotypes of Dilated Cardiomyopathy (DCM), were sequenced and all cardiac related genes were analyzed. Several variants associated with cardiac disorders were detected, but only the LDB3 gene is directly associated with DCM (LIM domain-binding 3 gene LDB3; Cardiomyopathy, Dilated, 1C; OMIM#601493) and both sisters harbored the same missense variant (c.G352A, p.V118M; rs35507268). However, this exact LDB3 variant was also observed in the unaffected mother and upon further investigation categorized as likely benign by dbSNP, ClinVar, and HGMD. The other variants identified in the sisters were also identified in the unaffected family members, suggesting a lack of a clear pathogenic effect (see Fig 4 for mutational pedigree). Based upon this analysis, the true disease causing variants remain to be identified. We recommend whole exome sequencing be performed on this family in order to identify additional variants potentially associated with DCM. CNV analysis performed on the sisters did not identify variations suggestive of a potentially pathogenic nature.\\nPatient SS1, presenting with a dilated cardiomyopathy (DCM) with conduction defects (OMIM#115200) harbored a 3.74 kb deletion that resulted in the heterozygous loss of the alpha-T-catenin gene (CTNNA3). This gene maps to chromosome 10q21.3, a region linked to autosomal dominant familial DCM. The most common form of myocardial disease, DCM is associated with a high incidence of ventricular arrhythmias, severe congestive heart failure and an increased risk of sudden death. CTNNA3 is highly expressed at intercalated discs of cardiomyocytes and peritubular myoid cells of the testis, indicating a specific function for this gene in particular muscle tissues. Several reports link variants in the CTNNA3 gene with another form of cardiomyopathy, specifically, arrhythmogenic right ventricular dysplasia (ARVC; OMIM#107970). Li et al. examined the role of CTNNA3 in the hearts of mice and found that CTNNA3 acts as a molecular integrator of adherens junctional and desmosomal components at the area composita resulting in early onset of DCM. This CNV is not common and to our knowledge has never been reported based on a literature search or inquiry of CNV databases. We propose the deletion may be causative of the patient's phenotype.\\nPatients TG90.001 and TG90.002 (CASES 1 and 2 above), both harbored two duplications mapping to regions 2q21.1 and 6q27, resulting in an allelic gain to eleven and four genes, respectively. Two genes, tubulin, alpha 3d (TUBA3D) located in the 2q21 region and kinesin family member 25 (KIF25) located in the 6q27 region are involved in microtubule formation. The copy number gain observed at 2q21 was maternally inherited, while the gain seen at 6q27 was paternally inherited. We suspect based on segregation analysis that these duplications, in addition to the potentially pathogenic variant identified in the FBN1 gene (previously discussed) could be responsible for the skeletal and muscular abnormalities observed in the twins, however in order to confirm this functional studies would need to be performed.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 47,\n",
       "    'case_id': 'PMC5106230_01',\n",
       "    'case_text': 'Mr. X, a 47-year-old Caucasian male patient with no medical history visited the emergency unit on July 17, 2007 because of diplopia and dysphonia that had appeared during the night. On admission, the Glasgow coma scale score was 15/15, hemodynamics were preserved, and body temperature was 37.4 C. Medical history showed that the patient had diarrhea that lasted for one week, without improvement even after 5 days of symptomatic treatment. There was no report of recent vaccinations or travel. Clinical examination showed diplopia and dysphonia with nasal speech. He did not present any muscular weakness or sensory loss, and osteotendinous reflexes were present and symmetrical. Cranial nerve examination did not show swallowing disorder, oculomotor disorder, or facial paralysis. The patient had no difficulty in walking, no pain or amyotrophy, no sphincter disorder, and no cauda equina syndrome. The plantar reflex was in flexion.\\nLaboratory tests were also normal. A brain CT with and without contrast was unremarkable. Lumbar puncture showed a clear cerebrospinal fluid with normal leukocyte count (less than 5/mm3 cells), proteins 44 mg/dL (normal range 20-40 mg/dL), glucose 61 mg/dL (n=45-80), and chloride 123 mEq/L (n=116-127). Cerebrospinal fluid culture remained negative after 2 days.\\nYet, 3 hours after admission, became marked impairing speech, and paresthesia and numbness of the tongue was observed. Mr. X also reported paresthesia in his hands, without motor deficit. A Doppler ultrasound of carotid and vertebral arteries was unremarkable. While awaiting the results of bacteriological and viral testing, an empirical antibiotic treatment with amoxicillin, acyclovir, and sulfamethoxazole-trimethoprime was started in the eventuality of meningitis or meningoencephalitis.\\nA Guillain-Barre syndrome was suspected, and so the patient was transferred to the medical intensive care unit. On admission to the intensive care unit, the patient was conscious and had a Glasgow coma scale score of 15/15. There was persistent dysphonia and impaired swallowing and vision; otherwise, the neurological examination was unchanged. Invasive ventilation was initiated soon after.\\nAntibiotic therapy was switched to amoxicillin-clavulanic acid for one week in view of suspected aspiration pneumonia. Intravenous immunoglobulin (IVIG) therapy was started on admission at 0.4 g/kg a day for 5 days. Sedation (midazolam and remifentanil) was stopped on day 1; on day 3, the patient showed no sign of awakening. The Glasgow coma scale score was 3. The pupils were in nonreactive bilateral mydriasis.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 60,\n",
       "    'case_id': 'PMC4387336_01',\n",
       "    'case_text': \"A 60-year-old man presented with a medical history significant for biopsy proven PAN (on prednisone and cyclophosphamide with prior failure on cyclophosphamide alone), paroxysmal atrial fibrillation, hypertension (not on calcium channels blocker), dyslipidemia, non-insulin dependent diabetes mellitus, with multiple prior admissions for PAN flares in the past, and with a history of an admission for septic shock 2 years prior to the current admission without any identifiable sources of infection.\\nThe patient initially presented with a scrotal pain, a fever of 103 F, and fatigue. The patient was also found to be tachycardic to 130 beats per minute, hypotensive to 103/40 mm Hg.\\nThe patient was initially started on broad-spectrum antibiotics consisting of vancomycin and Zosyn (piperacillin/tazobactam) in the emergency department followed by an admission under medicine service. During the hospital course the patient's kidney function worsened leading to a switch in antibiotics to meropenem. Despite switching antibiotics, the creatinine level continued to rise. The patient was on 40 mg of prednisone daily making a suspicion of acute interstitial nephritis less likely. Meanwhile, he continued to spike fevers without a specific source of an infection found in any of the blood, urine, and sputum cultures. Also, no focus was found on the CT chest, abdomen, and pelvis which led to stopping all antibiotics.\\nAfter a time span of 1-2 weeks our patient started developing a previously present macular rash that progressed slowly to involve his axillary area, later including his chest, head, neck, and abdomen. Accompanied with these symptoms, the patient suffered an incendiary mental status than what was previously noted during the orientation exam. This was followed by a worsening of skin lesions with an element of bullae and vesicles. The dermatology team was involved, and a biopsy was obtained with a recommendation of initiating local steroid cream for the diagnosis of AGEP because of the given skin distribution and biopsy result, along with kidney injury, neutrophilia, and cyclic fevers. Nine days after the initial appearance of the rash, the rash became pustular, accompanied by high grade fever of 109 F leading to a transfer to the intensive care unit with a protocol of cooling. Given prior discussions with rheumatology, nephrology, and infectious disease, the patient was administered pulse steroids, given low suspicion of infection and his prior history of PAN flares and the general probability of autoimmune process.\\nAfter completion of the third day of pulse steroids, the patient's fever subsided and subsequent improvement of the initial rash was observed, along with a decreased progression of sloughing and complete resolution of acute kidney injury. A taper in steroids followed pulse steroids.\\nSkin biopsy\\nUrine analysis\\nCT chest/abdomen/pelvis\\nCBC/BMP/coagulation\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': None,\n",
       "    'case_id': 'PMC6692872_01',\n",
       "    'case_text': 'The cadaver of a wild female European rabbit, O. cuniculus, was one of a group shot for population management and donated for research and teaching to the veterinary anatomic pathology service of the Department of Veterinary Medicine, University of Cambridge (UK). The rabbit weighed 1.78 kg. Post mortem examination revealed a very firm, irregular mass with a smooth, gray/pink surface in the left abdomen. The mass had average dimensions 40 x 35 x 30 mm and had thin, tough, translucent adhesions to the left abdominal wall and the left uterine horn, the latter adhesion exhibiting evidence of vascularity, and the tension of the adhesion causing distortion of the left uterine horn (Figures 1A,B). On cut section, the mass was dry and multifocally gritty, but contained clearly discernable fetal remnants, including skin, hair, hard palate, and bone surrounded by lamellated fibrous tissue and fetal membranes (Figure 1C). The mass was interpreted to be a lithopedion, or mineralized abdominal ectopic pregnancy.\\nAt the point of attachment to the left uterine horn, the uterine lumen contained an irregular, cream, 12 x 8 x 5 mm concretion and a circumferential 10 mm band of the uterine endometrium was dark red at this focus. The right uterine horn contained two fetuses, with crown-rump lengths 55 and 53 mm. Macroscopically, the mammary gland exhibited some evidence of development consistent with early pregnancy, such as prominent vasculature and mild parenchymal development, but this was considered markedly less than expected for this stage of pregnancy based on previous analyses. The gastrointestinal tract, in particular the stomach, was subjectively less full than the majority of wild rabbits from the same region examined as part of ongoing studies and scarce fecal pellets were present in the rectum. No other abnormalities were detected macroscopically.\\nTissues were fixed in 10% neutral buffered formalin, and histological sections were prepared following standard procedures. The lithopedion was composed of amorphous eosinophilic material, indicative of degeneration and autolysis, which was multifocally heavily mineralized. Although nuclei were multifocally apparent, the degree of degeneration was such that cell populations were not identifiable and the presence of an inflammatory infiltrate could not be assessed. The uterus at the point of attachment of the lithopedion exhibited a locally extensive endometrial infiltrate of moderate numbers of lymphocytes, plasma cells, heterophils, and fewer macrophages, with locally extensive ulceration. Underlying this focus, there was a loss of distinction of the myometrial layers and locally extensive, mild to moderate, fibrosis. Together with the presence of the small concretion of mineralized material within the uterine lumen, this was considered strong evidence of abdominal pregnancy and formation of a lithopedion secondary to uterine rupture.',\n",
       "    'gender': 'Female'},\n",
       "   {'age': None,\n",
       "    'case_id': 'PMC6692872_02',\n",
       "    'case_text': 'The macroscopic impression that the mammary gland was markedly under-developed for the stage of pregnancy was confirmed histologically, with only a thin layer of mammary tissue present and mammary lobules interspersed by prominent, wide, bands of connective tissue. The mammary alveoli frequently lacked intraluminal proteinaceous material and ducts were generally empty except for small numbers of macrophages and desquamated epithelial cells. The lack of mammary development was particularly pronounced when compared with mammary tissue from another female carrying a litter of similarly developed fetuses (crown-rump length median: 51 cm; mean: 50 cm; n = 8; Figure 2).\\nHistologically the lungs exhibited multifocal, mild, granulomatous and heterophilic pneumonia with multinucleated giant cells and very rare adiaspores, with morphology consistent with Emmonsia spp. There were no other significant findings on histological examination.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 83,\n",
       "    'case_id': 'PMC6319684_01',\n",
       "    'case_text': 'Patient A.N. is an 83-year-old woman who was living in Iran in January of 2015 when she presented to a local hospital with painless jaundice and dark urine. A CT scan showed a pancreatic head mass compressing the common bile duct. For palliation of hyperbilirubinemia, a palliative stent was placed in the common bile duct. A fine needle aspirate obtained through an endoscopic ultrasound (EUS) revealed a poorly differentiated adenocarcinoma. A follow-up CT scan performed on February 13, 2015 revealed a 3.6 x 2.7 cm pancreatic head mass that abutted the superior mesenteric artery and one of its proximal branches. There were suspicious peripancreatic and retroperitoneal nodes and no evidence of distant disease. At the beginning of March, she began taking 50,000 U vitamin D3 (cholecalciferol) daily, ordered directly from the Internet and not under the direction of a healthcare practitioner. Repeat EUS and biopsy on March 3, 2015 again confirmed adenocarcinoma with papillary features. She was referred to an oncologist and surgeon for evaluation. A triple phase CT was done on March 16, 2015 that showed a stable mass without any evidence of involvement of the celiac axis or superior mesenteric artery. Upfront chemotherapy was recommended, with consideration of surgery in the future.\\nShe received gemcitabine/protein nanoparticle-bound paclitaxel in March. On day 10 of cycle 1, she developed neutropenic fever complicated by atrial fibrillation with rapid ventricular response. She was intubated for a brief time who then recovered to her baseline functional status. She was discharged on April 19. Based on her frailty, she was deemed to be a poor candidate for surgery and chemotherapy was not resumed.\\nShe was referred to radiation oncology for consideration of stereotactic body radiotherapy, but she decided to first pursue alternative therapies. She visited an alternative care clinic in April and began taking chelodium, curcumin, community mushroom blend, viscosin, and naltrexone. She also continued to take her daily dose of 50,000 U vitamin D3. Although she was somewhat inconsistent in taking her regimen prescribed by the alternative therapy clinic, she consistently took the same vitamin D3 dose from April until the time of writing.\\nShe was seen first at the Inova Schar Cancer Institute in September 2015. On September 4, 2015, CT scan revealed the pancreatic head mass to be 3.1 x 3.0 cm, slightly smaller than previously with a mild increase in pancreatic duct dilatation. On our first visit on September 5, 2015, we did not obtain a full supplement history, but checked a vitamin D, 25 OH level, which surprisingly was elevated above normal value of >150 ng/mL. Her calcium level was 9.7, which had been 7.7 in March 2015, before starting supplementation. In October, 8 months after her only dose of chemotherapy, she had a CT scan that showed continued disease stability (Fig. 1). As of December 4, 2015, she was stable with no evidence of disease progression by both CT and CA 19-9 level. She was admitted to Fairfax hospital in October of 2015 for diverticulitis with abscess formation that was treated with resection. Currently she describes as feeling quite well with no difficulty accomplishing her activities of daily living.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 19,\n",
       "    'case_id': 'PMC4773087_01',\n",
       "    'case_text': 'A 19-years-old single woman presented to the Emergency Surgery Department of Ghaem Hospital in Mashhad, northeast Iran with abdominal pain, icterus, and anemia. She was admitted to the Surgery Department with acute abdominal pain. \\n There was no significant disease in her medical history but in her social history she had addiction to hookah. She was a pilotage student and was working several hours of a day in the airport. There was no history of drug consumption in the recent months to justify related abnormal liver function tests. \\n Location of pain was in epigastrium with radiation to the left lower quadrant area. The pain was persistent from 4 days ago, without relation to oral feeding. The patient had nausea and vomiting intermittently and also had anorexia but without significant weight loss. \\n The patient\\'s physical examination revealed stable hemodynamic, and mildly icteric sclera . In abdominal examination , tenderness of LLQ (left lower quadrant) in deep palpation without rigidity, or rebound tenderness was revealed. The other examinations such as chest and bowel sounds and also digital rectal examination were normal. \\n Laboratory findings included a normocytic anemia and direct bilirubinemia (table 1). \\n Plain abdominal radiography was normal. Ultrasound study of the abdomen and pelvis revealed several lymphadenopathies in the right lower quadrant and anterior to right psoas muscle. The biggest size of the lymph nodes was 14x7/5 mm. \\n Abdominal pain subsided with conservative management in the Emergency Surgery Department, and the patient was referred to gastroenterologists for more evaluations because of abnormal liver function tests. Other potential causes of icter and abnormal aspartate transaminase and alanine transaminase including sepsis, viral hepatitis, autoimmune diseases, primary biliary cirrhosis, and primary sclerosing cholangitis were ruled out with proper laboratory and imaging modalities (table 1). \\n A new abdominopelvic sonography revealed normal liver and biliary tract except large amounts of sludge in the gallbladder. Gall bladder wall thickness was normal. Spleen, pancreas, retroperitoneum, and other abdominal organs were normal. Both kidneys and urinary bladder, uterus, and endometrium were normal. Ovaries size was 40x26 mm with several follicles (all<10 mm). There were five 11-13 mm adenopathies in the right lower quadrant. \\n Colonoscopy was normal until cecum. Terminal ileum was normal and biopsy of ileum revealed chronic inflammation, no villous atrophy, and no intraepithelial lymphocytosis. \\n According to hookah consumption and an unreliable history for addiction to opioids, serum lead level was examined to rule out lead poisoning. The serum lead level was 415/6 microg/L (41/5 microg/dL) with normal range of <150 microg/L, thus hematology and toxicology consult was performed. \\n Causes of anemia including iron deficiency and hemolytic anemia were excluded by checking serum iron, total iron binding capacity (TIBC), LDH(Lactate dehydrogenase), and reticulocyte count levels (table 1). \\n Morphology of RBC in peripheral blood smear showed anisocytosis(+), microcytosis(+), hypochromia(+), ovalocytosis(+), and ostomatocytosis (+). Basophilic stippling was also seen in the peripheral smear, which can be seen in lead poisoning (figure1). \\n Toxicology consult was done, and serum lead level was rechecked, which revealed 537 microg/L (53/7 mg/dL). Because of the serum lead level that was between 40 to 70 microg/dL and having considered the toxicology references  only oral chelator (succimer) was recommended for the patient.The recommended dose was 10 mg/kg three times a day for five days, followed by 10 mg/kg twice a day for two weeks (maximum 500 mg/dose). \\n Despite oral chelator consumption the pain continued, for which we decided to perform more evaluation for the patient. We found mild serum amylase and lipase elevation in the repeated lab tests (table 2). And according to the presence of sludge in the abdominal sonography of gallbladder, endosonography was done for more evaluation of common bile duct (CBD). The report read :\"there were multiple hyperechoic lesions and one small stone with posterior shadow inside the distal part of CBD. Diameter of CBD was 3/6 mm. pancreas was normal. Gall bladder had multiple small hyperechoic lesions\". \\n Because of these findings and the presence of severe abdominal pain, endoscopic retrograde cholangiopancreaticography (ERCP) was done. ERCP revealed no dilation of CBD, so sphincterotomy was done and sludges were extracted. \\n Despite these therapeutic managements, the abdominal pain deteriorated during the admission, and gradually did not respond to ordinary analgesics, and only opioid analgesics could relief the pain in the last nights of admission in the GI ward. Surgical consultation was done, by which laparoscopy was recommended to approach to the unknown origin of continuous pain and also to the lymphadenopathies, which were noted in the abdominal sonographies. The patient underwent laparascopy. Its report read: \"small intestine from proximal to distal was investigated which was normal but some lymphadenopathies was seen in the mesenter. Stomach, liver, uterus, ovaries, were normal.Cholecystectomy was done and biopsies obtained from the lymphnodes, liver and peritoneum.\" Pathological evaluation of the specimens revealed :1-cholecystectomy: acute on chronic cholecystitis, 2-mesenteric lymph node: reactive, 3- wedge liver biopsy: without significant pathologic changes, 4-labeled as peritoneal biopsy: fibromuscular tissue. \\n Conservative management was done after surgery, but the pain continued. Because of the patient\\'s job in the airport, consultation with occupational medicine specialist was done, who recommended re-evaluation for lead poisoning considering her work place that is a source of environmental lead poisoning and also history of substance abuse (hookah addiction) and unreliable history for probably opioid addiction. Therefore the patient was admitted to toxicology ward. \\n At the toxicology ward, BLL was rechecked, which was 54 microg/dL. Because of no response to previous oral chelator therapy in the same BLL, and the severe suspicious to lead poisoning as the cause of the abdominal pain, intravenous (IV) and intramuscular (IM) chelator therapy were recommended. \\n Dimercaprol or BAL (also referred to as British antilewisite) in conjunction with calcium EDTA was started for the patient. The recommended dose for BAL was 4 mg/kg to be injected deep IM every 4 hours for 3 days, in conjunction with edetate calcium disodium with the second dimercaprol dose; 25-50 mg/kg/day, IV for 5 days. A maximum dose of 3000 mg was considered for calcium EDTA. After 3 days of the treatment, clinical findings including nausea, vomiting, and abdominal pain subsided and finally the pain relieved dramatically. The patient was discharged after 5days of BAL prescription with maintenance therapy with oral succimer (10 mg/kg twice a day for two weeks). \\n The patient was recommended to avoid substance abuse (hookah consumption), and also she was referred to occupational and environmental medicine specialists to evaluate the relationship between lead toxicity and her working environment. She was visited again 10 days later. There was no icterus, pain, or new signs or symptoms. New laboratory findings were all in normal range. She was recommended for monthly follow-up visits for six months (table 2).',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 51,\n",
       "    'case_id': 'PMC4700856_01',\n",
       "    'case_text': \"A 51-year-old male presented with the chief complaint of dysphagia for over 30 years. Eight years ago, the patient was diagnosed with esophageal achalasia, and balloon dilation was performed several times in a previous hospital, but it was not effective. Endoscopic findings before POEM showed a narrow esophagus in the lower esophageal sphincter (LES) region and severe circumferential esophagitis in the esophageal body due to stasis. In addition, there was a slightly depressed, reddish lesion suspected to be cancerous in the mid-thoracic esophagus. Histological diagnosis of the biopsy specimen prior to POEM was esophagitis (non-cancerous part) (Fig. 1A). However, early esophageal cancer was highly suspected. We expected secure diagnosis of the lesion by reducing the inflammation of esophageal mucosa by the POEM procedure. Thus, we performed myotomy from the distal side of the lesion, and the patient planned to undergo endoscopic submucosal dissection (ESD) procedure after POEM. We selected a posterior method for POEM, as there was severe scarring on anterior wall in the lower esophagus. During the POEM procedure, it was very difficult to create the submucosal tunnel because the mucosa adhered to the muscles (Fig. 1B). Therefore, we inserted an endoscope into the extraesophageal space through a tear in the musculature (Fig. 1C). Both the inner circular muscle and longitudinal muscles were pulled and divided carefully using a Triangle Tip knife to prevent mucosal damage outside of the esophagus (Fig. 1D). The total length of myotomy was 8 cm (the gastric side was 1 cm).\\nAfter POEM, LES opened and patient's dysphagia improved. Endoscopic findings 3 months after POEM showed that the esophagitis had improved to mild. The reddish lesion in mid-thoracic esophagus was histologically diagnosed as cancer by repeat biopsy at that time. Intra-mucosal cancer was suspected based on the endoscopic appearance. It is difficult to take specimens by ESD for accurate pathological diagnosis when there is severe fibrosis in the submucosal space. As this was revealed in our patient during the POEM procedure, the patient instead underwent an esophagectomy (after informed consent). There were two main histological findings: first, intramucosal cancer; and second, the muscle tissue that had been divided by the POEM procedure was replaced with fibrotic tissue (Fig. 2 A,B,C,D).\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 32,\n",
       "    'case_id': 'PMC6385762_01',\n",
       "    'case_text': 'A 32-year-old male patient presented on March 14, 2015 with complaints of bilateral episodic pain of the bilateral lumbar region for 6 months. The history of his illness indicated that the patient used opium to reduce his pain. No significant medical or family history was mentioned and the laboratory findings were as follows: Hemoglobin: 14.6 g/dL, Blood urea nitrogen: 18 mg/dL, Creatinine: 1.3 mg/dL, Na: 142 m mol/L, K: 3.9 mmol/L, serum calcium: 9 mg/dL, and serum phosphorus: 3.5 mg/dL. Results of his physical examination on admission were unremarkable.\\nAccording to the clinical symptoms, the kidney, ureter and bladder (KUB) X-ray test was ordered. Findings illustrated a huge left distal ureteral calculus with 14 cm length and 106 g weight, a large right ureteral calculus with 3 cm longitudinal diameter and also an opaque staghorn stone in the left kidney (Figure 1). The total weight of these stones was more than 300 g. Although excretion was reduced slightly in the right kidney, his overall renal function was normal and acceptable excretion was observed on the left side.\\nWe employed the combination of open and endoscopic technique for treatment of this special case of ureteral stone. The patient underwent right side transurethral lithotripsy (TUL) and left open ureterolithotomy through the Gibson incision to remove the giant uretric calculus. Longitudinal incision was performed on the ureteral wall to remove the stone from the left ureter and the stone was extracted with difficulty due to its angle and impaction to the ureteral wall. Thereafter, the distal part of the left ureter was resected due to distal stenosis and then uretroscopy was performed through the resected ureter with advancement to the proximal part of the ureter; as we reached to the renal pelvis stone, it was fragmented. In fact, the retrograde intrarenal surgery (RIRS) was performed for three main goals: reducing the bulk of the stone, applying ureteral stents to ensure the patency of the ureter and facilitating percutaneous nephrolithotomy (PCNL) for the next surgery.\\nTwo weeks after the first surgery, in the second session, PCNL was conducted to remove the remaining kidney stones and then the patient was transferred to the ward for subsequent observation and management. The patient was discharged a few days later.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 7,\n",
       "    'case_id': 'PMC7757964_01',\n",
       "    'case_text': 'A seven-year-old male patient suffered dental avulsion of upper central incisors 11 and 21. In anamnesis, the patient described that he had suffered a trauma in an anterior-superior direction due to an accidental impact. The patient kept the teeth stored in dry media for 40 minutes, and an open apex was observed. The replantation procedure was made according to the International Association of Dental Traumatology (IADT) guidelines. The adopted protocol was the recommended for avulsed teeth with open apex and stored dry less than 60 minutes, and consisted of: roof surface and apical foramen cleaning with saline solution; local anaesthesia; alveolar socket evaluation for alveolar fracture (in the reported case it was not present); clot removal and gentle tooth replantation; no suture was necessary due to lacerations; removal of occlusal trauma; flexible splitting (for two weeks); systemic antibiotics; and antitetanic vaccination.\\nThe immediate post-operative period was uneventful (Figure 1a). At six-month follow-up, there were no signs of necrosis or mobility; however, the patient disappeared and returned to our service after five years (Figure 1b).\\nAt a five-year post-trauma evaluation, total apexification, complete PCC and yellow discoloration of the dental crown were observed in both central incisors, with an inconclusive response to pulp tests (Figure 1c). There were no signs of root resorption or pulp necrosis. After two years, tooth 11 showed a widening of the periodontal ligament space with occlusal trauma. At this moment, the probable cause was eliminated and the treatment chosen was the observation. However, at eight years post-trauma, a radiographically visible apical lesion was diagnosed, and the tooth did not respond to pulp tests and had light sensitivity to percussion (Figure 2a). Left central incisor 21 showed no lesion, symptomatology or signs of pulp necrosis.\\nAlthough radiography showed complete PCC, this exam is not the gold standard. A cone beam computed tomography (CBCT) is the indicated exam to evaluate anatomy of the pulp canal and degree of calcification in detail. However, the CBCT exam was not available in our public service. At this moment, there were two treatment plans: to perform a conventional endodontic treatment or to perform a periapical surgery. Faced with the difficulty of executing conventional endodontic treatment due to the extreme calcification of the root canal and the risk of perforation and/or incomplete endodontic treatment, the clinical treatment plan established was periapical surgery and apical root sealing with MTA-based (MTA, Angelus, Londrina, PR, Brazil) endodontic cement. Also, any marginal bone loss due to perforation would have compromised the tooth because of the reduced root height. The patient was informed about the treatment plan and consented to undergo it.\\nThe surgical procedure was performed under local anaesthesia using mepivacaine 3% with epinephrine 1:100,000. An intrasulcular trapezoidal incision was performed to provide an adequate surgical field and access to the apical area. The flap was reflected and spherical burs #5 (Microdent, Sao Paulo, Brazil) were used to cut and scrape the bone to access the root apical area of tooth 11 (Figure 2b). Periapical curettage was performed in order to remove granulation tissue (Figures 2bd). Due to the decreased length of the root, only a slight apical wear was performed. To prevent root perforation, preparation and regularisation of the apical cavity were performed until intracanal resistance was felt. Therefore, the preparation was limited to the apical third. Retrograde filling was done with MTA.\\nThe mucoperiosteal flap was sutured in position, and a periapical radiograph was taken to confirm the accuracy of the retrograde filling of tooth 11. The post-operative period was uneventful, and the lesion was diagnosed as apical granuloma. In the six-month follow-up, a periapical radiograph showed a slight radiolucency consistent with scar tissue (Figure 3a). At 53 months, no apical lesions, root resorption or bone loss were observed (Figure 3b). In this case report, the periapical surgery was successful. The sensibility disappeared, the lesion decreased and the patient had no complaint. The intraoral evaluation presented periodontal health without mobility or any signs of infection.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 37,\n",
       "    'case_id': 'PMC9553713_01',\n",
       "    'case_text': 'A 37-year-old female patient reported to the Department of Periodontics, Sree Mookambika Institute of Dental Sciences, Kulashekaram, Tamil Nadu, India, with a chief complaint of swelling of gums in the upper front tooth region. The medical history revealed that the patient reported to the hospital 9 months back as she felt a lump on her left breast. An incision biopsy was done and was pathologically diagnosed as invasive ductal carcinoma of histological grade II. Modified radical mastectomy (lumpectomy with axillary clearance) was done to remove the lump and involved axillary lymph nodes (levels I and II). Following the surgical removal, the patient was advised to start a course of radiotherapy and chemotherapy. The patient delayed the treatment by one month and later reported to the hospital with a complaint of memory loss, following which a positron emission tomography (PET) scan was done which showed the presence of brain metastasis. Palliative whole brain radiotherapy of 3000 cGy was administered, divided into 10 fractions. While on radiation treatment, the patient presented with multiple flaccid blisters, erythematous erosions spread throughout the body and was diagnosed as Steven Johnson syndrome (probably anti-epileptic drug induced) and this was managed conservatively. The patient was then started on chemotherapy 14 days later with paclitaxel. During chemotherapy, the patient developed a swelling of the gums which was symptomatic and hence was referred to the Periodontics department for further management. The swelling occurred 9 months after the initial breast swelling was noticed.\\nOn intra-oral clinical examination, a dumbbell-shaped swelling of the gums was seen extending from the buccal aspect through the interdental space to the palatal aspect in the upper maxillary teeth (between 11 and 21). The swelling on the buccal aspect appeared smooth and shiny, while the palatal swelling had a more irregular surface. The swelling was reddish pink in color. The dimension of the buccal swelling was 16 mm x 11 mm and the palatal swelling was 13 x 12 mm approximately (Figures 1(a) and 1(b)). The patient reported that the swelling was initially small and grew at a rapid rate to the current size within a span of 2 weeks, causing an increase in space between the central incisors. The patient also had a history of occasional pain and bleeding from the palatal side of the swelling. Plaque and calculus deposits were present with generalized gingival inflammation. On general examination, the patient presented with cancer cell deposits, presenting as a painless nodular swelling with a central necrotic crust on the tip of the middle finger of the right hand involving the fingernail, chin, scalp, and the upper arm (Figure 2).\\nRadiographic analysis was done to check for bony involvement and periapical radiographs showed bone loss extending beyond the middle third of the root in relation to 11 and 21. Cone beam computed tomography (CBCT) evaluation revealed that the height of maximum bone loss in the mid-alveolus region of 11 and 21 measured about 10.80 mm (Figures 1(c) and 1(d)). A panoramic radiograph was also taken to rule out the presence of other lytic bony lesions involving the jaw bones. Prior to surgery, routine hematological investigations were done and the reports showed that the blood parameters were just above the normal range.\\nA wide excision of the lesion was planned to remove the entire swelling with a 2 mm margin of healthy tissue using a 15c blade. On the removal of the lesion, the exposed underlying bone showed a moth-eaten appearance, which is characteristic of lytic lesions of the bone (Figure 3). The large defect was sealed with a gelatin sponge, sutures were given, and a periodontal dressing was placed to shield the surgical site. The patient was prescribed antibiotics and analgesics. Post-operative review after 3 months revealed satisfactory healing of the wound.\\nHistopathology of the hematoxylin and eosin-stained soft tissue section showed an atrophic ulcerated stratified squamous epithelium in association with a fibrovascular connective tissue. The connective tissue showed infiltrating solid islands of malignant epithelial tumour cells arranged in groups and clusters. The tumour cells were polygonal with eosinophilic cytoplasm and open-faced nuclei. Cells have pleomorphic hyperchromatic nuclei. The tumour cells showed numerous mitotic figures. Some of the dysplastic islands showed central necrosis resembling comedonecrosis. Focal areas of the tumour cells showed cytoplasmic clearing. The associated connective tissue was fibrovascular and scanty. The histopathological features were suggestive of infiltrating poorly differentiated adenocarcinoma (Figure 4). The tissue specimens were sent for immunohistochemistry (IHC) for confirmatory diagnosis. IHC evaluation showed that tumour cells were positive for cytokeratin (Pan CK) and specifically for CK7 while showing negative results for oestrogen receptor (ER), human epidermal growth factor receptor (HER)-2, GATA binding protein (GATA) 3, and thyroid transcription factor (TTF)1.\\nAfter excision of the gingival enlargement, a PET scan was done which revealed extensive Fluorodeoxyglucose (FDG) avid metastases in the brain, lung, liver, pancreas, nodes, subcutaneous and intramuscular soft tissue nodules, and sacrum (Figure 5). FDG avid lesions in both breasts were also seen. Compared with the previous PET-CT, the reports suggested progression of the disease. The patient was started on chemotherapy:Eribulin in view of disease progression. Unfortunately, fourteen months after the detection of the primary breast cancer tumour the patient passed away.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 84,\n",
       "    'case_id': 'PMC5623757_01',\n",
       "    'case_text': \"An 84-year-old patient with a history of Parkinson's disease was admitted to the cardiology ward because of chest pain. The day after admission, the patient complained of shaking limbs, for which the neurologist was consulted. Neurologic examination showed a pronounced negative myoclonus (Video 1). Laboratory examination including electrolytes, liver and renal function, thyroid function, glucose, and arterial blood gas was performed, showing no abnormalities. The patient had been using ciprofloxacin 500 mg twice a day for 5 days for a urinary tract infection. The ciprofloxacin was discontinued after which the negative myoclonus disappeared within 1 day.\\nNegative myoclonus is characterized by a brief sudden loss of muscle activity in agonist muscles followed by a compensatory jerk of the antagonistic muscles, appearing as involuntary jerky movements. Negative myoclonus may be of cortical or subcortical origin. Cortical negative myoclonus may be caused by epilepsy syndromes and a variety of acquired factors, such as focal brain lesions. Subcortical myoclonus occurs mainly in toxic-metabolic encephalopathy, caused by electrolyte disturbances, liver and respiratory failure or several drugs. To our knowledge, negative myoclonus has not been previously described in association with the use of ciprofloxacin. However, several neurotoxic effects have been associated with the use of quinolones, including seizures, extrapyramidal manifestations, and positive myoclonus. The hypothesized mechanism of the neurotoxicity is inhibition of gamma-aminobutyric acid (GABA-A) receptors and activation of excitatory N-methyl-D-aspartate (NMDA) receptors, leading to a toxic encephalopathy. Patients with prior central nervous system disease, such as Parkinson's disease, impaired renal function, and advanced age may be particularly vulnerable.\\nIn patients with negative myoclonus, laboratory examination and medication evaluation should be performed to identify the underlying cause. The differential diagnosis of negative myoclonus includes positive myoclonus and tremor. Electrophysiology can assist with determining this; however, this was not performed in our patient. The treatment includes correction of electrolyte disturbances or, like in our case, cessation of the provocative drug. If the negative myoclonus persists, neuro-imaging and/or emergent EEG may be useful to analyze other causes. If necessary, benzodiazepines such as clonazepam or anti-epileptic drugs can be administered to suppress the symptoms.\",\n",
       "    'gender': 'Unknown'}],\n",
       "  [{'age': 8,\n",
       "    'case_id': 'PMC6095991_01',\n",
       "    'case_text': \"A forty-eight year-old, right-handed female was admitted for gait disturbance and unusual movement of the left hand. She was treated for fever and cough before hospitalization. While her fever abated immediately, she had balance problems in walking and standing. Her past medical history was uneventful and there was no family history of optic neuritis, myelitis or NMOSD. She was alert and had no abnormal physical findings. On neurological examination, there was no weakness in muscles and no sensory disturbance, but she had uncoordinated movement in her both lower limbs in performing heel-knee test, and her gait was wide-based, and could not perform a tandem gait test. Neuropsychological examination revealed signs of the following corpus callosal disconnection syndromes: diagonistic apraxia, tactile anomia in the left hand, crossed tactile disorientation, crossed optic ataxia, alexia of the left visual field, auditory extinction of the left ear.\\nWith diagonistic apraxia, she experienced bizarre movements in her left hand while changing her clothes and having meals. When taking a meal, her left hand involuntarily grabbed her rice bowl, while her right hand was selecting and picking food from a dish with chopsticks. The errant hand came under control when reprimanded verbally.\\nIn laboratory testing, erythrocyte sedimentation rate was elevated 30 mm/1 h and 48 mm/2 h. Anti-aquaporin 4 (AQP4), Anti-Sjogren's syndrome-related antigen A (anti-SS-A), anti-SS-B, and anti-Mycoplasma pneumoniae-IgM antibodies were positive. Cerebrospinal fluid findings were lymphocytosis (9/muL), elevated protein content of 52 mg/dL, elevated myelin basic protein level of 1221.5 pg/mL (normal <102 pg/ml) and elevated IgG index of 0.9 (normal <0.8). The oligoclonal bands were negative. Her chest X-ray and CT examinations were normal.\\nBrain MRI showed high-signal intensities of the entire corpus callosum from genu to splenium (Figures 1A,B). The lesions on the corpus callosum were a mixture of patchy low and high-intensity signals. She had prodromal infection, elevation of cells and myelin basic protein in cerebrospinal fluid, and lesions in the corpus callosum on brain MRI. Multiple sclerosis, NMOSD, acute disseminated encephalomyelitis, clinically mild encephalitis/encephalopathy with a reversible splenial lesion due to mycoplasma infection or vasculitis were considered as differential diagnoses. Because Anti-AQP4, anti-SS-A, and anti-SS-B antigens were positive and salivary gland biopsy revealed inflammatory cell infiltration with lymphocytes and plasma cells, the patient was diagnosed with anti-AQP4-seropositive NMOSD with SS.\\nAfter intravenous steroid pulse therapy (1,000 mg of methylprednisolone for 3 days) was performed twice and the following symptoms improved; ataxia of the legs, unsteadiness in standing and walking, callosal disconnection syndromes such as left-hand diagonistic apraxia, left hand tactile anomia, crossed tactile disorientation, crossed optic ataxia, and left-visual field alexia. However, the patient's corpus callosum lesion was still edematous on MRI, and auditory extinction of left ear remained. Intravenous immunoglobulin (IVIg) was begun on day 21 for 5 days but changed little. She was discharged on day 40 with subsequent treatment of tapered prednisolone at 40 mg/day. Azathioprine 100 mg was also added. One year later the left-field alexia disappeared. A mottled signal inside the corpus callosum also remained (Figures 1C,D).\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': None,\n",
       "    'case_id': 'PMC6580008_01',\n",
       "    'case_text': 'A 83-old lady, a known case of pulmonary emphysema, presented to our hospital with right upper quadrant pain evolving since 3 days. On clinical examination, the patient was febrile, hemodynamically stable, with tenderness in the right upper quadrant and a palpable tender gallbladder. Laboratory tests showed leukocytosis (WBC-16000 cell/ mm3) and liver function tests were normal.\\nThe abdominal ultrasonography revealed a distended gallbladder with thickened edematous wall and surrounding loculated ascites. No gallstones were seen and the intrahepatic and extrahepatic bile duct were not dilated. Abdominal computed tomography (CT) revealed the presence of a distended, floating gallbladder measuring 12.2 x 8.2 x 7.6 cm located outside its normal fossa with thickened non-enhancing wall and a twisted pedicle (Fig. 1).\\nThe diagnosis of acute cholecystitis complicating gallbladder volvulus was made. Intravenous\\nfluid, broad spectrum antibiotics and analgesics were administrated followed by emergency laparotomy via right subcostal incision, the laparoscopic approach was refused by the anesthetist due to the history of pulmonary emphysema. At surgery, a distended gangrenous gallbladder was found. The gallbladder was completely rotated anticlockwise (360 ) around the cystic artery and the cystic duct (Fig. 2). After untwisting, it was found that the gallbladder had a complete long mesentery held closely to the liver (Fig. 3). Cholecystectomy was performed and suction drain was placed in the right subhepatic space. The postoperative course was uneventful. Histology revealed transmural gallbladder necrosis.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 69,\n",
       "    'case_id': 'PMC9098366_01',\n",
       "    'case_text': 'A 69-year-old male patient presents with a chief complaint of neck pain of several weeks, radiating to the head and right shoulder. The pain is reported to be intermittent, burning in quality, associated with weakness and numbness especially in the right hand. The patient has a past medical history of hypertension, hyperlipidemia, benign prostatic hyperplasia, DVT/pulmonary embolus in the past year for which he is on anticoagulant therapy, and a surgical history of bilateral knee replacement within the past two years. The patient has no history of neurofibromatosis or stigmata of another genetic disorder. Upon physical examination, the patient has right hemiparesis (-4/5) that has mildly progressed compared to prior examination. MRI of the cervical spine (performed at an outside institution) reveals a T1 hypointense and T2 heterogeneously hyperintense extramedullary mass causing impingement upon the right side of the spinal cord which is flattened and displayed to the left at the C2-C3 level. The mass measures approximately 35 mm in transverse diameter by 13 mm in AP diameter by 18 mm in craniocaudal diameter and laterally extends through the right C2-C3 neural foramen. The radiologic impression is that of a nerve sheath tumor of either benign or malignant nature (no images available). Surgery is recommended, and the patient undergoes a C2-C3 laminectomy at an outside institution with resection of the tumor. Intraoperatively, the tumor is seen on the right side of the canal with the cord. Dorsolaterally, the tumor appears to blend in with the dura at its base. The junction is coagulated with bipolar cautery. Then, some of the tumor is debulked along the base, allowing it to shrink away from the cord laterally. Working around the superior pole of the tumor then reveals rootlets that appear to be joining the tumor to the right superior pole along its posterior aspect. Attempting to dissect to release it reveals that the rootlets were not just adherent to the capsule but rather growing into the tumor. The rootlets are hence cauterized and amputated at base. The tumor is removed in piecemeal fashion, and the tissue is sent to pathology. Grossly, the specimen consists of multiple pieces of light tan, firm tissue measuring in aggregate (2.0 x 1.6 x 0.3 cm).\\nThe slides are sent to our institution for review. Microscopic examination reveals fragments of a benign nerve sheath tumor comprised of Schwannian cells arranged in loose fascicles set in an eosinophilic stroma with occasional hyalinized vessels and Verocay bodies, compatible with Schwannoma (Figures 1(a) and 1(b)). Also present was a small separate fibrous fragment with psammomatous calcifications and vaguely nested bland spindled to ovoid cells with focal crush artifact (Figure 2(a)). No necrosis or mitotic figures are identified. Immunohistochemical stains are performed and show that the tumor cells are diffusely positive for S100 and SOX-10 in the Schwannoma component (Figures 1(c) and 1(d)). The small fibrous fragment, on the other hand, is negative for SOX-10 (Figure 2(b)) and shows weak staining for S100 while PR and CD34 show patchy weak staining and EMA and SSTR2A are positive (Figures 2(c) and 2(d)) thus compatible with a meningothelial origin. HMB-45, Melan A, and STAT6 are negative.\\nThe overall histopathological and immunohistochemical findings are compatible with Schwannoma with a small focus of benign meningothelial proliferation compatible with benign meningothelial hyperplasia. MRI with and without contrast performed three months after the surgery shows postoperative changes of subtotal resection of the enhancing mass centered about the right C2-C3 foramen, with a residual 21 x 10 x 16 mm (axial long axis x axial short axis x craniocaudal) right neural foraminal mass and significant improvement in the spinal cord compression. At six month postsurgery, MRI demonstrates improved postsurgical changes with redemonstration of the residual spinal enhancing mass at the right C2-C3 neural foramen extending into the spinal canal with minimal mass effect on the spinal cord on the right aspect of the cord at this level. No further available clinical data could be obtained due to the patient being lost to follow-up.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 28,\n",
       "    'case_id': 'PMC8636095_01',\n",
       "    'case_text': \"A 28-year-old pregnant woman, 12 gestational weeks in July 2019, attracted our attention for recurrent abortions, as well as being strongly positive of anti-SSA /Ro and antinuclear antibodies, suspected fetal autoimmune associated AVB without cardiac structural abnormality.\\nThe first pregnancy of this woman was in March 2017 but it resulted in a spontaneous abortion at 50+ days of pregnancy. Her second pregnancy in February 2018 was a biochemical pregnancy. Subsequently, a thyroid function test suggested hypothyroidism and was successfully treated by oral thyroxine. Whereas, strongly positive antinuclear antibody (granular type) with a titer of 1:1,000 (normal reference value is negative) and anti-SSA/Ro antibody with a quantitative >400 RU/ml (normal reference range 0 to <20 RU/ml) of the patient was revealed and was diagnosed of undifferentiated connective tissue disease by entomologist, and was given hydroxychloroquine (200 mg, twice a day), tacrolimus (500 mg, twice a day), and low-dose methylprednisolone (4 mg, once a day). Except for repeated abortions, the patient had not complained of photosensitive rash, thrombosis, joint pain, and arthritis, Raynaud's phenomenon, xerophthalmia, or xerostomia.\\nThe patient was pregnant the third time in July 2019, and the re-examination of autoantibodies revealed antinuclear antibody-positive (particle type) with a titer of 1:320; anti-SSA/Ro antibody-positive with a quantitative >400 RU/ml. As the pregnancy progressed, monitoring the patient's serum antibody revealed that the anti-Sm antibody gradually became positive (>400 RU/ml, the normal reference range 0 to <20 RU/ml), but there was still no clinical sign of connective tissue disease. Hydroxychloroquine (200 mg, twice a day), tacrolimus (500 mg, twice a day), and low-dose methylprednisolone (4 mg, once a day) continued.\\nThe patient was transferred to our hospital due to recurrent abortion and undifferentiated connective tissue disease by a local obstetrician and endocrinologist. Considering that the first two pregnancies of the patient were both early miscarriages, it is still uncertain whether there exited fetal immune heart injury in the first two pregnancies, and they might be probands of fetal immune heart damage to this pregnancy. Existing epidemiological studies suggest that the risk of fetal AVB will be significantly increased in a pregnancy with a previously affected fetus or neonate, and the role of fetal genetic susceptibility in the development of autoimmune:associated fetal AVB cannot be ignored. Therefore, we classified this pregnancy as a high-risk pregnancy of cardiac immune attack. During the whole pregnancy, the fetal AV interval and maternal serum autoantibody titers were regularly monitored. The mother was generally in good physical condition during pregnancy and no abnormal findings in the ECG and echocardiogram examinations.\\nAt 12 weeks of gestation, we monitored the fetal echocardiogram and found that there exited strong light points about 2 mm in diameter in the left ventricular, as well as enhanced endocardial echo image, which indicated that the fetal heart might exit a certain degree of immune injury. At the same time, the fetal echocardiogram monitoring indicated that the AV interval was within the normal range (104-112 ms). Considering the relatively high incidence of fetal heart immune-mediated cardiac conduction injury in pregnancies that suffer from immune-mediated fetal congenital heart block, avoiding the occurrence of miscarriage or stillbirth, and potential fetal AVB, dexamethasone and intravenous immunoglobulin (IVIG) were treatment options according to the treatment regimens reported in previous literature.\\nAfter fully understanding the advantages and disadvantages of dexamethasone and IVIG, the patient determined to adopt IVIG treatment (Chengdu Rongsheng Pharmaceutical Co., LTD., 2.5 g, 50 ml/bottle). According to the characteristics of IVIG, and the reported usage in the literature, the patient received IVIG 1 g/kg twice a week at 12 and 13-week of pregnancy, respectively. Encouragingly, in a reexamination of the fetal echocardiogram, the enhanced echoes and endocardial echo enhancement of the left ventricle gradually disappeared, and the AV interval was normal without a tendency of prolongation. Meanwhile, the maternal serum antibody titers showed a downward trend after receiving IVIG (Table 1).\\nThen, the frequency of IVIG treatment was adjusted to once every 2 weeks, 1 month later, regarding fetal stable condition, and then adjusted once a month. However, at 25 + 6 weeks of gestation, a gradual prolongation of the AV interval was observed, increasing from 106 ms to 130-140 ms. Although the AV interval was still within the normal range, the rapidly extending within 1 week was urgent. In order to avoid progressive prolongation of the fetal AV interval, we upregulated the frequency of IVIG treatment to once every 3 weeks based on the half-life of immunoglobulin in human circulation (21 days). After adjusting the frequency of IVIG treatment, the AV interval of the fetal heart gradually returned to the previous condition. The last IVIG dosage was given at 33 + 6 GW. The fetal condition during pregnancy and maternal serum antibody level are shown in Table 1, and the use of IVIG is shown in Figure 1.\\nFetal echocardiography was regularly performed until successful delivery, and there were no signs of fetal arrhythmia and/or cardiac malformations. Cesarean section was performed at 39 weeks of gestation and a male newborn was born with a birth weight of 2,940 g. The amniotic fluid was clear at birth, the Apgar score was 10 points, and there were no abnormalities in the placenta or expectation.\\nThe newborn underwent a comprehensive physical examination after delivery and received blood routine tests, thyroid function tests, and echocardiography examination 3 days after being born, all showed within normal range. The electrocardiogram of the newborns was also performed on the first day after birth, and the results were normal with a PR interval of 104 ms, as well as the Holter monitoring. Meanwhile, the serum autoantibody examination of the baby showed positive results of anti-Sm antibodies (quantitative >400 RU/ml), anti-SSA/Ro antibodies (quantitative 148.7 RU/ml), and antinuclear antibodies (titer 1:100).\\nAt 1-, 3-, 6-, 12-, 18-month follow-ups, the growth and development, ECG, and echocardiography of the baby were normal. Additionally, all the serum antibody titers also turned negative at 3- or 6-month of follow-up (Table 2).\\nDuring the post-partum period, the mother remained asymptomatic and showed no signs of aggravation of the disease. The monitoring of maternal serum autoantibody level within 6-month follow-up indicated a gradual decline. While the recent laboratory tests showed that anti-Sm antibodies with quantitative >400 RU/ml, anti-SSA /Ro antibodies with quantitative 282.2 RU/ml, and antinuclear antibodies with titrum 1:320.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 65,\n",
       "    'case_id': 'PMC4247007_01',\n",
       "    'case_text': 'In January 2013, a 65-year-old male presented to Korea University Anam Hospital (Seoul, Republic of Korea), with an intra-abdominal mass that was localized to the right side. The mass had presented one month previously. In addition, the patient had experienced weight loss (5 kg) during the previous four months. The medical history was unremarkable, with the exception of pulmonary tuberculosis 30 years previously, from which the patient had recovered. On physical examination, a round mass was palpated and there was tenderness of the right upper quadrant area. Hematological examination revealed a marginal decrease of hematocrit (35.8%; normal range, 37-51%) and hemoglobin (11.8 g/dl; normal range, 12.6-17.4 g/dl). Liver function tests revealed elevated alkaline phosphatase (423 IU/l; normal range, 30-120 IU/l) and gamma-glutamyl transferase (587 IU/l; normal range, 9-64 IU/l) levels. Aspartate aminotransferase, alanine aminotransferase and bilirubin levels were within the normal ranges of 3-45 IU/l, 3-45 IU/l and 0.0-0.4 mg/dl, respectively. An upper gastrointestinal endoscopy revealed a subepithelial mass with a fistulous hole on the second portion of the duodenum (Fig. 1). A total colonoscopy revealed no abnormalities. A computed tomography (CT) scan, which was acquired from the referring local clinic (Choi Kang Sik Internal Medicine, Seoul, Republic of Korea), demonstrated a large, heterogeneously enhanced lobulated mass (11.5x9.3 cm; longest diameter x greatest perpendicular diameter) with internal necrosis at the pancreaticoduodenal groove (Fig. 2A). The internal cavity of the mass was connected to the second portion of the duodenum, which was consistent with the endoscopic findings. Furthermore, an ill-defined low-attenuation lesion was identified at segment eight of the liver, abutting the bile duct and hepatic artery (Fig. 2B). Significantly enlarged lymph nodes were not observed in the abdominal cavity. In addition, a fludeoxyglucose positron emission tomography (FDG-PET) scan also revealed hypermetabolic masses in the duodenal groove and in segment eight of the liver, which was consistent with the CT scan. Abdominal MRI (magnetic resonance imaging) was also conducted for further characterization of the duodenal and hepatic masses observed on the CT scan, which confirmed the same findings. An ultrasound-guided needle biopsy of the duodenal mass was performed and pathological examination identified whirling sheets of spindle-shaped cells (Fig. 3A). Immunohistochemical staining was positive for c-Kit, but negative for cluster of differentiation 34, S-100 and desmin (Fig. 3B). Mitotic features could not be evaluated, as a surgically excised sample was not obtained. The diagnosis of high-risk GIST with hepatic metastasis was determined and the patient was treated with 400 mg imatinib, daily. The treatment was tolerated well, and the abdominal mass and distension improved significantly. After seven weeks of treatment, the follow-up abdominal CT scan revealed that the duodenal mass had significantly reduced in size (7.9x6.5 cm; longest diameter x greatest perpendicular diameter) and exhibited an increased area of internal necrosis. However, the hepatic mass had increased from 1.7x1.5 cm to 3.9x3.2 cm in diameter (longest diameter x greatest perpendicular diameter) and the right hepatic duct was markedly dilated by the mass (Fig. 4). Various enlarged lymph nodes were observed in the left gastric area, including the porta hepatis and portocaval space. The ultrasound-guided needle biopsy was repeated for the hepatic mass and histopathological examination of the biopsy specimen showed malignant cells with a glandular structure, which was consistent with adenocarcinoma. Immunohistochemical analysis exhibited c-Kit-negative and cytokeratin 19-positive staining (Fig. 5). The final diagnosis was synchronous ICC and GIST. Two weeks after the ultrasound-guided liver biopsy, the patient developed jaundice and a fever, and the total level of bilirubin increased rapidly to 9.4 mg/dl (normal range, 0.0-0.4 mg/dl). Percutaneous transhepatic biliary drainage was conducted along with antibiotic treatment and administration of imatinib was withheld to allow the patient to recover from the condition. An abdominal CT scan following three weeks of conservative treatment revealed an increase in size of the liver mass (5.3x3.9 cm; longest diameter x greatest perpendicular diameter) with portal vein thrombosis, and the size of the duodenal mass had also increased to 9.5x8.7 cm (longest diameter x greatest perpendicular diameter). The treatment regimen became focused towards the ICC, which was associated with a poorer prognosis. Due to the well-known toxicity of combined chemotherapy, administration of imatinib was terminated and the patient was treated with intravenous gemcitabine (100 mg/m2 for 30 min, days 1 and 8) and cisplatin (25 mg/m2 for 1 h, days 1 and 8) every three weeks for four cycles. During chemotherapy, the abdominal mass reappeared, as a follow-up CT scan, performed six weeks following treatment, revealed a prominent increase in the size of the duodenal mass (10.7x10 cm; longest diameter x greatest perpendicular diameter). However, the hepatic mass did not demonstrate a significant change in size during that interval. As the patient had tolerated the initial chemotherapy well, combined chemotherapy (consisting of imatinib, gemcitabine and cisplatin) was initiated for symptom control and treatment of the GIST. The addition of imatinib resulted in the duodenal mass decreasing significantly and the patient exhibited a good response to the treatment. However, certain toxicities are associated with combined chemotherapy, such as grade 1 bone marrow suppression, as observed in the present case. The follow-up CT scan revealed disease progression of the ICC, whereas the size of the GIST mass had decreased. The treatment modality was altered, due to refractory cholangiocarcinoma, from chemotherapy to radiation therapy (daily dose of 180 Gy), whilst maintaining the imatinib treatment. To date, the patient has been undergoing treatment for one year and is tolerating the treatment well.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 55,\n",
       "    'case_id': 'PMC9047901_01',\n",
       "    'case_text': \"A 55-year-old male underwent thoracoscopic-assisted small-incision radical resection of lung cancer in October 11, 2017 after diagnosis of lung adenocarcinoma (stage pT1bN0M0, IA) ( Figure 1 ). His postoperative regular magnetic resonance imaging (MRI) and computerized tomography (CT) examinations showed no obvious abnormalities. Two years later (on October 12, 2019), the patient started to experience headache, blurred vision, and hearing loss. On October 31, 2019, his brain MRI exam showed multiple brain masses including multiple metastases in the lateral ventricle, right frontal lobe, and cerebellar hemisphere ( Figure 2A ). His genetic testing revealed the L858R mutation in exon 21 of EGFR. His positron emission tomography (PET) CT scan suggested bone metastasis ( Figure S1 ). The patient was then treated with osimertinib (80 mg oral administration daily), bevacizumab (7.5mg/kg q3w), and bisphosphonate (4mg q3w). After treatment for 1 month, his symptom of headache almost disappeared, but he developed blurred vision and unstable walking on both feet. On 2020-1-4, the patient complained increased blurred vision and occasional headache. On 2020-4-21, his brain MRI ( Figure 2B ) showed multiple dot-line enhancements (masses) in the cerebellar sulci, suggesting meningeal metastasis. On 2020-4-30, the patient underwent cerebrospinal fluid (CSF) cytology examination and cancer cells were found in the cerebrospinal fluid, which was in line with the characteristics of adenocarcinoma cells ( Figure 2C ). His CSF genetic testing results in May 2020 showed that mutations were EGFR p.L858R, TP53 p.R273C and ERBB2 p.S442L ( Figure 3A ). The patient was then treated with whole brain radiotherapy (40Gy/20 fractions). Between July 2020 and December 2020, the patient was treated with osimertinib (80 mg oral administration daily), anlotinib (12mg d1-14, q3w), pemetrexed (500mg/kg q4w), and temozolomide (300mg d1-5, q4w). Then, the patient experienced less headache. The re-test of the CSF samples showed that the mutations included EGFR p.L858R, TP53, ERBB2, and others (October 28, 2021). ( Figure 3A ). In January 2021, due to the continued elevated levels of tumor marker carcinoembryonic antigen (CEA) in his CSF ( Figure 3B ) and based on his CSF genetic test results, his treatment was switched to dacomitinib (30mg po qd), olaparib (100mg po bid), anlotinib (8mg po d1-14,q3w), pemetrexed (500mg/m2, q3w), and temozolomide (200mg/m2 d1-5, q4w). The patient's condition was stable after adjusting the treatment plan. His level of CEA was stable ( Figure 3B ), and his brain MRI showed no progression of the brain metastasis. The efficacy evaluation during the treatment period is shown in  Figure 4 . In addition, after switching to targeted therapy, the patient no longer experienced obvious headache and dizziness, and his quality of life was significantly improved. Although he had the 2nd degree bone marrow suppression, there was no obvious functional damage of the liver and kidney during the process of treatment. The patient died of cachexia caused by the tumor in June 2021. Based upon, targeted drug therapy helped this patient obtain 6 months of progression-free survival (PFS). After the diagnosis of CNS metastases, although he was no longer sensitive to osimertinib, his overall survival reached 13 months which might be benefited from the treatment of olaparib in combination with dacomitinib.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 59,\n",
       "    'case_id': 'PMC7175777_01',\n",
       "    'case_text': \"A 59-year-old man who presented with fever, headache, and awkward speech which specifically manifested as slow and unclear speech, was admitted to the hospital. He denied recent infections such as flu or gastroenteritis, travel, and other possible reasons, which could be responsible for the fever, which peaked at 39.5 C. Previous medical history revealed gout for 20 years, but no drugs were prescribed. His neurological examination and cranial computed tomography (CT) and magnetic resonance imaging (MRI) (Figure 1) scans were normal. EEG results showed minor irregularities in waves (5-20 muv 14-20 Hz beta) emitted from the bilateral hemispheres. Blood routine, C-reactive protein, serum vitamin B12, and folic acid, as well as other autoimmunity makers containing antinuclear antibody (ANA), anti-neutrophil cytoplasmic antibodies (ANCA), and rheumatoid factors were all unremarkable. The cerebrospinal fluid (CSF) showed an increased white blood cell (WBC) count (104 x 106/L, reference range 0-8 x 10^6/L) and elevated protein levels (1.68 g/L, reference range 0.15-0.45 g/L). Culture, smear, and bacterial, fungal, viral, and tubercle bacillus antibodies in the serum and CSF were negative. He was diagnosed with viral encephalitis and treated with antiviral agents. His symptoms eased within a week and he was discharged from the hospital. Five months later, he was referred to our hospital again due to a fever of 38.5 C and occasional sentence confusion. Another lumbar puncture was performed; the CSF had a WBC count of 39 x 10^6/L and the protein content was 1.32 g/L. The cranial MRI and laboratory test findings were almost normal except for decreased thyroid function and increased anti-thyroid autoantibody (ATA) levels in the serum and CSF. The initial findings were as follows: in the serum, the thyroid stimulating hormone (TSH) concentration was 43.39 uIU/ml (reference range (RR): 0.27-4.2 uIU/ml), free triiodothyronine (FT3) concentration was 2.89 pmol/ml (RR: 3.1-6.8 pmol/ml), free thyroxine (FT4) concentration was 7.18 pmol/ml (RR: 12.0-22.0 pmol/ml), total triiodothyronine (TT3) concentration was 1.17 pmol/ml (RR: 1.3-3.1 pmol/ml), and total thyroxine (TT4) concentration was 44.26 pmol/ml (RR: 66-181 pmol/ml); the titer of anti-thyroglobulin autoantibodies (TgAb) was 1274 IU/ml (RR: < 115 IU/ml) and the titer of anti-thyroperoxidase autoantibodies (TPOAb) was 600 IU/ml (RR: < 35 IU/ml). In the CSF, ATA was positive (TPOAb 17.06 IU/ml, TgAb 16.02 IU/ml). Ultrasound imaging indicated diffuse lesions of the thyroid. Antibody analysis of anti-NMDAR, AMPA1, AMPA2, LGI1, CASPR2, GABA, GAD, anti-Hu, Yo, Ri, MAI, MA2, CV2, Amphiphysin, SOX-1, Tr, Zic4, and GAD65, were all negative in both the serum and CSF. The patient was ultimately diagnosed with HE, Hashimoto's Thyroiditis, and hypothyroidism and prescribed methylprednisolone and Euthyrox. Methylprednisolone was started at a dose of 80 mg/day for 1 week and reduced to 40 mg/day in the 2 week; subsequently, oral prednisolone was prescribed, which was weaned at a rate of 5 mg per week, that is oral prednisolone was used for a total of 8 weeks. His symptoms were relieved in 3 days. The patient remained healthy during a follow up period of 1 year.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 57,\n",
       "    'case_id': 'PMC5494058_01',\n",
       "    'case_text': 'A 57-year-old man presented to the hospital with a two-month history of vague \"on-and-off\" abdominal discomfort. No associated symptoms such radiating pain, weight loss, hematuria, or change in bowel habits were reported by the patient. The patient\\'s medical, surgical, and family history were irrelevant. He also had no history of smoking. Physical examination revealed a soft lax abdomen with unremarkable systemic examination. The results of laboratory investigations, including a complete blood count, blood chemistry, serum urea, and urine analysis, were normal. An abdominal computed tomography (CT) scan showed a well-defined heterogeneous enhancing lesion measuring 2 x 1.5 cm located at the posterolateral upper pole of the left kidney. The lesion was in close proximity to the spleen. There was no evidence of hydronephrosis or kidney stones. The renal vein was patent. These findings suggested renal cell carcinoma (Figure 1). Two weeks later, the patient underwent left partial nephrectomy. The resected specimen was sent for histopathological analysis. Gross examination revealed a well-circumscribed but uncapsulated white-tan soft mass with homogenous cut surface measuring 2 x 1.5 x 1 cm located at the upper pole of the left kidney. The mass abutted but did not invade the renal capsule. No areas of necrosis were seen. No gross abnormality was observed in the rest of the renal parenchyma. Microscopic examination reveals a well-demarcated lesion composed of sheets of cells that were admixed with large, gaping, dilated cavernous-like spaces filled with blood (Figures 2(a) and 2(b)). These cells are monotonous, small, and round to oval, each containing a moderate amount of eosinophilic to amphophilic cytoplasm (Figures 2(e) and 2(f)). No pleomorphism was present. There was no evidence of necrosis (Figure 2(c)) or increased mitotic activity of more than 2/50 high-power field (HPF) (Figure 2(d)). No atypical mitosis was seen. High-power examination showed small nuclei with fine chromatin (Figure 2(f)) and smooth nuclear membrane embedded in a myxoid stroma (Figures 2(g) and 2(h)); other adjacent areas revealed hyalinized stromal reaction (Figure 2(d)). Capsular and lymphovascular invasion were not observed. Tumor cells showed diffuse and strong positivity for smooth muscle actin (alpha-SMA) (Figure 3(a)), vimentin, and pericellular net-like positivity for collagen type IV (Figure 3(b)). The tumor was negative for cytokeratins 7 and 20, RCC antigen, cluster of differentiation (CD10), epithelial membrane antigen (EMA), desmin, CD34, CD117, CD 99, synaptophysin, chromogranin, S100, renin, Melan A, and human melanoma black-45 (HMB-45). Periodic acid-Schiff (PAS) stain failed to reveal any cytoplasmic granules in any of the examined cells. CD31 and CD34 highlighted the vascular spaces and capillary network only. Ki67 index was less than 2%. Altogether, histopathology and immunohistochemical revealed findings consistent with primary glomangioma (glomus tumor) of the kidney. One year after surgery, a follow-up examination revealed that the patient was doing well and no tumor recurrence and/or metastasis was detected.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 12,\n",
       "    'case_id': 'PMC6282132_01',\n",
       "    'case_text': \"A 12-year-old female with SW-CAH presented to the pediatric endocrinology clinic for routine follow-up. She was diagnosed with SW-CAH in the newborn period after presenting with ambiguous genitalia and was treated with supraphysiologic hydrocortisone divided three times daily throughout her life (prepubertal dosing range 10-15 mg/m2/day, pubertal dosing range 15-25 mg/m2/day), as well as fludrocortisone (0.1 mg daily). She was monitored every 3-4 months with clinical examinations, growth parameters, and serum measurements of 17-hydroxyprogesterone (17-OHP), androstenedione, and testosterone (Esoterix Laboratory, Calabasas Hills, CA), which together guided her medication dosing. She had no evidence of glucocorticoid excess and her growth velocity was normal, without evidence of acceleration or suppression. She and her parents reported continued excellent compliance with her medication regimen.\\nAt age 12 3/12 years, she reported 3 recent emergency department visits for persistent vomiting without diarrhea, abdominal pain, inability to tolerate oral steroids, and tachycardia. One of the episodes was accompanied by fever >39 C. There was no hypotension during any of these episodes, but heart rates were elevated ranging from 124 to 154 beats per minute. Sodium and potassium were normal: Na 137-140 meq/L (reference range, 133-143 meq/L) and K 3.6-4.1 meq/L (reference range 3.4-4.7 meq/L). Each episode was treated with normal saline boluses and intravenous stress dose steroids, and treatment led to immediate improvement in symptoms. She was discharged from the emergency department with recommendations for stress dose steroids by mouth. Over the prior 9 months, she had also unintentionally lost 2.6 kg and had an accelerated annualized growth velocity of 10.6 centimeters per year. BMI was 15.4 kg/m2 (Z-score -1.38). She denied any heat intolerance, jitteriness, palpitations, sweating, diarrhea, or vision complaints. While in clinic, her resting pulse was elevated at 136 beats per minute and blood pressure was normal. She was noted to have new symmetric thyromegaly without nodules. She had no lid lag or stare. She was in mid-puberty, with tanner 3 breasts. There was no family history of autoimmune disease or thyroid disease. Labs (Table 1) showed a suppressed TSH, and an elevated free T4 and Total T3. Thyroid antibodies were consistent with Graves' disease, with a thyroid stimulating immunoglobulin (TSI) of 652% (reference range <140%). She had no prior thyroid studies for comparison. Adrenal androgens were markedly elevated with 17-OHP 11,600 ng/dl (reference range 11-155 ng/dl, target <1000 ng/dl in SW-CAH). At a clinic visit 15 weeks prior to this evaluation, her 17-OHP on the same dose of hydrocortisone (25 mg/m2/day) was improved at 639 ng/dl. She was initiated on methimazole 0.5 mg/kg/day. Her hydrocortisone dose was not changed and remained at 25 mg/m2/day. Four weeks later, repeat labs demonstrated normal free T4 with mildly suppressed TSH and normal total T3. 17-OHP was stable at 717 ng/dl (Figure 1). She had no further vomiting episodes after initiation of methimazole, and her tachycardia resolved.\\nThree months after treatment began for Graves' disease, her TSH and free T4 were in the reference range, and methimazole was decreased to 0.3 mg/kg/day. Repeat 17-OHP was low at 33 ng/dl, indicating suppression on the unchanged hydrocortisone dose of 25 mg/m2/day. Her hydrocortisone dose was decreased to 21 mg/m2/day.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 41,\n",
       "    'case_id': 'PMC6609725_01',\n",
       "    'case_text': \"A 41-year-old Caucasian woman presented to the emergency department with four day history of intermittent non-specific chest pain on a background of 30 pack years of smoking history. She also had a history of progressive exertional dyspnea for a few months and also loss of appetite during this presentation. She denied fever, cough, hemoptysis, pleurisy or coryzal symptoms. She had no significant past medical history, in particular, there was no history of diabetes and she was not on any regular medications. She had no significant occupational or travel history of significance. There was no history of exposure to tuberculosis. She was an avid gardener, residing in Darwin, Northern Territory of Australia. She usually walked barefoot in her garden and used large amounts of potting mix while gardening. She denied excessive alcohol consumption or recreational drug usage.\\nOn clinical examination, vital signs were normal. Respiratory examination was unremarkable, with normal breath sounds bilaterally and there were no crackles or rhonchi or pleural rub in particular. Cardiovascular examination was also normal. Systemic examination showed no evidence of clubbing, oedema, cyanosis or lymphadenopathy. Her ECG showed normal sinus rhythm without ischemic changes. Blood tests showed white cell count of 11.5 x 109/L with neutrophilia 7.9 x 109/L and CRP was 15 Mg/L, Serial troponins were negative. Liver function, electrolytes, renal function were within normal limits. Quantiferon gold test was negative. Pulmonary function showed FVC of 3.88 L, (97% predicted), FEV1 3.05 L (92% predicted), FEV1/FVC ratio 0.787 (96% predicted), DLCO 77% and TLC 4.75L (89% predicted). Chest X-ray showed an opacity in the right mid-zone (Fig. 1a). She underwent a CT scan of the chest, that showed a mass in the right lower lobe measuring approximately 36 x 22mm suspicious of malignancy. There was no endoluminal bronchial lesion nor mediastinal or hilar lymph node enlargement. (Fig. 1b). Due to the high index of suspicion of lung malignancy, a PET-CT was performed, which demonstrated mild to moderate FDG avidity of the mass in the right lower lobe (Fig. 2a) but no other FDG avid nodal or distant metastatic disease. The patient underwent flexible bronchoscopy that showed no endobronchial lesion, then using the Endobrochial radial Ultrasound (EBUS) probe and utilizing the Guide sheath technique, the lesion was localized in the posterior segment of the right lower lobe. The EBUS images (Fig. 2b) demonstrated a heterogeneous lesion with non-compressed blood vessels and scattered air space shadows. Brushings, biopsies and washings were taken from the guide sheath, along with a transbronchial cryobiopsy from the same site identified by the ultrasound probe. The EBUS-guided biopsy of the lesion showed necrotic tissues and malignant cells were not identified. Culture of bronchial brushings on Ashdown's agar medium, however, grew bacterial colonies which were identified microscopically as gram negative bacilli. Bacterial culture from bronchial brushings was subsequently confirmed as Burkholderia pseudomallei, making the diagnosis of pulmonary melioidosis (Fig. 3). She was treated with intravenous ceftazidime 2 g 6 hourly for 4 weeks, followed by oral sulphamethoxazole/trimethoprim (800mg/160mg) 2 tablets twice a day for 3 months with daily folic acid 5mg. During the follow up visits, the patient demonstrated significant improvement both clinically and radiologically. Her CRP was noted to be < 0.1 Mg/L consistently, with normal white cell and neutrophil counts. Her exertional dyspnea was considered to be related to early airway disease secondary to smoking, possibly aggravated in the presence of pulmonary melioidosis and she was provided with support for smoking cessation.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 7,\n",
       "    'case_id': 'PMC4397003_01',\n",
       "    'case_text': 'A 7-year-old girl reported to our hospital with a complaint of pain and swelling in the mandibular left posterior region for one month. The patient gave a history of bleeding from the swelling, which was aggravated upon brushing and chewing. The past medical and dental history were noncontributory. Clinical examination revealed a solitary, well defined, soft tissue growth on the posterior gingiva measuring about 2.5 x 1.5 cm, extending from the lingual and distal aspect of 36 to posteriorly 1 cm short of the anterior border of the ramus. The growth was sessile, dark red in colour, firm in consistency, tender on palpation, and nonfluctuant (Figure 1). Based on the history and clinical presentation a provisional diagnosis of pyogenic granuloma was made. The orthopantomograph showed no bony involvement (Figure 2). The initial clinical differential diagnosis included traumatic fibroma, peripheral giant cell lesion, neurofibroma, schwannoma, and hemangiopericytoma. Excisional biopsy was performed under local anaesthesia.\\nHistopathological examination revealed anastomosing squamous surface epithelium with elongated rete ridges. The tumor was composed mainly of streaming and interlacing fascicles of spindle-shaped cells resembling fibroblasts or smooth muscle cells, suggesting myofibroblastic differentiations (Figure 3), and a few mitotic figures. In some areas, the lesional cells appeared to be round or polygonal and closely packed (Figure 4). The findings were suggestive of myofibroma but a definitive diagnosis was warranted. Additional serial sections were obtained for immunohistochemical studies.\\nImmunohistochemistry showed a positive reaction in the tumor cells for alpha-smooth muscle actin (alpha-SMA) (Figure 5) but no immunoreactivity for antibodies directed against CD34 (Figure 6). We would have also done IHC for smooth muscle-specific myosin, in order to rule out leiomyoma, which would also be SMA-positive. It is still likely that the lesion is myofibroma, however. Based on the histopathologic and immunohistochemical features, a diagnosis of myofibroma involving the left gingiva was made.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 33,\n",
       "    'case_id': 'PMC9898587_01',\n",
       "    'case_text': \"A 33-year-old female with a history of asthma presented after a witnessed out-of-hospital respiratory arrest leading to cardiac arrest. She had reportedly been experiencing shortness of breath and wheezing prior to her arrest. Resuscitative efforts were begun by bystanders and subsequently taken over by emergency medical services. The patient was intubated in the field and received intramuscular naloxone. She attained return of spontaneous circulation after about 15 min of cardiopulmonary resuscitation. Upon presentation to the hospital, the patient was still comatose, but her brainstem reflexes were intact. She was noted to have an esophageal intubation and was subsequently re-intubated. On secondary survey, she was found to have a bag of heroin in her sock. Toxicology screen was positive for fentanyl. Magnetic resonance imaging (MRI) of the brain was obtained at the time of admission and did not show any findings concerning for anoxic brain injury.\\nWithin 12 hours of resuscitation, while she was still comatose, the patient developed generalized, stimulus-sensitive myoclonic jerks involving her arms, legs, and trunk with relative sparing of her face. Her diffuse, violent jerks led her to develop rhabdomyolysis necessitating propofol infusion for symptom control and precluding her from being weaned off sedation for an accurate neurological assessment. EEG obtained on day 3 of hospitalization, while the patient was still sedated, showed diffuse anteriorly prominent alpha and beta activity and occasional periods of diffuse delta slow-waves and diffuse voltage suppression and lack of any cerebral reactivity to external stimuli. A number of diffusely distributed bilaterally synchronous spike and wave epileptiform discharges were also noted. Given her overall picture with relative paucity of findings on MRI of the brain despite significant clinical myoclonus and findings on EEG, an MRI of the cervical spine was obtained but showed no notable findings consistent with anoxic injury.\\nThe patient was started on ketamine infusion which, in addition to propofol, significantly improved her myoclonus. She was also started on valproate (1 g three times a day) and levetiracetam (2 g twice daily). By day 4-5 of her hospital course, the patient regained consciousness and was noted to have some improvement in her motor activity, though she continued to have significant stimulus-sensitive myoclonus. The patient was subsequently weaned off propofol and ketamine infusions. She was switched to clonazepam (2 mg three times daily) which, in addition to valproate and levetiracetam, significantly improved her symptoms, though she never achieved complete remission in her symptoms. Her neurological function gradually improved to the point where she was able to follow simple commands. Her sedation was weaned and the patient was subsequently extubated and transferred out of the ICU on day 11 of her hospitalization.\\nThe patient remained on clonazepam and levetiracetam. Valproate was discontinued two weeks into her hospital course due to concern for drug-induced transaminitis. She was switched to zonisamide (100 mg three times a day) and remained on this combination regimen for the next two weeks. Approximately one month into the patient's hospital course, she started to exhibit significant resting and intention myoclonus as well as dysarthria, not responding to the current treatment. She underwent another video EEG and was noted to have recurrent episodes of jerking, of which some, but not all, were associated with underlying poly-spike discharges. The clinical impression of the neurology team was that the episodes not associated with poly-spike discharges could represent some component of brainstem or spinal myoclonus. The clinical team had a lower suspicion for functional myoclonus given the patient's overall clinical picture, though it could not be fully excluded based on scalp EEG. At this point, clonazepam did not seem to be significantly helpful in achieving symptom control and it was subsequently tapered off. Instead, the patient was treated with baclofen (20 mg every 6 hours) with significant improvement in her resting myoclonus, though she continued to have intention myoclonus. She was eventually discharged to a skilled nursing facility for further rehabilitation. She was seen again a month after her discharge for an unrelated complaint, and while she had preserved cognition and sensorimotor function, she continued to have significant, debilitating intention myoclonus.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 13,\n",
       "    'case_id': 'PMC10209118_01',\n",
       "    'case_text': \"A 13 year-old healthy female presented approximately 1 h after an intentional overdose of 10 tablets of an unknown drug. She was asymptomatic at the time of presentation. Parents reported acetaminophen, aspirin, fluoxetine, trazadone, and prazosin were available in the home and reported that the patient had also visited her grandmother earlier that same evening. It was unknown at that time what medications the grandmother was prescribed.\\nThe patient's vital signs were: blood pressure 128/87 mmHg, heart rate 82 beats per minute, respiratory rate 16 breaths per minute, peripheral oxygen saturation 99% on room air, and temperature 37.4  C. The initial physical examination revealed no abnormalities. No hyperreflexia, tremor, or clonus were noted. A complete blood count and comprehensive metabolic panel were within normal limits. The four hour acetaminophen concentration was 28 microg/ml. Serum aspirin and ethanol concentrations were undetectable. Urine drugs of abuse screening was negative for amphetamine, barbiturates, benzodiazepines, cannabinoids, cocaine, opiates, and PCP.\\nAfter the patient's initial medical examination, she was observed overnight on telemetry pending psychiatric evaluation in the morning. Approximately 10 h after ingestion, irregular cardiac activity was noted on telemetry (Fig. 1). A 12-lead ECG (Fig. 2A) was obtained to further characterize this rhythm, which was determined to be a Mobitz I (Wenckebach) atrioventricular block. No prior ECGs could be obtained for comparison. Vital signs remained normal during this time and the patient continued to be asymptomatic. The toxicology service was consulted at that time given concern for potential cardiotoxicity from her unknown ingestion.\\nToxicology recommendations included obtaining serum digoxin and lithium concentrations from index lab draw. Serum digoxin concentration was undetectable. Serum lithium concentration was 1.7 mEq/L (laboratory therapeutic range: 0.6-1.2 mEq/L). The patient was treated with intravenous fluids administered at twice the maintenance infusion rate for 14 h, after which a repeat lithium concentration was obtained and found to be less than the lower limit of detection. A repeat 12-lead EKG obtained approximately 20 h post-ingestion showed normal sinus rhythm with sinus arrhythmia (Fig. 2B).\\nThe patient was medically cleared after 36 h of monitoring and, following psychiatry clearance, discharged with an ambulatory cardiac monitor and cardiology clinic follow up.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 49,\n",
       "    'case_id': 'PMC5944445_01',\n",
       "    'case_text': 'A 49-year-old man was admitted with a suspected mass in the left lower pulmonary lobe found during health examination. The patient was a smoker with no family history of cancer. Chest computerized tomography (CT) (Figure 1) showed a quasi-circular mass (25.1 x 22.2 mm) in the left lower pulmonary lobe, together with an enlarged mediastinal lymph node (7.7 mm). The patient underwent CT-guided percutaneous biopsy in the left lung neoplasm. Pathological analysis revealed a poorly differentiated adenocarcinoma with neuroendocrine differentiation (Figure 2A). Immunohistochemistry showed positive staining of cytokeratin (CK), with CK7 and Ki-67 index of 60%, but negative staining of P63 and thyroid transcription factor-1 (Figure 2B-F). The discovered serum tumor markers included carcinoembryonic antigen (3.67 ng/mL), neuron-specific enolase (NSE; 19.36 ng/mL), and circulating cytokeration 19 fragments (CYFRA21-1; 2.15 ng/mL). Molecular analyses of exons 18, 19, 20, and 21 of EGFR revealed no mutation.\\nThe patient was diagnosed with clinical stage IIIA (T1bN2M0) pulmonary adenocarcinoma with mediastinal lymph node metastasis. Optimal management requires both local and systemic disease controls; as a result, treatment for clinical stage IIIA (N2) NSCLC has been one of the most controversial topics in Thoracic Oncology. Neoadjuvant chemotherapy and/or radiotherapy prior to surgical resection has been demonstrated to provide better progression-free survival (PFS) than definitive chemoradiotherapy for patients with stage IIIA (N2) NSCLC, in several reports. The tumor was technically resectable, which involved single-zone mediastinal node. Therefore, neoadjuvant chemotherapy was selected, with an aim to induce tumor downstaging, thus facilitating and simplifying the subsequent surgical treatment. After a multidisciplinary team meeting, the patient proceeded to undergo two cycles of neoadjuvant chemotherapy with pemetrexed (500 mg/m2 on day 1, every 3 weeks) and cisplatin (25 mg/m2 from days 1 to 3, every 3 weeks) from March to April 2015. Side effects were limited to grade 1 fatigue and grade 1 nausea. Chest CT scan in May 2015 showed that the left lower lobe tumor had significantly reduced to 12.7 x 7.4 mm in size, and the enlarged mediastinal lymph node almost disappeared (Figure 3). The patient achieved partial remission (PR) after neoadjuvant chemotherapy.\\nThe patient underwent left lower radical lobectomy completely (R0) resection and mediastinal lymph node dissection in video-assisted thoracoscopic surgery in May 2015. The postoperative sample was confirmed as pT1aN2M0 LCNEC upon pathological examination. Immunohistochemical analysis (Figure 4) demonstrated intense immunoreactivity of CK, CK7, as well as NSE, chromogranin-A (CgA), and cluster of differentiation 56 (CD56), which was a typical LCNEC component. Immunohistochemistry showed focally positive results of synaptophysin (SyN), and negative results of P63, P40, and NapsinA. No surgery-related complications occurred. Chest CT scan 1 month after surgical resection revealed no tumor recurrence (Figure 5A and B).\\nThe patient convalesced well after surgery and received adjuvant chemotherapy of the same regimen for four cycles. Meanwhile, sequential postoperative radiotherapy (PORT) at a total radiation dose of 45 Gy was given, which was divided into a daily dose of 1.5 Gy for twice after surgery for a month. The patient is followed up by tumor marker every month, and CT scan every 2 months. No evidence of recurrence has been detected during the 24-month follow-up after surgery (Figure 5C and D).',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 51,\n",
       "    'case_id': 'PMC5830816_01',\n",
       "    'case_text': 'A 51-year-old man presented to the emergency department with mild, dull central abdominal pain and dyspepsia for 4 days. There was no history of fever, flank pain, hematuria, or dysuria. There was no history of renal impairment or bowel complaints. His history was significant for diabetes, hypertension, and hyperlipidemia. Abdominal examination revealed soft abdomen with mild generalized tenderness. Laboratory investigation revealed raised serum lipase, amylase levels, along with obstructive jaundice. Urine full examination microscopy elements test and renal function tests revealed no evidence of urinary tract infection. A contrast-enhanced computed tomography (CT) scan of the abdomen and pelvis showed gallbladder wall thickening, biliary dilatation, and swollen pancreas with a subtle lucent halo around the pancreas, associated with mild peripancreatic lymphadenopathy. In addition, there were multiple wedge-shaped areas in both kidneys without any hydronephrosis, nephrolithiasis, or perinephric fat stranding [Figure 1a and b]. Magnetic resonance imaging (MRI) of the upper abdomen confirmed mild edematous pancreatitis and biliary dilation, pancreatic duct dilatation without any ductal calculi. MRI also showed a peripheral halo around the pancreas while diffusion-weighted images demonstrated diffuse restricted diffusion in the pancreas consistent with pancreatitis. MRI evaluation of the kidneys showed multiple T2 dark areas in both kidneys showing restricted diffusion [Figure 2a and b]. These areas were isointense on T1-weighted images, showed progressive enhancement on serial postcontrast images, and again well delineated on 5 min delayed images [Figure 2c-g]. Tumor markers were within normal limits. Endoscopic retrograde cholangiopancreatography showed stricture of the distal common bile duct and pancreatic duct. A biliary stent was placed and biliary brushings were sent for cytology analysis. Endoscopic ultrasound-guided fine needle aspiration cytology (FNAC) was performed sampling the pancreatic head, uncinate process, ampulla, and peripancreatic lymph node. Serum IgG and IgG4 levels performed after CT and MRI were very high. FNAC results showed IgG4 immunostaining of inflammatory cells from the sample from pancreatic head. No malignant cells were seen. A diagnosis of IgG4-related autoimmune pancreatitis, biliary disease, and kidney disease was made. Post-stenting, the markers of obstructive jaundice and pancreatitis went down.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 26,\n",
       "    'case_id': 'PMC7580483_01',\n",
       "    'case_text': \"A 26-year-old female, without any significant past history presented to department of critical care medicine with abnormal body movement, cough, fever, loss of consciousness, shortness of breath, vomiting for five days. At presentation her Glasgow Coma Scale (GCS) is 7/15, pulse rate-140 beats/per min, blood pressure-70/40 mmHg, respiratory rate-31 breaths/min, oxygen saturation-81% on 15 liter oxygen, and temperature-102 F. On examination, thyroid swelling, bilateral pitting edema, jaundice, neck rigidity and kerning's sign were present. On auscultation of chest, bilateral crepitation was present. Examination of other systems was normal. Immediately patient was resuscitated and intubated.\\nHer investigation profile showed Total Leucocyte Count (TLC)-25000/mm3, platelets-100000/mm3, Hemoglobin (Hb)-9gm/dl, urea-90 mg/dl, creatinine-1.8 mg/dl, sodium and potassium were within normal range. Total bilirubin was found to be 6mg/dl in which direct bilirubin corresponds to3mg/dl, total protein was found to be 5.9mg/dl in which albumin corresponds to 3.1 mg/ dl, alanine aminotransferase (ALT) 301U/L, aspartate aminotransferase (AST) 281U/L. Lumbar puncture (LP) showed viral meningoencephalitis. IgM for scrub typhus was positive.Chest X-ray showed bilateral pneumonia (Figure 1). She was diagnosed as scrub meningoencephalitis with multiorgan dysfunction and septic shock.\\nThe patient was started on meropenem, doxycycline, vasopressors, hydrocortisone, fluids and ventilator support. On second day, there was no improvement. Thyroid function test was done which showed free triiodothyronine (FT3) as 6 ng/dl, free tetraiodothyronine (FT4) as 5 ng/dl and thyroid stimulating hormone(TSH) as 0.02 mulU/ml.\\nBurch-Wartofsky point scale(BWPS) was 55. Oral carbimazole was started due to unavailability of intravenous form. There was no improvement in consciousness and parameters of organ dysfunction over next 3 days. She expired on fifth day.\",\n",
       "    'gender': 'Female'},\n",
       "   {'age': 41,\n",
       "    'case_id': 'PMC7580483_02',\n",
       "    'case_text': 'A 41-year-old female, without any significant past history presented to department of critical care medicinewith altered sensorium, fever, cough, shortness of breath, palpitation for 2 days. At presentation, her Glasgow Coma Scale (GCS) -12/15, pulse rate-190 beats/per min irregularly irregular, blood pressure-80/40 mm of Hg, respiratory rate-31breaths/ min, oxygen saturation-91% at five liter oxygen, and temperature -100 F. On examination thyroid swelling, bilateral pitting edema and jaundice were present.On auscultation of chest, bilateral crepitation was present. Cardiovascular examination showed tachycardia without murmur. Abdominal examination was normal. BWPS was 50.\\nHer investigation profile were TLC-15000/ mm3,platelets-110000/mm3, Hb-9gm/dl, urea 90-mg/dl, creatinine-1.6 mg/dl, sodium and potassium were within normal range. Total bilirubin was 5mg/dl in which direct bilirubin corresponds to 2mg/dl, total protein-5.9mg/dl in which albumin-2.9 mg/dl, ALT-256U/L, AST-201U/L, FT3-8 ng/dl, FT4-5 ng/dl and TSH-0.01 mulU/ml.Chest X-ray showed bilateral pneumonia (Figure 2).\\nImmediately the patient was resuscitated with fluid, hydrocortisone, broad spectrum antibiotics and cardio version. Heart rate got controlled with Digoxin followed by Propanolol (20 mg) three times a day orally. Carbimazole (20mg) was started thrice a day. The patient was transferred from Intensive Care Unit (ICU) on the fourth day. She was followed up at OPD after 2 weeks, thyroid function test was done and carbimazole was continued.',\n",
       "    'gender': 'Female'},\n",
       "   {'age': 48,\n",
       "    'case_id': 'PMC7580483_03',\n",
       "    'case_text': 'A 48-year-old female, with past history of hyperthyroidism not under treatment presented todepartment of critical care medicine with altered sensorium, abdominal pain, cough, fever, shortness of breath, loose stool and vomiting for 3 days. At presentation, her Glasgow Coma Scale (GCS) was 13/15. Her pulse rate-136 beats/per min, blood pressure-80/50 mmHg, respiratory rate-26 breaths/min, oxygen saturation -90% on 10 liter oxygen, and temperature-102 F. On examination, thyroid swelling, bilateral pitting edema and jaundice were found. On auscultation of chest, bilateral crepitations were present. Examination of other systems were normal. BWPS was 75.Her investigation profile showed TLC-17000/mm3, platelets-110000/mm3, Hb- 10gm/dl, urea-90 mg/dl, creatinine-1.8 mg/dl, sodium and potassium were normal. Total bilirubin 6mg/dl in which direct 2.3mg/dl, total protein 5.9mg/dl in which albumin 2.9 mg/dl, ALT- 356U/L, AST- 301U/L. FT3 4.2 ng/dl, FT4 5 ng/dl and TSH <=0.01 mulU/ml. Chest x-ray showed bilateral pneumonia (Figure 3). Rest of the examination was normal.\\nImmediately patient was resuscitated with fluids, vasopressors, broad spectrum antibiotics. Carbimazole (20mg) and propanolol (20mg) were started three times a day. Both blood pressure and heart rate got controlled on second and fourth days respectively. Sensorium was improved on the seventh day. The patient was transferred out of ICU on the ninth day. The patient was followed up at OPD after 2 weeks, thyroid function test was done and Carbimazole was continued.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 30,\n",
       "    'case_id': 'PMC10242558_01',\n",
       "    'case_text': \"A 30-year-old male with a past medical history significant for asthma presented to the emergency department with a chief complaint of shortness of breath. According to the patient, he had been experiencing worsening shortness of breath for the past few weeks which was initially present only on exertion but had recently progressed to being persistent at rest as well. The patient also complained of a concomitant non-productive cough during this time which was accompanied by intermittent febrile episodes. He also noted a 15-pound unintentional weight loss over the past two months. Vital signs on initial evaluation were significant for a temperature of 98.2 F, BP 153/89, HR 114 and sp02 95% on room air. Physical examination revealed an alert, cooperative male in mild respiratory distress, appearing his stated age, PERRL, conjunctiva/corneas clear, EOM's intact, fundi benign, no appreciable cervical/axillary/supraclavicular lymphadenopathy. Air entry was notably reduced in the right mid and lower chest region, regular, rate, and rhythm, S1 and S2 normal, no murmur, rub or gallop, abdomen was soft and non-tender, bowel sounds active in all four quadrants with no masses, no organomegaly. Lower extremities were without edema.\\nLabs were significant for WBC 15.62/nL, Hgb 13.4 g/dL, Platelets 428/nL, creatinine 0.94 mg/dL, AST 31, ALT 32, Na 137 mmol/L, LDH 817 U/L, Uric acid 5.4 mg/dL, ESR 28 mm/hr, CEA 0.9 ug/L, procalcitonin 0.06 ng/mL. CT angiogram of the chest was performed and showed a 20 x 7.8 cm predominantly low-density anterior mediastinal mass with no calcifications, seen in Fig. 1A. Some associated adenopathy in the precarinal space, 36 x 21 mm. Epicardial adenopathy was present measuring 31 x 22 mm. There was a also a small amount of pericardial fluid towards the cardiac apex. A large partially loculated right pleural effusion with areas of underlying consolidation and bilateral dependent changes was also seen and no filling defects in the central pulmonary arterial circulation that would suggest pulmonary embolism were appreciable. CT abdomen pelvis was also performed and showed no acute findings. Pulmonology was consulted for thoracentesis and Oncology was consulted for the mass seen on imaging. Echocardiogram was performed which was not suggestive of tamponade physiology and ejection fraction 60-65%. Thoracentesis revealed an exudative effusion with lymphocytic predominance, cytology was negative for malignant cells and flow cytometry revealed no immunophenotypic abnormalities. A mediastinal core needle biopsy was performed with findings of CD30 and CD15 positive lymphoid neoplasm, and negative for CD20 and EBV, consistent with Mediastinal Gray Zone Lymphoma. Additional serologic exams included an AFP <1.3 ng/mL, HCG <1.0 mIU/mL, Kappa Free light chain 1.18 mg/dL, Lambda free light chain 0.93 mg/dL, Kappa/Lambda ratio 1.27.\\nA bone marrow biopsy revealed a normocellular marrow with maturing trilineage hematopoiesis, negative for involvement by lymphoma. Concurrent flow cytometry was negative for lymphoma. The patient's clinical presentation was consistent with Stage 2, bulky disease. The patient proceeded with starting allopurinol for prevention of tumor lysis and began dose adjusted EPOCH. After 2 cycles, there was significant delbulking of his disease noted on PET scan seen in Fig. 1B and improvement of his symptoms. He continued with cycle 3/6 of dose adjusted EPOCH and was noted to have complete metabolic response with a Deauville Score of 2 seen in Fig. 1C.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': None,\n",
       "    'case_id': 'PMC2825652_01',\n",
       "    'case_text': 'There is substantial third-party objective evidence that O experienced unrelenting illness that generally increased in the 10 years that preceded glycine treatment and that O\\'s education and social life were profoundly disrupted. \\nEvidence for disruption of education resides in a comprehensive set of third-party records on school attendance and nonattendance, academic performance during attendance, results from standardized academic tests, financial records from academic institutions, and written correspondence from academic administrators and city truancy officials. For 8 years before glycine treatment, there was no attendance of school or commercial tutoring. Resumption of education following the initiation of glycine treatment is likewise supported by comprehensive third-party objective evidence. Over a period of approximately 2 years, evidence for sustained and increasing improvement resides in the fact that O passed the high school equivalency exam, prepared for the SAT test in a commercial course, preformed well on SAT test and began college. Academic records indicate excellent attendance and performance. \\n Disruption of education was accompanied by disruption of social life and a housebound state. Evidence for a resumption of social life following glycine treatment is likewise supported by substantial third-party objective evidence. For example, evidence for a resumption of social life resides in email correspondence with classmates that relates to social activities at specific events and locations in his city and another city. Credit card records indicate the purchase of clothes, attendance at restaurants and concerts in his city and another city. Thus, there is clear, third-party objective evidence for resumption of an active social life and normal mobility in his city that is not subject to concerns about subject, parental, or researcher bias relating to outcome assessment. This evidence for a major reduction in preglycine life disruptions suggests a major improvement in the OCD and BDD dimensions of O\\'s illness. However, before this major improvement can be considered a genuine effect of glycine, it is necessary to rule out placebo effects and a spontaneous remission. \\n Given that placebo effects derive from patient anticipations for treatment, there is the a priori expectation that placebo effects will not be durable in individuals experiencing powerful, life-disruptive psychiatric illness. This expectation has been confirmed by Quitkin and coworkers in systematic studies of placebo effects in depression. Specifically, there is a marked tendency for placebo responses to occur abruptly within the first two weeks and to disappear within the first 12 weeks of treatment. This placebo response pattern is in contrast to what the authors regard as the response pattern for a true pharmacologic response, where the initial effects appear after a period of two weeks and tend to last 12 weeks or longer. The placebo response pattern can, of course, be seen either with a true placebo or with an active drug. These authors \"conclude that a significant portion of relapses within the first 6 weeks of treatment with an active drug are not related to loss of a true drug effect. Rather some are related to loss of nonspecific placebo effects, and abrupt nonpersistent responses during drug treatment are most likely the result of placebo effects\". They note that the early occurrence of placebo effects is consistent with the notion that they derive from patient expectations. Others have made similar observations. In relation to studies of OCD patients, Ackerman and Greenland have noted that the observation of less improvement in longer trials of active drugs may be due to placebo effects from expectations generated by side effects: \"It is possible that in the early 10-week clomipramine and 8-week fluvoxamine trials, some of the subjects in the active treatment arms responded to nonspecific study effects (such as side effects). In longer studies, that improvement was not maintained.\" Here it can be noted that Quitkin et al. suggest that \"precise assessment of drug effects probably requires several months of observation.\" \\n In view of the above considerations, we suggest that it is highly unlikely that the objective, major, and long-lasting changes in life activities that followed glycine treatment represent a placebo effect. Unlike placebo effects, the change that followed initiation of glycine treatment was not abrupt. The subject and his parents report that the first sign of improvement (leaving home without parental escort for the first time in 5 years) occurred 5 weeks after initiation of glycine consumption. Further improvement was also gradual, with third-party objective evidence documenting a gradual resumption of education and social life over treatment periods totaling 150 weeks (in an observation period of 5.3 years). This is much longer than the \"several months\" described by Quitkin et al. as sufficient to detect true drug effects. \\n Although the above studies clearly suggest that effects generated by patient expectations tend to be transient, it is nonetheless possible to observe some cases in which improvement from a known placebo appears to be enduring. For example, Quitkin observed sustained improvement in placebo-treated individuals with depression. In these cases, the authors make the reasonable suggestion that the improvement was more likely to have been a spontaneous remission than a placebo effect. Therefore, it is necessary to consider the possibility that O\\'s enduring improvement following initiation of glycine treatment was due to spontaneous evolution of illness. \\n We first note that a spontaneous remission appears unlikely on the basis of prior longitudinal studies, which suggest that both OCD and BDD generally have a continuous course, with spontaneous remissions being rare, especially in SSRI-refractory cases. Moreover, the occurrence of both disorders together tends to be associated with a worse prognosis. Although suggestive, these considerations do not constitute definitive evidence against a spontaneous remission in a specific case. \\n One approach to distinguish true efficacy from spontaneous remission in a specific case is to determine if deteriorations occur during periods of nontreatment. To pursue this approach, this study was continued until we obtained objective, third-party evidence for an unequivocal deterioration during nontreatment that avoided concerns about subject expectations and outcome assessment bias in the observations made by the subject, his parents and researchers. \\n As noted for the long off-glycine periods, OP6 and OP10, modest relapses were seen for OCD and BDD. However, the clearest evidence of deterioration was for the cognitive dimension of O\\'s illness. Most notably, third-party objective evidence derived from clinical neuropsychological testing in OP10 suggests substantial deficits in selective aspects of cognition by the end of this period. This testing with formal methods was done by a neuropsychologist who was blinded to psychiatric and treatment histories. A comparison of this off-glycine data with the excellent SAT scores obtained in the on-glycine period, OP5, suggests a substantial decline in selective aspects of cognition in OP10 relative to OP5 levels, as discussed in Section 3.5.11. All of this evidence is objective except for some neuropsychological tests that required subjective evaluation by the clinical neuropsychologist, such as the Rey-Osterrieth test. In these cases, any subjective judgments were made under blinded conditions that precluded expectations of the neuropsychologist that were based on treatment history or psychiatric diagnoses. \\n The possibility that treatment cessation could have generated expectations in our subject that somehow affected his performance on the neuropsychological testing can also be considered. We first note that the subject reports that he initiated testing because of speech difficulties. The evaluation revealed normal verbal fluency but did reveal multiple other deficits. The point here is that the deficits found were different from the subject\\'s initially expressed complaints. Further evidence against expectations for a decline in memory after glycine cessation reside in the fact that in serial interviews, the subject has expressed doubts about the validity of the tests for memory deficits and has noted that friends have commented on his excellent memory of the distant past. Moreover, he has not resumed high-dose glycine consumption in response to the test results. It can also be noted that the neuropsychologist reported that the subject was euthymic and appeared to make a full effort. \\n On the basis of the above considerations, we suggest that the third-party evidence that we present for a cognitive deterioration is either fully objective evidence or is evidence that is not compromised by an absence of blinds or by subject expectations. An important point is that the selective cognitive deterioration was substantial, since some WMS-III scores were in the first percentile and since the Rey-Osterrieth copy score was more than 8 standard deviations below the mean. We suggest that it is unlikely that scores on these tests would have been much lower had they been measured before the initiation of glycine treatment. \\n In summary, we suggest that the bias-free evidence that we present for a major improvement of OCD and BDD during treatment and for a major deterioration of selective aspects of cognition during nontreatment is consistent with the possible efficacy of glycine.\\nIn response to the success achieved in the first year of this study, a collaborative initiative was begun to test glycine with other OCD patients. The first aspect of this initiative has been a placebo-controlled study in which glycine was used as an adjunct to pre-existing pharmacotherapy. The 5 individuals who were treated with glycine had a mean decrease in Y-BOCS score of 6.04 points where as the 9 subjects treated with placebo experienced a 1.00 point decrease (P = .053) (Greenberg, Benedict, Doerfer, Perrin, Panek, Cleveland, and Javitt, Adjunctive glycine in the treatment of obsessive-compulsive disorder in adults). Although much larger studies are needed to determine the frequency of responders, the results of Greenberg et al. are in agreement with this case study and raise the expectation that additional OCD patients will be glycine responders. To facilitate large trials, it would be desirable to identify glycine-responsive subtypes. The comprehensive case description in this paper has been motivated, in part, by this goal.\\nTo our knowledge, this case study represents the first use of high-dose glycine with OCD or BDD and the first use of glycine alone with any psychiatric disorder. In addition, there was no psychotherapy or behavior therapy during the 5-year period of monitoring. Thus, this study is free of factors that confound the interpretations of many studies. Given the magnitude of the improvement seen in this study, we suggest that trials of glycine alone be considered for future studies.\\nIn agreement with prior studies of glycine as an adjunct to conventional medication in schizophrenia, an initial response to glycine treatment was detected in this study only 23 days after reaching the target dose. However, the improvement reported for the first 12 weeks of treatment was only a small fraction of the improvement reported for the five on-glycine treatment periods that extended over a period of almost four years. This suggests that the short clinical trials used in the past, for example, 12 weeks, may have failed to reveal the full therapeutic potential of high-dose glycine treatment in the disorders studied.\\nThe results of this high-dose glycine trial with refractory OCD, BDD, and cognition deficits are in unequivocal agreement with the main prediction of the Hypo-NMDAR-ST hypothesis that inspired its initiation. However, it is also necessary that this hypothesis be compatible with prior, well-established findings for NMDAR neurotransmission. \\n Since our hypothesis was constructed to explain the apparent behavioral effects of clarithromycin, which has been reported to inhibit NMDAR-ST at a downstream point, it is reasonable to consider if other downstream NMDAR-ST inhibitors have similar effects. There are many studies of NMDAR inhibition on human behavior, but, to our knowledge, all employ global inhibitors, such as phencyclidine and ketamine, that act on the NMDAR itself. Thus, a direct comparison is not possible. With this caveat in mind, it is nonetheless of interest to consider known effects of ketamine and phencyclidine in relation to this study. \\n To our knowledge, controlled studies with phencyclidine and ketamine have considered either healthy subjects or subjects with schizophrenia. In healthy subjects, the basic findings are deficits of cognition and other signs and symptoms that are schizophrenia-like. In subjects with schizophrenia, a worsening of existing or reactivation of previously controlled symptoms is the main presentation. In these very short-term experiments, signs and symptoms of OCD, to our knowledge, have not been reported. Although visual distortions of body parts are a prominent consequence of ketamine and phencyclidine and somatosensory abnormalities have been suggested to be an aspect of BDD deriving from parietal-occipital abnormalities, full-fledged DSM-IV BDD has not, to our knowledge, been reported in these experiments. At first sight, these findings might be considered incompatible with our hypothesis. However, general considerations suggest that local defects in NMDAR-ST could be specific for OCD/BDD. The absence of such defects in normal individuals and in individuals with schizophrenia would explain the absence of OCD/BDD in the reported ketamine and phencyclidine experiments. Here it can be noted that disorder-specific defects appear to have influenced the exacerbations induced by clarithromycin in other cases. For example, in one case, previously controlled bipolar disorder was reactivated. In another, previously controlled posttraumatic stress disorder was reactivated. \\n It can also be noted that disorder-specific defects for OCD and BDD are plausible in relation to known neurobiology. Given that SSRIs are the first line drugs for both OCD and BDD, it is possible that abnormal serotonin neurotransmission plays a causal role in these disorders in some individuals. This raises the possibility of a local, OCD/BDD-specific defect that is restricted to serotonergic neurons of the raphe nuclei. Recent evidence indicates that NMDAR-ST regulates the firing rate of these neurons, suggesting that deficient NMDAR-ST could lead to an abnormal firing rate. The more downstream the defect the more likely it will involve the molecular systems that produce, release, and transport serotonin. Recent clarifications of mechanisms regulating serotonergic neurotransmission reveal a complex picture in which multiple processes couple NMDAR input with serotonin release/reuptake. Defects occurring in these processes could represent OCD/BDD-specific defects in NMDAR-ST. \\n Another possibility is a deficiency of NMDAR-ST in GABA-ergic inhibitory interneurons (abundant in both the dorsal and median raphe nuclei) that regulate serotonergic neurons. This scenario can be seen as a variant of the elegant and influential theory of Olney et al. in which deficient NMDAR-ST leads to loss of feedback inhibition. The core principle of this theory, which goes beyond \"hyperglutamatergic\" or \"hypoglutamatergic\" models, is that glutamate \"functions not only as a straightforward excitatory agent in the brain, but as a major regulator of inhibitory tone\". Local NMDAR-ST deficits restricted to interneurons that regulate serotonergic neurons could reasonably be expected to lead to abnormal serotonergic tone and the emergence of OCD/BDD. \\n In both of the above scenarios, there is an absence of the more widespread perturbations expected for global NMDAR-ST inhibition by ketamine and phencyclidine. The absence of these perturbations would be compatible with the emergence of OCD/BDD without the schizophrenia-like symptoms seen with ketamine and phencyclidine. Also, in both scenarios, it would be reasonable to expect worsening of signs and symptoms by an inhibitor and improvement from an enhancer of NMDAR-ST. However, it should be emphasized that the above analysis is intended only to suggest plausibility of disorder-specific defects, not to propose a specific mechanism for the case under study. \\n Although OCD and BDD have not been seen in ketamine experiments with humans, some of the cognitive deficits seen in O show substantial overlap with the cognitive effects of ketamine. A consistent finding in multiple ketamine studies is a robust, dose-dependent decrease in verbal declarative memory that occurs at doses below those that induce schizophrenia-like symptoms. Deficits in verbal memory and learning in ketamine experiments have been assessed with story recall and list learning tests. For example, Newcomer et al. found a dose-dependent decrease in verbal memory under ketamine using a paragraph recall test from the Wechsler Memory Scale-Revised. Immediate and delayed recall scores from this study can be compared with O\\'s corresponding scores on a revised version of this test, the WMS-III. O\\'s Auditory Immediate and Auditory Delayed scores were in the ~1st percentile. In other ketamine studies, a robust decline in verbal memory has been found with list learning tests such as the Hopkins Verbal Learning Test (HVLT). These results can be compared with the significant deficits seen in O\\'s scores on the CVLT-II, where the T score for Trials 1-5 was ~36 (Z = - 1.4) and Z-scores for delayed recalls (free and cued) ranged from ~-2 to ~-2.5, except for the short delay free recall, which was ~-1. The Z-score for total hits was ~-4. Thus, O\\'s off-glycine deficits in verbal memory are strongly reminiscent of those induced by ketamine. This similarity is clearly supportive of our hypothesis. Also supportive are O\\'s very high on-glycine scores on the GED and verbal SAT tests (99th and 90th percentiles, resp.), which suggest much improved verbal learning and memory in an on-glycine state, as discussed above. \\n The finding that ketamine-induced cognition deficits appear at doses lower than those needed for other types of symptoms is also of relevance to our hypothesis. Assuming that an endogenous NMDAR-ST defect would mimic ketamine, this finding leads us to expect that the return to a deficient NMDAR-ST state after cessation of glycine would manifest itself with a cognitive relapse whose emergence is earlier and more pronounced than the relapses for other categories of signs and symptoms. Our data from OPs 6 and 10 appear to be consistent with this prediction. Also of relevance is the fact that in the initial emergence of illness in early childhood, difficulties in cognition appeared before obsessive-compulsive behaviors and BDD-related signs and symptoms. \\n Finally, we note that additional support for our Hypo-NMDAR-ST hypothesis can be found in the course of O\\'s illness. Specifically, it is known that NMDAR inhibition has mild behavioral effects in childhood and much larger effects after puberty. Assuming that an endogenous NMDAR-ST defect would imitate an inhibitor, it follows that O\\'s very mild illness in childhood and the emergence of much more incapacitating illness after age 15 are consistent with an NMDAR-ST deficit.\\nAlthough the findings of this study support the Hypo-NMDAR-ST hypothesis on which it is based, it is appropriate to consider our findings in the light of alternative hypotheses proposed by others. \\nOne of the defining features of the PANDAS subtype is the occurrence of exacerbations with sudden, abrupt onset. The exacerbations are described as \"typically quite dramatic, with patients reporting that their symptoms \"...came on overnight\" or \"...appeared all of a sudden a few days after I had a sore throat.\"\" The fine details of O\\'s exacerbations are not congruent with this picture. For O\\'s age-19 exacerbation that followed a positive throat culture, detailed notes of O\\'s father indicate an improved relationship with his son during the acute phase of the infection. The behavioral deterioration is described as beginning \"as soon as the infection cleared.\" Worsening of existing symptoms (e.g., line-crossing obsession) occurred 24 days after the positive throat culture. Episodes of violent imagery appeared for the first time approximately 40 days after the positive throat culture. In addition to the slower kinetics, O\\'s nonresponse to IVIG therapy is unlike some PANDAS patients.\\nAlthough, O\\'s case cannot be classified as a clear case of PANDAS, it is still possible that it involves an antigen-specific autoimmune response induced by GABHS. There are, of course, multiple precedents, both experimental and theoretical, for the induction of antigen-specific anti-self-immune responses by foreign antigens that cross-react with self-epitopes or interact with self-receptors. Thus, the occurrence in O of two exacerbations following probable GABHS infections is immediately suggestive of an antigen-specific autoimmune mechanism. This follows from the major precedent residing in rheumatic fever (RF) as an antigen-specific autoimmune disease primed by GABHS. A comparison of O\\'s illness with RF is therefore warranted. \\n As expected for a pathogen-induced, antigen-specific autoimmune disease, recurrences of RF in adulthood are associated with probable reinfection with GABHS, often as a result of known, close contact with children having GABHS infections. The time interval between an initial occurrence of acute RF in childhood and a subsequent occurrence in adulthood can be multiple decades. During these long periods, there is an annual occurrence of upper respiratory viral infections, some of which are \"flu-like.\" As expected for infections which are unlikely to be antigenically related to GABHS, there is no retriggering of RF. Another point is that penicillin prophylaxis is effective in preventing a return of RF. This would not be expected if viral infections significantly trigger recurrence of RF. \\n In contrast to RF, exacerbations in O\\'s case and in some PANDAS cases appear to follow both GABHS and non-GABHS infections. It appears that Sydenham\\'s chorea, a sequela of RF, can reoccur without GABH infection. One might propose that, in these cases, antigen-specific clones primed by an initial GABHS infection are somehow retriggered by other pathogens, such as viruses. However, the failure to see this phenomenon in RF represents a major challenge to this proposal. \\n One possibility is that the putative brain injury responsible for O\\'s case arises from nonantigen-specific consequences of GABHS and other infections. Such a mechanism would be compatible with recurrence from both GABHS and non-GABHS infections and would not be incompatible with the peripheral antibrain antibodies reported in the recent literature, since the latter could be a result (rather than a primary cause) of brain injury due to the release of antigens from an immunologically protected site. Here it is of interest that Husby et al. who in 1976 found antistriatal antibodies in patients with Sydenham\\'s chorea, also found similar titers of antistriatal antibodies (using identical techniques) in patients with Huntington\\'s chorea. This led in 1977 to the suggestion that Huntington\\'s chorea could be an infection-triggered autoimmune disease. The latter is now known to be a polyglutamine disease that involves preferential death of striatal neurons. In brain-injury models of this type, it is formally possible that antibrain antibodies arising from brain injury could play a secondary role in pathogenesis. However, the demonstration that such antibodies play a causal role is a difficult task that is technically inaccessible in the absence of validated animal models, which are unavailable for psychiatric disorders that involve high-level human thinking.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': None,\n",
       "    'case_id': 'PMC8734028_01',\n",
       "    'case_text': \"There were two affected individuals in this family line, whose parents were not consanguineously married (Family  Figure 1A ). The proband born on October 24, 1984, was found to have elevated blood glucose and edema throughout the body in November 2018 and was admitted to the hospital for treatment. Physical examination showed sparse scalp hair and eyebrows, absence of axillary and pubic hair, infantile external genitalia, generalized edema and intellectual disability ( Figures 2A, B ). Other data were normal, including bedside hearing and sensory testing (although formal assessment was not performed). Laboratory tests showed that the fasting glucose was 40.22 mmol/L (reference range: 3.9-6.1 mmol/L), and the glycosylated hemoglobin (HbA1c) was 13.8% (reference range: < 6.4%). Sex hormone tests revealed low levels of luteinizing hormone (LH), follicle stimulating hormone (FSH) and estradiol. Routine blood tests suggested that the patient had anemia and thrombocytopenia ( Table 1 ). Insulin and C-peptide release tests showed that the patient's insulin and C-peptide secretion had no peak ( Supplementary Table 1A ). The OGTT-based measures of insulin secretion index homeostasis model assessment- beta (HOMA-beta = 20 x Ins0/(Glu0-3.5) was low ( Table 1 ). Thyroid hormone tests revealed normal thyroid-stimulating hormone (TSH), low free thyroxine (FT4), and a low free triiodothyronine level (FT3). Pancreatic CT indicated a slightly atrophied pancreas ( Figure 3A ). While ultrasound showed that the uterus was absent. The patient was treated with insulin injection, and the blood glucose was poorly controlled.\",\n",
       "    'gender': 'Unknown'},\n",
       "   {'age': None,\n",
       "    'case_id': 'PMC8734028_02',\n",
       "    'case_text': \"The brother of the proband, who was born on October 29, 1986, was found to have elevated blood glucose in 2019 and admitted to our hospital for a closed fracture in January 2020. Physical examination also showed sparse scalp hair and eyebrows ( Figures 2C, D ), absence of axillary and pubic hair, hypotrophy testicles, small penis, and intellectual disability. Laboratory tests revealed that his fasting glucose was 14.91 mmol/L, HbA1c was 9.0%, he had negative insulin antibodies, low IGF-1 level of 43 ng/ml (reference range: 111-320 ng/ml), low testosterone and LH. Routine blood tests also suggested that the patient had anemia and thrombocytopenia. Insulin and C-peptide release tests showed low insulin, C-peptide secretion ( Supplementary Table 1B ) and low HOMA-beta. Thyroid hormone tests revealed normal thyroid function. The patient exhibited an uneven pancreatic density by abdominal CT scan ( Figure 3B ), empty sella by pituitary MRI ( Figures 3C, D ), and osteoporosis that was not consistent with actual age by hip CT scan ( Figure 3E ). Before admission to the hospital, the patient had oral hypoglycemic agents to control glucose, and insulin pump treatment was given after admission to the hospital, but the glucose control was poor.\\n5ml venous blood was collected from the proband (II-1,  Figure 1A ) and her family members (I-1, I-2, II-2 and II-3,  Figure 1A ). Whole Exome sequencing (WES) was performed on proband using the xGen  Exome Research Panel v1.0 (IDT, USA) on the Illumina NovaSeq6000. Genomic DNA was extracted from whole blood, then sheared by sonication and hybridized for enrichment. And the library was enriched for target regions, sequencing was performed to generate 150 bp paired-end reads. To identify mutations, sequencing data was analyzed and annotated according to an in-house pipeline which we describe before. Based on the variant annotations, a series of prioritization strategies were applied to identify candidate variants associated with the phenotypes. The detailed steps were as follows: (1) excluding variants outside exonic and splicing regions; (2) excluding variants with minor allele frequency >=0.01 according to public databases (GnomAD, 1000 Genomes and ExAC); (3) excluding synonymous variants; (4) excluding variants not presenting damaging results in the function prediction from clinPred. To prioritize the most likely candidate disease-causing gene, all candidate genes were then ranked by Phenolyzer. Human Phenotype Ontology (HPO) Identifiers of the proband's disease phenotype (anemia, HP:0001903; alopecia, HP:0001596; diabetes mellitus, HP:0000819; hypogonadism, HP:000013; intellectual disability, HP:0001249) were input as phenotype terms into Phenolyzer. To confirm the candidate disease-causing variant, we PCR-amplified the genomic DNA fragments in the proband (II-1) and her family members (I-1, I-2, II-4 and III-2), then sequenced them by Sanger sequencing. The PCR primer pairs were uses as followings: forward 5'-TCCTGGGTCCAGAGTTCTTT-3', reverse 5'-TGGGGTGTTTGGCTAAAAGT-3').\\nBased on the aligned reads, 76,241 single nucleotide variants (SNVs) and 13,038 indels (deletions and insertions, <50bp) were identified by WES. After three filters of prioritization strategies, 271 variants from 244 genes were kept. Both these genes and HPO Identifiers of phenotypes of the proband were input Phenolyzer. Phenolyzer suggested that WSS was the most likely disease that can explain the syndrome phenotypes of the proband, and the DCAF17 gene was the candidate gene ( Supplementary Figure 1 ). A homozygous deletion DCAF17:c.1488_1489delAG was detected at genomic position 172,337,546-172,337,547 of chromosome 2 (GRCh37/Hg19), resulting in frameshift in reading frame in exon 14 leading to premature stop codon ( Figure 1B ). The full-length DDB1 and CUL4 associated factor 17 contains 520 amino acids. The premature termination was predicted to cause a truncated protein comprising 506 amino acids. The first 495 residues corresponding to the normal protein and the other extra 11 derived from the frameshift deletion. Sanger sequencing analysis showed the identified c.1488_1489delAG (deletion of nucleotide AG in coding region 1488-1489) was segregated with the disease in this family, which was in homozygous status in the proband's affected sibling (II-2) and heterozygous status in the proband's unaffected parents (I-1 and I-2) and sibling (II-3) ( Figure 1A ). Additionally, the identified variant allele has been recorded in the database of gnomAD with an extremely low allele frequency at 3/251,124 (dbSNP rs778488574). According to the ACMG/AMP criteria, the raw homozygous frameshift variant DCAF17:c.1488_1489delAG was classified as a pathogenic variant for WSS.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 52,\n",
       "    'case_id': 'PMC5730433_01',\n",
       "    'case_text': 'A 52 year old man with a history of NF-1 was referred for back pain that continued for 2 days. The computed tomography (CT) scan showed a large haematoma in the right retroperitoneal space due to rupture of a right lumbar artery aneurysm (Fig. 1). Clinical examination showed multiple cafe-au-lait macules and right flank pain. His vital signs were stable, but the blood test results indicated anaemia (hemoglobin level 8.2 g/dL).\\nThe emergency angiogram through the right femoral artery showed active extravasation of contrast medium from the ruptured aneurysm of the third right lumbar artery, which was successfully selected using a manually curved 4 Fr hook shaped catheter (RC-09; Medikit, Tokyo, Japan) (Fig. 2). At the distal side of the aneurysm, the lumbar artery branched into three. Through the 4 Fr catheter, a 2.9 Fr catheter (microcatheter with two coils for support; Hi-Lex, Takarazuka, Japan) was coaxially inserted using a 0.018 inch guidewire (AQUA VIII guidewire; Cardinal Health, Dublin, OH, USA). Three distal arterioles were successfully embolised using several microcoils (Tornado  Embolisation Coil, MReye  Embolisation Coil; Cook Medical, Bloomington, IN, USA), measuring 2-5 mm in diameter (Fig. 3). The aneurysm and residual tiny arteriole originating from the aneurysm were embolised using a mixture of N-butyl-2-cyanoacrylate and Lipiodol (Guerbet, Paris, France) in a 1:2 ratio. The inflow artery was embolised using the same microcoils measuring 2-4 mm in diameter. The final angiogram showed that the third right lumbar artery aneurysm was embolised successfully (Fig. 4). No blood transfusion was required and no complication was observed. The post-operative enhanced CT scan showed a thrombosed lumbar artery aneurysm with no extravasation and no additional aneurysm. The brain magnetic resonance imaging scan showed no aneurysm in the cervical or carotid arteries. The patient was discharged home in a good condition.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 73,\n",
       "    'case_id': 'PMC4015560_01',\n",
       "    'case_text': \"A 73 year old right hand dominant active lady complained of bilateral shoulder pain for about two months and did not respond to two ultrasound guided subacromial subdeltoid corticosteroid injections. Her shoulder injury occurred whilst she had been caring for her husband and working on their farm. In the past she had recovered from non-Hodgkin's lymphoma and currently was on antihypertensive medication (candesartan cilexetil once a day). She had led a physically active country life style prior to the presentation of the problem and had never smoked in her life.\\nAt presentation there was painful limitation of right sided shoulder abduction to less than 90 degrees. Ultrasound documented a 9mm x 14mm partial width full thickness footprint tear of the anterior to mid right supraspinatus with tendinosis of most of the tendon and enthesopathy at the greater tuberosity of the humeral head ( Figure 1). A plain radiograph of the right shoulder showed a down-sloping Type 2 acromion. There was mild wasting of the right supraspinatus muscle. A diagnosis of a recent footprint tear superimposed on degenerative supraspinatus tendon with mild muscle atrophy was made. Following written informed consent from the patient, 8ml of autologous unclotted blood was venesected and centrifuged for 5 minutes at about 3000 rotations per minute in a special tube for PRP preparation (BCT, REGEN Labs, Switzerland). 4 to 5ml of liquid PRP was injected through a 22g 5cm long needle into the tear and its margins with simultaneous percutaneous tenotomy directed into the footprint of the anterior facet of the greater tuberosity under direct ultrasound imaging control (GE Logic 9, 9MHz probe). 5ml 1% lignocaine was injected into the superficial soft tissues, subacromial bursa and the supraspinatus tear for local anaesthetic purposes. The shoulder was placed in a sling with 90 degree elbow flexion for 7 days. Physiotherapy was commenced at 4 to 5 weeks post PRP with a home exercise program. At 8 weeks follow up post PRP the patient verbally reported a marked reduction in pain with improvement in shoulder movement. At the 7 and 10 month follow up there was complete relief from pain with full range of movement of the right shoulder and she was able to lift bags of potting mix in her farm. At the 10 month follow up, ultrasound (GE Logic 9, 9MHz probe) performed by the author showed a near complete echogenic infilling obliterating the tear defect. The lateral margin of the tear merged with this neotendon tissue with mild medial retraction ( Figure 2). She was completely pain free at a follow up 1 year after PRP injection.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 5,\n",
       "    'case_id': 'PMC5866296_01',\n",
       "    'case_text': \"A 5-year old female patient came from a rural area of Ethiopia referred to MCM (the Korean Hospital) for CT angiography of the lower extremities, and to access the vascular supply of the tail like soft tissue growth. Her mother died after giving birth to this child. History from close relative remarked no similar congenital abnormality among the members of her family. There was no known maternal history of diabetes or teratogenic drug usage in the pregnancy. CT scan findings are summarized as follows.\\nProcedure done: Using multiplanar 8 slice General Electric CT machine, CT angiography of the lower extremities was performed., 17 cc of the Ultravist-370 was infused intravenously by using the power injector. The procedure was done under anesthesia using Ketamin IV infusion due to the patient's inability to stay still during the procedure\\nRadiologic findings: Image 1, demonstrate the morphologic CT appearance. There is an extra parasitic lower limb duplication attached from sacral area with extension to the presacral space (looks like a tail). Image 2 showes Skeletal images viewed from The oblique projections showing. normal right and left lower extremities\\nLength = 191 mm VS 238.8 mm\\nCortical thickness =4.7 mm vs 4.8 mm\\nFemoral shaft width= 8.9 mm vs 17.8 mm\\nExtra lower limb was seen between the normal lower limbs. Comparision of the Parasite Femur Versus accompanied normal Femur: \\nThe length of the parasitic (extra) femur was 80 % of the normal femur. Similarly, the width of the parasite femur was equvalent to 50%. However, the cortical thickness of both the parasitic and normal femur were almost equal.\\nIntervention: after evaluation of the radiologic images, surgical intervention was done. Incision was done by leaving adequate flap for wound coverage. then dissecting in a correct cleavage between the parasite and the main body. after reading the neurovascular bundle, the vessels and nerves were ligated. Parasitic tissue was resected completely leaving intact of the main body structures. Reconstruction of the ascess rectum, urogenetal structure and sphincter and wound coverage with proper musculo cutaneous flap was done.. All in all, the surgery was successful and the child returned to her rural village to continue the usual life. Yet, follow-up appointment was given.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': None,\n",
       "    'case_id': 'PMC10076629_01',\n",
       "    'case_text': \"A female preterm infant, the first child of healthy nonconsanguineous parents, was born at 30 + 2 weeks of gestation by normal delivery, with a birth weight of 1,210 g and a negative family history. After birth, multiple skin defects were found in the whole body, mainly in the lower limbs. Physical examination at birth indicated skin defects of both lower limbs with basal flushing and exudation, but no obvious signs of infection were found in the wounds (Figure 1). The dorsum of the foot was a hyperflexion deformity with low muscle tone in the extremities. The upper abdomen was distended with a distinct gastric pattern. Routine blood test was measured and revealed that white blood cell count (WBC) 10.53 x 109/L (reference range 15.0-20.0 x 109/L), neutrophil numerals (Neut#) 8.13 x 109/L (ref. 1.8-6.3 x 109/L), haemoglobin (Hb) 137 g/L (ref. 170-200 g/L), platelets (PLT) 230 x 109/L (ref. 125-350 x 109/L). The results of coagulation function showed prothrombin time (PT) 16.0 s (ref. 9.8-12.1 s), active partial thromboplastin time (APTT) 110.2 s (ref. 25.0-31.3 s), international normalized ratio (INR) 1.38 (ref. 0.88-1.08). x-ray showed gas in the stomach but no inflation in the small intestine, which is considered pyloric obstruction (Figure 2A). Contrast medium accumulation in the stomach lumen was observed on upper gastrointestinal angiography, with no development in the duodenum or distal part (Figure 2B). There were no abnormalities in the respiratory, cardiac or urinary systems. A skin biopsy was recommended to further confirm the diagnosis of EB, but her parents refused to perform this test.\\nThe patient's clinical manifestations and examinations indicated a genetic disease. After obtaining consent from the patient's family, we performed exome sequencing, which revealed heterozygous mutations in the affected ITGB4 gene, c.794dupC (p. S265fs*5) and c.2962G > A (p. A988T) (Table 1). These two variants were inherited from her parents respectively. The mutation c.794dupC is a frameshift mutation that results in the early termination of the amino acid code for protein synthesis. Another mutation c.2962G > A causes the substitution of a conserved amino acid. Computer analysis predicts that this mutation may affect protein structure and function.\",\n",
       "    'gender': 'Female'},\n",
       "   {'age': None,\n",
       "    'case_id': 'PMC10076629_02',\n",
       "    'case_text': \"In terms of treatment, sedation was given to reduce skin friction, and measures were taken to keep the skin clean and dry. Recombinant human epidermal growth factor gel was applied to the skin and covered with Vaseline gauze. Penicillin was also used to prevent infection. On the fourth day after admission, the baby began to develop a fever, and the result of routine blood tests showed WBC 1.89 x 109/L, Neut# 0.4 x 109/L, Hb 126 g/L, and PLT 127 x 109/L, while coagulation function revealed PT 18.7 s, APTT 70.6 s, INR 1.61. Meropenem, red blood cells and plasma were transfused, but the infection was difficult to control. The wound exudate increased and tended to bleed when touched. Abdominal distention also worsened. The patient was diagnosed with sepsis. The baby's parents refused further treatment because of the complexity of the disease, and the patient died shortly after being discharged from our hospital.\",\n",
       "    'gender': 'Unknown'}],\n",
       "  [{'age': 69,\n",
       "    'case_id': 'PMC6561004_01',\n",
       "    'case_text': \"A 69 year-old-man with a past medical history of hypertension and insulin dependent diabetes was admitted to the hospital after being found unconscious at his home. He was last seen normal about 9 hours prior to the emergency department arrival. Laboratory results revealed hypoglycemia, a blood sugar level of 29 mg/dL (1.6 mmol/L) on arrival. He received intravenous glucose (50% dextrose) immediately as per hypoglycemia protocol. Since his Glasgow Coma Scale (GCS) was low (<8) and with poor airway protection, he underwent endotracheal intubation with mechanical ventilation. There was no immediate clinical improvement even after the serum glucose was normalized. As per the family, he has had several episodes of hypoglycemia in the past and had responded well to immediate replenishment of glucose. Recent dosage modifications of his home insulin by his primary care physician had occurred due to the hypoglycemic events. On neurological examination, he was comatose, not following commands, there was no eye opening to noxious stimuli, pupils appeared to be equal and reactive to light and roving eye movements were noted. Doll's eye phenomenon was preserved. In response to painful stimuli, bilateral flexion of upper extremities was noted. Absent bilateral Babinski's reflex. Stroke was considered in the differential diagnosis. Computed tomography (CT) of head without contrast showed no hemorrhage and CT angiography (CTA) of head and neck was negative for large vessel occlusion. A magnetic resonance imaging (MRI) of brain revealed a hyperintense signal involving the head and tail of the left hippocampus on diffusion weighted image (DWI) sequence (Figure 1, Figure 2). A corresponding hypointense lesion was noted on apparent diffusion coefficient (ADC) sequence (Figure 3). He was transferred to the intensive care unit (ICU) for close neurological monitoring with frequent glycemic checks. His condition improved and was extubated a few days later, he was discharged home with no residual focal deficits.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 65,\n",
       "    'case_id': 'PMC6592670_01',\n",
       "    'case_text': 'Taking into account the evaluation of all mortality causes, depending on risk factors, in patients treated for left main coronary artery disease, we observed a higher mortality in the smoking group compared to the nonsmoking group (HR log=1.58, 95% CI ratio 0.4920 to 4.827 for active smoking, and HR log=0.6327, 95% CI ratio 0.2071 to 2.032 for nonsmoking, p=0.4682) as it can be seen in Fig.3A. Also, higher morality was recorded in the group of patients with diabetes mellitus compared to those without diabetes (HR logrank=7.833, 95% CI ratio 2.114 to 17.51 for patients with diabetes mellitus, and HR logrank=0.1277, 95% CI ratio 0.05712 to 0.4730 for patients without diabetes, p=0.0011) (Fig.3B), in the male group compared to the female group (HR log=8.289, 95% CI ratio 2.246 to 16.06 for the male group, and HR log=0.1206, 95% CI ratio 0.06228 to 0.4453 for the female group, p =0.0005) (Fig.3C), but also in 65 years old patients or older compared to the patients aged less than 65 years (HR logrank=2.419, 95% CI ratio 0.8086 to 7.123 for age>=65 years group, and HR log=0.4134, 95% CI ratio 0.1404 to 1.237 for age <65 years group, p=0.1218) (Fig.3D). Thus, with regard to the mortality assessment, statistically significant differences were recorded only depending on the presence of diabetes mellitus and gender.',\n",
       "    'gender': 'Female'},\n",
       "   {'age': 65,\n",
       "    'case_id': 'PMC6592670_02',\n",
       "    'case_text': 'Analyzing the left ventricular ejection fraction (LVEF) for three years, in patients treated for left main coronary artery disease, we observed a decrease in LVEF in active smoking group compared to nonsmoking group (HR log=1.539, 95% CI ratio 0.7263 to 3.289 for active smoking, and HR log=0.6496, 95% CI ratio 0.3040 to 1.377 for nonsmoking, p=0.2838) as it can be seen in Fig.4A. Also, a significant decrease in LVEF was recorded in the group of patients with diabetes mellitus compared to the group without diabetes (HR logrank=9.139, 95% CI ratio 3.662 to 14.82 for patients with diabetes mellitus, and HR logrank=0.1094, 95% CI ratio 0.06745 to 0.2731 for patients without diabetes, p<0.0001) (Fig. 4B), in the male group compared to the female group (HR log=2.045, 95% CI ratio 1.058 to 4.448 for male group, and HR log=0.4889, 95% CI (Fig. 4C), but also in the 65-year-old patient group compared to patients aged less than 65 years (HR logrank=1.737, 95% CI ratio 0.9394 to 3.607 for age>=65 years group, and HR log=0.5759, 95% CI ratio 0.2772 to 1.064 for age <65 years group, p=0.0933) (Fig. 4D). Thus, in terms of left ventricular ejection fraction (LVEF), statistically significant differences were recorded only in relation to the presence of diabetes and gender.\\nIn what the occurrence of ischemic heart disease symptomatology manifested by angina pectoris depending on risk factors in patients treated for left main coronary artery disease is concerned, we observed an increase in symptomatology in the smoking group compared to the nonsmoking group (HR logrank=1.94, 95% CI ratio 1.240 to 3.925 for active smoking, and HR log=0.5156, 95% CI ratio 0.2548 to 0.8063 for nonsmoking, p=0.0226) as it can be seen in Fig. 5A. Also, an increased rate of symptomatic patients was recorded in the group of patients with diabetes mellitus compared to those without diabetes (HR logrank=2.684, 95% CI ratio 2.280 to 6.625 for patients with diabetes mellitus, and HR logrank=0.3726, 95% CI ratio 0.1509 to 0.4385 for patients without diabetes, p<0.0001) (Fig. 5B), in the male group compared to the female group (HR log=1.861, 95% CI ratio 1.390 to 4.055 for the male group, HR log=0.5374, 95 % CI ratio 0.2466 to 0.7195 for the female group,=0.0075) (Fig. 5C), but also in patients older than or equal to 65 years of age compared to patients aged less than 65 years (HR logran=1.355, 95% CI ratio 0.8773 to 2.604 for age >=65 years group, and HR log=0.7378, 95% CI ratio 0.3840 to 1.140 for age <65 years group, p=0.2021) (Fig. 5D). Thus, with regard to the occurrence of ischemic heart disease symptomatology manifested by angina pectoris, statistically significant differences were recorded onlyforsmoking, diabetes mellitus and gender.\\n Looking at the incidence of the acute nonfatal myocardial infarction in patients with left ventricular coronary artery disease, we observed an increase in the rate of acute nonfatal myocardial infarction in the active smoking group compared to the nonsmoking group (HR log=1.832, 95% CI ratio 0.6961 to 4.492 for active smoking, and HR log=0.5459, 95% CI ratio 0.2226 to 1.437 for nonsmoking, p=0.2496) as it can be seen in Fig. 6A. Also, an increase in the rate of acute nonfatal myocardial infarction was recorded in the group of patients with diabetes mellitus compared to those without diabetes (HR logrank=7.833, 95% CI ratio 2.732 to 15.35 for patients with diabetes mellitus, and HR logrank=0.1277 , 95% CI ratio 0.06515 to 0.3660 for patients without diabetes, p<0.0001) (Fig. 6B), in the male group compared to the female group (HR log=1.924, 95% CI ratio 0.8567 to 4.770 for male group and HR log=0.5197, 95% CI ratio 0.2097 to 1.167 for female group, p=0.1227) (Fig. 6C), but also in the group of patients aged 65 years or older compared with patients aged less than 65 (HR logrank=2.15, 95% CI ratio 0.9473 to 5.248 for age >=65 years group, and HR log=0.4651, 95% CI ratio 0.1906 to 1.056 for age <65 years group, p=0.0778) (Fig. 6D). Thus, with regard to the occurrence of acute nonfatal myocardial infarction, statistically significant differences were recorded only depending on the presence of diabetes mellitus.\\nRegarding the need for revascularization after treatment (PCI vs. CABG) in patients with LMCAD depending on the risk factors, we noticed a higher need for revascularization in the smoking group compared to the nonsmoking group (HR logrank=2.155, 95% CI ratio 1.232 to 4.229 for active smoking, and HR logrank=0.464, 95% CI ratio 0.2365 to 0.8117 for nonsmoking, p=0.021) as it can be seen in Fig.7A. Also, a higher need for revascularization was recorded in the group of patients with diabetes mellitus compared to those without diabetes (HR logrank=3.808, 95% CI ratio 2.822 to 8.946 for patients with diabetes mellitus, and HR logrank=0.2626, 95% CI ratio of 0.1118 to 0.3544 for patients without diabetes, p<0.0001) (Fig. 7B), in the male group compared to the female group (HR log=1.842, 95% CI ratio 1.217 to 3.884 for male group, and HR log=0.5429, 95% CI ratio 0.2575 to 0.8214 for female groups, p=0.0202) (Fig. 7C), but also in patients aged 65 years or older compared with patients aged less than 65 years (HR logrank=1.528, 95% CI ratio 0.9601 to 3.053 for age >=65 years group, and HR log=0.6546, 95% CI ratio 0.3276 to 1.042 for age <65 years group, p=0.107) (Fig. 7D). Thus, in what the need for revascularization is concerned statistically significant differences were recorded only depending on smoking, diabetes mellitus and gender.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 9,\n",
       "    'case_id': 'PMC8635928_01',\n",
       "    'case_text': 'A 9-year-old young girl was referred to the rheumatology clinic from the ophthalmology unit as a case of systemic vasculitis with episcleritis. She presented with recurrent bilateral red painful eyes, a painful swollen left ear, and left knee pain in the preceding 10 months. A month prior to the presentation, she had developed an intermittent fever and reduced hearing. Three months prior to this, she had been admitted with painful swelling of the left knee and a fever, for which she was treated for septic arthritis of the left knee. Two years preceding the visit to the rheumatology clinic, she had also presented to the otorhinolaryngology unit on several occasions with complaints of hearing difficulty and was diagnosed with otitis externa. She has sickle cell disease-genotype SF and is a regular attendant at the pediatric sickle cell clinic. She did not suffer from an autoimmune condition, but had a first-degree cousin with systemic lupus erythematosus. She is the first of 2 children (her younger sibling is well) and has been unable to attend school due to arthralgia and difficulty hearing.\\nOn examination, there was mild pallor, axillary lymphadenopathy, and bilateral conjunctival injection with proptosis. The pinnae were swollen, erythematous, and tender, resembling \"cauliflower ears\" (Figure 1). The cardiorespiratory system examination was normal. There was acute synovitis of both knees with an old arthrotomy scar on the left (Figure 2).\\nResults from a previous synovial biopsy showed moderate, chronic inflammatory infiltrates composed of lymphocytes and plasma cells with stromal edema and congested vessels, but no malignant cells were seen, in keeping with chronic synovitis. The audiology assessment confirmed bilateral sensorineural hearing loss, worse in the left ear.\\nLaboratory investigations showed the following: Hb 10.7 g/dl (11-18 g/dl): microcytic, hypochromic pattern; WBC 15.7 x 10^9/L (2.5-8.5 x 10^9); and platelets 688 x 10^9/L (150-450 x 10^9). Erythrocyte sedimentation rate (ESR) and C reactive protein (CRP) were elevated at 96 mm/hr (0-15 mm/hr) and 143.7 mg/l (<5 mg/l), respectively. Hepatitis B, hepatitis C, and retroviral screens were negative. Hb electrophoresis-Hb A2-3%, Hb F-38.8%, Hb S-57.7%. The rheumatoid factor, ANA, and ENA panel were negative.\\nThe initial diagnoses considered were juvenile idiopathic arthritis, septic arthritis of the left knee, systemic vasculitis, relapsing polychondritis (RP), and Cogan\\'s syndrome, but the condition was subsequently confirmed to be RP with inflammatory arthritis based on the diagnostic criteria by McAdam et al. She initially fulfilled 4 out of the 6 features which are as follows: recurrent chondritis of both auricles, nonerosive inflammatory arthritis, inflammation of ocular structures, and bilateral sensorineural hearing loss, and later went on to develop an additional feature of chondritis of laryngeal and or tracheal cartilages as outlined below.\\nShe was admitted and started on intravenous (IV) clindamycin 180 mg 6 hourly and IV ciprofloxacin 200 mg 12 hourly for septic arthritis; oral ibuprofen 200 mg 12 hourly, oral paracetamol 250 mg 8 hourly, and prednisolone 15 mg daily to which she showed initial signs of response. The steroids and analgesia were started to help control the inflammation and pain associated with the disease. However, her disease flared up again with significant knee pain and swelling, a left conjunctival injection associated with pain, and high inflammatory markers. Prednisolone was increased from 15 mg to 20 mg daily, and oral methotrexate 7.5 mg weekly and folic acid 5 mg weekly were introduced. The inflammation in the eye persisted, though there was a reduction in inflammatory markers (ESR 70 mm/hr., CRP 111.7 mg/l) at subsequent reviews. The methotrexate dose was titrated up to 10 mg weekly, and the prednisolone dose was further increased to 30 mg daily. Two months after initiation of therapy, she had resolution of the auricular inflammation and a reduction in intermittent eye inflammation. Her knee swelling and tenderness had improved (Figure 2(c)), with a significant decline in her inflammatory markers (ESR-34 mm/hr, CRP 42.7 mg/l). The dose of methotrexate was increased further from 10 mg to 15 mg weekly. This was to provide steroid-sparing treatment, as she still had significant symptoms despite the higher doses of steroids used for control of inflammation. Despite the increase in the methotrexate dose, there was still significant disease activity after 2 months which signified some degree of corticosteroid dependence. The dose of prednisolone was tapered gradually at a dose of 5 mg weekly anytime there was a decrease in inflammatory markers, suggesting a reduction in inflammation.\\nDue to failure to respond adequately to methotrexate, as evidenced by the frequency of disease flares and worsening of her eye symptoms, she also developed cataracts due to the high doses of steroids used. This led to the introduction of infliximab 10 months into treatment. She received the loading course of 100 mg of intravenous infliximab at 0, 2, and 6 weeks, but was unable to continue with the maintenance therapy of 8-weekly infusions due to financial constraints. Despite the short course of infliximab, clinical benefits such as reduction in arthritis and eye inflammation were noted. Six weeks after her last infliximab infusion, she developed difficulty breathing.\\nThis progressed, leading to her presenting in the emergency room with signs of respiratory distress. On examination, she had audible inspiratory stridor, tachypnea, inspiratory rhonchi, and a slight reduction in breath sounds bilaterally, though vesicular in nature.\\nLateral cervical X-ray showed partial narrowing in the region of the cricoid cartilage (Figure 3). A diagnosis of upper airway obstruction (subglottic) secondary to perichondritis of the cricoid cartilage with respiratory fatigue was made upon review by the otorhinolaryngologist and pulmonologist. Treatment ensued with intravenous dexamethasone 2 mg 8 hourly, nebulized Pulmicort 500 mcg 12 hourly, and salbutamol 2.5 mg 4 hourly, and she was transferred to the intensive care unit. An emergency tracheostomy to relieve the subglottic stenosis was performed. She recovered well and was discharged on day 4 of admission.\\nHer medications were reviewed, taking into account the financial challenges to include oral colchicine 500 mcg twice daily, oral methotrexate 15 mg weekly and oral prednisolone 40 mg daily which was to be tapered gradually. Knee synovitis persisted, requiring intra-articular injections of 80 mg of methylprednisolone acetate into each joint. Tracheostomy care was carried out regularly at the otorhinolaryngology department, and close vigilance for infection was maintained.\\nA year and a half from the start of her treatment, she developed mid- to low-back pain. An X-ray of the lumbosacral spine showed a vertebral collapse at the L1 vertebra. A compression fracture was confirmed on MRI, with similar but less pronounced changes seen in T11, L3, and L4 vertebrae, suggestive of a bone softening process in keeping with glucocorticoid-induced osteoporosis and underlying hemoglobinopathy (Figure 4).\\nSteroid dose reduction continued and bisphosphonate therapy with alendronate 35 mg weekly was introduced. Oral dapsone 25 mg daily was added to her treatment for disease control due to its immunosuppressive and anti-inflammatory properties, but she continues to have remitting and relapsing disease.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 69,\n",
       "    'case_id': 'PMC5966628_01',\n",
       "    'case_text': \"A 69-year-old man with severe COPD requiring chronic oxygen supplementation (1 L/min) and suspected underlying X-linked granulomatous disease was admitted to the ICU with acute-on-chronic respiratory failure. He had a progressively worsening cough, shortness of breath, increased sputum production and had experienced a 10 kg weight loss with muscle depletion in the preceding three months. The patient had been treated for pulmonary tuberculosis at the age of 23 years, with no subsequent recurrence of infection. Chronic treatment with clomipramine (75 mg/day) was ongoing for a major depressive syndrome which had been diagnosed five years earlier. He was being monitored with monthly seriated electrocardiograms for QT prolongation attributable to clomipramine therapy.\\nAt ICU admission, the patient presented with severe dyspnea. Arterial blood-gas analysis showed mixed respiratory failure (pH 7.22, PaO2 58 mmHg, PaCO2 80 mmHg, HCO3- 35 mMol/L) requiring non-invasive ventilation. Chest examination revealed bilateral crackles, with no signs of chronic heart failure. Blood tests showed the white blood cell count to be in the normal range (8000/mm3), with no neutropenia (neutrophil count 1846/mm3), but mild lymphopenia was present (lymphocytes 810/mm3). The patient was anemic (Hb 10.9 g/dL). Platelet count was high (438,000/muL) and C-reactive protein (CRP) was markedly increased (35 mg/L; normal level <5 mg/L). Renal function was normal (serum creatinine 0.9 mg/dL), as were liver function tests (aspartate transaminase [AST] 11 IU/L, alanine transaminase [ALT] 14 IU/L, gamma-glutamyl transpeptidase [GGT] 30 IU/L, total bilirubin 0.15 mg/dL). Baseline electrocardiogram showed a sinus rhythm with a right bundle branch block and prolonged QT interval (453 ms).\\nChest x-ray showed multiple bilateral lung opacities. CT and [18F] fluorodeoxyglucose (FDG)-PET/CT scans revealed bilateral nodular infiltrates.\\nDue to the patient's critical condition and the multiple potential etiologies for the pulmonary infection, a bronchoscopy was performed, which demonstrated purulent secretions. Broncho-alveolar lavage (BAL) fluid was negative for bacteria, fungi, mycobacteria, Actinomyces spp. and Nocardia, but tested positive for galactomannan (GM; ODI 2.6).\\nAccording to the European Organisation for Research and Treatment of Cancer (EORTC) criteria for non-neutropenic patients, the diagnosis of probable IPA was made based on the presence of baseline predisposing comorbidities (severe COPD and suspected X-linked granulomatous disease), the presence of bilateral nodular infiltrates, and GM positivity on BAL.\\nVoriconazole was considered unsuitable due to the patient's baseline QT prolongation and the risk of a drug-drug interaction with clomipramine, potentially leading to further QT prolongation and severe cardiac arrhythmias. Isavuconazole therapy was selected, and started with a loading dose of 200 mg every 8 h for six doses, following by 200 mg daily.\\nAfter starting antifungal treatment with isavuconazole, the patient showed a progressive improvement in his clinical condition. At week 2, the arterial blood-gas analysis showed resolution of the decompensated respiratory acidosis, with normalization of pH (pH 7.40, PaO2 62 mmHg, PaCO2 50 mmHg, HCO3- 30 mMol/L). There was no further need of non-invasive ventilation. On day 17, the patient was moved from the ICU to the infectious diseases ward, and required only low flow oxygen supplementation (1 L/min). He was discharged on day 42. CT scanning and FDG-PET/TC after eight weeks of antifungal treatment confirmed the improvement of pulmonary infiltrates. In total, a three-month course of isavuconazole treatment was completed, and there were no clinical or radiologic signs of infection after six months' follow-up. Isavuconazole was well-tolerated, with no adverse events and no change in liver enzymes. Serial ECG monitoring showed no prolongation of the QT interval.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 39,\n",
       "    'case_id': 'PMC8688253_01',\n",
       "    'case_text': 'A 39 years old man was admitted to our hospital on January 2, 2019 with the chief complaint of recurrent diarrhea and black stool for 3 weeks. A gastroscopy showed erosion, hyperplasia and protuberance of cardia mucosa. Pathological biopsy of the protuberant lesions showed cardia adenocarcinoma. Further immunohistochemistry showed MSH2 (+), MSH6 (+), PMS2 (+), MLH1 (+), HER-2 (2+). And negative for HER-2 fluorescence in situ hybridization (FISH) test and Epstein-Barr encoding region (EBER) polymerase chain reaction (PCR) test. A positron emission tomography - computed tomography (PET-CT) was conducted and showed thickened gastric cardia wall, multiple enlarged lymph nodes with high standard uptake value (SUV), including left supraclavicular lymph nodes, multiple lymph nodes adjacent to the cardia and retroperitoneal lymph nodes, multiple destructive bones (left scapula, right 5th rib, Th8-10 vertebrae, L3 left adnexa, sacrum and left iliac bone). He denied any family history of hereditary diseases and special medical history. The laboratory examination showed elevated carbohydrate antigen 199 (CA19-9) of 52.1U/ml and normal carcinoembryonic antigen (CEA), carbohydrate antigen 125 (CA125) and alpha fetoprotein (AFP) level.\\nAfter admission, the patient received 4 cycles of FOLFOX4 chemotherapy from January 9, to February 27, 2019. After the initial 4 cycles of chemotherapy, the patient complaint of aggravated chest and back pain. Besides, CA125 and CA19-9 were increased from 32.1 U/ml to 62.9 U/ml and from 52.1 U/ml to 78.4 U/ml respectively. A computed tomography (CT) scan suggested an increase in the size of metastatic lymph nodes and the extent of bone metastases compared to that before treatment (Figure 1). Thus, the curative effect was evaluated as progressive disease (PD) with a progression-free survival (PFS) of 3.5 months.\\nIn order to look for more effective treatment, a next generation sequencing (NGS) (unpublished report) was performed and showed CCND1 gene amplification, RICTOR gene amplification, TMB-L (TMB 5 Muts/Mb) and MSS. The immunohistochemistry of PD-L1 with 22C3 antibody showed a Combined Positive Score (CPS) with 0 (Supplementary Figure 1). Then, the patient accepted second-line chemotherapy of albumin paclitaxel combined with tegafur (S-1) for 6 cycles from March 15th to July 10th, 2019. In the meantime, thoracic spine and lumbar spine radiotherapy of DT 36Gy/12F was performed to relieve the pain. CT scans after every 2 cycles of chemotherapy suggested sustained stable disease (SD). CA125 and CA19-9 decreased to the normal level during the second-line chemotherapy gradually. The patient reported improving quality of life by relieving pain. Thus, single agent maintenance chemotherapy with S-1 was initiated from Aug. 2nd,2019. The regular visit 2 months later showed increased CA19-9 from 30.8 U/ml to 354 U/ml. And the pain was aggravated gradually. The CT scan suggested PD with newly formed bone metastases after maintenance chemotherapy with S-1 for only 2 months (Figure 2). Therefore, a third-line treatment was considered. And in the choice of third-line treatment regimen, either Apatinib or anti-PD-1 was considered according to the Chinese guideline at that time. While considering that the previous paclitaxel was effective as the second line therapy and the high cost of Apatinib or PD-1 antibody at that time, single-agent docetaxel was accepted as the final choice. Docetaxel was used for 3 cycles. And at the same time, right iliac and left acromioclavicular head radiotherapy was conducted at a dose of 30Gy/10F to relieve the pain. The evaluation after three cycles of third line docetaxel showed enlarged lymph nodes in the neck and axilla with aggravated cough, which suggested PD (Figure 3).\\nLuckily, a clinical trial of PD-1 antibody SCT-I10A (unlisted) for metastatic gastric cancer was recruiting in our center and the patient was a qualified participant. After informed consent, the patient took part in the clinical trial and received the first dose of PD-1 antibody (SCT-I10A) on January 10, 2020. Surprisingly, the patient reported that the cough disappeared around 3 weeks after the first dose of the drug. Then, due to the pandemic of Corona Virus Disease 2019 (COVID-19), the treatment was discontinued for nearly 3 months without any treatment. After the pandemic, the patient returned to the hospital for further evaluation. The result showed reduced pleural fluid, shrunken mediastinal, neck, axillary and retroperitoneal lymph nodes and normal tumor markers, which were suggestive of partial response (PR) (Figure 4). Considering the inspiring response, another 23 cycles of PD-1 antibody therapy were conducted with the last treatment on 2021.7.16 and the efficacy was assessed as sustained PR.\\nTo further clarify whether this patient has specific gene mutations that make him sensitive to immunotherapy, a NGS test of peripheral blood was conducted on Jan. 28th, 2021. The results showed no gene mutations with MSS and TMB-L.\\nUp to now, the patient has an overall survival (OS) of over 30 months and has no discomfort. The timeline of patient treatment and change of tumor markers was shown in Supplementary Figure 2.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 77,\n",
       "    'case_id': 'PMC7326191_01',\n",
       "    'case_text': \"The case review was conducted according to all guidelines outlined in the Declaration of Helsinki. Written informed consent for publication of any case details and any accompanying images was obtained from the patient's family. A 77-year-old male was taken to our emergency department after being found at the foot of a flight of stairs in a semicomatose state. Although nobody witnessed the fall, the trauma was apparent from multiple abrasions and bruising on the face and chest. Upon arrival at the emergency room, the Glasgow coma scale (GCS) score was 6 (E1M3V2), and the pupil size and light reflex were intact. The neurologic examination demonstrated no focal neurologic deficits, including motor weakness or sensory change in all four extremities. The patient had no underlying disease such as hypertension, diabetes, or heart disease, and did not take any medication that induces coagulopathy.\\nInitial CT of the brain disclosed diffuse SAH of the basal cistern, accompanying intraventricular hemorrhage (IVH), and hydrocephalus, which are common in nontraumatic aneurysmal SAH (Figure 1). Despite the external wounds and skull fracture, the appearance of the SAH was different from that of usual traumatic SAH, which typically shows small amounts of blood in the sulci of the cerebral convexities. We suspected that an aneurysm might have ruptured spontaneously just before the patient fell down the stairs, causing trauma secondarily. However, the subsequent head and neck CT angiography failed to reveal a cerebral aneurysm or other vascular malformation that could give rise to basal SAH.\\nWe performed extraventricular drainage (EVD) emergently at the right Kocher's point to relieve the hydrocephalus. The opening pressure was as high as 15 cm H2O and the intracranial pressure (ICP) decreased after draining the bloody cerebrospinal fluid (CSF). However, the patient showed minimal neurologic improvement postoperatively.\\nAfter stabilizing the ICP, we performed digital subtraction angiography (DSA) to identify a cerebral aneurysm or other vascular malformation that might have been missed on CT angiography. The DSA disclosed a 1.8 mm sized traumatic pseudoaneurysm at the mid-portion of the right PCoA that was inapparent on CT angiography (Figure 2). We observed extravasation of contrast media from it, resulting in basal SAH (Figure 2B). In this manner, because no other aneurysm or pre-existing vascular abnormality was found on DSA, the patient's basal SAH was confirmed as traumatic in origin.\\nAfter confirming adequate blood flow of the right posterior cerebral artery through the posterior circulation, we performed endovascular trapping from the mid- to distal portion of the right PCoA using coils (Figure 3A and B). There was no intraoperative unexpected event or thromboembolic complication. Postoperatively, we confirmed the absence of extravasated contrast media and intactness and patency of the collateral vessels (Figure 3C and D). Despite successful trapping of the PCoA, the patient had an unfavorable clinical course. Although the patient's mental status improved minimally, to stuporous mentality, the hydrocephalus persisted, requiring repeated EVD. The patient did not recover alert mentality and was transferred to another local hospital.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 39,\n",
       "    'case_id': 'PMC4427135_01',\n",
       "    'case_text': \"A 39-year-old male with no significant past medical history presented with a 1-week history of increasing pain in the calf of the right leg associated with bluish-black discoloration on the back of right leg from the upper thigh to the ankle area. He denied any history of trauma to the leg and reported that he was driving when he noticed a 'pop' noise from his right leg. Since then he had noticed gradually increasing swelling, pain and discoloration of the leg. His social history was significant for consumption of twelve 16-ounce bottles of beer every day for 20 years (232 g of alcohol daily). He denied any history of blood in stool or urine, epistaxis, easy bruising or bleeding in joints or any surgeries in the past. His family history was noncontributory in terms of bleeding disorders.\\nAt first presentation, his pulse was 96/min, blood pressure 137/79 mm Hg, respiratory rate 20/min, temperature 98.7 F. General examination showed a well-developed man in no distress, with pallor and icterus. Local examination was significant for severe tenderness over the right calf region with tense rigidity. Extensive tense ecchymosis was noted over the back of the right leg extending from the lower gluteal fold to the ankle (fig. 1). Distal pulses were intact. Neurologic examination showed intact power and sensation to pain, pressure and vibration. Systemic examination was significant for smooth liver margin palpable at least 2 cm below the costal margin with a liver span of approximately 9 cm and splenomegaly. Labs at admission were significant for hemoglobin (9.2 mg/dl), hematocrit (26.8%), reticulocyte index (1.4), mean corpuscular volume (105.2 fl) and platelet count (64,000/mul). Liver function tests showed total bilirubin 7.2 mg/dl and direct bilirubin 2.1 mg/dl, total protein 6.5 g/dl, albumin 2.3 g/dl, alkaline phosphatase 164 U/l, gamma-glutamyltransferase 133 U/l, aspartate aminotransferase 59 U/l and alanine aminotransferase 30 U/l. Coagulation profile showed prothrombin time 25.1, activated partial thromboplastin time 44.2 and international normalized ratio 2.43. Direct Coombs test was negative. Creatinine kinase at admission was 63 U/l. Individual coagulation factor assays are shown in table 1. A computed tomography scan of the lower extremity without contrast showed multiple loculated fluid collections in the medial head of the gastrocnemius muscle which measured 4.5 x 2.6 cm (fig. 2). Compartment syndrome was ruled out in the absence of signs of gangrene or neurovascular compromise. After admission, the patient received 2 units of fresh frozen plasma to correct the coagulopathy; however, overnight his hemoglobin dropped to 7.2 g/dl, which raised suspicion of rebleed. Doppler ultrasound of the legs showed a stable hematoma of 14.2 x 3.0 x 4.2 cm and a fecal occult blood sample was negative for blood. Abdominal ultrasound showed nodular appearance of the liver consistent with cirrhosis and splenomegaly and a large ascites. Ascitic fluid analysis showed a high serum-ascites albumin gradient which was consistent with cirrhosis as the cause of ascites. Other causes of cirrhosis were ruled out with a negative autoimmunity workup and negative hepatitis profile. Serum and urine immunofixation were negative for monoclonal bands. Though the patient did not exhibit any neurologic signs, we ruled out Wilson's disease with a normal ceruloplasmin level. Coagulopathy workup showed prolonged thrombin time and correction of prothrombin time/activated partial thromboplastin time on both immediate and incubated mixing studies, indicating factor deficiency.\\nSpecific factor assays showed depletion of all factors except for factor VIII, which further confirmed the suspicion that the factor depletion was secondary to liver cirrhosis. Liver biopsy was deferred in view of the deranged coagulation profile. He was discharged after 8 days in stable condition, having been told that he had a life-threatening condition and that complete abstinence from alcohol for 6 months would be necessary before transplantation could be considered. Screening esophagoscopy showed large esophageal varices without any stigmata of bleeding. On follow-up visits to the outpatient clinic the hematoma continued to resolve, however liver function tests and coagulation profile continued to worsen. Four months later he was readmitted with worsening ascites and increasing bilateral swelling. He was found to have renal insufficiency and a high serum-ascites albumin gradient. He was also diagnosed with heart failure with preserved ejection fraction; the presentation was suggestive of hepatorenal syndrome. The patient requested a return to his home country (Mexico) for further care. This was arranged with the help of palliative services.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 71,\n",
       "    'case_id': 'PMC9726840_01',\n",
       "    'case_text': \"A 71-year-old woman who had previously been diagnosed with rheumatoid arthritis presented with generalized edema, worsening hypertension, and non-blanchable erythematous papules with reticulation on both legs, which had been presented for 4 months, as shown in Figure 1. Rheumatoid arthritis had been diagnosed 5 years prior when she presented with polyarthralgia and positivity for rheumatoid factor. Prednisolone, methotrexate, and subcutaneous etanercept were prescribed, and complete clinical remission had been achieved after 2 years of treatment. The medications were then discontinued, and the patient sustained her clinical remission afterward.\\nThe patient had developed both ankle edema 4 months prior to this admission, which slowly progressed to the pretibial areas. Her urine appeared foamier for 2 months, which was accompanied by rising of blood pressure according to a home monitoring device. Urine color and volume were unchanged from the patient's perspective. Physical examination indicated high blood pressure (190/94 mm Hg), bilateral pitting edema, and livedo reticularis of both legs. No other skin lesion was found. There was no active arthritis, fever, or lymphadenopathy. The results of the initial investigation are displayed in Table 1, which shows a serum creatinine of 1.86 mg/dL, dysmorphic red blood cells in urine, and proteinuria.\\nFurther investigations showed a positive result for antinuclear antibody (ANA) with a homogeneous, fine-speckled, and nucleolar pattern (titer > 1:1280). The level of rheumatoid factor was 54.40 IU/mL (normal < 20 IU/mL). Serum cryoglobulin was positive. Serological tests for HCV and human immunodeficiency virus (HIV) were negative. The serology results for hepatitis B virus (HBV) were negative for HBsAg, positive for anti-HBc, and positive for anti-HBs antibodies. Complement C3 was normal, and C4 was 3.09 mg/dL (10-40 mg/dL).\\nA percutaneous kidney biopsy was performed and kidney pathology is shown in Figures 2 and 3. The kidney pathology revealed diffuse endocapillary hypercellularity and mesangial expansion with lobular accentuation of glomeruli in hematoxylin and eosin (H&E) staining. Periodic acid-Schiff (PAS) staining demonstrated global and diffuse double-contour thickening of the glomerular basement membrane, which was compatible with a pattern of MPGN. No crescentic lesion was observed.\\nThe immunofluorescence (IF) study revealed predominant IgM (2+) staining. IgG (1+) and C3 (1+) granular staining in mesangium and capillary loops were also observed. Equivalent kappa and lambda staining was found in the capillary loops (1+). C1q and IgA results were negative. Figure 3 displays the results of an electron microscopic (EM) study, which revealed the deposition of organized electron-dense materials at the mesangium and subendothelium. The substructures were composed of short microtubules (~20 nm thickness) with hollow centers. Neomembrane formation and diffuse foot process effacement were also noted.\\nThe positive result for serum cryoglobulin, bilateral skin rash compatible with leukocytoclastic vasculitis, polytypic IgM-dominant deposits in the IF study, and organizing deposits in the EM study help to narrow the diagnosis to cryoglobulinemic glomerulonephritis. The kidney pathology did not show any light-chain restriction since there was equal intensity of kappa and lambda staining, suggesting mixed cryoglobulinemic glomerulonephritis. The underlying cause of cryoglobulinemia was then investigated in this elderly patient.\\nCommon causes of mixed cryoglobulinemia such as HCV and HBV were ruled out by negative serology results. The results of age-appropriate cancer screenings including colonoscopy, mammography, and pelvic examination were all negative. However, serum protein electrophoresis revealed a monoclonal spike of 0.35 g/dL. Serum immunofixation showed IgM kappa monoclonal gammopathy. The immunofixation of cryoprecipitate was not done at that time due to the logistic issue in the out-patient setting. Serum kappa was 248.31 mg/dL (3.3-19.4 mg/dL) and serum lambda was 40.84 mg/dL (5.71-26.30 mg/dL) with a kappa-to-lambda free light-chain ratio of 6.08. These findings raised the possibility of lymphoproliferative disorder. However, bone marrow aspiration and biopsy showed normocellular trilineage marrow without evidence of abnormal clonality, lymphoma, or plasma cell disorders.\\nBased on all evidence, particularly the detectable monoclonal IgM kappa gammopathy in the patient's serum despite not revealing lymphoproliferative disease, a diagnosis of MGRS with non-hepatitis-associated mixed cryoglobulinemic glomerulonephritis was suspected. After a multidisciplinary team discussion and informing the patient of all the possibilities, clone-directed therapy was initiated, including a 3-week cycle of oral cyclophosphamide at 200 mg/day and dexamethasone. After six cycles, the bilateral leg edema and rash were completely resolved. Serum creatinine was decreased to 0.83 mg/dL, and proteinuria was 0.49 g/g creatinine. The monoclonal protein level was decreased to 0.13 g/dL, and the serum kappa-to-lambda ratio was 1.3. The patient is still in remission as of 3 years after the completion of treatment.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': None,\n",
       "    'case_id': 'PMC2892669_01',\n",
       "    'case_text': 'A British Caucasian male patient, born in 1946, fell down from a ladder in 2002 and sustained concussional brain injury, soft tissue injury to left shoulder, burst fracture of thoracic vertebrae 4, 5, and 6, paraplegia T-5 (American Spinal Injury Association grade B), multiple rib fractures and mediastinal haematoma. Following rehabilitation, this patient had been managing his bladder by long-term indwelling catheter drainage.',\n",
       "    'gender': 'Male'},\n",
       "   {'age': None,\n",
       "    'case_id': 'PMC2892669_02',\n",
       "    'case_text': 'In June 2009, he developed temperature of 38.8 degrees Celsius. White cell count was high (18.1 x 109/L). Neutrophils were increased (15.85 x 109/L). C-reactive protein was elevated (121.1 mg/L). Total protein: 65 g/L. Albumin: 39 g/L. Globulin: 26 g/L. Urine microbiology showed growth of Klebsiella pneumoniae, which produced an extended spectrum beta-lactamase and multiresistant. This patient was prescribed gentamicin 320 mg once daily. In October 2009, this patient again developed urine infection. C-reactive protein was high at 165.8 mg/L. Total protein: 69 g/L. Albumin: 38 g/L. Globulin: 31 g/L. Haemoglobin was 12.7 g/dL. Urine showed growth of Escherichia coli; antibiotic sensitivity report was not available. This patient was prescribed meropenem, one gram intravenously every eight hours. While the patient received meropenem, another sample of urine was sent for microbiology; this sample of urine showed no growth. Intravenous urography was performed in November 2009 to exclude stones in the upper urinary tract as a reason for the recurrent urinary tract infection. No renal or ureteric calculi were found.',\n",
       "    'gender': 'Male'},\n",
       "   {'age': None,\n",
       "    'case_id': 'PMC2892669_03',\n",
       "    'case_text': 'In January 2010, this patient decided to undergo suprapubic cystostomy so that he could discard permanent catheter in the penis. At the time of undergoing suprapubic cystostomy, this patient was feeling well; he did not have symptomatic urine infection. He did not suffer from any comorbid condition such as diabetes mellitus, pressure sore, ischaemic heart disease, hypertension, or mental health problem. This patient had Medtronic programmable pump implanted for intrathecal administration of baclofen for control of spasticity. His medications were senna syrup, sugar-free, 30 mg on alternate evenings; Micralax Micro-enema 5 mL on alternate mornings; oxybutynin modified release 10 mg, once daily. Neither blood tests nor urodynamics were performed prior to suprapubic cystostomy. He was given gentamicin 240 mg intravenously, as antibiotic sensitivity report of urine sample was not available to physicians treating this patient. Suprapubic cystostomy was performed in the outpatient department using Add a Cath. The urinary bladder was located by ultrasound scan. The procedure was carried out uneventfully. Following suprapubic cystostomy, there was mild haematuria. Two hours later, this patient was feeling unwell; he had tachycardia, spasms, and cold fingers. Temperature was 38 degrees Celsius; oxygen saturation was 97%; urine was stained with blood; there was some oozing of blood from suprapubic cystostomy site. Suprapubic catheter was patent. Diagnosis was septicaemia. He had received one dose of gentamicin 240 mg intravenously. Subsequently, a review of laboratory reports revealed that in October 2009, urine showed growth of coliforms, sensitive to meropenem. Therefore, this patient was prescribed meropenem 1 gram intravenously every eight hours. He was given fluids intravenously. A Foley catheter was inserted per urethra. Blood culture was taken. This blood culture yielded growth of Escherichia coli; however, antibiotic sensitivity was not available. Full blood count revealed low white cell count of 2.7 x 109/L, which indicated severe sepsis. Blood test showed Total Protein: 72 g/L; Albumin: 40 g/L; Globulin: 32 g/L.',\n",
       "    'gender': 'Male'},\n",
       "   {'age': None,\n",
       "    'case_id': 'PMC2892669_04',\n",
       "    'case_text': 'Sixteen hours after undergoing suprapubic cystostomy, this patient was afebrile. He was breathing spontaneously with 40% oxygen by nasal mask. Heart rate was 93 per minute; Blood pressure was 80/33 mm Hg; respiratory rate was 16 per minute. There was peripheral cyanosis; capillary circulation return time was greater than two seconds. Examination of chest revealed bilateral equal air entry and vesicular breath sounds. Abdomen was soft and bowel sounds were present. Clinical impression was septicaemia and hypovolaemia. Rate of administration of intravenous fluids was increased to 160 mL per hour. Arterial blood gas showed pH: 7.393;  pCO2: 5.87 kPa; pO2: 8.25 kPa; actual bicarbonate: 26.2 mmol/L; standard bicarbonate: 25.2 mmol/L; base excess: 1.0 mmol/L. Full blood count showed leucocytosis (15.6 x 109/L); neutrophils count was high (15.3 x 109/L). APTT ratio was high at 1.40 (reference range: 0.84-1.16). C-reactive protein was high at 123.1 mg/L. Blood urea: 9.1 mmol/L; creatinine: 148 micromol/L; sodium: 133 mmol/L; potassium: 4.3 mmol/L.',\n",
       "    'gender': 'Male'},\n",
       "   {'age': None,\n",
       "    'case_id': 'PMC2892669_05',\n",
       "    'case_text': 'Thirty-four hours after performing suprapubic cystostomy, this patient was found to be confused. Heart rate was 113 per minute; blood pressure was 119/63 mm Hg. Physical examination revealed clear chest; abdomen was silent; penis was oedematous. Blood tests showed sodium: 133 mmol/L; potassium: 4.3 mmol/L; urea: 9.1 mmol/L; creatinine 148 micromol/L. This patient was given intravenous infusion of succinylated gelatine (Gelofusine) 500 mL. Even after this fluid challenge, urine output was only 15 mL. Both urinary catheters were patent. On clinical examination, abdomen was soft and nontender. Urinary bladder was not palpable; suprapubic wound was healthy; penis was very oedematous.',\n",
       "    'gender': 'Unknown'},\n",
       "   {'age': None,\n",
       "    'case_id': 'PMC2892669_06',\n",
       "    'case_text': \"Thirty-six hours after undergoing suprapubic cystostomy, this patient was in renal failure; urine output was 5 mL in two hours. Full blood count showed very high white cell count (23.6 x 109/L). Haemoglobin was slightly low at 10.5 g/dL. Platelet count was also low at 12 x 109/L 1. Neutrophils were greatly increased (22.4 x 109/L). Blood urea had risen to 16.4 mmol/L. Creatinine concentration also had increased to 253 micromol/L. Sodium was low at 127 mmol/L. Potassium level had increased from 4.3 mmol/L to 5.4 mmol/L. This patient developed cardiac arrest 38 hours after suprapubic cystostomy. After 28 minutes of unsuccessful resuscitation, he was declared dead. Patient's wife did not give permission for autopsy.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 0,\n",
       "    'case_id': 'PMC3245498_01',\n",
       "    'case_text': 'A 45-day-old male baby born at term with a birth weight of 2600 g presented with vomiting and poor sucking. Body weight was 2600 g, indicating that the patient had not gained weight since birth. Physical examination revealed severe dehydration and mild scrotal hyperpigmentation. Laboratory results were as follows: Serum Na: 114 mEq/L (N: 135-143 mEq/L),  K: 7.7 mEq/L (N: 3.5-5.5mEq/L), blood pH: 7.3, HCO3: 12 mmol/L, BUN: 24 mg/dL (0-10 mg/dL), creatinine: 0.5 mg/dL (0.3-1.2 mg/dL). Urinalysis revealed leukocytes and urine culture grew 100 000 colonies/mL E. coli. Intravenous saline treatment was started together with antibiotics for the UTI. Hormonal evaluation results were adrenocorticotropic hormone (ACTH): 186 pg/mL (N: 3-46 pg/mL), basal cortisol: 8 mug/dL, renin: 836 pg/mL (N: 2.4-37 pg/mL) and aldosterone: 450 pg/mL (N: 20-700 pg/mL) - findings  which led to a preliminary diagnosis of PHA. A high ACTH value was noted. The ACTH stimulation test performed to rule out CAH gave the following results for 17-hydroxyprogesterone (17-OHP) response: 27.7 ng/mL at 0 time, 37.2 ng/mL at 30 minutes and 35.3 ng/mL at 60 minutes. The patient was therefore diagnosed as CAH. Treatment was started with hydrocortisone and fludrocortisone and 1 g/day salt was added to the diet. A high level of aldosterone despite salt loss is not expected in CAH. We therefore performed renal ultrasonography to detect any renal anomaly that could cause a lack of response to aldosterone and found grade 2 hydronephrosis of the left kidney and bilateral grade 4-5 VUR on voiding cystogram. Amoxicillin prophylaxis was started. Genetic analysis revealed a heterozygous Q318X and homozygous IVS2 mutation of the 21-OH gene. Bilateral Teflon injection was performed for the VUR. The patient is currently 4 years old, is on hydrocortisone and fludrocortisone and is being followed-up without any problems.\\nPatient 2',\n",
       "    'gender': 'Male'},\n",
       "   {'age': 0,\n",
       "    'case_id': 'PMC3245498_02',\n",
       "    'case_text': 'A 35-day-old male baby born with a birth weight of 3500 g at term presented to the emergency service of our hospital with vomiting and failure to thrive. His weight was 3200 g,',\n",
       "    'gender': 'Male'},\n",
       "   {'age': 1,\n",
       "    'case_id': 'PMC3245498_03',\n",
       "    'case_text': \"indicating a weight loss of 8% since birth. The patient's general condition was poor. Marked dehydration and mild scrotal hyperpigmentation were present. Laboratory results were as follows: Serum Na: 95 mEq/L (N: 135-143 mEq/L), K: 6.9 mEq/L (N: 3.5-5.5 mEq/L ), blood pH: 7.3, HCO3: 11.7 mmol/L, BUN: 26 mg/dL (0-10 mg/dL), creatinine: 0.47 mg/dL (0.3-1.2 mg/dL). Urinalysis was positive for nitrite and leukocytes and there was a growth of 100 000 colonies of Klebsiella on urine culture. Fludrocortisone and antibiotics were started together with intravenous fluid treatment. Renal ultrasonographic investigation for UTI showed prominent collective structures in the left kidney and grade 2 VUR on the voiding cystogram. Antibiotic prophylaxis was started. Hormonal evaluation revealed basal cortisol of 18 mug/dL, ACTH 89.5 pg/mL (N: 3-46 pg/mL), renin: 186 pg/mL (N: 2.4-37 pg/mL), and aldosterone level of 2 000 pg/mL (N:20-700 pg/mL). The preliminary diagnosis was PHA. The patient benefited from fludrocortisone treatment. Taking into account the high serum ACTH level, an ACTH stimulation test was performed to rule out CAH and the 17-OHP response was as follows: 27.6 ng/mL at 0 time, 44.1 ng/mL at 30 minutes and 41.2 ng/mL at 60 minutes. Hydrocortisone was added to the fludrocortisone and salt treatment. Genetic analysis revealed a large deletion of the 21-OH gene. The patient is currently 1 year old and is being followed-up without any problems on hydrocortisone, fludrocortisone and oral 1 g/day salt treatment. Age at presentation and laboratory findings of the patients are given in Table 1.\",\n",
       "    'gender': 'Unknown'}],\n",
       "  [{'age': 62,\n",
       "    'case_id': 'PMC5369366_01',\n",
       "    'case_text': \"A 62-year-old man was admitted to our hospital with three weeks of non-productive cough, dyspnea, fatigue, and anorexia. He had started ibrutinib six weeks prior to admission for relapsed CLL. He was retired and lived in western Oregon. He reported no exposure to tobacco, dust, birds, or other animals. His tuberculin skin test was negative prior to initiation of ibrutinib. On examination, the patient was afebrile (36.7 C); pulse was 66/min; BP was 82/52 mm Hg; respiratory rate 16/min; and oxygen saturation 96% on room air. Cardiopulmonary examination was normal. Laboratory investigations revealed anemia (Hgb 5.0 g/dL), leukocytosis (21.2 x 103/mul), decreased platelets (140 x 103/mul), and a normal neutrophil count (1.91 x 103/mul). Serum chemistries were notable for a sodium of 129 mmol/L, chloride of 97 mmol/L, bicarbonate of 17 mmol/L, urea nitrogen of 26 mg/dL, and creatinine of 1.2 mg/dL.\\nComputed tomography scan of the lung showed multifocal upper lobe centrilobular nodules, patchy consolidations with air bronchograms, and small areas of cavitation (Fig. 1A), findings that were not present prior to ibrutinib initiation. Bronchoscopy revealed endobronchial masses in the lingula and right upper lobe (Fig. 1B). Biopsy of the masses showed necrotic mucosa containing septate fungal hyphae with acute angle branching, consistent with Aspergillus (Fig. 1C). Bronchoalveolar lavage (BAL) was performed in the right middle lobe. BAL fluid grew Aspergillus fumigatus and showed no evidence of acid-fast bacilli or nocardia. BAL galactomannan was positive.\\nThe patient was treated with voriconazole and ibrutinib was briefly discontinued. The patient developed hypercalcemia suspicious for relapsed CLL and ibrutinib was resumed at a lower dose. Serial chest radiographs showed resolution of the multifocal consolidative opacities and nodules over the subsequent two months. The patient's CLL continued to progress despite additional chemotherapy and he died five months after starting ibrutinib.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 29,\n",
       "    'case_id': 'PMC4996573_01',\n",
       "    'case_text': 'A 29-year-old female presented to the emergency department with severe abdominal pain. A CT scan showed a possible urachal diverticulum with signs of surrounding infection and inflammation. Her urine culture grew out Escherichia coli and Enterococcus faecalis. She defervesced with antibiotics and conservative measures.\\nEight months later, she was referred to urology with a history of chronic suprapubic pain, dyspareunia, and dysorgasmia. The pain was described as intermittent lasting minutes to hours. She also noted soreness in the suprapubic area and bloating. Follow-up MRI revealed a benign-appearing multilocular urachal cyst with thin nonenhancing septations as depicted in Figures 1 and 2. On cystoscopy, the bladder appeared normal. However, palpation of the tender abdominal area correlated cystoscopically with the dome of the bladder in the region of the urachal remnant. She opted for cyst removal in an attempt to alleviate her symptoms and reduce the risk of reinfection or malignant transformation.\\nThe patient was positioned in the steep Trendelenburg position and an 18F three-way Foley catheter was inserted. We insufflated the abdomen supraumbilically using a Veress needle. The procedure was done transperitoneally with port placement similar to a standard robotic prostatectomy. The urachus was divided and the bladder was mobilized from the anterior abdominal wall by incising the peritoneum lateral to the medial umbilical ligaments. The space of Retzius was developed. A flexible cystoscope was placed into the bladder to illuminate the bladder dome and urachal remnant:this video feed was transmitted into the Tile Pro  software of the robot to allow simultaneous cystoscopic visualization through the robotic console illustrated in Figure 3. The urachal cyst was mobilized and skeletonized down to a small neck at its insertion. The detrusor muscle layer was incised with thermal energy just below the neck of the cyst but superficial to the bladder mucosa. The cyst was extracted and sent for frozen section, which was negative for malignancy, obviating the need for partial cystectomy. The overlying detrusor was repaired with a 3-0 V-Loc followed by a second 3-0 V-Loc on the muscle and peritoneum. The bladder was filled and the repair was noted to be watertight.\\nThe patient was discharged home the same day. Her catheter was removed on day 3. She has remained symptom free over the past 12 months since surgery.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 37,\n",
       "    'case_id': 'PMC6217883_01',\n",
       "    'case_text': 'A 37-year-old African American man with a history of type 1 diabetes and sickle cell trait was referred to the Gastroenterology service for ERCP/EUS to evaluate jaundice. He presented with right upper quadrant (RUQ) abdominal pain with associated nausea and vomiting ongoing in the past ten days. He denied the use of tobacco, alcohol, or other illicit drugs. The patient reported several female sexual partners in the past six months. Physical exam revealed scleral icterus and RUQ abdominal tenderness. Laboratory studies were notable for alanine aminotransferase (ALT) of 59 U/L, aspartate aminotransferase (AST) of 39 U/L, total bilirubin of 11.4 mg/dL, and alkaline phosphatase (ALP) of 657 U/L. His hepatitis A antibody, hepatitis B surface antigen, hepatitis B surface antibody, and hepatitis C antibody were negative. HIV-1 and HIV-2 antibodies were negative. Serum autoimmune markers, alpha-1 antitrypsin, iron profile, and ceruloplasmin were also negative. Antimitochondrial antibody was positive and smooth muscle antibody was weakly positive. Lactate dehydrogenase and haptoglobin levels were within normal limits.\\nLiver ultrasound showed mild hepatic fatty infiltration without biliary obstruction or stones. Magnetic resonance cholangiopancreatography (MRCP) was negative for biliary or pancreatic ductal dilation. RPR returned positive with a reflex titer of 1:64. Treponema pallidum IgG was sent for confirmation and it was reactive. Liver biopsy demonstrated chronic hepatitis with normal hepatic architecture, Kupffer cell hyperplasia, hepatic cholestasis and ductal proliferation (Figure 1). Iron stain was positive. Periodic acid-Schiff and Periodic acid-Schiff-diastase stains were negative for alpha 1 anti-trypsin granules. Warthin starry stain was negative. Immunochemical stain for Treponema pallidum revealed no organisms. These findings were suggestive of syphilitic hepatitis. Patient had a reported allergy of pruritus to penicillins in the past. The allergist was consulted and patient underwent a challenge with oral penicillin and tolerated it well, no reaction was noted. The patient was given a single dose treatment: penicillin G 2.4 million units intramuscular route (IM) once. He showed symptomatic improvement subsequently, including resolution of nausea/RUQ abdominal pain. He was discharged to be followed up outpatient. Follow-up visit in two weeks revealed improvement in serum biochemical tests with ALT of 45 U/L, AST of 39 U/L, ALP of 298 U/L, total bilirubin 1.7 mg/dL, and absence of abdominal pain.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 57,\n",
       "    'case_id': 'PMC9207123_01',\n",
       "    'case_text': 'A 57-year-old male was consulted by the internal medicine department with a chief complaint of painful tumors on the chest, right shoulder and neck. Eleven months prior to the consultation, the patient complained of multiple lymphadenopathies on the right side of the neck, covered by multiple marble-sized tumors overlying the lymphadenopathy after one month. The tumors spread to the chest and neck in two months. The patient also complained of coughing and voice hoarseness. Within two months prior to the consult, the skin lesion increased in number and became painful. The complaint was followed by shortness of breath, voice hoarseness, coughing, and weakness; hence, the patient was treated by a hematology-oncology specialist. The history of malignancy in the family was unknown. The patient admitted to having a history of smoking as a risk factor.\\nPhysical examination revealed rapid breathing, pale conjunctiva, increased jugular venous pressure, asymmetrical chest movement, diminished vesicular breathing sound on the left hemithorax, and multiple immobile and non-tender lymphadenopathies in the anterior and posterior sides of the neck and around the cervical region. Dermatological status revealed multiple tumors on the chest, right shoulder and neck with well-defined border and serous crust found on several tumor surfaces (Figure 1). In the internal medicine department, the patient had undergone several examinations; chest radiography showed right pleural effusion with lymphocytic effusion on cytologic examination, while enhanced chest CT-scan showed a solid mass in the anterior mediastinum, superior vena cava syndrome, and pleural effusion (Figure 2). Histopathological examination of the lymph node revealed metastatic carcinoma in the right supraclavicular region, and immunohistochemistry (IHC) examination of the lymph node was positive for CK7.\\nThe histopathological result from affected skin revealed round, hyperplastic, and hyperchromatic cells in the dermis consistent with metastases to the skin (Figure 3). We continued the immunohistochemical (IHC) staining to find the primary tumor, resulting in positive CK7. Meanwhile, IHC results for CD5, CD117, p63, CK20, P40, and TTF-1 were negative (Figure 4). It was determined that the primary tumor originated from thymic carcinoma because CK7 was positive on IHC examination of the skin tissue and lymph nodes, and enhanced chest CT-scan revealed a mass in the mediastinum that favors thymic carcinoma.\\nThe patient was treated with a chemotherapy regimen of cyclophosphamide, doxorubicin, and carboplatin planned for six cycles. Unfortunately, the patient passed away after receiving only three cycles of chemotherapy.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 9,\n",
       "    'case_id': 'PMC3700476_01',\n",
       "    'case_text': 'A 9-year-old boy was presented to our emergency department complaining of left hip pain, fever, malaise, and inability to bear weight. The pain was described as \"dull\" and was aggravated by movement and only partially relieved by rest and analgesics. The condition started 14 days prior to presenting at our department with left knee pain and limping. The fever was intermittent. There was a history of sore throat 5 days before the knee pain, for which the patient received an incomplete course of antibiotics. Ten days later, the knee pain progressed to an increasing pain that started in the left groin, with inability to bear weight. At this stage of the disease the patient presented to our hospital. The patient denied any history of trauma.\\nOn examination the patient was unwell, with a temperature of 39.5 C. No other focus of infection was identified on examination. His left hip was held in flexion, abduction, and external rotation. His hip and thigh were tender, but there was no erythema or swelling. Active movements were more painful than passive movements. The painful limitation of all ranges of motion suggested an acute hip problem.\\nLaboratory investigations at the time of presentation showed evidence of acute infectious process. Leukocytic count was 22 300/mm3, erythrocyte sedimentation rate (ESR) was 135 mm/h, and C-reactive protein was 4.6 mg/dl. The patient\\'s blood culture grew Staphylococcus aureus sensitive to oxacillin, cefoxitin, and gentamicin.\\nThe plain radiograph of the hip and pelvis revealed normal contour, joint space, and alignment, with no soft-tissue abnormalities, but the left hip was in abduction, flexion, and external rotation (Figure 1). Ultrasound of both hips revealed mild left hip effusion.\\nThe clinical picture and laboratory investigations were strongly suggestive of septic arthritis of the hip, and the patient had signs of sepsis that needed urgent intervention. An informed consent for urgent arthrotomy and drainage was obtained after discussion with the family.\\nUnder general anesthesia and with the help of an image intensifier, aspiration of the hip was performed, which showed blood-stained fluid that was sent for gram staining, culture, and sensitivity testing. The decision was made to proceed with open drainage of the hip through an anterior approach. Exploration of the left hip revealed no pus and the synovial membrane was normal. Samples of synovial fluid and synovium were taken for gram staining, culture, sensitivity testing, and for histopathological examination; the results were normal.\\nAntibiotics were started in the operating room - intravenous cefoxitin 100 mg/kg /day in 4 divided doses and cloxacillin 100 mg/kg/day in 4 divided doses - after taking the necessary samples. Skin traction was applied to the left hip.\\nMRI (Figures 2 and 3) was requested to rule out osteomyelitis of the proximal femur, pelvic collection, or sacroiliitis. It revealed lobulated collection, of low attenuation, with enhancing rim at the left side of the pelvis involving the left OI and extending to the left OE muscles, as well as small abscesses seen in the left vastus intermedius and vastus lateralis muscles. MRI findings confirmed the diagnosis of pyomyositis of the left OI extending to the OE.\\nTreatment was continued in the form of antibiotics and skin traction. The patient showed steady improvement and his temperature returned to normal within 48 hours, with gradual improvement of the hip pain. After 3 days the patient regained painless movement of the left hip and he was walking with a slight limp. The patient was discharged from the hospital in good general condition, with full weight-bearing and without limping after completing a 1-week course of intravenous antibiotics. When C-reactive protein returned to normal, oral cloxacillin, 500 mg every 6 hours was started and continued for 2 weeks. The patient was followed in our outpatient clinic for 2 years without any complaints. At the final follow-up the patient was fully active and had full range of motion.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 12,\n",
       "    'case_id': 'PMC9873306_01',\n",
       "    'case_text': \"Our case refers to a 12-year-old boy with painless exophthalmos in the left eye. He had no relevant clinical symptoms, a previous medical history of binocular vision, and a family history of neurofibromatosis. Physical examination showed that binocular vision was normal, the eyeballs could move freely in all directions, and the eyes were sensitive to light reflection. In addition, there were no facial paresthesias or abnormal facial expression.\\nA computed tomography (CT) scan revealed a homogeneous and non-calcified mass in the extraconal compartment of the left posterior eyeball that was similar in density to the brain parenchyma. The inner bone wall of the left orbit was thinner than before, with compressive displacement of the adjacent bone and widening of the supraorbital fissure (Figure 1). Magnetic resonance imaging (MRI) demonstrated an elliptical, well-defined, and homogeneous retrobulbar mass, including the left orbit, the orbital apex, and even the left cavernous sinus. The superior orbital rectus muscle was compressed and transformed; the optic foramen was enlarged, but the optic nerve was not obviously pressed. The mass presented as a slightly uneven hypointense signal, a hyperintense signal, and an isointense signal on T1-weighted images (T1WI), T2-weighted images (T2WI), and fluid-attenuated inversion recovery (FLAIR), respectively. Meanwhile, the mass showed a hypointense signal on diffusion-weighted imaging (DWI) and a low value of apparent diffusion coefficient (ADC), with apparent and inhomogeneous enhancement after gadolinium (Gd) injection (Figure 2). An MRI performed 3 months after surgery showed no tumor persistence (Figure 3).\\nA gross total excision was performed via a left frontotemporal craniotomy. The solid tumor was found to be located above the eyeball and the optic nerve, which occupied the middle and posterior parts of the orbital region and extended to the anterior part of the cavernous sinus through the enlarged supraorbital fissure. The result of the intraoperative pathological diagnosis was a spindle cell tumor. Postoperatively, the patient's painless exophthalmos had completely disappeared, with no evidence of postoperative sequelae or visual impairment during a follow-up.\\nThe mass had a biphasic pattern of Antoni A (palisading spindle tumor cells are arranged vertically and tightly) and Antoni B (haphazardly spindle and multipolar cells are arranged loosely as a reticular structure) under a microscope. Immunohistochemical analysis showed that the neural marker (S100 protein) was firmly and positively stained, which was specific for the diagnosis. The nuclei of those cells showed positive immunoreactivity for SOX10 and less than 1% of the nuclei showed positive immunoreactivity for KI67 (Figure 4).\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 65,\n",
       "    'case_id': 'PMC8739263_01',\n",
       "    'case_text': 'A 65-year-old woman with a longstanding history of hypertension noticed a sudden decrease in vision in her left eye. She had no other ocular problems apart from a mild cataract in both eyes before. Her best-corrected visual acuity was 20/33 in her right eye, and 6/100 in her left eye. Fluorescein angiography showed a retinal arterial macroaneurysm with telangiectatic retinal vascular changes in the inferior temporal macular region (Figure 1). Optical coherence tomography (OCT) examination demonstrated the presence of subretinal hemorrhage which extends into the foveal area, and incomplete posterior vitreous detachment (Figure 2). Because of the presence of submacular hemorrhage, some medicine was administrated and the patient was followed up. Then, 5 months later, the hemorrhage was absorbed. OCT examination exhibited a full-thickness MH with a macular epiretinal membrane (Figure 3). The size of the MH was 722 mum in diameter. She was then given a standard three-port pars plana vitrectomy, along with peeling of the internal limiting membrane and filling the vitreous cavity with air. Anatomic closure of the MH was achieved after 4 weeks of the surgery by the examination of OCT (Figure 4). The BCVA was improved to 15/100.\\nPars plana vitrectomy (PPV) method:\\nStandard three-port vitrectomy was performed, followed by surgical separation of the posterior cortical vitreous from the optic nerve and posterior retina. About 1% indocyanine green (ICG) was injected over the macula region after temporarily stopping the infusion. The ILM with 2 disk diameters of the fovea was removed. The vitreous cavity was filled with air. The patient was asked to remain face down for a week following the surgery.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 35,\n",
       "    'case_id': 'PMC5067447_01',\n",
       "    'case_text': 'A 35-year-old man was admitted to our hospital 3 months back with history of fever with chills for five days. The patient had undergone PBMV for severe rheumatic mitral stenosis 2 weeks prior to this episode. No other predisposition was found. There was no history of dental procedures or injections of intravenous drugs. On physical examination, blood pressure was 110/70 mmHg, pulse rate 85/min, and body temperature of 38  C. Cardiac examination revealed loud S1 and P2 with grade III mid-diastolic murmur at the apex. The remaining physical examination was unremarkable. There were no peripheral signs of infective endocarditis. Laboratory tests showed that his Hemoglobin was 12.8 gm/dl, white blood cell (WBC) was 18,900/L, erythrocyte sedimentation rate (ESR) was 52 mm in first hour, and urinalysis was normal. Renal parameters were normal. Cardiomegaly was apparent in chest radiography. Electrocardiogram revealed a normal sinus rhythm. The transthoracic echo demonstrated moderate mitral stenosis, severe eccentric mitral regurgitation, which was not there previously, and suspicious vegetation was present on mitral valve. The transesophagial echocardiogram revealed freely mobile sessile vegetation of size 5 mm x 5 mm over both anterior and posterior mitral leaflets (Fig. 1). The patient was started with a regimen of ceftriaxone and gentamycin. S. maltophilia was identified on blood culture and the antibiotics were changed to co-trimoxazole and levofloxacin as per culture sensitivity report. After 1 week of antibiotics, patient became afebrile, and repeat transesophagial echo after 2 weeks revealed disappearance of vegetation (Fig. 2). Antibiotics were continued for 6 weeks. He was discharged successfully.',\n",
       "    'gender': 'Male'},\n",
       "   {'age': 40,\n",
       "    'case_id': 'PMC5067447_02',\n",
       "    'case_text': 'A 40-year-old man was admitted for fever and chill for a period of 2 months following mechanical valve replacement (27 mm Carbo-Medics) of mitral valve for severe rheumatic mitral stenosis. No other comorbidities were found. There was no history of dental procedures or injections of intravenous drugs. At presentation, he was drowsy, pale, and edematous with raised jugular venous pulsation. Blood pressure was 90/60 mmHg, pulse rate 120/min, and body temperature was 38  C. Cardiac examination revealed soft S1, normal S2 with metallic heart sound. There was no audible murmur. Chest examination revealed bilateral basal crepitations. Glasgow Coma Scale (GCS) at presentation was E3 M5 V4 with no focal neurological deficits. The rest of the physical examination was unremarkable. Laboratory tests showed that Hb was 7.6 gm/dl, WBC 17,500/L, and ESR was 80 mm/hr. The renal parameters were elevated with urea of 65 mg/dl and serum creatinine of 3.0 mg/dl. Arterial Blood Gas (ABG) revealed metabolic acidosis. Increased cardiothoracic ratio and features suggestive of pulmonary edema were observed on chest radiography. Electrocardiogram revealed sinus tachycardia. The transthoracic echo demonstrated large mobile vegetation of 2 cm x 1.6 cm in size on prosthetic mitral valve (Fig. 3). There was mild paravalvular leak with partial dehiscence, moderate mitral regurgitation, moderate tricuspid valve regurgitation, moderate pulmonary arterial hypertension, and moderate left ventricular dysfunction. The patient was empirically started on vancomycin and ceftriaxone. Initially, blood cultures grew MRSA sensitive to only teicoplanin, gentamycin, and linezolid. Fever continued with spikes. Supportive treatment was given in the form of inotropic support, vasodilators, and peritoneal dialysis for rapidly worsening renal dysfunction. By the time, the repeat blood culture could identify the culprit bacteria to be S. maltophilia, the patient died of septicemia and renal dysfunction.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 9,\n",
       "    'case_id': 'PMC10288866_01',\n",
       "    'case_text': 'The girl with mosaic DS had a mild intellectual handicap and had been attending a special educational class since the age of 9, but she had no medical complications as a result of trisomy 21. Her premorbid demeanor was upbeat, and she enjoyed dancing and singing. She was somewhat obstinately diligent in academic works, and would cry with stress when she was called on in class but could not answer well to the questions. No autistic traits had been reported. Her intellectual quotient was assessed as 58 on the Wechsler Intelligence Scale for Children, 4th edition, at the age of 11 years.',\n",
       "    'gender': 'Female'},\n",
       "   {'age': 12,\n",
       "    'case_id': 'PMC10288866_02',\n",
       "    'case_text': 'Shortly after starting junior high school at the age of 12 years, the patient complained of fatiguability and paroxysmal weakening of fingers and acquired an unsteady gait over 3 months period. Slowness in the speech was also observed (Figure 1). Blood tests and brain MRI results were normal (Figure 2A), and the symptoms resolved spontaneously. But, following a summer holiday, the patient had weakness, insomnia, and severe gait disturbance, for which she was taken to the hospital for medical assessments. Brain and spinal cord MRI revealed no specific abnormalities, and routine blood, urine, and CSF samples, analyses, as well as nerve conduction velocity testing, were all unremarkable. She was tentatively diagnosed with adjustment disorder and was discharged. Thereafter nonspecific complaints waxed and waned.',\n",
       "    'gender': 'Female'},\n",
       "   {'age': None,\n",
       "    'case_id': 'PMC10288866_03',\n",
       "    'case_text': \"Nine months later, a few weeks after the COVID-19 pandemic was settled down and the school activity restarted, the girl's linguistic communication and eye contact continued to deteriorate, as did her sleep maintenance insomnia, and night terrors. Within a week, she complained of chest pain, nausea, the delusion of observation, and the perception of how each piece of furniture was feeling. The next morning, she was discovered incontinent and unresponsive to her surroundings, her facial appearance being completely lost. When she arrived at our hospital, her body temperature was 38.1 C, which subsided soon after admission. Her awareness level fluctuated substantially, between E4V1M6 and E1V1M4 on the Glasgow Coma Scale. She demonstrated her intent by shaking or nodding her head. No focal neurological signs were noted on examination. However, she was akinetic and completely mute, stared into space, and held a fixed posture or showed waxy flexibility in her extremities. Drooling and retching, were common, as was oral dyskinesia. Blood and CSF tests, including herpes simplex virus DNA, came back within normal ranges. Brain MRI indicated several high-intensity spots in the frontal white matter, but no abnormalities in the hippocampus sections; sleep EEG revealed a widespread high voltage slow-wave activity, that progressed to irregular activity with a frequency range of 3-10 Hz upon awakening (Figures 2B, C, F). Lorazepam was prescribed to treat catatonic syndrome. The patient could talk in sentences the next morning, though as slow as uttering her name in 30 s or more. It was also established that she had experienced visual hallucinations of an unknown person. She could socially smile and laugh a few days later, but she had a prolonged appetite loss, that required tube feeding. The treatment regimen was supplemented with escitalopram, aripiprazole, and ramelteon. On day 14 of admission, she began playing card games, and the stomach tube was withdrawn. She was discharged, with some persistent behavioral and motor issues (Figure 1).\",\n",
       "    'gender': 'Female'},\n",
       "   {'age': None,\n",
       "    'case_id': 'PMC10288866_04',\n",
       "    'case_text': 'Soon thereafter, the patient came to manifest with a silly smile, paradoxical laughter, and monology. The patient claimed that there are many, invisible people or goods in her house, that dwarf and fairly are sitting on the air cleaner or her head/arms/clothing, that she was talking with someone in her ear and/or neck, that there are tubes in her ear/mouth/body, and that bad ideas come into her head prompting an urge to stab someone with a pair of scissors. A SPECT examination found hypoperfusion in the bilateral parietal and left occipital lobes (Figure 2E), contradicting the pathophysiology of primary psychiatric illness to explain the catatonia and subsequent psychosis. CSF specimens from both admissions tested positive for anti-NMDA receptor antibodies by enzyme-linked immunosorbent assay (ELISA) (Figure 3). Anti-TPO antibody was found to be positive; but, the patient was euthyroid. Clinical and paraclinical findings in this patient were compatible with DSDD, and at the same time fulfilled the criteria for probable NMDARE. However, following points were rather atypical for NMDARE (Figure 1, Supplementary Tables S1, S2); (1) the presence of psychosocial stressors triggering each phase of illness, (2) the first phase of nonspecific complaints as long as 12 months, (3) the order of predominant movement disorder (catatonia) phase and late-evolving psychiatric phase, (4) negative CSF results, and (5) hypoperfusion on SPECT imaging not involving the limbic areas. With a diagnosis of DSDD, intravenous methylprednisolone was provided 3 months after the last admission, at age 13 years and 9 months. However, the effect of this treatment was minimal. Follow-up MRI revealed nonspecific high signal regions (arrows) in the bilateral deep parietal white matter (Figure 2D).',\n",
       "    'gender': 'Female'},\n",
       "   {'age': 12,\n",
       "    'case_id': 'PMC10288866_05',\n",
       "    'case_text': 'She then claimed to have delusions that her voices were recorded, that another person arose while she was fake, and that the present day was the dinosaur age. These psychotic symptoms were relieved by increasing the dosage of aripiprazole. During the period of preparation for high school admission, however, complaints of somatic symptoms or cenesthopathy predominated including throat discomfort, feeling like her face was slipping off, stubbed or dirty abdomen, dysesthesia in the distal extremities, and difficulty in chewing. Coupled with an auditory hallucination that someone was requesting and/or ordering her to die, the patient was influenced by thoughts over suicide and/or life expectancy, as well as the belief that she was already dead. She is currently a high school student, with persistent psychiatric issues. Such an extended course of hallucinations and delusions prompted us to examine the CSF specimen with cell based assay (CBA), which qualified a positive result of anti-NMDA receptor antibodies for the specimen taken just before the intravenous methylprednisolone (Figure 3). The patient was diagnosed with definite NMDARE, for whom second-line immunotherapies are being planned. Ovarian tumor was not seen on an abdominal MRI.\\nCSF levels of IL-5, IL-15, CCL-5, granulocyte colony-stimulating factor, platelet-derived growth factor (PDGF)-bb, and vascular endothelial growth factor (VEGF) were raised throughout the course, highest at the first examination at the age of 12 years (Figure 3).',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 91,\n",
       "    'case_id': 'PMC9845545_01',\n",
       "    'case_text': 'A 91-year-old male patient with a nonischemic cardiomyopathy status post dual-chamber ICD implantation in 2010 and upgrade to left prepectoral biventricular ICD in 2013, permanent atrial fibrillation, and essential thrombocythemia on hydroxyurea presented to an outside hospital for 2 weeks of progressive ICD pocket swelling and erythema. The patient denied pain at the ICD pocket site. Examination revealed an erythematous, swollen pocket with overlying telangiectasias. The patient was afebrile with mild leukocytosis. Ultrasound of the pocket revealed an irregular fluid collection inferior to the ICD generator measuring 4 x 2.6 x 3.3 cm. The patient was treated empirically with broad-spectrum antibiotics for presumed ICD pocket infection and transferred to our center for pocket exploration and possible extraction.\\nPocket exploration revealed a solid mass with cystic components extending onto the ICD generator, leads, and surrounding tissues. A biopsy specimen was obtained. The device was left in position and the pocket was closed. Bacterial and acid-fast bacilli wound cultures showed no growth, and blood cultures remained negative. Antibiotics were discontinued given low clinical suspicion for infection and absence of supportive microbiologic data. Microscopy of the biopsy specimen revealed fragments of fibrous tissue with focal chronic inflammation and fibrosis. No malignant cells were observed.\\nThe patient was seen in follow-up approximately 1 month later for consideration of surgical excision of the ICD pocket mass. Computed tomography scan of the chest revealed a large complex fluid collection measuring up to 11.5 cm involving the ICD pocket, few top-normal mediastinal lymph nodes, and a rounded density within the left pectoralis muscle measuring up to 1.8 cm. The patient was admitted following this evaluation for worsening ICD pocket swelling and erythema. The patient underwent repeat pocket exploration and resection of the 418 g, 14 x 8 x 6 cm mass including a segment of the left pectoralis major muscle. Microscopy revealed a partially necrotic tumor with diffuse proliferation of atypical cells with frequent mitotic figures and apoptosis extending into skeletal muscle. Flow cytometry revealed evidence of abnormal B cells, confirming the diagnosis of diffuse large B-cell lymphoma, activated immunophenotype (Figure 1). An interdisciplinary team including the patient, oncology, and electrophysiology favored holding further staging and treatment owing to poor functional status. The patient was transitioned to hospice care and died.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 45,\n",
       "    'case_id': 'PMC3716248_01',\n",
       "    'case_text': 'This 45-year-old patient was referred by gastroenterologist as surgical emergency with signs of perforative peritonitis following attempted colonoscopic retrieval of intra luminal ileal mass. The plain X-ray chest with both domes of diaphragm showed gas under right dome of diaphragm. Patient was resuscitated and taken up for emergency laparotomy. Preoperative abdominal examination showed two healed scar marks on in right sub costal region (open cholecystectomy scar) and lower abdomen pfannelstiel incision (Abdominal hysterectomy scar). On exploration about 500 ml of bile stained fluid was found and small bowel perforation was noticed about 20 cm from ileocecal junction. A large thick wall ileal loop with some unusual intra luminal mass was felt. Ileal mass was resected along with perforated site with end-to-end ileal-ileal anastomosis. Patient had postoperative wound infection which responded to the antibiotic and other supportive measures. On incision of resectedileal loop [Figures 1 and 2] abdominal sponge was retrieved [Figure 3].',\n",
       "    'gender': 'Unknown'}],\n",
       "  [{'age': 45,\n",
       "    'case_id': 'PMC7298528_01',\n",
       "    'case_text': 'A 45-year-old man presented to the emergency room 30 min after developing left hemiparesis and SICH was diagnosed. He refused the treatment on admission. Seven hours later, the patient was brought back to the hospital with diminished level of consciousness and left hemiparesis. The Glasgow Coma Scale (GCS) was E3V3M5.\\nHead MRI showed acute ICH in the right basal ganglia with volume 55 cc. The perifocal edema displaced the right lateral and third ventricles, causing midline shifting as much as 5 mm to the other side. The patient consented to undergo stereotactic aspiration surgery without anticoagulant for evacuating the clot.\\nStereotactic aspiration of ICH was performed under general anesthesia 10 h after admission. Ten cc of residual hematoma was detected on repeat CT scan and decision was made to manage it conservatively. The patient was treated for 23 days with a satisfactory result. GCS improved to E4V5M6 with residual left hemiparesis. Fig. 1 shows MRI scan two months after surgery.',\n",
       "    'gender': 'Male'},\n",
       "   {'age': 52,\n",
       "    'case_id': 'PMC7298528_02',\n",
       "    'case_text': 'A 52-year-old woman was admitted to the hospital 15 min after developing a decline in level of consciousness. The GCS was E4V2M5 and no hemiparesis. Head MRI showed hyperacute ICH in left temporal lobe (left external capsule and left corona radiate) with volume of 25.6 cc. The perifocal edema pushed the left lateral ventricle, causing midline structure deviation to the right side as much as 6 mm.\\nWe performed stereotactic surgery without anticoagulant for ICH evacuation 6 h after the onset of symptoms. Fig. 2 presents the postoperative head CT scan showing 80 percent reduction in the amount of hemorrhage. The patient was treated for 11 days. She had GCS E4V5M6 and was able to do routine activities independently before discharge.',\n",
       "    'gender': 'Female'},\n",
       "   {'age': 27,\n",
       "    'case_id': 'PMC7298528_03',\n",
       "    'case_text': 'A 27-year-old girl arrived in the emergency room with diminished consciousness 30 min after the onset of symptoms. The GCS was E3V2M5 with no hemiparesis. A head CT scan revealed ICH on the frontal and parietal regions with a volume of 35 cc causing midline shift to the right side as far as 4 mm. There was non-communicating hydrocephalus, intraventricular hemorrhage, and brain edema.\\nStereotactic aspiration surgery for evacuating the hemorrhage and external ventricular drainage was done without any anticoagulant. The post procedure CT scan showed 90 percent reduction in the amount of hemorrhage. A week later another CT scan was repeated. We found that the ICH in left subcortical frontal lobe (left basal ganglia) had significantly reduced (Fig. 3). The patient was treated for 16 days. Her level of consciousness was E4V5M6 with no neurological deficits, and she was able to take on routine activities independently.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 47,\n",
       "    'case_id': 'PMC10174326_01',\n",
       "    'case_text': \"A 47-year-old woman, accompanied by her husband, voluntarily visited the psychiatric clinic after 2 months of anxiety, weight loss and sleep problems linked to work stress. The patient complained of constant nervousness, muscular tension, restlessness, sweating, heart palpitations, dizziness, and epigastric discomfort. She has been exhibiting obsessive behavior since adolescence. The patient has no family history of mental disorders or severe physical diseases. Laboratory tests, including complete hemogram, electrolytes (sodium, potassium, calcium, magnesium, chlorine), and thyroid function, were all within normal range. For a preliminary diagnosis of anxiety disorder, unspecified, paroxetine 20 mg/d and lorazepam 1.5 mg/d were prescribed. Lorazepam was changed to clonazepam 4 mg/d after one week due to unresolved anxiety, restlessness, and insomnia. Following a panic attack, the patient visited the emergency department, which revealed hypokalemia (potassium 3.0 mmol/l). She gradually developed depression and delusions as more symptoms appeared, convinced that all physical symptoms were signs of severe organ dysfunction, which led her to have suicidal thoughts. Following a suicide attempt, she was involuntarily admitted to another psychiatric facility. During hospitalization, blood tests revealed persistent hypokalemia and progressive hypothyroidism, which could not be fully explained by inadequate dietary intake. Immunologic markers, including autoantibodies, immunoglobins, and complements, were not remarkable. A CT scan of the head yielded no significant findings. Electroconvulsive therapy and a variety of medications were utilized to treat major depressive episode with nihilistic delusion, as shown in Figure 1. Upon discharge, the patient achieved clinical remission of depression. Nevertheless, anxiety was still present, and an undiscovered physical condition was suspected.\\nAfter presenting to the Department of Endocrinology, the patient underwent an enhanced MRI of the head and found a microadenoma 0.3 cm in diameter to the right side of the lower pituitary gland, as shown in Figure 2. In a further review of symptoms, the patient recalled a rounder face and increased waist circumference prior to anxiety symptoms, and amenorrhea following anxiety symptoms and reduced food intake. Purple striae and buffalo hump were absent, as were signs of secondary diabetes, hypertension, or osteoporosis. Laboratory tests revealed elevated serum free cortisol, ACTH, and 24-h urinary free cortisol (24-h UFC), and the phenomenon that 24-h UFC and serum cortisol was not suppressed after low-dose dexamethasone suppression test, all indicated the diagnosis of CS. Elevated ACTH suggested the possibility of ACTH-dependent CS. Furthermore, bilateral petrosal sinus sampling (BIPSS) with desmopressin stimulation test showed inferior petrosal sinus/peripheral (IPS/P) ACTH gradient at baseline as 3.1, and IPS/P ACTH gradient after desmopressin stimulation as 10.6. Taking all of the above into account, the patient was diagnosed with CD and subsequently transferred to the Department of Neurosurgery for pituitary microadenoma resection. Psychiatric medication was not discontinued or reduced until the day of surgery. The day after surgery, the patient developed tachycardia, tachypnea, elevated temperatures, tremors, and strong anxiety. Over the next few days, her condition progressed to hypovolemic shock. She refused to take oral medication and refused to cooperate with verbal responses. Considering that the above-mentioned manifestations are due to postoperative adrenal insufficiency, hydrocortisone supplementation was introduced. All psychiatric medications were resumed to alleviate anxiety. After resumption of medication, extrapyramidal symptoms were observed during psychiatric consultations, which prompted recommendations for tapering psychotropic agents. Before discharge, the patient maintained the preoperative dose of all antidepressants, anxiolytics, and antipsychotics because her anxiety had not improved.\\nOne week after discharge, the patient was again admitted to the emergency department with a high fever, tachycardia, hypertension, and impaired consciousness. The initial diagnosis was secondary adrenal insufficiency after excluding infection. Physical examination indicated tremor, dysarthria, increased muscle tone in the extremities and neck, and myoclonic manifestations of the lower extremities, all of which could not be fully explained by adrenal insufficiency. A psychiatric follow-up consultation revealed that the patient was still taking multiple antidepressants due to persistent anxiety, raising the possibility of serotonin syndrome. Serotoninergic medications were recommended to be discontinued despite the discovery of normal creatine kinase level, with only clonazepam remaining to treat anxiety. Blood pressure, heart rate, and temperature all decreased to normal the next day, as did muscle spasticity. The patient's subjective anxiety slowly subsided by the time she was discharged 4 weeks later. Clonazepam was gradually replaced by estazolam due to daytime sleepiness. The trajectories of serum cortisol, ACTH, and creatine kinase are shown in Figure 3. During the one-month follow-up after discharge, the patient expressed concern for her health and made plans to eventually resume family and work responsibilities once her condition stabilized.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 13,\n",
       "    'case_id': 'PMC6699327_01',\n",
       "    'case_text': 'The first case was of a Japanese man in his mid-30s. His major psychiatric issues included bipolar I disorder, intellectual developmental disorder, and transvestism. Although formal genetic testing was not performed, he showed typical clinical presentation of EDS: skin hyperextensibility, generalized joint hypermobility (which satisfied the two major criteria, as set in 2017), soft and doughy skin including the nose septum and auricular, flexible flatfoot, epicanthal folds on the tongue (which satisfied three minor criteria), and phlebitis in his legs (as an additional symptom). His medical history included fetal asphyxia, pediatric asthma, congenital hip arthritis, for which he had undergone two surgeries at 5 and 20 years of age, and hepatitis C caused by blood transfusion that was performed at the second surgery. Since there was no history of interferon therapy during the 10 years before the first visit to a psychiatrist (at year X), the possibility is remote that he had interferon-associated psychiatric disturbances. His premorbid personality traits included nervousness, obstinance, and incoordination. He had no relatives with EDS. The patient was the second son among three siblings. His father had bipolar disorder and committed suicide when the patient was 13 years old.\\nHe was evaluated for intellectual developmental disorder in his adulthood twice at years X+1 and X+6. His verbal intelligence quotient (IQ) was found to be 67 and 77, performance IQ 69 and 49, and full IQ 66 and 62, respectively. In addition, magnetic resonance imaging scans revealed cavum septi pellucidi (CSP) and small infarct lesions in the cerebral white matter. The psychological examinations, including the Rorschach test and the Minnesota Multiphasic Personality Inventory suggested a low degree of autonomy or insight but no abnormality in recognizing himself as male gender.\\nThe patient had experienced sexual trauma, as he had been molested by his father in his elementary-school years. He also experienced bullying by classmates because of his poor academic performance at that time. During this difficult time, the father committed suicide. After his father\\'s death, the patient started exhibiting cross-dressing behavior. There was no particular evidence indicating a correlation between his transvestic behavior and his father\\'s death.\\nDespite his poor academic performance, he was able to graduate from senior high school. After spending 1 year at a training school for persons with disabilities, he secured a clerk position at a general corporation as an employee with disabilities. He first visited a psychiatrist (at year X) because he had started experiencing paranoia in the workplace. The symptom subsided with a low dose of haloperidol but at year X+3, paranoia reappeared along with irritation, insomnia, loss of motivation, hypochondriac symptoms, and depressive mood as his job became more demanding. One month after the relapse, his mood changed to mania with insomnia, anger, irritation, and increased appetite and libido. The patient recovered with mood stabilizers, antipsychotics, and a 6-month sick leave from his job. However, he again relapsed 3 months after remission was achieved. Since then, his affect has remained cyclic while receiving medical treatment either as an outpatient or inpatient.\\nThe intellectual developmental disorder in this case could have possibly been caused by several factors: (1) EDS, (2) past history of fetal asphyxia, (3) presence of CSP, and (4) others. CSP reportedly occasionally causes intellectual developmental disorder, emotional mood disorders, and schizotypal symptoms in adulthood. Although remarkably enlarged CSP (anteroposterior diameter >= 6 mm) is associated with serious mental illnesses such as schizophrenia, many patients with less prominent CSP remain asymptomatic. The association between CSP and bipolar disorder is generally weaker than that with schizophrenia; the CSP in this case was not enlarged to the extent that could account for all symptoms.\\nWhile his cross-dressing habit began in childhood, first in private in his room, and persisted in public through adulthood, his behaviors and symptoms did not meet the DSM-5 criteria of gender dysphoria. Although he used complete female attire, including upper and lower undergarments, he did not apply female make up on his face and did not look himself in the mirror when wearing female clothes; moreover, his desire to wear female clothes expired when he received psychological support from a nurse at the Company Health Office. His desire was primarily to wear female clothes and his consideration for a sex-change was secondary to feelings of slight guilt and shame that accompanied the desire for cross-dressing. He did not have intense sexual arousal, distress, or impairment in social life, and thus did not meet the DSM-5 criteria for transvestic disorder.\\nRegarding the relationship between transvestism and mood disorders, cross-dressing is reportedly more remarkable during the manic phase and becomes inconspicuous during the remission phase. In this case, his desire to cross-dress remained consistent in the remission phase of the bipolar disorder, and the cycle of mood symptoms did not affect the degree of cross-dressing to a considerable degree. We considered that his symptoms could be attributable to (a) his mother\\'s overprotectiveness and excessive interference due to his intellectual developmental disorder and EDS, (b) conflict with his older brother when he was in the manic phase, and (c) maladaptation in the job environment and failures in the establishment of human relationships. While patients with intellectual developmental disorder may exhibit the so-called pseudo-transvestism used as a means to fantasize women during masturbation, cross-dressing was the objective per se for this patient. Additionally, because he was more interested in looking at pictures of himself wearing female underwear than in changing his gender, his behavior could have been obsessive/compulsive to some degree in the sense that he was overwhelmingly driven to wear female clothes; by doing so, he considered that he could escape into a fantasy world where he could cope with his desire. Anupama et al. reported three cases of patients who cross-dressed; two had intellectual developmental disorder and one had obsessive-compulsive disorder. Meanwhile, Bowler et al. proposed that patients with intellectual developmental disorder tended to engage in cross-dressing, as it was difficult for them to communicate with the opposite sex, both personally and socially. Although cross-dressing is more frequently observed in patients with intellectual developmental disorder than in the general population, their symptoms subside when they are involved in a relationship, while their preference for brilliant clothing continues.\\nThe family environments during childhood have been carefully studied in relation to transvestism; coldness, high pressure, or weak presence with only few emotional exchanges all have been associated with distorted father images in these patients.\\nThe second case was of a Japanese woman in her late 20s. Her major diagnoses were dissociative identify disorder, gender dysphoria, dysthymia, and anorexia nervosa (restriction type). She had classical EDS with skin hyperextensibility and atrophic scarring, generalized joint hypermobility (which satisfied the second major criterion based on the 2017 criteria), easy bruising, soft and doughy skin, skin fragility and traumatic splitting, complications of joint hypermobility such as pain, and family history (which satisfied the fifth minor criterion). The final diagnosis was straightforward even without genetic testing. She did not have notable past medical history and had nervousness as her premorbid personality trait. Her monozygotic twin sister also had EDS, and except for her twin sister, she also had an older brother; none of her other relatives had EDS or diagnosed psychiatric disorders including gender dysphoria and dissociative identity disorder.\\nThe patient was brought up as older sister in contrast with that another twin sister was treated as younger sister in their family, although they are monozygotic twins. She was prone to injuries and dislocations and had led an infirm life since childhood. In elementary school, she was frequently bullied for her facial scars and suffering from dysthymic status. In addition, as far as the patient could recollect, she started to feel uncomfortable wearing women\\'s clothes in her early elementary-school years. Her mother reacted to the situation by overprotection, imposing rules to prohibit the patient from playing outdoors or behaving as a boy and restricting her behavior inside the house. Compared with her mother\\'s parental control, her father was judgmental against her \"laziness\" because she was unable to overcome her dysthymic personality/character and secure regular employment after graduating from high school.\\nShe was aware of having dissociative identity disorder since childhood based on her recollections of first experiencing a personality change at the age of 5 years. The original personality (A) corresponded to a patient with anorexia nervosa and was mainly dormant. She was aware of two male personalities present most of the time; personality (B) who oversaw meals and personal activities and personality (C) who oversaw contact with others (including during consultation with the psychiatrist). The replacement personalities appeared depending on the circumstances; several male personalities, including (B) and (C), dominated during housekeeping, eating, and social encounters, while the female personalities were likely to surface when the patient was required to dress and behave in a female manner during her school years and, currently, those personalities appear to be integrated as personality (D), emerging only when the patient is concerned with feminine hygiene during bathing and menstruation. In the past, she presented with a larger number of personalities, but they were consolidated to the relatively few personalities mentioned above, presumably as a coping mechanism in an effort to maintain wellness.\\nWhen limb movement paralysis and inability to open her eyes appeared at the age of mid-20s, a physical examination was performed at a hospital as her first major psychiatric consultation (at year Y). Meanwhile, no physical abnormalities were detected and she was diagnosed with dissociative movement disorder. Since then, she has been occasionally treated as an outpatient at the psychiatric department of the university hospital. Despite her main complaint of excessive dietary restriction and self-induced vomiting based on her desire to lose weight, psychiatric treatment was intermittent. She had strong desire for social support, self-acceptance, and integration of a male identity. To fulfil what she considered were the requirements of a male identity, she habitually used male public restrooms. Finally, she received a first psychiatric diagnosis of gender dysphoria based on the DSM-5 criteria, with the disorder involving years of marked incongruence between the self-referenced and assigned genders. At year Y+2, she relocated without her parents\\' permission to the house of a friend with dissociative identity disorder who she knew through the Social Network Service. She was then transferred to another hospital located near her home at year Y+3, where the psychiatric diagnosis of gender dysphoria was confirmed based on the DSM-5 criteria.\\nThe difference in intellectual level between the two patients may have led to different phenotypes, hypochondriac behavior in Case 1 and dissociative identity disorder in Case 2. Patients with dissociative identity disorder often experience considerable stress during early and late childhood, which may include (a) bullying from schoolmates and siblings, (b) restrictions in self-expression by overly controlling parents, (c) child abuse including neglect, and (d) mental trauma caused by accidents or other incidents. Factors (a) to (c), as well as (d), render individuals susceptible to trauma and were present and constituted high risk of dissociative identity disorder in Case 2. The specific personalities of dissociative identity disorder were deemed to stem from the clinical features of EDS. Primary personality (A) had anorexia nervosa, possibly influenced by insufficiency of maternal separation from early childhood because of her mothers\\' overprotectiveness and excessive interference driven by her concern for the high risk of trauma associated with EDS. Eating disorder is a symbolic disease mainly observed in women, and the patient attempted to deny her femininity through her gender dysphoria. Although she reported experiencing a strong sense of discomfort and disgust for being treated as a woman, she also understood the risks of surgery because of her EDS and did not consider a sex-change operation. As a compensatory mechanism against these feelings, the male personalities (B) and (C) became dominant, overseeing meals to counter anorexia nervosa, which is a symbol of femininity, controlling physical health, and acting as a form of psychological coping mechanism to protect the patient against the discomfort of gender dysphoria. It is difficult to discern whether anorexia nervosa or gender dysphoria was the primary disorder. To summarize, the prolongation of her dissociative identity disorder maintained her original personality at a dormant state. In fact, the memory rupture and amnesia are well recognized in dissociative identity disorder and did not occur with personalities (B) and (C), which retained almost all the memories of the other personalities.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 54,\n",
       "    'case_id': 'PMC4620392_01',\n",
       "    'case_text': 'A 54-year-old male patient was referred by the physiotherapist with 1 year history of anterior left knee pain. He had sustained a patellar tendon tear, requiring surgical repair 30 years ago. Clinical examination was mainly suggestive of patellofemoral arthritis. This was confirmed on plain radiographs and MRI. A knee arthroscopy was performed that showed grade 2 changes in the trochlea with grade 3 changes on the patella. At six-month review the patient reported no significant improvement in symptoms; he was therefore listed for patellofemoral joint replacement (PFJR). Following his surgery using the Zimmer Gender Solutions Patello-Femoral Joint his symptoms progressively worsened (Figure 1).\\nThe patient was systemically well; however, his mobility and left knee range of motion worsened to the extent that he required 2 crutches. His infection screen, including full blood count, CRP, and plasma viscosity, was not raised. All possible nonoperative measures were exhausted therefore we decided to perform a single stage revision to a total knee replacement. Intraoperatively, a large cyst was discovered under the femoral component. This necessitated a change of plan to a 2-stage revision. Multiple samples were taken and sent for microbiological and histological study. The cyst was curetted and packed with bone graft and a cement spacer was placed (Figure 2).\\nThe microbiological studies were negative and histopathological studies showed nonspecific inflammatory response. In the absence of any other cause of implant failure metal allergy was considered. The patient was referred to the allergy clinic for further investigation. A patch test was strongly positive for nickel allergy. This patient went on to have a 2nd stage revision using a nickel-free revision knee system (Figure 3), and at 6-month follow-up showed dramatic improvement in his symptoms.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 66,\n",
       "    'case_id': 'PMC9086612_01',\n",
       "    'case_text': \"The participant is a (currently) 66-year-old Chinese Han man born and raised in Guizhou, China. He is married, well-educated, and retired (used to work as a teacher and civil servant). He does not smoke, does not take drugs, and drinks alcohol in moderation (<140 ml of ethanol/week). We investigated his daily habits, eating preferences, physical activities, etc., and there was nothing special except the handstand concerned in this study. The participant was healthy 40 years ago, and he did handstand exercise because he wanted to stay fit.\\nThe participant designed the passive handstand device. The device includes a V-shaped support frame, a high bracket for handstand, and a foot retainer (Figure 1). When he was young, he used the device to exercise for approximately 30 min at a time, but because of his busy schedule and many business trips, he was sometimes unable to exercise on time. When he retired at age 60, he persisted in doing handstand exercises once daily for only 10 min. When using the device, he did not experience discomfort.\\nWe quantified health through physical and auxiliary examinations, including imaging studies to evaluate the participant's cerebrovascular, spinal health, facial aging, mental health, and visual acuity. Assessments were performed every 10 years. In the first 20 years of follow-up, due to the underdeveloped medical technology and the lack of auxiliary examination at that time, physical examination was mainly used.\\nIn 2021, spinal health evaluation comprised physical examination at each follow-up and magnetic resonance imaging. At the 20-year follow-up, we examined the participant's cervical spine using radiography. Cerebrovascular assessment consisted of computed tomography angiography and magnetic resonance angiography. We compared his current cerebrovascular condition (assessed by magnetic resonance angiography) with that 10 years prior (assessed by computed tomography angiography) to confirm the effect of long-term handstand suspension on cerebrovascular elasticity. We also evaluated his cerebrovascular health by measuring his blood pressure before, during, and after using the device.\\nWe took pictures of the participant and compared them with those taken more than a decade prior to assess the rate of facial aging. Facial aging was assessed according to the severity of eyelid pouches and facial wrinkles. The severity of eyelid pouches was categorized as no pouches, mild pouches (slight herniation of the lower orbital septum fat accompanied by slight relaxation of the lower eyelid skin), moderate pouches (moderate herniation of the lower orbital septum fat accompanied by moderate relaxation of the lower eyelid skin), and severe pouches (severe herniation of the lower orbital septum fat or severe relaxation of the lower eyelid skin). The severity of facial wrinkles was evaluated using the Wrinkle Severity Rating Scale.\\nSince 1991, the visual acuity of this man was measured according to the Early Treatment of Diabetic Retinopathy Study protocol using a LogMAR chart. The test results of the better eye were expressed in logarithmic units ranging from 1 (20/200) to -0 3 (20/10), with lower values indicating better vision.\\nMoreover, since 1991, we have assessed his mental health and cognitive function using the Mini Mental State Examination scale.\\nThe sponsor (Science and Technology Innovation Talent Team Project of Guizhou Province, China) provided financial support in the collection and interpretation of data.\\nThe patient and the public were involved in the design, reporting, or dissemination plans of our research. The participant made some suggestions for the design of our research.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 74,\n",
       "    'case_id': 'PMC9468777_01',\n",
       "    'case_text': 'A 74-year-old Japanese man with end-stage renal failure, precipitated by an unknown primary disease, had been maintained on hemodialysis since 2018. In April 2019, he was diagnosed with advanced sigmoid colon cancer and underwent a colectomy for the same. The pathological stage of the tumor was confirmed as IIIC (T4aN2M0). Although the patient was informed that there was a high chance of cancer recurrence, he did not wish to receive adjuvant therapy. Follow-up computed tomography scan performed in December 2019 revealed multiple lung and liver metastases, considered to be recurrent colon cancers. The molecular biology of the tumor was as follows; microsatellite instability, MSS; KRAS mutation, exon 2 (G12D); BRAF mutation, wild type; UGT1A1 mutation, absent ( Table 1 ). Thereafter, the patient was treated with modified FOLFOX6 as first-line chemotherapy in April 2020. Unfortunately, the liver metastases increased after 21 cycles of treatment, and in April 2021, the patient was referred to our hospital for further treatment. Physical and blood examinations revealed no notable changes, and his performance status was 0 at admission. Laboratory data obtained on admission to our hospital and the genetic information of the cancer are shown in  Table 1 .\\nThe body surface area of the patient was 1.46 m2, and he was treated with FOLFIRI [irinotecan 120 mg/m2 intravenously infused over 120 min (80% of the standard dose in Japan), with levofolinate 200 mg/m2 over 120 min, followed by 5-FU 2400 mg/m2 intravenously infuse over 46 h (without 5-FU bolus)] plus bevacizumab (5 mg/kg intravenously infused over 30 min) every 2 weeks. Hemodialysis was performed on the second day for convenience and scheduling following FOLFIRI therapy and repeated 3 times per week. To measure serum bevacizumab concentrations, blood samples were collected at five time points: pretreatment (defined as day 0), before hemodialysis on day 2, day 4, day 6, and day 8. For days 4, 6, and 8, blood samples were obtained just before the start of dialysis. All blood samples were centrifuged immediately after collection at 3000 rpm for 10 min, and the obtained serum was further centrifuged at 3000 rpm for 20 min. The centrifuged samples were stored in a freezer until measurement using a bevacizumab ELISA Kit (#ab237642; Abcam, Cambridge, UK).\\nIt was observed that the serum concentration of bevacizumab increased to 56.3 microg/mL on day 2 but then decreased over time regardless of hemodialysis; the serum concentration on day 8 decreased to 37.1 microg/mL ( Figure 1A ). At the fifth cycle after treatment initiation, neutropenia (grade 4) was observed, and thus we reduced the dosage of 5-FU to 2000 mg/m2 and that of irinotecan to 100 mg/m2. However, no bevacizumab-related AEs were observed. Regarding therapeutic effects, stable disease was maintained for 7.5 months under treatment with FOLFIRI plus bevacizumab. Thereafter, the disease showed progression with elevated tumor markers and increased size and number of lung and liver metastases ( Figure 1B ), following which the treatment regimen was changed to trifluridine/tipiracil. Unfortunately, the therapeutic effect was poor, and the treatment was transitioned from chemotherapy to best supportive care.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 57,\n",
       "    'case_id': 'PMC10319284_01',\n",
       "    'case_text': \"A 57-year-old man with history of double LTx in October 2019 (lung donated voluntarily with written informed consent, and that this was conducted in accordance with the Declaration of Istanbul) for bronchiectasis secondary to CVID. He was supplemented by subcutaneous immunoglobulin G and had a prior history of pan-sensitive Pseudomonas aeruginosa colonization. The immunosuppressive regimen included induction with basiliximab and maintenance with steroids, tacrolimus, and mycophenolate mofetil. After transplant, the patient rapidly developed severe recurrent bronchopulmonary infections due to Pseudomonas aeruginosa despite several repeated associative antibiotic therapies and continuous inhaled colistin (Figure 1, description of the clinical course and therapies). The patient's respiratory function progressively deteriorated (obstructive pattern) leading to severe chronic respiratory failure requiring oxygen supplementation associated with recurrence of bronchiectasis on chest CT scan (Figure 1). \\nAs a result of antibiotic pressure, an XDR strain emerged, which was only susceptible to colistin, cefiderocol, amikacin, and gentamicin. The use of aminoglycosides was challenging to manage due to side effects with multiple episodes of acute kidney injury that evolved to severe chronic kidney failure and hearing loss.\\nWithin the first-year post-transplant, steroids were rapidly tapered, azithromycin introduced (250 mg given once daily) as a treatment of chronic lung allograft dysfunction (CLAD), the mycophenolate mofetil stopped and never reintroduced to minimize the infection risk (antimetabolite agent), and cyclosporin A finally tapered to 10 mg per day resulting in an undetectable residual rate of blood cyclosporin A because the infection was not controlled despite the mycophenolate mofetil stopped. No acute rejection was found on the repeated lung biopsies. We enhanced the immunoglobulin supplementation with IgM/IgA-enriched immunoglobulins (Pentaglobin , Biotest, Dreieich, Germany), Figure 2. \\nFrom that adaptation of the immunosuppressive regimen, we managed to obtain clinical stability (oxygen requirement decreased to 1 L/min, no sepsis, decreased sputum) but every attempt to stop the antibiotic treatment failed.\\nIn this context of therapeutic impasse, a decolonization strategy with bacteriophage therapy (BT) has been considered. Pherecydes Pharma (Pherecydes Pharma, Romainville, France, https://www.pherecydes-pharma.com/en/) owns a collection of anti-Pseudomonas aeruginosa phages. In the scope of compassionate use and in agreement with the French health authorities, the strains isolated from the patient were sent to the company, which performed a phagogram (equivalent to an antibiogram but with phages). Among the phages produced in compliance with the Good Manufacturing Practices (GMP) and that were available as ready-to-use by the company, PP1450, PP1792, and PP1797 have shown activity on the patient's strains (Figure 3). Multisite samples revealed the presence of the XDR Pseudomonas aeruginosa in the stool and the nose. For that reason, we associated inhaled phage therapy (2 inhalations a day using vibrating mesh, Aeroneb , Aerogen, Galway, Ireland) and oral ingestion of phages 2 times a day for 7 days (Figure 4).  \\nThe phages were supplied by Pherecydes Pharma as well as the stability data which allowed us to prepare the treatment for 2 days (4 administrations). Four mL of each phage at 10Log were collected and completed with 48 mL of a saline solution. From that mixture, nebulizations were performed with 8 mL and oral ingestion with 6 mL of the solution. A sterility test was performed with 1 mL of each prepared solution.\\nBecause phages survival is favor by basic condition, we treated the patient with double dose of proton pump inhibitor to maximize the efficacy. We had thought of a fecal transplantation to decolonize the digestive tract. The request was refused due to a shortage of stool available in the context of the COVID19 pandemic. In June 2021, the strain was susceptible to cefiderocol and colistin. Thus, we associated these antibiotics with the BT, Figure 4. Oral and nasal decolonization were performed with chlorhexidine 4%, 4 times a day for 14 days. Daily skin decolonization was performed with chlorhexidine 2% for 14 days. The patient was isolated in a single bedroom with contact and droplet precaution. Personal belongings have been taken out of the room and isolated (including clothes, computer, and mobile phone). Daily bio-cleaning with disinfectant were performed. Finally, the patient was moved to another room at the end of the BT.\\nDuring the BT, the patient's respiratory conditions improved (less sputum production) allowing a weaning from oxygen supplementation. At the end of the first cycle of BT, XDR Pseudomonas aeruginosa was still identified in sputum and stool. We sent new samples to Pherecydes Pharma laboratory who confirmed that the strain was still susceptible to bacteriophages initially tested. As we were waiting for the second cycle of BT, the patient presented a new acute respiratory failure related to the worsening of the bronchopulmonary infection, despite no discontinuation of the antibiotic therapy, that required mechanical ventilation. The second cycle of BT was administrated through bronchoscopy and by nasogastric tube with the same protocol as described for the first cycle. The patient presented a severe obstructive pattern on the ventilator, and despite aggressive intensive care and protective ventilation, the patient progressed to multi-organ failure and died at 24 months post-LTx. For the first time, all samples collected (rectal smear, bronchial aspiration, and bronchoalveolar lavage) were interpreted as sterile from day 5 of the second cycle of BT (and confirmed the days after till the death).\\nIn summary, we could observe first clinical stability (low oxygen supplementation and no more sepsis) after adapting the immunosuppressive regimen and mainly after initiating the IgM/IgA-enriched immunoglobulins, but without the possibility to stop the antibiotic treatment. And second, we could obtain sterilization of the different sites that were previously infected or colonized by Pseudomonas aeruginosa after the second cycle of BT, despite the fatal outcome.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 71,\n",
       "    'case_id': 'PMC8100614_01',\n",
       "    'case_text': \"A 71-year-old woman with remitting multi-resistant tender papules with a metameric disposition was initially treated as herpes zoster. She later developed a chronic ulcer on the scalp that, after investigation, was indicative of pyoderma gangrenosum (PG) or pyoderma-like. She had a previous history of pulmonary tuberculosis and PG on both legs in 2003. She was treated with cyclosporine, infliximab, clofazimine, doxycycline, and intralesional triamcinolone injections with varying results for over four years. PG was finally controlled in mid-2007. She remained asymptomatic until March 2020, when intense and sudden pain on the vertex and left parietal region developed. Multiple tender papules with peripheral erythema were present. Although no vesicles were found, a tentative diagnosis of cephalic herpes zoster was suspected. Despite treatment with valacyclovir and pregabalin, symptoms increased, and papules evolved into multiple, deep, ulcerated lesions with a central necrotic scab and undermining border. Expression yielded a significant amount of purulent secretion. Skin biopsy findings were of an ulcer with exuberant granulation tissue. Histology study was performed on the material obtained while curetting one of the large abscesses rather than by a wedge excision of the border. Although the vertex aspect on the scalp suggested an erosive pustular dermatosis of the scalp, histology was more consistent with PG. Attempts to obtain microbiological cultures were twice negative.\\nPrevious comorbidities include IgA multiple myeloma in remission for the past seven years and remission of pulmonary tuberculosis treated with triple therapy 18 years ago. In the process of choosing a proper therapy, the Quantiferon test was performed, which was negative. After a short period of use of oral Dapsone, the disease progressed. Due to the previous history of tuberculosis and possible contra-indications for anti-TNF alpha therapy, she was started on baricitinib, a novel Janus kinase (JAK) inhibitor, 4 mg orally daily, taking into consideration the past attempts with more conservative approaches mentioned above. The idea of using JAK inhibitors was considered in the case of failed treatments, which proved helpful. Lesions started to improve, and by seven days, no new lesions were identified. Complete regression was achieved after five weeks, leaving a depressed scar (Fig. 1, Fig. 2).\\nCase 2 A 59-year-old female with rheumatoid arthritis since 2011, controlled with methotrexate 15 mg/week, developed in 2018 a leg skin ulcer for which PG was diagnosed. Healing was obtained with dressings and MTX maintenance.\\nIn 2019, another PG occurred on the left leg and ankle; treatment consisted of prednisone 0.7 mg/kg/d associated with MTX 20 mg/week. PG resolved in 4 months; corticotherapy was gradually tapered, and MTX was maintained. Severe Cushing's syndrome signs were noted, impairing quality of life.\\nIn 2020, another outbreak of PG compromised the right leg; methotrexate was suspended, and baricitinib 4 mg/day was introduced, with the lesion's healing in 3 months presented in the photos (Fig. 3, Fig. 4).\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 10,\n",
       "    'case_id': 'PMC10190599_01',\n",
       "    'case_text': 'P1 was a 10-year-old girl with autism. Her mother had canceled all her therapy sessions, since the beginning of the pandemic, so she did not get any other therapy for emotion recognition. Her mother reported that her main problem was in recognizing the fear emotion. She also had problems in her social interactions and did not know how to interact with others. For instance, she showed friendly behaviors with unfamiliar individuals and could not keep the right social distance, when speaking to others. In addition, she had stubborn behaviors and persisted in her requests without considering the situation.',\n",
       "    'gender': 'Female'},\n",
       "   {'age': 6,\n",
       "    'case_id': 'PMC10190599_02',\n",
       "    'case_text': \"P2 was a 6-year-old boy with autism who showed difficulty in recognizing sadness and fear emotions. His mother said that he did not enter other children's group play and did not share his interests with others. He did not know the rules and norms of group play, so he was not successful in making good relationships with his peers. Moreover, he mostly expected confirmation of his actions from his parents, otherwise, he would become very nervous.\",\n",
       "    'gender': 'Male'},\n",
       "   {'age': 7,\n",
       "    'case_id': 'PMC10190599_03',\n",
       "    'case_text': 'P3 was a 7-year-old boy with developmental delay and with major problems in recognizing anger and \"fear\" emotions. His mother complained that he was shy and could not speak and communicate comfortably with other people while he was good at doing his school homework. In addition, he had problems with the theory of mind ability and did not comprehend the concept of winning or losing in games or how to behave when he was a winner or a loser. It was also reported that he could not play properly with others.',\n",
       "    'gender': 'Male'},\n",
       "   {'age': 8,\n",
       "    'case_id': 'PMC10190599_04',\n",
       "    'case_text': 'P4 was also an 8-year-old boy who showed major difficulty in recognizing sad emotions. Also, his mother reported that he did not vocally express his emotions or express them on his face when he experienced emotional situations. In addition, he had major problems in his relationship with his classmates, because his social skills were lower than his peers. For example, he could not tolerate when he would lose in a game. Also, he rarely could pass theory of mind tests which was his major problem for which he was referred for further evaluations and interventions.',\n",
       "    'gender': 'Male'},\n",
       "   {'age': 11,\n",
       "    'case_id': 'PMC10190599_05',\n",
       "    'case_text': 'P5 was an 11-year-old boy with autism, whose major problem was recognizing anger and fear emotions. It was reported that he was addicted to playing computer games and did not attend social activities. In addition, he mostly wanted to leave in the middle of his therapy sessions. His therapist expressed that his language abilities were lower than his age group, so he rarely made a good connection with his peers. In addition, it was reported that he could have had better cognitive and social abilities if he had not left his therapy sessions periodically due to his good learning abilities.',\n",
       "    'gender': 'Male'},\n",
       "   {'age': 10,\n",
       "    'case_id': 'PMC10190599_06',\n",
       "    'case_text': 'P6, was a 10-year-old boy with autism diagnosis of severity level 2, with a major problem in recognizing anger and fear emotions. Also, he had difficulty recognizing happy facial expressions. Regarding expressing emotions, he could not show any emotions on his face. He had some movement difficulties and when he was left alone, he would start to tip-toe walking. His mother reported that he had low patience to wait when he demanded something. In addition, he rarely interacted with other people spontaneously and never initiated entering his peers\\' games. Also, most of the time, he did not initiate communication unless to satisfy his needs. The others asked questions to communicate with him. Furthermore, he was behind his age in his language competencies compared to his age group.\\nIt should be mentioned that none of the participants received other emotion recognition interventions during our study period.\\nThe RSE setup, i.e., a 50 cm high table with two robots and a tablet, was set in a 3 x 3 meters room. The tablet was placed on a stand between the robots to display the images or run the designed games. The game was developed using the Unity game engine to show the desired emotions. A camera was positioned at one corner of the room to record the overall view of the setting so that we can analyze the sessions later. In each session, there was a psychologist who was overseeing the whole process to make sure everything run smoothly and according to general therapy rules. Furthermore, his feedback was collected for future improvements. Besides the therapist, the main researcher was present during all the sessions making sure that the sessions run according to the plan. The overall structure of the designed RSE can be seen in Figure 3.\\nTo investigate the effect of the proposed RSE in teaching facial expressions (happiness, sadness, anger, and fear) to children with autism, a single case A-B-A design experiment with a generalization probe across novel stimuli and setting was conducted. The A-B-A technique is a reversal design that has three phases: 1) Phase A or the first baseline in which no treatment is introduced, and the behavior is evaluated, 2) Phase B in which the treatment is introduced, 3) Phase A (that we called it A\\') or second baseline which is a return to the baseline by stopping the treatment. In this technique, the effectiveness of a proposed protocol is evaluated using multiple measures to see the changes by comparing Phase A to Phase B and then to Phase A\\'.\\nWithin 1 week after baseline phase (A), a familiarization session was conducted to introduce the robots to the participants and reduce their novelty effect. In this session, the session conductor invited the participants to become familiar with the two robots. Then the robots started greeting the participants, introduced themselves, and asked the participants\\' names, ages, and favorite activities to make a sense of friendship. Then the robots started playing with a robotic ball, called Sphero, to attract the participants. In this familiarization session, the participants were free to play with the robots. Within 1 week after this session, the training phase (B) was started.\\nBefore starting the training sessions, we evaluated the participants\\' abilities in recognizing emotions in three sessions for 2 weeks. The images were selected from the Child Affective Facial Expression (CAFE) set and Radboud Faces Database to have both adults\\' and children\\'s images. Twenty images, 10 males and 10 females, were randomly selected from these datasets, including 5 images for every facial expression. The order of the images was also random to avoid memorizing the images based on the order. Each participant sat on a chair in front of a laptop computer and the session conductor presented the images one by one and asked the participant \"what is her/his feeling?\", then she waited for 3s. If the participant did not look at the images, she delivered the question up to two additional times. No feedback was provided on the responses of the participants. At the end of the task, the participants were praised for their attentiveness. The participants scored one for each right answer and zero for each wrong answer or lack of an answer.\\nThe first therapy session was started 1 week after the familiarization session. A fixed protocol was given to the robots\\' operator to run all the sessions. Thirty-two images of 4 emotions, i.e. 8 images per expression, were chosen to be displayed on the tablet. These images were different from the images that were used in the baseline phases to prevent children from memorizing them. The schematic of the familiarization and Phase B can be seen in Figure 4.\\n1. Robots greet the participant.\\n2. If the participant shows a tendency to speak to the robots, the robots answer him/her and give them feedback with laughing, movement, and funny voices.\\n3. The robots invite the participant to sit on a chair and watch them play.\\n4. The game is run for the robots to correctly name the emotions.\\n5. The robots start the conversation about the current image and name the emotion.\\n6. Another image is displayed, and this process repeats until the termination of the game (going back to step 5).\\n7. If the session ends, the robots say goodbye to the participant and invite him/her to the next session.\\nBefore starting the therapy, the operator practiced the scenario several times. For all steps of the scenario, potential interaction sentences were determined. The scenario and the overall setup were tested by 5 members of our laboratory. They gave us feedback about the speed and ability of the operator to run the system. We used their comments to run the scenario smoother and more naturally. The steps of the scenario are as follows. \\nIf there is any problem with the interaction that would cause any disruptive behavior the session conductor reacted accordingly.\\nIn step 5, RoboParrot asked Red \"what is this boy/girl/man/woman feeling?\", then Red answered the question and explained why that face convey that feeling, such as \"he is laughing so he is happy\". Also, the robot may explain the same thing from the effect point of view of the emotion, i.e., \"When we are happy, we may laugh\". As a verbal reward, Roboparrot praised Red saying \"bravo\" to reinforce his correct answer. Furthermore, a star or a flower was displayed on the screen as a visual reinforcement for Red. To ensure that the participants do not miss the named emotion, one of the robots would repeat the named emotion again. Every training session took a maximum of 30 min. A view of the experimental set-up is shown in Figure 5.\\nIt should be mentioned that we had designed several questions and sentences based on our previous studies such as \"how are you? How old are you? sit on the chair, listen to me, what is your name? and I am fine\", to interact with children if they showed interest to interact. For instance, at the start of a conversation, P2 asked one of the robots \"are you talking to your friend, is it possible to talk to me too?\" or asked them \"are you playing together\". Also, P4 hugged and touched them and asked their names. In such cases, the robots answered the participants. These behaviors mostly occurred at the beginning or end of the sessions.\\nAt the end of each session, the participants were taken to another room and the researcher evaluated their emotion recognition capabilities, with a similar process to the baseline phase. Every participant had one or two training sessions weekly with at least 3 days gap, so the whole training phase took 8 weeks.\\nThree sessions were conducted for the second baseline, which was similar to the first baseline. The second baseline was done 2 weeks after the training phase.\\nA generalization probe was conducted 2 weeks after the second baseline. In this session, a similar evaluation to the baselines was conducted with 20 new images that were randomly selected from Radboud and CAFE datasets. In other words, we wanted to show that the subjects did not only learn the emotions in the images used in the therapy sessions, but they learned to recognize the four emotions in a set of new images. This evaluation was designed and performed in a room different from the therapy room to see if children could generalize the newly-learned skills to unseen stimulus items and setting.\\nTo evaluate the effects of the proposed RES on children\\'s emotion recognition skills, we used descriptive analysis, i.e., visualization of the gathered data from the sessions, and a non-parametric rank order correlation effect size measure, called TAU-U. This method helps interpret single-case experiments. Using graphs to show each participant\\'s data point in all sessions, enables us to track the level, trend, and changes within and between phases. Using these two methods together can make the evaluation more reliable.\\nThe TAU-U non-parametric analysis is a useful and desirable method for single-case experiments to calculate and illustrate the effects of therapy on both within-phase trends and across-phase differences separately. It considers all pairwise comparisons of non-overlap points in a time-forward direction similar to the NAP method (non-overlap of all pairs). However, NAP is insensitive to the trend of the data and cannot consider the pre-existing trend of the baseline which would be an indicator of the participants\\' improvement even without intervention. The pairwise comparisons in TAU-U result in three decisions of Pos (positive), Neg (negative), or Tie. Pos shows a score improvement and Neg shows a score decrement from Phase A to B. TAU-U is calculated based on the number of Pos and Neg pairwise points. It also considers controlling undesirable baseline monotonic trend with baseline correction by calculating Tau-UA vs. B-trend A In this study three TAU-U calculations were considered: 1) Tau-Utrend A to control the trend of baseline, 2) Tau-UA vs. B to evaluate the effect of the training, and 3) Tau-UA vs. A\\' to compare the second baseline with the first baseline to examine the sustained effect of the training. When Tau-Utrend A >= 0.4, which means that there is a trend in the baseline, a baseline trend control is needed to remove its effect in the analysis process. The conditions for interpreting TAU-U are as follows: 1) above 0.8 is a very large change, 2) between 0.6 and 0.8 is a large change, 3) between 0.2 and 0.6 is a moderate change, and 4) 0.2 and below is considered a small change.\\nIn addition to the above evaluation approaches, the mothers of participants were interviewed at the end of RSE therapy to see if they had observed any changes in their children\\'s abilities in recognizing and expressing emotions.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 9,\n",
       "    'case_id': 'PMC4093733_01',\n",
       "    'case_text': 'A 9-year-old boy presented with a progressive spastic quadriparesis following trivial trauma. X-ray studies showed an occipitalized CO-C1 and congential C2-3 fusion; both contributed to an irreducible AAD resulting in cervico-medullary junction compression. Of interest, the C1 sagittal inferior facet angles measured 138 . The computed tomography (CT) angiogram clearly defined the anomalous course of the V3 segments of both VA; the VA exited from the C2 transverse foramen, took a lateral course toward the C1 transverse foramen, but instead of traversing the C1 foramen, turned inferiorly and coursed medially beneath the C1 posterior arch before piercing the dura [Figure 1]. Therefore, both VA lay posterior to the inferior facet of C1 (3D CT; Figure 1).\\nAs the patient was incompletely reduced with traction, surgical intervention was warranted. The C1-2 joints were approached posteriorly, and both C2 nerve root ganglia were cut to expose the anomalous VAs just anterior to it. In order to avoid inadvertent injury to the VAs, the loops crossing the C1 facets were carefully exposed; the posterior wedge of the C2 and anterior wedge of the C1 facets were drilled making the inferior facet angle flat in order to reduce the AAD. Spacers and bone grafts were placed in the C1-2 joint spaces. Next, the VAs were gently retracted inferiorly to insert the C1 lateral mass screws, which were sufficiently tightened to leave enough space between the screw head and the facet surface for the VA; the postoperative CT also showed adequate reduction [Figure 2 and 3]. Postoperatively, the child did well, becoming ambulatory, and 4 months later, the CT exhibited good bony fusion.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 73,\n",
       "    'case_id': 'PMC5434259_01',\n",
       "    'case_text': '73-year-old female with history of hypertension, and a recent diagnosis of right lower lobe (RLL) lung mass, presented to the emergency department (ED) complaining of progressively worsening dysphagia for few weeks. The patient had difficulty in swallowing both liquids and solids. She reported decreased appetite, weight loss, and multiple episodes of nonbloody vomit. She was scheduled to have an endoscopy as an outpatient on the same day of admission; however, she decided to come to the ED instead, as her symptoms became more severe.\\nThe patient had a remote history of 20 pack-year of cigarettes smoking. Her medications included Aspirin, Iron Pills, Atorvastatin, and Lisinopril. On physical exam, she was hypothermic with a temperature of 35.6 degrees Celsius and tachycardic with a heart rate of 103. The patient looked cachectic and chronically ill. She also had dry oral mucous membranes. The initial laboratory results showed significant leukocytosis with a white blood cell count of 29.3 thousand/ul and hyponatremia with a sodium of 127 mmol/L. The urine was cloudy in appearance, and it contained leukocytes esterase and more than 50 white blood cells. The chest X-ray revealed RLL mass, with no evidence of pulmonary consolidation. The patient was admitted to a telemetry bed and was started on aggressive IV hydration and IV ceftriaxone as a treatment for severe sepsis syndrome. The source of the sepsis was thought to be a urinary tract infection as the urine culture grew Kluyvera ascorbata and Streptococcus agalactiae (group B), and both organisms were sensitive to ceftriaxone. The hospital course was prolonged and complicated. During the first 24 hours, the patient went into atrial fibrillation with rapid ventricular rate and was started on IV amiodarone and heparin drip. She also had an abrupt onset of cold and discolored left leg that required an emergent vascular surgery evaluation. The patient was found to have left femoral artery occlusion and underwent left iliac artery stenting and left femoral endarterectomy.\\nFurthermore, she had a CT-guided biopsy of the RLL mass and the pathology was consistent with primary adenocarcinoma. The patient was intubated for the surgical procedure and the biopsy. Few days later, she was briefly extubated; however, she continued to have significant hypoxia and hypotension. There was also a concern for aspiration pneumonia. Palliative care team was involved and after an extensive discussion with family, the decision was taken to change the code status to DNR. Patient expired after 2 weeks of hospitalization. The endoscopy was never done as the patient was never in a stable condition throughout her hospital stay.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 81,\n",
       "    'case_id': 'PMC4133753_01',\n",
       "    'case_text': 'An 81-year-old Turkish woman with a mechanical bowel obstruction was referred to our emergency department. The patient had complained of acute abdominal pain, vomiting, and mechanical obstruction for five days before her admission to our emergency service. Her records confirmed that she had cholecystolithiasis for 15 years; a cholecystectomy was offered to her many times by different surgeons, but she refused to undergo the surgery. At physical examination, her abdomen was moderately distended, and tympanic bowel sounds were auscultated. The rectal examination revealed empty ampulla recti. The laboratory test an elevated total leukocyte count (15.6 x 109 cells/L) and slightly increased renal function test values, which could be considered as an indication of pre-renal azotemia. The liver function test results and serum bilirubin levels were normal. Plain radiographs of the abdomen revealed multiple air-fluid levels in the small intestine. The patient was treated with intravenous fluids and antibiotics in the tertiary hospital. On the fifth day of hospitalization, she was referred to our hospital because of the deterioration of her clinical condition. After the initial examination, computed tomography (CT) was performed, which demonstrated small-bowel obstruction by a 40 mm high-density image in a jejunal loop (Fig. 1). Additionally, the scan showed pneumobilia in the left hepatic biliary branch and thickening between the gallbladder and the duodenal walls (Fig. 2). The contrast liquid was observed in the gallbladder, and the air-fluid levels were detected on the CT scan. A cholecystoduodenal fistula resulting from chronic cholelithiasis was suspected.\\nAn exploratory laparoscopy was performed. Moderately dilated jejunal loops proximal to the distal jejunum were observed during the laparoscopy. An obstruction was observed approximately 50-60 cm from the ligament of Treitz, where an enterotomy was performed to extirpate a 5 x 4 x 3 cm gallstone (Fig. 3). After the removal of the gallstone, the defect in the intestinal wall was closed, primarily with vicryl sutures. The patient had an uneventful postoperative course and was discharged on postoperative day 5.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 14,\n",
       "    'case_id': 'PMC8311769_01',\n",
       "    'case_text': 'A 14-year-old female patient reported to the Department of Periodontology, Jaipur with a complaint of swollen gums on both the arches for 3 years, which was slow at the outset, and then the swelling started to dilate for 4 months. Due to swollen gums, she was facing a hurdle in speech, while chewing food, and during the cleaning of teeth with the brush and also complaint of bleeding gums and bad breath since last 4 months. The patient had also gone for surgical intervention for similar swollen gums 3 years ago.\\nThe patient had no signs of mental retardation, hypertrichosis, or epilepsy and had no history of any medication that can be the reason for the occurrence of the overgrowth of the gingiva. The history of the family was noncontributory.\\nExtraoral examination of the patient revealed a convex profile and prominent lips. Intraoral examination exhibiting generalized overgrowth of the gingiva in both the arches. More than half of the crown was covered with gingival tissue (Fig. 1). The gingiva color was normal with dense consistency. Maxillary anterior teeth were proclined. There was spacing between the teeth and a deep bite was also present. Orthopantomogram (OPG) showed localized vertical bone loss with respect to 46 and horizontal bone loss 16 and 47 and except for the third molars, all the permanent teeth were present. The treatment plan was followed by phase 1 therapy (scaling and root planing) and after completion of phase 1 therapy, the labial tissue from the mandibular anterior region was excised and sent for histopathological examination. Histopathological appearance revealed idiopathic gingival fibromatosis which showed parakeratinized stratified squamous cell epithelium with elongated rete pegs. The connective tissue showed densely packed collagen bundles (Fig. 2). After the result of the biopsy, the external bevel gingivectomy in association with gingivoplasty was planned and performed under local anesthesia quadrant-wise (Fig. 3). And after the required crown lengthening was attained (Fig. 4) then the excised site was thoroughly irrigated and the periodontal dressing was applied for 7 days and the chlorhexidine mouthwash (0.2%) was instructed to the patient, to rinse it twice a day and to maintain proper oral hygiene.\\nAfter 1-week dressing was removed and postoperative healing was uneventful. And after 1 week next quadrant was excised similarly. After 1 month of the recall, it was observed that there was no recurrence of the enlargement (Figs 5 and 6).',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': None,\n",
       "    'case_id': 'PMC10231445_01',\n",
       "    'case_text': 'A woman in her mid 50s presented to the emergency department of a large metropolitan teaching hospital in a critical condition. Initial investigations demonstrated hyperleukocytosis, severe anaemia and hypo-osmolar hyponatraemia (white cell count 290 x109/L, haemoglobin 39 g/L, sodium 108 mEq/L). She was transferred to the high-dependency unit for ongoing assessment and multidisciplinary management with haematology, renal and intensive care specialists.\\nShe underwent computed tomography (CT) chest/abdomen/pelvis with contrast and positron emission tomography whole body fluorodeoxyglucose studies, which demonstrated extensive nodal disease above and below the diaphragm, with splenic and skeletal involvement. Blood film and diagnostic bone marrow aspirate and trephine was performed which confirmed a diagnosis of DLBCL (Figure 1). The tumour cells were large and show marked nuclear pleomorphism. On immunohistochemistry, they were positive for CD20, PAX5, CD5, BCL2, cMYC and MUM1, and negative for cyclin D1 and TdT. Weak-to-moderate Bcl-6 immunostaining was seen in around 30% of tumour cells. The Ki-67 proliferation index is approximately 25% by visual estimation. The immunophenotype based on flow cytometric assessment was CD45+/HLA-DR+/CD19+/CD20+/CD22+/CD23-/CD200+/CD5+/CD10-/CD38-/CD11c+/FMC7+/cyto-Kappa+ with absent surface light chain expression. MYC, BCL2 and BCL6 gene rearrangements were not detected by FISH. Cytogenetics analysis reveal an abnormal clone with [42-44, XX, add(1)(p32), add (4)(p14), add(12)(p11.2)]. TP53 variant was present at 92%VRF on NGS. CNS involvement was present with 19% lymphoma cells noted in the CSF at diagnosis. Non-contrast CT brain demonstrated no abnormality.',\n",
       "    'gender': 'Female'},\n",
       "   {'age': None,\n",
       "    'case_id': 'PMC10231445_02',\n",
       "    'case_text': 'One week into her hospital admission, the patient reported bilateral, painless blurred vision and difficulty focusing on near objects. The onset of these symptoms was reported to have coincided with her presentation to the emergency department seven days prior. Aside from presbyopia, the patient had no previous ophthalmological history. Best corrected visual acuity (BCVA) was 6/9 in the right eye and 6/6 in the left, with no relative afferent pupillary defect. The intraocular pressures were normal in both eyes (15 OD and 12 OS). Ophthalmoscopy demonstrated bilateral venous dilation and tortuosity in the retinal vasculature, superficial retinal hemorrhages scattered throughout the posterior pole of the eye and cotton wool spots indicative of localized ischemia (Figure 2). Dynamic fundoscopy demonstrated raised retinal venous pressure, with ocular compression causing closure of the retinal arterioles prior to the retinal venules. However, there was no evidence of anterior or posterior uveitis, no keratic precipitates and no other features suggestive of intraocular lymphoma. Similarly, optical coherence tomography (OCT) imaging found no associated macular edema in either eye (Figure 3).',\n",
       "    'gender': 'Female'},\n",
       "   {'age': None,\n",
       "    'case_id': 'PMC10231445_03',\n",
       "    'case_text': \"The patient was diagnosed with bilateral CRVO, secondary to leukostasis. Given her concurrent systemic illness, the management centred around treating her underlying lymphoma, with ongoing ophthalmology follow-up. In the absence of cystoid macular oedema or retinal neovascularisation, no active ophthalmic intervention was indicated.\\nShe was subsequently commenced on the first of eight planned cycles of non-Hodgkin lymphoma R-CHOEP14 (rituximab, cyclophosphamide, doxorubicin, vincristine, etoposide, prednisolone) immunochemotherapy. One week later she was reviewed again in ophthalmology clinic. Her BCVA had improved to 6/6 OD and was stable at 6/6 OS, whilst funduscopic and OCT examination showed no change in the patient's ocular signs. After two weeks, she was discharged from hospital with a plan for ongoing ophthalmology follow-up.\",\n",
       "    'gender': 'Female'},\n",
       "   {'age': None,\n",
       "    'case_id': 'PMC10231445_04',\n",
       "    'case_text': \"Three weeks later she was re-admitted to hospital with chest pain in the context of DLBCL. She had a complicated admission with ongoing pain and cytopenias, which required multiple specialist medical team input. Whilst her ocular disease remained subjectively stable, the patient's condition continued to deteriorate, as she developed febrile neutropenia, a gram negative (pseudomonas) bacteraemia, as well as COVID-19 infection. Despite ongoing active treatment of her infections, the patient sadly passed away less than two months after commencing chemotherapy.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 11,\n",
       "    'case_id': 'PMC4943128_01',\n",
       "    'case_text': 'An 11-year-old male child was presented in outpatient department with complaints of pain in the abdomen. Stool examination was advised. Stool examination showed the presence of eggs. The eggs were bile stained, thick walled, approximately around 70-75 mum in size in wet mount preparation. An embryo could be identified with six hooklets without polar filaments [Figure 1]. The eggs were identified as of H. diminuta. The peripheral smear showed eosinophilia.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 17,\n",
       "    'case_id': 'PMC10062505_01',\n",
       "    'case_text': \"The patient was a 17-year-old female and was admitted from the emergency department to our urology ward with a complaint of dysuria. Her symptoms were distressing with pelvic pain, hematuria, and suprapubic pain, followed by the insertion of the pen in the urinary bladder. The patient's physical examination revealed suprapubic tenderness bladder. In addition, the pelvic examination showed an intact hymen and no major damage to the reproductive organs. Similarly, the laboratory findings were unremarkable, except the presence of red blood cells in the urine sample.\\nFurthermore, the computed tomography of the bladder confirmed the presence of a foreign body in the urinary bladder [Figure 1]. After obtaining confirmed consent, the patient was shifted to the operative room; general anesthesia was given to the patient, preceded by the initiation of the operating procedure. A nephroscope size 26 French was intruded into the bladder transurethrally, and the pen was extracted by a grasper in its whole length [Figures 2 and 3]. About half an hour (30 min) was allocated to the operating procedure, and the surgery was successful with no severe complications. The patient showed a good operative recovery at the end of the period of care.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 79,\n",
       "    'case_id': 'PMC9022146_01',\n",
       "    'case_text': '79-year-old female, with no ophthalmic history, was referred by general ophthalmologist for the management of a MH and cataract in the right eye (OD). She was evaluated by a retina specialist in our center confirming the diagnosis. \\nBest corrected visual acuity (BCVA): OD 20/100 and left eye (OS) 20/70. At slit lamp, anterior segment was unremarkable and NO4 cataract in both eyes (OU) was found. Fundus examination showed OD with MH larger than 600 microns and adjacent mild RPE atrophy; OS healthy macula with applied retina. It was decided to perform combined surgery of PPV + ILM peeling + gas tamponade + phacoemulsification with intraocular lens (IOL) implant in OD. No dyes were used and the procedure was performed without complications. Subsequently, routine controls were made during the first month. BCVA OD at 1-month was counting fingers at 2-feet, which did not improve with pinhole. Fundus examination showed a closed MH with severe hyperplasia of the central macular RPE. At 2-months follow-up, OD fundus color photography evidenced large RPE atrophic changes in the peeling zone (Fig. 1A), marked hypoautofluorescence at the same level (Fig. 1B), and macular optical coherence tomography (OCT) showed loss of retinal layers parallelism, irregular RPE enlargement with disruption at inner/outer segment junction and posterior optical reinforcement (Fig. 2). After 2-years, BCVA was hand motion in the OD with persisting rounded hyperplasia of the RPE corresponding to the size of the peeling zone.\\n Case 2',\n",
       "    'gender': 'Female'},\n",
       "   {'age': 69,\n",
       "    'case_id': 'PMC9022146_02',\n",
       "    'case_text': '69-year-old female, with no ophthalmic history, came to our center because of metamorphopsia in her OS and a diagnosis of ERM and bilateral cataract given by a general ophthalmologist. She was evaluated by a retina specialist in our center confirming the diagnosis. \\nBCVA was 20/30 OU. At slit lamp, anterior segment was unremarkable and P2 cataract in OU was present. Fundus exam showed ERM with applied retina OU. It was decided to perform a combined surgery of PPV + ERM peeling + gas tamponade + phacoemulsification with IOL implantation in OS. During the procedure, ERM was removed without any dye and ILM removal was stained with brilliant blue (BB). Peeling of ILM was difficult because of a great adherence of the membrane to the retina, therefore the procedure was performed without any further complications. Routine controls were scheduled during the first month. At 2-months follow-up, macular edema with OS central macular thickness of 327 mu was observed in OCT, so an Ozurdex  was implanted decreasing this value to 262 mu. After 5-months of follow-up, marked atrophy of the macular RPE with adjacent pigmentary changes was observed.\\nA new macular OCT of the OS was requested, showing loss of parallelism of the retinal layers, irregular RPE and disruption of the inner and outer retina compatible with atrophy at that level (Fig. 3); fundus autofluorescence showed an extensive RPE mottling characterized by an hypoautofluorescent area in the posterior pole extending outside the temporal vascular arcades associated with hyperreflective dots (Fig. 4).\\nIn the last control 2-years after surgery, BCVA was 20/40 in the OS that did not improve with pinhole.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 74,\n",
       "    'case_id': 'PMC2495020_01',\n",
       "    'case_text': 'Malignant lesions resected were colorectal metastases. Benign lesions treated included haemangiomas, liver cell adenoma, focal nodular hyperplasia, and deroofing of liver cysts and a bile duct cyst. Microwave ablation was utilised for hepatocellular carcinoma, haemangioma, metastatic parathyroid carcinoma, and focal nodular hyperplasia. Three operations incorporated multiple procedures these included a 74-year-old frail male patient who had a right inguinal hernia repair immediately before proceeding to a planned segment 5 resection of a colorectal metastasis. This negated the requirement for a second anaesthetic. A 73-year-old male who had a wedge excision of a haemangioma in segment 5 and microwave ablation of a second highly vascular haemangioma in segment 6, minimising the amount of tissue resected for benign disease. A 34-year-old female undergoing laparoscopic left lateral lobectomy for a suspicious lesion thought to be FNH, with a similar suspicious lesion found in segment 4a, intraoperative frozen section confirmed this lesion also to be FNH and a successful microwave ablation was performed preventing a formal hemihepatectomy in a young patient with benign disease.\\nThe operations included right hemihepatectomy n = 1, (a second right hemihepatectomy was aborted due to widespread peritoneal disease following an exploratory laparoscopy n = 1), left lateral lobectomy n = 4, bisegmentectomy n = 2, segmetectomy n = 8, wedge resection n = 11, microwave ablation n = 8, and deroofing of liver and bile duct cysts n = 7, right inguinal hernia repair n = 1. Table 1 describes the demographic, intraoperative and postoperative details of all the patients.\\nMedian operating time for the entire group of patients as judged by length of time under general anaesthetic in theatre was 120 minutes (range 40-240 minutes). Mean blood loss was 78 mL and only one patient required transfusion. Conversion to open operation was carried out in 1 out of 40 patients; this was a segment 5 resection for a colorectal metastasis and was due to CUSA failure. There was no perioperative mortality and no 30-day mortality. Median total length of stay in hospital was 3 days. No bile leaks were experienced and there were no other complications.\\nMedian operating time excluding patients having only cyst deroofing or microwave ablation, and excluding the patient who was converted to open hepatectomy and the patient having a failed right hemihepatectomy due to the presence of peritoneal metastasis, was unchanged at 120 minutes (range 60-240 minutes), mean blood loss was 104 mL, and median length of stay remained 3 days for this group. This data is described in Table 2.\\nMedian resection margins given by the pathologist were 10 mm (range 1-45 mm), where actual resection margins were not given malignant lesions were described as completely excised (CE). Of the 17 malignant tumours, one patient has died of coronary artery disease and one patient who had a segment 5 resection of colorectal liver metastasis has developed lung metastases. No patient has had locally recurrent disease.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 54,\n",
       "    'case_id': 'PMC4755470_01',\n",
       "    'case_text': 'In April 2012, the ENT (ear, nose, and throat) Department at the University Hospital of Clermont-Ferrand examined a 54-year-old patient suffering from a blood discharge of the right nostril progressing over a couple of months. In the patient\\'s personal history, there was a retinoblastoma of the right eye at the age of 7 months, which received enucleating treatment followed by radiotherapy (two doses of 40 Gy in 18 fractions and 14 fractions, by small fields of 4-6 cm2), due to the radiation-induced sequelae of the right hemifacial requiring multiple reconstructive surgeries and a prosthetic device.\\nHe is under levothyroxine treatment after a thyroidectomy for a benign tumor, carries a defibrillator, and is being treated for hypotension. The patient has also smoked since the age of 16 years (approximately 35 packs per year) and has presented three episodes of \"angioneurotic\" edema following an allergic reaction to penicillin. In the family history, his mother has breast cancer. A bilateral retinoblastoma detected in his daughter at the age of 3 months was treated by enucleation of the left-eye and right-eye radiotherapy (45 Gy in 24 sessions over 32 days) associated with chemotherapy, which led to a sarcoma pleomorphic undifferentiated in the irradiation zone, and was treated with surgery and chemotherapy.\\nThe ENT examination revealed at the right nostril a blackish tumor on the anterior part of the nasal septum. The left nasal cavity was normal, the orbital floors were free, and the examination of the cervical area was normal. The computed tomography scan found thickening tissue of the right nasal cavity remaining confined without any suspicious abnormality (Figure 1). No magnetic resonance imaging was done, because of the presence of the defibrillator. The biopsy performed under local anesthesia with a histopathological analysis of the sample reported a malignant melanoma globocellular type of nasal septum (Figure 2). An endonasal resection performed with immunohistochemical examination confirmed the diagnosis of malignant melanoma. The lesion was strongly expressing vimentin and human melanoma black 45 (HBM45) (Figure 3). It was an epithelial membrane antigen (EMA) and negative pankeratin. Surgery on the tumor was performed under general anesthesia by the endonasal route, with excision of the tumor in one piece and all the nasal septum. Extemporaneous examinations were performed on all incision samples, which yielded negative results. A consultation was performed in addictology in order to help the patient stop smoking. The anatomopathological analysis of surgical specimens confirmed the malignant melanoma (1.5 cm-long axis, infiltration and ulceration of the right nasal cavity, globular cells of an epitheloid appearance rich in cytonuclear irregularity, large nucleus with nucleolus strongly thickened with nuclear membrane and a coarse chromatin with mitosis), which came into contact with the overlap of the lower septum (Figure 4). Adjuvant radiotherapy of 54 Gy was delivered in 18 fractions of 3 Gy. Clinical (ENT, ophthalmology, medical) and radiological (computed tomography, chest X-ray, ultrasound) examinations performed every 3 months were unremarkable (Figure 5). This case report followed the tenets of the Declaration of Helsinki and was approved by the Center Hospital University of Clermont-Ferrand ethics committee. Written consent was obtained from the patient.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 80,\n",
       "    'case_id': 'PMC7605928_01',\n",
       "    'case_text': 'An 80-year-old man with flu symptoms collapsed at his house because of lightheadedness. He received a diagnosis of lumbar compression fracture at a local clinic. He obtained nerve block injection to control his backache at another medical facility. However, he lost his appetite and could not stand, and his backache condition deteriorated, so his family called for an ambulance.',\n",
       "    'gender': 'Male'},\n",
       "   {'age': 31,\n",
       "    'case_id': 'PMC7605928_02',\n",
       "    'case_text': 'He had a history of gastrectomy at 31 years old, cerebral infarction at 71 years old, lumbar spinal canal stenosis at 73 years old, and acute coronary syndrome requiring percutaneous coronary intervention at 79 years old. He had no specific family history. On arrival, his blood pressure was 142/110 mmHg, his heart rate was 92 beats per minute, his body temperature was 37.2 C, and his percutaneous oxygen saturation was 97% under room air. He complained of backache on motion. He had no sensory or motor disturbance. The main results of a blood test are shown in Table 1. Chest X-ray showed reduced permeability of the right lung field (Figure 1), and truncal computed tomography (CT) suggested right multilobular empyema and right iliopsoas abscess (Figure 2). Exploratory puncture under ultrasonic guidance resulted in confirmation of the abscess, and we performed right small thoracotomy for empyema; about 300 ml of bloody pus was removed. We then inserted a continuous double lumen catheter into the right chest. Next, we performed drainage under ultrasonic guidance for the right iliopsoas abscess, and about 100 ml of bloody pus was also removed. We inserted a catheter for drainage of the remaining iliopsoas abscess. We diagnosed him with empyema with an iliopsoas abscess and started intravenous administration of doripenem hydrate after obtaining culture samples.\\nAfter these treatments, his general condition improved, and he was able to feed himself. On day 7, S. intermedius was cultured from all sites, and doripenem hydrate was deescalated to ampicillin based on the results of a drug sensitivity test and the possibility of switching to medicines for internal use. On day 9, all drainage tubes were removed because of an improvement in his inflammatory response. On day 16, lumbar fusion was performed for lumbar compression fracture. Following the operation, he continued rehabilitation and intravenous administration of ampicillin for three months. With these treatments, the abscess shrank. Finally, he was transferred to another hospital for rehabilitation.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 43,\n",
       "    'case_id': 'PMC8650644_01',\n",
       "    'case_text': 'A 43-year-old male patient with underlying diabetes mellitus and a history of admission for meningitis lesser than one year before this current condition presented with lower abdominal pain with radiation to the left thigh. He also complained of having fever and lethargy for the past three days and eventually unable to ambulate due to worsening pain. On physical examination, he appeared lethargic, while his vital signs were still stable. Both iliac fossae were tender, and crepitus was felt along the anteromedial aspect of the left thigh. The neurovascular status of the bilateral lower limbs was intact. Blood investigations showed lymphocytosis. A CT scan was done urgently and revealed retroperitoneal collection from the L1/L2 vertebral body and the collection was extending to bilateral iliacus muscle. However, it extended beyond the iliopsoas insertion on the left side. The CT scan images revealed also the destruction of the first and second lumbar vertebrae (Figure 1). \\nThe patient was resuscitated adequately and, then, taken for surgical intervention on the same day as the presentation. Extensive incision and drainage were done bilaterally. Intraoperatively, more than 1,000 mL pus was drained, and the extensive slough tissue was debrided. The collection was found to unusually breach the deep fascia and extent into the left adductor canal (Figure 2). \\nDuring this setting, a diagnostic laparoscopy was also performed, and intra-abdominal involvement was ruled out. Specimens were sent for culture and sensitivity intraoperatively, which later revealed the growth of Klebsiella pneumoniae (K. pneumoniae). The patient was treated with intravenous amoxicillin/clavulanic acid. A repeat CT scan was done one week later and showed a residual collection. The patient was taken in for another surgical drainage, while intravenous antibiotics were continued. Subsequent repeat scan revealed only minimal residual collection, while there was no worsening of vertebral bony destruction. Although the collection was visualized to involve the L1 and L2 vertebral bodies with bony destruction, no surgical interventions were performed for the spine, as the patient did not have neurological deficits and there was no worsening of the spinal column during treatment with intravenous antibiotics. \\nEventually, the patient improved clinically and was deemed fit for discharge. He was followed in the outpatient setting. However, eight months later, the patient was re-admitted for a left hip intramuscular abscess for which left hip drainage of the intramuscular abscess and arthrotomy washout was done, revealing about 40 mL of pus. During the same admission, the patient was also treated for lung empyema and bilateral pleural effusion by the surgical and medical team, respectively. Culture and sensitivity of specimens sent intraoperatively yielded growth of K. pneumoniae and he was treated with intravenous meropenem. Unfortunately, the patient eventually succumbed to sepsis due to the deep-seated intramuscular abscess and lung empyema. A written informed consent was obtained from the patient.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 18,\n",
       "    'case_id': 'PMC2948899_01',\n",
       "    'case_text': \"A 18-year-old patient with a history of Matched-Unrelated-Donor Peripheral Blood Stem Cell Transplantation (MUD-PBSCT) was admitted to the hospital because of renal failure. In November 2007 the patient was first diagnosed with acute lymphoblastic leukemia of T cells (T-ALL) at another institution, where he was treated with induction therapy according to Hyper-CVAD Protocol (Cyclophosphamide 300 mg/m2 intravenously (IV) over 3 hours every 12 hours for six doses on days 1 through 3, with mesna given by continuous infusion, vincristine 2 mg IV days 4 and 11, doxorubicin 50 mg/m2 IV day 4, and dexamethasone 40 mg daily on days 1 through 4 and 11 through 14) and was refractory when he presented in our department of hematology/oncology. The diagnosis of T-ALL has been confirmed, immunophenotype precursor T-ALL (CD7, CD3, CD2, CD4, and CD8 pos), cytogenetic 46, XY, Fluorescein in sito hybridisation (FISH) analysis 87% deletion of p16 on the chromosome 9 region p21. He was then treated with induction therapy according to the German multicenter ALL protocol (GMALL) achieving only reduction of blasts after Induction II. Briefly, the induction in GMALL protocol was composed of eight cytotoxic drugs administered sequentially in two phases over an 8-week period. During the first 4 weeks (phase I), the patient received 60 mg/m2 prednisolone PO daily (days 1 through 28) plus 45 mg/m2 daunorubicin and 2 mg vincristine IV weekly (days 1, 8, 15, and 22). L-asparaginase (5 000 U/m2) was administered IV daily (days 15 through 28). In the second 4 weeks (phase II), the patient received two doses of 650 mg/m2 cyclophosphamide IV (days 29, 43, and 57) together with 60 mg/m2 6-mercaptopurine PO daily (days 29 through 57) and four courses of 75 mg/m2 cytarabine IV (days 31 through 34, 38 through 41, 45 through 48, and 52 through 55). He was then treated with nelarabine and achieved complete remission (CR1) following MUD-PBSCT. The conditioning consisted of total body irradiation (TBI), 12 Gy, given fractionated 2 times daily for three days, from day -6 to day -4, and cyclophosphamide 60 mg/kg once daily i.v. on days -3 and -2 (total dose 120 mg/kg b.w.). A Human Leukocyte Antigen (HLA) identical unrelated donor peripheral blood stem cells were infused on day 0. Graft-versus-Host Disease (GvHD) prophylaxis consisted of thymoglobulin (2 mg/kg b.w. daily, from day -3 to -1, total dose of 6 mg/kg b.w.), cyclosporine 5 mg/kg starting on day -1, and methotrexate at days +1, +3, +6, and +11 intravenously 15 mg absolute. The bone marrow puncture on day +28 showed a complete hematological remission with 100% donor chimerism. Along with the regeneration of white blood cells the patient developed a methylprednisolone-dependent GvHD of the skin and gastrointestinal, grade II. After 10 days the therapy with corticosteroids could be discontinued by rapid improvement of the GvHD-related symptoms. Under the therapy with corticosteroids the patient developed a herpes simplex related oesophagitis on day 21 post transplant which was treated with 30 g daily over 5 days i.v. immunoglobulin and foscarnet 90 mg/kg b.w. divided in 2 doses. On day +28 after PBSCT the patient developed a hemorrhagic cystitis with high urine titers of BK polyoma virus and CMV infection. A therapy with ganciclovir was initiated for ten days. Under treatment with ganciclovir, CMV infection improved, and the treatment with cidofovir was started (1 mg/kg b.w. for two weeks). The BK Virus viruria and viremia improved, and the patient received ganciclovir treatment for additional two weeks (Figure 1). The cyclosporine level was from 200 to 150 from day 0 to day 30, followed with level of 100 from day 30 to day 40 post transplant, and level of 50 from day 40 to day 50. The cyclosporine has been discontinued on day +70 after MUD-PBSCT in absence of acute GvHD and as recommended in GMALL protocol. On day +48 after PBSCT a cystoscopy with a continuous intravesical saline irrigation was started and discontinued 2 weeks later. The patient symptoms improved, and creatinine levels returned to normal. He was discharged from hospital; his medications at the time of discharge included ciprofloxacin (250 mg twice daily), valacyclovir (500 mg twice daily), fluconazole (200 mg daily), folate, and cotrimoxazole twice weekly for prophylaxis of pneumocystis carinii infection.\\nOver the next year the levels of urea nitrogen and creatinine gradually rose (Table 1), which was attributed to drug toxicity. cotrimoxazole prophylaxis was stopped. Cyclosporine was discontinued since no signs of GvHD were present 6 months after PBSCT. The serum creatinine level was 153 mumol/l (Table 1). Routine urinary diagnostic measures were carried out and showed inconsistent microhematuria. BK viruria was negative in this period. \\nOn admission, blood pressure was 130/80 mmHg with 90 heart beats per minute, a temperature of 36.4 C, and an oxygen saturation of 99% when the patient was breathing ambient air. The lungs were clear, the results of the remainder of the examination were normal. The complete blood count and levels of serum electrolytes, liver function tests, and levels of total protein and albumin were normal. The urine sediment was not nephritic but contained a small amount of leukocytes indicating an inflammatory process such as cystitis. Results of other laboratory tests are shown in Table 1. \\nUltrasonographic examination of the kidneys showed bilateral hydronephrosis stage III-IV (Figure 2(a)). In addition, decreased echotexture bladder tumours were seen (Figure 2(b)). The patient was presented to the urologist. Cystoscopy with urethrography has shown exophytic bladder tumours in both ostii. The extirpation of the tumours was performed and sent off for pathological examination. In addition a double-J catheter was placed. The hydronephrosis of the left kidney improved immediately and improved to grade II in the right kidney. For histological examination tissues were formalin-fixed overnight and embedded in paraffin. Hematoxylin & Eosin staining of 5 micrometer sections was performed following standard procedures. \\nThe pathohistology of the specimen showed a chronic cystical urocystitis with bleedings (Figure 3(a)). Tissue probes of both ureters were stained for SV40 large T antigen (clone pAb416, Oncogene Science, Boston, Mass, USA; dilution 1 : 100, antigen retrieval and amplification with catalyzed system amplification, Dako, Carpinteria, CA). The reactions were detected by means of the streptavidin-biotin method and were revealed using diaminobenzidine as a chromogen. In all tissue probes immunohistochemistry for large T antigen was negative (Figure 3(b)). \\nThe patient has undergone double-J catheter controls and changes every two months and is doing well 2 years after PBSCT and 1 year after operative extirpation of tumours. The last control was in April 2010 (Table 1).\\nTwo different regions of the BKV genome were amplified by PCR, VP2 in serum and urine, and large T antigen from tissue biopsies.\\nNucleic acids were extracted from 200 microliter blood or urine using magnetic beads (MagNA Pure LC total NA isolation kit, Roche, Mannheim, Germany) according to the manufacturer's instructions while from formalin-fixed, paraffin-embedded material nucleic acids were extracted using the QIAamp DNA FFPE Tissue Kit (Qiagen, Hilden, Germany). VP2 primers lead to amplification of a 131 bp fragment. PCR reaction was carried out in 20 microliter capillaries containing master mix (6 mM MgCl2, 0.1 mg/ml BSA (Sigma, St. Louis, USA)) and 10 picoM of each primer (Metabion, Martinsried, Germany), 3 picoM of each hybridization probe (5'-GGCTGCTGCTGCCACAGGATTTTC-FL (probe 1) and 5'LC Red640-GTAGCTGAAATTGCTGCTGGAGAG-ph (probe 2), 0.25 mM dNTP's (Roche)), and 1U Platinum Taq Polymerase (Invitrogen, Karlsruhe, Germany). Target DNA was added in a volume of 5 microliters. Two negative and 4 positive controls in different concentrations were included into each run performed on a LightCycler 1.0 instrument (Roche, Mannheim, Germany) under the following conditions: initial denaturation and activation of hot-start enzyme at 95 C for 30 s, followed by 45 cycles of denaturation at 95 C for 0 s, annealing of primers at 58 C for 10 s, and primer extension at 72 C for 20 s. Fluorescence was monitored by single acquisition during the annealing phase of each PCR cycle and channel setting F2/F1 (640 nm/530 nm). Differentiation of BK virus amplicons from JC virus depends on the binding of the probe 2, which perfectly matches JC virus but differs at the two underlined positions from BK virus. Thus binding to BK virus results in a shifted melting curve (61.5 C for BK versus 63.8 C for JC).\\nFor detection of the viral large T-antigen, a 128 bp long fragment was amplified using modified primers from that match BKV genotypes 1 to 4, forward primer 5'-CAGGCAAGGGTTCTATTACTAAAT-3', reverse primer 5'-GCAACAGCAGATTCYCAACA-3', probe 5'-6FAM-AAACTGGTGTAGATCAGARGGAAAGTCTTTAGGGTCTT-BBQ. \\nPCR conditions were identical to the one described above except TaqMan probe that was used at 4 pico molar, primer annealing was 56 C for 10 s, and fluorescence acquisition was at the end of each primer extension phase at 530 nm.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 70,\n",
       "    'case_id': 'PMC9316585_01',\n",
       "    'case_text': \"A 70-year-old male was referred to our hospital in June 2020 because of a right renal mass accidentally detected on computed tomography (CT). There were no complaints of haematuria, abdominal masses, pain, or weight loss. The patient's past medical history included hypertension, coronary artery disease, and chronic hepatitis B. His medications included olmesartan, aspirin and entecavir. There was no family history of cancer, and the physical examination was unremarkable.\\nAbdominal contrast-enhanced CT revealed a round-like mass with obvious early enhancement in the middle part of the right kidney. The mass did not protrude beyond the renal contour and was accompanied by slight shrinkage of the renal cortex ( Figures 1A-E ). For the purpose of partial nephrectomy, 8 and 4 points were evaluated according to PADUA and SPARE nephrometry scoring systems, respectively.\\nIn preoperative discussion, urologists did not believe that the small renal mass could be accurately identified or palpated during nephron-sparing surgery. Considering that the mass was located in the lateral region of the right kidney and intraoperative ultrasound (US) was highly dependent on the operator, we decided to perform microcoil implantation prior to laparoscopy to provide a direction for partial nephrectomy.\\nAfter preoperative evaluations were performed and informed consent was obtained, the patient underwent CT-guided localization of the small renal mass without any complications or obvious inconvenience. A tornado-like radio-opaque microcoil (MWCE-18S-6/2-TORNADO, Cook Medical, Bloomington, IN, USA) was implanted into the renal parenchyma targeting the small renal mass ( Figure 1F ).\\nThe right kidney was scanned by CT five times, and the cumulative effective radiation dosage was 5.1 mSv. The span between CT-guided microcoil localization and the start of the operation was 15 hours. Under general anaesthesia, the patient underwent laparoscopic partial nephrectomy in the left lateral position. Laparoscopic exploration of the retroperitoneal cavity revealed the implanted microcoil protruding from the dorsal surface of the right kidney ( Figure 2A ). The resection range was 2 cm in radius with the implanted microcoil as the centre. The mass was completely removed without excessive damage to the renal vasculature or collecting system ( Figure 2B ). The operation time was 105 minutes, and the warm ischaemia time was 25 minutes.\\nThe postoperative recovery was smooth, and no perioperative complications occurred. The postoperative serum creatinine concentration was 88.4 mumol/L, within the normal range, and no hydronephrosis was observed on US at the postoperative follow-up. The final pathological result revealed T1a renal cell carcinoma (RCC, American Joint Committee on Cancer TNM stage), WHO/ISUP grade 2 ( Figure 2C ), 16 mm in greatest dimension. The tumour did not involve the perirenal capsule and was at least 2 mm away from the surgical margin. Eleven months later, follow-up magnetic resonance imaging showed no RCC recurrence, and the patient remained asymptomatic.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 11,\n",
       "    'case_id': 'PMC9329137_01',\n",
       "    'case_text': 'The first case presented at birth with imperforate anus and intestinal obstruction for which a sigmoid colostomy was performed in the neonatal period. This case represented an extreme form of anorectal anomaly with severe sacral dysplasia, pelvic asymmetry, and deformed genitalia. Chromosomal analysis confirmed normal male karyotype (46 XY). Perineal examination revealed a caudally positioned hypospadiac phallus with severe penoscrotal transposition ( Fig. 1A and B ). A single wide perineal orifice proved to be the bladder neck directly communicating with the perineum without recognizable urethra in-between (vesico-perineal fistula). The urinary bladder was very small (underdeveloped) due to continuous leakage of urine through the wide and incompetent bladder neck. Distal colostogram demonstrated no communication with the urinary tract (imperforate anus without fistula) ( Fig. 1C ). A perineal swelling was located just beside the central perineal orifice which proved to be a lipoma on magnetic resonance imaging (MRI) ( Fig. 1D and E ). This case had other associated major anomalies: renal and testicular agenesis on the right side as well as poor lower limb development on the same side ( Fig. 1D ), asymmetrical lower vertebral dysplasia, and lipomyelomeningocele. Because of the severe distortion and asymmetry of pelvic anatomy, in addition to the presence of significant sacral dysplasia and spinal anomalies, a very poor prognosis for continence (both urinary and fecal) was expected in this case. After counseling with the parents, we decided to leave the patient with colostomy, while continent urinary diversion was performed later at the age of 4 years. The ureter of the single left kidney was disconnected from the hypoplastic bladder, and then was reimplanted in a pouch formed from intestine (ileocecal pouch), while the appendix was used as a conduit for self-catheterization (Mitrofanoff principle). The parents were instructed to keep on long-term follow-up at nephrology clinic for his special renal condition (single kidney draining into pouch of intestine). This patient is now 11 years old; and he is doing well at school. He is continent to urine through regular self-catheterization, and his single left kidney shows normal sonographic appearance at follow-up. He still has a colostomy, while the lipomyelomeningocele was managed conservatively. He underwent above knee amputation for the poorly developed right lower limb, and he is walking using artificial limb (right side) and crutches. He is now counseling for possibility of some sort of corrective surgery for the external genitalia. \\n The second case was referred to our hospital at the age of 9 months with a sigmoid colostomy performed elsewhere at birth. Perineal examination revealed similar anatomical derangement ( Fig. 2 ): single perineal orifice, caudally positioned hypospadiac phallus, severe penoscrotal transposition, in addition to a perineal swelling covered with mucous membrane. Chromosomal analysis confirmed normal male karyotype (46 XY). Imaging studies demonstrated the rectum joining with the urethra 1.5 cm below the bladder neck to form a common excretory orifice just distal to their confluence. Compared with the first case, this case represented a milder form of the anomaly, not only for the absence of major associated anomalies but also for the presence of a recognizable segment of proximal urethra below the bladder neck. However, the urethral segment was too short (like the female urethra); and the bladder neck was still wide and was located at a lower level in the pelvis opposite the distal end of the pubic symphysis ( Fig. 2D ). At the age of 18 months, posterior sagittal anorectoplasty was performed to mobilize the rectum and reposition it backward within the sphincter muscle complex, in addition to excision of the perineal swelling ( Fig. 2E , F ). Histopathological examination of excised perineal swelling was compatible with hamartomatous polyp ( Fig. 3 ). Correction of the penile deformity will require staged reconstruction.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 16,\n",
       "    'case_id': 'PMC4236770_01',\n",
       "    'case_text': \"A 16-year-old man presented with a one month history of fever, pubic pain which irradiates to the genitals and increases when hip is mobilized, and this fact produces gait claudicating. The symptoms started a few days after playing a football match, though the patient denied any history of trauma. He had a temperature of 38.5 C and a normal testicular and abdominal examination. The C reactive protein had risen to 12 mg/l with an erythrocyte sedimentation rate of 25 mm/h and a white blood cell of 16410 per mm3. Echocardiogram was normal and autoimmune screen was negative. The blood culture was negative. The magnetic resonance imagery (MRI) of the pelvis showed a bone oedema of symphysis pubis and abdominal muscles (Figure 1, Figure 2). The puncture guided by computed tomography (CT) of the articulation of pubis returned of Staphylococcus aureus methicillin-susceptible (SAMS). The patient was prescribed intravenous flucloxacillin 1 g six times a day for six weeks and discharged with further four months of oral flucloxacillin at 1g three times a day on microbiologist's advice. A repeat MRI after four months showed a complete resolution.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 13,\n",
       "    'case_id': 'PMC6515074_01',\n",
       "    'case_text': \"A 13-year-old boy underwent pericardial fenestration and thoracic duct ligation for pericardial and pleural effusion at 3 years of age and was diagnosed with GLA after a pleural biopsy. The patient experienced no pleural effusion before his 11th birthday. The patient had a history of cerebrospinal fluid leakage due to a skull fracture at 7 years of age. The patient was referred to our department immediately following pleural effusion when he was 11 years old. A hematological examination showed high values for D-dimer (22.2 mug/mL) and P-FDP (50.9 mug/mL). A radiograph showed pleural effusion in the right lung (Figure 1). Thoracentesis revealed chylothorax mixed with blood components. Magnetic resonance imaging showed additional lesions on the lymph ducts on both sides of the inner auditory channels; computed tomography (CT) showed diffuse osteolytic changes on both sides of the femoral neck and thoracic vertebra.  Figure 2 shows the patient's clinical course. Although the patient abstained from eating and parenteral nutrition was provided in addition to octreotide testing and pulse steroid therapy, pleural effusion worsened and became bilateral. Two or more liters were drained on days when there was a large amount of pleural effusion. We were unable to locate the site of the leakage even though we conducted a lymphogram to treat the pleural effusion and identify the leakage site. Sirolimus administration was initiated at 0.88 mg/m2/day, which proved to be an insufficient dosage. However, when the dosage was increased to 1.3 mg/m2/day after 1 month, the patient experienced an onset of disseminated intravascular coagulation (DIC) after 1 week. At that time, a blood examination showed platelet (1.4 x 104/muL), P-FDP (590 mug/mL), fibrinogen (114 mg/dL), prothrombin time rate (1.35), antithrombin (129%), and no liver dysfunction. The urine and blood cultures were negative. Viral serology was negative for cytomegalovirus, and aspergillus antigen was negative. Rheumatoid factor and antinuclear antibody were normal levels. The CT scan showed no sign of pneumonia or pyothorax. We diagnosed him with DIC using DIC score. Although we temporarily paused the administration of sirolimus, the patient experienced an additional onset of DIC 10 days after we resumed administration. Thus, he underwent thoracoscopic removal of the hematoma (Figure 3). The trough level of sirolimus during administration was 3.4-8.9 ng/mL, which does not represent abnormal elevation. Although an additional pause in the administration of sirolimus did not reduce the amount of pleural fluid, there were no additional onsets of DIC. Subsequently, there was a significant decrease in pleural fluid once Eppikajyutsuto was administered at 0.2 g/kg/day. We were able to proceed with tube thoracostomy removal 40 days after the initiation of oral administration. There was no re-accumulation of pleural fluids in the 18 months following the initiation of oral administration.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 66,\n",
       "    'case_id': 'PMC4348141_01',\n",
       "    'case_text': 'A 66-year-old man was referred to our hospital, the National Defense Medical College, Tokorozawa City, Japan from an ophthalmology clinic with a 1-week history of visual disturbance in his right eye. There was no ocular history of trauma, inflammation, or medication. His family history and medical history for systemic diseases were unremarkable. At presentation, the best corrected visual acuity was 20/30 in the right eye and 20/15 in the left eye. Intraocular pressure (IOP) was 30 mmHg in the right eye and 14 mmHg in the left eye. Biomicroscopy revealed ciliary injection, corneal epithelial edema, mutton-fat keratic precipitates, flare, and infiltrating cells in the anterior chamber of the right eye (Figure 1A and B). In addition, pigmentation of trabecular pigment band in the angle was increased in the right eye compared with the left eye (Figure 1C and D). Although mild opacity and cell infiltration in the anterior vitreous of the right eye were present, retinitis or retinal vasculitis was not observed. No abnormalities were found in the left eye.\\nIn addition to the laboratory blood tests, the multiplex polymerase chain reaction (PCR) for human herpes viruses (HHVs) 1 through 8, of the aqueous humor from the right eye was performed, and treatment with topical 0.1% betamethasone, mydriatic (0.1% phenylephrine and 0.1% tropicamide), and 0.005% latanoprost for ocular hypertension was initiated. The serological tests were negative for syphilis and anti-herpes simplex virus, as well as anti-VZV antibodies. However, VZV-DNA was detected by multiplex PCR in the aqueous humor obtained from the right eye, and quantitative real-time PCR revealed VZV-DNA copies of 1.28x107 copies/mL. Although the patient had not been vaccinated for VZV, there was no history of chickenpox in childhood or later, and serum anti-VZV antibodies were not detected. However, ZSH was diagnosed since the clinical findings were compatible with VZV-associated anterior uveitis and skin lesions were absent, thus excluding HZO.\\nWe initiated medical treatment for VZV with oral valaciclovir 1,500 mg three times a day for 1 month, in addition to the topical treatment. Ocular inflammation resolved gradually, and IOP decreased to lower than 21 mmHg. VZV-DNA in the aqueous humor was reduced to 4.08x104 copies/mL at 3 months after the first visit, and serum anti-VZV antibodies were first detected after 4 months. Distorted pupil and fan-shaped iris atrophy, which are characteristics of VZV iridocyclitis, appeared at the upper nasal iris (Figure 2). Ocular inflammation was not observed at 6 months, and VZV-DNA was not detected from the aqueous humor. Written informed consent was obtained from the patient for publication of this case report and accompanying images.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 35,\n",
       "    'case_id': 'PMC6525288_01',\n",
       "    'case_text': 'A 35-year-old healthy pregnant lady with a history of 3 previous cesarean sections was scheduled for her 4th cesarean delivery. The operation was performed under spinal anesthesia. Severe adhesion of the urinary bladder to the lower uterine segment was encountered but there was no apparent lower urinary tract injury. Her postoperative period was uneventful and she was discharged home the next day. On the 11th postoperative day she was readmitted to the emergency unit at 11 pm with considerable abdominal distension, shortness of breath and difficulty of micturition with straining to void. Further questioning revealed sudden inability to void 5 days earlier followed by mild hematuria and passing a small amount of urine. On examination she was dyspneic, the abdomen was distended, pulse rate was 100 BPM, blood pressure was 100/60 mm/Hg and afebrile. Immediate resuscitation was started and Foley catheter was inserted which drained 100 ml concentrated urine. Serum creatinine (6.8 mg/dl), blood urea (123 mg/dl) and serum potassium (5.6 meq/l) were high. Abdominal and pelvic ultrasound showed marked ascites (Fig. 1), normal both kidneys with no hydronephrosis. A trial of diagnostic and therapeutic ascitic fluid drainage was performed by putting a percutaneous 12 French pigtail catheter in the right lower abdomen under ultrasonic guidance (Fig. 2). Six and a half liters of clear fluid was drained. Biochemical investigation of the drained fluid showed high urea (145 mg/dl) and creatinine (20 mg/dl). Diagnosis of urinary ascites was confirmed. Later on, there was a dramatic improvement in the general condition of the patient. Next day blood chemistry was repeated and showed normal blood urea and serum creatinine. Through cystoscopy, we detected a perforation at the posterior wall of the bladder (Fig. 3), while both ureters were normal. Then a Foley catheter was fixed to completely drain the urine in addition to the peritoneal drain to allow the perforation to heal. The patient was put on intravenous fluid and antibiotics with monitoring of vital signs. Three days later the intraperitoneal drain nearly had no drainage and no more free fluid could be seen on ultrasound scan, therefore the tube was removed. The patient was discharged with Foley catheter in place. Two weeks later voiding cystography was performed which showed no more leak (Fig. 4) and the Foley catheter was removed. The patient was discharged home with a good health and returned to her daily life.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 66,\n",
       "    'case_id': 'PMC10338080_01',\n",
       "    'case_text': \"This patient was a 66-year-old male farmer, who suffered from left eye swelling and pain. Six months ago, the patient developed mild blurred vision with a small amount of eye discharge. Twenty days before presenting to the hospital, the patient developed the sudden onset of swelling, pain, and blurred vision in the left eye. He was treated with intravenous amoxicillin/clavulanic acide at a local hospital but had progression of the blurred vision and distension. The patient had a history of hypertension for four years and was taking amlodipine benzoate.\\nPhysical examination: There was no light perception in the left eye. Conjunctival hyperemia and corneal edema were evident. A large amount of flocculent milky white pus was seen in the anterior chamber. The texture of the iris could not been clearly seen via slit lamp examination. The examinations of corneal topography showed an abnormal corneal curvature of left eye ( Figure 1A ). The corneal endothelial cell quality detection showed that almost no intact corneal cells could be seen in the left eye ( Figure 1B ). These results meant that the cornea and eyeball of left eye were almost completely destroyed ( Figure 1 ).\\nThe diagnosis was left eye endophthalmitis and left eye blindness, accompanied with progressive worsening of symptoms and lack of ocular preservation value. Left eye evisceration was performed. A large amount of milky white purulent flocs was seen during the operation, and the pus in the anterior chamber was taken for microbial smear and culture. Clear mycelium with septa and branches were observed in smear test, and grayish-white fluffy colonies were cultured in different types of medium. After surgery, erythromycin eye ointment and levofloxacin eye drops were given to control infection. The patient recovered well after surgery and was discharged from hospital on 10 January 2022. No antifungal drugs were given. No abnormalities were found during follow-up.\\nPus samples were taken from intraoperative milky white purulent flocculent.\\nDry leaves were cut into pieces and soaked in distilled water for 6 h and then boiled and centrifuged at 2,500 rpm for 10 min. The supernatant was filtered through a 0.22-mum sterilization filter. Natural substrate potato dextrose agar (PDA) agar medium was prepared using 20 g of dry powder of PDA medium (Beijing Tiantan Bio) dissolved in 1,000 ml of supernatant of distilled water soaked in dry leaves. Meanwhile, ordinary PDA agar medium was prepared using distilled water.\\nFungal DNA extraction kit (EE101, TransGen Biotech, Beijing, China) was used to extract DNA of the isolates. Internal transcribed spacer (ITS), beta-tubulin (BT2), translation elongation factor 1-alpha (tef-1), and RNA polymerase II (RPB2) gene were amplified using PCR as follows. PCR reaction system: Taq of 0.5 mul, 2x Taq Master Mix of 25 mul, deoxynucleotide triphosphates (dNTPs) of 5 mul, upstream and downstream primers of 0.5 mul each, template DNA of 2 mul, and ddH2O of up to 50 mul. Reaction conditions: pre-denaturation at 94 C for 2 min; denaturation at 94 C for 30 s, annealing at 58 C for 30 s, extension at 72 C for 90s, cycle number 35; extension at 72 C for 7 min. The primer sequences (5'-3') were ITS1: TCCGTAGGTGAACCTGCGG and ITS4: TCCTCCGCTTATTGATATGC for ITS; T1: AACATGCGTGAGATTGTAAGT and Bt2b: ACCCTCA-GTGTAGTGACCCTTGGC for BT2; EF1-1018F: GAYTTCATCAAGAACATGAT and EF1-1620R: GACGTTGAADCCRACRTTGTC for tef-1; DRPB2-5F: GAYACNGAYGAYCGWGAYCAYTTYGG and DRPB2-7R: AANCCCATDGCYTGYTTDCCCAT for RPB2. The PCR products were identified by 1% agarose gel electrophoresis and sequenced by Tsingke Biotechnology Co (Chengdu, China).\\nThe sequences were submitted to GenBank, and accession numbers were obtained (OQ658167 for ITS, OQ700917 for BT2, OQ700916 for tef-1, and OQ700915 for RPB2). Phylogenetic trees of ITS, tef-1, and RPB2 were constructed by neighbor-joining and maximum likelihood methods with 1,000 bootstrap replicates using MEGA 6.06 software.\\nAntifungal susceptibility tests were performed by using the Sensititre YeastOne  YO10 (CN15009V2, Thermo Scientific, Cleveland, OH, USA) according to the manufacturer's instructions. Briefly, the conidia were collected with a cotton swab, suspended in a sterile saline solution containing Tween-20, and inoculated on the drug-sensitive plate. The broth microdilution panel was incubated in a non-CO2 incubator at 35 C for 72 h. Candida albicans ATCC14053 was used as the quality control strain in this test. The minimum inhibitory concentration (MIC) values were read according to the MIC interpretation standard of Aspergillus following the kit instructions (recommended by CLSI M38 and EUCAST).\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 3,\n",
       "    'case_id': 'PMC4503302_01',\n",
       "    'case_text': 'This is a 3 year-old girl with Caucasian ethnicity with severe lipoatrophy, pulmonary hypertension, and a progeroid appearance (Fig A in S1 File). Amniocentesis was performed during this pregnancy and showed a normal fetal karyotype. Fetal ultrasound revealed bilateral pleural cavity fluid collections, thought to represent chylothorax. These resolved by the 7th or 8th month of gestation. Fetal growth rate was slow.\\nDelivery was uncomplicated, by repeat C-section at term, and no fetal resuscitation was required. A chest X-ray was done for tachypnea, which revealed bilateral small pneumothoraces. This resolved spontaneously. As a neonate, she had a poor suck, and cried inconsolably while she nursed.\\nAs an infant, skin findings noted on her exam included a fine reticular pattern of her skin (livedoreticularis or cutis marmorata), large anterior fontanelle, absence of subcutaneous fat, with a history of feeding problems, vomiting and failure to thrive. She was given N-G tube feedings of breast milk. Weight gain remained poor, and she did not tolerate greater than 1-oz bolus feedings. She continued to have daily episodes of projectile vomiting, in spite of thickened feedings. At 8 months of age, a feeding gastrostomy was placed and she was fed continuously. She presented with hypertriglyceridemia at age 3 months, and has had fluctuating episodes of elevated triglyceride levels and normal levels since her first test.\\nHer development has been normal. She did not have seizures and was always active. Initial Neurological Examination at 7 months found that she was thin, her weight well below 5%, and her height and head circumference were between 60-75%. She had very little subcutaneous fat, livedoreticularis of the skin, prominent skin veins, a triangular appearance to her face, and a large anterior fontanelle, extending into the metopic suture.\\nSubsequent examinations continued to show lack of subcutaneous fat, livedoreticularis, large and open anterior fontanelle, but no focal neurological findings. She was active, playful, interactive, and was speaking in sentences. She developed echocardiographic features of pulmonary hypertension, confirmed by catheterization. Ophthalmological examination was normal.',\n",
       "    'gender': 'Female'},\n",
       "   {'age': 4,\n",
       "    'case_id': 'PMC4503302_02',\n",
       "    'case_text': \"Brain MRI done at 3 months and 8 months showed prominent subarachnoid spaces, ventricles, and Sylvian fissure, raising the possibility of cerebral atrophy. Upper GI studies were normal. Thyroid function tests, complete metabolic profile, plasma amino acids, urine organic acids, and array CGH were normal. Bone age was normal; skull X-ray showed only the large anterior fontanelle, but absence of Wormian bones. Genetic testing for Russell-Silver syndrome, mandibulo acral dysplasia were negative. Sweat chloride test was normal, and a chest CT scan was normal. Lung biopsy showed focal smooth muscle thickening of pre-acinar arterioles. At 4-years old, the patient's fasting serum leptin was 0.7 ng/mL, which is much lower than healthy 4-year old females: 1.9 (1.5-2.7).\\nAverage genome sequencing depth was 39x, with 96.93% over 10x depth. Variant calling revealed a de novo frame-shift mutation in the CAV1 gene (chr7:116199282-3>delTT; NM_001172897.1:c.385_386delTT;NP_001166368.1:p.Phe129X; NM_001753.4:c.478_479delTT;NP_001744.2:p.Phe160X), previously associated with Congenital generalized lipodystrophy type 3. The mutation introduces an immediate stop into the protein. Whole genome sequencing could not reveal a second mutation in CAV1, although coverage across all exons was sufficient to detect variations. In addition, we also found a second variant of interest in a gene associated with congenital generalized lipodystrophy type 1: AGPAT2 (chr9:139581758insCAG; NM_006412.3:c.51_52insGTC; NP_006403.2:p.X18Leu; rs201504151). The variant in AGPAT2 is inherited from the father, though quite frequently present in the normal population (7.18%, exome variant server). It is unclear whether this variant contributes to any symptoms present the patient. A last interesting variant was found in lipin 1 (LPIN1), in which mutations cause a lipoatrophic phenotype in the mouse (chr2: 11927238G>A;NP_001248356.1:p.Val500Met; rs33997857). This variant has a 2.2% frequency in the population, was inherited from the mother, and is predicted damaging. The CADD scores and details of all 3 variants are listed in Table 1. All variants were confirmed with Sanger sequencing in the patient and parents. Studying mRNA extracted from the patient's whole blood revealed that both mutant and wild type CAV1 were transcribed (Fig B in S1 File), and that the RNA from the mutant allele was neither degraded by nonsense mediated RNA decay; nor was the second allele silenced by a regulatory mutation.\\nOverrepresentation analysis was done to identify pathways that are dysregulated in our patient compared to 4 healthy controls, unaffected relatives from patients of our rare childhood disorder center. 1346 genes reached significance after multiple testing (FDR correction) (2.5% of total genes), 519 were recognized in a REACTOME pathway for analysis (Table A in S1 File). Most genes were found to be downregulated. Most significantly dysregulated pathways are: Translational regulation, RNA metabolism and protein metabolism and most interesting pathways are shown in Fig 1.\\nIn addition, we looked at genes involved in other progeroid and lipodystrophy syndromes (Fig 2). We found that several progeroid syndrome genes are dysregulated: LMNA, ATM, RECQL4 and WRN. The gene causing Berardinelli-Seip Congenital Lipodystrophy (AGPAT2) is very significantly underexpressed (padj = 0.002; Fig 2). BSCL2, PTRF and LPIN1 lipodystrophy genes are not differentially expressed.\\n129 proteins are found to interact directly with Cav1 based previous studies (NCBI gene interactions; http://www.ncbi.nlm.nih.gov/gene), and 102 of these were expressed highly enough in RNA extracted from whole blood to perform differential analysis. Of these 102, 30 were significantly different between our case and the controls (29.4%) (Table B in S1 File), and 72 (73.3%) are down regulated (Fig 2).\\nCaveolins interact with a variety of downstream signaling molecules, including Src-family tyrosine kinases, p42/44 mitogen activated protein (MAP) kinase, and endothelial nitric oxide synthase (eNOS). In the Caveolin downstream pathway, we found a significant under expression of NOSIP, a modulator of eNOS. MAPK3 (p44) is underexpressed, and HCK and FGR are also significantly underexpressed (SRC-family tyrosine kinases) (Fig 2). Caveolin-1 associates with TRAF2 to form a complex that is recruited to tumor necrosis factor receptors. In this pathway, TRADD, TRAF2, TNFRSF1A and TNFRSF1B are also significantly underexpressed (Fig 2).\\nProtein lysates from case and control fibroblasts were subjected to western blotting to measure protein expression of CAV1 (in triplicate). Two different antibodies were used: one that targets the C-terminus of CAV1 (and would only recognize the wild type (WT) CAV1), and one that recognized an internal epitope of CAV1 (which would recognize both WT and mutant (MT) CAV1 if expressed). All blots showed a significant decrease in expression of CAV1 compared to the control that was similar between an antibody that detected WT CAV1 only and an antibody detecting both WT + MT CAV1, suggesting MT CAV1 is not expressed or expressed at a very low level (Fig 3). In addition, fibroblasts were grown on glass coverslips, fixed and stained for localization of CAV1 and PTRF (Caveolae marker) (Fig 3). In the control, co-localization of CAV1 and the caveolae marker was perfect, however, the co-localization was not entirely fully concordant in the case (Fig 3).\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 77,\n",
       "    'case_id': 'PMC9699840_01',\n",
       "    'case_text': 'A 77-year-old woman with a history of cerebral infarction and chronic low back pain was taking antiplatelet drugs and selective serotonin reuptake inhibitors (SSRI). She had undergone magnetic resonance imaging (MRI) at another hospital 3 years before bleeding because of a headache, and an incidental tumor (volume 4.31 cm3) along the right falx cerebri had been identified. MRI showed the tumor as a well-circumscribed, slightly high-intensity area on T2-weighted images and a dural tail sign. The tumor was suspected to be a falx meningioma. The follow-up MRI 1 year before bleeding showed that the tumor had rapidly grown to 12.76 cm3. The follow-up MRI 2 weeks before bleeding showed 22.27 cm3 of volume and grown not only to the right but also to the left falx cerebri. Furthermore, MRI revealed a left flow void showing blood vessels that had moved from the median side to the lateral side due to tumor growth [Figure 1]. She was scheduled for tumor removal as MRI showed a rapidly growing tumor. However, she experienced a sudden onset of disturbance of consciousness and was transferred to our hospital before scheduled treatment. On arrival, her Glasgow Coma Scale (GCS) was 6 (E1V1M4) and the right hemiplegia was observed. She had no history of traumatic events or physical scarring. After admission, the patient presented with generalized convulsions and was administered anti-seizure medication. Computed tomography (CT) revealed left hemispheric ASDH, interhemispheric ASDH, and intracerebral hematoma extending from the left intra-/ extra-tumoral lesion. Contrast CT showed extravasation in the hematoma of the left frontal lobe. Digital subtraction angiography (DSA) performed 1 day after admission showed neither tumor staining nor abnormal vessels. In the venous phase of the bilateral common carotid angiogram, the anterior part of the superior sagittal sinus (SSS) revealed no obliteration [Figure 2].\\nTumor removal and hematoma evacuation were performed 3 days after admission. First, we removed the left frontal hematoma due to an increase in dural pressure and subsequently confirmed a decrease in dural pressure. Second, we performed internal decompression of the tumor and incised the SSS and falx to block feeding arteries. Third, we dissected the tumor from the surrounding normal brain parenchyma, removed the gross total of the tumor together with the falx of the attachment (Simpson Grade I), and drained the hematoma. No clear active bleeding points or intratumoral subacute clot was found intraoperatively. Fragile and irregular vessels were attached to the tumor wall.\\nThe pathological diagnosis was confirmed as meningothelial meningioma (the World Health Organization [WHO] Grade I according to the 2016 Classification of Tumors of the Central Nervous System). Postoperative CT confirmed the removal of the tumor and hematoma. Postoperative enhanced MRI revealed gross total tumor removal [Figure 3]. Her GCS score was 10 (E4V1M5) and she was transferred to a rehabilitation hospital.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 38,\n",
       "    'case_id': 'PMC9797860_01',\n",
       "    'case_text': 'A 38-year-old woman without cardiovascular risk factors was suffering since the age of 14 from endometriosis refractory to non-steroidal anti-inflammatory drugs. At the age of 25, progesterone replacement therapy (PRT) was prescribed with a significant decrease in pain and cramps around menstruations, but worsening episodes of migraine with aura concomitantly occurred. She reported no neurologic symptoms. On neurological examination, strength, skin sensation, visual field, reflexes, and coordination were normal.\\nShe was suffering since childhood from prodromal symptoms (sensitivity to light) preceding recurrent attacks of unilateral reversible visual aura and sensory symptoms (numbness) that were usually followed by intensive headache lasting up to 24 h occurring two times a week with nausea often followed by emesis with aggravation of the headaches, meeting International Classification of Headache Disorders-3rd edition for migraine aura. Tryptans did not ameliorate her headaches. T1-, T2-, T2-FLAIR, and diffusion-weighted brain magnetic resonance imaging (MRI) showed scanty focal bilateral supratentorial white matter hyperintensities (WMHs).\\nPregnancy was planned and HRT was suspended. After an uneventful delivery, HRT was re-started and a severe migraine aura occurred thereafter.\\nOn control MRI 1 year later, WMHs of the same size and number were identified (Figure 1) as it has been reported in shunt-associated migraine (SAM) patients.\\nElectrocardiogram showed persistent sinus rhythm and incomplete right bundle branch block. Chest X-ray, computed tomography angiography (CTA), and 2D TTE/TEE color Doppler were performed resulting within normal limits. Contrast TTE/TEE using agitated saline solution showed no RLS across the interatrial septum (Figure 2, Supplementary Videos 1, 2) but conversely demonstrated bubbles arriving from left pulmonary veins to the left atrium and left ventricle via a pulmonary arteriovenous fistula (Supplementary Figure 1) in basal conditions. Contrast-enhanced Transcranial Doppler (cTCD) raised the suspicion of an extracardiac RLS by showing in basal conditions high-intensity transient signals passing through the middle cerebral artery with a delayed (17 s) \"shower\" pattern (Figure 3, Supplementary Video 2). Of note, aura migraine symptoms occurred 4 min after agitated saline injection (\"bubble migraine positive\" patient). According to the protocol of the Venice 1999 Consensus conference, the bubble count was performed twice, during normal breathing and after Valsalva strain. It is worth to mention that no evidence or family history of HHT was documented in her past medical history.\\nThe decision was made by our multidisciplinary heart and brain team to offer a clinical re-evaluation in order to stratify the risk of paradoxical embolism and consequently to perform possibly a catheter-based embolization using detachable coils or vascular plugs of the isolated intrapulmonary RLS. Written informed consent, after explanation, was obtained from the patient. During the hospital stay, she was monitored for vital parameters without any abnormalities except for a slight reduction in arterial oxygen saturation (SaO2) of 94%. Continuous ECG ruled out atrial fibrillation. Right heart catheterization to evaluate hemodynamic parameters and selective pulmonary angiograms were performed in order to definitively check for an isolated PAVM and to search for accompanying malformations. Right atrial pressure, pulmonary artery pressure, pulmonary vascular resistance, and pulmonary to systemic flow ratio (QP/QS) were within normal limits. It has been impossible to cross the interatrial septum with a multipurpose catheter despite multiple attempts. Oddly, selective right and left pulmonary arteriograms did not show abnormalities of the pulmonary vasculature or arteriovenous shunts (Figure 4, Supplementary Video 3). Brachiocephalic vein angiogram ruled out the presence of persistent left superior vena cava draining into the left atrium, another possible rare cause of RLS and paradoxical embolism (Supplementary Video 4).\\nThe Heart and Brain team then decided to discharge the patient on off-label thienopyridine agents (clopidogrel 75 mg die) in terms of primary prophylaxis for paradoxical embolization of thrombotic material that could bypass the pulmonary capillary filter. Surprisingly, a substantial reduction in aura migraine symptoms in our patient was achieved using P2Y12 platelet inhibition, suggesting a platelet-based trigger. HRT was advantageously resumed without migraine attacks. During 2 years of follow-up on thienopyridine therapy, the resolution of migraine aura episodes was accomplished.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 85,\n",
       "    'case_id': 'PMC5709343_01',\n",
       "    'case_text': 'An 85-year-old man with a history of rheumatic heart disease status-post mechanical mitral and aortic valve replacements, persistent atrial fibrillation on anticoagulation, and longstanding recurrent admissions for congestive heart failure presented with progressive fatigue and shortness of breath for 3 days. He denied any fevers, or sputum production. His heart rate was 78 bpm with a blood pressure of 141/68, and an oxygen saturation of 90% on room air. Physical exam was significant for respiratory distress, jugular venous distension, bibasilar rales, decreased breath sounds at the right lung base, and warm lower extremities without edema. INR was therapeutic at 3.2 and routine chemistries and CBC were unremarkable. Chest X-ray revealed a large right-sided pleural effusion, pulmonary vascular congestion, and cardiomegaly. The patient was admitted and treated with intravenous diuretics for acute decompensated heart failure.\\nOn hospital day 8, the patient remained dyspneic despite negative fluid balance. The procedure team was consulted and bedside ultrasound revealed a persistent, large right-sided pleural effusion with an apparent large loculation of fluid 6 cm from the posterior chest wall (Fig. 1, A). A diagnostic and therapeutic thoracentesis was planned. Prior to the procedure, a CT scan of the chest from two years prior was reviewed (Fig. 1, B and C). The apparent loculation of fluid seen on bedside ultrasound was determined to be a \"giant left atrium\" (15 cm x 7.2 cm), which is likely the sequela of rheumatic heart disease.\\nGiven the patient\\'s high risk of stroke from mechanical aortic and mitral valves with atrial fibrillation, his therapeutic anticoagulation was not reversed prior to thoracentesis, but coumadin had been held. A therapeutic thoracentesis was successfully performed via a posterior-lateral approach and 800 ml of clear yellow fluid was removed with improvement in patient\\'s dyspnea. His hemodynamics and post-procedure hematocrit remained stable. His INR was 3 the morning before therapeutic thoracentesis and 1.8 the next day, which required bridging with low molecular weight heparin. Post-procedure chest X-ray showed a reduction in the right-sided pleural effusion and no pneumothorax. Fluid characteristics were consistent with a transudative pleural effusion and cytology was negative for malignant cells.\\nThe availability of ultrasound at the bedside has enabled clinicians to make rapid assessments and treatment decisions at the point-of-care. Ultrasound assistance in thoracentesis has even been shown to reduce pneumothorax rates. However, this case illustrates the importance of reviewing relevant prior diagnostic imaging before a bedside procedure, even when point-of-care ultrasound is used; attempting to drain the apparent fluid loculation (the giant left atrium) could have had devastating consequences. Furthermore, this case supports the growing evidence that performing a bedside thoracentesis is safe at an INR >1.5.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 5,\n",
       "    'case_id': 'PMC9595572_01',\n",
       "    'case_text': 'A 5 year and 4 month old boy was referred to us for polydipsia and polyuria. His blood glucose was 29.5 mmol/L, hemoglobin A1c (HbA1c) was 8.9%, and fasting C-peptide was 0.07 ng/ml. Serum anti-glutamate decarboxylase antibody and anti-islet cell antibody were both positive. He was diagnosed with T1DM at the onset. He had a history of recurrent oral mucocutaneous Candida fungi and respiratory infections after birth. At the age of 1 year, he suffered from herpetic pharyngitis with alanine transferase (ALT) 1,000-2,000 U/L, which was relieved by anti-infective and liver-protecting treatment. Increased ALT levels occurred several times after infection. A left under axillary abscess incision and drainage was performed when he was 3 years and 8 months old. He was the first child of non-consanguineous parents without any family history of hereditary diseases.\\nPhysical examination showed the weight was 18 kg (25th percentile), and the height was 110 cm (25th percentile). The blood pressure was normal. He was conscious, his thyroid and cardiopulmonary systems were normal, and there was no evidence of an enlarged lymph node. The liver is 4 cm under the right rib, and the spleen is 5 cm below the left rib, with blunt edges, and there is no swelling in the lower limbs.\\nLaboratory investigation revealed normal blood routine analysis, thyroid function, immunoglobulin A (IgA), immunoglobulin M, immunoglobulin G, ammonia, lactic acid, blood amino acids, acylcarnitine, and urine organic acid analysis. The level of aspartate aminotransferase was 100 U/L, ALT was 16.2 U/L. Hepatophilic virus antibodies [anti-cytomegalovirus-immunoglobulin M (CMV-IgM), anti-Epstein-Barr virus (EBV)-IgM, hepatitis A/B/C/E virus antibodies] and autoimmune liver disease antibodies were negative. The thyroglobulin antibody, thyroid peroxidase antibody, and thyroid-stimulating hormone receptor antibody were negative. The percentage of CD4 lymphocytes was 21%, CD8 lymphocytes was 45%, and CD4/CD8 was 0.46, which indicated immunodeficiency, the detailed laboratory information was shown in Table 1.\\nWES identified a heterozygous de novo STAT1 mutation in the child, c.866A > G, p.Y289C, which was further confirmed by Sanger sequencing (Figure 1). It was previously shown to be a GOF mutation and was defined as pathogenic according to criteria published by the American College of Medical Genetics and Genomics (ACMG). The child was corrected diagnosed with monogenic autoimmune diabetes.\\nBased on the presence of CMC, immunodeficiency, autoimmune diabetes, and autoimmune hepatitis, as well as genetic results, the boy was diagnosed with syndromic CMC that was caused by a heterozygous GOF mutation of STAT1.\\nUpon admission, he was given rapid-acting insulin with meals and long-acting insulin at bedtime, with a total amount of 1.27 IU/kg/d, with blood glucose levels of 6-7 mmol/L before meals and 6-12 mmol/L after meals. During the follow-up, he was given oral antifungal therapy of fluconazole (75 mg/d) and intravenous injection of human immunoglobulin once a month for candidiasis and recurrent infections.',\n",
       "    'gender': 'Male'},\n",
       "   {'age': 8,\n",
       "    'case_id': 'PMC9595572_02',\n",
       "    'case_text': \"As of now, he was 8 years old and his insulin dosage was 1.1 IU/kg/d. Even under fluconazole therapy, he developed oral mucocutaneous Candida fungi twice every month, but he did not develop recurrent viral or bacterial infections. He was given antituberculosis drugs (isoniazide, rifampicin) for tuberculosis infection. The liver function was normal at the last follow-up, and the HbA1c was 6.5%. Ruxolitinib was recommended to the patient's parents, but they refused because of concerns about side effects.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 45,\n",
       "    'case_id': 'PMC5958580_01',\n",
       "    'case_text': \"A 45-year-old female patient with no known previous medical and psychiatric history was referred to a psychiatric clinic for abnormal behavior. She initially had symptoms of depression, including social withdrawal, fatigue and hypersomnia, with loss of interest in her work and her family. She was brought to multiple traditional healers. No medical treatment was sought. After 6 months, her symptoms worsened, whereby she was noted to have developed childish behavior and was unable to take care of herself. She also had become forgetful with poor insight. There was no history of head trauma or any focal neurological deficit. There was no history of psychiatric illness in her family. She never smoked or consumed alcohol and was not on any illicit drugs.\\nOn examination, she was found to be oriented to time, place, and person but had poor attention and concentration with poor judgments. Her Mini-Mental state examination score was 21/30. She weighed 70 kg. Her blood pressure was 125/70 mmHg, with a pulse rate of 80 beats/min. A fundoscopy examination showed bilateral papilloedema. Neurological examinations, including cranial nerve and other systemic examinations, were all unremarkable. Her blood test results, including hematological and biochemical parameters, were normal.\\nA contrast-enhanced computed tomography (CECT) of the patient's brain was performed, and the findings showed a well-defined markedly enhancing lesion in the frontal region that measured 5.5 cm x 5.2 cm x 4.4 cm compressing on the adjacent brain parenchyma with an associated marked surrounding edema. These features are in keeping with a bifrontal tumor - olfactory groove meningioma [Figures 1 and 2]. A bifrontal craniotomy and tumor excision were performed after the patient was referred to the Department of Neurosurgery. Two months postsurgery, the patient was referred to neuropsychology for a neuropsychological assessment. Her symptoms resolved after the surgical treatment, and her quality of life also significantly improved.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 35,\n",
       "    'case_id': 'PMC5096402_01',\n",
       "    'case_text': \"The patient is a 35-year-old Caucasian female who first presented in 1988 at the age of 11 with cramping abdominal pain associated with watery, non-bloody diarrhea during a trip to the southern United States. Her mother experienced similar symptoms at that time, and so a self-limited infectious etiology was presumed. The patient at that time had a personal history of bacterial upper respiratory infections and scarlet fever. Her family history is significant for hypertension and dyslipidemia (father) and myocardial infarction at age 52 (paternal grandfather). The patient's abdominal pain led to an extensive GI work-up in 1989 revealing normal upper and lower endoscopic biopsies, a normal hepatobiliary iminodiacetic acid (HIDA) scan, normal fecal cultures for bacteria, ova, and parasites, a negative study for lactase deficiency, and unrevealing serology for auto-immune disease. An HIV test and screen for cystic fibrosis were negative. Laboratory screening for thyroid function, copper, ceruloplasmin, gastrin, and porphyrin levels was also unrevealing. The patient did have significant dyslipidemia in 1989 as follows: total cholesterol 406, LDL 356, HDL 16, VLDL 41, and triglyceride 206. Additional lab work indicated ApoA1 was 63 mg/dL (normal > 140) and ApoB was 162 mg/dL (normal < 130). Liver function tests in 1989 were also abnormal as follows: AST 74, ALT 134, ALP 196. The patient continued to suffer from frequent GI upset and increased bowel motions with pediatric growth charts indicating a failure to thrive. A decision was made to start the patient on cholestyramine with a low-fat diet which showed some improvement in her lipid profile as indicated in Figure 1A. When hepatomegaly was appreciated in 1990, a liver biopsy led to a suspected diagnosis of a glycogen storage disease, and she was started on cornstarch. Cholestyramine was discontinued, but then re-started shortly after it was discovered she still had marked dyslipidemia. A second liver wedge biopsy performed in 1990 showed a non-specific storage disease of a lipid nature and, ultimately, deficiency of lysosomal acid lipase (LAL) confirmed the disorder to be CESD.\\nThe patient was managed initially by a pediatric gastroenterologist until it was believed that her GI symptoms were unrelated to her dyslipidemia, and then a pediatric cardiologist assumed care for the patient. A modified Bruce exercise stress test was completed in 1992 (age 15), which was negative for inducible ischemia, and carotid duplex imaging showed only mild, non-obstructive disease. The patient was, then, started on atorvastatin 20 mg daily and aspirin 325 mg daily, which remained her treatment regimen for years, until it was changed to rosuvastatin 40 mg in 2009. The patient's lipid profile (Figure 1A) and liver function tests (Figure 1B) are indicated graphically at the time of diagnosis and throughout the evolution of her treatment regimen.\",\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 0,\n",
       "    'case_id': 'PMC5360091_01',\n",
       "    'case_text': \"A 9-day-old normal spontaneous vaginal delivery full-term male infant was referred to our institute from a regional hospital as a case of chronic heart disease. After birth, he was diagnosed ultrasonically with persistent truncus arteriosus, atrial septal defect, and a perimembranous ventricular septal defect. The patient was stabilized and then discharged on anti-heart failure medications. Two days later, he was readmitted as a result of cyanosis.\\nOn examination, the patient was found to have dysmorphic features and hypocalcemia, in addition to the congenital cardiac anomalies described earlier. Further tests were performed, and he was found to have DiGeorge syndrome, as well as cholestasis and jaundice. The patient was started on ursodiol (ursodeoxycholic acid), oral feeding with Similac 20 (Abbott, Ill), and synchronized intermittent mandatory ventilation with pressure control and support.\\nAt the age of 27 days, the patient was found to have developed a small localized swelling on the dorsum of the right hand. It was initially thought to be an injury caused by intravenous cannulation. The mass persisted for 2 weeks and then the infant became febrile and the right hand dorsal swelling became erythematous and hot to touch. Cellulitis was suspected; thus, empiric treatment with morphine, meropenem, vancomycin, and colistin was commenced by the primary team while the septic workup was being undertaken.\\nThree days later, the plastic surgery service was consulted on the slowly growing swelling on the back of the hand. The plastic surgeon's examination revealed a small area of fluctuation over the mass. An ultrasound scan was ordered, and aspiration of the swelling was done and the fluid was sent for gram staining, culture, and sensitivity testing. Silver sulfadiazine cream and dressings were ordered to be applied to the wound twice daily until such time as the results of investigations were apparent. Ultrasound assessment of the hand revealed soft-tissue swelling and calcification.\\nOn the next day, an x-ray film was obtain and the image exhibited a central area of calcification within the swelling as well. Moreover, results of blood and fluid cultures were inconclusive and found no organisms; antibiotic treatment was discontinued. However, silver sulfadiazine cream application was continued but reduced to once daily, and the hand was kept elevated. The swelling on the dorsum of the hand reduced gradually over the following few days, and dressing protocol was continued. A week later, however, at the age of 51 days, the swelling increased in size once more. Aspiration was conducted a second time, and the fluid sent for staining and culture, which proved to be negative again. Blood investigations did not yield any insight into the cause of the patient's condition either. It was at this juncture when the diagnosis of HO was considered. No further treatment was ordered except for frequent monitoring to rule out superimposed infection and cellulitis.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 0,\n",
       "    'case_id': 'PMC4941117_01',\n",
       "    'case_text': \"A 6 month old infant brought to the emergency room in the King Fahad Specialist Hospital-Dammam, Saudi Arabia with cough, fever, difficulty breathing, sneezing, irritation, excessive crying, decreased oral intake, and cyanosis. He had been diagnosed with infantile nephrotic syndrome 5 months earlier. In his past medical history, he had several episodes of septicemia caused mainly by Pseudomonas aeruginosa. In addition, he was previously on multiple courses of antibiotics including meropenem, ceftriaxone, and vancomycin. He was intubated and ventilated. Blood specimens revealed mild neutrophilia and elevated CRP. Blood culture and urine culture were negative. Chest X rays revealed left sided pleural effusion with left lower lobe opacities. Several respiratory specimens from endotracheal tube (ETT) were submitted to the microbiology laboratory for culture. Round yellow pigmented non hemolytic colonies grew on blood agar plates. Gram stain revealed Gram negative bacilli. The organism was catalase and oxidase positive. Organism identification and antimicrobial susceptibility testing were carried out using the Vitek 2 automatic system (bioMerieux, Paris, France) according the manufacturer's instructions. E. coli ATCC 25922 and Pseudomonas aeruginosa ATCC 27853 strains were used as controls for the antimicrobial susceptibility testing. There are no Clinical and Laboratory Standards Institute (CLSI) guidelines specific for Chryseobacterium species. However, minimum inhibitory concentrations (MIC) and breakpoints were determined according to the CLSI recommendation for other Non-Enterobacteriaceae. The organism was identified as Chryseobacterium gleum and it was confirmed using API20NE kit and 16 S rRNA sequencing. The organism was resistant to ceftazidime (MIC >= 64 mug/mL), cefepime (MIC >= 64 mug/mL), meropenem (MIC >= 16 mug/mL), piperacillin-tazobactam (MIC >= 128 mug/mL), colistin (MIC >= 8 mug/mL), gentamicin (MIC >= 16 mug/mL), and amikacin (MIC >= 64 mug/mL). It was intermediate to imipenem (MIC = 8 mug/mL), ciprofloxacin (MIC = 2 mug/mL), and tigecycline (MIC = 4 mug/mL). The organism was susceptible to trimethoprim-sulfamethoxazole (MIC <= 20 mug/mL), minocycline (MIC <= 1 mug/mL), and levofloxacin (MIC = 0.5 mug/mL). In addition, the isolate was resistant to vancomycin. Environmental samples from the mechanical ventilator and the patient room did not grow any Chryseobacterium isolate. Chryseobacterium was tested for the presence of carbapenem resistant genes (OXA48, NDM1, IMP, VIM, CTX-14, CTX-M15, and KPC) by multiplex PCR methodology using ARM-D for beta-Lactamase ID kit (Streck, Omaha, NE, USA) as instructed by the manufacturer. Positive controls and an internal control are included in the kit. In addition, molecular grade water (Promega, WI, USA) was used as a negative control to detect contamination. None of the tested genes was detected by PCR. The patient improved on levofloxacin for a period of 16 days and subsequent respiratory specimens did not grow C. gleum. Neither trimethoprim-sulfamethoxazole nor minocycline was used since they were not available in hospital at time of treatment.\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 41,\n",
       "    'case_id': 'PMC4353120_01',\n",
       "    'case_text': 'The proband, a 41-year-old man, was referred to the Neurology Department of Xuanwu Hospital with hemiparesis, dysarthria, and mild cognitive deficits. At 31 years of age, the patient experienced a slight weakness in the left leg that included numbness, which resulted in gait problems that did not interfere with a normal lifestyle. Over the next four years, symptoms progressively worsened and led to weakness in the left leg. Simultaneously, the right leg became weak and numb, and urinary retention and urgent micturition ensued, which persisted to time of the study. Over the last two years, the left hand became uncoordinated and mild dysarthria developed. Since then, the patient experienced mood disorders, as well as involuntary and frequent crying spells. The patient exhibited slight cognitive impairment over a ten-year period, which interfered with employment status, social interactions, and daily life. The patient did not suffer from migraine headaches during this period.\\nPast medical history revealed right central retinal artery occlusion and retinal hemorrhage at age 33, which was surgically treated. However, right-eye vision was also lost at time of study. There was no family history of diabetes, hypertension, or hypercholesterolaemia. Seven members in his family experienced similar syndromes (Table 1, Figure 1).\\nNeurological examination revealed normal vital signs, slight dysarthria, loss of vision, and direct and indirect light reflexes in the abducted right eye, with a 5-mm dilated pupil. Fundoscopic examination revealed optical nerve atrophy. Left-eye visual acuity and fields remained intact. Muscle mass was within normal limits. Strength was 4+/5 in the left leg, 5-/5 in the left arm and right leg, and intact in the right arm. Deep tendon reflex was significantly increased, in particular on the left side. Extensor plantar responses were elicited on both sides. Gait was hemiparetic, with poor bilateral coordination. Patellar and ankle clonus was bilaterally present. Brown hemochromatosis and hypesthesia were noted on calf areas of both legs (supplementary Figure 2 online). Remaining physical examinations were unremarkable.\\nComplete blood count, tests of hepatic and renal function, and measurements of lipoprotein A, electrolytes, glucose, thyroxine, vitamin B12, antinuclear antibodies and rheumatoid factor were all within normal limits. Serological examination for syphilis, human immunodeficiency virus, and tumor markers were negative. No abnormalities were found on cerebrospinal fluid analysis.\\nPrevious brain computed tomography (CT) and MRI results revealed multiple infarctions, as well as multiple abnormal signals and bilateral pontine atrophy in the head MRI. Hyperintense signals were noted in the corpus pons, genu of the callosum, left basal ganglia, corona radiate, and semiovale centrum on T2-weighted images, as well as symmetrical high signals in the bilateral temporal lobes (Figures 2A, B, D). A fluid-attenuated inversion recovery sequence revealed diffuse hyperintense signals in the subcortical and deep white matter (Figure 2C). Diffusion sequences produced negative results.\\nA sural nerve biopsy was performed and the glutaraldehyde-fixed tissue was examined by transmission electron microscopy, revealing granular osmophilic material (GOM) deposits in the extracellular matrix adjacent to and within smooth muscle cells of dermal arterioles. The deposits were variable in size; the largest measured approximately 0.4-0.6 mm (Figure 3). Screening exons 2-4 for mutations of NOTCH 3 by direct sequencing produced negative results.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 65,\n",
       "    'case_id': 'PMC6362694_01',\n",
       "    'case_text': 'Hallux valgus is the most common forefoot deformity presenting to foot and ankle surgeons, often accompanied by foot pain and severe functional constraint. The global prevalence, as described in the international literature, is 23 % in 18 to 65 year old patients and up to 35 % in elderly over 65 years of age. It has been widely reported, that women are more often affected than men - there are female / male ratios reported up to a level of 15:1. The valgus deformity can be caused by multiple exogenous and endogenous factors such as wearing of tight and high-heeled shoes or genetic predisposition.   Diagnosis of hallux valgus is achieved by clinical examination. A plain radiograph of the weight bearing foot is required additionally. There still is no consensus about which clinical and radiographic findings lead to the indication of which method of operative correction of hallux valgus.   \\nWe report our experience with special regard to the correlation of radiographic findings and resulting method of operative correction of the valgus deformity by developing a schema that helps to determine the correct indication.',\n",
       "    'gender': 'Female'}],\n",
       "  [{'age': 16,\n",
       "    'case_id': 'PMC9970259_01',\n",
       "    'case_text': 'Case 1 is a 16-year-old male who presented with well-controlled type 2 diabetes, obstructive sleep apnea (OSA), severe obesity, and acute onset severe back pain with limited mobility. Initial biochemical evaluation was concerning for acute lymphocytic leukemia (ALL), requiring magnetic resonance imaging (MRI) to determine staging and appropriate treatment. However, due to limitations of the MRI machine at the pediatric center, the patient was unable to obtain imaging secondary to body habitus presenting a significant diagnostic challenge. The obesity medicine team was consulted for assistance with acute weight loss to promote ability for accurate diagnosis, prognosis, and initiation of an appropriate treatment regimen for his oncologic process. The patient was admitted to inpatient rehabilitation for two weeks. On admission, his type 2 diabetes was controlled with insulin and metformin and he had a hgA1c of 6.4. However, due to worsening hepatotoxicity, his Metformin was discontinued. Given his new onset AL.L and concern for chemotherapy induced pancreatitis, the oncology team did not feel comfortable starting a glucagon-like peptide 1 (GLP-1) medication. Interventions included placing the patient on the institutional inpatient obesity protocol including: (1) intake with a registered dietitian; (2) dietary composition: 1,500 calorie per day, less than 150 grams of carbohydrates, no sugar-sweetened beverages, 35 grams of fiber, 32 ounces of water; (3) structured mealtimes (3 meals and 2 snacks); (4) daily physical therapy as tolerated; (5) initiation of weight loss medications (phentermine 15 mg daily). One week after initiation of this protocol, his weight was down trending and he was tolerating phentermine without side effect. Given lack of side effects but increasing hunger with goal of continued weight loss in efforts to obtain an MRI, his phentermine was increased to 37.5 mg daily and dietary program intensified to 1,200 calories and less than 100 grams of carbohydrates daily. At admission, his weight was at 190% BMIp95 (Figure 3). Upon discharge and after two weeks after initiation of his individualized weight-management plan, it decreased to 175%BMIp95 and his hgba1c improved to 6.0. He also reported decreased appetite and no side effects throughout his treatment. He continued his outpatient weight-management program with monthly virtual visits with obesity medicine specialists and dietitian. One month after discharge, his %BMI95 had decreased to 165% BMIp95, and by month six, to 160% BMIp95 (associated with a total BMI reduction of 4.85 kg/m2 and BMI z-score reduction of 0.12 standard deviations).',\n",
       "    'gender': 'Male'},\n",
       "   {'age': 15,\n",
       "    'case_id': 'PMC9970259_02',\n",
       "    'case_text': 'Case 2 is a 15-year-old male with Prader-Willi Syndrome, class III obesity, impaired fasting glucose, hypertriglyceridemia, and obstructive sleep apnea (OSA) controlled on continuous positive air pressure (CPAP) admitted for acute respiratory failure and placed on a ventilator. Patient had a history of excessive weight gain due to hyperphagia associated with significant anxiety exacerbated by the Covid-19 pandemic. Outpatient, he was taking Metformin 1,000 mg twice daily and Topiramate 100 mg nightly for off-label weight control. Family had completed three, intensive outpatient lifestyle modifications programs and set up a food safe zone (locked cabinets and food storage units) with limited success. Upon admission, he had a 40-pound gain since his last outpatient encounter four months prior and his respiratory function had worsened significantly in response to this weight gain with blood gases demonstrating carbon dioxide retention levels in the upper 70s. He underwent extensive evaluation for hypertension, cardiac dysfunction, and worsening obstructive sleep apnea and his acutely worsened respiratory status was thought to be largely secondarily to his weight gain. This evaluation included a normal electrocardiogram, echocardiogram and renal ultrasound. He underwent a polysomnography which was abnormal due to breath stacking, hyperventilation, and hypoxemia for which his CPAP machine was adjusted. He also had a number of screening labs during his hospitalization with normal thyroid function (TSH 2.62 uIU/ml, T4 7.5 mcg/dl), free cortisol (0.18), ACTH (21) hgbA1c (5.3%), lipid panel (triglycerides 94, total cholesterol 150). Notably he had low testosterone (Free 2.09 ng/dl, total 83 ng/dl), LH (0.31 mIU/mL), FSH (<0.66 mIU/ml), IGF-1(26 ng/ml) and IGF-BP3 and (0.8 mg/L) ultimately started on 100 mg Testosterone supplementation.\\nThe obesity medicine team was consulted by pulmonology to address diagnostic and treatment challenges by supporting acute weight loss interventions while inpatient. This was in an effort to optimize respiratory control for ability to discharge home. The personalized intervention for this patient included placing him on the institutional inpatient obesity protocol including: (1) intake with a registered dietitian; (2) dietary composition: 800 calories daily, less than 90 grams of carbohydrates, no sugar-sweetened beverages, 35 grams of fiber, 32 ounces of water; (3) structured mealtimes (2 meals and 2 snacks); (4) daily physical therapy as tolerated; (5) optimization of weight loss medication regimen (topiramate increased to 200 mg nightly and initiation of semaglutide 0.25 mg weekly). He remained admitted to the rehabilitation unit for one month, during which, his %BMIp95 decreased from 313% to 300% BMIp95 (Figure 3). At the same time, his ventilatory needs decreased with successful transition to continuous positive airway pressure (CPAP) overnight and oxygen by nasal cannula during the day, allowing for safe discharge home. He reported no side effects from the medications during this time period. Given lack of side effects and meeting goal of decreasing respiratory support, no further medication changes were made inpatient. Upon discharge, he was enrolled in the outpatient weight-management program and attended monthly visits with obesity medicine specialists and dietitian. Two and a half months after discharge, his weight had decreased to 297% BMIp95 (associated with a total BMI reduction of 1.2 kg/m2 and BMI z-score reduction of 0.01 standard deviations). His triglycerides and hgba1c were stable at 94 and 5.3% respectively at this time and Testosterone increased with injections.',\n",
       "    'gender': 'Male'},\n",
       "   {'age': 6,\n",
       "    'case_id': 'PMC9970259_03',\n",
       "    'case_text': 'Case 3 is a 6-year-old male with history of a parapharyngeal desmoid tumor resected in June 2019, who had subsequent weight gain of 20 kg over the next two years in association with the Covid-19 pandemic. He was getting serial MRIs with sedation for tumor monitoring, which required admission for respiratory support in the context of his obesity. The obesity medicine team was consulted by oncology and anesthesiology to support acute weight loss interventions while inpatient in an effort to minimize airway risk with his recurrent sedation needs. He was placed on the institutional inpatient obesity protocol including: (1) intake with a registered dietitian; (2) dietary composition: 1,200 calories daily, less than 100 grams of carbohydrates, no sugar-sweetened beverages, 35 grams of fiber, 32 ounces of water; (3) structured mealtimes (3 meals and 2 snacks); and (4) thirty minutes of moderate intensity physical activity daily. One challenge the obesity medicine team faced during the goal of acute weight loss was parental preference not to start anti-obesity medications. He did continue to have normal Hgb A1c (5.1-5.2%) as well as normal lipid panel (triglycerides 74, total cholesterol 161) but elevated alanine aminotransferase and aspartate aminotransferase of 62 and 48 respectively. He remained admitted to the rehabilitation unit for one week with associated weight stabilization. Upon discharge, he was enrolled in the outpatient weight-management program and met with obesity medicine specialists and a dietitian monthly. Five months after discharge, his weight had decreased from 195% BMIp95 to 175% BMIp95 (Figure 3).',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 35,\n",
       "    'case_id': 'PMC8826099_01',\n",
       "    'case_text': \"In the morning of 8 May, a 35-year-old man was admitted to the emergency department complaining of episodes of pressure pain behind the sternum, lasting from 2-5 min to 1 h; the pain radiated to the left upper limb, arose after gardening works and persisted both at rest and during moderate physical exertion.\\nIt is known from the anamnesis that, since April 2019, the patient had complaints of blurred vision; the patient was observed by an ophthalmologist with a diagnosis Serpiginous Choroiditis of both eyes. He was initially received pulse therapy with glucocorticoids (methylprednisolone in a cumulative dose of 1000 mg); then, he administrated methylprednisolone at a dose of 4 mg/day per os. On 20 April, the patient noted weakness, fever up to 38 C, nasal congestion, anosmia, dry cough, and chest congestion. The repeated polymerase chain reaction (PCR) test for 2019-nCoV was positive. The patient was hospitalized at the clinic for patients with COVID-19, where he was staying from 21 April to 3 May 2020, with a diagnosis of Coronavirus disease 2019 (mild case), nasopharyngitis. During hospitalization, computed tomography (CT) scanning of the chest was performed, according to which no pathological changes were detected. In the course of hospitalization, there was a moderate increase of C-reactive protein (up to 12.5 mg/L, reference values:up to 8.0 mg/L). During hospitalization for COVID-2019, the patient received hydroxychloroquine and clarithromycin.\\nIt is also known from the anamnesis that the patient has no established cardiovascular diseases. Among cardiovascular risk factors were active smoking for 26 years (20 cigarettes/day), overweight (height = 171 cm, weight = 85 kg, body mass index (BMI) = 29.1 kg/m2). The patient denied the use of psychoactive substances (cocaine, etc.).\\nOn admission to the emergency department on 8 May, according to objective examination, the parameters were as follows: blood pressure = 126/78 mm Hg, heart rate = 84 beats per minute, respiratory rate = 18 per minute, additional respiratory sounds in the lungs were not auscultated, saturation (on room air) = 99%. On admission, a high-sensitive cardiac troponin was within the reference values. The patient was given loading doses of acetylsalicylic acid, clopidogrel, and heparin. The electrocardiogram (ECG) on admission is shown in Figure 1.\\nTaking into account the clinical picture of ACS with ST segment elevation, the patient underwent coronary angiography. A linear dissection of ramus intermedius (RI) was established over 20 mm with stenosis of the lumen up to 80% in diameter against the background of thrombolysis in myocardial infarction (TIMI) 3 blood flow in all coronary arteries (Figure 2).\\nIt was decided to stent RI dissection area with a drug-coated sirolimus stent. TIMI 3 blood flow on control angiograms is shown in Figure 3. The results of laboratory tests are presented in Table 1.\\nSubsequently, the patient received therapy consistent with the clinical recommendations, including triple antithrombotic therapy using acetylsalicylic acid, clopidogrel, and infusion of unfractionated heparin intravenously.\\nAt 7:20 p.m. of the same day, in the intensive care unit, the patient again had anginal pain syndrome without significant effect from nitroglycerin; the pain was relieved with morphine. ECG was performed (see Figure 4).\\nGiven the appearance of ST segment elevation in the leads from the inferior wall of the left ventricle, the patient underwent repeated angiography (see Figure 5).\\nIt was established that the stented segment and other sections of the left coronary artery (LCA) had no stenosis. Blood flow along the right coronary artery (RCA) TIMI 0-1 with occlusion in the distal section. Also, stenosis of the initial and middle sections of the RCA was detected (up to 60%-75%) over the entire length according to the type of possible spasm in comparison with the initial coronary angiograms. After two injections of contrast into the RCA and 2.0 mL of a 0.01% solution of nitroglycerin, recanalization was observed with the restoration of the initial caliber of the artery with visualization of linear dissections throughout the initial and middle sections. According to the control angiography, after 15 min (see Figure 6), a decrease in the length of the dissected segment in the initial and middle sections of the RCA and posterior lateral branch of the RCA was established. Taking into account the TIMI 3 blood flow, extended lesions of the RCA, and the posterolateral branch of the RCA, spontaneous positive dynamics in relation to this dissected segment, conservative management were applied.\\nOver the next 72 h, the patient's condition remained stable, and chest pain did not recur. In the morning of 14 May, the patient again felt a pain behind the sternum, lasting up to 10-15 min and stopping on its own. ECG was performed, and found that there were no significant dynamic changes from previous ECGs (see Figure 7).\\nIt was decided to conduct control angiography. It was detected that there was no change either in the RCA or the posterolateral branch of the RCA in comparison with the previous examination. The stented segment of the RI LCA was passable; however, in one of the RI branches, immediately after its bifurcation, stenosis of up to 85% in diameter with a length of 20-25 mm was detected, which was absent in the previous two angiograms (see Figure 8). With intracoronary administration of 2 mL of 0.01% nitroglycerin, there were no changes in the degree of stenosis in the affected artery.\\nSubsequently, anginal pain did not recur. The patient was discharged from the clinic on 20 May 2020. Written informed consent has been obtained from the patient for publication of the case report and accompanying images.\\nIt should be noted that, during the hospitalization, the patient was consulted by a rheumatologist. Additional examinations were performed (antinuclear antibodies, HLA-B27 test, rheumatoid factor, antibodies to beta2-macroglobulin:all tests were negative), which allowed the rheumatologist to exclude the presence of chronic systemic inflammatory disease. CT of the chest in dynamics from April 2020 was also performed, which also showed no pathological changes (see Figure 9).\",\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': None,\n",
       "    'case_id': 'PMC7931941_01',\n",
       "    'case_text': 'Typical data mining models train on data collected in the past, and then are used to make decisions about the future. If there are historical inequalities inherent in the training data, they will be perpetuated, and possibly even exacerbated by our predictive model. Skewed training data can lead to better accuracy for some groups vs. others. We discussed the example of gender stereotypes encoded in word embeddings used in natural language processing (Bolukbasi et al.,), and the example of facial recognition tools trained on majority white, male faces (Buolamwini and Gebru,). These examples demonstrate cases where fairness research had a real world impact, as these papers have prompted companies to improve facial recognition software, and the development of bias mitigation techniques for text analysis. We discussed questions to consider when developing/applying new method, e.g., \"Who will use this technology, and will it work equally well for everyone?\" and \"Is my dataset representative of all groups?\"\\nThe learning objectives of the tutorial are to examine some examples of structural inequality in society that is buttressed by data mining practices including developing ways to recognize ways in which unfair bias might be introduced into a data mining pipeline. Because vulnerable populations are often placed in the position of being whistleblowers for structural inequalities, we discussed how to perform analyses to verify whether a predictive model is fair or unfair and what outcomes should be considered when developing data mining techniques beyond accuracy. To address these concerns we have to develop tools to democratize the development of data mining techniques and technologies using open and transparent methods with clearly reproducible findings. This tutorial demonstrates one approach to doing this [i.e., with interactive Jupyter notebooks (Kluyver et al.,)] and give students hands-on experience with open software tools.\\nThe Algorithmic Fairness for Vulnerable Populations tutorial steps through a typical data analysis pipeline. First the data is cleaned and preprocessed according to the steps taken in the ProPublica analysis. Then a number of statistical and visualization methods are applied to allow participants to assess the attributes in the training dataset and understand whether there is any unfair bias present. Finally, three notions of group fairness are introduced, covering state-of the-art bias detection metrics from the recent literature:\\nDisparate Impact. This legal concept is used to describe situations when an entity such as an employer inadvertently discriminates against a certain protected group. This is distinct from disparate treatment where discrimination is intentional. To demonstrate cases of disparate impact, the Equal Opportunity Commission (EEOC) proposed \"rule of thumb\" is known as the 80% rule.\\nCalibration. This statistical test was used to verify the fairness of the COMPAS model by the company Northpoint that created the tool. The basic idea behind calibrating a classifier is to have the confidence of the predictor reflect the true outcomes. In a well-calibrated classifier, if 100 people are assigned 90% confidence of being in the positive class, then in reality, 90 of them should actually have had a positive label. To use calibration as a fairness metric we compare the calibration of the classifier for each group.\\nEqualized Odds. The last fairness metric we consider is based on the difference in error rates between groups. The equalized odds criterion (Hardt et al.,) proposes to look at the difference in the true positive and false positive rates for each group. This aligns with the analysis performed by ProPublica.\\nThe goal of this tutorial\\'s implementation was to allow for hands-on analysis right away, without requiring any heavy overhead from installing many tools or having to clean and pre-process the data. At the same time, all analysis was fully transparent and available for experimentation. Participants could step through the notebook and simply follow along, or dig deeper and edit the code directly to experiment with the data. Suggestions for possible further experimentation are provided throughout. Links to datasets, research papers, Wikipedia entries, and Python data mining tools provide context and avenues for deeper investigation into the topics and methods described. A clear outcomes was that trainees who undertook the data manipulation and assessment felt empowered to identify the limitations of data resulting from structural inequalities and to identify mechanisms to address those biases in data.\\nIndigenous communities represent a classic example of a vulnerable population for whom territorial rights, educational attainment and health status are all under stress. Nevertheless, they remain a subject of keen genomic interest to western scientists. Unfortunately, these largely one-sided cross cultural scientific interactions between Indigenous populations and European ancestried scientists have long been steeped in misunderstanding and mistrust. Cases like the Havasupai Nation\\'s inclusion in stigmatizing mental health research against their will have helped to drive many Indigenous peoples to reassess their willingness to work with non-Indigenous scientists (Garrison,). The development of novel large scale data generation tools have emphasized the voluntary exclusion of Indigenous populations and the paucity of data upon which to gain meaningful insights on Indigenous communities\\' health and well-being.\\nThe utility of data analysis has been readily adopted by human geneticists, who have willingly accepted the tools of big data to better understand the features of the genome including variable sites across the genome, chromosomal arrangements, and population level variation.\\nThis pursuit of ever increasing data has lead to breakthroughs in ancestry assessments, multi-omic precision medicine models and has spurred molecular breakthroughs like the Crispr-Cas9 system of gene editing. Crispr-Cas9, most recently made infamous by the ethically condemned modification of Chinese twins (Schmitz,).\\nWhile genome sequencing is a great tool for identifying genetic variation that might be involved in disease mechanisms, correlation does not equal causality. Gene editing tools offer the population geneticists the opportunity to identify population-specific variation derived from large scale sequencing experiments and to conduct further assessment of the functional significance of genome sequence variation, thus potentially identifying the changeable sites underlying traits or disorders. For example, gene editing technologies can be used to investigate population-specific, positively selected point mutations implicated in a range of diseases (Komor et al.,). In addition to using these tools that are already in existence to functionally investigate individual variants in clonal cell lines, multiple laboratories have begun to develop new editing tools to simultaneously introduce multiple mutations in the human genome via multiplex nucleotide editing of population specific haplotypes under selection, or multiple point mutations on different chromosomes in human genome.\\nEngineering new tools to functionally investigate single nucleotide changes is an exciting prospect for two primary reasons: (A) Creating accountability. Culturally competent empirical evidence and detailed theoretical considerations should be used for evolutionary explanations of phenotypic variation observed in humans (especially Indigenous populations). Population genetics investigators frequently overlook the importance of these ethnographic criteria when associating observed trait variation with evolutionary analysis. Functional investigation of population specific variation has the potential to empower the population genetics community by holding evolutionary explanations accountable (Gould and Lewontin,). This need for mechanistic insight is framed by problematic narratives and exacerbated by correlation based studies that fail to properly functionally investigate single nucleotide changes. Because Indigenous populations are vulnerable (i.e., at risk populations), it is the genomic technology development community\\'s responsibility to take these potentially problematic narratives to task (Neel,). Not to just reclaim Indigenous history through the population genetics projects we champion, but potentially empower Indigenous history with genome editing tools. (B) Democratizing tools. Indigenous peoples are under-represented in both population-based genomic studies, and as primary investigators in academia. For Indigenous researchers, this leads to questions as to how Indigenous peoples will meaningfully participate in human population genetics, and how to address the disparities currently existing in Indigenous communities? One way that Indigenous scientists are addressing this is the formation of an educational consortium that is focused on educating Indigenous genetics, such as the Summer Internship for Indigenous Peoples in Genomics (SING Consortium). This research consortium works with Indigenous communities to generate large scale data to address the genomic and health disparity questions that those communities have Claw et al..\\nIn addition to standard metrics of academic success such as grant awards and paper publications, Indigenous researchers must transition our research focus to understanding how independent research programs will become actionable. If participating Indigenous communities are not presented with tangible benefits to collaborating with non-Indigenous scientists, such as access to medicine, developments to infrastructure, or capacity building, then research focusing on Indigenous communities could potentially continue a legacy of colonial exploitation. Technological independence, self-governance, and democratization of the tools should always be the long-term goal of ethical partnerships in genomic sample collection, large scale data analysis and inference generation. Some easy solutions to address these concerns include engaging Indigenous communities in educational seminars within Indigenous spaces including Native American Reservations, Hawaiian Heiau, and Maori Marae. Another priority must be to transition genomic research toward focusing on the development of biomedical tools to make gene editing of deleterious genomic changes more affordable, empowering Indigenous populations across the globe to gain agency over their own future.',\n",
       "    'gender': 'Male'}],\n",
       "  [{'age': 62,\n",
       "    'case_id': 'PMC8495127_01',\n",
       "    'case_text': \"A 62-year-old non-smoking woman with cough and chest tightness was initially found to have space-occupying lesions in her lungs in a physical examination at another hospital. Then she came to our hospital for further treatment. At this time, she had an Eastern Cooperative Oncology Group (ECOG) performance status of 1. And she had no relevant medical or surgical history. Enhanced CT showed a 3.0 x 3.0 cm mass in the left lower lung with diffuse miliary metastases in both lungs and no distant lymph node metastasis. The clinical stage was T1cN0M1a, and the pathological puncture diagnosis was lung adenocarcinoma in December 2016. She refused the gene test and received first-line treatment: pemetrexed 0.5 mg/m2 d1 + cisplatin 75 mg/m2 d1, q3w, for six cycles from January 2017 to June 2017. From July 2017 to April 2018, pemetrexed was given 0.8 d1, q3w, for nine cycles, and the best response was stable disease (SD) ( Figure 1 ). In May 2018, CT reexamination revealed multiple vertebral metastases in the spine, and the efficacy was evaluated as progressive disease (PD). Therefore, second-line treatment regimen was used: docetaxel 120 mg d1, q21d, five cycles, from May 2018 to September 2018. Then CT reexamination after the end of treatment showed that the response was PD.\\nThis time, the patient expressed a strong desire for treatment, and we had full discussions with the patient and her family to determine the next step of treatment. On October 22, 2018, we performed genetic testing on the patient using PCR, and the results showed that EGFR, ALK, and ROS1 were all wild types ( Figure 2A ). Atezolizumab treatment was initiated on November 2, 2018, based on the results of the OAK clinical trial and the guidelines. After two cycles, CT showed partial response (PR) ( Figure 3 ).\\nAt cycle 18 of atezolizumab, free triiodothyronine (FT3) decreased to 3.62 pmol/L, and the patient was treated with the addition of levothyroxine sodium tablet 50 mug qd po. Liver metastasis occurred, and lung disease progressed on October 13, 2020 ( Figure 2C ). PFS was as long as 23 months. The clinical stage at this time was T2aN0M1c. After discussion of the multidisciplinary team (MDT), pathological puncture and genetic testing were conducted again for the patient, and the results showed EGFR L858R and T790M mutations ( Figure 2B ). Research by Hsu et al. suggested that mutations in EGFR are associated with a higher rate of miliary lung metastases; for the sake of precision, we redid genetic testing on the patient's 2018 pathological specimen using a more accurate next-generation sequencing (NGS), and we found that the patient had the EGFR L858R mutation prior to the use of atezolizumab. Then the patient was treated with osimertinib in view of EGFRT790M, but the follow-up CT until March 2021 showed that the lesion continued to progress ( Figure 2D ).\\nIn order to explore why the patient responded well to atezolizumab but not to osimertinib, we performed the whole gene test (825 gene) by NGS and immunohistochemistry (IHC). At this time, the patient carried EGFR L858R, T790M, and TP53 R282W mutations; and her plasma sample had a low tumor mutational burden (TMB) of 6.45 muts/Mb. IHC showed PD-L1 tumor proportion score (TPS) <1% (antibody was 22C3), but the expression of PD-L1 in immune cells was 5%. In addition, CD4+ and CD8+ T cells were highly infiltrated ( Figure 4 ).\",\n",
       "    'gender': 'Female'}],\n",
       "  ...],\n",
       " 'article_id': ['PMC3738355',\n",
       "  'PMC5015624',\n",
       "  'PMC6381877',\n",
       "  'PMC5912312',\n",
       "  'PMC5287946',\n",
       "  'PMC9106225',\n",
       "  'PMC7276389',\n",
       "  'PMC3134036',\n",
       "  'PMC9184873',\n",
       "  'PMC6186336',\n",
       "  'PMC9937515',\n",
       "  'PMC10196249',\n",
       "  'PMC4122203',\n",
       "  'PMC7174775',\n",
       "  'PMC7969344',\n",
       "  'PMC5769854',\n",
       "  'PMC7265352',\n",
       "  'PMC6159178',\n",
       "  'PMC3678730',\n",
       "  'PMC7201103',\n",
       "  'PMC7373792',\n",
       "  'PMC8138243',\n",
       "  'PMC3546213',\n",
       "  'PMC9852490',\n",
       "  'PMC4108191',\n",
       "  'PMC8200619',\n",
       "  'PMC5420015',\n",
       "  'PMC6288572',\n",
       "  'PMC6921157',\n",
       "  'PMC4550780',\n",
       "  'PMC5987309',\n",
       "  'PMC5337835',\n",
       "  'PMC8668347',\n",
       "  'PMC6545747',\n",
       "  'PMC4508704',\n",
       "  'PMC3722985',\n",
       "  'PMC8574116',\n",
       "  'PMC9869191',\n",
       "  'PMC2750244',\n",
       "  'PMC3108731',\n",
       "  'PMC6398058',\n",
       "  'PMC6537081',\n",
       "  'PMC9834804',\n",
       "  'PMC9941022',\n",
       "  'PMC3981348',\n",
       "  'PMC5259936',\n",
       "  'PMC3273437',\n",
       "  'PMC8712131',\n",
       "  'PMC6831859',\n",
       "  'PMC4717627',\n",
       "  'PMC5114320',\n",
       "  'PMC3894025',\n",
       "  'PMC6834456',\n",
       "  'PMC4258217',\n",
       "  'PMC6396444',\n",
       "  'PMC6742877',\n",
       "  'PMC9108155',\n",
       "  'PMC9302883',\n",
       "  'PMC6205350',\n",
       "  'PMC10323808',\n",
       "  'PMC9273775',\n",
       "  'PMC4064426',\n",
       "  'PMC10415754',\n",
       "  'PMC4980514',\n",
       "  'PMC3683444',\n",
       "  'PMC5846908',\n",
       "  'PMC10228719',\n",
       "  'PMC9641636',\n",
       "  'PMC9512840',\n",
       "  'PMC10182372',\n",
       "  'PMC9282702',\n",
       "  'PMC7439188',\n",
       "  'PMC5773468',\n",
       "  'PMC9328801',\n",
       "  'PMC3615933',\n",
       "  'PMC7481816',\n",
       "  'PMC4929381',\n",
       "  'PMC8222603',\n",
       "  'PMC6929939',\n",
       "  'PMC3540647',\n",
       "  'PMC9500339',\n",
       "  'PMC8407642',\n",
       "  'PMC10310350',\n",
       "  'PMC5317073',\n",
       "  'PMC6800088',\n",
       "  'PMC6174749',\n",
       "  'PMC9450605',\n",
       "  'PMC2925208',\n",
       "  'PMC8128506',\n",
       "  'PMC6317835',\n",
       "  'PMC9037883',\n",
       "  'PMC9463015',\n",
       "  'PMC5055922',\n",
       "  'PMC7132354',\n",
       "  'PMC5574252',\n",
       "  'PMC9294239',\n",
       "  'PMC2947750',\n",
       "  'PMC5846373',\n",
       "  'PMC3135060',\n",
       "  'PMC9285893',\n",
       "  'PMC3257067',\n",
       "  'PMC9261228',\n",
       "  'PMC8437380',\n",
       "  'PMC3687645',\n",
       "  'PMC8168796',\n",
       "  'PMC7262964',\n",
       "  'PMC6388523',\n",
       "  'PMC7283137',\n",
       "  'PMC3938365',\n",
       "  'PMC6005296',\n",
       "  'PMC4397223',\n",
       "  'PMC4253035',\n",
       "  'PMC6077650',\n",
       "  'PMC10174457',\n",
       "  'PMC3884199',\n",
       "  'PMC8282370',\n",
       "  'PMC4664549',\n",
       "  'PMC9608240',\n",
       "  'PMC4322374',\n",
       "  'PMC7102445',\n",
       "  'PMC4956902',\n",
       "  'PMC2628935',\n",
       "  'PMC6381922',\n",
       "  'PMC9066584',\n",
       "  'PMC3328781',\n",
       "  'PMC8531932',\n",
       "  'PMC3363304',\n",
       "  'PMC3736967',\n",
       "  'PMC6902614',\n",
       "  'PMC6731353',\n",
       "  'PMC9795177',\n",
       "  'PMC5828284',\n",
       "  'PMC6370615',\n",
       "  'PMC5864713',\n",
       "  'PMC6222037',\n",
       "  'PMC9513563',\n",
       "  'PMC8437821',\n",
       "  'PMC3934774',\n",
       "  'PMC8580735',\n",
       "  'PMC3542952',\n",
       "  'PMC9391998',\n",
       "  'PMC6514481',\n",
       "  'PMC4735458',\n",
       "  'PMC8242995',\n",
       "  'PMC10369008',\n",
       "  'PMC7712411',\n",
       "  'PMC3347879',\n",
       "  'PMC5698921',\n",
       "  'PMC10395095',\n",
       "  'PMC9560591',\n",
       "  'PMC6886636',\n",
       "  'PMC8327232',\n",
       "  'PMC5109712',\n",
       "  'PMC2828432',\n",
       "  'PMC5484424',\n",
       "  'PMC6348503',\n",
       "  'PMC3447230',\n",
       "  'PMC5491809',\n",
       "  'PMC8329603',\n",
       "  'PMC6450236',\n",
       "  'PMC4276263',\n",
       "  'PMC9282816',\n",
       "  'PMC10084577',\n",
       "  'PMC6332946',\n",
       "  'PMC4866062',\n",
       "  'PMC8243102',\n",
       "  'PMC3716026',\n",
       "  'PMC6421597',\n",
       "  'PMC2718207',\n",
       "  'PMC8164024',\n",
       "  'PMC10421585',\n",
       "  'PMC4897088',\n",
       "  'PMC2719788',\n",
       "  'PMC2838360',\n",
       "  'PMC8710692',\n",
       "  'PMC9990775',\n",
       "  'PMC4000300',\n",
       "  'PMC7256205',\n",
       "  'PMC8428556',\n",
       "  'PMC9432856',\n",
       "  'PMC7336214',\n",
       "  'PMC6604042',\n",
       "  'PMC6949674',\n",
       "  'PMC8639588',\n",
       "  'PMC9946755',\n",
       "  'PMC10318351',\n",
       "  'PMC4802983',\n",
       "  'PMC4007786',\n",
       "  'PMC8337056',\n",
       "  'PMC7166055',\n",
       "  'PMC5818931',\n",
       "  'PMC8081048',\n",
       "  'PMC6743703',\n",
       "  'PMC6345152',\n",
       "  'PMC6167587',\n",
       "  'PMC6111644',\n",
       "  'PMC8313121',\n",
       "  'PMC7527615',\n",
       "  'PMC9170507',\n",
       "  'PMC5320041',\n",
       "  'PMC10201373',\n",
       "  'PMC7406448',\n",
       "  'PMC7204375',\n",
       "  'PMC5757404',\n",
       "  'PMC3924740',\n",
       "  'PMC8571307',\n",
       "  'PMC3991122',\n",
       "  'PMC7368181',\n",
       "  'PMC4492508',\n",
       "  'PMC7796826',\n",
       "  'PMC4150516',\n",
       "  'PMC5922340',\n",
       "  'PMC8589514',\n",
       "  'PMC7288206',\n",
       "  'PMC7374222',\n",
       "  'PMC7376414',\n",
       "  'PMC5774598',\n",
       "  'PMC6491627',\n",
       "  'PMC3583069',\n",
       "  'PMC10387763',\n",
       "  'PMC5841115',\n",
       "  'PMC6475553',\n",
       "  'PMC6925741',\n",
       "  'PMC5480228',\n",
       "  'PMC8107669',\n",
       "  'PMC3862226',\n",
       "  'PMC7737542',\n",
       "  'PMC6585220',\n",
       "  'PMC10166216',\n",
       "  'PMC7680930',\n",
       "  'PMC5066193',\n",
       "  'PMC6743686',\n",
       "  'PMC8110827',\n",
       "  'PMC7171645',\n",
       "  'PMC6446130',\n",
       "  'PMC4131002',\n",
       "  'PMC2718185',\n",
       "  'PMC5925949',\n",
       "  'PMC9124883',\n",
       "  'PMC4789418',\n",
       "  'PMC7711970',\n",
       "  'PMC8176203',\n",
       "  'PMC7218215',\n",
       "  'PMC3014856',\n",
       "  'PMC5869570',\n",
       "  'PMC4744614',\n",
       "  'PMC4821156',\n",
       "  'PMC3551515',\n",
       "  'PMC6452554',\n",
       "  'PMC5771727',\n",
       "  'PMC4831491',\n",
       "  'PMC9380446',\n",
       "  'PMC7682142',\n",
       "  'PMC8392798',\n",
       "  'PMC4862798',\n",
       "  'PMC5719537',\n",
       "  'PMC8415387',\n",
       "  'PMC4531616',\n",
       "  'PMC5118371',\n",
       "  'PMC8010170',\n",
       "  'PMC9490482',\n",
       "  'PMC7472830',\n",
       "  'PMC7700966',\n",
       "  'PMC6026916',\n",
       "  'PMC8097002',\n",
       "  'PMC6744724',\n",
       "  'PMC9845397',\n",
       "  'PMC4708069',\n",
       "  'PMC4900306',\n",
       "  'PMC4367057',\n",
       "  'PMC4341321',\n",
       "  'PMC8267556',\n",
       "  'PMC8184239',\n",
       "  'PMC4330689',\n",
       "  'PMC7876995',\n",
       "  'PMC5315209',\n",
       "  'PMC4711340',\n",
       "  'PMC5097962',\n",
       "  'PMC10368104',\n",
       "  'PMC5726742',\n",
       "  'PMC3757911',\n",
       "  'PMC4242899',\n",
       "  'PMC4379640',\n",
       "  'PMC4483173',\n",
       "  'PMC3338239',\n",
       "  'PMC4782661',\n",
       "  'PMC7568180',\n",
       "  'PMC6691664',\n",
       "  'PMC4276086',\n",
       "  'PMC6130174',\n",
       "  'PMC7393219',\n",
       "  'PMC4118727',\n",
       "  'PMC3447225',\n",
       "  'PMC4939985',\n",
       "  'PMC9133385',\n",
       "  'PMC8355995',\n",
       "  'PMC4742477',\n",
       "  'PMC9852504',\n",
       "  'PMC9597005',\n",
       "  'PMC8683245',\n",
       "  'PMC3420475',\n",
       "  'PMC6350017',\n",
       "  'PMC4629570',\n",
       "  'PMC10352529',\n",
       "  'PMC5228701',\n",
       "  'PMC5139886',\n",
       "  'PMC4303471',\n",
       "  'PMC5012799',\n",
       "  'PMC4049038',\n",
       "  'PMC6395856',\n",
       "  'PMC3401649',\n",
       "  'PMC6243306',\n",
       "  'PMC6900946',\n",
       "  'PMC9539137',\n",
       "  'PMC9271968',\n",
       "  'PMC7756012',\n",
       "  'PMC8799927',\n",
       "  'PMC6744794',\n",
       "  'PMC7970248',\n",
       "  'PMC10416632',\n",
       "  'PMC5648305',\n",
       "  'PMC8733335',\n",
       "  'PMC4891586',\n",
       "  'PMC10408600',\n",
       "  'PMC9123637',\n",
       "  'PMC3700967',\n",
       "  'PMC6347510',\n",
       "  'PMC5998277',\n",
       "  'PMC6586124',\n",
       "  'PMC5899866',\n",
       "  'PMC6180851',\n",
       "  'PMC5771915',\n",
       "  'PMC6267726',\n",
       "  'PMC7661465',\n",
       "  'PMC2787018',\n",
       "  'PMC7391113',\n",
       "  'PMC4763553',\n",
       "  'PMC3546216',\n",
       "  'PMC3350111',\n",
       "  'PMC9705577',\n",
       "  'PMC7687474',\n",
       "  'PMC3535818',\n",
       "  'PMC5937516',\n",
       "  'PMC6116301',\n",
       "  'PMC6180860',\n",
       "  'PMC4769045',\n",
       "  'PMC9354553',\n",
       "  'PMC4345035',\n",
       "  'PMC9577112',\n",
       "  'PMC8113859',\n",
       "  'PMC4065704',\n",
       "  'PMC6477499',\n",
       "  'PMC5492790',\n",
       "  'PMC5822820',\n",
       "  'PMC4312440',\n",
       "  'PMC8361550',\n",
       "  'PMC7160736',\n",
       "  'PMC6907107',\n",
       "  'PMC6159306',\n",
       "  'PMC6465717',\n",
       "  'PMC8084685',\n",
       "  'PMC9846588',\n",
       "  'PMC9053256',\n",
       "  'PMC9829981',\n",
       "  'PMC5295181',\n",
       "  'PMC10098112',\n",
       "  'PMC3323263',\n",
       "  'PMC3726520',\n",
       "  'PMC8526214',\n",
       "  'PMC10076737',\n",
       "  'PMC10266800',\n",
       "  'PMC8605226',\n",
       "  'PMC7474778',\n",
       "  'PMC8077606',\n",
       "  'PMC6005275',\n",
       "  'PMC6472062',\n",
       "  'PMC6390555',\n",
       "  'PMC4678526',\n",
       "  'PMC8791849',\n",
       "  'PMC4663175',\n",
       "  'PMC6701301',\n",
       "  'PMC5015501',\n",
       "  'PMC4444167',\n",
       "  'PMC7537644',\n",
       "  'PMC5380828',\n",
       "  'PMC2778822',\n",
       "  'PMC7458500',\n",
       "  'PMC6197703',\n",
       "  'PMC4109119',\n",
       "  'PMC6744365',\n",
       "  'PMC5460377',\n",
       "  'PMC8486010',\n",
       "  'PMC4488956',\n",
       "  'PMC6402212',\n",
       "  'PMC6497487',\n",
       "  'PMC4257017',\n",
       "  'PMC4996063',\n",
       "  'PMC8795594',\n",
       "  'PMC9850095',\n",
       "  'PMC4150428',\n",
       "  'PMC8233070',\n",
       "  'PMC3523579',\n",
       "  'PMC6122280',\n",
       "  'PMC4533487',\n",
       "  'PMC6195931',\n",
       "  'PMC5514622',\n",
       "  'PMC2719756',\n",
       "  'PMC9377306',\n",
       "  'PMC4821441',\n",
       "  'PMC5360453',\n",
       "  'PMC10414553',\n",
       "  'PMC5366803',\n",
       "  'PMC9922378',\n",
       "  'PMC8077721',\n",
       "  'PMC8013978',\n",
       "  'PMC9555291',\n",
       "  'PMC4879337',\n",
       "  'PMC9551989',\n",
       "  'PMC6120592',\n",
       "  'PMC4879802',\n",
       "  'PMC9622464',\n",
       "  'PMC3678502',\n",
       "  'PMC5820864',\n",
       "  'PMC6178910',\n",
       "  'PMC5723361',\n",
       "  'PMC2732509',\n",
       "  'PMC6010925',\n",
       "  'PMC6449812',\n",
       "  'PMC4005093',\n",
       "  'PMC9082205',\n",
       "  'PMC5635244',\n",
       "  'PMC8685438',\n",
       "  'PMC4821151',\n",
       "  'PMC6393948',\n",
       "  'PMC8017431',\n",
       "  'PMC6796728',\n",
       "  'PMC4427155',\n",
       "  'PMC5994735',\n",
       "  'PMC10326381',\n",
       "  'PMC4724686',\n",
       "  'PMC8573117',\n",
       "  'PMC6201379',\n",
       "  'PMC3350232',\n",
       "  'PMC8464216',\n",
       "  'PMC6915124',\n",
       "  'PMC3201100',\n",
       "  'PMC7086418',\n",
       "  'PMC8039197',\n",
       "  'PMC6376526',\n",
       "  'PMC9148238',\n",
       "  'PMC9344096',\n",
       "  'PMC4898292',\n",
       "  'PMC10276592',\n",
       "  'PMC9990766',\n",
       "  'PMC3350277',\n",
       "  'PMC4422723',\n",
       "  'PMC5551466',\n",
       "  'PMC8794318',\n",
       "  'PMC8463768',\n",
       "  'PMC4166343',\n",
       "  'PMC7433960',\n",
       "  'PMC8046462',\n",
       "  'PMC5390662',\n",
       "  'PMC6304870',\n",
       "  'PMC5219585',\n",
       "  'PMC8639279',\n",
       "  'PMC8247706',\n",
       "  'PMC6240727',\n",
       "  'PMC8128129',\n",
       "  'PMC5046003',\n",
       "  'PMC5131811',\n",
       "  'PMC5457933',\n",
       "  'PMC7090256',\n",
       "  'PMC6299974',\n",
       "  'PMC9479491',\n",
       "  'PMC8599274',\n",
       "  'PMC4038000',\n",
       "  'PMC9019075',\n",
       "  'PMC4901150',\n",
       "  'PMC7332490',\n",
       "  'PMC6302554',\n",
       "  'PMC7351623',\n",
       "  'PMC4759896',\n",
       "  'PMC9263511',\n",
       "  'PMC7358707',\n",
       "  'PMC5738199',\n",
       "  'PMC7255984',\n",
       "  'PMC6831797',\n",
       "  'PMC5566717',\n",
       "  'PMC7472920',\n",
       "  'PMC10077779',\n",
       "  'PMC5887785',\n",
       "  'PMC8349526',\n",
       "  'PMC3047773',\n",
       "  'PMC10345200',\n",
       "  'PMC6390208',\n",
       "  'PMC7727623',\n",
       "  'PMC6436336',\n",
       "  'PMC4823498',\n",
       "  'PMC483056',\n",
       "  'PMC9584726',\n",
       "  'PMC7226668',\n",
       "  'PMC7269521',\n",
       "  'PMC3585775',\n",
       "  'PMC7248319',\n",
       "  'PMC3262997',\n",
       "  'PMC8411882',\n",
       "  'PMC8655870',\n",
       "  'PMC5944016',\n",
       "  'PMC8182299',\n",
       "  'PMC10311060',\n",
       "  'PMC8648468',\n",
       "  'PMC9676932',\n",
       "  'PMC6356047',\n",
       "  'PMC5680665',\n",
       "  'PMC3420376',\n",
       "  'PMC4598389',\n",
       "  'PMC7591673',\n",
       "  'PMC4227511',\n",
       "  'PMC8273265',\n",
       "  'PMC6215577',\n",
       "  'PMC10359673',\n",
       "  'PMC7224471',\n",
       "  'PMC4602942',\n",
       "  'PMC9632847',\n",
       "  'PMC10328123',\n",
       "  'PMC6562175',\n",
       "  'PMC7086431',\n",
       "  'PMC4331673',\n",
       "  'PMC2892671',\n",
       "  'PMC3245192',\n",
       "  'PMC5362702',\n",
       "  'PMC5791444',\n",
       "  'PMC5368395',\n",
       "  'PMC2738499',\n",
       "  'PMC3003993',\n",
       "  'PMC5502805',\n",
       "  'PMC7071810',\n",
       "  'PMC9421220',\n",
       "  'PMC6364124',\n",
       "  'PMC6381921',\n",
       "  'PMC9629861',\n",
       "  'PMC2958542',\n",
       "  'PMC8626178',\n",
       "  'PMC6008880',\n",
       "  'PMC5070353',\n",
       "  'PMC4068338',\n",
       "  'PMC9649972',\n",
       "  'PMC5019914',\n",
       "  'PMC3742348',\n",
       "  'PMC4217363',\n",
       "  'PMC7318809',\n",
       "  'PMC4659706',\n",
       "  'PMC7566087',\n",
       "  'PMC8226359',\n",
       "  'PMC4768458',\n",
       "  'PMC4942733',\n",
       "  'PMC9614080',\n",
       "  'PMC1236954',\n",
       "  'PMC6700242',\n",
       "  'PMC8560288',\n",
       "  'PMC5622815',\n",
       "  'PMC4322812',\n",
       "  'PMC9922053',\n",
       "  'PMC8645473',\n",
       "  'PMC3881385',\n",
       "  'PMC10328728',\n",
       "  'PMC6417323',\n",
       "  'PMC5803942',\n",
       "  'PMC6166281',\n",
       "  'PMC7531809',\n",
       "  'PMC2796233',\n",
       "  'PMC5220406',\n",
       "  'PMC2836895',\n",
       "  'PMC5282427',\n",
       "  'PMC3442446',\n",
       "  'PMC5320816',\n",
       "  'PMC5313436',\n",
       "  'PMC4378320',\n",
       "  'PMC6260389',\n",
       "  'PMC3555002',\n",
       "  'PMC4900127',\n",
       "  'PMC4178356',\n",
       "  'PMC9135378',\n",
       "  'PMC1192821',\n",
       "  'PMC2797594',\n",
       "  'PMC8214893',\n",
       "  'PMC3350299',\n",
       "  'PMC5872664',\n",
       "  'PMC4789394',\n",
       "  'PMC4900105',\n",
       "  'PMC3604869',\n",
       "  'PMC4296998',\n",
       "  'PMC2778135',\n",
       "  'PMC7263430',\n",
       "  'PMC3529871',\n",
       "  'PMC6123837',\n",
       "  'PMC6332758',\n",
       "  'PMC9893367',\n",
       "  'PMC9479501',\n",
       "  'PMC10313132',\n",
       "  'PMC7007016',\n",
       "  'PMC5471581',\n",
       "  'PMC3761953',\n",
       "  'PMC10321783',\n",
       "  'PMC10159324',\n",
       "  'PMC9243420',\n",
       "  'PMC4438634',\n",
       "  'PMC5771871',\n",
       "  'PMC4475344',\n",
       "  'PMC6679641',\n",
       "  'PMC7336922',\n",
       "  'PMC10272408',\n",
       "  'PMC3012841',\n",
       "  'PMC8076759',\n",
       "  'PMC6344176',\n",
       "  'PMC6313968',\n",
       "  'PMC7417938',\n",
       "  'PMC3406614',\n",
       "  'PMC8012864',\n",
       "  'PMC7585050',\n",
       "  'PMC3730474',\n",
       "  'PMC7308213',\n",
       "  'PMC9726922',\n",
       "  'PMC5620405',\n",
       "  'PMC4724101',\n",
       "  'PMC6458882',\n",
       "  'PMC5741137',\n",
       "  'PMC9479505',\n",
       "  'PMC8093374',\n",
       "  'PMC9619325',\n",
       "  'PMC6161692',\n",
       "  'PMC8574110',\n",
       "  'PMC10164996',\n",
       "  'PMC4204450',\n",
       "  'PMC7363694',\n",
       "  'PMC3607913',\n",
       "  'PMC5457932',\n",
       "  'PMC3662738',\n",
       "  'PMC7229232',\n",
       "  'PMC5498208',\n",
       "  'PMC5485299',\n",
       "  'PMC5569634',\n",
       "  'PMC7265835',\n",
       "  'PMC5396431',\n",
       "  'PMC9159873',\n",
       "  'PMC9320325',\n",
       "  'PMC3015617',\n",
       "  'PMC4681885',\n",
       "  'PMC5340951',\n",
       "  'PMC4272654',\n",
       "  'PMC5061310',\n",
       "  'PMC7817230',\n",
       "  'PMC4080668',\n",
       "  'PMC8047179',\n",
       "  'PMC4836125',\n",
       "  'PMC9617715',\n",
       "  'PMC8502108',\n",
       "  'PMC10010872',\n",
       "  'PMC6350572',\n",
       "  'PMC10020938',\n",
       "  'PMC3356992',\n",
       "  'PMC5477857',\n",
       "  'PMC10141254',\n",
       "  'PMC3279504',\n",
       "  'PMC5894322',\n",
       "  'PMC10083011',\n",
       "  'PMC8326275',\n",
       "  'PMC7378605',\n",
       "  'PMC9894875',\n",
       "  'PMC5890374',\n",
       "  'PMC7649943',\n",
       "  'PMC3567412',\n",
       "  'PMC6536776',\n",
       "  'PMC10313112',\n",
       "  'PMC4802324',\n",
       "  'PMC9830020',\n",
       "  'PMC4499615',\n",
       "  'PMC6109579',\n",
       "  'PMC6739703',\n",
       "  'PMC10035645',\n",
       "  'PMC9772969',\n",
       "  'PMC6642751',\n",
       "  'PMC4628715',\n",
       "  'PMC9674928',\n",
       "  'PMC7204860',\n",
       "  'PMC3617894',\n",
       "  'PMC3864908',\n",
       "  'PMC8378491',\n",
       "  'PMC6051121',\n",
       "  'PMC9116235',\n",
       "  'PMC3956971',\n",
       "  'PMC8448584',\n",
       "  'PMC8675622',\n",
       "  'PMC4319252',\n",
       "  'PMC6324112',\n",
       "  'PMC6409012',\n",
       "  'PMC5366790',\n",
       "  'PMC6899263',\n",
       "  'PMC9253533',\n",
       "  'PMC6417290',\n",
       "  'PMC4854227',\n",
       "  'PMC5406521',\n",
       "  'PMC3420418',\n",
       "  'PMC9062931',\n",
       "  'PMC4735083',\n",
       "  'PMC9139337',\n",
       "  'PMC8285566',\n",
       "  'PMC3350215',\n",
       "  'PMC4226570',\n",
       "  'PMC3785357',\n",
       "  'PMC5484609',\n",
       "  'PMC9792275',\n",
       "  'PMC2799640',\n",
       "  'PMC10250735',\n",
       "  'PMC3426826',\n",
       "  'PMC4159397',\n",
       "  'PMC3173925',\n",
       "  'PMC3606735',\n",
       "  'PMC4311031',\n",
       "  'PMC6883338',\n",
       "  'PMC10308279',\n",
       "  'PMC9149410',\n",
       "  'PMC8326104',\n",
       "  'PMC4232202',\n",
       "  'PMC4367056',\n",
       "  'PMC5180436',\n",
       "  'PMC10157198',\n",
       "  'PMC9199574',\n",
       "  'PMC6787949',\n",
       "  'PMC5259602',\n",
       "  'PMC4993919',\n",
       "  'PMC4524006',\n",
       "  'PMC5839875',\n",
       "  'PMC6296693',\n",
       "  'PMC10265348',\n",
       "  'PMC6348196',\n",
       "  'PMC10369060',\n",
       "  'PMC8268003',\n",
       "  'PMC6350110',\n",
       "  'PMC5111013',\n",
       "  'PMC9719080',\n",
       "  'PMC7728115',\n",
       "  'PMC8554224',\n",
       "  'PMC10202565',\n",
       "  'PMC4898297',\n",
       "  'PMC4309504',\n",
       "  'PMC8493334',\n",
       "  'PMC7533312',\n",
       "  'PMC8077640',\n",
       "  'PMC5778723',\n",
       "  'PMC7034944',\n",
       "  'PMC4073032',\n",
       "  'PMC3654631',\n",
       "  'PMC8264843',\n",
       "  'PMC3909696',\n",
       "  'PMC5015792',\n",
       "  'PMC6500649',\n",
       "  'PMC5259666',\n",
       "  'PMC10035883',\n",
       "  'PMC8329363',\n",
       "  'PMC9626241',\n",
       "  'PMC7369465',\n",
       "  'PMC5356200',\n",
       "  'PMC3358721',\n",
       "  'PMC6803738',\n",
       "  'PMC7399133',\n",
       "  'PMC8804283',\n",
       "  'PMC6296698',\n",
       "  'PMC4302971',\n",
       "  'PMC7750755',\n",
       "  'PMC9428849',\n",
       "  'PMC9536313',\n",
       "  'PMC5702414',\n",
       "  'PMC4997775',\n",
       "  'PMC9643303',\n",
       "  'PMC7591958',\n",
       "  'PMC4156985',\n",
       "  'PMC3184519',\n",
       "  'PMC8013530',\n",
       "  'PMC6735193',\n",
       "  'PMC3959373',\n",
       "  'PMC2939437',\n",
       "  'PMC10331202',\n",
       "  'PMC10119779',\n",
       "  'PMC4987474',\n",
       "  'PMC6175750',\n",
       "  'PMC4766290',\n",
       "  'PMC2259370',\n",
       "  'PMC4501463',\n",
       "  'PMC4352736',\n",
       "  'PMC6136482',\n",
       "  'PMC9036379',\n",
       "  'PMC4531034',\n",
       "  'PMC7268156',\n",
       "  'PMC4246683',\n",
       "  'PMC6721507',\n",
       "  'PMC4352650',\n",
       "  'PMC10310325',\n",
       "  'PMC5143702',\n",
       "  'PMC8287412',\n",
       "  'PMC6369501',\n",
       "  'PMC8728800',\n",
       "  'PMC5985244',\n",
       "  'PMC7652926',\n",
       "  'PMC3085326',\n",
       "  'PMC5437796',\n",
       "  'PMC4267161',\n",
       "  'PMC5422736',\n",
       "  'PMC3616049',\n",
       "  'PMC4231314',\n",
       "  'PMC4821335',\n",
       "  'PMC4643352',\n",
       "  'PMC8668381',\n",
       "  'PMC10046697',\n",
       "  'PMC6884723',\n",
       "  'PMC3921775',\n",
       "  'PMC5827702',\n",
       "  'PMC4382053',\n",
       "  'PMC7165356',\n",
       "  'PMC4031092',\n",
       "  'PMC4612613',\n",
       "  'PMC7182763',\n",
       "  'PMC4559873',\n",
       "  'PMC9815528',\n",
       "  'PMC4119434',\n",
       "  'PMC6594286',\n",
       "  'PMC6159251',\n",
       "  'PMC10183579',\n",
       "  'PMC7395541',\n",
       "  'PMC3558351',\n",
       "  'PMC5377292',\n",
       "  'PMC7566195',\n",
       "  'PMC4809441',\n",
       "  'PMC6938193',\n",
       "  'PMC9873479',\n",
       "  'PMC7074520',\n",
       "  'PMC5591568',\n",
       "  'PMC4898005',\n",
       "  'PMC4821337',\n",
       "  'PMC3785351',\n",
       "  'PMC4899547',\n",
       "  'PMC5838830',\n",
       "  'PMC9353025',\n",
       "  'PMC3362849',\n",
       "  'PMC6292857',\n",
       "  'PMC4719911',\n",
       "  'PMC8683450',\n",
       "  'PMC6510510',\n",
       "  'PMC3884727',\n",
       "  'PMC5851018',\n",
       "  'PMC4314886',\n",
       "  'PMC4376922',\n",
       "  'PMC9858885',\n",
       "  'PMC7666633',\n",
       "  'PMC6864125',\n",
       "  'PMC6396587',\n",
       "  'PMC9287348',\n",
       "  'PMC4525444',\n",
       "  'PMC6041995',\n",
       "  'PMC3350101',\n",
       "  'PMC10242137',\n",
       "  'PMC8822334',\n",
       "  'PMC10203705',\n",
       "  'PMC3184518',\n",
       "  'PMC3234154',\n",
       "  'PMC2883827',\n",
       "  'PMC3195389',\n",
       "  'PMC9403065',\n",
       "  'PMC8457354',\n",
       "  'PMC5965336',\n",
       "  'PMC9137965',\n",
       "  'PMC9125062',\n",
       "  'PMC3752856',\n",
       "  'PMC10311010',\n",
       "  'PMC10267872',\n",
       "  'PMC3245497',\n",
       "  'PMC4322405',\n",
       "  'PMC2738533',\n",
       "  'PMC7332718',\n",
       "  'PMC4664626',\n",
       "  'PMC6554484',\n",
       "  'PMC9241052',\n",
       "  'PMC5437802',\n",
       "  'PMC5219627',\n",
       "  'PMC3864171',\n",
       "  'PMC9503891',\n",
       "  'PMC2698061',\n",
       "  'PMC7534522',\n",
       "  'PMC3420684',\n",
       "  'PMC7229345',\n",
       "  'PMC5161787',\n",
       "  'PMC3992216',\n",
       "  'PMC5917864',\n",
       "  'PMC4891467',\n",
       "  'PMC5340088',\n",
       "  'PMC6438861',\n",
       "  'PMC4795147',\n",
       "  'PMC8168694',\n",
       "  'PMC7656049',\n",
       "  'PMC4359789',\n",
       "  'PMC4516357',\n",
       "  'PMC5106230',\n",
       "  'PMC4387336',\n",
       "  'PMC6692872',\n",
       "  'PMC6319684',\n",
       "  'PMC4773087',\n",
       "  'PMC4700856',\n",
       "  'PMC6385762',\n",
       "  'PMC7757964',\n",
       "  'PMC9553713',\n",
       "  'PMC5623757',\n",
       "  'PMC6095991',\n",
       "  'PMC6580008',\n",
       "  'PMC9098366',\n",
       "  'PMC8636095',\n",
       "  'PMC4247007',\n",
       "  'PMC9047901',\n",
       "  'PMC7175777',\n",
       "  'PMC5494058',\n",
       "  'PMC6282132',\n",
       "  'PMC6609725',\n",
       "  'PMC4397003',\n",
       "  'PMC9898587',\n",
       "  'PMC10209118',\n",
       "  'PMC5944445',\n",
       "  'PMC5830816',\n",
       "  'PMC7580483',\n",
       "  'PMC10242558',\n",
       "  'PMC2825652',\n",
       "  'PMC8734028',\n",
       "  'PMC5730433',\n",
       "  'PMC4015560',\n",
       "  'PMC5866296',\n",
       "  'PMC10076629',\n",
       "  'PMC6561004',\n",
       "  'PMC6592670',\n",
       "  'PMC8635928',\n",
       "  'PMC5966628',\n",
       "  'PMC8688253',\n",
       "  'PMC7326191',\n",
       "  'PMC4427135',\n",
       "  'PMC9726840',\n",
       "  'PMC2892669',\n",
       "  'PMC3245498',\n",
       "  'PMC5369366',\n",
       "  'PMC4996573',\n",
       "  'PMC6217883',\n",
       "  'PMC9207123',\n",
       "  'PMC3700476',\n",
       "  'PMC9873306',\n",
       "  'PMC8739263',\n",
       "  'PMC5067447',\n",
       "  'PMC10288866',\n",
       "  'PMC9845545',\n",
       "  'PMC3716248',\n",
       "  'PMC7298528',\n",
       "  'PMC10174326',\n",
       "  'PMC6699327',\n",
       "  'PMC4620392',\n",
       "  'PMC9086612',\n",
       "  'PMC9468777',\n",
       "  'PMC10319284',\n",
       "  'PMC8100614',\n",
       "  'PMC10190599',\n",
       "  'PMC4093733',\n",
       "  'PMC5434259',\n",
       "  'PMC4133753',\n",
       "  'PMC8311769',\n",
       "  'PMC10231445',\n",
       "  'PMC4943128',\n",
       "  'PMC10062505',\n",
       "  'PMC9022146',\n",
       "  'PMC2495020',\n",
       "  'PMC4755470',\n",
       "  'PMC7605928',\n",
       "  'PMC8650644',\n",
       "  'PMC2948899',\n",
       "  'PMC9316585',\n",
       "  'PMC9329137',\n",
       "  'PMC4236770',\n",
       "  'PMC6515074',\n",
       "  'PMC4348141',\n",
       "  'PMC6525288',\n",
       "  'PMC10338080',\n",
       "  'PMC4503302',\n",
       "  'PMC9699840',\n",
       "  'PMC9797860',\n",
       "  'PMC5709343',\n",
       "  'PMC9595572',\n",
       "  'PMC5958580',\n",
       "  'PMC5096402',\n",
       "  'PMC5360091',\n",
       "  'PMC4941117',\n",
       "  'PMC4353120',\n",
       "  'PMC6362694',\n",
       "  'PMC9970259',\n",
       "  'PMC8826099',\n",
       "  'PMC7931941',\n",
       "  'PMC8495127',\n",
       "  ...]}"
      ]
     },
     "execution_count": 7,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "mdc.full_cases"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "nombre de cas cliniques disponibles : 85653\n"
     ]
    }
   ],
   "source": [
    "nb_cases = len(mdc.full_cases['cases'])\n",
    "\n",
    "print(f'nombre de cas cliniques disponibles : {nb_cases}')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 30,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Fichier 'full_df' cr avec succs.\n"
     ]
    }
   ],
   "source": [
    "file_full_df = \"full_df\"\n",
    "path = f'data/{file_full_df}'\n",
    "\n",
    "# Vrifier si le fichier existe avant d'excuter le traitement\n",
    "if not os.path.exists(path):\n",
    "    df = pd.DataFrame()\n",
    "    for i in range(len(mdc.full_cases['cases'])):\n",
    "        temp = pd.DataFrame(mdc.full_cases['cases'][i])\n",
    "        df = pd.concat([df, temp])\n",
    "\n",
    "    df.to_parquet(path)\n",
    "    print(\"Fichier 'full_df' cr avec succs.\")\n",
    "else:\n",
    "    print(\"Le fichier 'full_df' existe dj. Aucune action effectue.\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 37,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[{'age': 40,\n",
       "  'case_id': 'PMC9106225_01',\n",
       "  'case_text': 'A 40-year-old female patient was referred for evaluation of an asymptomatic swelling on the lower lip of 6 months duration with a history of local trauma. Clinical examination revealed a well-defined, nontender, smooth-surfaced, roughly oval, fluctuant swelling [Figure 1]. No relevant medical history was elicited. Oral hygiene was fair. A provisional diagnosis of mucocele was made; the lesion was excised under local anesthesia. Histopathological examination of the excised tissue revealed cystic lumen devoid of lining epithelium and surrounded by compressed granulation tissue and peripherally located mixed salivary glands. The lumen was filled with numerous mucinous globular structures which were oval or round in shape and of varying sizes [Figure 2]. Most of the globules present in the cystic lumen were attached to the surrounding cystic capsule and seemed dissociated from one another because of their globular organization. Some of the globules were suspended freely within the lumen [Figure 3]. Individual globules exhibited a mildly cellular core with peripheral laminations of dystrophic calcifications [Figure 4]. The granulation tissue forming the cystic wall was highly cellular, consisting of chronic inflammatory cells. The mucinous globules showed positive results for PAS and Alcian blue [Figures 3 and 4].',\n",
       "  'gender': 'Female'}]"
      ]
     },
     "execution_count": 37,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "mdc.full_cases['cases'][5]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "(85653, 14)"
      ]
     },
     "execution_count": 9,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_metadata = pd.DataFrame(mdc.full_metadata['article_metadata'])\n",
    "df_metadata.shape"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 36,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>authors</th>\n",
       "      <th>case_amount</th>\n",
       "      <th>doi</th>\n",
       "      <th>journal</th>\n",
       "      <th>journal_detail</th>\n",
       "      <th>keywords</th>\n",
       "      <th>license</th>\n",
       "      <th>link</th>\n",
       "      <th>major_mesh_terms</th>\n",
       "      <th>mesh_terms</th>\n",
       "      <th>pmcid</th>\n",
       "      <th>pmid</th>\n",
       "      <th>title</th>\n",
       "      <th>year</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>[Wenhua Liang, Jingjing Lu, Mingwei Qin, Xinti...</td>\n",
       "      <td>1</td>\n",
       "      <td>10.1258/arsr.2012.120031</td>\n",
       "      <td>Acta Radiol Short Rep</td>\n",
       "      <td>2012 Jul 31;1(6):arsr.2012.120031.</td>\n",
       "      <td>[vascular tumor, diagnostic imaging, liver, pa...</td>\n",
       "      <td>CC BY-NC</td>\n",
       "      <td>https://pubmed.ncbi.nlm.nih.gov/23986846/</td>\n",
       "      <td>None</td>\n",
       "      <td>[Case Reports]</td>\n",
       "      <td>PMC3738355</td>\n",
       "      <td>23986846</td>\n",
       "      <td>Littoral cell angioma mimicking hepatic tumor</td>\n",
       "      <td>2012</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>[Payal J Shah, Brian Ellis, Lauren R DiGiovine...</td>\n",
       "      <td>1</td>\n",
       "      <td>10.3205/oc000036</td>\n",
       "      <td>GMS Ophthalmol Cases</td>\n",
       "      <td>2015 Dec 2;5:Doc14.</td>\n",
       "      <td>[mri, aortic arch, carotid artery stenosis, ca...</td>\n",
       "      <td>CC BY</td>\n",
       "      <td>https://pubmed.ncbi.nlm.nih.gov/27625958/</td>\n",
       "      <td>None</td>\n",
       "      <td>[Case Reports]</td>\n",
       "      <td>PMC5015624</td>\n",
       "      <td>27625958</td>\n",
       "      <td>Central retinal artery occlusion following las...</td>\n",
       "      <td>2015</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>[Nobuhiko Seki, Maika Natsume, Ryosuke Ochiai,...</td>\n",
       "      <td>1</td>\n",
       "      <td>10.1159/000493088</td>\n",
       "      <td>Case Rep Oncol</td>\n",
       "      <td>2019 Jan 21;12(1):91-97.</td>\n",
       "      <td>[bevacizumab, egfr mutation, erlotinib, lung c...</td>\n",
       "      <td>CC BY-NC</td>\n",
       "      <td>https://pubmed.ncbi.nlm.nih.gov/30792648/</td>\n",
       "      <td>None</td>\n",
       "      <td>[Case Reports]</td>\n",
       "      <td>PMC6381877</td>\n",
       "      <td>30792648</td>\n",
       "      <td>Promising Combination Therapy with Bevacizumab...</td>\n",
       "      <td>2019</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>[Ali Raza Ghani, Faisal Inayat, Nouman Safdar ...</td>\n",
       "      <td>9</td>\n",
       "      <td>10.1177/2324709618770479</td>\n",
       "      <td>J Investig Med High Impact Case Rep</td>\n",
       "      <td>2018 Apr 18;6:2324709618770479.</td>\n",
       "      <td>[acute coronary syndrome, diagnosis, fibromusc...</td>\n",
       "      <td>CC BY</td>\n",
       "      <td>https://pubmed.ncbi.nlm.nih.gov/29707593/</td>\n",
       "      <td>None</td>\n",
       "      <td>[]</td>\n",
       "      <td>PMC5912312</td>\n",
       "      <td>29707593</td>\n",
       "      <td>Spontaneous Coronary Artery Dissection: A Case...</td>\n",
       "      <td>2018</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>[Xiangyi Kong, Dongmei Li, Yanguo Kong, Dingro...</td>\n",
       "      <td>1</td>\n",
       "      <td>10.1097/MD.0000000000005657</td>\n",
       "      <td>Medicine (Baltimore)</td>\n",
       "      <td>2017 Jan;96(4):e5657.</td>\n",
       "      <td>None</td>\n",
       "      <td>CC BY</td>\n",
       "      <td>https://pubmed.ncbi.nlm.nih.gov/28121922/</td>\n",
       "      <td>[Adenoma, Oxyphilic / pathology, Ki-67 Antigen...</td>\n",
       "      <td>[Adenoma, Oxyphilic / pathology, Ki-67 Antigen...</td>\n",
       "      <td>PMC5287946</td>\n",
       "      <td>28121922</td>\n",
       "      <td>Malignant adenohypophysis spindle cell oncocyt...</td>\n",
       "      <td>2017</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>[Rutuja Gajanan Vidhale, Subraj Shetty, Nikita...</td>\n",
       "      <td>1</td>\n",
       "      <td>10.4103/jomfp.jomfp_214_21</td>\n",
       "      <td>J Oral Maxillofac Pathol</td>\n",
       "      <td>2022 Jan-Mar;26(1):101-103.</td>\n",
       "      <td>[mucocele, mucus extravasation cyst, myxoglobu...</td>\n",
       "      <td>CC BY-NC-SA</td>\n",
       "      <td>https://pubmed.ncbi.nlm.nih.gov/35571290/</td>\n",
       "      <td>None</td>\n",
       "      <td>[Case Reports]</td>\n",
       "      <td>PMC9106225</td>\n",
       "      <td>35571290</td>\n",
       "      <td>A novel mucocele: Myxoglobulosis</td>\n",
       "      <td>2022</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>[Liaqat A Khan, Ali M Al-Neami, Ayman F Solima...</td>\n",
       "      <td>1</td>\n",
       "      <td>10.1016/j.ijscr.2020.03.051</td>\n",
       "      <td>Int J Surg Case Rep</td>\n",
       "      <td>2020;71:364-366.</td>\n",
       "      <td>[bochdalek, diaphragm, emergency care, hernia,...</td>\n",
       "      <td>CC BY</td>\n",
       "      <td>https://pubmed.ncbi.nlm.nih.gov/32506006/</td>\n",
       "      <td>None</td>\n",
       "      <td>[Case Reports]</td>\n",
       "      <td>PMC7276389</td>\n",
       "      <td>32506006</td>\n",
       "      <td>Bochdalek hernia with retrocardiac spleen - Di...</td>\n",
       "      <td>2020</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>[Ryuji Kawaguchi, Naoto Furukawa, Yoshihiko Ya...</td>\n",
       "      <td>2</td>\n",
       "      <td>10.1159/000330239</td>\n",
       "      <td>Case Rep Oncol</td>\n",
       "      <td>2011;4(2):358-62.</td>\n",
       "      <td>[alpha-fetoprotein, hepatoid adenocarcinoma, r...</td>\n",
       "      <td>CC BY-NC-ND</td>\n",
       "      <td>https://pubmed.ncbi.nlm.nih.gov/21769295/</td>\n",
       "      <td>None</td>\n",
       "      <td>[Case Reports]</td>\n",
       "      <td>PMC3134036</td>\n",
       "      <td>21769295</td>\n",
       "      <td>Carcinosarcoma of the uterine corpus with alph...</td>\n",
       "      <td>2011</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>[Ludovica Fucci, Lorenzo Gensini, Ugo Coppetel...</td>\n",
       "      <td>1</td>\n",
       "      <td>10.1016/j.lrr.2022.100330</td>\n",
       "      <td>Leuk Res Rep</td>\n",
       "      <td>2022 May 30;17:100330.</td>\n",
       "      <td>[daratumumab, multiple myeloma, real-word expe...</td>\n",
       "      <td>CC BY-NC-ND</td>\n",
       "      <td>https://pubmed.ncbi.nlm.nih.gov/35694449/</td>\n",
       "      <td>None</td>\n",
       "      <td>[Case Reports]</td>\n",
       "      <td>PMC9184873</td>\n",
       "      <td>35694449</td>\n",
       "      <td>Daratumumab triplet therapies in patients with...</td>\n",
       "      <td>2022</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>[Pradyumna Agasthi, Hemalatha Narayanasamy, Da...</td>\n",
       "      <td>1</td>\n",
       "      <td>10.1155/2018/3953579</td>\n",
       "      <td>Case Rep Cardiol</td>\n",
       "      <td>2018 Sep 30;2018:3953579.</td>\n",
       "      <td>None</td>\n",
       "      <td>CC BY</td>\n",
       "      <td>https://pubmed.ncbi.nlm.nih.gov/30363961/</td>\n",
       "      <td>None</td>\n",
       "      <td>[Case Reports]</td>\n",
       "      <td>PMC6186336</td>\n",
       "      <td>30363961</td>\n",
       "      <td>Decitabine Induced Delayed Cardiomyopathy in H...</td>\n",
       "      <td>2018</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                             authors  case_amount  \\\n",
       "0  [Wenhua Liang, Jingjing Lu, Mingwei Qin, Xinti...            1   \n",
       "1  [Payal J Shah, Brian Ellis, Lauren R DiGiovine...            1   \n",
       "2  [Nobuhiko Seki, Maika Natsume, Ryosuke Ochiai,...            1   \n",
       "3  [Ali Raza Ghani, Faisal Inayat, Nouman Safdar ...            9   \n",
       "4  [Xiangyi Kong, Dongmei Li, Yanguo Kong, Dingro...            1   \n",
       "5  [Rutuja Gajanan Vidhale, Subraj Shetty, Nikita...            1   \n",
       "6  [Liaqat A Khan, Ali M Al-Neami, Ayman F Solima...            1   \n",
       "7  [Ryuji Kawaguchi, Naoto Furukawa, Yoshihiko Ya...            2   \n",
       "8  [Ludovica Fucci, Lorenzo Gensini, Ugo Coppetel...            1   \n",
       "9  [Pradyumna Agasthi, Hemalatha Narayanasamy, Da...            1   \n",
       "\n",
       "                           doi                              journal  \\\n",
       "0     10.1258/arsr.2012.120031                Acta Radiol Short Rep   \n",
       "1             10.3205/oc000036                 GMS Ophthalmol Cases   \n",
       "2            10.1159/000493088                       Case Rep Oncol   \n",
       "3     10.1177/2324709618770479  J Investig Med High Impact Case Rep   \n",
       "4  10.1097/MD.0000000000005657                 Medicine (Baltimore)   \n",
       "5   10.4103/jomfp.jomfp_214_21             J Oral Maxillofac Pathol   \n",
       "6  10.1016/j.ijscr.2020.03.051                  Int J Surg Case Rep   \n",
       "7            10.1159/000330239                       Case Rep Oncol   \n",
       "8    10.1016/j.lrr.2022.100330                         Leuk Res Rep   \n",
       "9         10.1155/2018/3953579                     Case Rep Cardiol   \n",
       "\n",
       "                       journal_detail  \\\n",
       "0  2012 Jul 31;1(6):arsr.2012.120031.   \n",
       "1                 2015 Dec 2;5:Doc14.   \n",
       "2            2019 Jan 21;12(1):91-97.   \n",
       "3     2018 Apr 18;6:2324709618770479.   \n",
       "4               2017 Jan;96(4):e5657.   \n",
       "5         2022 Jan-Mar;26(1):101-103.   \n",
       "6                    2020;71:364-366.   \n",
       "7                   2011;4(2):358-62.   \n",
       "8              2022 May 30;17:100330.   \n",
       "9           2018 Sep 30;2018:3953579.   \n",
       "\n",
       "                                            keywords      license  \\\n",
       "0  [vascular tumor, diagnostic imaging, liver, pa...     CC BY-NC   \n",
       "1  [mri, aortic arch, carotid artery stenosis, ca...        CC BY   \n",
       "2  [bevacizumab, egfr mutation, erlotinib, lung c...     CC BY-NC   \n",
       "3  [acute coronary syndrome, diagnosis, fibromusc...        CC BY   \n",
       "4                                               None        CC BY   \n",
       "5  [mucocele, mucus extravasation cyst, myxoglobu...  CC BY-NC-SA   \n",
       "6  [bochdalek, diaphragm, emergency care, hernia,...        CC BY   \n",
       "7  [alpha-fetoprotein, hepatoid adenocarcinoma, r...  CC BY-NC-ND   \n",
       "8  [daratumumab, multiple myeloma, real-word expe...  CC BY-NC-ND   \n",
       "9                                               None        CC BY   \n",
       "\n",
       "                                        link  \\\n",
       "0  https://pubmed.ncbi.nlm.nih.gov/23986846/   \n",
       "1  https://pubmed.ncbi.nlm.nih.gov/27625958/   \n",
       "2  https://pubmed.ncbi.nlm.nih.gov/30792648/   \n",
       "3  https://pubmed.ncbi.nlm.nih.gov/29707593/   \n",
       "4  https://pubmed.ncbi.nlm.nih.gov/28121922/   \n",
       "5  https://pubmed.ncbi.nlm.nih.gov/35571290/   \n",
       "6  https://pubmed.ncbi.nlm.nih.gov/32506006/   \n",
       "7  https://pubmed.ncbi.nlm.nih.gov/21769295/   \n",
       "8  https://pubmed.ncbi.nlm.nih.gov/35694449/   \n",
       "9  https://pubmed.ncbi.nlm.nih.gov/30363961/   \n",
       "\n",
       "                                    major_mesh_terms  \\\n",
       "0                                               None   \n",
       "1                                               None   \n",
       "2                                               None   \n",
       "3                                               None   \n",
       "4  [Adenoma, Oxyphilic / pathology, Ki-67 Antigen...   \n",
       "5                                               None   \n",
       "6                                               None   \n",
       "7                                               None   \n",
       "8                                               None   \n",
       "9                                               None   \n",
       "\n",
       "                                          mesh_terms       pmcid      pmid  \\\n",
       "0                                     [Case Reports]  PMC3738355  23986846   \n",
       "1                                     [Case Reports]  PMC5015624  27625958   \n",
       "2                                     [Case Reports]  PMC6381877  30792648   \n",
       "3                                                 []  PMC5912312  29707593   \n",
       "4  [Adenoma, Oxyphilic / pathology, Ki-67 Antigen...  PMC5287946  28121922   \n",
       "5                                     [Case Reports]  PMC9106225  35571290   \n",
       "6                                     [Case Reports]  PMC7276389  32506006   \n",
       "7                                     [Case Reports]  PMC3134036  21769295   \n",
       "8                                     [Case Reports]  PMC9184873  35694449   \n",
       "9                                     [Case Reports]  PMC6186336  30363961   \n",
       "\n",
       "                                               title  year  \n",
       "0      Littoral cell angioma mimicking hepatic tumor  2012  \n",
       "1  Central retinal artery occlusion following las...  2015  \n",
       "2  Promising Combination Therapy with Bevacizumab...  2019  \n",
       "3  Spontaneous Coronary Artery Dissection: A Case...  2018  \n",
       "4  Malignant adenohypophysis spindle cell oncocyt...  2017  \n",
       "5                   A novel mucocele: Myxoglobulosis  2022  \n",
       "6  Bochdalek hernia with retrocardiac spleen - Di...  2020  \n",
       "7  Carcinosarcoma of the uterine corpus with alph...  2011  \n",
       "8  Daratumumab triplet therapies in patients with...  2022  \n",
       "9  Decitabine Induced Delayed Cardiomyopathy in H...  2018  "
      ]
     },
     "execution_count": 36,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_metadata['major_mesh_terms'] = df_metadata['major_mesh_terms'].apply(lambda x: None if x == [] else x)\n",
    "df_metadata.head(10)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 32,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "nombre de ligne avec keywords non vide : 59628\n",
      "nombre de ligne avec major_mesh_terms non vide : 13211\n"
     ]
    }
   ],
   "source": [
    "print('nombre de ligne avec keywords non vide : ' + str(df_metadata.keywords.notna().sum()))\n",
    "print('nombre de ligne avec major_mesh_terms non vide : ' + str(df_metadata.major_mesh_terms.notna().sum()))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Le fichier 'df_metadata' existe dj. Aucune action effectue.\n"
     ]
    }
   ],
   "source": [
    "file = \"df_metadata\"\n",
    "path = f'data/{file}'\n",
    "\n",
    "if not os.path.exists(path):\n",
    "    df_metadata.to_parquet(path)\n",
    "else:\n",
    "    print(\"Le fichier 'df_metadata' existe dj. Aucune action effectue.\")\n"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "base",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.12.7"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
